Authors,Title,Year,Source title,Volume,Issue,Art. No.,Page start,Page end,Page count,Cited by,DOI,Link,Affiliations,Authors with affiliations,Abstract,Author Keywords,References,Document Type,Source,EID
"Yue J., Wu J., Liu D., Zhao X., Lu W.W.","BMP2 gene delivery to bone mesenchymal stem cell by chitosan-g-PEI nonviral vector",2015,"Nanoscale Research Letters","10","1",,"","",11,,10.1186/s11671-015-0906-3,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928905701&partnerID=40&md5=5c494ed0a39b6989a2efc796c87d070c","Center for Human Tissues and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Rd.Shenzhen, China; Department of Orthopaedic and Traumatology, The University of Hong Kong, 21 Sassoon Rd., PokfulamHong Kong, China; Department of Pharmacology, Harbin Medical University, 157 Baojian Rd.Harbin, China; Shenzhen Key Laboratory of Marine Biomedical Materials, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Rd.Shenzhen, China","Yue, J., Center for Human Tissues and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Rd.Shenzhen, China, Shenzhen Key Laboratory of Marine Biomedical Materials, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Rd.Shenzhen, China; Wu, J., Department of Orthopaedic and Traumatology, The University of Hong Kong, 21 Sassoon Rd., PokfulamHong Kong, China; Liu, D., Center for Human Tissues and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Rd.Shenzhen, China, Department of Pharmacology, Harbin Medical University, 157 Baojian Rd.Harbin, China; Zhao, X., Center for Human Tissues and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Rd.Shenzhen, China, Shenzhen Key Laboratory of Marine Biomedical Materials, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Rd.Shenzhen, China; Lu, W.W., Department of Orthopaedic and Traumatology, The University of Hong Kong, 21 Sassoon Rd., PokfulamHong Kong, China","Nanotechnology has made a significant impact on the development of nanomedicine. Nonviral vectors have been attracting more attention for the advantage of biosafety in gene delivery. Polyethylenimine (PEI)-conjugated chitosan (chitosan-g-PEI) emerged as a promising nonviral vector and has been demonstrated in many tumor cells. However, there is a lack of study focused on the behavior of this vector in stem cells which hold great potential in regenerative medicine. Therefore, in this study, in vitro gene delivering effect of chitosan-g-PEI was investigated in bone marrow stem cells. pIRES2-ZsGreen1-hBMP2 dual expression plasmid containing both the ZsGreen1 GFP reporter gene and the BMP2 functional gene was constructed for monitoring the transgene expression level. Chitosan-g-PEI-mediated gene transfer showed 17.2% of transfection efficiency and more than 80% of cell viability in stem cells. These values were higher than that of PEI. The expression of the delivered BMP2 gene in stem cells enhanced the osteogenic differentiation. These results demonstrated that chitosan-g-PEI is capable of applying in delivering gene to stem cells and providing potential applications in stem cell-based gene therapy. © 2015, Yue et al.; licensee Springer.","Chitosan; Gene delivery; Osteogenic differentiation; Polyethylenimine; Stem cell","Lo, K.W., Ulery, B.D., Ashe, K.M., Laurencin, C.T., Studies of bone morphogenetic protein-based surgical repair (2012) Adv Drug Deliv Rev, 64 (12), pp. 1277-1291; Shi, J.J., Votruba, A.R., Farokhzad, O.C., Langer, R., Nanotechnology in drug delivery and tissue engineering: from discovery to applications (2010) Nano Lett, 10 (9), pp. 3223-3230; Tannoury, C.A., An, H.S., Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery (2014) Spine J, 14 (3), pp. 552-559; Ronga, M., Fagetti, A., Canton, G., Paiusco, E., Surace, M.F., Cherubino, P., Clinical applications of growth factors in bone injuries: experience with BMPs (2013) Injury, 44, pp. S34-S39; Evans, C.H., Ghivizzani, S.C., Robbins, P.D., Progress and prospects: genetic treatments for disorders of bones and joints (2009) Gene Ther, 16 (8), pp. 944-952; Kimelman Bleich, N., Kallai, I., Lieberman, J.R., Schwarz, E.M., Pelled, G., Gazit, D., Gene therapy approaches to regenerating bone (2012) Adv Drug Deliv Rev, 64 (12), pp. 1320-1330; Ginn, S.L., Alexander, I.E., Edelstein, M.L., Abedi, M.R., Wixon, J., Gene therapy clinical trials worldwide to 2012 - an update (2013) J Gene Med, 15 (2), pp. 65-77; Hackett, P.B., Largaespada, D.A., Switzer, K.C., Cooper, L.J., Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy (2013) Transl Res, 161 (4), pp. 265-283; Elsabahy, M., Nazarali, A., Foldvari, M., Non-viral nucleic acid delivery: key challenges and future directions (2011) Curr Drug Deliv, 8 (3), pp. 235-244; Lam, A.P., Dean, D.A., Progress and prospects: nuclear import of nonviral vectors (2010) Gene Ther, 17 (4), pp. 439-447; Kawai, M., Bessho, K., Kaihara, S., Sonobe, J., Oda, K., Iizuka, T., Ectopic bone formation by human bone morphogenetic protein-2 gene transfer to skeletal muscle using transcutaneous electroporation (2003) Hum Gene Ther, 14 (16), pp. 1547-1556; Kirtane, A.R., Panyam, J., Polymer nanoparticles weighing up gene delivery (2013) Nat Nanotechnol, 8 (11), pp. 805-806; Saranya, N., Moorthi, A., Saravanan, S., Devi, M.P., Selvamurugan, N., Chitosan and its derivatives for gene delivery (2011) Int J Biol Macromol, 48 (2), pp. 234-238; Patnaik, S., Gupta, K.C., Novel polyethylenimine-derived nanoparticles for in vivo gene delivery (2013) Expert Opin Drug Del, 10 (2), pp. 215-228; Yamano, S., Dai, J., Hanatani, S., Haku, K., Yamanaka, T., Ishioka, M., Long-term efficient gene delivery using polyethylenimine with modified Tat peptide (2014) Biomaterials, 35 (5), pp. 1705-1715; Moghimi, S.M., Symonds, P., Murray, J.C., Hunter, A.C., Debska, G., Szewczyk, A., A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy (2005) Mol Ther, 1 (6), pp. 990-995; Yu, Y.Y., Wang, Z., Cai, L., Wang, G., Yang, X., Wan, X.P., Synthesis and characterization of methoxy poly(ethylene glycol)-O-chitosan-polyethylenimine for gene delivery (2010) Carbohydr Polym, 81 (2), pp. 269-274; Peng, Y.S., Lai, P.L., Peng, S., Wu, H.C., Yu, S., Tseng, T.Y., Glial cell line-derived neurotrophic factor gene delivery via a polyethylene imine grafted chitosan carrier (2014) Int J Nanomed, 9, pp. 3163-3174; Ping, Y., Liu, C., Zhang, Z., Liu, K.L., Chen, J., Li, J., Chitosan-graft-(PEI-beta-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery (2011) Biomaterials, 32 (32), pp. 8328-8341; Jiang, H.L., Kwon, J.T., Kim, E.M., Kim, Y.K., Arote, R., Jere, D., Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting (2008) J Control Release, 131 (2), pp. 150-157; Jiang, H.L., Xu, C.X., Kim, Y.K., Arote, R., Jere, D., Lim, H.-T., The suppression of lung tumorigenesis by aerosol-delivered folate–chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway (2009) Biomaterials, 30 (29), pp. 5844-5852; Jiang, H.L., Kim, Y.K., Arote, R., Jere, D., Quan, J.S., Yu, J.-H., Mannosylated chitosan-graft-polyethylenimine as a gene carrier for Raw 264.7 cell targeting (2009) Int J Pharm, 375 (1-2), pp. 133-139; Jiang, H.L., Kwon, J.T., Kim, Y.K., Kim, E.M., Arote, R., Jeong, H.J., Galactosylated chitosan-graft-polyethylenimine as a gene carrier for hepatocyte targeting (2007) Gene Ther, 14 (19), pp. 1389-1398; Jia, L.J., Li, Z.Y., Zhang, D.R., Zhang, Q., Shen, J.Y., Guo, H.J., Redox-responsive catiomer based on PEG-ss-chitosan oligosaccharide-ss-polyethylenimine copolymer for effective gene delivery (2013) Polym Chem Uk, 4 (1), pp. 156-165; Liu, C.C., Zhu, Q., Wu, W.H., Xu, X.L., Wang, X.Y., Gao, S., Degradable copolymer based on amphiphilic N-octyl-N-quatenary chitosan and low-molecular weight polyethylenimine for gene delivery (2012) Int J Nanomed, 7, pp. 5339-5350; Lu, B., Xu, X.D., Zhang, X.Z., Cheng, S.X., Zhuo, R.X., Low molecular weight polyethylenimine grafted N-maleated chitosan for gene delivery: properties and in vitro transfection studies (2008) Biomacromolecules, 9 (10), pp. 2594-2600; Tripathi, S.K., Goyal, R., Kumar, P., Gupta, K.C., Linear polyethylenimine-graft-chitosan copolymers as efficient DNA/siRNA delivery vectors in vitro and in vivo (2012) Nanomedicine, 8 (3), pp. 337-345; Jere, D., Jiang, H.-L., Kim, Y.K., Arote, R., Choi, Y.-J., Yun, C.-H., Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells (2009) Int J Pharm, 378 (1-2), pp. 194-200; Huh, M.S., Lee, S.Y., Park, S., Lee, S., Chung, H., Lee, S., Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice (2010) J Control Release, 144 (2), pp. 134-143; Gao, J.Q., Zhao, Q.Q., Lv, T.F., Shuai, W.P., Zhou, J., Tang, G.P., Gene-carried chitosan-linked-PEI induced high gene transfection efficiency with low toxicity and significant tumor-suppressive activity (2010) Int J Pharm, 387 (1-2), pp. 286-294; Hu, F.Q., Chen, W.W., Zhao, M.D., Yuan, H., Du, Y.Z., Effective antitumor gene therapy delivered by polyethylenimine-conjugated stearic acid-g-chitosan oligosaccharide micelles (2013) Gene Ther, 20 (6), pp. 597-606; Lu, H.D., Dai, Y.H., Lv, L.L., (2014) Zhao HQ, , Chitosan-graft-polyethylenimine/DNA nanoparticles as novel non-viral gene delivery vectors targeting osteoarthritis, PLoS One:; Zhao, X.L., Li, Z.Y., Pan, H.B., Liu, W.G., Lv, M.M., Leung, F., Enhanced gene delivery by chitosan-disulfide-conjugated LMW-PEI for facilitating osteogenic differentiation (2013) Acta Biomater, 9 (5), pp. 6694-6703; Yang, H.Y., Vonk, L.A., Licht, R., van Boxtel, A.M.G., Bekkers, J.E.J., Kragten, A.H.M., Cell type and transfection reagent-dependent effects on viability, cell content, cell cycle and inflammation of RNAi in human primary mesenchymal cells (2014) Eur J Pharm Sci, 53, pp. 35-44; Holladay, C., Keeney, M., Greiser, U., Murphy, M., O’Brien, T., Pandit, A., A matrix reservoir for improved control of non-viral gene delivery (2009) J Control Release, 136 (3), pp. 220-225; Park, J., Ries, J., Gelse, K., Kloss, F., von der Mark, K., Wiltfang, J., Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes (2003) Gene Ther, 10 (13), pp. 1089-1098; Lu, K., Zeng, D., Zhang, Y., Xia, L., Xu, L., Kaplan, D.L., BMP-2 gene modified canine bMSCs promote ectopic bone formation mediated by a nonviral PEI derivative (2011) Ann Biomed Eng, 39 (6), pp. 1829-1839; Zhu, H., Guo, Z.K., Jiang, X.X., Li, H., Wang, X.Y., Yao, H.Y., A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone (2010) Nat Protoc, 5 (3), pp. 550-560; Ohyama, M., Okano, H., Promise of human induced pluripotent stem cells in skin regeneration and investigation (2014) J Invest Dermatol, 134 (3), pp. 605-609; Hamm, A., Krott, N., Breibach, I., Blindt, R., Bosserhoff, A.K., Efficient transfection method for primary cells (2002) Tissue Eng, 8 (2), pp. 235-245; Abdallah, B., Hassan, A., Benoist, C., Goula, D., Behr, J.P., Demeneix, B.A., A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine (1996) Hum Gene Ther, 7 (16), pp. 1947-1954; Lowery, J.W., de Caestecker, M.P., BMP signaling in vascular development and disease (2010) Cytokine Growth Factor Rev, 21 (4), pp. 287-298; Rosen, V., BMP2 signaling in bone development and repair (2009) Cytokine Growth Factor Rev, 20 (5-6), pp. 475-480; Sieber, C., Kopf, J., Hiepen, C., Knaus, P., Recent advances in BMP receptor signaling (2009) Cytokine Growth Factor Rev, 20 (5-6), pp. 343-355; Lee, K.S., Hong, S.H., Bae, S.C., Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein (2002) Oncogene, 21 (47), pp. 7156-7163; Kumar, S., Wan, C., Ramaswamy, G., Clemens, T.L., Ponnazhagan, S., Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect (2010) Mol Ther, 18 (5), pp. 1026-1034; Granero-Moltó, F., Weis, J.A., Miga, M.I., Landis, B., Myers, T.J., O’Rear, L., Regenerative effects of transplanted mesenchymal stem cells in fracture healing (2009) Stem Cells, 27 (8), pp. 1887-1898; Kumar, S., Nagy, T.R., Ponnazhagan, S., Therapeutic potential of genetically modified adult stem cells for osteopenia (2010) Gene Ther, 17 (1), pp. 105-116; Hanada, K., Dennis, J.E., Caplan, A.I., Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells (1997) J Bone Miner Res, 12 (10), pp. 1606-1614; Evans, C., Gene therapy for the regeneration of bone (2011) Injury, 42 (6), pp. 599-604; Jane, J.A., Dunford, B.A., Kron, A., Pittman, D.D., Sasaki, T., Li, J.Z., Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer (2002) Mol Ther, 6 (4), pp. 464-470; Gafni, Y., Pelled, G., Zilberman, Y., Turgeman, G., Apparailly, F., Yotvat, H., Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system (2004) Mol Ther, 9 (4), pp. 587-595; Chen, Y., Luk, K.D.K., Cheung, K.M.C., Xu, R., Lin, M.C., Lu, W.W., Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors (2003) Gene Ther, 10 (16), pp. 1345-1353; Huang, Y.C., Simmons, C., Kaigler, D., Rice, K.G., Mooney, D.J., Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4) (2005) Gene Ther, 12 (5), pp. 418-426; Aslan, H., Zilberman, Y., Arbeli, V., Sheyn, D., Matan, Y., Liebergall, M., Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration (2006) Tissue Eng, 12 (4), pp. 877-889",Article,Scopus,2-s2.0-84928905701
"Alashi A.M., Blanchard C.L., Mailer R.J., Agboola S.O., Mawson A.J., Aluko R.E., Strappe P.","Effects of canola proteins and hydrolysates on adipogenic differentiation of C3H10T/2 mesenchymal stem cells",2015,"Food Chemistry","185",, 17301,"226","232",,,10.1016/j.foodchem.2015.03.054,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927665733&partnerID=40&md5=4a3c8db50cbf247718b54abdbd64692b","Graham Centre for Agricultural Innovation, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia; School of Agricultural and Wine Sciences, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia; School of Biomedical Sciences, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia; Department of Human Nutritional Sciences, Richardson Centre for Functional Foods and Nutraceuticals, University of ManitobaWinnipeg, Canada","Alashi, A.M., Graham Centre for Agricultural Innovation, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia, School of Agricultural and Wine Sciences, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia; Blanchard, C.L., Graham Centre for Agricultural Innovation, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia, School of Biomedical Sciences, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia; Mailer, R.J., Graham Centre for Agricultural Innovation, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia; Agboola, S.O., Graham Centre for Agricultural Innovation, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia, School of Agricultural and Wine Sciences, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia; Mawson, A.J., Graham Centre for Agricultural Innovation, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia, School of Agricultural and Wine Sciences, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia; Aluko, R.E., Department of Human Nutritional Sciences, Richardson Centre for Functional Foods and Nutraceuticals, University of ManitobaWinnipeg, Canada; Strappe, P., Graham Centre for Agricultural Innovation, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia, School of Biomedical Sciences, Charles Sturt University, Locked Bag 588Wagga Wagga, NSW, Australia","Abstract This study assessed the ability of canola protein isolate (CPI) and enzymatic hydrolysates (CPHs) to inhibit adipogenic differentiation of C3H10T1/2 murine mesenchymal stem cells in vitro. Cell viability was maintained at concentrations of 60 μg/ml of sample. Cells treated with Alcalase hydrolysate demonstrated a higher reduction in anti-adipogenic differentiation through quantitation by oil-red O staining. qPCR analysis showed that CPI and CPH-treated cells significantly inhibited PPARγ expression, a key transcription factor involved in adipocyte differentiation, as evident in an ∼60-80% fold reduction of PPARγ mRNA. Immunofluorescence staining for PPARγ protein also showed a reduced expression in some treated cells when compared to differentiated untreated cells. The 50% inhibition concentration (IC<inf>50</inf>) of CPI, CPHs and their membrane ultrafiltration fractions on pancreatic lipase (PL) activity ranged between 0.75 and 2.5 mg/ml, (p < 0.05) for the hydrolysed and unhydrolysed samples. These findings demonstrate that CPI and CPHs contain bioactive components which can modulate in vitro adipocyte differentiation. Crown Copyright © 2015 Published by Elsevier Ltd. All rights reserved.","Adipocyte differentiation; C3H10T1/2 mesenchymal stem cells; Canola protein; Pancreatic lipase; PPAR gamma; Protein hydrolysates","Akoh, C.C., Lipid based fat substitutes (1995) Critical Reviews in Food Science and Nutrition, 35, pp. 405-430; Alashi, A.M., Blanchard, C.L., Mailer, R.J., Agboola, S.O., Mawson, A.J., He, R., Blood pressure lowering effects of Australian canola protein hydrolysates in spontaneously hypertensive rats (2014) Food Research International, 55, pp. 281-287; Alashi, A.M., Blanchard, C.L., Mailer, R.J., Agboola, S.O., Mawson, A.J., He, R., Antioxidant properties of Australian canola meal protein hydrolysates (2014) Food Chemistry, 146, pp. 500-506; Ballinger, A., Peikin, S.R., Orlistat: Its current status as an anti-obesity drug (2002) European Journal of Pharmacology, 440, pp. 109-117; Chaput, J.P., St-Pierre, S., Tremblay, A., Currently available drugs for the treatment of obesity: Sibutramine and Orlistat (2007) Mini Reviews in Medicinal Chemistry, 7, pp. 3-10; Cumby, N., Zhong, Y., Naczk, M., Shahidi, F., Antioxidant activity and water-holding capacity of canola protein hydrolysates (2008) Food Chemistry, 109, pp. 144-148; De Simone, G., D'Addeo, G., Sibutramine: Balancing weight loss benefit and possible cardiovascular risk (2008) Nutrition, Metabolism and Cardiovascular Diseases, 18, pp. 337-341; Hasani-Ranjbar, S., Jouyandeh, Z., Abdollahi, M., A systematic review of anti-obesity medicinal plants - an update (2013) Journal of Diabetes and Metabolic Disorders, 12, p. 28; Huang, H., Song, T.-J., Li, X., Hu, L., He, Q., Liu, M., BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage (2009) Proceedings of the National Academy of Sciences USA, 106, pp. 12670-12675; Hwang, J.-H., Moon, S.A., Lee, C.H., Byun, M.R., Kim, A.R., Sung, M.K., Idesolide inhibits the adipogenic differentiation of mesenchymal cells through the suppression of nitric oxide production (2012) European Journal of Pharmacology, 685, pp. 218-223; Karamadouskis, L., Shivashankar, G.H., Ludeman, L., Williams, A.J., An unusual complication of treatment with Orlistat (2009) Clinical Nephrology, 71, pp. 430-432; Kim, D.M., Choi, H.-R., Park, A., Shin, S.-M., Bae, K.-H., Lee, S.C., Retinoic acid inhibits adipogenesis via activation of Wnt signaling pathway in 3T3-L1 preadipocytes (2013) Biochemical and Biophysical Research Communications, 434, pp. 455-459; Kim, H.-K., Kim, J.N., Han, S.N., Nam, J.-H., Na, H.-N., Ha, T.J., Black soybean anthocyanins inhibit adipocyte differentiation in 3T3-L1 cells (2012) Nutrition Research, 32, pp. 770-777; Kopleman, P.G., Obesity as a medical problem (2000) Nature, 404, pp. 635-643; Kowalska, K., Olejnik, A., Rychlik, J., Grajek, W., Cranberries (Oxycoccus quadripetalus) inhibit adipogenesis and lipogenesis in 3T3-L1 cells (2014) Food Chemistry, 148, pp. 246-252; Lean, M.E., How does sibutramine work? (2001) International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity, 25, p. S8; Lee, M., Song, J.Y., Chin, Y.-W., Sung, S.H., Anti-adipogenic diarylheptanoids from Alnus hirsuta F. sibirica on 3T3-L1 cells (2013) Bioorganic & Medicinal Chemistry letters, 23, pp. 2069-2073; Liu, Y., Zhang, Z.C., Qian, S.W., Zhang, Y.Y., Huang, H.Y., Tang, Y., MicroRNA-140 Promotes Adipocyte lineage commitment of C3H10T1/2 pluripotent stem cells via targeting osteopetrosis-associated transmembrane protein (2013) Journal of Biological Chemistry, 288, pp. 8222-8230; Lowe, C.E., O'rahilly, S., Rochford, J.J., Adipogenesis at a glance (2011) Journal of Cell Science, 124, p. 3726; Markwell, M.A.K., Haas, S.M., Bieber, L.L., Tolbert, N.E., A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples (1978) Analytical Biochemistry, 87, pp. 206-210; Molan, A.L., Lila, M.A., Mawson, J., Satiety in rats following blueberry extract consumption induced by appetite-suppressing mechanisms unrelated to in vitro or in vivo antioxidant capacity (2008) Food Chemistry, 107, pp. 1039-1044; Moon, J., Do, H.-J., Kim, O.Y., Shin, M.-J., Antiobesity effects of quercetin-rich onion peel extract on the differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats (2013) Food and Chemical Toxicology, 58, pp. 347-354; Moreno, D.A., Ilic, N., Poulev, A., Brasaemle, D.L., Fried, S.K., Raskin, I., Inhibitory effects of grape seed extract on lipases (2003) Nutrition, 19, pp. 876-879; Moriyama, T., Kishimoto, K., Nagai, K., Urade, R., Ogawa, T., Utsumi, S., Soybean & beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of & beta;-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption (2004) Bioscience, Biotechnology, and Biochemistry, 68, pp. 352-359; Nakai, M., Fukui, Y., Asami, S., Toyoda-Ono, Y., Iwashita, T., Shibata, H., Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro (2005) Journal of Agricultural and Food Chemistry, 53, pp. 4593-4598; Rayalam, S., Della-Fera, M.A., Baile, C.A., Phytochemicals and regulation of the adipocyte life cycle (2008) The Journal of Nutritional Biochemistry, 19, pp. 717-726; Reznikoff, C.A., Brankow, D.W., Heidelberger, C., Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division (1973) Cancer research, 33, pp. 3231-3238; Rodgers, R.J., Tschöp, M.H., Wilding, J.P.H., Anti-obesity drugs: past, present and future (2012) Disease Models & Mechanisms, 5, pp. 621-626; Rosen, E.D., MacDougald, O.A., Adipocyte differentiation from the inside out (2006) Nature Reviews: Molecular Cell Biology, 7, pp. 885-896; Rosen, E.D., Sarraf, P., Troy, A.E., Bradwin, G., Moore, K., Milstone, D.S., PPARγ is required for the differentiation of adipose tissue in vivo and in vitro (1999) Molecular Cell, 4, pp. 611-617; Rudkowska, I., Roynette, C.E., Demonty, I., Vanstone, C.A., Jew, S., Jones, P.J.H., Diacylglycerol: Efficacy and mechanism of action of an anti-obesity agent (2005) Obesity Research, 13, pp. 1864-1867; Rupérez, A.I., Gil, A., Aguilera, C.M., Genetics of oxidative stress in obesity (2014) International Journal of Molecular Sciences, 15, pp. 3118-3144; Siersbæk, R., Nielsen, R., Mandrup, S., PPARγ in adipocyte differentiation and metabolism - Novel insights from genome-wide studies (2010) FEBS Letters, 584, pp. 3242-3249; Singh, R., Artaza, J.N., Taylor, W.E., Gonzalez-Cadavid, N.F., Bhasin, S., Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway (2003) Endocrinology, 144, pp. 5081-5088; Trigueros, L., Peña, S., Ugidos, A.V., Sayas-Barberá, E., Pérez-Álvarez, J.A., Sendra, E., Food ingredients as anti-obesity agents: a review (2013) Critical Reviews in Food Science and Nutrition, 53, pp. 929-942; Tsujita, T., Takaichi, H., Takaku, T., Aoyama, S., Hiraki, J., Antiobesity action of ε-polylysine, a potent inhibitor of pancreatic lipase (2006) Journal of Lipid Research, 47, pp. 1852-1858; Tziomalos, K., Krassas, K., Tzotzas, T., The use of sibutramine in the management of obesity and other related disorders (2009) Vascular Health and Risk Management, 5, pp. 441-452; WHO, (2009) Obesity and overweight, , http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/; Wu, J., Aluko, R.E., Muir, A.D., Purification of angiotensin I-converting enzyme-inhibitory peptides from the enzymatic hydrolysate of defatted canola meal (2008) Food Chemistry, 111, pp. 942-950; Yun, J.W., Possible anti-obesity therapeutics from nature: A review (2010) Phytochemistry, 71, pp. 1625-1641; Zhang, X.-Z., Wang, H.-Y., Fu, X.-Q., Wu, X.-X., Xu, G.-L., Bioactive small peptides from soybean protein (1998) Annals of the New York Academy of Sciences, 864, pp. 640-645",Article,Scopus,2-s2.0-84927665733
"Ammakkanavar N.R., Matei D., Abonour R., Einhorn L.H.","High-Dose Chemotherapy for Recurrent Ovarian Germ Cell Tumors",2015,"Journal of Clinical Oncology","33","2",,"226","227",,,10.1200/JCO.2014.59.4325,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920973668&partnerID=40&md5=f1ea8ec6c5ca315cf52dd76ee0faa2ed","Indiana University School of MedicineIndianapolis, IN, United States; Indiana University Simon Cancer CenterIndianapolis, IN, United States","Ammakkanavar, N.R., Indiana University School of MedicineIndianapolis, IN, United States, Indiana University Simon Cancer CenterIndianapolis, IN, United States; Matei, D., Indiana University School of MedicineIndianapolis, IN, United States, Indiana University Simon Cancer CenterIndianapolis, IN, United States; Abonour, R., Indiana University School of MedicineIndianapolis, IN, United States, Indiana University Simon Cancer CenterIndianapolis, IN, United States; Einhorn, L.H., Indiana University School of MedicineIndianapolis, IN, United States, Indiana University Simon Cancer CenterIndianapolis, IN, United States",[No abstract available],,"Einhorn, L.H., Williams, S.D., Chamness, A., High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors (2007) N Engl J Med, 357, pp. 340-348; Tewari, K., Cappuccini, F., Disaia, P.J., Malignant germ cell tumors of the ovary (2000) Obstet Gynecol, 95, pp. 128-133; Matei, D.E., Schilder, J.M., Michael, H., (2012) Germ Cell Tumors of the Ovary, Textbook of Uncommon Cancer, pp. 519-530. , New York, NY, John Wiley & Sons; Gershenson, D.M., Management of ovarian germ cell tumors (2007) J Clin Oncol, 25, pp. 2938-2943; Messing, M.J., Gershenson, D.M., Morris, M., Primary treatment failure in patients with malignant ovarian germ cell neoplasms (1992) Int J Gynecol Cancer, 2, pp. 295-300; Murugaesu, N., Schmid, P., Dancey, G., Malignant ovarian germ cell tumors: Identification of novel prognostic markers and long-term outcome after multimodality treatment (2006) J Clin Oncol, 24, pp. 4862-4866; Nawa, A., Obata, N., Kikkawa, F., Prognostic factors of patients with yolk sac tumors of the ovary (2001) Am J Obstet Gynecol, 184, pp. 1182-1188; Loehrer, P.J., Sr., Gonin, R., Nichols, C.R., Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor (1998) J Clin Oncol, 16, pp. 2500-2504; Kondagunta, G.V., Bacik, J., Donadio, A., Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors (2005) J Clin Oncol, 23, pp. 6549-6555; Lorch, A., Bascoul-Mollevi, C., Kramar, A., Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: Evidence from a large international database (2011) J Clin Oncol, 29, pp. 2178-2184",Letter,Scopus,2-s2.0-84920973668
"Sledge G.W.","Anti-vascular endothelial growth factor therapy in breast cancer: Game over?",2015,"Journal of Clinical Oncology","33","2",,"133","135",,,10.1200/JCO.2014.58.1298,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920933145&partnerID=40&md5=f374f82aaffa059ee0ca9d96fa77b318","Stanford University School of MedicinePalo Alto, CA, United States","Sledge, G.W., Stanford University School of MedicinePalo Alto, CA, United States",[No abstract available],,"Mackey, J.R., Ramos-Vazquez, M., Lipatov, O., Primary results of ROSE/TRIO-12, a randomized, placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer (2015) J Clin Oncol, 33, pp. 141-148; Miller, K., Wang, M., Gralow, J., Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer (2007) N Engl J Med, 357, pp. 2666-2676; Miles, D.W., Chan, A., Dirix, L.Y., Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer (2010) J Clin Oncol, 28, pp. 3239-3247; Robert, N.J., Dieras, V., Glaspy, J., RIBBON-1: Tandomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer (2011) J Clin Oncol, 29, pp. 1252-1260; Sledge, G.W., Jr., VEGF-targeting therapy for breast cancer (2005) J Mammary Gland Biol Neoplasia, 10, pp. 319-323; Sledge, G.W., Jr., Miller, K.D., Angiogenesis and antiangiogenic therapy (2002) Curr Probl Cancer, 26, pp. 1-60; Sweeney, C.J., Miller, K.D., Sissons, S.E., The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors (2001) Cancer Res, 61, pp. 3369-3372; Lau, D.H., Xue, L., Young, L.J., Paclitaxel (Taxol): An inhibitor of angiogenesis in a highly vascularized transgenic breast cancer (1999) Cancer Biother Radiopharm, 14, pp. 31-36; Miles, D.W., Diéras, V., Cortés, J., First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: Pooled and subgroup analyses of data from 2447 patients (2013) Ann Oncol, 24, pp. 2773-2780; Miller, K., O'Neill, A., Dang, C., Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103 (2014) J Clin Oncol, 32 (5); Slamon, D., Swain, S., Buyse, M., (2013) Primary Results from BETH, a Phase 3 Controlled Study of Adjuvant Chemotherapy and Trastuzumab Bevacizumab in Patients with HER2-positive, Node-positive or High Risk Node-negative Breast Cancer, pp. S1-03. , San Antonio Breast Cancer Symposium, San Antonio, TX, December 10-14; Cameron, D., Brown, J., Dent, R., Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): Primary results of a randomised, phase 3 trial (2013) Lancet Oncol, 14, pp. 933-942; Robert, N.J., Saleh, M.N., Paul, D., Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: A phase III, randomized, open-label trial (2011) Clin Breast Cancer, 11, pp. 82-92; Bergh, J., Bondarenko, I.M., Lichinitser, M.R., First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Tesults of a prospective, randomized phase III study (2012) J Clin Oncol, 30, pp. 921-929; Crown, J.P., Diéras, V., Staroslawska, E., Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer (2013) J Clin Oncol, 31, pp. 2870-2878; Barrios, C.H., Liu, M.C., Lee, S.C., Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer (2010) Breast Cancer Res Treat, 121, pp. 121-131; Fuchs, C.S., Tomasek, J., Yong, C.J., Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): An international, randomised, multicentre, placebo-controlled, phase 3 trial (2014) Lancet, 383, pp. 31-39; Schneider, B.P., Sledge, G.W., Jr., Anti-vascular endothelial growth factor therapy for breast cancer: Can we pick the winners? (2011) J Clin Oncol, 29, pp. 2444-2447; Schneider, B.P., Wang, M., Radovich, M., Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100 (2008) J Clin Oncol, 26, pp. 4672-4678; Maru, D., Venook, A.P., Ellis, L.M., Predictive biomarkers for bevacizumab: Are we there yet? (2013) Clin Cancer Res, 19, pp. 2824-2827; De Haas, S., Delmar, P., Bansal, A.T., Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy (2014) Angiogenesis, , epub ahead of print on July 11; Giuliano, S., Pagès, G., Mechanisms of resistance to anti-angiogenesis therapies (2013) Biochimie, 95, pp. 1110-1119; Kerbel, R.S., A cancer therapy resistant to resistance (1997) Nature, 390, pp. 335-336; Allegra, C.J., Yothers, G., O'Connell, M.J., Bevacizumab in stage II-III colon cancer: 5-year update of the National Surgical Adjuvant Breast and Bowel Project C-08 trial (2013) J Clin Oncol, 31, pp. 359-364; Bruix, J., Takayama, T., Mazzaferro, V., STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC) (2014) J Clin Oncol, 32, p. 256s; Voron, T., Marcheteau, E., Pernot, S., Control of the immune response by pro-angiogenic factors (2014) Front Oncol, 4, p. 70; Osada, T., Chong, G., Tansik, R., The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients (2008) Cancer Immunol Immunother, 57, pp. 1115-1124; Jin, Y., Chauhan, S.K., El, A.J., A novel function for programmed death ligand-1 regulation of angiogenesis (2011) Am J Pathol, 178, pp. 1922-1929; Combination with Avastin (Bevacizumab) And/or with Chemotherapy in Patients with Locally Advanced or Metastatic Solid Tumors, , http://clinicaltrials.gov/show/NCT01633970, gov: A Phase 1b Study of MPDL3280A (an Engineered Anti-PDL1 Antibody)",Editorial,Scopus,2-s2.0-84920933145
"Lok C.","Curing blindness: Vision quest",2014,"Nature","513","7517",,"160","162",,1,10.1038/513160a,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84907259370&partnerID=40&md5=7235bb374c52cf834fffe7bb93e5c90d",,"Lok, C.",[No abstract available],,"Maguire, A.M., (2009) Lancet, 374, pp. 1597-1605; Maguire, A.M., (2008) N. Engl. J. Med., 358, pp. 2240-2248; Bainbridge, J.W.B., (2008) N. Engl. J. Med., 358, pp. 2231-2239; Hauswirth, W.W., (2008) Hum. Gene Ther., 19, pp. 979-990; Cideciyan, A.V., (2013) Proc. Natl Acad. Sci. USA, 110, pp. E517-E525; Cepko, C.L., Vandenberghe, L.H., (2013) Hum. Gene Ther., 24, pp. 242-244; MacLaren, R.E., (2014) Lancet, 383, pp. 1129-1137; Pearson, R.A., (2012) Nature, 485, pp. 99-103; Gonzalez-Cordero, A., (2013) Nature Biotechnol., 31, pp. 741-747; Hubel, D.H., Wiesel, T.N., (1964) Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol., 248, pp. 492-497; Sinha, P., Held, R., (2012) F1000 Med. Rep, 4, p. 17; Ashtari, M., (2011) J. Clin. Invest., 121, pp. 2160-2168",Short Survey,Scopus,2-s2.0-84907259370
"Fonseca-Pereira D., Arroz-Madeira S., Rodrigues-Campos M., Barbosa I.A.M., Domingues R.G., Bento T., Almeida A.R.M., Ribeiro H., Potocnik A.J., Enomoto H., Veiga-Fernandes H.","The neurotrophic factor receptor RET drives haematopoietic stem cell survival and function",2014,"Nature","514","7520",,"98","101",,2,10.1038/nature13498,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84908019053&partnerID=40&md5=1364bf79d5439c84687fa16ed17c061e","Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Avenida Professor Egas Moniz, Edifício Egas MonizLisboa, Portugal; Division of Molecular Immunology, MRC National Institute for Medical Research, The Ridgeway, Mill HillLondon, United Kingdom; Institute of Immunology and Infection Research, University of Edinburgh, West Mains RoadEdinburgh, United Kingdom; Laboratory for Neuronal Differentiation and Regeneration, RIKEN Center for Developmental BiologyKobe, Japan; Graduate School of Medicine, Kobe University, 7-5-1 Kusunoki-choChuo-ku, Kobe City, Hyogo, Japan","Fonseca-Pereira, D., Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Avenida Professor Egas Moniz, Edifício Egas MonizLisboa, Portugal; Arroz-Madeira, S., Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Avenida Professor Egas Moniz, Edifício Egas MonizLisboa, Portugal; Rodrigues-Campos, M., Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Avenida Professor Egas Moniz, Edifício Egas MonizLisboa, Portugal; Barbosa, I.A.M., Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Avenida Professor Egas Moniz, Edifício Egas MonizLisboa, Portugal; Domingues, R.G., Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Avenida Professor Egas Moniz, Edifício Egas MonizLisboa, Portugal; Bento, T., Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Avenida Professor Egas Moniz, Edifício Egas MonizLisboa, Portugal; Almeida, A.R.M., Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Avenida Professor Egas Moniz, Edifício Egas MonizLisboa, Portugal; Ribeiro, H., Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Avenida Professor Egas Moniz, Edifício Egas MonizLisboa, Portugal; Potocnik, A.J., Division of Molecular Immunology, MRC National Institute for Medical Research, The Ridgeway, Mill HillLondon, United Kingdom, Institute of Immunology and Infection Research, University of Edinburgh, West Mains RoadEdinburgh, United Kingdom; Enomoto, H., Laboratory for Neuronal Differentiation and Regeneration, RIKEN Center for Developmental BiologyKobe, Japan, Graduate School of Medicine, Kobe University, 7-5-1 Kusunoki-choChuo-ku, Kobe City, Hyogo, Japan; Veiga-Fernandes, H., Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Avenida Professor Egas Moniz, Edifício Egas MonizLisboa, Portugal","Haematopoiesis is a developmental cascade that generates all blood cell lineages in health and disease. This process relies on quiescent haematopoietic stem cells capable of differentiating, self renewing and expanding upon physiological demand. However, the mechanisms that regulate haematopoietic stem cell homeostasis and function remain largely unknown. Here we show that the neurotrophic factor receptor RET (rearranged during transfection) drives haematopoietic stem cell survival, expansion and function. We find that haematopoietic stem cells express RET and that its neurotrophic factor partners are produced in the haematopoietic stem cell environment. Ablation of Ret leads to impaired survival and reduced numbers of haematopoietic stem cells with normal differentiation potential, but loss of cell-autonomous stress response and reconstitution potential. Strikingly, RET signals provide haematopoietic stem cells with critical Bcl2 and Bcl2l1 surviving cues, downstream of p38 mitogen-activated protein (MAP) kinase and cyclic-AMP-response element binding protein (CREB) activation. Accordingly, enforced expression of RET downstream targets, Bcl2 or Bcl2l1, is sufficient to restore the activity of Ret null progenitors in vivo. Activation of RET results in improved haematopoietic stem cell survival, expansion and in vivo transplantation efficiency. Remarkably, human cord-blood progenitor expansion and transplantation is also improved by neurotrophic factors, opening the way for exploration of RET agonists in human haematopoietic stem cell transplantation. Our work shows that neurotrophic factors are novel components of the haematopoietic stem cell microenvironment, revealing that haematopoietic stem cells and neurons are regulated by similar signals. ©2014 Macmillan Publishers Limited. All rights reserved.",,"Trumpp, A., Essers, M., Wilson, A., Awakening dormant haematopoietic stem cells (2010) Nature Rev. Immunol., 10, pp. 201-209; Morrison, S.J., Scadden, D.T., The bone marrow niche for haematopoietic stem cells (2014) Nature, 505, pp. 327-334; Yamazaki, S., Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche (2011) Cell, 147, pp. 1146-1158; Mendez-Ferrer, S., Lucas, D., Battista, M., Frenette, P.S., Haematopoietic stem cell release is regulated by circadian oscillations (2008) Nature, 452, pp. 442-447; Lucas, D., Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration (2013) Nature Med., 19, pp. 695-703; Veiga-Fernandes, H., Tyrosine kinase receptor RET is a key regulator of Peyer's Patch organogenesis (2007) Nature, 446, pp. 547-551; Mulligan, L.M., RET revisited: Expanding the oncogenic portfolio (2014) Nature Rev. Cancer, 14, pp. 173-186; Almeida, A.R., RET/GFRα signals are dispensable for thymic T cell development in vivo (2012) PLoS ONE, 7, p. e52949; Kiel, M.J., Yilmaz, O.H., Iwashita, T., Terhorst, C., Morrison, S.J., SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells (2005) Cell, 121, pp. 1109-1121; Kim, I., He, S., Yilmaz, O.H., Kiel, M.J., Morrison, S.J., Enhanced purification of fetal liver hematopoietic stem cells using SLAM family receptors (2006) Blood, 108, pp. 737-744; Patel, A., Differential RET signaling pathways drive development of the enteric lymphoid and nervous systems (2012) Sci. Signal., 5, p. ra55; Winkler, I.G., Positioning of bone marrow hematopoietic and stromal cells relative to blood flow in vivo: Serially reconstituting hematopoietic stem cells reside in distinct nonperfused niches (2010) Blood, 116, pp. 375-385; Ding, L., Morrison, S.J., Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches (2013) Nature, 495, pp. 231-235; Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F., Pachnis, V., Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret (1994) Nature, 367, pp. 380-383; De Boer, J., Transgenic mice with hematopoietic and lymphoid specific expression of Cre (2003) Eur. J. Immunol., 33, pp. 314-325; McMahon, K.A., Mll has a critical role in fetal and adult hematopoietic stem cell self-renewal (2007) Cell Stem Cell, 1, pp. 338-345; Mansson, R., Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors (2007) Immunity, 26, pp. 407-419; Terskikh, A.V., Miyamoto, T., Chang, C., Diatchenko, L., Weissman, I.L., Gene expression analysis of purified hematopoietic stem cells and committed progenitors (2003) Blood, 102, pp. 94-101; Thompson, B.J., Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7 (2008) J. Exp. Med., 205, pp. 1395-1408; Perianayagam, M.C., Madias, N.E., Pereira, B.J., Jaber, B.L., CREB transcription factor modulates Bcl2 transcription in response to C5a in HL-60-derived neutrophils (2006) Eur. J. Clin. Invest., 36, pp. 353-361; Shukla, A., Activated cAMP response element binding protein is overexpressed in human mesotheliomas and inhibits apoptosis (2009) Am. J. Pathol., 175, pp. 2197-2206; Nakayama, K., Negishi, I., Kuida, K., Sawa, H., Loh, D.Y., Targeted disruption of Bcl-2αβ in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia (1994) Proc. Natl Acad. Sci. USA, 91, pp. 3700-3704; Motoyama, N., Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice (1995) Science, 267, pp. 1506-1510; Cacalano, G., GFRα1 is an essential receptor component for GDNF in the developing nervous system and kidney (1998) Neuron, 21, pp. 53-62; Nishino, J., GFR α3, a component of the artemin receptor, is required for migration and survival of the superior cervical ganglion (1999) Neuron, 23, pp. 725-736; Rossi, J., Retarded growth and deficits in the enteric and parasympathetic nervous system in mice lacking GFR α2, a functional neurturin receptor (1999) Neuron, 22, pp. 243-252; Katayama, Y., Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow (2006) Cell, 124, pp. 407-421; Mendez-Ferrer, S., Mesenchymal and haematopoietic stem cells form a unique bone marrow niche (2010) Nature, 466, pp. 829-834; Spiegel, A., Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling (2007) Nature Immunol., 8, pp. 1123-1131; Mombaerts, P., RAG-1-deficient mice have no mature B and T lymphocytes (1992) Cell, 68, pp. 869-877; Uesaka, T., Enomoto, H., Neural precursor death is central to the pathogenesis of intestinal aganglionosis in Ret hypomorphic mice (2010) J. Neurosci., 30, pp. 5211-5218; Kunisaki, Y., Arteriolar niches maintain haematopoietic stem cell quiescence (2014) Nature, 502, pp. 637-643; Van De Pavert, S.A., Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity (2014) Nature, 508, pp. 123-127; Peixoto, A., CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response (2007) J. Exp. Med., 204, pp. 1193-1205",Article,Scopus,2-s2.0-84908019053
"Gamal W., Borooah S., Smith S., Underwood I., Srsen V., Chandran S., Bagnaninchi P.O., Dhillon B.","Real-time quantitative monitoring of hiPSC-based model of macular degeneration on Electric Cell-substrate Impedance Sensing microelectrodes",2015,"Biosensors and Bioelectronics","71",,,"445","455",,,10.1016/j.bios.2015.04.079,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928744942&partnerID=40&md5=91d3ccd4d33d250c6fafc69dc0930bb1","MRC Centre for Regenerative Medicine, The University of Edinburgh, United Kingdom; Institute for Bioengineering, School of Engineering, The University of Edinburgh, United Kingdom; Institute for Integrated Micro and Nano Systems, School of Engineering, The University of Edinburgh, United Kingdom; Centre for Clinical Brain Sciences, The University of Edinburgh, United Kingdom; Euan MacDonald Centre for MND Research, The University of Edinburgh, United Kingdom; Centre for Neuroregeneration, The University of Edinburgh, United Kingdom; The Anne Rowling Regenerative Neurology Clinic, The University of Edinburgh, United Kingdom; School of Clinical Sciences, The University of Edinburgh, United Kingdom","Gamal, W., Institute for Bioengineering, School of Engineering, The University of Edinburgh, United Kingdom; Borooah, S., MRC Centre for Regenerative Medicine, The University of Edinburgh, United Kingdom, Centre for Clinical Brain Sciences, The University of Edinburgh, United Kingdom, Euan MacDonald Centre for MND Research, The University of Edinburgh, United Kingdom, Centre for Neuroregeneration, The University of Edinburgh, United Kingdom, The Anne Rowling Regenerative Neurology Clinic, The University of Edinburgh, United Kingdom; Smith, S., Institute for Bioengineering, School of Engineering, The University of Edinburgh, United Kingdom; Underwood, I., Institute for Integrated Micro and Nano Systems, School of Engineering, The University of Edinburgh, United Kingdom; Srsen, V., Institute for Bioengineering, School of Engineering, The University of Edinburgh, United Kingdom; Chandran, S., MRC Centre for Regenerative Medicine, The University of Edinburgh, United Kingdom, Centre for Clinical Brain Sciences, The University of Edinburgh, United Kingdom, Euan MacDonald Centre for MND Research, The University of Edinburgh, United Kingdom, Centre for Neuroregeneration, The University of Edinburgh, United Kingdom, The Anne Rowling Regenerative Neurology Clinic, The University of Edinburgh, United Kingdom; Bagnaninchi, P.O., MRC Centre for Regenerative Medicine, The University of Edinburgh, United Kingdom; Dhillon, B., Centre for Clinical Brain Sciences, The University of Edinburgh, United Kingdom, The Anne Rowling Regenerative Neurology Clinic, The University of Edinburgh, United Kingdom, School of Clinical Sciences, The University of Edinburgh, United Kingdom","Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. Humanized disease models are required to develop new therapies for currently incurable forms of AMD.In this work, a tissue-on-a-chip approach was developed through combining human induced pluripotent stem cells, Electric Cell-substrate Impedance Sensing (ECIS) and reproducible electrical wounding assays to model and quantitatively study AMD. Retinal Pigment Epithelium (RPE) cells generated from a patient with an inherited macular degeneration and from an unaffected sibling were used to test the model platform on which a reproducible electrical wounding assay was conducted to model RPE damage. First, a robust and reproducible real-time quantitative monitoring over a 25-day period demonstrated the establishment and maturation of RPE layers on the microelectrode arrays. A spatially controlled RPE layer damage that mimicked cell loss in AMD disease was then initiated. Post recovery, significant differences (P<0.01) in migration rates were found between case (8.6±0.46μm/h) and control cell lines (10.69±0.21μm/h). Quantitative data analysis suggested this was achieved due to lower cell-substrate adhesion in the control cell line. The ECIS cell-substrate adhesion parameter (α) was found to be 7.8±0.28Ω1/2cm for the case cell line and 6.5±0.15Ω1/2cm for the control. These findings were confirmed using cell adhesion biochemical assays. The developed disease model-on-a-chip is a powerful platform for translational studies with considerable potential to investigate novel therapies by enabling real-time, quantitative and reproducible patient-specific RPE cell repair studies. © 2015.","Disease model; Human induced pluripotent stem cells; Impedance sensing; Macular degeneration; Tissue-on-a-chip; Wound healing","Alge, C.S., Hauck, S.M., Priglinger, S.G., Kampik, A.M.U., Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodelling and cell survival (2006) J. Proteome Res., 5 (4), pp. 862-878; Bagnaninchi, P.O., Drummond, N., Real-time label-free monitoring of adipose-derived stem cell differentiation with electric cell-substrate impedance sensing (2011) Proc. Natl. Acad. Sci., 108 (16), pp. 6462-6467; Bilican, B., Serio, A., Barmada, S.J., Nishimura, A.L., Carrasco, M., Phatnani, H.P., Puddifoot, C.A., Chandran, S., Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability (2012) Proc. Natl. Acad. Sci., 109 (15), pp. 5803-5808; Borooah, S., Collins, C., Wright, A., Dhillon, B., Late-onset retinal macular degeneration: clinical insights into an inherited retinal degeneration (2009) Postgrad. Med. J., 85, pp. 495-500; Borooah, S., Phillips, M.J., Bilican, B., Wright, A.F., Wilmut, I., Chandran, S., Gamm, D., Dhillon, B., Using human induced pluripotent stem cells to treat retinal disease (2013) Progr. Ret. Eye Res., 37, pp. 163-181; Cai, H., Del Priore, L.V., Bruch membrane aging alters the gene expression profile of human retinal pigment epithelium (2006) Curr. Eye Res., 31 (2), pp. 181-189; Chan, C.M., Chang, H.H., Wang, V.C., Huang, C.L., Hung, C.F., Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRb,PI3K/Akt and MAPK pathways (2013) PLoS One, 8 (2), p. e56819; Chan, C.M., Fang, J.Y., Lin, H.H., Yang, C.Y., Hung, C.F., Lycopene inhibits PDGF-BB-induced retinal pigment epithelial cell migration by suppression of PI3K/Akt and MAPK pathways (2009) Biochem. Biophys. Res. Commun., 388, pp. 172-176; Chan, C.M., Huang, J.H., Chiang, H.S., Wu, W.B., Lin, H.H., Hong, J.Y., Hung, C.F., Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion (2010) Mol. Vis., 16, pp. 586-595; Chen, X., Xiao, W., Wang, W., Luo, L., Ye, S., Liu, Y., The complex interplay between ERK1/2, TGFβ/Smad, and Jagged/Notch signaling pathways in the regulation of epithelial-mesenchymal transition in retinal pigment epithelium cells (2014) PLoS One, 9 (5), p. e96365; David Schneider, D., Tarantola, M., Janshoff, A., Dynamics of TGF-β induced epithelial-to-mesenchymal transition monitored by Electric Cell-Substrate Impedance Sensing (2011) Biochim. Biophys. Acta, 1813 (12), pp. 2099-2107; Doran, M.R., Mills, R.J., Parker, A.J., Landman, K.A., Cooper-White, J.J., A cell migration device that maintains a defined surface with no cellular damage during wound edge generation (2009) Lab Chip, 9, pp. 2364-2369; Fronzaa, M., Heinzmann, B., Hamburger, M., Laufer, S., Merfort, I., Determination of the wound healing effect of Calendula extracts using the scratch assay with 3T3 fibroblasts (2009) J. Ethnopharmacol., 126, pp. 463-467; Gamboa, O.L., Pu, J., Townend, J., Forrester, J.V., Zhao, M., McCaig, C., Lois, N., Electrical estimulation of retinal pigment epithelial cells (2010) Exp. Eye Res., 91, pp. 195-204; Giaever, I., Keese, C.R., Monitoring fibroblast behaviour in tissue culture with an applied electric field (1984) Proc. Natl. Acad. Sci. USA, 81 (12), pp. 3761-3764; Giaever, I., Keese, C.R., Micromotion of mammalian cells measured electrically (1991) Proc. Natl. Acad. Sci., 88, pp. 7896-7900; Gupton, S.L., Waterman-Storer, C.M., Spatiotemporal feedback between actomyosin and focal-adhesion systems optimizes rapid cell migration (2006) Cell, 125, pp. 1361-1374; Han, J., Liu, G., Profirovic, J., Niu, J., Voyno-Yasenetskaya, T., Zyxin is involved in thrombin signaling via interaction with PAR-1 receptor (2009) FASEB, 23, pp. 4193-4206; Hayward, C., Shu, X., Cideciyan, A., Lennon, A., Barran, P., Zareparsi, S., Sawyer, L., Wright, A., Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration (2003) Hum. Mol. Genet., 12 (20), pp. 2657-2667; Heijink, I.H., Brandenburg, S.M., Noordhoek, J.A., Postma, D.S., Slebos, D.J., van Oosterhout, A.J.M., Characterisation of cell adhesion in airway epithelial cell types using electric cell-substrate impedance sensing (2010) Eur. Respir. J., 35, pp. 894-903; Ho, J., Witkin, A.J., Liu, J., Chen, Y., Fujimoto, J.G., Schuman, J.S., Duker, J.S., Documentation of intraretinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography (2011) Ophthalmology, 118 (4), pp. 687-693; Huttenlocher, A., Horwitz, A.R., Integrins in cell migration (2011) Cold Spring Harb. Perspect. Biol., 3, p. a005074; Inoue, H., Yamanaka, S., The use of induced pluripotent stem cells in drug development (2011) Clin. Pharmacol. Ther., 89 (5), pp. 655-661; Johnson, P.T., Brown, M.N., Pulliam, B.C., Anderson, D.H., Johnson, L.V., Synaptic pathology, altered gene expression, and degeneration in photoreceptors impacted by drusen (2005) Invest. Ophthalmol. Vis. Sci., 46, pp. 4788-4795; Keese, C.R., Bhawe, K., Wegener, J., Giaever, I., Real-time impedance assay to follow the invasive activities of metastatic cells in culture (2002) BioTechniques, 33, pp. 842-850; Keese, C.R., Wegener, J., Walker, S.R., Giaever, I., Electrical wound-healing assay for cells in vitro (2004) Proc. Natl. Acad. Sci., 101 (6), pp. 1554-1559; Klimanskaya, I., Hipp, J., Rezai, K.A., West, M., Atala, A.R.L., Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics (2004) Clon. Stem Cells, 6 (3), pp. 217-245; Kuschel, C., Steuer, H., Maurer, A., Kanzok, B., Stoop, R., Angres, B., Cell adhesion profiling using extracellular matrix protein microarrays (2006) Biotechniques, 40 (4), pp. 523-531; Lane, J., Jiang, W.G., Epithelial-mesenchymal transition and the use of ECIS (2012) Electric Cell-Substrate Impedance Sensing and Cancer Metastasis, pp. 71-84. , Springer, W.G. Jiang (Ed.); Lane, J., Jiang, W.G., Metastasis suppressor 1 (MTSS1) and epithelial to mesenchymal transition (EMT) in cancer progression (2013) Eur. J. Cancer, 49, p. S132; Lee, J., Wang, Y., Ren, F., Lele, T.P., Stamp wound assay for studying coupled cell migration and cell debris clearance (2010) Langmuir, 26 (22), pp. 16672-16676; Legrand, C., Gilles, C., Zahm, J., Polette, M., Buisson, A., Kaplan, H., Birembaut, P., Tournier, J., Airway epithelial cell migration dynamics: mmp-9 role in cell-extracellular matrix remodeling (1999) J. Cell Biol., 146 (2), pp. 517-529; Li, M., Firth, J.D., Putnins, E.E., An in vitro analysis of mechanical wounding-induced ligand-independent KGFR activation (2009) J. Dermatol. Sci., 53, pp. 182-191; Lo, C.M., Keese, C.R., Giaever, I., Impedance analysis of MDCK cells measured by electric cell-substrate impedance sensing (1995) Biophys. J., 69, pp. 2800-2807; Lovelady, D.C., Friedman, J., Patel, S., Rabson, D.A., Lo, C., Detecting effects of low levels of cytochalasin B in 3T3 fibroblast cultures by analysis of electrical noise obtained from cellular micromotion (2009) Biosens. Bioelectron., 24, pp. 2250-2254; Mandal, M., Vasireddy, V., Reddy, G., Wang, X., Moroi, S., Pattnaik, B., Hughes, B., Ayyagari, R., CTRP5 is a membrane-associated and secretory protein in the RPE and ciliary body and the S163R mutation of CTRP5 impairs its secretion (2006) Invest. Ophthalmol. Vis. Sci., 47 (12), pp. 5505-5513; Meyer, J.S., Shearer, R.L., Capowski, E.E., Wright, L.S., Wallace, K.A., McMillan, E.L., Zhang, S.C., Gamm, D.M., Modeling early retinal development with human embryonic and induced pluripotent stem cells (2009) Proc. Natl. Acad. Sci., 106, pp. 16698-16703; Navarrete, E.G., Liang, P., Lan, F., Sanchez-Freire, V., Simmons, C., Gong, T., Sharma, A., Wu, J.C., Screening drug-induced arrhythmia using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays (2013) Circulation, 128, pp. S3-S13; Opp, D., Wafula, B., Lim, J., Huang, E., Lo, J., Lo, C., Use of electric cell-substrate impedance sensing to assess in vitro cytotoxicity (2009) Biosens. Bioelectron., 24, pp. 2625-2629; Panda-Jonas, S., Jonas, J.B.M.J.-Z., Retinal pigment epithelial cell count, distribution, and correlations in normal human eyes (1996) Am. J. Ophthalmol., 121 (2), pp. 181-189; Poujade, M., Grasland-Mongrain, E., Hertzog, A., Jouanneau, J., Chavrier, P., Ladoux, B., Buguin, A., Silberzan, P., Collective migration of an epithelial monolayer in response to a model wound (2007) Proc. Natl. Acad. Sci., 104 (41), pp. 15988-15993; Shu, X., Tulloch, B., Lennon, A., Vlachantoni, D., Zhou, X., Hayward, C.A.F.W., Disease mechanisms in late-onset retinal macular degeneration associated with mutation in C1QTNF5 (2006) Hum. Mol. Genet., 15 (10), pp. 1680-1689; Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S., Induction of pluripotent stem cells from adult human fibroblasts by defined factors (2007) Cell, 131, pp. 861-872; Thurman, J.M., Renner, B., Kunchihapautham, K., Ferreira, V.P., Pangbum, M.K., Ablonczy, Z., Tomlinson, S., Rohrer, B., Oxidative stress renders retinal pigment epithelial cells susceptible to complement mediated injury (2009) J. Biol. Chem., 284 (25), pp. 16939-16947; Tsapara, A., Luthert, P., Greenwood, J., Hill, C.S., Matter, K., Balda, M.S., The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration (2010) Mol. Biol. Cell, 21, pp. 860-870; Tu, X., Palczewski, K., Crystal structure of the globular domain of C1QTNF5: implications for late-onset retinal macular degeneration (2012) J. Struct. Biol., 180 (3), pp. 439-446; Varani, J., Orr, W., Ward, P.A., A comparison of the migration patterns of normal and malignant cells in two assay systems (1978) Am. J. Pathol., 90, pp. 159-172; Wegener, J., Keese, C.R., Giaever, I., Electric cell-substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces (2000) Exp. Cell Res., 259, pp. 158-166; Yusa, K., Rashid, S.T., Strick-Marchand, H., Varela, I., Liu, P.Q., Paschon, D.E., Miranda, E., Bradley, A.L.V., (2011) Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature, 478 (7369), pp. 391-394; Zordan, M.D., Mill, C.P., Riese, D.J., Leary, J.F., A high throughput, interactive imaging, bright-field wound healing assay (2011) Cytom. Part A, 79A, pp. 227-232",Article,Scopus,2-s2.0-84928744942
"Cameron S.H., Alwakeel A.J., Goddard L., Hobbs C.E., Gowing E.K., Barnett E.R., Kohe S.E., Sizemore R.J., Oorschot D.E.","Delayed post-treatment with bone marrow-derived mesenchymal stem cells is neurorestorative of striatal medium-spiny projection neurons and improves motor function after neonatal rat hypoxia-ischemia",2015,"Molecular and Cellular Neuroscience","68",,,"56","72",,,10.1016/j.mcn.2015.03.019,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927548996&partnerID=40&md5=8c0b411e7b68a2e89517eec43e0a55a7","Department of Anatomy, Otago School of Medical Sciences, The Brain Health Research Centre, University of OtagoDunedin, New Zealand","Cameron, S.H., Department of Anatomy, Otago School of Medical Sciences, The Brain Health Research Centre, University of OtagoDunedin, New Zealand; Alwakeel, A.J., Department of Anatomy, Otago School of Medical Sciences, The Brain Health Research Centre, University of OtagoDunedin, New Zealand; Goddard, L., Department of Anatomy, Otago School of Medical Sciences, The Brain Health Research Centre, University of OtagoDunedin, New Zealand; Hobbs, C.E., Department of Anatomy, Otago School of Medical Sciences, The Brain Health Research Centre, University of OtagoDunedin, New Zealand; Gowing, E.K., Department of Anatomy, Otago School of Medical Sciences, The Brain Health Research Centre, University of OtagoDunedin, New Zealand; Barnett, E.R., Department of Anatomy, Otago School of Medical Sciences, The Brain Health Research Centre, University of OtagoDunedin, New Zealand; Kohe, S.E., Department of Anatomy, Otago School of Medical Sciences, The Brain Health Research Centre, University of OtagoDunedin, New Zealand; Sizemore, R.J., Department of Anatomy, Otago School of Medical Sciences, The Brain Health Research Centre, University of OtagoDunedin, New Zealand; Oorschot, D.E., Department of Anatomy, Otago School of Medical Sciences, The Brain Health Research Centre, University of OtagoDunedin, New Zealand","Perinatal hypoxia-ischemia is a major cause of striatal injury and may lead to cerebral palsy. This study investigated whether delayed administration of bone marrow-derived mesenchymal stem cells (MSCs), at one week after neonatal rat hypoxia-ischemia, was neurorestorative of striatal medium-spiny projection neurons and improved motor function. The effect of a subcutaneous injection of a high-dose, or a low-dose, of MSCs was investigated in stereological studies. Postnatal day (PN) 7 pups were subjected to hypoxia-ischemia. At PN14, pups received treatment with either MSCs or diluent. A subset of high-dose pups, and their diluent control pups, were also injected intraperitoneally with bromodeoxyuridine (BrdU), every 24. h, on PN15, PN16 and PN17. This permitted tracking of the migration and survival of neuroblasts originating from the subventricular zone into the adjacent injured striatum. Pups were euthanized on PN21 and the absolute number of striatal medium-spiny projection neurons was measured after immunostaining for DARPP-32 (dopamine- and cAMP-regulated phosphoprotein-32), double immunostaining for BrdU and DARPP-32, and after cresyl violet staining alone. The absolute number of striatal immunostained calretinin interneurons was also measured. There was a statistically significant increase in the absolute number of DARPP-32-positive, BrdU/DARPP-32-positive, and cresyl violet-stained striatal medium-spiny projection neurons, and fewer striatal calretinin interneurons, in the high-dose mesenchymal stem cell (MSC) group compared to their diluent counterparts. A high-dose of MSCs restored the absolute number of these neurons to normal uninjured levels, when compared with previous stereological data on the absolute number of cresyl violet-stained striatal medium-spiny projection neurons in the normal uninjured brain. For the low-dose experiment, in which cresyl violet-stained striatal medium-spiny neurons alone were measured, there was a lower statistically significant increase in their absolute number in the MSC group compared to their diluent controls. Investigation of behavior in another cohort of animals showed that delayed administration of a high-dose of bone marrow-derived MSCs, at one week after neonatal rat hypoxia-ischemia, improved motor function on the cylinder test. Thus, delayed therapy with a high- or low-dose of adult MSCs, at one week after injury, is effective in restoring the loss of striatal medium-spiny projection neurons after neonatal rat hypoxia-ischemia and a high-dose of MSCs improved motor function. © 2015 Elsevier Inc.","Adult mesenchymal stem cells; Cavalieri's method; DARPP-positive striatal neurons; Dose-effect; Forepaw motor skills; Stereology; Striatal medium-spiny projection neurons; Striatal neurorestoration; Subcutaneous injection","Alexander, G.E., DeLong, M.R., Strick, P.L., Parallel organization of functionally segregated circuits linking basal ganglia and cortex (1986) Annu. Rev. Neurosci., 9, pp. 357-381; Anderson, K.D., Reiner, A., Immunohistochemical localization of DARPP-32 in striatal projection neurons and striatal interneurons: implications for the localization of D1-like dopamine receptors on different types of striatal neurons (1991) Brain Res., 568, pp. 235-243; Anjos-Afonso, F., Siapati, E.K., Bonnet, D., In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions (2004) J. Cell Sci., 117, pp. 5655-5664; Bae, S.-H., Kong, T.-H., Lee, H.-S., Kim, K.-S., Hong, K.S., Chopp, M., Kang, M.-S., Moon, J., Long-lasting paracrine effects of human cord blood cells on damaged neocortex in an animal model of cerebral palsy (2012) Cell Transplant., 21, pp. 2497-2515; Bedi, K., Effects of Undernutrition on Brain Morphology: A Critical Review of Methods and Results (1984) Current Topics in Research on Synapses, 2, pp. 93-163. , Alan R. Liss, Inc., New York; Borlongan, C.V., Hadman, M., Sanberg, C.D., Sanberg, P.R., Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke (2004) Stroke, 35, pp. 2385-2389; Boyce, R.W., Dorph-Petersen, K.-A., Lyck, L., Gundersen, H.J.G., Design-based stereology: introduction to basic concepts and practical approaches for estimation of cell number (2010) Toxicol. Pathol., 38, pp. 1011-1025; Braendgaard, H., Evans, S.M., Howard, C.V., Gundersen, H.J.G., The total number of neurons in the human neocortex unbiasedly estimated using optical disectors (1990) J. Microsc., 157, pp. 285-304; Chen, J., Li, Y., Chopp, M., Intracerebral transplantation of bone marrow with BDNF after MCAo in rat (2000) Neuropharmacology, 39, pp. 711-716; Chen, J., Li, Y., Katakowski, M., Chen, X.G., Wang, L., Lu, D.Y., Lu, M., Chopp, M., Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat (2003) J. Neurosci. Res., 73, pp. 778-786; Chmielnicki, E., Benraiss, A., Economides, A.N., Goldman, S.A., Adenovirally expressed noggin and brain-derived neurotrophic factor cooperate to induce new medium spiny neurons from resident progenitor cells in the adult striatal ventricular zone (2004) J. Neurosci., 24, pp. 2133-2142; Cho, S.-R., Benraiss, A., Chmielnicki, E., Samdani, A., Economides, A., Goldman, S.A., Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease (2007) J. Clin. Investig., 117, pp. 2899-2902; Constantin, G., Marconi, S., Rossi, B., Angiari, S., Calderan, L., Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis (2009) Stem Cells, 27, pp. 2624-2635; Covey, M.V., Oorschot, D.E., Effect of hypothermic post-treatment on hypoxic-ischemic striatal injury, and normal striatal development, in neonatal rats: a stereological study (2007) Pediatr. Res., 62, pp. 646-651; Dailey, T., Mosley, Y., Pabon, M., Acosta, S., Tajiri, N., van Loveren, H., Kaneko, Y., Borlongan, C.V., Advancing critical care medicine with stem cell therapy and hypothermia for cerebral palsy (2013) NeuroReport, 24, pp. 1067-1071; Decressac, M., Prestoz, L., Veran, J., Cantereau, A., Jaber, M., Gaillard, A., Neuropeptide Y stimulates proliferation, migration and differentiation of neural precursors from the subventricular zone in adult mice (2009) Neurobiol. Dis., 34, pp. 441-449; Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noel, D., Jorgensen, C., Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals (2003) Blood, 102, pp. 3837-3844; Donega, V., van Velthoven, C.T.J., Nijboer, C.H., Kavelaars, A., Heijnen, C.J., The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment (2013) J. Cereb. Blood Flow Metab., 33, pp. 625-634; Felling, R.J., Snyder, M.J., Romanko, M.J., Rothstein, R.P., Ziegler, A.N., Yang, Z., Givogri, M.I., Levison, S.W., Neural stem/progenitor cells participate in the regenerative response to perinatal hypoxia/ischemia (2006) J. Neurosci., 26, pp. 4359-4369; Frenette, P.S., Pinho, S., Lucas, D., Scheiermann, C., Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine (2013) Annu. Rev. Immunol., 31, pp. 285-316; Galvin, K.A., Oorschot, D.E., Postinjury magnesium sulfate treatment is not markedly neuroprotective for striatal medium spiny neurons after perinatal hypoxia/ischemia in the rat (1998) Pediatr. Res., 44, pp. 740-745; Gao, J., Dennis, J.E., Muzic, R.F., Lundberg, M., Caplan, A.I., The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion (2001) Cell Tissue Organ, 169, pp. 12-20; Gerfen, C.R., Staines, W.A., Arbuthnott, G.W., Fibiger, H.C., Crossed connections of the substantia nigra in the rat (1982) J. Comp. Neurol., 207, pp. 283-303; Gordon, D., Pavlovska, G., Glover, C.P., Uney, J.B., Wraith, D., Scolding, N.J., Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration (2008) Neurosci. Lett., 448, pp. 71-73; Grabowski, M., Brundin, P., Johansson, B.B., Paw-reaching, sensorimotor, and rotational behavior after brain infarction in rats (1993) Stroke, 24, pp. 889-895; Grow, J.L., Liu, Y.Q., Barks, J.D., Can lateralizing sensorimotor deficits be identified after neonatal cerebral hypoxia-ischemia in rats? (2003) Dev. Neurosci., 25, pp. 394-402; Gundersen, H.J.G., Notes on the estimation of numerical density of arbitrary profiles: the edge effect (1977) J. Microsc., 111, pp. 219-223; Gundersen, H.J.G., Jensen, E.B.V., Kieu, K., Nielsen, J., The efficiency of systematic sampling in stereology - reconsidered (1999) J. Microsc., 193, pp. 199-211; Hess, D.C., Borlongan, C.V., Stem cells and neurological diseases (2008) Cell Prolif., 41, pp. 94-114; Hewlitt, K.A., Corbett, D., Delayed minocycline treatment reduces long-term functional deficits and histological injury in a rodent model of focal ischemia (2006) Neurosciences, 141, pp. 27-33; Hill, A., Current concepts of hypoxic-ischemic cerebral injury in the term newborn (1991) Pediatr. Neurol., 7, pp. 317-325; Hobbs, C.E., Oorschot, D.E., Neonatal rat hypoxia-ischemia: long-term rescue of striatal neurons and motor skills by combined antioxidant-hypothermia treatment (2008) Brain Pathol., 18, pp. 443-454; Im, S.H., Yu, J.H., Park, E.S., Lee, J.E., Kim, H.O., Park, K.I., Wim, G.W., Cho, S.-R., Induction of striatal neurogenesis enhances functional recovery in an adult animal model of neonatal hypoxic-ischemic brain injury (2010) Neurosci., 169, pp. 259-268; Larsen, M., Bjarkam, C.R., Ostergaard, K., West, M.J., Sørensen, J.C., The anatomy of the porcine subthalamic nucleus evaluated with immunohistochemistry and design-based stereology (2004) Anat. Embryol., 208, pp. 239-247; Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Ringden, O., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study (2008) Lancet, 371, pp. 1579-1586; Lee, J.A., Kim, B.I., Jo, C.H., Choi, C.W., Kim, E.-K., Kim, H.-S., Yoon, K.-S., Choi, J.-H., Mesenchymal stem-cell transplantation for hypoxic-ischemic brain injury in neonatal rat model (2010) Pediatr. Res., 67, pp. 42-46; Li, Y., Chopp, M., Chen, J., Wang, L., Gautam, S.C., Xu, Y.-X., Zhang, Z., Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice (2000) J. Cereb. Blood Flow Metab., 20, pp. 1311-1319; Liu, Z., Li, Y., Zhang, Z.G., Cui, X., Cui, Y., Lu, M., Savant-Bhonsale, S., Chopp, M., Bone marrow stromal cells enhance inter- and intracortical axonal connections after ischemic stroke in adult rats (2010) J. Cereb. Blood Flow Metab., 30, pp. 1288-1295; Luskin, M.B., Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone (1993) Neuron, 11, pp. 173-189; Montoya, C.P., Campbell-Hope, L.J., Pemberton, K.D., Dunnett, S.B., The ""staircase test"": a measure of independent forelimb reaching and grasping abilities in rats (1991) J. Neurosci. Methods, 36, pp. 219-228; Moore, N., Okocha, F., Cui, J.K., Liu, P.K., Homogeneous repair of nuclear genes after experimental stroke (2002) J. Neurochem., 80, pp. 111-118; Nagaya, N., Fujii, T., Iwase, T., Ohgushi, H., Itoh, T., Uematsu, M., Yamagishi, M., Kitamura, S., Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis (2004) Am. J. Physiol. Heart Circ. Physiol., 287, pp. H2670-H2676; Oh, J.Y., Kim, T.W., Jeong, H.Y., Lee, H.J., Ryu, J.S., Wee, W.R., Heo, J.W., Kim, M.K., Intraperitoneal infusion of mesenchymal stem/stromal cells prevents experimental autoimmune uveitis in mice (2014) Mediators Inflamm.; Ong, J., Plane, J.M., Parent, J.M., Silverstein, F.S., Hypoxic-ischemic injury stimulates subventricular zone proliferation and neurogenesis in the neonatal rat (2005) Pediatr. Res., 58, pp. 600-606; Oorschot, D.E., Are you using neuronal densities, synaptic densities or neurochemical densities as your definitive data? There is a better way to go (1994) Prog. Neurobiol., 44, pp. 233-247; Oorschot, D.E., Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the Cavalieri and optical disector methods (1996) J. Comp. Neurol., 366, pp. 580-599; Oorschot, D.E., Indirect measures of neuroprotection are parameters to avoid: examples from research on neonatal rat hypoxia-ischemia (2011) Image Anal. Stereol., 30, pp. 1-9; Oorschot, D.E., The percentage of interneurons in the dorsal striatum of the rat, cat, monkey and human: a critique of the evidence (2013) Basal Ganglia, 3, pp. 19-24; Oorschot, D.E., Tunstall, M.J., Wickens, J.R., Local connectivity between striatal spiny projection neurons: a re-evaluation (2002) The Basal Ganglia VII, pp. 421-434. , Kluwer Academic/Plenum Publishers, New York, L.F.B. Nicholson, R.L.M. Faull (Eds.); Oorschot, D.E., Lin, N., Cooper, B.H., Reynolds, J.N.J., Sun, H., Wickens, J.R., Synaptic connectivity between rat striatal spiny projection neurons in vivo: unexpected multiple somatic innervation in the context of overall sparse proximal connectivity (2013) Basal Ganglia, 3, pp. 93-108; Oorschot, D.E., Voss, L., Covey, M.V., Goddard, L., Huang, W., Birchall, P., Bilkey, D.K., Kohe, S.E., Spectrum of short- and long-term brain pathology and long-term behavioral deficits in male repeated hypoxic rats closely resembling human extreme prematurity (2013) J. Neurosci., 33, pp. 11863-11877; Ouimet, C.C., Langley-Gullion, K.C., Greengard, P., Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen (1998) Brain Res., 808, pp. 8-12; Paxinos, G., Watson, C., (2007) The Rat Brain in Stereotaxic Co-ordinates, , Academic Press, Amsterdam; Perlman, J.M., Summary proceedings from the neurology group on hypoxic-ischemic encephalopathy (2006) Pediatrics, 117, pp. S28-S33; Plane, J.M., Liu, R., Wang, T.-W., Silverstein, F.S., Parent, J.M., Neonatal hypoxic-ischemic injury increases forebrain subventricular zone neurogenesis in the mouse (2004) Neurobiol. Dis., 16, pp. 585-595; Price, A.W., Fowler, S.C., Deficits in contralateral and ipsilateral forepaw motor control following unilateral motor cortical ablations in rats (1981) Brain Res., 205, pp. 81-90; Raadsheer, F.C., Oorschot, D.E., Verwer, R.W.H., Tilders, F.J.H., Swaab, D.F., Age-related increase in the total number of corticotropin-releasing hormone neurons in the human paraventricular nucleus in controls and Alzheimer's Disease: comparison of the disector with an unfolding method (1994) J. Comp. Neurol., 339, pp. 447-457; Rakic, P., Adult neurogenesis in mammals: an identity crisis (2002) J. Neurosci., 22, pp. 614-618; Rice, J.E., Vannucci, R.C., Brierley, J.B., The influence of immaturity on hypoxic-ischemic brain damage in the rat (1981) Ann. Neurol., 9, pp. 131-141; Rosenkranz, K., Kumbruch, S., Lebermann, K., Marschner, K., Jensen, A., Dermietzel, R., Meier, C., The chemokine SDF-1/CXCL12 contributes to the 'homing' of umbilical cord blood cells to a hypoxic-ischemic lesion in the rat brain (2010) J. Neurosci. Res., 88, pp. 1223-1233; Schallert, T., Fleming, S.M., Leasure, J.L., Tillerson, J.L., Bland, S.T., CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury (2000) Neuropharmacology, 39, pp. 777-787; Slomianka, L., West, M.J., Estimators of the precision of stereological estimates: an example based on the CA1 pyramidal cell layer of rats (2005) Neurosciences, 136, pp. 757-767; Sun, X., Zhang, Q.W., Xu, M., Guo, J.J., Shen, S.W., Wang, Y.Q., Sun, F.Y., New striatal neurons form projections to substantia nigra in adult rat brain after stroke (2012) Neurobiol. Dis., 45, pp. 601-609; Tattersfield, A.S., Croon, R.J., Liu, Y.W., Kells, A.P., Faull, R.L.M., Connor, B., Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease (2004) Neurosciences, 127, pp. 319-332; Tavazoie, M., Van der Veken, L., Silva-Vargas, V., Louissaint, M., Colonna, L., Zaidi, B., Garcia-Verdugo, J.M., Doetsch, F., A specialized vascular niche for adult neural stem cells (2008) Cell Stem Cell, 3, pp. 279-288; Titomanlio, L., Kavelaars, A., Dalous, J., Mani, S., El Ghouzzi, V., Heijnen, C., Baud, O., Gressens, P., Stem cell therapy for neonatal brain injury: perspectives and challenges (2011) Ann. Neurol., 70, pp. 698-712; Tuor, U.I., Hudzik, T.J., Malisza, K., Sydserff, S., Kozlowski, P., Del Bigio, M.R., Long-term deficits following cerebral hypoxia-ischemia in four-week-old rats: correspondence between behavioral, histological, and magnetic resonance imaging assessments (2001) Exp. Neurol., 167, pp. 272-281; Uccelli, A., Mesenchymal stem cells exert a remarkable regenerative effect requiring minimal CNS integration (2013) Exp. Neurol., 247, pp. 292-295; van Velthoven, C.T.J., Kavelaars, A., van Bel, F., Heijnen, C.J., Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration (2010) Brain Behav. Immun., 24, pp. 387-393; van Velthoven, C.T.J., Kavelaars, A., van Bel, F., Heijnen, C.J., Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function (2010) J. Neurosci., 30, pp. 9603-9611; van Velthoven, C.T.J., Kavelaars, A., van Bel, F., Heijnen, C.J., Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage (2010) Pediatr. Res., 68, pp. 419-422; van Velthoven, C.T.J., Kavelaars, A., van Bel, F., Heijnen, C.J., Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain (2011) Brain Behav. Immun., 25, pp. 1342-1348; van Velthoven, C.T.J., Kavelaars, A., Heijnen, C.J., Mesenchymal stem cells as a treatment for neonatal ischemic brain damage (2012) Pediatr. Res., 71, pp. 474-481; Volpe, J.J., Perinatal hypoxic-ischemic brain injury: overview (1992) Fetal and Perinatal Neurology, pp. 232-252. , Karger, Tokyo, Y. Fukuyama, Y. Suzuki, S. Kamoshita, P. Casaer (Eds.); Wang, Y., Deng, Y., Zhou, G.-Q., SDF-1[alpha]/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model (2008) Brain Res., 1195, pp. 104-112; West, M.J., Gundersen, H.J.G., Unbiased stereological estimation of the number of neurons in the human hippocampus (1990) J. Comp. Neurol., 296, pp. 1-22; Williams, M.A., Quantitative methods in biology (1977) Practical Methods in Electron Microscopy, Volume 6, , North Holland Publishing Company, Amsterdam, A.M. Glauert (Ed.); Williams, C.G., Kim, T.K., Taboas, A., Malik, A., Manson, P., Elisseeff, J., In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymerizing hydrogel (2003) Tissue Eng., 9, pp. 679-688; Willing, A., Foran, E.A., Cord blood as a treatment for stroke (2015) Cellular Therapy for Stroke and CNS Injuries, , Springer, L.-R. Zhao, J.H. Zhang (Eds.); Wilson, T., Stark, C., Holmbom, J., Rosling, A., Kuusilehto, A., Tirri, T., Penttinen, R., Ekholm, E., Fate of bone marrow-derived stromal cells after intraperitoneal infusion of implantation into femoral bone defects in the host animal (2010) J. Tissue Eng.; Yang, Z., Levison, S.W., Hypoxia/ischemia expands the regenerative capacity of progenitors in the perinatal subventricular zone (2006) Neurosci., 139, pp. 555-564; Yang, Z., Levison, S.W., Perinatal hypoxic/ischemic brain injury induces persistent production of striatal neurons from subventricular zone progenitors (2007) Dev. Neurosci., 29, pp. 331-340; Yang, Z., You, Y., Levison, S.W., Neonatal hypoxic/ischemic brain injury induces production of calretinin-expressing interneurons in the striatum (2008) J. Comp. Neurol., 511, pp. 19-33; Yoshikawa, G., Momiyama, T., Oya, S., Takai, K., Tanaka, J., Higashiyama, S., Saito, N., Kawahara, N., Induction of striatal neurogenesis and generation of region-specific functional mature neurons after ischemia by growth factors (2010) J. Neurosurg., 113, pp. 835-850",Article,Scopus,2-s2.0-84927548996
"Pei M., Li J., McConda D.B., Wen S., Clovis N.B., Danley S.S.","A comparison of tissue engineering based repair of calvarial defects using adipose stem cells from normal and osteoporotic rats",2015,"Bone","78",,,"1","10",,,10.1016/j.bone.2015.04.040,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928954169&partnerID=40&md5=67ac06b884622d4553d06b5db2cdb32c","Stem Cell and Tissue Engineering Laboratory, Department of Orthopaedics, West Virginia UniversityMorgantown, WV, United States; Division of Exercise Physiology, West Virginia UniversityMorgantown, WV, United States; Department of Biostatistics, West Virginia UniversityMorgantown, United States","Pei, M., Stem Cell and Tissue Engineering Laboratory, Department of Orthopaedics, West Virginia UniversityMorgantown, WV, United States, Division of Exercise Physiology, West Virginia UniversityMorgantown, WV, United States; Li, J., Stem Cell and Tissue Engineering Laboratory, Department of Orthopaedics, West Virginia UniversityMorgantown, WV, United States, Division of Exercise Physiology, West Virginia UniversityMorgantown, WV, United States; McConda, D.B., Stem Cell and Tissue Engineering Laboratory, Department of Orthopaedics, West Virginia UniversityMorgantown, WV, United States; Wen, S., Department of Biostatistics, West Virginia UniversityMorgantown, United States; Clovis, N.B., Stem Cell and Tissue Engineering Laboratory, Department of Orthopaedics, West Virginia UniversityMorgantown, WV, United States; Danley, S.S., Stem Cell and Tissue Engineering Laboratory, Department of Orthopaedics, West Virginia UniversityMorgantown, WV, United States","Repairing large bone defects presents a significant challenge, especially in those people who have a limited regenerative capacity such as in osteoporotic (OP) patients. The aim of this study was to compare adipose stem cells (ASCs) from both normal (NORM) and ovariectomized (OVX) rats in osteogenic potential using both in vitro and in vivo models. After successful establishment of a rat OP model, we found that ASCs from OVX rats exhibited a comparable proliferation capacity to those from NORM rats but had significantly higher adipogenic and relatively lower osteogenic potential. Thirty-two weeks post-implantation with poly(lactic-co-glycolic acid) (PLGA) alone or PLGA seeded with osteogenic-induced ASCs for critical-size calvarial defects, the data from Herovici's collagen staining and micro-computed tomography suggested that the implantation of ASC-PLGA constructs exhibited a higher bone volume density compared to the PLGA alone group, especially in the NORM rat group. Intriguingly, the defects from OVX rats exhibited a higher bone volume density compared to NORM rats, especially for implantation of the PLGA alone group. Our results indicated that ASC based tissue constructs are more beneficial for the repair of calvarial defects in NORM rats while implantation of PLGA scaffold contributed to defect regeneration in OVX rats. © 2015 Elsevier Inc.","Adipose stem cells; Calvarial defect; Osteogenesis; Osteoporosis; Poly(lactic-co-glycolic acid)","Rodan, G.A., Control of bone formation and resorption: biological and clinical perspective (1998) J Cell Biochem Suppl, pp. 55-61; Hanson, J.W., Sayers, M.P., Knopp, L.M., Macdonald, C., Smith, D.W., Subtotal neonatal calvariectomy for severe craniosynostosis (1977) J Pediatr, 91, pp. 257-260; Mabbutt, L.W., Kokich, V.G., Moffett, B.C., Loeser, J.D., Subtotal neonatal calvariectomy. A radiographic and histological evaluation of calvarial and sutural redevelopment in rabbits (1979) J Neurosurg, 51, pp. 691-696; Szpalski, C., Barr, J., Wetterau, M., Saadeh, P.B., Warren, S.M., Cranial bone defects: current and future strategies (2010) Neurosurg Focus, 29. , E8; Christiansen, C., Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis (1993) Am J Med, 94, pp. 646-650; Clinician's guide to prevention and treatment of osteoporosis, , http://www.nof.org/sites/default/files/pdfs/NOF_ClinicianGuide2009_v7.pdf.%20Accessed%20December%203,%202010, (Available at); Pizzute, T., Lynch, K., Pei, M., Impact of tissue-specific stem cells on lineage-specific differentiation: a focus on the musculoskeletal system (2015) Stem Cell Rev, 11, pp. 119-132; Stockmann, P., Park, J., von Wilmowsky, C., Guided bone regeneration in pig calvarial bone defects using autologous mesenchymal stem/progenitor cells-a comparison of different tissue sources (2012) J Craniomaxillofac Surg, 40, pp. 310-320; Chen, H.T., Lee, M.J., Chen, C.H., Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures (2012) J Cell Mol Med, 16, pp. 582-593; Mirsaidi, A., Kleinhans, K.N., Rimann, M., Telomere length, telomerase activity and osteogenic differentiation are maintained in adipose-derived stromal cells from senile osteoporotic SAMP6 mice (2012) J Tissue Eng Regen Med, 6, pp. 378-390; Rodríguez, J.P., Garat, S., Gajardo, H., Pino, A.M., Seitz, G., Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics (1999) J Cell Biochem, 75, pp. 414-423; Cowan, C.M., Shi, Y.Y., Aalami, O.O., Adipose-derived adult stromal cells heal critical-size mouse calvarial defects (2004) Nat Biotechnol, 22, pp. 560-567; De Ugarte, D.A., Morizono, K., Elbarbary, A., Comparison of multi-lineage cells from human adipose tissue and bone marrow (2003) Cells Tissues Organs, 174, pp. 101-109; Dudas, J.R., Marra, K.G., Cooper, G.M., The osteogenic potential of adipose-derived stem cells for the repair of rabbit calvarial defects (2006) Ann Plast Surg, 56, pp. 543-548; Levi, B., James, A.W., Nelson, E.R., Human adipose derived stromal cells heal critical size mouse calvarial defects (2010) PLoS One, 5, p. e11177; Wang, C.Z., Chen, S.M., Chen, C.H., The effect of the local delivery of alendronate on human adipose-derived stem cell-based bone regeneration (2010) Biomaterials, 31, pp. 8674-8683; Yoon, E., Dhar, S., Chun, D.E., Gharibjanian, N.A., Evans, G.R., In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model (2007) Tissue Eng, 13, pp. 619-627; Lin, K., Xia, L., Li, H., Enhanced osteoporotic bone regeneration by strontium-substituted calcium silicate bioactive ceramics (2013) Biomaterials, 34, pp. 10028-10042; Durão, S.F., Gomes, P.S., Colaço, B.J., The biomaterial-mediated healing of critical size bone defects in the ovariectomized rat (2014) Osteoporos Int, 25, pp. 1535-1545; Pei, M., He, F., Boyce, B.M., Kish, V.L., Repair of full-thickness femoral condyle cartilage defects using allogeneic synovial cell-engineered tissue constructs (2009) Osteoarthritis Cartilage, 17, pp. 714-722; Tan, Y., Zhang, Y., Pei, M., Meniscus reconstruction through coculturing meniscus cells with synovium-derived stem cells on small intestine submucosa-a pilot study to engineer meniscus tissue constructs (2010) Tissue Eng Part A, 16, pp. 67-79; Bouxsein, M.L., Boyd, S.K., Christiansen, B.A., Guidelines for assessment of bone microstructure in rodents using micro-computed tomography (2010) J Bone Miner Res, 25, pp. 1468-1486; Pino, A.M., Rosen, C.J., Rodríguez, J.P., In osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis (2012) Biol Res, 45, pp. 279-287; Shi, Y.Y., Nacamuli, R.P., Salim, A., Longaker, M.T., The osteogenic potential of adipose-derived mesenchymal cells is maintained with aging (2005) Plast Reconstr Surg, 116, pp. 1686-1696; Boeloni, J.N., Ocarino, N.M., Goes, A.M., Serakides, R., Comparative study of osteogenic differentiation potential of mesenchymal stem cells derived from bone marrow and adipose tissue of osteoporotic female rats (2014) Connect Tissue Res, 55, pp. 103-114; Zhu, M., Kohan, E., Bradley, J., The effect of age on osteogenic, adipogenic and proliferative potential of female adipose-derived stem cells (2009) J Tissue Eng Regen Med, 3, pp. 290-301; Li, D.J., Ge, D.X., Wu, W.C., Wu, J., Li, L., Osteogenic potential of bone marrow mesenchymal stem cells from ovariectomied osteoporotic rat (2005) Sichuan Da Xue Xue Bao Yi Xue Ban, 36, pp. 318-321; Oreffo, R.O., Bord, S., Triffitt, J.T., Skeletal progenitor cells and ageing human populations (1998) Clin Sci (Lond), 94, pp. 549-555; Di Bella, C., Farlie, P., Penington, A.J., Bone regeneration in a rabbit critical-sized skull defect using autologous adipose derived cells (2008) Tissue Eng Part A, 14, pp. 483-490; Cowan, C.M., Aalami, O.O., Shi, Y.Y., Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover (2005) Tissue Eng, 11, pp. 645-658; Wan, D.C., Siedhoff, M.T., Kwan, M.D., Refining retinoic acid stimulation for osteogenic differentiation of murine adipose-derived adult stromal cells (2007) Tissue Eng, 13, pp. 1623-1631; Lo, D.D., Hyun, J.S., Chung, M.T., Repair of a critical-sized calvarial defect model using adipose-derived stromal cells harvested from lipoaspirate (2012) J Vis Exp, 68. , 4221; Carvalho, P.P., Leonor, I.B., Smith, B.J., Undifferentiated human adipose-derived stromal/stem cells loaded onto wet-spun starch-polycaprolactone scaffolds enhance bone regeneration: nude mice calvarial defect in vivo study (2014) J Biomed Mater Res A, 102, pp. 3102-3111; Zong, C., Xue, D., Yuan, W., Reconstruction of rat calvarial defects with human mesenchymal stem cell and osteoblast-like cells in poly-lactic-co-glycolic acid scaffolds (2010) Eur Cell Mater, 20, pp. 109-120; Woo, B.H., Fink, B.F., Page, R., Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix (2001) Pharm Res, 18, pp. 1747-1753; Kim, S.S., Gwak, S.J., Kim, B.S., Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2 (2008) J Biomed Mater Res A, 87, pp. 245-253; Levi, B., Nelson, E.R., Li, S., Dura mater stimulates human adipose-derived stromal cells to undergo bone formation in mouse calvarial defects (2011) Stem Cells, 29, pp. 1241-1255; Missana, L.R., Jammal, M.V., Critical size defect regeneration by rhPTH-collagen membrane as a new tissue engineering tool (2014) J Biomed Mater Res A, 102, pp. 4358-4364; Veronesi, F., Pagani, S., Della Bella, E., Giavaresi, G., Fini, M., Estrogen deficiency does not decrease the in vitro osteogenic potential of rat adipose-derived mesenchymal stem cells (2014) Age (Dordr), 36, p. 9647; Dalle Carbonare, L., Valenti, M.T., Zanatta, M., Donatelli, L., Lo, C.V., Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis (2009) Arthritis Rheum, 60, pp. 3356-3365; Jaiswal, R.K., Jaiswal, N., Bruder, S.P., Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase (2000) J Biol Chem, 275, pp. 9645-9652; Kim, E.K., Lim, S., Park, J.M., Human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by AMP-activated protein kinase (2012) J Cell Physiol, 227, pp. 1680-1687; Rossini, M., Gatti, D., Adami, S., Involvement of WNT/β-catenin signaling in the treatment of osteoporosis (2013) Calcif Tissue Int, 93, pp. 121-132",Article,Scopus,2-s2.0-84928954169
"Sirbulescu R.F., Ilies I., Zupanc G.K.H.","Matrix metalloproteinase-2 and -9 in the cerebellum of teleost fish: Functional implications for adult neurogenesis",2015,"Molecular and Cellular Neuroscience","68",,,"9","23",,,10.1016/j.mcn.2015.03.015,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925967691&partnerID=40&md5=f3085c08bd4761920a41a0a472ed4783","Laboratory of Neurobiology, Department of Biology, Northeastern UniversityBoston, MA, United States","Sîrbulescu, R.F., Laboratory of Neurobiology, Department of Biology, Northeastern UniversityBoston, MA, United States; Ilieş, I., Laboratory of Neurobiology, Department of Biology, Northeastern UniversityBoston, MA, United States; Zupanc, G.K.H., Laboratory of Neurobiology, Department of Biology, Northeastern UniversityBoston, MA, United States","Matrix metalloproteinases (MMPs) are a family of highly conserved zinc-dependent proteases involved in both development and pathogenesis. The present study examines the role of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) in adult neurogenesis, using the corpus cerebelli, a subdivision of the cerebellum, of knifefish (Apteronotus leptorhynchus) as a model system. Transcripts of five isoforms of these gelatinases were identified in the central nervous system of this species. Sequence similarity analysis and homology modeling indicated that functionally and structurally critical elements were highly conserved in knifefish gelatinases. Immunohistochemical staining revealed a differential distribution of MMP-2 and MMP-9 at both the cellular and subcellular level. MMP-2 expression was found mainly in Sox2-immunopositive stem/progenitor cells, both quiescent and mitotically active; and was localized in both the cytoplasmic compartment and the nucleus. By contrast, MMP-9 immunoreactivity was absent in neurogenic niches and displayed a more homogenous distribution, with low to moderate intensity levels, in the molecular and granular layers. MMP-9 expression appeared to be restricted to the extracellular space. In situ zymography indicated that gelatinase activity matched the cellular and subcellular distributions of the two MMPs. The observed patterns of gelatinase activity and expression support the hypothesis that MMP-2 is primarily involved in regulation of the activity of stem/progenitor cells that give rise to new granule neurons, whereas MMP-9 facilitates migration of the progeny of these cells by proteolysis of extracellular matrix proteins. © 2015 Elsevier Inc.","Adult neurogenesis; Cell migration; Cerebellum; Knifefish; Matrix metalloproteinase; Stem/progenitor cell","Allan, J.A., Docherty, A.J.P., Barker, P.J., Huskisson, N.S., Reynolds, J.J., Murphy, G., Binding of gelatinases A and B to type-I collagen and other matrix components (1995) Biochem. J., 309, pp. 299-306; Altschul, S.F., Gish, W., Miller, W., Myers, E.W., Lipman, D.J., Basic local alignment search tool (1990) J. Mol. Biol., 215, pp. 403-410; Aoudjit, F., Masure, S., Opdenakker, G., Potworowski, E.F., St-Pierre, Y., Gelatinase B (MMP-9), but not its inhibitor (TIMP-1), dictates the growth rate of experimental thymic lymphoma (1999) Int. J. Cancer, 82, pp. 743-747; Arnold, K., Bordoli, L., Kopp, J., Schwede, T., The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling (2006) Bioinformatics, 22, pp. 195-201; Ayoub, A.E., Cai, T.Q., Kaplan, R.A., Luo, J., Developmental expression of matrix metalloproteinases 2 and 9 and their potential role in the histogenesis of the cerebellar cortex (2005) J. Comp. Neurol., 481, pp. 403-415; Barton, K.M., Levine, E.M., Expression patterns and cell cycle profiles of PCNA, MCM6, cyclin D1, cyclin A2, cyclin B1, and phosphorylated histone H3 in the developing mouse retina (2008) Dev. Dyn., 237, pp. 672-682; Benkert, P., Biasini, M., Schwede, T., Toward the estimation of the absolute quality of individual protein structure models (2011) Bioinformatics, 27, pp. 343-350; Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., Kiefer, F., Bordoli, L., SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information (2014) Nucleic Acids Res., 42, pp. W252-W258; Butler, G.S., Butler, M.J., Atkinson, S.J., Will, H., Tamura, T., van Westrum, S.S., Crabbe, T., Murphy, G., The TIMP2 membrane type 1 metalloproteinase ""receptor"" regulates the concentration and efficient activation of progelatinase A: a kinetic study (1998) J. Biol. Chem., 273, pp. 871-880; Butler, G.S., Apte, S.S., Willenbrock, F., Murphy, G., Human tissue inhibitor of metalloproteinases 3 interacts with both the N-and C-terminal domains of gelatinases A and B: regulation by polyanions (1999) J. Biol. Chem., 274, pp. 10846-10851; Cha, H., Kopetzki, E., Huber, R., Lanzendörfer, M., Brandstetter, H., Structural basis of the adaptive molecular recognition by MMP9 (2002) J. Mol. Biol., 320, pp. 1065-1079; Cuadrado, E., Rosell, A., Borrell-Pages, M., Garcia-Bonilla, L., Hernandez-Guillamon, M., Ortega-Aznar, A., Montaner, J., Matrix metalloproteinase-13 is activated and is found in the nucleus of neural cells after cerebral ischemia (2009) J. Cereb. Blood Flow Metab., 29, pp. 398-410; Daniel, C., Duffield, J., Brunner, T., Steinmann-Niggli, K., Lods, N., Marti, H.P., Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular mesangial cells (2001) J. Pharmacol. Exp. Ther., 297, pp. 57-68; Ekström, P., Johnsson, C.-M., Ohlin, L.-M., Ventricular proliferation zones in the brain of an adult teleost fish and their relation to neuromeres and migration (secondary matrix) zones (2001) J. Comp. Neurol., 436, pp. 92-110; Elkins, P.A., Ho, Y.S., Smith, W.W., Janson, C.A., D'Alessio, K.J., McQueney, M.S., Cummings, M.D., Romanic, A.M., Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase (2002) Acta Crystallogr. D Biol. Crystallogr., 58, pp. 1182-1192; Frederiks, W.M., Mook, O.R.F., Metabolic mapping of proteinase activity with emphasis on in situ zymography of gelatinases: review and protocols (2004) J. Histochem. Cytochem., 52, pp. 711-722; Fujita, S., Quantitative analysis of cell proliferation and differentiation in the cortex of the postnatal mouse cerebellum (1967) J. Cell Biol., 32, pp. 277-287; Gama Salgado, J.A., Zupanc, G.K.H., Echo response to chirping in the weakly electric brown ghost knifefish (Apteronotus leptorhynchus): role of frequency and amplitude modulations (2011) Can. J. Zool., 89, pp. 498-508; Gohlke, U., Gomis-Rüth, F.-X., Crabbe, T., Murphy, G., Docherty, A.J.P., Bode, W., The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP-2): structural implications for its function (1996) FEBS Lett., 378, pp. 126-130; Goldberg, G.I., Strongin, A., Collier, I.E., Genrich, L.T., Marmer, B.L., Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin (1992) J. Biol. Chem., 267, pp. 4583-4591; Golubkov, V.S., Boyd, S., Savinov, A.Y., Chekanov, A.V., Osterman, A.L., Remacle, A., Rozanov, D.V., Strongin, A.Y., Membrane type-1 matrix metalloproteinase (MT1-MMP) exhibits an important intracellular cleavage function and causes chromosome instability (2005) J. Biol. Chem., 280, pp. 25079-25086; Grandel, H., Kaslin, J., Ganz, J., Wenzel, I., Brand, M., Neural stem cells and neurogenesis in the adult zebrafish brain: origin, proliferation dynamics, migration and cell fate (2006) Dev. Biol., 295, pp. 263-277; Haas, B.J., Papanicolaou, A., Yassour, M., Grabherr, M., Blood, P.D., Bowden, J., Couger, M.B., Regev, A., De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis (2013) Nat. Protoc., 8, pp. 1494-1512; Hibi, M., Shimizu, T., Development of the cerebellum and cerebellar neural circuits (2012) Dev. Neurobiol., 72, pp. 282-301; Ilieş, I., Sîrbulescu, R.F., Zupanc, G.K.H., Indeterminate body growth and lack of gonadal decline in the brown ghost knifefish (Apteronotus leptorhynchus), an organism exhibiting negligible brain senescence (2014) Can. J. Zool., 92, pp. 947-953; Kaslin, J., Kroehne, V., Benato, F., Argenton, F., Brand, M., Development and specification of cerebellar stem and progenitor cells in zebrafish: from embryo to adult (2013) Neural Dev., 8, p. 9; Kaufmann, S.H., Desnoyers, S., Ottaviano, Y., Davidson, N.E., Poirier, G.G., Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis (1993) Cancer Res., 53, pp. 3976-3985; Klein, T., Bischoff, R., Physiology and pathophysiology of matrix metalloproteases (2011) Amino Acids, 41, pp. 271-290; Kwan, J.A., Schulze, C.J., Wang, W., Leon, H., Sariahmetoglu, M., Sung, M., Sawicka, J., Schulz, R., Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro (2004) FASEB J., 18, pp. 690-692; Luo, J., The role of matrix metalloproteinases in the morphogenesis of the cerebellar cortex (2005) Cerebellum, 4, pp. 239-245; Mannello, F., Medda, V., Nuclear localization of matrix metalloproteinases (2012) Prog. Histochem. Cytochem., 47, pp. 27-58; Massova, I., Kotra, L.P., Fridman, R., Mobashery, S., Matrix metalloproteinases: structures, evolution, and diversification (1998) FASEB J., 12, pp. 1075-1095; McWilliam, H., Li, W., Uludag, M., Squizzato, S., Park, Y.M., Buso, N., Cowley, A.P., Lopez, R., Analysis tool web services from the EMBL-EBI (2013) Nucleic Acids Res., 41, pp. W597-W600; Morgunova, E., Tuuttila, A., Bergmann, U., Isupov, M., Lindqvist, Y., Schneider, G., Tryggvason, K., Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed (1999) Science, 284, pp. 1667-1670; Morrison, C.J., Butler, G.S., Bigg, H.F., Roberts, C.R., Soloway, P.D., Overall, C.M., Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway (2001) J. Biol. Chem., 276, pp. 47402-47410; Murphy, G., Nguyen, Q., Cockett, M.I., Atkinson, S.J., Allan, J.A., Knight, C.G., Willenbrock, F., Docherty, A.J.P., Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant (1994) J. Biol. Chem., 269, pp. 6632-6636; Nagase, H., Visse, R., Murphy, G., Structure and function of matrix metalloproteinases and TIMPs (2006) Cardiovasc. Res., 69, pp. 562-573; Oberhammer, F.A., Hochegger, K., Froschl, G., Tiefenbacher, R., Pavelka, M., Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase (1994) J. Cell Biol., 126, pp. 827-837; O'Connell, J.P., Willenbrock, F., Docherty, A.J.P., Eaton, D., Murphy, G., Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B (1994) J. Biol. Chem., 269, pp. 14967-14973; Olson, M.W., Gervasi, D.C., Mobashery, S., Fridman, R., Kinetic analysis of the binding of human matrix metalloproteinase-2 and-9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 (1997) J. Biol. Chem., 272, pp. 29975-29983; Overall, C.M., Molecular determinants of metalloproteinase substrate specificity (2002) Mol. Biotechnol., 22, pp. 51-86; Overall, C.M., King, A.E., Sam, D.K., Ong, A.D., Lau, T.T., Wallon, U.M., DeClerck, Y.A., Atherstone, J., Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis (1999) J. Biol. Chem., 274, pp. 4421-4429; Patterson, M.L., Atkinson, S.J., Knäuper, V., Murphy, G., Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain (2001) FEBS Lett., 503, pp. 158-162; Piccard, H., Van den Steen, P.E., Opdenakker, G., Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins (2007) J. Leukoc. Biol., 81, pp. 870-892; Rosenberg, G.A., Matrix metalloproteinases and their multiple roles in neurodegenerative diseases (2009) Lancet Neurol., 8, pp. 205-216; Rosenblum, G., Van den Steen, P.E., Cohen, S.R., Grossmann, J.G., Frenkel, J., Sertchook, R., Slack, N., Sagi, I., Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B (2007) Structure, 15, pp. 1227-1236; Ruh, M.F., Dunn, R., Ruh, T.S., Interrelationships between nuclear structure and ligand-activated intracellular receptors (1996) Crit. Rev. Eukaryot. Gene Expr., 6, pp. 271-283; Salisbury, J.P., Sîrbulescu, R.F., Moran, B., Auclair, J.R., Zupanc, G.K.H., Agar, J.N., The central nervous system transcriptome of the weakly electric brown ghost knifefish (Apteronotus leptorhynchus): de novo assembly, annotation, and proteomics validation (2015) BMC Genomics, 16, p. 166; Sans-Fons, M.G., Sole, S., Sanfeliu, C., Planas, A.M., Matrix metalloproteinase-9 and cell division in neuroblastoma cells and bone marrow macrophages (2010) Am. J. Pathol., 177, pp. 2870-2885; Sievers, F., Wilm, A., Dineen, D., Gibson, T.J., Karplus, K., Li, W., Lopez, R., Söding, J., Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega (2011) Mol. Syst. Biol., 7, p. 539; Sîrbulescu, R.F., Ilieş, I., Vitalo, A.G., Trull, K., Zhu, J., Traniello, I.M., Zupanc, G.K.H., Adult stem cells in the knifefish cerebellum (2015) Dev. Neurobiol., 75, pp. 39-65; Si-Tayeb, K., Monvoisin, A., Mazzocco, C., Lepreux, S., Decossas, M., Cubel, G., Taras, D., Rosenbaum, J., Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis (2006) Am. J. Pathol., 169, pp. 1390-1401; Sternlicht, M.D., Werb, Z., How matrix metalloproteinases regulate cell behavior (2001) Annu. Rev. Cell Dev. Biol., 17, pp. 463-516; Teles, M.C., Sîrbulescu, R.F., Wellbrock, U.M., Oliveira, R.F., Zupanc, G.K.H., Adult neurogenesis in the brain of the Mozambique tilapia, Oreochromis mossambicus (2012) J. Comp. Physiol. A., 198, pp. 427-449; Traniello, I.M., Sîrbulescu, R.F., Ilieş, I., Zupanc, G.K.H., Age-related changes in stem cell dynamics, neurogenesis, apoptosis, and gliosis in the adult brain: a novel teleost fish model of negligible senescence (2014) Dev. Neurobiol., 74, pp. 514-530; Vaillant, C., Didier-Bazes, M., Hutter, A., Belin, M.F., Thomasset, N., Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum (1999) J. Neurosci., 19, pp. 4994-5004; Vaillant, C., Meissirel, C., Mutin, M., Belin, M.F., Lund, L.R., Thomasset, N., MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum (2003) Mol. Cell. Neurosci., 24, pp. 395-408; Van Wart, H.E., Birkedal-Hansen, H., The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family (1990) Proc. Natl. Acad. Sci. U. S. A., 87, pp. 5578-5582; Verslegers, M., Van Hove, I., Buyens, T., Dekeyster, E., Knevels, E., Moons, L., Identification of MMP-2 as a novel enhancer of cerebellar granule cell proliferation (2013) Mol. Cell. Neurosci., 57, pp. 63-72; Verslegers, M., Van Hove, I., Dekeyster, E., Gantois, I., Hu, T.T., D'Hooge, R., Arckens, L., Moons, L., MMP-2 mediates Purkinje cell morphogenesis and spine development in the mouse cerebellum (2014) Brain Struct. Funct., , (in press); Visse, R., Nagase, H., Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry (2003) Circ. Res., 92, pp. 827-839; Ward, R.V., Atkinson, S.J., Reynolds, J.J., Murphy, G., Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts (1994) Biochem. J., 304, pp. 263-269; Yang, Y., Candelario-Jalil, E., Thompson, J.F., Cuadrado, E., Estrada, E.Y., Rosell, A., Montaner, J., Rosenberg, G.A., Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia (2010) J. Neurochem., 112, pp. 134-149; Yong, V.W., Metalloproteinases: mediators of pathology and regeneration in the CNS (2005) Nat. Rev. Neurosci., 6, pp. 931-944; Yong, V.W., Power, C., Forsyth, P., Edwards, D.R., Metalloproteinases in biology and pathology of the nervous system (2001) Nat. Rev. Neurosci., 2, pp. 502-511; Zhao, W.Q., Li, H., Yamashita, K., Guo, X.K., Hoshino, T., Yoshida, S., Shinya, T., Hayakawa, T., Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts (1998) J. Cell Sci., 111, pp. 1147-1153; Zupanc, G.K.H., Clint, S.C., Potential role of radial glia in adult neurogenesis of teleost fish (2003) Glia, 43, pp. 77-86; Zupanc, G.K.H., Horschke, I., Proliferation zones in the brain of adult gymnotiform fish: a quantitative mapping study (1995) J. Comp. Neurol., 353, pp. 213-233; Zupanc, G.K.H., Horschke, I., Ott, R., Rascher, G.B., Postembryonic development of the cerebellum in gymnotiform fish (1996) J. Comp. Neurol., 370, pp. 443-464; Zupanc, G.K.H., Hinsch, K., Gage, F.H., Proliferation, migration, neuronal differentiation, and long-term survival of new cells in the adult zebrafish brain (2005) J. Comp. Neurol., 488, pp. 290-319; Zupanc, G.K.H., Sîrbulescu, R.F., Ilieş, I., Radial glia in the cerebellum of adult teleost fish: implications for the guidance of migrating new neurons (2012) Neuroscience, 210, pp. 416-430",Article,Scopus,2-s2.0-84925967691
"Lee J.-S., Park J.-C., Kim T.-W., Jung B.-J., Lee Y., Shim E.-K., Park S., Choi E.-Y., Cho K.-S., Kim C.-S.","Human bone marrow stem cells cultured under hypoxic conditions present altered characteristics and enhanced in vivo tissue regeneration",2015,"Bone","78",,,"34","45",,,10.1016/j.bone.2015.04.044,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928943629&partnerID=40&md5=e643ce1983968f918b1e8158aa93d2e7","Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei UniversitySeoul, South Korea; Department of Periodontology, College of Dentistry, Dankook UniversityCheonan, South Korea; Naeun Hospital, NeurosurgerySeoul, South Korea; Department of Bio and Fermentation Convergence Technology, Kookmin UniversitySeoul, South Korea; Biomedical Research Institute, IBMTAnyang, South Korea; Department of Applied Life Science, BK21 PLUS Project, College of Dentistry, Yonsei UniversitySeoul, South Korea","Lee, J.-S., Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei UniversitySeoul, South Korea; Park, J.-C., Department of Periodontology, College of Dentistry, Dankook UniversityCheonan, South Korea; Kim, T.-W., Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei UniversitySeoul, South Korea; Jung, B.-J., Naeun Hospital, NeurosurgerySeoul, South Korea; Lee, Y., Department of Bio and Fermentation Convergence Technology, Kookmin UniversitySeoul, South Korea; Shim, E.-K., Biomedical Research Institute, IBMTAnyang, South Korea; Park, S., Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei UniversitySeoul, South Korea; Choi, E.-Y., Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei UniversitySeoul, South Korea; Cho, K.-S., Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei UniversitySeoul, South Korea; Kim, C.-S., Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei UniversitySeoul, South Korea, Department of Applied Life Science, BK21 PLUS Project, College of Dentistry, Yonsei UniversitySeoul, South Korea","Human bone marrow mesenchymal stem cells (hBMSCs) were isolated from bone marrow of the vertebral body. The hBMSCs were cultured under either hypoxic (1% O<inf>2</inf>) or normoxic (21% O<inf>2</inf>; control) conditions and the characteristics as mesenchymal stem cells were compared. Results revealed that hypoxia reduced proliferative potential and colony-forming efficiency of hBMSCs, and significantly enhanced osteogenic and chondrogenic differentiation. The hBMSCs enhanced the regenerative potential of bone in vivo. In vitro synthesis of soluble and insoluble collagen was significantly increased in the hypoxic condition. In vivo collagen tissue regeneration was also enhanced under the hypoxic condition, with concomitant increased expressions of various subtypes of collagen and lysyl-oxidase family mRNA. MicroRNA assays revealed that miR-155-5p, which negatively regulates HIF-1α, was significantly highly expressed. These observations demonstrate that hBMSCs obtained from human vertebrae exhibit altered characteristics under hypoxic conditions, and each factor contributing to hBMSC-mediated tissue healing should be evaluated with the goal of allowing their clinical application. © 2015 Elsevier Inc.","Hypoxia; Mesenchymal stem cells; Stem cell microenvironment interactions; Tissue regeneration","Delaine-Smith, R.M., Reilly, G.C., Mesenchymal stem cell responses to mechanical stimuli (2012) Muscles Ligaments Tendons J, 2, pp. 169-180; Li, N., Liu, N., Zhou, J., Tang, L., Ding, B., Duan, Y., Inflammatory environment induces gingival tissue-specific mesenchymal stem cells to differentiate towards a pro-fibrotic phenotype (2013) Biol Cell, 105, pp. 261-275; Sen, C.K., Wound healing essentials: let there be oxygen (2009) Wound Repair Regen, 17, pp. 1-18; Haque, N., Rahman, M.T., Abu Kasim, N.H., Alabsi, A.M., Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy (2013) ScientificWorldJournal, 2013, p. 632972; Grunhagen, T., Wilde, G., Soukane, D.M., Shirazi-Adl, S.A., Urban, J.P., Nutrient supply and intervertebral disc metabolism (2006) J Bone Joint Surg Am, 88, pp. 30-35; Chow, D.C., Wenning, L.A., Miller, W.M., Papoutsakis, E.T., Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models (2001) Biophys J, 81, pp. 685-696; Eliasson, P., Jonsson, J.I., The hematopoietic stem cell niche: low in oxygen but a nice place to be (2010) J Cell Physiol, 222, pp. 17-22; Das, R., Jahr, H., van Osch, G.J., Farrell, E., The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches (2010) Tissue Eng Part B Rev, 16, pp. 159-168; Charbord, P., Bone marrow mesenchymal stem cells: historical overview and concepts (2010) Hum Gene Ther, 21, pp. 1045-1056; Tsai, C.C., Yew, T.L., Yang, D.C., Huang, W.H., Hung, S.C., Benefits of hypoxic culture on bone marrow multipotent stromal cells (2012) Am J Blood Res, 2, pp. 148-159; Stamm, C., Westphal, B., Kleine, H.D., Petzsch, M., Kittner, C., Klinge, H., Autologous bone-marrow stem-cell transplantation for myocardial regeneration (2003) Lancet, 361, pp. 45-46; Lennon, D.P., Edmison, J.M., Caplan, A.I., Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis (2001) J Cell Physiol, 187, pp. 345-355; Tandara, A.A., Mustoe, T.A., Oxygen in wound healing-more than a nutrient (2004) World J Surg, 28, pp. 294-300; Park, D.S., Park, J.C., Lee, J.S., Kim, T.W., Kim, K.J., Jung, B.J., Effect of FGF-2 on collagen tissue regeneration by human vertebral bone marrow stem cells (2015) Stem Cells Dev, 24, pp. 228-243; Park, J.C., Kim, J.C., Kim, Y.T., Choi, S.H., Cho, K.S., Im, G.I., Acquisition of human alveolar bone-derived stromal cells using minimally irrigated implant osteotomy: in vitro and in vivo evaluations (2012) J Clin Periodontol, 39, pp. 495-505; Park, J.C., Kim, J.M., Jung, I.H., Kim, J.C., Choi, S.H., Cho, K.S., Isolation and characterization of human periodontal ligament (PDL) stem cells (PDLSCs) from the inflamed PDL tissue: in vitro and in vivo evaluations (2011) J Clin Periodontol, 38, pp. 721-731; Kim, J., Park, J.C., Kim, S.H., Im, G.I., Kim, B.S., Lee, J.B., Treatment of FGF-2 on stem cells from inflamed dental pulp tissue from human deciduous teeth (2014) Oral Dis, 20, pp. 191-204; Baddela, V.S., Baufeld, A., Yenuganti, V.R., Vanselow, J., Singh, D., Suitable housekeeping genes for normalization of transcript abundance analysis by real-time RT-PCR in cultured bovine granulosa cells during hypoxia and differential cell plating density (2014) Reprod Biol Endocrinol, 12, p. 118; Jung, I.H., Park, J.C., Kim, J.C., Jeon, D.W., Choi, S.H., Cho, K.S., Novel application of human periodontal ligament stem cells and water-soluble chitin for collagen tissue regeneration: in vitro and in vivo investigations (2012) Tissue Eng Part A, 18, pp. 643-653; Grayson, W.L., Zhao, F., Bunnell, B., Ma, T., Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells (2007) Biochem Biophys Res Commun, 358, pp. 948-953; Saller, M.M., Prall, W.C., Docheva, D., Schonitzer, V., Popov, T., Anz, D., Increased stemness and migration of human mesenchymal stem cells in hypoxia is associated with altered integrin expression (2012) Biochem Biophys Res Commun, 423, pp. 379-385; Tepper, O.M., Capla, J.M., Galiano, R.D., Ceradini, D.J., Callaghan, M.J., Kleinman, M.E., Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells (2005) Blood, 105, pp. 1068-1077; Basciano, L., Nemos, C., Foliguet, B., de Isla, N., de Carvalho, M., Tran, N., Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status (2011) BMC Cell Biol, 12, p. 12; Weijers, E.M., Van Den Broek, L.J., Waaijman, T., Van Hinsbergh, V.W., Gibbs, S., Koolwijk, P., The influence of hypoxia and fibrinogen variants on the expansion and differentiation of adipose tissue-derived mesenchymal stem cells (2011) Tissue Eng Part A, 17, pp. 2675-2685; Holzwarth, C., Vaegler, M., Gieseke, F., Pfister, S.M., Handgretinger, R., Kerst, G., Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells (2010) BMC Cell Biol, 11, p. 11; Hawkins, K.E., Sharp, T.V., McKay, T.R., The role of hypoxia in stem cell potency and differentiation (2013) Regen Med, 8, pp. 771-782; Jin, Y., Kato, T., Furu, M., Nasu, A., Kajita, Y., Mitsui, H., Mesenchymal stem cells cultured under hypoxia escape from senescence via down-regulation of p16 and extracellular signal regulated kinase (2010) Biochem Biophys Res Commun, 391, pp. 1471-1476; Valorani, M.G., Montelatici, E., Germani, A., Biddle, A., D'Alessandro, D., Strollo, R., Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potentials (2012) Cell Prolif, 45, pp. 225-238; Hung, S.P., Ho, J.H., Shih, Y.R., Lo, T., Lee, O.K., Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells (2012) J Orthop Res, 30, pp. 260-266; Yang, D.C., Yang, M.H., Tsai, C.C., Huang, T.F., Chen, Y.H., Hung, S.C., Hypoxia inhibits osteogenesis in human mesenchymal stem cells through direct regulation of RUNX2 by TWIST (2011) PLoS One, 6, p. e23965; Markowicz, M., Koellensperger, E., Neuss, S., Koenigschulte, S., Bindler, C., Pallua, N., Human bone marrow mesenchymal stem cells seeded on modified collagen improved dermal regeneration in vivo (2006) Cell Transplant, 15, pp. 723-732; Sharp, F.R., Bernaudin, M., HIF1 and oxygen sensing in the brain (2004) Nat Rev Neurosci, 5, pp. 437-448; Ginouves, A., Ilc, K., Macias, N., Pouyssegur, J., Berra, E., PHDs overactivation during chronic hypoxia ""desensitizes"" HIFalpha and protects cells from necrosis (2008) Proc Natl Acad Sci U S A, 105, pp. 4745-4750; Stiehl, D.P., Wirthner, R., Koditz, J., Spielmann, P., Camenisch, G., Wenger, R.H., Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system (2006) J Biol Chem, 281, pp. 23482-23491; Bruning, U., Cerone, L., Neufeld, Z., Fitzpatrick, S.F., Cheong, A., Scholz, C.C., MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia (2011) Mol Cell Biol, 31, pp. 4087-4096",Article,Scopus,2-s2.0-84928943629
"Lutz M., Worschech A., Alb M., Gahn S., Bernhard L., Schwab M., Obermeier S., Einsele H., Kammerer U., Heuschmann P., Klinker E., Otto C., Mielke S.","Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy",2015,"Blood","125","2",,"261","272",,,10.1182/blood-2014-09-601302,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920971354&partnerID=40&md5=e8e5f9cda0767206229f6d6b4e09ded5","Allogeneic Stem Cell Transplantation Program, Department of Internal Medicine II, Würzburg University Medical Center, Oberdürrbacher Strasse 6Würzburg, Germany; Department of Surgery, Würzburg University Medical CenterWürzburg, Germany; Department of Obstetrics and Gynecology, Würzburg University Medical CenterWürzburg, Germany; Institute of Clinical Epidemiology and Biometry, Würzburg University Medical CenterWürzburg, Germany; Institute of Clinical Transfusion Medicine and Hemotherapy, Würzburg University Medical CenterWürzburg, Germany; Department of Genetic Medicine, Weill Cornell Medical College in QatarDoha, Qatar","Lutz, M., Allogeneic Stem Cell Transplantation Program, Department of Internal Medicine II, Würzburg University Medical Center, Oberdürrbacher Strasse 6Würzburg, Germany; Worschech, A., Allogeneic Stem Cell Transplantation Program, Department of Internal Medicine II, Würzburg University Medical Center, Oberdürrbacher Strasse 6Würzburg, Germany, Department of Genetic Medicine, Weill Cornell Medical College in QatarDoha, Qatar; Alb, M., Allogeneic Stem Cell Transplantation Program, Department of Internal Medicine II, Würzburg University Medical Center, Oberdürrbacher Strasse 6Würzburg, Germany; Gahn, S., Allogeneic Stem Cell Transplantation Program, Department of Internal Medicine II, Würzburg University Medical Center, Oberdürrbacher Strasse 6Würzburg, Germany; Bernhard, L., Department of Surgery, Würzburg University Medical CenterWürzburg, Germany; Schwab, M., Department of Obstetrics and Gynecology, Würzburg University Medical CenterWürzburg, Germany; Obermeier, S., Allogeneic Stem Cell Transplantation Program, Department of Internal Medicine II, Würzburg University Medical Center, Oberdürrbacher Strasse 6Würzburg, Germany; Einsele, H., Allogeneic Stem Cell Transplantation Program, Department of Internal Medicine II, Würzburg University Medical Center, Oberdürrbacher Strasse 6Würzburg, Germany; Kämmerer, U., Department of Obstetrics and Gynecology, Würzburg University Medical CenterWürzburg, Germany; Heuschmann, P., Institute of Clinical Epidemiology and Biometry, Würzburg University Medical CenterWürzburg, Germany; Klinker, E., Institute of Clinical Transfusion Medicine and Hemotherapy, Würzburg University Medical CenterWürzburg, Germany; Otto, C., Department of Surgery, Würzburg University Medical CenterWürzburg, Germany; Mielke, S., Allogeneic Stem Cell Transplantation Program, Department of Internal Medicine II, Würzburg University Medical Center, Oberdürrbacher Strasse 6Würzburg, Germany","Donor-derived immunity against tumor-associated antigens (TAAs) may exert selective antileukemic activity reprieving the allogeneic recipient from graft-versus-host disease. As TAAs are highly expressed in placental tissues we hypothesized that pregnancy could drive respective immunity in healthy individuals. Thus,weinvestigated the frequency and level of immune responses against clinically relevant TAAs in 114 blood donors and 44 women during their first pregnancy. Quantitative reverse-transcription polymerase chain reaction was employed to detect low levels of interferon-γ after primary peptide stimulation of CD8+ T lymphocytes. In blood donors, primary immune responses of low and/or high avidity were found againstWT1(15%), MUC1(14%), PRAME(7%), and HER2/neu (5%) and exerted killing functions against leukemic cells.Menhadhigher responses thanwomen,likely due to gonadal cancer-testis-antigen expression. Interestingly, a history of prior deliverywasnot associated with increased responses, whereasthe strongest responses during pregnancy werefound in early trimesters to disappear after delivery. This boost and loss of TAA-specific immunity suggests that virtually every donor harbors the potential to mount antileukemic immune responses in a recipient. However, in the absence of the driving target and a permissive environment, they are short-lived and thus require supplemental strategies such as vaccination or immunomodulation to facilitate their persistence. © 2015 by The American Society of Hematology",,"Weiden, P.L., Flournoy, N., Thomas, E.D., Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts (1979) N Engl J Med, 300 (19), pp. 1068-1073; Sullivan, K.M., Storb, R., Buckner, C.D., Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms (1989) N Engl J Med, 320 (13), pp. 828-834; Horowitz, M.M., Gale, R.P., Sondel, P.M., Graft-versus-leukemia reactions after bone marrow transplantation (1990) Blood, 75 (3), pp. 555-562; Loren, A.W., Bunin, G.R., Boudreau, C., Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation (2006) Biol Blood Marrow Transplant, 12 (7), pp. 758-769; Mutis, T., Verdijk, R., Schrama, E., Esendam, B., Brand, A., Goulmy, E., Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens (1999) Blood, 93 (7), pp. 2336-2341; Feng, X., Hui, K.M., Younes, H.M., Brickner, A.G., Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses (2008) Trends Immunol, 29 (12), pp. 624-632; Falkenburg, J.H., Marijt, W.A., Heemskerk, M.H., Willemze, R., Minor histocompatibility antigens as targets of graft-versus-leukemia reactions (2002) Curr Opin Hematol, 9 (6), pp. 497-502; Falkenburg, J.H., Willemze, R., Minor histocompatibility antigens as targets of cellular immunotherapy in leukaemia (2004) Best Pract Res Clin Haematol, 17 (3), pp. 415-425; Nonn, M., Herr, W., Khan, S., Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering (2008) Transplantation, 86 (10), pp. 1427-1435; Molldrem, J.J., Lee, P.P., Wang, C., Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia (2000) Nat Med, 6 (9), pp. 1018-1023; Rezvani, K., Barrett, A.J., Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation (2008) Best Pract Res Clin Haematol, 21 (3), pp. 437-453; Rezvani, K., Grube, M., Brenchley, J.M., Functional leukemia-associated antigen-specific memory CD81 T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation (2003) Blood, 102 (8), pp. 2892-2900; Molldrem, J.J., Komanduri, K., Wieder, E., Overexpressed differentiation antigens as targets of graft-versus-leukemia reactions (2002) Curr Opin Hematol, 9 (6), pp. 503-508; Morris, E.C., Bendle, G.M., Stauss, H.J., Prospects for immunotherapy of malignant disease (2003) Clin Exp Immunol, 131 (1), pp. 1-7; Natzke, A.M., Shaw, J.L., McKeller, M.R., Emo, K.L., Mullen, C.A., Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease (2007) Biol Blood Marrow Transplant, 13 (1), pp. 34-45; Wrzesinski, C., Paulos, C.M., Gattinoni, L., Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells (2007) J Clin Invest, 117 (2), pp. 492-501; Piper, K.P., McLarnon, A., Arrazi, J., Functional HY-specific CD81 T cells are found in a high proportion of women following pregnancy with a male fetus (2007) Biol Reprod, 76 (1), pp. 96-101; Verdijk, R.M., Kloosterman, A., Pool, J., Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: Implications for stem cell transplantation and immunotherapy (2004) Blood, 103 (5), pp. 1961-1964; Takami, A., Sugimori, C., Feng, X., Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versusleukemia response (2004) Bone Marrow Transplant, 34 (8), pp. 703-709; Nakamura, R., La Rosa, C., Tsai, W., Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients (2014) Transpl Immunol, 30 (4), pp. 128-135; Meden, H., Mielke, S., Schauer, A., Kuhn, W., Serum levels of the c-erbB-2 (HER2/neu) encoded oncoprotein fragment p105 in normal pregnancies (1997) In Vivo, 11 (1), pp. 51-54; Jeschke, U., Richter, D.U., Hammer, A., Briese, V., Friese, K., Karsten, U., Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro (2002) Histochem Cell Biol, 117 (3), pp. 219-226; Ikeda, H., Lethé, B., Lehmann, F., Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor (1997) Immunity, 6 (2), pp. 199-208; Feingold, M., Zilberstein, M., Srivastava, R.K., Seibel, M.M., Bar-Ami, S., Hambartsoumian, E., Expression of Wilms' tumor suppressor gene (WT1) in term human trophoblast: Regulation by cyclic adenosine 39, 5 9-monophosphate (1998) J Clin Endocrinol Metab, 83 (7), pp. 2503-2508; Dietz, A.B., Bulur, P.A., Emery, R.L., A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers (2006) Transfusion, 46 (12), pp. 2083-2089; Fisk, B., Blevins, T.L., Wharton, J.T., Ioannides, C.G., Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines (1995) J Exp Med, 181 (6), pp. 2109-2117; Brossart, P., Schneider, A., Dill, P., The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes (2001) Cancer Res, 61 (18), pp. 6846-6850; Rezvani, K., Yong, A.S., Tawab, A., Ex vivo characterization of polyclonal memory CD81 T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia (2009) Blood, 113 (10), pp. 2245-2255; Salter, R.D., Howell, D.N., Cresswell, P., Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids (1985) Immunogenetics, 21 (3), pp. 235-246; Britten, C.M., Meyer, R.G., Kreer, T., Drexler, I., Wölfel, T., Herr, W., The use of HLA-A∗0201-transfected K562 as standard antigenpresenting cells for CD8(1) T lymphocytes in IFN-gamma ELISPOT assays (2002) J Immunol Methods, 259 (1-2), pp. 95-110; Römer, P.S., Berr, S., Avota, E., Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412 (2011) Blood, 118 (26), pp. 6772-6782; Bleakley, M., Turtle, C.J., Riddell, S.R., Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation (2012) Expert Rev Hematol, 5 (4), pp. 409-425; Gooley, T.A., Chien, J.W., Pergam, S.A., Reduced mortality after allogeneic hematopoietic-cell transplantation (2010) N Engl J Med, 363 (22), pp. 2091-2101; Warren, E.H., Deeg, H.J., Dissecting graft-versusleukemia from graft-versus-host-disease using novel strategies (2013) Tissue Antigens, 81 (4), pp. 183-193; Arora, M., Therapy of chronic graft-versus-host disease (2008) Best Pract Res Clin Haematol, 21 (2), pp. 271-279; Inamoto, Y., Flowers, M.E., Lee, S.J., Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation (2011) Blood, 118 (2), pp. 456-463; Kotsiou, E., Davies, J.K., New ways to separate graft-versus-host disease and graft-versustumour effects after allogeneic haematopoietic stem cell transplantation (2013) Br J Haematol, 160 (2), pp. 133-145; Rezvani, K., Yong, A.S., Savani, B.N., Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia (2007) Blood, 110 (6), pp. 1924-1932; Fujiwara, H., Adoptive T-cell therapy for hematological malignancies using T cells genemodified to express tumor antigen-specific receptors (2014) Int J Hematol, 99 (2), pp. 123-131; Kolb, H.J., Graft-versus-leukemia effects of transplantation and donor lymphocytes (2008) Blood, 112 (12), pp. 4371-4383; Rezvani, K., Brenchley, J.M., Price, D.A., T-cell responses directed against multiple HLA-A∗0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: Identification, quantification, and characterization (2005) Clin Cancer Res, 11 (24), pp. 8799-8807; Weber, G., Karbach, J., Kuçi, S., WT1 peptidespecific T cells generated from peripheral blood of healthy donors: Possible implications for adoptive immunotherapy after allogeneic stem cell transplantation (2009) Leukemia, 23 (9), pp. 1634-1642; Scheibenbogen, C., Letsch, A., Thiel, E., CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia (2002) Blood, 100 (6), pp. 2132-2137; Agrawal, B., Reddish, M.A., Krantz, M.J., Longenecker, B.M., Does pregnancy immunize against breast cancer? (1995) Cancer Res, 55 (11), pp. 2257-2261; Jungbluth, A.A., Silva, W.A., Jr., Iversen, K., Expression of cancer-testis (CT) antigens in placenta (2007) Cancer Immun, 7, p. 15; Lahita, R.G., The effects of sex hormones on the immune system in pregnancy (1992) Am J Reprod Immunol, 28 (3-4), pp. 136-137; Jansson, L., Holmdahl, R., Estrogen-mediated immunosuppression in autoimmune diseases (1998) Inflamm Res, 47 (7), pp. 290-301; Valdimarsson, H., Mulholland, C., Fridriksdottir, V., Coleman, D.V., A longitudinal study of leucocyte blood counts and lymphocyte responses in pregnancy: A marked early increase of monocytelymphocyte ratio (1983) Clin Exp Immunol, 53 (2), pp. 437-443; Inoue, K., Ogawa, H., Sonoda, Y., Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia (1997) Blood, 89 (4), pp. 1405-1412; Rezvani, K., Yong, A.S., Mielke, S., Leukemiaassociated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies (2008) Blood, 111 (1), pp. 236-242; Boon, T., Van Der Bruggen, P., Human tumor antigens recognized by T lymphocytes (1996) J Exp Med, 183 (3), pp. 725-729; Scanlan, M.J., Simpson, A.J., Old, L.J., The cancer/testis genes: Review, standardization, and commentary (2004) Cancer Immun, 4, p. 1; Simpson, A.J., Caballero, O.L., Jungbluth, A., Chen, Y.T., Old, L.J., Cancer/testis antigens, gametogenesis and cancer (2005) Nat Rev Cancer, 5 (8), pp. 615-625; Kohrt, H.E., Müller, A., Baker, J., Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation (2011) Blood, 118 (19), pp. 5319-5329; Bos, R., Marquardt, K.L., Cheung, J., Sherman, L.A., Functional differences between low- and highaffinity CD8(1) T cells in the tumor environment (2012) Oncoimmunology, 1 (8), pp. 1239-1247; Dummer, W., Niethammer, A.G., Baccala, R., T cell homeostatic proliferation elicits effective antitumor autoimmunity (2002) J Clin Invest, 110 (2), pp. 185-192; Smyth, K., Garcia, K., Sun, Z., Tuo, W., Xiao, Z., Repetitive peptide boosting progressively enhances functional memory CTLs (2012) Biochem Biophys Res Commun, 424 (3), pp. 635-640; Mielke, S., McIver, Z.A., Shenoy, A., Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies (2011) Biol Blood Marrow Transplant, 17 (12), pp. 1855-1861; Mielke, S., Nunes, R., Rezvani, K., A clinicalscale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique (2008) Blood, 111 (8), pp. 4392-4402; Nishikawa, H., Sakaguchi, S., Regulatory T cells in cancer immunotherapy (2014) Curr Opin Immunol, 27, pp. 1-7; Hobeika, A.C., Morse, M.A., Osada, T., Peplinski, S., Lyerly, H.K., Clay, T.M., Depletion of human regulatory T cells (2011) Methods Mol Biol, 707, pp. 219-231; Sugiyama, D., Nishikawa, H., Maeda, Y., Anti-CCR4 mAb selectively depletes effector-type FoxP31CD41 regulatory T cells, evoking antitumor immune responses in humans (2013) Proc Natl Acad Sci USA, 110 (44), pp. 17945-17950; Mielke, S., Solomon, S.R., Barrett, A.J., Selective depletion strategies in allogeneic stem cell transplantation (2005) Cytotherapy, 7 (2), pp. 109-115; Resource for Clinical Investigation in Blood and Marrow Transplantation, Alsina, M., Becker, P.S., Zhong, X., Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation (2014) Biol Blood Marrow Transplant, 20 (8), pp. 1183-1189; Suzuki, K., Aida, K., Miyakawa, R., Preimmunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation (2013) Cancer Med, 2 (5), pp. 636-645; Worschech, A., Lutz, M., Methner, L., Correlation of humoral and cellular Cytomegalovirus-specific immune responses in healthy donors: Who is really negative or positive [abstract]? (2011) CIMT Annual Meeting Abstracts, p. 121; Lutz, M., Worschech, A., Gahn, S., Immune responses against the tumor-associated antigens WT1, MUC-1, PRAME and HER2/neu in 114 prospectively screened healthy donors: Effects of gender and prior pregnancy and implications for immunotherapy [abstract] (2012) Blood, 120, p. 4115; Lutz, M., Alb, M., Worschech, A., Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for immunotherapy [abstract] (2013) Blood, 122, p. 4505",Article,Scopus,2-s2.0-84920971354
"Bhattacharya D.","Basophils take a slice of IRF8 pie",2015,"Blood","125","2",,"214","215",,,10.1182/blood-2014-12-612580,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920954779&partnerID=40&md5=50f68126b8ccfa7ddddc4921fbe22fd3","Washington University School of Medicine, United States","Bhattacharya, D., Washington University School of Medicine, United States","In this issue of Blood, Sasaki and colleagues demonstrate a strict requirement for the transcription factor interferon regulator factor 8 (IRF8) in the development of mouse basophils. © 2015 by The American Society of Hematology.",,"Sasaki, H., Kurotaki, D., Osato, N., Transcription factor IRF8 plays a critical role in the development of murine basophils and mast cells (2015) Blood, 125 (2), pp. 358-369; Karasuyama, H., Mukai, K., Obata, K., Tsujimura, Y., Wada, T., Nonredundant roles of basophils in immunity (2011) Annu Rev Immunol, 29, pp. 45-69; Arber, C., Bitmansour, A., Shashidhar, S., Wang, S., Tseng, B., Brown, J.M., Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted (2005) J Infect Dis, 192 (9), pp. 1666-1671; Arinobu, Y., Iwasaki, H., Gurish, M.F., Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis (2005) Proc Natl Acad Sci USA, 102 (50), pp. 18105-18110; Franco, C.B., Chen, C.C., Drukker, M., Weissman, I.L., Galli, S.J., Distinguishing mast cell and granulocyte differentiation at the single-cell level (2010) Cell Stem Cell, 6 (4), pp. 361-368; Becker, A.M., Michael, D.G., Satpathy, A.T., Sciammas, R., Singh, H., Bhattacharya, D., IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors (2012) Blood, 119 (9), pp. 2003-2012; Hambleton, S., Salem, S., Bustamante, J., IRF8 mutations and human dendritic-cell immunodeficiency (2011) N Engl J Med, 365 (2), pp. 127-138; Tamura, T., Nagamura-Inoue, T., Shmeltzer, Z., Kuwata, T., Ozato, K., ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages (2000) Immunity, 13 (2), pp. 155-165; Escalante, C.R., Brass, A.L., Pongubala, J.M., Crystal structure of PU.1/IRF-4/DNA ternary complex (2002) Mol Cell, 10 (5), pp. 1097-1105; Murphy, T.L., Tussiwand, R., Murphy, K.M., Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks (2013) Nat Rev Immunol, 13 (7), pp. 499-509",Review,Scopus,2-s2.0-84920954779
"Chen E., Schneider R.K., Breyfogle L.J., Rosen E.A., Poveromo L., Elf S., Ko A., Brumme K., Levine R., Ebert B.L., Mullally A.","Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms",2015,"Blood","125","2",,"327","335",,2,10.1182/blood-2014-04-567024,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920939031&partnerID=40&md5=84f32d3f7f1cc31bd5d5cc90d474f520","Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1 Blackfan CircleBoston, United States; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer CenterNew York, United States; Broad InstituteCambridge, United States","Chen, E., Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1 Blackfan CircleBoston, United States; Schneider, R.K., Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1 Blackfan CircleBoston, United States; Breyfogle, L.J., Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1 Blackfan CircleBoston, United States; Rosen, E.A., Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1 Blackfan CircleBoston, United States; Poveromo, L., Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1 Blackfan CircleBoston, United States; Elf, S., Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1 Blackfan CircleBoston, United States; Ko, A., Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1 Blackfan CircleBoston, United States; Brumme, K., Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1 Blackfan CircleBoston, United States; Levine, R., Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer CenterNew York, United States; Ebert, B.L., Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1 Blackfan CircleBoston, United States, Broad InstituteCambridge, United States; Mullally, A., Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1 Blackfan CircleBoston, United States, Broad InstituteCambridge, United States","Signaling mutations (eg, JAK2V617F) and mutations in genes involved in epigenetic regulation (eg, TET2) are the most common cooccurring classes of mutations in myeloproliferative neoplasms (MPNs). Clinical correlative studies have demonstrated that TET2 mutations are enriched in more advanced phases of MPNs such as myelofibrosis and leukemic transformation, suggesting that theymay cooperate with JAK2V617F to promote disease progression. Todissect the effects of concomitant Jak2V617F expression and Tet2 loss within distinct hematopoietic compartments in vivo, we generated Jak2V617F/Tet2 compound mutant genetic mice. We found that the combination of Jak2V617F expression and Tet2 loss resulted in a more florid MPN phenotype than that seen with either allele alone. Concordant with this, we found that Tet2 deletion conferred a strong functional competitive advantage to Jak2V617F-mutant hematopoietic stem cells (HSCs). Transcriptional profiling revealed that both Jak2V617F expression and Tet2 loss were associated with distinct and nonoverlapping gene expression signatures within the HSC compartment. In aggregate, our findings indicate that Tet2 loss drives clonal dominance in HSCs, and Jak2V617F expression causes expansion of downstream precursor cell populations, resulting in disease progression through combinatorial effects. This work provides insight into the functional consequences of JAK2V617F-TET2 comutation in MPNs, particularly as it pertains to HSCs. © 2015 by The American Society of Hematology.",,"Walter, M.J., Shen, D., Ding, L., Clonal architecture of secondary acute myeloid leukemia (2012) N Engl J Med, 366 (12), pp. 1090-1098; Cancer Genome Atlas Research Network, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia (2013) N Engl J Med, 368 (22), pp. 2059-2074; Nangalia, J., Massie, C.E., Baxter, E.J., Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2 (2013) N Engl J Med, 369 (25), pp. 2391-2405; Vainchenker, W., Delhommeau, F., Constantinescu, S.N., Bernard, O.A., New mutations and pathogenesis of myeloproliferative neoplasms (2011) Blood, 118 (7), pp. 1723-1735; Baxter, E.J., Scott, L.M., Campbell, P.J., Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders (2005) Lancet, 365 (9464), pp. 1054-1061; James, C., Ugo, V., Le Couédic, J.P., A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera (2005) Nature, 434 (7037), pp. 1144-1148; Kralovics, R., Passamonti, F., Buser, A.S., A gain-of-function mutation of JAK2 in myeloproliferative disorders (2005) N Engl J Med, 352 (17), pp. 1779-1790; Levine, R.L., Wadleigh, M., Cools, J., Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis (2005) Cancer Cell, 7 (4), pp. 387-397; Scott, L.M., Tong, W., Levine, R.L., JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis (2007) N Engl J Med, 356 (5), pp. 459-468; Pikman, Y., Lee, B.H., Mercher, T., MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia (2006) PLoS Med, 3 (7), p. e270; Oh, S.T., Simonds, E.F., Jones, C., Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms (2010) Blood, 116 (6), pp. 988-992; Grand, F.H., Hidalgo-Curtis, C.E., Ernst, T., Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms (2009) Blood, 113 (24), pp. 6182-6192; Klampfl, T., Gisslinger, H., Harutyunyan, A.S., Somatic mutations of calreticulin in myeloproliferative neoplasms (2013) N Engl J Med, 369 (25), pp. 2379-2390; Shih, A.H., Abdel-Wahab, O., Patel, J.P., Levine, R.L., The role of mutations in epigenetic regulators in myeloid malignancies (2012) Nat Rev Cancer, 12 (9), pp. 599-612; Abdel-Wahab, O., Mullally, A., Hedvat, C., Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies (2009) Blood, 114 (1), pp. 144-147; Tefferi, A., Pardanani, A., Lim, K.H., TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis (2009) Leukemia, 23 (5), pp. 905-911; Soucie, E., Hanssens, K., Mercher, T., In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells (2012) Blood, 120 (24), pp. 4846-4849; Lundberg, P., Karow, A., Nienhold, R., Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms (2014) Blood, 123 (14), pp. 2220-2228; Rampal, R., Al-Shahrour, F., Abdel-Wahab, O., Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis (2014) Blood, 123 (22), pp. e123-e133; Mullally, A., Lane, S.W., Brumme, K., Ebert, B.L., Myeloproliferative neoplasm animal models (2012) Hematol Oncol Clin North Am, 26 (5), pp. 1065-1081; Li, J., Kent, D.G., Chen, E., Green, A.R., Mouse models of myeloproliferative neoplasms: JAK of all grades (2011) Dis Model Mech, 4 (3), pp. 311-317; Mullally, A., Lane, S.W., Ball, B., Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells (2010) Cancer Cell, 17 (6), pp. 584-596; Moran-Crusio, K., Reavie, L., Shih, A., Tet2 loss leads to increased hematopoietic stem cell selfrenewal and myeloid transformation (2011) Cancer Cell, 20 (1), pp. 11-24; Georgiades, P., Ogilvy, S., Duval, H., VavCre transgenic mice: A tool for mutagenesis in hematopoietic and endothelial lineages (2002) Genesis, 34 (4), pp. 251-256; Gould, J., Getz, G., Monti, S., Reich, M., Mesirov, J.P., Comparative gene marker selection suite (2006) Bioinformatics, 22 (15), pp. 1924-1925; Subramanian, A., Tamayo, P., Mootha, V.K., Gene set enrichment analysis: A knowledgebased approach for interpreting genome-wide expression profiles (2005) Proc Natl Acad Sci USA, 102 (43), pp. 15545-15550; Wierenga, A.T., Vellenga, E., Schuringa, J.J., Maximal STAT5-induced proliferation and self-renewal at intermediate STAT5 activity levels (2008) Mol Cell Biol, 28 (21), pp. 6668-6680; Krivtsov, A.V., Twomey, D., Feng, Z., Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9 (2006) Nature, 442 (7104), pp. 818-822; Abdel-Wahab, O., Manshouri, T., Patel, J., Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias (2010) Cancer Res, 70 (2), pp. 447-452; Beer, P.A., Delhommeau, F., Lecouédic, J.P., Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm (2010) Blood, 115 (14), pp. 2891-2900; Zhang, S.J., Rampal, R., Manshouri, T., Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome (2012) Blood, 119 (19), pp. 4480-4485; Varricchio, L., Mancini, A., Migliaccio, A.R., Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis (2009) Expert Rev Hematol, 2 (3), pp. 315-334; Mullally, A., Bruedigam, C., Poveromo, L., Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon - A in a murine model of polycythemia vera (2013) Blood, 121 (18), pp. 3692-3702; Mullally, A., Poveromo, L., Schneider, R.K., Al-Shahrour, F., Lane, S.W., Ebert, B.L., Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617Fmediated polycythemia vera (2012) Blood, 120 (1), pp. 166-172; Pronk, C.J., Rossi, D.J., Mansson, R., Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy (2007) Cell Stem Cell, 1 (4), pp. 428-442; Vannucchi, A.M., Lasho, T.L., Guglielmelli, P., Mutations and prognosis in primary myelofibrosis (2013) Leukemia, 27 (9), pp. 1861-1869; Delhommeau, F., Dupont, S., Della Valle, V., Mutation in TET2 in myeloid cancers (2009) N Engl J Med, 360 (22), pp. 2289-2301; Schaub, F.X., Looser, R., Li, S., Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms (2010) Blood, 115 (10), pp. 2003-2007; Campbell, P.J., Baxter, E.J., Beer, P.A., Mutation of JAK2 in the myeloproliferative disorders: Timing, clonality studies, cytogenetic associations, and role in leukemic transformation (2006) Blood, 108 (10), pp. 3548-3555; Theocharides, A., Boissinot, M., Girodon, F., Leukemic blasts in transformed JAK2-V617Fpositive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation (2007) Blood, 110 (1), pp. 375-379; Stein, B.L., Williams, D.M., Rogers, O., Isaacs, M.A., Spivak, J.L., Moliterno, A.R., Disease burden at the progenitor level is a feature of primary myelofibrosis: A multivariable analysis of 164 JAK2 V617F-positive myeloproliferative neoplasm patients (2011) Exp Hematol, 39 (1), pp. 95-101",Article,Scopus,2-s2.0-84920939031
"Benajiba L., Salvado C., Dalle J.-H., Jubert C., Galambrun C., Soulier J., Socie G., De Latour R.P.","HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabine",2015,"Blood","125","2",,"417","418",,,10.1182/blood-2014-10-605113,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84921047833&partnerID=40&md5=a9e4815a4e48a4536f65d0c24795f19e","Service d'Hématologie Greffe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint LouisParis, France; Service d'Hématologie Pédiatrique, Assistance Publique-Hôpitaux de Paris, Hôpital Robert DebréParis, France; Service d'Hématologie Pédiatrique, Centre Hospitalier UniversitaireBordeaux, France; Service d'Hématologie, Centre Hospitalier UniversitaireMarseille, France; Institut National Pour la Santé et la Recherche Médicale U.944, Laboratoire d'Hématologie, Hôpital Saint LouisParis, France; Institut Universitaire d'Hématologie, Université Paris DiderotParis, France; Service d'Hématologie Greffe, Hôpital Saint Louis, 1, Ave Claude VellefauxParis, France","Benajiba, L., Service d'Hématologie Greffe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint LouisParis, France, Service d'Hématologie Greffe, Hôpital Saint Louis, 1, Ave Claude VellefauxParis, France; Salvado, C., Service d'Hématologie Pédiatrique, Assistance Publique-Hôpitaux de Paris, Hôpital Robert DebréParis, France; Dalle, J.-H., Service d'Hématologie Pédiatrique, Centre Hospitalier UniversitaireBordeaux, France; Jubert, C., Service d'Hématologie, Centre Hospitalier UniversitaireMarseille, France; Galambrun, C., Institut National Pour la Santé et la Recherche Médicale U.944, Laboratoire d'Hématologie, Hôpital Saint LouisParis, France; Soulier, J., Institut Universitaire d'Hématologie, Université Paris DiderotParis, France; Socié, G., Service d'Hématologie Greffe, Hôpital Saint Louis, 1, Ave Claude VellefauxParis, France; De Latour, R.P., Service d'Hématologie Greffe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint LouisParis, France",[No abstract available],,"Kutler, D.I., Singh, B., Satagopan, J., A 20-year perspective on the International Fanconi Anemia Registry (IFAR) (2003) Blood, 101 (4), pp. 1249-1256; Gluckman, E., Auerbach, A.D., Horowitz, M.M., Bone marrow transplantation for Fanconi anemia (1995) Blood, 86 (7), pp. 2856-2862; Peffault De Latour, R., Porcher, R., Dalle, J.H., Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: The European Group for Blood and Marrow Transplantation experience (2013) Blood, 122 (26), pp. 4279-4286; Gluckman, E., Devergie, A., Dutreix, J., Radiosensitivity in Fanconi anaemia: Application to the conditioning regimen for bone marrow transplantation (1983) Br J Haematol, 54 (3), pp. 431-440; Medeiros, C., Zanis-Neto, J., Pasquini, R., Bone marrow transplantation for patients with Fanconi anemia: Reduced doses of cyclophosphamide without irradiation as conditioning (1999) Bone Marrow Transplant, 24 (8), pp. 849-852; De La Fuente, J., Reiss, S., McCloy, M., Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors (2003) Bone Marrow Transplant, 32 (7), pp. 653-656; Locatelli, F., Zecca, M., Pession, A., The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: A report from the Italian pediatric group (2007) Haematologica, 92 (10), pp. 1381-1388; Shimada, A., Takahashi, Y., Muramatsu, H., Excellent outcome of allogeneic bone marrow transplantation for Fanconi anemia using fludarabine-based reduced-intensity conditioning regimen (2012) Int J Hematol, 95 (6), pp. 675-679; Stepensky, P., Shapira, M.Y., Balashov, D., Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning (2011) Biol Blood Marrow Transplant, 17 (9), pp. 1282-1288; Bonfim, C.M., De Medeiros, C.R., Bitencourt, M.A., HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide (2007) Biol Blood Marrow Transplant, 13 (12), pp. 1455-1460",Article,Scopus,2-s2.0-84921047833
"Kameda T., Shide K., Yamaji T., Kamiunten A., Sekine M., Taniguchi Y., Hidaka T., Kubuki Y., Shimoda H., Marutsuka K., Sashida G., Aoyama K., Yoshimitsu M., Harada T., Abe H., Miike T., Iwakiri H., Tahara Y., Sueta M., Yamamoto S., Hasuike S., Nagata K., Iwama A., Kitanaka A., Shimoda K.","Loss of TET2 has dual roles in murine myeloproliferative neoplasms: Disease sustainer and disease accelerator",2015,"Blood","125","2",,"304","315",,1,10.1182/blood-2014-04-555508,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920950250&partnerID=40&md5=1df3b4f166a8ba0860d729fa23367fe3","Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Department of Pathology, Faculty of Medicine, University of MiyazakiMiyazaki, Japan; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba UniversityChiba, Japan; Division of Hematology and Immunology, Graduate School of Medical and Dental Sciences, Kagoshima UniversityKagoshima, Japan","Kameda, T., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Shide, K., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Yamaji, T., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Kamiunten, A., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Sekine, M., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Taniguchi, Y., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Hidaka, T., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Kubuki, Y., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Shimoda, H., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Marutsuka, K., Department of Pathology, Faculty of Medicine, University of MiyazakiMiyazaki, Japan; Sashida, G., Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba UniversityChiba, Japan; Aoyama, K., Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba UniversityChiba, Japan; Yoshimitsu, M., Division of Hematology and Immunology, Graduate School of Medical and Dental Sciences, Kagoshima UniversityKagoshima, Japan; Harada, T., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Abe, H., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Miike, T., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Iwakiri, H., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Tahara, Y., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Sueta, M., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Yamamoto, S., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Hasuike, S., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Nagata, K., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Iwama, A., Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba UniversityChiba, Japan; Kitanaka, A., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan; Shimoda, K., Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 KiharaKiyotake, Miyazaki, Japan","Acquired mutations of JAK2 and TET2 are frequent in myeloproliferative neoplasms (MPNs).We examined the individual and cooperative effects of these mutations onMPN development. Recipients of JAK2V617F cells developed primary myelofibrosis-like features; the addition of loss of TET2 worsened this JAK2V617F-induced disease, causing prolonged leukocytosis, splenomegaly, extramedullary hematopoiesis, and modestly shorter survival. Double-mutant (JAK2V617F plus loss of TET2) myeloid cells were more likely to be in a proliferative state than JAK2V617F single-mutant myeloid cells. In a serial competitive transplantation assay, JAK2V617F cells resulted in decreased chimerism in the second recipients, which did not develop MPNs. In marked contrast, cooperation between JAK2V617F and loss of TET2 developed and maintained MPNs in the second recipients by compensating for impaired hematopoietic stem cell (HSC) functioning. In-vitro sequential colony formation assays also supported the observation that JAK2V617F did not maintain HSC functioning over the long-term, but concurrent loss of TET2 mutation restored it. Transcriptional profiling revealed that loss of TET2 affected the expression of many HSC signature genes. We conclude that loss of TET2 has two different roles in MPNs: disease accelerator and disease initiator and sustainer in combination with JAK2V617F. © 2015 by The American Society of Hematology",,"James, C., Ugo, V., Le Couédic, J.P., A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera (2005) Nature, 434 (7037), pp. 1144-1148; Baxter, E.J., Scott, L.M., Campbell, P.J., Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders (2005) Lancet, 365 (9464), pp. 1054-1061; Kralovics, R., Passamonti, F., Buser, A.S., A gain-of-function mutation of JAK2 in myeloproliferative disorders (2005) N Engl J Med, 352 (17), pp. 1779-1790; Levine, R.L., Wadleigh, M., Cools, J., Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis (2005) Cancer Cell, 7 (4), pp. 387-397; Pikman, Y., Lee, B.H., Mercher, T., MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia (2006) PLoS Med, 3 (7), p. e270; Nangalia, J., Massie, C.E., Baxter, E.J., Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2 (2013) N Engl J Med, 369 (25), pp. 2391-2405; Klampfl, T., Gisslinger, H., Harutyunyan, A.S., Somatic mutations of calreticulin in myeloproliferative neoplasms (2013) N Engl J Med, 369 (25), pp. 2379-2390; Scott, L.M., Tong, W., Levine, R.L., JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis (2007) N Engl J Med, 356 (5), pp. 459-468; Pietra, D., Li, S., Brisci, A., Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders (2008) Blood, 111 (3), pp. 1686-1689; Tiedt, R., Hao-Shen, H., Sobas, M.A., Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice (2008) Blood, 111 (8), pp. 3931-3940; Xing, S., Wanting, T.H., Zhao, W., Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice (2008) Blood, 111 (10), pp. 5109-5117; Shide, K., Shimoda, H.K., Kumano, T., Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F (2008) Leukemia, 22 (1), pp. 87-95; Akada, H., Yan, D., Zou, H., Fiering, S., Hutchison, R.E., Mohi, M.G., Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease (2010) Blood, 115 (17), pp. 3589-3597; Marty, C., Lacout, C., Martin, A., Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice (2010) Blood, 116 (5), pp. 783-787; Mullally, A., Lane, S.W., Ball, B., Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells (2010) Cancer Cell, 17 (6), pp. 584-596; Li, J., Spensberger, D., Ahn, J.S., JAK2 V617F impairs hematopoietic stem cell function in a conditional knockin mouse model of JAK2 V617F-positive essential thrombocythemia (2010) Blood, 116 (9), pp. 1528-1538; Kim, E., Abdel-Wahab, O., Focus on the epigenome in the myeloproliferative neoplasms (2013) Hematology Am Soc Hematol Educ Program, 2013, pp. 538-544; Tahiliani, M., Koh, K.P., Shen, Y., Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 (2009) Science, 324 (5929), pp. 930-935; Ko, M., Huang, Y., Jankowska, A.M., Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 (2010) Nature, 468 (7325), pp. 839-843; Koh, K.P., Yabuuchi, A., Rao, S., Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells (2011) Cell Stem Cell, 8 (2), pp. 200-213; Tefferi, A., Pardanani, A., Lim, K.H., TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis (2009) Leukemia, 23 (5), pp. 905-911; Abdel-Wahab, O., Mullally, A., Hedvat, C., Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies (2009) Blood, 114 (1), pp. 144-147; Delhommeau, F., Dupont, S., Della Valle, V., Mutation in TET2 in myeloid cancers (2009) N Engl J Med, 360 (22), pp. 2289-2301; Saint-Martin, C., Leroy, G., Delhommeau, F., Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms (2009) Blood, 114 (8), pp. 1628-1632; Couronné, L., Lippert, E., Andrieux, J., Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias (2010) Leukemia, 24 (1), pp. 201-203; Beer, P.A., Delhommeau, F., LeCouédic, J.P., Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm (2010) Blood, 115 (14), pp. 2891-2900; Abdel-Wahab, O., Manshouri, T., Patel, J., Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias (2010) Cancer Res, 70 (2), pp. 447-452; Li, Z., Cai, X., Cai, C.L., Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies (2011) Blood, 118 (17), pp. 4509-4518; Moran-Crusio, K., Reavie, L., Shih, A., Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation (2011) Cancer Cell, 20 (1), pp. 11-24; Quivoron, C., Couronné, L., Della Valle, V., TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis (2011) Cancer Cell, 20 (1), pp. 25-38; Shide, K., Kameda, T., Shimoda, H., TET2 is essential for survival and hematopoietic stem cell homeostasis (2012) Leukemia, 26 (10), pp. 2216-2223; Shide, K., Kameda, T., Markovtsov, V., R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm (2011) Blood, 117 (25), pp. 6866-6875; Subramanian, A., Tamayo, P., Mootha, V.K., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles (2005) Proc Natl Acad Sci USA, 102 (43), pp. 15545-15550; Hasan, S., Lacout, C., Marty, C., JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα (2013) Blood, 122 (8), pp. 1464-1477; Boggs, D.R., The total marrow mass of the mouse: A simplified method of measurement (1984) Am J Hematol, 16 (3), pp. 277-286; Wierenga, A.T., Vellenga, E., Schuringa, J.J., Maximal STAT5-induced proliferation and self-renewal at intermediate STAT5 activity levels (2008) Mol Cell Biol, 28 (21), pp. 6668-6680; Pronk, C.J., Rossi, D.J., Mansson, R., Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy (2007) Cell Stem Cell, 1 (4), pp. 428-442; Chambers, S.M., Boles, N.C., Lin, K.Y., Hematopoietic fingerprints: An expression database of stem cells and their progeny (2007) Cell Stem Cell, 1 (5), pp. 578-591; Dominici, M., Tadjali, M., Kepes, S., Transgenic mice with pancellular enhanced green fluorescent protein expression in primitive hematopoietic cells and all blood cell progeny (2005) Genesis, 42 (1), pp. 17-22; Wernig, G., Mercher, T., Okabe, R., Levine, R.L., Lee, B.H., Gilliland, D.G., Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model (2006) Blood, 107 (11), pp. 4274-4281; Lacout, C., Pisani, D.F., Tulliez, M., Gachelin, F.M., Vainchenker, W., Villeval, J.L., JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis (2006) Blood, 108 (5), pp. 1652-1660; Zaleskas, V.M., Krause, D.S., Lazarides, K., Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F (2006) PLoS ONE, 1 (1), p. e18; Bumm, T.G.P., Elsea, C., Corbin, A.S., Characterization of murine JAK2V617F-positive myeloproliferative disease (2006) Cancer Res, 66 (23), pp. 11156-11165; Mullally, A., Poveromo, L., Schneider, R.K., Al-Shahrour, F., Lane, S.W., Ebert, B.L., Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera (2012) Blood, 120 (1), pp. 166-172; Lundberg, P., Takizawa, H., Kubovcakova, L., Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F (2014) J Exp Med, 211 (11), pp. 2213-2230; James, C., Mazurier, F., Dupont, S., The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity (2008) Blood, 112 (6), pp. 2429-2438; Williams, D.M., Rogers, O., Morse, S., Single cell analysis of JAK2V617F positive MPN stem/progenitor cells in chronic phase and leukemic transformation (2013) Blood, 122 (21), p. 1609; Abdel-Wahab, O., Gao, J., Adli, M., Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo (2013) J Exp Med, 210 (12), pp. 2641-2659; Mullally, A., Bruedigam, C., Poveromo, L., Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera (2013) Blood, 121 (18), pp. 3692-3702; Schaub, F.X., Looser, R., Li, S., Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms (2010) Blood, 115 (10), pp. 2003-2007",Article,Scopus,2-s2.0-84920950250
"Reinisch A., Etchart N., Thomas D., Hofmann N.A., Fruehwirth M., Sinha S., Chan C.K., Senarath-Yapa K., Seo E.-Y., Wearda T., Hartwig U.F., Beham-Schmid C., Trajanoski S., Lin Q., Wagner W., Dullin C., Alves F., Andreeff M., Weissman I.L., Longaker M.T., Schallmoser K., Majeti R., Strunk D.","Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation",2015,"Blood","125","2",,"249","260",,,10.1182/blood-2014-04-572255,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920973388&partnerID=40&md5=315b0f717dc3dfdccb1fc0d794d7a89c","Stem Cell Research Unit, Medical University of GrazGraz, Austria; Division of Hematology and Stem Cell Transplantation, Department of Internal Medicine, Medical University of GrazGraz, Austria; Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford UniversityStanford, CA, United States; Department of Blood Group Serology and Transfusion Medicine, Medical University of GrazGraz, Austria; Department of Computer Science, Stanford UniversityStanford, CA, United States; Department of Surgery, Stanford School of Medicine, Stanford UniversityStanford, CA, United States; University Medical Center, Third Department of Medicine, Johannes Gutenberg-UniversityMainz, Germany; Institute of Pathology, Medical University of GrazGraz, Austria; Center for Medical Research, Medical University of GrazGraz, Austria; Helmholtz-Institute for Biomedical Engineering, Stem Cell Biology and Cellular Engineering, Rheinisch-Westfälische Technische Hochschule Aachen University Medical SchoolAachen, Germany; Department of Diagnostic and Interventional Radiology, University Medical CenterGoettingen, Germany; Department of Molecular Biology of Neuronal Signals, Max Planck Institute for Experimental MedicineGoettingen, Germany; Department of Hematology and Oncology, University Medical Center GoettingenGoettingen, Germany; Departmentof Stem Cell Transplantation and Cellular Therapy, Molecular Hematology and Therapy and Leukemia, University of Texas MD Anderson Cancer CenterHouston, TX, United States; Department of Pathology, Stanford School of Medicine, Stanford UniversityStanford, CA, United States; Department of Blood Group Serology and Transfusion Medicine, Paracelsus Medical UniversitySalzburg, Austria; Department of Medicine, Stanford School of Medicine, Stanford UniversityStanford, CA, United States; Institute for Experimental and Clinical Cell Therapy, Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical UniversitySalzburg, Austria; Experimental and ClinicalCell Therapy Institute, Spinal Cord and Tissue Regeneration Center Salzburg, Paracelsus Medical University, Strubergasse 22Salzburg, Austria; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, 265 Campus DrStanford, CA, United States","Reinisch, A., Stem Cell Research Unit, Medical University of GrazGraz, Austria, Division of Hematology and Stem Cell Transplantation, Department of Internal Medicine, Medical University of GrazGraz, Austria, Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford UniversityStanford, CA, United States, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, 265 Campus DrStanford, CA, United States; Etchart, N., Stem Cell Research Unit, Medical University of GrazGraz, Austria, Division of Hematology and Stem Cell Transplantation, Department of Internal Medicine, Medical University of GrazGraz, Austria, Department of Blood Group Serology and Transfusion Medicine, Medical University of GrazGraz, Austria; Thomas, D., Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford UniversityStanford, CA, United States; Hofmann, N.A., Stem Cell Research Unit, Medical University of GrazGraz, Austria, Division of Hematology and Stem Cell Transplantation, Department of Internal Medicine, Medical University of GrazGraz, Austria; Fruehwirth, M., Stem Cell Research Unit, Medical University of GrazGraz, Austria, Division of Hematology and Stem Cell Transplantation, Department of Internal Medicine, Medical University of GrazGraz, Austria; Sinha, S., Department of Computer Science, Stanford UniversityStanford, CA, United States; Chan, C.K., Department of Surgery, Stanford School of Medicine, Stanford UniversityStanford, CA, United States; Senarath-Yapa, K., Department of Surgery, Stanford School of Medicine, Stanford UniversityStanford, CA, United States; Seo, E.-Y., Department of Surgery, Stanford School of Medicine, Stanford UniversityStanford, CA, United States; Wearda, T., Department of Surgery, Stanford School of Medicine, Stanford UniversityStanford, CA, United States; Hartwig, U.F., University Medical Center, Third Department of Medicine, Johannes Gutenberg-UniversityMainz, Germany; Beham-Schmid, C., Institute of Pathology, Medical University of GrazGraz, Austria; Trajanoski, S., Center for Medical Research, Medical University of GrazGraz, Austria; Lin, Q., Helmholtz-Institute for Biomedical Engineering, Stem Cell Biology and Cellular Engineering, Rheinisch-Westfälische Technische Hochschule Aachen University Medical SchoolAachen, Germany; Wagner, W., Helmholtz-Institute for Biomedical Engineering, Stem Cell Biology and Cellular Engineering, Rheinisch-Westfälische Technische Hochschule Aachen University Medical SchoolAachen, Germany; Dullin, C., Department of Diagnostic and Interventional Radiology, University Medical CenterGoettingen, Germany; Alves, F., Department of Molecular Biology of Neuronal Signals, Max Planck Institute for Experimental MedicineGoettingen, Germany, Department of Hematology and Oncology, University Medical Center GoettingenGoettingen, Germany; Andreeff, M., Departmentof Stem Cell Transplantation and Cellular Therapy, Molecular Hematology and Therapy and Leukemia, University of Texas MD Anderson Cancer CenterHouston, TX, United States; Weissman, I.L., Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford UniversityStanford, CA, United States, Department of Pathology, Stanford School of Medicine, Stanford UniversityStanford, CA, United States; Longaker, M.T., Department of Surgery, Stanford School of Medicine, Stanford UniversityStanford, CA, United States; Schallmoser, K., Stem Cell Research Unit, Medical University of GrazGraz, Austria, Department of Blood Group Serology and Transfusion Medicine, Medical University of GrazGraz, Austria, Department of Blood Group Serology and Transfusion Medicine, Paracelsus Medical UniversitySalzburg, Austria; Majeti, R., Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford UniversityStanford, CA, United States, Department of Medicine, Stanford School of Medicine, Stanford UniversityStanford, CA, United States; Strunk, D., Stem Cell Research Unit, Medical University of GrazGraz, Austria, Division of Hematology and Stem Cell Transplantation, Department of Internal Medicine, Medical University of GrazGraz, Austria, Institute for Experimental and Clinical Cell Therapy, Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical UniversitySalzburg, Austria, Experimental and ClinicalCell Therapy Institute, Spinal Cord and Tissue Regeneration Center Salzburg, Paracelsus Medical University, Strubergasse 22Salzburg, Austria","In the last decade there has been a rapid expansion in clinical trials using mesenchymal stromal cells (MSCs) from a variety of tissues. However, despite similarities in morphology, immunophenotype, and differentiation behavior in vitro, MSCs sourced from distinct tissues do not necessarily have equivalent biological properties. We performed a genome-wide methylation, transcription, and in vivo evaluation of MSCs from human bone marrow (BM), white adipose tissue, umbilical cord, and skin cultured in humanized media. Surprisingly, only BM-derived MSCs spontaneously formed a BM cavity through a vascularized cartilage intermediate in vivo that was progressively replaced by hematopoietic tissue and bone. Only BM-derived MSCs exhibited a chondrogenic transcriptional program with hypomethylation and increased expression of RUNX3, RUNX2 , BGLAP, MMP13, and ITGA10 consistent with a latent and primed skeletal developmental potential. The humanized MSC-derived microenvironment permitted homing and maintenance of long-term murine SLAM+ hematopoietic stem cells (HSCs), as well as human CD34+/CD38-/CD90+/CD45RA+ HSCs after cord blood transplantation. These studies underscore the profound differences in developmental potential between MSC sources independent of donor age, with implications for their clinical use. We also demonstrate a tractable human niche model for studying homing and engraftment of human hematopoietic cells in normal and neoplastic states. © 2015 by The American Society of Hematology",,"Mendicino, M., Bailey, A.M., Wonnacott, K., Puri, R.K., Bauer, S.R., MSC-based product characterization for clinical trials: An FDA perspective (2014) Cell Stem Cell, 14 (2), pp. 141-145; Park, D., Spencer, J.A., Koh, B.I., Endogenous bone marrow MSCs are dynamic, faterestricted participants in bone maintenance and regeneration (2012) Cell Stem Cell, 10 (3), pp. 259-272; Shi, S., Gronthos, S., Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp (2003) J Bone Miner Res, 18 (4), pp. 696-704; Bonewald, L.F., Harris, S.E., Rosser, J., Von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation (2003) Calcif Tissue Int, 72 (5), pp. 537-547; Battula, V.L., Chen, Y., Cabreira, M.G., Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment (2013) Blood, 122 (3), pp. 357-366; Chen, Y., Jacamo, R., Shi, Y.X., Human extramedullary bone marrow in mice: A novel in vivo model of genetically controlled hematopoietic microenvironment (2012) Blood, 119 (21), pp. 4971-4980; Shao, K., Koch, C., Gupta, M.K., Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles (2013) Mol Ther, 21 (1), pp. 240-250; Tavassoli, M., Crosby, W.H., Transplantation of marrow to extramedullary sites (1968) Science, 161 (3836), pp. 54-56; Friedenstein, A.J., Piatetzky-Shapiro, I.I., Petrakova, K.V., Osteogenesis in transplants of bone marrow cells (1966) J Embryol Exp Morphol, 16 (3), pp. 381-390; Long, F., Building strong bones: Molecular regulation of the osteoblast lineage (2011) Nat Rev Mol Cell Biol, 13 (1), pp. 27-38; Chan, C.K., Chen, C.C., Luppen, C.A., Endochondral ossification is required for haematopoietic stem-cell niche formation (2009) Nature, 457 (7228), pp. 490-494; Scotti, C., Tonnarelli, B., Papadimitropoulos, A., Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering (2010) Proc Natl Acad Sci USA, 107 (16), pp. 7251-7256; Caplan, A.I., Mesenchymal stem cells (1991) J Orthop Res, 9 (5), pp. 641-650; Prockop, D.J., Marrow stromal cells as stem cells for nonhematopoietic tissues (1997) Science, 276 (5309), pp. 71-74; Erices, A., Conget, P., Minguell, J.J., Mesenchymal progenitor cells in human umbilical cord blood (2000) Br J Haematol, 109 (1), pp. 235-242; Reinisch, A., Bartmann, C., Rohde, E., Humanized system to propagate cord bloodderived multipotent mesenchymal stromal cells for clinical application (2007) Regen Med, 2 (4), pp. 371-382; Zuk, P.A., Zhu, M., Ashjian, P., Human adipose tissue is a source of multipotent stem cells (2002) Mol Biol Cell, 13 (12), pp. 4279-4295; Reinisch, A., Strunk, D., Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs) (2009) J Vis Exp, (32); Vaculik, C., Schuster, C., Bauer, W., Human dermis harbors distinct mesenchymal stromal cell subsets (2012) J Invest Dermatol, 132 (3), pp. 563-574; In 'T Anker, P.S., Scherjon, S.A., Kleijburg-van Der Keur, C., Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta (2004) Stem Cells, 22 (7), pp. 1338-1345; Schallmoser, K., Bartmann, C., Rohde, E., Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells (2007) Transfusion, 47 (8), pp. 1436-1446; Schallmoser, K., Rohde, E., Bartmann, C., Obenauf, A.C., Reinisch, A., Strunk, D., Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells (2009) Biomed Mater Eng, 19 (4-5), pp. 271-276; Schallmoser, K., Strunk, D., Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures (2009) J Vis Exp, (32); Schallmoser, K., Rohde, E., Reinisch, A., Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum (2008) Tissue Eng Part C Methods, 14 (3), pp. 185-196; Jakobsen, R.B., Shahdadfar, A., Reinholt, F.P., Brinchmann, J.E., Chondrogenesis in a hyaluronic acid scaffold: Comparison between chondrocytes and MSC from bone marrow and adipose tissue (2010) Knee Surg Sports Traumatol Arthrosc, 18 (10), pp. 1407-1416; Majeti, R., Park, C.Y., Weissman, I.L., Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood (2007) Cell Stem Cell, 1 (6), pp. 635-645; Dennis, G., Jr., Sherman, B.T., Hosack, D.A., DAVID: Database for annotation, visualization, and integrated discovery (2003) Genome Biol, 4 (5), p. 3; Dominici, M., Le Blanc, K., Mueller, I., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement (2006) Cytotherapy, 8 (4), pp. 315-317; Zhang, X., Hirai, M., Cantero, S., Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: Reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue (2011) J Cell Biochem, 112 (4), pp. 1206-1218; Brocher, J., Janicki, P., Voltz, P., Inferior ectopic bone formation of mesenchymal stromal cells from adipose tissue compared to bone marrow: Rescue by chondrogenic pre-induction (2013) Stem Cell Res (Amst), 11 (3), pp. 1393-1406; Zhu, H., Bendall, A.J., Dlx5 is a cell autonomous regulator of chondrocyte hypertrophy in mice and functionally substitutes for Dlx6 during endochondral ossification (2009) PLoS ONE, 4 (11), p. e8097; Wigner, N.A., Soung, Y., Einhorn, T.A., Drissi, H., Gerstenfeld, L.C., Functional role of Runx3 in the regulation of aggrecan expression during cartilage development (2013) J Cell Physiol, 228 (11), pp. 2232-2242; Horvath, S., DNA methylation age of human tissues and cell types (2013) Genome Biol, 14 (10), p. R115; Song, J., Kiel, M.J., Wang, Z., An in vivo model to study and manipulate the hematopoietic stem cell niche (2010) Blood, 115 (13), pp. 2592-2600; Mankani, M.H., Kuznetsov, S.A., Robey, P.G., Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density (2007) Exp Hematol, 35 (6), pp. 995-1004; Scotti, C., Piccinini, E., Takizawa, H., Engineering of a functional bone organ through endochondral ossification (2013) Proc Natl Acad Sci USA, 110 (10), pp. 3997-4002; Kuznetsov, S.A., Krebsbach, P.H., Satomura, K., Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo (1997) J Bone Miner Res, 12 (9), pp. 1335-1347; Sacchetti, B., Funari, A., Michienzi, S., Selfrenewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment (2007) Cell, 131 (2), pp. 324-336; Crisan, M., Yap, S., Casteilla, L., A perivascular origin for mesenchymal stem cells in multiple human organs (2008) Cell Stem Cell, 3 (3), pp. 301-313; Tormin, A., Li, O., Brune, J.C., CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization (2011) Blood, 117 (19), pp. 5067-5077; Battula, V.L., Treml, S., Bareiss, P.M., Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1 (2009) Haematologica, 94 (2), pp. 173-184; Ye, L., Fan, Z., Yu, B., Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs (2012) Cell Stem Cell, 11 (1), pp. 50-61; Bianco, P., Cao, X., Frenette, P.S., The meaning, the sense and the significance: Translating the science of mesenchymal stem cells into medicine (2013) Nat Med, 19 (1), pp. 35-42; Murdoch, A.D., Grady, L.M., Ablett, M.P., Katopodi, T., Meadows, R.S., Hardingham, T.E., Chondrogenic differentiation of human bone marrow stem cells in transwell cultures: Generation of scaffold-free cartilage (2007) Stem Cells, 25 (11), pp. 2786-2796; Serafini, M., Sacchetti, B., Pievani, A., Establishment of bone marrow and hematopoietic niches in vivo by reversion of chondrocyte differentiation of human bone marrow stromal cells (2014) Stem Cell Res (Amst), 12 (3), pp. 659-672; Yamashiro, T., Aberg, T., Levanon, D., Groner, Y., Thesleff, I., Expression of Runx1, -2 and -3 during tooth, palate and craniofacial bone development (2002) Mech Dev, 119, pp. S107-S110; Rongvaux, A., Willinger, T., Martinek, J., Development and function of human innate immune cells in a humanized mouse model (2014) Nat Biotechnol, 32 (4), pp. 364-372; Rongvaux, A., Willinger, T., Takizawa, H., Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo (2011) Proc Natl Acad Sci USA, 108 (6), pp. 2378-2383; Wunderlich, M., Chou, F.S., Link, K.A., AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GMCSF and IL-3 (2010) Leukemia, 24 (10), pp. 1785-1788",Article,Scopus,2-s2.0-84920973388
"Stritt S., Wolf K., Lorenz V., Vogtle T., Gupta S., Bosl M.R., Nieswandt B.","Rap1-GTP-interacting adaptor molecule (RIAM) is dispensable for platelet integrin activation and function in mice",2015,"Blood","125","2",,"219","222",,1,10.1182/blood-2014-08-597542,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920996869&partnerID=40&md5=6171a90dc23aa62485d532d87326ea09","Department of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Josef-Schneider-Strasse 2Würzburg, Germany","Stritt, S., Department of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Josef-Schneider-Strasse 2Würzburg, Germany; Wolf, K., Department of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Josef-Schneider-Strasse 2Würzburg, Germany; Lorenz, V., Department of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Josef-Schneider-Strasse 2Würzburg, Germany; Vögtle, T., Department of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Josef-Schneider-Strasse 2Würzburg, Germany; Gupta, S., Department of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Josef-Schneider-Strasse 2Würzburg, Germany; Bösl, M.R., Department of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Josef-Schneider-Strasse 2Würzburg, Germany; Nieswandt, B., Department of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Josef-Schneider-Strasse 2Würzburg, Germany","Platelet aggregation at sites of vascular injury is essential for hemostasis but also thrombosis. Platelet adhesiveness is critically dependent on agonist-induced inside-out activation of heterodimeric integrin receptors by amechanisminvolving the recruitment of talin-1 to the cytoplasmic integrin tail. Experiments in heterologous cells have suggested a critical role of Rap1-guanosine triphosphate-interacting adaptor molecule (RIAM) for talin-1 recruitment and thus integrin activation, but direct in vivo evidence to support this has been missing. We generated RIAM-null mice and found that they are viable, fertile, and apparently healthy. Unexpectedly, platelets from these mice show unaltered b3- and b1-integrin activation and consequently normal adhesion and aggregation responses under static andflowconditions.Similarly,hemostasis andarterial thrombus formationwere indistinguishable between wild-type and RIAM-nullmice. These results reveal that RIAMis dispensable for integrin activation and function in mouse platelets, strongly suggesting the existence of alternative mechanisms of talin-1 recruitment. © 2015 by The American Society of Hematology.",,"Jackson, S.P., The growing complexity of platelet aggregation (2007) Blood., 109 (12), pp. 5087-5095; Sachs, U.J., Nieswandt, B., In vivo thrombus formation in murine models (2007) Circ Res., 100 (7), pp. 979-991; Shattil, S.J., Newman, P.J., Integrins: Dynamic scaffolds for adhesion and signaling in platelets (2004) Blood., 104 (6), pp. 1606-1615; Nieswandt, B., Varga-Szabo, D., Elvers, M., Integrins in platelet activation (2009) J Thromb Haemost., 7, pp. 206-209; Calderwood, D.A., Campbell, I.D., Critchley, D.R., Talins and kindlins: Partners in integrin-mediated adhesion (2013) Nat Rev Mol Cell Biol., 14 (8), pp. 503-517; Nieswandt, B., Moser, M., Pleines, I., Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo (2007) J Exp Med., 204 (13), pp. 3113-3118; Moser, M., Nieswandt, B., Ussar, S., Pozgajova, M., Fässler, R., Kindlin-3 is essential for integrin activation and platelet aggregation (2008) Nat Med., 14 (3), pp. 325-330; Tadokoro, S., Shattil, S.J., Eto, K., Talin binding to integrin beta tails: A final common step in integrin activation (2003) Science., 302 (5642), pp. 103-106; Han, J., Lim, C.J., Watanabe, N., Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3 (2006) Curr Biol., 16 (18), pp. 1796-1806; Lee, H.S., Lim, C.J., Puzon-Mclaughlin, W., Shattil, S.J., Ginsberg, M.H., RIAM activates integrins by linking talin to ras GTPase membrane-targeting sequences (2009) J Biol Chem., 284 (8), pp. 5119-5127; Watanabe, N., Bodin, L., Pandey, M., Mechanisms and consequences of agonistinduced talin recruitment to platelet integrin alphaIIbbeta3 (2008) J Cell Biol., 181 (7), pp. 1211-1222; Chrzanowska-Wodnicka, M., Smyth, S.S., Schoenwaelder, S.M., Fischer, T.H., White, I.I.G.C., Rap1b is required for normal platelet function and hemostasis in mice (2005) J Clin Invest., 115 (3), pp. 680-687; Wynne, J.P., Wu, J., Su, W., Rap1-interacting adapter molecule (RIAM) associates with the plasma membrane via a proximity detector (2012) J Cell Biol., 199 (2), pp. 317-330; Lafuente, E.M., Van Puijenbroek, A.A., Krause, M., RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1- induced adhesion (2004) Dev Cell., 7 (4), pp. 585-595; Bender, M., Stritt, S., Nurden, P., Megakaryocyte-specific Profilin1-deficiency alters microtubule stability and causes a Wiskott-Aldrich syndrome-like platelet defect (2014) Nat Commun., 5, p. 4746; Kasirer-Friede, A., Kang, J., Kahner, B., Ye, F., Ginsberg, M.H., Shattil, S.J., ADAP interactions with talin and kindlin promote platelet integrin aIIbb3 activation and stable fibrinogen binding (2014) Blood., 123 (20), pp. 3156-3165; Pleines, I., Hagedorn, I., Gupta, S., Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis (2012) Blood., 119 (4), pp. 1054-1063; Grüner, S., Prostredna, M., Aktas, B., Antiglycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy (2004) Circulation., 110 (18), pp. 2946-2951; Bergmeier, W., Schulte, V., Brockhoff, G., Bier, U., Zirngibl, H., Nieswandt, B., Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody (2002) Cytometry., 48 (2), pp. 80-86; Lenter, M., Uhlig, H., Hamann, A., Jenö, P., Imhof, B., Vestweber, D., A monoclonal antibody against an activation epitope on mouse integrin chain beta 1 blocks adhesion of lymphocytes to the endothelial integrin alpha 6 beta 1 (1993) Proc Natl Acad Sci USA., 90 (19), pp. 9051-9055; Crittenden, J.R., Bergmeier, W., Zhang, Y., CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation (2004) Nat Med., 10 (9), pp. 982-986; Hernández-Varas, P., Coló, G.P., Bartolomé, R.A., Rap1-GTP-interacting adaptor molecule (RIAM) protein controls invasion and growth of melanoma cells (2011) J Biol Chem., 286 (21), pp. 18492-18504; Coló, G.P., Hernández-Varas, P., Lock, J., Focal adhesion disassembly is regulated by a RIAM to MEK-1 pathway (2012) J Cell Sci., 125, pp. 5338-5352; Thapa, N., Sun, Y., Schramp, M., Choi, S., Ling, K., Anderson, R.A., Phosphoinositide signaling regulates the exocyst complex and polarized integrin trafficking in directionally migrating cells (2012) Dev Cell., 22 (1), pp. 116-130; Lawson, C., Lim, S.T., Uryu, S., Chen, X.L., Calderwood, D.A., Schlaepfer, D.D., FAK promotes recruitment of talin to nascent adhesions to control cell motility (2012) J Cell Biol., 196 (2), pp. 223-232",Article,Scopus,2-s2.0-84920996869
"Vainchenker W., Plo I.","TET2 loss, a rescue of JAK2V617F HSCs",2015,"Blood","125","2",,"212","213",,,10.1182/blood-2014-10-606624,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920972676&partnerID=40&md5=e3b8a2dc0e1537410054e55399008243","Institut de Cancérologie Gustave Roussy, United States","Vainchenker, W., Institut de Cancérologie Gustave Roussy, United States; Plo, I., Institut de Cancérologie Gustave Roussy, United States","In this issue of Blood, Chen et al1 and Kameda et al2 demonstrate that Tet2 loss has 2 effects in Jak2V617F mice: it increases both the severity of the myeloproliferative disorders and the self-renewal properties of the Jak2V617F hematopoietic stem cells (HSCs). © 2015 by The American Society of Hematology.",,"Chen, E., Schneider, R.K., Breyfogle, L.J., Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms (2015) Blood, 125 (2), pp. 327-335; Kameda, T., Shide, K., Yamaji, T., Loss-of-TET2 has dual roles in myeloproliferative neoplasms: Disease sustainer and disease accelerator (2015) Blood, 125 (2), pp. 304-315; Vainchenker, W., Delhommeau, F., Constantinescu, S.N., Bernard, O.A., New mutations and pathogenesis of myeloproliferative neoplasms (2011) Blood., 118 (7), pp. 1723-1735; Tiedt, R., Hao-Shen, H., Ma, S., Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice (2008) Blood, 111 (8), pp. 3931-3940; Kent, D.G., Li, J., Tanna, H., Self-renewal of single mouse hematopoietic stem cells is reduced by JAK2V617F without compromising progenitor cell expansion (2013) PLoS Biol, 11 (6), p. e1001576; Lundberg, P., Takizawa, H., Kubovcakova, L., Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F (2014) J Exp Med, 211 (11), pp. 2213-2230; Delhommeau, F., Dupont, S., Della Valle, V., Mutation in TET2 in myeloid cancers (2009) N Engl J Med, 360 (22), pp. 2289-2301; Abdel-Wahab, O., Gao, J., Adli, M., Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo (2013) J Exp Med, 210 (12), pp. 2641-2659; Busque, L., Patel, J.P., Figueroa, M.E., Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis (2012) Nat Genet, 44 (11), pp. 1179-1181; Kiladjian, J.J., Massé, A., Et Al., C.B., Clonal analysis of erythroid progenitors suggests that pegylated interferon alpha-2a treatment targets JAK2V617F clones without affecting TET2 mutant cells (2010) Leukemia, 24 (8), pp. 1519-1523",Review,Scopus,2-s2.0-84920972676
"Sinha S., Thomas D., Yu L., Gentles A.J., Jung N., Corces-Zimmerman M.R., Chan S.M., Reinisch A., Feinberg A.P., Dill D.L., Majeti R.","Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibition",2015,"Blood","125","2",,"316","326",,,10.1182/blood-2014-03-566018,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920994589&partnerID=40&md5=e3fd896b4ef01e5ab425e05a48d98ecc","Department of Computer Science, Stanford University, Gates Building 3AStanford, CA, United States; Division of Hematology, Department of Medicine, Stanford University School of MedicineStanford, CA, United States; Cancer Institute, Stanford University School of MedicineStanford, CA, United States; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Lokey Stem Cell Building, 265 Campus DrStanford, CA, United States; Department of Radiology, Stanford UniversityStanford, CA, United States; Center for Epigenetics, Institute for Basic Biomedical Science, Johns Hopkins School of MedicineBaltimore, MD, United States","Sinha, S., Department of Computer Science, Stanford University, Gates Building 3AStanford, CA, United States; Thomas, D., Division of Hematology, Department of Medicine, Stanford University School of MedicineStanford, CA, United States, Cancer Institute, Stanford University School of MedicineStanford, CA, United States, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Lokey Stem Cell Building, 265 Campus DrStanford, CA, United States; Yu, L., Division of Hematology, Department of Medicine, Stanford University School of MedicineStanford, CA, United States, Cancer Institute, Stanford University School of MedicineStanford, CA, United States, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Lokey Stem Cell Building, 265 Campus DrStanford, CA, United States; Gentles, A.J., Department of Radiology, Stanford UniversityStanford, CA, United States; Jung, N., Center for Epigenetics, Institute for Basic Biomedical Science, Johns Hopkins School of MedicineBaltimore, MD, United States; Corces-Zimmerman, M.R., Division of Hematology, Department of Medicine, Stanford University School of MedicineStanford, CA, United States, Cancer Institute, Stanford University School of MedicineStanford, CA, United States, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Lokey Stem Cell Building, 265 Campus DrStanford, CA, United States; Chan, S.M., Division of Hematology, Department of Medicine, Stanford University School of MedicineStanford, CA, United States, Cancer Institute, Stanford University School of MedicineStanford, CA, United States, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Lokey Stem Cell Building, 265 Campus DrStanford, CA, United States; Reinisch, A., Division of Hematology, Department of Medicine, Stanford University School of MedicineStanford, CA, United States, Cancer Institute, Stanford University School of MedicineStanford, CA, United States, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Lokey Stem Cell Building, 265 Campus DrStanford, CA, United States; Feinberg, A.P., Center for Epigenetics, Institute for Basic Biomedical Science, Johns Hopkins School of MedicineBaltimore, MD, United States; Dill, D.L., Department of Computer Science, Stanford University, Gates Building 3AStanford, CA, United States; Majeti, R., Division of Hematology, Department of Medicine, Stanford University School of MedicineStanford, CA, United States, Cancer Institute, Stanford University School of MedicineStanford, CA, United States, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Lokey Stem Cell Building, 265 Campus DrStanford, CA, United States","Acute myeloid leukemia (AML) is associated with deregulation of DNA methylation; however, many cases do not bear mutations in known regulators of cytosine guanine dinucleotide (CpG) methylation. We found that mutations in WT1 , IDH2 , and CEBPA were strongly linked to DNA hypermethylation in AML using a novel integrative analysis of The Cancer Genome Atlas data based on Boolean implications, if-then rules that identify all individual CpG sites that are hypermethylated in the presence of a mutation. Introduction of mutant WT1 (WT1mut) into wild-type AML cells induced DNA hypermethylation, confirming mutant WT1 to be causally associated with DNA hypermethylation. Methylated genes in WT1mut primary patient samples were highly enriched for polycomb repressor complex 2 (PRC2) targets, implicating PRC2 dysregulation in WT1mut leukemogenesis. We found that PRC2 target genes were aberrantly repressed in WT1mut AML, and that expression of mutant WT1 in CD34+ cord blood cells induced myeloid differentiation block. Treatment of WT1mut AML cells with short hairpin RNA or pharmacologic PRC2/ enhancer of zeste homolog 2 (EZH2) inhibitors promoted myeloid differentiation, suggesting EZH2 inhibitors may be active in this AML subtype. Our results highlight a strong association between mutant WT1 and DNA hypermethylation in AML and demonstrate that Boolean implications can be used to decipher mutation-specific methylation patterns that may lead to therapeutic insights. © 2015 by The American Society of Hematology",,"Akalin, A., Garrett-Bakelman, F.E., Kormaksson, M., Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia (2012) PLoS Genet, 8 (6); Figueroa, M.E., Abdel-Wahab, O., Lu, C., Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation (2010) Cancer Cell, 18 (6), pp. 553-567; Moran-Crusio, K., Reavie, L., Shih, A., Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation (2011) Cancer Cell, 20 (1), pp. 11-24; Yan, X.J., Xu, J., Gu, Z.H., Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia (2011) Nat Genet, 43 (4), pp. 309-315; Ley, T.J., Ding, L., Walter, M.J., DNMT3A mutations in acute myeloid leukemia (2010) N Engl J Med, 363 (25), pp. 2424-2433; Shih, A.H., Abdel-Wahab, O., Patel, J.P., Levine, R.L., The role of mutations in epigenetic regulators in myeloid malignancies (2012) Nat Rev Cancer, 12 (9), pp. 599-612; Gal-Yam, E.N., Egger, G., Iniguez, L., Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line (2008) Proc Natl Acad Sci USA, 105 (35), pp. 12979-12984; Gal-Yam, E.N., Saito, Y., Egger, G., Jones, P.A., Cancer epigenetics: Modifications, screening, and therapy (2008) Annu Rev Med, 59, pp. 267-280; Figueroa, M.E., Lugthart, S., Li, Y., DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia (2010) Cancer Cell, 17 (1), pp. 13-27; Welch, J.S., Ley, T.J., Link, D.C., The origin and evolution of mutations in acute myeloid leukemia (2012) Cell, 150 (2), pp. 264-278; Jan, M., Snyder, T.M., Corces-Zimmerman, M.R., Vyas, P., Weissman, I.L., Quake, S.R., Majeti, R., Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia (2012) Sci Transl Med, 4 (149), p. 149ra118; Corces-Zimmerman, M.R., Hong, W.J., Weissman, I.L., Medeiros, B.C., Majeti, R., Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission (2014) Proc Natl Acad Sci USA, 111 (7), pp. 2548-2553; Shlush, L.I., Zandi, S., Mitchell, A., Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia (2014) Nature, 506 (7488), pp. 328-333. , published correction appears in Nature. 2014;508(7496):420; Cancer Genome Atlas Research Network, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia (2013) N Engl J Med, 368 (22), pp. 2059-2074; Sahoo, D., Dill, D.L., Gentles, A.J., Tibshirani, R., Plevritis, S.K., Boolean implication networks derived from large scale, whole genome microarray datasets (2008) Genome Biol, 9 (10), p. R157; Haber, D.A., Buckler, A.J., Glaser, T., An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor (1990) Cell, 61 (7), pp. 1257-1269; Chau, Y.Y., Brownstein, D., Mjoseng, H., Acute multiple organ failure in adult mice deleted for the developmental regulator Wt1 (2011) PLoS Genet, 7 (12), p. e1002404; Virappane, P., Gale, R., Hills, R., Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party (2008) J Clin Oncol, 26 (33), pp. 5429-5435; Summers, K., Stevens, J., Kakkas, I., Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML (2007) Leukemia, 21 (3), pp. 550-551. , author reply 552; King-Underwood, L., Renshaw, J., Pritchard-Jones, K., Mutations in the Wilms' tumor gene WT1 in leukemias (1996) Blood, 87 (6), pp. 2171-2179; Hájková, H., Marková, J., Haškovec, C., Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation (2012) Leuk Res, 36 (9), pp. 1128-1133; Kim, S.J., Zhao, H., Hardikar, S., Singh, A.K., Goodell, M.A., Chen, T., A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells (2013) Blood, 122 (25), pp. 4086-4089; Patel, J.P., Gönen, M., Figueroa, M.E., Prognostic relevance of integrated genetic profiling in acute myeloid leukemia (2012) N Engl J Med, 366 (12), pp. 1079-1089; Russler-Germain, D.A., Spencer, D.H., Young, M.A., The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers (2014) Cancer Cell, 25 (4), pp. 442-454; Subramanian, A., Tamayo, P., Mootha, V.K., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles (2005) Proc Natl Acad Sci USA, 102 (43), pp. 15545-15550; Lee, N., Maurange, C., Ringrose, L., Paro, R., Suppression of Polycomb group proteins by JNK signalling induces transdetermination in Drosophila imaginal discs (2005) Nature, 438 (7065), pp. 234-237; Ku, M., Koche, R.P., Rheinbay, E., Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains (2008) PLoS Genet, 4 (10), p. e1000242; Wu, H., Coskun, V., Tao, J., Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes (2010) Science, 329 (5990), pp. 444-448; Saxonov, S., Berg, P., Brutlag, D.L., A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters (2006) Proc Natl Acad Sci USA, 103 (5), pp. 1412-1417; Ben-Porath, I., Thomson, M.W., Carey, V.J., An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors (2008) Nat Genet, 40 (5), pp. 499-507; An integrated encyclopedia of DNA elements in the human genome (2012) Nature, 489 (7414), pp. 57-74; Becker, H., Marcucci, G., Maharry, K., Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study (2010) Blood, 116 (5), pp. 788-792; Novershtern, N., Subramanian, A., Lawton, L.N., Densely interconnected transcriptional circuits control cell states in human hematopoiesis (2011) Cell, 144 (2), pp. 296-309; McCabe, M.T., Ott, H.M., Ganji, G., EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations (2012) Nature, 492 (7427), pp. 108-112; Shen, H., Laird, P.W., Interplay between the cancer genome and epigenome (2013) Cell, 153 (1), pp. 38-55; Sinha, S., Tsang, E.K., Zeng, H., Meister, M., Dill, D.L., Mining TCGA data using Boolean implications (2014) PLoS ONE, 9 (7), p. e102119; Bert, S.A., Robinson, M.D., Strbenac, D., Regional activation of the cancer genome by long-range epigenetic remodeling (2013) Cancer Cell, 23 (1), pp. 9-22; Tanaka, S., Miyagi, S., Sashida, G., Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia (2012) Blood, 120 (5), pp. 1107-1117; Neff, T., Sinha, A.U., Kluk, M.J., Polycomb repressive complex 2 is required for MLL-AF9 leukemia (2012) Proc Natl Acad Sci USA, 109 (13), pp. 5028-5033",Article,Scopus,2-s2.0-84920994589
"Hsieh W.-C., Mackinnon A.C., Lu W.-Y., Jung J., Boulter L., Henderson N.C., Simpson K.J., Schotanus B., Wojtacha D., Bird T.G., Medine C.N., Hay D.C., Sethi T., Iredale J.P., Forbes S.J.","Galectin-3 regulates hepatic progenitor cell expansion during liver injury",2015,"Gut","64","2",,"312","321",,,10.1136/gutjnl-2013-306290,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920950457&partnerID=40&md5=577a3b7f91122bade8d73ff1827a478a","MRC Centre for Regenerative Medicine, SCRM Building, University of Edinburgh, 5 Little France DriveEdinburgh, United Kingdom; MRC/Centre for Inflammation Research, Queen's Medical Research Institute, University of EdinburghEdinburgh, United Kingdom; Department of Hepatology, Edinburgh Royal InfirmaryEdinburgh, United Kingdom; Department of Respiratory Medicine and Allergy, Kings College Denmark Hill CampusLondon, United Kingdom","Hsieh, W.-C., MRC Centre for Regenerative Medicine, SCRM Building, University of Edinburgh, 5 Little France DriveEdinburgh, United Kingdom; Mackinnon, A.C., MRC Centre for Regenerative Medicine, SCRM Building, University of Edinburgh, 5 Little France DriveEdinburgh, United Kingdom; Lu, W.-Y., MRC Centre for Regenerative Medicine, SCRM Building, University of Edinburgh, 5 Little France DriveEdinburgh, United Kingdom; Jung, J., MRC Centre for Regenerative Medicine, SCRM Building, University of Edinburgh, 5 Little France DriveEdinburgh, United Kingdom; Boulter, L., MRC Centre for Regenerative Medicine, SCRM Building, University of Edinburgh, 5 Little France DriveEdinburgh, United Kingdom; Henderson, N.C., MRC/Centre for Inflammation Research, Queen's Medical Research Institute, University of EdinburghEdinburgh, United Kingdom; Simpson, K.J., Department of Hepatology, Edinburgh Royal InfirmaryEdinburgh, United Kingdom; Schotanus, B., MRC Centre for Regenerative Medicine, SCRM Building, University of Edinburgh, 5 Little France DriveEdinburgh, United Kingdom; Wojtacha, D., MRC Centre for Regenerative Medicine, SCRM Building, University of Edinburgh, 5 Little France DriveEdinburgh, United Kingdom; Bird, T.G., MRC Centre for Regenerative Medicine, SCRM Building, University of Edinburgh, 5 Little France DriveEdinburgh, United Kingdom; Medine, C.N., MRC Centre for Regenerative Medicine, SCRM Building, University of Edinburgh, 5 Little France DriveEdinburgh, United Kingdom; Hay, D.C., MRC Centre for Regenerative Medicine, SCRM Building, University of Edinburgh, 5 Little France DriveEdinburgh, United Kingdom; Sethi, T., Department of Respiratory Medicine and Allergy, Kings College Denmark Hill CampusLondon, United Kingdom; Iredale, J.P., Department of Hepatology, Edinburgh Royal InfirmaryEdinburgh, United Kingdom; Forbes, S.J., MRC Centre for Regenerative Medicine, SCRM Building, University of Edinburgh, 5 Little France DriveEdinburgh, United Kingdom","Objective: Following chronic liver injury or when hepatocyte proliferation is impaired, ductular reactions containing hepatic progenitor cells (HPCs) appear in the periportal regions and can regenerate the liver parenchyma. HPCs exist in a niche composed of myofibroblasts, macrophages and laminin matrix. Galectin-3 (Gal-3) is a β-galactoside-binding lectin that binds to laminin and is expressed in injured liver in mice and humans. Design: We examined the role of Gal-3 in HPC activation. HPC activation was studied following dietary induced hepatocellular (choline-deficient ethioninesupplemented diet) and biliary (3,5-diethoxycarbonyl-1,4-dihydrocollidine supplemented diet) injury in wild type and Gal-3(-/-) mice. Results: HPC proliferation was signi ficantly reduced in Gal-3(-/-) mice. Gal-3(-/-) mice failed to form a HPC niche, with reduced laminin formation. HPCs isolated from wild type mice secrete Gal-3 which enhanced adhesion and proliferation of HPCs on laminin in an undifferentiated form. These effects were attenuated in Gal3(-/-) HPCs and in wild type HPCs treated with the Gal-3 inhibitor lactose. Gal-3( -/-) HPCs in vitro showed increased hepatocyte function and prematurely upregulated both biliary and hepatocyte differentiation markers and regulated cell cycle genes leading to arrest in G0/G1. Conclusions: We conclude that Gal-3 is required for the undifferentiated expansion of HPCs in their niche in injured liver.",,"WHO, (2004) The Global Burden of Disease, , http://www.who.int/healthinfo/global_burden_disease/2004_report_update; Marshall, A., Rushbrook, S., Davies, S.E., Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection (2005) Gastroenterology, 128, pp. 33-42; Diehl, A.M., Chute, J., Underlying potential: Cellular and molecular determinants of adult liver repair (2013) J Clin Invest, 123, pp. 1858-1860; Dorrell, C., Erker, L., Schug, J., Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice (2011) Genes Dev, 25, pp. 1193-1203; Clouston, A.D., Powell, E.E., Walsh, M.J., Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis (2005) Hepatology, 41, pp. 809-818; Richardson, M.M., Jonsson, J.R., Powell, E.E., Progressive fibrosis in nonalcoholic steatohepatitis: Association with altered regeneration and a ductular reaction (2007) Gastroenterology, 133, pp. 80-90; Gouw, A.S., Clouston, A.D., Theise, N.D., Ductular reactions in human liver: Diversity at the interface (2011) Hepatology, 54, pp. 1853-1863; Katoonizadeh, A., Nevens, F., Verslype, C., Liver regeneration in acute severe liver impairment: A clinicopathological correlation study (2006) Liver Int, 26, pp. 1225-1233; Lowes, K.N., Brennan, B.A., Yeoh, G.C., Oval cell numbers in human chronic liver diseases are directly related to disease severity (1999) Am J Pathol, 154, pp. 537-541; Lorenzini, S., Bird, T.G., Boulter, L., Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver (2010) Gut, 59, pp. 645-654; Boulter, L., Govaere, O., Bird, T.G., Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease (2012) Nat Med, 18, pp. 572-579; Terada, T., Nakanuma, Y., Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma (1994) Histopathology, 25, pp. 143-150; Paku, S., Schnur, J., Nagy, P., Origin and structural evolution of the early proliferating oval cells in rat liver (2001) Am J Pathol, 158, pp. 1313-1323; Henderson, N.C., Mackinnon, A.C., Farnworth, S.L., Galectin-3 regulates myofibroblast activation and hepatic fibrosis (2006) Proc Natl Acad Sci USA, 103, pp. 5060-5065; Saravanan, C., Cao, Z., Head, S.R., Detection of differentially expressed wound-healing-related glycogenes in galectin-3-deficient mice (2009) Invest Ophthalmol Vis Sci, 50, pp. 5690-5696; Friedrichs, J., Torkko, J.M., Helenius, J., Contributions of galectin-3 and -9 to epithelial cell adhesion analyzed by single cell force spectroscopy (2007) J Biol Chem, 282, pp. 29375-29383; Friedrichs, J., Manninen, A., Muller, D.J., Galectin-3 regulates integrin alpha2beta1-mediated adhesion to collagen-I and -IV (2008) J Biol Chem, 283, pp. 32264-32272; Lagana, A., Goetz, J.G., Cheung, P., Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells (2006) Mol Cell Biol, 26, pp. 3181-3193; Hsu, D.K., Yang, R.Y., Pan, Z., Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses (2000) Am J Pathol, 156, pp. 1073-1083; Knight, B., Akhurst, B., Matthews, V.B., Attenuated liver progenitor (oval) cell and fibrogenic responses to the choline deficient, ethionine supplemented diet in the BALB/c inbred strain of mice (2007) J Hepatol, 46, pp. 134-141; Ichikawa, S., Mucida, D., Tyznik, A.J., Hepatic stellate cells function as regulatory bystanders (2011) J Immunol, 186, pp. 5549-5555; Bird, T.G., Lu, W.Y., Boulter, L., Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling (2013) Proc Natl Acad Sci USA, 110, pp. 6542-6547; Li, W.L., Su, J., Yao, Y.C., Isolation and characterization of bipotent liver progenitor cells from adult mouse (2006) Stem Cells, 24, pp. 322-332; MacKinnon, A.C., Farnworth, S.L., Hodkinson, P.S., Regulation of alternative macrophage activation by galectin-3 (2008) J Immunol, 180, pp. 2650-2658; Henderson, N.C., Mackinnon, A.C., Farnworth, S.L., Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis (2008) Am J Pathol, 172, pp. 288-298; Volarevic, V., Milovanovic, M., Ljujic, B., Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice (2012) Hepatology, 55, pp. 1954-1964; Dragomir, A.C., Sun, R., Choi, H., Role of galectin-3 in classical and alternative macrophage activation in the liver following acetaminophen intoxication (2012) J Immunol, 189, pp. 5934-5941; Dragomir, A.C., Sun, R., Mishin, V., Role of galectin-3 in acetaminopheninduced hepatotoxicity and inflammatory mediator production (2012) Toxicol Sci, 127, pp. 609-619; Murray, P.J., Wynn, T.A., Protective and pathogenic functions of macrophage subsets (2011) Nat Rev Immunol, 11, pp. 723-737; Bird, T.G., Lorenzini, S., Forbes, S.J., Activation of stem cells in hepatic diseases (2008) Cell Tissue Res, 331, pp. 283-300; Radi, Z.A., Koza-Taylor, P.H., Bell, R.R., Increased serum enzyme levels associated with kupffer cell reduction with no signs of hepatic or skeletal muscle injury (2011) Am J Pathol, 179, pp. 240-247; Clayton, E., Forbes, S.J., The isolation and in vitro expansion of hepatic Sca-1 progenitor cells (2009) Biochem Biophys Res Commun, 381, pp. 549-553; Williams, M.J., Clouston, A.D., Forbes, S.J., Links between hepatic fibrosis, ductular reaction and progenitor cell expansion (2013) Gastroenterology, 146, pp. 349-356; Cheong, T.C., Shin, J.Y., Chun, K.H., Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents (2010) Cancer Sci, 101, pp. 94-102; Kim, H.R., Lin, H.M., Biliran, H., Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells (1999) Cancer Res, 59, pp. 4148-4154; Lin, H.M., Pestell, R.G., Raz, A., Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells (2002) Oncogene, 21, pp. 8001-8010; Wang, X., Foster, M., Al-Dhalimy, M., The origin and liver repopulating capacity of murine oval cells (2003) Proc Natl Acad Sci USA, 100, pp. 11881-11888. , Suppl 1; Ochieng, J., Warfield, P., Green-Jarvis, B., Galectin-3 regulates the adhesive interaction between breast carcinoma cells and elastin (1999) J Cell Biochem, 75, pp. 505-514; Ochieng, J., Leite-Browning, M.L., Warfield, P., Regulation of cellular adhesion to extracellular matrix proteins by galectin-3 (1998) Biochem Biophys Res Commun, 246, pp. 788-791; Ochieng, J., Green, B., Evans, S., Modulation of the biological functions of galectin-3 by matrix metalloproteinases (1998) Biochim Biophys Acta, 1379, pp. 97-106; Goetz, J.G., Joshi, B., Lajoie, P., Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1 (2008) J Cell Biol, 180, pp. 1261-1275; Dong, S., Hughes, R.C., Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen) (1997) Glycoconj J, 14, pp. 267-274; Henderson, N.C., Collis, E.A., Mackinnon, A.C., CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation (2004) J Biol Chem, 279, pp. 54731-54741; Fenczik, C.A., Sethi, T., Ramos, J.W., Complementation of dominant suppression implicates CD98 in integrin activation (1997) Nature, 390, pp. 81-85; Hsu, D.K., Chen, H.Y., Liu, F.T., Galectin-3 regulates T-cell functions (2009) Immunol Rev, 230, pp. 114-127; Haudek, K.C., Spronk, K.J., Voss, P.G., Dynamics of galectin-3 in the nucleus and cytoplasm (2010) Biochim Biophys Acta, 1800, pp. 181-189; Thomas, J.A., Pope, C., Wojtacha, D., Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function (2011) Hepatology, 53, pp. 2003-2015",Article,Scopus,2-s2.0-84920950457
"Nakamura L., Bertling A., Brodde M.F., Stadt U.Z., Schulz A.S., Ammann S., Sandrock-Lang K., Beutel K., Zieger B., Kehrel B.E.","First characterization of platelet secretion defect in patients with familial hemophagocytic lymphohistiocytosis type 3 (FHL-3)",2015,"Blood","125","2",,"412","414",,,10.1182/blood-2014-07-587568,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920973155&partnerID=40&md5=ccd21b7992fb4a564919a02b7393281a","Department of Pediatrics and Adolescent Medicine, University Hospital FreiburgFreiburg, Germany; Department of Anesthesiology, Intensive Care and Pain Medicine, Experimental and Clinical Hemostasis, University of MuensterMuenster, Germany; Center for Diagnostic, University Medical Center Hamburg EppendorfHamburg, Germany; Department of Pediatrics and Adolescent Medicine, University Hospital UlmUlm, Germany; Center for Chronic Immunodeficiency, University of FreiburgFreiburg, Germany; Department of Pediatric Hematology and Oncology, University Hospital MuensterMuenster, Germany; University Hospital Freiburg, Department of Pediatrics and Adolescent Medicine, Mathildenstrasse 1Freiburg, Germany","Nakamura, L., Department of Pediatrics and Adolescent Medicine, University Hospital FreiburgFreiburg, Germany; Bertling, A., Department of Anesthesiology, Intensive Care and Pain Medicine, Experimental and Clinical Hemostasis, University of MuensterMuenster, Germany; Brodde, M.F., Department of Anesthesiology, Intensive Care and Pain Medicine, Experimental and Clinical Hemostasis, University of MuensterMuenster, Germany; Stadt, U.Z., Center for Diagnostic, University Medical Center Hamburg EppendorfHamburg, Germany; Schulz, A.S., Department of Pediatrics and Adolescent Medicine, University Hospital UlmUlm, Germany; Ammann, S., Center for Chronic Immunodeficiency, University of FreiburgFreiburg, Germany; Sandrock-Lang, K., Department of Pediatrics and Adolescent Medicine, University Hospital FreiburgFreiburg, Germany; Beutel, K., Department of Pediatric Hematology and Oncology, University Hospital MuensterMuenster, Germany; Zieger, B., Department of Pediatrics and Adolescent Medicine, University Hospital FreiburgFreiburg, Germany, University Hospital Freiburg, Department of Pediatrics and Adolescent Medicine, Mathildenstrasse 1Freiburg, Germany; Kehrel, B.E., Department of Anesthesiology, Intensive Care and Pain Medicine, Experimental and Clinical Hemostasis, University of MuensterMuenster, Germany",[No abstract available],,"Pachlopnik Schmid, J., Côte, M., Ménager, M.M., Inherited defects in lymphocyte cytotoxic activity[published correction appears in Immunol Rev. 2010;236(1):276] (2010) Immunol Rev, 235 (1), pp. 10-23; Pivot-Pajot, C., Varoqueaux, F., De Saint Basile, G., Bourgoin, S.G., Munc13-4 regulates granule secretion in human neutrophils (2008) J Immunol, 180 (10), pp. 6786-6797; Shirakawa, R., Higashi, T., Tabuchi, A., Munc13-4 is a GTP-Rab27-binding protein regulating dense core granule secretion in platelets (2004) J Biol Chem., 279 (11), pp. 10730-10737; Feldmann, J., Callebaut, I., Raposo, G., Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3) (2003) Cell., 115 (4), pp. 461-473; Ren, Q., Wimmer, C., Chicka, M.C., Munc13-4 is a limiting factor in the pathway required for platelet granule release and hemostasis (2010) Blood., 116 (6), pp. 869-877; Nakao, T., Shimizu, T., Fukushima, T., Fatal sibling cases of familial hemophagocytic lymphohistiocytosis (FHL) with MUNC13-4 mutations: Case reports (2008) Pediatr Hematol Oncol., 25 (3), pp. 171-180; Chen, Y., Wang, Z., Cheng, Y., Tang, Y., Novel mutations in the UNC13D gene carried by a Chinese neonate with hemophagocytic lymphohistiocytosis (2013) Yonsei Med J., 54 (4), pp. 1053-1057; Sandrock, K., Nakamura, L., Vraetz, T., Beutel, K., Ehl, S., Zieger, B., Platelet secretion defect in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) (2010) Blood., 116 (26), pp. 6148-6150; Al Hawas, R., Ren, Q., Ye, S., Karim, Z.A., Filipovich, A.H., Whiteheart, S.W., Munc18b/ STXBP2 is required for platelet secretion (2012) Blood., 120 (12), pp. 2493-2500; Henter, J.I., Horne, A., Aricó, M., HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis (2007) Pediatr Blood Cancer., 48 (2), pp. 124-131",Article,Scopus,2-s2.0-84920973155
"Zhou C., Deng C., Chen X., Zhao X., Chen Y., Fan Y., Zhang X.","Mechanical and biological properties of the micro-/nano-grain functionally graded hydroxyapatite bioceramics for bone tissue engineering",2015,"Journal of the Mechanical Behavior of Biomedical Materials","48",,,"1","11",,,10.1016/j.jmbbm.2015.04.002,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928156416&partnerID=40&md5=be0e1e9ac18b0232b557af67c3a13c48","National Engineering Research Center for Biomaterials, Sichuan UniversityChengdu, China; School of Manufacturing Science and Engineering, Sichuan UniversityChengdu, China","Zhou, C., National Engineering Research Center for Biomaterials, Sichuan UniversityChengdu, China; Deng, C., School of Manufacturing Science and Engineering, Sichuan UniversityChengdu, China; Chen, X., National Engineering Research Center for Biomaterials, Sichuan UniversityChengdu, China; Zhao, X., School of Manufacturing Science and Engineering, Sichuan UniversityChengdu, China; Chen, Y., National Engineering Research Center for Biomaterials, Sichuan UniversityChengdu, China; Fan, Y., National Engineering Research Center for Biomaterials, Sichuan UniversityChengdu, China; Zhang, X., National Engineering Research Center for Biomaterials, Sichuan UniversityChengdu, China","Functionally graded materials (FGM) open the promising approach for bone tissue repair. In this study, a novel functionally graded hydroxyapatite (HA) bioceramic with micrograin and nanograin structure was fabricated. Its mechanical properties were tailored by composition of micrograin and nanograin. The dynamic mechanical analysis (DMA) indicated that the graded HA ceramics had similar mechanical property compared to natural bones. Their cytocompatibility was evaluated via fluorescent microscopy and MTT colorimetric assay. The viability and proliferation of rabbit bone marrow mesenchymal stem cells (BMSCs) on ceramics indicated that this functionally graded HA ceramic had better cytocompatibility than conventional HA ceramic. This study demonstrated that functionally graded HA ceramics create suitable structures to satisfy both the mechanical and biological requirements of bone tissues. © 2015 Elsevier Ltd.","Biological property; Bone tissue engineering; Functionally graded materials; Mechanical property; Two-step sintering","Akbarzadeh, R., Minton, J., Janney, C., Smith, T., James, P., Yousefi, A.M., Hierarchical polymeric scaffolds support the growth of MC3T3-E1 cells (2015) J. Mater. Sci.: Mater. Med., 26, pp. 1-12; Albayrak, O., El-Atwani, O., Altintas, S., Hydroxyapatite coating on titanium substrate by electrophoretic deposition method: effects of titanium dioxide inner layer on adhesion strength and hydroxyapatite decomposition (2008) Surf. Coat. Technol., 202, pp. 2482-2487; Altomare, L., Bellucci, D., Bolelli, G., Bonferroni, B., Cannillo, V., De Nardo, L., Gadow, R., Stiegler, N., Microstructure and in vitro behavior of 45S5 bioglass coatings deposited by high velocity suspension flame spraying (HVSFS) (2011) J. Mater. Sci. Mater. Med., 22, pp. 1303-1319; Balasundaram, G., Sato, M., Webster, T.J., Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD (2006) Biomaterials, 27, pp. 2798-2805; Biggs, M.J., Richards, R.G., Gadegaard, N., McMurray, R.J., Affrossman, S., Wilkinson, C.D., Oreffo, R.O., Dalby, M.J., Interactions with nanoscale topography: adhesion quantification and signal transduction in cells of osteogenic and multipotent lineage (2009) J. Biomed. Mater. Res.. Part A, 91, pp. 195-208; Bolelli, G., Bellucci, D., Cannillo, V., Lusvarghi, L., Sola, A., Stiegler, N., Müller, P., De Nardo, L., Suspension thermal spraying of hydroxyapatite: microstructure and in vitro behaviour (2014) Mater. Sci. Eng. C, 34, pp. 287-303; Bolelli, G., Cannillo, V., Gadow, R., Killinger, A., Lusvarghi, L., Rauch, J., Microstructural and in vitro characterisation of high-velocity suspension flame sprayed (HVSFS) bioactive glass coatings (2009) J. Eur. Ceram. Soc., 29, pp. 2249-2257; Campo, R.D., Savoini, B., Munoz, A., Monge, M.A., Garces, G., Mechanical properties and corrosion behavior of Mg-HAP composites (2014) J. Mech. Behav. Biomed. Mater., 39 C, pp. 238-246; Cannillo, V., Lusvarghi, L., Manfredini, T., Montorsi, M., Siligardi, C., Sola, A., Glass-ceramic functionally graded materials produced with different methods (2007) J. Eur. Ceram. Soc., 27, pp. 1293-1298; Cattini, A., Bellucci, D., Sola, A., Pawłowski, L., Cannillo, V., Suspension plasma spraying of optimised functionally graded coatings of bioactive glass/hydroxyapatite (2013) Surf. Coat. Technol., 236, pp. 118-126; Chen, I.W., Wang, X.H., Sintering dense nanocrystalline ceramics without final-stage grain growth (2000) Nature, 404, pp. 168-171; Chen, L., Tang, C.Y., Tsui, C.P., Chen, D.Z., Mechanical properties and in vitro evaluation of bioactivity and degradation of dexamethasone-releasing poly-d-L-lactide/nano-hydroxyapatite composite scaffolds (2013) J. Mech. Behav. Biomed. Mater., 22, pp. 41-50; Chen, Y., Gan, C.H., Zhang, T.N., Yu, G., Bai, P.C., Kaplan, A., Laser-surface-alloyed carbon nanotubes reinforced hydroxyapatite composite coatings (2005) Appl. Phys. Lett., 86, pp. 251905-251930; Choi, S.W., Zhang, Y., Thomopoulos, S., Xia, Y., In vitro mineralization by preosteoblasts in poly(DL-lactide-co-glycolide) inverse opal scaffolds reinforced with hydroxyapatite nanoparticles (2010) Langmuir: ACS J. Surf. Colloids, 26, pp. 12126-12131; Cui, C., Sun, J., Optimizing the design of bio-inspired functionally graded material (FGM) layer in all-ceramic dental restorations (2014) Dent. Mater. J., 33, pp. 173-178; de Peppo, G.M., Agheli, H., Karlsson, C., Ekstrom, K., Brisby, H., Lenneras, M., Gustafsson, S., Petronis, S., Osteogenic response of human mesenchymal stem cells to well-defined nanoscale topography in vitro (2014) Int. J. Nanomed., 9, pp. 2499-2515; Devis, B., Antonella, S., Alexandre, A., Roberta, S., Luigi, C., Valeria, C., Bioactive glass/hydroxyapatite composites: mechanical properties and biological evaluation (2015) Mater. Sci. Eng. C, 51, pp. 196-205; Dorozhkin, S.V., Nanosized and nanocrystalline calcium orthophosphates (2010) Acta Biomater., 6, pp. 715-734; Gasik, M., Keski-Honkola, A., Bilotsky, Y., Friman, M., Development and optimisation of hydroxyapatite-ss-TCP functionally gradated biomaterial (2014) J. Mech. Behav. Biomed. Mater., 30, pp. 266-273; Ghomi, H., Fathi, M.H., Edris, H., Effect of the composition of hydroxyapatite/bioactive glass nanocomposite foams on their bioactivity and mechanical properties (2012) Mater. Res. Bull., 47, pp. 3523-3532; Goenka, S., Balu, R., Sampath Kumar, T.S., Effects of nanocrystalline calcium deficient hydroxyapatite incorporation in glass ionomer cements (2012) J. Mech. Behav. Biomed. Mater., 7, pp. 69-76; Guo, W.G., Qiu, Z.Y., Cui, H., Wang, C.M., Zhang, X.J., Lee, I.S., Dong, Y.Q., Cui, F.Z., Strength and fatigue properties of three-step sintered dense nanocrystal hydroxyapatite bioceramics (2013) Front. Mater. Sci., 7, pp. 190-195; Gyorgy, E., Grigorescu, S., Socol, G., Mihailescu, I.N., Janackovic, D., Dindune, A., Kanepe, Z., Petrescu, S.M., Bioactive glass and hydroxyapatite thin films obtained by pulsed laser deposition (2007) Appl. Surf. Sci., 253, pp. 7981-7986; Hautamaki, M.P., Puska, M., Aho, A.J., Kopperud, H.M., Vallittu, P.K., Surface modification of fiber reinforced polymer composites and their attachment to bone simulating material (2013) J. Mater. Sci.: Mater. Med., 24, pp. 1145-1150; Hieda, J., Niinomi, M., Nakai, M., Cho, K., Gozawa, T., Katsui, H., Tu, R., Goto, T., Enhancement of adhesive strength of hydroxyapatite films on Ti-29Nb-13Ta-4.6Zr by surface morphology control (2013) J. Mech. Behav. Biomed. Mater., 18, pp. 232-239; Kalbacova, M., Rezek, B., Baresova, V., Wolf-Brandstetter, C., Kromka, A., Nanoscale topography of nanocrystalline diamonds promotes differentiation of osteoblasts (2009) Acta Biomater., 5, pp. 3076-3085; Kandori, K., Kuroda, T., Togashi, S., Katayama, E., Preparation of calcium hydroxyapatite nanoparticles using microreactor and their characteristics of protein adsorption (2011) J. Phys. Chem. B, 115, pp. 653-659; Kim, D.W., Cho, I.S., Kim, J.Y., Jang, H.L., Han, G.S., Ryu, H.S., Shin, H., Hong, K.S., Simple large-scale synthesis of hydroxyapatite nanoparticles: in situ observation of crystallization process (2010) Langmuir: ACS J. Surf. Colloids, 26, pp. 384-388; Kraaij, G., Zadpoor, A.A., Tuijthof, G.J., Dankelman, J., Nelissen, R.G., Valstar, E.R., Mechanical properties of human bone-implant interface tissue in aseptically loose hip implants (2014) J. Mech. Behav. Biomed. Mater., 38, pp. 59-68; Kumar, R.R., Maruno, S., Functionally graded coatings of HA-G-Ti composites and their in vivo studies (2002) Mater. Sci. Eng. A-Struct., 334, pp. 156-162; Lavine, M., Frisk, M., Pennisi, E., Biomaterials introduction (2012) Science, 338, p. 899; Liao, X.L., Xu, W.F., Wang, Y.L., Jia, B., Zhou, G.Y., Effect of porous structure on mechanical properties of C/PLA/nano-HA composites scaffold (2009) Trans. Nonferr. Metals Soc. China, 19, pp. S748-S751; Lin, K.L., Chen, L., Chang, J., Fabrication of dense hydroxyapatite nanobioceramics with enhanced mechanical properties via two-step sintering process (2012) Int. J. Appl. Ceram. Technol., 9, pp. 479-485; Martin, B., Wondraczek, L., Deubener, J., Yue, Y.Z., Mechanically induced excess enthalpy in inorganic glasses (2005) Appl. Phys. Lett., 86, pp. 121917-121924; Maruno, S., Imamura, K., Hanaichi, T., Ban, S., Iwata, H., Itoh, H., Characterization and stability of bioactive HA-G-Ti composite materials and bonding to bone (1994) Bioceramics, 7, pp. 249-254; Maruno, S., Itoh, H., Ban, S., Iwata, H., Ishikawa, T., Micro-observation and characterization of bonding between bone and Ha-glass-titanium functionally gradient composite (1991) Biomaterials, 12, pp. 225-230; Mehdikhani, N.M., Fathi, M.H., Mortazavi, V., Mousavi, S.B., Hashemi-Beni, B., Razavi, S.M., Novel nanocomposite coating for dental implant applications in vitro and in vivo evaluation (2012) J. Mater. Sci. Mater. Med., 23, pp. 485-495; Mehrali, M., Shirazi, F.S., Mehrali, M., Metselaar, H.S., Kadri, N.A., Osman, N.A., Dental implants from functionally graded materials (2013) J. Biomed. Mater. Res. Part A, 101, pp. 3046-3057; Mulargia, S., Dooley, C., Cristofolini, L., Taylor, D., Fracture and fatigue in osteocytes (2014) J. Mech. Behav. Biomed. Mater., 39 C, pp. 231-237; Park, J., Lu, W., Self-assembly of functionally gradient nanoparticle structures (2008) Appl. Phys. Lett., 93, pp. 243109-243114; Pompe, W., Worch, H., Epple, M., Friess, W., Gelinsky, M., Greil, P., Hempel, U., Schulte, K., Functionally graded materials for biomedical applications (2003) Mater. Sci. Eng. A-Struct., 362, pp. 40-60; Qu, S.X., Guo, X., Weng, J., Cheng, J.C., Feng, B., Yeung, H.Y., Zhang, X.D., Evaluation of the expression of collagen type I in porous calcium phosphate ceramics implanted in an extra-osseous site (2004) Biomaterials, 25, pp. 659-667; Rabiei, A., Thomas, B., Jin, C., Narayan, R., Cuomo, J., Yang, Y., Ong, J.L., A study on functionally graded HA coatings processed using ion beam assisted deposition with in situ heat treatment (2006) Surf. Coat. Technol., 200, pp. 6111-6116; Rakngarm Nimkerdphol, A., Otsuka, Y., Mutoh, Y., Effect of dissolution/precipitation on the residual stress redistribution of plasma-sprayed hydroxyapatite coating on titanium substrate in simulated body fluid (SBF) (2014) J. Mech. Behav. Biomed. Mater., 36, pp. 98-108; Rodriguez, R., Loske, A.M., Fernandez, F., Estevez, M., Vargas, S., Fernandez, G., Paredes, M.I., In vivo evaluation of implant-host tissue interaction using morphology-controlled hydroxyapatite-based biomaterials (2011) J. Biomater. Sci. Polym. Ed., 22, pp. 1799-1810; Schagemann, J.C., Kurz, H., Casper, M.E., Stone, J.S., Dadsetan, M., Sun, Y.L., Mrosek, E.H., Reinholz, G., The effect of scaffold composition on the early structural characteristics of chondrocytes and expression of adhesion molecules (2010) Biomaterials, 31, pp. 2798-2805; Shim, J.H., Kim, J.Y., Park, M., Park, J., Cho, D.W., Development of a hybrid scaffold with synthetic biomaterials and hydrogel using solid freeform fabrication technology (2011) Biofabrication, 3, pp. 34102-34111; Stiegler, N., Bellucci, D., Bolelli, G., Cannillo, V., Gadow, R., Killinger, A., Lusvarghi, L., Sola, A., High-velocity suspension flame sprayed (HVSFS) hydroxyapatite coatings for biomedical applications (2012) J. Therm. Spray Technol., 21, pp. 275-287; Wang, C.X., Tong, J., Interfacial strength of novel PMMA/HA/nanoclay bone cement (2008) Bio-Med. Mater. Eng., 18, pp. 367-375; Wang, J., Shaw, L.L., Morphology-enhanced low-temperature sintering of nanocrystalline hydroxyapatite (2007) Adv. Mater., 19, pp. 2364-2369; Wang, X.H., Chen, P.L., Chen, I.W., Two-step sintering of ceramics with constant grain-size Y<inf>2</inf>O<inf>3</inf> (2006) J. Am. Ceram. Soc., 89, pp. 431-437; Watari, F., Yokoyama, A., Omori, M., Hirai, T., Kondo, H., Uo, M., Kawasaki, T., Biocompatibility of materials and development to functionally graded implant for bio-medical application (2004) Compos. Sci. Technol., 64, pp. 893-908; Watari, F., Yokoyama, A., Saso, F., Uo, M., Kawasaki, T., Fabrication and properties of functionally graded dental implant (1997) Compos. B-Eng., 28, pp. 5-11; Zhang, S., Zeng, X.T., Wang, Y.S., Cheng, K., Weng, W.J., Adhesion strength of sol-gel derived fluoridated hydroxyapatite coatings (2006) Surf. Coat. Technol., 200, pp. 6350-6354; Zhang, Y., Sun, M.J., Zhang, D., Designing functionally graded materials with superior load-bearing properties (2012) Acta Biomater., 8, pp. 1101-1108; Zheng, L., Kim, H.M., Low-Rac1 activity downregulates MC3T3-E1 osteoblastic cell motility on a nanoscale topography prepared on polystyrene substrates in vitro (2013) J. Biomed. Mater. Res. A, 101, pp. 1629-1636; Zhitomirskya, D., Roetherb, J.A., Boccaccini, A.R., Zhitomirsky, I., Electrophoretic deposition of bioactive glass/polymer composite coatings with and without HA nanoparticle inclusions for biomedical applications (2009) J. Mater. Process. Technol., 209, pp. 1853-1860; Zhou, C.C., Hong, Y.L., Zhang, X.D., Applications of nanostructured calcium phosphate in tissue engineering (2013) Biomater. Sci., 1, pp. 1012-1028; Zhu, W., Xiao, J., Wang, D., Liu, J., Xiong, J., Liu, L., Zhang, X., Zeng, Y., Experimental study of nano-HA artificial bone with different pore sizes for repairing the radial defect (2009) Int. Orthop., 33, pp. 567-571; Zhu, Y., Wu, H., Sun, S., Zhou, T., Wu, J., Wan, Y., Designed composites for mimicking compressive mechanical properties of articular cartilage matrix (2014) J. Mech. Behav. Biomed. Mater., 36, pp. 32-46",Article,Scopus,2-s2.0-84928156416
"Alvarez B., Escalona Z., Uenishi H., Toki D., Revilla C., Yuste M., del Moral M.G., Alonso F., Ezquerra A., Dominguez J.","Molecular and functional characterization of porcine Siglec-3/CD33 and analysis of its expression in blood and tissues",2015,"Developmental and Comparative Immunology","51","2",,"238","250",,,10.1016/j.dci.2015.04.002,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928723473&partnerID=40&md5=7de5042a37ab18e03fa5978337000edc","Dpto. de Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Ctra de la Coruña Km 7.5Madrid, Spain; National Institute of Agrobiological Sciences (NIAS), 2 IkenodaiTsukuba, Ibaraki, Japan; Institute of Japan Association for Techno-innovation in Agriculture, Forestry and Fisheries, 446-1 Ippaizuka, KamiyokobaTsukuba, Ibaraki, Japan; Dpto. de Biología Celular y de Inmunología, Facultad de Medicina, Universidad Complutense de Madrid, Avda. Complutense s/nMadrid, Spain","Álvarez, B., Dpto. de Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Ctra de la Coruña Km 7.5Madrid, Spain; Escalona, Z., Dpto. de Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Ctra de la Coruña Km 7.5Madrid, Spain; Uenishi, H., National Institute of Agrobiological Sciences (NIAS), 2 IkenodaiTsukuba, Ibaraki, Japan; Toki, D., Institute of Japan Association for Techno-innovation in Agriculture, Forestry and Fisheries, 446-1 Ippaizuka, KamiyokobaTsukuba, Ibaraki, Japan; Revilla, C., Dpto. de Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Ctra de la Coruña Km 7.5Madrid, Spain; Yuste, M., Dpto. de Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Ctra de la Coruña Km 7.5Madrid, Spain; del Moral, M.G., Dpto. de Biología Celular y de Inmunología, Facultad de Medicina, Universidad Complutense de Madrid, Avda. Complutense s/nMadrid, Spain; Alonso, F., Dpto. de Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Ctra de la Coruña Km 7.5Madrid, Spain; Ezquerra, A., Dpto. de Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Ctra de la Coruña Km 7.5Madrid, Spain; Domínguez, J., Dpto. de Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Ctra de la Coruña Km 7.5Madrid, Spain","A cDNA clone encoding a 380 a-a type 1 transmembrane protein with homology to human Siglec-3/CD33 was obtained from a swine small intestine library. An analysis of protein sequence identified two immunoglobulin-like domains, a transmembrane region, and a carboxi-terminal tail with two tyrosine-based signalling motifs. Binding assays of Siglec-3 transfected CHO cells to polyacrylamide glycoconjugates showed a preference for α2-6-linked sialic acids. Using mAbs raised against a fragment containing the two Ig-like domains, porcine Siglec-3 was found to be expressed on monocytes and granulocytes, and their bone marrow precursors. It was also detected in lymph node, splenic and alveolar macrophages. MAbs immunoprecipitated, from granulocyte lysates, a protein of 51-60 kDa under both non-reducing and reducing conditions. MAbs were also used to analyse functional activity of Siglec-3 on bone marrow and blood cells. Engagement of Siglec-3 by mAb had no apparent effect on cell proliferation or cytokine production. © 2015 Elsevier Ltd.","CD33; Monoclonal antibody; Monocyte; Myeloid cells; Siglec-3; Swine","Alvarez, B., Revilla, C., Domenech, N., Perez, C., Martinez, P., Alonso, F., Expression of toll-like receptor 2 (TLR2) in porcine leukocyte subsets and tissues (2008) Vet. Res, 39, p. 13; Andrews, R.G., Torokstorb, B., Bernstein, I.D., Myeloid-associated differentiation antigens on stem-cells and their progeny identified by monoclonal-antibodies (1983) Blood, 62, pp. 124-132; Angata, T., Molecular diversity and evolution of the Siglec family of cell-surface lectins (2006) Mol. Divers, 10, pp. 555-566; Angata, T., Margulies, E.H., Green, E.D., Varki, A., Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms (2004) Proc. Natl. Acad. Sci. U.S.A., 101, pp. 13251-13256; Boyd, C.R., Orr, S.J., Spence, S., Burrows, J.F., Elliott, J., Carroll, H.P., Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production (2009) J. Immunol, 183, pp. 7703-7709; Brinkman-Vand der Linden, E.C.M., Angata, T., Reynolds, S.A., Powell, L.D., Hedrick, S.M., Varki, A., CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice (2003) Mol. Cell. Biol, 23, pp. 4199-4206; Carrasco, C.P., Rigden, R.C., Schaffner, R., Gerber, H., Neuhaus, V., Inumaru, S., Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties (2001) Immunology, 104, pp. 175-184; Chamorro, S., Revilla, C., Gomez, N., Alvarez, B., Alonso, F., Ezquerra, A., In vitro differentiation of porcine blood CD163- and CD163+ monocytes into functional dendritic cells (2004) Immunobiology, 209, pp. 57-65; Chamorro, S., Revilla, C., Alvarez, B., Alonso, F., Ezquerra, A., Dominguez, J., Phenotypic and functional heterogeneity of porcine blood monocytes and its relation with maturation (2005) Immunology, 114, pp. 63-71; Cornish, A.L., Freeman, S., Forbes, G., Ni, J., Zhang, M., Cepeda, M., Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33 (1998) Blood, 92, pp. 2123-2132; Cravens, P.D., Hayashida, K., Davis, L.S., Nanki, T., Lipsky, P.E., Human peripheral blood dendritic cells and monocyte subsets display similar chemokine receptor expression profiles with differential migratory responses (2007) Scand. J. Immunol, 65, pp. 514-524; Crespo, H.J., Cabral, M.G., Teixeira, A.V., Lau, J.T.Y., Trindade, H., Videira, P.A., Effect of sialic acid loss on dendritic cell maturation (2009) Immunology, 128, pp. e621-e631; Crocker, P.R., Varki, A., Siglecs in the immune system (2001) Immunology, 103, pp. 137-145; Crocker, P.R., Paulson, J.C., Varki, A., Siglecs and their roles in the immune system (2007) Nat. Rev. Immunol, 7, pp. 255-266; Escalona, Z., Alvarez, B., Uenishi, H., Toki, D., Yuste, M., Revilla, C., Molecular characterization and expression of porcine Siglec-5 (2014) Dev. Comp. Immunol, 44, pp. 206-216; Escalona, Z., Alvarez, B., Uenishi, H., Toki, D., Yuste, M., Revilla, C., Molecular characterization of porcine Siglec-10 and analysis of its expression in blood and tissues (2015) Dev. Comp. Immunol, 48, pp. 116-123; Ezquerra, A., Revilla, C., Alvarez, B., Perez, C., Alonso, F., Dominguez, J., Porcine myelomonocytic markers and cell populations (2009) Dev. Comp. Immunol, 33, pp. 284-298; Ferlazzo, G., Spaggiari, G.M., Semino, C., Melioli, G., Moretta, L., Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors (2000) Eur. J. Immunol, 30, pp. 827-833; Freeman, S.D., Kelm, S., Barber, E.K., Crocker, P.R., Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules (1995) Blood, 85, pp. 2005-2012; Garnache-Ottou, F., Chaperot, L., Biichle, S., Ferrand, C., Remy-Martin, J.P., Deconinck, E., Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells (2005) Blood, 105, pp. 1256-1264; Ishida, A., Ohta, M., Toda, M., Murata, T., Usui, T., Akita, K., Mucin-induced apoptosis of monocyte-derived dendritic cells during maturation (2008) Proteomics, 8, pp. 3342-3349; Lajaunias, F., Dayer, J.M., Chizzolini, C., Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling (2005) Eur. J. Immunol, 35, pp. 243-251; Lock, K., Zhang, J., Lu, J., Lee, S.H., Crocker, P.R., Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells (2004) Immunobiology, 209, pp. 199-207; Magyar, A., Mihalik, R., Olah, I., The surface phenotype of swine blood and tissue eosinophil granulocytes (1995) Vet. Immunol. Immunopathol, 47, pp. 273-281; Mingari, M.C., Vitale, C., Romagnani, C., Falco, M., Moretta, L., P75/AIRM1 and CD33, two sialoadhesin receptors that regulate the proliferation or the survival of normal and leukemic myeloid cells (2001) Immunol. Rev, 181, pp. 260-268; Moreno, S., Alvarez, B., Martinez, P., Uenishi, H., Revilla, C., Ezquerra, A., Analysis of chemokine receptor CCR7 expression on porcine blood T lymphocytes using a CCL19-Fc fusion protein (2013) Dev. Comp. Immunol, 39, pp. 207-213; Mussa, T., Rodriguez-Carino, C., Pujol, M., Cordoba, L., Busquets, N., Crisci, E., Interaction of porcine conventional dendritic cells with swine influenza virus (2011) Virology, 420, pp. 125-134; O'Reilly, M.K., Paulson, J.C., Multivalent ligands for siglecs (2010) Methods Enzymol, 478, pp. 343-363. , Glycomics 478; Paul, S.P., Taylor, L.S., Stansbury, E.K., McVicar, D.W., Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2 (2000) Blood, 96, pp. 483-490; Perez, C., Moreno, S., Summerfield, A., Domenech, N., Alvarez, B., Correa, C., Characterisation of porcine bone marrow progenitor cells identified by the anti-c-kit (CD117) monoclonal antibody 2B8/BM (2007) J. Immunol. Methods, 321, pp. 70-79; Perez, C., Revilla, C., Alvarez, B., Chamorro, S., Correa, C., Domenech, N., Phenotypic and functional characterization of porcine granulocyte developmental stages using two new markers (2007) Dev. Comp. Immunol, 31, pp. 296-306; Petersen, T.N., Brunak, S., von Heijne, G., Nielsen, H., SignalP 4.0: discriminating signal peptides from transmembrane regions (2011) Nat. Methods, 8, pp. 785-786; Poderoso, T., Martinez, P., Alvarez, B., Handler, A., Moreno, S., Alonso, F., Delivery of antigen to sialoadhesin or CD163 improves the specific immune response in pigs (2011) Vaccine, 29, pp. 4813-4820; Quevillon, E., Silventoinen, V., Pillai, S., Harte, N., Mulder, N., Apweiler, R., InterProScan: protein domains identifier (2005) Nucleic Acids Res, 33, pp. W116-W120; Sidorenko, S.P., Clark, E.A., The dual-function CD150 receptor subfamily: the viral attraction (2003) Nat. Immunol, 4, pp. 19-24; Sigrist, C.J., Cerutti, L., de Castro, E., Langendijk-Genevaux, P.S., Bulliard, V., Bairoch, A., PROSITE, a protein domain database for functional characterization and annotation (2009) Nucleic Acids Res, 38, pp. D161-D166; Stamatos, N.M., Curreli, S., Zella, D., Cross, A.S., Desialylation of glycoconjugates on the surface of monocytes activates the extracellular signal-related kinases ERK 1/2 and results in enhanced production of specific cytokines (2004) J. Leukoc. Biol, 75, pp. 307-313; Taylor, V.C., Buckley, C.D., Douglas, M., Cody, A.J., Simmons, D.L., Freeman, S.D., The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2 (1999) J. Biol. Chem, 274, pp. 11505-11512; Uenishi, H., Eguchi-Ogawa, T., Shinkai, H., Okumura, N., Suzuki, K., Toki, D., PEDE (Pig EST Data Explorer) has been expanded into Pig Expression Data Explorer, including 10 147 porcine full-length cDNA sequences (2007) Nucleic Acids Res, 35, pp. D650-D653; Ulyanova, T., Blasioli, J., Woodford-Thomas, T.A., Thomas, M.L., The sialoadhesin CD33 is a myeloid-specific inhibitory receptor (1999) Eur. J. Immunol, 29, pp. 3440-3449; Varki, A., Angata, T., Siglecs-the major subfamily of I-type lectins (2006) Glycobiology, 16, pp. 1R-27R; Veillette, A., Dong, Z.J., Perez-Quintero, L.A., Zhong, M.C., Cruz-Munoz, M.E., Importance and mechanism of 'switch' function of SAP family adapters (2009) Immunol. Rev, 232, pp. 229-239; Vitale, C., Romagnani, C., Falco, M., Ponte, M., Vitale, M., Moretta, A., Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells (1999) Proc. Natl. Acad. Sci. U.S.A., 96, pp. 15091-15096; Zhang, J., Raper, A., Sugita, N., Hingorani, R., Salio, M., Palmowski, M.J., Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors (2006) Blood, 107, pp. 3600-3608",Article,Scopus,2-s2.0-84928723473
"Chiu W.-H., Depboylu C., Hermanns G., Maurer L., Windolph A., Oertel W.H., Ries V., Hoglinger G.U.","Long-term treatment with l-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease",2015,"Neuropharmacology","95",, 5792,"367","376",,,10.1016/j.neuropharm.2015.03.020,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928802705&partnerID=40&md5=f7fa6e730049e22738fa43d4c99e0188","Department of Neurology, Philipps-University, BaldingerstrasseMarburg, Germany; Department of Neurology, Technical UniversityMunich, Germany; German Center for Neurodegenerative DiseasesMunich, Germany","Chiu, W.-H., Department of Neurology, Philipps-University, BaldingerstrasseMarburg, Germany; Depboylu, C., Department of Neurology, Philipps-University, BaldingerstrasseMarburg, Germany; Hermanns, G., Department of Neurology, Philipps-University, BaldingerstrasseMarburg, Germany; Maurer, L., Department of Neurology, Philipps-University, BaldingerstrasseMarburg, Germany; Windolph, A., Department of Neurology, Philipps-University, BaldingerstrasseMarburg, Germany; Oertel, W.H., Department of Neurology, Philipps-University, BaldingerstrasseMarburg, Germany; Ries, V., Department of Neurology, Philipps-University, BaldingerstrasseMarburg, Germany; Höglinger, G.U., Department of Neurology, Philipps-University, BaldingerstrasseMarburg, Germany, Department of Neurology, Technical UniversityMunich, Germany, German Center for Neurodegenerative DiseasesMunich, Germany","Abstract Non-motor symptoms such as hyposmia and depression are often observed in Parkinson's disease (PD) and can precede the onset of motor symptoms for years. The underlying pathological alterations in the brain are not fully understood so far. Dysregulation of adult neurogenesis in the dentate gyrus of the hippocampus and the olfactory bulb has been recently suggested to be implicated in non-motor symptoms of PD. However, there is so far no direct evidence to support the relationship of non-motor symptoms and the modulation of adult neurogenesis following dopamine depletion and/or dopamine replacement. In this study, we investigated the long-term effects of l-DOPA and pramipexole, a dopamine agonist, in a mouse model of bilateral intranigral 6-OHDA lesion, in order to assess the impact of adult neurogenesis on non-motor behavior. We found that l-DOPA and pramipexole can normalize decreased neurogenesis in the hippocampal dentate gyrus and the periglomerular layer of the olfactory bulb caused by a 6-OHDA lesion. Interestingly, pramipexole showed an antidepressant and anxiolytic effect in the forced swim test and social interaction test. However, there was no significant change in learning and memory function after dopamine depletion and dopamine replacement, respectively. © 2015 Elsevier Ltd. All rights reserved.","6-Hydroxydopamine; Adult neurogenesis; Hippocampal dentate gyrus; l-DOPA; Olfactory bulb; Parkinson's disease; Pramipexole","Altman, J., Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb (1969) J. Comp. Neurol., 137, pp. 433-457; Alvarez-Fischer, D., Henze, C., Strenzke, C., Westrich, J., Ferger, B., Höglinger, G.U., Oertel, W.H., Hartmann, A., Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice (2008) Exp. Neurol., 210, pp. 182-193; Baker, S.A., Baker, K.A., Hagg, T., Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone (2004) Eur. J. Neurosci., 20, pp. 575-579; Barone, P., Poewe, W., Albrecht, S., Debieuvre, C., Massey, D., Rascol, O., Tolosa, E., Weintraub, D., Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial (2010) Lancet Neurol., 9, pp. 573-580; Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., Seitelberger, F., Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations (1973) J. Neurol. Sci., 20, pp. 415-455; Bonito-Oliva, A., Pignatelli, M., Spigolon, G., Yoshitake, T., Seiler, S., Longo, F., Piccinin, S., Fisone, G., Cognitive impairment and dentate gyrus synaptic dysfunction in experimental Parkinsonism (2013) Biol. Psychiatry, 75, pp. 701-710; Borta, A., Hoglinger, G.U., Dopamine and adult neurogenesis (2007) J. Neurochem., 100, pp. 587-595; Branchi, I., D'Andrea, I., Armida, M., Cassano, T., Pezzola, A., Potenza, R.L., Morgese, M.G., Alleva, E., Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model (2008) J. Neurosci. Res., 86, pp. 2050-2061; Braun, A.A., Graham, D.L., Schaefer, T.L., Vorhees, C.V., Williams, M.T., Dorsal striatal dopamine depletion impairs both allocentric and egocentric navigation in rats (2012) Neurobiol. Learn. Mem., 97, pp. 402-408; Brusa, L., Bassi, A., Stefani, A., Pierantozzi, M., Peppe, A., Caramia, M.D., Boffa, L., Stanzione, P., Pramipexole in comparison to l-dopa: a neuropsychological study (2003) J. Neural Transm., 110, pp. 373-380; Burns, K.A., Kuan, C.Y., Low doses of bromo- and iododeoxyuridine produce near-saturation labeling of adult proliferative populations in the dentate gyrus (2005) Eur. J. Neurosci., 21, pp. 803-807; Castro, A.A., Wiemes, B.P., Matheus, F.C., Lapa, F.R., Viola, G.G., Santos, A.R., Tasca, C.I., Prediger, R.D., Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease (2013) Brain Res., 1513, pp. 103-116; Chaudhuri, K.R., Schapira, A.H., Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment (2009) Lancet Neurol., 8, pp. 464-474; Chiu, W.-H., Carlsson, T., Depboylu, C., Höglinger, G.U., Oertel, W.H., Ries, V., Selegiline normalizes, while L-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson's disease (2014) Neuropharmacology, 79, pp. 212-221; Costa, A., Peppe, A., Dell'Agnello, G., Caltagirone, C., Carlesimo, G.A., Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory (2009) Neuropsychologia, 47, pp. 1374-1381; Costa, C., Sgobio, C., Siliquini, S., Tozzi, A., Tantucci, M., Ghiglieri, V., Di Filippo, M., Calabresi, P., Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease (2012) Brain, 135, pp. 1884-1899; Crews, L., Mizuno, H., Desplats, P., Rockenstein, E., Adame, A., Patrick, C., Winner, B., Masliah, E., Alpha-synuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice (2008) J. Neurosci., 28, pp. 4250-4260; Depboylu, C., Maurer, L., Matusch, A., Hermanns, G., Windolph, A., Behe, M., Oertel, W.H., Hoglinger, G.U., Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [(123)I]FP-CIT SPECT and histochemistry (2013) Neuroimage, 79, pp. 191-200; Depboylu, C., Stricker, S., Ghobril, J.P., Oertel, W.H., Priller, J., Hoglinger, G.U., Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease (2012) Exp. Neurol., 238, pp. 183-191; Du, F., Li, R., Huang, Y., Li, X., Le, W., Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons (2005) Eur. J. Neurosci., 22, pp. 2422-2430; Eriksson, P.S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.M., Nordborg, C., Peterson, D.A., Gage, F.H., Neurogenesis in the adult human hippocampus (1998) Nat. Med., 4, pp. 1313-1317; Eskow Jaunarajs, K.L., George, J.A., Bishop, C., L-DOPA-induced dysregulation of extrastrital dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease (2012) Neuroscience, 218, pp. 243-256; Fahn, S., The history of dopamine and levodopa in the treatment of Parkinson's disease (2008) Mov. Disord., 23, pp. S497-S508; Favier, M., Duran, T., Carcenac, C., Drui, G., Savasta, M., Carnicella, S., Pramipexole reverses Parkinson's disease-related motivational deficits in rats (2014) Mov. Disord., 29, pp. 912-920; Ferger, B., Buck, K., Shimasaki, M., Koros, E., Voehringer, P., Buerger, E., Continuous dopaminergic stimulation by pramipexole is effective to treat early morning akinesia in animal models of Parkinson's disease: a pharmacokinetic-pharmacodynamic study using in vivo microdialysis in rats (2010) Synapse, 64, pp. 533-541; Fernandez-Ruiz, J., Doudet, D., Aigner, T.G., Spatial memory improvement by levodopa in Parkinsonian MPTP-treated monkeys (1999) Psychopharmacology, 147, pp. 104-107; Ferro, M.M., Bellissimo, M.I., Anselmo-Franci, J.A., Angellucci, M.E., Canteras, N.S., Da Cunha, C., Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations (2005) J. Neurosci. Methods, 148, pp. 78-87; File, S.E., Seth, P., A review of 25 years of the social interaction test (2003) Eur. J. Pharmacol., 463, pp. 35-53; Freundlieb, N., Francois, C., Tande, D., Oertel, W.H., Hirsch, E.C., Hoglinger, G.U., Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates (2006) J. Neurosci., 26, pp. 2321-2325; Gage, F.H., Mammalian neural stem cells (2000) Science, 287, pp. 1433-1438; Garthe, A., Kempermann, G., An old test for new neurons: refining the Morris water maze to study the functional relevance of adult hippocampal neurogenesis (2013) Front. Neurosci., 7, p. 63; Gasbarri, A., Sulli, A., Packard, M.G., The dopaminergic mesencephalic projections to the hippocampal formation in the rat (1997) Prog. Neuropsychopharmacol. Biol. Psychiatry, 21, pp. 1-22; Heuer, A., Smith, G.A., Lelos, M.J., Lane, E.L., Dunnett, S.B., Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites (2012) Behav. Brain Res., 228, pp. 30-43; Hinkle, K.M., Yue, M., Behrouz, B., Dachsel, J.C., Lincoln, S.J., Bowles, E.E., Beevers, J.E., Melrose, H.L., LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors (2012) Mol. Neurodegener., 7, p. 25; Hiramoto, T., Kanda, Y., Satoh, Y., Takishima, K., Watanabe, Y., Dopamine D2 receptor stimulation promotes the proliferation of neural progenitor cells in adult mouse hippocampus (2007) Neuroreport, 18, pp. 659-664; Hirsch, E., Graybiel, A.M., Agid, Y.A., Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease (1988) Nature, 334, pp. 345-348; Höglinger, G.U., Arias-Carrion, O., Ipach, B., Oertel, W.H., Origin of the dopaminergic innervation of adult neurogenic areas (2014) J. Comp. Neurol., 10, pp. 2336-2348; Höglinger, G.U., Rizk, P., Muriel, M.P., Duyckaerts, C., Oertel, W.H., Caille, I., Hirsch, E.C., Dopamine depletion impairs precursor cell proliferation in Parkinson disease (2004) Nat. Neurosci., 7, pp. 726-735; Honig, H., Antonini, A., Martinez-Martin, P., Forgacs, I., Faye, G.C., Fox, T., Fox, K., Chaudhuri, K.R., Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life (2009) Mov. Disord., 24, pp. 1468-1474; Huisman, E., Uylings, H.B.M., Hoogland, P.V., A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease (2004) Mov. Disord., 19, pp. 687-692; Kern, A., Albarran-Zeckler, R., Walsh, H.E., Smith, R.G., Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism (2012) Neuron, 73, pp. 317-332; Kitagawa, K., Kitamura, Y., Miyazaki, T., Miyaoka, J., Kawasaki, H., Asanuma, M., Sendo, T., Gomita, Y., Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats (2009) Naunyn-Schmied Arch. Pharmacol., 380, pp. 59-66; Kim, H.J., Park, S.Y., Cho, Y.J., Hong, K.S., Cho, J.Y., Seo, S.Y., Lee, D.H., Jeon, B.S., Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment (2009) J. Neurol. Sci., 287, pp. 200-204; Kohl, Z., Winner, B., Ubhi, K., Rockenstein, E., Mante, M., Munch, M., Barlow, C., Winkler, J., Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model (2012) Eur. J. Neurosci., 35, pp. 10-19; Lagos, P., Scorza, C., Monti, J.M., Jantos, H., Reyes-Parada, M., Silveira, R., Ponzoni, A., Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats (1998) Eur. Neuropsychopharmacol., 8, pp. 113-120; Liebsch, G., Linthorst, A.C., Neumann, I.D., Reul, J.M., Holsboer, F., Langraf, R., Behavioral, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behavior (1998) Neuropsychopharmacology, 19, pp. 381-396; Luchtman, D.W., Meng, Q., Song, C., Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease (2012) Behav. Brain Res., 226, pp. 386-396; Marxreiter, F., Ettle, B., May, V.E., Esmer, H., Patrick, C., Kragh, C.L., Klucken, J., Nuber, S., Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice (2013) Neurobiol. Dis., 59 C, pp. 38-51; Merlo, S., Canonico, P.L., Sortino, M.A., Distinct effects of pramipexole on the proliferation of adult mouse sub-ventricular zone-derived cells and the appearance of a neuronal phenotype (2011) Neuropharmacology, 60, pp. 892-900; Ming, G.-L., Song, H., Adult neurogenesis in the mammalian brain: significant answers and significant questions (2011) Neuron, 70, pp. 687-702; Moeller, J.C., Oertel, W.H., Koester, J., Pezzoli, G., Provinciali, L., Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial (2005) Mov. Disord., 20, pp. 602-610; Molloy, S.A., Rowan, E.N., O'Brien, J.T., McKeith, I.G., Wesnes, K., Burn, D.J., Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies (2006) J. Neurol. Neurosurg. Psychiatry, 77, pp. 1323-1328; Mundiñano, I.-C., Caballero, M.-C., Ordóñez, C., Hernandez, M., DiCaudo, C., Marcilla, I., Erro, M.-E., Luquin, M.-R., Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders (2011) Acta Neuropathol., 122, pp. 61-74; Nuber, S., Petrasch-Parwez, E., Winner, B., Winkler, J., Von Horsten, S., Schmidt, T., Boy, J., Riess, O., Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease (2008) J. Neurosci., 28, pp. 2471-2484; O'Keeffe, G.C., Barker, R.A., Caldwell, M.A., Dopaminergic modulation of neurogenesis in the subventricular zone of the adult brain (2009) Cell Cycle, 8, pp. 2888-2894; O'Keeffe, G.C., Tyers, P., Aarsland, D., Dalley, J.W., Barker, R.A., Caldwell, M.A., Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 8754-8759; Park, J.H., Enikolopov, G., Transient elevation of adult hippocampal neurogenesis after dopamine depletion (2010) Exp. Neurol., 222, pp. 267-276; Piercey, M.F., Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease (1998) Clin. Neuropharmacol., 21, pp. 141-151; Porsolt, R.D., Le Pichon, M., Jalfre, M., Depression: a new animal model sensitive to antidepressant treatments (1977) Nature, 266, pp. 730-732; Pothakos, K., Kurz, M.J., Lau, Y.S., Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration (2009) BMC Neurosci., 10, p. 6; Presgraves, S.P., Borwege, S., Millan, M.J., Joyce, J.N., Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells (2004) Exp. Neurol., 190, pp. 157-170; Rektorova, I., Rektor, I., Bares, M., Dostal, V., Ehler, E., Fanfrdlova, Z., Fiedler, J., Veliskova, J., Cognitive performance in people with Parkinson's disease and mild or moderate depression: effects of dopamine agonists in an add-on to L-dopa therapy (2005) Eur. J. Neurol., 12, pp. 9-15; Remy, P., Doder, M., Lees, A., Turjanski, N., Brooks, D., Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system (2005) Brain, 128, pp. 1314-1322; Ross, G.W., Petrovitch, H., Abbott, R.D., Tanner, C.M., Popper, J., Masaki, K., Launer, L., White, L.R., Association of olfactory dysfunction with risk for future Parkinson's disease (2008) Ann. Neurol., 63, pp. 167-173; Scatton, B., Simon, H., Le Moal, M., Bischoff, S., Origin of dopaminergic innervation of the rat hippocampal formation (1980) Neurosci. Lett., 18, pp. 125-131; Schneider, J.S., Pioli, E.Y., Jianzhong, Y., Li, Q., Bezard, E., Levodopa improves motor deficits but can further disrupt cognition in a macaque Parkinson model (2013) Mov. Disord., 28, pp. 663-667; Schneider, J.S., Yuwiler, A., Markham, C.H., Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP (1987) Brain Res., 411, pp. 144-150; Schulte-Herbruggen, O., Vogt, M.A., Hortnagl, H., Gass, P., Hellweg, R., Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice (2012) Eur. J. Pharmacol., 677, pp. 77-86; Schwarting, R.K., Huston, J.P., Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae (1996) Prog. Neurobiol., 49, pp. 215-266; Siuciak, J.A., Fujiwara, R.A., The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors (2004) Psychopharmacology, 175, pp. 163-169; Stiasny-Kolster, K., Doerr, Y., Moller, J.C., Hoffken, H., Behr, T.M., Oertel, W.H., Mayer, G., Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT (2005) Brain, 128, pp. 126-137; Suzuki, K., Okada, K., Wakuda, T., Shinmura, C., Kameno, Y., Iwata, K., Takahashi, T., Mori, N., Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine (2010) PLoS ONE, 5; Tadaiesky, M.T., Dombrowski, P.A., Figueiredo, C.P., Cargnin-Ferreira, E., Da Cunha, C., Takahashi, R.N., Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease (2008) Neuroscience, 156, pp. 830-840; Ungerstedt, U., 6-Hydroxy-dopamine induced degeneration of central monoamine neurons (1968) Eur. J. Pharmacol., 5, pp. 107-110; Winner, B., Desplats, P., Hagl, C., Klucken, J., Aigner, R., Ploetz, S., Laemke, J., Winkler, J., Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model (2009) Exp. Neurol., 219, pp. 543-552; Winner, B., Geyer, M., Couillard-Despres, S., Aigner, R., Bogdahn, U., Aigner, L., Kuhn, G., Winkler, J., Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb (2006) Exp. Neurol., 197, pp. 113-121; Yang, P., Arnold, S.A., Habas, A., Hetman, M., Hagg, T., Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice (2008) J. Neurosci., 28, pp. 2231-2241",Article,Scopus,2-s2.0-84928802705
"Li L.-M., Ruan G.-X., Huangfu M.-Y., Chen Z.-L., Liu H.-N., Li L.-X., Hu Y.-L., Han M., Davidson G., Levkin P.A., Gao J.-Q.","ScreenFect A: An efficient and low toxic liposome for gene delivery to mesenchymal stem cells",2015,"International Journal of Pharmaceutics","488","1-2",,"1","11",,,10.1016/j.ijpharm.2015.04.050,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928411889&partnerID=40&md5=8377d5e3f65320e60dae88b2e6d8578b","Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang RoadHangzhou, Zhejiang, China; Institute of Toxicology and Genetics, Karlsruhe Institute of TechnologyKarlsruhe, Germany; Department of Organic Chemistry, University of HeidelbergHeidelberg, Germany; Incella GmbH, KIT HighTech InkubatorKarlsruhe, Germany; Department of Applied Physical Chemistry, University of HeidelbergHeidelberg, Germany","Li, L.-M., Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang RoadHangzhou, Zhejiang, China; Ruan, G.-X., Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang RoadHangzhou, Zhejiang, China; Huangfu, M.-Y., Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang RoadHangzhou, Zhejiang, China; Chen, Z.-L., Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang RoadHangzhou, Zhejiang, China; Liu, H.-N., Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang RoadHangzhou, Zhejiang, China; Li, L.-X., Institute of Toxicology and Genetics, Karlsruhe Institute of TechnologyKarlsruhe, Germany, Department of Organic Chemistry, University of HeidelbergHeidelberg, Germany; Hu, Y.-L., Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang RoadHangzhou, Zhejiang, China; Han, M., Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang RoadHangzhou, Zhejiang, China; Davidson, G., Incella GmbH, KIT HighTech InkubatorKarlsruhe, Germany; Levkin, P.A., Institute of Toxicology and Genetics, Karlsruhe Institute of TechnologyKarlsruhe, Germany, Department of Applied Physical Chemistry, University of HeidelbergHeidelberg, Germany; Gao, J.-Q., Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang RoadHangzhou, Zhejiang, China","Mesenchymal stem cells (MSCs) hold great promise in variety of therapeutic applications including tissue engineering and cancer therapy. Genetic modification of MSCs can be used to enhance the therapeutic effect of MSCs by facilitating a specific function or by transforming MSCs into more effective gene therapy tools. However, the successful generation of genetically modified MSCs is often limited by the poor transfection efficiency or high toxicity of available transfection reagents. In our previous study, we used thiol-yne click chemistry to develop new liposomal vectors, including ScreenFect® A (SF) (Li et al., 2012). In this study, we investigated the transfection performance of SF on MSCs. A comparative evaluation of transfection efficiency, cell viability and cellular DNA uptake was performed using the Lipofectamine™ 2000 (L2K) as a control, and the results show that SF is superior to L2K for MSC transfection. The presence of serum did not significantly influence the transfection efficiency of either SF or L2K but greatly reduced the viability of MSC transfected by L2K. The higher efficiency of SF-mediated transfection compared to L2K was also correlated with better proliferation of cells. These results were supported by monitoring the intracellular fate of DNA, which confirmed stable transportation of DNA from lysosomes and efficient nuclear localization. TGF-β1 gene delivery by SF promoted MSC osteogenic differentiation in an osteogenic induction condition. As the first study of SF lipofection on stem cells, this study highlights a promising role of SF in gene delivery to MSCs as well as other stem cells to facilitate tissue engineering and other therapeutic effects based on genetically modified stem cells.","Cytocompatibility; Lipofection; Mesenchymal stem cells; Osteogenic differentiation","Adler, A.F., Leong, K.W., Emerging links between surface nanotechnology and endocytosis: Impact on nonviral gene delivery (2010) Nano Today, 5, pp. 553-569; Bai, D., Zhang, J., Xiao, W., Zheng, X., Regulation of the HDM2-p53 pathway by ribosomal protein L6 in response to ribosomal stress (2014) Nucleic Acids Res., 42, pp. 1799-1811; Brisson, M., Huang, L., Liposomes: Conquering the nuclear barrier (1999) Curr. Opi. Mol. Ther., 1, pp. 140-146; Brunner, S., Sauer, T., Carotta, S., Cotten, M., Saltik, M., Wagner, E., Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus (2000) Gene Ther., 7, pp. 401-407; Cashman, T.J., Gouon-Evans, V., Costa, K.D., Mesenchymal stem cells for cardiac therapy: Practical challenges and potential mechanisms (2013) Stem Cell Rev., 9, pp. 254-265; Chesnoy, S., Huang, L., Structure and function of lipid-DNA complexes for gene delivery (2000) Annu. Rev. Biophys. Biomol. Struct., 29, pp. 27-47; Clackson, T., Regulated gene expression systems (2000) Gene Ther., 7, pp. 120-125; Dehghanifard, A., Shahjahani, M., Soleimani, M., Saki, N., The emerging role of mesenchymal stem cells in tissue engineering (2013) Int. J. Hematol. Oncol. Stem Cell Res., 7, pp. 46-47; Diefenbacher, M.E., Reich, D., Dahley, O., Kemler, D., Litfin, M., Herrlich, P., Kassel, O., The LIM domain protein nTRIP6 recruits the mediator complex to AP-1-regulated promoters (2014) PLoS One, 9, p. e97549; Durinikova, E., Kucerova, L., Matuskova, M., Mesenchymal stromal cells retrovirally transduced with prodrug-converting genes are suitable vehicles for cancer gene therapy (2014) Acta Virol., 58, pp. 1-13; Enlund, E., Fischer, S., Handrick, R., Otte, K., Debatin, K.M., Wabitsch, M., Fischer-Posovszky, P., Establishment of lipofection for studying miRNA function in human adipocytes (2014) PLoS One, 9, p. e98023; Fischer, S., Wagner, A., Kos, A., Aschrafi, A., Handrick, R., Hannemann, J., Otte, K., Breaking limitations of complex culture media: Functional non-viral miRNA delivery into pharmaceutical production cell lines (2013) J. Biotechnol., 168, pp. 589-600; Forostyak, S., Jendelova, P., Sykova, E., The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications (2013) Biochimie, 95, pp. 2257-2270; Freise, C., Querfeld, U., Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34 (2014) Pharmacol. Res., 85, pp. 6-14; Gao, Z., Zhang, L., Hu, J., Sun, Y., Mesenchymal stem cells: A potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles (2013) Nanomedicine, 9, pp. 174-184; Gheisari, Y., Soleimani, M., Azadmanesh, K., Zeinali, S., Multipotent mesenchymal stromal cells: Optimization and comparison of five cationic polymer-based gene delivery methods (2008) Cytotherapy, 10, pp. 815-823; Gjorgieva, D., Zaidman, N., Bosnakovski, D., Mesenchymal stem cells for anti-cancer drug delivery (2013) Recent Pat. Anti-cancer Drug Discov., 8, pp. 310-318; Greco, S.J., Rameshwar, P., Mesenchymal stem cells in drug/gene delivery: Implications for cell therapy (2012) Ther. Deliv., 3, pp. 997-1004; Gu, J., Lin, C.M., Gu, W., Cai, X.Z., Li, Z., Ren, M.M., Sun, X., Wu, W., [Immunomodulatory effect of UC-MSC on function of immunocytes of rats with collagen type II induced arthritis] (2014) Zhongguo Shi Yan Xue Ye Xue Za Zhi, 22, pp. 166-170; Hackl, M., Jadhav, V., Klanert, G., Karbiener, M., Scheideler, M., Grillari, J., Borth, N., Analysis of microRNA transcription and post-transcriptional processing by Dicer in the context of CHO cell proliferation (2014) J. Biotechnol.; He, C.X., Li, N., Hu, Y.L., Zhu, X.M., Li, H.J., Han, M., Miao, P.H., Liang, W.Q., Effective gene delivery to mesenchymal stem cells based on the reverse transfection and three-dimensional cell culture system (2011) Pharm. Res., 28, pp. 1577-1590; Her, G.J., Wu, H.C., Chen, M.H., Chen, M.Y., Chang, S.C., Wang, T.W., Control of three-dimensional substrate stiffness to manipulate mesenchymal stem cell fate toward neuronal or glial lineages (2013) Acta Biomater., 9, pp. 5170-5180; Hu, Y.L., Huang, B., Zhang, T.Y., Miao, P.H., Tang, G.P., Tabata, Y., Gao, J.Q., Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection (2012) Mol. Pharm., 9, pp. 2698-2709; Hu, Y.L., Miao, P.H., Huang, B., Zhang, T.Y., Hu, Z.J., Tabata, Y., Gao, J.Q., Reversal of tumor growth by gene modification of mesenchymal stem cells using spermine-pullulan/DNA nanoparticles (2014) J. Biomed. Nanotechnol., 10, pp. 299-308; Ito, K., Suda, T., Metabolic requirements for the maintenance of self-renewing stem cells (2014) Nat. Rev. Mol. Cell Biol., 15, pp. 243-256; Jones, C.H., Chen, C.K., Ravikrishnan, A., Rane, S., Pfeifer, B.A., Overcoming nonviral gene delivery barriers: Perspective and future (2013) Mol. Pharm., 10, pp. 4082-4098; Knaan-Shanzer, S., Van De Watering, M.J., Van Der Velde, I., Goncalves, M.A., Valerio, D., De Vries, A.A., Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells (2005) Stem Cells, 23, pp. 1598-1607; Kusadasi, N., Groeneveld, A.B., A perspective on mesenchymal stromal cell transplantation in the treatment of sepsis (2013) Shock, 40, pp. 352-357; Li, L., Zahner, D., Su, Y., Gruen, C., Davidson, G., Levkin, P.A., A biomimetic lipid library for gene delivery through thiol-yne click chemistry (2012) Biomaterials, 33, pp. 8160-8166; Lin, C.S., Xin, Z.C., Dai, J., Lue, T.F., Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges (2013) Histol. Histopathol., 28, pp. 1109-1116; Liu, X., Kato, Y., Kaneko, M.K., Sugawara, M., Ogasawara, S., Tsujimoto, Y., Naganuma, Y., Takagi, M., Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi-specific monoclonal antibody MsMab-1 (2013) Cancer Med., 2, pp. 803-814; Liu, Y., Hu, J., Wang, S., Mesenchymal stem cell-mediated treatment of oral diseases (2014) Histol. Histopathol.; Lungwitz, U., Breunig, M., Blunk, T., Gopferich, A., Polyethylenimine-based non-viral gene delivery systems (2005) Eur. J. Pharm. Biopharm., 60, pp. 247-266; Menon, L.G., Picinich, S., Koneru, R., Gao, H., Lin, S.Y., Koneru, M., Mayer-Kuckuk, P., Banerjee, D., Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells (2007) Stem Cells, 25, pp. 520-528; Mortimer, I., Tam, P., Maclachlan, I., Graham, R.W., Saravolac, E.G., Joshi, P.B., Cationic lipid-mediated transfection of cells in culture requires mitotic activity (1999) Gene Ther., 6, pp. 403-411; Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Dembinski, J., Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas (2005) Cancer Res., 65, pp. 3307-3318; Peng, Y., Xu, R., Zheng, X., HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling pathway by inhibiting TRAF3 ubiquitination via recruiting OTUB1 (2014) PLoS Pathog., 10, p. e1004041; Porada, C.D., Almeida-Porada, G., Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery (2010) Adv. Drug Deli. Rev., 62, pp. 1156-1166; Rejman, J., Conese, M., Hoekstra, D., Gene transfer by means of lipo- and polyplexes: Role of clathrin and caveolae-mediated endocytosis (2006) J. Liposome Res., 16, pp. 237-247; Ribeiro, S.C., Mendes, R., Madeira, C., Monteiro, G.A., Da Silva, C.L., Cabral, J.M., A quantitative method to evaluate mesenchymal stem cell lipofection using real-time PCR (2010) Biotechnol. Prog., 26, pp. 1501-1504; Ross, P.C., Hui, S.W., Lipoplex size is a major determinant of in vitro lipofection efficiency (1999) Gene Ther., 6, pp. 651-659; Ruponen, M., Ronkko, S., Honkakoski, P., Pelkonen, J., Tammi, M., Urtti, A., Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes (2001) J. Biol. Chem., 276, pp. 33875-33880; Togel, F., Hu, Z., Weiss, K., Isaac, J., Lange, C., Westenfelder, C., Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms (2005) Am. J. Physiol. Renal Physiol., 289, pp. F31-42; Tseng, W.C., Haselton, F.R., Giorgio, T.D., Mitosis enhances transgene expression of plasmid delivered by cationic liposomes (1999) Biochim. Biophys. Acta, 1445, pp. 53-64; Uchibori, R., Tsukahara, T., Ohmine, K., Ozawa, K., Cancer gene therapy using mesenchymal stem cells (2014) Int. J. Hematol., 99, pp. 377-382; Wakimoto, H., Tanaka, S., Curry, W.T., Loebel, F., Zhao, D., Tateishi, K., Chen, J., Kim, J.C., Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas (2014) Clin. Cancer Res., 20, pp. 2898-2909; Wei, X., Yang, X., Han, Z.P., Qu, F.F., Shao, L., Shi, Y.F., Mesenchymal stem cells: A new trend for cell therapy (2013) Acta Pharmacol. Sin., 34, pp. 747-754; Wiethoff, C.M., Middaugh, C.R., Barriers to nonviral gene delivery (2003) J. Pharm. Sci., 92, pp. 203-217; Xu, Y., Szoka, Jr.F.C., Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection (1996) Biochemistry, 35, pp. 5616-5623; Zabner, J., Fasbender, A.J., Moninger, T., Poellinger, K.A., Welsh, M.J., Cellular and molecular barriers to gene transfer by a cationic lipid (1995) J. Biol. Chem., 270, pp. 18997-19007; Zelphati, O., Szoka, Jr.F.C., Mechanism of oligonucleotide release from cationic liposomes (1996) Proc. Natl. Acad. Sci. U. S. A., 93, pp. 11493-11498; Zhang, T.Y., Hu, Y.L., Liang, W.Q., Gao, J.Q., [Research progress of gene recombinant mesenchymal stem cells as tumor targeting delivery vehicles] (2013) Yao Xue Xue Bao, 48, pp. 1209-1220; Zhang, T.Y., Huang, B., Yuan, Z.Y., Hu, Y.L., Tabata, Y., Gao, J.Q., Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection (2014) Nanomedicine, 10, pp. 257-267; Zhao, L., Hantash, B.M., TGF-beta1 regulates differentiation of bone marrow mesenchymal stem cells (2011) Vitamins Hormones, 87, pp. 127-141",Article,Scopus,2-s2.0-84928411889
"Briehl M.M.","Oxygen in human health from life to death - An approach to teaching redox biology and signaling to graduate and medical students",2015,"Redox Biology","5",,,"124","139",,,10.1016/j.redox.2015.04.002,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928232797&partnerID=40&md5=08fd706377fae717c7d4d36df3d48b86","Department of Pathology, University of Arizona, PO Box 24-5043Tucson, AZ, United States","Briehl, M.M., Department of Pathology, University of Arizona, PO Box 24-5043Tucson, AZ, United States","In the absence of oxygen human life is measured in minutes. In the presence of oxygen, normal metabolism generates reactive species (ROS) that have the potential to cause cell injury contributing to human aging and disease. Between these extremes, organisms have developed means for sensing oxygen and ROS and regulating their cellular processes in response. Redox signaling contributes to the control of cell proliferation and death. Aberrant redox signaling underlies many human diseases. The attributes acquired by altered redox homeostasis in cancer cells illustrate this particularly well. This teaching review and the accompanying illustrations provide an introduction to redox biology and signaling aimed at instructors of graduate and medical students. © 2015 The Authors.","Apoptosis; Cancer; Hydrogen peroxide; Mitochondria; Proliferation; Superoxide","Woese, C.R., Kandler, O., Wheelis, M.L., Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya (1990) Proceedings of the National Academy of Sciences of the United States of America, 87 (12), pp. 4576-4579. , http://www.ncbi.nlm.nih.gov/pubmed/2112744; Knoll, A.H., A new molecular window on early life (1999) Science, 285 (5430), pp. 1025-1026. , http://www.ncbi.nlm.nih.gov/pubmed/10475845; Woese, C., The universal ancestor (1998) Proceedings of the National Academy of Sciences of the United States of America, 95 (12), pp. 6854-6859. , http://www.ncbi.nlm.nih.gov/pubmed/9618502; Slesak, I., Slesak, H., Kruk, J., Oxygen and hydrogen peroxide in the early evolution of life on earth: in silico comparative analysis of biochemical pathways (2012) Astrobiology, 12 (8), pp. 775-784. , http://www.ncbi.nlm.nih.gov/pubmed/22970865; Marinho, H.S., Real, C., Cyrne, L., Soares, H., Antunes, F., Hydrogen peroxide sensing, signaling and regulation of transcription factors (2014) Redox Biology, 2, pp. 535-562. , http://www.ncbi.nlm.nih.gov/pubmed/24634836; Wilson, A.J., Kerns, J.K., Callahan, J.F., Moody, C.J., Keap calm, and carry on covalently (2013) Journal of Medicinal Chemistry, 56 (19), pp. 7463-7476. , http://www.ncbi.nlm.nih.gov/pubmed/23837912; Lushchak, V.I., Adaptive response to oxidative stress: Bacteria, fungi, plants and animals (2011) Comparative Biochemistry and Physiology C: Toxicology Pharmacology, 153 (2), pp. 175-190. , http://www.ncbi.nlm.nih.gov/pubmed/20959147; Storz, G., Tartaglia, L.A., Ames, B.N., Transcriptional regulator of oxidative stress-inducible genes: direct activation by oxidation (1990) Science, 248 (4952), pp. 189-194. , http://www.ncbi.nlm.nih.gov/pubmed/2183352; Choi, H., Kim, S., Mukhopadhyay, P., Cho, S., Woo, J., Storz, G., Structural basis of the redox switch in the OxyR transcription factor (2001) Cell, 105 (1), pp. 103-113. , http://www.ncbi.nlm.nih.gov/pubmed/11301006; Mongkolsuk, S., Helmann, J.D., Regulation of inducible peroxide stress responses (2002) Molecular Microbiology, 45 (1), pp. 9-15. , http://www.ncbi.nlm.nih.gov/pubmed/12100544; Dubbs, J.M., Mongkolsuk, S., Peroxide-sensing transcriptional regulators in bacteria (2012) Journal of Bacteriology, 194 (20), pp. 5495-5503. , http://www.ncbi.nlm.nih.gov/pubmed/22797754; Corcoran, A., Cotter, T.G., Redox regulation of protein kinases (2013) FEBS Journal, 280 (9), pp. 1944-1965. , http://www.ncbi.nlm.nih.gov/pubmed/23461806; D'Autréaux, B., Toledano, M.B., ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis (2007) Nature Reviews Molecular Cell Biology, 8 (10), pp. 813-824. , http://www.ncbi.nlm.nih.gov/pubmed/17848967; Winterbourn, C.C., Reconciling the chemistry and biology of reactive oxygen species (2008) Nature Chemical Biology, 4 (5), pp. 278-286. , http://www.ncbi.nlm.nih.gov/pubmed/18421291; Pryor, W.A., Oxy-radicals and related species: their formation, lifetimes, and reactions (1986) Annual Review of Physiology, 48, pp. 657-667. , http://www.ncbi.nlm.nih.gov/pubmed/3010829; Han, D., Antunes, F., Canali, R., Rettori, D., Cadenas, E., Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol (2003) Journal of Biological Chemistry, 278 (8), pp. 5557-5563. , http://www.ncbi.nlm.nih.gov/pubmed/12482755; Winterbourn, C.C., Metodiewa, D., Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide (1999) Free Radical Biology and Medicine, 27 (3-4), pp. 322-328. , http://www.ncbi.nlm.nih.gov/pubmed/10468205; Bienert, G.P., Schjoerring, J.K., Jahn, T.P., Membrane transport of hydrogen peroxide (2006) Biochimica et Biophysica Acta, 1758 (8), pp. 994-1003. , http://www.ncbi.nlm.nih.gov/pubmed/16566894; Bienert, G.P., Møller, A.L., Kristiansen, K.A., Schulz, A., Møller, I.M., Schjoerring, J.K., Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes (2007) Journal of Biological Chemistry, 282 (2), pp. 1183-1192. , http://www.ncbi.nlm.nih.gov/pubmed/17105724; Gardner, P.R., Raineri, I., Epstein, L.B., White, C.W., Superoxide radical and iron modulate aconitase activity in mammalian cells (1995) Journal of Biological Chemistry, 270 (22), pp. 13399-13405. , http://www.ncbi.nlm.nih.gov/pubmed/7768942; White, M.F., Dillingham, M.S., Iron-sulphur clusters in nucleic acid processing enzymes (2012) Current Opinion in Structural Biology, 22 (1), pp. 94-100. , http://www.ncbi.nlm.nih.gov/pubmed/22169085; Pacher, P., Beckman, J.S., Liaudet, L., Nitric oxide and peroxynitrite in health and disease (2007) Physiological Reviews, 87 (1), pp. 315-424. , http://www.ncbi.nlm.nih.gov/pubmed/17237348; Denu, J.M., Tanner, K.G., Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation (1998) Biochemistry, 37 (16), pp. 5633-5642. , http://www.ncbi.nlm.nih.gov/pubmed/9548949; Winterbourn, C.C., Hampton, M.B., Thiol chemistry and specificity in redox signaling (2008) Free Radical Biology and Medicine, 45 (5), pp. 549-561. , http://www.ncbi.nlm.nih.gov/pubmed/18544350; Lind, C., Gerdes, R., Hamnell, Y., Schuppe-Koistinen, I., von Löwenhielm, H.B., Holmgren, A., Identification of S-glutathionylated cellular proteins during oxidative stress and constitutive metabolism by affinity purification and proteomic analysis (2002) Archives of Biochemistry and Biophysics, 406 (2), pp. 229-240. , http://www.ncbi.nlm.nih.gov/pubmed/12361711; Baty, J.W., Hampton, M.B., Winterbourn, C.C., Proteomic detection of hydrogen peroxide-sensitive thiol proteins in Jurkat cells (2005) Biochemical Journal, 389 (3), pp. 785-795. , http://www.ncbi.nlm.nih.gov/pubmed/15801906; McDonagh, B., Ogueta, S., Lasarte, G., Padilla, C.A., Bárcena, J.A., Shotgun redox proteomics identifies specifically modified cysteines in key metabolic enzymes under oxidative stress in Saccharomyces cerevisiae (2009) Journal of Proteomics, 72 (4), pp. 677-689. , http://www.ncbi.nlm.nih.gov/pubmed/19367685; Ferrer-Sueta, G., Manta, B., Botti, H., Radi, R., Trujillo, M., Denicola, A., Factors affecting protein thiol reactivity and specificity in peroxide reduction (2011) Chemical Research in Toxicology, 24 (4), pp. 434-450. , http://www.ncbi.nlm.nih.gov/pubmed/21391663; Peskin, A.V., Low, F.M., Paton, L.N., Maghzal, G.J., Hampton, M.B., Winterbourn, C.C., The high reactivity of peroxiredoxin 2 with H(2)O(2) is not reflected in its reaction with other oxidants and thiol reagents (2007) Journal of Biological Chemistry, 282 (16), pp. 11885-11892. , http://www.ncbi.nlm.nih.gov/pubmed/17329258; Wood, Z.A., Poole, L.B., Karplus, P.A., Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling (2003) Science, 300 (5619), pp. 650-653. , http://www.ncbi.nlm.nih.gov/pubmed/12714747; Woo, H.A., Yim, S.H., Shin, D.H., Kang, D., Yu, D.Y., Rhee, S.G., Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling (2010) Cell, 140 (4), pp. 517-528. , http://www.ncbi.nlm.nih.gov/pubmed/20178744; Koppenol, W.H., Bounds, P.L., Dang, C.V., Otto Warburg's contributions to current concepts of cancer metabolism (2011) Nature Reviews Cancer, 11 (5), pp. 325-337. , http://www.ncbi.nlm.nih.gov/pubmed/21508971; Warburg, O., Beobachtungen über die Oxydationsprozesse im Seeigelei (1908) Hoppe-SeylerDs Zeitschrift für physiologische Chemie, 57 (1-2), pp. 1-16; Warburg, O., Notizen zur Entwicklungsphysiologie des Seeigeleies (1915) Arch F & D Ges Physiol, 160 (4-6), pp. 324-332; Foerder, C.A., Klebanoff, S.J., Shapiro, B.M., Hydrogen peroxide production, chemiluminescence, and the respiratory burst of fertilization: interrelated events in early sea urchin development (1978) Proceedings of the National Academy of Sciences of the United States of America, 75 (7), pp. 3183-3187. , http://www.ncbi.nlm.nih.gov/pubmed/277920; Heinecke, J.W., Shapiro, B.M., Respiratory burst oxidase of fertilization (1989) Proceedings of the National Academy of Sciences of the United States of America, 86 (4), pp. 1259-1263. , http://www.ncbi.nlm.nih.gov/pubmed/2537493; Wong, J.L., Créton, R., Wessel, G.M., The oxidative burst at fertilization is dependent upon activation of the dual oxidase Udx1 (2004) Dev. Cell, 7 (6), pp. 801-814. , http://www.ncbi.nlm.nih.gov/pubmed/15572124; Hall, H.G., Hardening of the sea urchin fertilization envelope by peroxidase-catalyzed phenolic coupling of tyrosines (1978) Cell, 15 (2), pp. 343-355. , http://www.ncbi.nlm.nih.gov/pubmed/569021; Wong, J.L., Wessel, G.M., Free-radical crosslinking of specific proteins alters the function of the egg extracellular matrix at fertilization (2008) Development, 135 (3), pp. 431-440. , http://www.ncbi.nlm.nih.gov/pubmed/18094022; Lo, Y.Y., Cruz, T.F., Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes (1995) Journal of Biological Chemistry, 270 (20), pp. 11727-11730. , http://www.ncbi.nlm.nih.gov/pubmed/7744816; Sundaresan, M., Yu, Z.X., Ferrans, V.J., Irani, K., Finkel, T., Requirement for generation of H<inf>2</inf>O<inf>2</inf> for platelet-derived growth factor signal transduction (1995) Science, 270 (5234), pp. 296-299. , http://www.ncbi.nlm.nih.gov/pubmed/7569979; Bae, Y.S., Kang, S.W., Seo, M.S., Baines, I.C., Tekle, E., Chock, P.B., Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation (1997) Journal of Biological Chemistry, 272 (1), pp. 217-221. , http://www.ncbi.nlm.nih.gov/pubmed/8995250; Truong, T.H., Carroll, K.S., Redox regulation of protein kinases (2013) Critical Reviews in Biochemistry and Molecular Biology, 48 (4), pp. 332-356. , http://www.ncbi.nlm.nih.gov/pubmed/23639002; Scheffzek, K., Ahmadian, M.R., Kabsch, W., Wiesmüller, L., Lautwein, A., Schmitz, F., The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants (1997) Science, 277 (5324), pp. 333-338. , http://www.ncbi.nlm.nih.gov/pubmed/9219684; Irani, K., Xia, Y., Zweier, J.L., Sollott, S.J., Der, C.J., Fearon, E.R., Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts (1997) Science, 275 (5306), pp. 1649-1652. , http://www.ncbi.nlm.nih.gov/pubmed/9054359; Suh, Y.A., Arnold, R.S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Cell transformation by the superoxide-generating oxidase Mox1 (1999) Nature, 401 (6748), pp. 79-82. , http://www.ncbi.nlm.nih.gov/pubmed/10485709; Bedard, K., Krause, K.H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology (2007) Physiological Reviews, 87 (1), pp. 245-313. , http://www.ncbi.nlm.nih.gov/pubmed/17237347; Royer-Pokora, B., Kunkel, L.M., Monaco, A.P., Goff, S.C., Newburger, P.E., Baehner, R.L., Cloning the gene for an inherited human disorder -chronic granulomatous disease -on the basis of its chromosomal location (1986) Nature, 322 (6074), pp. 32-38. , http://www.ncbi.nlm.nih.gov/pubmed/2425263; Harman, D., Aging: a theory based on free radical and radiation chemistry (1956) Journal of Gerontology, 11 (3), pp. 298-300. , http://www.ncbi.nlm.nih.gov/pubmed/13332224; McCord, J.M., Fridovich, I., Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein) (1969) Journal of Biological Chemistry, 244 (22), pp. 6049-6055. , http://www.ncbi.nlm.nih.gov/pubmed/5389100; McCord, J.M., Fridovich, I., Superoxide dismutases: you've come a long way, baby (2014) Antioxidants & Redox Signaling, 20 (10), pp. 1548-1549. , http://www.ncbi.nlm.nih.gov/pubmed/23924157; Balaban, R.S., Nemoto, S., Finkel, T., Mitochondria, oxidants, and aging (2005) Cell, 120 (4), pp. 483-495. , http://www.ncbi.nlm.nih.gov/pubmed/15734681; Pérez, V.I., Bokov, A., Van Remmen, H., Mele, J., Ran, Q., Ikeno, Y., Is the oxidative stress theory of aging dead? (2009) Biochimica et Biophysica Acta, 1790 (10), pp. 1005-1014. , http://www.ncbi.nlm.nih.gov/pubmed/19524016; Ku, H.H., Brunk, U.T., Sohal, R.S., Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species (1993) Free Radical Biology and Medicine, 15 (6), pp. 621-627. , http://www.ncbi.nlm.nih.gov/pubmed/8138188; Orr, W.C., Sohal, R.S., Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster (1994) Science, 263 (5150), pp. 1128-1130. , http://www.ncbi.nlm.nih.gov/pubmed/8108730; Sohal, R.S., Weindruch, R., Oxidative stress, caloric restriction, and aging (1996) Science, 273 (5271), pp. 59-63. , http://www.ncbi.nlm.nih.gov/pubmed/8658196; Colman, R.J., Anderson, R.M., Johnson, S.C., Kastman, E.K., Kosmatka, K.J., Beasley, T.M., Caloric restriction delays disease onset and mortality in rhesus monkeys (2009) Science, 325 (5937), pp. 201-204. , http://www.ncbi.nlm.nih.gov/pubmed/19590001; Rubner, M., (1908) Das problem der lebensdauer und seine bezeihunger zum wachstum und ernarhnung, , R. Oldenburg, Munchen; Pearl, R., (1928) The Rate of Living, , University of London Press, UK; Barja, G., Mitochondrial free radical production and aging in mammals and birds (1998) Annals of the New York Academy of Sciences, 854, pp. 224-238. , http://www.ncbi.nlm.nih.gov/pubmed/9928433; Montgomery, M.K., Hulbert, A.J., Buttemer, W.A., The long life of birds: the rat-pigeon comparison revisited (2011) PLOS One, 6 (8), p. e24138. , http://www.ncbi.nlm.nih.gov/pubmed/21904609; Hulbert, A.J., Pamplona, R., Buffenstein, R., Buttemer, W.A., Life and death: metabolic rate, membrane composition, and life span of animals (2007) Physiological Reviews, 87 (4), pp. 1175-1213. , http://www.ncbi.nlm.nih.gov/pubmed/17928583; Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P.P., The p66shc adaptor protein controls oxidative stress response and life span in mammals (1999) Nature, 402 (6759), pp. 309-313. , http://www.ncbi.nlm.nih.gov/pubmed/10580504; Trinei, M., Giorgio, M., Cicalese, A., Barozzi, S., Ventura, A., Migliaccio, E., A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis (2002) Oncogene, 21 (24), pp. 3872-3878. , http://www.ncbi.nlm.nih.gov/pubmed/12032825; Giorgio, M., Migliaccio, E., Orsini, F., Paolucci, D., Moroni, M., Contursi, C., Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis (2005) Cell, 122 (2), pp. 221-233. , http://www.ncbi.nlm.nih.gov/pubmed/16051147; Polyak, K., Xia, Y., Zweier, J.L., Kinzler, K.W., Vogelstein, B., A model for p53-induced apoptosis (1997) Nature, 389 (6648), pp. 300-305. , http://www.ncbi.nlm.nih.gov/pubmed/9305847; Nicholls, P., Cytochrome c binding to enzymes and membranes (1974) Biochimica et Biophysica Acta, 346 (3-4), pp. 261-310. , http://www.ncbi.nlm.nih.gov/pubmed/4374236; Demel, R.A., Jordi, W., Lambrechts, H., van Damme, H., Hovius, R., de Kruijff, B., Differential interactions of apo- and holocytochrome c with acidic membrane lipids in model systems and the implications for their import into mitochondria (1989) Journal of Biological Chemistry, 264 (7), pp. 3988-3997. , http://www.ncbi.nlm.nih.gov/pubmed/2537300; Kagan, V.E., Tyurin, V.A., Jiang, J., Tyurina, Y.Y., Ritov, V.B., Amoscato, A.A., Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors (2005) Nature Chemical Biology, 1 (4), pp. 223-232. , http://www.ncbi.nlm.nih.gov/pubmed/16408039; Kagan, V.E., Bayir, H.A., Belikova, N.A., Kapralov, O., Tyurina, Y.Y., Tyurin, V.A., Cytochrome c/cardiolipin relations in mitochondria: a kiss of death (2009) Free Radical Biology and Medicine, 46 (11), pp. 1439-1453. , http://www.ncbi.nlm.nih.gov/pubmed/19285551; Kagan, V.E., Tyurina, Y.Y., Bayir, H., Chu, C.T., Kapralov, A.A., Vlasova, I.I., The ""pro-apoptotic genies"" get out of mitochondria: oxidative lipidomics and redox activity of cytochrome c/cardiolipin complexes (2006) Chem. Biol. Interact., 163 (1-2), pp. 15-28. , http://www.ncbi.nlm.nih.gov/pubmed/16797512; Shidoji, Y., Hayashi, K., Komura, S., Ohishi, N., Yagi, K., Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation (1999) Biochem. Biophys. Res. Commun., 264 (2), pp. 343-347. , http://www.ncbi.nlm.nih.gov/pubmed/10529366; Ott, M., Robertson, J.D., Gogvadze, V., Zhivotovsky, B., Orrenius, S., Cytochrome c release from mitochondria proceeds by a two-step process (2002) Proceedings of the National Academy of Sciences of the United States of America, 99 (3), pp. 1259-1263. , http://www.ncbi.nlm.nih.gov/pubmed/11818574; Heit, B., Yeung, T., Grinstein, S., Changes in mitochondrial surface charge mediate recruitment of signaling molecules during apoptosis (2011) American Journal of Physiology - Cell Physiology, 300 (1), pp. C33-C41. , http://www.ncbi.nlm.nih.gov/pubmed/20926778; Kim, T.H., Zhao, Y., Ding, W.X., Shin, J.N., He, X., Seo, Y.W., Bid-cardiolipin interaction at mitochondrial contact site contributes to mitochondrial cristae reorganization and cytochrome C release (2004) Molecular Biology of the Cell, 15 (7), pp. 3061-3072. , http://www.ncbi.nlm.nih.gov/pubmed/15107464; Gonzalvez, F., Pariselli, F., Dupaigne, P., Budihardjo, I., Lutter, M., Antonsson, B., TBid interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates Bax and Bak (2005) Cell Death & Differentiation, 12 (6), pp. 614-626. , http://www.ncbi.nlm.nih.gov/pubmed/15818416; Szatrowski, T.P., Nathan, C.F., Production of large amounts of hydrogen peroxide by human tumor cells (1991) Cancer Research, 51 (3), pp. 794-798. , http://www.ncbi.nlm.nih.gov/pubmed/1846317; Oberley, T.D., Oberley, L.W., Antioxidant enzyme levels in cancer (1997) Histology and Histopathology, 12 (2), pp. 525-535. , http://www.ncbi.nlm.nih.gov/pubmed/9151141; Shan, W., Zhong, W., Zhao, R., Oberley, T.D., Thioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression (2010) Free Radical Biology and Medicine, 49 (12), pp. 2078-2087. , http://www.ncbi.nlm.nih.gov/pubmed/20955789; Toyokuni, S., Okamoto, K., Yodoi, J., Hiai, H., Persistent oxidative stress in cancer (1995) FEBS Letters, 358 (1), pp. 1-3. , http://www.ncbi.nlm.nih.gov/pubmed/7821417; Loft, S., Poulsen, H.E., Cancer risk and oxidative DNA damage in man (1996) Journal of Molecular Medicine, 74 (6), pp. 297-312. , http://www.ncbi.nlm.nih.gov/pubmed/8862511; Cheng, K.C., Cahill, D.S., Kasai, H., Nishimura, S., Loeb, L.A., 8-hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions (1992) Journal of Biological Chemistry, 267 (1), pp. 166-172. , http://www.ncbi.nlm.nih.gov/pubmed/1730583; Møller, P., Wallin, H., Adduct formation, mutagenesis and nucleotide excision repair of DNA damage produced by reactive oxygen species and lipid peroxidation product (1998) Mutation Research, 410 (3), pp. 271-290. , http://www.ncbi.nlm.nih.gov/pubmed/9630671; Jackson, A.L., Loeb, L.A., The contribution of endogenous sources of DNA damage to the multiple mutations in cancer (2001) Mutation Research, 477 (1-2), pp. 7-21. , http://www.ncbi.nlm.nih.gov/pubmed/11376682; Brandon, M., Baldi, P., Wallace, D.C., Mitochondrial mutations in cancer (2006) Oncogene, 25 (34), pp. 4647-4662. , http://www.ncbi.nlm.nih.gov/pubmed/16892079; Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y., Chen, Z., Pelicano, H., Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate (2006) Cancer Cell, 10 (3), pp. 241-252. , http://www.ncbi.nlm.nih.gov/pubmed/16959615; Mitsushita, J., Lambeth, J.D., Kamata, T., The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation (2004) Cancer Research, 64 (10), pp. 3580-3585. , http://www.ncbi.nlm.nih.gov/pubmed/15150115; Church, S.L., Grant, J.W., Meese, E.U., Trent, J.M., Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping (1992) Genomics, 14 (3), pp. 823-825. , http://www.ncbi.nlm.nih.gov/pubmed/1427917; Trent, J.M., Cytogenetics of human malignant melanoma (1991) Cancer and Metastasis Reviews, 10 (2), pp. 103-113. , http://www.ncbi.nlm.nih.gov/pubmed/1873851; Bastian, B.C., LeBoit, P.E., Hamm, H., Bröcker, E.B., Pinkel, D., Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization (1998) Cancer Research, 58 (10), pp. 2170-2175. , http://www.ncbi.nlm.nih.gov/pubmed/9605762; Trent, J.M., Stanbridge, E.J., McBride, H.L., Meese, E.U., Casey, G., Araujo, D.E., Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6 (1990) Science, 247 (4942), pp. 568-571. , http://www.ncbi.nlm.nih.gov/pubmed/2300817; Church, S.L., Grant, J.W., Ridnour, L.A., Oberley, L.W., Swanson, P.E., Meltzer, P.S., Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells (1993) Proceedings of the National Academy of Sciences of the United States of America, 90 (7), pp. 3113-3117. , http://www.ncbi.nlm.nih.gov/pubmed/8464931; Yan, T., Oberley, L.W., Zhong, W., St Clair, D.K., Manganese-containing superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts (1996) Cancer Research, 56 (12), pp. 2864-2871. , http://www.ncbi.nlm.nih.gov/pubmed/8665527; Sarsour, E.H., Venkataraman, S., Kalen, A.L., Oberley, L.W., Goswami, P.C., Manganese superoxide dismutase activity regulates transitions between quiescent and proliferative growth (2008) Aging Cell, 7 (3), pp. 405-417. , http://www.ncbi.nlm.nih.gov/pubmed/18331617; Sarsour, E.H., Kalen, A.L., Goswami, P.C., Manganese superoxide dismutase regulates a redox cycle within the cell cycle (2014) Antioxidants & Redox Signaling, 20 (10), pp. 1618-1627; Sporn, M.B., The war on cancer (1996) Lancet, 347 (9012), pp. 1377-1381. , http://www.ncbi.nlm.nih.gov/pubmed/8637346; Connor, K.M., Hempel, N., Nelson, K.K., Dabiri, G., Gamarra, A., Belarmino, J., Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells (2007) Cancer Research, 67 (21), pp. 10260-10267. , http://www.ncbi.nlm.nih.gov/pubmed/17974967; Brenneisen, P., Briviba, K., Wlaschek, M., Wenk, J., Scharffetter-Kochanek, K., Hydrogen peroxide (H<inf>2</inf>O<inf>2</inf>) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts (1997) Free Radical Biology and Medicine, 22 (3), pp. 515-524. , http://www.ncbi.nlm.nih.gov/pubmed/8981044; Wenk, J., Brenneisen, P., Wlaschek, M., Poswig, A., Briviba, K., Oberley, T.D., Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1 (1999) Journal of Biological Chemistry, 274 (36), pp. 25869-25876. , http://www.ncbi.nlm.nih.gov/pubmed/10464329; Dhar, S.K., St Clair, D.K., Manganese superoxide dismutase regulation and cancer (2012) Free Radical Biology and Medicine, 52 (11-12), pp. 2209-2222. , http://www.ncbi.nlm.nih.gov/pubmed/22561706; Jones, P.L., Ping, D., Boss, J.M., Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB (1997) Molecular and Cellular Biology, 17 (12), pp. 6970-6981. , http://www.ncbi.nlm.nih.gov/pubmed/9372929; Xu, Y., Kiningham, K.K., Devalaraja, M.N., Yeh, C.C., Majima, H., Kasarskis, E.J., An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta (1999) DNA Cell Biology, 18 (9), pp. 709-722. , http://www.ncbi.nlm.nih.gov/pubmed/10492402; Xu, Y., Porntadavity, S., St Clair, D.K., Transcriptional regulation of the human manganese superoxide dismutase gene: the role of specificity protein 1 (Sp1) and activating protein-2 (AP-2) (2002) Biochemical Journal, 362 (2), pp. 401-412. , http://www.ncbi.nlm.nih.gov/pubmed/11853549; Pani, G., Bedogni, B., Anzevino, R., Colavitti, R., Palazzotti, B., Borrello, S., Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells (2000) Cancer Research, 60 (16), pp. 4654-4660. , http://www.ncbi.nlm.nih.gov/pubmed/10969820; Dhar, S.K., Tangpong, J., Chaiswing, L., Oberley, T.D., St Clair, D.K., Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages (2011) Cancer Research, 71 (21), pp. 6684-6695. , http://www.ncbi.nlm.nih.gov/pubmed/22009531; Kops, G.J., Dansen, T.B., Polderman, P.E., Saarloos, I., Wirtz, K.W., Coffer, P.J., Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress (2002) Nature, 419 (6904), pp. 316-321. , http://www.ncbi.nlm.nih.gov/pubmed/12239572; Powis, G., Briehl, M., Oblong, J., Redox signalling and the control of cell growth and death (1995) Pharmacology & Therapeutics, 68 (1), pp. 149-173. , http://www.ncbi.nlm.nih.gov/pubmed/8604436; Wong, G.H., Elwell, J.H., Oberley, L.W., Goeddel, D.V., Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor (1989) Cell, 58 (5), pp. 923-931. , http://www.ncbi.nlm.nih.gov/pubmed/2476237; Rogers, R.J., Chesrown, S.E., Kuo, S., Monnier, J.M., Nick, H.S., Cytokine-inducible enhancer with promoter activity in both the rat and human manganese-superoxide dismutase genes (2000) Biochemical Journal, 347 (1), pp. 233-242. , http://www.ncbi.nlm.nih.gov/pubmed/10727424; Huang, Y., He, T., Domann, F.E., Decreased expression of manganese superoxide dismutase in transformed cells is associated with increased cytosine methylation of the SOD2 gene (1999) DNA Cell Biology, 18 (8), pp. 643-652. , http://www.ncbi.nlm.nih.gov/pubmed/10463060; Hurt, E.M., Thomas, S.B., Peng, B., Farrar, W.L., Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines (2007) British Journal of Cancer, 97 (8), pp. 1116-1123. , http://www.ncbi.nlm.nih.gov/pubmed/17895890; Hurt, E.M., Thomas, S.B., Peng, B., Farrar, W.L., Integrated molecular profiling of SOD2 expression in multiple myeloma (2007) Blood, 109 (9), pp. 3953-3962. , http://www.ncbi.nlm.nih.gov/pubmed/17192397; Cho, R.W., Clarke, M.F., Recent advances in cancer stem cells (2008) Current Opinion in Genetics & Development, 18 (1), pp. 48-53. , http://www.ncbi.nlm.nih.gov/pubmed/18356041; Mimeault, M., Batra, S.K., Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells (2013) Journal of Cellular and Molecular Medicine, 17 (1), pp. 30-54. , http://www.ncbi.nlm.nih.gov/pubmed/23301832; Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M.M., Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics (2000) Cancer Research, 60 (6), pp. 1541-1545. , http://www.ncbi.nlm.nih.gov/pubmed/10749120; Stoeltzing, O., Liu, W., Reinmuth, N., Fan, F., Parikh, A.A., Bucana, C.D., Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer (2003) American Journal of Pathology, 163 (3), pp. 1001-1011. , http://www.ncbi.nlm.nih.gov/pubmed/12937141; Wenger, R.H., Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression (2002) FASEB Journal, 16 (10), pp. 1151-1162. , http://www.ncbi.nlm.nih.gov/pubmed/12153983; Quail, D.F., Taylor, M.J., Postovit, L.M., Microenvironmental regulation of cancer stem cell phenotypes (2012) Current Stem Cell Research & Therapy, 7 (3), pp. 197-216. , http://www.ncbi.nlm.nih.gov/pubmed/22329582; Diehn, M., Cho, R.W., Lobo, N.A., Kalisky, T., Dorie, M.J., Kulp, A.N., Association of reactive oxygen species levels and radioresistance in cancer stem cells (2009) Nature, 458 (7239), pp. 780-783. , http://www.ncbi.nlm.nih.gov/pubmed/19194462; Tsujimoto, Y., Croce, C.M., Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma (1986) Proceedings of the National Academy of Sciences of the United States of America, 83 (14), pp. 5214-5218. , http://www.ncbi.nlm.nih.gov/pubmed/3523487; Korsmeyer, S.J., Bcl-2 initiates a new category of oncogenes: regulators of cell death (1992) Blood, 80 (4), pp. 879-886. , http://www.ncbi.nlm.nih.gov/pubmed/1498330; Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L., Korsmeyer, S.J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis (1993) Cell, 75 (2), pp. 241-251. , http://www.ncbi.nlm.nih.gov/pubmed/7503812; Kane, D.J., Sarafian, T.A., Anton, R., Hahn, H., Gralla, E.B., Valentine, J.S., Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species (1993) Science, 262 (5137), pp. 1274-1277. , http://www.ncbi.nlm.nih.gov/pubmed/8235659; Veis, D.J., Sorenson, C.M., Shutter, J.R., Korsmeyer, S.J., Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair (1993) Cell, 75 (2), pp. 229-240. , http://www.ncbi.nlm.nih.gov/pubmed/8402909; Esposti, M.D., Hatzinisiriou, I., McLennan, H., Ralph, S., Bcl-2 and mitochondrial oxygen radicals. New approaches with reactive oxygen species-sensitive probes (1999) Journal of Biological Chemistry, 274 (42), pp. 29831-29837. , http://www.ncbi.nlm.nih.gov/pubmed/10514462; Kowaltowski, A.J., Fiskum, G., Redox mechanisms of cytoprotection by Bcl-2 (2005) Antioxidants & Redox Signaling, 7 (3-4), pp. 508-514. , http://www.ncbi.nlm.nih.gov/pubmed/15706098; Lee, M., Hyun, D.H., Marshall, K.A., Ellerby, L.M., Bredesen, D.E., Jenner, P., Effect of overexpression of BCL-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses, and the proteasome (2001) Free Radical Biology and Medicine, 31 (12), pp. 1550-1559. , http://www.ncbi.nlm.nih.gov/pubmed/11744329; Cory, S., Huang, D.C., Adams, J.M., The Bcl-2 family: roles in cell survival and oncogenesis (2003) Oncogene, 22 (53), pp. 8590-8607. , http://www.ncbi.nlm.nih.gov/pubmed/14634621; Akao, Y., Otsuki, Y., Kataoka, S., Ito, Y., Tsujimoto, Y., Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes (1994) Cancer Research, 54 (9), pp. 2468-2471. , http://www.ncbi.nlm.nih.gov/pubmed/8162596; Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked (1997) Science, 275 (5303), pp. 1129-1132. , http://www.ncbi.nlm.nih.gov/pubmed/9027314; Green, D.R., Kroemer, G., The pathophysiology of mitochondrial cell death (2004) Science, 305 (5684), pp. 626-629. , http://www.ncbi.nlm.nih.gov/pubmed/15286356; Kroemer, G., Galluzzi, L., Brenner, C., Mitochondrial membrane permeabilization in cell death (2007) Physiological Reviews, 87 (1), pp. 99-163. , http://www.ncbi.nlm.nih.gov/pubmed/17237344; Llambi, F., Moldoveanu, T., Tait, S.W., Bouchier-Hayes, L., Temirov, J., McCormick, L.L., A unified model of mammalian BCL-2 protein family interactions at the mitochondria (2011) Molecular Cell, 44 (4), pp. 517-531. , http://www.ncbi.nlm.nih.gov/pubmed/22036586; Li, J., Yuan, J., Caspases in apoptosis and beyond (2008) Oncogene, 27 (48), pp. 6194-6206. , http://www.ncbi.nlm.nih.gov/pubmed/18931687; Chen, Z.X., Pervaiz, S., Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells (2007) Cell Death & Differentiation, 14 (9), pp. 1617-1627. , http://www.ncbi.nlm.nih.gov/pubmed/17510660; Chen, Z.X., Pervaiz, S., Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2 (2010) Cell Death & Differentiation, 17 (3), pp. 408-420. , http://www.ncbi.nlm.nih.gov/pubmed/19834492; Krishna, S., Low, I.C., Pervaiz, S., Regulation of mitochondrial metabolism: yet another facet in the biology of the oncoprotein Bcl-2 (2011) Biochemical Journal, 435 (3), pp. 545-551. , http://www.ncbi.nlm.nih.gov/pubmed/21486225; Sarosiek, K.A., Ni Chonghaile, T., Letai, A., Mitochondria: gatekeepers of response to chemotherapy (2013) Trends in Cell Biology, 23 (12), pp. 612-619. , http://www.ncbi.nlm.nih.gov/pubmed/24060597; Ni Chonghaile, T., Sarosiek, K.A., Vo, T.T., Ryan, J.A., Tammareddi, A., Moore, V.G., Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy (2011) Science, 334 (6059), pp. 1129-1133. , http://www.ncbi.nlm.nih.gov/pubmed/22033517; Cantor, J.R., Sabatini, D.M., Cancer cell metabolism: one hallmark, many faces (2012) Cancer Discovery, 2 (10), pp. 881-898. , http://www.ncbi.nlm.nih.gov/pubmed/23009760; DeBerardinis, R.J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis (2007) Proceedings of the National Academy of Sciences of the United States of America, 104 (49), pp. 19345-19350. , http://www.ncbi.nlm.nih.gov/pubmed/18032601; Ward, P.S., Thompson, C.B., Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate (2012) Cancer Cell, 21 (3), pp. 297-308. , http://www.ncbi.nlm.nih.gov/pubmed/22439925; Vander Heiden, M.G., Cantley, L.C., Thompson, C.B., Understanding the Warburg effect: the metabolic requirements of cell proliferation (2009) Science, 324 (5930), pp. 1029-1033. , http://www.ncbi.nlm.nih.gov/pubmed/19460998; Wise, D.R., DeBerardinis, R.J., Mancuso, A., Sayed, N., Zhang, X.Y., Pfeiffer, H.K., Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction (2008) Proceedings of the National Academy of Sciences of the United States of America, 105 (48), pp. 18782-18787. , http://www.ncbi.nlm.nih.gov/pubmed/19033189; Gao, P., Tchernyshyov, I., Chang, T.C., Lee, Y.S., Kita, K., Ochi, T., C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism (2009) Nature, 458 (7239), pp. 762-765. , http://www.ncbi.nlm.nih.gov/pubmed/19219026; Schwartzenberg-Bar-Yoseph, F., Armoni, M., Karnieli, E., The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression (2004) Cancer Research, 64 (7), pp. 2627-2633. , http://www.ncbi.nlm.nih.gov/pubmed/15059920; Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M., P53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase (2011) Nature Cell Biology, 13 (3), pp. 310-316. , http://www.ncbi.nlm.nih.gov/pubmed/21336310; Cifone, M.A., Fidler, I.J., Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma (1980) Proceedings of the National Academy of Sciences of the United States of America, 77 (2), pp. 1039-1043. , http://www.ncbi.nlm.nih.gov/pubmed/6928659; Weinberg, F., Hamanaka, R., Wheaton, W.W., Weinberg, S., Joseph, J., Lopez, M., Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity (2010) Proceedings of the National Academy of Sciences of the United States of America, 107 (19), pp. 8788-8793. , http://www.ncbi.nlm.nih.gov/pubmed/20421486; Mori, S., Chang, J.T., Andrechek, E.R., Matsumura, N., Baba, T., Yao, G., Anchorage-independent cell growth signature identifies tumors with metastatic potential (2009) Oncogene, 28 (31), pp. 2796-2805. , http://www.ncbi.nlm.nih.gov/pubmed/19483725; Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis (2008) Science, 320 (5876), pp. 661-664. , http://www.ncbi.nlm.nih.gov/pubmed/18388260; Hanahan, D., Weinberg, R.A., The hallmarks of cancer (2000) Cell, 100 (1), pp. 57-70. , http://www.ncbi.nlm.nih.gov/pubmed/10647931; Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation (2011) Cell, 144 (5), pp. 646-674. , http://www.ncbi.nlm.nih.gov/pubmed/21376230; Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Helicobacter pylori infection and the development of gastric cancer (2001) New England Journal of Medicine, 345 (11), pp. 784-789. , http://www.ncbi.nlm.nih.gov/pubmed/11556297; Askling, J., Dickman, P.W., Karlén, P., Broström, O., Lapidus, A., Löfberg, R., Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study (2001) Lancet, 357 (9252), pp. 262-266. , http://www.ncbi.nlm.nih.gov/pubmed/11214128; El-Serag, H.B., Rudolph, K.L., Hepatocellular carcinoma: epidemiology and molecular carcinogenesis (2007) Gastroenterology, 132 (7), pp. 2557-2576. , http://www.ncbi.nlm.nih.gov/pubmed/17570226; Grivennikov, S.I., Greten, F.R., Karin, M., Immunity, inflammation, and cancer (2010) Cell, 140 (6), pp. 883-899. , http://www.ncbi.nlm.nih.gov/pubmed/20303878; Smith, M.L., Fornace, A.J., Genomic instability and the role of p53 mutations in cancer cells (1995) Current Opinion in Oncology, 7 (1), pp. 69-75. , http://www.ncbi.nlm.nih.gov/pubmed/7696366; Guo, Z., Kozlov, S., Lavin, M.F., Person, M.D., Paull, T.T., ATM activation by oxidative stress (2010) Science, 330 (6003), pp. 517-521. , http://www.ncbi.nlm.nih.gov/pubmed/20966255; Shiloh, Y., ATM and related protein kinases: safeguarding genome integrity (2003) Nature Reviews Cancer, 3 (3), pp. 155-168. , http://www.ncbi.nlm.nih.gov/pubmed/12612651; Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., Gianni, L., Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity (2004) Pharmacological Reviews, 56 (2), pp. 185-229. , http://www.ncbi.nlm.nih.gov/pubmed/15169927; Doroshow, J.H., Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase (1983) Cancer Research, 43 (10), pp. 4543-4551. , http://www.ncbi.nlm.nih.gov/pubmed/6309369; Gajewski, E., Gaur, S., Akman, S.A., Matsumoto, L., van Balgooy, J.N., Doroshow, J.H., Oxidative DNA base damage in MCF-10A breast epithelial cells at clinically achievable concentrations of doxorubicin (2007) Biochem. Pharmacol., 73 (12), pp. 1947-1956. , http://www.ncbi.nlm.nih.gov/pubmed/17445777; Wouters, K.A., Kremer, L.C., Miller, T.L., Herman, E.H., Lipshultz, S.E., Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies (2005) British Journal of Haematology, 131 (5), pp. 561-578. , http://www.ncbi.nlm.nih.gov/pubmed/16351632; Gewirtz, D.A., A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin (1999) Biochemical Pharmacology, 57 (7), pp. 727-741. , http://www.ncbi.nlm.nih.gov/pubmed/10075079; Wondrak, G.T., Redox-directed cancer therapeutics: molecular mechanisms and opportunities (2009) Antioxidants & Redox Signaling, 11 (12), pp. 3013-3069. , http://www.ncbi.nlm.nih.gov/pubmed/19496700; Gorrini, C., Harris, I.S., Mak, T.W., Modulation of oxidative stress as an anticancer strategy (2013) Nature Reviews Drug Discovery, 12 (12), pp. 931-947. , http://www.ncbi.nlm.nih.gov/pubmed/24287781; Huang, P., Feng, L., Oldham, E.A., Keating, M.J., Plunkett, W., Superoxide dismutase as a target for the selective killing of cancer cells (2000) Nature, 407 (6802), pp. 390-395. , http://www.ncbi.nlm.nih.gov/pubmed/11014196; Lee, K., Briehl, M.M., Mazar, A.P., Batinic-Haberle, I., Reboucas, J.S., Glinsmann-Gibson, B., The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies (2013) Free Radical Biology and Medicine, 60, pp. 157-167. , http://www.ncbi.nlm.nih.gov/pubmed/23416365; Glasauer, A., Sena, L.A., Diebold, L.P., Mazar, A.P., Chandel, N.S., Targeting SOD1 reduces experimental non-small-cell lung cancer (2014) Journal of Clinical Investigation, 124 (1), pp. 117-128. , http://www.ncbi.nlm.nih.gov/pubmed/24292713; Montero, A.J., Jassem, J., Cellular redox pathways as a therapeutic target in the treatment of cancer (2011) Drugs, 71 (11), pp. 1385-1396. , http://www.ncbi.nlm.nih.gov/pubmed/21812504; Barr, P.M., Miller, T.P., Friedberg, J.W., Peterson, D.R., Baran, A.M., Herr, M., Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma (2014) Blood, 124 (8), pp. 1259-1265. , http://www.ncbi.nlm.nih.gov/pubmed/25016003; Hayes, J.D., McMahon, M., NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer (2009) Trends in Biochemical Sciences, 34 (4), pp. 176-188. , http://www.ncbi.nlm.nih.gov/pubmed/19321346; Jaramillo, M.C., Zhang, D.D., The emerging role of the Nrf2-Keap1 signaling pathway in cancer (2013) Genes & Development, 27 (20), pp. 2179-2191. , http://www.ncbi.nlm.nih.gov/pubmed/24142871; Letai, A., BCL-2: found bound and drugged! (2005) Trends in Molecular Medicine, 11 (10), pp. 442-444. , http://www.ncbi.nlm.nih.gov/pubmed/16150641; Schumacker, P.T., Reactive oxygen species in cancer cells: live by the sword, die by the sword (2006) Cancer Cell, 10 (3), pp. 175-176. , http://www.ncbi.nlm.nih.gov/pubmed/16959608; Jones, D.P., Redefining oxidative stress (2006) Antioxidants & Redox Signaling, 8 (9-10), pp. 1865-1879. , http://www.ncbi.nlm.nih.gov/pubmed/16987039; Jones, D.P., Radical-free biology of oxidative stress (2008) American Journal of Physiology - Cell Physiology, 295 (4), pp. C849-C868. , http://www.ncbi.nlm.nih.gov/pubmed/18684987; Trachootham, D., Alexandre, J., Huang, P., Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? (2009) Nature Reviews Drug Discovery, 8 (7), pp. 579-591. , http://www.ncbi.nlm.nih.gov/pubmed/19478820; Finkel, T., Signal transduction by reactive oxygen species (2011) Journal of Cell Biology, 194 (1), pp. 7-15. , http://www.ncbi.nlm.nih.gov/pubmed/21746850; Dickinson, B.C., Chang, C.J., Chemistry and biology of reactive oxygen species in signaling or stress responses (2011) Nature Chemical Biology, 7 (8), pp. 504-511. , http://www.ncbi.nlm.nih.gov/pubmed/21769097",Review,Scopus,2-s2.0-84928232797
"Baulch J.E., Craver B.M., Tran K.K., Yu L., Chmielewski N., Allen B.D., Limoli C.L.","Persistent oxidative stress in human neural stem cells exposed to low fluences of charged particles",2015,"Redox Biology","5",,,"24","32",,,10.1016/j.redox.2015.03.001,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925109486&partnerID=40&md5=b8e6747c57a243c9d59aa39be55efe57","Department of Radiation Oncology, University of CaliforniaIrvine, CA, United States","Baulch, J.E., Department of Radiation Oncology, University of CaliforniaIrvine, CA, United States; Craver, B.M., Department of Radiation Oncology, University of CaliforniaIrvine, CA, United States; Tran, K.K., Department of Radiation Oncology, University of CaliforniaIrvine, CA, United States; Yu, L., Department of Radiation Oncology, University of CaliforniaIrvine, CA, United States; Chmielewski, N., Department of Radiation Oncology, University of CaliforniaIrvine, CA, United States; Allen, B.D., Department of Radiation Oncology, University of CaliforniaIrvine, CA, United States; Limoli, C.L., Department of Radiation Oncology, University of CaliforniaIrvine, CA, United States","Exposure to the space radiation environment poses risks for a range of deleterious health effects due to the unique types of radiation encountered. Galactic cosmic rays are comprised of a spectrum of highly energetic nuclei that deposit densely ionizing tracks of damage along the particle trajectory. These tracks are distinct from those generated by the more sparsely ionizing terrestrial radiations, and define the geometric distribution of the complex cellular damage that results when charged particles traverse the tissues of the body. The exquisite radiosensitivity of multipotent neural stem and progenitor cells found within the neurogenic regions of the brain predispose the central nervous system to elevated risks for radiation induced sequelae. Here we show that human neural stem cells (hNSC) exposed to different charged particles at space relevant fluences exhibit significant and persistent oxidative stress. Radiation induced oxidative stress was found to be most dependent on total dose rather than on the linear energy transfer of the incident particle. The use of redox sensitive fluorogenic dyes possessing relative specificity for hydroxyl radicals, peroxynitrite, nitric oxide (NO) and mitochondrial superoxide confirmed that most irradiation paradigms elevated reactive oxygen and nitrogen species (ROS and RNS, respectively) in hNSC over a 1 week interval following exposure. Nitric oxide synthase (NOS) was not the major source of elevated nitric oxides, as the use of NOS inhibitors had little effect on NO dependent fluorescence. Our data provide extensive evidence for the capability of low doses of charged particles to elicit marked changes in the metabolic profile of irradiated hNSC. Radiation induced changes in redox state may render the brain more susceptible to the development of neurocognitive deficits that could affect an astronaut's ability to perform complex tasks during extended missions in deep space. © 2015 The Authors.","Charged particle; Human neural stem cells; Oxidative stress; Space radiation","Curtis, S.B., Letaw, J.R., Galactic cosmic rays and cell-hit frequencies outside the magnetosphere (1989) Advances in Space Research, 9 (10), pp. 293-298. , http://www.ncbi.nlm.nih.gov/pubmed/11537306; Plante, I., Cucinotta, F.A., Energy deposition and relative frequency of hits of cylindrical nanovolume in medium irradiated by ions: Monte Carlo simulation of tracks structure (2010) Radiation and Environmental Biophysics, 49 (1), pp. 5-13. , http://www.ncbi.nlm.nih.gov/pubmed/19916014; Cucinotta, F.A., Alp, M., Sulzman, F.M., Wang, M., Space radiation risks to the central nervous system (2014) Life Sciences in Space Research, 2, pp. 54-69; Fike, J.R., Rosi, S., Limoli, C.L., Neural precursor cells and central nervous system radiation sensitivity (2009) Seminars in Radiation Oncology, 19 (2), pp. 122-132. , http://www.ncbi.nlm.nih.gov/pubmed/19249650; Wong, C.S., Van der Kogel, A.J., Mechanisms of radiation injury to the central nervous system: implications for neuroprotection (2004) Molecular Interventions, 4 (5), pp. 273-284. , http://www.ncbi.nlm.nih.gov/pubmed/15471910; Tofilon, P.J., Fike, J.R., The radioresponse of the central nervous system: a dynamic process (2000) Radiation Research, 153 (4), pp. 357-370. , http://www.ncbi.nlm.nih.gov/pubmed/10798963; Mizumatsu, S., Monje, M.L., Morhardt, D.R., Rola, R., Palmer, T.D., Fike, J.R., Extreme sensitivity of adult neurogenesis to low doses of X-irradiation (2003) Cancer Research, 63 (14), pp. 4021-4027. , http://www.ncbi.nlm.nih.gov/pubmed/12874001; Rola, R., Raber, J., Rizk, A., Otsuka, S., VandenBerg, S.R., Morhardt, D.R., Fike, J.R., Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice (2004) Experimental Neurology, 188 (2), pp. 316-330. , http://www.ncbi.nlm.nih.gov/pubmed/15246832; Tseng, B.P., Giedzinski, E., Izadi, A., Suarez, T., Lan, M.L., Tran, K.K., Acharya, M.M., Limoli, C.L., Functional consequences of radiation-induced oxidative stress in cultured neural stem cells and the brain exposed to charged particle irradiation (2014) Antioxidants & Redox Signaling, 20 (9), pp. 1410-1422. , http://www.ncbi.nlm.nih.gov/pubmed/23802883; Giedzinski, E., Rola, R., Fike, J.R., Limoli, C.L., Efficient production of reactive oxygen species in neural precursor cells after exposure to 250 MeV protons (2005) Radiation Research, 164 (42), pp. 540-544. , http://www.ncbi.nlm.nih.gov/pubmed/16187784; Limoli, C.L., Giedzinski, E., Rola, R., Otsuka, S., Palmer, T.D., Fike, J.R., Radiation response of neural precursor cells: linking cellular sensitivity to cell cycle checkpoints, apoptosis and oxidative stress (2004) Radiation Research, 161 (1), pp. 17-27. , http://www.ncbi.nlm.nih.gov/pubmed/14680400; Limoli, C.L., Giedzinski, E., Baure, J., Rola, R., Fike, J.R., Redox changes induced in hippocampal precursor cells by heavy ion irradiation (2007) Radiation and Environmental Biophysics, 46 (2), pp. 167-172. , http://www.ncbi.nlm.nih.gov/pubmed/17103219; Lewén, A., Matz, P., Chan, P.H., Free radical pathways in CNS injury (2000) Journal of Neurotrauma, 17 (10), pp. 871-890. , http://www.ncbi.nlm.nih.gov/pubmed/11063054; Acharya, M.M., Lan, M.L., Kan, V.H., Patel, N.H., Giedzinski, E., Tseng, B.P., Limoli, C.L., Consequences of ionizing radiation-induced damage in human neural stem cells (2010) Free Radical Biology and Medicine, 49 (12), pp. 1846-1855. , http://www.ncbi.nlm.nih.gov/pubmed/20826207; Nojima, K., Vazquez, M.E., Nagaoka, S., Effects of low dose particle radiation to mouse neonatal neurons in culture (2003) Uchu Seibutsu Kagaku, 17 (3), pp. 263-264. , http://www.ncbi.nlm.nih.gov/pubmed/14676408; Nojima, K., Nakadai, T., Kohno, Y., Vazquez, M.E., Yasuda, N., Nagaoka, S., Effects of heavy ion to the primary [correction of rimary] culture of mouse brain cells (2004) Uchu Seibutsu Kagaku, 18 (3), pp. 114-115. , http://www.ncbi.nlm.nih.gov/pubmed/15858347; Grabham, P., Sharma, P., Bigelow, A., Geard, C., Two distinct types of the inhibition of vasculogenesis by different species of charged particles (2013) Vascular Cell, 5 (1), p. 16. , http://www.ncbi.nlm.nih.gov/pubmed/24044765; Plante, I., Ponomarev, A., Cucinotta, F.A., 3D visualisation of the stochastic patterns of the radial dose in nano-volumes by a Monte Carlo simulation of HZE ion track structure (2011) Radiation Protection Dosimetry, 143 (2-4), pp. 156-161. , http://www.ncbi.nlm.nih.gov/pubmed/21199826; Forstermann, U., Sessa, W.C., Nitric oxide synthases: regulation and function (2012) European Heart Journal, 33 (7), pp. 829-837; Roe, N.D., Ren, J., Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases (2012) Vascular Pharmacology, 57 (5-6), pp. 168-172. , http://www.ncbi.nlm.nih.gov/pubmed/22361333; Kalyanaraman, B., Darley-Usmar, V., Davies, K.J., Dennery, P.A., Forman, H.J., Grisham, M.B., Mann, G.E., Ischiropoulos, H., Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations (2012) Free Radical Biology and Medicine, 52 (1), pp. 1-6. , http://www.ncbi.nlm.nih.gov/pubmed/22027063; Wardman, P., Use of the dichlorofluorescein assay to measure ""reactive oxygen species"" (2008) Radiation Research, 170 (3), pp. 406-407. , http://www.ncbi.nlm.nih.gov/pubmed/18763870; Wardman, P., Methods to measure the reactivity of peroxynitrite-derived oxidants toward reduced fluoresceins and rhodamines (2008) Methods in Enzymology, 441, pp. 261-282. , http://www.ncbi.nlm.nih.gov/pubmed/18554539; Parihar, V.K., Pasha, J., Tran, K.K., Craver, B.M., Acharya, M.M., Limoli, C.L., Persistent changes in neuronal structure and synaptic plasticity caused by proton irradiation (2015) Brain Structure & Function, 220, pp. 1161-1171. , http://www.ncbi.nlm.nih.gov/pubmed/24446074; Parihar, V.K., Allen, B.D., Tran, K.K., Chmielewski, N.N., Craver, B.M., Martirosian, V., Morganti, J.M., Limoli, C.L., Targeted overexpression of mitochondrial catalase prevents radiation-induced cognitive dysfunction (2015) Antioxidants & Redox Signaling, 22, pp. 78-91. , http://www.ncbi.nlm.nih.gov/pubmed/24949841; Smith, J., Ladi, E., Mayer-Proschel, M., Noble, M., Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell (2000) Proceedings of National Academy of Sciences of the United States of America, 97 (18), pp. 10032-10037. , http://www.ncbi.nlm.nih.gov/pubmed/10944195",Article,Scopus,2-s2.0-84925109486
"Zamani M., Prabhakaran M.P., Thian E.S., Ramakrishna S.","Controlled delivery of stromal derived factor-1α from poly lactic-co-glycolic acid core-shell particles to recruit mesenchymal stem cells for cardiac regeneration",2015,"Journal of Colloid and Interface Science","451",,,"144","152",,,10.1016/j.jcis.2015.04.005,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927739376&partnerID=40&md5=ea572f5a5a540a6be4700252ccda867e","Department of Mechanical Engineering, National University of Singapore, 2 Engineering Drive 3, Singapore; Center for Nanofibers and Nanotechnology, Nanoscience and Nanotechnology Initiative, Faculty of Engineering, National University of Singapore, 2 Engineering Drive 3, E3-05-14, Singapore","Zamani, M., Department of Mechanical Engineering, National University of Singapore, 2 Engineering Drive 3, Singapore, Center for Nanofibers and Nanotechnology, Nanoscience and Nanotechnology Initiative, Faculty of Engineering, National University of Singapore, 2 Engineering Drive 3, E3-05-14, Singapore; Prabhakaran, M.P., Center for Nanofibers and Nanotechnology, Nanoscience and Nanotechnology Initiative, Faculty of Engineering, National University of Singapore, 2 Engineering Drive 3, E3-05-14, Singapore; Thian, E.S., Department of Mechanical Engineering, National University of Singapore, 2 Engineering Drive 3, Singapore; Ramakrishna, S., Department of Mechanical Engineering, National University of Singapore, 2 Engineering Drive 3, Singapore, Center for Nanofibers and Nanotechnology, Nanoscience and Nanotechnology Initiative, Faculty of Engineering, National University of Singapore, 2 Engineering Drive 3, E3-05-14, Singapore","Stromal derived factor-1α (SDF-1α) has shown promising results in treatment of myocardial infarction (MI), via recruitment of endogenous stem cells into the injured myocardium. However, the bioactivity of this susceptible signalling chemokine is reduced significantly during the common fabrication processes of drug delivery systems, due to the exposure to organic-aqueous interfaces or elevated temperature. In this study, we developed a novel SDF-1α delivery system using coaxial electrospraying, the technique which enables fabrication of core-shell particles with minimized contact of organic-aqueous phases. The SDF-1α incorporated PLGA particles exhibited distinct core-shell structure, confirmed by transmission electron microscopy (TEM). Controlled release of SDF-1α was obtained for at least 40. days, and the release rate was tailored by co-encapsulation of bovine serum albumin (BSA) into the core of the particles. The SDF-1α released from PLGA/SDF-1α and PLGA/BSA-SDF-1α particles retained its chemotactic activity, and enhanced the number of migrated mesenchymal stem cells (MSCs) by 38% and 54%, respectively, compared to basal medium used as the control. Moreover, both SDF-1α and BSA supported the proliferation of MSCs within 3. days of cell culture. The SDF-1α incorporated core-shell particles developed by electrospraying technique, can be effectively employed as injectable drug delivery system for in situ cardiac regeneration. © 2015 Elsevier Inc.","Cardiac tissue engineering; Coaxial electrospraying; Microencapsulation; Poly lactic-co-glycolic acid; Stromal derived factor-1α","Mathers, C.D., Loncar, D., (2006) PLoS Med., 3 (11), pp. 2011-2030; Ravichandran, R., Venugopal, J.R., Sundarrajan, S., Mukherjee, S., Sridhar, R., Ramakrishna, S., (2012) Nanotechnolgy, 23 (38); Tomita, S., Li, R.K., Weisel, R.D., Mickle, D.A.G., Kim, E.J., Sakai, T., (1999) Circulation, 100, pp. 247-256; Scott, R.C., Crabbe, D., Krynska, B., Ansari, R., Kiani, M.F., (2008) Expert Opin. Drug Deliv., 5 (4), pp. 459-470; Segers, V.F., Lee, R.T., (2008) Nature, 451 (7181), pp. 937-942; Schantz, J.T., Chim, H., Whiteman, M., (2007) Tissue Eng., 13 (11), pp. 2615-2624; Thevenot, P.T., Nair, A.M., Shen, J., Lotfi, P., Ko, C.Y., Tang, L., (2010) Biomaterials, 31 (14), pp. 3997-4008; Lau, T.T., Wang, D.A., (2011) Expert Opin. Biol. Ther., 11 (2), pp. 189-197; Zhao, T., Zhang, D., Millard, R.W., Ashraf, M., Wang, Y., (2009) Am. J. Physiol. Heart Circ. Physiol., 296 (4), pp. 976-986; McQuibban, G.A., Butler, G.S., Gong, J.H., Bendall, L., Power, C., Clark-Lewis, I., (2001) J. Biol. Chem., 276 (47), pp. 43503-43508; Peterson, J.T., Li, H., Dillon, L., Bryant, J.W., (2000) Cardiovasc. Res., 46 (2), pp. 307-315; Gonçalves, R.M., Antunes, J.C., Barbosa, M.A., (2012) Eur. Cell Mater., 23, pp. 249-261; Kimura, Y., Tabata, Y., (2010) J. Biomater. Sci. Polym. Ed., 21 (1), pp. 37-51; Huang, Y.C., Liu, T.J., (2012) Acta Biomater., 8 (3), pp. 1048-1056; Prokoph, S., Chavakis, E., Levental, K.R., Zieris, A., Freudenberg, U., Dimmeler, S., (2012) Biomaterials, 33 (19), pp. 4792-4800; Henderson, P.W., Singh, S.P., Krijgh, D.D., Yamamoto, M., Rafii, D.C., Sung, J.J., (2011) Wound Rep. Reg., 19 (3), pp. 420-425; Rabbany, S.Y., Pastore, J., Yamamoto, M., Miller, T., Rafii, S., Aras, R., (2010) Cell Transplant., 19 (4), pp. 399-408; Purcell, B.P., Elser, J.A., Mu, A., Margulies, K.B., Burdick, J.A., (2012) Biomaterials, 33 (31), pp. 7849-7857; Kuraitis, D., Zhang, P., Zhang, Y., Padavan, D.T., (2011) Eur. Cell Mater., 22, pp. 109-123; Cross, D.P., Wang, C., (2011) Pharm. Res., 28 (10), pp. 2477-2489; Wu, F., Jin, T., (2008) AAPS PharmSciTech., 9 (4), pp. 1218-1229; Bock, N., Dargaville, T.R., Woodruff, M.A., (2012) Prog. Polym. Sci., 37 (11), pp. 1510-1551; Brandenberger, H., Nussli, D., Piech, V., Widmer, F., (1999) J. Electrostat., 45, pp. 227-238; Zamani, M., Prabhakaran, M.P., Ramakrishna, S., (2013) Int. J. Nanomed., 8 (1), pp. 2997-3017; Zamani, M., Prabhakaran, M.P., Thian, E.S., Ramakrishna, S., (2014) Int. J. Pharm., 473 (1-2), pp. 134-143; Enayati, M., Chang, M.W., Bragman, F., Edirisinghe, M., Stride, E., (2011) Colloids Surf. A, 382 (1-3), pp. 154-164; Costa, P., Lobo, J.M.S., (2001) Eur. J. Pharm. Sci., 13 (2), pp. 123-133; Askari, A., Unzek, S., Popovic, Z.B., Goldman, C.K., Forudi, F., Kiedrowski, M., (2003) Lancet, 362, pp. 697-703; Tous, E., Weber, H.M., Lee, M.H., Koomalsingh, K.J., Shuto, T., Kondo, N., (2012) Acta Biomater., 8 (9), pp. 3218-3227; Tabata, Y., Ikada, Y., (1988) Biomaterials, 9 (4), pp. 356-362; Champion, J.A., Walker, A., Mitragotri, S., (2008) Pharm. Res., 25 (8), pp. 1815-1821; Simon, S., Schmidschonbein, G.W., (1988) Biophys. J., 53 (2), pp. 163-173; Chun, K.W., Yoo, H.S., Yoon, J.J., Park, T.G., (2004) Biotechnol. Prog., 20 (6), pp. 1797-1801; Wu, Y.N., Yang, Z., Hui, J.H., Ouyang, H.W., Lee, E.H., (2007) Biomaterials, 28 (28), pp. 4056-4067; Ye, M., Kim, S., Park, K., (2010) J. Control. Release, 146 (2), pp. 241-260; Sleep, D., Cameron, J., Evans, L.R., (2013) Biochim. Biophys. Acta, 1830 (12), pp. 5526-5534; Böhme, U., Scheler, U., (2007) Chem. Phys. Lett., 435 (4-6), pp. 342-345; Davis, M.E., Hsieh, P.C., Grodzinsky, A.J., Lee, R.T., (2005) Circ. Res., 97 (1), pp. 8-15; Wynn, R.F., Hart, C.A., Corradi-Perini, C., O'Neill, L., Evans, C.A., Wraith, J.E., (2004) Blood, 104 (9), pp. 2643-2645; Kitaori, T., Ito, H., Schwarz, E.M., Tsutsumi, R., Yoshitomi, H., Oishi, S., (2009) Arthritis Rheum., 60 (3), pp. 813-823; Ponte, A.L., Marais, E., Gallay, N., Langonne, A., Delorme, B., Herault, O., (2007) Stem cells, 25 (7), pp. 1737-1745; Hamada, T., Mohle, R., Hesselgesser, J., Hoxie, J., Nachman, R.L., Moore, M.A., (1998) J. Exp. Med., 188 (3), pp. 539-548; Ji, Y., (2003) Circulation, 107 (9), pp. 1322-1328; Francis, G.L., (2010) Cytotechnology, 62 (1), pp. 1-16; Fleischer, S., Shapira, A., Regev, O., Nseir, N., Zussman, E., Dvir, T., (2014) Biotechnol. Bioeng., 111 (6), pp. 1246-1257",Article,Scopus,2-s2.0-84927739376
"Wang Y., Wei Y., Zhang X., Xu M., Liu F., Ma Q., Cai Q., Deng X.","PLGA/PDLLA core-shell submicron spheres sequential release system: Preparation, characterization and promotion of bone regeneration in vitro and in vivo",2015,"Chemical Engineering Journal","273",,,"490","501",,,10.1016/j.cej.2015.03.068,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926431195&partnerID=40&md5=532fe6fbcfd105ee715e7d662326921e","Department of Geriatric Dentistry, Peking University School and Hospital of StomatologyBeijing, China; First Clinical Division, Peking University School and Hospital of StomatologyBeijing, China; Beijing Laboratory of Biomedical Materials and State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical TechnologyBeijing, China; Department of Dental Materials, Peking University School and Hospital of StomatologyBeijing, China; National Engineering Laboratory for Digital and Material Technology of StomatologyBeijing, China; Department of Prosthodontics, Peking University School and Hospital of StomatologyBeijing, China","Wang, Y., Department of Geriatric Dentistry, Peking University School and Hospital of StomatologyBeijing, China, First Clinical Division, Peking University School and Hospital of StomatologyBeijing, China; Wei, Y., Department of Geriatric Dentistry, Peking University School and Hospital of StomatologyBeijing, China, Department of Prosthodontics, Peking University School and Hospital of StomatologyBeijing, China; Zhang, X., Department of Dental Materials, Peking University School and Hospital of StomatologyBeijing, China; Xu, M., Department of Geriatric Dentistry, Peking University School and Hospital of StomatologyBeijing, China; Liu, F., First Clinical Division, Peking University School and Hospital of StomatologyBeijing, China; Ma, Q., Department of Geriatric Dentistry, Peking University School and Hospital of StomatologyBeijing, China; Cai, Q., Beijing Laboratory of Biomedical Materials and State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical TechnologyBeijing, China; Deng, X., Department of Geriatric Dentistry, Peking University School and Hospital of StomatologyBeijing, China, National Engineering Laboratory for Digital and Material Technology of StomatologyBeijing, China, Department of Prosthodontics, Peking University School and Hospital of StomatologyBeijing, China","Core-shell polymer spheres of submicron diameter are a promising vehicle for sequential delivery of angiogenic and osteogenic growth factors to bone defect sites, to simulate the orchestrated temporal sequence of angiogenesis and osteogenesis. To achieve a homogeneous distribution pattern in the scaffold matrix and avoid fast biological clearance in vivo, attention should be paid to the particle size of the spheres, using a modified coaxial electrospraying technique, we prepared core-shell spheres about 1. μm in diameter using the polymers poly-(. d,l-lactide) in the shell and poly(. l-lactide-co-glycolic acid) in the core, and loaded them with VEGF and BMP-2, growth factors that stimulate angiogenesis and osteogenesis, respectively. PLGA/PDLLA controlled sequential delivery profiles, including an initial burst release of VEGF and a sustained release behavior of BMP-2 from the VEGF//BMP-2 spheres, were obtained. The VEGF and BMP-2 released from the spheres maintained their bioactivity; VEGF could enhance the proliferation of endothelial cells and BMP-2 could promote the osteogenic differentiation of bone marrow mesenchymal stem cells. Micro-computed tomography analysis showed that, among all the experimental groups, implantation of VEGF//BMP-2 spheres into rat cranial critical-sized bone defects enhanced new bone formation to the greatest extent, resulting in the largest amount of new bone volume and the largest isolated bone islands. Histological examination showed that VEGF//BMP-2 spheres also significantly increased in-growth of blood vessels with positive CD31 staining. All these findings suggest that the submicron-scale core-shell VEGF//BMP-2 spheres developed in this study are capable of yielding sequentially coupled angiogenesis and osteogenesis, implying their extensive application in bone tissue regeneration. © 2015 Elsevier B.V.","BMP-2; Bone regeneration; Core-shell submicron spheres; Sequential release; VEGF","Eppley, B.L., Pietrzak, W.S., Blanton, M.W., Allograft and alloplastic bone substitutes: a review of science and technology for the craniomaxillofacial surgeon (2005) J. Craniofac. Surg., 16 (6), pp. 981-989. , 2005-11-01; Rinker, B., Vyas, K.S., Clinical applications of autografts, conduits, and allografts in repair of nerve defects in the hand: current guidelines (2014) Clin. Plast. Surg., 41 (3), pp. 533-550. , 2014-07-01; Hernandez, A., Reyes, R., Sanchez, E., Rodriguez-Evora, M., Delgado, A., Evora, C., In vivo osteogenic response to different ratios of BMP-2 and VEGF released from a biodegradable porous system (2012) J. Biomed. Mater. Res. A, 100 (9), pp. 2382-2391. , 2012-09-01; Polo-Corrales, L., Latorre-Esteves, M., Ramirez-Vick, J.E., Scaffold design for bone regeneration (2014) J. Nanosci. Nanotechnol., 14 (1), pp. 15-56. , 2014-01-01; Jeon, S.Y., Park, J.S., Yang, H.N., Woo, D.G., Park, K.H., Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs (2012) Biomaterials, 33 (17), pp. 4413-4423. , 2012-06-01; Patel, Z.S., Young, S., Tabata, Y., Jansen, J.A., Wong, M.E., Mikos, A.G., Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model (2008) Bone, 43 (5), pp. 931-940. , 2008-11-01; Mehta, M., Schmidt-Bleek, K., Duda, G.N., Mooney, D.J., Biomaterial delivery of morphogens to mimic the natural healing cascade in bone (2012) Adv. Drug Deliv. Rev., 64 (12), pp. 1257-1276. , 2012-09-01; Guldberg, R.E., Spatiotemporal delivery strategies for promoting musculoskeletal tissue regeneration (2009) J. Bone Miner. Res., 24 (9), pp. 1507-1511. , 2009-09-01; Carvalho, R.S., Einhorn, T.A., Lehmann, W., Edgar, C., Al-Yamani, A., Apazidis, A., The role of angiogenesis in a murine tibial model of distraction osteogenesis (2004) Bone, 34 (5), pp. 849-861. , 2004-05-01; Gerber, H.P., Vu, T.H., Ryan, A.M., Kowalski, J., Werb, Z., Ferrara, N., VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation (1999) Nat. Med., 5 (6), pp. 623-628. , 1999-06-01; Brandi, M.L., Collin-Osdoby, P., Vascular biology and the skeleton (2006) J. Bone Miner. Res., 21 (2), pp. 183-192. , 2006-02-01; Percival, C.J., Richtsmeier, J.T., Angiogenesis and intramembranous osteogenesis (2013) Dev. Dyn., 242 (8), pp. 909-922. , 2013-08-01; Kempen, D.H., Lu, L., Heijink, A., Hefferan, T.E., Creemers, L.B., Maran, A., Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration (2009) Biomaterials, 30 (14), pp. 2816-2825. , 2009-05-01; Behr, B., Sorkin, M., Lehnhardt, M., Renda, A., Longaker, M.T., Quarto, N., A comparative analysis of the osteogenic effects of BMP-2, FGF-2, and VEGFA in a calvarial defect model (2012) Tissue Eng. Part A, 18 (9-10), pp. 1079-1086. , 2012-05-01; Okuda, T., Tominaga, K., Kidoaki, S., Time-programmed dual release formulation by multilayered drug-loaded nanofiber meshes (2010) J. Control. Release, 143 (2), pp. 258-264. , 2010-04-19; de Matos, M.B., Piedade, A.P., Alvarez-Lorenzo, C., Concheiro, A., Braga, M.E., de Sousa, H.C., Dexamethasone-loaded poly(epsilon-caprolactone)/silica nanoparticles composites prepared by supercritical CO2 foaming/mixing and deposition (2013) Int. J. Pharm., 456 (2), pp. 269-281. , 2013-11-18; Amini, N., Mazinani, S., Ranaei-Siadat, S.O., Kalaee, M.R., Hormozi, S., Niknam, K., Acetylcholinesterase immobilization on polyacrylamide/functionalized multi-walled carbon nanotube nanocomposite nanofibrous membrane (2013) Appl. Biochem. Biotechnol., 170 (1), pp. 91-104. , 2013-05-01; Chang, M.W., Stride, E., Edirisinghe, M., A new method for the preparation of monoporous hollow microspheres (2010) Langmuir, 26 (7), pp. 5115-5121. , 2010-04-06; Borselli, C., Ungaro, F., Oliviero, O., D'Angelo, I., Quaglia, F., La Rotonda, M.I., Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres (2010) J. Biomed. Mater. Res. A, 92 (1), pp. 94-102. , 2010-01-01; Xu, Q., Chin, S.E., Wang, C.H., Pack, D.W., Mechanism of drug release from double-walled PDLLA(PLGA) microspheres (2013) Biomaterials, 34 (15), pp. 3902-3911. , 2013-05-01; Li, B., Yoshii, T., Hafeman, A.E., Nyman, J.S., Wenke, J.C., Guelcher, S.A., The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora (2009) Biomaterials, 30 (35), pp. 6768-6779. , 2009-12-01; Choi, D.H., Subbiah, R., Kim, I.H., Han, D.K., Park, K., Dual growth factor delivery using biocompatible core-shell microcapsules for angiogenesis (2013) Small, 9 (20), pp. 3468-3476. , 2013-10-25; Cao, L., Luo, J., Tu, K., Wang, L.Q., Jiang, H., Generation of nano-sized core-shell particles using a coaxial tri-capillary electrospray-template removal method (2014) Colloids Surf. B Biointerfaces, 115, pp. 212-218. , 2014-03-01; Mehta, M., Schmidt-Bleek, K., Duda, G.N., Mooney, D.J., Biomaterial delivery of morphogens to mimic the natural healing cascade in bone (2012) Adv. Drug Deliv. Rev., 64 (12), pp. 1257-1276; Mitragotri, S., Lahann, J., Physical approaches to biomaterial design (2009) Nat. Mater., 8 (1), pp. 15-23. , 2009-01-01; Blüm, C., Scheibel, T., Control of drug loading and release properties of spider silk sub-microparticles (2012) BioNanoScience, 2 (2), pp. 67-74; Liu, B., Earl, H.M., Baban, D., Shoaibi, M., Fabra, A., Kerr, D.J., Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF (1995) Biochem. Biophys. Res. Commun., 217 (3), pp. 721-727. , 1995-12-26; Wang, L., Huang, Y., Pan, K., Jiang, X., Liu, C., Osteogenic responses to different concentrations/ratios of BMP-2 and bFGF in bone formation (2010) Ann. Biomed. Eng., 38 (1), pp. 77-87. , 2010-01-01; Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method (2001) Methods, 25 (4), pp. 402-408. , 2001-12-01; Wang, Y., Yang, X., Liu, W., Zhang, F., Cai, Q., Deng, X., Controlled release behaviour of protein-loaded microparticles prepared via coaxial or emulsion electrospray (2013) J. Microencapsul., 30 (5), pp. 490-497. , 2013-01-20; Kusumbe, A.P., Ramasamy, S.K., Adams, R.H., Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone (2014) Nature, 507 (7492), pp. 323-328. , 2014-03-20; Li, X., Wang, J., Su, G., Zhou, Z., Shi, J., Liu, L., Spatiotemporal control over growth factor delivery from collagen-based membrane (2011) J. Biomed. Mater. Res. A, pp. 11-14. , 2011-11-14; Huang, Y.C., Kaigler, D., Rice, K.G., Krebsbach, P.H., Mooney, D.J., Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration (2005) J. Bone Miner. Res., 20 (5), pp. 848-857. , 2005-05-01; Zhu, H., Yu, D., Zhou, Y., Wang, C., Gao, M., Jiang, H., Biological activity of a nanofibrous barrier membrane containing bone morphogenetic protein formed by core-shell electrospinning as a sustained delivery vehicle (2013) J. Biomed. Mater. Res. B Appl. Biomater., 101 (4), pp. 541-552. , 2013-05-01; Suzuki, S., Asoh, T.A., Kikuchi, A., Design of core-shell gel beads for time-programmed protein release (2013) J. Biomed. Mater. Res. A, 101 (5), pp. 1345-1352. , 2013-05-01; Yang, Y., Li, X., Cui, W., Zhou, S., Tan, R., Wang, C., Structural stability and release profiles of proteins from core-shell poly (DL-lactide) ultrafine fibers prepared by emulsion electrospinning (2008) J. Biomed. Mater. Res. A, 86 (2), pp. 374-385. , 2008-08-01; Li, X., Du, P., Liu, P., Novel biocompatible pH-stimuli responsive superparamagnetic hybrid hollow microspheres as tumor-specific drug delivery system (2014) Colloids Surf. B Biointerfaces, 122 C, pp. 99-106. , 2014-07-01; Arya, N., Chakraborty, S., Dube, N., Katti, D.S., Electrospraying: a facile technique for synthesis of chitosan-based micro/nanospheres for drug delivery applications (2009) J. Biomed. Mater. Res. B Appl. Biomater., 88 (1), pp. 17-31. , 2009-01-01; Gupta, D., Venugopal, J., Mitra, S., Giri, D.V., Ramakrishna, S., Nanostructured biocomposite substrates by electrospinning and electrospraying for the mineralization of osteoblasts (2009) Biomaterials, 30 (11), pp. 2085-2094. , 2009-04-01; Valo, H., Peltonen, L., Vehvilainen, S., Karjalainen, M., Kostiainen, R., Laaksonen, T., Electrospray encapsulation of hydrophilic and hydrophobic drugs in poly(L-lactic acid) nanoparticles (2009) Small, 5 (15), pp. 1791-1798. , 2009-08-03; Kanczler, J.M., Oreffo, R.O., Osteogenesis and angiogenesis: the potential for engineering bone (2008) Eur. Cell Mater., 15, pp. 100-114. , 2008-01-20; Perri, B., Cooper, M., Lauryssen, C., Anand, N., Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study (2007) Spine J., 7 (2), pp. 235-239. , 2007-03-01; Patterson, J., Siew, R., Herring, S.W., Lin, A.S., Guldberg, R., Stayton, P.S., Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration (2010) Biomaterials, 31 (26), pp. 6772-6781. , 2010-09-01; Schmitt, C., Lutz, R., Doering, H., Lell, M., Ratky, J., Schlegel, K.A., Bio-Oss(R) blocks combined with BMP-2 and VEGF for the regeneration of bony defects and vertical augmentation (2013) Clin. Oral Implants Res., 24 (4), pp. 450-460. , 2013-04-01; Ramasamy, S.K., Kusumbe, A.P., Wang, L., Adams, R.H., Endothelial Notch activity promotes angiogenesis and osteogenesis in bone (2014) Nature, 507 (7492), pp. 376-380. , 2014-03-20",Article,Scopus,2-s2.0-84926431195
"Ajita J., Saravanan S., Selvamurugan N.","Effect of size of bioactive glass nanoparticles on mesenchymal stem cell proliferation for dental and orthopedic applications",2015,"Materials Science and Engineering C","53",,,"142","149",,,10.1016/j.msec.2015.04.041,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928953065&partnerID=40&md5=9ee76d9eb2f52150bf06f40f3dc614eb","Department of Biotechnology, School of Bioengineering, SRM UniversityKattankulathur Tamil Nadu, India","Ajita, J., Department of Biotechnology, School of Bioengineering, SRM UniversityKattankulathur Tamil Nadu, India; Saravanan, S., Department of Biotechnology, School of Bioengineering, SRM UniversityKattankulathur Tamil Nadu, India; Selvamurugan, N., Department of Biotechnology, School of Bioengineering, SRM UniversityKattankulathur Tamil Nadu, India","Bioactive glass nanoparticles (nanostructured bioglass ceramics or nBGs) have been widely employed as a filler material for bone tissue regeneration. The physical properties of nBG particles govern their biological actions. In this study, the impact of the size of nBG particles on mouse mesenchymal stem cell (mMSC) proliferation was investigated. Three different sizes of nBG particles were prepared via the sol-gel method with varying concentrations of the surfactant and polyethylene glycol (PEG), and the particles were characterized. Increased concentrations of PEG decreased the size of nBG particles (nBG-1: 74.7 ± 0.62 nm, nBG-2: 43.25 ± 1.5 nm, and nBG-3: 37.6 ± 0.81 nm). All three nBGs were non-toxic at a concentration of 20 mg/mL. Increased proliferation was observed in mMSCs treated with smaller nBG particles. Differential mRNA expression of cyclin A2, B2, D1, and E1 genes induced by nBG particles was noticed in the mMSCs. nBG-1 and nBG-3 particles promoted cells in the G0/G1 phase to enter the S and G2/M phases. nBG particles activated ERK, but prolonged activation was achieved with nBG-3 particles. Among the prepared nBG particles, nBG-3 particles showed enhanced mMSC proliferation via the sustained activation of ERKs, upregulation of cyclin gene(s) expression, and promotion of cell transition from the G0/G1 phase to the S and G2/M phases. Thus, this study indicates that small nBG particles have clinical applications in dental and bone treatments as fillers or bone-tissue bond forming materials. © 2015 Elsevier B.V.All rights reserved.","Bioactive glass nanoparticles; Cell proliferation; Cyclins; ERK activation; Size","Hench, L.L., West, J.K., Biological applications of bioactive glasses (1996) Life Chem. Rep., 13, pp. 187-241; Hench, L.L., (1990) Handbook of Bioactive Ceramics, , seventh ed. CRC Press Bocaraton; Ylanen, H., Karlsson, K.H., Itala, A., Aro, H.T., Effect of immersion in SBF on porous bioactive bodies made by sintering bioactive glass microspheres (2000) J. Non-Cryst. Solids, 275, pp. 107-115; Hamlekhan, A., Mozafari, M., Nezafati, N., Azami, M., Hadipour, H., A proposed fabrication method of novel PCL-GEL-Hap nanocomposite scaffolds for bone tissue engineering applications (2010) Adv. Compos. Lett., 19, pp. 123-130; Yli-Urpo, H., Vallittu, P.K., Narhi, T.O., Forsback, A.P., Väkiparta, M., Release of silica, calcium, phosphorous and fluoride from glass ionomer cement containing bioactive glass (2004) J. Biomater. Appl., 19, pp. 5-20; Nourmohammadi, J., Sadrnezhaad, S.K., Ghader, A.B., Bone-like apatite formation on the new resin-modified glass-ionomer cement (2008) J. Mater. Sci. Mater. Med., 19, pp. 3507-3514; Zamet, J.S., Darbar, U.R., Griffiths, G.S., Bulman, J.S., Brägger, U., Bürgin, W., Newman, H., Particulate bioglass as a grafting material in the treatment of periodontal intrabony defects (1997) J. Clin. Periodontol., 24, pp. 410-418; Pielichowska, K., Blazewicz, S., Bioactive polymer/hydroxyapatite nanocomposites for bone tissue regeneration (2010) Adv. Polym. Sci., 232, pp. 97-207; Mozafari, M., Moztarzadeh, F., Synthesis, characterization and biocompatibility evaluation of sol-gel derived bioactive glass scaffolds prepared by freeze casting method (2014) Ceram. Int., 40, pp. 5349-5355; Mozafari, M., Moztarzadeh, F., Tahriri, M., Investigation of the physico-chemical reactivity of a mesoporous bioactive SiO<inf>2</inf>-CaO-P<inf>2</inf>O<inf>5</inf> glass in simulated body fluid (2010) J. Non-Cryst. Solids, 356, pp. 1470-1478; Suh, W.H., Suslick, K.S., Stucky, G.D., Suh, Y.H., Nanotechnology, nanotoxicology, and neuroscience (2009) Prog. Neurobiol., 87, pp. 133-170; Simchi, A., Tamjid, E., Pishbin, F., Boccaccini, A.R., Recent progress in inorganic and composite coatings with bactericidal capability for orthopaedic applications (2011) Nanomedicine, 7, pp. 22-39; Moorthi, A., Parihar, P.R., Saravanan, S., Vairamani, M., Selvamurugan, N., Effects of silica and calcium levels in nanobioglass ceramic particles on osteoblast proliferation (2014) Mater. Sci. Eng. C Mater. Biol. Appl., 43, pp. 458-464; Vimalraj, S., Patridge, N.C., Selvamurugan, N., A positive role of microRNA-15b on regulation of osteoblast differentiation (2014) J. Cell. Physiol., 229, pp. 1236-1244; Sun, J., Fan, W., Wu, D., Sun, Y., Structure control of SiO<inf>2</inf> sol-gels via addition of PEG (1998) Stud. Surf. Sci. Catal., 118, pp. 617-624; Saranya, N., Saravanan, S., Moorthi, A., Ramyakrishna, B., Selvamurugan, N., Enhanced osteoblast adhesion on polymeric nano-scaffolds for bone tissue engineering (2011) J. Biomed. Nanotechnol., 7, pp. 238-244; Li, X., Wang, L., Fan, Y., Feng, Q., Cui, F.Z., Watari, F., Nanostructured scaffolds for bone tissue engineering (2013) J. Biomed. Mater. Res. Part A, 101, pp. 2424-2435; El Batal, H.A., Azooz, M.A., Khalil, E.M.A., Soltan Monem, A., Hamdy, Y.M., Characterization of some bioglass-ceramics (2003) Mater. Chem. Phys., 80, pp. 599-609; Hong, Z., Reis, R.L., Mano, J.F., Preparation and in vitro characterization of novel bioactive glass ceramic nanoparticles (2009) J. Biomed. Mater. Res. Part A, 88, pp. 304-313; Silver, I.A., Deas, J., Erecińska, M., Interactions of bioactive glasses with osteoblasts in vitro: Effects of 45S5 Bioglass, and 58S and 77S bioactive glasses on metabolism, intracellular ion concentrations and cell viability (2001) Biomaterials, 22, pp. 175-185; Yamaguchi, D.T., Green, J., Kleeman, C.R., Muallem, S., Properties of the depolarization-activated calcium and barium entry in osteoblast-like cells (1989) J. Biol. Chem., 264, pp. 197-204; Li, H., Chang, J., PH-compensation effect of bioactive inorganic fillers on the degradation of PLGA (2005) Compos. Sci. Technol., 65, pp. 2226-2232; Hoppe, A., Güldal, N.S., Boccaccini, A.R., A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics (2011) Biomaterials, 32, pp. 2757-2774; Reilly, G.C., Radin, S., Chen, A.T., Ducheyne, P., Differential alkaline phosphatase responses of rat and human bone marrow derived mesenchymal stem cells to 45S5 bioactive glass (2007) Biomaterials, 28, pp. 4091-4097; Oh, S.A., Kim, S.H., Won, J.E., Kim, J.J., Shin, U.S., Kim, H.W., Effects on growth and osteogenic differentiation of mesenchymal stem cells by the zinc-added sol-gel bioactive glass granules (2010) J. Tissue Eng., 1, p. 475260; Valerio, P., Pereira, M.M., Goes, A.M., Leite, M.F., The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production (2004) Biomaterials, 25, pp. 2941-2948; Johnson, D.G., Walker, C.L., Cyclins and cell cycle checkpoints (1999) Annu. Rev. Pharmacol. Toxicol., 39, pp. 295-312; Grana, X., Reddy, E.P., Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs) (1995) Oncogene, 11, pp. 211-219; Roskoski, Jr.R., ERK1/2 MAP kinases: Structure, function, and regulation (2012) Pharmacol. Res., 66, pp. 105-143; Moorthi, A., Parihar, P.R., Saravanan, S., Vairamani, M., Selvamurugan, N., Effects of silica and calcium levels in nanobioglass ceramic particles on osteoblast proliferation (2014) Mater. Sci. Eng. C Mater. Biol. Appl., 43, pp. 458-464. , 10.1016/j.msec.2014.07.040 (Epub 2014 Jul 18)",Article,Scopus,2-s2.0-84928953065
"Liu H., Li M., Du L., Yang P., Ge S.","Local administration of stromal cell-derived factor-1 promotes stem cell recruitment and bone regeneration in a rat periodontal bone defect model",2015,"Materials Science and Engineering C","53",,,"83","94",,,10.1016/j.msec.2015.04.002,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928952956&partnerID=40&md5=daedfb91bd7d0290c448b2612e3ea751","Department of Periodontology, School of Stomatology, Shandong UniversityJinan, Shandong Province, China; Second Hospital of Shandong University, Department of StomatologyJinan, Shandong Province, China","Liu, H., Department of Periodontology, School of Stomatology, Shandong UniversityJinan, Shandong Province, China; Li, M., Department of Periodontology, School of Stomatology, Shandong UniversityJinan, Shandong Province, China; Du, L., Department of Periodontology, School of Stomatology, Shandong UniversityJinan, Shandong Province, China, Second Hospital of Shandong University, Department of StomatologyJinan, Shandong Province, China; Yang, P., Department of Periodontology, School of Stomatology, Shandong UniversityJinan, Shandong Province, China; Ge, S., Department of Periodontology, School of Stomatology, Shandong UniversityJinan, Shandong Province, China","Stromal cell-derived factor-1 (SDF-1) recruits adult stem/progenitor cells via its specific receptor, C-X-C motif receptor 4 (CXCR4), to promote heart, kidney and tendon regeneration, but little is known about the effects of SDF-1 on bone regeneration in periodontal diseases. The objective of this study was to investigate whether local administration of SDF-1 in a collagen membrane scaffold enhanced the recruitment of host stem cells and improved periodontal bone defect repair. To this end, bone defects were established on the buccal side of bilateral mandibles in Wistar rats. After application of collagen membranes loaded with SDF-1 or phosphate-buffered saline (PBS) to the defects, the effects of SDF-1 on stem cell recruitment, inflammatory cell responses, angiogenesis, osteoclastogenesis, scaffold degradation, and bone regeneration were evaluated. It showed that SDF-1 recruited host-derived mesenchymal stem cells and hematopoietic stem cells to the wound area and significantly reduced the CD11b + inflammatory cell response. Moreover, SDF-1 increased vascular formation, induced early bone osteoclastogenesis, accelerated scaffold degradation, and promoted the quality and quantity of regenerated bone. Our results suggest that this cell-free approach by local administration of SDF-1 may be an effective strategy for development as a simple and safe technique for periodontal bone regeneration. © 2015 Elsevier B.V.All rights reserved.","Chemotaxis; Mesenchymal stem cells; Periodontal bone regeneration; SDF-1; Tissue engineering","Li, H., Yan, F., Lei, L., Li, Y., Xiao, Y., Application of autologous cryopreserved bone marrow mesenchymal stem cells for periodontal regeneration in dogs (2009) Cells Tissues Organs, 190, pp. 94-101; Tobita, M., Mizuno, H., Adipose-derived stem cells for periodontal tissue regeneration (2011) Methods Mol. Biol., 702, pp. 461-470; Liu, Y., Zheng, Y., Ding, G., Fang, D., Zhang, C., Periodontal ligament stem cell-mediated treatment for periodontitis in miniature swine (2008) Stem Cells, 26, pp. 1065-1073; Guo, W., Chen, L., Gong, K., Ding, B., Duan, Y., Heterogeneous dental follicle cells and the regeneration of complex periodontal tissues (2012) Tissue Eng., 18, pp. 459-470; Schantz, J.T., Chim, H., Whiteman, M., Cell guidance in tissue engineering: SDF-1 mediates site-directed homing of mesenchymal stem cells within three-dimensional polycaprolactone scaffolds (2007) Tissue Eng., 13, pp. 2615-2624; Hernigou, P., Poignard, A., Beaujean, F., Rouard, H., Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells (2005) J. Bone Joint Surg. Am., 87, pp. 1430-1437; Kucia, M., Ratajczak, M.Z., Stem cells as a two edged sword - From regeneration to tumor formation (2006) J. Physiol. Pharmacol., 7, pp. 5-16; Shyu, W.C., Lee, Y.J., Liu, D.D., Lin, S.Z., Li, H., Homing genes, cell therapy and stroke (2006) Front. Biosci., 11, pp. 899-907; Thevenot, P.T., Nair, A.M., Shen, J., Lotfi, P., Ko, C.Y., The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response (2010) Biomaterials, 31, pp. 3997-4008; Chavakis, E., Urbich, C., Dimmeler, S., Homing and engraftment of progenitor cells: A prerequisite for cell therapy (2008) J. Mol. Cell. Cardiol., 45, pp. 514-522; Liu, Z.J., Zhuge, Y., Velazquez, O.C., Trafficking and differentiation of mesenchymal stem cells (2009) J. Cell. Biochem., 106, pp. 984-991; Kollet, O., Shivtiel, S., Chen, Y.Q., Suriawinata, J., Thung, S.N., HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34 + stem cell recruitment to the liver (2003) J. Clin. Invest., 112, pp. 160-169; Rehimi, R., Khalida, N., Yusuf, F., Dai, F., Morosan-Puopolo, G., Stromal-derived factor-1 (SDF-1) expression during early chick development (2008) Int. J. Dev. Biol., 52, pp. 87-92; Baggiolini, M., Chemokines and leukocyte traffic (1998) Nature, 392, pp. 565-568; Yu, X., Huang, Y., Collin-Osdoby, P., Osdoby, P., Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration (2003) J. Bone Miner. Res., 18, pp. 1404-1418; Dar, A., Kollet, O., Lapidot, T., Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice (2006) Exp. Hematol., 34, pp. 967-975; Gronthos, S., Simmons, P.J., Graves, S.E., Robey, P.G., Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix (2001) Bone, 28, pp. 174-181; Peled, A., Kollet, O., Ponomaryov, T., Petit, I., Franitza, S., The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34 (+) cells: Role in transendothelial/stromal migration and engraftment of NOD/SCID mice (2000) Blood, 95, pp. 3289-3296; Ardelt, A.A., Bhattacharyya, B.J., Belmadani, A., Ren, D., Miller, R.J., Stromal derived growth factor-1 (CXCL12) modulates synaptic transmission to immature neurons during post-ischemic cerebral repair (2013) Exp. Neurol., 248 C, pp. 246-253; Cavalera, M., Frangogiannis, N.G., Targeting the chemokines in cardiac repair (2014) Curr. Pharm. Des., 20, pp. 1971-1979; Hajjar, R.J., Hulot, J.S., Myocardial delivery of stromal cell-derived factor 1 in patients with ischemic heart disease: Safe and promising (2013) Circ. Res., 112, pp. 746-747; Wang, K., Zhao, X., Kuang, C., Qian, D., Wang, H., Overexpression of SDF-1α enhanced migration and engraftment of cardiac stem cells and reduced infarcted size via CXCR4/PI3K pathway (2012) PLoS One, 7, p. e43922; Brzoska, E., Kowalewska, M., Markowska-Zagrajek, A., Kowalski, K., Archacka, K., Sdf-1 (CXCL12) improves skeletal muscle regeneration via the mobilisation of Cxcr4 and CD34 expressing cells (2012) Biol. Cell., 104, pp. 722-737; Lau, T.T., Wang, D.A., Stromal cell-derived factor-1 (SDF-1): Homing factor for engineered regenerative medicine (2011) Expert. Opin. Biol. Ther., 11, pp. 189-197; Oliver, J.A., Maarouf, O., Cheema, F.H., Liu, C., Zhang, Q.Y., SDF-1 activates papillary label-retaining cells during kidney repair from injury (2012) Am. J. Physiol. Ren. Physiol., 302, pp. F1362-F1373; Takabatake, Y., Sugiyama, T., Kohara, H., Matsusaka, T., Kurihara, H., The CXCL12 (SDF-1)/CXCR4 axis is essential for the development of renal vasculature (2009) J. Am. Soc. Nephrol., 20, pp. 1714-1723; Yang, D., Sun, S., Wang, Z., Zhu, P., Yang, Z., Stromal cell-derived factor-1 receptor CXCR4-overexpressing bone marrow mesenchymal stem cells accelerate wound healing by migrating into skin injury areas (2013) Cell. Reprogram., 15, pp. 206-215; Shen, W., Chen, X., Chen, J., Yin, Z., Heng, B.C., The effect of incorporation of exogenous stromal cell-derived factor-1 alpha within a knitted silk-collagen membrane scaffold on tendon regeneration (2010) Biomaterials, 31, pp. 7239-7249; Ji, W., Yang, F., Ma, J., Bouma, M.J., Boerman, O.C., Incorporation of stromal cell-derived factor-1α in PCL/gelatin electrospun membranes for guided bone regeneration (2013) Biomaterials, 34, pp. 735-745; Li, S., Tu, Q., Zhang, J., Stein, G., Lian, J., Systemically transplanted bone marrow stromal cells contributing to bone tissue regeneration (2008) J. Cell. Physiol., 215, pp. 204-209; Du, L., Yang, P., Ge, S., Stromal cell-derived factor-1 significantly induces proliferation, migration and collagen type i expression in a human periodontal ligament stem cell subpopulation (2012) J. Periodontol., 83, pp. 379-388; Higashino, K., Viggeswarapu, M., Bargouti, M., Liu, H., Titus, L., Stromal cell-derived factor-1 potentiates bone morphogenetic protein-2 induced bone formation (2011) Tissue Eng. A, 17, pp. 523-530; Sordi, V., Malosio, M.L., Marchesi, F., Mercalli, A., Melzi, R., Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets (2005) Blood, 106, pp. 419-427; Zhang, G., Nakamura, Y., Wang, X., Hu, Q., Suggs, L.J., Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit + cell homing to the infarcted heart (2007) Tissue Eng., 13, pp. 2063-2071; Hattori, K., Heissig, B., Tashiro, K., Honjo, T., Tateno, M., Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells (2001) Blood, 97, pp. 3354-3360; Chen, F.M., Wu, L.A., Zhang, M., Zhang, R., Sun, H.H., Homing of endogenous stem/progenitor cells for in situ tissue regeneration: Promises, strategies, and translational perspectives (2011) Biomaterials, 32, pp. 3189-3209; Abbott, J.D., Huang, Y., Liu, D., Hickey, R., Krause, D.S., Stromal cell-derived factor-1 alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury (2004) Circulation, 110, pp. 3300-3305; Chen, F.M., Lu, H., Wu, L.A., Gao, L.N., An, Y., Surface-engineering of glycidyl methacrylated dextran/gelatin microcapsules with thermo-responsive poly(N-isopropylacrylamide) gates for controlled delivery of stromal cell-derived factor-1α (2013) Biomaterials, 34, pp. 6515-6527; Godot, V., Arock, M., Garcia, G., Capel, F., Flys, C., H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12 (2007) J. Allergy Clin. Immunol., 120, pp. 827-834; Melief, S.M., Zwaginga, J.J., Fibbe, W.E., Roelofs, H., Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts (2013) Stem Cells Transl. Med., 2, pp. 455-463; Kim, K.S., Kim, H.S., Park, J.M., Kim, H.W., Park, M.K., Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model (2013) Neurobiol. Aging, 34, pp. 2408-2420; Lindhorst, D., Tavassol, F., Von See, C., Schumann, P., Laschke, M.W., Effects of VEGF loading on scaffold-confined vascularization (2010) J. Biomed. Mater. Res. A, 95, pp. 783-792; Lu, J., Pompili, V.J., Das, H., Neovascularization and hematopoietic stem cells (2013) Cell Biochem. Biophys., 67, pp. 235-245; Wright, L.M., Maloney, W., Yu, X., Kindle, L., Collin-Osdoby, P., Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts (2005) Bone, 36, pp. 840-853",Article,Scopus,2-s2.0-84928952956
"Gujer C., Chatterjee B., Landtwing V., Raykova A., McHugh D., Munz C.","Animal models of Epstein Barr virus infection",2015,"Current Opinion in Virology","13",,,"6","10",,,10.1016/j.coviro.2015.03.014,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926149699&partnerID=40&md5=6d07ae764b5ea70854ebd7a46157ae37","Viral Immunobiology, Institute for Experimental Immunology, University of Zürich, Switzerland","Gujer, C., Viral Immunobiology, Institute for Experimental Immunology, University of Zürich, Switzerland; Chatterjee, B., Viral Immunobiology, Institute for Experimental Immunology, University of Zürich, Switzerland; Landtwing, V., Viral Immunobiology, Institute for Experimental Immunology, University of Zürich, Switzerland; Raykova, A., Viral Immunobiology, Institute for Experimental Immunology, University of Zürich, Switzerland; McHugh, D., Viral Immunobiology, Institute for Experimental Immunology, University of Zürich, Switzerland; Münz, C., Viral Immunobiology, Institute for Experimental Immunology, University of Zürich, Switzerland","Epstein Barr virus (EBV) was the first human tumor virus to be described. Despite its discovery now more than fifty years ago, immune control of this virus is still not very well understood and no vaccine is available. This knowledge gap is due in part to the lack of a preclinical small animal model which can faithfully recapitulate EBV infection and immune control, and would allow testing of EBV specific vaccine candidates. With the advent of mice with reconstituted human immune system compartments (HIS mice) during the past decade this is changing. We will discuss which aspects of EBV infection and its immune control can already be modeled in HIS mice, and which shortcomings still need to be overcome in order to recapitulate the immunobiology of oncogenic EBV infection. © 2015 Elsevier B.V.",,"Rickinson, A.B., Long, H.M., Palendira, U., Münz, C., Hislop, A., Cellular immune controls over Epstein-Barr virus infection: New lessons from the clinic and the laboratory (2014) Trends Immunol, 35, pp. 159-169; Cesarman, E., Gammaherpesviruses and lymphoproliferative disorders (2014) Annu Rev Pathol, 9, pp. 349-372; Thorley-Lawson, D.A., Hawkins, J.B., Tracy, S.I., Shapiro, M., The pathogenesis of Epstein-Barr virus persistent infection (2013) Curr Opin Virol, 3, pp. 227-232; Woellmer, A., Arteaga-Salas, J.M., Hammerschmidt, W., BZLF1 governs CpG-methylated chromatin of Epstein-Barr virus reversing epigenetic repression (2012) PLoS Pathog, 8, p. e1002902; Hutt-Fletcher, L.M., Chesnokova, L.S., Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection (2010) Virulence, 1, pp. 395-398; Tovey, M.G., Lenoir, G., Begon-Lours, J., Activation of latent Epstein-Barr virus by antibody to human IgM (1978) Nature, 276, pp. 270-272; Hoagland, R.J., The transmission of infectious mononucleosis (1955) Am J Med Sci, 229, pp. 262-272; Svedmyr, E., Ernberg, I., Seeley, J., Weiland, O., Masucci, G., Tsukuda, K., Szigeti, R., Berthold, W., Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis (1984) Clin Immunol Immunopathol, 30, pp. 437-450; Luzuriaga, K., Sullivan, J.L., Infectious mononucleosis (2010) N Engl J Med, 362, pp. 1993-2000; Savoldo, B., Cubbage, M.L., Durett, A.G., Goss, J., Huls, M.H., Liu, Z., Teresita, L., Heslop, H.E., Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals (2002) J Immunol, 168, pp. 909-918; Gottschalk, S., Rooney, C.M., Heslop, H.E., Post-transplant lymphoproliferative disorders (2005) Annu Rev Med, 56, pp. 29-44; Epstein, M.A., Achong, B.G., Barr, Y.M., Virus particles in cultured lymphoblasts from Burkitt's lymphoma (1964) Lancet, 1, pp. 702-703; Epstein, M.A., Henle, G., Achong, B.G., Barr, Y.M., Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt's lymphoma (1964) J Exp Med, 121, pp. 761-770; Chatterjee, B., Leung, C.S., Münz, C., Animal models of Epstein Barr virus infection (2014) J Immunol Methods, 410, pp. 80-87; Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J.C., Lanzavecchia, A., Manz, M.G., Development of a human adaptive immune system in cord blood cell-transplanted mice (2004) Science, 304, pp. 104-107; Strowig, T., Gurer, C., Ploss, A., Liu, Y.F., Arrey, F., Sashihara, J., Koo, G., Cohen, J.I., Priming of protective T cell responses against virus-induced tumors in mice with human immune system components (2009) J Exp Med, 206, pp. 1423-1434; Yajima, M., Imadome, K., Nakagawa, A., Watanabe, S., Terashima, K., Nakamura, H., Ito, M., Fujiwara, S., A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses (2008) J Infect Dis, 198, pp. 673-682; Miller, G., Lipman, M., Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus (1973) J Exp Med, 138, pp. 1398-1412; Chijioke, O., Muller, A., Feederle, R., Barros, M.H., Krieg, C., Emmel, V., Marcenaro, E., Bossart, W., Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection (2013) Cell Rep, 5, pp. 1489-1498; Antsiferova, O., Müller, A., Rämer, P., Chijioke, O., Chatterjee, B., Raykova, A., Planas, R., Delecluse, H.J., Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice (2014) PLoS Pathog, 10, p. e1004333; Tsai, M.H., Raykova, A., Klinke, O., Bernhardt, K., Gartner, K., Leung, C.S., Geletneky, K., Delecluse, H.J., Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas (2013) Cell Rep, 5, pp. 458-470; Ma, S.D., Hegde, S., Young, K.H., Sullivan, R., Rajesh, D., Zhou, Y., Jankowska-Gan, E., Tang, W., A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas (2011) J Virol, 85, pp. 165-177; Heuts, F., Rottenberg, M.E., Salamon, D., Rasul, E., Adori, M., Klein, G., Klein, E., Nagy, N., T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized mice (2014) J Virol, 88, pp. 3235-3245; Cocco, M., Bellan, C., Tussiwand, R., Corti, D., Traggiai, E., Lazzi, S., Mannucci, S., Tosi, P., CD34+ cord blood cell-transplanted Rag2-/- gamma c-/- mice as a model for Epstein-Barr virus infection (2008) Am J Pathol, 173, pp. 1369-1378; Nochi, T., Denton, P.W., Wahl, A., Garcia, J.V., Cryptopatches are essential for the development of human GALT (2013) Cell Rep, 3, pp. 1874-1884; Salguero, G., Daenthanasanmak, A., Münz, C., Raykova, A., Guzman, C.A., Riese, P., Figueiredo, C., Sundarasetty, B.S., Dendritic cell-mediated immune humanization of mice: Implications for allogeneic and xenogeneic stem cell transplantation (2014) J Immunol, 192, pp. 4636-4647; White, R.E., Ramer, P.C., Naresh, K.N., Meixlsperger, S., Pinaud, L., Rooney, C., Savoldo, B., Ibrahim, H.A., EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors (2012) J Clin Investig, 122, pp. 1487-1502; Ma, S.D., Xu, X., Plowshay, J., Ranheim, E.A., Burlingham, W.J., Jensen, J.L., Asimakopoulos, F., Gumperz, J.E., LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis (2015) J Clin Investig, 125, pp. 304-315; Strowig, T., Chijioke, O., Carrega, P., Arrey, F., Meixlsperger, S., Ramer, P.C., Ferlazzo, G., Münz, C., Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence (2010) Blood, 116, pp. 4158-4167; Meixlsperger, S., Leung, C.S., Ramer, P.C., Pack, M., Vanoaica, L.D., Breton, G., Pascolo, S., Steinman, R.M., CD141+ dendritic cells produce prominent amounts of IFN-alpha after dsRNA recognition and can be targeted via DEC-205 in humanized mice (2013) Blood, 121, pp. 5034-5044; Melkus, M.W., Estes, J.D., Padgett-Thomas, A., Gatlin, J., Denton, P.W., Othieno, F.A., Wege, A.K., Garcia, J.V., Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1 (2006) Nat Med, 12, pp. 1316-1322; Ishikawa, F., Niiro, H., Iino, T., Yoshida, S., Saito, N., Onohara, S., Miyamoto, T., Harada, M., The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways (2007) Blood, 110, pp. 3591-3660; Ding, Y., Wilkinson, A., Idris, A., Fancke, B., O'Keeffe, M., Khalil, D., Ju, X., Rodwell, R., FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo (2014) J Immunol, 192, pp. 1982-1989; Severa, M., Giacomini, E., Gafa, V., Anastasiadou, E., Rizzo, F., Corazzari, M., Romagnoli, A., Coccia, E.M., EBV stimulates TLR- and autophagy-dependent pathways and impairs maturation in plasmacytoid dendritic cells: Implications for viral immune escape (2013) Eur J Immunol, 43, pp. 147-158; Fiola, S., Gosselin, D., Takada, K., Gosselin, J., TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells (2010) J Immunol, 185, pp. 3620-3631; Iwakiri, D., Zhou, L., Samanta, M., Matsumoto, M., Ebihara, T., Seya, T., Imai, S., Takada, K., Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3 (2009) J Exp Med, 206, pp. 2091-2099; Lim, W.H., Kireta, S., Russ, G.R., Coates, P.T., Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice (2006) Blood, 109, pp. 1043-1050; Lotz, M., Tsoukas, C.D., Fong, S., Carson, D.A., Vaughan, J.H., Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma (1985) Eur J Immunol, 15, pp. 520-525; Bickham, K., Goodman, K., Paludan, C., Nikiforow, S., Tsang, M.L., Steinman, R.M., Münz, C., Dendritic cells initiate immune control of Epstein-Barr virus transformation of B lymphocytes in vitro (2003) J Exp Med, 198, pp. 1653-1663; Chijioke, O., Azzi, T., Nadal, D., Münz, C., Innate immune responses against Epstein Barr virus infection (2013) J Leukoc Biol, 94, pp. 1185-1190; Ferlazzo, G., Tsang, M.L., Moretta, L., Melioli, G., Steinman, R.M., Münz, C., Human dendritic cells activate resting NK cells and are recognized via the NKp30 receptor by activated NK cells (2002) J Exp Med, 195, pp. 343-351; Barreira Da Silva, R., Graf, C., Münz, C., Cytoskeletal stabilization of inhibitory interactions in immunologic synapses of mature human dendritic cells with natural killer cells (2011) Blood, 118, pp. 6487-6498; Biron, C.A., Byron, K.S., Sullivan, J.L., Severe herpesvirus infections in an adolescent without natural killer cells (1989) N Engl J Med, 320, pp. 1731-1735; Williams, H., McAulay, K., Macsween, K.F., Gallacher, N.J., Higgins, C.D., Harrison, N., Swerdlow, A.J., Crawford, D.H., The immune response to primary EBV infection: A role for natural killer cells (2005) Br J Haematol, 129, pp. 266-274; Azzi, T., Lunemann, A., Murer, A., Ueda, S., Beziat, V., Malmberg, K.J., Staubli, G., Chijioke, O., Role for early-differentiated natural killer cells in infectious mononucleosis (2014) Blood, 124, pp. 2533-2543; Shultz, L.D., Saito, Y., Najima, Y., Tanaka, S., Ochi, T., Tomizawa, M., Doi, T., Yasukawa, M., Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class i expressing NOD/SCID/IL2r gammanull humanized mice (2010) Proc Natl Acad Sci USA, 107, pp. 13022-13027; Yajima, M., Imadome, K., Nakagawa, A., Watanabe, S., Terashima, K., Nakamura, H., Ito, M., Fujiwara, S., T cell-mediated control of Epstein-Barr virus infection in humanized mice (2009) J Infect Dis, 200, pp. 1611-1615; Ishikawa, F., Yasukawa, M., Lyons, B., Yoshida, S., Miyamoto, T., Yoshimoto, G., Watanabe, T., Harada, M., Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chainnull mice (2005) Blood, 106, pp. 1565-1573; Shultz, L.D., Lyons, B.L., Burzenski, L.M., Gott, B., Chen, X., Chaleff, S., Kotb, M., Greiner, D.L., Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells (2005) J Immunol, 174, pp. 6477-6489",Article,Scopus,2-s2.0-84926149699
"Grillner S., Robertson B.","The basal ganglia downstream control of brainstem motor centres-an evolutionarily conserved strategy",2015,"Current Opinion in Neurobiology","33",,,"47","52",,,10.1016/j.conb.2015.01.019,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84922637002&partnerID=40&md5=001bda591da48acf7bae993904c2a0bc","The Nobel Institute for Neurophysiology, Department of Neuroscience, Karolinska InstitutetStockholm, Sweden","Grillner, S., The Nobel Institute for Neurophysiology, Department of Neuroscience, Karolinska InstitutetStockholm, Sweden; Robertson, B., The Nobel Institute for Neurophysiology, Department of Neuroscience, Karolinska InstitutetStockholm, Sweden","The basal ganglia plays a crucial role in decision-making and control of motion. The output of the basal ganglia consists of tonically active GABAergic neurons, a proportion of which project to different brainstem centres and another part projecting to thalamus and back to cortex. The focus here is on the former part, which keeps the different brainstem motor-centres tonically inhibited under resting conditions. These centres will be disinhibited when called into action. In the control of motion the direct pathway will promote movement and the indirect pathway inhibit competing movement patterns counteracting the motor-command issued. The basal ganglia detailed structure and function are conserved throughout the vertebrate evolution, including the afferent (e.g. habenulae) and efferent control of the dopamine system. © 2015 Elsevier Ltd.",,"Doig, N.M., Moss, J., Bolam, J.P., Cortical and thalamic innervation of direct and indirect pathway medium-sized spiny neurons in mouse striatum (2010) J Neurosci, 30, pp. 14610-14618; Gerfen, C.R., Surmeier, D.J., Modulation of striatal projection systems by dopamine (2011) Annu Rev Neurosci, 34, pp. 441-466; Nelson, A.B., Kreitzer, A.C., Reassessing models of basal ganglia function and dysfunction (2014) Annu Rev Neurosci, 37, pp. 117-135; Redgrave, P., Gurney, K., The short-latency dopamine signal: a role in discovering novel actions? (2006) Nat Rev Neurosci, 7, pp. 967-975; Bjursten, L.M., Norrsell, K., Norrsell, U., Behavioural repertory of cats without cerebral cortex from infancy (1976) Exp Brain Res, 25, pp. 115-130; Sorenson, C.A., Ellison, G.D., Striatal organization of feeding behavior in the decorticate rat (1970) Exp Neurol, 29, pp. 162-174; Hikosaka, O., GABAergic output of the basal ganglia (2007) Prog Brain Res, 160, pp. 209-226; Carpenter, M.B., Anatomy of the corpus striatum and brainstem integrating systems (1981) The Nervous System, , American Physiological Society, V.B. Brooks, M.D. Bethesda (Eds.); DeLong, M.R., AP, G., Motor function of the basal ganglia (1981) The Nervous System, pp. 1017-1061. , American Physiological Society; Saitoh, K., Hattori, S., Song, W.J., Isa, T., Takakusaki, K., Nigral GABAergic inhibition upon cholinergic neurons in the rat pedunculopontine tegmental nucleus (2003) Eur J Neurosci, 18, pp. 879-886; Stephenson-Jones, M., Samuelsson, E., Ericsson, J., Robertson, B., Grillner, S., Evolutionary conservation of the basal ganglia as a common vertebrate mechanism for action selection (2011) Curr Biol, 21, pp. 1081-1091; Takakusaki, K., Habaguchi, T., Ohtinata-Sugimoto, J., Saitoh, K., Sakamoto, T., Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction (2003) Neuroscience, 119, pp. 293-308; Takakusaki, K., Obara, K., Nozu, T., Okumura, T., Modulatory effects of the GABAergic basal ganglia neurons on the PPN and the muscle tone inhibitory system in cats (2011) Arch Ital Biol, 149, pp. 385-405; Beckstead, R.M., Long collateral branches of substantia nigra pars reticulata axons to thalamus, superior colliculus and reticular formation in monkey and cat. Multiple retrograde neuronal labeling with fluorescent dyes (1983) Neuroscience, 10, pp. 767-779; Parent, M., Parent, A., The pallidofugal motor fiber system in primates (2004) Parkinsonism Relat Disord, 10, pp. 203-211; Swanson, L.W., Cerebral hemisphere regulation of motivated behavior (2000) Brain Res, 886, pp. 113-164; Hikosaka, O., Wurtz, R.H., Modification of saccadic eye movements by GABA-related substances, II. Effects of muscimol in monkey substantia nigra pars reticulata (1985) J Neurophysiol, 53, pp. 292-308; Wurtz, R.H., Hikosaka, O., Role of the basal ganglia in the initiation of saccadic eye movements (1986) Prog Brain Res, 64, pp. 175-190; Freeze, B.S., Kravitz, A.V., Hammack, N., Berke, J.D., Kreitzer, A.C., Control of basal ganglia output by direct and indirect pathway projection neurons (2013) J Neurosci, 33, pp. 18531-18539; Ménard, A., Grillner, S., Diencephalic locomotor region in the lamprey-afferents and efferent control (2008) J Neurophysiol, 100, pp. 1343-1353; Wenger, K.K., Musch, K.L., Mink, J.W., Impaired reaching and grasping after focal inactivation of globus pallidus pars interna in the monkey (1999) J Neurophysiol, 82, pp. 2049-2060; Reig, R., Silberberg, G., Multisensory integration in the mouse striatum (2014) Neuron, 83, pp. 1200-1212; Kravitz, A.V., Freeze, B.S., Parker, P.R., Kay, K., Thwin, M.T., Deisseroth, K., Kreitzer, A.C., Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry (2010) Nature, 466, pp. 622-626; Tai, L.H., Lee, A.M., Benavidez, N., Bonci, A., Wilbrecht, L., Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value (2012) Nat Neurosci, 15, pp. 1281-1289; Cui, G., Jun, S.B., Jin, X., Pham, M.D., Vogel, S.S., Lovinger, D.M., Costa, R.M., Concurrent activation of striatal direct and indirect pathways during action initiation (2013) Nature, 494, pp. 238-242; Isomura, Y., Takekawa, T., Harukuni, R., Handa, T., Aizawa, H., Takada, M., Fukai, T., Reward-modulated motor information in identified striatum neurons (2013) J Neurosci, 33, pp. 10209-10220; Ericsson, J., Silberberg, G., Robertson, B., Wikstrom, M.A., Grillner, S., Striatal cellular properties conserved from lampreys to mammals (2011) J Physiol, 589, pp. 2979-2992; Ericsson, J., Stephenson-Jones, M., Kardamakis, A., Robertson, B., Silberberg, G., Grillner, S., Evolutionarily conserved differences in pallial and thalamic short-term synaptic plasticity in striatum (2013) J Physiol, 591, pp. 859-874; Ericsson, J., Stephenson-Jones, M., Pérez-Fernández, J., Robertson, B., Silberberg, G., Grillner, S., Dopamine differentially modulates the excitability of striatal neurons of the direct and indirect pathways in lamprey (2013) J Neurosci, 33, pp. 8045-8054; Stephenson-Jones, M., Ericsson, J., Robertson, B., Grillner, S., Evolution of the basal ganglia: dual-output pathways conserved throughout vertebrate phylogeny (2012) J Comp Neurol, 520, pp. 2957-2973; Ocaña, F.M., Suryanarayana, S.M., Saitoh, K., Kardamakis, A.A., Capantini, L., Robertson, B., Grillner, S., The lamprey pallium provides a blueprint of the mammalian motor projections from cortex (2015) Curr. Biol., 25, pp. 1-11; Reiner, A., Jiao, Y., Del Mar, N., Laverghetta, A.V., Lei, W.L., Differential morphology of pyramidal tract-type and intratelencephalically projecting-type corticostriatal neurons and their intrastriatal terminals in rats (2003) J Comp Neurol, 457, pp. 420-440; Pérez-Fernández, J., Stephenson-Jones, M., Suryanarayana, S.M., Robertson, B., Grillner, S., Evolutionarily conserved organization of the dopaminergic system in lamprey: SNc/VTA afferent and efferent connectivity and D2 receptor expression (2014) J Comp Neurol, 522, pp. 3775-3794; Campbell, K.J., Takada, M., Bilateral tectal projection of single nigrostriatal dopamine cells in the rat (1989) Neuroscience, 33, pp. 311-321; Ryczko, D., Gratsch, S., Auclair, F., Dube, C., Bergeron, S., Alpert, M.H., Cone, J.J., Dubuc, R., Forebrain dopamine neurons project down to a brainstem region controlling locomotion (2013) Proc Natl Acad Sci U S A, 110, pp. E3235-E3242; Lammel, S., Lim, B.K., Ran, C., Huang, K.W., Betley, M.J., Tye, K.M., Deisseroth, K., Malenka, R.C., Input-specific control of reward and aversion in the ventral tegmental area (2012) Nature, 491, pp. 212-217; Hong, S., Jhou, T.C., Smith, M., Saleem, K.S., Hikosaka, O., Negative reward signals from the lateral habenula to dopamine neurons are mediated by rostromedial tegmental nucleus in primates (2011) J Neurosci, 31, pp. 11457-11471; Stephenson-Jones, M., Floros, O., Robertson, B., Grillner, S., Evolutionary conservation of the habenular nuclei and their circuitry controlling the dopamine and 5-hydroxytryptophan (5-HT) systems (2012) Proc Natl Acad Sci U S A, 109, pp. E164-E173; Stephenson-Jones, M., Kardamakis, A.A., Robertson, B., Grillner, S., Independent circuits in the basal ganglia for the evaluation and selection of actions (2013) Proc Natl Acad Sci U S A, 110, pp. E3670-E3679; Hikosaka, O., The habenula: from stress evasion to value-based decision-making (2010) Nat Rev Neurosci, 11, pp. 503-513; Rajakumar, N., Elisevich, K., Flumerfelt, B.A., Compartmental origin of the striato-entopeduncular projection in the rat (1993) J Comp Neurol, 331, pp. 286-296; Graybiel, A.M., Habits, rituals, and the evaluative brain (2008) Annu Rev Neurosci, 31, pp. 359-387; Newman, H.L.F.-C., Graybiel, A.M., Dynamic ordering of early generated striatal cells destined to form the striosomal compartment of the striatum (2015) J Comp Neurol; Duval, C., Panisset, M., Strafella, A.P., Sadikot, A.F., The impact of ventrolateral thalamotomy on tremor and voluntary motor behavior in patients with Parkinson's disease (2006) Exp Brain Res, 170, pp. 160-171; Brazhnik, E., Novikov, N., McCoy, A.J., Cruz, A.V., Walters, J.R., Functional correlates of exaggerated oscillatory activity in basal ganglia output in hemiparkinsonian rats (2014) Exp Neurol, 261, pp. 563-577; Grillner, S., Robertson, B., Stephenson-Jones, M., The evolutionary origin of the vertebrate basal ganglia and its role in action selection (2013) J Physiol, 591, pp. 5425-5431",Review,Scopus,2-s2.0-84922637002
"Yamaguchi K.K.D.L., Pereira L.F.R., Lamarao C.V., Lima E.S., Da Veiga-Junior V.F.","Amazon acai: Chemistry and biological activities: A review",2015,"Food Chemistry","179",,,"137","151",,,10.1016/j.foodchem.2015.01.055,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84922504050&partnerID=40&md5=72da83127ad19f52eee536d6cddc878c","Chemistry Department, Amazonas Federal University, Av. Rodrigo Octávio, 6.200Japiim, Manaus, AM, Brazil; Pharmaceutical Sciences Faculty, Amazonas Federal University, Alexandre Amorin Street, 330Aparecida, Manaus, AM, Brazil","Yamaguchi, K.K.D.L., Chemistry Department, Amazonas Federal University, Av. Rodrigo Octávio, 6.200Japiim, Manaus, AM, Brazil; Pereira, L.F.R., Chemistry Department, Amazonas Federal University, Av. Rodrigo Octávio, 6.200Japiim, Manaus, AM, Brazil; Lamarão, C.V., Chemistry Department, Amazonas Federal University, Av. Rodrigo Octávio, 6.200Japiim, Manaus, AM, Brazil; Lima, E.S., Pharmaceutical Sciences Faculty, Amazonas Federal University, Alexandre Amorin Street, 330Aparecida, Manaus, AM, Brazil; Da Veiga-Junior, V.F., Chemistry Department, Amazonas Federal University, Av. Rodrigo Octávio, 6.200Japiim, Manaus, AM, Brazil","Acai (acai or assai) is one of the Amazon's most popular functional foods and widely used in the world. There are many benefits to its alleged use in the growing market for nutraceuticals. The acai extracts have a range of polyphenolic components with antioxidant properties, some of those present in greater quantity are orientin, isoorientin and vanillic acid, as well as anthocyanins cyanidin-3-glucoside and cyanidin-3-rutinoside. The presence of these substances is linked mainly to the antioxidant, anti- inflammatory, anti-proliferative and cardioprotective activities. Importantly, there are two main species of the Euterpe genus which produce acai. There are several differences between them but they are still quite unknown, from literature to producers and consumers. In this review are highlighted the chemical composition, botanical aspects, pharmacological, marketing and nutrition of these species based on studies published in the last five years in order to unify the current knowledge and dissimilarities between them. © 2015 Elsevier Ltd. All rights reserved.","Amazon; Euterpe genus; Pharmacological activities; Polyphenols","Alexandre, D., Cunha, R.L., Conservação do açaí pela tecnologia de obstáculos (2004) Ciências e Tecnologia em Alimentos, 24 (1), pp. 114-119; Balaswamy, K., Rao, P.P., Nagender, A., Satyanarayana, A., Preparation of sour grape (Vitis vinifera) beverages and evaluation of their storability (2011) Journal of Food Processing and Technology, 2, p. 1000116; Bobbio, F.O., Druzian, J.I., Abrao, P.A., Bobbio, P.A., Fadelli, S., Identification and quantification of anthocyanins from the acai fruit (Euterpe oleracea) Mart (2000) Ciência e Tecnologia de Alimentos, 20, pp. 388-390; Boghani, A.H., Raheem, A., Hashmi, S.I., Development and storage studies of blended papaya-aloe vera ready to serve (RTS) beverage (2012) Journal of Food Processing and Technology, 3, p. 1000185; Bourdy, G., Dewalt, S.J., Michel, L.R.C., Roca, A., Deharo, E., Muñoz, V., Medicinal plants uses of the Tacana, an Amazonian Bolivian ethnic group (2000) Journal of Ethnopharmacology, 70, pp. 87-109; Bovi, M.L.A., Castro, A., Assaí (1993) Selected Species and Strategies to Enhance Income Generation from Amazonian Forests, pp. 58-67. , Clay, J.W. & Clement, C.R. (Eds.) Roma: Food and Agriculture Organization of the United Nations; Brian, M.B., (1998) Ethnobotany of the Chacobo Indians and Their Palms. Advanced in Economic Botany, , The New York Botanic Garden New York; Canuto, G.A.B., Xavier, A.A.O., Neves, L.C., Benassi, M.T., Physical and chemical characterization of fruit pulps from Amazonia and their correlation to free radical scavenger activity (2010) Revista Brasileira de Fruticultura, 32, pp. 1196-1205; Carneiro, A.P.G., Silva, L.M.R., Figueiredo, R.W., Sousa, P.H.M., Maia, G.A., Efeito da Temperatura no Comportamento Reológico de Pó de Açaí (Euterpe oleracea) Reconstituído (2012) UNOPAR Científica Ciências Biológicas e da Saúde, 14, pp. 241-245; Chin, Y.W., Chai, H.B., Keller, W.J., Kinghorn, A.D., Lignans and other constituents of the fruits of Euterpe oleraceae (acai) with antioxidant and cytoprotective activities (2008) Journal of Agricultural and Food Chemistry, 56, pp. 7759-7764; Choi, W.S., Lee, S.E., Lee, H.S., Lee, Y.H., Park, B.S., Antioxidative activities of methanol extracts of tropical and oriental medicinal plants (1998) Han'Guk Nonghwa Hakhoechi, 41, pp. 556-559; Clewell, A., Qureshi, I., Endres, J., Horváth, J., Financsek, I., Neal-Kababick, J., Toxicological evaluation of a dietary supplement formulated for male sexual health prior to market release (2010) Regulatory Toxicology and Pharmacology, 57, pp. 55-61; (2014) CONAB - COMPANHIA NACIONAL de ABASTECIMENTO, , http://www.conab.gov.br, Política de garantia de preços mínimos. Disponível em: < >. Acesso em: May 4th; Constant, P.B.L., (2003) Extração, Caracterização e Aplicação de Antocianinas de Açaí (Euterpe Oleracea, M.), p. 183. , Doctor Scientiae em Ciência e Tecnologia de Alimentos) - Universidade Federal de Viçosa, Viçosa, MG; Córdova-Fraga, T., De Araujo, D.B., Sanchez, T.A., Elias, Jr.J., Carneiro, A.A., Brandt-Oliveira, R., Euterpe oleracea (Açaí) as an alternative oral contrast agent in MRI of the gastrointestinal system: Preliminary results (2004) Magnetic Resonance Imaging, 22, pp. 389-393; Costa, A.G.V., Garcia-Diaz, D.F., Jimenez, P., Silva, P.I., Bioactive compounds and health benefits of exotic tropical red-black berries (2013) Journal of Functional Foods, 5, pp. 539-549; Costa, P.A., Ballus, C.A., Teixeira, J., Godoy, H.T., Phytosterols and tocopherols content of pulps and nuts of Brazilian fruits (2010) Food Research International, 43, pp. 1603-1606; Crozier, S.J., Preston, A.G., Hurst, J.W., Payne, M.J., Mann, J., Hainly, L., Cacao seeds are a ""super Fruit"": A comparative analysis of various fruit powders and products (2011) Chemistry Central Journal, 5; Darnet, S., Serra, J.L., Rodrigues, A.M.C., Silva, L.H.M., A high-performance liquid chromatography method to measure tocopherols in assai pulp (Euterpe oleracea) (2011) Food Research International, 44, pp. 2107-2111; Deharo, E., Baelmans, R., Gimenez, A., Quenevo, C., Bourdy, G., In vitro immunomodulatory activity of plants used by the Tacana ethnic group in Bolivia (2004) Phytomedicine, 11, pp. 516-522; Del Pozo-Insfran, D., Brenes, C.H., Talcott, S.T., Phytochemical Composition and Pigment Stability of Açai (Euterpe oleracea Mart.) (2004) Journal of Agricultural and Food Chemistry, 52 (6), pp. 1539-1545; Del Pozo-Insfran, D., Percival, S.S., Talcott, S.T., Acai (Euterpe oleracea Mart.) polyphenolics in their glycoside and aglycone forms induce apoptosis of HL-60 leukemia cells (2006) Journal of Agricultural and Food Chemistry, 54, pp. 1222-1229; Desmarchelier, C., Repetto, M., Coussio, J., Llesuy, S., Ciccia, G., Total reactive antioxidant potential (TRAP) and total antioxidant reactivity (TAR) of medicinal plants used in Southwest Amazonia (Bolivia and Peru) (1997) International Journal of Pharmacognosy, 35 (4), pp. 288-296; Dias, A.L.S., Rozet, E., Chataigné, G., Oliveira, A.C., Rabelo, C.A.S., Hubert, P., A rapid validated UHPLC-PDA method for anthocyanins quantification from Euterpe oleracea fruits (2012) Journal of Chromatography B, 907, pp. 108-116; Favacho, H.A.S., Oliveira, B.R., Santos, K.C., Medeiros, B.J.L., Sousa, P.J.C., Perazzo, F.F., Anti-inflammatory and antinociceptive activities of Euterpe oleracea Mart., Arecaceae, oil (2010) Revista Brasileira de Farmacognosia, 21, pp. 105-114; Feio, C.A., Izar, M.C., Ihara, S.S., Kasmas, S.H., Martins, C.M., Feio, M.N., Euterpe oleracea (açai) modifies sterol metabolism and attenuates experimentally-induced atherosclerosis (2012) Journal of Atherosclerosis and Thrombosis, 19 (3), pp. 237-245; Fragoso, M.F., Prado, M.G., Barbosa, L., Rocha, N.S., Barbisan, L.F., Inhibition of mouse urinary bladder carcinogenesis by açai fruit (Euterpe oleracea Martius) intake (2012) Plant Foods for Human Nutrition, 67, pp. 235-241; Fragoso, M.F., Romualdo, R.G., Ribeiro, D.A., Barbisan, L.F., Açai (Euterpe oleracea Mart.) feeding attenuates dimethylhydrazine-induced rat colon carcinogenesis (2013) Food and Chemical Toxicology, 58, pp. 68-76; Frasson, A.P., Canssi, C.M., Análise da qualidade de cremes com hidroquinona 2% manipulados no município de Ijuí/RS (2008) Revista de Ciências Farmacêuticas Básica e Aplicada, 29, pp. 197-201; Gallori, S., Bilia, A.R., Bergonzi, M.C., Barbosa, W.L.R., Vincieri, F.F., Polyphenolic constituents of fruit pulp of Euterpe oleraceae Mart. (acai palm) (2004) Chromatographia, 59, pp. 739-743; Galotta, A.L.Q.A., Boaventura, M.A.D., Chemical constituents from roots and leaf stalks of açaí (Euterpe precatoria Mart., Arecaceae) (2005) Química Nova, 28 (4), pp. 610-613; Galotta, A.L.Q.A., Boaventura, M.A.D., Lima, L.A.R.S., Antioxidant and cytotoxic activities of 'açaí' (Euterpe precatoria Mart.) (2008) Química Nova, 31 (6), pp. 1427-1430; Gordon, A., Cruz, A.P.G., Cabral, L.M.C., De Freitas, S.C., Dib Taxi, C.M.A., Donangelo, C.M., Chemical characterisation and evaluation of antioxidant properties of Açai fruits (Euterpe oleracea Mart.) during ripening (2012) Food Chemistry, 133, pp. 256-263; Gouvêa, A.C.M.S., Araujo, M.C.P., Schulz, D.F., Pacheco, S., Godoy, R.L.O., Cabral, L.M.C., Anthocyanins standards (cyanidin-3-O-glucoside and cyaniding-3-O-rutinoside) isolation from freeze-dried açaí (Euterpe oleracea Mart.) by HPLC (2012) Ciência e Tecnologia de Alimentos, 32, pp. 43-46; Hassimotto, N.M.A., Genovese, M.I., Lajolo, F.M., Antioxidant activity of dietary fruits, vegetables, and commercial frozen fruit pulps (2005) Journal of Agricultural and Food Chemistry, 53, pp. 2928-2935; Heinrich, M., Dhanji, T., Casselman, I., Açaí (Euterpe oleracea) - A phytochemical and pharmacological assessment of the species health claims (2011) Phytochemistry Letters, 4, pp. 10-21; Henderson, A., (1995) The Palms of the Amazon, , Oxford University Press New York; Herculano, F.E.B., (2013) Produção Industrial de Cosméticos: O Protagonismo da Biodiversidade Vegetal da Amazônia, p. 146. , Tese. UFAM; Hogan, S., Chung, H., Zhang, L., Li, J., Lee, Y., Dai, Y., Antiproliferative and antioxidant properties of anthocyanin-rich extract from açai (2010) Food Chemistry, 118, pp. 208-214; Homma, A.K., Maia, C., Nicoli, L., Açaí: Novos desafios e tendências (2006) Amazônia: Ciência & Desenvolvimento, 1, pp. 7-23; (2014) Contas Regionais Do Brasil 2008, , http://www.ibge.gov.br, IBGE - INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA Disponível em: < >. Acesso em: 26 junho; Inácio, M.R.C., Lima, S.M.G., Lopes, V.G., Pessoa, J.D., Teixeira, G.H.T., Total anthocyanin content determination in intact acai (Euterpe oleracea Mart.) and palomitero-jucara (Euterpe edulis Mart.) fruit using near infrared spectroscopy (NIR) and multivariate calibration (2013) Food Chemistry, 136, pp. 1160-1164; Jensen, G.S., Wu, X., Patterson, K.M., Barnes, J., Carter, S.G., Scherwitz, L., In vitro and in vivo antioxidant and anti-inflammatory capacities of an antioxidant-rich fruit and berry juice blend. Results of a pilot and randomized, double-blinded, placebo-controlled, crossover study (2008) Journal of Agricultural and Food Chemistry, 56 (18), pp. 8326-8333; Jensen, J.F., Kvist, L.P., Christensen, S.B., An antiplasmodial lignan from Euterpe precatoria (2002) Journal of Natural Product, 65, pp. 1915-1917; Kang, J., Li, Z., Wu, T., Jensen, G.S., Schauss, A.G., Wu, X., Anti-oxidant capacities of flavonoid compounds isolated from acai pulp (Euterpe oleracea Mart.) (2010) Food Chemistry, 122, pp. 610-617; Kang, J., Thakali, K.M., Xie, C., Kondo, M., Tong, Y., Ou, B., Bioactivities of açaí (Euterpe precatoria Mart.) fruit pulp, superior antioxidant and anti-inflammatory properties to Euterpe oleracea Mart (2012) Food Chemistry, 133, pp. 671-677; Kang, J., Xie, C., Li, Z., Nagarajan, S., Schauss, A.G., Wu, T., Flavonoids from acai (Euterpe oleracea Mart.) pulp and their antioxidant and anti-inflammatory activities (2011) Food Chemistry, 128 (1), pp. 152-157; Kuskoski, E.M., Asuero, A.G., Morales, M.T., Fett, R., Frutos tropicais silvestres e polpas de frutas congeladas: Atividade antioxidante, polifenóis e antocianinas (2006) Ciência Rural, 36, pp. 1283-1287; Lichtenthaler, R., Rodrigues, R.B., Maia, J.G.S., Papgiannopoulos, M., Fabricius, H., Marx, F., Total oxidant scavenging capacity of the Euterpe oleracea Mart. (Açaí) fruits (2005) International Journal of Food Sciences and Nutrition, 56 (1), pp. 56-64; Lima, F.E.L., Menezes, T.N., Tavares, M.P., Szarfac, S.C., Fisberg, R.M., Fatty acids and cardiovascular diseases: A review (2000) Revista de Nutrição, 13, pp. 73-80; Mantovani, I.S.B., Fernandes, S.B.O., Menezes, F.S., Constituintes apolares do fruto do açaí (Euterpe oleracea M. - Arecaceae) (2003) Revista Brasileira de Farmacognosia, 13, pp. 41-42; Marinho, B.G., Herdy, S.A., Sá, A.C., Santos, G.B., Matheus, M.E., Menezes, F.S., Atividade antinociceptiva de extratos de açaí (Euterpe oleraceae Mart.) (2002) Revista Brasileira de Farmacognosia, 12, pp. 52-53; Matheus, M.E., Fernandes, D.B.S.O., Silveira, C.S., Rodrigues, V.P., Menezes, D.F.S., Fernandes, P.D., Inhibitory effects of Euterpe oleracea Mart. on nitric oxide production and iNOS expression (2006) Journal of Ethnopharmacology, 107, pp. 291-296; Matheus, M.E., Mantovani, I.S.B., Santos, G.B., Fernandes, S.B.O., Menezes, F.S., Fernandes, P.D., Ação de extratos de açaí (Euterpe oleraceae Mart.) sobre a produção de óxido nítrico em células RAW 264.7 (2003) Revista Brassileira de Farmacognosia, 13, pp. 3-5; Menezes, E.M.S., Rosenthal, A., Sabaa-Srur, A., Carmargo, L., Calado, V., Santos, A., High hydrostatic pressure effect on enzyme activity of açaí pulp (2008) Ciência e Tecnologia de Alimentos, 28, pp. 14-19; Menezes, E., Deliza, R., Chan, H.L., Guinard, J.X., Preferences and attitudes towards açaí-based products among North American consumers (2011) Food Research International, 44, pp. 1997-2008; Mertens-Talcott, S.U., Rios, J., Jilma-Stohlawetz, P., Pacheco-Palencia, L.A., Meibohm, B., Talcott, S.T., Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin-rich acai juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers (2008) Journal of Agricultural and Food Chemistry, 56, pp. 7796-7802; Moura, R.S., Ferreira, T.S., Lopes, A.A., Pires, K.M.P., Nesi, R.T., Resende, A.C., Effects of Euterpe oleracea Mart. (açaí) extract in acute lung inflammation induced by cigarette smoke in the mouse (2012) Phytomedicine, 19, pp. 262-269; Moura, R.S., Pires, K.M.P., Ferreira, T.S., Lopes, A.A., Nesi, R.T., Resende, A.C., Addition of açaí (Euterpe oleracea) to cigarettes has a protective effect against emphysema in mice (2011) Food and Chemical Toxicology, 49, pp. 855-863; Mulabagal, V., Calderón, A.I., Liquid chromatography/mass spectrometry based fingerprinting analysis and mass profiling of Euterpe oleracea (açaí) dietary supplement raw materials (2012) Food Chemistry, 134, pp. 1156-1164; Muñiz-Miret, N., Vamos, R., Hiraoka, M., Montagnini, F., Mendelsohn, R.O., The economic value of managing the acai palm (Euterpe oleracea mart.) in the floodplains of the Amazon estuary, Para, Brazil (1996) Forest Ecology and Management, 87, pp. 163-173; Nascimento, R.J.S., Couril, S., Antoniassi, R., Freitas, S.P., Composição em ácidos graxos do óleo da polpa de açaí extraído com enzimas e com hexano (2008) Revista Brasileira de Fruticultura, 30, pp. 498-502; Nogueira, O.L., (2005) Açaí, , (1th ed.). Belém: Embrapa Amazônia Oriental; Odonne, G., Berger, F., Stien, D., Grenand, P., Bourdy, G., Treatment of leishmaniasis in the Oyapock basin (French Guiana): A K.A.P. Survey and analysis of the evolutionary of phytotherapy knowledge amongst Wayãpi Indians (2011) Journal of Ethnopharmacology, 137, pp. 1228-1239; Pacheco-Palencia, L.A., Duncan, C.E., Talcott, S.T., Phytochemical composition and thermal stability of two commercial acai species, Euterpe oleracea and Euterpe precatoria (2009) Food Chemistry, 115, pp. 1199-1205; Pacheco-Palencia, L., Hawken, P., Talcott, S., Juice matrix composition and ascorbic acid fortification effects on the phytochemical, antioxidant, and pigment stability of açai (Euterpe oleracea Mart.) (2007) Food Chemistry, 105, pp. 28-35; Pacheco-Palencia, L., Hawken, P., Talcott, S., Phytochemical, antioxidant and pigment stability of açai (Euterpe oleracea Mart.) as affected by clarification, ascorbic acid fortification and storage (2007) Food Research International, 40, pp. 620-628; Pacheco-Palencia, L.A., Talcott, S.T., Chemical stability of açai fruit (Euterpe oleracea Mart.) anthocyanins as influenced by naturally occurring and externally added polyphenolic cofactors in model systems (2010) Food Chemistry, 118, pp. 17-25; Pacheco-Palencia, L.A., Mertens-Talcott, S., Talcott, S.T., Chemical composition, antioxidant properties, and thermal stability of a phytochemical enriched oil from Açai (Euterpe oleracea Mart.) (2008) Journal of Agricultural and Food Chemistry, 56, pp. 4631-4636; Pagliarussi, M.S.A., (2010) Cadeia Produtiva Agroindustrial Do Açaí: Estudo da Cadeia e Proposta de Um Modelo Matemático, , 65f. TCC, Escola de Engenharia de São Carlos, Universidade de São Paulo; Pompeu, D.R., Silva, E.M., Rogez, H., Optimisation of the solvent extraction of phenolic antioxidants from fruits of Euterpe oleracea using response surface methodology (2009) Bioresource Technology, 100, pp. 6076-6082; Poulose, S.M., Fisher, D.R., Larson, J., Bielinski, D.F., Rimando, A.M., Carey, A.N., Anthocyanin-rich acai (Euterpe oleracea Mart.) fruit pulp fractions attenuate inflammatory stress signaling in mouse brain BV-2 microglial cells (2012) Journal of Agricultural and Food Chemistry, 60, pp. 1084-1093; Queiroz, J.A.L., Melém, N.J., Jr., Efeito do tamanho do recipiente sobre o desenvolvimento de mudas do açaí (Euterpe oleracea Mart.) (2001) Revista Brasileira de Fruticultura, 23, pp. 460-462; Ribeiro, J.C., Antunes, L.M., Aissa, A.F., Darin, J.D., De Rosso, V.V., Mercadante, A.Z., Evaluation of the genotoxic and antigenotoxic effects after acute and subacute treatments with acai pulp (Euterpe oleracea Mart.) on mice using the erythrocytes micronucleus test and the comet assay (2010) Mutation Research, 695, pp. 22-28; Rocha, A.P., Carvalho, L.C., Sousa, M.A., Madeira, S.V., Sousa, P.J., Tano, T., Endothelium-dependent vasodilator effect of Euterpe oleracea Mart. (acai) extracts in mesenteric vascular bed of the rat (2007) Vascular Pharmacology, 46, pp. 97-104; Rodrigues, R.B., Lichtenthaler, R., Zimmerman, B.F., Papgiannopoulos, M., Fabricius, H., Marx, F., Total oxidant scavenging capacity of Euterpe oleracea Mart. (Acai) seeds and identification of their polyphenolic compounds (2006) Journal of Agricultural and Food Chemistry, 54, pp. 4162-4167; Rogez, H., (2000) Açaí: Preparo, Composição e Melhoramento da Conservação, , 1th ed. UFPA Belém; Rogez, H., Pompeu, D.R., Akwie, S.N.T., Larondelle, Y., Sigmoidal kinetics of anthocyanin accumulation during fruit ripening: A comparison between açai fruits (Euterpe oleracea) and other anthocyanin-rich fruits (2011) Journal of Food Composition and Analysis, 24, pp. 796-800; Rojano, B.A., Vahos, I.C.Z., Arbeláez, A.F.A., Martínez, A.J.M., Correa, F.B.C., Carvajal, L.G., Polifenoles y Actividad Antioxidante del Fruto Liofilizado de Palma Naidi (Açaí Colombiano) (Euterpe oleracea Mart.) (2011) Revista Facultad Nacional de Agronomía Medellín, 64, pp. 6213-6220; Rosso, V.V., Hillbrand, S., Montilla, E.C., Bobbio, F.O., Winterhalter, P., Mercadante, A.Z., Determination of anthocyanins from acerola (Malpighia emarginata DC.) and açaí (Euterpe oleracea Mart.) by HPLC-PDA-MS/MS (2008) Journal of Food Composition and Analysis., 21, pp. 291-299; Rufino, M.S.M., Alves, R.E., Fernandes, F.A.N., Brito, E.S., Free radical scavenging behavior of ten exotic tropical fruits extracts (2011) Food Research International, 44, pp. 2072-2075; Rufino, M.S.M., Alves, R.E., Brito, E.S., Pérez-Jiménez, J., Saura-Calixto, F., Mancini-Filho, J., Bioactive compounds and antioxidant capacities of 18 non-traditional tropical fruits from Brazil (2010) Food Chemistry, 121, pp. 996-1002; Ruiz, L., Maco, M., Cobos, M., Gutierrez-Choquevilca, A.L., Roumy, V., Plants used by native Amazonian groups from the Nanay River (Peru) for the treatment of malária (2011) Journal of Ethnopharmacology, 133, pp. 917-921; Sabbe, S., Verbeke, W., Deliza, R., Matta, V., Van Damme, P., Effect of a health claim and personal characteristics on consumer acceptance of fruit juices with different concentrations of acai (Euterpe oleracea mart) (2009) Appetite, 53, pp. 84-92; Santos, V.S., Nardini, V., Cunha, Jr.L.C., Barbosa, Jr.F., Teixeira, G.H.A., Identification of species of the Euterpe genus by rare earth elements using inductively coupled plasma mass spectrometry and linear discriminant analysis (2014) Food Chemistry, 153, pp. 334-339; Schauss, A.G., Acai (Euterpe oleracea Mart.): A macro and nutrient rich palm fruit from the Amazon rain forest with demonstrated bioactivities in vitro and in vivo (2010) Bioactive Foods Promotion Health, pp. 479-490. , D.R. Watson, V.R. Preedy, Academic Press Oxford; Schauss, A.G., Wu, X., Prior, R.L., Ou, B., Patel, D., Huang, D., Phytochemical and nutrient composition of the freeze-dried amazonian palm berry, Euterpe oleraceae Mart. (acai) (2006) Journal of Agricultural and Food Chemistry, 54, pp. 8598-8603; Schauss, A.G., Wu, X., Prior, R.L., Ou, B., Huang, D., Owens, J., Antioxidant capacity and other bioactivities of the freeze-dried Amazonian palm berry, Euterpe oleracea Mart. (acai) (2006) Journal of Agricultural and Food Chemistry, 54, pp. 8604-8610; Silva, J.A.P., Tavares, F.F.C., Estudo da aplicação de sementes de açaí (Euterpe oleracea Mart.) para produção de carvão ativado (2013) Revista de Ciências da Amazônia, 1, pp. 55-66; Silva, J.J.M., Rógez, H., Avaliação da estabilidade oxidativa do óleo bruto de açaí (Euterpe oleracea) na presença de compostos fenólicos puros ou de extratos vegetais amazônicos (2013) Química Nova, 36, pp. 400-406; Silva, J.A., Munaro, E., Pereira, L.R., (2002) Produtos Florestais Não Madeireiros: Açaí, , Ibama/CNPT Brasília; Souza, M.O., Silva, L.S., Magalhães, C.L.B., Figueiredo, B.B., Costa, D.C., Silva, M.E., The hypocholesterolemic activity of açaí (Euterpe oleracea Mart.) is mediated by the enhanced expression of ATP-binding cassette, subfamily G transporters 5 and 8 low-density lipoprotein receptor genes in rat (2012) Nutrition Research, 32, pp. 976-984; Souza, M.O., Silva, M., Silva, M.E., Oliveira, R.P., Pedrosa, M.L., Diet supplementation with açaí (Euterpe oleracea Mart.) pulp improves biomarkers of oxidative stress and the serum lipid profile in rats (2010) Nutrition, 26, pp. 804-810; Spada, P.D., Dani, C., Bortolini, G.V., Funchal, C., Henriques, J.A., Salvador, M., Frozen fruit pulp of Euterpe oleraceae Mart. (acai) prevents hydrogen peroxide-induced damage in the cerebral cortex, cerebellum, and hippocampus of rats (2009) Journal of Medicinal Food, 12, pp. 1084-1088; Sun, X., Seeberger, J., Alberico, T., Wang, C., Wheeler, C.T., Schauss, A.G., Açaí palm fruit (Euterpe oleracea Mart.) pulp improves survival of flies on high fat diet (2010) Experimental Gerontology, 45, pp. 243-251; Tonon, R.V., Alexandre, D., Hubinger, M.D., Cunha, R.L., Steady and dynamic shear rheological properties of açai pulp (Euterpe oleraceae Mart.) (2009) Journal of Food Engineering, 92, pp. 425-431; Vandresen, S., Quadri, M.G.N., Souza, J.A.R., Hotza, D., Temperature effect on the rheological behavior of carrot juices (2009) Journal of Food Engineering, 92, pp. 269-274; Vigneron, M., Deparis, X., Deharo, E., Bourdy, G., Antimalarial remedies in French Guiana: A knowledge attitudes and practices study (2005) Journal of Ethnopharmacology, 98, pp. 351-360; Xie, C., Kang, J., Burris, R., Ferguson, M.E., Schauss, A.G., Nagarajan, S., Açaí juice attenuates atherosclerosis in ApoE deficient mice through antioxidant and anti-inflammatory activities (2011) Atherosclerosis, 216, pp. 327-333; Xie, C., Kang, J., Li, Z., Schauss, A.G., Badger, T.M., Nagarajan, S., The açaí flavonoid velutin is a potent anti-inflammatory agent: Blockade of LPS-mediated TNF-αand IL-6 production through inhibiting NF-κB activation and MAPK pathway (2012) Journal of Nutrition Biochemistry, 23, pp. 1184-1191; Youdim, K.A., Martin, A., Joseph, J.A., Incorporation of the elderberry anthocyanins by endothelial cells increases protection against oxidative stress (2000) Free Radical Biology & Medicine, 29 (1), pp. 51-60; Yuyama, L.K.O., Aguiar, J.P.L., Filho, D.F.S., Yuyama, K., Varejão, M.J., Fávaro, D.I.T., Physicochemical characterization of acai juice of Euterpe precatoria Mart. from different Amazonian ecosystems (2011) Acta Amazônica, 41, pp. 545-552; Yuyama, L.K.O., Aguiar, J.P.L., Silva Filho, D.F.S., Yuyama, K., Varejão, M.J., Favaro, D.I.T., Caracterização físico-química do suco de açaí de Euterpe precatoria Mart. Oriundo de diferentes ecossistemas amazônicos (2012) Acta Amazônica, 41, pp. 545-552",Review,Scopus,2-s2.0-84922504050
"Ke K., Safder M.A., Sul O.-J., Kim W.-K., Suh J.-H., Joe Y., Chung H.-T., Choi H.-S.","Hemeoxygenase-1 maintains bone mass via attenuating a redox imbalance in osteoclast",2015,"Molecular and Cellular Endocrinology","409",,,"11","20",,,10.1016/j.mce.2015.03.022,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927546996&partnerID=40&md5=9e071bd05267ca823f410181e67a8c10","Department of Biological Sciences, University of UlsanUlsan, South Korea; Department of Pathology, Ulsan University HospitalUlsan, South Korea","Ke, K., Department of Biological Sciences, University of UlsanUlsan, South Korea; Safder, M.A., Department of Biological Sciences, University of UlsanUlsan, South Korea; Sul, O.-J., Department of Biological Sciences, University of UlsanUlsan, South Korea; Kim, W.-K., Department of Biological Sciences, University of UlsanUlsan, South Korea; Suh, J.-H., Department of Pathology, Ulsan University HospitalUlsan, South Korea; Joe, Y., Department of Biological Sciences, University of UlsanUlsan, South Korea; Chung, H.-T., Department of Biological Sciences, University of UlsanUlsan, South Korea; Choi, H.-S., Department of Biological Sciences, University of UlsanUlsan, South Korea","Heme oxygenase-1 (HO-1) has long been considered to be an endogenous antioxidant. However, the role of HO-1 is highly controversial in developing metabolic diseases. We hypothesized that HO-1 plays a role in maintaining bone mass by alleviating a redox imbalance. We investigated its role in bone remodeling. The absence of HO-1 in mice led to decreased bone mass with elevated activity and number of OCs, as well as higher serum levels of reactive oxygen species (ROS). HO-1, which is constitutively expressed at a high level in osteoclast (OC) precursors, was down-regulated during OC differentiation. HO-1 deficiency in bone marrow macrophages (BMM) in vitro resulted in increased numbers and activity of OCs due to enhanced receptor activator of nuclear factor-κB ligand (RANKL) signaling. This was associated with increased activation of nuclear factor-κB and of nuclear factor of activated T-cells, cytoplasmic 1 along with elevated levels of intracellular calcium and ROS. Decreased bone mass in the absence of HO-1 appears to be mainly due to increased osteoclastogenesis and bone resorption resulting from elevated RANKL signaling in OCs. Our data highlight the potential role of HO-1 in maintaining bone mass by negatively regulating OCs. © 2015 Elsevier Ireland Ltd.","Heme oxygenase-1; Osteoclast; Reactive oxygen species; Receptor activator of nuclear factor-κB ligand signaling","Allwood, M.A., Kinobe, R.T., Ballantyne, L., Romanova, N., Melo, L.G., Ward, C.A., Heme oxygenase-1 overexpression exacerbates heart failure with aging and pressure overload but is protective against isoproterenol-induced cardiomyopathy in mice (2014) Cardiovasc. Pathol, 23 (4), pp. 231-237; Bao, W., Song, F., Li, X., Rong, S., Yang, W., Wang, D., Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes mellitus: a HuGE review and meta-analysis (2010) Am. J. Epidemiol, 172 (6), pp. 631-636; Barbagallo, I., Vanella, A., Peterson, S.J., Kim, D.H., Tibullo, D., Giallongo, C., Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation (2010) J. Bone Miner. Metab, 28 (3), pp. 276-288; Basu, S., Michaelsson, K., Olofsson, H., Johnsson, S., Melhus, H., Association between oxidative stress and bone mineral density (2001) Biochem. Biophys. Res. Commun, 288 (1), pp. 275-279; Collinson, E.J., Wimmer-Kleikamp, S., Gerega, S.K., Yang, Y.H., Parish, C.R., Dawes, I.W., The yeast homolog of heme oxygenase-1 affords cellular antioxidant protection via the transcriptional regulation of known antioxidant genes (2011) J. Biol. Chem, 286 (3), pp. 2205-2214; Cunnington, A.J., de Souza, J.B., Walther, M., Riley, E.M., Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization (2011) Nat. Med, 18 (1), pp. 120-127; Doré, S., Takahashi, M., Ferris, C.D., Zakhary, R., Hester, L.D., Guastella, D., Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury (1999) Proc. Natl. Acad. Sci. U.S.A., 96 (5), pp. 2445-2450; Fuller, K., Kirstein, B., Chambers, T.J., Murine osteoclast formation and function: differential regulation by humoral agents (2006) Endocrinolology, 147 (4), pp. 1979-1985; Iotsova, V., Okan, I., Fritsche, M., Strom, M., Groner, B., Grafstrom, R.C., Osteopetrosis in mice lacking NF-κB1 and NF-κB2 (1997) Nat. Med, 3 (11), pp. 1285-1289; Jais, A., Einwallner, E., Sharif, O., Gossens, K., Lu, T.T., Soyal, S.M., Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man (2014) Cell, 158 (1), pp. 25-40; Jimi, E., Akiyama, S., Tsurukai, T., Okahashi, N., Kobayashi, K., Udagawa, N., Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function (1999) J. Immunol, 163 (1), pp. 434-442; Kapturczak, M.H., Wasserfall, C., Brusko, T., Campbell-Thompson, M., Ellis, T.M., Atkinson, M.A., Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse (2004) Am. J. Pathol, 165 (3), pp. 1045-1053; Kim, M.S., Yang, Y., Son, A., Tian, Y.S., Lee, S., Kang, S.W., RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis (2010) J. Biol. Chem, 285 (10), pp. 6913-6921; Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C., OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis (1999) Nature, 397 (6717), pp. 315-323; Lean, J.M., Davies, J.T., Fuller, K., Jagger, C.J., Kirstein, B., Partington, G.A., A crucial role for thiol antioxidants in estrogen-deficiency bone loss (2003) J. Clin. Invest., 112 (6), pp. 915-923; Lee, N.K., Choi, Y.G., Baik, J.Y., Han, S.Y., Jeong, D., Bae, Y.S., A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation (2005) Blood, 106 (3), pp. 852-859; Li, M., Kim, D.H., Tsenovoy, P.L., Peterson, S.J., Rezzani, R., Rodella, L.F., Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance (2008) Diabetes, 57 (6), pp. 1526-1535; Lin, Q., Weis, S., Yang, G., Weng, Y.H., Helston, R., Rish, K., Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress (2007) J. Biol. Chem, 282 (28), pp. 20621-20633; Lin, T.H., Tang, C.H., Hung, S.Y., Liu, S.H., Lin, Y.M., Fu, W.M., Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts (2010) J. Cell. Physiol, 222 (3), pp. 757-768; Maggio, D., Barabani, M., Pierandrei, M., Polidori, M.C., Catani, M., Mecocci, P., Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study (2003) J. Clin. Endocrinol. Metab, 88 (4), pp. 1523-1527; Maines, M.D., The heme oxygenase system: past, present, and future (2004) Antioxid. Redox Signal., 6 (5), pp. 797-801; Ndisang, J.F., Lane, N., Jadhav, A., Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes (2009) Am. J. Physiol. Endocrinol. Metab, 296 (5), pp. E1029-E1041; Phan, T.V., Sul, O.J., Ke, K., Lee, M.H., Kim, W.K., Cho, Y.S., Carbon monoxide protects against ovariectomy-induced bone loss by inhibiting osteoclastogenesis (2013) Biochem. Pharmacol, 85 (8), pp. 1145-1152; Phan, T.V., Ke, K., Sul, O.J., Park, Y.K., Kim, K.K., Cho, Y.S., Protection against ovariectomy-induced bone loss by tranilast (2014) PLoS ONE, 9 (4), p. e95585; Reddy, S.V., Regulatory mechanisms operative in osteoclasts (2004) Crit. Rev. Eukaryot. Gene Expr, 14 (4), pp. 255-270; Roodman, G.D., Advances in bone biology: the osteoclast (1996) Endocr. Rev, 17 (4), pp. 308-332; Rueda, B., Oliver, J., Robledo, G., López-Nevot, M.A., Balsa, A., Pascual-Salcedo, D., HO-1 promoter polymorphism associated with rheumatoid arthritis (2007) Arthritis Rheum, 56 (12), pp. 3953-3958; Ryter, S.W., Alam, J., Choi, A.M., Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications (2006) Physiol. Rev, 86 (2), pp. 583-650; Sanders, K.M., Kotowicz, M.A., Nicholson, G.C., Potential role of the antioxidant N-acetylcysteine in slowing bone resorption in early post-menopausal women, a pilot study (2007) Transl. Res., 150 (4), p. 215; Sato, M., Sugano, N., Ohzono, K., Nomura, S., Kitamura, Y., Tsukamoto, Y., Apoptosis and expression of stress protein (ORP150, HO1) during development of ischaemic osteonecrosis in the rat (2001) J. Bone Joint Surg. Br, 83 (5), pp. 751-759; Schett, G., Teitelbaum, S.L., Osteoclasts and arthritis (2009) J. Bone Miner. Res, 24 (7), pp. 1142-1146; Seixas, E., Gozzelino, R., Chora, A., Ferreira, A., Silva, G., Larsen, R., Heme oxygenase-1 affords protection against noncerebral forms of severe malaria (2009) Proc. Natl. Acad. Sci. U.S.A., 106 (37), pp. 15837-15842; Sies, H., Stahl, W., Sundquist, A.R., Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids (1992) Ann. N. Y. Acad. Sci, 669, pp. 7-20; Sohal, R.S., Weindruch, R., Oxidative stress, caloric restriction, and aging (1996) Science, 273 (5271), pp. 59-63; Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M.T., Martin, T.J., Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families (1999) Endocr. Rev., 20 (3), pp. 345-357; Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts (2002) Dev. Cell, 3 (6), pp. 889-901; Uretmen, S., Gol, M., Cimrin, D., Irmak, E., Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women (2005) Eur. J. Obstet. Gynecol. Reprod. Biol, 123 (1), pp. 67-71; Vanella, L., Sanford, C., Kim, D.H., Abraham, N.G., Ebraheim, N., Oxidative stress and heme oxygenase-1 regulated human mesenchymal stem cells differentiation (2012) Int. J. Hypertens, 2012, p. 890671; Wagener, F.A., Toonen, E.J., Wigman, L., Fransen, J., Creemers, M.C., Radstake, T.R., HMOX1 promoter polymorphism modulates the relationship between disease activity and joint damage in rheumatoid arthritis (2008) Arthritis Rheum, 58 (11), pp. 3388-3393; Wong, B.R., Josin, R., Lee, S.Y., Vologodskaia, M., Steinman, R.M., Choi, Y., The TRAF family of signal transducers mediates NF-kB activation by the TRANCE receptor (1998) J. Biol. Chem, 273 (43), pp. 28355-28359; Yachie, A., Niida, Y., Wada, T., Igarashi, N., Kaneda, H., Toma, T., Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency (1999) J. Clin. Invest, 103 (1), pp. 129-135; Yamashita, T., Yao, Z., Li, F., Zhang, Q., Badell, I.R., Schwarz, E.M., NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1 (2007) J. Biol. Chem., 282 (25), pp. 18245-18253; Young, A.J., Lowe, G.M., Antioxidant and prooxidant properties of carotenoids (2001) Arch. Biochem. Biophys, 385 (1), pp. 20-27; Zwerina, J., Tzima, S., Hayer, S., Redlich, K., Hoffmann, O., Hanslik-Schnabel, B., Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption (2005) FASEB J., 19 (14), pp. 2011-2013",Article,Scopus,2-s2.0-84927546996
"Svobodova J., Kabatkova M., Smerdova L., Brenerova P., Dvorak Z., Machala M., Vondracek J.","The aryl hydrocarbon receptor-dependent disruption of contact inhibition in rat liver WB-F344 epithelial cells is linked with induction of survivin, but not with inhibition of apoptosis",2015,"Toxicology","333",,,"37","44",,,10.1016/j.tox.2015.04.001,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927551341&partnerID=40&md5=7f0f0e33b0793488b79cab9a79477025","Department of Cytokinetics, Institute of Biophysics AS CRBrno, Czech Republic; Institute of Experimental Biology, Faculty of Science, Masaryk UniversityBrno, Czech Republic; Department of Chemistry and Toxicology, Veterinary Research InstituteBrno, Czech Republic; Department of Cell Biology and Genetics, Faculty of Science, Palacky UniversityOlomouc, Czech Republic","Svobodová, J., Department of Cytokinetics, Institute of Biophysics AS CRBrno, Czech Republic, Institute of Experimental Biology, Faculty of Science, Masaryk UniversityBrno, Czech Republic; Kabátková, M., Department of Cytokinetics, Institute of Biophysics AS CRBrno, Czech Republic, Institute of Experimental Biology, Faculty of Science, Masaryk UniversityBrno, Czech Republic; Šmerdová, L., Department of Cytokinetics, Institute of Biophysics AS CRBrno, Czech Republic; Brenerová, P., Department of Chemistry and Toxicology, Veterinary Research InstituteBrno, Czech Republic; Dvořák, Z., Department of Cell Biology and Genetics, Faculty of Science, Palacky UniversityOlomouc, Czech Republic; Machala, M., Department of Chemistry and Toxicology, Veterinary Research InstituteBrno, Czech Republic; Vondráček, J., Department of Cytokinetics, Institute of Biophysics AS CRBrno, Czech Republic","Inhibition of apoptosis by the ligands of the aryl hydrocarbon receptor (AhR) has been proposed to play a role in their tumor promoting effects on liver parenchymal cells. However, little is presently known about the impact of toxic AhR ligands, such as 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD) on apoptosis in other liver cell types, such as in liver epithelial/progenitor cells. In the present study, we focused on the effects of TCDD on apoptosis regulation in a model of liver progenitor cells, rat WB-F344 cell line, during the TCDD-elicited release from contact inhibition. The stimulation of cell proliferation in this cell line was associated with deregulated expression of a number of genes known to be under transcriptional control of the Hippo signaling pathway, a principal regulatory pathway involved in contact inhibition of cell proliferation. Interestingly, we found that mRNA and protein levels of survivin, a known Hippo target, which plays a role both in cell division and inhibition of apoptosis, were significantly up-regulated in rat liver epithelial cell model, as well as in undifferentiated human liver HepaRG cells. Using the short interfering RNA-mediated knockdown, we confirmed that survivin plays a central role in cell division of WB-F344 cells. When evaluating the effects of TCDD on apoptosis induction by camptothecin, a genotoxic topoisomerase I inhibitor, we observed that the pre-treatment of WB-F344 cells with TCDD increased number of cells with apoptotic nuclear morphology, and it potentiated cleavage of both caspase-3 and poly(ADP-ribose) polymerase I. This indicated that despite the observed up-regulation of survivin, apoptosis induced by the genotoxin was potentiated in the model of rat liver progenitor cells. The present results indicate that, unlike in hepatocytes, AhR agonists may not prevent induction of apoptosis elicited by DNA-damaging agents in a model of rat liver progenitor cells. © 2015 Elsevier Ireland Ltd.","AhR; Apoptosis; BIRC5/survivin; Contact inhibition; Hippo signaling; TCDD","Altieri, D.C., New wirings in the survivin networks (2008) Oncogene, 27, pp. 6276-6284; Andrysík, Z., Vondráček, J., Machala, M., Krčmář, P., Švihálková-Šindlerová, L., Kranz, A., Weiss, C., Dietrich, C., The aryl hydrocarbon receptor-dependent deregulation of cell cycle control induced by polycyclic aromatic hydrocarbons in rat liver epithelial cells (2007) Mutat. Res., 615, pp. 87-97; Athanasoula, K., Gogas, H., Polonifi, K., Vaiopoulos, A.G., Polyzos, A., Mantzourani, M., Survivin beyond physiology: orchestration of multistep carcinogenesis and therapeutic potentials (2014) Cancer Lett., 347, pp. 175-182; Baba, H.A., Wohlschlaeger, J., Schmitz, K.J., Nadalin, S., Lang, H., Benesch, A., Gu, Y., Levkau, B., Survivin is upregulated during liver regeneration in rats and humans and is associated with hepatocyte proliferation (2009) Liver Int., 29, pp. 585-592; Bai, H., Gayyed, M.F., Lam-Himlin, D.M., Klein, A.P., Nayar, S.K., Xu, Y., Khan, M., Anders, R.A., Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies (2012) Hum. Pathol., 43, pp. 1376-1385; Bock, K.W., Köhle, C., Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis (2005) Biochem. Pharmacol., 69, pp. 1403-1408; Bui, L.C., Tomkiewicz, C., Chevallier, A., Pierre, S., Bats, A.S., Mota, S., Raingeaud, J., Coumoul, X., Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity (2009) Oncogene, 28, pp. 3642-3651; Caruso, J.A., Mathieu, P.A., Joiakim, A., Zhang, H., Reiners, J.J., Aryl hydrocarbon receptor modulation of tumor necrosis factor-alpha-induced apoptosis and lysosomal disruption in a hepatoma model that is caspase-8-independent (2006) J. Biol. Chem., 281, pp. 10954-10967; Chopra, M., Dharmarajan, A.M., Meiss, G., Schrenk, D., Inhibition of UV-C light-induced apoptosis in liver cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (2009) Toxicol. Sci., 111, pp. 49-63; Chopra, M., Schrenk, D., Dioxin toxicity aryl hydrocarbon receptor signaling, and apoptosis-persistent pollutants affect programmed cell death (2011) Crit. Rev. Toxicol., 41, pp. 292-320; Dai, D., Liang, Y., Xie, Z., Fu, J., Zhang, Y., Zhang, Z., Survivin deficiency induces apoptosis and cell cycle arrest in HepG2 hepatocellular carcinoma cells (2012) Oncol. Rep., 27, pp. 621-627; Deveraux, Q.L., Reed, J.C., IAP family proteins-suppressors of apoptosis (1999) Genes Dev., 13, pp. 239-252; Dietrich, C., Kaina, B., The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth (2010) Carcinogenesis, 31, pp. 1319-1328; Faust, D., Vondráček, J., Krčmář, P., Šmerdová, L., Procházková, J., Hrubá, E., Hulinková, P., Machala, M., AhR-mediated changes in global gene expression in rat liver progenitor cells (2013) Arch. Toxicol., 87, pp. 681-698; Frauenstein, K., Sydlik, U., Tigges, J., Majora, M., Wiek, C., Hanenberg, H., Abel, J., Haarmann-Stemmann, T., Evidence for a novel anti-apoptotic pathway in human keratinocytes involving the aryl hydrocarbon receptor E2F1, and checkpoint kinase 1 (2013) Cell Death Differ., 20, pp. 1425-1434; Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Guguen-Guillouzo, C., Infection of a human hepatoma cell line by hepatitis B virus (2015) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 15655-15660; Hagemann, S., Wohlschlaeger, J., Bertram, S., Levkau, B., Musacchio, A., Conway, E.M., Moellmann, D., Baba, H.A., Loss of Survivin influences liver regeneration and is associated with impaired Aurora B function (2013) Cell Death Differ., 20, pp. 834-844; Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation (2011) Cell, 144, pp. 646-674; Ito, T., Shiraki, K., Sugimoto, K., Yamanaka, T., Fujikawa, K., Ito, M., Takase, K., Suzuki, A., Survivin promotes cell proliferation in human hepatocellular carcinoma (2000) Hepatology, 31, pp. 1080-1085; Ito, T., Tsukumo, S., Suzuki, N., Motohashi, H., Yamamoto, M., Fujii-Kuriyama, Y., Mimura, J., Nohara, K., A constitutively active arylhydrocarbon receptor induces growth inhibition of jurkat T cells through changes in the expression of genes related to apoptosis and cell cycle arrest (2004) J. Biol. Chem., 279, pp. 25204-25210; Kaufmann, S.H., Cell death induced by topoisomerase-targeted drugs: more questions than answers (1998) Biochim. Biophys. Acta, 1400, pp. 195-211; Knight, B., Matthews, V.B., Olynyk, J.K., Yeoh, G.C., Jekyll and Hyde: evolving perspectives on the function and potential of the adult liver progenitor (oval) cell (2005) Bioessays, 27, pp. 1192-1202; Lai, D., Ho, K.C., Hao, Y., Yang, X., Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF (2011) Cancer Res., 71, pp. 2728-2738; Li, H., Wolfe, A., Septer, S., Edwards, G., Zhong, X., Abdulkarim, A.B., Ranganathan, S., Apte, U., Deregulation of Hippo kinase signalling in human hepatic malignancies (2012) Liver Int., 32, pp. 38-47; Li, Y., Chen, G., Zhao, J., Nie, X., Wan, C., Liu, J., Duan, Z., Xu, G., 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces microglial nitric oxide production and subsequent rat primary cortical neuron apoptosis through p38/JNK MAPK pathway (2013) Toxicology, 312, pp. 132-141; McIntosh, B.E., Hogenesch, J.B., Bradfield, C.A., Mammalian Per-Arnt-Sim proteins in environmental adaptation (2010) Annu. Rev. Physiol., 72, pp. 625-645; Mitchell, K.A., Lockhart, C.A., Huang, G., Elferink, C.J., Sustained aryl hydrocarbon receptor activity attenuates liver regeneration (2006) Mol. Pharmacol., 70, pp. 163-170; Mulero-Navarro, S., Pozo-Guisado, E., Perez-Mancera, P.A., Alvarez-Barrientos, A., Catalina-Fernandez, I., Hernandez-Nieto, E., Saenz-Santamaria, J., Fernandez-Salguero, P.M., Immortalized mouse mammary fibroblasts lacking dioxin receptor have impaired tumorigenicity in a subcutaneous mouse xenograft model (2005) J. Biol. Chem., 280, pp. 28731-28741; Nebert, D.W., Dalton, T.P., The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis (2006) Nat. Rev. Cancer, 6, pp. 947-960; Park, S., Matsumura, F., Characterization of anti-apoptotic action of TCDD as a defensive cellular stress response reaction against the cell damaging action of ultra-violet irradiation in an immortalized normal human mammary epithelial cell line, MCF10A (2006) Toxicology, 217, pp. 139-146; Park, K.T., Mitchell, K.A., Huang, G., Elferink, C.J., The aryl hydrocarbon receptorpredisposes hepatocytes to Fas-mediated apoptosis (2005) Mol. Pharmacol., 67, pp. 612-622; Pobbati, A.V., Hong, W., Emerging roles of TEAD transcription factors and its coactivators in cancers (2013) Cancer Biol. Ther., 14, pp. 390-398; Puga, A., Xia, Y., Elferink, C., Role of the aryl hydrocarbon receptor in cell cycle regulation (2002) Chem. Biol. Interact., 141, pp. 117-130; Puga, A., Ma, C., Marlowe, J.L., The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways (2009) Biochem. Pharmacol., 77, pp. 713-722; Reiners, J.J., Clift, R.E., Aryl hydrocarbon receptor regulation of ceramide-induced apoptosis in murine hepatoma 1c1c7 cells A function independent of aryl hydrocarbon receptor nuclear translocator (1999) J. Biol. Chem., 274, pp. 2502-2510; Rodríguez-Hernández, Á., Brea-Calvo, G., Fernández-Ayala, D.J., Cordero, M., Navas, P., Sánchez-Alcázar, J.A., Nuclear caspase-3 and caspase-7 activation, and poly(ADP-ribose) polymerase cleavage are early events in camptothecin-induced apoptosis (2006) Apoptosis, 11, pp. 131-139; Roskams, T., Liver stem cells and their implication in hepatocellular and cholangiocarcinoma (2006) Oncogene, 25, pp. 3818-3822; Ryan, A.J., Squires, S., Strutt, H.L., Johnson, R.T., Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA (1991) Nucleic Acids Res., 19, pp. 3295-3300; Safe, S., Lee, S.O., Jin, U.H., Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target (2013) Toxicol. Sci., 135, pp. 1-16; Schmittgen, T.D., Livak, K.J., Analyzing real-time PCR data by the comparative C(T) method (2008) Nat. Protoc., 3, pp. 1101-1108; Schwarz, M., Buchmann, A., Stinchcombe, S., Kalkuhl, A., Bock, K., Ah receptor ligands and tumor promotion: survival of neoplastic cells (2000) Toxicol. Lett., pp. 69-77; Shafritz, D.A., Dabeva, M.D., Liver stem cells and model systems for liver repopulation (2002) J. Hepatol., 36, pp. 552-564; Singh, N.P., Nagarkatti, M., Nagarkatti, P.S., Role of dioxin response element and nuclear factor-kappaB motifs in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated regulation of Fas and Fas ligand expression (2007) Mol. Pharmacol., 71, pp. 145-157; Šmerdová, L., Svobodová, J., Kabátková, M., Kohoutek, J., Blažek, D., Machala, M., Vondráček, J., Upregulation of CYP1B1 expression by inflammatory cytokines is mediated by the p38 MAP kinase signal transduction pathway (2014) Carcinogenesis, 35, pp. 2534-2543; Stinchcombe, S., Buchmann, A., Bock, K.W., Schwarz, M., Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver (1995) Carcinogenesis, 16, pp. 1271-1275; Walkup, M.H., Gerber, D.A., Hepatic stem cells: in search of (2006) Stem Cells, 24, pp. 1833-1840; Wang, K., Lin, B., Inhibitor of apoptosis proteins (IAPs) as regulatory factors of hepatic apoptosis (2013) Cell. Signalling, 25, pp. 1970-1980; Weiss, C., Faust, D., Schreck, I., Ruff, A., Farwerck, T., Melenberg, A., Schneider, S., Dietrich, C., TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A (2008) Oncogene, 27, pp. 2198-2207; Wörner, W., Schrenk, D., Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene ultraviolet light, or transforming growth factor beta 1 (1996) Cancer Res., 56, pp. 1272-1278; Wu, R., Zhang, L., Hoagland, M.S., Swanson, H.I., Lack of the aryl hydrocarbon receptor leads to impaired activation of AKT/protein kinase B and enhanced sensitivity to apoptosis induced via the intrinsic pathway (2007) J. Pharmacol. Exp. Ther., 320, pp. 448-457; Yu, F.X., Guan, K.L., The Hippo pathway: regulators and regulations (2013) Genes Dev., 27, pp. 355-371; Zhao, B., Wei, X., Li, W., Udan, R.S., Yang, Q., Kim, J., Xie, J., Guan, K.L., Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control (2007) Genes Dev., 21, pp. 2747-2761; Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Lin, J.D., Guan, K.L., TEAD mediates YAP-dependent gene induction and growth control (2008) Genes Dev., 22, pp. 1962-1971",Article,Scopus,2-s2.0-84927551341
"Druwe I., Freudenrich T.M., Wallace K., Shafer T.J., Mundy W.R.","Sensitivity of neuroprogenitor cells to chemical-induced apoptosis using a multiplexed assay suitable for high-throughput screening",2015,"Toxicology","333",,,"14","24",,,10.1016/j.tox.2015.03.011,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927722477&partnerID=40&md5=766e66b37c3070a6fbfebcc1c7db5f4a","University of North Carolina at Chapel Hill, Curriculum in Toxicology, CB 7270Chapel Hill, NC, United States; Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protections Agency, B105-06Research Triangle Park, NC, United States; National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protections Agency, B243-01Research Triangle Park, NC, United States","Druwe, I., University of North Carolina at Chapel Hill, Curriculum in Toxicology, CB 7270Chapel Hill, NC, United States, Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protections Agency, B105-06Research Triangle Park, NC, United States, National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protections Agency, B243-01Research Triangle Park, NC, United States; Freudenrich, T.M., Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protections Agency, B105-06Research Triangle Park, NC, United States; Wallace, K., Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protections Agency, B105-06Research Triangle Park, NC, United States; Shafer, T.J., Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protections Agency, B105-06Research Triangle Park, NC, United States; Mundy, W.R., Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protections Agency, B105-06Research Triangle Park, NC, United States","High-throughput methods are useful for rapidly screening large numbers of chemicals for biological activity, including the perturbation of pathways that may lead to adverse cellular effects. In vitro assays for the key events of neurodevelopment, including apoptosis, may be used in a battery of tests for detecting chemicals that could result in developmental neurotoxicity. Apoptosis contributes to nervous system development by regulating the size of the neuroprogenitor cell pool, and the balance between cellular proliferation and apoptosis during neuroprogenitor cell proliferation helps to determine the size and shape of the nervous system. Therefore, chemicals that affect apoptosis during neuronal development can have deleterious effects on the developing brain. The present study examined the utility of a high-throughput assay to detect chemical-induced apoptosis in mouse or human neuroprogenitor cells, as well as differentiated human neurons derived from induced pluripotent stem cells. Apoptosis was assessed using an assay that measures enzymatic activity of caspase-3/7 in a rapid and cost efficient manner. The results show that all three commercially available models generated a robust source of proliferating neuroprogenitor cells, and that the assay was sensitive and reproducible when used in a multi-well plate format. There were differences in the response of rodent and human neuroprogenitor cells to a set of chemicals previously shown to induce apoptosis in vitro. Neuroprogenitor cells were more sensitive to chemical-induced apoptosis than differentiated neurons, suggesting that neuroprogenitor cells are one of the cell models that should be considered for use in a developmental neurotoxicity screening battery. © 2015.","Apoptosis; Developmental neurotoxicity; High throughput screening; In vitro models; Neuroprogenitor cells","Akhtar, R.S., Ness, J.M., Roth, K.A., Bcl-2 family regulation of neuronal development and neurodegeneration (2004) Biochim. Biophys. Acta, 1644, pp. 189-203; Akhtar, R.S., Geng, Y., Klocke, B.J., Roth, K.A., Neural precursor cells possess multiple p53-dependent apoptotic pathways (2006) Cell Death Differ., 13, pp. 1727-1739; Alenzi, F.Q.B., Links between apoptosis, proliferation and the cell cycle (2004) Br. J. Biomed. Sci., 61, pp. 1-4; Bai, X., Yan, Y., Canfield, S., Muravyeva, M.Y., Kikuchi, C., Zaja, I., Corbett, J.A., Bosnjak, Z.J., Ketamine enhances human neural stem cell proliferation and induces neuronal apoptosis via reactive oxygen species-mediated mitochondrial pathway (2013) Anesth. Analg., 116, pp. 869-880; Bal-Price, A.K., Coecke, S., Costa, L., Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation (2012) ALTEX, 29, pp. 202-215; Ceccatelli, S., Tamm, C., Sleeper, E., Orrenius, S., Neural stem cells and cell death (2004) Toxicol. Lett., 149, pp. 59-66; Coecke, S., Goldberg, A.M., Allen, S., Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies (2007) Environ. Health Perspect., 115, pp. 924-931; Conti, L., Cattaneo, E., Neural stem cell systems: physiological players or in vitro entities? (2010) Nat. Rev., 11, pp. 176-187; Crofton, K.M., Mundy, W.R., Lein, P.J., Bal-Price, A., Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals (2011) ALTEX, 28, pp. 9-15; Crouch, A., Kozlowski, R., Slater, K., The use of ATP bioluminescence as a measure of proliferation and cytotoxicity (1993) J. Immunol. Methods, 160, pp. 81-88; Culbreth, M.E., Harrill, J.A., Freudenrich, T.M., Mundy, W.R., Shafer, T.J., Comparison of chemical-induced changes in proliferation and apoptosis in human and mouse neuroprogenitor cells (2012) Neurotoxicology, 33, pp. 1499-1510; Dash, A., Blackman, B.R., Wamhoff, B.R., Organotypic systems in drug metabolism and toxicity: challenges and opportunities (2012) Expert Opin. Drug Metab. Toxicol., 8, pp. 999-1014; De Groot, M.W., Westerink, R.H., Dingemans, M.M., Do not judge a neuron only by its cover: neuronal function in in vitro developmental neurotoxicity testing (2013) Toxicol. Sci., 132, pp. 1-7; De Zio, D., Giunta, L., Covaro, M., Ferraro, E., Cecconi, F., Expanding roles of programmed cell death in mammalian neurodevelopment (2005) Semin. Cell Dev. Biol., 16, pp. 281-294; Earnshaw, W.C., Martins, L.M., Kaufmann, S.H., Mammalian caspases: structure activation substrates, and functions during apoptosis (1999) Annu. Rev. Biochem., 68, pp. 383-424; Gassmann, K., Abel, J., Bothe, H., Haarmann-Stemmann, T., Merk, H.F., Quasthoff, K.N., Rockel, T.D., Fritsche, E., Species-specific differential AhR expression protects human neural progenitor cells against developmental neurotoxicity of PAHs (2010) Environ. Health Perspect., 118, pp. 1571-1577; Geng, Y., Walls, K.C., Ghosh, A.P., Akhtar, R.S., Klocke, B.J., Roth, K.A., Cytoplasmic p53 and activated bax regulate p53-dependent, transcription-independent neural precursor cell apoptosis (2010) J. Histochem. Cytochem., 58, pp. 265-275; Grandjean, P., Landrigan, P.J., Neurobehavioural effects of developmental neurotoxicity (2014) Lancet Neurol., 13, pp. 330-338; Harrill, J.A., Robinette, B.L., Mundy, W.R., Use of high content image analysis to detect chemical-induced changes in synaptogenesis (2011) Toxicol. In Vitro, 25, pp. 368-387; Judson, R., Richard, A., Dix, D.J., Houck, K., Kavlock, R., Dellarco, V., Holderman, T., Smith, E., The toxicity data landscape for environmental chemicals (2009) Environ. Health Perspect., 117, pp. 685-695; Kavlock, R., Chandler, K., Houck, K., Hunter, S., Judson, R., Kleinstreuer, N., Knudsen, T., Dix, D., Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management (2012) Chem. Res. Toxicol., 25, pp. 1287-1302; Köhler, C., Orrenius, S., Zhivotovsky, B., Evaluation of caspase activity in apoptotic cells (2002) J. Immunol. Methods, 265, pp. 97-110; Lein, P., Locke, P., Goldberg, A., Meeting report: alternatives for developmental neurotoxicity testing (2007) Environ. Health Perspect., 115, pp. 764-768; Malo, N., Hanley, J.A., Cerquozzi, S., Pelletier, J., Nadon, R., Statistical practice in high-throughput screening data analysis (2006) Nat. Biotechnol., 24, pp. 167-175; Matsumura, I., Tanaka, H., Kanakura, Y., E2F1 and c-Myc in cell growth and death (2003) Cell Cycle, 2, pp. 333-338; Meletis, K., Wirta, V., Hede, S.M., Nistr, M., Lundeberg, J., Frisen, J., P53 suppresses the self-renewal of adult neural stem cells (2006) Development, 133, pp. 363-369; (2007) Toxicity Testing in the 21st Century: a Vision and a Strategy, , National Academies Press, Washington, D.C; Prochazkova, J., Kylarova, D., Vranka, P., Lichnovsky, V., Comparative study of apoptosis-detecting techniques: TUNEL, apostain, and lamin B (2003) BioTechniques, 35, pp. 528-534; Radio, N.M., Mundy, W.R., Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth (2008) Neurotoxicology, 29, pp. 361-376; Rice, D., Barone, S., Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models (2000) Environ. Health Perspect., 108, pp. 511-533; Schwartz, P.H., Nethercott, H., Kirov, I.I., Ziaeian, B., Young, M.J., Klassen, H., Expression of neurodevelopmental markers by cultured porcine neural precursor cells (2005) Stem Cells, 23, pp. 1286-1294; Siegal, S., Castellan, N.J., (1988) Nonparametric Statistics for the Behavioral Sciences, , McGraw Hill, New York; Sidhu, J.S., Ponce, R.A., Vredevoogd, M.A., Yu, X., Gribble, E., Hong, S.-W., Schneider, E., Faustman, E.M., Cell cycle inhibition by sodium arsenite in primary embryonic rat midbrin neuroepithelial cells (2006) Toxicol. Sci., 89, pp. 475-484; Suzuki, J.S., Ishido, M., Transcriptome of tributyltin-induced apoptosis of the cultured rat mesencephalic neural stem cells (2011) Toxicology, 287, pp. 61-68; Tamm, C., Duckworth, J., Hermanson, O., Ceccatelli, S., High susceptibility of neural stem cells to methylmercury toxicity: effects on cell survival and neuronal differentiation (2006) J. Neurochem., 97, pp. 69-78; Tamm, C., Sabri, F., Ceccatelli, S., Mitochondrial-mediated apoptosis in neural stem cells exposed to manganese (2008) Toxicol. Sci., 101, pp. 310-320; Thomaidou, D., Mione, M.C., Cavanagh, J.F.R., Parnavelas, J.G., Apoptosis and its relation to the cell cycle in the developing cerebral cortex (1997) J. Neurosci., 17, pp. 1075-1085; Thompson, E.B., The many roles of c-Myc in apoptosis (1998) Annu. Rev. Physiol., 60, pp. 575-600; Vousdan, K.H., Lu, X., Live or let die: the cell's response to p53 (2002) Nat. Rev. Cancer, 2, pp. 594-604; Walter, J., Dihné, M., Species-dependent differences of embryonic stem cell-derived neural stem cells after interferon gamma treatment (2012) Front. Cell. Neurosci., 6, p. 52; Wang, L., Ohishi, T., Shiraki, A., Morita, R., Akane, H., Ikarashi, Y., Mitsumori, K., Shibutani, M., Developmental exposure to manganese chloride induces sustained aberration of neurogenesis in the hippocampal dentate gyrus of mice (2012) Toxicol. Sci., 127, pp. 508-521; Weil, M., Jacobson, M.D., Coles, H.S.R., Davies, T.J., Gardner, R.L., Raff, K.D., Raff, M.C., Constitutive expression of the machinery for programmed cell death (1996) J. Cell Biol., 133, pp. 1053-1059; Woodruff, T.J., Zota, A.R., Schwartz, J.M., Environmental chemicals in pregnant women in the United States: NHANES 2003-2004 (2011) Environ. Health Perspect., 119, pp. 878-885; Xu, X., Lei, Y., Luo, J., Wang, J., Zhang, S., Yang, X.J., Sun, M., Zhong, Z., Prevention of β-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of cyclin-dependent kinases and associated cell cycle events (2013) Stem Cell Res., 10, pp. 213-227; Yoneyama, M., Seko, K., Kawada, K., Sugiyama, C., Ogita, K., High susceptibility of cortical neural progenitor cells to trimethyltin toxicity: involvement of both caspases and calpain in cell death (2009) Neurochem. Int., 55, pp. 257-264; Yu, S., Patchev, A.V., Wu, Y., Lu, J., Holsboer, F., Zhang, J.Z., Sousa, N., Almeida, O.F.X., Depletion of the neural precursor cell poos by glucocorticoids (2010) Ann. Neurol., 67, pp. 21-30",Article,Scopus,2-s2.0-84927722477
"Baumgartner W., Welti M., Hild N., Hess S.C., Stark W.J., Burgisser G.M., Giovanoli P., Buschmann J.","Tissue mechanics of piled critical size biomimetic and biominerizable nanocomposites: Formation of bioreactor-induced stem cell gradients under perfusion and compression",2015,"Journal of the Mechanical Behavior of Biomedical Materials","47",,,"124","134",,,10.1016/j.jmbbm.2015.03.022,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928336758&partnerID=40&md5=f054a474c34069ebe882cd234b7601de","Division of Plastic and Hand Surgery, University Hospital Zurich, Rämistrasse 100Zurich, Switzerland; Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH ZurichZurich, Switzerland","Baumgartner, W., Division of Plastic and Hand Surgery, University Hospital Zurich, Rämistrasse 100Zurich, Switzerland; Welti, M., Division of Plastic and Hand Surgery, University Hospital Zurich, Rämistrasse 100Zurich, Switzerland; Hild, N., Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH ZurichZurich, Switzerland; Hess, S.C., Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH ZurichZurich, Switzerland; Stark, W.J., Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH ZurichZurich, Switzerland; Bürgisser, G.M., Division of Plastic and Hand Surgery, University Hospital Zurich, Rämistrasse 100Zurich, Switzerland; Giovanoli, P., Division of Plastic and Hand Surgery, University Hospital Zurich, Rämistrasse 100Zurich, Switzerland; Buschmann, J., Division of Plastic and Hand Surgery, University Hospital Zurich, Rämistrasse 100Zurich, Switzerland","Background: Perfusion bioreactors are used to solve problems in critical size bone tissue engineering. Biominerizable and biocompatible nanocomposites are suitable scaffold materials for this purpose because they offer mineral components in organic carriers. Human adipose derived stem cells (ASCs) can potentially be used to increase bone healing. Materials and methods: Electrospun nanocomposite disks of poly-lactic-co-glycolic acid and amorphous calcium phosphate nanoparticles (PLGA/a-CaP) were seeded with ASCs and eight disks were stacked in a bioreactor running with normal culture. Under perfusion and uniaxial cyclic compression, load-displacement curves as a function of time were assessed. Stiffness and energy dissipation were recorded. Moreover, stem cell densities in the layers of the piled scaffold were determined as well as their morphologies and differentiation status. Results: While the stiffness of the cell free constructs increased over time based on the transformation of the a-CaP nanoparticles into flake-like apatite, ASC-seeded constructs showed a constant stiffness. Stem cell density gradients had a linear increase from the bottom to the top of the pile (r2>0.95). Stem cells were getting more roundish at higher flow rates. Some osteogenesis was found upon osteopontin immunostaining, while no endothelial cell differentiation and no chondrogenesis was triggered. Conclusions: The fabrication of a critical size bone graft is presented based on a biominerizable bone-biomimetic nanocomposite with preserved stiffness when seeded with ASCs. The cell densities of ASCs inside the piled construct varied with a linear gradient. Beginning osteogenesis was triggered by the dynamic culture conditions including perfusion and compression. © 2015 Elsevier Ltd.","Adipose-derived stem cell; Amorphous calcium phosphate; Apatite; Bone; Composite; Nanoparticle; PLGA; Stiffness","Angele, P., Cyclic, mechanical compression enhances chondrogenesis of mesenchymal progenitor cells in tissue engineering scaffolds (2004) Biorheology, 41 (3-4), pp. 335-346; Bannasch, H., Skin tissue engineering (2003) Clin. Plast. Surg., 30 (4), pp. 573-579; Bodle, J.C., Hanson, A.D., Loboa, E.G., Adipose-derived stem cells in functional bone tissue engineering: lessons from bone mechanobiology (2011) Tissue Eng. Part B-Rev., 17 (3), pp. 195-211; Buschmann, J., Tissue engineered bone grafts based on biomimetic nanocomposite PLGA/amorphous calcium phosphate scaffold and human adipose-derived stem cells (2012) Injury, 43 (10), pp. 1689-1697; Buschmann, J., Yield and proliferation rate of adipose-derived stem cells as a function of age, BMI and harvest site: Increasing the yield by using adherent and supernatant fractions? (2013) Cytotherapy, 15, pp. 1098-1105; Chen, Y.-J., Effects of cyclic mechanical stretching on the mRNA expression of tendon/ligament-related and osteoblast-specific genes in human mesenchymal stem cells (2008) Connect. Tissue Res., 49 (1), pp. 7-14; Declercq, H.A., Bone grafts engineered from human adipose-derived stem cells in dynamic 3D-environments (2013) Biomaterials, 34 (4), pp. 1004-1017; Ducheyne, P., Mauck, R.L., Smith, D.H., Biomaterials in the repair of sports injuries (2012) Nat. Mater., 11 (8), pp. 652-654; Duty, A.O., Oest, M.E., Guldberg, R.E., Cyclic mechanical compression increases mineralization of cell-seeded polymer scaffolds in vivo (2007) J. Biomech. Eng. ASME, 129 (4), pp. 531-539; Elbert, D.L., Bottom-up tissue engineering (2011) Curr. Opin. Biotechnol., 22 (5), pp. 674-680; Gao, S.P., Proliferation of ASC-derived endothelial cells in a 3D electrospun mesh: impact of bone-biomimetic nanocomposite and co-culture with ASC-derived osteoblasts (2014) Inj.-Int. J. Care Inj., 45 (6), pp. 974-980; Gelinsky, M., Porous three-dimensional scaffolds made of mineralised collagen: preparation and properties of a biomimetic nanocomposite material for tissue engineering of bone (2008) Chem. Eng. J., 137 (1), pp. 84-96; Georgiou, A., Generation of 3D mineralized cellular constructs from mESCs in a perfusion bioreactor using simvastatin (2012) J. Tissue Eng. Regen. Med., 6, p. 252; Grässel, S., Lorenz, J., Tissue-engineering strategies to repair chondral and osteochondral tissue in osteoarthritis: use of mesenchymal stem cells (2014) Curr. Rheumatol. Rep., 16 (10), pp. 1-16; Grayson, W.L., Optimizing the medium perfusion rate in bone tissue engineering bioreactors (2011) Biotechnol. Bioeng., 108 (5), pp. 1159-1170; Gronthos, S., Surface protein characterization of human adipose tissue-derived stromal cells (2001) J. Cell. Physiol., 189 (1), pp. 54-63; Heinemann, C., Development of an osteoblast/osteoclast co-culture derived by human bone marrow stromal cells and human monocytes for biomaterials testing (2011) Eur. Cells Mater., 21, pp. 80-93; Hsieh, A.H., Time-dependent increases in type-III collagen gene expression in medial collateral ligament fibroblasts under cyclic strains (2000) J. Orthop. Res., 18 (2), pp. 220-227; Juncosa-Melvin, N., Effects of mechanical stimulation on the biomechanics and histology of stem cell-collagen sponge constructs for rabbit patellar tendon repair (2006) Tissue Eng., 12 (8), pp. 2291-2300; Juncosa-Melvin, N., Mechanical stimulation increases collagen type I and collagen type III gene expression of stem cell - collagen sponge constructs for patellar tendon repair (2007) Proceedings of the ASME Summer Bioengineering Conference, American Society of Mechanical Engineers, , Keystone, CO; Jungraithmayr, W., Bioactive nanocomposite for chest-wall replacement: cellular response in a murine model (2013) J. Biomater. Appl., 29 (1), pp. 36-45; Koike, M., Effects of mechanical strain on proliferation and differentiation of bone marrow stromal cell line ST2 (2005) J. Bone Miner. Metab., 23 (3), pp. 219-225; Kuhbier, J.W., Stem cells from fatty tissue. A new resource for regenerative medicine? (2010) Chirurg, 81 (9), pp. 826-832; Laschke, M.W., Three-dimensional spheroids of adipose-derived mesenchymal stem cells are potent initiators of blood vessel formation in porous polyurethane scaffolds (2013) Acta Biomater., 9 (6), pp. 6876-6884; Lenas, P., Modularity in developmental biology and artificial organs: a missing concept in tissue engineering (2011) Artif. Organs, 35 (6), pp. 656-662; Li, X.M., Nanostructured scaffolds for bone tissue engineering (2013) J. Biomed. Mater. Res. Part A, 101 (8), pp. 2424-2435; Li, Y., Snedeker, J.G., Elastography: modality-specific approaches, clinical applications, and research horizons (2011) Skelet. Radiol., 40 (4), pp. 389-397; Liu, C., Influence of perfusion and compression on the proliferation and differentiation of bone mesenchymal stromal cells seeded on polyurethane scaffolds (2012) Biomaterials, 33 (4), pp. 1052-1064; Loher, S., Fluoro-apatite and calcium phosphate nanoparticles by flame synthesis (2005) Chem. Mater., 17 (1), pp. 36-42; Loher, S., Improved degradation and bioactivity of amorphous aerosol derived tricalcium phosphate nanoparticles in poly(lactide-co-glycolide) (2006) Nanotechnology, 17 (8), pp. 2054-2061; Lynch, M., Fischbach, C., Biomechanical forces in the skeleton and their relevance to bone metastasis: Biology and engineering considerations (2014) Adv. Drug Deliv. Rev., 15 (79-80), pp. 119-134; Mangano, C., Human dental pulp stem cells hook into biocoral scaffold forming an engineered biocomplex (2011) PLoS One, 6, p. 4; Meretoja, V.V., Osteoblast response to continuous phase macroporous scaffolds under static and dynamic culture conditions (2009) J. Biomed. Mater. Res. Part A, 89 (2), pp. 317-325; Mouw, J.K., Dynamic compression regulates the expression and synthesis of chondrocyte-specific matrix molecules in bone marrow stromal cells (2007) Stem Cells, 25 (3), pp. 655-663; Mullender, M., Mechanotransduction of bone cells in vitro: mechanobiology of bone tissue (2004) Med. Biol. Eng. Comput., 42 (1), pp. 14-21; Murugan, R., Ramakrishna, S., Development of nanocomposites for bone grafting (2005) Compos. Sci Technol., 65 (15-16), pp. 2385-2406; Nguyen, L.H., Vascularized bone tissue engineering: approaches for potential improvement (2012) Tissue Eng. Part B-Rev., 18 (5), pp. 363-382; Park, J.G., Chondrogenic differentiation of human adipose tissue-derived stem cells in functional PLGA scaffolds (2011) Tissue Eng. Regen. Med., 8 (1), pp. 47-54; Pelaez, D., Huang, C.-Y.C., Cheung, H.S., Cyclic compression maintains viability and induces chondrogenesis of human mesenchymal stem cells in fibrin gel scaffolds (2009) Stem cells Dev., 18 (1), pp. 93-102; Poole, C.A., Review. Articular cartilage chondrons: form, function and failure (1997) J. Anat., 191 (1), pp. 1-13; Randle, W.L., Integrated 3-dimensional expansion and osteogenic differentiation of murine embryonic stem cells (2007) Tissue Eng., 13 (12), pp. 2957-2970; Rezwan, K., Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering (2006) Biomaterials, 27 (18), pp. 3413-3431; Roberts, S.J., van Gastel, N., Carmeliet, G., Luyten, F.P., Uncovering the periosteum for skeletal regeneration: The stem cell that lies beneath (2014) Bone, 70, pp. 10-18; Rodrigues, A.I., Bioactive starch-based scaffolds and human adipose stem cells are a good combination for bone tissue engineering (2012) Acta Biomater., 8 (10), pp. 3765-3776; Ronca, A., Ambrosio, L., Grijpma, D.W., Preparation of designed poly(d,l-lactide)/nanosized hydroxyapatite composite structures by stereolithography (2013) Acta Biomater., 9 (4), pp. 5989-5996; Ronca, D., Critical analysis on dynamic-mechanical performance of spongy bone: the effect of an acrylic cement (2014) Hard Tissue, 3 (1), pp. 9-16; Salarian, M., Hydroxapatite-TiO<inf>2</inf>-based nanocomposites synthesized in supercritical CO<inf>2</inf> for bone tissue engineering: physical and mechanical properties (2014) ACS Appl. Mater. Interfaces; Santos, M.I., Reis, R.L., Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges (2010) Macromol. Biosci., 10 (1), pp. 12-27; Scherberich, A., Adipose tissue-derived progenitors for engineering osteogenic and vasculogenic grafts (2010) J. Cell. Physiol., 225 (2), pp. 348-353; Schmitt, T., Human flexor tendon tissue engineering: in vivo effects of stem cell reseeding (2013) Plast. Reconstr. Surg., 132 (4), pp. 567e-576e; Schneider, O.D., Cotton wool-like nanocomposite biomaterials prepared by electrospinning: in vitro bioactivity and osteogenic differentiation of human mesenchymal stem cells (2008) J. Biomed. Mater. Res. Part B-Appl. Biomater. B, 84 (2), pp. 350-362; Schneider, O.D., Flexible, silver containing nanocomposites for the repair of bone defects: antimicrobial effect against E. coli infection and comparison to tetracycline containing scaffolds (2008) J. Mater. Chem., 18 (23), pp. 2679-2684; Schroeder, J.E., Mosheiff, R., Tissue engineering approaches for bone repair: concepts and evidence (2011) Inj.-Int. J. Care Inj., 42 (6), pp. 609-613; Sim, W.Y., A pneumatic micro cell chip for the differentiation of human mesenchymal stem cells under mechanical stimulation (2007) Lab Chip, 7 (12), pp. 1775-1782; Szpalski, C., Bony engineering using time-release porous scaffolds to provide sustained growth factor delivery (2012) J. Craniofac. Surg., 23 (3), pp. 638-644; Takeda, K., Adipose-derive stem cells promote proliferation, migration, and tube formation of lymphatic endothelial cells in vitro by secreting lymphangiogenic factors (2014) Ann. Plast. Surg., , http://dx.doi.org/10.1097/SAP.0000000000000084; Teo, A., A novel perfusion bioreactor for cardiomyogenesis (2012) J. Tissue Eng. Regen. Med., 6, p. 109; Terai, H., In vitro engineering of bone using a rotational oxygen-permeable bioreactor system (2002) Mater. Sci. Eng. C-Biomim. Supramol. Syst., 20 (1-2), pp. 3-8; Thibault, R.A., Mikos, A.G., Kasper, F.K., Protein and mineral composition of osteogenic extracellular matrix constructs generated with a flow perfusion bioreactor (2011) Biomacromolecules, 12 (12), pp. 4204-4212; Varila, L., Surface reactions of bioactive glasses in buffered solutions (2012) J. Eur. Ceram. Soc., 32 (11), pp. 2757-2763; Wang, J.H.C., Thampatty, B.P., An introductory review of cell mechanobiology (2006) Biomech. Model. Mechanobiol., 5 (1), pp. 1-16; Xing, Z., Copolymer cell/scaffold constructs for bone tissue engineering: Co-culture of low ratios of human endothelial and osteoblast-like cells in a dynamic culture system (2013) J. Biomed. Mater. Res. Part A, 101 (4), pp. 1113-1120; Yeatts, A.B., Fisher, J.P., Bone tissue engineering bioreactors: dynamic culture and the influence of shear stress (2011) Bone, 48 (2), pp. 171-181; Yeatts, A.B., Human mesenchymal stem cell position within scaffolds influences cell fate during dynamic culture (2012) Biotechnol. Bioeng., 109 (9), pp. 2381-2391; Yeatts, A.B., Choquette, D.T., Fisher, J.P., Bioreactors to influence stem cell fate: augmentation of mesenchymal stem cell signaling pathways via dynamic culture systems (2013) Biochim. Biophys. Acta-General Subj., 1830 (2), pp. 2470-2480; Yeatts, A.B., In vivo bone regeneration using tubular perfusion system bioreactor cultured nanofibrous scaffolds (2014) Tissue Eng. Part A, 20 (1-2), pp. 139-146; Zhang, Z.Y., The potential of human fetal mesenchymal stem cells for off-the-shelf bone tissue engineering application (2012) Biomaterials, 33 (9), pp. 2656-2672; Zuk, P.A., Multilineage cells from human adipose tissue: implications for cell-based therapies (2001) Tissue Eng., 7 (2), pp. 211-228; Zuk, P.A., Human adipose tissue is a source of multipotent stem cells (2002) Mol. Biol. Cell, 13 (12), pp. 4279-4295",Article,Scopus,2-s2.0-84928336758
"Wu X., Meng G., Wang S., Wu F., Huang W., Gu Z.","Zn and Sr incorporated 64S bioglasses: Material characterization, in-vitro bioactivity and mesenchymal stem cell responses",2015,"Materials Science and Engineering C","52",,,"242","250",,,10.1016/j.msec.2015.03.057,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926152284&partnerID=40&md5=77a5574106658fc42f18f16af17bfe05","College of Materials Science and Engineering, Sichuan UniversityChengdu, China; National Engineering Research Center for Biomaterials, Sichuan UniversityChengdu, China; Analytical and Testing Center, Sichuan UniversityChengdu, China","Wu, X., College of Materials Science and Engineering, Sichuan UniversityChengdu, China; Meng, G., National Engineering Research Center for Biomaterials, Sichuan UniversityChengdu, China; Wang, S., Analytical and Testing Center, Sichuan UniversityChengdu, China; Wu, F., National Engineering Research Center for Biomaterials, Sichuan UniversityChengdu, China; Huang, W., College of Materials Science and Engineering, Sichuan UniversityChengdu, China; Gu, Z., National Engineering Research Center for Biomaterials, Sichuan UniversityChengdu, China","Essential element like Zn or Sr is known to play an important role in bone remodeling process. In this study, we have used the sol-gel process to synthesize the Zn (2%) and Sr (5%) doped 64S bioglasses (BGs, 64SiO2-5P2O5-31CaO, mol.%), alone and co-doped. The synthesized glasses were characterized by XRD, FTIR and STEM. For biological evaluation, the effects of Zn and Sr incorporation on the in vitro bioactivity of the synthesized BGs were studied using the simulated body fluid (SBF) soaking. The proliferation and differentiation (ALP, OCN) of rat mesenchymal stem cells (MSCs) on these BGs were studied using CCK-8 and ELISA analyses. The results indicated that Zn had been uniformly incorporated into the bioglass, and demonstrated a stimulating effect on apatite-like layer formation, MSC proliferation and differentiation. On the other hand, most of Sr appeared to form a secondary crystal phase with extremely high solubility in SBF, showing an enhancing effect only in MSC differentiation but not in proliferation, as well as an inhibitory effect on apatite-like layer formation. The different dissolution behaviors of Sr and Zn ions seemed to have a strong correlation with the different apatite-like layer formation capabilities and the cellular responses of Zn and Sr containing BGs. © 2015 Elsevier B.V. All rights reserved.","Bioglass; Differentiation; MSC; Sr; Zn","Murphy, S., Wren, A.W., Towler, M.R., Boyd, D., (2010) J. Mater. Sci. Mater. Med., 21, p. 2827; Chen, Y.W., Shi, G.Q., Ding, Y.L., Yu, X.X., Zhang, X.H., Zhao, C.S., Wan, C.X., (2008) J. Mater. Sci. Mater. Med., 19, p. 2655; Bonnelye, E., Chabadel, A., Saltel, F., Jurdic, P., (2008) Bone, 42, p. 129; Zhu, L.L., Zaidi, S., Peng, Y., Zhou, H., Moonga, B.S., Blesius, A., Dupin-Roger, I., Sun, L., (2007) Biochem. Biophys. Res. Commun., 355, p. 307; Popp, J.R., Love, B.J., Goldstein, A.S., (2007) J. Biomed. Mater. Res. A, 81 A, p. 766; Yamaguchi, M., (1998) J. Trace Elem. Exp. Med., 11, p. 119; Kwun, I.-S., Cho, Y.-E., Lomeda, R.-A.R., Shin, H.-I., Choi, J.-Y., Kang, Y.-H., Beattie, J.H., (2010) Bone, 46, p. 732; Hench, L.L., (1991) J. Am. Ceram. Soc., 74, p. 1487; Erol, M., Öyuguran, A., Çelebican, O., (2010) Chem. Eng. Technol., 33, p. 1066; Saravanapavan, P., Jones, J.R., Pryce, R.S., Hench, L.L., (2003) J. Biomed. Mater. Res. A, 66, p. 110; Oki, A., Parveen, B., Hossain, S., Adeniji, S., Donahue, H., (2004) J. Biomed. Mater. Res. A, 69, p. 216; Balamurugan, A., Balossier, G., Kannan, S., Michel, J., Rebelo, A.H.S., Ferreira, J.M.F., (2007) Acta Biomater., 3, p. 255; Isaac, J., Nohra, J., Lao, J., Jallot, E., Nedelec, J.-M., Berdal, A., Sautier, J.-M., (2011) Eur. Cell. Mater., 21, p. 130; Lusvardi, G., Malavasi, G., Menabue, L., Menziani, M.C., Pedone, A., Segre, U., Aina, V., Cannas, M., (2008) J. Biomater. Appl., 22, p. 505; Saino, E., Grandi, S., Quartarone, E., Maliardi, V., Galli, D., Bloise, N., Fassina, L., Visai, L., (2011) Eur. Cells Mater., 21, p. 59; Aina, V., Malavasi, G., Pla, A.F., Munaron, L., Morterra, C., (2009) Acta Biomater., 5, p. 1211; Hesaraki, S., Gholami, M., Vazehrad, S., Shahrabi, S., (2010) Mater. Sci. Eng. C, 30, p. 383; Wu, C., Ramaswamy, Y., Kwik, D., Zreiqat, H., (2007) Biomaterials, 28, p. 3171; Hesaraki, S., Alizadeh, M., Nazarian, H., Sharifi, D., (2010) J. Mater. Sci. Mater. Med., 21, p. 695; Haimi, S., Gorianc, G., Moimas, L., Lindroos, B., Huhtala, H., Räty, S., Kuokkanen, H., Suuronen, R., (2009) Acta Biomater., 5, p. 3122; Aina, V., Bonino, F., Morterra, C., Miola, M., Bianchi, C.L., Malavasi, G., Marchetti, M., Bolis, V., (2011) J. Phys. Chem. C, 115, p. 2196; Gentleman, E., Fredholm, Y.C., Jell, G., Lotfibakhshaiesh, N., O'Donnell, M.D., Hill, R.G., (2010) Biomaterials, 31, p. 3949; Fredholm, Y.C., Karpukhina, N., Law, R.V., Hill, R.G., (2010) J. Non-Cryst. Solids, 356, p. 2546; Goel, A., Rajagopal, R.R., Ferreira, J.M.F., (2011) Acta Biomater., 7, p. 4071; Boyd, D., Carroll, G., Towler, M.R., Freeman, C., Farthing, P., Brook, I.M., (2009) J. Mater. Sci. Mater. Med., 20, p. 413; Li, R., Clark, A.E., Hench, L.L., (1991) J. Appl. Biomater., 2, p. 231; Kokubo, T., Kushitani, H., Sakka, S., Kitsugi, T., Yamamuro, T., (1990) J. Biomed. Mater. Res., 24, p. 721; Ravarian, R., Moztarzadeh, F., Solati Hashjin, M., Rabiee, S.M., Khoshakhlagh, P., Tahriri, M., (2010) Ceram. Int., 36, p. 291; Jalota, S., Bhaduri, S.B., Tas, A.C., (2008) Mater. Sci. Eng. C, 28, p. 129; Zhang, J., Zhao, S., Zhu, Y., Huang, Y., Zhu, M., Tao, C., Zhang, C., (2014) Acta Biomater., 10, p. 2269; Zhang, W., Shen, Y., Pan, H., Lin, K., Liu, X., Darvell, B.W., Lu, W.W., Huang, W., (2011) Acta Biomater., 7, p. 800; Kapoor, S., Goel, A., Tilocca, A., Dhuna, V., Bhatia, G., Dhuna, K., Ferreira, J.M.F., (2014) Acta Biomater., 10, p. 3264; Wu, C., Zhou, Y., Lin, C., Chang, J., Xiao, Y., (2012) Acta Biomater., 8, p. 3805; Hill, R.G., Stamboulis, A., Law, R.V., Clifford, A., Towler, M.R., Crowley, C., (2004) J. Non-Cryst. Solids, 336, p. 223; Lotfibakhshaiesh, N., Brauer, D.S., Hill, R.G., (2010) J. Non-Cryst. Solids, 356, p. 2583; Linati, L., Lusvardi, G., Malavasi, G., Menabue, L., Menziani, M.C., Mustarelli, P., (2005) J. Phys. Chem. B, 109, p. 4989; Aida, K., Komatsu, T., Dimitrov, V., (2001) Phys. Chem. Glasses, 42, p. 103; Bohner, M., Lemaitre, J., (2009) Biomaterials, 30, p. 2175; Bini, M., Grandi, S., Capsoni, D., Mustarelli, P., Saino, E., Visai, L., (2009) J. Phys. Chem. C, 113, p. 8821; Courthécoux, L., Lao, J., Nedelec, J.M., Jallot, E., (2008) J. Phys. Chem. C, 112, p. 13663; Oudadesse, H., Dietrich, E., Bui, X.V., Le Gal, Y., Pellen, P., Cathelineau, G., (2011) Appl. Surf. Sci., 257, p. 8587; Wang, X., Li, X., Ito, A., Sogo, Y., (2011) Acta Biomater., 7, p. 3638; Zhang, Y., Wei, L., Chang, J., Miron, R.J., Shi, B., Yia, S., Wu, C., (2013) J. Mater. Chem., 1 B, p. 5711",Article,Scopus,2-s2.0-84926152284
"Park H.J., Lee O.J., Lee M.C., Moon B.M., Ju H.W., Lee J.M., Kim J.-H., Kim D.W., Park C.H.","Fabrication of 3D porous silk scaffolds by particulate (salt/sucrose) leaching for bone tissue reconstruction",2015,"International Journal of Biological Macromolecules","78",,,"215","223",,,10.1016/j.ijbiomac.2015.03.064,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928341405&partnerID=40&md5=16c588b973677f6ceff41b7013bd7621","Nano-Bio Regenerative Medical Institute, Hallym UniversityChuncheon, Gangwon, South Korea; Department of Otorhinolaryngology - Head and Neck Surgery, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, 153 Kyo-DongChuncheon, Gangwon, South Korea","Park, H.J., Nano-Bio Regenerative Medical Institute, Hallym UniversityChuncheon, Gangwon, South Korea; Lee, O.J., Nano-Bio Regenerative Medical Institute, Hallym UniversityChuncheon, Gangwon, South Korea; Lee, M.C., Nano-Bio Regenerative Medical Institute, Hallym UniversityChuncheon, Gangwon, South Korea; Moon, B.M., Nano-Bio Regenerative Medical Institute, Hallym UniversityChuncheon, Gangwon, South Korea; Ju, H.W., Nano-Bio Regenerative Medical Institute, Hallym UniversityChuncheon, Gangwon, South Korea; Lee, J.M., Nano-Bio Regenerative Medical Institute, Hallym UniversityChuncheon, Gangwon, South Korea; Kim, J.-H., Nano-Bio Regenerative Medical Institute, Hallym UniversityChuncheon, Gangwon, South Korea; Kim, D.W., Nano-Bio Regenerative Medical Institute, Hallym UniversityChuncheon, Gangwon, South Korea; Park, C.H., Nano-Bio Regenerative Medical Institute, Hallym UniversityChuncheon, Gangwon, South Korea, Department of Otorhinolaryngology - Head and Neck Surgery, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, 153 Kyo-DongChuncheon, Gangwon, South Korea","Silk fibroin is a biomaterial being actively studied in the field of bone tissue engineering. In this study, we aimed to select the best strategy for bone reconstruction on scaffolds by changing various conditions. We compared the characteristics of each scaffold via structural analysis using scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), the swelling ratio, water uptake, porosity, compressive strength, cell infiltration and cell viability (CCK-8). The scaffolds had high porosity with good inter pore connectivity and showed high compressive strength and modulus. In addition, to confirm bone reconstruction, animal studies were conducted in which samples were implanted in rat calvaria and investigated by micro-CT scans. In conclusion, the presented study indicates that using sucrose produces scaffolds showing better pore interconnectivity and cell infiltration than scaffolds made by using a salt process. In addition, in vivo experiments showed that hydroxyapatite accelerates bone reconstruction on implanted scaffolds. Accordingly, our scaffold will be expected to have a useful application in bone reconstruction. © 2015 Elsevier B.V.","Bone reconstruction; Hydroxyapatite; Particulate leaching; Silk fibroin","Logeart-Avramoglou, D., Anagnostou, F., Bizios, R., Petite, H., (2005) J. Cell. Mol. Med., 9, pp. 72-84; Cancedda, R., Giannoni, P., Mastrogiacomo, M., (2007) Biomaterials, 28, pp. 4240-4250; Fosso, F., Giordano, A., Barbarisi, M., Barbarisi, A., (2004) J. Cell. Physiol., 199, pp. 174-180; Shin, H., Jo, S., Mikos, A.G., (2003) Biomaterials, 24, pp. 4353-4364; Nam, Y.S., Yoon, J.J., Park, T.G., (2000) J. Biomed. Mater. Res. A, 53, pp. 1-7; Fukasawa, T., Ando, M., Ohji, T., Kanzaki, S., (2001) J. Am. Ceram. Soc., 84, pp. 230-232; Reignier, J., Huneault, M.A., (2006) Polymer, 47, pp. 4703-4717; Yoshimoto, H., Shin, Y.M., Terai, H., Vacanti, J.P., (2003) Biomaterials, 24, pp. 2077-2082; Mikos, A.G., Thorsen, A.J., Czerwonka, L.A., Bao, Y., Langer, R., Winslow, D.N., (1994) Polymer, 35, pp. 1068-1077; Pittenger, M.F., Mosca, J.D., McIntosh, K.R., (2000) Curr. Top. Microbiol. Immunol., 251, pp. 3-11; Wanga, Y., Kim, H.J., Vunjak-Novakovicb, G., Kaplan, D.L., (2006) Biomaterials, 27, pp. 6064-6082; Lennon, D.P., Haynesworth, S.E., Arm, D.M., Baber, M.A., Caplan, A.I., (2000) Dev. Dyn., 219, pp. 50-62; Kadiyala, S., Young, R.G., Thiede, M.A., Bruder, S.P., (1997) Cell Transplant., 6, pp. 125-134; Guobao, W., Peter, X.M., (2004) Biomaterials, 25, pp. 4749-4757; Wang, Y., Blasioli, D.J., Kim, H.J., Kim, H.S., Kaplan, D.L., (2006) Biomaterials, 27, p. 4434; Yang, Y., Chen, X., Ding, F., Zhang, P., Liu, J., Gu, X., (2007) Biomaterials, 28, pp. 1643-1652; Horan, R.L., Antle, K., Collette, A.L., Wang, Y., Huang, J., Moreau, J.E., Volloch, V., Kaplan, D.L., (2005) Biomaterials, 26, pp. 3385-3393; Park, H.J., Lee, J.S., (2014) Macromol. Res., 22, pp. 592-599; Zhang, X., Cao, C., Ma, X., Li, Y., (2012) J. Mater. Sci.: Mater. Med., 23, pp. 315-324; Kim, U.J., Park, J., Kim, H.J., Wada, M., Kaplan, D.L., (2005) Biomaterials, 26, pp. 2775-2785; Soliman, S., Sant, S., Nichol, J.W., Khabiry, M., Traversa, E., Khademhosseini, A., (2011) J. Biomed.: Mater. Res. A, 96, p. 566; Zhang, R., Ma, P.X., (1999) J. Biomed.: Mater. Res., 44, p. 446; Anjuvan, Singh, Purohit, K.M., (2011) Bioproces. Biotechniq., 1, p. 1; El Mhammedi, M.A., Bakasse, M., Chtaini, A., (2007) Leonardo El. J. Pract. Technol., 6, pp. 1-12; Zhao, Y., Yan, X., Ding, F., Yang, Y., Gu, X., (2011) J. Mater. Sci.: Mater. Med., 4, pp. 397-402; Tang, X., Ding, F., Yang, Y., Hu, N., Wu, H., Gu, X., (2009) J. Biomed.: Mater. Res. A, 91 A, pp. 166-174; Puchtler, H., Meloan, S.N., Terry, M.S., (1969) J. Histochem. Cytochem., 17, pp. 110-124; Kim, H.J., Kim, U.J., Kim, H.S., Li, C., Wada, M., Leisk, G.G., Kaplan, D.L., (2008) Bone, 42, pp. 1226-1234; Sheikh, F.A., Ju, H.W., Moon, B.M., Lee, O.J., Kim, J.H., Park, H.J., Kim, D.W., Kim, D.K., (2015) J. Tissue Eng. Regen. Med.",Article,Scopus,2-s2.0-84928341405
"Dyck S.M., Karimi-Abdolrezaee S.","Chondroitin sulfate proteoglycans: Key modulators in the developing and pathologic central nervous system",2015,"Experimental Neurology","269",,,"169","187",,,10.1016/j.expneurol.2015.04.006,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928673857&partnerID=40&md5=2ab320bf4c693a2483fd03e95ef70bb9","Regenerative Medicine Program, Department of Physiology and the Spinal Cord Research Centre, University of ManitobaWinnipeg, MB, Canada","Dyck, S.M., Regenerative Medicine Program, Department of Physiology and the Spinal Cord Research Centre, University of ManitobaWinnipeg, MB, Canada; Karimi-Abdolrezaee, S., Regenerative Medicine Program, Department of Physiology and the Spinal Cord Research Centre, University of ManitobaWinnipeg, MB, Canada","Chondroitin Sulfate Proteoglycans (CSPGs) are a major component of the extracellular matrix in the central nervous system (CNS) and play critical role in the development and pathophysiology of the brain and spinal cord. Developmentally, CSPGs provide guidance cues for growth cones and contribute to the formation of neuronal boundaries in the developing CNS. Their presence in perineuronal nets plays a crucial role in the maturation of synapses and closure of critical periods by limiting synaptic plasticity. Following injury to the CNS, CSPGs are dramatically upregulated by reactive glia which form a glial scar around the lesion site. Increased level of CSPGs is a hallmark of all CNS injuries and has been shown to limit axonal plasticity, regeneration, remyelination, and conduction after injury. Additionally, CSPGs create a non-permissive milieu for cell replacement activities by limiting cell migration, survival and differentiation. Mounting evidence is currently shedding light on the potential benefits of manipulating CSPGs in combination with other therapeutic strategies to promote spinal cord repair and regeneration. Moreover, the recent discovery of multiple receptors for CSPGs provides new therapeutic targets for targeted interventions in blocking the inhibitory properties of CSPGs following injury. Here, we will provide an in depth discussion on the impact of CSPGs in normal and pathological CNS. We will also review the recent preclinical therapies that have been developed to target CSPGs in the injured CNS. © 2015 Elsevier Inc.","Axonal regeneration; Central; Chondroitin sulfate proteoglycans; Development; Extracellular matrix; Glial scar; Intacellular mechanisms; LAR; Multiple sclerosis; Nervous system; Plasticity; PTPσ; Spinal cord injury","Akita, K., Holst, A., Furukawa, Y., Mikami, T., Sugahara, K., Faissner, A., Expression of multiple chondroitin/dermatan sulfotransferases in the neurogenic regions of the embryonic and adult central nervous system implies that complex chondroitin sulfates have a role in neural stem cell maintenance (2008) Stem Cells, 26, pp. 798-809; Alilain, W.J., Horn, K.P., Hu, H., Dick, T.E., Silver, J., Functional regeneration of respiratory pathways after spinal cord injury (2011) Nature, 475, pp. 196-200; Alluin, O., Karimi-Abdolrezaee, S., Delivet-Mongrain, H., Leblond, H., Fehlings, M.G., Rossignol, S., Kinematic study of locomotor recovery after spinal cord clip compressio injury in rats (2011) J. Neurotrauma, 28, pp. 1963-1981; Alluin, O., Delivet-Mongrain, H., Gauthier, M.-K., Fehlings, M.G., Rossignol, S., Karimi-Abdolrezaee, S., Examination of the combined effects of chondroitinase ABC, growth factors and locomotor training following compressive spinal cord injury on neuroanatomical plasticity and kinematics (2014) PLoS One, 9, p. e111072; Apte, S.S., A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: Functions and mechanisms (2009) J. Biol. Chem., 284, pp. 31493-31497; Aricescu, A.R., McKinnell, I.W., Halfter, W., Stoker, A.W., Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma (2002) Mol. Cell. Biol., 22, pp. 1881-1892; Arvantan, V.I., Schnell, I., Lou, I., Golshant, R., Hunanyan, A., Ghosh, A., Pearse, D.D., Mendell, L.M., Chronic spinal hemisection in rats induces a progressive decline in transmission in uninjured fiber to motorneurons (2009) Exp. Neurol., 216, pp. 471-480; Asher, R.A., Morgenstern, D.A., Fidler, P.S., Adcock, K.H., Oohira, A., Braistead, J.E., Levine, J.M., Fawcett, J.W., Neurocan is upregulated in injured brain and in cytokine-treated astrocytes (2000) J. Neurosci., 20, pp. 2427-2438; Asher, R.A., Morgenstern, D.A., Shearer, M.C., Adcock, K.H., Pesheva, P., Fawcett, J.W., Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells (2002) J. Neurosci., 22, pp. 2225-2236; Back, S.A., Tuohy, T.M.F., Chen, H., Wallingford, N., Craig, A., Struve, J., Luo, N.L., Sherman, L.S., Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation (2005) Nat. Med., 11, pp. 966-972; Bandtlow, C.E., Zimmermann, D.R., Proteoglycans in the developing brain: New conceptual insights for Old proteins (2000) Physiol. Rev., 80, pp. 1267-1290; Barnabé-Heider, F., Göritz, C., Sabelström, H., Takebayashi, H., Pfrieger, F.W., Meletis, K., Frisén, J., Origin of New glial cells in intact and injured adult spinal cord (2010) Cell Stem Cell, 7, pp. 470-482; Barritt, A.W., Davies, M., Marchand, F., Hartley, R., Grist, J., Yip, P., McMahon, S.B., Bradbury, E.J., Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury (2006) J. Neurosci., 26; Bartus, K., James, N.D., Didangelos, A., Bosch, K.D., Verhaagen, J., Yanez-Munoz, R.J., Rogers, J.H., Bradbury, E.J., Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury (2014) J. Neurosci., 34, pp. 4822-4836; Beller, J.A., Kulengowski, B., Kobraei, E., Curinga, G., Calulot, C.M., Bahrami, A., Hering, T.M., Snow, D.M., Comparison of sensory neuron growth cone and filopodial response to structurally diverse aggrecan variants, in vitro (2013) Exp. Neurol., 247, pp. 143-157; Beurdeley, M., Spatazza, J., Lee, H.H.C., Sugiyama, S., Bernar, C., Nardo, A.A.D., Hensch, T.K., Prochiantz, A., Otx2 binding to perineuronal nets persistently regulates plasticity in the mature visual corex (2012) J. Neurosci., 32, pp. 9429-9437; Biersmith, B.H., Hammel, M., Geisbrecht, E.R., Bouyain, S., The immunoglobulin-like domains 1 and 2 of the protein tyrosine phosphatase LAR adopt an unusual horseshoe-like conformation (2011) J. Mol. Biol., 408, pp. 616-627; Binette, F., Cravens, J., Kahoussi, B., Haudenschild, D.R., Goetinck, P.F., Link protein is ubiquitously expressed in non-cartilginous tissues where it enhances and stabilized the interaction of proteoglycans with hyaluronic acid (1994) J. Neurosci., 269, pp. 19116-19122; Bradbury, E.J., Moon, L.D.F., Popat, R.J., King, V.R., Bennett, G.S., Patel, P.N., Fawcett, J.W., McMahon, S.B., Chondroitinase ABC promotes functional recovery after spinal cord injury (2002) Nature, 416, pp. 636-640; Brittis, P.A., Canning, D.R., Silver, J., Chondroitin sulfate as a regulator of neuronal patterning in the retina (1992) Science, 255, pp. 733-736; Brown, J.M., Xia, J., Zhuang, B., Cho, K.-S., Rogers, C.J., Gama, C.I., Rawat, M., Hsieh-Wilson, L.C., A sulfated carbohydrate epitope inhibits axon regeneration after injury (2012) PNAS, 109, pp. 4768-4773; Buffo, A., Rolando, C., Ceruti, S., Astrocytes in the damaged brain: Molecular and cellular insights into their reactive response and healing potential (2010) Biochem. Pharmacol., 79, pp. 77-89; Busch, S.A., Horn, K.P., Silver, D.J., Silver, J., Overcoming macrophage-mediated axonal dieback following CNS injury (2009) J. Neurosci., 29, pp. 9967-9976; Buss, A., Pech, K., Kakulas, B.A., Martin, D., Schoenen, J., Noth, J., Brook, G.A., NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury (2009) BMC Neurol., 9; Butt, S.J., Duncan, A., Hornby, M.F., Kirvell, S.L., Hunter, A., Levine, J.M., Berry, M., Cells expressing the NG2 antigen contact nodes of Ranvier in adult CNS white matter (1999) Glia, 26, pp. 84-91; Cafferty, W.B.J., Yang, S.-H., Duffy, P.J., Li, S., Strittmatter, S.M., Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans (2007) J. Neurosci., 27, pp. 2176-2185; Cafferty, W.B.J., Bradbury, E.J., Lidierth, M., Jones, M., Duffy, P.J., Pezet, S., McMahon, S.B., Chondroitinase ABC-mediated plasticity of spinal sensory function (2008) J. Neurosci., 28, pp. 11998-12009; Caggiano, A., Zimber, M., Ganguly, A., Gruskin, A.B.E., Chondroitinase ABC improves locomotion and bladder function following contusion injury of rat spinal cord (2005) J. Neurotrauma, 22, pp. 226-236; Carter, L.M., Starkey, M.L., Akrimi, S.F., Davies, M., McMahon, S.B., Bradbury, E.J., The yellow fluorescent protein (YFP-H) mouse reveals neuroprotection as a novel mechanism underlying chondroitinase ABC-mediated repair after spinal cord injury (2008) J. Neurosci., 28, pp. 14107-14120; Carter, L.M., McMahon, S.B., Bradbury, E.J., Delayed treatment with chondroitinase ABC reverses chronic atrophy of rubrospinal neurons following spinal cord injury (2011) Exp. Neurol., 228, pp. 149-156; Chagnon, M.J., Uetani, N., Tremblay, M.I., Functional significance of the LAR receptor protein tyrosine phosphatase family in deveopment and diseases (2004) Biochem. Cell Biol., 82, pp. 664-675; Chan, C.C.M., Khodarahmi, K., Liu, J., Sutherland, D., Oschipok, L.W., Steeves, J.D., Tetzlaff, M., Dose-dependent benficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury (2005) Exp. Neurol., 196, pp. 352-364; Chang, A., Staugaitis, S.M., Dutta, R., Batt, C.E., Easley, K.E., Chomyk, A.M., Yong, V.W., Trapp, B.D., Cortical remyelination: a new target for repair therapies in multiple sclerosis (2012) Ann. Neurol., 72, pp. 918-926; Chau, C.H., Shum, D.K.Y., Li, H., Pei, J., Lui, Y.Y., Wirthlin, L., Chan, Y.S., Xu, X., Chondroitinase ABC enhances axonal regrowth through Schwann cell-seeded guidance channels after spinal cord injury (2003) FASEB J., 18, pp. 194-196; Chen, Z., Negra, M., LEvine, A., Ughrin, Y., Levine, J., Oligodendrocyte precursor cells: reactive cells that inhibit axon growth and regeneration (2002) J. Neurocytol., 6, p. 481; Clandinin, T.R., Lee, C.-H., Herman, T., Lee, R.C., Yang, A.Y., Ovasapyan, S., Zipursky, S.L., Drosophilia LAR Regulates R1-R6 and R7 target specificity in the visual system (2001) Neuron, 32, pp. 237-248; Coles, C.H., Shen, Y., Tenney, A.P., Siebold, C., Sutton, G.C., Lu, W., Gallagher, J.T., Aricescu, A.R., Proteoglycan-specific molecular switch for RPTPσ clustering and neuronal extension (2011) Science, 332; Conrad, S., Schluesener, H.J., Trautmann, K., Joannin, N., Meyermann, R., Schwab, J.M., Prolonged lesional expression of RhoA and RhoB following spinal cord injury (2005) J. Comp. Neurol., 487, pp. 166-175; CÔté, M.-P., Hanna, A., Houlé, J.D., Peripheral nerve grafts after cervical spinal cord injury in adult cats (2010) Exp. Neurol., 225, pp. 173-182; Cua, R.C., Lau, L.W., Keough, M.B., Midha, R., Apte, S.S., Yong, V.W., Overcoming neurite-inhibitory chondroitin sulfate proteoglhycans in the astrocyte matrix (2013) Glia, 61, pp. 972-984; Davies, J.E., Tang, X., Denning, J.W., Archibald, S.J., Davies, S.J.A., Decorine suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries (2004) Eur. J. Neurosci., 19, pp. 1226-1242; Deepa, S.S., Carulli, D., Rhodes, K., Fukuda, J., Mikami, T., Sugahara, K., Fawcett, J.W., Composition of perineuronal nets extracellular matrix in rat brain (2006) J. Biol. Chem., 281, pp. 17789-17800; Dergham, P., Ellezam, B., Essaglan, C., Essaglan, H., Lubell, H.D., McKerracher, L., Rho signaling pathway targeted to promote spinal cord repair (2002) J. Neurosci., 22, pp. 6570-6577; Dernych, R., Zhang, Y.E., Smad-dependent and Smad-independent pathways in TGF-b family signalling (2003) Nature, 425, pp. 577-584; Dickendesher, T.L., Mironova, K.T.B.Y.A., Koriyama, Y., Raiker, S.K., Askew, K.L., Wood, A., Geoffroy, C.G., Giger, R.J., NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans (2012) Nat. Neurosci., 15, pp. 703-712; Didangelos, A., Iberl, M., Vinsland, E., Bartus, K., Bradbury, E.J., Regulation of IL-10 by chondroitinase ABC promotes a distinct immune response following spinal cord injury (2014) J. Neurosci., 34, pp. 16424-16432; Dobbertin, A., Rhodes, K.E., Garwood, J., Properzi, F., Heck, N., Rogers, J.H., Fawcett, J.W., Faissner, A., Regulation of RPTPβ/phosphacan expression and glycosaminoglycan epitopes in injured brain and cytokine-treated glia (2003) Mol. Cell. Neurosci., 24, pp. 951-971; Dou, C.-L., Levine, J.M., (1994) Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan, 14 (12), pp. 7616-7628; Dubreuil, C.I., Winton, M.J., McKerracher, L., Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system (2003) J. Cell Biol., 162, pp. 233-243; Duffy, P., Schmandke, A., Schmandke, A., Sigworth, J., Narumiya, S., Cafferty, W.B.K., Strittmatter, S.M., Rho-associated kinase II (ROCKII) limits axonal growth after trauma with the adult mouse spinal cord (2009) J. Neurosci., 29, pp. 15266-15276; Dunah, A.W., Hueske, E., Wyszynski, M., Hoogenraad, C.C., Jaworski, J., Pak, D.T., Simonetta, A., Sheng, M., LAR receptor protein tyrosine phosphatases in the development and maintenance of excitatory synapses (2005) Nat. Neurosci., 8, pp. 458-467; Dyck, S., Alizadeh, A., Santhosh, T., Proulx, E., Wu, C.-L., Karimi-Abdolrezaee, S., Chondroitin sulfate proteoglycans negatively modulate spinal cord neural precursor cells by signaling through LAR and RPTPσ and modulation of the Rho/ROCK pathway (2015) Stem Cells; Ebert, S., Schoberl, T., alczak, Y., Stoecker, K., Stempfl, T., Moehle, C., Weber, B.H.F., Langmann, T., Chondroitin sulfate disaccharide stimulate microglia to adopt a novel regulatory phenotype (2008) J. Leukoc. Biol., 83, pp. 736-740; Eftekharpour, E., Karimi-Abdolrezaee, S., Wang, J., Beheiry, H.E., Morshead, C., Fehlings, M.G., Myelination of congenitally dysmyelinated spinal cord axons by adult neural precursor cells results in formation of nodes of ranview and improved axonal conduction (2007) J. Neurosci., 27, pp. 3416-3428; Ensslen-Craig, S.E., Brady-Kalnay, S.M., Receptor protein tyrosine phosphatases regulate neural development and axon guidance (2004) Dev. Biol., 275, pp. 12-22; Ethell, I.M., Ethell, D.W., Matrix metalloproteases in brain development and remodeling: synaptic functions and targets (2007) J. Neurosci. Res., 85, pp. 2813-2823; Faissner, A., Clement, A., Lochter, A., Streit, A., Mandl, C., Schachner, M., Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties (1994) J. Cell Biol., 126, pp. 785-799; Fancy, S.P.J., Baranzini, S.E., Zhao, C., Yuk, D.I., Irvine, K.A., Kaing, S., Sanai, N., Rowitch, D.K., Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS (2009) Genes Dev., 23, pp. 1571-1585; Faulkner, J.R., Herrmann, J.E., Woo, M.J., Tansey, K.E., Doan, N.B., Sofroniew, M.V., Reactive astrocytes protect tissue and preserve function after spinal cord injury (2004) J. Neurosci., 24, pp. 2143-2155; Fehlings, M., Vawda, R., Cellular treatments for spinal cord injury: the time is right for clinical trials (2011) Neurotherapeutics, 8, pp. 704-720; Fehlings, M.G., Theodore, N., Harrop, J., Maurais, G., Kuntz, C., Shaffrey, C.I., Kwon, B.K., McKerracher, L., A phase I/IIa clinical trial of recombinant Rho protein antagonist in acute spinal cord injury (2011) J. Neurotrauma, 28, pp. 787-796; Fisher, D., Xing, B., Dill, J., Li, H., Hoang, H.H., Zhao, Z., Yang, X.-L., Li, S., Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors (2011) J. Neurosci., 31, pp. 14051-14066; Fitch, M.T., Silver, J., CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure (2008) Exp. Neurol., 209, pp. 294-301; Fouad, K., Schnell, L., Bunge, M.B., Schwab, M.E., Liebscher, T., Pearse, D.D., Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locmotor recovery after completed transection of the spinal cord (2005) J. Neurosci., 25, pp. 1169-1178; Fouad, K., Pearse, D., Tetzlaff, W., Vavrek, R., Transplantation and repair: combined cell implantation and chondroitinase delivery prevent deterioration of bladder function in rats with complete spinal cord injury (2009) Spinal Cord, 47, pp. 727-732; Fournier, A.E., Takizawa, B.T., Strittmatter, S.M., Rho kinase inhibition enhances axonal regeneration in the injury CNS (2003) J. Neurosci., 24, pp. 1416-1423; Fox, A.N., Zinn, K., The hepran sulfate proteoglycan syndecan is an in vivo ligand for the drosophilia LAR receptor tyrosine phosphatase (2005) Curr. Biol., 15, pp. 1701-1711; Fry, E.J., Chagnon, M.J., López-Vales, R., Tremblay, M.L., David, S., Corticospinal tract regeneration after spinal cord injury in receptor protein tyrosine phosphatase sigma deficient mice (2010) Glia, 58, pp. 423-433; Galtrey, C.M., Fawcett, J.W., The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system (2007) Brain Res. Rev., 54, p. 1; Galtrey, C.M., Asher, R.A., Nothias, F., HAwcett, J.W., Promoting plasticity in the spinal cord with chondroitinase improves functional recovery after peripheral nerve damage (2007) Brain, 130, pp. 926-936; Gama, C., Tully, S., Sotogaku, N., Clark, P., Rawat, M., Vaidehi, N., Goddard, W., Hsieh-Wilson, L., Sulfation patterns of glycosaminoglycans endoce molecular recognition and activity (2006) Nat. Chem. Biol., 2, pp. 467-473; Garcia-Alias, G., Barkhuysen, S., Buckle, M., Fawcett, J.W., Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation (2009) Nat. Neurosci., 12, pp. 1145-1151; García-Alías, G., Petrosyan, H.A., Schnell, I., Horner, P.J., Bowers, W.J., Mendell, L.M., Fawcett, J.W., Arvanian, V.L., Chondroitinase ABC combined with neurotrophin NT-3 secrrtion and NR2D expression promotes axonal plasticity and functional recovery in rats with lateral hemisection of the spinal cord (2011) J. Neurosci., 21, pp. 17788-17799; Gauthier, M.-K., Kosciuczyk, K., Tapley, L., Karimi-Abdolrezaee, S., Dysregulation of the neuregulin-1-ErbB network modulates endogenous oligodendrocyte differentiation and preservation after spinal cord injury (2013) Eur. J. Neurosci., 38, pp. 2693-2715; Gilbert, R.J., McKeon, R.J., Darr, A., Calabro, A., Hascall, V.C., Bellamkonda, R.V., CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension (2005) Mol. Cell. Neurosci., 29, pp. 545-558; Gogolla, N., Caroni, P., Lthi, A., Herry, C., Perineuronal nets protect fear memories from erasure (2009) Science, 325, pp. 1258-1261; Goretzki, L., Burg, M.A., Grako, K.A., Stallcup, W.B., High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan (1999) J. Biol. Chem., 274, pp. 16831-16837; Grimpe, B., Silver, J., A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord (2004) J. Neurosci., 24, pp. 1393-1397; Gu, X., Dig, F., Yang, Y., Liu, J., Construction of tissue engineered nerve grafts and their application in peripheral nerve regeneration (2011) Prog. Neurobiol., 93, pp. 204-230; Guimaraes, A., Zaremba, S., Hockfield, S., Molecular and morpholigical changes in the cat lateral geniculate nucleus and visual cortex induced by visual deprivation are revealed by monoclonal antibodies Cat-204 and Cat-301 (1990) J. Neurosci., 10, pp. 3014-3024; Hamel, M.G., Ajmo, J.M., Leonardo, C.C., Zuo, F., Sandy, J.D., GOttschall, P.E., Multimodal signaling by the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin motifs) promotes neurite extension (2008) Exp. Neurol., 210, pp. 428-440; Hayashi, M., Miyata, S., Yamada, M., Kamei, K., Oohira, A., Neuronal expression of the chondroitin sulfate proteoglycan receptor-type protein-tyrosine phosphataseB and phosphacan (2006) Neuroscience, 131, pp. 331-348; He, X.L., Bazan, J.F., McDermott, G., Park, J.B., He, Z., Garcia, K.C., Structure of the nogo receptor ectoderm: A recognition module implicated in myelin inhibition (2003) Neuron, 38, pp. 177-186; Hensch, T., Critical period plasticity in local cortical circuits (2005) Nat. Rev. Neurosci., 27, pp. 877-888; Herrmann, J.E., Imura, T., Qi, B.J., Ao, Y., Nguyen, T.K., Korsak, R.A., Yakeda, K., Sofroniew, M.V., STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury (2008) J. Neurosci., 28, pp. 7231-7243; Hockfield, S., Kalb, R.G., Zaemba, S., Fryer, H., Expression of neural proteoglycans correlates with the aquisition of mature neuronal properties in the mammalian brain (1990) Cold Spring Harb. Symp. Quant. Biol., 55, pp. 505-514; Hofmeyer, K., Treisman, J.E., The receptor protein tyrosine phosphatase LAR promotes R7 photoreceptor axon targeting by a phosphatase-independent signaling mechanism (2009) PNAS, pp. 1-6; Holst, A., Sirko, S., Faissner, A., The unique 473HD-chondroitinsulfate epitope is expressed by radial glia and involved in neural precursor cell proliferation (2006) J. Neurosci., 26, pp. 4082-4094; Houle, J.D., Tom, V.J., Mayes, D., Phillips, G.W.N., Silver, J., Combining an autologous peripheral nervous system ""bridge"" and matrix modification by chondroitinase allows robust. Functional regeneration beyond a hemisection lesion of the adult Rat spinal cord (2006) J. Neurosci., 26, pp. 7405-7415; Hu, Z., Koprivica, V., The Nogo signaling pathway for regeneration block (2004) Annu. Rev. Neurosci., 27, pp. 341-368; Hunanyan, A.S., García-Alías, G., Alessi, V., Levine, J.M., Fawcett, J.W., Mendell, L.M., Arvanian, V.L., Role of chondroitin sulfate proteoglycans in axonal conduction in Mammalian spinal cord (2010) J. Neurosci., 30, p. 7761; Ida, M., Shuo, T., Hirano, K., Tokita, Y., Nakanishi, K., Matsui, F., Aono, S., Oohira, A., Identification and functions of chondroitin sulfate in the milieu of neural stem cells (2006) J. Biol. Chem., 281, pp. 5982-5991; Ikegami, T., Nakamura, M., Yamane, J., Katoh, H., Okada, S., Iwanami, A., Watanabe, K., Okano, H., Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury (2005) Eur. J. Neurosci., 22, pp. 3036-3046; Ishikawa, H., Nohara, Y., Miyauti, S., Action of chondroitinase ABC on epidurally transplanted nucleus pulposus in the rabbit (1999) Spine, 24, pp. 1071-1076; Jahan, N., Hannila, S.S., Transforming growth factor β-induced expression of chondroitin sulfate proteoglycans is mediated through non-Smad signaling pathways (2014) Exp. Neurol., 263, pp. 372-384; Jakeman, L.B., Hoschouer, E.L., Basso, D.M., Injured mice at the gym: Review, results and considerations for combining chondroitinase and locomotor exercise to enhance recovery after spinal cord injury (2011) Brain Res. Bull., 84, pp. 317-326; John, N., Krugel, H., Rischknecht, R., Smalla, K.H., Schultz, C., Kreutz, M.R., Gundelfinger, E.D., Seidenbecher, C.I., Brevican-containing perineuronal nets of extracellular matrix in dissociated hippocampal primary cultures (2006) Mol. Cell. Neurosci., 31, pp. 774-784; Johns, L.D., Babcock, G., Green, D., Freedman, M., Sriram, S., Ransohoff, R.M., Transforming growth factor-β1 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures (1992) Brain Res., 585, pp. 229-236; Jones, L.L., Yamaguchi, Y., Stallcup, W.B., Tuszynski, M.H., NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors (2002) J. Neurosci., 22, pp. 2792-2803; Jones, L.L., Margolis, R.U., Tuszynski, M.H., The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury (2003) Exp. Neurol., 182, pp. 399-411; Kaczmarek, L., Lapinska-Dzwonek, J., Szymczak, S., Matrix metalloprotease in the adult brain physiology: a link between C-Fox, AP-1 and remodeling of neuronal connections? (2002) EMBO J., 21, pp. 6643-6648; Karimi-Abdolrezaee, S., Billakanti, R., Reactive Astrogliosis after Spinal Cord Injury-Beneficial and Detrimental Effects (2012) Mol. Neurobiol., 46, pp. 251-264; Karimi-Abdolrezaee, S., Eftekharpour, E., Stem cells and spinal cord repair (2012) Adv. Exp. Med. Biol., 760, pp. 53-73; Karimi-Abdolrezaee, S., Eftekharpour, E., Wang, J., Morshead, C.M., Fehlings, M.G., Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury (2006) J. Neurosci., 26, pp. 3377-3389; Karimi-Abdolrezaee, S., Eftekharpour, E., Wang, J., Schut, D., Fehlings, M.G., Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord (2010) J. Neurosci., 30, pp. 1657-1676; Karimi-Abdolrezaee, S., Schut, D., Wang, J., Fehlings, M.G., Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury (2012) PLoS One, 7, pp. 1-16; Kaufmann, N., DeProto, J., Ranjan, R., Wan, H., Vactor, D.V., Drosophilia liprin-alpha and the receptor phosphatase Dlar control synapse morphogenesis (2002) Neuron, 34, pp. 27-38; Kawashima, H., Hirose, M., Hirose, J., NAgakubo, D., Plaas, A.H., Mlyasaka, M., Binding of a large chondroitin sulfate/dermantan sulfate proteoglycan versican, to L-selectin, P-selectin, and CD44 (2000) J. Biol. Chem., 275, pp. 35448-35456; Kazanis, I., Lathia, J.D., Vadakkan, T.J., Raborn, E., Wan, R., Rughal, M., Eckley, D.M., ffrench-Constant, C., Quiescence and activation of stem and precursor cell populations in the subependymal zone of the mammalian brain are associated with distinct cellular and extracellular matrix signals (2010) J. Neurosci., 30, pp. 9771-9781; Keirstead, H.S., Nistor, G., Bernal, G., Totoiu, M., Coutier, F., Sharp, K., Steward, O., Human embryonic stem cell-derived oligodendrocyte progenitor cell transplant remyelinate and restore locomotion after spinal cord injury (2005) J. Neurosci., 25, pp. 4694-4705; Ketschek, A.R., Haas, C., Gallo, G., Fischer, I., The roles of neuronal and glial precursors in overcoming chondroitin sulfate proteoglycan inhibition (2012) Exp. Neurol., 235, pp. 627-637; Kim, S., Takahashi, H., Lin, W.W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J.I., Karin, M., Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis (2009) Nature, 457, pp. 102-106; Kolkman, M.J., Streijger, F., Linkels, M., Boemen, M., Heeren, D.J., Hendriks, W.J., Zee, C., Mice lacking leukocyte common antigen related (LAR) protein tyrosine phosphatase domains demonstrate spatial learning impairment in the two-trial water maze and hyperactivity in multiple behavioural tests (2004) Behav. Brain Res., 154, pp. 171-182; Koprivica, V., Cho, K.-S., Park, H.B., Yiu, C., Atwal, J., Gore, B., Kim, J.A., He, Z., EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans (2005) Science, 310, pp. 106-110; Krueger, N., The transmembrane tyrosine phosphatase DLAR controls motor axon guidance in Drosophilia (1996) Cell, 84, pp. 611-622; Kuboyama, S., Fujikawa, A., Masumura, M., Suzuki, R., Matsumoto, M., Noda, M., Protein tyrosine phosphatase receptor type z negatively regulated oligodendrocyte differentiation and myelination (2012) PLoS One, p. e48797; Kuboyama, T., Luo, X., Park, K., Blackmore, M.G., Tojima, T., Tohda, C., Bixby, J.L., Kamiguchi, H., Paxillin phophorylation counteracts proteoglycan-mediated inhibition of axon regeneration (2013) Exp. Neurol., 248, pp. 157-169; Kucharova, K., Stallcup, W.B., The NG2 proteoglycan promotes oligodendrocyte progenitor proliferation and developmental myelination (2010) Neuroscience, 166, pp. 192-201; Kucharova, K., Chang, Y., Boor, A., Yong, V.W., Stallcup, W.B., Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord (2011) J. Neuroinflammation, 8; Kuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., Bruck, W., Differentiation block of oligodendroglial progenitor cells as a cause fo remyelination failure in chronic multiple sclerosis (2008) Brain, 131, pp. 1749-1758; Kurazono, S., Okamoto, M., Sakuyama, J., Mori, S., Nakata, Y., Fukuoka, J., Amano, S., Matsui, H., Expression of brain specific chondroitin sulfate proteoglycans, neurocan and phosphacan, in the developing and adult hippocampus of Ihara's epileptic rats (2001) Brain Res., 898, pp. 36-48; Kurimoto, T., Yin, Y., Omura, K., Gilbert, H.Y., Kim, D., Cen, L.P., Moko, L., Benowitz, L.I., Long-distance axon regeneration in the mature optic nerve: contributions of oncomodulin, cAMP, and pten gene deletion (2010) J. Neurosci., 30, pp. 15654-15663; Lander, T., Carulli, D., Maleski, M., Hockfield, S., A family of activity-dependent neuronal cell-surface chondroitin sulfate proteoglycans in cat visual cortex (1997) J. Neurosci., 17, pp. 1928-1939; Lang, B., Cregg, J., DePaul, M., Tran, A., Xu, K., Dyck, S., Madalena, K., Silver, J., Modulation of the proteoglycan receptor PTPσ promotes recovery after spinal cord injury (2015) Nature, 518, pp. 404-408; Larsen, P.H., Wells, J.E., Stallcup, W.B., Opdenakker, G., Yong, V.W., Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan (2003) J. Neurosci., 23, pp. 11127-11135; Lau, L.W., Keough, M.B., Haylock-Jacobs, S., Cua, R., Doring, A., Sloka, S., Stirling, D.P., Yong, V.W., Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination (2012) Ann. Neurol., 72, pp. 419-432; Lau, L.W., Cua, R., Keough, M.B., Haylock-Jacobs, S., Yong, V.W., Pathophysiology of the brain extracellular matrix: a new target for remyelination (2013) Nat. Rev., 14, pp. 722-728; Lee, S.J., Kalinski, A.L., Twiss, J.L., Awakening the stalled axon - Surprises in CSPG gradients (2014) Exp. Neurol., 254, pp. 12-17; Lemarchant, S., Pruvost, M., Hebert, M., Gauberti, M., Hommet, Y., Briens, A., Maubert, E., Vivien, D., TPA promotes ADAMTS-4-induced CSPG degradation, thereby enhancing neuroplasticity following spinal cord injury (2014) Neurobiol. Dis., 66, pp. 28-42; Lemons, M.L., Condic, M.L., Integrin signaling is integral to regeneration (2008) Exp. Neurol., 2009, pp. 343-352; Lemons, M.L., Howland, D.R., Anderson, D.K., Chondroitin Sulfate Proteoglycan Immunoreactivity Increases Following Spinal Cord Injury and Transplantation (1999) Exp. Neurol., 160, pp. 51-65; Levine, J.M., Nishiyama, A., The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells (1996) Perspect. Dev. Neurobiol., 3, pp. 245-259; Li, Z., Tang, R., Zhang, J., Tang, Z., Qu, W., Zhu, W., Li, J., Wang, W., Inhibiting epidermal growth factor receptor attentuated reactive astrogliosis and improves functional outcome after spinal cord injury in rats (2011) Neurochem. Int., 58, pp. 812-819; Lin, R., Rosahl, T.W., Whiting, P.J., Fawcett, J.W., 6-sulphated chondroitins have a positive influence on axonal regeneration (2011) PLoS One, 6, p. e21499; Lord-Fontaine, S., Yang, F., Diep, Q., Dergham, P., Munzer, S., Tremblay, P., McKerracher, L., Local inhibition of Rho signaling by cell-permeable recombinant protein Ba-210 prevents secondary damage and promotes functional recovery following acute spinal cord injury (2008) J. Neurotrauma, 25, pp. 1309-1322; Maeda, N., Structural variation of chondroitin sulfate and its role in the central nervous system (2010) Cent. Nerv. Syst. Agents Med. Chem., 10, pp. 22-31; Maekawa, M., Ishizaki, T., Boku, S., Watanabe, N., Fujita, A., Iwamatsu, A., Obinata, T., Narumiya, S., Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase (1999) Science, 285, pp. 895-898; Makaglansar, I.T., Williams, S., Mustelin, T., Stallcup, W.B., Differential phosphorylation of NG2 proteoglycan by ERK and PKCalpha helps balance cell proliferation and migration (2008) J. Cell Biol., 178, pp. 155-165; Maolood, N., Hardin-Pouzet, H., Grange-Messent, V., Matrix metalloproteinases MMP2 and MMP9 are upregulated by noradrenaline in the mouse neuroendocrine hypothalamus (2008) Eur. J. Neurosci., 27, pp. 1143-1152; Martin, S., Levine, A.K., Chen, Z.J., Ughrin, Y., Levine, J.M., Deposition of the NG2 proteoglycan at nodes of ranvier in the peripheral nervous system (2001) J. Neurosci., 21, pp. 8119-8125; Massey, J.M., Hubscher, C.H., Wagoner, M.R., Decker, J.A., Amps, J., Silver, J., Onifer, S.M., Chondroitinase ABC digestion of the perineuronal Net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury (2006) J. Neurosci., 26, pp. 4406-4414; Massey, J.M., Amps, J., Viapiano, M.S., Matthews, R.T., Wagoner, M.R., Whitaker, C.M., Alilain, W., Onifer, S.M., Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3 (2008) Exp. Neurol., 209, pp. 426-445; Mataga, N., Nagai, N., Hensch, T.K., Permissive proteolytic activity for visual cortical plasticity (2002) Proc. Natl. Acad. Sci., 99, pp. 771-7721; Mataga, N., Muzughuchi, Y., Hensch, T.K., Experience-dependent pruning of dendritic spines in visual cortex by tissue plasminogen activator (2004) Neuron, 44, pp. 1031-1041; Matsui, F., Kawashima, S., Shuo, T., Yamauchi, S., Tokita, Y., Aono, S., Keino, H., Oohira, A., Transient expression of juvenile-type neurocan by reactive astrocytes in adult rat brains injured by kainate-induced seizures as well as surgical incision (2002) Neuroscience, 112, pp. 773-781; Matthews, R.T., Kelly, G.M., Zerillo, C.A., Grey, G., Tiemeyer, M., Hockfield, S., Aggrecan glycoforms contribute to the molecular heterogeneity of perineuronal nets (2002) J. Neurosci., 22, pp. 7536-7547; Maurel, P., Rauch, U., Flad, M., Margolis, R.L., Margolis, R.U., Phosphacan, a chondroitin sulfate proteoglycan of brain that interacts with neurons and neural cell-adhesion molecules, is an extracellular varient of a receptor-type protein tyrosine phosphatase (1994) PNAS, 91, pp. 2512-2516; McClain, C.R., Sim, F.J., Goldman, S.A., Pleiotrophin suppression of receptor protein tyrosine phosphatase-β/ζ maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells (2012) J. Neurosci., 32, pp. 15066-15075; McKeon, R.J., Hoke, A., SIlver, J., Injury-induced proteoglycans inhibit the potential for laminin-meditated axon growth on astrocytic scars (1995) Exp. Neurol., 126, pp. 32-43; McKeon, R.J., Schreiber, R.C., Rudge, J.S., Silver, J., Reduction of Neurite Outgrowth in a Model of Glial Scarring following CNS Injury Is Correlated with the Expression of Inhibitory Molecules on Reactive Astrocytes (1991) J. Neurosci., 11, pp. 3396-3411; McLean, J., Batt, J., Doering, L.C., Rotin, D., Bain, J.R., Enhanced rate of nerve regeneration and directional errors after sciatic nerve injury in receptor protein tyrosine phosphatase σ knock-Out mice (2002) J. Neurosci., 22, pp. 5481-5491; Meletis, K., Barnabé-Heider, F., Carlén, M., Evergren, E., Tomilin, N., Shupliakov, O., Frisén, J., Spinal cord injury reveals multilineage differentiation of ependymal cells (2008) PLoS Biol., 6; Miyata, S., Komatsu, Y., Yoshimura, Y., Taya, C., Kitagawa, H., Persistent cortical plasticity by upregulation of chondroitin 6-sulfation (2012) Nat. Neurosci., 15, pp. 414-424; Monnier, P.P., Sierra, A., Schwab, J.M., Henke-Fahle, S., Mueller, B.K., The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar (2003) Mol. Cell. Neurosci., 22, pp. 319-330; Monsul, N.T., Geisendorfer, A.R., Han, P.J., Banik, R., Pease, M.E., Skolasky, R.L., Hoffman, P.N., Intraocular injection of dibutyryl cyclic AMP promotes axon regeneration in rat optic nerve (2004) Exp. Neurol., 186, pp. 124-133; Moon, L.D., Asher, R.A., Rhodes, K.E., Fawcett, J.W., Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC (2001) Nat. Neurosci., 4, pp. 465-466; Morawski, M., Bruckner, G., Arendt, T., Matthews, R.T., Aggrecan: Beyond cartilage and into the brain (2012) Int. J. Biochem. Cell Biol., 44, pp. 690-693; Morita, S., Oohira, A., Miyata, S., Activity-dependent remodeling of chondroitin sulfate proteoglycans extracellular matrix in the hypothalamo-neurophyophysial system (2010) Neuroscience, 166, pp. 1068-1082; Morshead, C., Reynolds, B., Fraig, C., McBurney, M., Staines, W., Morassutti, D., Weiss, S., Kooy, D., Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells (1994) Neuron, 13, pp. 1071-1082; Mothe, A.J., Tator, C.H., Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat (2005) Neuroscience, 131, p. 177; Mountney, A., Zahner, M.R., Sturgill, E.R., Riley, C.J., Aston, J.W., Oudega, M., Schramm, L.P., Schnaar, R.L., Sialidase, chondroitinase ABC, and combination therapy after spinal cord contusion injury (2013) J. Neurotrauma, 30, pp. 181-190; Murphy, K.J., Merry, C.L., Lyon, M., Thompson, J.E., Roberts, I.S., Gallagher, J.T., A new model for the domain structure of heperan sulfate based on the novel specifity of K5 lyase (2004) J. Biol. Chem., 279, pp. 27239-27245; Nashmi, R., Fehlings, M.G., Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels (2001) Brain Res. Brain Res. Rev., 38, pp. 165-191; Nashmi, R., Jones, O.T., Fehlings, M.G., Abnormal axonal physiology is associated with altered expression and distribution of Kv1.1 and Kv1.2K+ channels after chronic spinal cord injury (2000) Eur. J. Neurosci., 12, pp. 491-506; Niederöst, B., Oertle, T., Fritsche, J., McKinney, R.A., Bandtlow, C.E., Nogo-a and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1 (2002) J. Neurosci., 22, pp. 10368-10378; Okada, S., Nakamura, M., Katoh, H., Miyao, T., Shimazaki, Y., Ishii, K., Yamane, J., Okano, H., Conditional ablation of Stat3 or Socs3 discloses a dual role of reactive astrocytes after spinal cord injury (2006) Nat. Med., 12, pp. 829-834; Oohira, A., Shuo, T., Tokita, Y., Nakanishi, K., Aono, S., Neuroglycan C, a brain-specific part-time proteoglycan, with a particular multdomain structure (2004) Glycoconj. J., 21, pp. 53-57; Oray, S., Majewska, A., Sur, M., Dendritic spine dynamics are regulated by monocular deprivation and extracellular matrix degradation (2004) Neuron, 44, pp. 1021-1030; Orlando, C., Ster, J., Gerber, U., Fawcett, J.W., Raineteau, O., Perisynaptic chondroitin sulfate proteoglycans restrict structural plasticity in an integrin-dependent manner (2012) J. Neurosci., 32, pp. 18009-18017; Pendleton, J.C., Shamblott, M.J., Gary, D.S., Belegu, V., Hurtado, A., Malone, M.L., McDonald, J.W., Chondroitin Sulfate Proteoglycans Inhibit Oligodendrocyte Myelination through PTPσ (2013) Exp. Neurol., 247, pp. 113-121; Petrosyan, H.A., Hunanyan, A.S., Alessi, V., Schnell, L., Levine, J., Arvanian, V.I., Neutralization of inhibitory molecule NG2 improves synaptic transmission, retrograde transport, and locomotor function after spinal cord injury in adult rats (2013) J. Neurosci., 33, pp. 4032-4043; Pindzola, R.R., Doller, C., Silver, J., Putative Inhibitory Extracellular Matrix Molecules at the Dorsal Root Entry Zone of the Spinal Cord during Development and after Root and Sciatic Nerve Lesions (1993) Dev. Biol., 156, pp. 34-48; Pizzorusso, T., Erasing fear memories (2009) Science, 325, pp. 1214-1215; Pizzorusso, T., Medini, P., Berardi, N., Chierzi, S., Fawcett, J.W., Maffei, L., Reactivation of ocular dominance plasticity in the adult visual cortex (2002) Science, 298, pp. 1248-1251; Pizzorusso, T., Medini, P., Landi, S., Baldini, S., Berardi, N., Maffei, L., Structural and functional recovery from early monocular deprivation in adult rats (2006) Proc. Natl. Acad. Sci., 103, pp. 8517-8522; Plemel, J.R., Keough, M.B., Duncan, G.J., Sparling, J.S., Yong, V.W., Stys, P.K., Tetzlaff, W., Remyelination after spinal cord injury: Is it a target for repair? (2014) Prog. Neurobiol., 117, pp. 54-72; Pohl, H.B.F., Porcheri, C., Mueggler, T., Bachmann, L.C., Martino, G., Rithmacher, D., Franklin, R.J.M., Suter, U., Genetically induced adult oligodendrocyte cell death is associate with poor myelin clearance, reduced remyelination, and axonal damage (2011) J. Neurosci., 31, pp. 1069-1080; Popp, S., Maurel, P., Andersen, J.S., Margolis, R.U., Developmental changes of aggrecan, versican and neurocan in the retina and optic nerve (2004) Exp. Eye Res., 79, pp. 351-356; Properzi, F., Carulli, D., Asher, R.A., Muir, E., Camargo, L.M., Huppevelt, T., Dam, G., Fawcett, J.W., Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia (2005) Eur. J. Neurosci., 2, pp. 378-390; Rabchevsky, A.G., Weinitz, J.M., Coulpier, M., Fages, C., Tinel, M., Junier, M.P., A role for transforming growth factor alpha as an inducer of astrogliosis (1998) J. Neurosci., 18, pp. 10541-10552; Ramer, L.M., Borisoff, J.F., Ramer, M.S., Rho-kinase inhibition enhances axonal plasticity and attenuates cold hyperalgesia after drosal rhizotomy (2004) J. Neurosci., 24, pp. 10796-10805; Rauch, U., Gao, P., Janetzko, A., Flaccus, A., Hilgenberg, L., Tekotte, H., Margolis, R.K., Margolis, R.U., Isolation and characterization of developmentally regulated chondroitin sulfate and chondroitin-keratan sulfate proteoglycans of brain identified with monoclonal antibodies (1991) J. Biol. Chem., 266, pp. 14785-14801; Reynolds, B., Weiss, S., Generation of neurons and astrocyte from isolated cells of the adult mammalian central nervous system (1992) Science, 255, pp. 1001-1020; Rhodes, K.E., Fawcett, J.W., Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS? (2004) J. Anat., 204, pp. 33-48; Rideta, J.L., Privata, A., Malhotrab, S.K., Gagec, F.H., Reactive astrocytes: cellular and molecular cues to biological function (1997) Trends Neurosci., 20, pp. 570-577; Rolls, A., Avidan, H., Cahalon, L., Schori, H., Bakalash, S., Litvak, V., Lev, S., Schwartz, M., A disaccharide-derived from chondroitin sulfate proteoglycan promotes central nervous system repair (2004) Eur. J. Neurosci., 20, pp. 1973-1983; Rolls, A., Cahalon, L., Bakalash, S., Avidan, H., Lider, O., Schwartz, M., A sulfated disaccharide derived from chondroitn sulfate proteoglycan protects agast inflammation-associated neurodegeneration (2006) FASEB J., 20; Rolls, A., Shechter, R., London, A., Segev, Y., Jacob-Hirsch, J., Amariglio, N., Rechavi, G., Schwartz, M., Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activate (2008) PLoS Med., 5, pp. 1262-1277; Ruff, C.A., Wilcox, J.T., Fehlings, M.G., Cell-based transplantation strategies to promote plasticity following spinal cord injury (2012) Exp. Neurol., 235, pp. 78-80; Sapeiha, P.S., Duplan, L., Ietani, N., Joly, S., Tremplay, M.I., Kennedy, T.E., Polo, A.D., Receptor protein tyrosine phosphatase sigma inhibits axon regrowth in the adult injured CNS (2005) Mol. Cell. Neurosci., 28, pp. 353-359; Schachtrup, C., Ryu, J.K., Helmrick, M., Vagena, E., Galanakis, D.K., Degen, J.L., Margolis, R.U., Akassoglou, K., Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-B after vascular damage (2010) J. Neurosci., 30, pp. 5843-5854; Schiller, M., Javelaud, J., Mauviel, A., TGF-b-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing (2004) J. Dermatol. Sci., 35, pp. 83-92; Schmalfeldt, M., Bandtlow, C.E., Dours-Zimmermann, M.T., Winterhalter, K.H., Zimmerman, D.R., Brain derived versican V2 is a potent inhibitor of axonal growth (2000) J. Cell Sci., 113, pp. 807-816; See, J., Bonner, J., Neuhuber, B., Fischer, I., Neurite outgrowth of neural progenitors in presence of inhibitory proteoglycans (2010) J. Neurotrauma, 27, pp. 951-957; Seidenbecher, C.I., Richter, K., Rauch, U., Fassler, R., Garner, C.C., Gundelfinger, E.D., Brevican, a chondroitin sulfate proteoglycan of rat brain, occurs as secreted and cell curface glycosylphosphatidylinositol-anchored isoforms (1995) J. Biol. Chem., 270, pp. 27206-27212; Seidenbecher, C.I., Gundelfinger, E.D., Bockers, T.M., Trotter, J., Kreutz, M.R., Transcripts for secreted and GPI-anchored brevican are differentially distrubuted in rat brain (1998) Eur. J. Neurosci., 10, pp. 1621-1630; Shen, Y., Tenney, A.P., Busch, S.A., Horn, K.P., Cuascut, F.X., Liu, K., He, Z., Flanagan, J.G., PTPσ is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration (2009) Science, 326, pp. 592-596; Sherman, L.S., Back, S.A., A 'GAG' reflex prevents repair of the damaged CNS (2008) Trends Neurosci., 31; Shimbo, M., Ando, S., Sigiura, N., Kimata, K., Ichijo, H., Moderate repulsive effectsof E-unit-containing chondroitin sulfate (CSE) on behavior of retinal growth cones (2013) Brain Res., 1491, pp. 34-43; Siebert, J.R., Stelzner, D.J., Osterhout, D.J., Chondroitinase treatment following spinal contusion injury increases migration of oligodendrocyte progenitor cells (2011) Exp. Neurol., 231, pp. 19-29; Silbert, J.E., Sugumaran, G., Biosynthesis of chondroitin/dermatan sulfate (2002) IUBMB Life, 54, pp. 177-186; Sim, F.J., Lang, J.K., Waldau, B., Roy, N.S., Schwartz, T.E., Pilcher, W.H., Chandross, K.J., Goldman, S.A., Complementary patterns of gene expression by adult human oligodendrocyte progenitor cells and their white matter environment (2006) Ann. Neurol., 59, pp. 763-779; Sirko, S., Holst, A., Wizenmann, A., Götz, M., Faissner, A., Chondroitin sulfate glycosaminoglycans control proliferation, radial glia cell differentiation and neurogenesis in neural stem/progenitor cells (2007) Development, 134, p. 2727; Snow, D.M., Lemmon, V., Carrino, D.A., Caplan, A.I., Silver, J., Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro (1990) Exp. Neurol, 109, pp. 111-130; Snow, D.M., Steindler, D.A., Silver, J., Molecular and cellular characterization of the glial roof plate of the spinal cord and optic tectum: a possible role for a proteoglycan in the development of an axon barrier (1990) Dev. Biol, 156, pp. 359-376; Sobel, R.A., Ahmed, A.S., White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple schlerosis (2001) J. Neuropathol. Exp. Neurol., 60, pp. 1198-1207; Sofroniew, M.V., Molecular dissection of reactive astrogliosis and glial scar formation (2009) Trends Neurosci., 32, pp. 638-647; Stanton, H., Golub, S.B., Rogerson, F.M., Little, K.L.C.B., Fosang, A.J., Investigatin ADAMTS-mediated aggrecanolysis in mouse cartilage (2011) Nat. Protoc., 6, pp. 388-404; Sung, J.-K., Miao, L., Calvert, J.W., Huang, L., Harkey, H.L., Zhang, J.H., A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat (2003) Brain Res., 959, pp. 29-38; Susarla, B.T., Laing, E.D., Yu, P., Katagiri, Y., Geller, H.M., Symes, A.J., Smad proteins differentially regulate transforming growth factor-B-mediated induction of chondroitin sulfate proteoglycans (2011) J. Neurochem., 119, pp. 868-878; Takahashi, H., Arstikaitis, P., Prasad, T., Bartlett, T.E., Wang, Y.T., Murphy, T.H., Craif, A.M., Postsynaptic TrkC and presynaptic PTPσ function as a bidirectional excitatory synaptic organizing complex (2011) Neuron, 69, pp. 287-303; Tan, A.M., Colletti, M., Rorai, A.T., Skene, J.H.P., Levine, J.M., Antibodies against the NG2 proteoglycan promote the regeneration of sensory axons within the dorsal columns of the spinal cord (2006) J. Neurosci., 26, pp. 4729-4739; Tan, C.L., Kwok, J.C.F., Patani, R., ffrench-Constant, C., Chandran, S., Fawcett, J.W., Integrin activation promotes axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling (2011) J. Neurosci., 33, pp. 6289-6295; Tauchi, R., Imagama, S., Natori, T., Ohgomori, T., Muramoto, A., Shinjo, R., Matsuyama, Y., Kadomatsu, K., The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury (2012) J. Neuroinflammation, 9; Tester, N.J., Howland, D.R., Chondroitinase ABC improves basic and skilled locomotion in spinal cord injured cats (2008) Exp. Neurol., 209, pp. 483-496; Tetzlaff, W., Okon, E., Karimi-Abdolrezaee, S., Hill, S., Sparling, J.S., Plemel, J.R., Plunet, W., Kwon, K.W., A systematic review of cellular transplantation therapies for spinal cord injury (2011) J. Neurotrauma, 28, pp. 1611-1682; Thompson, K.M., Uetani, N., Manitt, C., Elchebly, M., Trembley, M.I., Kennedy, T.E., Receptor protein tyrosine phosphatase sigma inhibits axonal regeneration and the rate of axon extension (2003) Mol. Cell. Neurosci., 24, pp. 681-692; Tom, T., Houle, J., Intraspinal microinjection of chondroitinase ABC following injury promotes axonal regeneration out of a peripheral nerve graft bridge (2008) Exp. Neurol., 211, pp. 315-319; Tom, V., Kadakia, R., Santi, L., Houle, J., Administration of chondroitinase ABC rostral or caudal to a spinal cord injury site promotes anatomical but not functional plasticity (2009) J. Neurotrauma, 26, pp. 2323-2333; Tom, V.J., Sandrow-Feinberg, H.R., Miller, K., Santi, L., Connors, T., Lemay, M.A., Houle, J.D., Combining peripheral nerve grafts and chondroitinase promotes functional axonal regeneration in the chronically injured spinal cord (2009) J. Neurosci., 29, pp. 14881-14890; Tortorella, M., Pratta, M., Liu, R.-Q., Abbaszade, I., Ross, H., Burn, T., Arner, E., The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage (2000) J. Biol. Chem., 275, pp. 25791-25797; Tortorella, M.D., Malfait, A.M., Deccico, C., Arner, E., The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-5) in a model of carilage degradation (2001) Osteoarthr. Cartil., 9, pp. 539-552; Tsujikawa, K., Ichijo, T., Moriyama, K., Tadotsu, N., Sakamoto, K., Sakane, N., Fukada, S., Yamamoto, H., Regulation of Lek and Fyn tyrosine kinase activities by transmembrane protein tyrosine photphatase leukocyte common antigen-related molecule (2002) Mol. Cancer Res., 1, pp. 155-163; Ughrin, Y.M., Chen, Z.J., Levine, J.M., Multiple regions of the NG2 proteoglycan inhibit neurite growth and induce growth cone collapse (2003) J. Neurosci., 23, pp. 175-186; Vorobyov, V., Kwok, J.C.F., Fawcett, J.W., Sengpiel, F., Effects of digesting chondroitin sulfate proteoglycans on plasticity in Cat primary visual cortex (2013) J. Neurosci., 33, pp. 234-243; Walker, B.A., Ji, S.-J., Jaffrey, S.R., Intra-axonal translation of RhoA promotes axon growth inhibition by CSPG (2012) J. Neurosci., 32, pp. 14442-14447; Wang, Y., Moges, H., Bharucha, Y., Symes, A., Smad3 null mice display more rapid wound closure and reduced scar formation after a stab wound to the cerebral cortex (2006) Exp. Neurol., 203, pp. 168-184; Wang, H., Katagiri, Y., McCann, T.E., Unsworth, E., Goldsmith, P., Yu, Z.-X., Tan, F., Geller, H.M., Chondroitin-4-sulfation negatively regulates axonal guidance and growth (2008) J. Cell Sci., 121, pp. 3083-3091; Wang, D., Ichiyama, R.M., Zhao, R., Andrews, M.R., Fawcett, J.W., Chondroitinase combined with rehabilitation promotes recovery of forelimb function in rats with chronic spinal cord injury (2011) J. Neurosci., 31, pp. 9332-9344; Wang, Y., Cheng, X., He, Q., Zheng, Y., Kim, D.H., Whittemore, S.R., Cao, Q.L., Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins (2011) J. Neurosci., 31, pp. 6053-6058; Weiss, S., Dunne, C., Hewson, J., Wohl, C., Wheatly, M., Peterson, A.C., Reynolds, B.A., Multipotent CNS stem cells Are present in the adult mammalian spinal cord and ventricular neuroaxis (1996) J. Neurosci., 16, pp. 7599-7609; Wight, T.N., Kang, I., Merrilees, M.J., Versican and the control of inflammation (2014) Matrix. Biol., 35, pp. 152-161; Woo, J., Kwon, S.K., Choi, S., Kim, S., Lee, J.R., Dunah, A.W., Sheng, M., Kim, E., Transsynaptic adhesion between NGL-3 and LAR regulates the formation of excitatory synapses (2009) Nat. Neurosci., 12, pp. 428-437; Wu, Y.J., Pierre, D.P.L., Wu, J., Yee, A.J., Yang, B.B., The interaction of versican with its binding partners (2005) Cell Res., 15, pp. 483-494; Xie, Y., Yeo, T.T., Zhang, C., Yang, T., Tisi, M.T., Massa, S.M., Longo, F.M., The leukocyte common antigen-related protein tyrosine phosphatase receptor regulates regenerative neurite outgrowth in vivo (2001) J. Neurosci., 21, pp. 5130-5138; Xie, Y., Massa, S.M., Ensslen-Craig, S.E., Major, D.L., Yang, T., Tisi, M.A., Derevyanny, V.D., Longo, F.M., Protein-tyrosine phosphatase (PTP) wedge domain peptides: a novel approach for inhibition of PTP funciton and augmentation of protein-tyrosine kinase function (2006) J. Biol. Chem., 281, pp. 16482-16492; Xu, B., Park, D., Ohtake, Y., Li, H., Hayat, U., Liu, J., Selzer, M.E., Li, S., Role of CSPG receptor LAR phosphatase in restricting axon regeneration after CNS injury (2015) Neurobiol. Dis., 73, pp. 36-48; Yamada, H., Watanabe, K., Shimonaka, M., Yamaguchi, Y., Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family (1994) J. Biol. Chem., 269, pp. 10119-10126; Yamagata, M., Sanes, J.R., Versican in the developing brain: lamina-specific expression in interneuronal subsets and role in presynaptic maturation (2005) J. Neurosci., 25, pp. 8457-8467; Yamaguchi, Y., Lecticans: organizers of the brain extracellular matrix (2000) Cell. Mol. Life Sci., 57, pp. 276-289; Yang, T., Bernabeu, R., Xie, Y., Zhang, J.S., Massa, S.M., Rempel, H.C., Longo, R.M., Leukocyte antigen-related protein tyrosine phosphatase receptor: a small ectodomain isoform functions as a homophilic ligand and promotes neurite outgrowth (2003) J. Neurosci., 23, pp. 3353-3363; Yang, T., Yin, W., Derevyanny, V.D., Moore, L.A., Longo, F.M., Identification of an ectodomain within the LAR protein tyrosine phosphatase receptor that binds homophilically and activates signalling pathways promoting neurite outgrowth (2005) Eur. J. Neurosci., 22, pp. 2159-2170; Yepes, M., Lawrence, D.A., New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous sytem (2004) Exp. Biol. Med., 229, pp. 1295-1304; Yi, J.-H., Katagiri, Y., Yu, P., Lourie, J., Bangayan, N.J., Symes, A.J., Geller, H.M., Receptor protein tyrosine phosphatase σ binds to neurons in the adult mouse brain (2014) Exp. Neurol., 255, pp. 12-18; Yick, L., So, K., Cheung, P., Wu, W., Lithium chloride reinforces the regeneration-promoting effect of chondroitinase ABC on rubrospinal neurons after spinal cord injury (2007) J. Neurotrauma, 21, pp. 932-943; Yim, Y.S., Kwon, Y., Nam, J., Yoon, H.I., Lee, K., Kim, D.G., Kim, E., Ko, J., Slitrks control excitatory and inhibitory synapse formation with LAR receptor protein tyrosine phosphatases (2013) Proc. Natl. Acad. Sci. U. S. A., 110, pp. 4057-4062; Yiu, G., He, Z., Glial inhibition of CNS axon regeneration (2006) Nat. Rev. Neurosci., 7, pp. 617-627; Zee, C., Man, T.Y., Lieshout, E.M.V., Heigden, I., Bree, M.V., Hendriks, W.J.A.J., Delayed peripheral nerve regeneration and central nervous sytem collateral sprouting in leukocyte common antigen-related protein tyrosine phosphatase-deficient mice (2003) Eur. J. Neurosci., 17, pp. 991-1005; Zhang, J.S., Longo, F.M., LAR tyrosine phosphatase receptor: alternative splcing is preferential to the nervous system, coordinated with cell growth and generates novel isoforms containing extensive CAG repeats (1995) J. Cell Biol., 128, pp. 415-431; Zhang, G., Hu, J., Li, S., Huang, L., Selzer, M.E., Selective expression of CSPG receptors PTPσ and LAR selectively in poorly regenerating reticulospinal neurons of lamprey (2014) J. Comp. Neurol., 522, pp. 2209-2229; Zhou, F.Q., Walzer, M., Wu, Y.H., Zhou, J., Dedhar, S., Snider, W.D., Neurotrophins support regenerative axon assembly over CSPGs by an ECM-integrin-independent mechanism (2006) J. Cell Sci., 119, pp. 2787-2796; Zhou, H.-X., Li, X.-Y., Li, F.-Y., Liu, C., Liang, Z.-P., Liu, S., Zhang, B., Feng, S.-Q., Targeting RPTPσ with lentiviral shRNA promotes neurites outgrowth of cortical neurons and improves functional recovery in a rat spinal cord contusion model (2014) Brain Res., 1586, pp. 46-63; Zuo, J., Ferguson, T.A., Hernandez, Y.J., Steler-Stevenson, W.G., Muir, D., Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroint sulfate proteoglycan (1998) J Neurosci, 18, pp. 5203-5211",Review,Scopus,2-s2.0-84928673857
"Kazanis I., Feichtner M., Lange S., Rotheneichner P., Hainzl S., Oller M., Schallmoser K., Rohde E., Reitsamer H.A., Couillard-Despres S., Bauer H.-C., Franklin R.J.M., Aigner L., Rivera F.J.","Lesion-Induced Accumulation of Platelets Promotes Survival of Adult Neural Stem / Progenitor Cells",2015,"Experimental Neurology","269",,,"75","89",,,10.1016/j.expneurol.2015.03.018,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927600711&partnerID=40&md5=4bfb0f08d42f2ac80eadc25270d8a0ac","Wellcome Trust and MRC Cambridge Stem Cell Institute and Department of Veterinary Medicine, University of CambridgeCambridge, United Kingdom; Department of Biology, University of PatrasPatras, Greece; Institute of Molecular Regenerative Medicine, Paracelsus Medical University SalzburgSalzburg, Austria; Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University SalzburgSalzburg, Austria; Department of Blood Group Serology and Transfusion Medicine, Federal Hospital and Paracelsus Medical University Salzburg SalzburgSalzburg, Austria; Institute of Experimental Neuroregeneration, Paracelsus Medical University SalzburgSalzburg, Austria; Division of Molecular Dermatology and EB House Austria, Department of Dermatology, Paracelsus Medical University SalzburgSalzburg, Austria; Paracelsus Medical UniversitySalzburg, Austria; Institute of Tendon and Bone Regeneration, Paracelsus Medical University SalzburgSalzburg, Austria","Kazanis, I., Wellcome Trust and MRC Cambridge Stem Cell Institute and Department of Veterinary Medicine, University of CambridgeCambridge, United Kingdom, Department of Biology, University of PatrasPatras, Greece; Feichtner, M., Institute of Molecular Regenerative Medicine, Paracelsus Medical University SalzburgSalzburg, Austria, Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University SalzburgSalzburg, Austria, Department of Blood Group Serology and Transfusion Medicine, Federal Hospital and Paracelsus Medical University Salzburg SalzburgSalzburg, Austria; Lange, S., Institute of Molecular Regenerative Medicine, Paracelsus Medical University SalzburgSalzburg, Austria, Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University SalzburgSalzburg, Austria; Rotheneichner, P., Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University SalzburgSalzburg, Austria, Institute of Experimental Neuroregeneration, Paracelsus Medical University SalzburgSalzburg, Austria; Hainzl, S., Division of Molecular Dermatology and EB House Austria, Department of Dermatology, Paracelsus Medical University SalzburgSalzburg, Austria; Öller, M., Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University SalzburgSalzburg, Austria, Department of Blood Group Serology and Transfusion Medicine, Federal Hospital and Paracelsus Medical University Salzburg SalzburgSalzburg, Austria; Schallmoser, K., Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University SalzburgSalzburg, Austria, Department of Blood Group Serology and Transfusion Medicine, Federal Hospital and Paracelsus Medical University Salzburg SalzburgSalzburg, Austria; Rohde, E., Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University SalzburgSalzburg, Austria, Department of Blood Group Serology and Transfusion Medicine, Federal Hospital and Paracelsus Medical University Salzburg SalzburgSalzburg, Austria; Reitsamer, H.A., Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University SalzburgSalzburg, Austria, Paracelsus Medical UniversitySalzburg, Austria; Couillard-Despres, S., Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University SalzburgSalzburg, Austria, Institute of Experimental Neuroregeneration, Paracelsus Medical University SalzburgSalzburg, Austria; Bauer, H.-C., Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University SalzburgSalzburg, Austria, Institute of Tendon and Bone Regeneration, Paracelsus Medical University SalzburgSalzburg, Austria; Franklin, R.J.M., Wellcome Trust and MRC Cambridge Stem Cell Institute and Department of Veterinary Medicine, University of CambridgeCambridge, United Kingdom; Aigner, L., Institute of Molecular Regenerative Medicine, Paracelsus Medical University SalzburgSalzburg, Austria, Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University SalzburgSalzburg, Austria; Rivera, F.J., Wellcome Trust and MRC Cambridge Stem Cell Institute and Department of Veterinary Medicine, University of CambridgeCambridge, United Kingdom, Institute of Molecular Regenerative Medicine, Paracelsus Medical University SalzburgSalzburg, Austria, Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University SalzburgSalzburg, Austria","The presence of neural stem/progenitor cells (NSPCs) in specific areas of the central nervous system (CNS) supports tissue maintenance as well as regeneration. The subependymal zone (SEZ), located at the lateral ventricle's wall, represents a niche for NSPCs and in response to stroke or demyelination becomes activated with progenitors migrating towards the lesion and differentiating into neurons and glia. The mechanisms that underlie this phenomenon remain largely unknown. The vascular niche and in particular blood-derived elements such as platelets, has been shown to contribute to CNS regeneration in different pathological conditions. Indeed, intracerebroventricularly administrated platelet lysate (PL) stimulates angiogenesis, neurogenesis and neuroprotection in the damaged CNS. Here, we explored the presence of platelets in the activated SEZ after a focal demyelinating lesion in the corpus callosum of mice and we studied the effects of PL on proliferating SEZ-derived NSPCs in vitro. We showed that the lesion-induced increase in the size of the SEZ and in the number of proliferating SEZ-resident NSPCs correlates with the accumulation of platelets specifically along the activated SEZ vasculature. Expanding on this finding, we demonstrated that exposure of NSPCs to PL in vitro led to increased numbers of cells by enhanced cell survival and reduced apoptosis without differences in proliferation and in the differentiation potential of NSPCs. Finally, we demonstrate that the accumulation of platelets within the SEZ is spatially correlated with reduced numbers of apoptotic cells when compared to other periventricular areas. In conclusion, our results show that platelet-derived compounds specifically promote SEZ-derived NSPC survival and suggest that platelets might contribute to the enlargement of the pool of SEZ NSPCs that are available for CNS repair in response to injury. © 2015 Elsevier Inc.","Cell survival; CNS damage; Neural stem / progenitor cells; Platelets; Subependymal zone; Subventricular zone; Vascular niche","Aigner, L., Bogdahn, U., TGF-beta in neural stem cells and in tumors of the central nervous system (2008) Cell Tissue Res., 331, pp. 225-241; Alvarez-Buylla, A., Garcia-Verdugo, J.M., Neurogenesis in adult subventricular zone (2002) J. Neurosci., 22, pp. 629-634; Anitua, E., Zalduendo, M.M., Alkhraisat, M.H., Orive, G., Release kinetics of platelet-derived and plasma-derived growth factors from autologous plasma rich in growth factors (2013) Ann. Anat., 195, pp. 461-466; Brill, A., Dashevsky, O., Rivo, J., Gozal, Y., Varon, D., Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization (2005) Cardiovasc. Res., 67, pp. 30-38; Carleton, A., Petreanu, L.T., Lansford, R., Alvarez-Buylla, A., Lledo, P.-M., Becoming a new neuron in the adult olfactory bulb (2003) Nat. Neurosci., 6, pp. 507-518; Chen, B., Sun, H.H., Wang, H.G., Kong, H., Chen, F.M., Yu, Q., The effects of human platelet lysate on dental pulp stem cells derived from impacted human third molars (2012) Biomaterials, 33, pp. 5023-5035; Culver, J.C., Vadakkan, T.J., Dickinson, M.E., A specialized microvascular domain in the mouse neural stem cell niche (2013) PLoS One, 8, p. e53546; Delgado, A.C., Ferron, S.R., Vicente, D., Porlan, E., Perez-Villalba, A., Endothelial NT-3 delivered by vasculature and CSF promotes quiescence of subependymal neural stem cells through nitric oxide induction (2014) Neuron, 83, pp. 572-585; Deng, W., Aimone, J.B., Gage, F.H., New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? (2010) Nat. Rev. Neurosci., 11, pp. 339-350; Doetsch, F., Scharff, C., Challenges for Brain Repair: Insights from Adult Neurogenesis in Birds and Mammals (2001) Brain Behav. Evol., 58, pp. 306-322; Franklin, R.J., ffrench-Constant, C., Remyelination in the CNS: from biology to therapy (2008) Nat. Rev. Neurosci., 9, pp. 839-855; Franklin, R.J., Kotter, M.R., The biology of CNS remyelination: the key to therapeutic advances (2008) J. Neurol., 255, pp. 19-25; Gage, F.H., Mammalian Neural Stem Cells (2000) Science, 287, pp. 1433-1438; Gago, N., Avellana-Adalid, V., Baron-Van Evercooren, A., Schumacher, M., Control of cell survival and proliferation of postnatal PSA-NCAM(+) progenitors (2003) Mol. Cell. Neurosci., 22, pp. 162-178; Goldberg, J.S., Hirschi, K.K., Diverse roles of the vasculature within the neural stem cell niche (2009) Regen. Med., 4, pp. 879-897; Gonzalez-Perez, O., Romero-Rodriguez, R., Soriano-Navarro, M., Garcia-Verdugo, J.M., Alvarez-Buylla, A., Epidermal growth factor induces the progeny of subventricular zone type B cells to migrate and differentiate into oligodendrocytes (2009) Stem Cells, 27, pp. 2032-2043; Hayon, Y., Dashevsky, O., Shai, E., Brill, A., Varon, D., Leker, R.R., Platelet microparticles induce angiogenesis and neurogenesis after cerebral ischemia (2012) Curr. Neurovasc. Res., 9, pp. 185-192; Hayon, Y., Shai, E., Varon, D., Leker, R.R., The role of platelets and their microparticles in rehabilitation of ischemic brain tissue (2012) CNS Neurol. Disord. Drug Targets, 11, pp. 921-925; Hayon, Y., Dashevsky, O., Shai, E., Varon, D., Leker, R.R., Platelet lysates stimulate angiogenesis, neurogenesis and neuroprotection after stroke (2013) Thromb. Haemost., 110, pp. 323-330; Horstman, L.L., Jy, W., Ahn, Y.S., Zivadinov, R., Maghzi, A.H., Role of platelets in neuroinflammation: a wide-angle perspective (2010) J. Neuroinflammation, 7, p. 10; Hunt, J., Cheng, A., Hoyles, A., Jervis, E., Morshead, C.M., Cyclosporin A has direct effects on adult neural precursor cells (2010) J. Neurosci., 30, pp. 2888-2896; Kandasamy, M., Couillard-Despres, S., Raber, K.A., Stephan, M., Lehner, B., Stem cell quiescence in the hippocampal neurogenic niche is associated with elevated transforming growth factor-beta signaling in an animal model of Huntington disease (2010) J. Neuropathol. Exp. Neurol., 69, pp. 717-728; Kaushansky, K., Lineage-specific hematopoietic growth factors (2006) N. Engl. J. Med., 354, pp. 2034-2045; Kazanis, I., Neurogenesis in the adult mammalian brain: how much do we need, how much do we have? (2013) Curr. Top. Behav. Neurosci., 15, pp. 3-29; Kazanis, I., Lathia, J.D., Vadakkan, T.J., Raborn, E., Wan, R., Quiescence and activation of stem and precursor cell populations in the subependymal zone of the mammalian brain are associated with distinct cellular and extracellular matrix signals (2010) J. Neurosci., 30, pp. 9771-9781; Kazanis, I., Gorenkova, N., Zhao, J.W., Franklin, R.J., Modo, M., ffrench-Constant, C., The late response of rat subependymal zone stem and progenitor cells to stroke is restricted to directly affected areas of their niche (2013) Exp. Neurol., 248, pp. 387-397; Lange, S., Trost, A., Tempfer, H., Bauer, H.C., Bauer, H., Brain pericyte plasticity as a potential drug target in CNS repair (2013) Drug Discov. Today, 18, pp. 456-463; Langer, H.F., Chavakis, T., Platelets and neurovascular inflammation (2013) Thromb. Haemost., 110; Langer, H.F., Choi, E.Y., Zhou, H., Schleicher, R., Chung, K.J., Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis (2012) Circ. Res., 110, pp. 1202-1210; Levine, J.M., Reynolds, R., Fawcett, J.W., The oligodendrocyte precursor cell in health and disease (2001) Trends Neurosci., 24, pp. 39-47; Li, Z., Burns, A.R., Han, L., Rumbaut, R.E., Smith, C.W., IL-17 and VEGF are necessary for efficient corneal nerve regeneration (2011) Am. J. Pathol., 178, pp. 1106-1116; Lohmann, M., Walenda, G., Hemeda, H., Joussen, S., Drescher, W., Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells (2012) PLoS One, 7, p. e37839; Lois, C., Garcia-Verdugo, J.M., Alvarez-Buylla, A., Chain migration of neuronal precursors (1996) Science, 271, pp. 978-981; Menn, B., Garcia-Verdugo, J.M., Yaschine, C., Gonzalez-Perez, O., Rowitch, D., Alvarez-Buylla, A., Origin of oligodendrocytes in the subventricular zone of the adult brain (2006) J. Neurosci., 26, pp. 7907-7918; Michelson, A.D., Antiplatelet therapies for the treatment of cardiovascular disease (2010) Nat. Rev. Drug Discov., 9, pp. 154-169; Morshead, C.M., van der Kooy, D., Postmitotic death is the fate of constitutively proliferating cells in the subependymal layer of the adult mouse brain (1992) J. Neurosci., 12, pp. 249-256; Nait-Oumesmar, B., Decker, L., Lachapelle, F., Avellana-Adalid, V., Bachelin, C., Van Evercooren, A.B., Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination (1999) Eur. J. Neurosci., 11, pp. 4357-4366; Nurden, A.T., Platelets, inflammation and tissue regeneration (2011) Thromb. Haemost., 105, pp. S13-S33; Ottone, C., Krusche, B., Whitby, A., Clements, M., Quadrato, G., Direct cell-cell contact with the vascular niche maintains quiescent neural stem cells (2014) Nat. Cell Biol., 16, pp. 1045-1056; Picard-Riera, N., Decker, L., Delarasse, C., Goude, K., Nait-Oumesmar, B., Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 13211-13216; Raff, M.C., Lillien, L.E., Richardson, W.D., Burne, J.F., Noble, M.D., Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture (1988) Nature, 333, pp. 562-565; Rivera, F.J., Couillard-Despres, S., Pedre, X., Ploetz, S., Caioni, M., Mesenchymal Stem Cells Instruct Oligodendrogenic Fate Decision on Adult Neural Stem Cells (2006) Stem Cells, 24, pp. 2209-2219; Sandner, B., Rivera, F.J., Caioni, M., Nicholson, L., Eckstein, V., Bone morphogenetic proteins prevent bone marrow stromal cell-mediated oligodendroglial differentiation of transplanted adult neural progenitor cells in the injured spinal cord (2013) Stem Cell Res., 11, pp. 758-771; Schallmoser, K., Strunk, D., Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures (2009) J. Vis. Exp, 32, p. 1523; Schallmoser, K., Strunk, D., Generation of a pool of human platelet lysate and efficient use in cell culture (2013) Methods Mol. Biol., 946, pp. 349-362; Schallmoser, K., Bartmann, C., Rohde, E., Reinisch, A., Kashofer, K., Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells (2007) Transfusion, 47, pp. 1436-1446; Schanzer, A., Wachs, F.P., Wilhelm, D., Acker, T., Cooper-Kuhn, C., Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor (2004) Brain Pathol., 14, pp. 237-248; Semple, J.W., Italiano, J.E., Freedman, J., Platelets and the immune continuum (2011) Nat. Rev. Immunol., 11, pp. 264-274; Shen, Q., Wang, Y., Kokovay, E., Lin, G., Chuang, S.M., Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions (2008) Cell Stem Cell, 3, pp. 289-300; Sotnikov, I., Veremeyko, T., Starossom, S.C., Barteneva, N., Weiner, H.L., Ponomarev, E.D., Platelets recognize brain-specific glycolipid structures, respond to neurovascular damage and promote neuroinflammation (2013) PLoS One, 8, p. e58979; Steffenhagen, C., Kraus, S., Dechant, F.X., Kandasamy, M., Lehner, B., Identity, fate and potential of cells grown as neurospheres: species matters (2011) Stem Cell Rev., 7, pp. 815-835; Steffenhagen, C., Dechant, F.X., Oberbauer, E., Furtner, T., Weidner, N., Mesenchymal Stem Cells Prime Proliferating Adult Neural Progenitors Towards An Oligodendrocyte Fate (2012) Stem Cells Dev, 21 (11), pp. 1838-1851; Steinman, L., Platelets provide a bounty of potential targets for therapy in multiple sclerosis (2012) Circ. Res., 110, pp. 1157-1158; Tavazoie, M., Van der Veken, L., Silva-Vargas, V., Louissaint, M., Colonna, L., A specialized vascular niche for adult neural stem cells (2008) Cell Stem Cell, 3, pp. 279-288; Thored, P., Wood, J., Arvidsson, A., Cammenga, J., Kokaia, Z., Lindvall, O., Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke (2007) Stroke, 38, pp. 3032-3039; Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes (2002) Genome Biol., 3. , (RESEARCH0034); Wachs, F.P., Winner, B., Couillard-Despres, S., Schiller, T., Aigner, R., Transforming growth factor-beta1 is a negative modulator of adult neurogenesis (2006) J. Neuropathol. Exp. Neurol., 65, pp. 358-370; Warnke, P.H., Humpe, A., Strunk, D., Stephens, S., Warnke, F., A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies (2013) J. Craniomaxillofac. Surg., 41, pp. 153-161; Woodruff, R.H., Franklin, R.J., Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study (1999) Glia, 25, pp. 216-228",Article,Scopus,2-s2.0-84927600711
"Bauters D., Scroyen I., Van Hul M., Lijnen H.R.","Gelatinase A (MMP-2) promotes murine adipogenesis",2015,"Biochimica et Biophysica Acta - General Subjects","1850","7",,"1449","1456",,,10.1016/j.bbagen.2015.04.003,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928400161&partnerID=40&md5=53886d654679e9b2bd0c0ff9e5b54e05","University of Leuven, Department of Cardiovascular Sciences, Center for Molecular and Vascular BiologyLeuven, Belgium","Bauters, D., University of Leuven, Department of Cardiovascular Sciences, Center for Molecular and Vascular BiologyLeuven, Belgium; Scroyen, I., University of Leuven, Department of Cardiovascular Sciences, Center for Molecular and Vascular BiologyLeuven, Belgium; Van Hul, M., University of Leuven, Department of Cardiovascular Sciences, Center for Molecular and Vascular BiologyLeuven, Belgium; Lijnen, H.R., University of Leuven, Department of Cardiovascular Sciences, Center for Molecular and Vascular BiologyLeuven, Belgium","Background Expansion of adipose tissue is dependent on adipogenesis, angiogenesis and extracellular matrix remodeling. A functional role in these processes was suggested for the gelatinase subfamily of the matrix metalloproteinases. Here, we have evaluated a potential role of gelatinase A (MMP-2) in adipogenesis. Methods Murine embryonic fibroblasts (MEF) were derived from wild-type or MMP-2 deficient mice. Genetic manipulation of Mmp2 (shRNA-knockdown or overexpression) was performed in 3T3-F442A preadipocytes. Cell cultures were subjected to an adipogenic medium. As an in vivo model for de novo adipogenesis, 3T3-F442A preadipocytes with or without knockdown were injected subcutaneously in Nude BALB/c mice kept on high fat diet. Results Mmp2 deficient MEF, as compared to controls, showed significantly impaired differentiation into mature adipocytes, as demonstrated by 90% reduced intracellular lipid content and reduced expression of pro-adipogenic markers. Moreover, selective Mmp2 knockdown in 3T3-F442A preadipocytes resulted in significantly reduced differentiation. In contrast, overexpression of Mmp2 resulted in markedly enhanced differentiation. In de novo formed fat pads resulting from preadipocytes with Mmp2 knockdown expression of aP2, Ppar-γ and adiponectin was significantly lower, and collagen was more preserved. The fat pad weights as well as size and density of adipocytes or blood vessels were, however, not significantly different from controls. Conclusion Our data directly support a functional role of MMP-2 in adipogenesis in vitro, and suggest a potential role in in vivo adipogenesis. General significance Selective modulation of MMP-2 levels affects adipogenesis. © 2015 Elsevier B.V. All rights reserved.","Adipogenesis; Gelatinase; Matrix metalloproteinase; Obesity; Preadipocyte","Roth, J., Qiang, X., Marban, S.L., Redelt, H., Lowell, B.C., The obesity pandemic: Where have we been and where are we going? (2004) Obes. Res., 12 (SUPPL. 2), pp. 88S-101S; Mariman, E.C., Wang, P., Adipocyte extracellular matrix composition, dynamics and role in obesity (2010) Cell. Mol. Life Sci., 67, pp. 1277-1292; Sun, K., Kusminski, C.M., Scherer, P.E., Adipose tissue remodeling and obesity (2011) J. Clin. Invest., 121, pp. 2094-2101; Kubo, Y., Kaidzu, S., Nakajima, I., Takenouchi, K., Nakamura, F., Organization of extracellular matrix components during differentiation of adipocytes in long-term culture (2000) Vitro Cell. Dev. Biol. Anim., 36, pp. 38-44; Nakajima, I., Yamaguchi, T., Ozutsumi, K., Aso, H., Adipose tissue extracellular matrix: Newly organized by adipocytes during differentiation (1998) Differentiation, 63, pp. 193-200; Lijnen, H.R., Van Hoef, B., Rodriguez, J.A., Paramo, J.A., Stromelysin-2 (MMP-10) deficiency does not affect adipose tissue formation in a mouse model of nutritionally induced obesity (2009) Biochem. Biophys. Res. Commun., 389, pp. 378-381; Van Hul, M., Piccard, H., Lijnen, H.R., Gelatinase B (MMP-9) deficiency does not affect murine adipose tissue development (2010) Thromb. Haemost., 104, pp. 165-171; Bauters, D., Van Hul, M., Lijnen, H.R., Macrophage elastase (MMP-12) in expanding murine adipose tissue (2013) Biochim. Biophys. Acta, 1830, pp. 2954-2959; Lijnen, H.R., Van, H.B., Frederix, L., Rio, M.C., Collen, D., Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesity (2002) Thromb. Haemost., 87, pp. 530-535; Maquoi, E., Demeulemeester, D., Voros, G., Collen, D., Lijnen, H.R., Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation (2003) Thromb. Haemost., 89, pp. 696-704; Pendas, A.M., Folgueras, A.R., Llano, E., Caterina, J., Frerard, F., Rodriguez, F., Astudillo, A., Lopez-Otin, C., Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice (2004) Mol. Cell. Biol., 24, pp. 5304-5313; Chun, T.H., Hotary, K.B., Sabeh, F., Saltiel, A.R., Allen, E.D., Weiss, S.J., A pericellular collagenase directs the 3-dimensional development of white adipose tissue (2006) Cell, 125, pp. 577-591; Van Hul, M., Lijnen, H.R., A functional role of gelatinase A in the development of nutritionally induced obesity in mice (2008) J. Thromb. Haemost., 6, pp. 1198-1206; Inoue, K., Mikuni-Takagaki, Y., Oikawa, K., Itoh, T., Inada, M., Noguchi, T., Park, J.S., Itohara, S., A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism (2006) J. Biol. Chem., 281, pp. 33814-33824; Bouloumie, A., Sengenes, C., Portolan, G., Galitzky, J., Lafontan, M., Adipocyte produces matrix metalloproteinases 2 and 9: Involvement in adipose differentiation (2001) Diabetes, 50, pp. 2080-2086; Lijnen, H.R., Maquoi, E., Holvoet, P., Mertens, A., Lupu, F., Morange, P., Alessi, M.C., Juhan-Vague, I., Adipose tissue expression of gelatinases in mouse models of obesity (2001) Thromb. Haemost., 85, pp. 1111-1116; Van Hul, M., Lijnen, H.R., Effect of weight loss on gelatinase levels in obese mice (2011) Clin. Exp. Pharmacol. Physiol., 38, pp. 647-649; Lee, Y.J., Heo, Y.S., Park, H.S., Lee, S.H., Lee, S.K., Jang, Y.J., Serum SPARC and matrix metalloproteinase-2 and metalloproteinase-9 concentrations after bariatric surgery in obese adults (2014) Obes. Surg., 24, pp. 604-610; Brown, L.M., Fox, H.L., Hazen, S.A., Lanoue, K.F., Rannels, S.R., Lynch, C.J., Role of the matrixin MMP-2 in multicellular organization of adipocytes cultured in basement membrane components (1997) Am. J. Physiol., 272, pp. C937-C949; Chavey, C., Mari, B., Monthouel, M.N., Bonnafous, S., Anglard, P., Van Obberghen, E., Tartare-Deckert, S., Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation (2003) J. Biol. Chem., 278, pp. 11888-11896; Bourlier, V., Zakaroff-Girard, A., De Barros, S., Pizzacalla, C., De Saint Front, V.D., Lafontan, M., Bouloumie, A., Galitzky, J., Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation (2005) J. Pharmacol. Exp. Ther., 312, pp. 1272-1279; Croissandeau, G., Chretien, M., Mbikay, M., Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes (2002) Biochem. J., 364, pp. 739-746; Bauters, D., Van Hul, M., Lijnen, H.R., Gelatinase B (MMP-9) gene silencing does not affect murine preadipocyte differentiation (2014) Adipocyte, 3, pp. 50-53; Green, H., Meuth, M., An established pre-adipose cell line and its differentiation in culture (1974) Cell, 3, pp. 127-133; Christiaens, V., Van Hul, M., Lijnen, H.R., Scroyen, I., CD36 promotes adipocyte differentiation and adipogenesis (2012) Biochim. Biophys. Acta, 1820, pp. 949-956; Mandrup, S., Loftus, T.M., Macdougald, O.A., Kuhajda, F.P., Lane, M.D., Obese gene expression at in vivo levels by fat pads derived from S.C. Implanted 3T3-F442A preadipocytes (1997) Proc. Natl. Acad. Sci. U. S. A., 94, pp. 4300-4305; Van Hul, M., Bauters, D., Himmelreich, U., Kindt, N., Noppen, B., Vanhove, M., Lijnen, H.R., Effect of gelatinase inhibition on adipogenesis and adipose tissue development (2012) Clin. Exp. Pharmacol. Physiol., 39, pp. 49-56; Kleiner, D.E., Stetler-Stevenson, W.G., Quantitative zymography: Detection of picogram quantities of gelatinases (1994) Anal. Biochem., 218, pp. 325-329; Whittaker, P., Kloner, R.A., Boughner, D.R., Pickering, J.G., Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light (1994) Basic Res. Cardiol., 89, pp. 397-410; Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E.C., Oti, S.O., Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013 (2014) Lancet, 384, pp. 766-781; Spalding, K.L., Arner, E., Westermark, P.O., Bernard, S., Buchholz, B.A., Bergmann, O., Blomqvist, L., Arner, P., Dynamics of fat cell turnover in humans (2008) Nature, 453, pp. 783-787; Christiaens, V., Scroyen, I., Lijnen, H.R., Role of proteolysis in development of murine adipose tissue (2008) Thromb. Haemost., 99, pp. 290-294; Lijnen, H.R., Maquoi, E., Hansen, L.B., Van Hoef, B., Frederix, L., Collen, D., Matrix metalloproteinase inhibition impairs adipose tissue development in mice (2002) Arterioscler. Thromb. Vasc. Biol., 22, pp. 374-379; Demeulemeester, D., Collen, D., Lijnen, H.R., Effect of matrix metalloproteinase inhibition on adipose tissue development (2005) Biochem. Biophys. Res. Commun., 329, pp. 105-110; Van Hul, M., Lijnen, H.R., Matrix metalloproteinase inhibition impairs murine adipose tissue development independently of leptin (2011) Endocr. J., 58, pp. 101-107; Fanjul-Fernandez, M., Folgueras, A.R., Cabrera, S., Lopez-Otin, C., Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models (2010) Biochim. Biophys. Acta, 1803, pp. 3-19; Morgan, A.R., Han, D.Y., Thompson, J.M., Mitchell, E.A., Ferguson, L.R., Analysis of MMP2 promoter polymorphisms in childhood obesity (2011) BMC Res. Notes, 4, p. 253; Rosen, E.D., Macdougald, O.A., Adipocyte differentiation from the inside out (2006) Nat. Rev. Mol. Cell Biol., 7, pp. 885-896; Scroyen, I., Frederix, L., Lijnen, H.R., Axl deficiency does not affect adipogenesis or adipose tissue development (2012) Obesity (Silver Spring), 20, pp. 1168-1173; Van Hul, M., Bauters, D., Lijnen, R.H., Differential effects of a gelatinase inhibitor on adipocyte differentiation and adipose tissue development (2013) Clin. Exp. Pharmacol. Physiol., 40, pp. 689-697; Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., Ferrante, Jr.A.W., Obesity is associated with macrophage accumulation in adipose tissue (2003) J. Clin. Invest., 112, pp. 1796-1808; Sorisky, A., Molgat, A.S., Gagnon, A., Macrophage-induced adipose tissue dysfunction and the preadipocyte: Should i stay (and differentiate) or should i go? (2013) Adv. Nutr., 4, pp. 67-75; Fukumura, D., Ushiyama, A., Duda, D.G., Xu, L., Tam, J., Krishna, V., Chatterjee, K., Jain, R.K., Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis (2003) Circ. Res., 93, pp. e88-e97; Soukas, A., Socci, N.D., Saatkamp, B.D., Novelli, S., Friedman, J.M., Distinct transcriptional profiles of adipogenesis in vivo and in vitro (2001) J. Biol. Chem., 276, pp. 34167-34174; Cauwe, B., Opdenakker, G., Intracellular substrate cleavage: A novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases (2010) Crit. Rev. Biochem. Mol. Biol., 45, pp. 351-423",Article,Scopus,2-s2.0-84928400161
"Watanabe J., Matsumoto M., Kageyama H., Murai N., Sasaki S., Hirako S., Wada N., Arata S., Shioda S.","Ghrelin suppresses proliferation of fetal neural progenitor cells, and induces their differentiation into neurons",2015,"Peptides","69",,,"40","46",,,10.1016/j.peptides.2015.03.014,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927749652&partnerID=40&md5=74e0d312af7b1b0141ff9126d5873aa5","Department of Anatomy, Showa University School of Medicine, 1-5-8 HatanodaiShinagawa-ku, Tokyo, Japan; Center for Biotechnology, Showa University, 1-5-8 HatanodaiShinagawa-ku, Tokyo, Japan; Faculty of Health Care, Kiryu UniversityMidori City, Gunma, Japan","Watanabe, J., Department of Anatomy, Showa University School of Medicine, 1-5-8 HatanodaiShinagawa-ku, Tokyo, Japan, Center for Biotechnology, Showa University, 1-5-8 HatanodaiShinagawa-ku, Tokyo, Japan; Matsumoto, M., Department of Anatomy, Showa University School of Medicine, 1-5-8 HatanodaiShinagawa-ku, Tokyo, Japan; Kageyama, H., Department of Anatomy, Showa University School of Medicine, 1-5-8 HatanodaiShinagawa-ku, Tokyo, Japan, Faculty of Health Care, Kiryu UniversityMidori City, Gunma, Japan; Murai, N., Department of Anatomy, Showa University School of Medicine, 1-5-8 HatanodaiShinagawa-ku, Tokyo, Japan; Sasaki, S., Department of Anatomy, Showa University School of Medicine, 1-5-8 HatanodaiShinagawa-ku, Tokyo, Japan; Hirako, S., Department of Anatomy, Showa University School of Medicine, 1-5-8 HatanodaiShinagawa-ku, Tokyo, Japan; Wada, N., Department of Anatomy, Showa University School of Medicine, 1-5-8 HatanodaiShinagawa-ku, Tokyo, Japan; Arata, S., Center for Biotechnology, Showa University, 1-5-8 HatanodaiShinagawa-ku, Tokyo, Japan; Shioda, S., Department of Anatomy, Showa University School of Medicine, 1-5-8 HatanodaiShinagawa-ku, Tokyo, Japan","Although considerable progress has been made in understanding how the temporal and regional control of neural progenitor cells (NPCs) dictates their fate, their key regulators during neural development are still unknown. Ghrelin, which is isolated from porcine stomach extract, is an endogenous ligand for the growth hormone secretagogue receptor (GHS-R). The widespread expression of ghrelin and GHS-R in the central nervous system during development suggests that ghrelin may be involved in developmental neural growth. However, its role in regulating fetal NPCs is still unclear. In this study, we investigated the effects of ghrelin on primary cultured NPCs derived from fetal mouse telencephalon. The expressions of both ghrelin and its receptor were observed in NPCs using RT-PCR, immunoblotting and immunocytostaining. Interestingly, the exposure of fetal NPCs to ghrelin at concentrations of 10-7 and 10-9 M suppressed their proliferation, and caused them to differentiate into neurons and to extend neurites. These results strongly suggest that ghrelin plays an autocrine modulatory role in fetal neural development. © 2015 Elsevier Inc. All rights reserved.","Differentiation; Ghrelin; GHS-R; Neural progenitor cells; Neuron","Al-Zaid, F.S., Alhader, A.A., Al-Ayadhi, L.Y., Altered ghrelin levels in boys with autism: A novel finding associated with hormonal dysregulation (2014) Sci Rep, 4, p. 6478; Braun, S.M., Jessberger, S., Adult neurogenesis: Mechanisms and functional significance (2014) Development, 141, pp. 1983-1986; Chung, H., Li, E., Kim, Y., Kim, S., Park, S., Multiple signaling pathways mediate ghrelin-induced proliferation of hippocampal neural stem cells (2013) J Endocrinol, 218, pp. 49-59; Diano, S., Farr, S.A., Benoit, S.C., McNay, E.C., Da Silva, I., Horvath, B., Ghrelin controls hippocampal spine synapse density and memory performance (2006) Nat Neurosci, 9, pp. 381-388; Doze, V.A., Perez, D.M., G-protein-coupled receptors in adult neurogenesis (2012) Pharmacol Rev, 64, pp. 645-675; Ferrini, F., Salio, C., Lossi, L., Merighi, A., Ghrelin in central neurons (2009) Curr Neuropharmacol, 7, pp. 37-49; Fong, A.K., Wong, S.K., Lam, C.C., Ng, E.K., Ghrelin level and weight loss after laparoscopic sleeve gastrectomy and gastric mini-bypass for Prader-Willi syndrome in Chinese (2012) Obes Surg, 22, pp. 1742-1745; Gage, F.H., Ray, J., Fisher, L.J., Isolation, characterization, and use of stem cells from the CNS (1995) Annu Rev Neurosci, 18, pp. 159-192; Gage, F.H., Temple, S., Neural stem cells: Generating and regenerating the brain (2013) Neuron, 80, pp. 588-601; Ghanizadeh, A., Ghrelin as a promising therapeutic target for co-occurring autism and epilepsy (2011) Epilepsy Behav, 20, pp. 420-421; Hara, M., Nishi, Y., Yamashita, Y., Hirata, R., Takahashi, S., Nagamitsu, S., Relation between circulating levels of GH, IGF-1, ghrelin and somatic growth in Rett syndrome (2014) Brain Dev, 36, pp. 794-800; Hara, M., Nishi, Y., Yamashita, Y., Yoh, J., Takahashi, S., Nagamitsu, S., Ghrelin levels are reduced in Rett syndrome patients with eating difficulties (2011) Int J Dev Neurosci, 29, pp. 899-902; Inoue, Y., Nakahara, K., Kangawa, K., Murakami, N., Transitional change in rat fetal cell proliferation in response to ghrelin and des-acyl ghrelin during the last stage of pregnancy (2010) Biochem Biophys Res Commun, 393, pp. 455-460; Jiang, H., Betancourt, L., Smith, R.G., Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers (2006) Mol Endocrinol, 20, pp. 1772-1785; Kageyama, H., Kitamura, Y., Hosono, T., Kintaka, Y., Seki, M., Takenoya, F., Visualization of ghrelin-producing neurons in the hypothalamic arcuate nucleus using ghrelin-EGFP transgenic mice (2008) Regul Pept, 145, pp. 116-121; Kageyama, H., Takenoya, F., Shiba, K., Shioda, S., Neuronal circuits involving ghrelin in the hypothalamus-mediated regulation of feeding (2010) Neuropeptides, 44, pp. 133-138; Kageyama, H., Takenoya, F., Shioda, S., Morphological analysis of ghrelin neurons in the hypothalamus (2012) Methods Enzymol, 514, pp. 91-99; Kawamura, K., Sato, N., Fukuda, J., Kodama, H., Kumagai, J., Tanikawa, H., Ghrelin inhibits the development of mouse preimplantation embryos in vitro (2003) Endocrinology, 144, pp. 2623-2633; Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., Kangawa, K., Ghrelin is a growth-hormone-releasing acylated peptide from stomach (1999) Nature, 402, pp. 656-660; Li, E., Chung, H., Kim, Y., Kim, D.H., Ryu, J.H., Sato, T., Ghrelin directly stimulates adult hippocampal neurogenesis: Implications for learning and memory (2013) Endocr J, 60, pp. 781-789; Li, E., Kim, Y., Kim, S., Sato, T., Kojima, M., Park, S., Ghrelin stimulates proliferation, migration and differentiation of neural progenitors from the subventricular zone in the adult mice (2014) Exp Neurol, 252, pp. 75-84; Malva, J.O., Xapelli, S., Baptista, S., Valero, J., Agasse, F., Ferreira, R., Multifaces of neuropeptide y in the brain - Neuroprotection, neurogenesis and neuroinflammation (2012) Neuropeptides, 46, pp. 299-308; Masuda, Y., Tanaka, T., Inomata, N., Ohnuma, N., Tanaka, S., Itoh, Z., Ghrelin stimulates gastric acid secretion and motility in rats (2000) Biochem Biophys Res Commun, 276, pp. 905-908; Maya-Espinosa, G., Collazo-Navarrete, O., Millán-Aldaco, D., Palomero-Rivero, M., Guerrero-Flores, G., Drucker-Colín, R., Mouse embryonic stem cell-derived cells reveal niches that support neuronal differentiation in the adult rat brain (2015) Stem Cells, 33, pp. 491-502; Nakahara, K., Nakagawa, M., Baba, Y., Sato, M., Toshinai, K., Date, Y., Maternal ghrelin plays an important role in rat fetal development during pregnancy (2006) Endocrinology, 147, pp. 1333-1342; Nakamachi, T., Farkas, J., Watanabe, J., Ohtaki, H., Dohi, K., Arata, S., Role of PACAP in neural stem/progenitor cell and astrocyte - From neural development to neural repair (2011) Curr Pharm des, 17, pp. 973-984; Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., A role for ghrelin in the central regulation of feeding (2001) Nature, 409, pp. 194-198; Sarchielli, E., Marini, M., Ambrosini, S., Peri, A., Mazzanti, B., Pinzani, P., Multifaceted roles of BDNF and FGF2 in human striatal primordium development. An in vitro study (2014) Exp Neurol, 257, pp. 130-147; Shen, P.J., Yuan, C.G., Ma, J., Cheng, S., Yao, M., Turnley, A.M., Galanin in neuro(glio)genesis: Expression of galanin and receptors by progenitor cells in vivo and in vitro and effects of galanin on neurosphere proliferation (2005) Neuropeptides, 39, pp. 201-205; Steculorum, S.M., Bouret, S.G., Developmental effects of ghrelin (2011) Peptides, 32, pp. 2362-2366; Tschöp, M., Smiley, D.L., Heiman, M.L., Ghrelin induces adiposity in rodents (2000) Nature, 407, pp. 908-913; Wade, A., McKinney, A., Phillips, J.J., Matrix regulators in neural stem cell functions (2014) Biochim Biophys Acta, 1840, pp. 2520-2525; Watanabe, J., Nakamachi, T., Ogawa, T., Naganuma, A., Nakamura, M., Shioda, S., Characterization of antioxidant protection of cultured neural progenitor cells (NPC) against methylmercury (MeHg) toxicity (2009) J Toxicol Sci, 34, pp. 315-325; Watanabe, J., Nakamachi, T., Ohtaki, H., Naganuma, A., Shioda, S., Nakajo, S., Low dose of methylmercury (MeHg) exposure induces caspase mediated-apoptosis in cultured neural progenitor cells (2013) J Toxicol Sci, 38, pp. 931-935; Watanabe, J., Ohba, M., Ohno, F., Kikuyama, S., Nakamura, M., Nakaya, K., Pituitary adenylate cyclase-activating polypeptide-induced differentiation of embryonic neural stem cells into astrocytes is mediated via the beta isoform of protein kinase C (2006) J Neurosci Res, 84, pp. 1645-1655; Watanabe, J., Ohno, F., Shioda, S., Kikuyama, S., Nakaya, K., Nakajo, S., Involvement of protein kinase C in the PACAP-induced differentiation of neural stem cells into astrocytes (2006) Ann N y Acad Sci, 1070, pp. 597-601; Watanabe, J., Shetty, A.K., Hattiangady, B., Kim, D.K., Foraker, J.E., Nishida, H., Administration of TSG-6 improves memory after traumatic brain injury in mice (2013) Neurobiol Dis, 59, pp. 86-99; Weissman, I.L., Anderson, D.J., Gage, F., Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiations (2001) Annu Rev Cell Dev Biol, 17, pp. 387-403; Yada, T., Damdindorj, B., Rita, R.S., Kurashina, T., Ando, A., Taguchi, M., Ghrelin signalling in β-cells regulates insulin secretion and blood glucose (2014) Diabetes Obes Metab, 16 (SUPPL. 1), pp. 111-117; Zaben, M.J., Gray, W.P., Neuropeptides and hippocampal neurogenesis (2013) Neuropeptides, 47, pp. 431-438; Zhang, W., Hu, Y., Lin, T.R., Fan, Y., Mulholland, M.W., Stimulation of neurogenesis in rat nucleus of the solitary tract by ghrelin (2005) Peptides, 26, pp. 2280-2288",Article,Scopus,2-s2.0-84927749652
"Boccardi V., Pelini L., Ercolani S., Ruggiero C., Mecocci P.","From cellular senescence to Alzheimer's disease: The role of telomere shortening",2015,"Ageing Research Reviews","22",,,"1","8",,,10.1016/j.arr.2015.04.003,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928328478&partnerID=40&md5=846478a7523ec816f812d92e815c256e","Institute of Gerontology and Geriatrics, Department of Medicine, University of PerugiaPerugia, Italy","Boccardi, V., Institute of Gerontology and Geriatrics, Department of Medicine, University of PerugiaPerugia, Italy; Pelini, L., Institute of Gerontology and Geriatrics, Department of Medicine, University of PerugiaPerugia, Italy; Ercolani, S., Institute of Gerontology and Geriatrics, Department of Medicine, University of PerugiaPerugia, Italy; Ruggiero, C., Institute of Gerontology and Geriatrics, Department of Medicine, University of PerugiaPerugia, Italy; Mecocci, P., Institute of Gerontology and Geriatrics, Department of Medicine, University of PerugiaPerugia, Italy","The old age population is increasing worldwide as well as age related diseases, including neurodegenerative disorders, such as Alzheimer's disease (AD), which negatively impacts on the health care systems. Aging represents per se a risk factor for AD. Thus, the study and identification of pathways within the biology of aging represent an important end point for the development of novel and effective disease-modifying drugs to treat, delay, or prevent AD. Cellular senescence and telomere shortening represent suitable and promising targets. Several studies show that cellular senescence is tightly interconnected to aging and AD, while the role of telomere dynamic and stability in AD pathogenesis is still unclear. This review will focus on the linking mechanisms between cellular senescence, telomere shortening, and AD. © 2015 Elsevier B.V.","Aging; Alzheimer's disease; Senescence; Telomerase; Telomeres","Aubert, G., Lansdorp, P.M., Telomeres and aging (2008) Physiol. Rev., 88, pp. 557-579; Bachstetter, A.D., Xing, B., de Almeida, L., Dimayuga, E.R., Watterson, D.M., Van Eldik, L.J., Microglial p38alpha MAPK is a key regulator of proinflammatory cytokine upregulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Abeta) (2011) J. Neuroinflammation, 8, p. 79; Baird, D.M., Kipling, D., The extent and significance of telomere loss with age (2004) Ann. N. Y. Acad. Sci., 1019, pp. 265-268; Benarroch, E.E., Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system (2005) Mayo Clin. Proc., 80, pp. 1326-1338; Bhat, R., Crowe, E.P., Bitto, A., Moh, M., Katsetos, C.D., Garcia, F.U., Johnson, F.B., Torres, C., Astrocyte senescence as a component of Alzheimer's disease (2012) PLoS One, 7, p. e45069; Bitto, A., Sell, C., Crowe, E., Lorenzini, A., Malaguti, M., Hrelia, S., Torres, C., Stressinduced senescence in human and rodent astrocytes (2010) Exp. Cell Res., 316, pp. 2961-2968; Blackburn, E.H., Telomere states and cell fates (2000) Nature, 408 (6808), pp. 53-56; Blasco, M.A., Telomeres and human disease: ageing, cancer and beyond (2005) Nat. Rev. Genet., 6, pp. 611-622; Boccardi, V., Paolisso, G., Malleability of short telomeres by telomerase activators: a mini-review (2013) J. Aging Sci., 1, p. 108; Boccardi, V., Herbig, U., Telomerase gene therapy: a novel approach to combat aging (2012) EMBO Mol. Med., 4 (8), pp. 685-687; Boccardi, V., Paolisso, G., Telomerase activation: a potential key modulator for human healthspan and longevity (2014) Ageing Res. Rev., 15, pp. 1-5; Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P., Morin, G.B., Harley, C.B., Wright, W.E., Extension of life-span by introduction of telomerase into normal human cells (1998) Science, 279 (5349), pp. 349-352; Bonda, D.J., Bajić, V.P., Spremo-Potparevic, B., Casadesus, G., Zhu, X., Smith, M.A., Lee, H.G., Review: cell cycle aberrations and neurodegeneration (2010) Neuropathol. Appl. Neurobiol., 36 (2), pp. 157-163; Brookmeyer, R., Johnson, E., Ziegler-Graham, K., Arrighi, H.M., Forecasting the global burden of Alzheimer's disease (2007) Alzheimers Dement., 3, pp. 186-191; Campisi, J., Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) Cell, 120, pp. 513-522; Campisi, J., d'Adda di Fagagna, F., Cellular senescence: when bad things happen to good cells (2007) Nat. Rev. Mol. Cell Biol., 8, pp. 729-740; Casoli, T., Balietti, M., Giorgetti, B., Solazzi, M., Scarpino, O., Fattoretti, P., Platelets in Alzheimer's disease-associated cellular senescence and inflammation (2013) Curr. Pharm. Des., 19 (9), pp. 1727-1738; Chen, W., Kimura, M., Kim, S., Cao, X., Srinivasan, S.R., Berenson, G.S.J.D., Kark, A.A., Aviv, A., Longitudinal A versus cross-sectional evaluations of leukocyte telomere length dynamics: age-dependent telomere shortening is the rule (2011) J. Gerontol. Ser. A Biol. Sci. Med. Sci., 66, pp. 312-319; Chinta, S.J., Woods, G., Rane, A., Demaria, M., Campisi, J., Andersen, J.K., Cellular senescence and the aging brain (2014) Exp. Gerontol., , [Epub ahead of print]; Collado, M., Blasco, M.A., Serrano, M., Cellular senescence in cancer and aging (2007) Cell, 130 (2), pp. 223-233; Coppe, J.P., Desprez, P.Y., Krtolica, A., Campisi, J., The senescence-associated secretory phenotype: the dark side of tumor suppression (2010) Ann. Rev. Pathol., 5, pp. 99-118; Coppe, J.P., Patil, C.K., Rodier, F., Krtolica, A., Beausejour, C.M., Parrinello, S., Hodgson, J.G., Campisi, J., A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen (2010) PLoS One, 5, p. e9188; de Jesus, B.B., Vera, E., Schneeberger, K., Tejera, A.M., Ayuso, E., Bosch, F., Blasco, M.A., Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) EMBO Mol. Med., 4, pp. 1-14; de Lange, T., Protection of mammalian telomeres (2002) Oncogene, 21, pp. 532-540; Demetrius, L.A., Driver, J., Alzheimer's as a metabolic disease (2013) Biogerontology, 14 (6), pp. 641-649; Diniz, D.G., Foro, C.A., Rego, C.M., Gloria, D.A., de Oliveira, F.R., Paes, J.M., de Sousa, A.A., Diniz, C.W., Environmental impoverishment and aging alter object recognition, spatial learning, and dentate gyrus astrocytes (2010) Eur. J. Neurosci., 32, pp. 509-519; Eitan, E., Hutchison, E.R., Mattson, M.P., Telomere shortening in neurological disorders: an abundance of unanswered questions (2014) Trends Neurosci., 37 (5), pp. 256-263; Eitan, E., Tichon, A., Daniel, G., Priel, E., Telomerase expression in adult and old mouse Purkinje neurons (2012) Rejuvenation Res., 15, pp. 206-209; Eitan, E., Tichon, A., Gazit, A., Gitler, D., Slavin, S., Priel, E., Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis (2012) EMBO Mol. Med., 4, pp. 313-329; Fabricius, K., Jacobsen, J.S., Pakkenberg, B., Effect of age on neocortical brain cells in 90+ year old human females - a cell counting study (2013) Neurobiol. Aging, 34, pp. 91-99; Fernandez, M., Gobartt, A.L., Balana, M., COOPERA Study Group. Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment (2010) BMC Neurol., 10, p. 87; Ferrón, S.R., Marqués-Torrejón, M.A., Mira, H., Flores, I., Taylor, K., Blasco, M.A., Fariñas, I., Telomere shortening in neural stem cells disrupts neuronal differentiation and neuritogenesis (2009) J. Neurosci., 29, pp. 14394-14407; Flanary, B.E., Streit, W.J., Effects of axotomy on telomere length, telomerase activity, and protein in activated microglia (2005) J. Neurosci. Res., 82, pp. 160-171; Flanary, B.E., Sammons, N.W., Nguyen, C., Walker, D., Streit, W.J., Evidence that aging and amyloid promote microglial cell senescence (2007) Rejuvenation Res., 10 (1), pp. 61-74; Flanary, B.E., Streit, W.J., Telomeres shorten with age in rat cerebellum and cortex in vivo (2003) J. Anti Aging Med., 6, pp. 299-308; Flanary, B.E., Streit, W.J., Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes (2004) Glia, 45, pp. 75-88; Franco, S., Blasco, M.A., Siedlak, S.L., Harris, P.L., Moreira, P.I., Perry, G., Smith, M.A., Telomeres and telomerase in Alzheimer's disease: epiphenomena or a new focus for therapeutic strategy? (2006) Alzheimers Dement., 2, pp. 164-168; Fu, W., Killen, M., Culmsee, C., Dhar, S., Pandita, T.K., Mattson, M.P., The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function (2000) J. Mol. Neurosci., 14, pp. 3-15; Fu, W., Lee, J., Guo, Z., Mattson, M.P., Seizures and tissue injury induce telomerase in hippocampal microglial cells (2002) Exp. Neurol., 178, pp. 294-300; Fumagalli, M., Rossiello, F., Mondello, C., d'Adda di Fagagna, F., Stable cellular senescence is associated with persistent DDR activation (2014) PLoS One, 9 (10), p. e110969; Fumagalli, M., Rossiello, F., Clerici, M., Barozzi, S., Cittaro, D., Kaplunov, J.M., Bucci, G., d'Adda di Fagagna, F., Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation (2012) Nat. Cell Biol., 14 (4), pp. 355-365. , Erratum in: Nat. Cell Biol., 2012, May; 14(5): 555; Guan, J.Z., Guan, W.P., Maeda, T., Makino, N., The subtelomere of short telomeres is hypermethylated in Alzheimer's disease (2012) Aging Dis., 3 (2), pp. 164-170; Guan, J.Z., Guan, W.P., Maeda, T., Makino, N., Analysis of telomere length and subtelomeric methylation of circulating leukocytes in women with Alzheimer's disease (2013) Aging Clin. Exp. Res., 25, pp. 17-23; Harley, C.B., Futcher, A.B., Greider, C.W., Telomeres shorten during ageing of human fibroblasts (1990) Nature, 345, pp. 458-460; Hayflick, L., The cell biology of human aging (1976) N. Engl. J. Med., 295 (23), pp. 1302-1308; Hebert, L.E., Scherr, P.A., Bienias, J.L., Bennett, D.A., Evans, D.A., Alzheimer disease in the US population: prevalence estimates using the 2000 census (2003) Arch. Neurol., 60, pp. 1119-1122; Heneka, M.T., Sastre, M., Dumitrescu-Ozimek, L., Dewachter, I., Walter, J., Klockgether, T., Van Leuven, F., Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice (2005) J. Neuroinflammation, 2, p. 22; Herbig, U., Ferreira, M., Condel, L., Carey, D., Sedivy, J.M., Cellular senescence in aging primates (2006) Science, 311, p. 1257; Herbig, U., Sedivy, J.M., Regulation of growth arrest in senescence: telomere damage is not the end of the story (2006) Mech. Ageing Dev., 127, pp. 16-24; Hewitt, G., Jurk, D., Marques, F.D., Correia-Melo, C., Hardy, T., Gackowska, A., Anderson, R., Passos, J.F., Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence (2012) Nat. Commun., 28 (3), p. 708; Hochstrasser, T., Marksteiner, J., Humpel, C., Telomere length is age-dependent and reduced in monocytes of Alzheimer patients (2012) Exp. Gerontol., 47 (2), pp. 160-163; Honig, L.S., Schupf, N., Lee, J.H., Tang, M.X., Mayeux, R., Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia (2006) Ann. Neurol., 60, pp. 181-187; Jaskelioff, M., Muller, F.L., Paik, J.H., Thomas, E., Jiang, S., Adams, A.C., Sahin, E., Depinho, R.A., Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice (2011) Nature, 469, pp. 102-106; Jenkins, E.C., Velinov, M.T., Ye, L., Gu, H., Li, S., Jenkins, E.C., Brooks, S.S., Silverman, W.P., Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia (2006) Neurobiol. Aging, 27, pp. 941-945; Jeyapalan, J.C., Ferreira, M., Sedivy, J.M., Herbig, U., Accumulation of senescent cells in mitotic tissue of aging primates (2007) Mech. Ageing Dev., 128, pp. 36-44; Jeyapalan, J.C., Sedivy, J.M., Cellular senescence and organismal aging (2008) Mech. Ageing Dev., 129, pp. 467-474; Jiang, T., Cadenas, E., Astrocytic metabolic and inflammatory changes as a function of age (2014) Aging Cell, 13 (6), pp. 1059-1067; Jurk, D., Wang, C., Miwa, S., Maddick, M., Korolchuk, V., Tsolou, A., Gonos, E.S., von Zglinicki, T., Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response (2012) Aging Cell, 11, pp. 996-1004; Klapper, W., Shin, T., Mattson, M.P., Differential regulation of telomerase activity and TERT expression during brain development in mice (2001) J. Neurosci. Res., 64, pp. 252-260; Klement, K., Goodarzi, A.A., DNA double strand break responses and chromatin alterations within the aging cell (2014) Exp. Cell Res., 329 (1), pp. 42-52; Lee, J., Jo, Y.S., Sung, Y.H., Hwang, I.K., Kim, H., Kim, S.Y., Yi, S.S., Lee, H.W., Telomerase deficiency affects normal brain functions in mice (2010) Neurochem. Res., 35, pp. 211-218; Liu, L., Rando, T.A., Manifestations and mechanisms of stem cell aging (2011) J. Cell Biol., 193 (2), pp. 257-266; Lukens, J.N., Van Deerlin, V., Clark, C.M., Xie, S.X., Johnson, F.B., Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease (2009) Alzheimers Dement., 5, pp. 463-469; Magistretti, P.J., Neuron-glia metabolic coupling and plasticity (2006) J. Exp. Biol., 209, pp. 2304-2311; Mai, S., Klinkenberg, M., Auburger, G., Bereiter-Hahn, J., Jendrach, M., Decreased expression of Drp1 and Fis1 mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINK1 (2010) J. Cell Sci., 123, pp. 917-926; Martin-Ruiz, C., Dickinson, H.O., Keys, B., Rowan, E., Kenny, R.A., Von Zglinicki, T., Telomere length predicts poststroke mortality, dementia, and cognitive decline (2006) Ann. Neurol., 60 (2), pp. 174-180; Masutomi, K., Yu, E.Y., Khurts, S., Ben-Porath, I., Currier, J.L., Metz, G.B., Brooks, M.W., Hahn, W.C., Telomerase maintains telomere structure in normal human cells (2003) Cell, 114, pp. 241-253; Mather, K.A., Jorm, A.F., Parslow, R.A., Christensen, H., Is telomere length a biomarker of aging? A review (2011) J. Gerontol. A Biol. Sci. Med. Sci., 66 (2), pp. 202-213; Movérare-Skrtic, S., Johansson, P., Mattsson, N., Hansson, O., Wallin, A., Johansson, J.O., Zetterberg, H., Svensson, J., Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study (2012) Exp. Gerontol., 47 (2), pp. 179-182; Myung, N.H., Zhu, X., Kruman, I.I., Castellani, R.J., Petersen, R.B., Siedlak, S.L., Perry, G., Lee, H.G., Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes (2008) Age (Dordrecht), 30, pp. 209-215; Nichols, N.R., Day, J.R., Laping, N.J., Johnson, S.A., Finch, C.E., GFAP mRNA increases with age in rat and human brain (1993) Neurobiol. Aging, 14, pp. 421-429; Ota, Y., Zanetti, A.T., Hallock, R.M., The role of astrocytes in the regulation of synaptic plasticity and memory formation (2013) Neural Plast., 2013, p. 185463; Panossian, L.A., Porter, V.R., Valenzuela, H.F., Zhu, X., Reback, E., Masterman, D., Cummings, J.L., Effros, R.B., Telomere shortening in T cells correlates with Alzheimer's disease status (2003) Neurobiol. Aging, 4, pp. 77-84; Pelvig, D.P., Pakkenberg, H., Stark, A.K., Pakkenberg, B., Neocortical glial cell numbers in human brains (2008) Neurobiol. Aging, 29, pp. 1754-1762; Rodríguez-Arellano, J.J., Parpura, V., Zorec, R., Verkhratsky, A., Astrocytes in physiological aging and Alzheimer's disease (2015) Neuroscience, (15), pp. 31-37. , S0306-4522; Rolyan, H., Scheffold, A., Heinrich, A., Begus-Nahrmann, Y., Langkopf, B.H., Hölter, S.M., Vogt-Weisenhorn, D.M., Rudolph, K.L., Telomere shortening reduces Alzheimer's disease amyloid pathology in mice (2011) Brain, 134, pp. 2044-2056; Rubio-Perez, J.M., Morillas-Ruiz, J.M., A Review: inflammatory process in Alzheimer's disease (2012) Role of Cytokines ScientificWorld Journal, 2012, p. 756357; Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., Soininen, H., Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype (2011) Eur. J. Neurosci., 34 (1), pp. 3-11; Sanders, J.L., Newman, A.B., Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? (2013) Epidemiol. Rev., , (Epub ahead of print); Schneider, L., Pellegatta, S., Favaro, R., Pisati, F., Roncaglia, P., Testa, G., Nicolis, S.K., d'Adda di Fagagna, F., DNA damage in mammalian neural stem cells leads to astrocytic differentiation mediated by BMP2 signaling through JAK-STAT (2013) Stem Cell Rep., 1 (2), pp. 123-138; Selkoe, D.J., Preventing Alzheimer's disease (2012) Science, 337, pp. 1488-1492; Serrano-Pozo, A., Frosh, M.P., Masliah, E., Hyman, B.T., Neuropathological alterations in Alzheimer disease (2011) Cold Spring Harbor Perspect. Med., 1, p. a006189; Sfeir, A.J., Chai, W., Shay, J.W., Wright, W.E., Telomere end processing: the terminal nucleotides of human chromosomes (2005) Mol. Cell, 18, pp. 131-138; Sokolova, A., Hill, M.D., Rahimi, F., Warden, L.A., Halliday, G.M., Shepherd, C.E., Monocyte chemoattractant protein-1 plays a dominant role in the chornic inflammation observed in Alzheimer's disease (2008) Brain Pathol., 19, pp. 392-398; Spilsbury, A., Miwa, S., Attems, J., Saretzki, G., The role of telomerase protein TERT in Alzheimer's disease and in tau-related pathology in vitro (2015) J. Neurosci., 35 (4), pp. 1659-1674; Streit, W.J., Xue, Q.S., Tischer, J., Bechmann, I., Microglial pathology (2014) Acta Neuropathol. Commun., 2 (1), p. 142; Streit, W.J., Microglia and the response to brain injury (2002) Ernst Schering Res. Found. Workshop, 39, pp. 11-24; Streit, W.J., Microglia as neuroprotective, immunocompetent cells of the CNS (2002) Glia, 40, pp. 133-139; Tacutu, R., Budovsky, A., Yanai, H., Fraifeld, V.E., Molecular links between cellular senescence, longevity and agerelated diseases - a systems biology perspective (2011) Aging, 3, pp. 1178-1191; Takata, Y., Kikukawa, M., Hanyu, H., Koyama, S., Shimizu, S., Umahara, T., Sakurai, H., Ohyashiki, J.H., Association between ApoE phenotypes and telomere erosion in Alzheimer's disease (2012) J. Gerontol. A Biol. Sci. Med. Sci., 67, pp. 330-335; Tan, F.C., Hutchison, E.R., Eitan, E., Mattson, M.P., Are there roles for brain cell senescence in aging and neurodegenerative disorders? (2014) Biogerontology, 15 (6), pp. 643-660; Thomas, P., O' Callaghan, N.J., Fenech, M., Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease (2008) Mech. Ageing Dev., 129, pp. 183-190; Tomás-Loba, A., Flores, I., Fernández-Marcos, P.J., Cayuela, M.L., Maraver, A., Tejera, A., Borrás, C., Blasco, M.A., Telomerase reverse transcriptase delays aging in cancer resistant mice (2008) Cell, 135, pp. 609-622; Valdes, A.M., Deary, I.J., Gardner, J., Kimura, M., Lu, X., Spector, T.D., Aviv, A., Cherkas, L.F., Leukocyte telomere length is associated with cognitive performance in healthy women (2010) Neurobiol. Aging, 31, pp. 986-992; Vera, E., Bernardes de Jesus, B., Foronda, M., Flores, J.M., Blasco, M.A., The rate of increase of short telomeres predicts longevity in mammals (2012) Cell Rep., 2 (4), pp. 732-737; Verkhratsky, A., Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease (2008) PloS One, 3, p. e2935; von Zglinicki, T., Oxidative stress shortens telomeres (2002) Trends Biochem. Sci., 27, pp. 339-344; von Zglinicki, T., Martin-Ruiz, C.M., Telomeres as biomarkers for ageing and age-related diseases (2005) Curr. Mol. Med., 5 (2), pp. 197-203; Wan, C., Liu, J., Nie, X., Zhao, J., Zhou, S., Duan, Z., Tang, C., Xu, G., 2,3,7,8-Tetrachlorodibenzo-P-dioxin (TCDD) induces premature senescence in human and rodent neuronal cells via ROS-dependent mechanisms (2014) PLoS One, 9, p. e89811; Wang, J., Zhao, C., Zhao, A., Li, M., Ren, J., Qu, X., New insights in amyloid beta interactions with human telomerase (2015) J. Am. Chem. Soc., 137 (3), pp. 1213-1219; Weng, N.P., Telomeres and immune competency (2012) Curr. Opin. Immunol., 24, pp. 470-475; Xie, Z., Jay, K.A., Smith, D.L., Zhang, Y., Liu, Z., Zheng, J., Tian, R., Blackburn, E.H., Early telomerase inactivation accelerates aging independently of telomere length (2015) Cell, 160 (5), pp. 928-939; Yu, H.M., Zhao, Y.M., Luo, X.G., Feng, Y., Ren, Y., Shang, H., He, Z.Y., Wang, X.Y., Repeated lipopolysaccharide stimulation induces cellular senescence in BV2 cells (2012) Neuroimmunomodulation, 19, pp. 131-136; Zekry, D., Herrmann, F.R., Irminger-Finger, I., Graf, C., Genet, C., Vitale, A.M., Michel, J.P., Krause, K.H., Telomere length and ApoE polymorphism in mild cognitive impairment, degenerative and vascular dementia (2010) J. Neurol. Sci., 299, pp. 108-111; Zekry, D., Herrmann, F.R., Irminger-Finger, I., Ortolan, L., Genet, C., Vitale, A.M., Michel, J.P., Krause, K.H., Telomere length is not predictive of dementia or MCI conversion in the oldest old (2010) Neurobiol. Aging, 31, pp. 719-720; Zhang, J., Kong, Q., Zhang, Z., Ge, P., Ba, D., He, W., Telomere dysfunction of lymphocytes in patients with Alzheimer disease (2003) Cognit. Behav. Neurol., 16, pp. 170-176; Zhu, H., Fu, W., Mattson, M.P., The catalytic subunit of telomerase protects neurons against amyloid peptide-induced apoptosis (2000) J. Neurochem., 75, pp. 117-124; Zhu, X., Rottkamp, C.A., Raina, A.K., Brewer, G.J., Ghanbari, H.A., Boux, H., Smith, M.A., Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease (2000) Neurobiol. Aging, 21 (6), pp. 807-813; Zou, Y., Zhang, N., Ellerby, L.M., Davalos, A.R., Zeng, X., Campisi, J., Desprez, P.Y., Responses of human embryonic stem cells and their differentiated progeny to ionizing radiation (2012) Biochem. Biophys. Res. Commun., 426 (1), pp. 100-105",Review,Scopus,2-s2.0-84928328478
"Roforth M.M., Farr J.N., Fujita K., McCready L.K., Atkinson E.J., Therneau T.M., Cunningham J.M., Drake M.T., Monroe D.G., Khosla S.","Global transcriptional profiling using RNA sequencing and DNA methylation patterns in highly enriched mesenchymal cells from young versus elderly women",2015,"Bone","76",,,"49","57",,,10.1016/j.bone.2015.03.017,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926311562&partnerID=40&md5=44365f2f9b73506cfbb21ce6a9af9ef7","Endocrine Research Unit and Kogod Center on Aging, Mayo ClinicRochester, MN, United States; Health Sciences Research, Mayo ClinicRochester, MN, United States; Experimental Pathology and Laboratory Medicine, Mayo ClinicRochester, MN, United States","Roforth, M.M., Endocrine Research Unit and Kogod Center on Aging, Mayo ClinicRochester, MN, United States; Farr, J.N., Endocrine Research Unit and Kogod Center on Aging, Mayo ClinicRochester, MN, United States; Fujita, K., Endocrine Research Unit and Kogod Center on Aging, Mayo ClinicRochester, MN, United States; McCready, L.K., Endocrine Research Unit and Kogod Center on Aging, Mayo ClinicRochester, MN, United States; Atkinson, E.J., Health Sciences Research, Mayo ClinicRochester, MN, United States; Therneau, T.M., Health Sciences Research, Mayo ClinicRochester, MN, United States; Cunningham, J.M., Experimental Pathology and Laboratory Medicine, Mayo ClinicRochester, MN, United States; Drake, M.T., Endocrine Research Unit and Kogod Center on Aging, Mayo ClinicRochester, MN, United States; Monroe, D.G., Endocrine Research Unit and Kogod Center on Aging, Mayo ClinicRochester, MN, United States; Khosla, S., Endocrine Research Unit and Kogod Center on Aging, Mayo ClinicRochester, MN, United States","Age-related bone loss in humans is associated with a decrease in bone formation relative to bone resorption, although the mechanisms for this impairment in bone formation with aging are not well understood. It is known that the precursors for the bone-forming osteoblasts reside in the mesenchymal cell population in bone marrow. Thus, in an effort to identify relevant genetic pathways that are altered with aging, we examined the gene expression and DNA methylation patterns from a highly enriched bone marrow mesenchymal cell population from young (mean age, 28.7. years) versus old (mean age, 73.3. years) women. Bone marrow mononuclear cells from these women were depleted of hematopoietic lineage (lin) and endothelial cells using a combination of magnetic- and fluorescence-activated cell sorting, yielding a previously characterized mesenchymal cell population (lin. -/CD34. -/CD31. - cells) that is capable of osteoblast differentiation. Whole transcriptome RNA sequencing (RNAseq) of freshly isolated cells (without in vitro culture) identified 279 differentially expressed genes (p < 0.05, false discovery rate [q]. < 0.10) between the young and old subjects. Pathway analysis revealed statistically significant (all p < 0.05) alterations in protein synthesis and degradation pathways, as well as mTOR, gap junction, calcium, melatonin and NFAT signaling pathways. Further, Reduced Representational Bisulphite sequencing (RRBS DNA methylation sequencing) revealed significant differences in methylation between the young and old subjects surrounding the promoters of 1528 target genes that also exhibited significant differences in gene expression by RNAseq. In summary, these studies provide novel insights into potential pathways affected by aging in a highly enriched human mesenchymal cell population analyzed without the confounding effects of in vitro culture. Specifically, our finding of alterations in several genes and pathways leading to impaired protein synthesis and turnover with aging in bone marrow mesenchymal cells points to the need for further studies examining how these changes, as well as the other alterations with aging that we identified, may contribute to the age-related impairment in osteoblast formation and/or function. © 2015 Elsevier Inc.","Aging; Osteoporosis; Transcriptional profiling","Khosla, S., Pathogenesis of age-related bone loss in humans (2013) J Gerontol A Biol Sci Med Sci, 68, pp. 1226-1235; Zhou, S., Greenberger, J.S., Epperly, M.W., Goff, J.P., Adler, C., Leboff, M.S., Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts (2008) Aging Cell, 7, pp. 335-343; Munoz-Najar, U., Sedivy, J.M., Epigenetic control of aging (2011) Antioxid Redox Signal, 14, pp. 241-259; Goll, M.G., Bestor, T.H., Eukaryotic cytosine methyltransferases (2005) Annu Rev Biochem, 74, pp. 481-514; Modder, U.I., Roforth, M.M., Nicks, K.M., Peterson, J.M., McCready, L.K., Monroe, D.G., Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selection (2012) Bone, 50, pp. 804-810; Itoh, S., Aubin, J.E., A novel purification method for multipotential skeletal stem cells (2009) J Cell Biochem, 108, pp. 368-377; Mckenzie, K.P., Mayer, D.C., Aubin, J.E., Osteogenesis and expression of the bone marrow niche in endothelial cell-deleted HipOPs (2013) J Cell Biochem, 114, pp. 1066-1073; Dafforn, A., Chen, P., Deng, G., Herrler, M., Iglehart, D., Koritala, S., Linear mRNA amplification from as little as 5ng total RNA for global gene expression (2004) Biotechniques, 37, pp. 854-857; Nygaard, V., Hovig, E., Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling (2006) Nucleic Acids Res, 34, pp. 996-1014; Radonic, A., Thulke, S., Mackay, I.M., Landt, O., Siegert, W., Nitsche, A., Guideline to reference gene selection for quantitative real-time PCR (2004) Biochem Biophys Res Commun, 313, pp. 856-862; Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., Accurate normalization of real-time quantitative RT-PCR data by geometeric averaging of multiple internal control genes (2002) Genome Biol, 3. , [research0034.1-0-34.11]; Fujita, K., Roforth, M.M., Atkinson, E.J., Peterson, J.M., Drake, M.T., McCready, L.K., Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture (2014) Osteoporos Int, 25, pp. 887-895; Ramskold, D., Wang, E.T., Burge, C.B., Sandberg, R., An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data (2009) PLoS Comput Biol, 5, p. e1000598; Wagner, G.P., Kin, K., Lynch, V.J., Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples (2012) Theory Biosci, 131, pp. 281-284; Hansen, K.D., Irizarry, R.A., Wu, Z., Removing technical variability in RNA-seq data using conditional quantile normalization (2012) Biostatistics, 13, pp. 204-216; Robinson, M.D., McCarthy, D.J., Smyth, G.K., EdgeR: a Bioconductor package for differential expression analysis of digital gene expression data (2010) Bioinformatics, 26, pp. 139-140; Sun, Z., Baheti, S., Middha, S., Kanwar, R., Zhang, Y., Li, X., SAAP-RRBS: streamlined analysis and annotation pipeline for reduced representation bisulfite sequencing (2012) Bioinformatics, 28, pp. 2180-2181; Roforth, M.M., Fujita, K., McGregor, U.I., Kirmani, S., McCready, L.K., Peterson, J.M., Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans (2014) Bone, 59, pp. 1-6; Zhou, B.O., Yue, R., Murphpy, M.M., Peyer, J.G., Morrison, S.J., Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow (2014) Cell Stem Cell, 15, pp. 154-168; Reiner, A., Yekutieli, D., Benjamini, Y., Identifying differentially expressed genes using false discovery rate controlling procedures (2003) Bioinformatics, 19, pp. 368-375; Hirakawa, A., Sato, Y., Sozu, T., Hamada, C., Yoshimura, I., Estimating the false discovery rate using mixed normal distribution for identifying differentially expressed genes in microarray data analysis (2008) Cancer Inform, 22, pp. 140-148; Hershko, A., Ciechanover, A., The ubiquitin system for protein degradation (1992) Annu Rev Biochem, 61, pp. 761-807; Phillips, T., The role of methylation in gene expression (2008) Nat Educ, 1, p. 116; Bork, S., Pfister, S., Witt, H., Horn, P., Korn, B., Ho, A.D., DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells (2010) Aging Cell, 9, pp. 54-63; Cuanalo-Contreras, K., Mukherjee, A., Soto, C., Role of protein misfolding and proteostasis deficiency in protein misfolding diseases and aging (2013) Int J Cell Biol, 2013, p. 638083; Hwang, J.S., Chang, I., Kim, S., Age-associated decrease in proteasome content and activities in human dermal fibroblasts: restoration of normal level of proteasome subunits reduces aging markers in fibroblasts from elderly persons (2007) J Gerontol A Biol Sci Med Sci, 62, pp. 490-499; Tydlacka, S., Wang, C.E., Wang, X., Li, S., Li, X.J., Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons (2008) J Neurosci, 28, pp. 13285-13295; Keller, J.N., Huang, F.F., Markesbery, W.R., Decreased levels of proteasome activity and proteasome expression in aging spinal cord (2000) Neuroscience, 98, pp. 149-156; Kaeberlein, M., MTOR inhibition: from aging to autism and beyond (2013) Scientifica, 2013, p. 849186; Kennedy, B.K., Kaeberlein, M., Hot topics in aging research: protein translation, 2009 (2009) Aging Cell, 8, pp. 617-623; Huang, T.Y., Hanani, M., Ledda, M., De Palo, S., Pannese, E., Aging is associated with an increase in dye coupling and in gap junction number in satellite glial cells of murine dorsal root ganglia (2006) Neuroscience, 137, pp. 1185-1192; Hoskins, B., Scott, J.M., Changes in activities of calmodulin-mediated enzymes in rat brain during aging (1984) Mech Ageing Dev, 26, pp. 231-239; Hardeland, R., Melatonin and the theories of aging: a critical appraisal of melatonin's role in antiaging mechanisms (2013) J Pineal Res, 55, pp. 325-356; Oliveira, A.M., Bading, H., Calcium signaling in cognition and aging-dependent cognitive decline (2011) Biofactors, 37, pp. 168-174; Wilson, V.L., Jones, P.A., DNA methylation decreases in aging but not in immortal cells (1983) Science, 220, pp. 1055-1057; Casillas, M.A., Lopatina, N., Andrews, L.G., Tollefsbol, T.O., Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts (2003) Mol Cell Biochem, 252, pp. 33-43; Issa, J.P., Age-related epigenetic changes and the immune system (2003) Clin Immunol, 109, pp. 103-108; Bornman, D.M., Mathew, S., Alsruhe, J., Herman, J.G., Gabrielson, E., Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals (2001) Am J Pathol, 159, pp. 831-835; Choi, E.K., Uyeno, S., Nishida, N., Okumoto, T., Fujimura, S., Aoki, Y., Alterations of c-fos gene methylation in the processes of aging and tumorigenesis in human liver (1996) Mutat Res, 354, pp. 123-128; Takatsu, M., Uyeno, S., Komura, J., Watanabe, M., Ono, T., Age-dependent alterations in mRNA level and promoter methylation of collagen alpha1(I) gene in human periodontal ligament (1999) Mech Ageing Dev, 110, pp. 37-48; Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., Karsenty, G., Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation (1997) Cell, 89, pp. 747-754; Bauer, O., Sharir, A., Kimura, A., Hantisteanu, S., Takeda, S., Groner, Y., Loss of osteoblast Runx3 produces severe congenital osteopenia (2015) Mol Cell Biol, , [Epub ahead of print]], MCB.01106-14; Devoto, M., Shimoya, K., Caminis, J., Ott, J., Tenenhouse, A., Whyte, M.P., First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p, and 4q (1998) Eur J Hum Genet, 6, pp. 151-157; Modder, U.I., Roforth, M.M., Hoey, K., McCready, L.K., Peterson, J.M., Monroe, D.G., Effects of estrogen on osteoprogenitor cells and cytokines/bone regulatory factors in postmenopausal women (2011) Bone, 49, pp. 202-207",Article,Scopus,2-s2.0-84926311562
"Mefford M.E., Kunstman K., Wolinsky S.M., Gabuzda D.","Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 bridging sheet that increase macrophage-tropism through enhanced interactions with CCR5",2015,"Virology","481",,,"210","222",,,10.1016/j.virol.2015.01.032,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925047739&partnerID=40&md5=5e084e54c9151be373e5105d497102e2","Department of Cancer Immunology and AIDS, Dana-Farber Cancer InstituteBoston, MA, United States; Northwestern University Medical SchoolChicago, IL, United States; Department of Neurology (Microbiology and Immunobiology), Harvard Medical SchoolBoston, MA, United States","Mefford, M.E., Department of Cancer Immunology and AIDS, Dana-Farber Cancer InstituteBoston, MA, United States; Kunstman, K., Northwestern University Medical SchoolChicago, IL, United States; Wolinsky, S.M., Northwestern University Medical SchoolChicago, IL, United States; Gabuzda, D., Department of Cancer Immunology and AIDS, Dana-Farber Cancer InstituteBoston, MA, United States, Department of Neurology (Microbiology and Immunobiology), Harvard Medical SchoolBoston, MA, United States","Macrophages express low levels of the CD4 receptor compared to T-cells. Macrophage-tropic HIV strains replicating in brain of untreated patients with HIV-associated dementia (HAD) express Envs that are adapted to overcome this restriction through mechanisms that are poorly understood. Here, bioinformatic analysis of env sequence datasets together with functional studies identified polymorphisms in the β3 strand of the HIV gp120 bridging sheet that increase M-tropism. D197, which results in loss of an N-glycan located near the HIV Env trimer apex, was detected in brain in some HAD patients, while position 200 was estimated to be under positive selection. D197 and T/V200 increased fusion and infection of cells expressing low CD4 by enhancing gp120 binding to CCR5. These results identify polymorphisms in the HIV gp120 bridging sheet that overcome the restriction to macrophage infection imposed by low CD4 through enhanced gp120-CCR5 interactions, thereby promoting infection of brain and other macrophage-rich tissues. © 2015 Elsevier Inc.","Bridging sheet; CCR5; CD4; Envelope; HIV; Macrophage; Tropism; V1/V2 stem","Anand, R., Thayer, R., Srinivasan, A., Nayyar, S., Gardner, M., Luciw, P., Dandekar, S., Biological and molecular characterization of human immunodeficiency virus (HIV-1BR) from the brain of a patient with progressive dementia (1989) Virology, 168, pp. 79-89; Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Fujino, M., A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity (1999) Proc. Natl. Acad. Sci. USA, 96, pp. 5698-5703; Bannert, N., Schenten, D., Craig, S., Sodroski, J., The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses (2000) J. Virol., 74, pp. 10984-10993; Binley, J.M., Wrin, T., Korber, B., Zwick, M.B., Wang, M., Chappey, C., Stiegler, G., Burton, D.R., Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies (2004) J. Virol., 78, pp. 13232-13252; Bowley, D.R., Labrijn, A.F., Zwick, M.B., Burton, D.R., Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage (2007) Protein Eng. Des. Sel., 20, pp. 81-90; Brown, R.J., Peters, P.J., Caron, C., Gonzalez-Perez, M.P., Stones, L., Ankghuambom, C., Pondei, K., Ball, J.K., Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors (2011) J. Virol., 85, pp. 6024-6037; Chen, B., Vogan, E.M., Gong, H., Skehel, J.J., Wiley, D.C., Harrison, S.C., Structure of an unliganded simian immunodeficiency virus gp120 core (2005) Nature, 433, pp. 834-841; Cheng-Mayer, C., Liu, R., Landau, N.R., Stamatatos, L., Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor (1997) J. Virol., 71, pp. 1657-1661; Chenine, A.L., Pion, M., Matouskova, E., Gondois-Rey, F., Vigne, R., Hirsch, I., Adaptation of a CXCR4-using human immunodeficiency type 1 NDK virus in intestinal cells is associated with CD4-independent replication (2002) Virology, 304, pp. 403-414; Dayton, A.I., Hitting HIV where it hides (2008) Retrovirology, 5, p. 15; Dey, B., Pancera, M., Svehla, K., Shu, Y., Xiang, S.H., Vainshtein, J., Li, Y., Wyatt, R., Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state: antigenicity, biophysics, and immunogenicity (2007) J. Virol., 81, pp. 5579-5593; Doms, R.W., Trono, D., The plasma membrane as a combat zone in the HIV battlefield (2000) Genes Dev., 14, pp. 2677-2688; Duenas-Decamp, M.J., Peters, P., Burton, D., Clapham, P.R., Natural resistance of human immunodeficiency virus type 1 to the CD4bs antibody b12 conferred by a glycan and an arginine residue close to the CD4 binding loop (2008) J. Virol., 82, pp. 5807-5814; Duenas-Decamp, M.J., Peters, P.J., Burton, D., Clapham, P.R., Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopes (2009) J. Virol., 83, pp. 2575-2583; Duncan, C.J., Sattentau, Q.J., Viral determinants of HIV-1 macrophage tropism (2011) Viruses, 3, pp. 2255-2279; Dunfee, R., Thomas, E.R., Gorry, P.R., Wang, J., Ancuta, P., Gabuzda, D., Mechanisms of HIV-1 neurotropism (2006) Curr. HIV Res., 4, pp. 267-278; Dunfee, R.L., Thomas, E.R., Gorry, P.R., Wang, J., Taylor, J., Kunstman, K., Wolinsky, S.M., Gabuzda, D., The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia (2006) Proc. Natl. Acad. Sci. USA, 103, pp. 15160-15165; Dunfee, R.L., Thomas, E.R., Wang, J., Kunstman, K., Wolinsky, S.M., Gabuzda, D., Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia (2007) Virology, 367, pp. 222-234; Etemad-Moghadam, B., Sun, Y., Nicholson, E.K., Fernandes, M., Liou, K., Gomila, R., Lee, J., Sodroski, J., Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo (2000) J. Virol., 74, pp. 4433-4440; Gartner, S., McDonald, R.A., Hunter, E.A., Bouwman, F., Liu, Y., Popovic, M., Gp120 sequence variation in brain and in T-lymphocyte human immunodeficiency virus type 1 primary isolates (1997) J. Hum. Virol., 1, pp. 3-18; Gorry, P.R., Bristol, G., Zack, J.A., Ritola, K., Swanstrom, R., Birch, C.J., Bell, J.E., Gabuzda, D., Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity (2001) J. Virol., 75, pp. 10073-10089; Gorry, P.R., Churchill, M., Crowe, S.M., Cunningham, A.L., Gabuzda, D., Pathogenesis of macrophage tropic HIV-1 (2005) Curr. HIV Res., 3, pp. 53-60; Gorry, P.R., Taylor, J., Holm, G.H., Mehle, A., Morgan, T., Cayabyab, M., Farzan, M., Gabuzda, D., Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate (2002) J. Virol., 76, pp. 6277-6292; Gray, L., Sterjovski, J., Churchill, M., Ellery, P., Nasr, N., Lewin, S.R., Crowe, S.M., Gorry, P.R., Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome (2005) Virology, 337, pp. 384-398; Gray, L.R., Gabuzda, D., Cowley, D., Ellett, A., Chiavaroli, L., Wesselingh, S.L., Churchill, M.J., Gorry, P.R., CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates (2011) J. Neurovirol., 17, pp. 82-91; Haim, H., Si, Z., Madani, N., Wang, L., Courter, J.R., Princiotto, A., Kassa, A., Sodroski, J., Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state (2009) PLoS Pathog., 5, p. e1000360; Haim, H., Strack, B., Kassa, A., Madani, N., Wang, L., Courter, J.R., Princiotto, A., Sodroski, J., Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivity (2011) PLoS Pathog., 7, p. e1002101; Huang, K.J., Alter, G.M., Wooley, D.P., The reverse transcriptase sequence of human immunodeficiency virus type 1 is under positive evolutionary selection within the central nervous system (2002) J. Neurovirol., 8, pp. 281-294; Huang, X., Jin, W., Hu, K., Luo, S., Du, T., Griffin, G.E., Shattock, R.J., Hu, Q., Highly conserved HIV-1 gp120 glycans proximal to CD4-binding region affect viral infectivity and neutralizing antibody induction (2012) Virology, 423, pp. 97-106; Hughes, E.S., Bell, J.E., Simmonds, P., Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes (1997) J. Virol., 71, pp. 1272-1280; Igarashi, T., Imamichi, H., Brown, C.R., Hirsch, V.M., Martin, M.A., The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys (2003) J. Leukoc. Biol., 74, pp. 772-780; Johnston, S.H., Lobritz, M.A., Nguyen, S., Lassen, K., Delair, S., Posta, F., Bryson, Y.J., Lee, B., A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains (2009) J. Virol., 83, pp. 11016-11026; Julien, J.P., Cupo, A., Sok, D., Stanfield, R.L., Lyumkis, D., Deller, M.C., Klasse, P.J., Wilson, I.A., Crystal structure of a soluble cleaved HIV-1 envelope trimer (2013) Science, 342, pp. 1477-1483; Keele, B.F., Tazi, L., Gartner, S., Liu, Y., Burgon, T.B., Estes, J.D., Thacker, T.C., Burton, G.F., Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1 (2008) J. Virol., 82, pp. 5548-5561; Kolchinsky, P., Kiprilov, E., Bartley, P., Rubinstein, R., Sodroski, J., Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops (2001) J. Virol., 75, pp. 3435-3443; Kolchinsky, P., Kiprilov, E., Sodroski, J., Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants (2001) J. Virol., 75, pp. 2041-2050; Kuhmann, S.E., Platt, E.J., Kozak, S.L., Kabat, D., Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1 (2000) J. Virol., 74, pp. 7005-7015; Kwong, P.D., Wyatt, R., Majeed, S., Robinson, J., Sweet, R.W., Sodroski, J., Hendrickson, W.A., Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates (2000) Structure, 8, pp. 1329-1339; Lamers, S.L., Salemi, M., Galligan, D.C., de Oliveira, T., Fogel, G.B., Granier, S.C., Zhao, L., McGrath, M.S., Extensive HIV-1 intra-host recombination is common in tissues with abnormal histopathology (2009) PloS One, 4, p. e5065; Le Douce, V., Herbein, G., Rohr, O., Schwartz, C., Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage (2010) Retrovirology, 7, p. 32; Li, Y., Cleveland, B., Klots, I., Travis, B., Richardson, B.A., Anderson, D., Montefiori, D., Hu, S.L., Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses (2008) J. Virol., 82, pp. 638-651; Liu, J., Bartesaghi, A., Borgnia, M.J., Sapiro, G., Subramaniam, S., Molecular architecture of native HIV-1 gp120 trimers (2008) Nature, 455, pp. 109-113; Liu, L., Cimbro, R., Lusso, P., Berger, E.A., Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer (2011) Proc. Natl. Acad. Sci. USA, 108, pp. 20148-20153; Liu, Y., Tang, X.P., McArthur, J.C., Scott, J., Gartner, S., Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain (2000) J. Neurovirol., 6, pp. S70-S81; Ly, A., Stamatatos, L., V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies (2000) J. Virol., 74, pp. 6769-6776; Lyumkis, D., Julien, J.P., de Val, N., Cupo, A., Potter, C.S., Klasse, P.J., Burton, D.R., Ward, A.B., Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer (2013) Science, 342, pp. 1484-1490; Madani, N., Perdigoto, A.L., Srinivasan, K., Cox, J.M., Chruma, J.J., LaLonde, J., Head, M., Sodroski, J.G., Localized changes in the gp120 envelope glycoprotein confer resistance to human immunodeficiency virus entry inhibitors BMS-806 and #155 (2004) J. Virol., 78, pp. 3742-3752; Martin-Garcia, J., Cao, W., Varela-Rohena, A., Plassmeyer, M.L., Gonzalez-Scarano, F., HIV-1 tropism for the central nervous system: brain-derived envelope glycoproteins with lower CD4 dependence and reduced sensitivity to a fusion inhibitor (2006) Virology, 346, pp. 169-179; Mefford, M.E., Gorry, P.R., Kunstman, K., Wolinsky, S.M., Gabuzda, D., Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5×4 HIV type 1 in brain and other tissues (2008) AIDS Res. Hum. Retroviruses, 24, pp. 1215-1220; Monken, C.E., Wu, B., Srinivasan, A., High resolution analysis of HIV-1 quasispecies in the brain (1995) AIDS, 9, pp. 345-349; Moore, J.P., Sodroski, J., Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein (1996) J. Virol., 70, pp. 1863-1872; Moore, P.L., Gray, E.S., Choge, I.A., Ranchobe, N., Mlisana, K., Abdool Karim, S.S., Williamson, C., Team, C.S., The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection (2008) J. Virol., 82, pp. 1860-1869; Morris, A., Marsden, M., Halcrow, K., Hughes, E.S., Brettle, R.P., Bell, J.E., Simmonds, P., Mosaic structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations (1999) J. Virol., 73, pp. 8720-8731; Musich, T., Peters, P.J., Duenas-Decamp, M.J., Gonzalez-Perez, M.P., Robinson, J., Zolla-Pazner, S., Ball, J.K., Clapham, P.R., A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection (2011) J. Virol., 85, pp. 2397-2405; O'Connell, O., Repik, A., Reeves, J.D., Gonzalez-Perez, M.P., Quitadamo, B., Anton, E.D., Duenas-Decamp, M., Clapham, P.R., Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism (2013) J. Virol., 87, pp. 187-198; O'Rourke, S.M., Schweighardt, B., Phung, P., Mesa, K.A., Vollrath, A.L., Tatsuno, G.P., To, B., Berman, P.W., Sequences in glycoprotein gp41, the CD4 binding site, and the V2 domain regulate sensitivity and resistance of HIV-1 to broadly neutralizing antibodies (2012) J. Virol., 86, pp. 12105-12114; Ohagen, A., Devitt, A., Kunstman, K.J., Gorry, P.R., Rose, P.P., Korber, B., Taylor, J., Gabuzda, D., Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS (2003) J. Virol., 77, pp. 12336-12345; Otto, C., Puffer, B.A., Pohlmann, S., Doms, R.W., Kirchhoff, F., Mutations in the C3 region of human and simian immunodeficiency virus envelope have differential effects on viral infectivity, replication, and CD4-dependency (2003) Virology, 315, pp. 292-302; Pan, Y., Ma, B., Nussinov, R., CD4 binding partially locks the bridging sheet in gp120 but leaves the beta2/3 strands flexible (2005) J. Mol. Biol., 350, pp. 514-527; Pantophlet, R., Ollmann Saphire, E., Poignard, P., Parren, P.W., Wilson, I.A., Burton, D.R., Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120 (2003) J. Virol., 77, pp. 642-658; Peters, P.J., Bhattacharya, J., Hibbitts, S., Dittmar, M.T., Simmons, G., Bell, J., Simmonds, P., Clapham, P.R., Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages (2004) J. Virol., 78, pp. 6915-6926; Peters, P.J., Duenas-Decamp, M.J., Sullivan, W.M., Brown, R., Ankghuambom, C., Luzuriaga, K., Robinson, J., Clapham, P.R., Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors (2008) Retrovirology, 5, p. 5; Peters, P.J., Duenas-Decamp, M.J., Sullivan, W.M., Clapham, P.R., Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissues (2007) J. Neuroimmune Pharmacol., 2, pp. 32-41; Pierson, T., McArthur, J., Siliciano, R.F., Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy (2000) Annu. Rev. Immunol., 18, pp. 665-708; Pikora, C., Wittish, C., Desrosiers, R.C., Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4 (2005) J. Virol., 79, pp. 12575-12583; Platt, E.J., Wehrly, K., Kuhmann, S.E., Chesebro, B., Kabat, D., Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1 (1998) J. Virol., 72, pp. 2855-2864; Pond, S.L., Frost, S.D., A genetic algorithm approach to detecting lineage-specific variation in selection pressure (2005) Mol. Biol. Evol., 22, pp. 478-485; Pond, S.L., Frost, S.D., Grossman, Z., Gravenor, M.B., Richman, D.D., Brown, A.J., Adaptation to different human populations by HIV-1 revealed by codon-based analyses (2006) PLoS Comput. Biol., 2, p. e62; Pond, S.L.K., Poon, A.F.Y., Zarate, S., Smith, D.M., Little, S.J., Pillai, S.K., Ellis, R.J., Frost, S.D.W., Estimating selection pressures on HIV-1 using phylogenetic likelihood models (2008) Stat. Med., 27, pp. 4779-4789; Poon, A.F., Frost, S.D., Pond, S.L., Detecting signatures of selection from DNA sequences using Datamonkey (2009) Methods Mol. Biol., 537, pp. 163-183; Poon, A.F., Lewis, F.I., Pond, S.L., Frost, S.D., Evolutionary interactions between N-linked glycosylation sites in the HIV-1 envelope (2007) PLoS Comput. Biol., 3, p. e11; Power, C., McArthur, J.C., Johnson, R.T., Griffin, D.E., Glass, J.D., Dewey, R., Chesebro, B., Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence (1995) Curr. Top. Microbiol. Immunol., 202, pp. 89-104; Puffer, B.A., Altamura, L.A., Pierson, T.C., Doms, R.W., Determinants within gp120 and gp41 contribute to CD4 independence of SIV Envs (2004) Virology, 327, pp. 16-25; Reeves, J.D., Gallo, S.A., Ahmad, N., Miamidian, J.L., Harvey, P.E., Sharron, M., Pohlmann, S., Doms, R.W., Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics (2002) Proc. Natl. Acad. Sci. USA, 99, pp. 16249-16254; Richards, K.H., Aasa-Chapman, M.M., McKnight, A., Clapham, P.R., Modulation of HIV-1 macrophage-tropism among R5 envelopes occurs before detection of neutralizing antibodies (2010) Retrovirology, 7, p. 48; Rizzuto, C.D., Wyatt, R., Hernandez-Ramos, N., Sun, Y., Kwong, P.D., Hendrickson, W.A., Sodroski, J., A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding (1998) Science, 280, pp. 1949-1953; Saphire, E.O., Parren, P.W., Barbas, C.F., Burton, D.R., Wilson, I.A., Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: an antibody that broadly neutralizes primary isolates of HIV-1 (2001) Acta Crystallogr. D: Biol. Crystallogr., 57, pp. 168-171; Shapshak, P., Segal, D.M., Crandall, K.A., Fujimura, R.K., Zhang, B.T., Xin, K.Q., Okuda, K., Goodkin, K., Independent evolution of HIV type 1 in different brain regions (1999) AIDS Res. Hum. Retroviruses, 15, pp. 811-820; Si, Z., Madani, N., Cox, J.M., Chruma, J.J., Klein, J.C., Schon, A., Phan, N., Sodroski, J.G., Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins (2004) Proc. Natl. Acad. Sci. USA, 101, pp. 5036-5041; Smurzynski, M., Wu, K., Letendre, S., Robertson, K., Bosch, R.J., Clifford, D.B., Evans, S., Ellis, R., Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort (2011) AIDS, 25, pp. 357-365; Sterjovski, J., Churchill, M.J., Ellett, A., Gray, L.R., Roche, M.J., Dunfee, R.L., Purcell, D.F., Gorry, P.R., Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS (2007) Retrovirology, 4, p. 89; Sterjovski, J., Roche, M., Churchill, M.J., Ellett, A., Farrugia, W., Gray, L.R., Cowley, D., Gorry, P.R., An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes (2010) Virology, 404, pp. 269-278; Thomas, E.R., Dunfee, R.L., Stanton, J., Bogdan, D., Taylor, J., Kunstman, K., Bell, J.E., Gabuzda, D., Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion (2007) Virology, 360, pp. 105-119; Walter, B.L., Wehrly, K., Swanstrom, R., Platt, E., Kabat, D., Chesebro, B., Role of low CD4 levels in the influence of human immunodeficiency virus type 1 envelope V1 and V2 regions on entry and spread in macrophages (2005) J. Virol., 79, pp. 4828-4837; Wang, J., Crawford, K., Yuan, M., Wang, H., Gorry, P.R., Gabuzda, D., Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines (2002) J. Infect. Dis., 185, pp. 885-897; Wang, T.H., Donaldson, Y.K., Brettle, R.P., Bell, J.E., Simmonds, P., Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system (2001) J. Virol., 75, pp. 11686-11699; Watkins, J.D., Diaz-Rodriguez, J., Siddappa, N.B., Corti, D., Ruprecht, R.M., Efficiency of neutralizing antibodies targeting the CD4-binding site: influence of conformational masking by the V2 loop in R5-tropic clade C simian-human immunodeficiency virus (2011) J. Virol., 85, pp. 12811-12814; Yen, P.J., Herschhorn, A., Haim, H., Salas, I., Gu, C., Sodroski, J., Gabuzda, D., Loss of a conserved N-linked glycosylation site in the SIV envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission (2015) J. Virol., 88, pp. 5014-5028; Zhang, W., Godillot, A.P., Wyatt, R., Sodroski, J., Chaiken, I., Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4 (2001) Biochemistry, 40, pp. 1662-1670; Zhu, C.B., Zhu, L., Holz-Smith, S., Matthews, T.J., Chen, C.H., The role of the third beta strand in gp120 conformation and neutralization sensitivity of the HIV-1 primary isolate DH012 (2001) Proc. Natl. Acad. Sci. USA, 98, pp. 15227-15232",Article,Scopus,2-s2.0-84925047739
"Filipcik P., Cente M., Zilka N., Smolek T., Hanes J., Kucerak J., Opattova A., Kovacech B., Novak M.","Intraneuronal accumulation of misfolded tau protein induces overexpression of Hsp27 in activated astrocytes",2015,"Biochimica et Biophysica Acta - Molecular Basis of Disease","1852","7",,"1219","1229",,,10.1016/j.bbadis.2015.03.003,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925740928&partnerID=40&md5=bafa4e8014b3b98c331ea2789cdc04cd","Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9Bratislava, Slovakia; Axon Neuroscience SEBratislava, Slovakia","Filipcik, P., Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9Bratislava, Slovakia, Axon Neuroscience SEBratislava, Slovakia; Cente, M., Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9Bratislava, Slovakia, Axon Neuroscience SEBratislava, Slovakia; Zilka, N., Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9Bratislava, Slovakia, Axon Neuroscience SEBratislava, Slovakia; Smolek, T., Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9Bratislava, Slovakia, Axon Neuroscience SEBratislava, Slovakia; Hanes, J., Axon Neuroscience SEBratislava, Slovakia; Kucerak, J., Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9Bratislava, Slovakia, Axon Neuroscience SEBratislava, Slovakia; Opattova, A., Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9Bratislava, Slovakia; Kovacech, B., Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9Bratislava, Slovakia, Axon Neuroscience SEBratislava, Slovakia; Novak, M., Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9Bratislava, Slovakia, Axon Neuroscience SEBratislava, Slovakia","Accumulation of misfolded forms of microtubule associated, neuronal protein tau causes neurofibrillary degeneration typical of Alzheimer's disease and other tauopathies. This process is accompanied by elevated cellular stress and concomitant deregulation of heat-shock proteins. We used a transgenic rat model of tauopathy to study involvement of heat shock protein 27 (Hsp27) in the process of neurofibrillary degeneration, its cell type specific expression and correlation with the amount of insoluble tau protein aggregates. The expression of Hsp27-mRNA is more than doubled and levels of Hsp27 protein tripled in aged transgenic animals with tau pathology. The data revealed a strong positive and highly significant correlation between Hsp27-mRNA and amount of sarkosyl insoluble tau. Interestingly, intracellular accumulation of insoluble misfolded tau protein in neurons was associated with overexpression of Hsp27 almost exclusively in reactive astrocytes, not in neurons. The topological dissociation of neuronally expressed pathological tau and the induction of astrocytic Hsp27, GFAP, and Vimentin along with up-regulation of microglia specific markers such as CD18, CD68 and C3 point to cooperation of astrocytes, microglia and neurons in response to intra-neuronal accumulation of insoluble tau. Our data suggest that over expression of Hsp27 represents a part of microglia-mediated astrocytic response mechanism in the process of neurofibrillary degeneration, which is not necessarily associated with neuroprotection and which in contrary may accelerate neurodegeneration in late stage of the disease. This phenomenon should be considered during development of disease modifying strategies for treatment of tauopathies and AD via regulation of activity of Hsp27. 2015 Elsevier B.V.","Alzheimer's disease; Astrocyte; Hsp27; Tauopathy; Transgenic rat; Truncated tau protein","Abisambra, J.F., Jinwal, U.K., Jones, J.R., Blair, L.J., Koren, J., Dickey, C.A., Exploiting the diversity of the heat-shock protein family for primary and secondary tauopathy therapeutics (2011) Curr. Neuropharmacol., 9 (4), pp. 623-631; Akbar, M.T., Lundberg, A.M., Liu, K., Vidyadaran, S., Wells, K.E., Dolatshad, H., Wynn, S., de Belleroche, J., The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death (2003) J. Biol. Chem., 278 (22), pp. 19956-19965; Arya, R., Mallik, M., Lakhotia, S.C., Heat shock genes-integrating cell survival and death (2007) J. Biosci., 32 (3), pp. 595-610; Bandyopadhyay, B., Li, G., Yin, H., Kuret, J., Tau aggregation and toxicity in a cell culture model of tauopathy (2007) J. Biol. Chem., 282 (22), pp. 16454-16464; Binder, L.I., Guillozet-Bongaarts, A.L., Garcia-Sierra, F., Berry, R.W., Tau, tangles, and Alzheimer's disease (2005) Biochim. Biophys. Acta, 1739 (2-3), pp. 216-223; Bjorkdahl, C., Sjogren, M.J., Zhou, X., Concha, H., Avila, J., Winblad, B., Pei, J.J., Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments (2008) J. Neurosci. Res., 86 (6), pp. 1343-1352; Braak, H., Del Tredici, K., The pathological process underlying Alzheimer's disease in individuals under thirty (2011) Acta Neuropathol., 121 (2), pp. 171-181; Braak, H., Del Tredici, K., Where, when, and in what form does sporadic Alzheimer's disease begin? (2012) Curr. Opin. Neurol., 25 (6), pp. 708-714; Buee, L., Delacourte, A., Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease (1999) Brain Pathol., 9 (4), pp. 681-693; Castellani, R.J., Perry, G., The complexities of the pathology-pathogenesis relationship in Alzheimer disease (2014) Biochem. Pharmacol., 88 (4), pp. 671-676; Cente, M., Filipcik, P., Mandakova, S., Zilka, N., Krajciova, G., Novak, M., Expression of a truncated human tau protein induces aqueous-phase free radicals in a rat model of tauopathy: implications for targeted antioxidative therapy (2009) J. Alzheimers Dis., 17 (4), pp. 913-920; Csokova, N., Skrabana, R., Liebig, H.D., Mederlyova, A., Kontsek, P., Novak, M., Rapid purification of truncated tau proteins: model approach to purification of functionally active fragments of disordered proteins, implication for neurodegenerative diseases (2004) Protein Expr. Purif., 35 (2), pp. 366-372; Dabir, D.V., Trojanowski, J.Q., Richter-Landsberg, C., Lee, V.M., Forman, M.S., Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology (2004) Am. J. Pathol., 164 (1), pp. 155-166; Davila, D., Jimenez-Mateos, E.M., Mooney, C.M., Velasco, G., Henshall, D.C., Prehn, J.H., Hsp27 binding to the 3'UTR of bim mRNA prevents neuronal death during oxidative stress-induced injury: a novel cytoprotective mechanism (2014) Mol. Biol. Cell, 25 (21), pp. 3413-3423; Dickey, C., Kraft, C., Jinwal, U., Koren, J., Johnson, A., Anderson, L., Lebson, L., Lewis, J., Aging analysis reveals slowed tau turnover and enhanced stress response in a mouse model of tauopathy (2009) Am. J. Pathol., 174 (1), pp. 228-238; Filipcik, P., Zilka, N., Bugos, O., Kucerak, J., Koson, P., Novak, P., Novak, M., First transgenic rat model developing progressive cortical neurofibrillary tangles (2012) Neurobiol. Aging, 33 (7), pp. 1448-1456; Franklin, T.B., Krueger-Naug, A.M., Clarke, D.B., Arrigo, A.P., Currie, R.W., The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system (2005) Int. J. Hyperth., 21 (5), pp. 379-392; Goedert, M., Spillantini, M.G., Pathogenesis of the tauopathies (2011) J. Mol. Neurosci., 45 (3), pp. 425-431; Grundke-Iqbal, I., Iqbal, K., Tung, Y.C., Quinlan, M., Wisniewski, H.M., Binder, L.I., Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology (1986) Proc. Natl. Acad. Sci. U. S. A., 83 (13), pp. 4913-4917; Horowitz, P.M., Patterson, K.R., Guillozet-Bongaarts, A.L., Reynolds, M.R., Carroll, C.A., Weintraub, S.T., Bennett, D.A., Binder, L.I., Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease (2004) J. Neurosci. Off. J. Soc. Neurosci., 24 (36), pp. 7895-7902; Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Heutink, P., Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 (1998) Nature, 393 (6686), pp. 702-705; Chen, S., Brown, I.R., Neuronal expression of constitutive heat shock proteins: implications for neurodegenerative diseases (2007) Cell Stress Chaperones, 12 (1), pp. 51-58; Chow, A.M., Tang, D.W., Hanif, A., Brown, I.R., Localization of heat shock proteins in cerebral cortical cultures following induction by celastrol (2014) Cell Stress Chaperones, 19 (6), pp. 845-851; Iqbal, K., Alonso Adel, C., Chen, S., Chohan, M.O., El-Akkad, E., Gong, C.X., Khatoon, S., Grundke-Iqbal, I., Tau pathology in Alzheimer disease and other tauopathies (2005) Biochim. Biophys. Acta, 1739 (2-3), pp. 198-210; Jaya, N., Garcia, V., Vierling, E., Substrate binding site flexibility of the small heat shock protein molecular chaperones (2009) Proc. Natl. Acad. Sci. U. S. A., 106 (37), pp. 15604-15609; Khlistunova, I., Biernat, J., Wang, Y., Pickhardt, M., von Bergen, M., Gazova, Z., Mandelkow, E., Mandelkow, E.M., Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs (2006) J. Biol. Chem., 281 (2), pp. 1205-1214; King, M., Nafar, F., Clarke, J., Mearow, K., The small heat shock protein Hsp27 protects cortical neurons against the toxic effects of beta-amyloid peptide (2009) J. Neurosci. Res., 87 (14), pp. 3161-3175; Korenova, M., Zilka, N., Stozicka, Z., Bugos, O., Vanicky, I., Novak, M., NeuroScale, the battery of behavioral tests with novel scoring system for phenotyping of transgenic rat model of tauopathy (2009) J. Neurosci. Methods, 177 (1), pp. 108-114; Korhonen, P., van Groen, T., Thornell, A., Kyrylenko, S., Soininen, M.L., Ojala, J., Peltomaa, E., Soininen, H., Characterization of a novel transgenic rat carrying human tau with mutation P301L (2011) Neurobiol. Aging, 32 (12), pp. 2314-2315; Kosik, K.S., Shimura, H., Phosphorylated tau and the neurodegenerative foldopathies (2005) Biochim. Biophys. Acta, 1739 (2-3), pp. 298-310; Koson, P., Zilka, N., Kovac, A., Kovacech, B., Korenova, M., Filipcik, P., Novak, M., Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load (2008) Eur. J. Neurosci., 28 (2), pp. 239-246; Kovacech, B., Skrabana, R., Novak, M., Transition of tau protein from disordered to misordered in Alzheimer's disease (2010) Neurodegener. Dis., 7 (1-3), pp. 24-27; Lopez-Gonzalez, I., Carmona, M., Arregui, L., Kovacs, G.G., Ferrer, I., AlphaB-crystallin and HSP27 in glial cells in tauopathies (2014) Neuropathology; Maeda, K., Idehara, R., Hashiguchi, A., Takashima, H., A family with distal hereditary motor neuropathy and a K141Q mutation of small heat shock protein HSPB1 (2014) Intern. Med., 53 (15), pp. 1655-1658; Majerova, P., Zilkova, M., Kazmerova, Z., Kovac, A., Paholikova, K., Kovacech, B., Zilka, N., Novak, M., Microglia display modest phagocytic capacity for extracellular tau oligomers (2014) J. Neuroinflammation, 11 (1), p. 161; McMillan, P.J., Kraemer, B.C., Robinson, L., Leverenz, J.B., Raskind, M., Schellenberg, G., Truncation of tau at E391 promotes early pathologic changes in transgenic mice (2011) J. Neuropathol. Exp. Neurol., 70 (11), pp. 1006-1019; Mena, R., Edwards, P.C., Harrington, C.R., Mukaetova-Ladinska, E.B., Wischik, C.M., Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease (1996) Acta Neuropathol., 91 (6), pp. 633-641; Nakamura, K., Greenwood, A., Binder, L., Bigio, E.H., Denial, S., Nicholson, L., Zhou, X.Z., Lu, K.P., Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease (2012) Cell, 149 (1), pp. 232-244; Novak, M., Jakes, R., Edwards, P.C., Milstein, C., Wischik, C.M., Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51 (1991) Proc. Natl. Acad. Sci. U. S. A., 88 (13), pp. 5837-5841; Novak, M., Kabat, J., Wischik, C.M., Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament (1993) EMBO J., 12 (1), pp. 365-370; Perry, G., Nunomura, A., Hirai, K., Zhu, X., Perez, M., Avila, J., Castellani, R.J., Smith, M.A., Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? (2002) Free Radic. Biol. Med., 33 (11), pp. 1475-1479; Read, D.E., Gorman, A.M., Heat shock protein 27 in neuronal survival and neurite outgrowth (2009) Biochem. Biophys. Res. Commun., 382 (1), pp. 6-8; Reitz, C., Mayeux, R., Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers (2014) Biochem. Pharmacol., 88 (4), pp. 640-651; Renkawek, K., Bosman, G.J., de Jong, W.W., Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia (1994) Acta Neuropathol., 87 (5), pp. 511-519; Shimura, H., Miura-Shimura, Y., Kosik, K.S., Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival (2004) J. Biol. Chem., 279 (17), pp. 17957-17962; Shinohara, H., Inaguma, Y., Goto, S., Inagaki, T., Kato, K., Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease (1993) J. Neurol. Sci., 119 (2), pp. 203-208; Spillantini, M.G., Goedert, M., Tau protein pathology in neurodegenerative diseases (1998) Trends Neurosci., 21 (10), pp. 428-433; Stege, G.J., Renkawek, K., Overkamp, P.S., Verschuure, P., van Rijk, A.F., Reijnen-Aalbers, A., Boelens, W.C., de Jong, W.W., The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity (1999) Biochem. Biophys. Res. Commun., 262 (1), pp. 152-156; Stetler, R.A., Cao, G., Gao, Y., Zhang, F., Wang, S., Weng, Z., Vosler, P., Chen, J., Hsp27 protects against ischemic brain injury via attenuation of a novel stress-response cascade upstream of mitochondrial cell death signaling (2008) J. Neurosci. Off. J. Soc. Neurosci., 28 (49), pp. 13038-13055; Stozicka, Z., Zilka, N., Novak, P., Kovacech, B., Bugos, O., Novak, M., Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease (2010) J. Neuroinflammation, 7, p. 64; Sydow, A., Van der Jeugd, A., Zheng, F., Ahmed, T., Balschun, D., Petrova, O., Drexler, D., Mandelkow, E.M., Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model (2011) J. Mol. Neurosci., 45 (3), pp. 432-437; Togo, T., Sahara, N., Yen, S.H., Cookson, N., Ishizawa, T., Hutton, M., de Silva, R., Dickson, D.W., Argyrophilic grain disease is a sporadic 4-repeat tauopathy (2002) J. Neuropathol. Exp. Neurol., 61 (6), pp. 547-556; Tolnay, M., Probst, A., Frontotemporal lobar degeneration-tau as a pied piper? (2002) Neurogenetics, 4 (2), pp. 63-75; Toth, M.E., Szegedi, V., Varga, E., Juhasz, G., Horvath, J., Borbely, E., Csibrany, B., Santha, M., Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice (2013) Cell Stress Chaperones, 18 (6), pp. 759-771; Verkhratsky, A., Olabarria, M., Noristani, H.N., Yeh, C.Y., Rodriguez, J.J., Astrocytes in Alzheimer's disease (2010) Neurotherapeutics, 7 (4), pp. 399-412; Vidyasagar, A., Wilson, N.A., Djamali, A., Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target (2012) Fibrogenesis Tissue Repair, 5 (1), p. 7; Vleminckx, V., Van Damme, P., Goffin, K., Delye, H., Van Den Bosch, L., Robberecht, W., Upregulation of HSP27 in a transgenic model of ALS (2002) J. Neuropathol. Exp. Neurol., 61 (11), pp. 968-974; Wilhelmus, M.M., de Waal, R.M., Verbeek, M.M., Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease (2007) Mol. Neurobiol., 35 (3), pp. 203-216; Wischik, C.M., Novak, M., Thogersen, H.C., Edwards, P.C., Runswick, M.J., Jakes, R., Walker, J.E., Klug, A., Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease (1988) Proc. Natl. Acad. Sci. U. S. A., 85 (12), pp. 4506-4510; Zilka, N., Filipcik, P., Koson, P., Fialova, L., Skrabana, R., Zilkova, M., Rolkova, G., Novak, M., Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo (2006) FEBS Lett., 580 (15), pp. 3582-3588; Zilkova, M., Zilka, N., Kovac, A., Kovacech, B., Skrabana, R., Skrabanova, M., Novak, M., Hyperphosphorylated truncated protein tau induces caspase-3 independent apoptosis-like pathway in the Alzheimer's disease cellular model (2011) J. Alzheimers Dis., 23 (1), pp. 161-169",Article,Scopus,2-s2.0-84925740928
"Gu C., Yang J., Yuan Y., Yao M., Zhang X.","The safety of photochemical tissue bonding for treating damaged corneal epithelium using limbal stem cells pre-cultured on human amniotic membrane",2015,"Journal of Photochemistry and Photobiology B: Biology","148",,,"59","65",,,10.1016/j.jphotobiol.2015.03.002,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927633453&partnerID=40&md5=3fe74cf3bc7709f12aa85d31f928cadb","Department of Burn and Plastic Surgery, 3 People's Hospital, Shanghai Jiao Tong UniversityShanghai, China; Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical SchoolBoston, MA, United States; Department of Plastic and Reconstructive Surgery, Ninth People's Hospital, Shanghai Jiao Tong UniversityShanghai, China; Department of Ophthalmology, Chengyang People's HospitalQingdao City, Shandong Province, China","Gu, C., Department of Burn and Plastic Surgery, 3 People's Hospital, Shanghai Jiao Tong UniversityShanghai, China, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical SchoolBoston, MA, United States, Department of Plastic and Reconstructive Surgery, Ninth People's Hospital, Shanghai Jiao Tong UniversityShanghai, China; Yang, J., Department of Plastic and Reconstructive Surgery, Ninth People's Hospital, Shanghai Jiao Tong UniversityShanghai, China; Yuan, Y., Department of Ophthalmology, Chengyang People's HospitalQingdao City, Shandong Province, China; Yao, M., Department of Burn and Plastic Surgery, 3 People's Hospital, Shanghai Jiao Tong UniversityShanghai, China, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical SchoolBoston, MA, United States; Zhang, X., Department of Burn and Plastic Surgery, 3 People's Hospital, Shanghai Jiao Tong UniversityShanghai, China","We previously demonstrated the feasibility of treating limbal stem cell deficiency (LSCD) with limbal stem cells (LSCs) pre-cultured on human amniotic membrane (HAM), using a suture-free technique called photochemical tissue bonding (PTB). However, important issues regarding the safety and the influence of PTB on LSCs have not been elucidated. In this study, LSCs, isolated from rabbit eyes and identified by cell markers, were labeled with BrdU prior to cultivation on de-epithelialized HAM to fabricate grafts. Rabbit LSCD models were created and randomly divided into groups for transplantation of fabricated grafts using sutures or PTB (n = 10). Possible phototoxicity of PTB to LSCs was analyzed in vitro and in vivo. Restoration of corneal epithelium was evaluated at 28 days after grafting. Our results showed that phototoxicity did not occur in the LSCs cultured on HAM after PTB in vitro. Transplantation of grafts with PTB restored the damaged cornea epithelium effectively and no significant influences on LSC characteristics were found in both sutured and PTB groups. BrdU positive cells were tracked at 28 days post grafting suggesting that the restored epithelium was derived from the in vitro fabricated HAM/LSC graft. These data suggest that PTB is a safe and potential strategy for securing LSC/HAM grafts that produces with better outcomes than sutured attachment. © 2015 Published by Elsevier B.V.",,"Yang, X., Moldovan, N.I., Zhao, Q., Mi, S., Zhou, Z., Chen, D., Reconstruction of damaged cornea by autologous transplantation of epidermal adult stem cells (2008) Mol. Vis., 14, pp. 1064-1070; Zhu, J., Zhang, K., Sun, Y., Gao, X., Li, Y., Chen, Y., Reconstruction of functional ocular surface by acellular porcine cornea matrix scaffold and limbal stem cells derived from human embryonic stem cells (2013) Tissue Eng. Part A, 19 (2122), pp. 2412-2425; Ortega, I., Deshpande, P., Gill, A.A., Macneil, S., Claeyssens, F., Development of a microfabricated artificial limbus with micropockets for cell delivery to the cornea (2013) Biofabrication, 5 (2), p. 025008; Tsai, R.J., Li, L.M., Chen, J.K., Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells (2000) N. Engl. J. Med., 343 (2), pp. 86-93; Stoiber, J., Ruckhofer, J., Muss, W., Grabner, G., Amniotic membrane transplantation with limbal stem cell transplantation as a combined procedure for corneal surface reconstruction after severe thermal or chemical burns (2002) Ophthalmologe, 99 (11), pp. 839-848; Sangwan, V.S., Matalia, H.P., Vemuganti, G.K., Rao, G.N., Amniotic membrane transplantation for reconstruction of corneal epithelial surface in cases of partial limbal stem cell deficiency (2004) Indian J. Ophthalmol., 52 (4), pp. 281-285; Chan, B.P., Amann, C., Yaroslavsky, A.N., Title, C., Smink, D., Zarins, B., Photochemical repair of Achilles tendon rupture in a rat model (2005) J. Surg. Res., 124 (2), pp. 274-279; O'Neill, A.C., Randolph, M.A., Bujold, K.E., Kochevar, I.E., Redmond, R.W., Winograd, J.M., Photochemical sealing improves outcome following peripheral neurorrhaphy (2009) J. Surg. Res., 151 (1), pp. 33-39; O'Neill, A.C., Randolph, M.A., Bujold, K.E., Kochevar, I.E., Redmond, R.W., Winograd, J.M., Preparation and integration of human amnion nerve conduits using a light-activated technique (2009) Plast. Reconstr. Surg., 124 (2), pp. 428-437; O'Neill, A.C., Winograd, J.M., Zeballos, J.L., Johnson, T.S., Randolph, M.A., Bujold, K.E., Microvascular anastomosis using a photochemical tissue bonding technique (2007) Lasers Surg. Med., 39 (9), pp. 716-722; Proano, C.E., Mulroy, L., Jones, E., Azar, D.T., Redmond, R.W., Kochevar, I.E., Photochemical keratodesmos for bonding corneal incisions (2004) Invest. Ophthalmol. Vis. Sci., 45 (7), pp. 2177-2181; Wang, Y., Kochevar, I.E., Redmond, R.W., Yao, M., A light-activated method for repair of corneal surface defects (2011) Lasers Surg. Med., 43 (6), pp. 481-489; Gu, C., Ni, T., Verter, E.E., Redmond, R.W., Kochevar, I.E., Yao, M., Photochemical tissue bonding: A potential strategy for treating limbal stem cell deficiency (2011) Lasers Surg. Med., 43 (5), pp. 433-442; Yao, M., Yaroslavsky, A., Henry, F.P., Redmond, R.W., Kochevar, I.E., Phototoxicity is not associated with photochemical tissue bonding of skin (2010) Lasers Surg. Med., 42 (2), pp. 123-131; Johnson, T.S., O'Neill, A.C., Motarjem, P.M., Amann, C., Nguyen, T., Randolph, M.A., Photochemical tissue bonding: A promising technique for peripheral nerve repair (2007) J. Surg. Res., 143 (2), pp. 224-229; Yin, J.Q., Liu, W.Q., Liu, C., Zhang, Y.H., Hua, J.L., Liu, W.S., Reconstruction of damaged corneal epithelium using Venus-labeled limbal epithelial stem cells and tracking of surviving donor cells (2013) Exp. Eye Res., 115, pp. 246-254; Chetprayoon, P., Kadowaki, K., Matsusaki, M., Akashi, M., Survival and structural evaluations of three-dimensional tissues fabricated by the hierarchical cell manipulation technique (2013) Acta Biomater., 9 (1), pp. 4698-4706; Sauerzweig, S., Baldauf, K., Braun, H., Reymann, K.G., Time-dependent segmentation of BrdU-signal leads to late detection problems in studies using BrdU as cell label or proliferation marker (2009) J. Neurosci. Methods, 177 (1), pp. 149-159; Henry, F.P., Goyal, N.A., David, W.S., Wes, D., Bujold, K.E., Randolph, M.A., Improving electrophysiologic and histologic outcomes by photochemically sealing amnion to the peripheral nerve repair site (2009) Surgery, 145 (3), pp. 313-321; Gomes, J.A., Geraldes Monteiro, B., Melo, G.B., Smith, R.L., Cavenaghi Pereira Da Silva, M., Lizier, N.F., Corneal reconstruction with tissue-engineered cell sheets composed of human immature dental pulp stem cells (2010) Invest Ophthalmol Vis Sci., 51 (3), pp. 1408-1414; Lin, J., Yoon, K.C., Zhang, L., Su, Z., Lu, R., Ma, P., A native-like corneal construct using donor corneal stroma for tissue engineering (2012) PLoS One, 7 (11), p. e49571; Di Iorio, E., Barbaro, V., Ferrari, S., Ortolani, C., De Luca, M., Pellegrini, G., Q-FIHC: Quantification of fluorescence immunohistochemistry to analyse p63 isoforms and cell cycle phases in human limbal stem cells (2006) Microsc. Res. Tech., 69 (12), pp. 983-991; Ahmad, S., Kolli, S., Li, D.Q., De Paiva, C.S., Pryzborski, S., Dimmick, I., A putative role for RHAMM/HMMR as a negative marker of stem cell-containing population of human limbal epithelial cells (2008) Stem Cells, 26 (6), pp. 1609-1619; Yao, M., Gu, C., Doyle, Jr.F.J., Zhu, H., Redmond, R.W., Kochevar, I.E., Why is rose bengal more phototoxic to fibroblasts in vitro than in vivo? (2014) Photochem. Photobiol., 90 (2), pp. 297-305; Uppal, A., Jain, B., Gupta, P.K., Das, K., Photodynamic action of Rose Bengal silica nanoparticle complex on breast and oral cancer cell lines (2011) Photochem. Photobiol., 87 (5), pp. 1146-1151; Verter, E.E., Gisel, T.E., Yang, P., Johnson, A.J., Redmond, R.W., Kochevar, I.E., Light-initiated bonding of amniotic membrane to cornea (2011) Invest Ophthalmol. Vis. Sci., 52 (13), pp. 9470-9477; Cordes, N., Integrin-mediated cell-matrix interactions for prosurvival and antiapoptotic signaling after genotoxic injury (2006) Cancer Lett., 242 (1), pp. 11-19; Park, K.S., Lim, C.H., Min, B.M., Lee, J.L., Chung, H.Y., Joo, C.K., The side population cells in the rabbit limbus sensitively increased in response to the central cornea wounding (2006) Invest. Ophthalmol. Vis. Sci., 47 (3), pp. 892-900; Lin, K.J., Loi, M.X., Lien, G.S., Cheng, C.F., Pao, H.Y., Chang, Y.C., Topical administration of orbital fat-derived stem cells promotes corneal tissue regeneration (2013) Stem Cell Res. Ther., 4 (3), p. 72; Lauweryns, B., Van Den Oord, J.J., Missotten, L., The transitional zone between limbus and peripheral cornea. An immunohistochemical study (1993) Invest. Ophthalmol. Vis. Sci., 34 (6), pp. 1991-1999; Park, S.M., Choi, J.W., Kim, S.T., Cho, M.C., Sung, R.H., Jang, L.C., Suppression of proliferative cholangitis in a rat model by local delivery of paclitaxel (2003) J. Hepatobiliary Pancreat. Surg., 10 (2), pp. 176-182; You, S., Tariq, A., Kublin, C.L., Zoukhri, D., Detection of BrdU-label retaining cells in the lacrimal gland: Implications for tissue repair (2011) Cell Tissue Res., 346 (3), pp. 317-326",Article,Scopus,2-s2.0-84927633453
"Kraft D., Ritter S., Durante M., Seifried E., Fournier C., Tonn T.","Transmission of clonal chromosomal abnormalities in human hematopoietic stem and progenitor cells surviving radiation exposure",2015,"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","777",,,"43","51",,,10.1016/j.mrfmmm.2015.04.007,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928721793&partnerID=40&md5=c84f3f7cac6b279383ef9e5e689a07ee","GSI Helmholtz Center for Heavy Ion Research, Department of Biophysics, Planckstr. 1Darmstadt, Germany; Institute for Transfusion Medicine und Immunohematology, DRK-Blutspendedienst Baden-Wuerttemberg-Hessen, Johann Wolfgang Goethe-University Hospital, Sandhofstrasse 1Frankfurt, Germany; Institute for Condensed Matter Physics, Physics Department, Technical University Darmstadt, Hochschulstraße 6-8Darmstadt, Germany; Technische Universität Dresden, Med. Fakultät Carl Gustav Carus; Institute for Transfusion Medicine Dresden, German Red Cross Blood Donation Service North-East, Blasewitzer Straße 68/70Dresden, Germany","Kraft, D., GSI Helmholtz Center for Heavy Ion Research, Department of Biophysics, Planckstr. 1Darmstadt, Germany, Institute for Transfusion Medicine und Immunohematology, DRK-Blutspendedienst Baden-Wuerttemberg-Hessen, Johann Wolfgang Goethe-University Hospital, Sandhofstrasse 1Frankfurt, Germany; Ritter, S., GSI Helmholtz Center for Heavy Ion Research, Department of Biophysics, Planckstr. 1Darmstadt, Germany; Durante, M., GSI Helmholtz Center for Heavy Ion Research, Department of Biophysics, Planckstr. 1Darmstadt, Germany, Institute for Condensed Matter Physics, Physics Department, Technical University Darmstadt, Hochschulstraße 6-8Darmstadt, Germany; Seifried, E., Institute for Transfusion Medicine und Immunohematology, DRK-Blutspendedienst Baden-Wuerttemberg-Hessen, Johann Wolfgang Goethe-University Hospital, Sandhofstrasse 1Frankfurt, Germany; Fournier, C., GSI Helmholtz Center for Heavy Ion Research, Department of Biophysics, Planckstr. 1Darmstadt, Germany; Tonn, T., Institute for Transfusion Medicine und Immunohematology, DRK-Blutspendedienst Baden-Wuerttemberg-Hessen, Johann Wolfgang Goethe-University Hospital, Sandhofstrasse 1Frankfurt, Germany, Technische Universität Dresden, Med. Fakultät Carl Gustav Carus; Institute for Transfusion Medicine Dresden, German Red Cross Blood Donation Service North-East, Blasewitzer Straße 68/70Dresden, Germany","In radiation-induced acute myeloid leukemia (rAML), clonal chromosomal abnormalities are often observed in bone marrow cells of patients, suggesting that their formation is crucial in the development of the disease. Since rAML is considered to originate from hematopoietic stem and progenitor cells (HSPC), we investigated the frequency and spectrum of radiation-induced chromosomal abnormalities in human CD34+ cells. We then measured stable chromosomal abnormalities, a possible biomarker of leukemia risk, in clonally expanded cell populations which were grown for 14 days in a 3D-matrix (CFU-assay). We compared two radiation qualities used in radiotherapy, sparsely ionizing X-rays and densely ionizing carbon ions (29 and 60-85keV/μm, doses between 0.5 and 4Gy). Only a negligible number of de novo arising, unstable aberrations (≤0.05 aberrations/cell, 97% breaks) were measured in the descendants of irradiated HSPC. However, stable aberrations were detected in colonies formed by irradiated HSPC. All cells of the affected colonies exhibited one or more identical aberrations, indicating their clonal origin. The majority of the clonal rearrangements (92%) were simple exchanges such as translocations (77%) and pericentric inversions (15%), which are known to contribute to the development of rAML. Carbon ions were more efficient in inducing cell killing (maximum of ~30-35% apoptotic cells for 2Gy carbon ions compared to ~25% for X-rays) and chromosomal aberrations in the first cell-cycle after exposure (~70% and ~40% for 1Gy of carbon ions and X-rays, respectively), with a higher fraction of non-transmissible aberrations. In contrast, for both radiation qualities the percentage of clones with chromosomal abnormalities was similar (40%). Using the frequency of colonies with clonal aberrations as a surrogate marker for the leukemia risk following radiotherapy of solid tumors, charged particle therapy is not expected to lead to an increased risk of leukemia in patients. © 2015 Elsevier B.V.","Carbon ions; Cell death; Clonal chromosomal abnormalities; Genomic instability; Hematopoietic stem and progenitor cells; Ionizing radiation","Allan, J.M., Travis, L.B., Mechanisms of therapy-related carcinogenesis (2005) Nat. Rev. Cancer, 5, pp. 943-955; Amenomori, T., Honda, T., Otake, M., Tomonaga, M., Ichimaru, M., Growth and differentiation of circulating hemopoietic stem cells with atomic bomb irradiation-induced chromosome abnormalities (1988) Exp. Hematol., 16, pp. 849-854; Anderson, R.M., Stevens, D.L., Sumption, N.D., Townsend, K.M.S., Goodhead, D.T., Hill, M.A., Effect of linear energy transfer (LET) on the complexity of alpha-particle-induced chromosome aberrations in human CD34+ cells (2007) Radiat. Res., 167 (5), pp. 541-550; Asaithamby, A., Uematsu, N., Chatterjee, A., Story, M.D., Burma, S., Chen, D.J., Repair of HZE-particle-induced DNA double-strand breaks in normal human fibroblasts (2008) Radiat. Res., 169, pp. 437-446; Bastianutto, C., Mian, A., Symes, J., Mocanu, J., Alajez, N., Sleep, G., Shi, W., Liu, F.-F., Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow (2007) Cancer Res., 67, pp. 10112-10116; Becker, D., Elsässer, T., Tonn, T., Seifried, E., Durante, M., Ritter, S., Fournier, C., Response of human hematopoietic stem and progenitor cells to energetic carbon ions (2009) Int. J. Radiat. Biol., 85 (11), pp. 1051-1059; Boothman, D.A., Burrows, H.L., Yang, C.-R., Davis, T.D., Wuerzberger, S.M., Planchon, S.M., Odegaard, E., Kinsella, T.J., Damage-sensing mechanisms in human cells after ionizing radiation (1997) Stem Cells, 15, pp. 27-42; Cornforth, M.N., Analyzing radiation-induced complex chromosome rearrangements by combinatorial painting (2001) Radiat. Res., 155, pp. 643-659; Crans, H.N., Sakamoto, K.M., Transcription factors and translocations in lymphoid and myeloid leukemia (2001) Leukemia, 15, pp. 313-331; Das-Gupta, E.P., Seedhouse, C.H., Russell, N.H., Microsatellite instability occurs in defined subsets of patients with acute myeloblastic leukaemia (2001) Br. J. Haematol., 114, pp. 307-312; Datta, K., Suman, S., Trani, D., Doiron, K., Rotolo, J.A., Kallakury, B.V.S., Kolesnick, R., Fornace, A.J., Accelerated hematopoietic toxicity by high energy (56)Fe radiation (2012) Int. J. Radiat. Biol., 88, pp. 213-222; Durante, M., George, K., Cucinotta, F.A., Chromosomes lacking telomeres are present in the progeny of human lymphocytes exposed to heavy ions (2006) Radiat. Res., 165, pp. 51-58; Durante, M., George, K., Wu, H., Cucinotta, F.A., Karyotypes of human lymphocytes exposed to high-energy iron ions (2002) Radiat. Res., 158, pp. 581-590; Friedman, D.L., Whitton, J., Leisenring, W., Mertens, A.C., Hammond, S., Stovall, M., Donaldson, S.S., Neglia, J.P., Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study (2010) J. Natl. Cancer Inst., 102, pp. 1083-1095; Gezer, D., Vukovic, M., Soga, T., Pollard, P.J., Kranc, K.R., Concise review: genetic dissection of hypoxia signaling pathways in normal and leukemic stem cells (2014) Stem Cells, 32, pp. 1390-1397; Greulich, K.M., Kreja, L., Heinze, B., Rhein, A.P., Weier, H.G., Brückner, M., Fuchs, P., Molls, M., Rapid detection of radiation-induced chromosomal aberrations in lymphocytes and hematopoietic progenitor cells by mFISH (2000) Mutat. Res., 452, pp. 73-81; Hagmar, L., Strömberg, U., Bonassi, S., Hansteen, I.-L., Knudsen, L.E., Lindholm, C., Norppa, H., Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts (2004) Cancer Res., 64, pp. 2258-2263; Harada, H., Harada, Y., Tanaka, H., Kimura, A., Inaba, T., Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia (2003) Blood, 101, pp. 673-680; Hsu, W.-L., Preston, D.L., Soda, M., Sugiyama, H., Funamoto, S., Kodama, K., Kimura, A., Mabuchi, K., The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001 (2013) Radiat. Res., 179, pp. 361-382; Huang, L., Snyder, A.R., Morgan, W.F., Radiation-induced genomic instability and its implications for radiation carcinogenesis (2003) Oncogene, 22, pp. 5848-5854; Kadhim, M.A., Role of genetic background in induced instability (2003) Oncogene, 22, pp. 6994-6999; Kadhim, M.A., Lorimore, S.A., Hepburn, M.D., Goodhead, D.T., Buckle, V.J., Wright, E.G., Alpha-particle-induced chromosomal instability in human bone marrow cells (1994) Lancet, 344, pp. 987-988; Kadhim, M.A., Macdonald, D.A., Goodhead, D.T., Lorimore, S.A., Marsden, S.J., Wright, E.G., Transmission of chromosomal instability after plutonium alpha-particle irradiation (1992) Nature, 355, pp. 738-740; Kadhim, M.A., Wright, E.G., Radiation-induced transmissable chromosomal instability in haemopoietic stem cells (1998) Adv. Space Res. Off. J. Comm. Space Res. COSPAR, 22, pp. 587-596; Kausch, H., (2003) Radiation Effects on Polymers for Biological Use, Advances in Polymer Science, , Springer, Berlin, Heidelberg; Kreja, L., Greulich, K.M., Fliedner, T.M., Heinze, B., Stable chromosomal aberrations in haemopoietic stem cells in the blood of radiation accident victims (1999) Int. J. Radiat. Biol., 75, pp. 1241-1250; Kusunoki, Y., Kodama, Y., Hirai, Y., Kyoizumi, S., Nakamura, N., Akiyama, M., Cytogenetic and immunologic identification of clonal expansion of stem cells into T and B lymphocytes in one atomic-bomb survivor (1995) Blood, 86, pp. 2106-2112; Kvinlaug, B.T., Chan, W.-I., Bullinger, L., Ramaswami, M., Sears, C., Foster, D., Lazic, S.E., Huntly, B.J.P., Common and overlapping oncogenic pathways contribute to the evolution of acute myeloid leukemias (2011) Cancer Res., 71, pp. 4117-4129; Limoli, C.L., Ponnaiya, B., Corcoran, J.J., Giedzinski, E., Morgan, W.F., Chromosomal instability induced by heavy ion irradiation (2000) Int. J. Radiat. Biol., 76, pp. 1599-1606; Lorimore, S.A., Mukherjee, D., Robinson, J.I., Chrystal, J.A., Wright, E.G., Long-lived inflammatory signaling in irradiated bone marrow is genome dependent (2011) Cancer Res., 71, pp. 6485-6491; Loucas, B.D., Cornforth, M.N., Complex chromosome exchanges induced by gamma rays in human lymphocytes: an mFISH study (2001) Radiat. Res., 155, pp. 660-671; Mathews, J.D., Forsythe, A.V., Brady, Z., Butler, M.W., Goergen, S.K., Byrnes, G.B., Giles, G.G., Darby, S.C., Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians (2013) BMJ, 346, p. f2360; (2015) Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer, , http://cgap.nci.nih.gov/Chromosomes/Mitelman; Monzen, S., Yoshino, H., Kasai-Eguchi, K., Kashiwakura, I., Characteristics of myeloid differentiation and maturation pathway derived from human hematopoietic stem cells exposed to different linear energy transfer radiation types (2013) PLoS ONE, 8, p. e59385; Muirhead, C.R., O'Hagan, J.A., Haylock, R.G.E., Phillipson, M.A., Willcock, T., Berridge, G.L.C., Zhang, W., Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers (2009) Br. J. Cancer, 100, pp. 206-212; Nakanishi, M., Tanaka, K., Shintani, T., Takahashi, T., Kamada, N., Chromosomal instability in acute myelocytic leukemia and myelodysplastic syndrome patients among atomic bomb survivors (1999) J. Radiat. Res. (Tokyo), 40, pp. 159-167; Negrini, S., Gorgoulis, V.G., Halazonetis, T.D., Genomic instability-an evolving hallmark of cancer (2010) Nat. Rev. Mol. Cell Biol., 11, pp. 220-228; Newhauser, W.D., Durante, M., Assessing the risk of second malignancies after modern radiotherapy (2011) Nat. Rev. Cancer, 11, pp. 438-448; Pignalosa, D., Ritter, S., Durante, M., Inversions in chromosome 10 of human thyroid cells induced by accelerated heavy ions (2010) Radiat. Res., 174, pp. 14-19; Plappert, U., Rutzen-Loesevitz, L., Chapter 8: perspectives for the use of biological indicators for the assessment of radiation induced responses and impairments: what is the status of molecular and cell biology approaches relevant to radiation effects assessment? (1995) Stem Cells, 13, pp. 318-322; Rassool, F.V., Gaymes, T.J., Omidvar, N., Brady, N., Beurlet, S., Pla, M., Reboul, M., Padua, R.A., Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia? (2007) Cancer Res., 67, pp. 8762-8771; Richardson, R.B., Stem cell niches and other factors that influence the sensitivity of bone marrow to radiation-induced bone cancer and leukaemia in children and adults (2011) Int. J. Radiat. Biol., 87, pp. 343-359; Rigat, B.A., Lorimore, S.A., Plumb, M.A., Wright, E.G., A PCR-based clonal analysis of radiation-induced loss of heterozygosity in haemopoietic stem cells (2001) Leukemia, 15, pp. 1604-1611; Ritter, S., Durante, M., Heavy-ion induced chromosomal aberrations: a review (2010) Mutat. Res., 701, pp. 38-46; Ritter, S., Nasonova, E., Gudowska-Novak, E., Effect of LET on the yield and quality of chromosomal damage in metaphase cells: a time-course study (2002) Int. J. Radiat. Biol., 78, pp. 191-202; Savage, J.R., Simpson, P.J., FISH painting patterns resulting from complex exchanges (1994) Mutat. Res., 312, pp. 51-60; Sheikhha, M.H., Tobal, K., Liu Yin, J.A., High level of microsatellite instability but not hypermethylation of mismatch repair genes in therapy-related and secondary acute myeloid leukaemia and myelodysplastic syndrome (2002) Br. J. Haematol, 117, pp. 359-365; Smith, S.M., Le Beau, M.M., Huo, D., Karrison, T., Sobecks, R.M., Anastasi, J., Vardiman, J.W., Larson, R.A., Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series (2003) Blood, 102, pp. 43-52; Tawn, E.J., Whitehouse, C.A., Martin, F.A., Sequential chromosome aberration analysis following radiotherapy-no evidence for enhanced genomic instability (2000) Mutat. Res., 465, pp. 45-51; Trosko, J.E., Inoue, T., Oxidative stress, signal transduction, and intercellular communication in radiation carcinogenesis (1997) Stem Cells, 15, pp. 59-67; Tsushima, H., Iwanaga, M., Miyazaki, Y., Late effect of atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes (2012) Int. J. Hematol., 95, pp. 232-238; Whitehouse, C.A., Tawn, E.J., No evidence for chromosomal instability in radiation workers with in vivo exposure to plutonium (2001) Radiat. Res., 156, pp. 467-475; Zharlyganova, D., Harada, H., Harada, Y., Shinkarev, S., Zhumadilov, Z., Zhunusova, A., Tchaizhunusova, N.J., Hoshi, M., High frequency of AML1/RUNX1 point mutations in radiation-associated myelodysplastic syndrome around Semipalatinsk nuclear test site (2008) J. Radiat. Res. (Tokyo), 49, pp. 549-555; Durante, M., Yamada, S., Ando, K., Furusawa, Y., Kawata, T., Majima, H., Nakano, T., Tsujii, H., X-rays vs. carbon-ion tumor therapy: cytogenetic damage in lymphocytes (2000) Int. J. Radiat. Oncol. Biol. Phys., 47 (3), pp. 793-798; Lee, R., Sommer, S., Hartel, C., Nasonova, E., Durante, M., Ritter, S., Complex exchanges are responsible for the increased effectiveness of C-ions compared to X-rays at the first post-irradiation mitosis (2010) Mutat. Res., 701 (1), pp. 52-59; Fournier, C., Zahnreich, S., Kraft, D., Friedrich, T., Voss, K.O., Durante, M., Ritter, S., The fate of a normal human cell traversed by a single charged particle (2012) Sci. Rep., 2, p. 643",Article,Scopus,2-s2.0-84928721793
"Lee H., Kim M., Kim N., Macfarlan T., Pfaff S.L., Mastick G.S., Song M.-R.","Slit and Semaphorin signaling governed by Islet transcription factors positions motor neuron somata within the neural tube",2015,"Experimental Neurology","269",,,"17","27",,,10.1016/j.expneurol.2015.03.024,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927155739&partnerID=40&md5=44cdce188e2ef633346f3924f2ea31c4","School of Life Sciences, Cell Dynamics Research Center, Gwangju Institute of Science and TechnologyOryong-dong, Buk-gu, Gwangju, South Korea; Department of Biology, University of NevadaReno, NV, United States; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of HealthBethesda, MD, United States; Gene Expression Laboratory and the Howard Hughes Medical Institute, The Salk Institute for Biological Studies, 10010 North Torrey PinesLa Jolla, CA, United States","Lee, H., School of Life Sciences, Cell Dynamics Research Center, Gwangju Institute of Science and TechnologyOryong-dong, Buk-gu, Gwangju, South Korea; Kim, M., Department of Biology, University of NevadaReno, NV, United States; Kim, N., School of Life Sciences, Cell Dynamics Research Center, Gwangju Institute of Science and TechnologyOryong-dong, Buk-gu, Gwangju, South Korea; Macfarlan, T., Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of HealthBethesda, MD, United States; Pfaff, S.L., Gene Expression Laboratory and the Howard Hughes Medical Institute, The Salk Institute for Biological Studies, 10010 North Torrey PinesLa Jolla, CA, United States; Mastick, G.S., Department of Biology, University of NevadaReno, NV, United States; Song, M.-R., School of Life Sciences, Cell Dynamics Research Center, Gwangju Institute of Science and TechnologyOryong-dong, Buk-gu, Gwangju, South Korea","Motor neurons send out axons to peripheral muscles while their cell bodies remain in the ventral spinal cord. The unique configuration of motor neurons spanning the border between the CNS and PNS has been explained by structural barriers such as boundary cap (BC) cells, basal lamina and radial glia. However, mechanisms in motor neurons that retain their position have not been addressed yet. Here we demonstrate that the Islet1 (Isl1) and Islet2 (Isl2) transcription factors, which are essential for acquisition of motor neuron identity, also contribute to restrict motor neurons within the neural tube. In mice that lack both Isl1 and Isl2, large numbers of motor neurons exited the neural tube, even prior to the appearance of BC cells at the ventral exit points. Transcriptional profiling of motor neurons derived from Isl1 null embryonic stem cells revealed that transcripts of major genes involved in repulsive mechanisms were misregulated. Particularly, expression of Neuropilin1 (Npr1) and Slit2 mRNA was diminished in Islet mutant mice, and these could be target genes of the Islet proteins. Consistent with this mechanism, Robo and Slit mutations in mice and knockdown of Npr1 and Slit2 in chick embryos caused motor neurons to migrate to the periphery. Together, our study suggests that Islet genes engage Robo-Slit and Neuropilin-Semaphorin signaling in motor neurons to retain motor somata within the CNS. © 2015 Elsevier Inc.","Islet1; Islet2; Motor neuron somata; Neuropilin1; Slit2","Altman, J., Bayer, S.A., Development of the cranial nerve ganglia and related nuclei in the rat (1982) Adv. Anat. Embryol. Cell Biol., 74, pp. 1-90; Altman, J., Bayer, S.A., The development of the rat spinal cord (1984) Adv. Anat. Embryol. Cell Biol., 85, p. 1; Bai, G., Chivatakarn, O., Bonanomi, D., Lettieri, K., Franco, L., Xia, C., Stein, E., Pfaff, S.L., Presenilin-dependent receptor processing is required for axon guidance (2011) Cell, 144, pp. 106-118; Bravo-Ambrosio, A., Kaprielian, Z., Crossing the border: molecular control of motor axon exit (2011) Int. J. Mol. Sci., 12, pp. 8539-8561; Bravo-Ambrosio, A., Mastick, G., Kaprielian, Z., Motor axon exit from the mammalian spinal cord is controlled by the homeodomain protein Nkx2. 9 via Robo-Slit signaling (2012) Development, 139, pp. 1435-1446; Bron, R., Eickholt, B.J., Vermeren, M., Fragale, N., Cohen, J., Functional knockdown of neuropilin-1 in the developing chick nervous system by siRNA hairpins phenocopies genetic ablation in the mouse (2004) Dev. Dyn., 230, pp. 299-308; Bron, R., Vermeren, M., Kokot, N., Andrews, W., Little, G.E., Mitchell, K.J., Cohen, J., Boundary cap cells constrain spinal motor neuron somal migration at motor exit points by a semaphorin-plexin mechanism (2007) Neural Dev., 2, p. 21; Brose, K., Bland, K.S., Wang, K.H., Arnott, D., Henzel, W., Goodman, C.S., Tessier-Lavigne, M., Kidd, T., Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance (1999) Cell, 96, pp. 795-806; Delloye-Bourgeois, C., Jacquier, A., Charoy, C., Reynaud, F., Nawabi, H., Thoinet, K., Kindbeiter, K., Kong, Y., PlexinA1 is a new Slit receptor and mediates axon guidance function of Slit C-terminal fragments (2015) Nat. Neurosci., 18, pp. 36-45; Demireva, E.Y., Shapiro, L.S., Jessell, T.M., Zampieri, N., Motor neuron position and topographic order imposed by β-and γ-catenin activities (2011) Cell, 147, pp. 641-652; Ericson, J., Thor, S., Edlund, T., Jessell, T.M., Yamada, T., Early stages of motor neuron differentiation revealed by expression of homeobox gene Islet-1 (1992) Science, 256, pp. 1555-1560; Fraher, J.P., Rossiter, J.P., Cell clusters on rat ventral roots: postnatal development (1983) J. Anat., 137, p. 555; Fraher, J.P., Dockery, P., O'Donoghue, O., Riedewald, B., O'Leary, D., Initial motor axon outgrowth from the developing central nervous system (2007) J. Anat., 211, pp. 600-611; Gadd, M.S., Bhati, M., Jeffries, C.M., Langley, D.B., Trewhella, J., Guss, J.M., Matthews, J.M., Structural basis for partial redundancy in a class of transcription factors, the LIM homeodomain proteins, in neural cell type specification (2011) J. Biol. Chem., 286, pp. 42971-42980; Gibson, D.A., Tymanskyj, S., Yuan, R.C., Leung, H.C., Lefebvre, J.L., Sanes, J.R., Chédotal, A., Ma, L., Dendrite self-avoidance requires cell-autonomous Slit/Robo signaling in cerebellar Purkinje cells (2014) Neuron, 81, pp. 1040-1056; Giovannone, D., Reyes, M., Reyes, R., Correa, L., Martinez, D., Ra, H., Gomez, G., Stein, M.P., Slits affect the timely migration of neural crest cells via Robo receptor (2012) Dev. Dyn., 241, pp. 1274-1288; Grieshammer, U., Plump, A.S., Wang, F., Tessier-Lavigne, M., Martin, G.R., SLIT2-mediated ROBO2 signaling restricts kidney induction to a single site (2004) Dev. Cell, 6, pp. 709-717; Halfter, W., Dong, S., Yip, Y.-P., Willem, M., Mayer, U., A critical function of the pial basement membrane in cortical histogenesis (2002) J. Neurosci., 22, pp. 6029-6040; Hammond, R., Vivancos, V., Naeem, A., Chilton, J., Mambitisaeva, E., Andrews, W., Sundaresan, V., Guthrie, S., Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain (2005) Development, 132, pp. 4483-4495; He, Z., Tessier-Lavigne, M., Neuropilin is a receptor for the axonal chemorepellent Semaphorin III (1997) Cell, 90, pp. 739-751; Hernandez-Miranda, L.R., Cariboni, A., Faux, C., Ruhrberg, C., Cho, J.H., Cloutier, J.-F., Eickholt, B.J., Andrews, W.D., Robo1 regulates semaphorin signaling to guide the migration of cortical interneurons through the ventral forebrain (2011) J. Neurosci., 31, pp. 6174-6187; Hutchinson, S.A., Eisen, J.S., Islet1 and Islet2 have equivalent abilities to promote motoneuron formation and to specify motoneuron subtype identity (2006) Development, 133, pp. 2137-2147; Jaworski, A., Tessier-Lavigne, M., Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling (2012) Nat. Neurosci., 15, pp. 367-369; Kania, A., Jessell, T.M., Topographic motor projections in the limb imposed by LIM homeodomain protein regulation of ephrin-A:EphA interactions (2003) Neuron, 38, pp. 581-596; Kim, M., Roesener, A.P., Mendonca, P.R.F., Mastick, G.S., Robo1 and Robo2 have distinct roles in pioneer longitudinal axon guidance (2011) Dev. Biol., 358, pp. 181-188; Kim, M., Fontelonga, T., Roesener, A.P., Lee, H., Gurung, S., Mendonca, P.R.F., Mastick, G.S., Motor neuron cell bodies are actively positioned by Slit/Robo repulsion and Netrin/DCC attraction (2015) Dev. Biol., 399, pp. 68-79; Kitsukawa, T., Shimizu, M., Sanbo, M., Hirata, T., Taniguchi, M., Bekku, Y., Yagi, T., Fujisawa, H., Neuropilin-Semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice (1997) Neuron, 19, pp. 995-1005; Kolodkin, A.L., Levengood, D.V., Rowe, E.G., Tai, Y.-T., Giger, R.J., Ginty, D.D., Neuropilin is a semaphorin III receptor (1997) Cell, 90, pp. 753-762; Kucenas, S., Takada, N., Park, H.-C., Woodruff, E., Broadie, K., Appel, B., CNS-derived glia ensheath peripheral nerves and mediate motor root development (2008) Nat. Neurosci., 11, pp. 143-151; Lee, H., Song, M.-R., The structural role of radial glial endfeet in confining spinal motor neuron somata is controlled by the Reelin and Notch pathways (2013) Exp. Neurol., 249, pp. 83-94; Lee, S.-K., Jurata, L.W., Funahashi, J., Ruiz, E.C., Pfaff, S.L., Analysis of embryonic motoneuron gene regulation: derepression of general activators function in concert with enhancer factors (2004) Development, 131, pp. 3295-3306; Lee, S., Cuvillier, J.M., Lee, B., Shen, R., Lee, J.W., Lee, S.-K., Fusion protein Isl1 Lhx3 specifies motor neuron fate by inducing motor neuron genes and concomitantly suppressing the interneuron programs (2012) Proc. Natl. Acad. Sci., 109, pp. 3383-3388; Livet, J., Sigrist, M., Stroebel, S., De Paola, V., Price, S.R., Henderson, C.E., Jessell, T.M., Arber, S., ETS gene Pea3 controls the central position and terminal arborization of specific motor neuron pools (2002) Neuron, 35, pp. 877-892; Long, H., Sabatier, C., Plump, A., Yuan, W., Ornitz, D.M., Tamada, A., Murakami, F., Tessier-Lavigne, M., Conserved roles for Slit and Robo proteins in midline commissural axon guidance (2004) Neuron, 42, pp. 213-223; Macfarlan, T.S., Gifford, W.D., Agarwal, S., Driscoll, S., Lettieri, K., Wang, J., Andrews, S.E., Ren, B., Endogenous retroviruses and neighboring genes are coordinately repressed by LSD1/KDM1A (2011) Genes Dev., 25, pp. 594-607; Mauti, O., Domanitskaya, E., Andermatt, I., Sadhu, R., Stoeckli, E.T., Semaphorin6A acts as a gate keeper between the central and the peripheral nervous system (2007) Neural Dev., 2, p. 28; Mazzoni, E.O., Mahony, S., Closser, M., Morrison, C.A., Nedelec, S., Williams, D.J., An, D., Wichterle, H., Synergistic binding of transcription factors to cell-specific enhancers programs motor neuron identity (2013) Nat. Neurosci., 16, pp. 1219-1227; Niederlander, C., Lumsden, A., Late emigrating neural crest cells migrate specifically to the exit points of cranial branchiomotor nerves (1996) Development, 122, pp. 2367-2374; Nornes, H.O., Carry, M., Neurogenesis in spinal cord of mouse: an autoradiographic analysis (1978) Brain Res., 159, pp. 1-16; Palmesino, E., Rousso, D.L., Kao, T.-J., Klar, A., Laufer, E., Uemura, O., Okamoto, H., Kania, A., Foxp1 and lhx1 coordinate motor neuron migration with axon trajectory choice by gating Reelin signalling (2010) PLoS Biol., 8, p. e1000446; Pfaff, S.L., Mendelsohn, M., Stewart, C.L., Edlund, T., Jessell, T.M., Requirement for LIM homeobox gene Isl1 in motor neuron generation reveals a motor neuron dependent step in interneuron differentiation (1996) Cell, 84, pp. 309-320; Plump, A.S., Erskine, L., Sabatier, C., Brose, K., Epstein, C.J., Goodman, C.S., Mason, C.A., Tessier-Lavigne, M., Slit1 and Slit2 cooperate to prevent premature midline crossing of retinal axons in the mouse visual system (2002) Neuron, 33, pp. 219-232; Santiago, C., Labrador, J.-P., Bashaw, G.J., The homeodomain transcription factor Hb9 controls axon guidance in Drosophila through the regulation of Robo receptors (2014) Cell Rep., 7, pp. 153-165; Sharma, K., Sheng, H.Z., Lettieri, K., Li, H., Karavanov, A., Potter, S., Westphal, H., Pfaff, S.L., LIM homeodomain factors Lhx3 and Lhx4 assign subtype identities for motor neurons (1998) Cell, 95, pp. 817-828; Song, M.-R., Sun, Y., Bryson, A., Gill, G.N., Evans, S.M., Pfaff, S.L., Islet-to-LMO stoichiometries control the function of transcription complexes that specify motor neuron and V2a interneuron identity (2009) Development, 136, pp. 2923-2932; Sun, Y., Dykes, I.M., Liang, X., Eng, S.R., Evans, S.M., Turner, E.E., A central role for Islet1 in sensory neuron development linking sensory and spinal gene regulatory programs (2008) Nat. Neurosci., 11, pp. 1283-1293; Thaler, J., Harrison, K., Sharma, K., Lettieri, K., Kehrl, J., Pfaff, S.L., Active suppression of interneuron programs within developing motor neurons revealed by analysis of homeodomain factor HB9 (1999) Neuron, 23, pp. 675-687; Thaler, J.P., Lee, S.-K., Jurata, L.W., Gill, G.N., Pfaff, S.L., LIM factor Lhx3 contributes to the specification of motor neuron and interneuron identity through cell-type-specific protein-protein interactions (2002) Cell, 110, pp. 237-249; Thaler, J.P., Koo, S.J., Kania, A., Lettieri, K., Andrews, S., Cox, C., Jessell, T.M., Pfaff, S.L., A postmitotic role for Isl-class LIM homeodomain proteins in the assignment of visceral spinal motor neuron identity (2004) Neuron, 41, pp. 337-350; Tsuchida, T., Ensini, M., Morton, S.B., Baldassare, M., Edlund, T., Jessell, T.M., Pfaff, S.L., Topographic organization of embryonic motor neurons defined by expression of LIM homeobox genes (1994) Cell, 79, pp. 957-970; Vermeren, M., Maro, G.S., Bron, R., McGonnell, I.M., Charnay, P., Topilko, P., Cohen, J., Integrity of developing spinal motor columns is regulated by neural crest derivatives at motor exit points (2003) Neuron, 37, pp. 403-415; Wichterle, H., Lieberam, I., Porter, J.A., Jessell, T.M., Directed differentiation of embryonic stem cells into motor neurons (2002) Cell, 110, pp. 385-397; Wright, K.M., Lyon, K.A., Leung, H., Leahy, D.J., Ma, L., Ginty, D.D., Dystroglycan organizes axon guidance cue localization and axonal pathfinding (2012) Neuron, 76, pp. 931-944; Zhang, H., Wang, W.-P., Guo, T., Yang, J.-C., Chen, P., Ma, K.-T., Guan, Y.-F., Zhou, C.-Y., The LIM-homeodomain protein ISL1 activates insulin gene promoter directly through synergy with BETA2 (2009) J. Mol. Biol., 392, pp. 566-577",Article,Scopus,2-s2.0-84927155739
"Thompson L.H., Bjorklund A.","Reconstruction of brain circuitry by neural transplants generated from pluripotent stem cells",2015,"Neurobiology of Disease","79",,,"28","40",,,10.1016/j.nbd.2015.04.003,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928598929&partnerID=40&md5=e9c139dcc02189335227934b3a2ff1c1","Florey Institute for Neuroscience and Mental Health, University of Melbourne, Royal ParadeParkville, VIC, Australia; Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund UniversityLund, Sweden","Thompson, L.H., Florey Institute for Neuroscience and Mental Health, University of Melbourne, Royal ParadeParkville, VIC, Australia; Björklund, A., Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund UniversityLund, Sweden","Pluripotent stem cells (embryonic stem cells, ESCs, and induced pluripotent stem cells, iPSCs) have the capacity to generate neural progenitors that are intrinsically patterned to undergo differentiation into specific neuronal subtypes and express in vivo properties that match the ones formed during normal embryonic development. Remarkable progress has been made in this field during recent years thanks to the development of more refined protocols for the generation of transplantable neuronal progenitors from pluripotent stem cells, and the access to new tools for tracing of neuronal connectivity and assessment of integration and function of grafted neurons. Recent studies in brains of neonatal mice or rats, as well as in rodent models of brain or spinal cord damage, have shown that ESC- or iPSC-derived neural progenitors can be made to survive and differentiate after transplantation, and that they possess a remarkable capacity to extend axons over long distances and become functionally integrated into host neural circuitry. Here, we summarize these recent developments in the perspective of earlier studies using intracerebral and intraspinal transplants of primary neurons derived from fetal brain, with special focus on the ability of human ESC- and iPSC-derived progenitors to reconstruct damaged neural circuitry in cortex, hippocampus, the nigrostriatal system and the spinal cord, and we discuss the intrinsic and extrinsic factors that determine the growth properties of the grafted neurons and their capacity to establish target-specific long-distance axonal connections in the damaged host brain. © 2015.","Cell replacement; Embryonic stem; Induced pluripotent; Integration; Regeneration; Transplantation","Alvarez-Dolado, M., Calcagnotto, M.E., Karkar, K.M., Southwell, D.G., Jones-Davis, D.M., Estrada, R.C., Rubenstein, J.L., Baraban, S.C., Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain (2006) J. Neurosci. Off. J. Soc. Neurosci., 26, pp. 7380-7389; Andrews, E.M., Tsai, S.Y., Johnson, S.C., Farrer, J.R., Wagner, J.P., Kopen, G.C., Kartje, G.L., Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat (2008) Exp. Neurol., 211, pp. 588-592; Armstrong, R.J., Hurelbrink, C.B., Tyers, P., Ratcliffe, E.L., Richards, A., Dunnett, S.B., Rosser, A.E., Barker, R.A., The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease (2002) Exp. Neurol., 175, pp. 98-111; Avaliani, N., Sorensen, A.T., Ledri, M., Bengzon, J., Koch, P., Brustle, O., Deisseroth, K., Kokaia, M., Optogenetics reveal delayed afferent synaptogenesis on grafted human-induced pluripotent stem cell-derived neural progenitors (2014) Stem Cells, 32, pp. 3088-3098; Baraban, S.C., Southwell, D.G., Estrada, R.C., Jones, D.L., Sebe, J.Y., Alfaro-Cervello, C., Garcia-Verdugo, J.M., Alvarez-Buylla, A., Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 15472-15477; Bjorklund, A., Lindvall, O., Cell replacement therapies for central nervous system disorders (2000) Nat. Neurosci., 3, pp. 537-544; Bjorklund, A., Stenevi, U., Reformation of the severed septohippocampal cholinergic pathway in the adult rat by transplanted septal neurons (1977) Cell Tissue Res., 185, pp. 289-302; Bjorklund, A., Stenevi, U., Svendgaard, N., Growth of transplanted monoaminergic neurones into the adult hippocampus along the perforant path (1976) Nature, 262, pp. 787-790; Bjorklund, A., Segal, M., Stenevi, U., Functional reinnervation of rat hippocampus by locus coeruleus implants (1979) Brain Res., 170, pp. 409-426; Bjorklund, A., Nilsson, O.G., Kalen, P., Reafferentation of the subcortically denervated hippocampus as a model for transplant-induced functional recovery in the CNS (1990) Prog. Brain Res., 83, pp. 411-426; Bonilla, S., Hall, A.C., Pinto, L., Attardo, A., Gotz, M., Huttner, W.B., Arenas, E., Identification of midbrain floor plate radial glia-like cells as dopaminergic progenitors (2008) Glia, 56, pp. 809-820; Brilli, E., Reitano, E., Conti, L., Conforti, P., Gulino, R., Consalez, G.G., Cesana, E., Cattaneo, E., Neural stem cells engrafted in the adult brain fuse with endogenous neurons (2013) Stem Cells Dev., 22, pp. 538-547; Brundin, P., Isacson, O., Bjorklund, A., Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival (1985) Brain Res., 331, pp. 251-259; Bryson, J.B., Machado, C.B., Crossley, M., Stevenson, D., Bros-Facer, V., Burrone, J., Greensmith, L., Lieberam, I., Optical control of muscle function by transplantation of stem cell-derived motor neurons in mice (2014) Science, 344, pp. 94-97; Bye, C.R., Thompson, L.H., Parish, C.L., Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into parkinsonian mice (2012) Exp. Neurol., 236, pp. 58-68; Carletti, B., Piemonte, F., Rossi, F., Neuroprotection: the emerging concept of restorative neural stem cell biology for the treatment of neurodegenerative diseases (2011) Curr. Neuropharmacol., 9, pp. 313-317; Chen, S.J., Chang, C.M., Tsai, S.K., Chang, Y.L., Chou, S.J., Huang, S.S., Tai, L.K., Chiou, S.H., Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue (2010) Stem Cells Dev., 19, pp. 1757-1767; Chung, S., Moon, J.I., Leung, A., Aldrich, D., Lukianov, S., Kitayama, Y., Park, S., Kim, K.S., ES cell-derived renewable and functional midbrain dopaminergic progenitors (2011) Proc. Natl. Acad. Sci. U. S. A., 108, pp. 9703-9708; Clarke, D.J., Gage, F.H., Bjorklund, A., Formation of cholinergic synapses by intrahippocampal septal grafts as revealed by choline acetyltransferase immunocytochemistry (1986) Brain Res., 369, pp. 151-162; Cummings, B.J., Uchida, N., Tamaki, S.J., Salazar, D.L., Hooshmand, M., Summers, R., Gage, F.H., Anderson, A.J., Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 14069-14074; Cunningham, M., Cho, J.H., Leung, A., Savvidis, G., Ahn, S., Moon, M., Lee, P.K., Chung, S., HPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice (2014) Cell Stem Cell, 15, pp. 559-573; Cusulin, C., Monni, E., Ahlenius, H., Wood, J., Brune, J.C., Lindvall, O., Kokaia, Z., Embryonic stem cell-derived neural stem cells fuse with microglia and mature neurons (2012) Stem Cells, 30, pp. 2657-2671; Daadi, M.M., Maag, A.L., Steinberg, G.K., Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model (2008) PLoS One, 3. , e1644; Daszuta, A., Strecker, R.E., Brundin, P., Bjorklund, A., Serotonin neurons grafted to the adult rat hippocampus. I. Time course of growth as studied by immunohistochemistry and biochemistry (1988) Brain Res., 458, pp. 1-19; De Feo, D., Merlini, A., Laterza, C., Martino, G., Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection (2012) Curr. Opin. Neurol., 25, pp. 322-333; Denham, M., Parish, C.L., Leaw, B., Wright, J., Reid, C.A., Petrou, S., Dottori, M., Thompson, L.H., Neurons derived from human embryonic stem cells extend long-distance axonal projections through growth along host white matter tracts after intra-cerebral transplantation (2012) Front. Cell. Neurosci., 6, p. 11; Doi, D., Morizane, A., Kikuchi, T., Onoe, H., Hayashi, T., Kawasaki, T., Motono, M., Takahashi, J., Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease (2012) Stem Cells, 30, pp. 935-945; Dunnett, S., Cholinergic grafts, memory and ageing (1991) Trends Neurosci., 14, pp. 371-376; Dunnett, S.B., Low, W.C., Iversen, S.D., Stenevi, U., Bjorklund, A., Septal transplants restore maze learning in rats with fornix-fimbria lesions (1982) Brain Res., 251, pp. 335-348; Dunnett, S.B., Wareham, A.T., Torres, E.M., Septal grafts improve acquisition of an operant timing task after fimbria-fornix lesions in rats: role of the interval between lesion and transplantation surgeries (1993) Restor. Neurol. Neurosci., 5, pp. 263-274; Dunnett, S.B., Nathwani, F., Bjorklund, A., The integration and function of striatal grafts (2000) Prog. Brain Res., 127, pp. 345-380; Englund, U., Bjorklund, A., Wictorin, K., Lindvall, O., Kokaia, M., Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 17089-17094; Erceg, S., Ronaghi, M., Oria, M., Rosello, M.G., Arago, M.A., Lopez, M.G., Radojevic, I., Stojkovic, M., Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection (2010) Stem Cells, 28, pp. 1541-1549; Eriksson, C., Bjorklund, A., Wictorin, K., Neuronal differentiation following transplantation of expanded mouse neurosphere cultures derived from different embryonic forebrain regions (2003) Exp. Neurol., 184, pp. 615-635; Espejel, S., Romero, R., Alvarez-Buylla, A., Radiation damage increases Purkinje neuron heterokaryons in neonatal cerebellum (2009) Ann. Neurol., 66, pp. 100-109; Espuny-Camacho, I., Michelsen, K.A., Gall, D., Linaro, D., Hasche, A., Bonnefont, J., Bali, C., Vanderhaeghen, P., Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo (2013) Neuron, 77, pp. 440-456; Foster, G.A., Schultzberg, M., Gage, F.H., Bjorklund, A., Hokfelt, T., Nornes, H., Cuello, A.C., Visser, T.J., Transmitter expression and morphological development of embryonic medullary and mesencephalic raphe neurones after transplantation to the adult rat central nervous system. I. Grafts to the spinal cord (1985) Exp. Brain Res., 60, pp. 427-444; Fricker-Gates, R.A., Shin, J.J., Tai, C.C., Catapano, L.A., Macklis, J.D., Late-stage immature neocortical neurons reconstruct interhemispheric connections and form synaptic contacts with increased efficiency in adult mouse cortex undergoing targeted neurodegeneration (2002) J. Neurosci. Off. J. Soc. Neurosci., 22, pp. 4045-4056; Fujimoto, Y., Abematsu, M., Falk, A., Tsujimura, K., Sanosaka, T., Juliandi, B., Semi, K., Nakashima, K., Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells (2012) Stem Cells, 30, pp. 1163-1173; Gage, F.H., Bjorklund, A., Cholinergic septal grafts into the hippocampal formation improve spatial learning and memory in aged rats by an atropine-sensitive mechanism (1986) J. Neurosci. Off. J. Soc. Neurosci., 6, pp. 2837-2847; Gage, F.H., Bjorklund, A., Stenevi, U., Dunnett, S.B., Kelly, P.A., Intrahippocampal septal grafts ameliorate learning impairments in aged rats (1984) Science, 225, pp. 533-536; Gaillard, A., Roger, M., Early commitment of embryonic neocortical cells to develop area-specific thalamic connections (2000) Cereb. Cortex, 10, pp. 443-453; Gaillard, A., Prestoz, L., Dumartin, B., Cantereau, A., Morel, F., Roger, M., Jaber, M., Reestablishment of damaged adult motor pathways by grafted embryonic cortical neurons (2007) Nat. Neurosci., 10, pp. 1294-1299; Gaillard, A., Decressac, M., Frappe, I., Fernagut, P.O., Prestoz, L., Besnard, S., Jaber, M., Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants (2009) Neurobiol. Dis., 35, pp. 477-488; Ganat, Y.M., Calder, E.L., Kriks, S., Nelander, J., Tu, E.Y., Jia, F., Battista, D., Studer, L., Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment (2012) J. Clin. Invest., 122, pp. 2928-2939; Gaspard, N., Vanderhaeghen, P., Mechanisms of neural specification from embryonic stem cells (2010) Curr. Opin. Neurobiol., 20, pp. 37-43; Gaspard, N., Bouschet, T., Hourez, R., Dimidschstein, J., Naeije, G., van den Ameele, J., Espuny-Camacho, I., Vanderhaeghen, P., An intrinsic mechanism of corticogenesis from embryonic stem cells (2008) Nature, 455, pp. 351-357; Gaspard, N., Bouschet, T., Herpoel, A., Naeije, G., van den Ameele, J., Vanderhaeghen, P., Generation of cortical neurons from mouse embryonic stem cells (2009) Nat. Protoc., 4, pp. 1454-1463; Gibbs, R.B., Anderson, K., Cotman, C.W., Factors affecting innervation in the CNS: comparison of three cholinergic cell types transplanted to the hippocampus of adult rats (1986) Brain Res., 383, pp. 362-366; Gomi, M., Takagi, Y., Morizane, A., Doi, D., Nishimura, M., Miyamoto, S., Takahashi, J., Functional recovery of the murine brain ischemia model using human induced pluripotent stem cell-derived telencephalic progenitors (2012) Brain Res., 1459, pp. 52-60; Grealish, S., Jonsson, M.E., Li, M., Kirik, D., Bjorklund, A., Thompson, L.H., The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease (2010) Brain J. Neurol., 133, pp. 482-495; Grealish, S., Diguet, E., Kirkeby, A., Mattsson, B., Heuer, A., Bramoulle, Y., Van Camp, N., Parmar, M., Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease (2014) Cell Stem Cell, 15, pp. 653-665; Hankin, M.H., Lund, R.D., Specific target-directed axonal outgrowth from transplanted embryonic rodent retinae into neonatal rat superior colliculus (1987) Brain Res., 408, pp. 344-348; Hao, L., Zou, Z., Tian, H., Zhang, Y., Zhou, H., Liu, L., Stem cell-based therapies for ischemic stroke (2014) BioMed Res. Int., 2014, p. 468748; Hargus, G., Cooper, O., Deleidi, M., Levy, A., Lee, K., Marlow, E., Yow, A., Isacson, O., Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats (2010) Proc. Natl. Acad. Sci. U. S. A., 107, pp. 15921-15926; Harper, J.M., Krishnan, C., Darman, J.S., Deshpande, D.M., Peck, S., Shats, I., Backovic, S., Kerr, D.A., Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 7123-7128; Henderson, K.W., Gupta, J., Tagliatela, S., Litvina, E., Zheng, X., Van Zandt, M.A., Woods, N., Naegele, J.R., Long-term seizure suppression and optogenetic analyses of synaptic connectivity in epileptic mice with hippocampal grafts of GABAergic interneurons (2014) J. Neurosci. Off. J. Soc. Neurosci., 34, pp. 13492-13504; Hernit-Grant, C.S., Macklis, J.D., Embryonic neurons transplanted to regions of targeted photolytic cell death in adult mouse somatosensory cortex re-form specific callosal projections (1996) Exp. Neurol., 139, pp. 131-142; Hodges, H., Allen, Y., Kershaw, T., Lantos, P.L., Gray, J.A., Sinden, J., Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system-I. Amelioration of cognitive deficits by transplants into cortex and hippocampus but not into basal forebrain (1991) Neuroscience, 45, pp. 587-607; Hunt, R.F., Girskis, K.M., Rubenstein, J.L., Alvarez-Buylla, A., Baraban, S.C., GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior (2013) Nat. Neurosci., 16, pp. 692-697; Ideguchi, M., Palmer, T.D., Recht, L.D., Weimann, J.M., Murine embryonic stem cell-derived pyramidal neurons integrate into the cerebral cortex and appropriately project axons to subcortical targets (2010) J. Neurosci. Off. J. Soc. Neurosci., 30, pp. 894-904; Isacson, O., Deacon, T.W., Specific axon guidance factors persist in the adult brain as demonstrated by pig neuroblasts transplanted to the rat (1996) Neuroscience, 75, pp. 827-837; Iwanami, A., Kaneko, S., Nakamura, M., Kanemura, Y., Mori, H., Kobayashi, S., Yamasaki, M., Okano, H., Transplantation of human neural stem cells for spinal cord injury in primates (2005) J. Neurosci. Res., 80, pp. 182-190; Johansson, C.B., Youssef, S., Koleckar, K., Holbrook, C., Doyonnas, R., Corbel, S.Y., Steinman, L., Blau, H.M., Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation (2008) Nat. Cell Biol., 10, pp. 575-583; Jonsson, M.E., Ono, Y., Bjorklund, A., Thompson, L.H., Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis (2009) Exp. Neurol., 219, pp. 341-354; Kang, S.K., Lee, D.H., Bae, Y.C., Kim, H.K., Baik, S.Y., Jung, J.S., Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats (2003) Exp. Neurol., 183, pp. 355-366; Keirstead, H.S., Nistor, G., Bernal, G., Totoiu, M., Cloutier, F., Sharp, K., Steward, O., Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury (2005) J. Neurosci. Off. J. Soc. Neurosci., 25, pp. 4694-4705; Kelly, C.M., Precious, S.V., Penketh, R., Amso, N., Dunnett, S.B., Rosser, A.E., Striatal graft projections are influenced by donor cell type and not the immunogenic background (2007) Brain J. Neurol., 130, pp. 1317-1329; Kim, T.G., Yao, R., Monnell, T., Cho, J.H., Vasudevan, A., Koh, A., Peeyush, K.T., Chung, S., Efficient specification of interneurons from human pluripotent stem cells by dorsoventral and rostrocaudal modulation (2014) Stem Cells, 32, pp. 1789-1804; Kirkeby, A., Grealish, S., Wolf, D.A., Nelander, J., Wood, J., Lundblad, M., Lindvall, O., Parmar, M., Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions (2012) Cell Rep., 1, pp. 703-714; Koch, P., Opitz, T., Steinbeck, J.A., Ladewig, J., Brustle, O., A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 3225-3230; Kondo, T., Funayama, M., Tsukita, K., Hotta, A., Yasuda, A., Nori, S., Kaneko, S., Inoue, H., Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice (2014) Stem Cell Rep., 3, pp. 242-249; Kriks, S., Shim, J.W., Piao, J., Ganat, Y.M., Wakeman, D.R., Xie, Z., Carrillo-Reid, L., Studer, L., Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease (2011) Nature, 480, pp. 547-551; Leanza, G., Nikkhah, G., Nilsson, O.G., Wiley, R.G., Bjorklund, A., Extensive reinnervation of the hippocampus by embryonic basal forebrain cholinergic neurons grafted into the septum of neonatal rats with selective cholinergic lesions (1996) J. Comp. Neurol., 373, pp. 355-357; Lee, H., Shamy, G.A., Elkabetz, Y., Schofield, C.M., Harrsion, N.L., Panagiotakos, G., Socci, N.D., Studer, L., Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons (2007) Stem Cells, 25, pp. 1931-1939; Lee, K.H., Suh-Kim, H., Choi, J.S., Jeun, S.S., Kim, E.J., Kim, S.S., Yoon, D.H., Lee, B.H., Human mesenchymal stem cell transplantation promotes functional recovery following acute spinal cord injury in rats (2007) Acta Neurobiol. Exp., 67, pp. 13-22; Lepore, A.C., Rauck, B., Dejea, C., Pardo, A.C., Rao, M.S., Rothstein, J.D., Maragakis, N.J., Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease (2008) Nat. Neurosci., 11, pp. 1294-1301; Lewis, E.R., Cotman, C.W., Mechanisms of septal lamination in the developing hippocampus revealed by outgrowth of fibers from septal implants. III. Competitive interactions (1982) Brain Res., 233, pp. 29-44; Li, Y., Raisman, G., Long axon growth from embryonic neurons transplanted into myelinated tracts of the adult rat spinal cord (1993) Brain Res., 629, pp. 115-127; Lin, Y.C., Ko, T.L., Shih, Y.H., Lin, M.Y., Fu, T.W., Hsiao, H.S., Hsu, J.Y., Fu, Y.S., Human umbilical mesenchymal stem cells promote recovery after ischemic stroke (2011) Stroke, 42, pp. 2045-2053; Lindvall, O., Bjorklund, A., Cell therapeutics in Parkinson's disease (2011) Neurotherapeutics, 8, pp. 539-548; Lindvall, O., Hagell, P., Clinical observations after neural transplantation in Parkinson's disease (2000) Prog. Brain Res., 127, pp. 299-320; Lu, P., Wang, Y., Graham, L., McHale, K., Gao, M., Wu, D., Brock, J., Tuszynski, M.H., Long-distance growth and connectivity of neural stem cells after severe spinal cord injury (2012) Cell, 150, pp. 1264-1273; Lu, P., Woodruff, G., Wang, Y., Graham, L., Hunt, M., Wu, D., Boehle, E., Tuszynski, M.H., Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury (2014) Neuron, 83, pp. 789-796; Lukovic, D., Moreno Manzano, V., Stojkovic, M., Bhattacharya, S.S., Erceg, S., Concise review: human pluripotent stem cells in the treatment of spinal cord injury (2012) Stem Cells, 30, pp. 1787-1792; Lund, R.D., Chang, F.L., Hankin, M.H., Lagenaur, C.F., Use of a species-specific antibody for demonstrating mouse neurons transplanted to rat brains (1985) Neurosci. Lett., 61, pp. 221-226; MacLaren, R.E., Pearson, R.A., MacNeil, A., Douglas, R.H., Salt, T.E., Akimoto, M., Swaroop, A., Ali, R.R., Retinal repair by transplantation of photoreceptor precursors (2006) Nature, 444, pp. 203-207; Magavi, S.S., Lois, C., Transplanted neurons form both normal and ectopic projections in the adult brain (2008) Dev. Neurobiol., 68, pp. 1527-1537; Maisano, X., Litvina, E., Tagliatela, S., Aaron, G.B., Grabel, L.B., Naegele, J.R., Differentiation and functional incorporation of embryonic stem cell-derived GABAergic interneurons in the dentate gyrus of mice with temporal lobe epilepsy (2012) J. Neurosci. Off. J. Soc. Neurosci., 32, pp. 46-61; Maroof, A.M., Keros, S., Tyson, J.A., Ying, S.W., Ganat, Y.M., Merkle, F.T., Liu, B., Studer, L., Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells (2013) Cell Stem Cell, 12, pp. 559-572; Michelsen, K.A., Acosta-Verdugo, S., Benoit-Marand, M., Espuny-Camacho, I., Gaspard, N., Saha, B., Gaillard, A., Vanderhaeghen, P., Area-specific reestablishment of damaged circuits in the adult cerebral cortex by cortical neurons derived from mouse embryonic stem cells (2015) Neuron, 85, pp. 982-997; Mohamad, O., Drury-Stewart, D., Song, M., Faulkner, B., Chen, D., Yu, S.P., Wei, L., Vector-free and transgene-free human iPS cells differentiate into functional neurons and enhance functional recovery after ischemic stroke in mice (2013) PLoS One, 8. , e64160; Nicholas, C.R., Chen, J., Tang, Y., Southwell, D.G., Chalmers, N., Vogt, D., Arnold, C.M., Kriegstein, A.R., Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development (2013) Cell Stem Cell, 12, pp. 573-586; Nilsson, O.G., Bjorklund, A., Behaviour-dependent changes in acetylcholine release in normal and graft-reinnervated hippocampus: evidence for host regulation of grafted cholinergic neurons (1992) Neuroscience, 49, pp. 33-44; Nilsson, O.G., Clarke, D.J., Brundin, P., Bjorklund, A., Comparison of growth and reinnervation properties of cholinergic neurons from different brain regions grafted to the hippocampus (1988) J. Comp. Neurol., 268, pp. 204-222; Nilsson, O.G., Kalen, P., Rosengren, E., Bjorklund, A., Acetylcholine release from intrahippocampal septal grafts is under control of the host brain (1990) Proc. Natl. Acad. Sci. U. S. A., 87, pp. 2647-2651; Nori, S., Okada, Y., Yasuda, A., Tsuji, O., Takahashi, Y., Kobayashi, Y., Fujiyoshi, K., Okano, H., Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice (2011) Proc. Natl. Acad. Sci. U. S. A., 108, pp. 16825-16830; Nornes, H., Bjorklund, A., Stenevi, U., Reinnervation of the denervated adult spinal cord of rats by intraspinal transplants of embryonic brain stem neurons (1983) Cell Tissue Res., 230, pp. 15-35; Nygren, L.G., Olson, L., Seiger, A., Monoaminergic reinnervation of the transected spinal cord by homologous fetal brain grafts (1977) Brain Res., 129, pp. 227-235; Nygren, J.M., Liuba, K., Breitbach, M., Stott, S., Thoren, L., Roell, W., Geisen, C., Jacobsen, S.E., Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion (2008) Nat. Cell Biol., 10, pp. 584-592; Oki, K., Tatarishvili, J., Wood, J., Koch, P., Wattananit, S., Mine, Y., Monni, E., Kokaia, Z., Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain (2012) Stem Cells, 30, pp. 1120-1133; Ono, Y., Nakatani, T., Sakamoto, Y., Mizuhara, E., Minaki, Y., Kumai, M., Hamaguchi, A., Imai, T., Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells (2007) Development, 134, pp. 3213-3225; Peljto, M., Wichterle, H., Programming embryonic stem cells to neuronal subtypes (2011) Curr. Opin. Neurobiol., 21, pp. 43-51; Peljto, M., Dasen, J.S., Mazzoni, E.O., Jessell, T.M., Wichterle, H., Functional diversity of ESC-derived motor neuron subtypes revealed through intraspinal transplantation (2010) Cell Stem Cell, 7, pp. 355-366; Polentes, J., Jendelova, P., Cailleret, M., Braun, H., Romanyuk, N., Tropel, P., Brenot, M., Onteniente, B., Human induced pluripotent stem cells improve stroke outcome and reduce secondary degeneration in the recipient brain (2012) Cell transplantation, 21, pp. 2587-2602; Rhee, Y.H., Ko, J.Y., Chang, M.Y., Yi, S.H., Kim, D., Kim, C.H., Shim, J.W., Lee, S.H., Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease (2011) J. Clin. Invest., 121, pp. 2326-2335; Ridley, R.M., Gribble, S., Clark, B., Baker, H.F., Fine, A., Restoration of learning ability in fornix-transected monkeys after fetal basal forebrain but not fetal hippocampal tissue transplantation (1992) Neuroscience, 48, pp. 779-792; Roy, N.S., Cleren, C., Singh, S.K., Yang, L., Beal, M.F., Goldman, S.A., Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes (2006) Nat. Med., 12, pp. 1259-1268; Sawamoto, K., Nakao, N., Kobayashi, K., Matsushita, N., Takahashi, H., Kakishita, K., Yamamoto, A., Okano, H., Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons (2001) Proc. Natl. Acad. Sci. U. S. A., 98, pp. 6423-6428; Segal, M., Bjorklund, A., Gage, F.H., Transplanted septal neurons make viable cholinergic synapses with a host hippocampus (1985) Brain Res., 336, pp. 302-307; Segal, M., Greenberger, V., Milgram, N.W., A functional analysis of connections between grafted septal neurons and host hippocampus (1987) Prog. Brain Res., 71, pp. 349-357; Sharp, J., Frame, J., Siegenthaler, M., Nistor, G., Keirstead, H.S., Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury (2010) Stem Cells, 28, pp. 152-163; Sorensen, A.T., Thompson, L., Kirik, D., Bjorklund, A., Lindvall, O., Kokaia, M., Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal grafts (2005) Eur. J. Neurosci., 21, pp. 2793-2799; Southwell, D.G., Nicholas, C.R., Basbaum, A.I., Stryker, M.P., Kriegstein, A.R., Rubenstein, J.L., Alvarez-Buylla, A., Interneurons from embryonic development to cell-based therapy (2014) Science, 344, p. 1240622; Steinbeck, J.A., Koch, P., Derouiche, A., Brustle, O., Human embryonic stem cell-derived neurons establish region-specific, long-range projections in the adult brain (2012) Cell. Mol. Life Sci., 69, pp. 461-470; Steinbeck, J.A., Choi, S.J., Mrejeru, A., Ganat, Y., Deisseroth, K., Sulzer, D., Mosharov, E.V., Studer, L., Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model (2015) Nat. Biotechnol., 33, pp. 204-209; Stromberg, I., Bygdeman, M., Almqvist, P., Target-specific outgrowth from human mesencephalic tissue grafted to cortex or ventricle of immunosuppressed rats (1992) J. Comp. Neurol., 315, pp. 445-456; Sundberg, M., Bogetofte, H., Lawson, T., Jansson, J., Smith, G., Astradsson, A., Moore, M., Isacson, O., Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons (2013) Stem Cells, 31, pp. 1548-1562; Thompson, L., Bjorklund, A., Survival, differentiation, and connectivity of ventral mesencephalic dopamine neurons following transplantation (2012) Prog. Brain Res., 200, pp. 61-95; Thompson, L., Barraud, P., Andersson, E., Kirik, D., Bjorklund, A., Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections (2005) J. Neurosci. Off. J. Soc. Neurosci., 25, pp. 6467-6477; Thompson, L.H., Andersson, E., Jensen, J.B., Barraud, P., Guillemot, F., Parmar, M., Bjorklund, A., Neurogenin2 identifies a transplantable dopamine neuron precursor in the developing ventral mesencephalon (2006) Exp. Neurol., 198, pp. 183-198; Thompson, L.H., Kirik, D., Bjorklund, A., Non-dopaminergic neurons in ventral mesencephalic transplants make widespread axonal connections in the host brain (2008) Exp. Neurol., 213, pp. 220-228; Thompson, L.H., Grealish, S., Kirik, D., Bjorklund, A., Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain (2009) Eur. J. Neurosci., 30, pp. 625-638; Tornero, D., Wattananit, S., Gronning Madsen, M., Koch, P., Wood, J., Tatarishvili, J., Mine, Y., Kokaia, Z., Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery (2013) Brain J. Neurol., 136, pp. 3561-3577; Torres, E.M., Monville, C., Gates, M.A., Bagga, V., Dunnett, S.B., Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease (2007) Neuroscience, 146, pp. 1606-1617; Wernig, M., Zhao, J.P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Jaenisch, R., Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 5856-5861; Wichterle, H., Garcia-Verdugo, J.M., Herrera, D.G., Alvarez-Buylla, A., Young neurons from medial ganglionic eminence disperse in adult and embryonic brain (1999) Nat. Neurosci., 2, pp. 461-466; Wichterle, H., Lieberam, I., Porter, J.A., Jessell, T.M., Directed differentiation of embryonic stem cells into motor neurons (2002) Cell, 110, pp. 385-397; Wictorin, K., Brundin, P., Gustavii, B., Lindvall, O., Bjorklund, A., Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts (1990) Nature, 347, pp. 556-558; Wictorin, K., Clarke, D.J., Bolam, J.P., Bjorklund, A., Fetal striatal neurons grafted into the ibotenate lesioned adult striatum: efferent projections and synaptic contacts in the host globus pallidus (1990) Neuroscience, 37, pp. 301-315; Wictorin, K., Lagenaur, C.F., Lund, R.D., Bjorklund, A., Efferent projections to the host brain from intrastriatal striatal mouse-to-rat grafts: time course and tissue-type specificity as revealed by a mouse specific neuronal marker (1991) Eur. J. Neurosci., 3, pp. 86-101; Yurek, D.M., Fletcher-Turner, A., Comparison of embryonic stem cell-derived dopamine neuron grafts and fetal ventral mesencephalic tissue grafts: morphology and function (2004) Cell Transplant., 13, pp. 295-306; Zhou, C.F., Li, Y., Raisman, G., Embryonic entorhinal transplants project selectively to the deafferented entorhinal zone of adult mouse hippocampi, as demonstrated by the use of Thy-1 allelic immunohistochemistry. Effect of timing of transplantation in relation to deafferentation (1989) Neuroscience, 32, pp. 349-362",Review,Scopus,2-s2.0-84928598929
"Su W.-T., Chou W.-L., Chou C.-M.","Osteoblastic differentiation of stem cells from human exfoliated deciduous teeth induced by thermosensitive hydrogels with strontium phosphate",2015,"Materials Science and Engineering C","52",,,"46","53",,,10.1016/j.msec.2015.03.025,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925881907&partnerID=40&md5=59982c3470026d52d4de897ee999ec3b","Department of Chemical Engineering and Biotechnology, National Taipei University of Technology, Chung-Hsiao E. RdTaipei, Taiwan; Department of Biochemistry, Taipei Medical UniversityTaipei, Taiwan","Su, W.-T., Department of Chemical Engineering and Biotechnology, National Taipei University of Technology, Chung-Hsiao E. RdTaipei, Taiwan; Chou, W.-L., Department of Chemical Engineering and Biotechnology, National Taipei University of Technology, Chung-Hsiao E. RdTaipei, Taiwan; Chou, C.-M., Department of Biochemistry, Taipei Medical UniversityTaipei, Taiwan","Stem cells from human exfoliated deciduous teeth (SHEDs) are a novel source of multi-potential stem cells for tissue engineering because of their potential to differentiate into multiple cell lineages. Strontium exhibits an important function in bone remodeling because it can simulate bone formation and decrease bone resorption. Hydrogels can mimic the natural cellular environment. The association of hydrogels with cell viability is determined using biological tests, including rheological experiments. In this study, osteogenic differentiation was investigated through SHED encapsulation in hydrogels containing strontium phosphate. Results of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) and proliferating cell nuclear antigen (PCNA) immunofluorescence staining indicated that the cells grew well and SHEDs proliferated in the hydrogels. Strontium-loaded chitosan-based hydrogels induced the biomineralization and high expression of alkaline phosphatase. Moreover, the expression levels of bone-related genes, including type-I collagen, Runx2, osteopontin (OP), and osteonectin (ON), were up-regulated during the osteogenic differentiation of SHEDs. This study demonstrated that strontium can be an effective inducer of osteogenesis for SHEDs. Elucidating the function of bioceramics (such as strontium) is useful in designing and developing strategies for bone tissue engineering. © 2015 Elsevier B.V. All rights reserved.","Differentiation; Osteoblast; Stem cells from human exfoliated deciduous teeth; Strontium phosphate; Thermosensitive hydrogel","Ding, K., Yang, Z., Zhang, Y.L., Xu, J.Z., Injectable thermosensitive chitosan/β-glycerophosphate/collagen hydrogel maintains the plasticity of skeletal muscle satellite cells and supports their in vivo viability (2013) Cell Biol. Int., 37, pp. 977-987; Supper, S., Anton, N., Sceidel, N., Riemenschnitter, M., Schoch, C., Vandamme, T., Rheologic study of chitosan/β-glycerophosphate systems: Influence of the polyol part on the thermo-induced gelation mechanism (2013) Langmuir, 29, pp. 10229-10237; Jo, S., Kim, S., Cho, T.H., Shin, E., Hwang, S.J., Noh, I., Effects of recombinant human bone morphogenic protein-2 and human bone marrow-derived stromal cells on in vivo bone regeneration of chitosan-poly(ethylene oxide) hydrogel (2013) J. Biomed. Mater. Res. A, 101, pp. 892-901; Liu, X., Ma, P.X., Phase separation, pore structure and properties of nanofibrous gelatin scaffolds (2009) Biomaterials, 30, pp. 4094-4103; Tong, W., Brown, S.E., Krebsbach, P.H., Human embryonic stem cells undergo osteogenic differentiation in human bone marrow stromal cell microenvironments (2007) J. Stem Cells, 2, pp. 139-147; Bilousova, G., Jun Du, H., King, K.B., De Langhe, S., Chick, W.S., Torchia, E.C., Chow, K.S., Majka, S.M., Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo (2011) Stem Cells, 29, pp. 206-216; Ongaro, A., Pellati, A., Bagheri, L., Fortini, C., Setti, S., De Mattei, M., Pulsed electromagnetic fields stimulate osteogenic differentiation in human bone marrow and adipose tissue derived mesenchymal stem cells (2014) Bioelectromagnetics, 35, pp. 426-436; Wen, Y., Gu, W., Cui, J., Yu, M., Zhang, Y., Tang, C., Yang, P., Xu, X., Platelet-rich plasma enhanced umbilical cord mesenchymal stem cells-based bone tissue regeneration (2014) Arch. Oral Biol., 59, pp. 1146-1154; Wang, J., Wang, X., Sue, Z., Wang, X., Yang, H., Shi, S., Wang, S., Stem cells from human-exfoliated deciduous teeth can differentiation into dopaminergic neuron-like cells (2010) Stem Cells Dev., 19, pp. 375-1383; Nishino, Y., Yamada, Y., Ebisawa, K., Nakamura, S., Okabe, K., Umemura, E., Hara, K., Ueda, M., Stem cells from exfoliated deciduous teeth (SHED) enhance wound healing and possibility of novel cell therapy (2011) Cytotherapy, 13, pp. 598-605; Su, W.T., Chen, X.W., Stem cells from human exfoliated deciduous teeth differentiate into functional hepatocyte-like cells by herbal medicine (2014) Biomed. Mater. Eng., 24, pp. 2243-2247; Sila-Asna, M., Bunyaratvej, A., Maeda, S., Kitaguchi, H., Bunyaratavej, N., Osteoblast differentiation and bone formation gene expression in strontium-inducing bone marrow mesenchymal stem cell (2007) Kobe J. Med. Sci., 53, pp. 25-35; Peng, S., Zhou, G., Luk, K.D., Cheung, K.M., Li, Z., Lam, W.M., Zhou, Z., Lu, W.W., Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway (2009) Cell. Physiol. Biochem., 23, pp. 165-174; Yang, F., Yang, D., Tu, J., Zheng, Q., Cai, L., Wang, L., Strontium enhances osteogenic differentiation of mesenchymal stem cells and in vivo bone formation by activating Wnt/catenin signaling (2011) Stem Cells, 29, pp. 981-991; Ni, G.X., Chiu, K.Y., Lu, W.W., Wang, Y., Zhang, Y.G., Hao, L.B., Li, Z.Y., Luk, K.D.K., Strontium-containing hydroxyapatite bioactive bone cement in revision hip arthroplasty (2006) Biomaterials, 27, pp. 4348-4355; Peng, S., Liu, X.S., Wang, T., Li, Z., Zhou, G., Luk, K.D.K., Guo, X.E., Lu, W.W., In vivo anabolic effect of strontium on trabecular bone was associated with increased osteoblastogenesis of bone marrow stromal cells (2010) J. Orthop. Res., 28, pp. 1208-1214; Marie, P.J., Strontium ranelate: A physiological approach for optimizing bone formation and resorption (2006) Bone, 38, pp. S10-S14; Su, W.T., Wu, P.S., Huang, T.Y., Osteogenic differentiation of stem cells from human exfoliated deciduous teeth on poly(ε-caprolactone) nanofibers containing strontium phosphate (2015) Mater. Sci. Eng. C, 46, pp. 427-434; Su, W.T., Wu, P.S., Ko, C.S., Huang, T.Y., Osteogenic differentiation and mineralization of human exfoliated deciduous teeth stem cells on modified chitosan scaffold (2014) Mater. Sci. Eng. C, 41, pp. 152-160; Chenite, A., Chaput, C., Wang, D., Combes, C., Buschmann, M.D., Hoemann, C.D., Leroux, J.C., Selmani, A., Novel injectable neutral solutions of chitosan form biodegradable gels in situ (2000) Biomaterials, 21, pp. 2155-2161; Qiu, X., Yang, Y., Wang, L., Lu, S., Shao, Z., Chen, X., Synergistic interactions during thermosensitive chitosan-β-glycerophosphate hydrogel formation (2011) R. Soc. Chem. Adv., 1, pp. 282-289; Cheng, Y.H., Yang, S.H., Su, W.Y., Chen, Y.C., Yang, K.C., Cheng, W.T.K., Wu, S.C., Lin, F.H., Thermosensitive chitosan-gelatin-glycerol phosphate hydrogel as a cell carrier for nucleus pulposus regeneration: An in vitro study (2010) Tissue Eng. A, 15, pp. 695-703; Niranjan, A., Koushik, C., Saravanan, S., Moorthi, A., Vairamani, M., Selvamurugan, N., A novel injectable temperature-sensitive zinc doped chitosan/β-glycerophosphate hydrogel for bone tissue engineering (2013) Int. J. Biol. Macromol., 54, pp. 24-29; Ahmadi, R., De Bruijn, J.D., Biocompatibility and gelation of chitosan-glycerol phosphate hydrogels (2008) J. Biomed. Mater. Res. A, 86, pp. 824-832; Song, K., Qiao, M., Liu, T., Jiang, B., Macedo, H.M., Ma, X., Cui, Z., Preparation, fabrication and biocompatibility of novel injectable temperature-sensitive chitosan/glycerophosphate/collagen hydrogels (2010) J. Mater. Sci. Mater. Med., 21, pp. 2835-2842; Drury, J.L., Mooney, D.J., Hydrogels for tissue engineering: Scaffold design variables and applications (2003) Biomaterials, 24, pp. 4337-4351; Li, Y.F., Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats (2010) Osteoporos. Int., 21, pp. 1889-1897; Yan, J., Myang, L., Wang, G., Xiao, Y., Zhang, B., Qi, N., Biocompatibility evaluation of chitosan-based injectable hydrogels for the culturing mice mesenchymal stem cells in vitro (2010) J. Biomater. Appl., 24, pp. 625-637; Yu, H.S., Jin, G.Z., Won, J.E., Wall, I., Kim, H.W., Macrochanneled bioactive ceramic scaffolds in combination with collagen hydrogel: A new tool for bone tissue engineering (2012) J. Biomed. Mater. Res. A, 100, pp. 2431-2440",Article,Scopus,2-s2.0-84925881907
"Pajer K., Nemes C., Berzsenyi S., Kovacs K.A., Pirity M.K., Pajenda G., Nogradi A., Dinnyes A.","Grafted murine induced pluripotent stem cells prevent death of injured rat motoneurons otherwise destined to die",2015,"Experimental Neurology","269",,,"188","201",,,10.1016/j.expneurol.2015.03.031,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928668663&partnerID=40&md5=779e18bae6ae693ac26a0a12fea238b4","Department of Anatomy, Histology and Embryology, Faculty of Medicine, University of SzegedSzeged, Hungary; Biotalentum Ltd.Gödöllo, Hungary; Department for Trauma Surgery, Medical University ViennaVienna, Austria; Molecular Animal Biotechnology Laboratory, Szent István UniversityGödöllo, Hungary","Pajer, K., Department of Anatomy, Histology and Embryology, Faculty of Medicine, University of SzegedSzeged, Hungary; Nemes, C., Biotalentum Ltd.Gödöllo, Hungary; Berzsenyi, S., Biotalentum Ltd.Gödöllo, Hungary; Kovács, K.A., Biotalentum Ltd.Gödöllo, Hungary; Pirity, M.K., Biotalentum Ltd.Gödöllo, Hungary; Pajenda, G., Department for Trauma Surgery, Medical University ViennaVienna, Austria; Nógrádi, A., Department of Anatomy, Histology and Embryology, Faculty of Medicine, University of SzegedSzeged, Hungary; Dinnyés, A., Biotalentum Ltd.Gödöllo, Hungary, Molecular Animal Biotechnology Laboratory, Szent István UniversityGödöllo, Hungary","Human plexus injuries often include the avulsion of one or more ventral roots, resulting in debilitating conditions. In this study the effects of undifferentiated murine iPSCs on damaged motoneurons were investigated following avulsion of the lumbar 4 (L4) ventral root, an injury known to induce the death of the majority of the affected motoneurons. Avulsion and reimplantation of the L4 ventral root (AR procedure) were accompanied by the transplantation of murine iPSCs into the injured spinal cord segment in rats. Control animals underwent ventral root avulsion and reimplantation, but did not receive iPSCs. The grafted iPSCs induced an improved reinnervation of the reimplanted ventral root by the host motoneurons as compared with the controls (number of retrogradely labeled motoneurons: 503. ±. 38 [AR. +. iPSCs group] vs 48. ±. 6 [controls, AR group]). Morphological reinnervation resulted in a functional recovery, i.e. the grafted animals exhibited more motor units in their reinnervated hind limb muscles, which produced a greater force than that in the controls (50. ±. 2.1% vs 11.9. ±. 4.2% maximal tetanic tension [% ratio of operated/intact side]). Grafting of undifferentiated iPSCs downregulated the astroglial activation within the L4 segment. The grafted cells differentiated into neurons and astrocytes in the injured cord. The grafted iPSCs, host neurons and glia were found to produce the cytokines and neurotrophic factors MIP-1a, IL-10, GDNF and NT-4. These findings suggest that, following ventral root avulsion injury, iPSCs are able to induce motoneuron survival and regeneration through combined neurotrophic and cytokine modulatory effects. © 2015 Elsevier Inc.",,"Aldskogius, H., Mechanisms and consequences of microglial responses to peripheral axotomy (2011) Front. Biosci. (Schol. Ed.), 3, pp. 857-868; Bachis, A., Colangelo, A.M., Vicini, S., Doe, P.P., De Bernardi, M.A., Brooker, G., Mocchetti, I., Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity (2001) J. Neurosci., 21, pp. 3104-3112; Bergerot, A., Shortland, P.J., Anand, P., Hunt, S.P., Carlstedt, T., Co-treatment with riluzole and GDNF is necessary for functional recovery after ventral root avulsion injury (2004) Exp. Neurol., 187, pp. 359-366; Bibel, M., Richter, J., Schrenk, K., Tucker, K.L., Staiger, V., Korte, M., Goetz, M., Barde, Y.A., Differentiation of mouse embryonic stem cells into a defined neuronal lineage (2004) Nat. Neurosci., 7, pp. 1003-1009; Blits, B., Carlstedt, T.P., Ruitenberg, M.J., de Winter, F., Hermens, W.T., Dijkhuizen, P.A., Claasens, J.W., Verhaagen, J., Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor (2004) Exp. Neurol., 189, pp. 303-316; Carlson, N.G., Bacchi, A., Rogers, S.W., Gahring, L.C., Nicotine blocks TNF-alpha-mediated neuroprotection to NMDA by an alpha-bungarotoxin-sensitive pathway (1998) J. Neurobiol., 35, pp. 29-36; Carlson, N.G., Wieggel, W.A., Chen, J., Bacchi, A., Rogers, S.W., Gahring, L.C., Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways (1999) J. Immunol., 163, pp. 3963-3968; Carlstedt, T., Root repair review: basic science background and clinical outcome (2008) Restor. Neurol. Neurosci., 26, pp. 225-241; Carlstedt, T., Linda, H., Cullheim, S., Risling, M., Reinnervation of hind limb muscles after ventral root avulsion and implantation in the lumbar spinal cord of the adult rat (1986) Acta Physiol. Scand., 128, pp. 645-646; Carlstedt, T., Risling, M., Linda, H., Cullheim, S., Ulfhake, B., Sjogren, A.M., Regeneration after spinal nerve root injury (1990) Restor. Neurol. Neurosci., 1, pp. 289-295; Chen, S.J., Chang, C.M., Tsai, S.K., Chang, Y.L., Chou, S.J., Huang, S.S., Tai, L.K., Chiou, S.H., Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue (2010) Stem Cells Dev., 19, pp. 1757-1767; Eggers, R., Hendriks, W.T., Tannemaat, M.R., van Heerikhuize, J.J., Pool, C.W., Carlstedt, T.P., Zaldumbide, A., Verhaagen, J., Neuroregenerative effects of lentiviral vector-mediated GDNF expression in reimplanted ventral roots (2008) Mol. Cell. Neurosci., 39, pp. 105-117; Eggers, R., Tannemaat, M.R., Ehlert, E.M., Verhaagen, J., A spatio-temporal analysis of motoneuron survival, axonal regeneration and neurotrophic factor expression after lumbar ventral root avulsion and implantation (2010) Exp. Neurol., 223, pp. 207-220; Eggers, R., de Winter, F., Hoyng, S.A., Roet, K.C., Ehlert, E.M., Malessy, M.J., Verhaagen, J., Tannemaat, M.R., Lentiviral vector-mediated gradients of GDNF in the injured peripheral nerve: effects on nerve coil formation, Schwann cell maturation and myelination (2013) PLoS One, 8, p. e71076; Fujimoto, Y., Abematsu, M., Falk, A., Tsujimura, K., Sanosaka, T., Juliandi, B., Semi, K., Nakashima, K., Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells (2012) Stem Cells, 30, pp. 1163-1173; Glezer, I., Simard, A.R., Rivest, S., Neuroprotective role of the innate immune system by microglia (2007) Neuroscience, 147, pp. 867-883; Hargus, G., Cooper, O., Deleidi, M., Levy, A., Lee, K., Marlow, E., Yow, A., Isacson, O., Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats (2010) Proc. Natl. Acad. Sci. U. S. A., 107, pp. 15921-15926; Hell, R.C.C.M., Goes, A.M., Oliveira, A.L., Local injection of BDNF producing mesenchymal stem cells increases neuronal survival and synaptic stability following ventral root avulsion (2009) Neurobiol. Dis., pp. 290-300; Jackson, C.A., Messinger, J., Peduzzi, J.D., Ansardi, D.C., Morrow, C.D., Enhanced functional recovery from spinal cord injury following intrathecal or intramuscular administration of poliovirus replicons encoding IL-10 (2005) Virology, 336, pp. 173-183; Juttler, E., Tarabin, V., Schwaninger, M., Interleukin-6 (IL-6): a possible neuromodulator induced by neuronal activity (2002) Neuroscientist, 8, pp. 268-275; Klusman, I., Schwab, M.E., Effects of pro-inflammatory cytokines in experimental spinal cord injury (1997) Brain Res., 762, pp. 173-184; Koliatsos, V.E., Price, W.L., Pardo, C.A., Price, D.L., Ventral root avulsion: an experimental model of death of adult motor neurons (1994) J. Comp. Neurol., 342, pp. 35-44; McNaught, K.S., Brown, G.C., Nitric oxide causes glutamate release from brain synaptosomes (1998) J. Neurochem., 70, pp. 1541-1546; Minichiello, L., Casagranda, F., Tatche, R.S., Stucky, C.L., Postigo, A., Lewin, G.R., Davies, A.M., Klein, R., Point mutation in trkB causes loss of NT4-dependent neurons without major effects on diverse BDNF responses (1998) Neuron, 21, pp. 335-345; Nemes, C.V.E., Polgar, Z., Klincumhom, N., Pirity, M.K., Dinnyes, A., Generation of mouse induced pluripotent stem cells by protein transduction (2014) Tissue Eng. Part C Methods, 20, pp. 383-392; Nogradi, A., Vrbova, G., Improved motor function of denervated rat hindlimb muscles induced by embryonic spinal cord grafts (1996) Eur. J. Neurosci., 8, pp. 2198-2203; Nogradi, A., Vrbova, G., The effect of riluzole treatment in rats on the survival of injured adult and grafted embryonic motoneurons (2001) Eur. J. Neurosci., 13, pp. 113-118; Nogradi, A., Szabo, A., Pinter, S., Vrbova, G., Delayed riluzole treatment is able to rescue injured rat spinal motoneurons (2007) Neuroscience, 144, pp. 431-438; Nori, S., Okada, Y., Yasuda, A., Tsuji, O., Takahashi, Y., Kobayashi, Y., Fujiyoshi, K., Okano, H., Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice (2011) Proc. Natl. Acad. Sci. U. S. A., 108, pp. 16825-16830; Novikov, L., Novikova, L., Kellerth, J.O., Brain-derived neurotrophic factor promotes axonal regeneration and long-term survival of adult rat spinal motoneurons in vivo (1997) Neuroscience, 79, pp. 765-774; Nutt, S.E., Chang, E.A., Suhr, S.T., Schlosser, L.O., Mondello, S.E., Moritz, C.T., Cibelli, J.B., Horner, P.J., Caudalized human iPSC-derived neural progenitor cells produce neurons and glia but fail to restore function in an early chronic spinal cord injury model (2013) Exp. Neurol., 248, pp. 491-503; Okita, K., Ichisaka, T., Yamanaka, S., Generation of germline-competent induced pluripotent stem cells (2007) Nature, 448, pp. 313-317; Pajenda, G., Pajer, K., Marton, G., Hegyi, P., Redl, H., Nogradi, A., Rescue of injured motoneurones by grafted neuroectodermal stem cells: effect of the location of graft (2013) Restor. Neurol. Neurosci., 31, pp. 263-274; Pajenda, G., Hercher, D., Márton, G., Pajer, K., Feichtinger, G.A., Maléth, J., Redl, H., Nógrádi, A., Spatiotemporally limited BDNF and GDNF overexpression rescues motoneurons destined to die and induces elongative axon growth (2014) Exp. Neurol., 261, pp. 367-376; Pajer, K., Feichtinger, G.A., Márton, G., Sabitzer, S., Klein, D., Redl, H., Nógrádi, A., Cytokine signaling by grafted neuroectodermal stem cells rescues motoneurons destined to die (2014) Exp. Neurol., 261, pp. 180-189; Pinter, S., Gloviczki, B., Szabo, A., Marton, G., Nogradi, A., Increased survival and reinnervation of cervical motoneurons by riluzole after avulsion of the C7 ventral root (2010) J. Neurotrauma, 27, pp. 2273-2282; Robertson, E., Embryo-derived stem cell lines (1987) Teratocarcinomas and Embryonic Stem Cells: A Practical Approach, pp. 71-112. , IRL press, Oxford; Spalloni, A., Nutini, M., Longone, P., Role of the N-methyl-d-aspartate receptors complex in amyotrophic lateral sclerosis (2013) Biochim. Biophys. Acta, 1832, pp. 312-322; Su, H.Z.W., Guo, J., Guo, A., Yuan, Q., Wu, W., Neural progenitor cells enhance the survival and axonal regeneration of injured motoneurons after transplantation into the avulsed ventral horn of adult rats (2009) J. Neurotrauma, pp. 67-80; Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors (2006) Cell, 126, pp. 663-676; Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S., Induction of pluripotent stem cells from adult human fibroblasts by defined factors (2007) Cell, 131, pp. 861-872; Tsuji, O., Miura, K., Okada, Y., Fujiyoshi, K., Mukaino, M., Nagoshi, N., Kitamura, K., Okano, H., Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury (2010) Proc. Natl. Acad. Sci. U. S. A., 107, pp. 12704-12709; Wu, W., Li, L., Yick, L.W., Chai, H., Xie, Y., Yang, Y., Prevette, D.M., Oppenheim, R.W., GDNF and BDNF alter the expression of neuronal NOS, c-Jun, and p75 and prevent motoneuron death following spinal root avulsion in adult rats (2003) J. Neurotrauma, 20, pp. 603-612; Zhou, Z., Peng, X., Insolera, R., Fink, D.J., Mata, M., IL-10 promotes neuronal survival following spinal cord injury (2009) Exp. Neurol., 220, pp. 183-190; Zhou, Z., Peng, X., Insolera, R., Fink, D.J., Mata, M., Interleukin-10 provides direct trophic support to neurons (2009) J. Neurochem., 110, pp. 1617-1627",Article,Scopus,2-s2.0-84928668663
"Xu L., Yang Y., Gao L., Zhao J., Cai Y., Huang J., Jing S., Bao X., Wang Y., Gao J., Xu H., Fan X.","Protective effects of resveratrol on the inhibition of hippocampal neurogenesis induced by ethanol during early postnatal life",2015,"Biochimica et Biophysica Acta - Molecular Basis of Disease","1852","7",,"1298","1310",,,10.1016/j.bbadis.2015.03.009,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925955129&partnerID=40&md5=6215b7528e6f7acfebe621bf05768cbc","Department of Developmental Neuropsychology, School of Psychology, Third Military Medical UniversityChongqing, China; The Battalion 5 of Cadet Brigade, Third Military Medical UniversityChongqing, China; Department of Neurosurgery, Southwest Hospital, Third Military Medical UniversityChongqing, China; Southwest Eye Hospital, Southwest Hospital, Third Military Medical University, China; Department of Anesthesiology, Xinqiao Hospital, Third Military Medical UniversityChongqing, China","Xu, L., Department of Developmental Neuropsychology, School of Psychology, Third Military Medical UniversityChongqing, China, The Battalion 5 of Cadet Brigade, Third Military Medical UniversityChongqing, China; Yang, Y., Department of Neurosurgery, Southwest Hospital, Third Military Medical UniversityChongqing, China; Gao, L., Southwest Eye Hospital, Southwest Hospital, Third Military Medical University, China; Zhao, J., Department of Developmental Neuropsychology, School of Psychology, Third Military Medical UniversityChongqing, China; Cai, Y., Department of Developmental Neuropsychology, School of Psychology, Third Military Medical UniversityChongqing, China; Huang, J., Department of Anesthesiology, Xinqiao Hospital, Third Military Medical UniversityChongqing, China; Jing, S., Department of Anesthesiology, Xinqiao Hospital, Third Military Medical UniversityChongqing, China; Bao, X., Department of Anesthesiology, Xinqiao Hospital, Third Military Medical UniversityChongqing, China; Wang, Y., Department of Developmental Neuropsychology, School of Psychology, Third Military Medical UniversityChongqing, China; Gao, J., Department of Developmental Neuropsychology, School of Psychology, Third Military Medical UniversityChongqing, China; Xu, H., Southwest Eye Hospital, Southwest Hospital, Third Military Medical University, China; Fan, X., Department of Developmental Neuropsychology, School of Psychology, Third Military Medical UniversityChongqing, China","Ethanol (EtOH) exposure during early postnatal life triggers obvious neurotoxic effects on the developing hippocampus and results in long-term effects on hippocampal neurogenesis. Resveratrol (RSV) has been demonstrated to exert potential neuroprotective effects by promoting hippocampal neurogenesis. However, the effects of RSV on the EtOH-mediated impairment of hippocampal neurogenesis remain undetermined. Thus, mice were pretreated with RSV and were later exposed to EtOH to evaluate its protective effects on EtOH-mediated toxicity during hippocampal development. The results indicated that a brief exposure of EtOH on postnatal day 7 resulted in a significant impairment in hippocampal neurogenesis and a depletion of hippocampal neural precursor cells (NPCs). This effect was attenuated by pretreatment with RSV. Furthermore, EtOH exposure resulted in a reduction in spine density on the granular neurons of the dentate gyrus (DG), and the spines exhibited a less mature morphological phenotype characterized by a higher proportion of stubby spines and a lower proportion of mushroom spines. However, RSV treatment effectively reversed these responses. We further confirmed that RSV treatment reversed the EtOH-induced down-regulation of hippocampal pERK and Hes1 protein levels, which may be related to the proliferation and maintenance of NPCs. Furthermore, EtOH exposure in the C17.2 NPCs also diminished cell proliferation and activated apoptosis, which could be reversed by pretreatment of RSV. Overall, our results suggest that RSV pretreatment protects against EtOH-induced defects in neurogenesis in postnatal mice and may thus play a critical role in preventing EtOH-mediated toxicity in the developing hippocampus. © 2015 Elsevier B.V.","Ethanol; Hippocampal development; Neural precursor cell; Neurogenesis; Resveratrol","Clarren, S.K., Smith, D.W., The fetal alcohol syndrome (1978) N. Engl. J. Med., 298 (19), pp. 1063-1067; Wood, C.E., Maternal binge drinking and fetal neuronal damage (2007) Exp. Physiol., 92 (5), p. 821; Ungerer, M., Knezovich, J., Ramsay, M., In utero alcohol exposure, epigenetic changes, and their consequences (2013) Alcohol. Res., 35 (1), pp. 37-46; Basavarajappa, B.S., Ninan, I., Arancio, O., Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons (2008) J. Neurochem., 107 (4), pp. 1001-1013; Singh, A.K., In vitro neurogenesis from neural progenitor cells isolated from the hippocampus region of the brain of adult rats exposed to ethanol during early development through their alcohol-drinking mothers (2009) Alcohol Alcohol., 44 (2), pp. 185-198; Livy, D.J., Fetal alcohol exposure and temporal vulnerability: effects of binge-like alcohol exposure on the developing rat hippocampus (2003) Neurotoxicol. Teratol., 25 (4), pp. 447-458; Ieraci, A., Herrera, D.G., Single alcohol exposure in early life damages hippocampal stem/progenitor cells and reduces adult neurogenesis (2007) Neurobiol. Dis., 26 (3), pp. 597-605; Hamilton, G.F., Neonatal alcohol exposure disrupts hippocampal neurogenesis and contextual fear conditioning in adult rats (2011) Brain Res., 1412, pp. 88-101; Temple, S., Alvarez-Buylla, A., Stem cells in the adult mammalian central nervous system (1999) Curr. Opin. Neurobiol., 9 (1), pp. 135-141; Schlessinger, A.R., Cowan, W.M., Gottlieb, D.I., An autoradiographic study of the time of origin and the pattern of granule cell migration in the dentate gyrus of the rat (1975) J. Comp. Neurol., 159 (2), pp. 149-175; Taffe, M.A., Long-lasting reduction in hippocampal neurogenesis by alcohol consumption in adolescent nonhuman primates (2010) Proc. Natl. Acad. Sci. U. S. A., 107 (24), pp. 11104-11109; Berman, R.F., Hannigan, J.H., Effects of prenatal alcohol exposure on the hippocampus: spatial behavior, electrophysiology, and neuroanatomy (2000) Hippocampus, 10 (1), pp. 94-110; Gehm, B.D., Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor (1997) Proc. Natl. Acad. Sci. U. S. A., 94 (25), pp. 14138-14143; Sovak, M., Grape extract, resveratrol, and its analogs: a review (2001) J. Med. Food, 4 (2), pp. 93-105; Yousuf, S., Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia (2009) Brain Res., 1250, pp. 242-253; Menard, C., Bastianetto, S., Quirion, R., Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma (2013) Front. Cell. Neurosci., 7, p. 281; Ates, O., Neuroprotection by resveratrol against traumatic brain injury in rats (2007) Mol. Cell. Biochem., 294 (1-2), pp. 137-144; Sonmez, U., Neuroprotective effects of resveratrol against traumatic brain injury in immature rats (2007) Neurosci. Lett., 420 (2), pp. 133-137; Moriya, J., Resveratrol improves hippocampal atrophy in chronic fatigue mice by enhancing neurogenesis and inhibiting apoptosis of granular cells (2011) Biol. Pharm. Bull., 34 (3), pp. 354-359; Park, H.R., Resveratrol inhibits the proliferation of neural progenitor cells and hippocampal neurogenesis (2012) J. Biol. Chem., 287 (51), pp. 42588-42600; West, T., Atzeva, M., Holtzman, D.M., Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury (2007) Dev. Neurosci., 29 (4-5), pp. 363-372; Madhyastha, S., Sekhar, S., Rao, G., Resveratrol improves postnatal hippocampal neurogenesis and brain derived neurotrophic factor in prenatally stressed rats (2013) Int. J. Dev. Neurosci., 31 (7), pp. 580-585; Steelman, L.S., JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis (2004) Leukemia, 18 (2), pp. 189-218; Ohtsuka, T., Roles of the basic helix-loop-helix genes Hes1 and Hes5 in expansion of neural stem cells of the developing brain (2001) J. Biol. Chem., 276 (32), pp. 30467-30474; Yang, Y., Activation of liver X receptor is protective against ethanol-induced developmental impairment of Bergmann glia and Purkinje neurons in the mouse cerebellum (2014) Mol. Neurobiol., 49 (1), pp. 176-186; Chakraborti, A., Cranial irradiation alters dendritic spine density and morphology in the hippocampus (2012) Plos One, 7 (7), p. e40844; Chen, X., Sodium iodate influences the apoptosis, proliferation and differentiation potential of radial glial cells in vitro (2014) Cell. Physiol. Biochem., 34 (4), pp. 1109-1124; Wang, S.J., Effect of optogenetic stimulus on the proliferation and cell cycle progression of neural stem cells (2014) J Membr Biol, 247 (6), pp. 493-500; Huang, J., Propofol administration during early postnatal life suppresses hippocampal neurogenesis (2015) Mol. Neurobiol., , (Epub Jan. 11, 2015); Pevny, L.H., Nicolis, S.K., Sox2 roles in neural stem cells (2010) Int. J. Biochem. Cell Biol., 42 (3), pp. 421-424; Subbanna, S., Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits (2013) J. Neurosci., 33 (15), pp. 6350-6366; Samudio-Ruiz, S.L., Prenatal ethanol exposure persistently impairs NMDA receptor-dependent activation of extracellular signal-regulated kinase in the mouse dentate gyrus (2009) J. Neurochem., 109 (5), pp. 1311-1323; Kamakura, S., Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling (2004) Nat. Cell Biol., 6 (6), pp. 547-554; Fournier, N.M., Vascular endothelial growth factor regulates adult hippocampal cell proliferation through MEK/ERK- and PI3K/Akt-dependent signaling (2012) Neuropharmacology, 63 (4), pp. 642-652; Shimojo, H., Ohtsuka, T., Kageyama, R., Oscillations in notch signaling regulate maintenance of neural progenitors (2008) Neuron, 58 (1), pp. 52-64; Bonthius, D.J., West, J.R., Alcohol-induced neuronal loss in developing rats: increased brain damage with binge exposure (1990) Alcohol. Clin. Exp. Res., 14 (1), pp. 107-118; Coleman, L.G., Postnatal day 7 ethanol treatment causes persistent reductions in adult mouse brain volume and cortical neurons with sex specific effects on neurogenesis (2012) Alcohol, 46 (6), pp. 603-612; Eckenhoff, M.F., Rakic, P., Radial organization of the hippocampal dentate gyrus: a Golgi, ultrastructural, and immunocytochemical analysis in the developing rhesus monkey (1984) J. Comp. Neurol., 223 (1), pp. 1-21; Rickmann, M., Amaral, D.G., Cowan, W.M., Organization of radial glial cells during the development of the rat dentate gyrus (1987) J. Comp. Neurol., 264 (4), pp. 449-479; Brunne, B., Origin, maturation, and astroglial transformation of secondary radial glial cells in the developing dentate gyrus (2010) Glia, 58 (13), pp. 1553-1569; Xu, L., Radial glia, the keystone of the development of the hippocampal dentate gyrus (2014) Mol. Neurobiol., 51 (1), pp. 131-141; Valles, S., Glial fibrillary acidic protein expression in rat brain and in radial glia culture is delayed by prenatal ethanol exposure (1996) J. Neurochem., 67 (6), pp. 2425-2433; Komatsu, S., Prenatal exposure to ethanol induces leptomeningeal heterotopia in the cerebral cortex of the rat fetus (2001) Acta Neuropathol., 101 (1), pp. 22-26; Mooney, S.M., Siegenthaler, J.A., Miller, M.W., Ethanol induces heterotopias in organotypic cultures of rat cerebral cortex (2004) Cereb. Cortex, 14 (10), pp. 1071-1080; Rubert, G., Ethanol exposure during embryogenesis decreases the radial glial progenitor pool and affects the generation of neurons and astrocytes (2006) J. Neurosci. Res., 84 (3), pp. 483-496; Mo, Z., Milivojevic, V., Zecevic, N., Enforced Pax6 expression rescues alcohol-induced defects of neuronal differentiation in cultures of human cortical progenitor cells (2012) Alcohol. Clin. Exp. Res., 36 (8), pp. 1374-1384; Zou, J., Crew, F.T., Inflammasome-IL-1β signaling mediates ethonal inhibition of hippocampal neurogenesis (2012) Front. Neurosci., 6, p. 77; Zhang, F., Liu, J., Shi, J.S., Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation (2010) Eur. J. Pharmacol., 636 (1-3), pp. 1-7; Quincozes-Santos, A., Gottfried, C., Resveratrol modulates astroglial functions: neuroprotective hypothesis (2011) Ann. N. Y. Acad. Sci., 1215, pp. 72-78; Singh, N., Agrawal, M., Dore, S., Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models (2013) ACS Chem. Neurosci., 4 (8), pp. 1151-1162; Harada, N., Resveratrol improves cognitive function in mice by increasing production of insulin-like growth factor-I in the hippocampus (2011) J. Nutr. Biochem., 22 (12), pp. 1150-1159; Morgado-Bernal, I., Learning and memory consolidation: linking molecular and behavioral data (2011) Neuroscience, 176, pp. 12-19; Patterson, M., Yasuda, R., Signalling pathways underlying structural plasticity of dendritic spines (2011) Br. J. Pharmacol., 163 (8), pp. 1626-1638; Bosch, M., Hayashi, Y., Structural plasticity of dendritic spines (2012) Curr. Opin. Neurobiol., 22 (3), pp. 383-388; Peters, A., Kaiserman-Abramof, I.R., The small pyramidal neuron of the rat cerebral cortex. The perikaryon, dendrites and spines (1970) Am. J. Anat., 127 (4), pp. 321-355; Harris, K.M., Jensen, F.E., Tsao, B., Three-dimensional structure of dendritic spines and synapses in rat hippocampus (CA1) at postnatal day 15 and adult ages: implications for the maturation of synaptic physiology and long-term potentiation (1992) J. Neurosci., 12 (7), pp. 2685-2705; Spacek, J., Harris, K.M., Three-dimensional organization of smooth endoplasmic reticulum in hippocampal CA1 dendrites and dendritic spines of the immature and mature rat (1997) J. Neurosci., 17 (1), pp. 190-203; Parnass, Z., Tashiro, A., Yuste, R., Analysis of spine morphological plasticity in developing hippocampal pyramidal neurons (2000) Hippocampus, 10 (5), pp. 561-568; Bourne, J., Harris, K.M., Do thin spines learn to be mushroom spines that remember? (2007) Curr. Opin. Neurobiol., 17 (3), pp. 381-386; Rice, J.P., Effects of exposure to moderate levels of ethanol during prenatal brain development on dendritic length, branching, and spine density in the nucleus accumbens and dorsal striatum of adult rats (2012) Alcohol, 46 (6), pp. 577-584; Cullen, C.L., Low dose prenatal ethanol exposure induces anxiety-like behaviour and alters dendritic morphology in the basolateral amygdala of rat offspring (2013) PLoS One, 8 (1), p. e54924; Romero, A.M., Chronic alcohol alters dendritic spine development in neurons in primary culture (2013) Neurotox. Res., 24 (4), pp. 532-548; Hao, Y.L., Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis (2004) J. Neurosci., 24 (29), pp. 6590-6599; Hsieh, J., Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells (2004) Proc. Natl. Acad. Sci. U. S. A., 101 (47), pp. 16659-16664; Spanos, M., Besheer, J., Hodge, C.W., Increased sensitivity to alcohol induced changes in ERK Map kinase phosphorylation and memory disruption in adolescent as compared to adult C57BL/6J mice (2012) Behav. Brain Res., 230 (1), pp. 158-166; Nelson, B.R., Dynamic interactions between intermediate neurogenic progenitors and radial glia in embryonic mouse neocortex: potential role in Dll1-notch signaling (2013) J. Neurosci., 33 (21), pp. 9122-9139; Hatakeyama, J., Hes genes regulate size, shape and histogenesis of the nervous system by control of the timing of neural stem cell differentiation (2004) Development, 131 (22), pp. 5539-5550; Ramadori, G., Brain SIRT1: anatomical distribution and regulation by energy availability (2008) J. Neurosci., 28 (40), pp. 9989-9996; Pasinetti, G.M., Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment (2015) Biochim. Biophys. Acta, 1852 (6), pp. 1202-1208; Tiberi, L., BCL6 controls neurogenesis through Sirt1-dependent epigenetic repression of selective Notch targets (2012) Nat. Neurosci., 12, pp. 1627-1635",Article,Scopus,2-s2.0-84925955129
"Wang J., He C., Cheng N., Yang Q., Chen M., You L., Zhang Q.","Bone marrow stem cells response to collagen/single-wall carbon nanotubes-COOHs nanocomposite films with transforming growth factor beta 1",2015,"Journal of Nanoscience and Nanotechnology","15","7",,"4844","4850",,,10.1166/jnn.2015.9844,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920653749&partnerID=40&md5=75da5cbac4c2e5d005e83aab442ee4fc","Institute of Biomedical and Pharmaceutical Technology, College of Chemistry and Chemical Engineering, Fuzhou UniversityFuzhou, China; Institute of Biomedical Engineering, Chinese Academy of Medical Science, Peking Union Medical CollegeTianjin, China","Wang, J., Institute of Biomedical and Pharmaceutical Technology, College of Chemistry and Chemical Engineering, Fuzhou UniversityFuzhou, China; He, C., Institute of Biomedical and Pharmaceutical Technology, College of Chemistry and Chemical Engineering, Fuzhou UniversityFuzhou, China; Cheng, N., Institute of Biomedical and Pharmaceutical Technology, College of Chemistry and Chemical Engineering, Fuzhou UniversityFuzhou, China; Yang, Q., Institute of Biomedical and Pharmaceutical Technology, College of Chemistry and Chemical Engineering, Fuzhou UniversityFuzhou, China; Chen, M., Institute of Biomedical and Pharmaceutical Technology, College of Chemistry and Chemical Engineering, Fuzhou UniversityFuzhou, China; You, L., Institute of Biomedical and Pharmaceutical Technology, College of Chemistry and Chemical Engineering, Fuzhou UniversityFuzhou, China; Zhang, Q., Institute of Biomedical and Pharmaceutical Technology, College of Chemistry and Chemical Engineering, Fuzhou UniversityFuzhou, China, Institute of Biomedical Engineering, Chinese Academy of Medical Science, Peking Union Medical CollegeTianjin, China","Single-wall carbon nanotubes (SWNTs) have attractive biochemical properties such as strong cell adhesion and protein absorption, which are very useful for a cell cultivation scaffold. In this study, collagen/SWNT-COOHs nanocomposite films composed of regenerated fish collagen and SWNTCOOHs (0, 0.5, 1.0 and 2.0 weight percent) were prepared by mixing solubilized pepsin-soluble collagen with solutions of SWNT-COOHs. Morphological observation by SEM indicated the homogenous dispersion of SWNT-COOHs in the collagen matrix. The application of FTIR confirmed that the process we applied to prepare the composites did not destroy the native structures of collagen and composites were crosslinked by D-ribose. The biocompatibility was evaluated in vitro using SD rat bone marrow stem cells (BMSCs). Compared with films without transforming growth factor beta 1 (TGF-β1), films with TGF-β 1 had superior performance on promotion of cell growth. Compared with pure collagen film with TGF-β- 1, SWNT-containing films might promote cellular functions by adsorbing more growth factors. In conclusion, the study suggested that the collagen/SWNTCOOHs nanocomposite films with TGF-β1 were expected to be useful scaffolds in cartilage tissue engineering. Copyright © 2015 American Scientific Publishers All rights reserved.","Bone marrow stem cells; Carbon nanotubes; Cartilage tissue engineering; Collagen","Simson, J.A., Strehin, I.A., Lu, Q., Uy, M.O., Elisseeff, J.H., (2013) Biomacromolecules, 14, p. 637; Chen, J.P., Li, S.F., Chiang, Y.P., (2010) J. Nanosci. Nanotechno., 10, p. 5393; Chen, H., Chunder, A., Liu, X., Haque, F., Zou, J., Austin, L., Huo, Q., (2011) Mater. Express, 1, p. 154; Prabhakaran, M.P., Mobarakeh, L.G., Ramakrishna, S., (2011) J. Nanosci. Nanotechno., 11, p. 3039; Getgood, A., Bhullar, T.P.S., Rushton, N., (2009) Orthop. Trauma., 23, p. 189; Cummings, C.L., Gawlitta, D., Nerem, R.M., Stegemann, J.P., (2004) Biomaterials, 25, p. 3699; Fujigaya, T., Nakashima, N., (2012) J. Nanosci. Nanotechno., 12, p. 1717; Mcinnis, M., Zhai, L., (2012) Rev. Nanosci. Nanotechno., 1, p. 119; Cho, S.Y., Yun, Y.S., Kim, E.S., Kim, M.S., Jin, H.J., (2011) J. Nanosci. Nanotechno., 11, p. 801; Khang, D., Park, G.E., Webster, T.J., (2008) J. Biomed. Mater. Res. Part A, 86, p. 253; Li, X., Gao, H., Uo, M., Sato, Y., Akasaka, T., Feng, Q., Cui, F., Watari, F., (2008) J. Biomed. Mater. Res. Part A, 91, p. 132; Aoki, N., Yokoyama, A., Nodasaka, Y., Akasaka, T., Uo, M., Sato, Y., Tohji, K., Watari, F., (2006) Chem. Lett., 35, p. 508; Aoki, N., Akasaka, T., Watari, F., Yokoyama, A., (2007) Dent. Mater. J., 26, p. 178; Kharlamova, M.V., Mochalin, V.N., Lukatskaya, M.R., Niu, J.J., Presser, V., Mikhalovsky, S., Gogotsi, Y., (2013) Mater. Express, 3, p. 1; Zanello, L.P., Zhao, B., Hu, H., Haddon, R.C., (2006) Nano Lett., 6, p. 562; Jorgensen, C., Gordeladze, J., Noel, D., (2004) Curr. Opin. Biotechnol., 15, p. 406; Danisovic, L., Varga, I., Polak, S., Hlavackova, L., Böhmer, D., Vojtassak, J., (2009) Gen. Physiol. Biophys., 28, p. 56; Zhang, Y., Liu, W.T., Li, G.Y., Shi, B., Miao, Y.Q., Wu, X.H., (2007) Food Chem., 103, p. 906; Matsuura, K., Saito, T., Okazaki, T., Ohshima, S., Yumura, M., Iijima, S., (2006) Chem. Phys. Lett., 429, p. 497; Ji, J.Y., Lively, B., Zhong, W.H., (2012) Mater. Express, 2, p. 76; Shi, J.W., Li, X.M., Liu, L.R., Guan, M., Zhang, Q.Q., (2009) J. Funct. Mater., 40, p. 1013; Sylvester, M.F., Yannas, I.V., Salzman, E.W., Forbes, M.J., (1989) Thromb. Res., 55, p. 135; Kretlow, J.D., Jin, Y.Q., Liu, W., Zhang, W.J., Hong, T.H., Zhou, G.D., Baggett, L.S., Cao, Y.L., (2008) BMC Cell Biol., 9, p. 60; Wörle-Knirsch, J.M., Pulskamp, K., Krug, H.F., (2006) Nano Lett., 6, p. 1261; Riviere, N.A.M., Nemanich, R.J., Inman, A.O., Wang, Y.Y., Riviere, J.E., (2005) Toxicol. Lett., 155, p. 377; Casey, A., Herzog, H., Davoren, M., Lyng, F.M., Byrne, H.J., Chambers, G., (2007) Carbon, 45, p. 1425; Lobo, A.O., Antunes, E.F., Palma, M.B.S., P-Soares, C., T-Airoldi, V.J., (2008) Mater. Sci. Eng. C, 28, p. 532; Lobo, A.O., Antunes, E.F., Machado, A.H.A., P-Soares, C., T-Airoldi, V.J., Corat, E.J., (2008) Mater. Sci. Eng. C, 28, p. 264; MacDonald, R.A., Laurenzi, B.F., Viswanathan, G., Ajayan, P.M., Stegemann, (2005) J. Biomed. Mater. Res. Part A, 74, p. 489; Payne, K.J., Veis, A., (1988) Biopolymers, 27, p. 1749; Li, X., Wang, J., Su, G., Zhou, Z., Shi, J., Liu, L., Guan, M., Zhang, Q., (2012) J. Biomed. Mater. Res. Part A, 100, p. 396; Brodsky, B., Berg, R.A., Avigad, G., (1990), U. S. PatentMuyonga, J.H., Cole, C.G.B., Duodu, K.G., (2004) Food Chem., 86, p. 325",Article,Scopus,2-s2.0-84920653749
"Zhang A., Zhang X., Tan X., Cai B., Ge W., Dai G., Cai J.","Resveratrol rescued the TNF-α-induced impairments of osteogenesis of bone-marrow derived mesenchymal stem cells and inhibited the TNF-α-activated NF-κB signaling pathway",2015,"International Immunopharmacology","26","2", 3662,"409","415",,,10.1016/j.intimp.2015.04.026,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928719324&partnerID=40&md5=a3427cf8aefc3217374dc9ea8cd1e53a","Wuxi Traditional Chinese Medicine HospitalWuxi, Jiangsu, China; Wuxi People's HospitalWuxi, Jiangsu, China; School of Life Science, Nantong UniversityNantong, Jiangsu, China; Guangxi Medical UniversityNanning, Guangxi, China","Zhang, A., Wuxi People's HospitalWuxi, Jiangsu, China; Zhang, X., Wuxi Traditional Chinese Medicine HospitalWuxi, Jiangsu, China; Tan, X., School of Life Science, Nantong UniversityNantong, Jiangsu, China; Cai, B., Guangxi Medical UniversityNanning, Guangxi, China; Ge, W., Wuxi Traditional Chinese Medicine HospitalWuxi, Jiangsu, China; Dai, G., Wuxi Traditional Chinese Medicine HospitalWuxi, Jiangsu, China; Cai, J., Wuxi Traditional Chinese Medicine HospitalWuxi, Jiangsu, China","Resveratrol, trans-3,4′-trihydroxystilbene, is a natural phytoalexin. Its anti-inflammatory activity has attracted more and more attention in clinic over the years for the treatment of inflammatory diseases. However, its effect on bone repair and new bone formation in an inflammatory microenvironment is quite little understood, especially when bone-marrow derived mesenchymal stem cells (MSCs) are used in stem cell therapy for the treatment of inflammatory bone diseases. In the present study, we investigated the effect of resveratrol on osteogenic differentiation of primary mouse bone marrow derived MSCs and potential mechanism involved when cells were exposed to TNF-α treatment. We found that resveratrol reversed the apoptotic effect of TNF-α and abrogated its inhibitory effect on osteogenic differentiation of bone marrow derived MSCs. Mechanistic studies demonstrated that resveratrol rescued the TNF-α-induced impairments of osteogenesis, and inhibited TNF-α-activated NF-κB signaling. Our study may help understand the mechanism involved in the inhibitory effect of inflammatory cytokines on osteogenic differentiation, and highlights the role of resveratrol as a potential therapeutic agent for bone repair and especially in MSC-based cell therapy for the treatment of inflammation-associated bone diseases. © 2015 Elsevier B.V. All rights reserved.","Bone marrow derived mesenchymal stem cells; Inflammatory bone disease; NF-kB signaling; Resveratrol; TNF-α","Aggarwal, B.B., Signalling pathways of the TNF superfamily: a double-edged sword (2003) Nat. Rev. Immunol., 3, pp. 745-756; Asagiri, M., Takayanagi, H., The molecular understanding of osteoclast differentiation (2007) Bone, 40, pp. 251-264; Osta, B., Benedetti, G., Miossec, P., Classical and paradoxical effects of TNF-alpha on bone homeostasis (2014) Front. Immunol., 5, p. 48; Horowitz, M.C., Xi, Y., Wilson, K., Kacena, M.A., Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands (2001) Cytokine Growth Factor Rev., 12, pp. 9-18; Moon, S.J., Ahn, I.E., Jung, H., Yi, H., Kim, J., Kim, Y., Temporal differential effects of proinflammatory cytokines on osteoclastogenesis (2013) Int. J. Mol. Med., 31, pp. 769-777; Gilbert, L., He, X., Farmer, P., Boden, S., Kozlowski, M., Rubin, J., Inhibition of osteoblast differentiation by tumor necrosis factor-alpha (2000) Endocrinology, 141, pp. 3956-3964; Gilbert, L., He, X., Farmer, P., Rubin, J., Drissi, H., Van Wijnen, A.J., Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha (2002) J. Biol. Chem., 277, pp. 2695-2701; Ehnert, S., Baur, J., Schmitt, A., Neumaier, M., Lucke, M., Dooley, S., TGF-beta1 as possible link between loss of bone mineral density and chronic inflammation (2010) PLoS One, 5; Kulterer, B., Friedl, G., Jandrositz, A., Sanchez-Cabo, F., Prokesch, A., Paar, C., Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation (2007) BMC Genomics, 8, p. 70; Kristjansson, B., Honsawek, S., Current perspectives in mesenchymal stem cell therapies for osteoarthritis (2014) Stem Cells Int., 2014, p. 194318; Tili, E., Michaille, J.J., Resveratrol, microRNAs, inflammation, and cancer (2011) J. Nucleic Acids, 2011, p. 102431; Fu, Y., Chang, H., Peng, X., Bai, Q., Yi, L., Zhou, Y., Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/beta-catenin signaling pathway (2014) PLoS One, 9; Bertelli, A.A., Baccalini, R., Battaglia, E., Falchi, M., Ferrero, M.E., Resveratrol inhibits TNF alpha-induced endothelial cell activation (2001) Therapie, 56, pp. 613-616; Ahn, J., Lee, H., Kim, S., Ha, T., Resveratrol inhibits TNF-alpha-induced changes of adipokines in 3T3-L1 adipocytes (2007) Biochem. Biophys. Res. Commun., 364, pp. 972-977; Tian, J., Chen, J.W., Gao, J.S., Li, L., Xie, X., Resveratrol inhibits TNF-alpha-induced IL-1beta, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway (2013) Rheumatol. Int., 33, pp. 1829-1835; Wang, D.T., Yin, Y., Yang, Y.J., Lv, P.J., Shi, Y., Lu, L., Resveratrol prevents TNF-alpha-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes (2014) Int. Immunopharmacol., 19, pp. 206-213; Marino, A., Santoro, G., Spataro, F., Lauriano, E.R., Pergolizzi, S., Cimino, F., Resveratrol role in Staphylococcus aureus-induced corneal inflammation (2013) Pathog. Dis., 68, pp. 61-64; Uguralp, S., Irsi, C., Aksoy, T., Karabulut, A.B., Kirimlioglu, H., Mizrak, B., Resveratrol attenuates inflammation and stricture formation in experimental caustic esophageal burns (2008) Pediatr. Surg. Int., 24, pp. 425-430; Bereswill, S., Munoz, M., Fischer, A., Plickert, R., Haag, L.M., Otto, B., Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation (2010) PLoS One, 5; Larrosa, M., Yanez-Gascon, M.J., Selma, M.V., Gonzalez-Sarrias, A., Toti, S., Ceron, J.J., Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model (2009) J. Agric. Food Chem., 57, pp. 2211-2220; Martin, A.R., Villegas, I., Sanchez-Hidalgo, M., De La Lastra, C.A., The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model (2006) Br. J. Pharmacol., 147, pp. 873-885; Sanchez-Fidalgo, S., Cardeno, A., Villegas, I., Talero, E., De La Lastra, C.A., Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice (2010) Eur. J. Pharmacol., 633, pp. 78-84; Gomez-Zorita, S., Fernandez-Quintela, A., Lasa, A., Hijona, E., Bujanda, L., Portillo, M.P., Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats (2013) Nutrition, 29, pp. 1374-1380; Larrosa, M., Azorin-Ortuno, M., Yanez-Gascon, M.J., Garcia-Conesa, M.T., Tomas-Barberan, F., Espin, J.C., Lack of effect of oral administration of resveratrol in LPS-induced systemic inflammation (2011) Eur. J. Nutr., 50, pp. 673-680; Palmieri, D., Pane, B., Barisione, C., Spinella, G., Garibaldi, S., Ghigliotti, G., Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development (2011) J. Surg. Res., 171, pp. e237-e246; Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Multilineage potential of adult human mesenchymal stem cells (1999) Science, 284, pp. 143-147; Krum, S.A., Chang, J., Miranda-Carboni, G., Wang, C.Y., Novel functions for NFkappaB: inhibition of bone formation (2010) Nat. Rev. Rheumatol., 6, pp. 607-611; Xiao, J., Song, J., Hodara, V., Ford, A., Wang, X.L., Shi, Q., Protective effects of resveratrol on TNF-alpha-induced endothelial cytotoxicity in baboon femoral arterial endothelial cells (2013) J. Diabetes Res., 2013, p. 185172; Losso, J.N., Truax, R.E., Richard, G., trans-resveratrol inhibits hyperglycemia-induced inflammation and connexin downregulation in retinal pigment epithelial cells (2010) J. Agric. Food Chem., 58, pp. 8246-8252; Alexander, N.S., Hatch, N., Zhang, S., Skinner, D., Fortenberry, J., Sorscher, E.J., Resveratrol has salutary effects on mucociliary transport and inflammation in sinonasal epithelium (2011) Laryngoscope, 121, pp. 1313-1319; Cerqueira, A.M., Khaper, N., Lees, S.J., Ulanova, M., The antioxidant resveratrol down-regulates inflammation in an in-vitro model of Pseudomonas aeruginosa infection of lung epithelial cells (2013) Can. J. Physiol. Pharmacol., 91, pp. 248-255; Zhu, X., Liu, Q., Wang, M., Liang, M., Yang, X., Xu, X., Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts (2011) PLoS One, 6; Gorbunov, N., Petrovski, G., Gurusamy, N., Ray, D., Kim Do, H., Das, D.K., Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells (2012) J. Cell. Mol. Med., 16, pp. 174-184; Konyalioglu, S., Armagan, G., Yalcin, A., Atalayin, C., Dagci, T., Effects of resveratrol on hydrogen peroxide-induced oxidative stress in embryonic neural stem cells (2013) Neural Regen. Res., 8, pp. 485-495; Macewan, D.J., TNF ligands and receptors - a matter of life and death (2002) Br. J. Pharmacol., 135, pp. 855-875; Mukai, T., Otsuka, F., Otani, H., Yamashita, M., Takasugi, K., Inagaki, K., TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling (2007) Biochem. Biophys. Res. Commun., 356, pp. 1004-1010",Article,Scopus,2-s2.0-84928719324
"Sawatjui N., Damrongrungruang T., Leeanansaksiri W., Jearanaikoon P., Hongeng S., Limpaiboon T.","Silk fibroin/gelatin-chondroitin sulfate-hyaluronic acid effectively enhances in vitro chondrogenesis of bone marrow mesenchymal stem cells",2015,"Materials Science and Engineering C","52",,,"90","96",,,10.1016/j.msec.2015.03.043,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925813555&partnerID=40&md5=8c3cd9b839ad5f48dee8479891905014","Biomedical Sciences, Graduate School, Khon Kaen UniversityKhon Kaen, Thailand; Department of Oral Diagnosis, Faculty of Dentistry, Khon Kaen UniversityKhon Kaen, Thailand; Stem Cell Therapy and Transplantation Research Group, Suranaree University of TechnologyNakhon Ratchasima, Thailand; School of Microbiology, Suranaree University of TechnologyNakhon Ratchasima, Thailand; Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Assoc. Medical Sciences, Khon Kaen UniversityKhon Kaen, Thailand; Department of Pediatrics, Ramathibodi Hospital, Mahidol UniversityBangkok, Thailand","Sawatjui, N., Biomedical Sciences, Graduate School, Khon Kaen UniversityKhon Kaen, Thailand, Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Assoc. Medical Sciences, Khon Kaen UniversityKhon Kaen, Thailand; Damrongrungruang, T., Department of Oral Diagnosis, Faculty of Dentistry, Khon Kaen UniversityKhon Kaen, Thailand; Leeanansaksiri, W., Stem Cell Therapy and Transplantation Research Group, Suranaree University of TechnologyNakhon Ratchasima, Thailand, School of Microbiology, Suranaree University of TechnologyNakhon Ratchasima, Thailand; Jearanaikoon, P., Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Assoc. Medical Sciences, Khon Kaen UniversityKhon Kaen, Thailand; Hongeng, S., Department of Pediatrics, Ramathibodi Hospital, Mahidol UniversityBangkok, Thailand; Limpaiboon, T., Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Assoc. Medical Sciences, Khon Kaen UniversityKhon Kaen, Thailand","Tissue engineering is becoming promising for cartilage repair due to the limited self-repair capacity of cartilage tissue. We previously fabricated and characterized a three-dimensional silk fibroin/gelatin-chondroitin sulfate-hyaluronic acid (SF-GCH) scaffold and showed that it could promote proliferation of human bone marrow mesenchymal stem cells (BM-MSCs). This study aimed to evaluate its biological performance as a new biomimetic material for chondrogenic induction of BM-MSCs in comparison to an SF scaffold and conventional pellet culture. We found that the SF-GCH scaffold significantly enhanced the proliferation and chondrogenic differentiation of BM-MSCs compared to the SF scaffold and pellet culture in which the production of sulfated glycoaminoglycan was increased in concordance with the up-regulation of chondrogenic-specific gene markers. Our findings indicate the significant role of SF-GCH by providing a supportive structure and the mimetic cartilage environment for chondrogenesis which enables cartilage regeneration. Thus, our fabricated SF-GCH scaffold may serve as a potential biomimetic material for cartilage tissue engineering. © 2015 Elsevier B.V. All rights reserved.","Biomaterials; Biomimetic; Cartilage tissue engineering; Chondrogenesis; Mesenchymal stem cells; Scaffold","Brittberg, M., Lindahl, A., Nilsson, A., Ohlsson, C., Isaksson, O., Peterson, L., Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation (1994) N. Engl. J. Med., 331, pp. 889-895; Chung, C., Burdick, J.A., Engineering cartilage tissue (2008) Adv. Drug Deliv. Rev., 60, pp. 243-262; Von Der Mark, K., Gauss, V., Von Der Mark, H., Muller, P., Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture (1977) Nature, 267, pp. 531-532; Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Marshak, D.R., Multilineage potential of adult human mesenchymal stem cells (1999) Science, 284, pp. 143-147; Athanasiou, K.A., Niederauer, G.G., Agrawal, C.M., Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers (1996) Biomaterials, 17, pp. 93-102; Jakobsen, R.B., Shahdadfar, A., Reinholt, F.P., Brinchmann, J.E., Chondrogenesis in a hyaluronic acid scaffold: Comparison between chondrocytes and MSC from bone marrow and adipose tissue (2010) Knee Surg. Sports Traumatol. Arthrosc., 18, pp. 1407-1416; Cao, H., Xu, S.Y., EDC/NHS-crosslinked type II collagen-chondroitin sulfate scaffold: Characterization and in vitro evaluation (2008) J. Mater. Sci. Mater. Med., 19, pp. 567-575; Wang, Y., Blasioli, D.J., Kim, H.J., Kim, H.S., Kaplan, D.L., Cartilage tissue engineering with silk scaffolds and human articular chondrocytes (2006) Biomaterials, 27, pp. 4434-4442; Awad, H.A., Wickham, M.Q., Leddy, H.A., Gimble, J.M., Guilak, F., Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds (2004) Biomaterials, 25, pp. 3211-3222; Wang, Y., Kim, H.J., Vunjak-Novakovic, G., Kaplan, D.L., Stem cell-based tissue engineering with silk biomaterials (2006) Biomaterials, 27, pp. 6064-6082; Wang, Y., Kim, U.J., Blasioli, D.J., Kim, H.J., Kaplan, D.L., In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells (2005) Biomaterials, 26, pp. 7082-7094; Garcia-Fuentes, M., Meinel, A.J., Hilbe, M., Meinel, L., Merkle, H.P., Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering (2009) Biomaterials, 30, pp. 5068-5076; Bhardwaj, N., Kundu, S.C., Chondrogenic differentiation of rat MSCs on porous scaffolds of silk fibroin/chitosan blends (2012) Biomaterials, 33, pp. 2848-2857; Malafaya, P.B., Silva, G.A., Reis, R.L., Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications (2007) Adv. Drug Deliv. Rev., 59, pp. 207-233; Stadlinger, B., Pilling, E., Mai, R., Bierbaum, S., Berhardt, R., Scharnweber, D., Eckelt, U., Effect of biological implant surface coatings on bone formation, applying collagen, proteoglycans, glycosaminoglycans and growth factors (2008) J. Mater. Sci. Mater. Med., 19, pp. 1043-1049; Jackson, R.L., Busch, S.J., Cardin, A.D., Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes (1991) Physiol. Rev., 71, pp. 481-539; Pieper, J.S., Van Der Kraan, P.M., Hafmans, T., Kamp, J., Buma, P., Van Susante, J.L.C., Van Den Berg, W.B., Van Kuppevelt, T.H., Crosslinked type II collagen matrices: Preparation, characterization, and potential for cartilage engineering (2002) Biomaterials, 23, pp. 3183-3192; Van Susante, J.L.C., Pieper, J., Buma, P., Van Kuppevelt, T.H., Van Beuningen, H., Van Der Kraan, P.M., Veerkamp, J.H., Veth, R.P.H., Linkage of chondroitin-sulfate to type i collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro (2001) Biomaterials, 22, pp. 2359-2369; Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C.B., Seed, B., CD44 is the principal cell surface receptor for hyaluronate (1990) Cell, 61, pp. 1303-1313; Sawatjui, N., Damrongrungruang, T., Leeanansaksiri, W., Jearanaikoon, P., Limpaiboon, T., Fabrication and characterization of silk fibroin-gelatin/chondroitin sulfate/hyaluronic acid scaffold for biomedical applications (2014) Mater. Lett., 126, pp. 207-210; Li, M., Ogiso, M., Minoura, N., Enzymatic degradation behavior of porous silk fibroin sheets (2003) Biomaterials, 24, pp. 357-365; Sa-Ngiamsuntorn, K., Wongkajornsilp, A., Kasetsinsombat, K., Duangsa-Ard, S., Nuntakarn, L., Borwornpinyo, S., Akarasereenont, P., Hongeng, S., Upregulation of CYP 450s expression of immortalized hepatocyte-like cells derived from mesenchymal stem cells by enzyme inducers (2011) BMC Biotechnol., 11, p. 89; Chonanant, C., Jearanaikoon, N., Leelayuwat, C., Limpaiboon, T., Tobin, M.J., Jearanaikoon, P., Heraud, P., Characterisation of chondrogenic differentiation of human mesenchymal stem cells using synchrotron FTIR microspectroscopy (2011) Analyst, 136, pp. 2542-2551; Yoon, I.S., Chung, C.W., Sung, J.H., Cho, H.J., Kim, J.S., Shim, W.S., Shim, C.K., Kim, D.D., Proliferation and chondrogenic differentiation of human adipose-derived mesenchymal stem cells in porous hyaluronic acid scaffold (2011) J. Biosci. Bioeng., 112, pp. 402-408; Farndale, R.W., Sayers, C.A., Barrett, A.J., A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures (1982) Connect. Tissue Res., 9, pp. 247-248; Zhang, L., Su, P., Xu, C., Yang, J., Yu, W., Huang, D., Chondrogenic differentiation of human mesenchymal stem cells: A comparison between micromass and pellet culture systems (2010) Biotechnol. Lett., 32, pp. 1339-1346; Annes, J.P., Rifkin, D.B., Munger, J.S., The integrin αvβ6 binds and activates latent TGFbeta3 (2002) FEBS Lett., 511, pp. 65-68; Salinas, C.N., Anseth, K.S., The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities (2008) Biomaterials, 29, pp. 2370-2377; Lim, J.J., Hammoudi, T.M., Bratt-Leal, A.M., Hamilton, S.K., Kepple, K.L., Bloodworth, N.C., McDevitt, T.C., Temenoff, J.S., Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery (2011) Acta Biomater., 7, pp. 986-995; Sechriest, V.F., Miao, Y.J., Niyibizi, C., Westerhausen-Larson, A., Matthew, H.W., Evans, C.H., Fu, F.H., Suh, J.K., GAG-augmented polysaccharide hydrogel: A novel biocompatible and biodegradable material to support chondrogenesis (2000) J. Biomed. Mater. Res., 49, pp. 534-541; Varghese, S., Hwang, N.S., Canver, A.C., Theprungsirikul, P., Lin, D.W., Elisseeff, J., Chondroitin sulfate based niches for chondrogenic differentiation of mesenchymal stem cells (2008) Matrix Biol., 27, pp. 12-21; Wu, S.C., Chen, C.H., Chang, J.K., Fu, Y.C., Wang, C.K., Eswaramoorthy, R., Lin, Y.S., Ho, M.L., Hyaluronan initiates chondrogenesis mainly via CD44 in human adipose-derived stem cells (2013) J. Appl. Physiol., 114, pp. 1610-1618; Knudson, C.B., Hyaluronan and CD44: Strategic players for cell-matrix interactions during chondrogenesis and matrix assembly (2003) Birth Defects Res. C Embryo Today, 69, pp. 174-196; Matsiko, A., Levingstone, T.J., O'Brien, F.J., Gleeson, J.P., Addition of hyaluronic acid improves cellular infiltration and promotes early-stage chondrogenesis in a collagen-based scaffold for cartilage tissue engineering (2012) J. Mech. Behav. Biomed. Mater., 11, pp. 41-52; Indrawattana, N., Chen, G., Tadokoro, M., Shann, L.H., Ohgushi, H., Tateishi, T., Tanaka, J., Bunyaratvej, A., Growth factor combination for chondrogenic induction from human mesenchymal stem cell (2004) Biochem. Biophys. Res. Commun., 320, pp. 914-919; Ikeda, T., Kawaguchi, H., Kamekura, S., Ogata, N., Mori, Y., Nakamura, K., Ikegawa, S., Chung, U.I., Distinct roles of Sox5, Sox6, and Sox9 in different stages of chondrogenic differentiation (2005) J. Bone Miner. Metab., 23, pp. 337-340; Sekiya, I., Vuoristo, J.T., Larson, B.L., Prockop, D.J., In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis (2002) Proc. Natl. Acad. Sci., 99, pp. 4397-4402; Sekiya, I., Colter, D.C., Prockop, D.J., BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells (2001) Biochem. Biophys. Res. Commun., 284, pp. 411-418; Chang, C.H., Liu, H.C., Lin, C.C., Chou, C.H., Lin, F.H., Gelatin-chondroitin-hyaluronan tri-copolymer scaffold for cartilage tissue engineering (2003) Biomaterials, 24, pp. 4853-4858; Ko, C.S., Huang, J.P., Huang, C.W., Chu, I.M., Type II collagen-chondroitin sulfate-hyaluronan scaffold cross-linked by genipin for cartilage tissue engineering (2009) J. Biosci. Bioeng., 107, pp. 177-182",Article,Scopus,2-s2.0-84925813555
"Luo Z., Deng Y., Zhang R., Wang M., Bai Y., Zhao Q., Lyu Y., Wei J., Wei S.","Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering",2015,"Colloids and Surfaces B: Biointerfaces","131",,,"73","82",,,10.1016/j.colsurfb.2015.04.043,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928953221&partnerID=40&md5=ccff425e6919e9980b9eef93fa24dc9a","Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Peking UniversityBeijing, China; Center for Biomedical Materials and Tissue Engineering, Academy for Advanced Interdisciplinary Studies, Peking UniversityBeijing, China; Department of Stomatology, Beijing Anzhen Hospital, Capital Medical UniversityBeijing, China; Department of Stomatology, Aviation General Hospital of China Medical Univ. and Beijing Inst. of Translational Medicine, Chinese Academy of ScienceBeijing, China; Key Laboratory for Ultrafine Materials of Ministry of Education, East China University of Science and TechnologyShanghai, China","Luo, Z., Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Peking UniversityBeijing, China, Center for Biomedical Materials and Tissue Engineering, Academy for Advanced Interdisciplinary Studies, Peking UniversityBeijing, China; Deng, Y., Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Peking UniversityBeijing, China, Center for Biomedical Materials and Tissue Engineering, Academy for Advanced Interdisciplinary Studies, Peking UniversityBeijing, China; Zhang, R., Department of Stomatology, Beijing Anzhen Hospital, Capital Medical UniversityBeijing, China; Wang, M., Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Peking UniversityBeijing, China; Bai, Y., Department of Stomatology, Aviation General Hospital of China Medical Univ. and Beijing Inst. of Translational Medicine, Chinese Academy of ScienceBeijing, China; Zhao, Q., Department of Stomatology, Aviation General Hospital of China Medical Univ. and Beijing Inst. of Translational Medicine, Chinese Academy of ScienceBeijing, China; Lyu, Y., Department of Stomatology, Beijing Anzhen Hospital, Capital Medical UniversityBeijing, China; Wei, J., Key Laboratory for Ultrafine Materials of Ministry of Education, East China University of Science and TechnologyShanghai, China; Wei, S., Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Peking UniversityBeijing, China, Center for Biomedical Materials and Tissue Engineering, Academy for Advanced Interdisciplinary Studies, Peking UniversityBeijing, China","Combination of mesoporous silica materials and bioactive factors is a promising niche-mimetic solution as a hybrid bone substitution for bone tissue engineering. In this work, we have synthesized biocompatible silica-based nanoparticles with abundant mesoporous structure, and incorporated bone-forming peptide (BFP) derived from bone morphogenetic protein-7 (BMP-7) into the mesoporous silica nanoparticles (MSNs) to obtain a slow-release system for osteogenic factor delivery. The chemical characterization demonstrates that the small osteogenic peptide is encapsulated in the mesoporous successfully, and the nitrogen adsorption-desorption isotherms suggest that the peptide encapsulation has no influence on mesoporous structure of MSNs. In the cell experiment, the peptide-laden MSNs (p-MSNs) show higher MG-63 cell proliferation, spreading and alkaline phosphatase (ALP) activity than the bare MSNs, indicating good in vitro cytocompatibility. Simultaneously, the osteogenesis-related proteins expression and calcium mineral deposition disclose enhanced osteo-differentiation of human mesenchymal stem cells (hMSCs) under the stimulation of the p-MSNs, confirming that BFP released from MSNs could significantly promote the osteogenic differentiation of hMSCs, especially at 500. μg/mL of p-MSNs concentration. The peptide-modified MSNs with better bioactivity and osteogenic differentiation make it a potential candidate as bioactive material for bone repairing, bone regeneration, and bio-implant coating applications. © 2015 Elsevier B.V.","Bioactivity; Bone tissue engineering; Mesoporous silica nanoparticles; Osteo-differentiation; Peptide","Betz, R.R., (2002) Orthopedics, 25, p. s561; Perka, C., Schultz, O., Spitzer, R.S., (2000) Biomaterials, 21, p. 1145; Zhang, X., Xu, M., Song, L., (2013) Biomaterials, 34, p. 9103; Fujibayashi, S., Neo, M., Kim, H.M., (2004) Biomaterials, 25, p. 443; Yavari, S.A., van der Stok, J., Chai, Y.C., (2014) Biomaterials, 35, p. 6172; Zhu, Y., Wu, C., Ramaswamy, Y., (2008) Microporous Mesoporous Mater., 112, p. 494; Wu, C., Zhou, Y., Fan, W., (2012) Biomaterials, 33, p. 2076; Ding, F., Deng, H., Du, Y., (2014) Nanoscale, 6, p. 9477; Peng, H., Liu, X., Wang, R., (2014) J. Mater. Chem. B: Mater. Biol. Med., 2, p. 6435; Wang, Q., Gu, Z., Jamal, S., (2013) Tissue Eng. A, 19, p. 2586; Wang, Q., Wang, J., Lu, Q., (2010) Biomaterials, 31, p. 4980; Wang, Q., Wang, L., Detamore, M.S., (2008) Adv. Mater., 20, p. 236; Song, F., Li, X., Wang, Q., (2015) J. Biomed. Nanotechnol., 11, p. 40; Singh, N., Karambelkar, A., Gu, L., (2011) J. Am. Chem. Soc., 133, p. 19582; Chen, Z., Li, X., He, H., (2012) Colloids Surf. B: Biointerfaces, 95, p. 274; Han, P., Wu, C., Xiao, Y., (2013) Biomater. Sci., 1, p. 379; Sun, J., Wei, L., Liu, X., (2009) Acta Biomater., 5, p. 1284; Kuo, Y.C., Wang, C.C., (2011) Colloids Surf. B: Biointerfaces, 84, p. 63; Kim, T.H., Kim, M., Eltohamy, M., (2013) J. Biomed. Mater. Res. A, 101, p. 1651; Gan, Q., Zhu, J., Yuan, Y., (2014) J. Mater. Chem. B; Matsumoto, T., Okazaki, M., Inoue, M., (2004) Biomaterials, 25, p. 3807; Liu, T., Wu, G., Wismeijer, D., (2013) Bone, 56, p. 110; Zhi, L., Chen, C., Pang, X., (2011) Int. Orthop., 35, p. 1889; Carpenter, R.S., Goodrich, L.R., Frisbie, D.D., (2010) J. Orthop. Res., 28, p. 1330; Lock, J., Liu, H., (2011) Int. J. Nanomed., 6, p. 2769; Mendes, L., Saska, S., Martines, M., (2013) Mater. Sci. Eng. C: Mater. Biol. Appl., 33, p. 4427; Kim, H.K., Kim, J.H., Park, D.S., (2012) Biomaterials, 33, p. 7057; Lee, Y.J., Lee, J.H., Cho, H.J., (2013) Biomaterials, 34, p. 5059; Wu, Z., Tang, T., Guo, H., (2014) Colloids Surf. B: Biointerfaces, 120, p. 38; Dai, C., Guo, H., Lu, J., (2011) Biomaterials, 32, p. 8506; Zhao, D., Feng, J., Huo, Q., (1998) Science, 279, p. 548; Dai, C., Liu, C., Wei, J., (2010) Biomaterials, 31, p. 7620; Barrett, E.P., Joyner, L.G., Halenda, P.P., (1951) J. Am. Chem. Soc., 73, p. 373; Izquierdo-Barba, I., Sousa, E., Doadrio, J.C., (2009) J. Solgel Sci. Technol., 50, p. 421; Deng, Y., Zhang, X., Zhao, X., (2013) Acta Biomater., 9, p. 8840; Cheng, C., Nie, S., Li, S., (2013) J. Mater. Chem. B: Mater. Biol. Med., 1, p. 265; Eteshola, E., Brillson, L.J., Lee, S.C., (2005) Biomol. Eng., 22, p. 201; Puddu, V., Perry, C.C., (2012) ACS Nano, 6, p. 6356; Huang, X., Teng, X., Chen, D., (2010) Biomaterials, 31, p. 438; Vivero-Escoto, J.L., Slowing, I.I., Lin, V.S.Y., (2010) Biomaterials, 31, p. 1325; Hattar, S., Berdal, A., Asselin, A., (2002) Eur. Cell Mater., 4, p. 61; Li, Q., Li, M., Zhu, P., (2012) J. Mater. Chem., 22, p. 20257; Senta, H., Park, H., Bergeron, E., (2009) Cytokine Growth Factor Rev., 20, p. 213",Article,Scopus,2-s2.0-84928953221
"Liu R., Zhang S., Yang H., Ju P., Xia Y., Shi Y., Lim T.H., Lim A.S., Liang F., Feng Z.","Characterization and therapeutic evaluation of a Nestin+ CNP+ NG2+ cell population on mouse spinal cord injury",2015,"Experimental Neurology","269",,,"28","42",,,10.1016/j.expneurol.2015.03.030,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927166110&partnerID=40&md5=f6ee790de3e6f997fc0f2bcfce902c44","Department of Physiology and Pathophysiology, Xi'an Jiaotong University Health Science CenterXi'an, China; Genomics and Genetics Division, School of Biological Sciences, Nanyang Technological University, Singapore; Cytogenetics Laboratory, Department of Pathology, Singapore General Hospital, Singapore; Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore","Liu, R., Department of Physiology and Pathophysiology, Xi'an Jiaotong University Health Science CenterXi'an, China; Zhang, S., Genomics and Genetics Division, School of Biological Sciences, Nanyang Technological University, Singapore; Yang, H., Genomics and Genetics Division, School of Biological Sciences, Nanyang Technological University, Singapore; Ju, P., Genomics and Genetics Division, School of Biological Sciences, Nanyang Technological University, Singapore; Xia, Y., Genomics and Genetics Division, School of Biological Sciences, Nanyang Technological University, Singapore; Shi, Y., Genomics and Genetics Division, School of Biological Sciences, Nanyang Technological University, Singapore; Lim, T.H., Cytogenetics Laboratory, Department of Pathology, Singapore General Hospital, Singapore; Lim, A.S., Cytogenetics Laboratory, Department of Pathology, Singapore General Hospital, Singapore; Liang, F., Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Feng, Z., Genomics and Genetics Division, School of Biological Sciences, Nanyang Technological University, Singapore","The NG2 chondroitin sulfate proteoglycan-expressing neural cells (NG2 cells) have originally been considered as oligodendrocyte progenitor cells (OPCs). However, recent findings on their diverse functions and lineage heterogeneity demonstrated that the NG2 cells contain various sub-populations whose concrete features and therapeutic potential yet remained elucidated. In the present study, we characterized a Nestin+ 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP)+ NG2+ subpopulation from embryonic rat cerebral cortex. The Nestin+ CNP+ NG2+ cells exhibited remarkable progenitor characteristics. Having been immortalized by human telomerase reverse transcriptase (hTERT), the life span of Nestin+ CNP+ NG2+ cells was extended to 230 population doublings (PDs). With immortalized NG2 cells, we demonstrated their differentiation capacities to oligodendrocytes, astrocytes and neurons. Furthermore, transplanted into injured spinal cord of a mouse model, they were able to promote remyelination and neuronal regeneration, thereby enhancing the functional recovery. Our findings suggest that the Nestin+ CNP+ NG2+ progenitor cells could be a good alternative cell source of cell therapy for neurological disorders. © 2015 Elsevier Inc.","Cell transplantation; Cerebral cortex; Multipotency; Neuronal regeneration; NG2; Progenitors; Remyelination; Spinal cord injury; Telomerase reverse transcriptase","Aguirre, A., Gallo, V., Postnatal neurogenesis and gliogenesis in the olfactory bulb from NG2-expressing progenitors of the subventricular zone (2004) J. Neurosci., 24, pp. 10530-10541; Aguirre, A.A., Chittajallu, R., Belachew, S., Gallo, V., NG2-expressing cells in the subventricular zone are type C-like cells and contribute to interneuron generation in the postnatal hippocampus (2004) J. Cell Biol., 165, pp. 575-589; Archer, D.R., Cuddon, P.A., Lipsitz, D., Duncan, I.D., Myelination of the canine central nervous system by glial cell transplantation: a model for repair of human myelin disease (1997) Nat. Med., 3, pp. 54-59; Baracskay, K.L., Kidd, G.J., Miller, R.H., Trapp, B.D., NG2-positive cells generate A2B5-positive oligodendrocyte precursor cells (2007) Glia, 55, pp. 1001-1010; Barnabe-Heider, F., Goritz, C., Sabelstrom, H., Takebayashi, H., Pfrieger, F.W., Meletis, K., Frisen, J., Origin of new glial cells in intact and injured adult spinal cord (2010) Cell Stem Cell, 7, pp. 470-482; Barres, B.A., Hart, I.K., Coles, H.S., Burne, J.F., Voyvodic, J.T., Richardson, W.D., Raff, M.C., Cell death and control of cell survival in the oligodendrocyte lineage (1992) Cell, 70, pp. 31-46; Basso, D.M., Beattie, M.S., Bresnahan, J.C., A sensitive and reliable locomotor rating scale for open field testing in rats (1995) J. Neurotrauma, 12, pp. 1-21; Belachew, S., Chittajallu, R., Aguirre, A.A., Yuan, X., Kirby, M., Anderson, S., Gallo, V., Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons (2003) J. Cell Biol., 161, pp. 169-186; Belletti, B., Nicoloso, M.S., Schiappacassi, M., Chimienti, E., Berton, S., Lovat, F., Colombatti, A., Baldassarre, G., P27(kip1) functional regulation in human cancer: a potential target for therapeutic designs (2005) Curr. Med. Chem., 12, pp. 1589-1605; Bergles, D.E., Roberts, J.D., Somogyi, P., Jahr, C.E., Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus (2000) Nature, 405, pp. 187-191; Blakemore, W.F., Chari, D.M., Gilson, J.M., Crang, A.J., Modelling large areas of demyelination in the rat reveals the potential and possible limitations of transplanted glial cells for remyelination in the CNS (2002) Glia, 38, pp. 155-168; Bottai, D., Scesa, G., Cigognini, D., Adami, R., Nicora, E., Abrignani, S., Di Giulio, A.M., Gorio, A., Third trimester NG2-positive amniotic fluid cells are effective in improving repair in spinal cord injury (2014) Exp. Neurol., 254, pp. 121-133; Bouslama-Oueghlani, L., Wehrle, R., Sotelo, C., Dusart, I., Heterogeneity of NG2-expressing cells in the newborn mouse cerebellum (2005) Dev. Biol., 285, pp. 409-421; Bull, N.D., Bartlett, P.F., The adult mouse hippocampal progenitor is neurogenic but not a stem cell (2005) J. Neurosci., 25, pp. 10815-10821; Burns, J.S., Abdallah, B.M., Guldberg, P., Rygaard, J., Schroder, H.D., Kassem, M., Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells (2005) Cancer Res., 65, pp. 3126-3135; Butt, A.M., Hamilton, N., Hubbard, P., Pugh, M., Ibrahim, M., Synantocytes: the fifth element (2005) J. Anat., 207, pp. 695-706; Cahoy, J.D., Emery, B., Kaushal, A., Foo, L.C., Zamanian, J.L., Christopherson, K.S., Xing, Y., Barres, B.A., A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function (2008) J. Neurosci., 28, pp. 264-278; Cao, Q.L., Zhang, Y.P., Howard, R.M., Walters, W.M., Tsoulfas, P., Whittemore, S.R., Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage (2001) Exp. Neurol., 167, pp. 48-58; Cao, Q., Xu, X.M., Devries, W.H., Enzmann, G.U., Ping, P., Tsoulfas, P., Wood, P.M., Whittemore, S.R., Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells (2005) J. Neurosci., 25, pp. 6947-6957; Cao, Q., He, Q., Wang, Y., Cheng, X., Howard, R.M., Zhang, Y., DeVries, W.H., Whittemore, S.R., Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury (2010) J. Neurosci., 30, pp. 2989-3001; Chittajallu, R., Aguirre, A., Gallo, V., NG2-positive cells in the mouse white and grey matter display distinct physiological properties (2004) J. Physiol., 561, pp. 109-122; Chow, S.Y., Moul, J., Tobias, C.A., Himes, B.T., Liu, Y., Obrocka, M., Hodge, L., Fischer, I., Characterization and intraspinal grafting of EGF/bFGF-dependent neurospheres derived from embryonic rat spinal cord (2000) Brain Res., 874, pp. 87-106; Clarke, L.E., Young, K.M., Hamilton, N.B., Li, H., Richardson, W.D., Attwell, D., Properties and fate of oligodendrocyte progenitor cells in the corpus callosum, motor cortex, and piriform cortex of the mouse (2012) J. Neurosci., 32, pp. 8173-8185; Constantini, S., Young, W., The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats (1994) J. Neurosurg., 80, pp. 97-111; De Biase, L.M., Nishiyama, A., Bergles, D.E., Excitability and synaptic communication within the oligodendrocyte lineage (2010) J. Neurosci., 30, pp. 3600-3611; Dhib-Jalbut, S., Arnold, D.L., Cleveland, D.W., Fisher, M., Friedlander, R.M., Mouradian, M.M., Przedborski, S., Yong, V.W., Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases (2006) J. Neuroimmunol., 176, pp. 198-215; Di Bello, I.C., Dawson, M.R., Levine, J.M., Reynolds, R., Generation of oligodendroglial progenitors in acute inflammatory demyelinating lesions of the rat brain stem is associated with demyelination rather than inflammation (1999) J. Neurocytol., 28, pp. 365-381; Diers-Fenger, M., Kirchhoff, F., Kettenmann, H., Levine, J.M., Trotter, J., AN2/NG2 protein-expressing glial progenitor cells in the murine CNS: isolation, differentiation, and association with radial glia (2001) Glia, 34, pp. 213-228; Dimou, L., Simon, C., Kirchhoff, F., Takebayashi, H., Gotz, M., Progeny of Oligo2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex (2008) J. Neurosci., 28, pp. 10434-10442; Doetsch, F., Caille, I., Lim, D.A., Garcia-Verdugo, J.M., Alvarez-Buylla, A., Subventricular zone astrocytes are neural stem cells in the adult mammalian brain (1999) Cell, 97, pp. 703-716; Duggal, N., Schmidt-Kastner, R., Hakim, A.M., Nestin expression in reactive astrocytes following focal cerebral ischemia in rats (1997) Brain Res., 768, pp. 1-9; Flores, I., Benetti, R., Blasco, M.A., Telomerase regulation and stem cell behaviour (2006) Curr. Opin. Cell Biol., 18, pp. 254-260; Franklin, R.J., Bayley, S.A., Milner, R., Ffrench-Constant, C., Blakemore, W.F., Differentiation of the O-2A progenitor cell line CG-4 into oligodendrocytes and astrocytes following transplantation into glia-deficient areas of CNS white matter (1995) Glia, 13, pp. 39-44; Gage, F.H., Coates, P.W., Palmer, T.D., Kuhn, H.G., Fisher, L.J., Suhonen, J.O., Peterson, D.A., Ray, J., Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain (1995) Proc. Natl. Acad. Sci. U. S. A., 92, pp. 11879-11883; Ge, W.P., Zhou, W., Luo, Q., Jan, L.Y., Jan, Y.N., Dividing glial cells maintain differentiated properties including complex morphology and functional synapses (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 328-333; Groves, A.K., Barnett, S.C., Franklin, R.J., Crang, A.J., Mayer, M., Blakemore, W.F., Noble, M., Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells (1993) Nature, 362, pp. 453-455; Guo, F., Maeda, Y., Ma, J., Xu, J., Horiuchi, M., Miers, L., Vaccarino, F., Pleasure, D., Pyramidal neurons are generated from oligodendroglial progenitor cells in adult piriform cortex (2010) J. Neurosci., 30, pp. 12036-12049; Haberlandt, C., Derouiche, A., Wyczynski, A., Haseleu, J., Pohle, J., Karram, K., Trotter, J., Jabs, R., Gray matter NG2 cells display multiple Ca2+-signaling pathways and highly motile processes (2011) PLoS ONE, 6, p. e17575; Haik, S., Gauthier, L.R., Granotier, C., Peyrin, J.M., Lages, C.S., Dormont, D., Boussin, F.D., Fibroblast growth factor 2 up regulates telomerase activity in neural precursor cells (2000) Oncogene, 19, pp. 2957-2966; Han, S.S., Liu, Y., Tyler-Polsz, C., Rao, M.S., Fischer, I., Transplantation of glial-restricted precursor cells into the adult spinal cord: survival, glial-specific differentiation, and preferential migration in white matter (2004) Glia, 45, pp. 1-16; Hill, C.E., Proschel, C., Noble, M., Mayer-Proschel, M., Gensel, J.C., Beattie, M.S., Bresnahan, J.C., Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration (2004) Exp. Neurol., 190, pp. 289-310; Hiyama, E., Hiyama, K., Telomere and telomerase in stem cells (2007) Br. J. Cancer, 96, pp. 1020-1024; Huang, W., Zhao, N., Bai, X., Karram, K., Trotter, J., Goebbels, S., Scheller, A., Kirchhoff, F., Novel NG2-CreERT2 knock-in mice demonstrate heterogeneous differentiation potential of NG2 glia during development (2014) Glia, 62, pp. 896-913; Irvine, K.A., Blakemore, W.F., Remyelination protects axons from demyelination-associated axon degeneration (2008) Brain, 131, pp. 1464-1477; Jeffery, N.D., Crang, A.J., O'Leary, M.T., Hodge, S.J., Blakemore, W.F., Behavioural consequences of oligodendrocyte progenitor cell transplantation into experimental demyelinating lesions in the rat spinal cord (1999) Eur. J. Neurosci., 11, pp. 1508-1514; Kang, S.H., Fukaya, M., Yang, J.K., Rothstein, J.D., Bergles, D.E., NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration (2010) Neuron, 68, pp. 668-681; Karadottir, R., Hamilton, N.B., Bakiri, Y., Attwell, D., Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter (2008) Nat. Neurosci., 11, pp. 450-456; Keirstead, H.S., Levine, J.M., Blakemore, W.F., Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord (1998) Glia, 22, pp. 161-170; Kondo, T., Raff, M., Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells (2000) Science, 289, pp. 1754-1757; Kronenberg, G., Wang, L.P., Synowitz, M., Gertz, K., Katchanov, J., Glass, R., Harms, C., Endres, M., Nestin-expressing cells divide and adopt a complex electrophysiologic phenotype after transient brain ischemia (2005) J. Cereb. Blood Flow Metab., 25, pp. 1613-1624; Kruglyakova, E.P., Khovryakov, A.V., Shikhanov, N.P., Maccann, G.M., Vael, I., Kruglyakov, P.P., Sosunov, A.A., Nestin-expressing cells in the human hippocampus (2005) Neurosci. Behav. Physiol., 35, pp. 891-897; Laywell, E.D., Rakic, P., Kukekov, V.G., Holland, E.C., Steindler, D.A., Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain (2000) Proc. Natl. Acad. Sci. U. S. A., 97, pp. 13883-13888; Lendahl, U., Zimmerman, L.B., McKay, R.D., CNS stem cells express a new class of intermediate filament protein (1990) Cell, 60, pp. 585-595; LeVine, S.M., Goldman, J.E., Spatial and temporal patterns of oligodendrocyte differentiation in rat cerebrum and cerebellum (1988) J. Comp. Neurol., 277, pp. 441-455; Lin, S.C., Bergles, D.E., Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus (2004) Nat. Neurosci., 7, pp. 24-32; Liu, Y., Wu, Y., Lee, J.C., Xue, H., Pevny, L.H., Kaprielian, Z., Rao, M.S., Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development (2002) Glia, 40, pp. 25-43; Ma, M., Basso, D.M., Walters, P., Stokes, B.T., Jakeman, L.B., Behavioral and histological outcomes following graded spinal cord contusion injury in the C57Bl/6 mouse (2001) Exp. Neurol., 169, pp. 239-254; Mangin, J.M., Kunze, A., Chittajallu, R., Gallo, V., Satellite NG2 progenitor cells share common glutamatergic inputs with associated interneurons in the mouse dentate gyrus (2008) J. Neurosci., 28, pp. 7610-7623; McTigue, D.M., Wei, P., Stokes, B.T., Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord (2001) J. Neurosci., 21, pp. 3392-3400; Miura, K., Okada, Y., Aoi, T., Okada, A., Takahashi, K., Okita, K., Nakagawa, M., Yamanaka, S., Variation in the safety of induced pluripotent stem cell lines (2009) Nat. Biotechnol., 27, pp. 743-745; Nishiyama, A., Lin, X.H., Giese, N., Heldin, C.H., Stallcup, W.B., Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain (1996) J. Neurosci. Res., 43, pp. 299-314; Nishiyama, A., Komitova, M., Suzuki, R., Zhu, X., Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity (2009) Nat. Rev. Neurosci., 10, pp. 9-22; Nunes, M.C., Roy, N.S., Keyoung, H.M., Goodman, R.R., McKhann, G., Jiang, L., Kang, J., Goldman, S.A., Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain (2003) Nat. Med., 9, pp. 439-447; Raff, M.C., Miller, R.H., Noble, M., A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium (1983) Nature, 303, pp. 390-396; Reynolds, B.A., Weiss, S., Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system (1992) Science, 255, pp. 1707-1710; Reynolds, R., Wilkin, G.P., Development of macroglial cells in rat cerebellum. II. An in situ immunohistochemical study of oligodendroglial lineage from precursor to mature myelinating cell (1988) Development, 102, pp. 409-425; Richardson, W.D., Young, K.M., Tripathi, R.B., McKenzie, I., NG2-glia as multipotent neural stem cells: fact or fantasy? (2011) Neuron, 70, pp. 661-673; Rivers, L.E., Young, K.M., Rizzi, M., Jamen, F., Psachoulia, K., Wade, A., Kessaris, N., Richardson, W.D., PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice (2008) Nat. Neurosci., 11, pp. 1392-1401; Serakinci, N., Guldberg, P., Burns, J.S., Abdallah, B., Schrodder, H., Jensen, T., Kassem, M., Adult human mesenchymal stem cell as a target for neoplastic transformation (2004) Oncogene, 23, pp. 5095-5098; Simonsen, J.L., Rosada, C., Serakinci, N., Justesen, J., Stenderup, K., Rattan, S.I., Jensen, T.G., Kassem, M., Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells (2002) Nat. Biotechnol., 20, pp. 592-596; Skoff, R.P., Knapp, P.E., Division of astroblasts and oligodendroblasts in postnatal rodent brain: evidence for separate astrocyte and oligodendrocyte lineages (1991) Glia, 4, pp. 165-174; Springer, J.E., Azbill, R.D., Knapp, P.E., Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury (1999) Nat. Med., 5, pp. 943-946; Stallcup, W.B., Beasley, L., Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan (1987) J. Neurosci., 7, pp. 2737-2744; Sypecka, J., Sarnowska, A., Domanska-Janik, K., Crucial role of the local micro-environment in fate decision of neonatal rat NG2 progenitors (2009) Cell Prolif., 42, pp. 661-671; Tamura, Y., Kataoka, Y., Cui, Y., Takamori, Y., Watanabe, Y., Yamada, H., Multi-directional differentiation of doublecortin- and NG2-immunopositive progenitor cells in the adult rat neocortex in vivo (2007) Eur. J. Neurosci., 25, pp. 3489-3498; Tanaka, Y., Tozuka, Y., Takata, T., Shimazu, N., Matsumura, N., Ohta, A., Hisatsune, T., Excitatory GABAergic activation of cortical dividing glial cells (2009) Cereb. Cortex, 19, pp. 2181-2195; Tsoa, R.W., Coskun, V., Ho, C.K., de Vellis, J., Sun, Y.E., Spatiotemporally different origins of NG2 progenitors produce cortical interneurons versus glia in the mammalian forebrain (2014) Proc. Natl. Acad. Sci. U. S. A., 111, pp. 7444-7449; Tsuji, O., Miura, K., Okada, Y., Fujiyoshi, K., Mukaino, M., Nagoshi, N., Kitamura, K., Okano, H., Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury (2010) Proc. Natl. Acad. Sci. U. S. A., 107, pp. 12704-12709; Walton, N.M., Sutter, B.M., Chen, H.X., Chang, L.J., Roper, S.N., Scheffler, B., Steindler, D.A., Derivation and large-scale expansion of multipotent astroglial neural progenitors from adult human brain (2006) Development, 133, pp. 3671-3681; Warrington, A.E., Barbarese, E., Pfeiffer, S.E., Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts (1993) J. Neurosci. Res., 34, pp. 1-13; Watanabe, M., Toyama, Y., Nishiyama, A., Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion (2002) J. Neurosci. Res., 69, pp. 826-836; Windrem, M.S., Nunes, M.C., Rashbaum, W.K., Schwartz, T.H., Goodman, R.A., McKhann, G., Roy, N.S., Goldman, S.A., Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain (2004) Nat. Med., 10, pp. 93-97; Windrem, M.S., Schanz, S.J., Guo, M., Tian, G.F., Washco, V., Stanwood, N., Rasband, M., Goldman, S.A., Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse (2008) Cell Stem Cell, 2, pp. 553-565; Yokoyama, A., Sakamoto, A., Kameda, K., Imai, Y., Tanaka, J., NG2 proteoglycan-expressing microglia as multipotent neural progenitors in normal and pathologic brains (2006) Glia, 53, pp. 754-768; Yuan, X., Chittajallu, R., Belachew, S., Anderson, S., McBain, C.J., Gallo, V., Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies (2002) J. Neurosci. Res., 70, pp. 529-545; Zawadzka, M., Rivers, L.E., Fancy, S.P., Zhao, C., Tripathi, R., Jamen, F., Young, K., Franklin, R.J., CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination (2010) Cell Stem Cell, 6, pp. 578-590; Zhang, S., Xia, Y.Y., Lim, H.C., Tang, F.R., Feng, Z.W., NCAM-mediated locomotor recovery from spinal cord contusion injury involves neuroprotection, axon regeneration, and synaptogenesis (2010) Neurochem. Int., 56, pp. 919-929; Zhu, X., Bergles, D.E., Nishiyama, A., NG2 cells generate both oligodendrocytes and gray matter astrocytes (2008) Development, 135, pp. 145-157; Zhu, X., Hill, R.A., Dietrich, D., Komitova, M., Suzuki, R., Nishiyama, A., Age-dependent fate and lineage restriction of single NG2 cells (2011) Development, 138, pp. 745-753",Article,Scopus,2-s2.0-84927166110
"Jiang Y., Yu L., Wang M.-H.","N-trans-feruloyltyramine inhibits LPS-induced NO and PGE<inf>2</inf> production in RAW 264.7 macrophages: Involvement of AP-1 and MAP kinase signalling pathways",2015,"Chemico-Biological Interactions","235",,,"56","62",,,10.1016/j.cbi.2015.03.029,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928113821&partnerID=40&md5=598cac5e621f7fabd1eb1106daba9184","Department of Medical Biotechnology, College of Biomedical Science, Kangwon National University, 1 Kangwondaehak-gilChuncheon, Gangwon-Do, South Korea; Institute of Medicinal Plant Development, Chinese Academy of Medical Science and Peking Union Medical CollegeBeijing, China; School of Medicine, China Three Gorges UniversityYichang, China","Jiang, Y., Department of Medical Biotechnology, College of Biomedical Science, Kangwon National University, 1 Kangwondaehak-gilChuncheon, Gangwon-Do, South Korea; Yu, L., Institute of Medicinal Plant Development, Chinese Academy of Medical Science and Peking Union Medical CollegeBeijing, China, School of Medicine, China Three Gorges UniversityYichang, China; Wang, M.-H., Department of Medical Biotechnology, College of Biomedical Science, Kangwon National University, 1 Kangwondaehak-gilChuncheon, Gangwon-Do, South Korea","Mitogen-activated protein kinase (MAPK) signalling pathway can regulate inflammatory and immune responses. N-trans-feruloyltyramine (FLA) is an active phenylpropanoid compound. It possesses antioxidant, antimicrobial, anti-melanogenesis, and anticancer activities. However, the precise molecular mechanisms underlying FLA modulation of cytokine expression in LPS-stimulated RAW 264.7 macrophages have not been fully investigated. In this study, we examined the mechanisms underlying the immunomodulative effects of FLA isolated from Arcangelisia gusanlung. FLA strongly suppressed mRNA expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), but not tumor necrosis factor (TNF)-α, thereby inhibiting the production of nitric oxide (NO) and prostaglandin E<inf>2</inf> (PGE<inf>2</inf>) in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. Furthermore, FLA also inhibited nuclear translocation of activation protein (AP)-1, and simultaneously decreased the expression and phosphorylation of the c-Jun N-terminal kinase (JNK) protein. These results suggest that the anti-inflammatory effects of FLA might be attributed to downregulation of COX-2 and iNOS via suppression of AP-1 and the JNK signalling pathway in RAW 264.7 macrophages. © 2015 Published by Elsevier Ireland Ltd.","Anti-inflammatory; Cyclooxygenase-2; Inducible nitric oxide synthase; Lipopolysaccharide; N-trans-feruloyltyramine","Darveau, R.P., The oral microbial consortium's interaction with the periodontal innate defense system (2009) DNA Cell Biol., 28, pp. 389-395; Davey, M.E., O'Toole, G.A., Microbial biofilms: From ecology to molecular genetics (2002) Microbiol. Mol. Biol. Rev., 64, pp. 847-867; Li, X., Kolltveit, K.M., Tronstad, L., Olsen, I., Systemic diseases caused by oral infection (2000) Clin. Microbiol. Rev., 13, pp. 547-558; Tilg, H., Moschen, A.R., Kaser, A., Suppression of interleukin-17 by type i interferons: A contributing factor in virus-induced immuno suppression? (2009) Eur. Cytokine Netw., 20, pp. 1-6; Lobo, V., Patil, A., Phatak, A., Chandra, N., Free radicals, antioxidants and functional foods: Impact on human health (2010) Pharmacogn. Rev., 4, pp. 118-126; Zhong, L.M., Zong, Y., Sun, L., Guo, J.Z., Zhang, W., He, Y., Song, R., Lu, D., Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells (2012) PLoS ONE, 7, p. e32195; Harizi, H., Gualde, N., Pivotal role of PGE<inf>2</inf> and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators (2006) Cell. Mol. Immunol., 3, pp. 271-277; Brambilla, D., Mancuso, C., Scuderi, M.R., Bosco, P., Cantarella, G., Lempereur, L., Di Benedetto, G., Bernardini, R., The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: A point of view for an assessment of the risk/benefit profile (2008) Nutr. J., 7, p. 29; Rahman, K., Studies on free radicals, antioxidants, andco-factors (2007) Clin. Interv. Aging, 2, pp. 219-236; Palsson-Mcdermott, E.M., O'Neill, L.A., Signal transduction by the lipopolysaccharide receptor, toll-like receptor-4 (2004) Immunology, 113, pp. 153-162; Han, D., Shinohara, M., Ybanez, M.D., Saberi, B., Kaplowitz, N., Signal transduction pathways involved in drug-induced liver injury (2010) Handb. Exp. Pharmacol., 196, pp. 267-310; Suzuki, T., Moraes, T.J., Vachon, E., Ginzberg, H.H., Huang, T.T., Matthay, M.A., Hollenberg, M.D., Downey, G.P., Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial (2005) Am. J. Respir. Cell Mol. Biol., 33, pp. 231-247; Son, Y., Cheong, Y.K., Kim, N.H., Chung, H.T., Kang, D.G., Pae, H.O., Mitogen-activated protein kinases and reactive oxygen species: How can ROS activate MAPK pathways? (2011) J. Signal Transduct., 2011, p. 792639; Trachootham, D., Lu, W., Ogasawara, M.A., Nilsa, R.D., Huang, P., Protective role of N-trans-feruloyltyramine against beta-amyloid peptide-induced neurotoxicity in rat cultured cortical neurons (2008) Antioxid. Redox Signal., 10, pp. 1343-1374; Cooke, M.S., Evans, M.D., Dizdaroglu, M., Lunec, J., Oxidative DNA damage: Mechanisms, mutation, and disease (2003) FASEB J., 17, pp. 1195-1214; Uttara, B., Singh, A.V., Zamboni, P., Mahajan, R.T., Oxidative stress and neurodegenerative disease: A review of upstream and downstream antioxidant therapeutic options (2009) Curr. Neuropharmacol., 7, pp. 65-74; Cavin, A., Hostettmann, K., Dyatmyko, W., Potterat, O., Antioxidant and lipophilic constituents of Tinospora crispa (1998) Planta Med., 64, pp. 393-396; Efdi, M., Ohguchi, K., Akao, Y., Nozawa, Y., Koketsu, M., Ishihara, H., Ishihara N-trans-Feruloyltyramine as a melanin biosynthesis inhibitor (2007) Biol. Pharm. Bull., 30, pp. 1972-1974; Thangnipon, W., Suwanna, N., Kitiyanant, N., Soi-Ampornkul, R., Tuchinda, P., Munyoo, B., Nobsathian, S., Protective role of N-trans-feruloyltyramine against beta-amyloid peptide-induced neurotoxicity in rat cultured cortical neurons (2012) Neurosci. Lett., 513, pp. 229-232; Kim, H.R., Min, H.Y., Jeong, Y.H., Lee, S.K., Lee, N.S., Seo, E.K., Cytotoxic constituents from the whole plant of Corydalis pallida (2005) Arch. Pharm. Res., 28, pp. 1224-1227; Yokozawa, T., Tanaka, T., Kimura, T., Examination of the nitric oxide production-suppressing component in Tinospora tuberculata (2001) Biol. Pharm. Bull., 24, pp. 1153-1156; Philip, M., Rowley, D.A., Schreiber, H., Inflammation as a tumor promoter in cancer induction (2004) Semin. Cancer Biol., 14, pp. 433-439; Coussens, L.M., Werb, Z., Inflammation and cancer (2002) Nature, 420, pp. 860-867; Posadas, I., Terencio, M.C., Guillen, I., Ferrandiz, M.L., Coloma, J., Paya, M., Alcaraz, M.J., Co-expression between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation (2000) Naunyn Schmiedebergs Arch. Pharmacol., 361, pp. 98-106; Niu, X., Xing, W., Li, W., Fan, T., Hu, H., Li, Y., Isofraxidin exhibited anti-inflammatory effects in vivo and inhibited TNF-α production in LPS-induced mouse peritoneal macrophages in vitro via the MAPK pathway (2012) Int. Immunopharmacol., 14, pp. 164-171; Zuo, L., Otenbaker, N.P., Rose, B.A., Salisbury, K.S., Molecular mechanisms of reactive oxygen species-related pulmonary inflammation and asthma (2013) Mol. Immunol., 56, pp. 57-63; Jang, J.H., Surh, Y.J., AP-1 mediates β-amyloid-induced iNOS expression in PC12 cells via the ERK2 and p38 MAPK signaling pathways (2005) Biochem. Biophys. Res. Commun., 331, pp. 1421-1428; Hambleton, J., Weunstein, S.J., Lem, L., Defranco, A.L., Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 2774-2778; Martin, C.B., Martin, B.K., Characterization of the murine C3a receptor enhancer-promoter: Expression control by an activator protein 1 sequence and an Ets-like sit (2005) J. Immunol., 175, pp. 3123-3132; Li, J.J., Cao, Y., Young, M.R., Colbum, N.H., Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes (2000) Mol. Carcinog., 29, pp. 159-169; Bost, F., Aouadi, M., Caron, L., Binetruy, B., The role of MAPKs in adipocyte differentiation and obesity (2005) Biochimie, 87, pp. 51-56; Chun, J., Choi, R.J., Khan, S., Lee, D.S., Kim, Y.C., Nam, Y.J., Lee, D.U., Kim, Y.S., Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells (2012) Int. Immunopharmacol., 14, pp. 375-383; Hseu, Y.C., Kumar, K.J.S., Chen, C.S., Cho, H.J., Lin, S.W., Shen, P.C., Lin, C.W., Yang, H.L., Humic acid in drinking well water induces inflammation through reactive oxygen species generation and activation of nuclear factor-κB/activator protein-1 signaling pathways: A possible role in atherosclerosis (2014) Toxicol. Appl. Pharmacol., 274, pp. 249-262; Huff, R.M., Signal transduction pathways modulated by the D2 subfamily of dopamine receptors (1996) Cell. Signal., 8, pp. 453-459; Zhong, H., Minneman, K.P., Differential activation of mitogen- activated protein kinase pathways in PC12 cells by closely related α<inf>1</inf>-adrenergic receptor subtypes (1999) J. Neurochem., 72, pp. 2388-2396; Kiyokawa, E., Takai, S., Tanaka, M., Iwase, T., Suzuki, M., Xiang, Y.Y., Naito, Y., Kino, I., Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors (1994) Cancer Res., 54, pp. 3645-3650; Winzen, R., Kracht, M., Ritter, B., Wilhelm, A., Chen, C.Y., Shyu, A.B., Muller, M., Holtmann, H., The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism (1999) EMBO J., 18, pp. 4969-4980",Article,Scopus,2-s2.0-84928113821
"Borkowska P., Kowalska J., Fila-Danilow A., Bielecka A.M., Paul-Samojedny M., Kowalczyk M., Kowalski J.","Affect of antidepressants on the in vitro differentiation of rat bone marrow mesenchymal stem cells into neuronal cells",2015,"European Journal of Pharmaceutical Sciences","73",,,"81","87",,,10.1016/j.ejps.2015.03.016,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927546448&partnerID=40&md5=352d67f2ddcb4cbf5827ac692ada5f57","Department of Medical Genetics, School of Pharmacy, Medical University of SilesiaSosnowiec, Poland; Department of Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland","Borkowska, P., Department of Medical Genetics, School of Pharmacy, Medical University of SilesiaSosnowiec, Poland; Kowalska, J., Department of Medical Genetics, School of Pharmacy, Medical University of SilesiaSosnowiec, Poland; Fila-Danilow, A., Department of Medical Genetics, School of Pharmacy, Medical University of SilesiaSosnowiec, Poland; Bielecka, A.M., Department of Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland; Paul-Samojedny, M., Department of Medical Genetics, School of Pharmacy, Medical University of SilesiaSosnowiec, Poland; Kowalczyk, M., Department of Medical Genetics, School of Pharmacy, Medical University of SilesiaSosnowiec, Poland; Kowalski, J., Department of Medical Genetics, School of Pharmacy, Medical University of SilesiaSosnowiec, Poland","Background Bone marrow is a valuable source of mesenchymal stem cells (MSCs) that can be used in regenerative medicine. MSCs are able to differentiate into cells from all three germ layers under specific conditions. The aim of the current work was to study the differentiation of rat MSCs (rMSCs) into neuron-like cells. New method We investigated how the antidepressants imipramine, desipramine, fluoxetine and tianeptine affect the differentiation of rMSCs. Furthermore, we present differentiation cocktails using a cortex astrocyte-conditioned medium (CACM) separately or in conjunction with each of the antidepressants and investigated their additive effect on the efficiency of differentiation. We also observed how various differentiation conditions affect the number of primary dendrites and branching dendrites per cell. Results Gene expression for an early neuronal marker (β-III-tubulin) and markers that are typical for adult neurons such as Th, Htr2A and Slc6a4 were observed. The Tubb3 and Htr2A gene expression were up-regulated, Th decreased slightly and Slc6a4 was down-regulated after differentiation We observed a two-fold higher percentage of β-III-tubulin positive cells after treatment with antidepressants and two-fold increase of neuron-like cells after using CACM with imipramine or fluoxetine simultaneously. Differentiation using imipramine or in conjunction with CACM and desipramine or fluoxetine simultaneously increased the number of cell dendrites. Comparison with existing methods The results that were obtained are completely new and need further investigations in the nearest future. Conclusions These results suggest that antidepressants improve differentiation efficiency of rMSCs and may be useful in the preparation of rMSCs for transplantation. Differentiation efficiency is higher after long-term exposure to antidepressants, than after a 24-h exposure. Nearly additive effect of CACM and imipramine or fluoxetine suggests a beneficial role of antidepressants after transplantation. © 2015 Elsevier B.V. All rights reserved.","Antidepressants; b-III-tubulin; Branching neurons; Differentiation; Mesenchymal stem cells","Borkowska, P., Fila-Danilow, A., Paul-Samojedny, M., Kowalczyk, M., Hart, J., Ryszawy, J., Kowalski, J., Differentiation of adult rat mesenchymal stem cells to GABAergic, dopaminergic and cholinergic neurons (2015) Pharmacol. Rep., 67, pp. 179-186; Bylund, M., Andersson, E., Novitch, B.G., Muhr, J., Vertebrate neurogenesis is counteracted by So1-3 activity (2003) Nat. Neurosci., 6, pp. 1162-1168; Cabras, S., Saba, F., Reali, C., Scorciapino, M.L., Sirgu, A., Talani, G., Biggio, G., Sogos, V., Antidepressant imipramine induces human astrocytes to differentiate into cells with neuronal phenotype (2010) Int. J. Neuropsychopharmacol., 13, pp. 603-615; Dezawa, M., Hoshino, M., Ide, C., Treatment of neurodegenerative diseases using adult bone marrow stromal cell derived neurons (2005) Exp. Opin. Biol. Ther., 5, pp. 427-435; Herman, A., Gastl, R., Liebau, S., Popa, M.O., Fiedler, J., Boehm, B.O., Maisel, M., Storch, A., Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. 2004 (2004) J. Cell Sci., 117, pp. 4411-4422; Joannides, A., Gaughwin, P., Scott, M., Watt, S., Compston, A., Chandran, S., Postnatal astrocytes promote neural induction from adult human bone marrow-derived stem cells (2003) J. Hematother. Stem Cell Res., 12, pp. 681-688; Kawabata, K., Sakurai, F., Koizumi, N., Hayakawa, T., Mizuguchi, H., Adenovirus vector-mediated gene transfer into stem cells (2006) Mol. Pharm., 3, pp. 95-103; Klempin, F., Babu, H., De Pietri Tonelli, D., Alarcon, E., Fabel, K., Kempermann, G., Oppositional effects of serotonin receptors 5-HT1a,2 and 2c in the regulation of adult hippocampal neurogenesis (2010) Front Mol. Neurosci., 3, p. 14; Kohyama, J., Abe, H., Shimazaki, T., Koizumi, A., Nakashima, K., Gojo, S., Taga, T., Umezawa, A., Brain from bone: Efficient"" meta-differentiation"" of marrow stroma derived mature osteoblasts to neurons with Noggin or demethylating agent (2001) Differentiation, 68, pp. 235-244; Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-Ct method (2001) Methods, 25, pp. 402-408; Malberg, J., Eisch, A., Nestler, E., Duman, R., Chronic antidepressant treatment increases neurogenesis in adult hippocampus (2000) J. Neurosci., 20, pp. 9104-9110; Nandra, K.S., Agius, M., The difference between typical and athypical antipsychotics: The effects on neurogenesis (2012) Psychiatr. Danub., 24, pp. 95-99; Valenzuela, M., Sidhu, K., Dean, S., Sachdev, P., Neural stem cell therapy for neuropsychiatric disorders (2007) Acta Neuropsychiatr., 19, pp. 11-26; Peng, C.H., Chiou, S.H., Chen, S.J., Chou, Y.C., Ku, H.H., Cheng, C.K., Yen, C.J., Kao, C.L., Neuroprotection by imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway (2008) Eur. Neuropsychopharmacol., 18, pp. 128-140; Pesce, M., Scholer, H.R., Oct-4: Control of totipotency and germline determination (2000) Mol. Reprod., 55, pp. 452-457; Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Marshak, D.R., Multilineage potential of adult human mesenchymal stem cells (1999) Science, 284, pp. 143-147; Rai, K.S., Hattiangady, B., Shetty, A.K., Enhanced production and dendritic growth of new dentatr granule cells in the middle-aged hippocampus following intracerebroventricular FGF-2 infusions (2007) Eur. J. Neurosci., 26, pp. 1765-1779; Rudge, J.S., Alderson, R.F., Pasnikowski, E., Expression of cilliary neurotrophic factor and the neurotrophins nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in cultured rat hippocampal astrocytes (1992) Eur. J. Neurosci., 4, pp. 459-471; Scintu, F., Reali, C., Pillai, R., Badiali, M., Sanna, M.A., Argiolu, F., Ristaldi, M.S., Sogos, V., Differentiation of human bone marrow stem cells into cells with a neural phenotype: Diverse effects of two specific treatments (2006) BMC Neurosci., 7, pp. 1-14; Trzaska, K.A., King, C.C., Li, K.Y., Kuzhikandathil, E.V., Nowycky, M.C., Ye, J.H., Rameshwar, P., Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons (2009) J. Neurochem., 110, pp. 1058-1069; Uzbay, T., Tianeptine: Potential effect on neuroplasticity and novel pharmacological effects (2008) Prog. Neuro-Psychopharmacol. Biol. Psychiatr., 32, pp. 915-924; Willerth, S.M., Faxel, T.E., Gottlieb, D.I., Sakiyama-Elbert, S.E., The effects of soluble growth factors on embryonic stem cell differentiation inside of fibrin scaffold (2007) Stem Cells, 25, pp. 2235-2244; Woodbury, D., Schwartz, E.J., Prockop, D.J., Black, I.B., Adult rat and human bone marrow stromal cells differentiate into neurons (2000) J. Neurosci. Res., 61, pp. 364-370; Yang, D., Chen, M., Russo-Neustadt, A., Antidepressants are neuroprotective against nutrient deprivation stress in rat hippocampal neurons (2012) Eur. J. Neurosci., 36, pp. 2573-2587; Zhang, F., Zhou, H., Wilson, B.C., Shi, J.S., Hong, J.S., Gao, H.M., Fluoxetine protects neurons against microglial activation-mediated neurotoxicity (2012) Parkinsonism Relat. Disord., 18, pp. 213-217; Zhao, M., Li, D., Shimazu, K., Zhou, Y.X., Lu, B., Deng, C.X., Fibroblast growth factor receptor-1 is required for long-term potentiation, memory consolidation and neurogenesis (2007) Biol. Psychiatr., 62, pp. 381-390; Zusso, M., Debetto, P., Guidolin, D., Barbierato, M., Manev, H., Giusti, P., Fluoxetine-induced proliferation and differentiation of neural progenitor cells isolated from rat postnatal cerebellum (2008) Biochem. Pharm., 76, pp. 391-403",Article,Scopus,2-s2.0-84927546448
"Limongi T., Schipani R., Di Vito A., Giugni A., Francardi M., Torre B., Allione M., Miele E., Malara N., Alrasheed S., Raimondo R., Candeloro P., Mollace V., Di Fabrizio E.","Photolithography and micromolding techniques for the realization of 3D polycaprolactone scaffolds for tissue engineering applications",2015,"Microelectronic Engineering","141",,,"135","139",,,10.1016/j.mee.2015.02.030,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924083333&partnerID=40&md5=6cd0d5570763c07ee4bbe7837bf547f3","King Abdullah University of Science and Technology, PSE DivisionThuwal, Saudi Arabia; King Abdullah University of Science and Technology, BESE DivisionThuwal, Saudi Arabia; Department of Experimental and Clinical Medicine, University of Catanzaro Magna Graecia, University Campus Salvatore VenutaGermaneto, Catanzaro, Italy; Istituto Italiano di Tecnologia (IIT), via Morego 30Genova, Italy; Department of Health Science, University Magna Graecia of Catanzaro, Complesso Ninì BarbieriRoccelletta di Borgia, Italy; BIONEM, Department of Experimental and Clinical Medicine, University of Magna Graecia Viale EuropaGermaneto, 88100 Catanzaro, Italy; Physical Science and Engineering Division, King Abdullah University of Science and Technology, Bldg. 3 (Ibn Sina)Thuwal, Saudi Arabia","Limongi, T., King Abdullah University of Science and Technology, PSE DivisionThuwal, Saudi Arabia, King Abdullah University of Science and Technology, BESE DivisionThuwal, Saudi Arabia; Schipani, R., King Abdullah University of Science and Technology, PSE DivisionThuwal, Saudi Arabia; Di Vito, A., Department of Experimental and Clinical Medicine, University of Catanzaro Magna Graecia, University Campus Salvatore VenutaGermaneto, Catanzaro, Italy; Giugni, A., King Abdullah University of Science and Technology, PSE DivisionThuwal, Saudi Arabia, King Abdullah University of Science and Technology, BESE DivisionThuwal, Saudi Arabia; Francardi, M., King Abdullah University of Science and Technology, PSE DivisionThuwal, Saudi Arabia, King Abdullah University of Science and Technology, BESE DivisionThuwal, Saudi Arabia; Torre, B., King Abdullah University of Science and Technology, PSE DivisionThuwal, Saudi Arabia, King Abdullah University of Science and Technology, BESE DivisionThuwal, Saudi Arabia; Allione, M., King Abdullah University of Science and Technology, PSE DivisionThuwal, Saudi Arabia, King Abdullah University of Science and Technology, BESE DivisionThuwal, Saudi Arabia; Miele, E., Istituto Italiano di Tecnologia (IIT), via Morego 30Genova, Italy; Malara, N., Department of Health Science, University Magna Graecia of Catanzaro, Complesso Ninì BarbieriRoccelletta di Borgia, Italy; Alrasheed, S., King Abdullah University of Science and Technology, PSE DivisionThuwal, Saudi Arabia; Raimondo, R., King Abdullah University of Science and Technology, PSE DivisionThuwal, Saudi Arabia, BIONEM, Department of Experimental and Clinical Medicine, University of Magna Graecia Viale EuropaGermaneto, 88100 Catanzaro, Italy; Candeloro, P., BIONEM, Department of Experimental and Clinical Medicine, University of Magna Graecia Viale EuropaGermaneto, 88100 Catanzaro, Italy; Mollace, V., Department of Health Science, University Magna Graecia of Catanzaro, Complesso Ninì BarbieriRoccelletta di Borgia, Italy; Di Fabrizio, E., King Abdullah University of Science and Technology, PSE DivisionThuwal, Saudi Arabia, King Abdullah University of Science and Technology, BESE DivisionThuwal, Saudi Arabia, BIONEM, Department of Experimental and Clinical Medicine, University of Magna Graecia Viale EuropaGermaneto, 88100 Catanzaro, Italy, Physical Science and Engineering Division, King Abdullah University of Science and Technology, Bldg. 3 (Ibn Sina)Thuwal, Saudi Arabia","Material science, cell biology, and engineering are all part of the research field of tissue engineering. It is the application of knowledge, methods and instrumentations of engineering and life science to the development of biocompatible solutions for repair and/or replace tissues and damaged organs. Last generation microfabrication technologies utilizing natural and synthetic biomaterials allow the realization of scaffolds resembling tissue-like structures as skin, brain, bones, muscles, cartilage and blood vessels. In this work we describe an effective and simple micromolding fabrication process allowing the realization of 3D polycaprolactone (PCL) scaffold for human neural stem cells (hNSC) culture. Scanning Electron Microscopy has been used to investigate the micro and nano features characterizing the surface of the device. Immunofluorescence analysis showed how, after seeding cells onto the substrate, healthy astrocytes grew up in a well-organized 3D network. Thus, we proposed this effective fabrication method for the production of nanopatterned PCL pillared scaffold providing a biomimetic environment for the growth of hNSC, a promising and efficient means for future applications in tissue engineering and regenerative medicine. © 2015 Elsevier B.V. All rights reserved.","Biocompatible substrate; Human stem cells; Microfabrication technique; Nanostructured PCL pillars; Neural networks","Dowell-Mesfin, N.M., Abdul-Karim, M.A., Turner, A.M.P., Schanz, S., Craighead, H.G., Roysam, B., Turner, J.N., Shain, W., (2004) J. Neural Eng., 1, pp. 78-90; Haq, F., Anandan, V., Keith, C., Zhang, G., (2007) Int. J. Nanomed., 2, pp. 107-115; Limongi, T., Cesca, F., Gentile, F., Marotta, R., Ruffilli, R., Barberis, A., Dal, M., (2013) Small, 9, pp. 402-412; Dinis, T.M., Elia, R., Vidal, G., Auffret, A., Kaplan, D.L., Egles, C., (2014) Appl. Mater. Interfaces, 6, pp. 16817-16826; Jeffries, E.M., Nakamura, S., Lee, K.W., Clampffer, J., Ijima, H., Wang, Y., (2014) Macromol. Biosci.; Silva, S.S., Luna, S.M., Gomes, M.E., Benesch, J., Pashkuleva, I., Mano, J.F., Reis, R.L., (2008) Macromol. Biosci., 8, pp. 568-576; Cesca, F., Limongi, T., Accardo, A., Rocchi, A., Orlando, M., Shalabaeva, V., Di Fabrizio, E., Benfenati, F., (2014) RSC Adv., 4 (2014), pp. 45696-45702; Zink, C., Hall, H., Brunette, D.M., Spencer, N.D., (2012) Biomaterials, 33, pp. 8055-8061; McCain, M.L., Agarwal, A., Nesmith, H.W., Nesmith, A.P., Parker, K.K., (2014) Biomaterials, 35, pp. 5462-5471; Qin, D., Xia, Y., Whitesides, G.M., (2010) Nat. Protoc., 5, pp. 491-502; Bettinger, C.J., Cyr, K.M., Matsumoto, A., Langer, R., Borenstein, J.T., Kaplan, D.L., (2007) Adv. Mater., 19, pp. 2847-2850; Gates, B.D., Xu, Q., Love, J.C., Wolfe, D.B., Whitesides, G.M., (2004) Annu. Rev. Mater. Res., 34, pp. 339-372; Rajnicek, A., Britland, S., McCaig, C., (1997) J. Cell Sci., 110, pp. 2905-2913; Goldner, J.S., Bruder, J.M., Li, G., Gazzola, D., Hoffman-Kim, D., (2006) Biomaterials, 27, pp. 460-472; Su, G., Zhao, Y., Wei, J., Han, J., Chen, L., Xiao, Z., Chen, B., Dai, J., (2013) Biomaterials, 34, pp. 3215-3222; Ma, W., Tavakoli, T., Chen, S., Maric, D., Liu, J.L., O'Shaughnessy, T.J., Barker, J.L., (2008) Tissue Eng. Part A, 14, pp. 1673-1686; Hoffman-Kim, D., Mitchel, J.A., Bellamkonda, R.V., (2010) Annu. Rev. Biomed. Eng., 12, pp. 203-231; Magnaghi, V., Conte, V., Procacci, P., Pivato, G., Cortese, P., Cavalli, E., Pajardi, G., Ferruti, P., (2011) J. Biomed. Mater. Res., 98, pp. 19-30; Sell, S.A., Wolfe, P.S., Garg, K., McCool, J.M., Rodriguez, I.A., Bowlin, G.L., (2010) Polymers, 2, pp. 522-553; Pérez, R.A., Won, J.E., Knowles, J.C., Kim, H.W., (2013) Adv. Drug Deliv. Rev., 65, pp. 471-496; Turner, A.M.P., Dowell, N., Turner, S.W.P., Kam, L., Isaacson, M., Turner, J.N., Craighead, H.G., Shain, W., (2000) J. Biomed. Mater. Res., 51, pp. 430-441; Sørensen, A., Alekseeva, T., Katechia, K., Robertson, M., Riehle, M.O., Barnett, S.C., (2007) Biomaterials, 28, pp. 5498-5508; Graeter, S.V., Huang, J., Perschmann, N., López-García, M., Kessler, H., Ding, J., Spartz, J.P., (2007) Nano Lett., 7, pp. 1413-1418; Eng, L.F., (1985) J. Neuroimmunol., 8, pp. 203-214",Article,Scopus,2-s2.0-84924083333
"Kang K.H., Reichert H.","Control of neural stem cell self-renewal and differentiation in Drosophila",2015,"Cell and Tissue Research","359","1",,"33","45",,,10.1007/s00441-014-1914-9,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926669343&partnerID=40&md5=71886506f0618de4e51804146557ecca","KAIST Institute of BioCentury, Korea Advanced Institute of Science and TechnologyDaejeon, South Korea; Biozentrum, University of Basel, Klingelbergstrasse 50/70Basel, Switzerland","Kang, K.H., KAIST Institute of BioCentury, Korea Advanced Institute of Science and TechnologyDaejeon, South Korea; Reichert, H., Biozentrum, University of Basel, Klingelbergstrasse 50/70Basel, Switzerland","The neural stem cells of Drosophila, called neuroblasts, have the ability to self-renew and at the same time produce many different types of neurons and glial cells. In the central brain and ventral ganglia, neuroblasts are specified and delaminate from the neuroectoderm during embryonic development under the control of proneural and neurogenic genes. In contrast, in the optic lobes, neuroepithelial cells are transformed into neuroblasts postembryonically by a spatial wave of proneural gene expression. Central brain and ventral nerve cord neuroblasts manifest a short embryonic proliferation period followed by a stage of quiescence and then undergo a prolonged postembryonic proliferation period during which most of the differentiated neurons of the adult CNS are generated. While most neuroblasts belong to a type I class that produces neuronal lineages through non-selfrenewing ganglion mother cells, a small subset of type II neuroblasts generates exceptionally large neuronal lineages through self-renewing intermediate progenitor cells that have a transit amplifying function. All neuroblasts in the CNS generate their neural progeny through an asymmetric cell division mode in which the interplay of apical complex and basal complex molecules in the mitotically active progenitor results in the segregation of cell fate determinants into the smaller more differentiated daughter cell. Defects in this molecular control of asymmetric cell division in neuroblasts can result in brain tumor formation. Proliferating neuroblast lineages in the developing CNS utilize transcription factor cascades as a generic mechanism for temporal patterning and birth order-dependent determination of differential neural cell fate. This contributes to the generation of a remarkable diversity of cell types in the developing CNS from a surprisingly small set of neural stem cell-like precursors. © Springer-Verlag Berlin Heidelberg 2014.","Asymmetric cell division; Neuroblast; Proliferation; Temporal series; Tumor","Almeida, M.S., Bray, S.J., Regulation of post-embryonic neuroblasts by Drosophila Grainyhead (2005) Mech Dev, 122, pp. 1282-1293; Artavanis-Tsakonas, S., Simpson, P., Choosing a cell fate: A view from the Notch locus (1991) Trends Genetics, 7, pp. 403-408; Atwood, S.X., Prehoda, K.E., aPKC Phosphorylates Miranda to polarize fate determinants during neuroblast asymmetric cell division (2009) Curr Biol, 19, pp. 723-729; Baumgardt, M., Karlsson, D., Terriente, J., Diaz-Benjumea, F.J., Thor, S., Neuronal subtype specification within a lineage by opposing temporal feed-forward loops (2009) Cell, 139, pp. 969-982; Bayraktar, O.A., Boone, J.Q., Drummond, M.L., Doe, C.Q., Drosophila type II neuroblast lineages keep Prospero levels low to generate large clones that contribute to the adult brain central complex (2010) Neural Dev, 5, p. 26; Bayraktar, O.A., Doe, C.Q., Combinatorial temporal patterning in progenitors expands neural diversity (2013) Nature, 498, pp. 449-455; Beaucher, M., Goodliffe, J., Hersperger, E., Trunova, S., Frydman, H., Shearn, A., Drosophila brain tumor metastases express both neuronal and glial cell type markers (2007) Dev Biol, 301, pp. 287-297; Bello, B., Holbro, N., Reichert, H., Polycomb group genes are required for neural stem cell survival in postembryonic neurogenesis of Drosophila (2007) Development, 134, pp. 1091-1099; Bello, B., Reichert, H., Hirth, F., The brain tumor gene negatively regulates neural progenitor cell proliferation in the larval central brain of Drosophila (2006) Development, 133, pp. 2639-2648; Bello, B.C., Hirth, F., Gould, A.P., A pulse of the Drosophila Hox protein Abdominal-A schedules the end of neural proliferation via neuroblast apoptosis (2003) Neuron, 37, pp. 209-219; Bello, B.C., Izergina, N., Caussinus, E., Reichert, H., Amplification of neural stem cell proliferation by intermediate progenitor cells in Drosophila brain development (2008) Neural Dev, 3, p. 5; Benito-Sipos, J., Estacio-Gomez, A., Moris-Sanz, M., Baumgardt, M., Thor, S., Diaz-Benjumea, F.J., A genetic cascade involving klumpfuss, nab and castor specifies the abdominal leucokinergic neurons in the Drosophila CNS (2010) Development, 137, pp. 3327-3336; Benito-Sipos, J., Ulvklo, C., Gabilondo, H., Baumgardt, M., Angel, A., Torroja, L., Thor, S., Seven up acts as a temporal factor during two different stages of neuroblast 5-6 development (2011) Development, 138, pp. 5311-5320; Berger, C., Harzer, H., Burkard, T.R., Steinmann, J., van der Horst, S., Laurenson, A.S., Novatchkova, M., Knoblich, J.A., FACS purification and transcriptome analysis of drosophila neural stem cells reveals a role for Klumpfuss in self-renewal (2012) Cell Rep, 2, pp. 407-418; Betschinger, J., Mechtler, K., Knoblich, J.A., The Par complex directs asymmetric cell division by phosphorylating the cytoskeletal protein Lgl (2003) Nature, 422, pp. 326-330; Betschinger, J., Mechtler, K., Knoblich, J.A., Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells (2006) Cell, 124, pp. 1241-1253; Boone, J.Q., Doe, C.Q., Identification of Drosophila type II neuroblast lineages containing transit amplifying ganglion mother cells (2008) Dev Neurol, 68, pp. 1185-1195; Bossing, T., Udolph, G., Doe, C.Q., Technau, G.M., The embryonic central nervous system lineages of Drosophila melanogaster. I. Neuroblast lineages derived from the ventral half of the neuroectoderm (1996) Dev Biol, 179, pp. 41-64; Bowman, S.K., Rolland, V., Betschinger, J., Kinsey, K.A., Emery, G., Knoblich, J.A., The tumor suppressors Brat and Numb regulate transitamplifying neuroblast lineages in Drosophila (2008) Dev Cell, 14, pp. 535-546; Broadus, J., Doe, C.Q., Evolution of neuroblast identity: Seven-up and prospero expression reveal homologous and divergent neuroblast fates in Drosophila and Schistocerca (1995) Development, 121, pp. 3989-3996; Brody, T., Odenwald, W.F., Programmed transformations in neuroblast gene expression during Drosophila CNS lineage development (2000) Dev Biol, 226, pp. 34-44; Buescher, M., Hing, F.S., Chia, W., Formation of neuroblasts in the embryonic central nervous system of Drosophila melanogaster is controlled by SoxNeuro (2002) Development, 129, pp. 4193-4203; Campos-Ortega, J.A., Mechanisms of early neurogenesis in Drosophila melanogaster (1993) J Neurobiol, 24, pp. 1305-1327; Caussinus, E., Gonzalez, C., Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster (2005) Nat Genet, 37, pp. 1125-1129; Cenci, C., Gould, A.P., Drosophila Grainyhead specifies late programmes of neural proliferation by regulating the mitotic activity and Hox-dependent apoptosis of neuroblasts (2005) Development, 132, pp. 3835-3845; Chang, K.C., Wang, C., Wang, H., Balancing self-renewal and differentiation by asymmetric division: Insights from brain tumor suppressors in Drosophila neural stem cells (2012) BioEssays, 34, pp. 301-310; Chell, J.M., Brand, A.H., Nutrition-responsive glia control exit of neural stem cells from quiescence (2010) Cell, 143, pp. 1161-1173; Choksi, S.P., Southall, T.D., Bossing, T., Edoff, K., de Wit, E., Fischer, B.E., van Steensel, B., Brand, A.H., Prospero acts as a binary switch between self-renewal and differentiation in Drosophila neural stem cells (2006) Dev Cell, 11, pp. 775-789; Colombani, J., Andersen, D.S., Leopold, P., Secreted peptide Dilp8 coordinates Drosophila tissue growth with developmental timing (2012) Science, 336, pp. 582-585; Doe, C.Q., Molecular markers for identified neuroblasts and ganglion mother cells in the Drosophila central nervous system (1992) Development, 116, pp. 855-863; Doe, C.Q., Neural stem cells: Balancing self-renewal with differentiation (2008) Development, 135, pp. 1575-1587; Doe, C.Q., Technau, G.M., Identification and cell lineage of individual neural precursors in the Drosophila CNS (1993) Trends Neurosci, 16, pp. 510-514; Egger, B., Boone, J.Q., Stevens, N.R., Brand, A.H., Doe, C.Q., Regulation of spindle orientation and neural stem cell fate in the Drosophila optic lobe (2007) Neural Dev, 2, p. 1; Egger, B., Chell, J.M., Brand, A.H., Insights into neural stem cell biology from flies (2008) Philos Trans R Soc Lond B, 363, pp. 39-56; Egger, B., Gold, K.S., Brand, A.H., Notch regulates the switch from symmetric to asymmetric neural stem cell division in the Drosophila optic lobe (2010) Development, 137, pp. 2981-2987; Egger, B., Gold, K.S., Brand, A.H., Regulating the balance between symmetric and asymmetric stem cell division in the developing brain (2011) Fly, 5, pp. 237-241; Fernandez-Hernandez, I., Rhiner, C., Moreno, E., Adult neurogenesis in Drosophila (2013) Cell Reports, 3, pp. 1857-1865; Grosskortenhaus, R., Pearson, B.J., Marusich, A., Doe, C.Q., Regulation of temporal identity transitions in Drosophila neuroblasts (2005) Dev Cell, 8, pp. 193-202; Grosskortenhaus, R., Robinson, K.J., Doe, C.Q., Pdm and Castor specify late-born motor neuron identity in the NB7-1 lineage (2006) Genes Dev, 20, pp. 2618-2627; Hartenstein, V., Wodarz, A., Initial neurogenesis in Drosophila (2013) Dev Biol, 2, pp. 701-721; Homem, C.C., Knoblich, J.A., Drosophila neuroblasts: A model for stem cell biology (2012) Development, 139, pp. 4297-4310; Ikeshima-Kataoka, H., Skeath, J.B., Nabeshima, Y., Doe, C.Q., Matsuzaki, F., Miranda directs Prospero to a daughter cell during Drosophila asymmetric divisions (1997) Nature, 390, pp. 625-629; Isshiki, T., Pearson, B., Holbrook, S., Doe, C.Q., Drosophila neuroblasts sequentially express transcription factors which specify the temporal identity of their neuronal progeny (2001) Cell, 106, pp. 511-521; Ito, K., Hotta, Y., Proliferation pattern of postembryonic neuroblasts in the brain of Drosophila melanogaster (1992) Dev Biol, 149, pp. 134-148; Izergina, N., Balmer, J., Bello, B., Reichert, H., Postembryonic development of transit amplifying neuroblast lineages in the Drosophila brain (2009) Neural Dev, 4, p. 44; Izumi, Y., Ohta, N., Hisata, K., Raabe, T., Matsuzaki, F., Drosophila Pins-binding protein Mud regulates spindle-polarity coupling and centrosome organization (2006) Nat Cell Biol, 8, pp. 586-593; Januschke, J., Gonzalez, C., Drosophila asymmetric division, polarity and cancer (2008) Oncogene, 27, pp. 6994-7002; Jiang, Y., Reichert, H., Programmed cell death in type II neuroblast lineages is required for central complex development in the Drosophila brain (2012) Neural Dev, 7, p. 3; Kambadur, R., Koizumi, K., Stivers, C., Nagle, J., Poole, S.J., Odenwald, W.F., Regulation of POU genes by castor and hunchback establishes layered compartments in the Drosophila CNS (1998) Genes Dev, 12, pp. 246-260; Karcavich, R., Doe, C.Q., Drosophila neuroblast 7-3 cell lineage: A model system for studying programmed cell death, Notch/Numb signaling, and sequential specification of ganglion mother cell identity (2005) J Comp Neurol, 481, pp. 240-251; Karcavich, R.E., Generating neuronal diversity in the Drosophila central nervous system: A view from the ganglion mother cells (2005) Dev Dyn, 232, pp. 609-616; Karlsson, D., Baumgardt, M., Thor, S., Segment-specific neuronal subtype specification by the integration of anteroposterior and temporal cues (2010) PLoS Biol, 8; Knoblich, J.A., Mechanisms of asymmetric stem cell division (2008) Cell, 132, pp. 583-597; Komori, H., Xiao, Q., McCartney, B.M., Lee, C.Y., Brain tumor specifies intermediate progenitor cell identity by attenuating betacatenin/Armadillo activity (2014) Development, 141, pp. 51-62; Kraut, R., Campos-Ortega, J.A., inscuteable, a neural precursor gene of Drosophila, encodes a candidate for a cytoskeleton adaptor protein (1996) Dev Biol, 174, pp. 65-81; Kraut, R., Chia, W., Jan, L.Y., Jan, Y.N., Knoblich, J.A., Role of inscuteable in orienting asymmetric cell divisions in Drosophila (1996) Nature, 383, pp. 50-55; Kumar, A., Bello, B., Reichert, H., Lineage-specific cell death in postembryonic brain development of Drosophila (2009) Development, 136, pp. 3433-3442; Kurusu, M., Maruyama, Y., Adachi, Y., Okabe, M., Suzuki, E., Furukubo-Tokunaga, K., A conserved nuclear receptor, Tailless, is required for efficient proliferation and prolonged maintenance of mushroom body progenitors in the Drosophila brain (2009) Dev Biol, 326, pp. 224-236; Larsen, C., Shy, D., Spindler, S.R., Fung, S., Pereanu, W., Younossi-Hartenstein, A., Hartenstein, V., Patterns of growth, axonal extension and axonal arborization of neuronal lineages in the developing Drosophila brain (2009) Dev Biol, 335, pp. 289-304; Lee, C.Y., Andersen, R.O., Cabernard, C., Manning, L., Tran, K.D., Lanskey, M.J., Bashirullah, A., Doe, C.Q., Drosophila Aurora-A kinase inhibits neuroblast self-renewal by regulating aPKC/Numb cortical polarity and spindle orientation (2006) Genes Dev, 20, pp. 3464-3474; Lee, C.Y., Wilkinson, B.D., Siegrist, S.E., Wharton, R.P., Doe, C.Q., Brat is a Miranda cargo protein that promotes neuronal differentiation and inhibits neuroblast self-renewal (2006) Dev Cell, 10, pp. 441-449; Li, L., Vaessin, H., Pan-neural Prospero terminates cell proliferation during Drosophila neurogenesis (2000) Genes Dev, 14, pp. 147-151; Li, S., Wang, C., Sandanaraj, E., Aw, S.S., Koe, C.T., Wong, J.J., Yu, F., Wang, H., The SCFSlimb E3 ligase complex regulates asymmetric division to inhibit neuroblast overgrowth (2014) EMBO Rep, 15, pp. 165-174; Li, X., Erclik, T., Bertet, C., Chen, Z., Voutev, R., Venkatesh, S., Morante, J., Desplan, C., Temporal patterning of Drosophila medulla neuroblasts controls neural fates (2013) Nature, 498, pp. 456-462; Lin, S., Lai, S.L., Yu, H.H., Chihara, T., Luo, L., Lee, T., Lineage-specific effects of Notch/Numb signaling in post-embryonic development of the Drosophila brain (2010) Development, 137, pp. 43-51; Lovick, J.K., Ngo, K.T., Omoto, J.J., Wong, D.C., Nguyen, J.D., Hartenstein, V., Postembryonic lineages of the Drosophila brain: I (2013) Development of the lineage associated fiber tracts Dev Biol, 384, pp. 228-257; Maurange, C., Cheng, L., Gould, A.P., Temporal transcription factors and their targets schedule the end of neural proliferation in Drosophila (2008) Cell, 133, pp. 891-902; Nakajima, A., Isshiki, T., Kaneko, K., Ishihara, S., Robustness under functional constraint: The genetic network for temporal expression in Drosophila neurogenesis (2010) PLoS Comput Biol, 6; Neumuller, R.A., Knoblich, J.A., Wicked views on stemcell news (2009) Nat Cell Biol, 11, pp. 678-679; Neumuller, R.A., Richter, C., Fischer, A., Novatchkova, M., Neumuller, K.G., Knoblich, J.A., Genome-wide analysis of self-renewal in Drosophila neural stem cells by transgenic RNAi (2011) Cell Stem Cell, 8, pp. 580-593; Novotny, T., Eiselt, R., Urban, J., Hunchback is required for the specification of the early sublineage of neuroblast 7-3 in the Drosophila central nervous system (2002) Development, 129, pp. 1027-1036; Ohshiro, T., Yagami, T., Zhang, C., Matsuzaki, F., Role of cortical tumour-suppressor proteins in asymmetric division of Drosophila neuroblast (2000) Nature, 408, pp. 593-596; Overton, P.M., Meadows, L.A., Urban, J., Russell, S., Evidence for differential and redundant function of the Sox genes Dichaete and SoxN during CNS development in Drosophila (2002) Development, 129, pp. 4219-4228; Pearson, B.J., Doe, C.Q., Regulation of neuroblast competence in Drosophila (2003) Nature, 425, pp. 624-628; Peng, C.Y., Manning, L., Albertson, R., Doe, C.Q., The tumoursuppressor genes lgl and dlg regulate basal protein targeting in Drosophila neuroblasts (2000) Nature, 408, pp. 596-600; Peterson, C., Carney, G.E., Taylor, B.J., White, K., reaper is required for neuroblast apoptosis during Drosophila development (2002) Development, 129, pp. 1467-1476; Prokop, A., Technau, G.M., The origin of postembryonic neuroblasts in the ventral nerve cord of Drosophila melanogaster (1991) Development, 111, pp. 79-88; Randhawa, R., Cohen, P., The role of the insulin-like growth factor system in prenatal growth (2005) Mol Genet Metab, 86, pp. 84-90; Reddy, B.V., Rauskolb, C., Irvine, K.D., Influence of fat-hippo and notch signaling on the proliferation and differentiation ofDrosophila optic neuroepithelia (2010) Development, 137, pp. 2397-2408; Reichert, H., Drosophila neural stem cells: Cell cycle control of selfrenewal, differentiation, and termination in brain development (2011) Results Probl Cell Differ, 53, pp. 529-546; Rhyu, M.S., Jan, L.Y., Jan, Y.N., Asymmetric distribution of numb protein during division of the sensory organ precursor cell confers distinct fates to daughter cells (1994) Cell, 76, pp. 477-491; Schaefer, M., Knoblich, J.A., Protein localization during asymmetric cell division (2001) Exp Cell Res, 271, pp. 66-74; Schmidt, H., Rickert, C., Bossing, T., Vef, O., Urban, J., Technau, G.M., The embryonic central nervous system lineages of Drosophila melanogaster. II. Neuroblast lineages derived from the dorsal part of the neuroectoderm (1997) Dev Biol, 189, pp. 186-204; Shen, C.P., Jan, L.Y., Jan, Y.N., Miranda is required for the asymmetric localization of Prospero during mitosis in Drosophila (1997) Cell, 90, pp. 449-458; Shim, J., Gururaja-Rao, S., Banerjee, U., Nutritional regulation of stem and progenitor cells in Drosophila (2013) Development, 140, pp. 4647-4656; Siegrist, S.E., Haque, N.S., Chen, C.H., Hay, B.A., Hariharan, I.K., Inactivation of both Foxo and reaper promotes long-term adult neurogenesis in Drosophila (2010) Curr Biol, 20, pp. 643-648; Siller, K.H., Cabernard, C., Doe, C.Q., The NuMA-related Mud protein binds Pins and regulates spindle orientation in Drosophila neuroblasts (2006) Nat Cell Biol, 8, pp. 594-600; Skeath, J.B., At the nexus between pattern formation and cell-type specification: The generation of individual neuroblast fates in the Drosophila embryonic central nervous system (1999) BioEssays, 21, pp. 922-931; Skeath, J.B., Thor, S., Genetic control of Drosophila nerve cord development (2003) Curr Opin Neurobiol, 13, pp. 8-15; Sousa-Nunes, R., Yee, L.L., Gould, A.P., Fat cells reactivate quiescent neuroblasts via TOR and glial insulin relays in Drosophila (2011) Nature, 471, pp. 508-512; Spana, E.P., Doe, C.Q., Numb antagonizes Notch signaling to specify sibling neuron cell fates (1996) Neuron, 17, pp. 21-26; Spana, E.P., Kopczynski, C., Goodman, C.S., Doe, C.Q., Asymmetric localization of numb autonomously determines sibling neuron identity in the Drosophila CNS (1995) Development, 121, pp. 3489-3494; Speicher, S., Fischer, A., Knoblich, J., Carmena, A., The PDZ protein Canoe regulates the asymmetric division of Drosophila neuroblasts and muscle progenitors (2008) Curr Biol, 18, pp. 831-837; Suzuki, T., Kaido, M., Takayama, R., Sato, M., A temporal mechanism that produces neuronal diversity in the Drosophila visual center (2013) Dev Biol, 380, pp. 12-24; Technau, G.M., Berger, C., Urbach, R., Generation of cell diversity and segmental pattern in the embryonic central nervous system of Drosophila (2006) Dev Dyn, 235, pp. 861-869; Touma, J.J., Weckerle, F.F., Cleary, M.D., Drosophila Polycomb complexes restrict neuroblast competence to generate motoneurons (2012) Development, 139, pp. 657-666; Tran, K.D., Doe, C.Q., Pdm and Castor close successive temporal identity windows in the NB3-1 lineage (2008) Development, 135, pp. 3491-3499; Truman, J.W., Bate, M., Spatial and temporal patterns of neurogenesis in the central nervous system of Drosophila melanogaster (1988) Dev Biol, 125, pp. 145-157; Truman, J.W., Moats, W., Altman, J., Marin, E.C., Williams, D.W., Role of Notch signaling in establishing the hemilineages of secondary neurons in Drosophila melanogaster (2010) Development, 137, pp. 53-61; Tsuji, T., Hasegawa, E., Isshiki, T., Neuroblast entry into quiescence is regulated intrinsically by the combined action of spatial Hox proteins and temporal identity factors (2008) Development, 135, pp. 3859-3869; Uemura, T., Shepherd, S., Ackerman, L., Jan, L.Y., Jan, Y.N., numb, a gene required in determination of cell fate during sensory organ formation in Drosophila embryos (1989) Cell, 58, pp. 349-360; Urbach, R., Technau, G.M., Molecular markers for identified neuroblasts in the developing brain of Drosophila (2003) Development, 130, pp. 3621-3637; Urbach, R., Technau, G.M., Neuroblast formation and patterning during early brain development in Drosophila (2004) BioEssays, 26, pp. 739-751; Viktorin, G., Riebli, N., Popkova, A., Giangrande, A., Reichert, H., Multipotent neural stem cells generate glial cells of the central complex through transit amplifying intermediate progenitors in Drosophila brain development (2011) Dev Biol, 356, pp. 553-565; Viktorin, G., Riebli, N., Reichert, H., A multipotent transit-amplifying neuroblast lineage in the central brain gives rise to optic lobe glial cells in Drosophila (2013) Dev Biol, 379, pp. 182-194; Wang, H., Cai, Y., Chia, W., Yang, X., Drosophila homologs of mammalian TNF/TNFR-related molecules regulate segregation of Miranda/Prospero in neuroblasts (2006) EMBO J, 25, pp. 5783-5793; Wang, H., Ouyang, Y., Somers, W.G., Chia, W., Lu, B., Polo inhibits progenitor self-renewal and regulates Numb asymmetry by phosphorylating Pon (2007) Nature, 449, pp. 96-100; Wang, H., Somers, G.W., Bashirullah, A., Heberlein, U., Yu, F., Chia, W., Aurora-A acts as a tumor suppressor and regulates self-renewal of Drosophila neuroblasts (2006) Genes Dev, 20, pp. 3453-3463; Weng, M., Golden, K.L., Lee, C.Y., dFezf/Earmuff maintains the restricted developmental potential of intermediate neural progenitors in Drosophila (2010) Dev Cell, 18, pp. 126-135; Weng, M., Lee, C.Y., Keeping neural progenitor cells on a short leash during Drosophila neurogenesis (2011) Curr Opin Neurobiol, 21, pp. 36-42; Wirtz-Peitz, F., Nishimura, T., Knoblich, J.A., Linking cell cycle to asymmetric division: Aurora-A phosphorylates the Par complex to regulate Numb localization (2008) Cell, 135, pp. 161-173; Wu, P.S., Egger, B., Brand, A.H., Asymmetric stem cell division: Lessons from Drosophila (2008) Semin Cell Dev Biol, 19, pp. 283-293; Xiao, Q., Komori, H., Lee, C.Y., klumpfuss distinguishes stem cells from progenitor cells during asymmetric neuroblast division (2012) Development, 139, pp. 2670-2680; Yamanaka, T., Horikoshi, Y., Izumi, N., Suzuki, A., Mizuno, K., Ohno, S., Lgl mediates apical domain disassembly by suppressing the PAR-3-aPKC-PAR-6 complex to orient apicalmembrane polarity (2006) J Cell Sci, 119, pp. 2107-2118; Yasugi, S., Mizuno, T., Molecular analysis of endoderm regionalization (2008) Dev Growth Differ, 50, pp. 79-96; Yasugi, T., Umetsu, D., Murakami, S., Sato, M., Tabata, T., Drosophila optic lobe neuroblasts triggered by a wave of proneural gene expression that is negatively regulated by JAK/STAT (2008) Development, 135, pp. 1471-1480; Younossi-Hartenstein, A., Nassif, C., Green, P., Hartenstein, V., Early neurogenesis of the Drosophila brain (1996) J Comp Neurol, 370, pp. 313-329; Zhong, W., Chia, W., Neurogenesis and asymmetric cell division (2008) Curr Opin Neurobiol, 18, pp. 4-11; Zhong, W., Feder, J.N., Jiang, M.M., Jan, L.Y., Jan, Y.N., Asymmetric localization of a mammalian numb homolog during mouse cortical neurogenesis (1996) Neuron, 17, pp. 43-53; Zhu, S., Lin, S., Kao, C.F., Awasaki, T., Chiang, A.S., Lee, T., Gradients of the Drosophila Chinmo BTB-zinc finger protein govern neuronal temporal identity (2006) Cell, 127, pp. 409-422",Article,Scopus,2-s2.0-84926669343
"Liechti F.D., Grandgirard D., Leib S.L.","The antidepressant fluoxetine protects the hippocampus from brain damage in experimental pneumococcal meningitis",2015,"Neuroscience","297",,,"89","94",,,10.1016/j.neuroscience.2015.03.056,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927672403&partnerID=40&md5=342b08214ff37eed8956f434988840b0","Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Friedbühlstrasse 51Bern, Switzerland; Biology Division, Spiez Laboratory, Swiss Federal Office for Civil Protection, AustrasseSpiez, Switzerland","Liechti, F.D., Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Friedbühlstrasse 51Bern, Switzerland; Grandgirard, D., Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Friedbühlstrasse 51Bern, Switzerland; Leib, S.L., Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Friedbühlstrasse 51Bern, Switzerland, Biology Division, Spiez Laboratory, Swiss Federal Office for Civil Protection, AustrasseSpiez, Switzerland","Background: High mortality and morbidity rates are observed in patients with bacterial meningitis (BM) and urge for new adjuvant treatments in addition to standard antibiotic therapies. In BM the hippocampal dentate gyrus is injured by apoptosis while in cortical areas ischemic necrosis occurs. Experimental therapies aimed at reducing the inflammatory response and brain damage have successfully been evaluated in animal models of BM. Fluoxetine (FLX) is an anti-depressant of the selective serotonin reuptake inhibitors (SSRI) and was previously shown to be neuroprotective in vitro and in vivo. We therefore assessed the neuroprotective effect of FLX in experimental pneumococcal meningitis. Methods: Infant rats were infected intracisternally with live Streptococcus pneumoniae. Intraperitoneal treatment with FLX (10mgkg-1d-1) or an equal volume of NaCl was initiated 15min later. 18, 27, and 42h after infection, the animals were clinically (weight, clinical score, mortality) evaluated and subject to a cisternal puncture and inflammatory parameters (i.e., cyto-/chemokines, myeloperoxidase activity, matrix metalloproteinase concentrations) were measured in cerebrospinal fluid (CSF) samples. At 42h after infection, animals were sacrificed and the brains collected for histomorphometrical analysis of brain damage. Results: A significant lower number of animals treated with FLX showed relevant hippocampal apoptosis when compared to littermates (9/19 animals vs 18/23, P=. 0.038). A trend for less damage in cortical areas was observed in FLX-treated animals compared to controls (13/19 vs 13/23, P=. ns). Clinical and inflammatory parameters were not affected by FLX treatment. Conclusion: A significant neuroprotective effect of FLX on the hippocampus was observed in acute pneumococcal meningitis in infant rats. © 2015 IBRO.","Hippocampus; Neuroinfection; Neuroinflammation; Stem cell niche; Streptococcus pneumoniae","Agyeman, P., Grandgirard, D., Leib, S., Pathogenesis and pathophysiology of bacterial infections (2014) Infections of the central nervous system, , Lippincott Williams & Wilkins, M.W. Scheld (Ed.); Altamura, A.C., Moro, A.R., Percudani, M., Clinical pharmacokinetics of fluoxetine (1994) Clin Pharmacokinet, 26, pp. 201-214; Barichello, T., Milioli, G., Generoso, J.S., Cipriano, A.L., Costa, C.S., Moreira, A.P., Vilela, M.C., Quevedo, J., Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats (2012) J Neural Transm, 119, pp. 653-660; Chandran, A., Herbert, H., Misurski, D., Santosham, M., Long-term sequelae of childhood bacterial meningitis: an underappreciated problem (2011) Pediatr Infect Dis J, 30, pp. 3-6; Chang, Y.C., Tzeng, S.F., Yu, L., Huang, A.M., Lee, H.T., Huang, C.C., Ho, C.J., Early-life fluoxetine exposure reduced functional deficits after hypoxic-ischemia brain injury in rat pups (2006) Neurobiol Dis, 24, pp. 101-113; Chen, Y.C., Shen, Y.C., Hung, Y.J., Chou, C.H., Yeh, C.B., Perng, C.H., Comparisons of glucose-insulin homeostasis following maprotiline and fluoxetine treatment in depressed males (2007) J Affect Disord, 103, pp. 257-261; Chiou, S.H., Chen, S.J., Peng, C.H., Chang, Y.L., Ku, H.H., Hsu, W.M., Ho, L.L., Lee, C.H., Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell (2006) Biochem Biophys Res Commun, 343, pp. 391-400; Chung, Y.C., Kim, S.R., Park, J.Y., Chung, E.S., Park, K.W., Won, S.Y., Bok, E., Jin, B.K., Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation (2011) Neuropharmacology, 60, pp. 963-974; Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., Lanctot, K.L., A meta-analysis of cytokines in major depression (2010) Biol Psychiatry, 67, pp. 446-457; Gerber, J., Nau, R., Mechanisms of injury in bacterial meningitis (2010) Curr Opin Neurol, 23, pp. 312-318; Hanson, N.D., Nemeroff, C.B., Owens, M.J., Lithium, but not fluoxetine or the corticotropin-releasing factor receptor 1 receptor antagonist R121919, increases cell proliferation in the adult dentate gyrus (2011) J Pharmacol Exp Ther, 337, pp. 180-186; Hitoshi, S., Maruta, N., Higashi, M., Kumar, A., Kato, N., Ikenaka, K., Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress (2007) J Neurosci Res, 85, pp. 3574-3585; Lee, H.J., Kim, J.W., Yim, S.V., Kim, M.J., Kim, S.A., Kim, Y.J., Kim, C.J., Chung, J.H., Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats (2001) Mol Psychiatry, 6 (610), pp. 725-728; Leib, S.L., Clements, J.M., Lindberg, R.L., Heimgartner, C., Loeffler, J.M., Pfister, L.A., Tauber, M.G., Leppert, D., Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis (2001) Brain, 124, pp. 1734-1742; Liechti, F.D., Grandgirard, D., Leppert, D., Leib, S.L., Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis (2014) Infect Immun, 82, pp. 1710-1718; Lim, C.M., Kim, S.W., Park, J.Y., Kim, C., Yoon, S.H., Lee, J.K., Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect (2009) J Neurosci Res, 87, pp. 1037-1045; Liu, J.X., Pinnock, S.B., Herbert, J., Novel control by the CA3 region of the hippocampus on neurogenesis in the dentate gyrus of the adult rat (2011) PLoS One, 6, p. e17562; Manev, H., Uz, T., Smalheiser, N.R., Manev, R., Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro (2001) Eur J Pharmacol, 411, pp. 67-70; Meli, D.N., Coimbra, R.S., Erhart, D.G., Loquet, G., Bellac, C.L., Tauber, M.G., Neumann, U., Leib, S.L., Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis (2006) Infect Immun, 74, pp. 3890-3896; Miller, A.H., Maletic, V., Raison, C.L., Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression (2009) Biol Psychiatry, 65, pp. 732-741; Schmidt, H., Heimann, B., Djukic, M., Mazurek, C., Fels, C., Wallesch, C.W., Nau, R., Neuropsychological sequelae of bacterial and viral meningitis (2006) Brain, 129, pp. 333-345; Thigpen, M.C., Whitney, C.G., Messonnier, N.E., Zell, E.R., Lynfield, R., Hadler, J.L., Harrison, L.H., Schuchat, A., Bacterial meningitis in the United States, 1998-2007 (2011) N Engl J Med, 364, pp. 2016-2025. , Emerging Infections Programs Network; Weisfelt, M., van de Beek, D., Spanjaard, L., Reitsma, J.B., de Gans, J., Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series (2006) Lancet Neurol, 5, pp. 123-129; Wittwer, M., Grandgirard, D., Rohrbach, J., Leib, S.L., Tracking the transcriptional host response from the acute to the regenerative phase of experimental pneumococcal meningitis (2010) BMC Infect Dis, 10, p. 176; Zhang, F., Zhou, H., Wilson, B.C., Shi, J.S., Hong, J.S., Gao, H.M., Fluoxetine protects neurons against microglial activation-mediated neurotoxicity (2012) Parkinsonism Relat Disorders, 18, pp. S213-217",Article,Scopus,2-s2.0-84927672403
"Gao Z., Nissen J.C., Legakis L., Tsirka S.E.","Nicotine modulates neurogenesis in the central canal during experimental autoimmune encephalomyelitis",2015,"Neuroscience","297",,,"11","21",,,10.1016/j.neuroscience.2015.03.031,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927615666&partnerID=40&md5=9c6a1c53784134b5b91c1dc210662947","Program in Neuroscience, Stony Brook UniversityStony Brook, NY, United States; Department of Pharmacological Sciences, Stony Brook UniversityStony Brook, NY, United States; Division of Hematology, Cincinnati Children's Hospital, 3333 Burnet AvenueCincinnati, OH, United States; Department Pharmacology, Virginia Commonwealth UniversityRichmond, VA, United States","Gao, Z., Program in Neuroscience, Stony Brook UniversityStony Brook, NY, United States, Department of Pharmacological Sciences, Stony Brook UniversityStony Brook, NY, United States, Division of Hematology, Cincinnati Children's Hospital, 3333 Burnet AvenueCincinnati, OH, United States; Nissen, J.C., Department of Pharmacological Sciences, Stony Brook UniversityStony Brook, NY, United States; Legakis, L., Department of Pharmacological Sciences, Stony Brook UniversityStony Brook, NY, United States, Department Pharmacology, Virginia Commonwealth UniversityRichmond, VA, United States; Tsirka, S.E., Program in Neuroscience, Stony Brook UniversityStony Brook, NY, United States, Department of Pharmacological Sciences, Stony Brook UniversityStony Brook, NY, United States","Nicotine has been shown to attenuate experimental autoimmune encephalomyelitis (EAE) through inhibiting inflammation in microglial populations during the disease course. In this study, we investigated whether nicotine modified the regenerative process in EAE by examining nestin-expressing neural stem cells (NSCs) in the spinal cord, which is the primary area of demyelination and inflammation in EAE. Our results show that the endogenous neurogenic responses in the spinal cord after EAE are limited and delayed: while nestin expression is increased, the proliferation of ependymal cells is inhibited compared to healthy animals. Nicotine application significantly reduced nestin expression and partially allowed for the proliferation of ependymal cells. We found that reduction of ependymal cell proliferation correlated with inflammation in the same area, which was relieved by the administration of nicotine. Further, increased numbers of oligodendrocytes (OLs) were observed after nicotine treatment. These findings give a new insight into the mechanism of how nicotine functions to attenuate EAE. © 2015 IBRO.","Central canal; EAE; Neural stem cells; Nicotine; Oligodendrocytes","Abrous, D.N., Adriani, W., Montaron, M.F., Aurousseau, C., Rougon, G., Le Moal, M., Piazza, P.V., Nicotine self-administration impairs hippocampal plasticity (2002) J Neurosci, 22, pp. 3656-3662; Barnabe-Heider, F., Goritz, C., Sabelstrom, H., Takebayashi, H., Pfrieger, F.W., Meletis, K., Frisen, J., Origin of new glial cells in intact and injured adult spinal cord (2010) Cell Stem Cell, 7, pp. 470-482; Bauer, J., Sminia, T., Wouterlood, F.G., Dijkstra, C.D., Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis (1994) J Neurosci Res, 38, pp. 365-375; Bhasin, M., Wu, M., Tsirka, S.E., Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis (2007) BMC Immunol, 8, p. 10; Butovsky, O., Landa, G., Kunis, G., Ziv, Y., Avidan, H., Greenberg, N., Schwartz, A., Schwartz, M., Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis (2006) J Clin Investig, 116, pp. 905-915; Butovsky, O., Ziv, Y., Schwartz, A., Landa, G., Talpalar, A.E., Pluchino, S., Martino, G., Schwartz, M., Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells (2006) Mol Cell Neurosci, 31, pp. 149-160; Colton, C., Wilcock, D.M., Assessing activation states in microglia (2010) CNS Neurol Disord Drug Targets, 9, pp. 174-191; Eisch, A.J., Mandyam, C.D., Adult neurogenesis and central nervous system cell cycle analysis: novel tools for exploration of neural causes and correlates of psychiatric disorders (2006) The cell cycle in the central nervous system, pp. 331-358. , Humana Press, NJ, D. Janigro (Ed.); Gao, Z., Tsirka, S.E., Animal models of MS reveal multiple roles of microglia in disease pathogenesis (2011) Neurol Res Int, 2011, p. 383087; Gao, X., Enikolopov, G., Chen, J., Moderate traumatic brain injury promotes proliferation of quiescent neural progenitors in the adult hippocampus (2009) Exp Neurol, 219, pp. 516-523; Gao, Z., Nissen, J.C., Ji, K., Tsirka, S.E., The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components (2014) PLoS One, 9, p. e107979; Grade, S., Bernardino, L., Malva, J.O., Oligodendrogenesis from neural stem cells: perspectives for remyelinating strategies (2013) Int J Dev Neurosci, 31, pp. 692-700; Guo, F., Maeda, Y., Ma, J., Delgado, M., Sohn, J., Miers, L., Ko, E.M., Pleasure, D., Macroglial plasticity and the origins of reactive astroglia in experimental autoimmune encephalomyelitis (2011) J Neurosci, 31, pp. 11914-11928; Hamilton, L.K., Truong, M.K., Bednarczyk, M.R., Aumont, A., Fernandes, K.J., Cellular organization of the central canal ependymal zone, a niche of latent neural stem cells in the adult mammalian spinal cord (2009) Neuroscience, 164, pp. 1044-1056; Hugnot, J.P., Franzen, R., The spinal cord ependymal region: a stem cell niche in the caudal central nervous system (2011) Front Biosci (Landmark Ed), 16, pp. 1044-1059; Jonat, W., Arnold, N., Is the Ki-67 labelling index ready for clinical use? (2011) Ann Oncol, 22, pp. 500-502; Lacroix, S., Hamilton, L.K., Vaugeois, A., Beaudoin, S., Breault-Dugas, C., Pineau, I., Levesque, S.A., Fernandes, K.J., Central canal ependymal cells proliferate extensively in response to traumatic spinal cord injury but not demyelinating lesions (2014) PLoS One, 9, p. e85916; Lee, H., Park, J.R., Yang, J., Kim, E., Hong, S.H., Woo, H.M., Ryu, S.M., Yang, S.R., Nicotine inhibits the proliferation by upregulation of nitric oxide and increased HDAC1 in mouse neural stem cells (2014) In Vitro Cell Dev Biol Anim, 50, pp. 731-739; Li, M.D., Konu, O., Kane, J.K., Becker, K.G., Microarray technology and its application on nicotine research (2002) Mol Neurobiol, 25, pp. 265-285; Lu, W., Bhasin, M., Tsirka, S., Involvement of tissue plasminogen activator in both onset and effector phases of experimental allergic encephalomyelitis (2002) J Neurosci, 22, pp. 10781-10789; Meletis, K., Barnabe-Heider, F., Carlen, M., Evergren, E., Tomilin, N., Shupliakov, O., Frisen, J., Spinal cord injury reveals multilineage differentiation of ependymal cells (2008) PLoS Biol, 6, p. e182; Mikita, J., Dubourdieu-Cassagno, N., Deloire, M.S., Vekris, A., Biran, M., Raffard, G., Brochet, B., Petry, K.G., Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration (2011) Mult Scler, 17, pp. 2-15; Murphy, A.C., Lalor, S.J., Lynch, M.A., Mills, K.H., Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis (2010) Brain Behav Immun, 24, pp. 641-651; Nissen, J.C., Selwood, D.L., Tsirka, S.E., Tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway (2013) J Neurochem; Nizri, E., Irony-Tur-Sinai, M., Lory, O., Orr-Urtreger, A., Lavi, E., Brenner, T., Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses (2009) J Immunol, 183, pp. 6681-6688; Patschan, D., Michurina, T., Shi, H.K., Dolff, S., Brodsky, S.V., Vasilieva, T., Cohen-Gould, L., Goligorsky, M.S., Normal distribution and medullary-to-cortical shift of nestin-expressing cells in acute renal ischemia (2007) Kidney Int, 71, pp. 744-754; Paulson, J.R., Yang, T., Selvaraj, P.K., Mdzinarishvili, A., Van der Schyf, C.J., Klein, J., Bickel, U., Abbruscato, T.J., Nicotine exacerbates brain edema during in vitro and in vivo focal ischemic conditions (2010) J Pharmacol Exp Ther, 332, pp. 371-379; Picard-Riera, N., Decker, L., Delarasse, C., Goude, K., Nait-Oumesmar, B., Liblau, R., Pham-Dinh, D., Baron-Van Evercooren, A., Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice (2002) Proc Natl Acad Sci U S A, 99, pp. 13211-13216; Pluchino, S., Muzio, L., Imitola, J., Deleidi, M., Alfaro-Cervello, C., Salani, G., Porcheri, C., Martino, G., Persistent inflammation alters the function of the endogenous brain stem cell compartment (2008) Brain, 131, pp. 2564-2578; Rasmussen, S., Imitola, J., Ayuso-Sacido, A., Wang, Y., Starossom, S.C., Kivisakk, P., Zhu, B., Khoury, S.J., Reversible neural stem cell niche dysfunction in a model of multiple sclerosis (2011) Ann Neurol, 69, pp. 878-891; Rogers, S.W., Gregori, N.Z., Carlson, N., Gahring, L.C., Noble, M., Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocyte progenitor cells (2001) Glia, 33, pp. 306-313; Scholzen, T., Gerdes, J., The Ki-67 protein: from the known and the unknown (2000) J Cell Physiol, 182, pp. 311-322; Shi, F.D., Piao, W.H., Kuo, Y.P., Campagnolo, D.I., Vollmer, T.L., Lukas, R.J., Nicotinic attenuation of central nervous system inflammation and autoimmunity (2009) J Immunol, 182, pp. 1730-1739; Sierra, A., Encinas, J.M., Deudero, J.J., Chancey, J.H., Enikolopov, G., Overstreet-Wadiche, L.S., Tsirka, S.E., Maletic-Savatic, M., Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis (2010) Cell Stem Cell, 7, pp. 483-495; Takarada, T., Nakamichi, N., Kitajima, S., Fukumori, R., Nakazato, R., Le, N.Q., Kim, Y.H., Yoneda, Y., Promoted neuronal differentiation after activation of alpha4/beta2 nicotinic acetylcholine receptors in undifferentiated neural progenitors (2012) PLoS One, 7, p. e46177; Wu, M., Nissen, J.C., Chen, E.I., Tsirka, S.E., Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis (2012) PLoS One, 7, p. e34933; Yang, J., Jiang, Z., Fitzgerald, D.C., Ma, C., Yu, S., Li, H., Zhao, Z., Zhang, G.X., Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis (2009) J Clin Investig, 119, pp. 3678-3691",Article,Scopus,2-s2.0-84927615666
"Puniredd S.R., Jayaraman S., Gandhimathi C., Ramakrishna S., Venugopal J.R., Yeo T.W., Guo S., Quintana R., Janczewski D., Srinivasan M.P.","Deposition of zwitteronic polymer brushes in a dense gas medium",2015,"Journal of Colloid and Interface Science","448",,,"156","162",,,10.1016/j.jcis.2015.01.070,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84923370483&partnerID=40&md5=739940cb56eebd3c739ac85078422064","Institute of Materials Research and Engineering, A STAR (Agency for Science Technology and Research), 3 Research LinkSingapore, Singapore; Environmental and Water Technology, Centre of Innovation, Ngee Ann PolytechnicSingapore, Singapore; Center for Nanofibers and Nanotechnology, Nanoscience and Nanotechnology Initiative, National University of SingaporeSingapore, Singapore; Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4Singapore, Singapore","Puniredd, S.R., Institute of Materials Research and Engineering, A STAR (Agency for Science Technology and Research), 3 Research LinkSingapore, Singapore; Jayaraman, S., Environmental and Water Technology, Centre of Innovation, Ngee Ann PolytechnicSingapore, Singapore; Gandhimathi, C., Center for Nanofibers and Nanotechnology, Nanoscience and Nanotechnology Initiative, National University of SingaporeSingapore, Singapore; Ramakrishna, S., Center for Nanofibers and Nanotechnology, Nanoscience and Nanotechnology Initiative, National University of SingaporeSingapore, Singapore; Venugopal, J.R., Center for Nanofibers and Nanotechnology, Nanoscience and Nanotechnology Initiative, National University of SingaporeSingapore, Singapore; Yeo, T.W., Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4Singapore, Singapore; Guo, S., Institute of Materials Research and Engineering, A STAR (Agency for Science Technology and Research), 3 Research LinkSingapore, Singapore; Quintana, R., Institute of Materials Research and Engineering, A STAR (Agency for Science Technology and Research), 3 Research LinkSingapore, Singapore; Janczewski, D., Institute of Materials Research and Engineering, A STAR (Agency for Science Technology and Research), 3 Research LinkSingapore, Singapore; Srinivasan, M.P., Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4Singapore, Singapore","Poly(sulfobetaine methacrylate) (PSBMA) films known for their resistance to nonspecific protein adsorption, cell/bacterial adhesion and biofilm formation were produced by surface initiated polymerization on a silicon surface via a batch reaction system in CO2 expanded liquid (CO2-EL) medium. Atom transfer radical polymerization (ATRP) was carried out using 2,2'-bipyridyl as ligand and CuBr as a catalyst in water/methanol mixture with trichloro[4-(chloromethyl)phenyl]silane (CMPS) used as the initiating species. The films were grown in the CO2-EL environment at a range of conditions and thickness up to 10nm. In contrast to films produced by conventional solvent systems at atmospheric pressure, the polymer films grown by the CO2-EL process showed uniform thickness and pin-hole free topography. Most importantly, the CO2-EL processed PSBMA films showed no trace of copper (used as the catalyst), thus obviating the need for post-deposition processing and avoiding adverse effects of the metal leaching during service. Finally, PSBMA films from both the conventional and CO2-EL processes were exposed to Human mesenchymal stem cells (hMSCs) and the results showed that, while in both the cases the cell proliferation rate was inhibited by the charged polymeric brush surface, the CO2-EL-processed brush exhibited inhibition to a larger extent due to the reduced occurrence of pinholes. The process can be easily exploited effectively when carrying out surface initiated polymerization on non-flat topographies, such as in trenches and nanostructured features with high aspect ratios. © 2015 Elsevier Inc.","CO2-expanded liquid medium; Polymer brush; Zwitter ions","Ladd, J., Zhang, Z., Chen, S., Hower, J.C., Jiang, S., (2008) Biomacromolecules, 9, p. 1357; Fan, X., Lin, L., Messersmith, P.B., (2006) Biomacromolecules, 7, p. 2443; Du, J.-Z., Tang, L.-Y., Song, W.-J., Shi, Y., Wang, J., (2009) Biomacromolecules, 10, p. 2169; Welch, M., Rastogi, A., Ober, C., (2011) Soft Matter, 7, p. 297; Kuang, J., Messersmith, P.B., (2012) Langmuir, 28, p. 7258; Quintana, R., Gosa, M., Janczewski, D., Kutnyanszky, E., Vancso, G.J., (2013) Langmuir, 29, p. 10859; Quintana, R., Jańczewski, D., Vasantha, V.A., Jana, S., Lee, S.S.C., Parra-Velandia, F.J., Guo, S., Vancso, G.J., (2014) Colloids Surf., B, 120, p. 118; Estephan, Z.G., Schlenoff, P.S., Schlenoff, J.B., (2011) Langmuir, 27, p. 6794; Chang, Y., Chang, W.-J., Shih, Y.-J., Wei, T.-C., Hsiue, G.-H., (2011) ACS Appl. Mater. Interfaces, 3, p. 1228; Matyjaszewski, K., (2012) Macromolecules, 45, p. 4015; Lowe, A.B., McCormick, C.L., (2002) Chem. Rev., 102, p. 4177; Chang, Y., Chang, Y., Higuchi, A., Shih, Y.-J., Li, P.-T., Chen, W.-Y., Tsai, E.-M., Hsiue, G.-H., (2012) Langmuir, 28, p. 4309; Zhang, Z., Finlay, J.A., Wang, L., Gao, Y., Callow, J.A., Callow, M.E., Jiang, S., (2009) Langmuir, 25, p. 13516; Chang, Y., Shu, S.-H., Shih, Y.-J., Chu, C.-W., Ruaan, R.-C., Chen, W.-Y., (2009) Langmuir, 26, p. 3522; Ostuni, E., Chapman, R.G., Holmlin, R.E., Takayama, S., Whitesides, G.M., (2001) Langmuir, 17, p. 5605; Neff, J.M., (2002) Bioaccumulation in Marine Organisms: Effect of Contaminants From Oil Well Produced Water, , Elsevier; Pintauer, T., Matyjaszewski, K., (2008) Chem. Soc. Rev., 37, p. 1087; Puniredd, S.R., Srinivasan, M., (2007) J. Colloid Interface Sci., 306, p. 118; Puniredd, S.R., Srinivasan, M.P., (2005) Ind. Eng. Chem. Res., 46, p. 464; Puniredd, S.R., Srinivasan, M.P., (2005) Langmuir, 21, p. 7812; Puniredd, S.R., Yin, C.M., Hooi, Y.S., Lee, P.S., Srinivasan, M.P., (2009) J. Colloid Interface Sci., 332, p. 505; Puniredd, S.R., Jayaraman, S., Yeong, S.H., Troadec, C., Srinivasan, M., (2013) J. Phys. Chem. Lett., 4, p. 1397; Xia, J., Johnson, T., Gaynor, S.G., Matyjaszewski, K., DeSimone, J., (1999) Macromolecules, 32, p. 4802; Yang, Y., Wang, Z., Gao, Y., Liu, T., Hu, C., Dong, Q., (2006) J. Appl. Polym. Sci., 102, p. 1146; Park, E.J., Richez, A.P., Birkin, N.A., Lee, H., Arrowsmith, N., Thurecht, K.J., Howdle, S.M., (2011) Polymer, 52, p. 5403; Zhou, J., Villarroya, S., Wang, W., Wyatt, M.F., Duxbury, C.J., Thurecht, K.J., Howdle, S.M., (2006) Macromolecules, 39, p. 5352; Grignard, B., Calberg, C., JérÔme, C., Wang, W., Howdle, S., Detrembleur, C., (2008) Chem. Commun., p. 5803; Grignard, B., JérÔme, C., Calberg, C., JérÔme, R., Detrembleur, C., (2008) Eur. Polym. J., 44, p. 861; Grignard, B., JérÔme, C., Calberg, C., JérÔme, R., Wang, W., Howdle, S.M., Detrembleur, C., (2008) Macromolecules, 41, p. 8575; He, G., Zhang, G., L.F., Fang, Y., (2009) Chem. Mater., 21, p. 1494; Cho, W.K., Kong, B., Choi, I.S., (2007) Langmuir, 23, p. 5678; Inoue, Y., Ishihara, K., (2010) Colloids Surf., B, 81, p. 350; Lin, F., Liu, D., Maiti Das, S., Prempeh, N., Hua, Y., Lu, J., (2014) Ind. Eng. Chem. Res., 53, p. 1866; Ventosa, C., Rébiscoul, D., Perrut, V., Ivanova, V., Renault, O., Passemard, G., (2008) Microelectron. Eng., 85, p. 1629; Cui, H., Wang, T., Shen, Z., (2001) Ind. Eng. Chem. Res., 40, p. 3659; Murphy, J.M., Erkey, C., (1997) Ind. Eng. Chem. Res., 36, p. 5371; Murphy, J.M., Erkey, C., (1997) Environ. Sci. Technol., 31, p. 1674; Cui, Z.-J., Liu, J.-C., Gao, L.-C., Wei, Y.-Q., (2000) J. Environ. Sci., 12, p. 444; Liu, J., Yang, W., Zareie, H.M., Gooding, J.J., Davis, T.P., (2009) Macromolecules, 42, p. 2931; Gandhimathi, C., Venugopal, J., Ravichandran, R., Sundarrajan, S., Suganya, S., Ramakrishna, S., (2013) Macromol. Biosci., 13, p. 696; Heo, S.-J., Kim, S.-E., Wei, J., Kim, D.H., Hyun, Y.-T., Yun, H.-S., Kim, H.K., Shin, J.-W., (2008) Tissue Eng. Part A, 15, p. 977; Ravichandran, R., Venugopal, J.R., Sundarrajan, S., Mukherjee, S., Ramakrishna, S., (2012) Biomaterials, 33, p. 846",Article,Scopus,2-s2.0-84923370483
"Nie L., Chen D., Fu J., Yang S., Hou R., Suo J.","Macroporous biphasic calcium phosphate scaffolds reinforced by poly-L-lactic acid/hydroxyapatite nanocomposite coatings for bone regeneration",2015,"Biochemical Engineering Journal","98",,,"29","37",,,10.1016/j.bej.2015.02.026,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84923283405&partnerID=40&md5=6bbedfc0110dbc1d6e003bf4ab39682e","Polymers and Composites Division, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of SciencesNingbo, China; Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; State Key Laboratory of Mould Technology, College of Materials Science and Engineering, Huazhong University of Science and TechnologyWuhan, China","Nie, L., Polymers and Composites Division, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of SciencesNingbo, China; Chen, D., Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Fu, J., Polymers and Composites Division, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of SciencesNingbo, China; Yang, S., Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Hou, R., Polymers and Composites Division, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of SciencesNingbo, China; Suo, J., State Key Laboratory of Mould Technology, College of Materials Science and Engineering, Huazhong University of Science and TechnologyWuhan, China","Three-dimensional (3D) interconnected porous scaffolds with biomimetic hierarchical architectures and mechanical characteristics are critical for the success of bone regeneration. In this paper, biphasic calcium phosphate (BCP) scaffolds were coated with medical-grade poly-. L-lactic acid/hydroxyapatite (mPLLA/HA) nanocomposites to create controlled surface roughness while remaining the interconnected porous structures. Such mPLLA/HA coatings substantially improved the compressive strength of the scaffolds to 3.17-3.95. MPa, in contrast to 0.31. MPa for the as-prepared bare porous BCP scaffolds. Moreover, these mPLLA/HA-coated porous scaffolds were demonstrated to provide excellent support to the growth and proliferation of human barrow mysenchymal stem cells (hBMSCs). The hBMSCs-seeded mPLLA/HA-coated scaffolds were implanted to large necrotic lesions in the rabbit femoral head. New bone tissues were observed after two months, followed by gradient new bone formation over months according to H&E and Masson staining analysis. These results suggest that the mPLLA/HA-coated BCP scaffolds with improved mechanical strength and osteogenesis may be applied for bone regeneration. © 2015 Elsevier B.V.","BCP scaffold; Biodegradation; Biomedical; Bone marrow mysenchymal stem cells; Bone regeneration; Osteogenesis; Viability","Murugan, R., Ramakrishna, S., Bioresorbable composite bone paste using polysaccharide based nano hydroxyapatite (2004) Biomaterials, 25, pp. 3829-3835; Hamilton, T.W., Goodman, S.M., Figgie, M., SAS weekly rounds: avascular necrosis (2009) HSS. J., 5, pp. 99-113; Yoo, M.C., Kim, K.I., Hahn, C.S., Parvizi, J., Long-term followup of vascularized fibular grafting for femoral head necrosis (2008) Clin. Orthop. Relat. Res., 466, pp. 1133-1140; Hollister, S.J., Porous scaffold design for tissue engineering (2005) Nat. Mater., 4, pp. 518-524; Wei, G., Ma, P.X., Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering (2004) Biomaterials, 25, pp. 4749-4757; Chris, A.J., Verdonschot, N., Schreurs, B.W., Buma, P., The use of a bioresorbable nano-crystalline hydroxyapatite paste in acetabular bone impaction grafting (2006) Biomaterials, 27, pp. 1110-1118; Manjubala, I., Scheler, S., Bössert, J., Jandt, K.D., Mineralisation of chitosan scaffolds with nano-apatite formation by double diffusion technique (2006) Acta Biomater., 2, pp. 75-84; Selvamurugan, N., Kwok, S., Vasilov, A., Jefcoat, S.C., Partridge, N.C., Effects of BMP-2 and pulsed electromagnetic field (PEMF) on rat primary osteoblastic cell proliferation and gene expression (2007) J. Orthop. Res., 25, pp. 1213-1220; Kwok, S., Partridge, N.C., Srinivasan, N., Nair, S.V., Selvamurugan, N., Mitogen activated protein kinase-dependent inhibition of osteocalcin gene expression by transforming growth factor-β1 (2009) J. Cell. Biochem., 106, pp. 161-169; Binulal, N., Deepthy, M., Selvamurugan, N., Shalumon, K., Suja, S., Mony, U., Nair, S.V., Role of nanofibrous poly (caprolactone) scaffolds in human mesenchymal stem cell attachment and spreading for in vitro bone tissue engineering-response to osteogenic regulators (2010) Tissue Eng. Part A, 16, pp. 393-404; Ijima, H., Hou, Y.T., Takei, T., Development of hepatocyte-embedded hydrogel-filled macroporous scaffold cultures using transglutaminase (2010) Biochem. Eng. J., 52, pp. 276-281; Fransiska, S., Ho, M.H., Li, C.H., Shih, J.L., Hsiao, S.W., Thien, D.V.H., To enhance protein production from osteoblasts by using micro-patterned surfaces (2013) Biochem. Eng. J., 78, pp. 120-127; Vallet-Regí, M., Ruiz-Hernández, E., Bioceramics: from bone regeneration to cancer nanomedicine (2011) Adv. Mater., 23, pp. 5177-5218; Wahl, D., Czernuszka, J., Collagen-hydroxyapatite composites for hard tissue repair (2006) Eur. Cell Mater., 11, pp. 43-56; Bandyopadhyay-Ghosh, S., Bone as a collagen-hydroxyapatite composite and its repair (2008) Trends Biomater. Artif. Organs, 22, pp. 116-124; Wang, L., Fan, H., Zhang, Z.Y., Lou, A.J., Pei, G.X., Jiang, S., Mu, T.W., Jin, D., Osteogenesis and angiogenesis of tissue-engineered bone constructed by prevascularized β-tricalcium phosphate scaffold and mesenchymal stem cells (2010) Biomaterials, 31, pp. 9452-9461; Yeo, M.G., Kim, G.H., Preparation and characterization of 3D composite scaffolds based on rapid-prototyped PCL/β-TCP struts and electrospun PCL coated with collagen and HA for bone regeneration (2011) Chem. Mater., 24, pp. 903-913; Roohani-Esfahani, S., Nouri-Khorasani, S., Lu, Z., Appleyard, R., Zreiqat, H., Effects of bioactive glass nanoparticles on the mechanical and biological behavior of composite coated scaffolds (2011) Acta Biomater., 7, pp. 1307-1318; Roohani-Esfahani, S., Nouri-Khorasani, S., Lu, Z., Fathi, M., Razavi, M., Appleyard, R., Zreiqat, H., Modification of porous calcium phosphate surfaces with different geometries of bioactive glass nanoparticles (2012) Mater. Sci. Eng. C, 32, pp. 830-839; Li, J.J., Gil, E.S., Hayden, R.S., Li, C., Roohani-Esfahani, S., Kaplan, D.L., Zreiqat, H., Multiple silk coatings on biphasic calcium phosphate scaffolds: effect on physical and mechanical properties and in vitro osteogenic response of human mesenchymal stem cells (2013) Biomacromolecules, 14, pp. 2179-2188; Nie, L., Chen, D., Suo, J., Zou, P., Feng, S., Yang, Q., Yang, S., Ye, S., Physicochemical characterization and biocompatibility in vitro of biphasic calcium phosphate/polyvinyl alcohol scaffolds prepared by freeze-drying method for bone tissue engineering applications (2012) Colloids Surf. B, 100, pp. 169-176; Li, S., de Wijn, J.R., Li, J., Layrolle, P., de Groot, K., Macroporous biphasic calcium phosphate scaffold with high permeability/porosity ratio (2003) Tissue Eng., 9, pp. 535-548; Yuan, H., Van Blitterswijk, C.A., De Groot, K., De Bruijn, J.D., Cross-species comparison of ectopic bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) scaffolds (2006) Tissue Eng., 12, pp. 1607-1615; Bao, T.Q., Franco, R.A., Lee, B.T., Preparation and characterization of a novel 3D scaffold from poly(epsilon-caprolactone)/biphasic calcium phosphate hybrid composite microspheres adhesion (2012) Biochem. Eng. J., 64, pp. 76-83; Ebrahimi, M., Pripatnanont, P., Monmaturapoj, N., Suttapreyasri, S., Fabrication and characterization of novel nano hydroxyapatite/β-tricalcium phosphate scaffolds in three different composition ratios (2012) J. Biomed. Mater. Res. A, 100, pp. 2260-2268; Bohner, M., Silicon-substituted calcium phosphates - a critical view (2009) Biomaterials, 30, pp. 6403-6406; Kim, H.W., Knowles, J.C., Kim, H.E., Hydroxyapatite/poly(ε-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery (2004) Biomaterials, 25, pp. 1279-1287; Miao, X., Tan, L.P., Tan, L.S., Huang, X., Porous calcium phosphate ceramics modified with PLGA - bioactive glass (2007) Mater. Sci. Eng. C, 27, pp. 274-279; Jun, I.K., Song, J.H., Choi, W.Y., Koh, Y.H., Kim, H.E., Kim, H.W., Porous hydroxyapatite scaffolds coated with bioactive apatite-wollastonite glass-ceramics (2007) J. Am. Ceram. Soc., 90, pp. 2703-2708; Tian, T., Jiang, D., Zhang, J., Lin, Q., Fabrication of bioactive composite by developing PLLA onto the framework of sintered HA scaffold (2008) Mater. Sci. Eng. C, 28, pp. 51-56; Miao, X., Tan, D.M., Li, J., Xiao, Y., Crawford, R., Mechanical and biological properties of hydroxyapatite/tricalcium phosphate scaffolds coated with poly(lactic-co-glycolic acid) (2008) Acta Biomater., 4, pp. 638-645; Wu, A., Ramaswamy, Y., Boughton, P., Zreiqat, H., Improvement of mechanical and biological properties of porous CaSiO3 scaffolds by poly(d, l-lactic acid) modification (2008) Acta Biomater., 4, pp. 343-353; Zhao, J., Lu, X., Duan, K., Guo, L., Zhou, S., Weng, J., Improving mechanical and biological properties of macroporous HA scaffolds through composite coatings (2009) Colloids Surf. B, 74, pp. 159-166; Jonker, A.M., Löwik, D.W., van Hest, J.C., Peptide-and protein-based hydrogels (2012) Chem. Mater., 24, pp. 759-773; Fan, H., Wang, L., Zhao, K., Li, N., Shi, Z., Ge, Z., Jin, Z., Fabrication, mechanical properties, and biocompatibility of graphene-reinforced chitosan composites (2010) Biomacromolecules, 11, pp. 2345-2351; Sui, G., Yang, X., Mei, F., Hu, X., Chen, G., Deng, X., Ryu, S.J., Poly-L-lactic acid/hydroxyapatite hybrid membrane for bone tissue regeneration (2007) Biomed. Mater. Res. A, 82, pp. 445-454; Nie, L., Chen, D., Yang, Q., Zou, P., Feng, S., Hu, H., Suo, J., Hydroxyapatite/poly-L-lactide nanocomposites coating improves the adherence and proliferation of human bone mesenchymal stem cells on porous biphasic calcium phosphate scaffolds (2013) Mater. Lett., 92, pp. 25-28; Nie, L., Suo, J., Zou, P., Feng, S., Preparation and properties of biphasic calcium phosphate scaffolds multiply coated with HA/PLLA nanocomposites for bone tissue engineering applications (2012) J. Nanomater., pp. 1-11; Kokubo, T., Takadama, H., How useful is SBF in predicting in vivo bone bioactivity? (2006) Biomaterials, 27, pp. 2907-2915; Millar, N.L., Halai, M., McKenna, R., McGraw, I., Millar, L.L., Hadidi, M., Uncemented ceramic-on-ceramic THA in adults with osteonecrosis of the femoral head (2010) Orthopedics, 33, p. 795; Tanck, E., Bakker, A., Kregting, S., Cornelissen, B., Klein-Nulend, J., Van Rietbergen, B., Predictive value of femoral head heterogeneity for fracture risk (2009) Bone, 44, pp. 590-595; Liu, T.V., Bhatia, S.N., Three-dimensional tissue fabrication (2004) Adv. Drug Delivery Rev., 56, pp. 1635-1647; Yim, E.K.F., Darling, E.M., Kulangara, K., Guilak, F., Leong, K.W., Nanotopography-induced changes in focal adhesions, cytoskeletal organization, and mechanical properties of human mesenchymal stem cells (2010) Biomaterials, 31, pp. 1299-1306; Roohani-Esfahani, S., Nouri-Khorasani, S., Lu, Z., Appleyard, R., Zreiqat, H., The influence hydroxyapatite nanoparticle shape and size on the properties of biphasic calcium phosphate scaffolds coated with hydroxyapatite-PCL composites (2010) Biomaterials, 31, pp. 5498-5509; Asmus, S.M., Nakahira, A., Pezzotti, G., Manufacture and bioactivity of tough hydroxyapatite/nylon hybrid composites (2002) Adv. Compos. Mater., 11, pp. 255-264; Jose, M.V., Thomas, V., Xu, Y., Bellis, S., Nyairo, E., Dean, D., Aligned bioactive multi-component nanofibrous nanocomposite scaffolds for bone tissue engineering (2010) Macromol. Biosci., 10, pp. 433-444; Mikołajczyk, T., Rabiej, S., Boguń, M., Szparaga, G., Draczyński, Z., Nanocomposite polyvinyl alcohol fibers for medical applications (2011) J. Appl. Polym. Sci., 120, pp. 1234-1244; Holy, A.E., Dang, S.M., Davies, J.E., Shoichet, M.S., In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam (1999) Biomaterials, 20, pp. 1177-1185; Gauthier, I., Bouler, J.M., Aguado, E., Pilet, P., Daculsi, G., Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth (1998) Biomaterials, 19, pp. 133-139; Mendonça, G., Mendonça, D.B.S., Simões, L.G.P., Araújo, A.L., Leite, E.R., Golin, A.L., Aragão, F.J.L., Cooper, L.F., Nanostructured implant surface effect on osteoblast gene expression and bone-to-implant contact in vivo (2011) Mater. Sci. Eng. C, 31, pp. 1809-1818; Khoshfetrat, A.B., Kino-oka, M., Sugawara, K., Taya, M., A collagen-coated surface enables quantitative evaluation of morphological behaviors of rabbit chondrocytes relating to cell differentiation in an early culture phase (2009) Biochem. Eng. J., 45, pp. 60-68; Gao, A., Seuntjens, J., Kaufman, G.N., Tran-Khanh, N., Butler, A., Li, A., Wang, H., Henderson, J.E.J., Mesenchymal stem cell transplantation to promote bone healing (2012) Orthop. Res., 30, pp. 1183-1189; Yu, H., Vande Vord, P.J., Mao, L., Matthew, H.W., Wooley, P.H., Yang, S.Y., Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization (2009) Biomaterials, 30, pp. 508-517; Leotot, J., Coquelin, L., Bodivit, G., Bierling, P., Hernigou, P., Rouard, H., Chevallier, N., Platelet lysate coating on scaffolds directly and indirectly enhances cell migration, improving bone and blood vessel formation (2013) Acta Biomater., 9, pp. 6630-6640; Zou, A., Zhang, Z., He, J., Zhang, K., Ye, D., Han, W., Zhou, J., Jiang, X., Blood vessel formation in the tissue-engineered bone with the constitutively active form of HIF-1α mediated BMSCs (2012) Biomaterials, 33, pp. 2097-2108",Article,Scopus,2-s2.0-84923283405
"Ruggiero C., Doghman M., Lalli E.","How genomic studies have improved our understanding of the mechanisms of transcriptional regulation by NR5A nuclear receptors",2015,"Molecular and Cellular Endocrinology","408",,,"138","144",,1,10.1016/j.mce.2014.10.022,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926684044&partnerID=40&md5=639ccefbfcea016c837585d4fe7d4367","Institut de Pharmacologie Moléculaire et Cellulaire CNRS UMR 7275Sophia Antipolis, Valbonne, France; Laboratoire International Associé (LIA) CNRS NEOGENEXSophia Antipolis, Valbonne, France; Université de NiceSophia Antipolis, Valbonne, France","Ruggiero, C., Institut de Pharmacologie Moléculaire et Cellulaire CNRS UMR 7275Sophia Antipolis, Valbonne, France, Laboratoire International Associé (LIA) CNRS NEOGENEXSophia Antipolis, Valbonne, France, Université de NiceSophia Antipolis, Valbonne, France; Doghman, M., Institut de Pharmacologie Moléculaire et Cellulaire CNRS UMR 7275Sophia Antipolis, Valbonne, France, Laboratoire International Associé (LIA) CNRS NEOGENEXSophia Antipolis, Valbonne, France, Université de NiceSophia Antipolis, Valbonne, France; Lalli, E., Institut de Pharmacologie Moléculaire et Cellulaire CNRS UMR 7275Sophia Antipolis, Valbonne, France, Laboratoire International Associé (LIA) CNRS NEOGENEXSophia Antipolis, Valbonne, France, Université de NiceSophia Antipolis, Valbonne, France","SF-1 and LRH-1 are transcription factors that belong to the NR5A family of nuclear receptors that both have an essential role during development. Recent studies at the genome-wide scale have enabled the characterization of the cistrome and transcriptome regulated by SF-1 and LRH-1 in different cell lines and tissues. Those studies have allowed us to make a significant leap forward in our understanding of the mechanisms of transcriptional regulation of NR5A nuclear receptors in stem cells and cancer. © 2014 Elsevier Ireland Ltd.","Adrenal cortex; Endocrine cancers; Nuclear receptors; Transcription factors","Achermann, J.C., Ozisik, G., Ito, M., Orun, U.A., Harmanci, K., Gurakan, B., Gonadal determination and adrenal development are regulated by the orphan nuclear receptor Steroidogenic factor- 1, in a dose-dependent manner (2002) J. Clin. Endocrinol. Metab, 87, pp. 1829-1833; Annicotte, J.S., Chavey, C., Servant, N., Teyssier, J., Bardin, A., Licznar, A., The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene (2005) Oncogene, 24, pp. 8167-8175; Baba, T., Otake, H., Sato, T., Miyabayashi, K., Shishido, Y., Wang, C.Y., Glycolytic genes are targets of the nuclear receptor Ad4BP/SF-1 (2014) Nat. Commun, 5, p. 3634; Bassett, M.H., Zhang, Y., Clyne, C., White, P.C., Rainey, W.E., Differential regulation of aldosterone synthase and 11β-hydroxylase transcription by Steroidogenic Factor-1 (2002) J. Mol. Endocrinol, 28, pp. 125-135; Benod, C., Vinogradova, M.V., Jouravel, N., Kim, G.E., Fletterick, R.J., Sablin, E.P., Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation (2011) Proc. Natl. Acad. Sci. USA, 108, pp. 16927-16931; Benod, C., Carlsson, J., Uthayaruban, R., Hwang, P., Irwin, J.J., Doak, A.K., Structure-based discovery of antagonists of nuclear receptor LRH-1 (2013) J. Biol. Chem, 288, pp. 19830-19844; Beuschlein, F., Mutch, C., Bavers, D.L., Ulrich-Lai, Y.M., Engeland, W.C., Keegan, C., Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy (2002) Endocrinology, 143, pp. 3122-3135; Bianco, S., Brunelle, M., Jangal, M., Magnani, L., Gévry, N., LRH-1 governs vital transcriptional programs in endocrine-sensitive and -resistant breast cancer cells (2014) Cancer Res, 74, pp. 2015-2025; Bland, M.L., Jamieson, C.A., Akana, S.F., Bornstein, S.R., Eisenhofer, G., Dallman, M.F., Haploinsufficiency of Steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 14488-14493; Botrugno, O.A., Fayard, E., Annicotte, J.S., Haby, C., Brennan, T., Wendling, O., Synergy between LRH-1 and β-catenin induces G<inf>1</inf> cyclin-mediated cell proliferation (2004) Mol. Cell, 15, pp. 499-509; Charest-Marcotte, A., Dufour, C.R., Wilson, B.J., Tremblay, A.M., Eichner, L.J., Arlow, D.H., The homeobox protein Prox1 is a negative modulator of ERRalpha/PGC-1alpha bioenergetic functions (2010) Genes Dev, 24, pp. 537-542; Chong, H.K., Infante, A.M., Seo, Y.-K., Jeon, T.I., Zhang, Y., Edwards, P.A., Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1 (2010) Nucleic Acids Res, 38, pp. 6007-6017; Chong, H.K., Biensinger, J., Seo, Y.-K., Xie, X., Osborne, T.F., Genome-wide analysis of hepatic LRH-1 reveals a promoter binding preference and suggests a role in regulating genes of lipid metabolism in concert with FXR (2012) BMC Genomics, 13, p. 51; Chong, J.A., Tapia-Ramírez, J., Kim, S., Toledo-Aral, J.J., Zheng, Y., Boutros, M.C., REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons (1995) Cell, 80, pp. 949-957; Clyne, C.D., Speed, C.J., Zhou, J., Simpson, E.R., Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes (2002) J. Biol. Chem, 277, pp. 20591-20597; Doghman, M., Lalli, E., A matter of dosage: SF-1 in adrenocortical development and cancer (2009) Ann. Endocrinol. (Paris), 70, pp. 148-152; Doghman, M., Karpova, T., Rodrigues, G.A., Arhatte, M., De Moura, J., Cavalli, L.R., Increased Steroidogenic Factor-1 dosage triggers adrenocortical cell proliferation and cancer (2007) Mol. Endocrinol, 21, pp. 2968-2987; Doghman, M., Arhatte, M., Thibout, H., Rodrigues, G., De Moura, J., Grosso, S., Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors (2007) J. Clin. Endocrinol. Metab, 92, pp. 3253-3260; Doghman, M., Cazareth, J., Douguet, D., Madoux, F., Hodder, P., Lalli, E., Inhibition of adrenocortical carcinoma cell proliferation by SF-1 inverse agonists (2009) J. Clin. Endocrinol. Metab, 94, pp. 2178-2183; Doghman, M., Figueiredo, B.C., Volante, M., Papotti, M., Lalli, E., Integrative analysis of SF-1 transcription factor dosage impact on genome-wide binding and gene expression regulation (2013) Nucleic Acids Res, 41, pp. 8896-8907; Duggavathi, R., Volle, D.H., Mataki, C., Antal, M.C., Messaddeq, N., Auwerx, J., Liver receptor homolog 1 is essential for ovulation (2008) Genes Dev, 22, pp. 1871-1876; Ehrlund, A., Holter Anthonisen, E., Gustafsson, N., Venteclef, N., Robertson Remen, K., Damdimopoulos, A.E., The E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis (2009) Mol. Cell. Biol, 29, pp. 2230-2242; Ehrlund, A., Jonsson, P., Vedin, L.L., Williams, C., Gustafsson, J.Å., Treuter, E., Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFβ, and Wnt/β-catenin signaling in adrenocortical carcinoma cells (2012) PLoS ONE, 7; El Wakil, A., Lalli, E., The Wnt/beta-catenin pathway in adrenocortical development and cancer (2011) Mol. Cell. Endocrinol, 332, pp. 32-37; Feng, D., Liu, T., Sun, Z., Bugge, A., Mullican, S.E., Alenghat, T., A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism (2011) Science, 331, pp. 1315-1319; Ferraz-de-Souza, B., Lin, L., Shah, S., Jina, N., Hubank, M., Dattani, M.T., ChIP-on-chip analysis reveals angiopoietin 2 (Ang2, ANGPT2) as a novel target of Steroidogenic Factor-1 (SF-1, NR5A1) in the human adrenal gland (2011) FASEB J., 25, pp. 1166-1175; Ferraz-de-Souza, B., Hudson-Davies, R.E., Lin, L., Parnaik, R., Hubank, M., Dattani, M.T., Sterol-O-Acyltransferase 1 (SOAT1, ACAT) is a novel target of Steroidogenic Factor-1 (SF-1, NR5A1, Ad4BP) in the human adrenal (2011) J. Clin. Endocrinol. Metab, 96, pp. E663-E668; Guo, G., Smith, A., A genome-wide screen in EpiSC identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency (2010) Development, 137, pp. 3185-3192; Heng, J.-C.D., Feng, B., Han, J., Jiang, J., Kraus, P., Ng, J.-H., The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells (2010) Cell Stem Cell, 6, pp. 167-174; Holmstrom, S.R., Deering, T., Swift, G.H., Poelwijk, F.J., Mangelsdorf, D.J., Kliewer, S.A., LRH-1 and PTF1-L coregulate an exocrine pancreas-specific transcriptional network for digestive function (2011) Genes Dev, 25, pp. 1674-1679; Johnsen, I.K., Beuschlein, F., Role of bone morphogenetic proteins in adrenal physiology and disease (2010) J. Mol. Endocrinol, 44, pp. 203-211; Lai, C.F., Flach, K.D., Alexi, X., Fox, S.P., Ottaviani, S., Thiruchelvam, P.T., Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells (2013) Nucleic Acids Res, 41, pp. 10228-10240; Lalli, E., Doghman, M., Latre de Late, P., El Wakil, A., Mus-Veteau, I., Beyond steroidogenesis: novel target genes for SF-1 discovered by genomics (2013) Mol. Cell. Endocrinol, 371, pp. 154-159; Lee, M., Marinoni, I., Irmler, M., Psaras, T., Honegger, J.B., Beschorner, R., Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenoma (2013) Acta Neuropathol, 126, pp. 137-150; Lee, Y.K., Moore, D.D., Liver receptor homolog-1, an emerging metabolic modulator (2008) Front. Biosci, 13, pp. 5950-5958; Lewis, S.R., Hedman, C.J., Ziegler, T., Ricke, W.A., Jorgensen, J.S., Steroidogenic factor 1 promotes aggressive growth of castration-resistant prostate cancer cells by stimulating steroid synthesis and cell proliferation (2014) Endocrinology, 155, pp. 358-369; Lin, L., Philibert, P., Ferraz-de-Souza, B., Kelberman, D., Homfray, T., Albanese, A., Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function (2007) J. Clin. Endocrinol. Metab, 92, pp. 991-999; Lu, T.T., Makishima, M., Repa, J.J., Schoonjans, K., Kerr, T.A., Auwerx, J., Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors (2000) Mol. Cell, 6, pp. 507-515; Luo, X., Ikeda, Y., Parker, K.L., A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation (1994) Cell, 77, pp. 481-490; Mataki, C., Magnier, B.C., Houten, S.M., Annicotte, J.S., Argmann, C., Thomas, C., Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1 (2007) Mol. Cell. Biol, 27, pp. 8330-8339; McLean, C.Y., Bristor, D., Hiller, M., Clarke, S.L., Schaar, B.T., Lowe, C.B., GREAT improves functional interpretation of cis-regulatory regions (2010) Nat. Biotechnol, 28, pp. 495-501; A unified nomenclature system for the nuclear receptor superfamily (1999) Cell, 97, pp. 161-163; Oosterveer, M.H., Mataki, C., Yamamoto, H., Harach, T., Moullan, N., van Dijk, T.H., LRH-1-dependent glucose sensing determines intermediary metabolism in liver (2012) J. Clin. Invest, 122, pp. 2817-2826; Pare, J.F., Malenfant, D., Courtemanche, C., Jacob-Wagner, M., Roy, S., Allard, D., The fetoprotein transcription factor (FTF) gene is essential to embryogenesis and cholesterol homeostasis and is regulated by a DR4 element (2004) J. Biol. Chem, 279, pp. 21206-21216; Parker, K.L., Schimmer, B.P., Steroidogenic Factor 1: a key determinant of endocrine development and function (1997) Endocr. Rev, 18, pp. 361-377; Petersen, G.M., Amundadottir, L., Fuchs, C.S., Kraft, P., Stolzenberg-Solomon, R.Z., Jacobs, K.B., A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 (2010) Nat. Genet, 42, pp. 224-228; Pianovski, M.A., Cavalli, L.R., Figueiredo, B.C., Santos, S.C., Doghman, M., Ribeiro, R.C., SF-1 overexpression in childhood adrenocortical tumours (2006) Eur. J. Cancer, 42, pp. 1040-1043; Rui, X., Tsao, J., Scheys, J.O., Hammer, G.D., Schimmer, B.P., Contributions of Specificity Protein-1 and Steroidogenic Factor 1 to Adcy4 expression in Y1 mouse adrenal cells (2008) Endocrinology, 147, pp. 2357-2367; Sbiera, S., Schmull, S., Assié, G., Voelker, H.-U., Kraus, L., Beyer, M., High diagnostic and prognostic value of Steroidogenic Factor-1 expression in adrenal tumors (2010) J. Clin. Endocrinol. Metab, 95, pp. E161-E171; Schimmer, B.P., Tsao, J., Cordova, M., Mostafavi, S., Morris, Q., Scheys, J.O., Contributions of Steroidogenic Factor-1 to the transcription landscape of Y1 mouse adrenocortical tumor cells (2011) Mol. Cell. Endocrinol, 336, pp. 85-91; Schoenherr, C.J., Anderson, D.J., The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes (1995) Science, 267, pp. 1360-1363; Schoonjans, K., Dubuquoy, L., Mebis, J., Fayard, E., Wendling, O., Haby, C., Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 2058-2062; Thiruchelvam, P.T., Lai, C.F., Hua, H., Thomas, R.S., Hurtado, A., Hudson, W., The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells (2011) Breast Cancer Res. Treat, 127, pp. 385-396; Williams, T.A., Monticone, S., Crudo, V., Warth, R., Veglio, F., Mulatero, P., Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis (2012) Hypertension, 59, pp. 833-839; Wilson, T.E., Fahrer, T.J., Millbrandt, J., The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction (1993) Mol. Cell. Biol, 13, pp. 5794-5804; Ye, P., Nakamura, Y., Lalli, E., Rainey, W., Differential effects of high and low Steroidogenic Factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells (2009) Endocrinology, 150, pp. 1303-1309; Zhang, C., Large, M.J., Duggavathi, R., DeMayo, F.J., Lydon, J.P., Schoonjans, K., Liver receptor homolog-1 is essential for pregnancy (2013) Nat. Med, 19, pp. 1061-1066; Zhou, J., Suzuki, T., Kovacic, A., Saito, R., Miki, Y., Ishida, T., Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer (2005) Cancer Res, 65, pp. 657-663",Review,Scopus,2-s2.0-84926684044
"Tuppy M., Barna B.F., Alves-dos-Santos L., Britto L.R.G., Chiavegatto S., Moreira T.S., Takakura A.C.","Respiratory deficits in a rat model of Parkinson's disease",2015,"Neuroscience","297",,,"194","204",,,10.1016/j.neuroscience.2015.03.048,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927720580&partnerID=40&md5=8bc5aa52537e22e35f0e0247d2058805","Department of Pharmacology, Institute of Biomedical Sciences, University of São PauloSão Paulo, SP, Brazil; Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São PauloSão Paulo, SP, Brazil","Tuppy, M., Department of Pharmacology, Institute of Biomedical Sciences, University of São PauloSão Paulo, SP, Brazil; Barna, B.F., Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São PauloSão Paulo, SP, Brazil; Alves-dos-Santos, L., Department of Pharmacology, Institute of Biomedical Sciences, University of São PauloSão Paulo, SP, Brazil; Britto, L.R.G., Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São PauloSão Paulo, SP, Brazil; Chiavegatto, S., Department of Pharmacology, Institute of Biomedical Sciences, University of São PauloSão Paulo, SP, Brazil; Moreira, T.S., Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São PauloSão Paulo, SP, Brazil; Takakura, A.C., Department of Pharmacology, Institute of Biomedical Sciences, University of São PauloSão Paulo, SP, Brazil","Parkinson's disease (PD) is a neurodegenerative disease characterized by loss of the dopaminergic nigrostriatal pathway. In addition to deficits in voluntary movement, PD involves a disturbance of breathing regulation. However, the cause and nature of this disturbance are not well understood. Here, we investigated breathing at rest and in response to hypercapnia (7% CO<inf>2</inf>) or hypoxia (8% O<inf>2</inf>), as well as neuroanatomical changes in brainstem regions essential for breathing, in a 6-hydroxydopamine (6-OHDA) rat model of PD. Bilateral injections of 6-OHDA (24μg/μl) into the striatum decreased tyrosine hydroxylase (TH+)-neurons in the substantia nigra pars compacta (SNpc), transcription factor phox2b-expressing neurons in the retrotrapezoid nucleus and neurokinin-1 receptors in the ventral respiratory column. In 6-OHDA-lesioned rats, respiratory rate was reduced at rest, leading to a reduction in minute ventilation. These animals also showed a reduction in the tachypneic response to hypercapnia, but not to hypoxia challenge. These results suggest that the degeneration of TH+ neurons in the SNpc leads to impairment of breathing at rest and in hypercapnic conditions. Our data indicate that respiratory deficits in a 6-OHDA rat model of PD are related to downregulation of neural systems involved in respiratory rhythm generation. The present study suggests a new avenue to better understand the respiratory deficits observed in chronic stages of PD. © 2015 IBRO.","Brainstem; Breathing; Hypercapnia; Hypoxia; Parkinson's disease","Axelrod, F.B., Chelimsky, G.G., Weese-Mayer, D.E., Pediatric autonomic disorders (2006) Pediatrics, 118, pp. 309-321; Barna, B.F., Takakura, A.C., Moreira, T.S., Pontomedullary and hypothalamic distribution of Fos-like immunoreactive neurons after acute exercise in rats (2012) Neuroscience, 212, pp. 120-130; Bassetti, C.L., Nonmotor disturbances in Parkinson's disease (2011) Neurodegener Dis, 8, pp. 95-108; Benarroch, E.E., Brainstem in multiple system atrophy: clinicopathological correlations (2003) Cell Mol Neurobiol, 23, pp. 519-526; Benarroch, E.E., Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy (2007) Mov Disord, 22, pp. 155-161; Benarroch, E.E., Schmeichel, A.M., Low, P.A., Parisi, J.E., Depletion of ventromedullary NK-1 receptor-immunoreactive neurons in multiple system atrophy (2003) Brain, 126, pp. 2183-2190; Biancardi, V., Bícego, K.C., Almeida, M.C., Gargaglioni, L.H., Locus coeruleus noradrenergic neurons and CO<inf>2</inf> drive to breathing (2008) Pflugers Arch, 455, pp. 1119-1128; Blum, D., Torch, S., Lambeng, N., Nissou, M., Benabid, A.L., Sadoul, R., Verna, J.M., Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease (2001) Prog Neurobiol, 65 (2), pp. 135-172; Budzinska, K., Andrzejewski, K., Respiratory activity in the 6-hydroxydopamine model of Parkinson's disease in the rat (2014) Acta Neurobiol Exp (Wars), 74, pp. 67-81; Bunton, K., Patterns of lung volume use during an extemporaneous speech task in persons with Parkinson disease (2005) J Commun Disord, 38, pp. 331-348; Chaudhuri, K.R., Odin, P., Antonini, A., Martinez-Martin, P., Parkinson's disease: the non-motor issues (2011) Parkinsonism Relat Disord, 17, pp. 717-723; Chiavegatto, S., Nasello, A.G., Bernardi, M.M., Histamine and spontaneous motor activity: biphasic changes, receptors involved and participation of the striatal dopamine system (1998) Life Sci, 62, pp. 1875-1888; da Silva, G.S., Giusti, H., Benedetti, M., Dias, M.B., Gargaglioni, L.H., Branco, L.G., Glass, M.L., Serotonergic neurons in the nucleus raphe obscurus contribute to interaction between central and peripheral ventilatory responses to hypercapnia (2011) Pflugers Arch, 462, pp. 407-418; Dean, J.B., Lawing, W.L., Millhorn, D.E., CO2 decreases membrane conductance and depolarizes neurons in the nucleus tractus solitarii (1989) Exp Brain Res, 76, pp. 656-661; Favero, M.T., Takakura, A.C., de Paula, P.M., Colombari, E., Menani, J.V., Moreira, T.S., Chemosensory control by commissural nucleus of the solitary tract in rats (2011) Respir Physiol Neurobiol, 179, pp. 227-234; Fearnley, J.M., Lees, A.J., Ageing and Parkinson's disease: substantia nigra regional selectivity (1991) Brain, 114, pp. 2283-2301; Feldman, J.L., Del Negro, C.A., Looking for inspiration: new perspectives on respiratory rhythm (2006) Nat Rev Neurosci, 7, pp. 232-242; Feldman, J.L., Ellenberger, H.H., Central coordination of respiratory and cardiovascular control in mammals (1988) Annu Rev Physiol, 50, pp. 593-606; Feldman, J.L., Del Negro, C.A., Gray, P.A., Understanding the rhythm of breathing: so near, yet so far (2013) Annu Rev Physiol, 75, pp. 423-452; Gargaglioni, L.H., Hartzler, L.K., Putnam, R.W., The locus coeruleus and central chemosensitivity (2010) Respir Physiol Neurobiol, 173, pp. 264-273; Guyenet, P.G., Wang, H., Pre-Bötzinger neurons with preinspiratory discharges ""in vivo"" express NK1 receptors in the rat (2001) J Neurophysiol, 86, pp. 438-446; Hammer, M.J., Barlow, S.M., Laryngeal somatosensory deficits in Parkinson's disease: implications for speech respiratory and phonatory control (2010) Exp Brain Res, 201, pp. 401-409; Idiaquez, J., Benarroch, E.E., Rosales, H., Milla, P., Ríos, L., Autonomic and cognitive dysfunction in Parkinson's disease (2007) Clin Auton Res, 17, pp. 93-98; Kortekaas, R., Leenders, K.L., van Oostrom, J.C., Vaalburg, W., Bart, J., Willemsen, A.T., Hendrikse, N.H., Blood-brain barrier dysfunction in parkinsonian midbrain in vivo (2005) Ann Neurol, 57, pp. 176-179; Lindner, M.D., Cain, C.K., Plone, M.A., Frydel, B.R., Blaney, T.J., Emerich, D.F., Hoane, M.R., Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats (1999) Behav Brain Res, 102, pp. 1-16; Malan, A., Ventilation measured by body plethysmography in hibernating mammals and in poikilotherms (1973) Respir Physiol, 17, pp. 32-44; McDowell, K., Chesselet, M.F., Animal models of the non-motor features of Parkinson's disease (2012) Neurobiol Dis, 46, pp. 597-606; Miguelez, C., Grandoso, L., Ugedo, L., Locus coeruleus and dorsal raphe neuron activity and response to acute antidepressant administration in a rat model of Parkinson's disease (2011) Int J Neuropsychopharmacol, 14, pp. 187-200; Mulkey, D.K., Stornetta, R.L., Weston, M.C., Simmons, J.R., Parker, A., Bayliss, D.A., Guyenet, P.G., Respiratory control by ventral surface chemoreceptor neurons in rats (2004) Nat Neurosci, 7, pp. 1360-1369; Nogués, M.A., Roncoroni, A.J., Benarroch, E., Breathing control in neurological diseases (2002) Clin Auton Res, 12, pp. 440-449; Overholt, J.L., Summers, B.A., Ficker, E., Prabhakar, N.R., CO<inf>2</inf>/HCO<inf>3</inf>- modulates K+ and Ca2+ currents in glomus cells of the carotid body (2001) Adv Exp Med Biol, 499, pp. 61-66; Paxinos, G., Watson, C., (1998) The rat brain: in stereotaxic coordinates, , Academic Press, San Diego; Prensa, L., Parent, A., The nigrostriatal pathway in the rat: a single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments (2001) J Neurosci, 21, pp. 7247-7260; Reyes, A., Ziman, M., Nosaka, K., Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review (2013) Chest, 143, pp. 1386-1394; Richerson, G.B., Bekkers, J.M., Learning to take a deep breath-with BDNF (2004) Nat Med, 10, pp. 25-26; Schreihofer, A.M., Guyenet, P.G., Identification of C1 presympathetic neurons in rat rostral ventrolateral medulla by juxtacellular labeling in vivo (1997) J Comp Neurol, 387, pp. 524-536; Schwarting, R.K., Huston, J.P., The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments (1996) Prog Neurobiol, 50, pp. 275-331; Schwarzacher, S.W., Rüb, U., Deller, T., Neuroanatomical characteristics of the human pre-Bötzinger complex and its involvement in neurodegenerative brainstem diseases (2011) Brain, 134, pp. 24-35; Seccombe, L.M., Giddings, H.L., Rogers, P.G., Corbett, A.J., Hayes, M.W., Peters, M.J., Veitch, E.M., Abnormal ventilatory control in Parkinson's disease-further evidence for non-motor dysfunction (2011) Respir Physiol Neurobiol, 179, pp. 300-304; Solomon, N.P., Hixon, T.J., Speech breathing in Parkinson's disease (1993) J Speech Hear Res, 36, pp. 294-310; Stornetta, R.L., Moreira, T.S., Takakura, A.C., Kang, B.J., Chang, D.A., West, G.H., Brunet, J.F., Guyenet, P.G., Expression of Phox2b by brainstem neurons involved in chemosensory integration in the adult rat (2006) J Neurosci, 26, pp. 10305-10314; Tadaiesky, M.T., Dombrowski, P.A., Figueiredo, C.P., Cargnin-Ferreira, E., Da Cunha, C., Takahashi, R.N., Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease (2008) Neuroscience, 156, pp. 830-840; Troche, M.S., Okun, M.S., Rosenbek, J.C., Musson, N., Fernandez, H.H., Rodriguez, R., Romrell, J., Sapienza, C.M., Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial (2010) Neurology, 75, pp. 1912-1919; Tzelepis, G.E., McCool, F.D., Friedman, J.H., Hoppin, F.G., Respiratory muscle dysfunction in Parkinson's disease (1988) Am Rev Respir Dis, 138, pp. 266-271; Weese-Mayer, D.E., Lieske, S.P., Boothby, C.M., Kenny, A.S., Bennett, H.L., Silvestri, J.M., Ramirez, J.M., Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome (2006) Pediatr Res, 60, pp. 443-449; Weese-Mayer, D.E., Lieske, S.P., Boothby, C.M., Kenny, A.S., Bennett, H.L., Ramirez, J.M., Autonomic dysregulation in young girls with Rett syndrome during nighttime in-home recordings (2008) Pediatr Pulmonol, 43, pp. 1045-1060; Wolters, E., Non-motor extranigral signs and symptoms in Parkinson's disease (2009) Parkinsonism Relat Disord, 15, pp. S6-S12; Yadav, A.P., Fuentes, R., Zhang, H., Vinholo, T., Wang, C.H., Freire, M.A., Nicolelis, M.A., Chronic spinal cord electrical stimulation protects against 6-hydroxydopamine lesions (2014) Sci Rep, 4, p. 3839",Article,Scopus,2-s2.0-84927720580
"Ferreira C.B., Schoorlemmer G.H., Rossi M.V., Takakura A.C., Barna B.F., Moreira T.S., Cravo S.L.","Brainstem areas activated by intermittent apnea in awake unrestrained rats",2015,"Neuroscience","297",,,"262","271",,,10.1016/j.neuroscience.2015.04.007,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928637174&partnerID=40&md5=2018a8f5d82f593ecaebedb0ebcf4452","Department of Physiology, Federal University of São PauloSão Paulo, SP, Brazil; Department of Pharmacology, Institute of Biomedical Science, University of São PauloSão Paulo, SP, Brazil; Department of Physiology and Biophysics, Institute of Biomedical Science, University of São PauloSão Paulo, SP, Brazil","Ferreira, C.B., Department of Physiology, Federal University of São PauloSão Paulo, SP, Brazil; Schoorlemmer, G.H., Department of Physiology, Federal University of São PauloSão Paulo, SP, Brazil; Rossi, M.V., Department of Physiology, Federal University of São PauloSão Paulo, SP, Brazil; Takakura, A.C., Department of Pharmacology, Institute of Biomedical Science, University of São PauloSão Paulo, SP, Brazil; Barna, B.F., Department of Physiology and Biophysics, Institute of Biomedical Science, University of São PauloSão Paulo, SP, Brazil; Moreira, T.S., Department of Physiology and Biophysics, Institute of Biomedical Science, University of São PauloSão Paulo, SP, Brazil; Cravo, S.L., Department of Physiology, Federal University of São PauloSão Paulo, SP, Brazil","We investigated the role of the autonomic nervous system to cardiovascular responses to obstructive apnea in awake, unrestrained rats, and measured expression of Fos induced by apnea in the brainstem. We implanted a tracheal balloon contained in a rigid tube to allow the induction of apnea without inducing pain in the trachea. During bouts of 15s of apnea, heart rate fell from 371±8 to 161±11bpm (mean±SEM, n=15, p<0.01) and arterial pressure increased from 115±2 to 131±4mmHg (p<0.01). Bradycardia was due to parasympathetic activity because it was blocked by the muscarinic antagonist, methylatropine. The pressor response was due to vasoconstriction caused by sympathetic activation because it was blocked by the α<inf>1</inf> antagonist, prazosin. Apnea induced Fos expression in several brainstem areas involved in cardiorespiratory control such as the nucleus of the solitary tract (NTS), ventrolateral medulla (VLM), and pons. Ligation of the carotid body artery reduced apnea-induced bradycardia, blocked heart rate responses to i.v. injection of cyanide, reduced Fos expression in the caudal NTS, and increased Fos expression in the rostral VLM. In conclusion, apnea activates neurons in regions that process signals from baroreceptors, chemoreceptors, pulmonary receptors, and regions responsible for autonomic and respiratory activity both in the presence and absence of carotid chemoreceptors. © 2015 IBRO.","Arterial chemoreceptors; CFos immunoreactivity; Hypoxia; Medulla oblongata; Obstructive apnea","Angheben, J.M., Schoorlemmer, G.H., Rossi, M.V., Silva, T.A., Cravo, S.L., Cardiovascular responses induced by obstructive apnea are enhanced in hypertensive rats due to enhanced chemoreceptor responsivity (2014) PLoS One, 9, p. e86868; Bao, G., Randhawa, P.M., Fletcher, E.C., Acute blood pressure elevation during repetitive hypocapnic and eucapnic hypoxia in rats (1997) J Appl Physiol (1985), 82, pp. 1071-1078; Berquin, P., Bodineau, L., Gros, F., Larnicol, N., Brainstem and hypothalamic areas involved in respiratory chemoreflexes: a Fos study in adult rats (2000) Brain Res, 857, pp. 30-40; Chamberlin, N.L., Functional organization of the parabrachial complex and intertrigeminal region in the control of breathing (2004) Respir Physiol Neurobiol, 143, pp. 115-125; Cruz Jde, C., Bonagamba, L.G., Stern, J.E., Machado, B.H., Fos expression in the NTS in response to peripheral chemoreflex activation in awake rats (2010) Auton Neurosci, 152, pp. 27-34; Dampney, R.A., Horiuchi, J., Functional organisation of central cardiovascular pathways: studies using c-fos gene expression (2003) Prog Neurobiol, 71, pp. 359-384; Dampney, R.A., Polson, J.W., Potts, P.D., Hirooka, Y., Horiuchi, J., Functional organization of brain pathways subserving the baroreceptor reflex: studies in conscious animals using immediate early gene expression (2003) Cell Mol Neurobiol, 23, pp. 597-616; Davenport, P.W., Vovk, A., Cortical and subcortical central neural pathways in respiratory sensations (2009) Respir Physiol Neurobiol, 167, pp. 72-86; Dempsey, J.A., Veasey, S.C., Morgan, B.J., O'Donnell, C.P., Pathophysiology of sleep apnea (2010) Physiol Rev, 90, pp. 47-112; Erickson, J.T., Millhorn, D.E., Fos-like protein is induced in neurons of the medulla oblongata after stimulation of the carotid sinus nerve in awake and anesthetized rats (1991) Brain Res, 567, pp. 11-24; Ezure, K., Tanaka, I., Distribution and medullary projection of respiratory neurons in the dorsolateral pons of the rat (2006) Neuroscience, 141, pp. 1011-1023; Finley, J.C., Katz, D.M., The central organization of carotid body afferent projections to the brainstem of the rat (1992) Brain Res, 572, pp. 108-116; Franchini, K.G., Krieger, E.M., Carotid chemoreceptors influence arterial pressure in intact and aortic-denervated rats (1992) Am J Physiol Regul Integr Comp Physiol, 262, pp. R677-R683; Gieroba, Z.J., Yu, Y.H., Blessing, W.W., Vasoconstriction induced by inhalation of irritant vapour is associated with appearance of Fos protein in C1 catecholamine neurons in rabbit medulla oblongata (1994) Brain Res, 636, pp. 157-161; Guyenet, P.G., Regulation of breathing and autonomic outflows by chemoreceptors (2014) Compr Physiol, 4, pp. 1511-1562; Guyenet, P.G., Stornetta, R.L., Bochorishvili, G., Depuy, S.D., Burke, P.G., Abbott, S.B., C1 neurons: the body's EMTs (2013) Am J Physiol Regul Integr Comp Physiol, 305, pp. R187-R204; Haxhiu, M.A., Yung, K., Erokwu, B., Cherniack, N.S., CO<inf>2</inf>-induced c-fos expression in the CNS catecholaminergic neurons (1996) Respir Physiol, 105, pp. 35-45; Hirooka, Y., Polson, J.W., Potts, P.D., Dampney, R.A., Hypoxia-induced Fos expression in neurons projecting to the pressor region in the rostral ventrolateral medulla (1997) Neuroscience, 80, pp. 1209-1224; King, T.L., Heesch, C.M., Clark, C.G., Kline, D.D., Hasser, E.M., Hypoxia activates nucleus tractus solitarii neurons projecting to the paraventricular nucleus of the hypothalamus (2012) Am J Physiol Regul Integr Comp Physiol, 302, pp. R1219-R1232; Kline, D.D., King, T.L., Austgen, J.R., Heesch, C.M., Hasser, E.M., Sensory afferent and hypoxia-mediated activation of nucleus tractus solitarius neurons that project to the rostral ventrolateral medulla (2010) Neuroscience, 167, pp. 510-527; Llewellyn-Smith, I.J., Dicarlo, S.E., Collins, H.L., Keast, J.R., Enkephalin-immunoreactive interneurons extensively innervate sympathetic preganglionic neurons regulating the pelvic viscera (2005) J Comp Neurol, 488, pp. 278-289; Malakhova, O.E., Davenport, P.W., C-Fos expression in the central nervous system elicited by phrenic nerve stimulation (2001) J Appl Physiol (1985), 90, pp. 1291-1298; McCulloch, P.F., Ollenberger, G.P., Bekar, L.K., West, N.H., Trigeminal and chemoreceptor contributions to bradycardia during voluntary dives in rats (1997) Am J Physiol, 273, pp. R814-R822; McCulloch, P.F., Panneton, W.M., Activation of brainstem catecholaminergic neurons during voluntary diving in rats (2003) Brain Res, 984, pp. 42-53; Nattie, E., Li, A., Central chemoreceptors: locations and functions (2012) Compr Physiol, 2, pp. 221-254; Nattie, E.E., Li, A., CO<inf>2</inf> dialysis in nucleus tractus solitarius region of rat increases ventilation in sleep and wakefulness (2002) J Appl Physiol (1985), 92, pp. 2119-2130; Pate, K.M., Davenport, P.W., Tracheal occlusions evoke respiratory load compensation and neural activation in anesthetized rats (2012) J Appl Physiol (1985), 112, pp. 435-442; Paxinos, G., Watson, C., The rat brain: in stereotaxic coordinates (1997), Academic Press, San DiegoPedrino, G.R., Maurino, I., de Almeida Colombari, D.S., Cravo, S.L., Role of catecholaminergic neurones of the caudal ventrolateral medulla in cardiovascular responses induced by acute changes in circulating volume in rats (2006) Exp Physiol, 91, pp. 995-1005; Reis, D.J., Granata, A.R., Joh, T.H., Ross, C.A., Ruggiero, D.A., Park, D.H., Brain stem catecholamine mechanisms in tonic and reflex control of blood pressure (1984) Hypertension, 6, pp. II7-II15; Roux, J.C., Pequignot, J.M., Dumas, S., Pascual, O., Ghilini, G., Pequignot, J., Mallet, J., Denavit-Saubie, M., O<inf>2</inf>-sensing after carotid chemodenervation: hypoxic ventilatory responsiveness and upregulation of tyrosine hydroxylase mRNA in brainstem catecholaminergic cells (2000) Eur J Neurosci, 12, pp. 3181-3190; Schoorlemmer, G.H., Johnson, A.K., Thunhorst, R.L., Circulating angiotensin II mediates sodium appetite in adrenalectomized rats (2001) Am J Physiol Regul Integr Comp Physiol, 281, pp. R723-R729; Schoorlemmer, G.H., Rossi, M.V., Tufik, S., Cravo, S.L., A new method to produce obstructive sleep apnoea in conscious unrestrained rats (2011) Exp Physiol, 96, pp. 1010-1018; Simpson, J.A., Brunt, K.R., Iscoe, S., Repeated inspiratory occlusions acutely impair myocardial function in rats (2008) J Physiol, 586, pp. 2345-2355; Spyer, K.M., Gourine, A.V., Chemosensory pathways in the brainstem controlling cardiorespiratory activity (2009) Philos Trans R Soc Lond B Biol Sci, 364, pp. 2603-2610; Takakura, A.C., Moreira, T.S., Colombari, E., West, G.H., Stornetta, R.L., Guyenet, P.G., Peripheral chemoreceptor inputs to retrotrapezoid nucleus (RTN) CO<inf>2</inf>-sensitive neurons in rats (2006) J Physiol, 572, pp. 503-523; Teppema, L.J., Veening, J.G., Kranenburg, A., Dahan, A., Berkenbosch, A., Olievier, C., Expression of c-fos in the rat brainstem after exposure to hypoxia and to normoxic and hyperoxic hypercapnia (1997) J Comp Neurol, 388, pp. 169-190; Zoccal, D.B., Machado, B.H., Sympathetic overactivity coupled with active expiration in rats submitted to chronic intermittent hypoxia (2010) Respir Physiol Neurobiol, 174, pp. 98-101",Article,Scopus,2-s2.0-84928637174
"Hosseini Farahabadi S.S., Ghaedi K., Ghazvini Zadegan F., Karbalaie K., Rabiee F., Nematollahi M., Baharvand H., Nasr-Esfahani M.-H.","ERK1/2 is a key regulator of Fndc5 and PGC1α expression during neural differentiation of mESCs",2015,"Neuroscience","297",,,"252","261",,,10.1016/j.neuroscience.2015.03.069,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928391421&partnerID=40&md5=54717af1a2e2eec20e91474d331b40c9","Cell and Molecular Biology Division, Biology Department, School of Sciences, University of IsfahanIsfahan, Iran; Department of Cellular Biotechnology at Cell Science Research Center, Royan Institute for Biotechnology, ACECRIsfahan, Iran; Department of Stem Cells and Developmental Biology at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECRTehran, Iran; Department of Developmental Biology, University of Science and Culture, ACECRTehran, Iran","Hosseini Farahabadi, S.S., Cell and Molecular Biology Division, Biology Department, School of Sciences, University of IsfahanIsfahan, Iran; Ghaedi, K., Cell and Molecular Biology Division, Biology Department, School of Sciences, University of IsfahanIsfahan, Iran, Department of Cellular Biotechnology at Cell Science Research Center, Royan Institute for Biotechnology, ACECRIsfahan, Iran; Ghazvini Zadegan, F., Department of Cellular Biotechnology at Cell Science Research Center, Royan Institute for Biotechnology, ACECRIsfahan, Iran; Karbalaie, K., Department of Cellular Biotechnology at Cell Science Research Center, Royan Institute for Biotechnology, ACECRIsfahan, Iran; Rabiee, F., Department of Cellular Biotechnology at Cell Science Research Center, Royan Institute for Biotechnology, ACECRIsfahan, Iran; Nematollahi, M., Department of Cellular Biotechnology at Cell Science Research Center, Royan Institute for Biotechnology, ACECRIsfahan, Iran; Baharvand, H., Department of Stem Cells and Developmental Biology at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECRTehran, Iran, Department of Developmental Biology, University of Science and Culture, ACECRTehran, Iran; Nasr-Esfahani, M.-H., Department of Cellular Biotechnology at Cell Science Research Center, Royan Institute for Biotechnology, ACECRIsfahan, Iran","Fibronectin type III domain containing 5 (. Fndc5) has already been distinguished to be involved in neural differentiation. However, cellular events of Fndc5 function are still ambiguous in the nervous system. One approach to shed light on duty of this protein in the nervous system is to find its cross-talks with various signaling pathways with defined characteristics and roles. Identification of the underlying molecular mechanism which controls Fndc5 expression and switches its activity up and down enables us to find out the Fndc5 functional map in the nervous system and other human body systems. Retinoic acid (RA) is a bio-small molecule which exerts its role as a neural inducer in the neurodevelopmental process of neural tube. RA up-regulates the expression of various genes involved in neural differentiation process via two distinct pathways: the genomic and the non-genomic. Our previous study has revealed that RA induces Fndc5 expression during neural differentiation process. In this study we have evaluated our hypothesis about the non-genomic up regulation of Fndc5 expression by RA. Interestingly we have identified that there is an association between ERK signaling pathway and Fndc5 expression. Furthermore, inhibition of this pathway by PD0325901 dramatically reduced Fndc5 mRNA level, while activating the pathway up-regulated Fndc5 transcription. In addition, it has been proven that ERK1/2 modulation via RA has more significant controlling effect on Fndc5 promoter rather than bFGF. This led us to conclude that RA enhances Fndc5 expression through a non-genomic pathway via the ERK signaling pathway. © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.","bFGF; ERK1/2; Fndc5; Neural differentiation; Signaling pathway","Amura, C.R., Marek, L., Winn, R.A., Heasley, L.E., Inhibited neurogenesis in JNK1-deficient embryonic stem cells (2005) Mol Cell Biol, 25, pp. 10791-10802; Austin, S., St-Pierre, J., PGC1α and mitochondrial metabolism emerging concepts and relevance in ageing and neurodegenerative disorders (2012) J Cell Sci, 125, pp. 4963-4971; Bostrom, P., Wu, J., Jedrychowski, M.P., Korde, A., Ye, L., Lo, J.C., Bostrom, E.A., Spiegelman, B.M., A PGC1-a-dependent myokine that drives brown-fat-like development of white fat and thermogenesis (2012) Nature, 481, pp. 463-468; Bourtchuladze, R., Frenguelli, B., Blendy, J., Cioffi, D., Schutz, G., Silva, A.J., Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein (1994) Cell, 79, pp. 59-68; Canon, E., Cosgaya, J.M., Scsucova, S., Arand, A., Rapid effects of retinoic acid on CREB and ERK phosphorylation in neuronal cells (2004) Mol Biol Cell, 15, pp. 5583-5592; Chan, E.D., Winston, B.W., Jarpe, M.B., Wynes, M.W., Riches, D.W., Preferential activation of the p46 isoform of JNK/SAPK in mouse macrophages by TNF alpha (1997) PNAS, 94 (24), pp. 13169-13174; Erickson, H.P., Irisin and FNDC5 in retrospect An exercise hormone or a transmembrane receptor? (2013) Adipocyte, 2, pp. 289-293; Ferrer-Martinez, A., Ruiz-Lozano, P., Chien, K.R., Mouse PeP: a novel peroxisomal protein linked to myoblast differentiation and development (2002) Dev Dyn, 224, pp. 154-167; Finkbeiner, S., Tavazoie, S.F., Maloratsky, A., Jacobs, K.M., Harris, K.M., Greenberg, M.E., CREB: a major mediator of neuronal neurotrophin responses (1997) Neuron, 19, pp. 1031-1047; Gao, Y., Deng, K., Hou, J., Bryson, J.B., Barco, A., Nikulina, E., Spencer, T., Filbin, M.T., Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo (2004) Neuron, 44, pp. 609-621; Hashemi, M.S., Ghaedi, K., Salamian, A., Karbalaie, K., Emadi-Baygi, M., Tanhaei, S., Nasr-Esfahani, M.H., Baharvand, H., Fndc5 knockdown significantly decreased neural differentiation rate of mouse embryonic stem cells (2013) Neuroscience, 231, pp. 296-304; Hassani, S.N., Totonchi, M., Sharifi-Zarchi, A., Mollamohammadi, S., Pakzad, M., Moradi, S., Samadian, A., Baharavand, H., Inhibition of TGFβ signaling promotes ground state pluripotency (2014) Stem Cell Rev, 10, pp. 16-30; Herzig, S., Long, F., Jhala, U.S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Montminy, M., CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 (2001) Nature, 413, pp. 179-183; Jin, J., Suzuki, H., Hirai, S., Mikoshiba, K., Ohshima, T., JNK phosphorylates Ser332 of doublecortin and regulates its function in neurite extension and neuronal migration (2010) Dev Neurobiol, 70, pp. 929-942; Leppa, S., Saffrich, R., Ansorge, W., Bohmann, D., Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation (1998) EMBO J, 17, pp. 4404-4413; Li, Z., Theus, M.H., Wei, L., Role of ERK 1/2 signaling in neuronal differentiation of cultured embryonic stem cells (2006) Develop. Growth Differ, 48, pp. 513-523; Morooka, T., Nishida, E., Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells (1998) J Biol Chem, 273, pp. 24285-24288; Ostadsharif, M., Ghaedi, K., Nasr-Esfahani, M.H., Mojbafan, M., Tanhaie, S., Karbalaie, K., Baharvand, H., The expression of peroxisomal protein transcripts increased by retinoic acid during neural differentiation (2010) Differentiation, 81, pp. 127-132; Qin, W., Haroutunian, V., Katsel, P., Cardozo, C.P., Ho, L., Buxbaum, J.D., Pasinetti, G.M., PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia (2009) Arch Neurol, 66 (3), pp. 352-361; Raschke, S., Elsen, M., Gassenhuber, H., Sommerfeld, M., Brockmann, B., Jung, R., Wisløff, U., Eckel, J., Evidence against a beneficial effect of irisin in humans (2013) PLoS One, 8 (9), p. e73680; Rassouli, H., Tabe Bordbar, M.S., Rezaei Larijani, M., Pakzad, M., Baharvand, H., Hosseini Salekdeh, G., Cloning, expression and functional characterization of in-house prepared human basic fibroblast growth factor (2012) Cell J, 14, pp. 282-291; Schmittgen, T.D., Kenneth, L.J., Analyzing real-time PCR data by the comparative CT method (2008) Nat Protoc, 3, pp. 1101-1108; Schuler, M., Tardivel, A., Ali, F., Desvergne, B., Chambon, C., Wahli, W., Duteil, D., Metzger, D., PGC1a expression is controlled in skeletal muscles by PPARb, whose ablation results in fiber-type switching, obesity, and type 2 diabetes (2006) Cell Metab, 4, pp. 407-414; Seifi, T., Ghaedi, K., Kiani-Esfahani, A., Tanhaei, S., Peymani, M., Nasr-Esfahani, M.H., Karamali, F., Baharvand, H., Identification, cloning, and functional analysis of the TATA-Less mouse FNDC5 promoter during neural differentiation (2014) Cell Mol Neurobiol, 34, pp. 715-725; Shan, Z.Y., Shen, J.L., Huang, X.Y., Li, Q.M., Guo, T.Y., Wang, Y., Liu, H.W., Jin, L.H., PCREB is involved in neural induction of mouse embryonic stem cells by RA (2008) Anat Rec, 291, pp. 519-526; Song, W., Song, Y., Kincaid, B., Bossy, B., Bossy-Wetzel, E., Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α (2013) Neurobiol Dis, 51, pp. 72-81; Teufel, A., Malik, N., Mukhopadhyay, M., Westphal, H., Frcp1 and Frcp2, two novel fibronectin type III repeat containing genes (2002) Gene, 297, pp. 79-83; Wrann, C.D., White, J.P., Salogiannnis, J., Laznik-Bogoslavski, D., Wu, J., Ma, D., Lin, J.D., Spiegelman, B.M., Exercise induces hippocampal BDNF through a PGC-1a/FNDC5 pathway (2013) Cell Metab, 18, pp. 649-659; Wu, J., Bostrom, P., Sparks, L.M., Ye, L., Choi, J.H., Giang, A.H., Khandekar, M., Spiegelman, B.M., Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human (2012) Cell, 150, pp. 366-376; Xu, H., Dhanasekaran, D.N., Lee, C.M., Reddy, E.P., Regulation of neurite outgrowth by interactions between the scaffolding protein, JNK-associated leucine zipper protein, and neuronal growth-associated protein superior cervical ganglia clone (2009) J Biol Chem, 285, pp. 3548-3553",Article,Scopus,2-s2.0-84928391421
"Morelli S., Salerno S., Holopainen J., Ritala M., De Bartolo L.","Osteogenic and osteoclastogenic differentiation of co-cultured cells in polylactic acid-nanohydroxyapatite fiber scaffolds",2015,"Journal of Biotechnology","204",,,"53","62",,,10.1016/j.jbiotec.2015.03.023,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927951051&partnerID=40&md5=2d733fdcfebcaf357614c741e0b28e45","Institute on Membrane Technology, National Research Council of Italy, ITM-CNR, via P. Bucci cubo 17/CRende, CS, Italy; Laboratory of Inorganic Chemistry, Department of Chemistry, University of Helsinki, PO Box 55Helsinki, Finland","Morelli, S., Institute on Membrane Technology, National Research Council of Italy, ITM-CNR, via P. Bucci cubo 17/CRende, CS, Italy; Salerno, S., Institute on Membrane Technology, National Research Council of Italy, ITM-CNR, via P. Bucci cubo 17/CRende, CS, Italy; Holopainen, J., Laboratory of Inorganic Chemistry, Department of Chemistry, University of Helsinki, PO Box 55Helsinki, Finland; Ritala, M., Laboratory of Inorganic Chemistry, Department of Chemistry, University of Helsinki, PO Box 55Helsinki, Finland; De Bartolo, L., Institute on Membrane Technology, National Research Council of Italy, ITM-CNR, via P. Bucci cubo 17/CRende, CS, Italy","The design of bone substitutes involves the creation of a microenvironment supporting molecular cross-talk between cells and scaffolds during tissue formation and remodelling. Bone remodelling process includes the cooperation of bone-building cells and bone-resorbing cells.In this paper we developed polylactic acid (PLA) and composite PLA-nanohydroxyapatite (nHA) scaffolds with 20 and 50. wt.% of nHA by electrospinning technique to be used in bone tissue engineering. The developed scaffolds have different fiber diameter, porosity with interconnected pores and mechanical properties. Taking cues from the bone environment features we investigated the differentiation of human mesenchymal stem cells (hMSCs) from bone marrow in osteoblasts and the osteoclastogenesis in the developed scaffolds in homotypic and in co-culture up to 46 days.PLA and composite PLA-nHA scaffolds induced osteogenic and osteoclastogenic differentiation. Both osteoblasts and osteoclasts displayed high expression of specific markers (osteopontin, osteocalcin, RANK, RANKL) and functions such as secretion of ALP, cathepsin K and TRAP activity on composite scaffolds especially on PLA-nHA containing 20. wt.% of nHA. The heterotypic interactions between osteoblasts and osteoclasts co-cultured in the developed scaffolds triggered their functional differentiation and activation. © 2015 Elsevier B.V.","Bone tissue engineering; Co-culture; Osteoblasts; Osteoclasts; Polylactic acid-nanohydroxyapatite fiber scaffolds","Bognitzki, M., Czado, W., Frese, T., Schaper, A., Hellwig, M., Steinhart, M., Greiner, A., Wendorff, J.H., Nanostructured fibers via electrospinning (2001) Adv. Mater., 13, pp. 70-72; Boyle, W.J., Simonet, W.S., Lacey, D.L., Osteoclast differentiation and activation (2003) Nature, 423, pp. 337-342; Casper, C.L., Stephens, J.S., Tassi, N.G., Chase, D.B., Rabolt, J.F., Controlling surface morphology of electrospun polystyrene fibers: effect of humidity and molecular weight in the electrospinning process (2004) Macromolecules, 37, pp. 573-578; Conway, J.D., Autograft and non unions: morbidity with intramedullary bone graft verss iliac crest bone graft (2010) Orthop. Clin. North Am., 41, pp. 75-84; Curcio, E., Macchiarini, P., De Bartolo, L., Oxygen mass transfer in a human tissue engineered trachea (2010) Biomaterials, 31, pp. 5131-5136; Curcio, E., Piscioneri, A., Morelli, S., Salerno, S., Macchiarini, P., De Bartolo, L., Kinetics of oxygen uptake by cells potentially used in a tissue engineered trachea (2014) Biomaterials, 35, pp. 6829-6837; Curran, J.M., Fawcett, S., Hamilton, L., Rhodes, N.P., Rahman, C.V., Alexander, M., Shakesheff, K., Hunt, J.A., The osteogenic response of mesenchymal stem cells to an injectable PLGA bone regeneration system (2013) Biomaterials, 34, pp. 9352-9364; Deng, X.L., Sui, G., Zhao, M.L., Chen, G.Q., Yang, X.P., Poly(l-lactic acid)/hydroxyapatite hybrid nanofibrous scaffolds prepared by electrospinning (2007) J. Biomater. Sci. Polym. Ed., 18, pp. 117-130; Gunatillake, P.A., Ahikari, R., Biodegradable synthetic polymers for tissue engineering (2003) Eur. Cells Mater., 5, pp. 1-16; Heinemann, C., Heinemann, S., Bernhardt, A., Lode, A., Worch, H., Hanke, T., In vitro osteoclastogenesis on textile chitosan scaffolds (2010) Eur. Cells Mater., 19, pp. 96-106; Heinemann, C., Heinemann, S., Worch, H., Hanke, T., Development of an osteoblast/osteoclast co-culture derived by human bone marrow stromal cells and human monocytes for biomaterial testing (2011) Eur. Cells Mater, 21, pp. 80-93; Hessle, L., Johnson, K.A., Anderson, H.C., Narisawa, S., Sali, A., Goding, J.W., Terkeltaub, R., Millan, J.L., Tissue non-specific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization (2002) Proc. Natl. Acad. Sci. U.S.A., 99, pp. 9445-9449; Jeong, S.I., Ko, E.K., Yum, J., Jung, C.H., Lee, Y.M., Shim, H., Nanofibrous poly(lactic acid)/hydroxyapatite composite scaffolds for guided tissue regeneration (2008) Macromol. Biosci., 8, pp. 328-338; Jones, G.L., Motta, A., Marshall, M.J., El Haj, A.J., Cartmell, S.H., Osteoblast: osteoclast co-cultures on silk fibroin, chitosan and PLLA films (2009) Biomaterials, 30, pp. 5376-5384; Khan, Y., Yaszemski, M.J., Mikosm, A.G., Laurencin, C.T., Tissue engineering of bone: material and matrix considerations (2008) J. Bone Joint Surg. Am., 90, pp. 36-42; Kim, H.J., Kim, U.J., Vunjak-Novakovic, G., Min, B.H., Kaplan, D.L., Influence of macroporous protein scaffolds on bone tissue engineering from bone marrow stem cells (2005) Biomaterials, 26, pp. 4442-4452; Kim, H.W., Lee, H.H., Knowles, J.C., Electrospinning biomedical nanocomposite fibers of hydroxyapatite/poly(lactic acid) for bone regeneration (2006) J. Biomed. Mater. Res. A, 79 A, pp. 643-649; Kleinhans, C., Schimd, F.F., Schimd, F.V., Kluger, P.J., Comparison of osteoclastogenesis and resorption activityof human osteoclasts on tissue culture polysrtyrene and on natural extracellular bone matrix in 2D and 3D (2015) J. Biotechnol.; Kutikov, A.B., Song, J., An amphiphilic degradable polymer/hydroxyapatite composite with enhanced handling characteristics promotes osteogenic gene expression in bone marrow stromal cells (2013) Acta Biomater., 9, pp. 8354-8364; Lao, L., Wang, Y., Zhu, Y., Zhang, Y., Gao, C., Poly(lactide-co-glycolide)/hydroxyapatite nanofibrous scaffolds fabricated by electrospinning for bone tissue engineering (2011) J. Mater. Sci.: Mater. Med., 22, pp. 1873-1884; Lee, E.J., Teng, A.H., Jang, T.S., Wang, P., Yook, S.W., Kim, H.E., Koh, Y.H., Nanostructured poly(e{open}-caprolactone)-silica xerogel fibrous membrane for guided bone regeneration (2010) Acta Biomater., 6, pp. 3557-3565; Liu, Y., Wang, G., Cai, Y., Ji, H., Zhou, G., Zhao Tang, X.R., Zhang, M., In vitro effects of nanophase hydroxyapatite particles on proliferation and osteogenic differentiation of bone marrow-derived mesenchymal stem cells (2009) J. Biomed. Mater. Res. A, 90, pp. 1083-1091; Lutter, A.H., Hempel, U., Wolf-Brandstetter, C., Garbe, A.I., Goettsch, C., Hofbauer, L.C., Jessberger, R., Dieter, P., A novel resorption assay for osteoclast functionality based on an osteoblast-derived native extracellular matrix (2010) J. Cell. Biochem., 109, pp. 1025-1032; Martin, I., Shastri, V.P., Padera, R.F., Yang, J., Mackaj, A.J., Langer, R., Vunjak-Novakovic, G., Freed, L.E., Selective differentiation of mammalian bone marrow stromal cells cultured on a tree-dimensional polymer foams (2001) J. Biomed. Mater. Res., 55, pp. 229-235; Minkin, C., Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function (1982) Calcif. Tissue Int., 34, pp. 285-290; Misch, C.E., Qu, Z., Bidez, M.W., Mechanical properties of trabecular bone in the human mandible: implications for dental implant treatment planning and surgical placement (1999) J. Oral Maxillofac. Surg., 57, pp. 700-706. , (discussion 706-8); Monchau, F., Lefevre, A., Descamps, M., Belquin-myrdycz, A., Laffargue, P., Hildebrand, H.F., In vitro studies of human and rat osteoclast activity on hydroxyapatite, beta-tricalcium phosphate, calcium carbonate (2002) Biomol. Eng., 19, pp. 143-152; Morelli, S., Facciolo, D., Messina, A., Piscioneri, A., Salerno, S., Drioli, E., De Bartolo, L., Polycaprolactone-hydroxyapatite composite membrane scaffolds for bone tissue engineering (2013) Mater. Res. Soc. Symp. Proc., 150, p. 2; Morelli, S., Piscioneri, A., Salerno, S., Al-Fageeh, M., Drioli, E., De Bartolo, L., Neuroprotective effect of didymin on H<inf>2</inf>O<inf>2</inf>-induced injury in neuronal membrane system (2014) Cells Tissue Organs, 199, pp. 184-200; Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Yano, K., Morinaga, T., Higashio, K., RANK is the essential signalling receptor for osteoclast differentiation factor in osteoclastogenesis (1998) Biochem. Biophys. Res. Commun., 253, pp. 395-400; Nakagawa, K., Abukawa, H., Shin, M.Y., Terai, H., Troulis, M.J., Vacanti, J.P., Osteoclastogenesis on tissue-engineered bone (2004) Tissue Eng., 10, pp. 93-100; Nejati, E., Mirzadeh, H., Zandi, M., Synthesis and characterization of nano-hydroxyapatite rods/poly(l-lactide acid) composite scaffolds for bone tissue engineering (2008) Composites, A: Appl. Sci. Manuf., 39, pp. 1589-1596; Ravichandran, R., Venugopal, J.R., Sundarrajan, S., Mukherjee, S., Ramakrishna, S., Precipitation of nanohydroxyapatite on PLLA/PBLG/Collagen nanofibrous structures for the differentiation of adipose derived stem cells to osteogenic lineage (2012) Biomaterials, 33, pp. 846-855; Tortelli, F., Pujic, N., Liu, Y., Laroche, N., Vico, L., Cancedda, R., Osteoblast and osteoclast differentiation in an in vitro three-dimensional model of bone (2009) Tissue Eng., A, 15, pp. 2373-2383; Venugopal, J., Vadgama, P., Kumat, T.S., Ramakrishna, S., Biocomposite nanofibres and osteoblasts for bone tissue engineering (2007) Nanotechnology, 18, p. 055101; Waite, P.D., Morawetz, R.B., Zeiger, H.E., Pincock, J.L., Reconstruction of cranial defects with porous hydroxyapatite block (1989) Neurosurgery, 25, pp. 214-217; Young, M.F., Kerr, J.M., Ibaraki, K., Heegard, A.M., Robey, P.G., Structure, expression, and regulation of the major non collageneous matrix proteins of bone (1992) Clin. Orthop. Relat. Res., 281, pp. 275-294; Zhang, Z.Y., Teoh, S.H., Teo, E.Y., Chong, M.S., Shin, C.W., Tien, F.T., Choolani, M.A., Chan, J.K., Neo-vascularization and bone formation mediated by fetal MSC tissue-engineered bone grafts in critical sized femoral defects (2010) Biomaterials, 31, pp. 8684-8695",Article,Scopus,2-s2.0-84927951051
"Paranjpe S.S., Veenstra G.J.C.","Establishing pluripotency in early development",2015,"Biochimica et Biophysica Acta - Gene Regulatory Mechanisms","1849","6",,"626","636",,,10.1016/j.bbagrm.2015.03.006,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927626047&partnerID=40&md5=ac3ee14fde9b4f467543a26b6c0c5829","Radboud University, Department of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life SciencesNijmegen, Netherlands","Paranjpe, S.S., Radboud University, Department of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life SciencesNijmegen, Netherlands; Veenstra, G.J.C., Radboud University, Department of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life SciencesNijmegen, Netherlands","The earliest steps of embryonic development involve important changes in chromatin and transcription factor networks, which are orchestrated to establish pluripotent cells that will form the embryo. DNA methylation, histone modifications, the pluripotency regulatory network of transcription factors, maternal factors and newly translated proteins all contribute to these transitions in dynamic ways. Moreover, these dynamics are linked to the onset of zygotic transcription. We will review recent progress in our understanding of chromatin state and regulation of gene expression in the context of embryonic development in vertebrates, in particular mouse, Xenopus and zebrafish. We include work on mouse embryonic stem cells and highlight work that illustrates how early embryonic dynamics establish gene regulatory networks and the state of pluripotency. © 2015.","Chromatin; Embryo; Methylation; Pluripotency; Zygotic genome activation","Arney, K.L., Bao, S., Bannister, A.J., Kouzarides, T., Surani, M.A., Histone methylation defines epigenetic asymmetry in the mouse zygote (2002) Int. J. Dev. Biol., 46 (3), pp. 317-320; Guo, H., Zhu, P., Yan, L., Li, R., Hu, B., Lian, Y., Yan, J., Fan, X., The DNA methylation landscape of human early embryos (2014) Nature, 511 (7511), pp. 606-610; Puschendorf, M., Terranova, R., Boutsma, E., Mao, X., Isono, K., Brykczynska, U., Kolb, C., Peters, A.H., PRC1 and Suv39h specify parental asymmetry at constitutive heterochromatin in early mouse embryos (2008) Nat. Genet., 40 (4), pp. 411-420; Santos, F., Peters, A.H., Otte, A.P., Reik, W., Dean, W., Dynamic chromatin modifications characterise the first cell cycle in mouse embryos (2005) Dev. Biol., 280 (1), pp. 225-236; Smallwood, S.A., Tomizawa, S., Krueger, F., Ruf, N., Carli, N., Segonds-Pichon, A., Sato, S., Kelsey, G., Dynamic CpG island methylation landscape in oocytes and preimplantation embryos (2011) Nat. Genet., 43 (8), pp. 811-814. , (PMCID 3146050); Smith, Z.D., Chan, M.M., Humm, K.C., Karnik, R., Mekhoubad, S., Regev, A., Eggan, K., Meissner, A., DNA methylation dynamics of the human preimplantation embryo (2014) Nature, 511 (7511), pp. 611-615. , (PMCID 4178976); Smith, Z.D., Chan, M.M., Mikkelsen, T.S., Gu, H., Gnirke, A., Regev, A., Meissner, A., A unique regulatory phase of DNA methylation in the early mammalian embryo (2012) Nature, 484 (7394), pp. 339-344. , (PMCID 3331945); Lee, M.T., Bonneau, A.R., Giraldez, A.J., Zygotic genome activation during the maternal-to-zygotic transition (2014) Annu. Rev. Cell Dev. Biol., 30, pp. 581-613; Tadros, W., Lipshitz, H.D., The maternal-to-zygotic transition: a play in two acts (2009) Development, 136 (18), pp. 3033-3042; Solter, D., From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research (2006) Nat. Rev. Genet., 7 (4), pp. 319-327; Newport, J., Kirschner, M., A major developmental transition in early Xenopus embryos: I. characterization and timing of cellular changes at the midblastula stage (1982) Cell, 30 (3), pp. 675-686; Borchers, A., Pieler, T., Programming pluripotent precursor cells derived from Xenopus embryos to generate specific tissues and organs (2010) Genes (Basel), 1 (3), pp. 413-426. , (PMCID 3966229); Kohli, R.M., Zhang, Y., TET enzymes, TDG and the dynamics of DNA demethylation (2013) Nature, 502 (7472), pp. 472-479. , (PMCID 4046508); Luna-Zurita, L., Bruneau, B.G., Chromatin modulators as facilitating factors in cellular reprogramming (2013) Curr. Opin. Genet. Dev., 23 (5), pp. 556-561; Simon, J.A., Kingston, R.E., Mechanisms of polycomb gene silencing: knowns and unknowns (2009) Nat. Rev. Mol. Cell Biol., 10 (10), pp. 697-708; Voigt, P., Tee, W.W., Reinberg, D., A double take on bivalent promoters (2013) Genes Dev., 27 (12), pp. 1318-1338. , (PMCID 3701188); Shilatifard, A., The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis (2012) Annu. Rev. Biochem., 81, pp. 65-95. , (PMCID 4010150); Marks, H., Stunnenberg, H.G., Transcription regulation and chromatin structure in the pluripotent ground state (2014) Biochim. Biophys. Acta, 1839 (3), pp. 129-137; Welling, M., Geijsen, N., Uncovering the true identity of naive pluripotent stem cells (2013) Trends Cell Biol., 23 (9), pp. 442-448; Bernstein, B.E., Meissner, A., Lander, E.S., The mammalian epigenome (2007) Cell, 128 (4), pp. 669-681; Bird, A., DNA methylation patterns and epigenetic memory (2002) Genes Dev., 16 (1), pp. 6-21; Bogdanovic, O., Veenstra, G.J., DNA methylation and methyl-CpG binding proteins: developmental requirements and function (2009) Chromosoma, 118 (5), pp. 549-565. , (PMCID 2729420); Li, E., Bestor, T.H., Jaenisch, R., Targeted mutation of the DNA methyltransferase gene results in embryonic lethality (1992) Cell, 69 (6), pp. 915-926; Okano, M., Bell, D.W., Haber, D.A., Li, E., DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development (1999) Cell, 99 (3), pp. 247-257; Piccolo, F.M., Fisher, A.G., Getting rid of DNA methylation (2014) Trends Cell Biol., 24 (2), pp. 136-143; He, Y.F., Li, B.Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Xu, G.L., Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA (2011) Science, 333 (6047), pp. 1303-1307. , (PMCID 3462231); Ito, S., Shen, L., Dai, Q., Wu, S.C., Collins, L.B., Swenberg, J.A., He, C., Zhang, Y., Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine (2011) Science, 333 (6047), pp. 1300-1303. , (PMCID 3495246); Deaton, A.M., Bird, A., CpG islands and the regulation of transcription (2011) Genes Dev., 25 (10), pp. 1010-1022. , (PMCID 3093116); Messerschmidt, D.M., Knowles, B.B., Solter, D., DNA methylation dynamics during epigenetic reprogramming in the germline and preimplantation embryos (2014) Genes Dev., 28 (8), pp. 812-828. , (PMCID 4003274); Mayer, W., Niveleau, A., Walter, J., Fundele, R., Haaf, T., Demethylation of the zygotic paternal genome (2000) Nature, 403 (6769), pp. 501-502; Oswald, J., Engemann, S., Lane, N., Mayer, W., Olek, A., Fundele, R., Dean, W., Walter, J., Active demethylation of the paternal genome in the mouse zygote (2000) Curr. Biol., 10 (8), pp. 475-478; Gu, T.P., Guo, F., Yang, H., Wu, H.P., Xu, G.F., Liu, W., Xie, Z.G., Xu, G.L., The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes (2011) Nature, 477 (7366), pp. 606-610; Iqbal, K., Jin, S.G., Pfeifer, G.P., Szabo, P.E., Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine (2011) Proc. Natl. Acad. Sci. U. S. A., 108 (9), pp. 3642-3647. , (PMCID 3048122); Inoue, A., Zhang, Y., Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos (2011) Science, 334 (6053), p. 194. , (PMCID 3799877); Dawlaty, M.M., Ganz, K., Powell, B.E., Hu, Y.C., Markoulaki, S., Cheng, A.W., Gao, Q., Jaenisch, R., Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development (2011) Cell Stem Cell, 9 (2), pp. 166-175. , (PMCID 3154739); Ito, S., D'Alessio, A.C., Taranova, O.V., Hong, K., Sowers, L.C., Zhang, Y., Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification (2010) Nature, 466 (7310), pp. 1129-1133. , (PMCID 3491567); Williams, K., Christensen, J., Pedersen, M.T., Johansen, J.V., Cloos, P.A., Rappsilber, J., Helin, K., TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity (2011) Nature, 473 (7347), pp. 343-348. , (PMCID Pmc3408592); Koh, K.P., Yabuuchi, A., Rao, S., Huang, Y., Cunniff, K., Nardone, J., Laiho, A., Rao, A., Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells (2011) Cell Stem Cell, 8 (2), pp. 200-213. , (PMCID 3134318); Bocker, M.T., Tuorto, F., Raddatz, G., Musch, T., Yang, F.C., Xu, M., Lyko, F., Breiling, A., Hydroxylation of 5-methylcytosine by TET2 maintains the active state of the mammalian HOXA cluster (2012) Nat. Commun., 3, p. 818. , (PMCID 3576573); Ficz, G., Branco, M.R., Seisenberger, S., Santos, F., Krueger, F., Hore, T.A., Marques, C.J., Reik, W., Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation (2011) Nature, 473 (7347), pp. 398-402; Santos, F., Hendrich, B., Reik, W., Dean, W., Dynamic reprogramming of DNA methylation in the early mouse embryo (2002) Dev. Biol., 241 (1), pp. 172-182; Tsumura, A., Hayakawa, T., Kumaki, Y., Takebayashi, S., Sakaue, M., Matsuoka, C., Shimotohno, K., Okano, M., Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b (2006) Genes Cells, 11 (7), pp. 805-814; Long, H.K., Sims, D., Heger, A., Blackledge, N.P., Kutter, C., Wright, M.L., Grutzner, F., Klose, R.J., Epigenetic conservation at gene regulatory elements revealed by non-methylated DNA profiling in seven vertebrates (2013) Elife, 2, p. e00348. , (PMCID 3583005); Bogdanovic, O., Long, S.W., van Heeringen, S.J., Brinkman, A.B., Gomez-Skarmeta, J.L., Stunnenberg, H.G., Jones, P.L., Veenstra, G.J., Temporal uncoupling of the DNA methylome and transcriptional repression during embryogenesis (2011) Genome Res., 21 (8), pp. 1313-1327. , (PMCID 3149498); van Heeringen, S.J., Akhtar, W., Jacobi, U.G., Akkers, R.C., Suzuki, Y., Veenstra, G.J., Nucleotide composition-linked divergence of vertebrate core promoter architecture (2011) Genome Res., 21 (3), pp. 410-421. , (PMCID 3044855); Jiang, L., Zhang, J., Wang, J.J., Wang, L., Zhang, L., Li, G., Yang, X., Liu, J., Sperm, but not oocyte, DNA methylome is inherited by zebrafish early embryos (2013) Cell, 153 (4), pp. 773-784. , (PMCID 4081501); Potok, M.E., Nix, D.A., Parnell, T.J., Cairns, B.R., Reprogramming the maternal zebrafish genome after fertilization to match the paternal methylation pattern (2013) Cell, 153 (4), pp. 759-772. , (PMCID 4030421); Macleod, D., Clark, V.H., Bird, A., Absence of genome-wide changes in DNA methylation during development of the zebrafish (1999) Nat. Genet., 23 (2), pp. 139-140; Veenstra, G.J., Wolffe, A.P., Constitutive genomic methylation during embryonic development of Xenopus (2001) Biochim. Biophys. Acta, 1521 (1-3), pp. 39-44; Stancheva, I., Meehan, R.R., Transient depletion of xDnmt1 leads to premature gene activation in Xenopus embryos (2000) Genes Dev., 14 (3), pp. 313-327. , (PMCID 316362); Dunican, D.S., Ruzov, A., Hackett, J.A., Meehan, R.R., XDnmt1 regulates transcriptional silencing in pre-MBT Xenopus embryos independently of its catalytic function (2008) Development, 135 (7), pp. 1295-1302; Xu, Y., Xu, C., Kato, A., Tempel, W., Abreu, J.G., Bian, C., Hu, Y., Kaiser, U.B., Tet3 CXXC domain and dioxygenase activity cooperatively regulate key genes for Xenopus eye and neural development (2012) Cell, 151 (6), pp. 1200-1213. , (PMCID 3705565); Spruijt, C.G., Vermeulen, M., DNA methylation: old dog, new tricks? (2014) Nat. Struct. Mol. Biol., 21 (11), pp. 949-954; Hammoud, S.S., Low, D.H., Yi, C., Carrell, D.T., Guccione, E., Cairns, B.R., Chromatin and transcription transitions of mammalian adult germline stem cells and spermatogenesis (2014) Cell Stem Cell, 15 (2), pp. 239-253; Rishi, V., Bhattacharya, P., Chatterjee, R., Rozenberg, J., Zhao, J., Glass, K., Fitzgerald, P., Vinson, C., CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes (2010) Proc. Natl. Acad. Sci. U. S. A., 107 (47), pp. 20311-20316. , (PMCID 2996703); Spruijt, C.G., Gnerlich, F., Smits, A.H., Pfaffeneder, T., Jansen, P.W., Bauer, C., Munzel, M., Carell, T., Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives (2013) Cell, 152 (5), pp. 1146-1159; Fouse, S.D., Shen, Y., Pellegrini, M., Cole, S., Meissner, A., Van Neste, L., Jaenisch, R., Fan, G., Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation (2008) Cell Stem Cell, 2 (2), pp. 160-169. , (PMCID 3070208); Habibi, E., Brinkman, A.B., Arand, J., Kroeze, L.I., Kerstens, H.H., Matarese, F., Lepikhov, K., Stunnenberg, H.G., Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells (2013) Cell Stem Cell, 13 (3), pp. 360-369; Leitch, H.G., McEwen, K.R., Turp, A., Encheva, V., Carroll, T., Grabole, N., Mansfield, W., Hajkova, P., Naive pluripotency is associated with global DNA hypomethylation (2013) Nat. Struct. Mol. Biol., 20 (3), pp. 311-316. , (PMCID 3591483); van Heeringen, S.J., Akkers, R.C., van Kruijsbergen, I., Arif, M.A., Hanssen, L.L., Sharifi, N., Veenstra, G.J., Principles of nucleation of H3K27 methylation during embryonic development (2014) Genome Res., 24 (3), pp. 401-410. , (PMCID 3941105); Lienert, F., Wirbelauer, C., Som, I., Dean, A., Mohn, F., Schubeler, D., Identification of genetic elements that autonomously determine DNA methylation states (2011) Nat. Genet., 43 (11), pp. 1091-1097; Lee, D.S., Shin, J.Y., Tonge, P.D., Puri, M.C., Lee, S., Park, H., Lee, W.C., Rhee, H., An epigenomic roadmap to induced pluripotency reveals DNA methylation as a reprogramming modulator (2014) Nat. Commun., 5, p. 5619; Bannister, A.J., Kouzarides, T., Regulation of chromatin by histone modifications (2011) Cell Res., 21 (3), pp. 381-395. , (PMCID 3193420); Margueron, R., Reinberg, D., Chromatin structure and the inheritance of epigenetic information (2010) Nat. Rev. Genet., 11 (4), pp. 285-296. , (PMCID 3760772); Bogdanovic, O., van Heeringen, S.J., Veenstra, G.J., The epigenome in early vertebrate development (2012) Genesis, 50 (3), pp. 192-206. , (PMCID 3294079); Lessard, J.A., Crabtree, G.R., Chromatin regulatory mechanisms in pluripotency (2010) Annu. Rev. Cell Dev. Biol., 26, pp. 503-532. , (PMCID 3085914); Wen, B., Wu, H., Shinkai, Y., Irizarry, R.A., Feinberg, A.P., Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells (2009) Nat. Genet., 41 (2), pp. 246-250. , (PMCID 2632725); Mikkelsen, T.S., Ku, M., Jaffe, D.B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Nusbaum, C., Genome-wide maps of chromatin state in pluripotent and lineage-committed cells (2007) Nature, 448 (7153), pp. 553-560. , (PMCID 2921165); Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., Lander, E.S., A bivalent chromatin structure marks key developmental genes in embryonic stem cells (2006) Cell, 125 (2), pp. 315-326; Schuettengruber, B., Chourrout, D., Vervoort, M., Leblanc, B., Cavalli, G., Genome regulation by polycomb and trithorax proteins (2007) Cell, 128 (4), pp. 735-745; Wang, P., Lin, C., Smith, E.R., Guo, H., Sanderson, B.W., Wu, M., Gogol, M., Shilatifard, A., Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II (2009) Mol. Cell. Biol., 29 (22), pp. 6074-6085. , (PMCID 2772563); Hu, D., Garruss, A.S., Gao, X., Morgan, M.A., Cook, M., Smith, E.R., Shilatifard, A., The Mll2 branch of the COMPASS family regulates bivalent promoters in mouse embryonic stem cells (2013) Nat. Struct. Mol. Biol., 20 (9), pp. 1093-1097. , (PMCID 3805109); Denissov, S., Hofemeister, H., Marks, H., Kranz, A., Ciotta, G., Singh, S., Anastassiadis, K., Stewart, A.F., Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant (2014) Development, 141 (3), pp. 526-537; Schmitges, F.W., Prusty, A.B., Faty, M., Stutzer, A., Lingaraju, G.M., Aiwazian, J., Sack, R., Fischle, W., Histone methylation by PRC2 is inhibited by active chromatin marks (2011) Mol. Cell, 42 (3), pp. 330-341; Marks, H., Kalkan, T., Menafra, R., Denissov, S., Jones, K., Hofemeister, H., Nichols, J., Stunnenberg, H.G., The transcriptional and epigenomic foundations of ground state pluripotency (2012) Cell, 149 (3), pp. 590-604. , (PMCID 3398752); Hong, S.H., Rampalli, S., Lee, J.B., McNicol, J., Collins, T., Draper, J.S., Bhatia, M., Cell fate potential of human pluripotent stem cells is encoded by histone modifications (2011) Cell Stem Cell, 9 (1), pp. 24-36; Voigt, P., LeRoy, G., Drury, W.J., Zee, B.M., Son, J., Beck, D.B., Young, N.L., Reinberg, D., Asymmetrically modified nucleosomes (2012) Cell, 151 (1), pp. 181-193. , (PMCID 3498816); Rugg-Gunn, P.J., Cox, B.J., Ralston, A., Rossant, J., Distinct histone modifications in stem cell lines and tissue lineages from the early mouse embryo (2010) Proc. Natl. Acad. Sci. U. S. A., 107 (24), pp. 10783-10790. , (PMCID 2890770); Dahl, J.A., Reiner, A.H., Klungland, A., Wakayama, T., Collas, P., Histone H3 lysine 27 methylation asymmetry on developmentally-regulated promoters distinguish the first two lineages in mouse preimplantation embryos (2010) PLoS One, 5 (2), p. e9150. , (PMCID 2818844); Akkers, R.C., van Heeringen, S.J., Jacobi, U.G., Janssen-Megens, E.M., Francoijs, K.J., Stunnenberg, H.G., Veenstra, G.J., A hierarchy of H3K4me3 and H3K27me3 acquisition in spatial gene regulation in Xenopus embryos (2009) Dev. Cell, 17 (3), pp. 425-434. , (PMCID 2746918); Lim, J.W., Hummert, P., Mills, J.C., Kroll, K.L., Geminin cooperates with Polycomb to restrain multi-lineage commitment in the early embryo (2011) Development, 138 (1), pp. 33-44. , (PMCID 2998164); Schneider, T.D., Arteaga-Salas, J.M., Mentele, E., David, R., Nicetto, D., Imhof, A., Rupp, R.A., Stage-specific histone modification profiles reveal global transitions in the Xenopus embryonic epigenome (2011) PLoS One, 6 (7), p. e22548. , (PMCID 3142184); Vastenhouw, N.L., Zhang, Y., Woods, I.G., Imam, F., Regev, A., Liu, X.S., Rinn, J., Schier, A.F., Chromatin signature of embryonic pluripotency is established during genome activation (2010) Nature, 464 (7290), pp. 922-926. , (PMCID 2874748); Lindeman, L.C., Andersen, I.S., Reiner, A.H., Li, N., Aanes, H., Ostrup, O., Winata, C., Collas, P., Prepatterning of developmental gene expression by modified histones before zygotic genome activation (2011) Dev. Cell, 21 (6), pp. 993-1004; Heintzman, N.D., Stuart, R.K., Hon, G., Fu, Y., Ching, C.W., Hawkins, R.D., Barrera, L.O., Ren, B., Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome (2007) Nat. Genet., 39 (3), pp. 311-318; Creyghton, M.P., Cheng, A.W., Welstead, G.G., Kooistra, T., Carey, B.W., Steine, E.J., Hanna, J., Jaenisch, R., Histone H3K27ac separates active from poised enhancers and predicts developmental state (2010) Proc. Natl. Acad. Sci. U. S. A., 107 (50), pp. 21931-21936. , (PMCID 3003124); Heintzman, N.D., Hon, G.C., Hawkins, R.D., Kheradpour, P., Stark, A., Harp, L.F., Ye, Z., Kellis, M., Histone modifications at human enhancers reflect global cell-type-specific gene expression (2009) Nature, 459 (7243), pp. 108-112. , (PMCID 2910248); Visel, A., Blow, M.J., Li, Z., Zhang, T., Akiyama, J.A., Holt, A., Plajzer-Frick, I., Pennacchio, L.A., ChIP-seq accurately predicts tissue-specific activity of enhancers (2009) Nature, 457 (7231), pp. 854-858. , (PMCID 2745234); Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S.A., Flynn, R.A., Wysocka, J., A unique chromatin signature uncovers early developmental enhancers in humans (2011) Nature, 470 (7333), pp. 279-283; Calo, E., Wysocka, J., Modification of enhancer chromatin: what, how, and why? (2013) Mol. Cell, 49 (5), pp. 825-837. , (PMCID 3857148); Herz, H.M., Mohan, M., Garruss, A.S., Liang, K., Takahashi, Y.H., Mickey, K., Voets, O., Shilatifard, A., Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4 (2012) Genes Dev., 26 (23), pp. 2604-2620. , (PMCID 3521626); Hu, D., Gao, X., Morgan, M.A., Herz, H.M., Smith, E.R., Shilatifard, A., The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers (2013) Mol. Cell. Biol., 33 (23), pp. 4745-4754. , (PMCID 3838007); Lee, J.E., Wang, C., Xu, S., Cho, Y.W., Wang, L., Feng, X., Baldridge, A., Ge, K., H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation (2013) Elife, 2, p. e01503. , (PMCID 3869375); Bogdanovic, O., Fernandez-Minan, A., Tena, J.J., de la Calle-Mustienes, E., Hidalgo, C., van Kruysbergen, I., van Heeringen, S.J., Gomez-Skarmeta, J.L., Dynamics of enhancer chromatin signatures mark the transition from pluripotency to cell specification during embryogenesis (2012) Genome Res., 22 (10), pp. 2043-2053. , (PMCID 3460198); Banaszynski, L.A., Allis, C.D., Lewis, P.W., Histone variants in metazoan development (2010) Dev. Cell, 19 (5), pp. 662-674. , (PMCID 3033583); Kamakaka, R.T., Biggins, S., Histone variants: deviants? (2005) Genes Dev., 19 (3), pp. 295-310; Skene, P.J., Henikoff, S., Histone variants in pluripotency and disease (2013) Development, 140 (12), pp. 2513-2524; Hu, G., Cui, K., Northrup, D., Liu, C., Wang, C., Tang, Q., Ge, K., Zhao, K., H2A.Z facilitates access of active and repressive complexes to chromatin in embryonic stem cell self-renewal and differentiation (2013) Cell Stem Cell, 12 (2), pp. 180-192. , (PMCID 3570599); Jullien, J., Astrand, C., Szenker, E., Garrett, N., Almouzni, G., Gurdon, J.B., HIRA dependent H3.3 deposition is required for transcriptional reprogramming following nuclear transfer to Xenopus oocytes (2012) Epigenetics Chromatin, 5 (1), p. 17. , (PMCID 3538669); Lim, C.Y., Reversade, B., Knowles, B.B., Solter, D., Optimal histone H3 to linker histone H1 chromatin ratio is vital for mesodermal competence in Xenopus (2013) Development, 140 (4), pp. 853-860; Steinbach, O.C., Wolffe, A.P., Rupp, R.A., Somatic linker histones cause loss of mesodermal competence in Xenopus (1997) Nature, 389 (6649), pp. 395-399; Zhang, Y., Cooke, M., Panjwani, S., Cao, K., Krauth, B., Ho, P.Y., Medrzycki, M., Fan, Y., Histone h1 depletion impairs embryonic stem cell differentiation (2012) PLoS Genet., 8 (5), p. e1002691. , (PMCID 3349736); Hargreaves, D.C., Crabtree, G.R., ATP-dependent chromatin remodeling: genetics, genomics and mechanisms (2011) Cell Res., 21 (3), pp. 396-420. , (PMCID 3110148); Saladi, S.V., de la Serna, I.L., ATP dependent chromatin remodeling enzymes in embryonic stem cells (2010) Stem Cell Rev., 6 (1), pp. 62-73. , (PMCID 2862992); Bultman, S., Gebuhr, T., Yee, D., La Mantia, C., Nicholson, J., Gilliam, A., Randazzo, F., Magnuson, T., A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes (2000) Mol. Cell, 6 (6), pp. 1287-1295; Ho, L., Ronan, J.L., Wu, J., Staahl, B.T., Chen, L., Kuo, A., Lessard, J., Crabtree, G.R., An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency (2009) Proc. Natl. Acad. Sci. U. S. A., 106 (13), pp. 5181-5186. , (PMCID 2654396); Kidder, B.L., Palmer, S., Knott, J.G., SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells (2009) Stem Cells, 27 (2), pp. 317-328; Ho, L., Miller, E.L., Ronan, J.L., Ho, W.Q., Jothi, R., Crabtree, G.R., EsBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function (2011) Nat. Cell Biol., 13 (8), pp. 903-913. , (PMCID Pmc3155811); Gaspar-Maia, A., Alajem, A., Polesso, F., Sridharan, R., Mason, M.J., Heidersbach, A., Ramalho-Santos, J., Ramalho-Santos, M., Chd1 regulates open chromatin and pluripotency of embryonic stem cells (2009) Nature, 460 (7257), pp. 863-868. , (PMCID 3891576); Guzman-Ayala, M., Sachs, M., Koh, F.M., Onodera, C., Bulut-Karslioglu, A., Lin, C.J., Wong, P., Ramalho-Santos, M., Chd1 is essential for the high transcriptional output and rapid growth of the mouse epiblast (2015) Development, 142 (1), pp. 118-127. , (PMCID Pmc4299150); Wade, P.A., Jones, P.L., Vermaak, D., Wolffe, A.P., A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase (1998) Curr. Biol., 8 (14), pp. 843-846; Kaji, K., Caballero, I.M., MacLeod, R., Nichols, J., Wilson, V.A., Hendrich, B., The NuRD component Mbd3 is required for pluripotency of embryonic stem cells (2006) Nat. Cell Biol., 8 (3), pp. 285-292; Reynolds, N., Latos, P., Hynes-Allen, A., Loos, R., Leaford, D., O'Shaughnessy, A., Mosaku, O., Hendrich, B., NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment (2012) Cell Stem Cell, 10 (5), pp. 583-594. , (PMCID Pmc3402183); Yildirim, O., Li, R., Hung, J.H., Chen, P.B., Dong, X., Ee, L.S., Weng, Z., Fazzio, T.G., Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells (2011) Cell, 147 (7), pp. 1498-1510. , (PMCID Pmc3252821); Kaji, K., Nichols, J., Hendrich, B., Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells (2007) Development, 134 (6), pp. 1123-1132; dos Santos, R.L., Tosti, L., Radzisheuskaya, A., Caballero, I.M., Kaji, K., Hendrich, B., Silva, J.C., MBD3/NuRD facilitates induction of pluripotency in a context-dependent manner (2014) Cell Stem Cell, 15 (1), pp. 102-110. , (PMCID 4082719); Luo, M., Ling, T., Xie, W., Sun, H., Zhou, Y., Zhu, Q., Shen, M., Grummt, I., NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells (2013) Stem Cells, 31 (7), pp. 1278-1286; Wang, L., Du, Y., Ward, J.M., Shimbo, T., Lackford, B., Zheng, X., Miao, Y.L., Hu, G., INO80 facilitates pluripotency gene activation in embryonic stem cell self-renewal, reprogramming, and blastocyst development (2014) Cell Stem Cell, 14 (5), pp. 575-591. , (PMCID 4154226); Boyer, L.A., Lee, T.I., Cole, M.F., Johnstone, S.E., Levine, S.S., Zucker, J.P., Guenther, M.G., Young, R.A., Core transcriptional regulatory circuitry in human embryonic stem cells (2005) Cell, 122 (6), pp. 947-956. , (PMCID 3006442); Loh, Y.H., Wu, Q., Chew, J.L., Vega, V.B., Zhang, W., Chen, X., Bourque, G., Wei, C.L., The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells (2006) Nat. Genet., 38 (4), pp. 431-440; Tutter, A.V., Kowalski, M.P., Baltus, G.A., Iourgenko, V., Labow, M., Li, E., Kadam, S., Role for Med12 in regulation of Nanog and Nanog target genes (2009) J. Biol. Chem., 284 (6), pp. 3709-3718; Dunn, S.J., Martello, G., Yordanov, B., Emmott, S., Smith, A.G., Defining an essential transcription factor program for naive pluripotency (2014) Science, 344 (6188), pp. 1156-1160. , (PMCID 4257066); Takashima, Y., Guo, G., Loos, R., Nichols, J., Ficz, G., Krueger, F., Oxley, D., Smith, A., Resetting transcription factor control circuitry toward ground-state pluripotency in human (2014) Cell, 158 (6), pp. 1254-1269. , (PMCID 4162745); Jiang, J., Chan, Y.S., Loh, Y.H., Cai, J., Tong, G.Q., Lim, C.A., Robson, P., Ng, H.H., A core Klf circuitry regulates self-renewal of embryonic stem cells (2008) Nat. Cell Biol., 10 (3), pp. 353-360; Buecker, C., Srinivasan, R., Wu, Z., Calo, E., Acampora, D., Faial, T., Simeone, A., Wysocka, J., Reorganization of enhancer patterns in transition from naive to primed pluripotency (2014) Cell Stem Cell, 14 (6), pp. 838-853; Yang, S.H., Kalkan, T., Morissroe, C., Marks, H., Stunnenberg, H., Smith, A., Sharrocks, A.D., Otx2 and Oct4 drive early enhancer activation during embryonic stem cell transition from naive pluripotency (2014) Cell Rep., 7 (6), pp. 1968-1981. , (PMCID 4074343); Lim, L.S., Hong, F.H., Kunarso, G., Stanton, L.W., The pluripotency regulator Zic3 is a direct activator of the Nanog promoter in ESCs (2010) Stem Cells, 28 (11), pp. 1961-1969; Lim, L.S., Loh, Y.H., Zhang, W., Li, Y., Chen, X., Wang, Y., Bakre, M., Stanton, L.W., Zic3 is required for maintenance of pluripotency in embryonic stem cells (2007) Mol. Biol. Cell, 18 (4), pp. 1348-1358. , (PMCID 1838990); Winata, C.L., Kondrychyn, I., Kumar, V., Srinivasan, K.G., Orlov, Y., Ravishankar, A., Prabhakar, S., Mathavan, S., Genome wide analysis reveals Zic3 interaction with distal regulatory elements of stage specific developmental genes in zebrafish (2013) PLoS Genet., 9 (10), p. e1003852. , (PMCID 3814314); Nakata, K., Nagai, T., Aruga, J., Mikoshiba, K., Xenopus Zic3, a primary regulator both in neural and neural crest development (1997) Proc. Natl. Acad. Sci. U. S. A., 94 (22), pp. 11980-11985. , (PMCID 23676); Han, D.W., Tapia, N., Joo, J.Y., Greber, B., Arauzo-Bravo, M.J., Bernemann, C., Ko, K., Scholer, H.R., Epiblast stem cell subpopulations represent mouse embryos of distinct pregastrulation stages (2010) Cell, 143 (4), pp. 617-627; Kojima, Y., Kaufman-Francis, K., Studdert, J.B., Steiner, K.A., Power, M.D., Loebel, D.A., Jones, V., Tam, P.P., The transcriptional and functional properties of mouse epiblast stem cells resemble the anterior primitive streak (2014) Cell Stem Cell, 14 (1), pp. 107-120; Pijnappel, W.W., Esch, D., Baltissen, M.P., Wu, G., Mischerikow, N., Bergsma, A.J., van der Wal, E., Timmers, H.T., A central role for TFIID in the pluripotent transcription circuitry (2013) Nature, 495 (7442), pp. 516-519; Frankenberg, S.R., Frank, D., Harland, R., Johnson, A.D., Nichols, J., Niwa, H., Scholer, H.R., Brickman, J.M., The POU-er of gene nomenclature (2014) Development, 141 (15), pp. 2921-2923; Hinkley, C.S., Martin, J.F., Leibham, D., Perry, M., Sequential expression of multiple POU proteins during amphibian early development (1992) Mol. Cell. Biol., 12 (2), pp. 638-649. , (PMCID 364253); Scerbo, P., Girardot, F., Vivien, C., Markov, G.V., Luxardi, G., Demeneix, B., Kodjabachian, L., Coen, L., Ventx factors function as Nanog-like guardians of developmental potential in Xenopus (2012) PLoS One, 7 (5), p. e36855. , (PMCID 3351468); Collart, C., Owens, N.D., Bhaw-Rosun, L., Cooper, B., De Domenico, E., Patrushev, I., Sesay, A.K., Gilchrist, M.J., High-resolution analysis of gene activity during the Xenopus mid-blastula transition (2014) Development, 141 (9), pp. 1927-1939. , (PMCID 3994770); Smits, A.H., Lindeboom, R.G., Perino, M., van Heeringen, S.J., Veenstra, G.J., Vermeulen, M., Global absolute quantification reveals tight regulation of protein expression in single Xenopus eggs (2014) Nucleic Acids Res., 42 (15), pp. 9880-9891; Cao, Y., Siegel, D., Donow, C., Knochel, S., Yuan, L., Knochel, W., POU-V factors antagonize maternal VegT activity and beta-catenin signaling in Xenopus embryos (2007) EMBO J., 26 (12), pp. 2942-2954. , (PMCID 1894774); Cao, Y., Siegel, D., Oswald, F., Knochel, W., Oct25 represses transcription of nodal/activin target genes by interaction with signal transducers during Xenopus gastrulation (2008) J. Biol. Chem., 283 (49), pp. 34168-34177. , (PMCID 2662234); Gupta, R., Wills, A., Ucar, D., Baker, J., Developmental enhancers are marked independently of zygotic Nodal signals in Xenopus (2014) Dev. Biol., 395 (1), pp. 38-49; Chiu, W.T., Charney Le, R., Blitz, I.L., Fish, M.B., Li, Y., Biesinger, J., Xie, X., Cho, K.W., Genome-wide view of TGFbeta/Foxh1 regulation of the early mesendoderm program (2014) Development, 141 (23), pp. 4537-4547; Nicetto, D., Hahn, M., Jung, J., Schneider, T.D., Straub, T., David, R., Schotta, G., Rupp, R.A., Suv4-20h histone methyltransferases promote neuroectodermal differentiation by silencing the pluripotency-associated Oct-25 gene (2013) PLoS Genet., 9 (1), p. e1003188. , (PMCID 3561085); Lee, M.T., Bonneau, A.R., Takacs, C.M., Bazzini, A.A., DiVito, K.R., Fleming, E.S., Giraldez, A.J., Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition (2013) Nature, 503 (7476), pp. 360-364. , (PMCID 3925760); Leichsenring, M., Maes, J., Mossner, R., Driever, W., Onichtchouk, D., Pou5f1 transcription factor controls zygotic gene activation in vertebrates (2013) Science, 341 (6149), pp. 1005-1009; Wu, G., Han, D., Gong, Y., Sebastiano, V., Gentile, L., Singhal, N., Adachi, K., Scholer, H.R., Establishment of totipotency does not depend on Oct4A (2013) Nat. Cell Biol., 15 (9), pp. 1089-1097. , (PMCID 3845671); Wu, G., Scholer, H.R., Role of Oct4 in the early embryo development (2014) Cell Regen. (Lond.), 3 (1), p. 7. , (PMCID 4230828); Guttman, M., Amit, I., Garber, M., French, C., Lin, M.F., Feldser, D., Huarte, M., Lander, E.S., Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals (2009) Nature, 458 (7235), pp. 223-227. , (PMCID 2754849); Guttman, M., Donaghey, J., Carey, B.W., Garber, M., Grenier, J.K., Munson, G., Young, G., Lander, E.S., LincRNAs act in the circuitry controlling pluripotency and differentiation (2011) Nature, 477 (7364), pp. 295-300. , (PMCID 3175327); Cifuentes-Rojas, C., Hernandez, A.J., Sarma, K., Lee, J.T., Regulatory interactions between RNA and polycomb repressive complex 2 (2014) Mol. Cell, 55 (2), pp. 171-185. , (PMCID 4107928); Davidovich, C., Zheng, L., Goodrich, K.J., Cech, T.R., Promiscuous RNA binding by Polycomb repressive complex 2 (2013) Nat. Struct. Mol. Biol., 20 (11), pp. 1250-1257. , (PMCID 3823624); Lin, N., Chang, K.Y., Li, Z., Gates, K., Rana, Z.A., Dang, J., Zhang, D., Rana, T.M., An evolutionarily conserved long noncoding RNA TUNA controls pluripotency and neural lineage commitment (2014) Mol. Cell, 53 (6), pp. 1005-1019. , (PMCID 4010157); Di Ruscio, A., Ebralidze, A.K., Benoukraf, T., Amabile, G., Goff, L.A., Terragni, J., Figueroa, M.E., Tenen, D.G., DNMT1-interacting RNAs block gene-specific DNA methylation (2013) Nature, 503 (7476), pp. 371-376. , (PMCID 3870304); Yang, Y.W., Flynn, R.A., Chen, Y., Qu, K., Wan, B., Wang, K.C., Lei, M., Chang, H.Y., Essential role of lncRNA binding for WDR5 maintenance of active chromatin and embryonic stem cell pluripotency (2014) Elife, 3, p. e02046. , (PMCID 3921674); Paranjpe, S.S., Jacobi, U.G., van Heeringen, S.J., Veenstra, G.J., A genome-wide survey of maternal and embryonic transcripts during Xenopus tropicalis development (2013) BMC Genomics, 14, p. 762. , (PMCID 3907017); Pauli, A., Valen, E., Lin, M.F., Garber, M., Vastenhouw, N.L., Levin, J.Z., Fan, L., Schier, A.F., Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis (2012) Genome Res., 22 (3), pp. 577-591. , (PMCID 3290793); Aanes, H., Winata, C.L., Lin, C.H., Chen, J.P., Srinivasan, K.G., Lee, S.G., Lim, A.Y., Mathavan, S., Zebrafish mRNA sequencing deciphers novelties in transcriptome dynamics during maternal to zygotic transition (2011) Genome Res., 21 (8), pp. 1328-1338. , (PMCID 3149499); Tan, M.H., Au, K.F., Yablonovitch, A.L., Wills, A.E., Chuang, J., Baker, J.C., Wong, W.H., Li, J.B., RNA sequencing reveals a diverse and dynamic repertoire of the Xenopus tropicalis transcriptome over development (2013) Genome Res., 23 (1), pp. 201-216. , (PMCID 3530680); Vesterlund, L., Jiao, H., Unneberg, P., Hovatta, O., Kere, J., The zebrafish transcriptome during early development (2011) BMC Dev. Biol., 11, p. 30. , (PMCID 3118190)",Review,Scopus,2-s2.0-84927626047
"Rodansky E.S., Johnson L.A., Huang S., Spence J.R., Higgins P.D.R.","Intestinal organoids: A model of intestinal fibrosis for evaluating anti-fibrotic drugs",2015,"Experimental and Molecular Pathology","98","3",,"346","351",,,10.1016/j.yexmp.2015.03.033,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926367272&partnerID=40&md5=fd4bae9a45c58b11aaf23f34274eee37","Division of Gastroenterology, Department of Internal Medicine, University of MichiganAnn Arbor, MI, United States; Department of Cell and Developmental Biology, University of MichiganAnn Arbor, MI, United States","Rodansky, E.S., Division of Gastroenterology, Department of Internal Medicine, University of MichiganAnn Arbor, MI, United States; Johnson, L.A., Division of Gastroenterology, Department of Internal Medicine, University of MichiganAnn Arbor, MI, United States; Huang, S., Division of Gastroenterology, Department of Internal Medicine, University of MichiganAnn Arbor, MI, United States; Spence, J.R., Division of Gastroenterology, Department of Internal Medicine, University of MichiganAnn Arbor, MI, United States, Department of Cell and Developmental Biology, University of MichiganAnn Arbor, MI, United States; Higgins, P.D.R., Division of Gastroenterology, Department of Internal Medicine, University of MichiganAnn Arbor, MI, United States","Background & aims: Intestinal fibrosis is a critical complication of Crohn's disease (CD). Current in vitro models of intestinal fibrosis cannot model the complex intestinal architecture, while in vivo rodent models do not fully recapitulate human disease and have limited utility for large-scale screening. Here, we exploit recent advances in stem cell derived human intestinal organoids (HIOs) as a new human model of fibrosis in CD. Methods: Human pluripotent stem cells were differentiated into HIOs. We identified myofibroblasts, the key effector cells of fibrosis, by immunofluorescence staining for alpha-smooth muscle actin (αSMA), vimentin, and desmin. We examined the fibrogenic response of HIOs by treatment with transforming growth factor beta (TGFβ) in the presence or absence of the anti-fibrotic drug spironolactone. Fibrotic response was assayed by expression of fibrogenic genes (COL1A1 (collagen, type I, alpha 1), ACTA2 (alpha smooth muscle actin), FN1 (fibronectin 1), MYLK (myosin light chain kinase), and MKL1 (megakaryoblastic leukemia (translocation) 1)) and proteins (αSMA). Results: Immunofluorescent staining of organoids identified a population of myofibroblasts within the HIO mesenchyme. TGFβ stimulation of HIOs produced a dose-dependent pro-fibrotic response. Spironolactone treatment blocked the fibrogenic response of HIOs to TGFβ. Conclusions: HIOs contain myofibroblasts and respond to a pro-fibrotic stimulus in a manner that is consistent with isolated human myofibroblasts. HIOs are a promising model system that might bridge the gap between current in vitro and in vivo models of intestinal fibrosis in IBD. © 2015 Elsevier Inc.","Drug screening; Fibrosis model; Myofibroblasts; Organoid; TGFβ","Andres, P.G., Friedman, L.S., Epidemiology and the natural course of inflammatory bowel disease (1999) Gastroenterol. Clin. N. Am., 28, pp. 255-281. , (vii); Astashkina, A., Grainger, D.W., Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments (2014) Adv. Drug Deliv. Rev., pp. 1-18; Brenna, O., Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and transcriptomic [corrected] characterization and correlation to IBD (2013) PLoS One, 8, p. e54543; Chen, X., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases (2008) Cell Res., 18, pp. 997-1006; Chen, Y.J., De novo formation of insulin-producing ""neo-beta cell islets"" from intestinal crypts (2014) Cell Rep., 6, pp. 1046-1058; Collard, H.R., Burden of illness in idiopathic pulmonary fibrosis (2012) J. Med. Econ., 15, pp. 829-835; Collins, A.J., Excerpts from the US Renal Data System 2009 annual data report (2010) Am. J. Kidney Dis., 55, pp. A6-A7. , S1-420; Ersoy, R., The effects of irbesartan and spironolactone in prevention of peritoneal fibrosis in rats (2007) Perit. Dial. Int., 27, pp. 424-431; Grassl, G.A., Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis (2008) Gastroenterology, 134, pp. 768-780; Gullulu, M., Aldosterone blockage in proliferative glomerulonephritis prevents not only fibrosis, but proliferation as well (2006) Ren. Fail., 28, pp. 509-514; Hinz, B., The myofibroblast: paradigm for a mechanically active cell (2010) J. Biomech., 43, pp. 146-155; Horowitz, J.C., Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis (2012) Int. J. Biochem. Cell Biol., 44, pp. 158-169; Johnson, L.A., Spironolactone and colitis: increased mortality in rodents and in humans (2012) Inflamm. Bowel Dis., 18, pp. 1315-1324; Johnson, L.A., Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a ""Top-Down"" approach to intestinal fibrosis in mice (2012) Inflamm. Bowel Dis., 18, pp. 460-471; Johnson, L.A., CARD-024, a vitamin D analog, attenuates the pro-fibrotic response to substrate stiffness in colonic myofibroblasts (2012) Exp. Mol. Pathol., 93, pp. 91-98; Johnson, L.A., Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts (2013) Inflamm. Bowel Dis., 19, pp. 891-903; Johnson, L.A., Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-beta-induced fibrogenesis in human colonic myofibroblasts (2014) Inflamm. Bowel Dis., 20, pp. 154-165; Kim, K., Noninvasive ultrasound elasticity imaging (UEI) of Crohn's disease: animal model (2008) Ultrasound Med. Biol., 34, pp. 902-912; Leslie, J.L., Persistence and toxin production by Clostridium difficile within human intestinal organoids results in disruption of epithelial paracellular barrier function (2014) Infect. Immun., 83, pp. 138-145; Liu, F., Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression (2010) J. Cell Biol., 190, pp. 693-706; McCracken, K.W., Generating human intestinal tissue from pluripotent stem cells in vitro (2011) Nat. Protoc., 6, pp. 1920-1928; Mestas, J., Hughes, C.C., Of mice and not men: differences between mouse and human immunology (2004) J. Immunol., 172, pp. 2731-2738; Mih, J.D., A multiwell platform for studying stiffness-dependent cell biology (2011) PLoS One, 6, p. e19929; Neff, G.W., The current economic burden of cirrhosis (2011) Gastroenterol. Hepatol., 7, pp. 661-671; Neurath, M., TNBS-colitis (2000) Int. Rev. Immunol., 19, pp. 51-62; Nishimura, H., Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model (2008) Am. J. Physiol. Ren. Physiol., 294, pp. F1084-F1093; O'Connell, J.B., Bristow, M.R., Economic impact of heart failure in the United States: time for a different approach (1994) J. Heart Lung Transplant., 13, pp. S107-S112; Pitt, B., The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators (1999) N. Engl. J. Med., 341, pp. 709-717; Powell, D.W., Myofibroblasts. II. Intestinal subepithelial myofibroblasts (1999) Am. J. Physiol., 277, pp. C183-C201; Rajagopalan, S., Pitt, B., Aldosterone as a target in congestive heart failure (2003) Med. Clin. North Am., 87, pp. 441-457; Ranga, A., Drug discovery through stem cell-based organoid models (2014) Adv. Drug Deliv. Rev., pp. 19-28; Rieder, F., Wound healing and fibrosis in intestinal disease (2007) Gut, 56, pp. 130-139; Sands, B.E., Risk of early surgery for Crohn's disease: implications for early treatment strategies (2003) Am. J. Gastroenterol., 98, pp. 2712-2718; Spence, J.R., Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro (2011) Nature, 470, pp. 105-109",Article,Scopus,2-s2.0-84926367272
"Thompson A.C., Fallon J.B., Wise A.K., Wade S.A., Shepherd R.K., Stoddart P.R.","Infrared neural stimulation fails to evoke neural activity in the deaf guinea pig cochlea",2015,"Hearing Research","324",,,"46","53",,,10.1016/j.heares.2015.03.005,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928322281&partnerID=40&md5=301119419a9e0614198dabca4758a10a","Faculty of Science Engineering and Technology, Swinburne University of TechnologyHawthorn, Australia; Bionics InstituteEast Melbourne, Australia; Medical Bionics Department, University of MelbourneEast Melbourne, Australia; Department of Otolaryngology, University of MelbourneEast Melbourne, Australia","Thompson, A.C., Faculty of Science Engineering and Technology, Swinburne University of TechnologyHawthorn, Australia; Fallon, J.B., Bionics InstituteEast Melbourne, Australia, Medical Bionics Department, University of MelbourneEast Melbourne, Australia, Department of Otolaryngology, University of MelbourneEast Melbourne, Australia; Wise, A.K., Bionics InstituteEast Melbourne, Australia, Medical Bionics Department, University of MelbourneEast Melbourne, Australia, Department of Otolaryngology, University of MelbourneEast Melbourne, Australia; Wade, S.A., Faculty of Science Engineering and Technology, Swinburne University of TechnologyHawthorn, Australia; Shepherd, R.K., Bionics InstituteEast Melbourne, Australia, Medical Bionics Department, University of MelbourneEast Melbourne, Australia, Department of Otolaryngology, University of MelbourneEast Melbourne, Australia; Stoddart, P.R., Faculty of Science Engineering and Technology, Swinburne University of TechnologyHawthorn, Australia","At present there is some debate as to the processes by which infrared neural stimulation (INS) activates neurons in the cochlea, as the lasers used for INS can potentially generate a range of secondary stimuli e.g. an acoustic stimulus is produced when the light is absorbed by water. To clarify whether INS in the cochlea requires functioning hair cells and to explore the potential relevance to cochlear implants, experiments using INS were performed in the cochleae of both normal hearing and profoundly deaf guinea pigs. A response to laser stimulation was readily evoked in normal hearing cochlea. However, no response was evoked in any profoundly deaf cochleae, for either acute or chronic deafening, contrary to previous work where a response was observed after acute deafening with ototoxic drugs. A neural response to electrical stimulation was readily evoked in all cochleae after deafening. The absence of a response from optical stimuli in profoundly deaf cochleae suggests that the response from INS in the cochlea is hair cell mediated. © 2015 Elsevier B.V.",,"Albert, E.S., Bec, J.-M., Desmadryl, G., Chekroud, K., Travo, C., Gaboyard, S., Bardin, F., Chabbert, C., TRPV4 channels mediate the infrared laser evoked response in sensory neurons (2012) J.Neurophysiol., 107 (12), pp. 3227-3234; Brown, W.G.A., Needham, K., Nayagam, B.A., Stoddart, P.R., Whole cell patch clamp for investigating the mechanisms of infrared neural stimulation (2013) J.Vis. Exp., 77; Cayce, J.M., Friedman, R.M., Chen, G., Jansen, E.D., Mahadevan-Jansen, A., Roe, A.W., Infrared neural stimulation of primary visual cortex in non-human primates (2014) NeuroImage, 84, pp. 181-190; Chernov, M., Roe, A.W., Infrared neural stimulation: a new stimulation tool for central nervous system applications (2014) Neurophotonics, 1 (1). , 011011-011011; Coco, A., Epp, S.B., Fallon, J.B., Xu, J., Millard, R.E., Shepherd, R.K., Does cochlear implantation and electrical stimulation affect residual hair cells and spiral ganglion neurons? (2007) Hear. Res., 225 (1-2), pp. 60-70; Dittami, G.M., Rajguru, S.M., Lasher, R.A., Hitchcock, R.W., Rabbitt, R.D., Intracellular calcium transients evoked by pulsed infrared radiation in neonatal cardiomyocytes (2011) J.Physiol., 589 (6), pp. 1295-1306; Friesen, L.M., Shannon, R.V., Baskent, D., Wang, X., Speech recognition in noise as a function of the number of spectral channels: comparison of acoustic hearing and cochlear implants (2001) J.Acoust. Soc. Am., 110, pp. 1150-1163; George, S.S., Wise, A.K., Shivdasani, M.N., Shepherd, R.K., Fallon, J.B., Evaluation of focused multipolar stimulation for cochlear implants in acutely deafened cats (2014) J.Neural Eng., 11 (6), p. 065003; Hardie, N.A., Shepherd, R.K., Sensorineural hearing loss during development: morphological and physiological response of the cochlea and auditory brainstem (1999) Hear. Res., 128 (1-2), pp. 147-165; Hernandez, V.H., Gehrt, A., Reuter, K., Jing, Z., Jeschke, M., Mendoza Schulz, A., Hoch, G., Moser, T., Optogenetic stimulation of the auditory pathway (2014) J.Clin. Investigation, 124 (3), pp. 1114-1129; Izzo, A.D., Richter, C.-P., Jansen, E.D., Walsh, J.T., Laser stimulation of the auditory nerve (2006) Lasers Surg. Med., 38 (8), pp. 745-753; Izzo, A.D., Walsh, J.T., Jansen, E.D., Bendett, M., Webb, J., Ralph, H., Richter, C.-P., Optical parameter variability in laser nerve stimulation: a study of pulse duration, repetition rate, and wavelength (2007) IEEE Trans. Biomed. Eng., 54 (6), pp. 1108-1114; Jenkins, M.W., Duke, A.R., Gu, S., Doughman, Y., Chiel, H.J., Fujioka, H., Watanabe, M., Rollins, A.M., Optical pacing of the embryonic heart (2010) Nat. Photonics, 4 (9), pp. 623-626; Kral, A., Hartmann, R., Tillein, J., Heid, S., Klinke, R., Hearing after congenital deafness: central auditory plasticity and sensory deprivation (2002) Cereb. Cortex, 12 (8), pp. 797-807; Kramer, R.H., Fortin, D.L., Trauner, D., New photochemical tools for controlling neuronal activity (2009) Curr. Opin. Neurobiol., 19 (5), pp. 544-552; Landry, T.G., Wise, A.K., Fallon, J.B., Shepherd, R.K., Spiral ganglion neuron survival and function in the deafened cochlea following chronic neurotrophic treatment (2011) Hear. Res., 282 (1-2), pp. 303-313; Liu, Q., Frerck, M.J., Holman, H.A., Jorgensen, E.M., Rabbitt, R.D., Exciting cell membranes with a blustering heat shock (2014) Biophys. J., 106 (8), pp. 1570-1577; Lumbreras, V., Bas, E., Gupta, C., Rajguru, S.M., Pulsed infrared radiation excites cultured neonatal spiral and vestibular ganglion neurons by modulating mitochondrial calcium cycling (2014) J.Neurophysiol.; Matic, A.I., Robinson, A.M., Young, H.K., Badofsky, B., Rajguru, S.M., Stock, S., Richter, C.-P., Behavioral and electrophysiological responses evoked by chronic infrared neural stimulation of the cochlea (2013) PLoS One, 8 (3); Moreno, L.E., Rajguru, S.M., Matic, A.I., Yerram, N., Robinson, A.M., Hwang, M., Stock, S., Richter, C.-P., Infrared neural stimulation: beam path in the guinea pig cochlea (2011) Hear. Res., 282 (1-2), pp. 289-302; http://www.nidcd.nih.gov/health/hearing/pages/coch.aspx, (accessed 27.02.15.)Okunade, O., Santos-Sacchi, J., IR laser-induced perturbations of the voltage-dependent solute carrier protein SLC26a5 (2013) Biophys. J., 105 (8), pp. 1822-1828; Paviolo, C., Haycock, J.W., Cadusch, P.J., McArthur, S.L., Stoddart, P.R., Laser exposure of gold nanorods can induce intracellular calcium transients (2013) J.Biophot., 7 (10), pp. 761-765; Rajguru, S.M., Richter, C.-P., Matic, A.I., Holstein, G.R., Highstein, S.M., Dittami, G.M., Rabbitt, R.D., Infrared photostimulation of the crista ampullaris (2011) J.Physiol., 589 (6), pp. 1283-1294; Rettenmaier, A., Lenarz, T., Reuter, G., Nanosecond laser pulse stimulation of spiral ganglion neurons and model cells (2014) Biomed. Opt. Express, 5 (4), p. 1014; Richter, C.-P., Bayon, R., Izzo, A.D., Otting, M., Suh, E., Goyal, S., Hotaling, J., Walsh, J.T., Optical stimulation of auditory neurons: effects of acute and chronic deafening (2008) Hear. Res., 242 (1-2), pp. 42-51; Richter, C.-P., Matic, A.I., Wells, J.D., Jansen, E.D., Walsh, J.T., Neural stimulation with optical radiation (2011) Laser & Photonics Rev., 5 (1), pp. 68-80; Schultz, M., Baumhoff, P., Kallweit, N., Sato, M., Krüger, A., Ripken, T., Lenarz, T., Kral, A., (2014) Optical Stimulation of the Hearing and Deaf Cochlea under Thermal and Stress Confinement Condition, 8928. , 892816-892816-7; Schultz, M., Baumhoff, P., Maier, H., Teudt, I.U., Krüger, A., Lenarz, T., Kral, A., Nanosecond laser pulse stimulation of the inner ear a wavelength study (2012) Biomed. Opt. Express, 3 (12), pp. 3332-3345; Shapiro, M.G., Homma, K., Villarreal, S., Richter, C.-P., Bezanilla, F., Infrared light excites cells by changing their electrical capacitance (2012) Nat. Commun., 3, p. 736; Shepherd, R.K., Hardie, N.A., Deafness-induced changes in the auditory pathway: implications for cochlear implants (2001) Audiol. Neurotol., 6 (6), pp. 305-318; Teudt, I.U., Maier, H., Richter, C.-P., Kral, A., Acoustic events and ""optophonic"" cochlear responses induced by pulsed near-infrared LASER (2011) IEEE Trans. Biomed. Eng., 58 (6), pp. 1648-1655; Teudt, I.U., Nevel, A.E., Izzo, A.D., Walsh, J.T., Richter, C.-P., Optical stimulation of the facial nerve: a new monitoring technique? (2007) Laryngoscope, 117 (9), pp. 1641-1647; Thompson, A.C., Wade, S.A., Brown, W.G.A., Stoddart, P.R., Modeling of light absorption in tissue during infrared neural stimulation (2012) J.Biomed. Opt., 17 (7). , 075002-075002-6; Thompson, A.C., Wade, S.A., Cadusch, P.J., Brown, W.G.A., Stoddart, P.R., Modeling of the temporal effects of heating during infrared neural stimulation (2013) J.Biomed. Opt., 18 (3). , 035004-035004; Thompson, A.C., Wade, S.A., Pawsey, N.C., Stoddart, P.R., Infrared neural stimulation: influence of stimulation site spacing and repetition rates on heating (2013) IEEE Trans. Biomed. Eng., 60 (12), pp. 3534-3541; Verma, R.U., Guex, A.A., Hancock, K.E., Durakovic, N., McKay, C.M., Slama, M.C.C., Brown, M.C., Lee, D.J., Auditory responses to electric and infrared neural stimulation of the rat cochlear nucleus (2014) Hear. Res., 310, pp. 69-75; Wells, J., Kao, C., Jansen, E.D., Konrad, P., Mahadevan-Jansen, A., Application of infrared light for invivo neural stimulation (2005) J.Biomed. Opt., 10 (6). , 064003-064003-12; Wells, J., Kao, C., Konrad, P., Milner, T., Kim, J., Mahadevan-Jansen, A., Jansen, E.D., Biophysical mechanisms of transient optical stimulation of peripheral nerve (2007) Biophys. J., 93 (7), pp. 2567-2580; Wells, J., Kao, C., Mariappan, K., Albea, J., Jansen, E.D., Konrad, P., Mahadevan-Jansen, A., Optical stimulation of neural tissue invivo (2005) Opt. Lett., 30 (5), pp. 504-506; Wenzel, G.I., Balster, S., Zhang, K., Lim, H.H., Reich, U., Massow, O., Lubatschowski, H., Reuter, G., Green laser light activates the inner ear (2009) J.Biomed. Opt., 14 (4). , 044007-044007; Wise, A.K., Fallon, J.B., Neil, A.J., Pettingill, L.N., Geaney, M.S., Skinner, S.J., Shepherd, R.K., Combining cell-based therapies and neural prostheses to promote neural survival (2011) Neurotherapeutics, 8 (4), pp. 774-787; Xu, S.-A., Shepherd, R.K., Chen, Y., Clark, G.M., Profound hearing loss in the cat following the single co-administration of kanamycin and ethacrynic acid (1993) Hear. Res., 70 (2), pp. 205-215; Zhou, Y., Gopalakrishnan, V., Richardson, J.S., Actions of neurotoxic β-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists (1996) J.Neurochem., 67 (4), pp. 1419-1425",Article,Scopus,2-s2.0-84928322281
"Al-Saqi S.H., Saliem M., Quezada H.C., Ekblad A., Jonasson A.F., Hovatta O., Gotherstrom C.","Defined serum- and xeno-free cryopreservation of mesenchymal stem cells",2015,"Cell and Tissue Banking","16","2",,"181","193",,,10.1007/s10561-014-9463-8,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928997723&partnerID=40&md5=9a8694767cdf294f8266cb6fa3d48ff4","Division of Obstetrics and Gynecology, K57, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, HuddingeStockholm, Sweden; Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University HospitalHuddinge, Sweden; Center for Hematology and Regenerative Medicine, Karolinska InstitutetStockholm, Sweden","Al-Saqi, S.H., Division of Obstetrics and Gynecology, K57, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, HuddingeStockholm, Sweden; Saliem, M., Division of Obstetrics and Gynecology, K57, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, HuddingeStockholm, Sweden; Quezada, H.C., Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University HospitalHuddinge, Sweden; Ekblad, Å., Division of Obstetrics and Gynecology, K57, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, HuddingeStockholm, Sweden, Center for Hematology and Regenerative Medicine, Karolinska InstitutetStockholm, Sweden; Jonasson, A.F., Division of Obstetrics and Gynecology, K57, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, HuddingeStockholm, Sweden; Hovatta, O., Division of Obstetrics and Gynecology, K57, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, HuddingeStockholm, Sweden; Götherström, C., Division of Obstetrics and Gynecology, K57, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, HuddingeStockholm, Sweden, Center for Hematology and Regenerative Medicine, Karolinska InstitutetStockholm, Sweden","Mesenchymal stem cells (MSCs) have vast potential in cell therapy, and are experimentally used in the clinic. Therefore, it is critical to find a serum- and xeno-free cryopreservation method. The aim of this study was to compare two serum- and xeno-free cryoprotectants for MSCs. Adipose tissue MSCs (Ad-MSCs) and bone marrow MSCs (BM-MSCs) were cryopreserved in two cryoprotectants: the defined serum- and xeno-free STEM-CELLBANKER™ (CB) and 10 % dimethyl sulfoxide (DMSO) in a xeno-free serum replacement cell culture medium and compared to non-cryopreserved MSCs. MSCs cryopreserved in CB or DMSO had similar morphology and surface marker expression compared to their respective non-cryopreserved MSC. Ad-MSCs and BM-MSC in both cryoprotectant media exhibited reduced mean fluorescence intensity (MFI) for CD105, BM-MSCs for CD73 and Ad-MSC increased MFI for HLA class I compared to non-cryopreserved MSCs. Population doubling time of CB cryopreserved and non-cryopreserved Ad-MSCs was similar (38.1 ± 13.6 and 36.8 ± 12.1 h), but somewhat higher when cryopreserved in DMSO (42.2 ± 10.8 h). BM-MSCs had higher population doubling time (CB 47.7 ± 11.4 and DMSO 62.3 ± 32.9 h respectively, p < 0.05) compared to Ad-MSCs. The viability of Ad-MSCs was significantly higher after cryopreservation in CB compared to DMSO (90.4 ± 4.5 % vs. 79.9 ± 3.8 % respectively). Ad-MSCs and BM-MSCs retained their mesodermal differentiation potential when cryopreserved in both cryoprotectants. The characteristics of Ad-MSCs post-thawing are better preserved by CB than by DMSO in serum- and xeno-free medium. Furthermore, Ad-MSCs and BM-MSCs are differently affected by the cryoprotectants, which may have implications for cell therapy. © 2014, Springer Science+Business Media Dordrecht.","Adipose; Bone marrow; Cryopreservation; DMSO; Mesenchymal stem cells; Mesenchymal stromal cells; Serum- and xeno-free cryoprotectant; STEM-CELLBANKER™","Al-Saqi, S.H., Saliem, M., Asikainen, S., Quezada, H.C., Hovatta, O., Le Blanc, K., Defined serum-free medium for in vitro expansion of adipose derived mesenchymal stem cells (2014) Cytotherapy, , PID: 24726655; Basu, J., Genheimer, C.W., Guthrie, K.I., Sangha, N., Quinlan, S.F., Bruce, A.T., Expansion of the human adipose-derived stromal vascular cell fraction yields a population of smooth muscle-like cells with markedly distinct phenotypic and functional properties relative to mesenchymal stem cells (2011) Tissue Eng Part C Methods, 17 (8), pp. 843-860. , COI: 1:CAS:528:DC%2BC3MXpsFWrs74%3D, PID: 21595545, Epub 2011/05/21; Bray LJ, Heazlewood CF, Atkinson K, Hutmacher DW, Harkin DG (2012) Evaluation of methods for cultivating limbal mesenchymal stromal cells. Cytotherapy 14(8):936–947 Epub 2012/05/17Campioni, D., Lanza, F., Moretti, S., Ferrari, L., Cuneo, A., Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics (2008) Cytotherapy, 10 (1), pp. 69-82. , COI: 1:CAS:528:DC%2BD1cXnsFektw%3D%3D, PID: 18202976, Epub 2008/01/19; Casteilla, L., Planat-Benard, V., Laharrague, P., Cousin, B., Adipose-derived stromal cells: their identity and uses in clinical trials, an update (2011) World J Stem Cells, 3 (4), pp. 25-33. , PID: 21607134, Epub 2011/05/25; de Lima Prata, K., de Santis, G.C., Orellana, M.D., Palma, P.V., Brassesco, M.S., Covas, D.T., Cryopreservation of umbilical cord mesenchymal cells in xenofree conditions (2012) Cytotherapy, 14 (6), pp. 694-700. , COI: 1:CAS:528:DC%2BC38XosVWkt7k%3D, PID: 22519634, Epub 2012/04/24; Dicker, A., Le Blanc, K., Astrom, G., van Harmelen, V., Gotherstrom, C., Blomqvist, L., Functional studies of mesenchymal stem cells derived from adult human adipose tissue (2005) Exp Cell Res, 308 (2), pp. 283-290. , COI: 1:CAS:528:DC%2BD2MXmvVCht7w%3D, PID: 15925364, Epub 2005/06/01; Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement (2006) Cytotherapy, 8 (4), pp. 315-317. , COI: 1:STN:280:DC%2BD28vpvFSjsA%3D%3D, PID: 16923606, Epub 2006/08/23; Ginis, I., Grinblat, B., Shirvan, M.H., Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium (2012) Tissue Eng Part C Methods, 18 (6), pp. 453-463. , COI: 1:CAS:528:DC%2BC38XotVOmtrg%3D, PID: 22196031, Epub 2011/12/27; Halvorsen, Y.D., Bond, A., Sen, A., Franklin, D.M., Lea-Currie, Y.R., Sujkowski, D., Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: biochemical, cellular, and molecular analysis (2001) Metabolism, 50 (4), pp. 407-413. , COI: 1:CAS:528:DC%2BD3MXis1KlurY%3D, PID: 11288034, Epub 2001/04/05; Holm, F., Strom, S., Inzunza, J., Baker, D., Stromberg, A.M., Rozell, B., An effective serum- and xeno-free chemically defined freezing procedure for human embryonic and induced pluripotent stem cells (2010) Hum Reprod, 25 (5), pp. 1271-1279. , COI: 1:CAS:528:DC%2BC3cXkvFOjtr0%3D, PID: 20208061, Epub 2010/03/09; Ikegame, Y., Yamashita, K., Hayashi, S., Mizuno, H., Tawada, M., You, F., Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy (2011) Cytotherapy, 13 (6), pp. 675-685. , COI: 1:CAS:528:DC%2BC3MXnsFKitrg%3D, PID: 21231804, Epub 2011/01/15; Janz Fde, L., Debes Ade, A., Cavaglieri Rde, C., Duarte, S.A., Romao, C.M., Moron, A.F., Evaluation of distinct freezing methods and cryoprotectants for human amniotic fluid stem cells cryopreservation. J Biomed Biotechnol 2012:649353 (2012) Epub 2012/06/06; Kim, W.S., Park, B.S., Sung, J.H., Protective role of adipose-derived stem cells and their soluble factors in photoaging (2009) Arch Dermatol Res, 301 (5), pp. 329-336. , PID: 19396609, Epub 2009/04/28; Le Blanc, K., Mesenchymal stromal cells: tissue repair and immune modulation (2006) Cytotherapy, 8 (6), pp. 559-561. , PID: 17148032, Epub 2006/12/07; Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S.E., Ringden, O., Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex (2003) Scand J Immunol, 57 (1), pp. 11-20. , PID: 12542793, Epub 2003/01/25; Lin, Y.T., Chern, Y., Shen, C.K., Wen, H.L., Chang, Y.C., Li, H., Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington’s disease mouse models (2011) PLoS ONE, 6 (8), p. 22924. , COI: 1:CAS:528:DC%2BC3MXhtFajt7nO, PID: 21850243, Epub 2011/08/19; Lin, R.Z., Moreno-Luna, R., Zhou, B., Pu, W.T., Melero-Martin, J.M., Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells (2012) Angiogenesis, 15 (3), pp. 443-455. , PID: 22527199, Epub 2012/04/25; Miwa, H., Hashimoto, Y., Tensho, K., Wakitani, S., Takagi, M., Xeno-free proliferation of human bone marrow mesenchymal stem cells (2012) Cytotechnology, 64 (3), pp. 301-308; Motta, J.P.R., Paraguassú-Braga, F.H., Bouzas, L.F., Porto, L.C., Evaluation of intracellular and extracellular trehalose as a cryoprotectant of stem cells obtained from umbilical cord blood (2014) Cryobiology, 68 (3), pp. 343-348; Naaldjik, Y., Staude, M., Federova, V., Stolzing, A., Effect of different freezing rates during cryopreservation of rat mesenchymal stem cells using combinations of hydroxyethyl starch and dimethylsulfoxide (2012) BMC Biotechnol, 12 (1), p. 49. , Epub 2012/08/15; Pal, R., Hanwate, M., Jan, M., Totey, S., Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells (2009) J Tissue Eng Regen Med, 3 (3), pp. 163-174. , COI: 1:CAS:528:DC%2BD1MXntFWksbw%3D, PID: 19229888, Epub 2009/02/21; Pegg, D.E., Principles of cryopreservation (2007) Methods Mol Biol, 368, pp. 39-57. , COI: 1:CAS:528:DC%2BD2sXot1Snurg%3D, PID: 18080461, Epub 2007/12/18; Qi, W., Ding, D., Salvi, R.J., Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures (2008) Hear Res, 236 (1-2), pp. 52-60. , COI: 1:CAS:528:DC%2BD1cXhsVyiu7g%3D, PID: 18207679, Epub 2008/01/22; Saliem, M., Holm, F., Bergström Tengzelius, R., Jorns, C., Nilsson, L.-M., Ericzon, B.-G., Improved cryopreservation of human hepatocytes using a new xeno free cryoprotectant solution (2012) World J Hepatol, 4 (5), p. 176. , PID: 22662286; Santos, N.C., Figueira-Coelho, J., Saldanha, C., Martins-Silva, J., Biochemical, biophysical and haemorheological effects of dimethylsulphoxide on human erythrocyte calcium loading (2002) Cell Calcium, 31 (4), pp. 183-188. , COI: 1:CAS:528:DC%2BD38XltlGiurw%3D, PID: 12027383, Epub 2002/05/25; Stiff, P.J., Koester, A.R., Weidner, M.K., Dvorak, K., Fisher, R.I., Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing (1987) Blood, 70 (4), pp. 974-978. , COI: 1:STN:280:DyaL1c%2FgtFShug%3D%3D, PID: 2443203, Epub 1987/10/01; Strem, B.M., Hicok, K.C., Zhu, M., Wulur, I., Alfonso, Z., Schreiber, R.E., Multipotential differentiation of adipose tissue-derived stem cells (2005) Keio J Med, 54 (3), pp. 132-141. , COI: 1:CAS:528:DC%2BD2MXht1CmurnN, PID: 16237275, Epub 2005/10/21; Witkowska-Zimny, M., Walenko, K., Stem cells from adipose tissue (2011) Cell Mol Biol Lett, 16 (2), pp. 236-257. , PID: 21394447, Epub 2011/03/12; Zeisberger, S.M., Schulz, J.C., Mairhofer, M., Ponsaerts, P., Wouters, G., Doerr, D., Biological and physicochemical characterization of a serum- and xeno-free chemically defined cryopreservation procedure for adult human progenitor cells (2011) Cell Transpl, 20 (8), pp. 1241-1257. , Epub 2010/12/24; Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Multilineage cells from human adipose tissue: implications for cell-based therapies (2001) Tissue Eng, 7 (2), pp. 211-228. , COI: 1:CAS:528:DC%2BD3MXjsFShtro%3D, PID: 11304456, Epub 2001/04/17",Article,Scopus,2-s2.0-84928997723
"Wang Q., Yang L., Wang Y.","Enhanced differentiation of neural stem cells to neurons and promotion of neurite outgrowth by oxygen-glucose deprivation",2015,"International Journal of Developmental Neuroscience","43",,,"50","57",,,10.1016/j.ijdevneu.2015.04.009,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928546381&partnerID=40&md5=7e010975030afbe948655d0eb92144cc","Department of Otorhinolarynology, The Second Xiangya Hospital, Central South UniversityChangsha, Hunan, China; Department of Anesthesiology, The Second Xiangya Hospital, Central South UniversityChangsha, Hunan, China","Wang, Q., Department of Otorhinolarynology, The Second Xiangya Hospital, Central South UniversityChangsha, Hunan, China; Yang, L., Department of Anesthesiology, The Second Xiangya Hospital, Central South UniversityChangsha, Hunan, China; Wang, Y., Department of Anesthesiology, The Second Xiangya Hospital, Central South UniversityChangsha, Hunan, China","Stroke has become the leading cause of mortality worldwide. Hypoxic or ischemic insults are crucial factors mediating the neural damage in the brain tissue of stroke patients. Neural stem cells (NSCs) have been recognized as a promising tool for the treatment of ischemic stroke and other neurodegenerative diseases due to their inducible pluripotency. In this study, we aim to mimick the cerebral hypoxic-ischemic injury in vitro using oxygen-glucose deprivation (OGD) strategy, and evaluate the effects of OGD on the NSC's neural differentiation, as well as the differentiated neurite outgrowth. Our data showed that NSCs under the short-term 2. h OGD treatment are able to maintain cell viability and the capability to form neurospheres. Importantly, this moderate OGD treatment promotes NSC differentiation to neurons and enhances the performance of the mature neuronal networks, accompanying increased neurite outgrowth of differentiated neurons. However, long-term 6. h and 8. h OGD exposures in NSCs lead to decreased cell survival, reduced differentiation and diminished NSC-derived neurite outgrowth. The expressions of neuron-specific microtubule-associated protein 2 (MAP-2) and growth associated protein 43 (GAP-43) are increased by short-term OGD treatments but suppressed by long-term OGD. Overall, our results demonstrate that short-term OGD exposure in vitro induces differentiation of NSCs while maintaining their proliferation and survival, providing valuable insights of adopting NSC-based therapy for ischemic stroke and other neurodegenerative disorders. © 2015 Elsevier Ltd.","Differentiation; Neural stem cells; Oxygen-glucose deprivation; Proliferation","Bachoo, R.M., Maher, E.A., Ligon, K.L., Sharpless, N.E., Chan, S.S., You, M.J., Tang, Y., DePinho, R.A., Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis (2002) Cancer Cell, 1, pp. 269-277; Berridge, M.J., Neuronal calcium signaling (1998) Neuron, 21, pp. 13-26; Brouhard, G.J., Rice, L.M., The contribution of alphabeta-tubulin curvature to microtubule dynamics (2014) J. Cell Biol., 207, pp. 323-334; Burgers, H.F., Schelshorn, D.W., Wagner, W., Kuschinsky, W., Maurer, M.H., Acute anoxia stimulates proliferation in adult neural stem cells from the rat brain (2008) Exp. Brain Res., 188, pp. 33-43; Caroli, A., Prestia, A., Chen, K., Ayutyanont, N., Landau, S.M., Madison, C.M., Haense, C., Frisoni, G.B., Summary metrics to assess Alzheimer disease - related hypometabolic pattern with 18F-FDG PET: head-to-head comparison (2012) J. Nucl. Med., 53, pp. 592-600; Carriel, V., Garzon, I., Campos, A., Cornelissen, M., Alaminos, M., Differential expression of GAP -43 and neurofilament during peripheral nerve regeneration through bio-artificial conduits (2014) J. Tissue Eng. Regener. Med.; Chen, J., Guo, Y., Cheng, W., Chen, R., Liu, T., Chen, Z., Tan, S., High glucose induces apoptosis and suppresses proliferation of adult rat neural stem cells following in vitro ischemia (2013) BMC Neurosci., 14, p. 24; Csete, M., Oxygen in the cultivation of stem cells (2005) Ann. N.Y. Acad. Sci., 1049, pp. 1-8; Ding, F., Yao, J., Rettberg, J.R., Chen, S., Brinton, R.D., Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention (2013) PLoS One, 8, p. e79977; Dirnagl, U., Iadecola, C., Moskowitz, M.A., Pathobiology of ischaemic stroke: an integrated view (1999) Trends Neurosci., 22, pp. 391-397; Fernandez-de-Miguel, F., Drapeau, P., Synapse formation and function: insights from identified leech neurons in culture (1995) J. Neurobiol., 27, pp. 367-379; Friedlander, R.M., Apoptosis and caspases in neurodegenerative diseases (2003) N. Engl. J. Med., 348, pp. 1365-1375; Friedlander, R.M., Gagliardini, V., Hara, H., Fink, K.B., Li, W., MacDonald, G., Fishman, M.C., Yuan, J., Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury (1997) J. Exp. Med., 185, pp. 933-940; Gage, F.H., Mammalian neural stem cells (2000) Science, 287, pp. 1433-1438; Hicks, A.U., Lappalainen, R.S., Narkilahti, S., Suuronen, R., Corbett, D., Sivenius, J., Hovatta, O., Jolkkonen, J., Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery (2009) Eur. J. Neurosci., 29, pp. 562-574; Hicks, A.U., MacLellan, C.L., Chernenko, G.A., Corbett, D., Long-term assessment of enriched housing and subventricular zone derived cell transplantation after focal ischemia in rats (2008) Brain Res., 1231, pp. 103-112; Horie, N., Moriya, T., Mitome, M., Kitagawa, N., Nagata, I., Shinohara, K., Lowered glucose suppressed the proliferation and increased the differentiation of murine neural stem cells in vitro (2004) FEBS Lett., 571, pp. 237-242; Huttner, H.B., Bergmann, O., Salehpour, M., Racz, A., Tatarishvili, J., Lindgren, E., Csonka, T., Frisen, J., The age and genomic integrity of neurons after cortical stroke in humans (2014) Nat. Neurosci., 17, pp. 801-803; Johansson, C.B., Momma, S., Clarke, D.L., Risling, M., Lendahl, U., Frisen, J., Identification of a neural stem cell in the adult mammalian central nervous system (1999) Cell, 96, pp. 25-34; Johnston, S.C., Mendis, S., Mathers, C.D., Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling (2009) Lancet Neurol., 8, pp. 345-354; Kalluri, H.S., Eickstaedt, J., Dempsey, R.J., Oxygen glucose deprivation inhibits the growth and ERK phosphorylation of neural progenitor cells in vitro (2007) Neurosci. Lett., 426, pp. 145-148; Krajewska, M., Wang, H.G., Krajewski, S., Zapata, J.M., Shabaik, A., Gascoyne, R., Reed, J.C., Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease (1997) Cancer Res., 57, pp. 1605-1613; Lawrence, M.S., Ho, D.Y., Sun, G.H., Steinberg, G.K., Sapolsky, R.M., Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo (1996) J. Neurosci., 6, pp. 486-496; Li, X., Zhu, L., Chen, X., Fan, M., Effects of hypoxia on proliferation and differentiation of myoblasts (2007) Med. Hypotheses, 69, pp. 629-636; Lim, D.A., Huang, Y.C., Alvarez-Buylla, A., The adult neural stem cell niche: lessons for future neural cell replacement strategies (2007) Neurosurg. Clin. N. Am., 18, pp. 81-92. , ix; Lipton, P., Ischemic cell death in brain neurons (1999) Physiol. Rev., 79, pp. 1431-1568; Liu, L., Wang, D., Wong, K.S., Wang, Y., Stroke and stroke care in China: huge burden, significant workload, and a national priority (2011) Stroke, 42, pp. 3651-3654; Macas, J., Nern, C., Plate, K.H., Momma, S., Increased generation of neuronal progenitors after ischemic injury in the aged adult human forebrain (2006) J. Neurosci., 26, pp. 13114-13119; MacManus, J.P., Buchan, A.M., Hill, I.E., Rasquinha, I., Preston, E., Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain (1993) Neurosci. Lett., 164, pp. 89-92; Okano, H., Stem cell biology of the central nervous system (2002) J. Neurosci. Res., 69, pp. 698-707; Portt, L., Norman, G., Clapp, C., Greenwood, M., Greenwood, M.T., Anti-apoptosis and cell survival: a review (2011) Biochim. Biophys. Acta, 1813, pp. 238-259; Rietze, R.L., Valcanis, H., Brooker, G.F., Thomas, T., Voss, A.K., Bartlett, P.F., Purification of a pluripotent neural stem cell from the adult mouse brain (2001) Nature, 412, pp. 736-739; Rossi, F., Cattaneo, E., Opinion: neural stem cell therapy for neurological diseases: dreams and reality (2002) Nat. Rev. Neurosci., 3, pp. 401-409; Studer, L., Csete, M., Lee, S.H., Kabbani, N., Walikonis, J., Wold, B., McKay, R., Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen (2000) J. Neurosci., 20, pp. 7377-7383; Thomas, A.P., Bird, G.S., Hajnoczky, G., Robb-Gaspers, L.D., Putney, J.W., Spatial and temporal aspects of cellular calcium signaling (1996) FASEB J., 10, pp. 1505-1517; Wu, S., Suzuki, Y., Kitada, M., Kitaura, M., Kataoka, K., Takahashi, J., Ide, C., Nishimura, Y., Migration, integration, and differentiation of hippocampus-derived neurosphere cells after transplantation into injured rat spinal cord (2001) Neurosci. Lett., 312, pp. 173-176",Article,Scopus,2-s2.0-84928546381
"Schmid T., Hajnal A.","Signal transduction during C. elegans vulval development: A NeverEnding story",2015,"Current Opinion in Genetics and Development","32",,,"1","9",,,10.1016/j.gde.2015.01.006,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84922364443&partnerID=40&md5=4bdf27286747038e77bde3fe7047b0de","University of Zurich, Institute of Molecular Life Sciences, Winterthurerstrasse 190Zurich, Switzerland","Schmid, T., University of Zurich, Institute of Molecular Life Sciences, Winterthurerstrasse 190Zurich, Switzerland; Hajnal, A., University of Zurich, Institute of Molecular Life Sciences, Winterthurerstrasse 190Zurich, Switzerland","The Caenorhabditis elegans hermaphrodite vulva is one of the best studied models for signal transduction and cell fate determination during organogenesis. Systematic forward genetic screens have identified a complex and highly interconnected signaling network formed by the conserved EGFR, NOTCH, and WNT signaling pathways that specifies an invariant pattern of cell fates among the six vulval precursor cells (VPCs). Multiple inhibitory interactions between the EGFR and NOTCH pathways ensure the selection of a single 1° VPC that is always flanked by two 2° VPCs thanks to lateral NOTCH signaling. Building on this 'central dogma' of cell fate specification, scientists have investigated a broad spectrum of novel questions that are summarized in this review. For example, vulval development is a unique model to study the intracellular trafficking of signaling molecules, such as NOTCH or EGFR, to investigate the interactions between the cell cycle and cell fate specification pathways, and to observe epithelial tube morphogenesis and cell invasion at single-cell resolution. Finally, computer scientists have integrated the experimental data into mathematical and state-based '. in silico' models of vulval development, allowing them to test the completeness and limits of our current understanding. © 2015.",,"Sulston, J.E., Horvitz, H.R., Post-embryonic cell lineages of the nematode, Caenorhabditis elegans (1977) Dev Biol, 56, pp. 110-156; Sternberg, P.W., Horvitz, H.R., Pattern formation during vulval development in C. elegans (1986) Cell, 44, pp. 761-772; Eisenmann, D.M., Maloof, J.N., Simske, J.S., Kenyon, C., Kim, S.K., The beta-catenin homolog BAR-1 and LET-60 Ras coordinately regulate the Hox gene lin-39 during Caenorhabditis elegans vulval development (1998) Development, 125, pp. 3667-3680; Gleason, J.E., Szyleyko, E.A., Eisenmann, D.M., Multiple redundant Wnt signaling components function in two processes during C. elegans vulval development (2006) Dev Biol, 298, pp. 442-457; Pénigault, J.-B., Félix, M.-A., High sensitivity of C. elegans vulval precursor cells to the dose of posterior Wnts (2011) Dev Biol, 357, pp. 428-438; Salser, S.J., Chang, C., Ambros, V., Loer, C.M., Kenyon, C., Multiple HOM-C gene interactions specify cell fates in the nematode central nervous system (1993) Genes Dev, 7, pp. 1714-1724; Clark, S., Chisholm, A., Horvitz, H., Control of cell fates in the central body region of C. elegans by the homeobox gene lin-39 (1993) Cell, 74, pp. 43-55; Wagmaister, J.A., Miley, G.R., Morris, C.A., Gleason, J.E., Miller, L.M., Kornfeld, K., Eisenmann, D.M., Identification of cis-regulatory elements from the C. elegans Hox gene lin-39 required for embryonic expression and for regulation by the transcription factors LIN-1, LIN-31 and LIN-39 (2006) Dev Biol, 297, pp. 550-565; Shemer, G., Podbilewicz, B., LIN-39/Hox triggers cell division and represses EFF-1/fusogen-dependent vulval cell fusion (2002) Genes Dev, 16, pp. 3136-3141; Koh, K., Peyrot, S.M., Wood, C.G., Wagmaister, J.A., Maduro, M.F., Eisenmann, D.M., Rothman, J.H., Cell fates and fusion in the C. elegans vulval primordium are regulated by the EGL-18 and ELT-6 GATA factors - apparent direct targets of the LIN-39 Hox protein (2002) Development, 129, pp. 5171-5180; Mohler, W.A., Shemer, G., del Campo, J.J., Valansi, C., Opoku-Serebuoh, E., Scranton, V., Assaf, N., Podbilewicz, B., The type I membrane protein EFF-1 is essential for developmental cell fusion (2002) Dev Cell, 2, pp. 355-362; Pénigault, J.-B., Félix, M.-A., Evolution of a system sensitive to stochastic noise: P3.p cell fate in Caenorhabditis (2011) Dev Biol, 357, pp. 419-427; Myers, T.R., Greenwald, I., Wnt signal from multiple tissues and lin-3/EGF signal from the gonad maintain vulval precursor cell competence in Caenorhabditis elegans (2007) Proc Natl Acad Sci U S A, 104, pp. 20368-20373; Chen, Z., Han, M., C. elegans Rb, NuRD, and Ras regulate lin-39-mediated cell fusion during vulval fate specification (2001) Curr Biol, 11, pp. 1874-1879; Hill, R.J., Sternberg, P.W., The gene lin-3 encodes an inductive signal for vulval development in C. elegans (1992) Nature, 358, pp. 470-476; Sternberg, P.W., Horvitz, H.R., The combined action of two intercellular signaling pathways specifies three cell fates during vulval induction in C. elegans (1989) Cell, 58, pp. 679-693; Dutt, A., Canevascini, S., Froehli-Hoier, E., Hajnal, A., EGF signal propagation during C. elegans vulval development mediated by ROM-1 rhomboid (2004) PLoS Biol, 2, p. e334; Katz, W.S., Hill, R.J., Clandinin, T.R., Sternberg, P.W., Different levels of the C. elegans growth factor LIN-3 promote distinct vulval precursor fates (1995) Cell, 82, pp. 297-307; Aroian, R.V., Koga, M., Mendel, J.E., Ohshima, Y., Sternberg, P.W., The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily (1990) Nature, 348, pp. 693-699; Barkoulas, M., van Zon, J.S., Milloz, J., Van Oudenaarden, A., Félix, M.-A., Robustness and epistasis in the C. elegans vulval signaling network revealed by pathway dosage modulation (2013) Dev Cell, 24, pp. 64-75; Hajnal, A., Whitfield, C.W., Kim, S.K., Inhibition of Caenorhabditis elegans vulval induction by gap-1 and by let-23 receptor tyrosine kinase (1997) Genes Dev, 11, pp. 2715-2728; Clark, S.G., Stern, M.J., Horvitz, H.R., C. elegans cell-signaling gene sem-5 encodes a protein with SH2 and SH3 domains (1992) Nature, 356, pp. 340-344; Chang, C., Hopper, N.A., Sternberg, P.W., Caenorhabditis elegans SOS-1 is necessary for multiple RAS-mediated developmental signals (2000) EMBO J, 19, pp. 3283-3294; Beitel, G.J., Clark, S.G., Horvitz, H.R., Caenorhabditis elegans ras gene let-60 acts as a switch in the pathway of vulval induction (1990) Nature, 348, pp. 503-509; Han, M., Golden, A., Han, Y., Sternberg, P.W., C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation (1993) Nature, 363, pp. 133-140; Kornfeld, K., Guan, K.L., Horvitz, H.R., The Caenorhabditis elegans gene mek-2 is required for vulval induction and encodes a protein similar to the protein kinase MEK (1995) Genes Dev, 9, pp. 756-768; Lackner, M., Kornfeld, K., Miller, L., Horvitz, H., Kim, S., A MAP kinase homolog, mpk-1, is involved in ras-mediated induction of vulval cell fates in Caenorhabditis elegans (1994) Genes Dev, 8, pp. 160-173; Lackner, M., Kim, S., Genetic analysis of the Caenorhabditis elegans MAP kinase gene mpk-1 (1998) Genetics, 150, pp. 103-117; Tan, P.B., Lackner, M.R., Kim, S.K., MAP kinase signaling specificity mediated by the LIN-1 Ets/LIN-31 WH transcription factor complex during C. elegans vulval induction (1998) Cell, 93, pp. 569-580; Jacobs, D., Beitel, G.J., Clark, S.G., Horvitz, H.R., Kornfeld, K., Gain-of-function mutations in the Caenorhabditis elegans lin-1 ETS gene identify a C-terminal regulatory domain phosphorylated by ERK MAP kinase (1998) genetics.org, 149, p. 1809; Miller, L.M., Gallegos, M.E., Morisseau, B.A., Kim, S.K., Lin-31, a Caenorhabditis elegans HNF-3/fork head transcription factor homolog, specifies three alternative cell fates in vulval development (1993) Genes Dev, 7, pp. 933-947; Leight, E.R., Glossip, D., Kornfeld, K., Sumoylation of LIN-1 promotes transcriptional repression and inhibition of vulval cell fates (2005) Development, 132, pp. 1047-1056; Nilsson, L., Tiensuu, T., Tuck, S., Caenorhabditis elegans lin-25: a study of its role in multiple cell fate specification events involving Ras and the identification and characterization of evolutionarily conserved domains (2000) Genetics, 156, pp. 1083-1096; Singh, N., Han, M., Sur-2, a novel gene, functions late in the let-60 ras-mediated signaling pathway during Caenorhabditis elegans vulval induction (1995) Genes Dev, 9, pp. 2251-2265; Guerry, F., Marti, C.-O., Zhang, Y., Moroni, P.S., Jaquiéry, E., Müller, F., The Mi-2 nucleosome-remodeling protein LET-418 is targeted via LIN-1/ETS to the promoter of lin-39/Hox during vulval development in C. elegans (2007) Dev Biol, 306, pp. 469-479; Maloof, J., Kenyon, C., The Hox gene lin-39 is required during C. elegans vulval induction to select the outcome of Ras signaling (1998) Development, 125, pp. 181-190; Clandinin, T.R., Hong, Y., Katz, W.S., Roy, R., Sternberg, P.W., Ambros, V., Caenorhabditis elegans HOM-C genes regulate the response of vulval precursor cells to inductive signal (1997) Dev Biol, 182, pp. 150-161; Pellegrino, M.W., Farooqui, S., Fröhli, E., Rehrauer, H., Kaeser-Pebernard, S., Müller, F., Gasser, R.B., Hajnal, A., LIN-39 and the EGFR/RAS/MAPK pathway regulate C. elegans vulval morphogenesis via the VAB-23 zinc finger protein (2011) Development, 138, pp. 4649-4660; Gleason, J.E., Korswagen, H.C., Eisenmann, D.M., Activation of Wnt signaling bypasses the requirement for RTK/Ras signaling during C. elegans vulval induction (2002) Genes Dev, 16, pp. 1281-1290; Hopper, N.A., Lee, J., Sternberg, P.W., ARK-1 inhibits EGFR signaling in C. elegans (2000) Mol Cell, 6, pp. 65-75; Yoon, C.H., Lee, J., Jongeward, G.D., Sternberg, P.W., Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl (1995) Science, 269, pp. 1102-1105; Berset, T.A., Hoier, E.F., Hajnal, A., The C. elegans homolog of the mammalian tumor suppressor Dep-1/Scc1 inhibits EGFR signaling to regulate binary cell fate decisions (2005) Genes Dev, 19, pp. 1328-1340; Chen, N., Greenwald, I., The lateral signal for LIN-12/Notch in C. elegans vulval development comprises redundant secreted and transmembrane DSL proteins (2004) Dev Cell, 6, pp. 183-192; Hoyos, E., Kim, K., Milloz, J., Barkoulas, M., Pénigault, J.-B., Munro, E., Félix, M.-A., Quantitative variation in autocrine signaling and pathway crosstalk in the Caenorhabditis vulval network (2011) Curr Biol, 21, pp. 527-538; Sternberg, P.W., Lateral inhibition during vulval induction in Caenorhabditis elegans (1988) Nature, 335, pp. 551-554; Berset, T., Hoier, E.F., Battu, G., Canevascini, S., Hajnal, A., Notch inhibition of RAS signaling through MAP kinase phosphatase LIP-1 during C. elegans vulval development (2001) Science, 291, pp. 1055-1058; Yoo, A.S., Bais, C., Greenwald, I., Crosstalk between the EGFR and LIN-12/Notch pathways in C. elegans vulval development (2004) Science, 303, pp. 663-666; Greenwald, I., Sternberg, P., Horvitz, H., The lin-12 locus specifies cell fates in Caenorhabditis elegans (1983) Cell, 34, pp. 435-444; Simske, J.S., Kim, S.K., Sequential signalling during Caenorhabditis elegans vulval induction (1995) Nature, 375, pp. 142-146; Kenyon, C., A perfect vulva every time: gradients and signaling cascades in C. elegans (1995) Cell, 82, pp. 171-174; Zand, T.P., Reiner, D.J., Der, C.J., Ras effector switching promotes divergent cell fates in C. elegans vulval patterning (2011) Dev Cell, 20, pp. 84-96; Shaye, D.D., Greenwald, I., LIN-12/Notch trafficking and regulation of DSL ligand activity during vulval induction in Caenorhabditis elegans (2005) Development, 132, pp. 5081-5092; Kaech, S.M., Whitfield, C.W., Kim, S.K., The LIN-2/LIN-7/LIN-10 complex mediates basolateral membrane localization of the C. elegans EGF receptor LET-23 in vulval epithelial cells (1998) Cell, 94, pp. 761-771; Haag, A., Gutierrez, P., Bühler, A., Walser, M., Yang, Q., Langouët, M., Kradolfer, D., Hajnal, A., An in vivo EGF receptor localization screen in C. elegans identifies the Ezrin homolog ERM-1 as a temporal regulator of signaling (2014) PLoS Genet, 10, p. e1004341; Simske, J., Kaech, S., Harp, S., Kim, S., LET-23 receptor localization by the cell junction protein LIN-7 during C. elegans vulval induction (1996) Cell, 85, pp. 195-204; Skorobogata, O., Escobar-Restrepo, J.M., Rocheleau, C.E., An AGEF-1/Arf GTPase/AP-1 ensemble antagonizes LET-23 EGFR basolateral localization and signaling during C. elegans vulva induction (2014) PLoS Genet, 10, p. e1004728; Stetak, A., Hoier, E.F., Croce, A., Cassata, G., Di Fiore, P.P., Hajnal, A., Cell fate-specific regulation of EGF receptor trafficking during Caenorhabditis elegans vulval development (2006) EMBO J, 25, pp. 2347-2357; Skorobogata, O., Rocheleau, C.E., RAB-7 antagonizes LET-23 EGFR signaling during vulva development in Caenorhabditis elegans (2012) PLoS ONE, 7, p. e36489; Levitan, D., Greenwald, I., LIN-12 protein expression and localization during vulval development in C. elegans (1998) Development, 125, pp. 3101-3109; Whitfield, C.W., Bénard, C., Barnes, T., Hekimi, S., Kim, S.K., Basolateral localization of the Caenorhabditis elegans epidermal growth factor receptor in epithelial cells by the PDZ protein LIN-10 (1999) Mol Biol Cell, 10, pp. 2087-2100; Shaye, D.D., Greenwald, I., Endocytosis-mediated downregulation of LIN-12/Notch upon Ras activation in Caenorhabditis elegans (2002) Nature, 420, pp. 686-690; Levitan, D., Greenwald, I., Effects of SEL-12 presenilin on LIN-12 localization and function in Caenorhabditis elegans (1998) Development, 125, pp. 3599-3606; de Souza, N., Vallier, L.G., Fares, H., Greenwald, I., SEL-2, the C. elegans neurobeachin/LRBA homolog, is a negative regulator of lin-12/Notch activity and affects endosomal traffic in polarized epithelial cells (2007) Development, 134, pp. 691-702; Hong, Y., Roy, R., Ambros, V., Developmental regulation of a cyclin-dependent kinase inhibitor controls postembryonic cell cycle progression in Caenorhabditis elegans (1998) Development, 125, pp. 3585-3597; Karp, X., Ambros, V., Developmental biology, encountering microRNAs in cell fate signaling (2005) Science, 310, pp. 1288-1289; Euling, S., Hoyos, E., Ambros, V., Heterochronic genes control cell cycle progress and developmental competence of C. elegans vulva precursor cells (1996) Cell, 84, pp. 667-676; Boxem, M., van den Heuvel, S., Lin-35 Rb and cki-1 Cip/Kip cooperate in developmental regulation of G1 progression in C. elegans (2001) Development, 128, pp. 4349-4359; Clayton, J.E., van den Heuvel, S.J.L., Saito, R.M., Transcriptional control of cell-cycle quiescence during C. elegans development (2008) Dev Biol, 313, pp. 603-613; Fay, D.S., Han, M., Mutations in cye-1, a Caenorhabditis elegans cyclin E homolog, reveal coordination between cell-cycle control and vulval development (2000) Development, 127, pp. 4049-4060; Ambros, V., Cell cycle-dependent sequencing of cell fate decisions in Caenorhabditis elegans vulva precursor cells (1999) Development, 126, pp. 1947-1956; Li, J., Greenwald, I., LIN-14 inhibition of LIN-12 contributes to precision and timing of C. elegans vulval fate patterning (2010) Curr Biol, 20, pp. 1875-1879; Nusser-Stein, S., Beyer, A., Rimann, I., Adamczyk, M., Piterman, N., Hajnal, A., Fisher, J., Cell-cycle regulation of NOTCH signaling during C. elegans vulval development (2012) Mol Syst Biol, 8, pp. 618-714; Kipreos, E.T., Lander, L.E., Wing, J.P., He, W.W., Hedgecock, E.M., Cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family (1996) Cell, 85, pp. 829-839; Kipreos, E.T., Gohel, S.P., Hedgecock, E.M., The C. elegans F-box/WD-repeat protein LIN-23 functions to limit cell division during development (2000) Development, 127, pp. 5071-5082; Sharma-Kishore, R., White, J.G., Southgate, E., Podbilewicz, B., Formation of the vulva in Caenorhabditis elegans: a paradigm for organogenesis (1999) Development, 126, pp. 691-699; Shemer, G., Kishore, R., Podbilewicz, B., Ring formation drives invagination of the vulva in Caenorhabditis elegans: Ras, cell fusion, and cell migration determine structural fates (2000) Dev Biol, 221, pp. 233-248; Green, J.L., Inoue, T., Sternberg, P.W., Opposing Wnt pathways orient cell polarity during organogenesis (2008) Cell, 134, pp. 646-656; Sapir, A., Choi, J., Leikina, E., Avinoam, O., Valansi, C., Chernomordik, L.V., Newman, A.P., Podbilewicz, B., AFF-1, a FOS-1-regulated fusogen, mediates fusion of the anchor cell in C. elegans (2007) Dev Cell, 12, pp. 683-698; Dalpé, G., Brown, L., Culotti, J., Vulva morphogenesis involves attraction of plexin 1-expressing primordial vulva cells to semaphorin 1a sequentially expressed at the vulva midline (2005) Development, 132, pp. 1387-1400; Liu, Z., Fujii, T., Nukazuka, A., Kurokawa, R., Suzuki, M., C. elegans PlexinA PLX-1 mediates a cell contact-dependent stop signal in vulval precursor cells (2005) Dev Biol, 282, pp. 138-151; Dalpé, G., Zhang, L.W., Zheng, H., Culotti, J.G., Conversion of cell movement responses to Semaphorin-1 and Plexin-1 from attraction to repulsion by lowered levels of specific RAC GTPases in C. elegans (2004) Development, 131, pp. 2073-2088; Farooqui, S., Pellegrino, M.W., Rimann, I., Morf, M.K., Müller, L., Fröhli, E., Hajnal, A., Coordinated lumen contraction and expansion during vulval tube morphogenesis in Caenorhabditis elegans (2012) Dev Cell, 23, pp. 494-506; Estes, K.A., Hanna-Rose, W., The anchor cell initiates dorsal lumen formation during C. elegans vulval tubulogenesis (2009) Dev Biol, 328, pp. 297-304; Hanna-Rose, W., Han, M., The Caenorhabditis elegans EGL-26 protein mediates vulval cell morphogenesis (2002) Dev Biol, 241, pp. 247-258; Hwang, H.-Y., Horvitz, H.R., The Caenorhabditis elegans vulval morphogenesis gene sqv-4 encodes a UDP-glucose dehydrogenase that is temporally and spatially regulated (2002) Proc Natl Acad Sci U S A, 99, pp. 14224-14229; Hwang, H.-Y., Horvitz, H.R., The SQV-1 UDP-glucuronic acid decarboxylase and the SQV-7 nucleotide-sugar transporter may act in the Golgi apparatus to affect Caenorhabditis elegans vulval morphogenesis and embryonic development (2002) Proc Natl Acad Sci U S A, 99, pp. 14218-14223; Bulik, D.A., Wei, G., Toyoda, H., Kinoshita-Toyoda, A., Waldrip, W.R., Esko, J.D., Robbins, P.W., Selleck, S.B., Sqv-3, -7, and -8, a set of genes affecting morphogenesis in Caenorhabditis elegans, encode enzymes required for glycosaminoglycan biosynthesis (2000) Proc Natl Acad Sci U S A, 97, pp. 10838-10843; Herman, T., Hartwieg, E., Horvitz HR: sqv mutants of Caenorhabditis elegans are defective in vulval epithelial invagination (1999) Proc Natl Acad Sci U S A, 96, pp. 968-973; Sherwood, D.R., Sternberg, P.W., Anchor cell invasion into the vulval epithelium in C. elegans (2003) Dev Cell, 5, pp. 21-31; Sherwood, D.R., Butler, J.A., Kramer, J.M., Sternberg, P.W., FOS-1 promotes basement-membrane removal during anchor-cell invasion in C. elegans (2005) Cell, 121, pp. 951-962; Rimann, I., Hajnal, A., Regulation of anchor cell invasion and uterine cell fates by the egl-43 Evi-1 proto-oncogene in Caenorhabditis elegans (2007) Dev Biol, 308, pp. 187-195; Ziel, J.W., Hagedorn, E.J., Audhya, A., Sherwood, D.R., UNC-6 (netrin) orients the invasive membrane of the anchor cell in C. elegans (2009) Nat Cell Biol, 11, pp. 183-189; Hagedorn, E.J., Yashiro, H., Ziel, J.W., Ihara, S., Wang, Z., Sherwood, D.R., Integrin acts upstream of netrin signaling to regulate formation of the anchor cell's invasive membrane in C. elegans (2009) Dev Cell, 17, pp. 187-198; Hagedorn, E.J., Sherwood, D.R., Cell invasion through basement membrane: the anchor cell breaches the barrier (2011) Curr Opin Cell Biol, 23, pp. 589-596; Sun, X., Hong, P., Computational modeling of Caenorhabditis elegans vulval induction (2007) Bioinformatics, 23, pp. i499-i507; Giurumescu, C.A., Sternberg, P.W., Asthagiri, A.R., Intercellular coupling amplifies fate segregation during Caenorhabditis elegans vulval development (2006) Proc Natl Acad Sci U S A, 103, pp. 1331-1336; Fisher, J., Piterman, N., Hajnal, A., Henzinger, T.A., Predictive modeling of signaling crosstalk during C. elegans vulval development (2007) PLoS Comput Biol, 3, p. e92; Li, C., Nagasaki, M., Ueno, K., Miyano, S., Simulation-based model checking approach to cell fate specification during Caenorhabditis elegans vulval development by hybrid functional Petri net with extension (2009) BMC Syst Biol, 3, p. 42; Kam, N., Kugler, H., Marelly, R., Appleby, L., Fisher, J., Pnueli, A., Harel, D., Hubbard, E.J.A., A scenario-based approach to modeling development: a prototype model of C. elegans vulval fate specification (2008) Dev Biol, 323, pp. 1-5; Fisher, J., Piterman, N., Hubbard, E.J.A., Stern, M.J., Harel, D., Computational insights into Caenorhabditis elegans vulval development (2005) Proc Natl Acad Sci U S A, 102, pp. 1951-1956",Review,Scopus,2-s2.0-84922364443
"Pandey A., Singh P., Jauhari A., Singh T., Khan F., Pant A.B., Parmar D., Yadav S.","Critical role of the miR-200 family in regulating differentiation and proliferation of neurons",2015,"Journal of Neurochemistry","133","5",,"640","652",,,10.1111/jnc.13089,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928008783&partnerID=40&md5=06ccf6362364e6cfb685067f14b992b9","Developmental Toxicology Division, CSIR-Indian Institute of Toxicology Research, PO Box-80Uttar Pradesh, Lucknow, India; Academy of Scientific and Innovative Research (AcSIR)New Delhi, India; Department of Biochemistry, Jamia Hamdard UniversityNew Delhi, India","Pandey, A., Developmental Toxicology Division, CSIR-Indian Institute of Toxicology Research, PO Box-80Uttar Pradesh, Lucknow, India; Singh, P., Developmental Toxicology Division, CSIR-Indian Institute of Toxicology Research, PO Box-80Uttar Pradesh, Lucknow, India; Jauhari, A., Developmental Toxicology Division, CSIR-Indian Institute of Toxicology Research, PO Box-80Uttar Pradesh, Lucknow, India, Academy of Scientific and Innovative Research (AcSIR)New Delhi, India; Singh, T., Developmental Toxicology Division, CSIR-Indian Institute of Toxicology Research, PO Box-80Uttar Pradesh, Lucknow, India; Khan, F., Department of Biochemistry, Jamia Hamdard UniversityNew Delhi, India; Pant, A.B., Developmental Toxicology Division, CSIR-Indian Institute of Toxicology Research, PO Box-80Uttar Pradesh, Lucknow, India; Parmar, D., Developmental Toxicology Division, CSIR-Indian Institute of Toxicology Research, PO Box-80Uttar Pradesh, Lucknow, India; Yadav, S., Developmental Toxicology Division, CSIR-Indian Institute of Toxicology Research, PO Box-80Uttar Pradesh, Lucknow, India","The generation of differentiated and functional neurons is a complex process, which requires coordinated expression of several proteins and microRNAs (miRNAs). The present study using nerve growth factor (NGF)-differentiated PC12 cells led to the identification of miR-200, miR-221/222 and miR-34 families as major up-regulated miRNAs in fully differentiated neurons. Similar to PC12 cells, induction of miR-200 family was observed in differentiating neural stem cells, demonstrating a direct role of miR-200 family in neuronal differentiation. Over-expression of miR-200 induced neurite formation in PC12 cells and regulated neuronal markers in favour of differentiation. However, inhibition of miR-200 induced proliferation of PC12 cells. In differentiating PC12 cells and neural stem cells, an inverse relationship was observed between expression of reprogramming transcription factors (SOX2, KLF4, NANOG, OCT4 and PAX6) and miR-200. Over-expression of miR-200 in PC12 cells significantly down-regulated mRNA and protein levels of SOX2 and KLF4. Moreover, we observed two phases of dramatic down-regulation of miR-200 expression in developing rat brains correlating with periods of neuronal proliferation. In conclusion, our results indicate that increased expression of the miR-200 family promotes neuronal differentiation, while decreased expression of the miR-200 family promotes neuronal proliferation by targeting SOX2 and KLF4. © 2015 International Society for Neurochemistry.","microRNA; miR-200; neural stem cells; neurogenesis; PC12; senescence","Abdelmohsen, K., Hutchison, E.R., Lee, E.K., MiR-375 inhibits differentiation of neurites by lowering HuD levels (2010) Mol. Cell. Biol., 30, pp. 4197-4210; Abemayor, E., Sidell, N., Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation (1989) Environ. Health Perspect., 80, pp. 3-15; Agostini, M., Tucci, P., Killick, R., Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets (2011) Proc. Natl Acad. Sci. USA, 108, pp. 21093-21098; Agostini, M., Tucci, P., Steinert, J.R., MicroRNA-34a regulates neurite outgrowth, spinal morphology, and function (2011) Proc. Natl Acad. Sci. USA, 108, pp. 21099-21104; Andersson, T., Rahman, S., Sansom, S.N., Alsio, J.M., Kaneda, M., Smith, J., O'Carroll, D., Livesey, F.J., Reversible block of mouse neural stem cell differentiation in the absence of dicer and microRNAs (2010) PLoS ONE, 5, p. e13453; Aranha, M.M., Santos, D.M., Sola, S., Steer, C.J., Rodrigues, C.M., MiR-34a regulates mouse neural stem cell differentiation (2011) PLoS ONE, 6, p. e21396; Bandeira, F., Lent, R., Herculano-Houzel, S., Changing numbers of neuronal and non-neuronal cells underlie postnatal brain growth in the rat (2009) Proc. Natl Acad. Sci. USA, 106, pp. 14108-14113; Bartel, D.P., MicroRNAs: Target recognition and regulatory functions (2009) Cell, 136, pp. 215-233; Chambers, I., Tomlinson, S.R., The transcriptional foundation of pluripotency (2009) Development, 136, pp. 2311-2322; Chen, H., Shalom-Feuerstein, R., Riley, J., MiR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro (2010) Biochem. Biophys. Res. Commun., 394, pp. 921-927; Cheng, L.C., Pastrana, E., Tavazoie, M., Doetsch, F., MiR-124 regulates adult neurogenesis in the subventricular zone stem cell niche (2009) Nat. Neurosci., 12, pp. 399-408; Choi, P.S., Zakhary, L., Choi, W.Y., Members of the miRNA-200 family regulate olfactory neurogenesis (2008) Neuron, 57, pp. 41-55; Chung, J., Kubota, H., Ozaki, Y., Uda, S., Kuroda, S., Timing-dependent actions of NGF required for cell differentiation (2010) PLoS ONE, 5, p. e9011; Dannemann, M., Prufer, K., Lizano, E., Nickel, B., Burbano, H.A., Kelso, J., Transcription factors are targeted by differentially expressed miRNAs in primates (2012) Genome Biol. Evol., 4, pp. 552-564; Dill, H., Linder, B., Fehr, A., Fischer, U., Intronic miR-26b controls neuronal differentiation by repressing its host transcript, ctdsp2 (2012) Genes Dev., 26, pp. 25-30; Federoff, H.J., Grabczyk, E., Fishman, M.C., Dual regulation of GAP-43 gene expression by nerve growth factor and glucocorticoids (1988) J. Biol. Chem., 263, pp. 19290-19295; Fiore, R., Khudayberdiev, S., Saba, R., Schratt, G., MicroRNA function in the nervous system (2011) Prog. Mol. Biol. Transl. Sci., 102, pp. 47-100; Greene, L.A., Angelastro, J.M., You can't go home again: Transcriptionally driven alteration of cell signaling by NGF (2005) Neurochem. Res., 30, pp. 1347-1352; Greene, L.A., Tischler, A.S., Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor (1976) Proc. Natl Acad. Sci. USA, 73, pp. 2424-2428; Hamada, N., Fujita, Y., Kojima, T., Kitamoto, A., Akao, Y., Nozawa, Y., Ito, M., MicroRNA expression profiling of NGF-treated PC12 cells revealed a critical role for miR-221 in neuronal differentiation (2012) Neurochem. Int., 60, pp. 743-750; Hoffrogge, R., Mikkat, S., Scharf, C., 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM) (2006) Proteomics, 6, pp. 1833-1847; Hohjoh, H., Fukushima, T., Marked change in microRNA expression during neuronal differentiation of human teratocarcinoma NTera2D1 and mouse embryonal carcinoma P19 cells (2007) Biochem. Biophys. Res. Commun., 362, pp. 360-367; Ikenaka, K., Nakahira, K., Takayama, C., Wada, K., Hatanaka, H., Mikoshiba, K., Nerve growth factor rapidly induces expression of the 68-kDa neurofilament gene by posttranscriptional modification in PC12 h-R cells (1990) J. Biol. Chem., 265, pp. 19782-19785; Kawase-Koga, Y., Low, R., Otaegi, G., Pollock, A., Deng, H., Eisenhaber, F., Maurer-Stroh, S., Sun, T., RNAase-III enzyme Dicer maintains signaling pathways for differentiation and survival in mouse cortical neural stem cells (2010) J. Cell Sci., 123, pp. 586-594; Ko, M.H., Kim, S., Hwang Do, W., Ko, H.Y., Kim, Y.H., Lee, D.S., Bioimaging of the unbalanced expression of microRNA9 and microRNA9∗ during the neuronal differentiation of P19 cells (2008) FEBS J., 275, pp. 2605-2616; Le, M.T., Xie, H., Zhou, B., MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets (2009) Mol. Cell. Biol., 29, pp. 5290-5305; Lee, Y., Kim, M., Han, J., Yeom, K.H., Lee, S., Baek, S.H., Kim, V.N., MicroRNA genes are transcribed by RNA polymerase II (2004) EMBO J., 23, pp. 4051-4060; Li, N., You, X., Chen, T., Global profiling of miRNAs and the hairpin precursors: Insights into miRNA processing and novel miRNA discovery (2013) Nucleic Acids Res., 41, pp. 3619-3634; Makeyev, E.V., Zhang, J., Carrasco, M.A., Maniatis, T., The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing (2007) Mol. Cell, 27, pp. 435-448; Maurer, M.H., Feldmann, Jr.R.E., Futterer, C.D., Butlin, J., Kuschinsky, W., Comprehensive proteome expression profiling of undifferentiated versus differentiated neural stem cells from adult rat hippocampus (2004) Neurochem. Res., 29, pp. 1129-1144; Meseguer, S., Mudduluru, G., Escamilla, J.M., Allgayer, H., Barettino, D., MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF) (2011) J. Biol. Chem., 286, pp. 4150-4164; Mori, M.A., Raghavan, P., Thomou, T., Role of microRNA processing in adipose tissue in stress defense and longevity (2012) Cell Metab., 16, pp. 336-347; Peng, C., Li, N., Ng, Y.K., A unilateral negative feedback loop between miR-200 microRNAs and Sox2/E2F3 controls neural progenitor cell-cycle exit and differentiation (2012) The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 32, pp. 13292-13308; Saba, R., Schratt, G.M., MicroRNAs in neuronal development, function and dysfunction (2010) Brain Res., 1338, pp. 3-13; Scott, R.E., Florine, D.L., Wille, Jr.J.J., Yun, K., Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: GD (1982) Proc. Natl Acad. Sci. USA, 79, pp. 845-849; Sempere, L.F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., Ambros, V., Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation (2004) Genome Biol., 5, p. R13; Skaper, S.D., Selak, I., Varon, S., Serum vulnerability and time-dependent stabilization of neurites induced by nerve growth factor in PC12 pheochromocytoma cells (1983) J. Neurosci. Res., 10, pp. 303-315; Terasawa, K., Ichimura, A., Sato, F., Shimizu, K., Tsujimoto, G., Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells (2009) FEBS J., 276, pp. 3269-3276; Vaudry, D., Stork, P.J., Lazarovici, P., Eiden, L.E., Signaling pathways for PC12 cell differentiation: Making the right connections (2002) Science, 296, pp. 1648-1649; Wang, G., Guo, X., Hong, W., Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation (2013) Proc. Natl Acad. Sci. USA, 110, pp. 2858-2863; Yadav, S., Johri, A., Dhawan, A., Seth, P.K., Parmar, D., Regional specificity in delta methrin-induced cytochrome P450 expression in rat brain (2006) Toxicol. Appl. Pharmacol., 217, pp. 15-24; Yadav, S., Pandey, A., Shukla, A., Talwelkar, S.S., Kumar, A., Pant, A.B., Parmar, D., MiR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2 (2011) J. Biol. Chem., 286, pp. 37347-37357; Yu, J.Y., Chung, K.H., Deo, M., Thompson, R.C., Turner, D.L., MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation (2008) Exp. Cell Res., 314, pp. 2618-2633; Zhou, T., Xu, B., Que, H., Lin, Q., Lv, S., Liu, S., Neurons derived from PC12 cells have the potential to develop synapses with primary neurons from rat cortex (2006) Acta Neurobiol. Exp. (Wars), 66, pp. 105-112",Article,Scopus,2-s2.0-84928008783
"Ryu J.-H., Park M., Kim B.-K., Ryu K.-H., Woo S.-Y.","Tonsil-derived mesenchymal stromal cells produce CXCR2-binding chemokines and acquire follicular dendritic cell-like phenotypes under TLR3 stimulation",2015,"Cytokine","73","2",,"225","235",,,10.1016/j.cyto.2015.02.028,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924935061&partnerID=40&md5=a2f06f38306d4457651590a884a85f26","Department of Microbiology, School of Medicine, Ewha Womans UniversitySeoul, South Korea; Department of Pediatrics, School of Medicine, Ewha Womans UniversitySeoul, South Korea","Ryu, J.-H., Department of Microbiology, School of Medicine, Ewha Womans UniversitySeoul, South Korea; Park, M., Department of Microbiology, School of Medicine, Ewha Womans UniversitySeoul, South Korea; Kim, B.-K., Department of Microbiology, School of Medicine, Ewha Womans UniversitySeoul, South Korea; Ryu, K.-H., Department of Pediatrics, School of Medicine, Ewha Womans UniversitySeoul, South Korea; Woo, S.-Y., Department of Microbiology, School of Medicine, Ewha Womans UniversitySeoul, South Korea","We previously isolated mesenchymal stromal cells from human tonsils (T-MSCs) and showed the potential of these cells to differentiate into the mesodermal lineage and acquire a follicular dendritic cell (FDC) phenotype under cytokine stimulation. Because these T-MSCs were originally isolated from inflamed tonsillar tissues, we were curious about their activation status in response to innate immune stimuli, such as Toll-like receptors (TLRs). Therefore, we analyzed the expression profile of TLRs in T-MSCs and stimulated the T-MSCs with TLR agonists. TLR3 stimuli induced C-C chemokine receptor type 6 expression in T-MSCs after 24. h. Furthermore, results from cytokine arrays showed increases in epithelial neutrophil-activating peptide-78/C-X-C motif chemokine (CXCL) 5, granulocyte chemotactic protein-2/CXCL6, growth-related oncogene-α/CXCL1, interleukin-8/CXCL8, and interferon gamma-induced protein-10/CXCL10. CD54 expression was also increased after TLR3 stimulation. However, co-culturing T-MSCs with human B cells did not induce B-cell proliferation. This suggests that TLR3 stimulates the differentiation of T-MSCs into FDC-like cells and induces chemokine secretion, possibly by recruiting C-X-C chemokine receptor 2-expressing immune cells. In addition, T-MSCs also appeared to exert immunomodulatory effects by inhibiting B-cell proliferation, possibly by down-regulating CD18. © 2015 Elsevier Ltd.","B cells; CD54; CXCR2; Toll-like receptors; Tonsil-derived mesenchymal stromal cells","Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas (2005) Cancer Res, 65, pp. 3307-3318; Picinich, S.C., Mishra, P.J., Mishra, P.J., Glod, J., Banerjee, D., The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy (2007) Expert Opin Biol Ther, 7, pp. 965-973; Ozawa, K., Sato, K., Oh, I., Ozaki, K., Uchibori, R., Obara, Y., Cell and gene therapy using mesenchymal stem cells (MSCs) (2008) J Autoimmun, 30, pp. 121-127; Aggarwal, S., Pittenger, M.F., Human mesenchymal stem cells modulate allogeneic immune cell responses (2005) Blood, 105, pp. 1815-1822; Prockop, D.J., Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms (2009) Mol Ther, 17, pp. 939-946; Ohtaki, H., Ylostalo, J.H., Foraker, J.E., Robinson, A.P., Reger, R.L., Shioda, S., Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses (2008) Proc Natl Acad Sci USA, 105, pp. 14638-14643; Cho, K.A., Woo, S.Y., Park, Y.S., Park, M.H., Ryu, K.H., Macrophage inflammatory protein-2 (MIP-2)/CXCR2 blockade attenuates acute graft-versus-host disease while preserving graft-versus-leukemia activity (2012) Biochem Biophys Res Commun, 426, pp. 558-564; Ryu, K.H., Cho, K.A., Park, H.S., Kim, J.Y., Woo, S.Y., Jo, I., Tonsil-derived mesenchymal stromal cells: evaluation of biologic, immunologic and genetic factors for successful banking (2012) Cytotherapy, 14, pp. 1193-1202; Cho, K.A., Kim, J.Y., Kim, H.S., Ryu, K.H., Woo, S.Y., Tonsil-derived mesenchymal progenitor cells acquire a follicular dendritic cell phenotype under cytokine stimulation (2012) Cytokine, 59, pp. 211-214; Romieu-Mourez, R., Francois, M., Boivin, M.N., Bouchentouf, M., Spaner, D.E., Galipeau, J., Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype (2009) J Immunol, 182, pp. 7963-7973; Hwa Cho, H., Bae, Y.C., Jung, J.S., Role of toll-like receptors on human adipose-derived stromal cells (2006) Stem Cells, 24, pp. 2744-2752; Pevsner-Fischer, M., Morad, V., Cohen-Sfady, M., Rousso-Noori, L., Zanin-Zhorov, A., Cohen, S., Toll-like receptors and their ligands control mesenchymal stem cell functions (2007) Blood, 109, pp. 1422-1432; Lei, J., Wang, Z., Hui, D., Yu, W., Zhou, D., Xia, W., Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity (2011) Cell Immunol, 271, pp. 147-156; Waterman, R.S., Tomchuck, S.L., Henkle, S.L., Betancourt, A.M., A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype (2010) PLoS ONE, 5, p. e10088; Garin, A., Meyer-Hermann, M., Contie, M., Figge, M.T., Buatois, V., Gunzer, M., Toll-like receptor 4 signaling by follicular dendritic cells is pivotal for germinal center onset and affinity maturation (2010) Immunity, 33, pp. 84-95; Rookhuizen, D.C., DeFranco, A.L., Toll-like receptor 9 signaling acts on multiple elements of the germinal center to enhance antibody responses (2014) Proc Natl Acad Sci USA, 111, pp. E3224-E3233; Zhou, Y., Guo, M., Wang, X., Li, J., Wang, Y., Ye, L., TLR3 activation efficiency by high or low molecular mass poly I:C (2013) Innate Immun, 19, pp. 184-192; Koopman, G., Parmentier, H.K., Schuurman, H.J., Newman, W., Meijer, C.J., Pals, S.T., Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways (1991) J Exp Med, 173, pp. 1297-1304; Clark, E.A., Grabstein, K.H., Shu, G.L., Cultured human follicular dendritic cells. Growth characteristics and interactions with B lymphocytes (1992) J Immunol, 148, pp. 3327-3335; DelaRosa, O., Lombardo, E., Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential (2010) Mediators Inflamm, 2010, p. 865601; Raicevic, G., Najar, M., Stamatopoulos, B., De Bruyn, C., Meuleman, N., Bron, D., The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties (2011) Cell Immunol, 270, pp. 207-216; Hirota, K., Yoshitomi, H., Hashimoto, M., Maeda, S., Teradaira, S., Sugimoto, N., Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model (2007) J Exp Med, 204, pp. 2803-2812; Lee, A.Y., Eri, R., Lyons, A.B., Grimm, M.C., Korner, H., CC chemokine ligand 20 and its cognate receptor CCR6 in mucosal T cell immunology and inflammatory bowel disease: odd couple or axis of evil? (2013) Front Immunol, 4, p. 194; Min Sung Park, Y.H.K., Jung, Y., Kim, S.H., Park, J.C., Yoon, D.S., Kim, S.-H., In situ recruitment of human BMSCs using chemokines for articular cartilage regeneration (2014) Cell Transplant; Lee, Y.S., Won, K.J., Park, S.W., Lee, H.W., Kim, B., Kim, J.H., Mesenchymal stem cells regulate the proliferation of T cells via the growth-related oncogene/CXC chemokine receptor, CXCR2 (2012) Cell Immunol, 279, pp. 1-11; Liotta, F., Angeli, R., Cosmi, L., Fili, L., Manuelli, C., Frosali, F., Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling (2008) Stem Cells, 26, pp. 279-289; Uccelli, A., Moretta, L., Pistoia, V., Immunoregulatory function of mesenchymal stem cells (2006) Eur J Immunol, 36, pp. 2566-2573; Koopman, G., Keehnen, R.M., Lindhout, E., Newman, W., Shimizu, Y., van Seventer, G.A., Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells (1994) J Immunol, 152, pp. 3760-3767; Palecek, S.P., Loftus, J.C., Ginsberg, M.H., Lauffenburger, D.A., Horwitz, A.F., Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness (1997) Nature, 385, pp. 537-540",Article,Scopus,2-s2.0-84924935061
"Kwon H.R., Larsen M.","The contribution of specific cell subpopulations to submandibular salivary gland branching morphogenesis",2015,"Current Opinion in Genetics and Development","32",,,"47","54",,,10.1016/j.gde.2015.01.007,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84923008497&partnerID=40&md5=ab99c062658891a0ca047f2a92ad5c0c","Graduate Program in Molecular, Cellular, Developmental and Neural Biology, University at Albany, SUNYAlbany, NY, United States; Department of Biological Sciences, University at Albany, SUNYAlbany, NY, United States","Kwon, H.R., Graduate Program in Molecular, Cellular, Developmental and Neural Biology, University at Albany, SUNYAlbany, NY, United States, Department of Biological Sciences, University at Albany, SUNYAlbany, NY, United States; Larsen, M., Department of Biological Sciences, University at Albany, SUNYAlbany, NY, United States","Branching morphogenesis is the developmental program responsible for generating a large surface to volume ratio in many secretory and absorptive organs. To accomplish branching morphogenesis, spatiotemporal regulation of specific cell subpopulations is required. Here, we review recent studies that define the contributions of distinct cell subpopulations to specific cellular processes during branching morphogenesis in the mammalian submandibular salivary gland, including the initiation of the gland, the coordination of cleft formation, and the contribution of stem/progenitor cells to morphogenesis. In conclusion, we provide an overview of technological advances that have opened opportunities to further probe the contributions of specific cell subpopulations and to define the integration of events required for branching morphogenesis. © 2015 Elsevier Ltd.",,"Borghese, E., Explantation experiments on the influence of the connective tissue capsule on the development of the epithelial part of the submandibular gland of Mus musculus (1950) J Anat, 84, pp. 303-318; Borghese, E., The development in vitro of the submandibular and sublingual glands of Mus musculus (1950) J Anat, 84, pp. 287-302; Ohuchi, H., Hori, Y., Yamasaki, M., Harada, H., Sekine, K., Kato, S., Itoh, N., FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development (2000) Biochem Biophys Res Commun, 277, pp. 643-649; Hoffman, M.P., Kidder, B.L., Steinberg, Z.L., Lakhani, S., Ho, S., Kleinman, H.K., Larsen, M., Gene expression profiles of mouse submandibular gland development: FGFR1 regulates branching morphogenesis in vitro through BMP- and FGF-dependent mechanisms (2002) Development, 129, pp. 5767-5778; Peters, S.B., Naim, N., Nelson, D.A., Mosier, A.P., Cady, N.C., Larsen, M., Biocompatible tissue scaffold compliance promotes salivary gland morphogenesis and differentiation (2014) Tissue Eng Part A, 20, pp. 1632-1642; Wei, C., Larsen, M., Hoffman, M.P., Yamada, K.M., Self-organization and branching morphogenesis of primary salivary epithelial cells (2007) Tissue Eng, 13, pp. 721-735; Knox, S.M., Lombaert, I.M., Reed, X., Vitale-Cross, L., Gutkind, J.S., Hoffman, M.P., Parasympathetic innervation maintains epithelial progenitor cells during salivary organogenesis (2010) Science, 329, pp. 1645-1647; Tucker, A.S., Salivary gland development (2007) Semin Cell Dev Biol, 18, pp. 237-244; Patel, V.N., Rebustini, I.T., Hoffman, M.P., Salivary gland branching morphogenesis (2006) Differentiation, 74, pp. 349-364; Ferreira, J.N., Hoffman, M.P., Interactions between developing nerves and salivary glands (2013) Organogenesis, 9, pp. 199-205; Knosp, W.M., Knox, S.M., Hoffman, M.P., Salivary gland organogenesis (2012) Wiley Interdiscip Rev Dev Biol, 1, pp. 69-82; Patel, V.N., Hoffman, M.P., Salivary gland development: a template for regeneration (2014) Semin Cell Dev Biol, pp. 52-60; Gresik, E.W., Koyama, N., Hayashi, T., Kashimata, M., Branching morphogenesis in the fetal mouse submandibular gland is codependent on growth factors and extracellular matrix (2009) J Med Invest, 56 (SUPPL), pp. 228-233; Rothova, M., Thompson, H., Lickert, H., Tucker, A.S., Lineage tracing of the endoderm during oral development (2012) Dev Dyn, 241, pp. 1183-1191; Jaskoll, T., Zhou, Y.M., Chai, Y., Makarenkova, H.P., Collinson, J.M., West, J.D., Hajihosseini, M.K., Melnick, M., Embryonic submandibular gland morphogenesis: stage-specific protein localization of FGFs, BMPs, Pax6 and Pax9 in normal mice and abnormal SMG phenotypes in FgfR2-IIIc(+/Delta), BMP7(-/-) and Pax6(-/-) mice (2002) Cell Tissue Org, 170, pp. 83-98; Wells, K.L., Gaete, M., Matalova, E., Deutsch, D., Rice, D., Tucker, A.S., Dynamic relationship of the epithelium and mesenchyme during salivary gland initiation: the role of Fgf10 (2013) Biol Open, 2, pp. 981-989; Govindarajan, V., Ito, M., Makarenkova, H.P., Lang, R.A., Overbeek, P.A., Endogenous and ectopic gland induction by FGF-10 (2000) Dev Biol, 225, pp. 188-200; Steinberg, Z., Myers, C., Heim, V.M., Lathrop, C.A., Rebustini, I.T., Stewart, J.S., Larsen, M., Hoffman, M.P., FGFR2b signaling regulates ex vivo submandibular gland epithelial cell proliferation and branching morphogenesis (2005) Development, 132, pp. 1223-1234; Dyachuk, V., Furlan, A., Shahidi, M.K., Giovenco, M., Kaukua, N., Konstantinidou, C., Pachnis, V., Muller, T., Neurodevelopment. Parasympathetic neurons originate from nerve-associated peripheral glial progenitors (2014) Science, 345, pp. 82-87; Matsumoto, K., Yoshitomi, H., Rossant, J., Zaret, K.S., Liver organogenesis promoted by endothelial cells prior to vascular function (2001) Science, 294, pp. 559-563; Lammert, E., Cleaver, O., Melton, D., Induction of pancreatic differentiation by signals from blood vessels (2001) Science, 294, pp. 564-567; Lazarus, A., Del-Moral, P.M., Ilovich, O., Mishani, E., Warburton, D., Keshet, E., A perfusion-independent role of blood vessels in determining branching stereotypy of lung airways (2011) Development, 138, pp. 2359-2368; Hines, E.A., Sun, X., Tissue crosstalk in lung development (2014) J Cell Biochem; DeFalco, T., Bhattacharya, I., Williams, A.V., Sams, D.M., Capel, B., Yolk-sac-derived macrophages regulate fetal testis vascularization and morphogenesis (2014) Proc Natl Acad Sci USA, 111, pp. E2384-E2393; Cool, J., DeFalco, T.J., Capel, B., Vascular-mesenchymal cross-talk through Vegf and Pdgf drives organ patterning (2011) Proc Natl Acad Sci USA, 108, pp. 167-172; Kera, H., Yuki, S., Nogawa, H., FGF7 signals are relayed to autocrine EGF family growth factors to induce branching morphogenesis of mouse salivary epithelium (2014) Dev Dyn, 243, pp. 552-559; Noguchi, Y., Okamoto, A., Kasama, T., Imajoh-Ohmi, S., Karatsu, T., Nogawa, H., Lysophosphatidic acid cooperates with EGF in inducing branching morphogenesis of embryonic mouse salivary epithelium (2006) Dev Dyn, 235, pp. 403-410; Chung, L., Yang, T.L., Huang, H.R., Hsu, S.M., Cheng, H.J., Huang, P.H., Semaphorin signaling facilitates cleft formation in the developing salivary gland (2007) Development, 134, pp. 2935-2945; Sakai, T., Larsen, M., Yamada, K.M., Fibronectin requirement in branching morphogenesis (2003) Nature, 423, pp. 876-881; Daley, W.P., Gulfo, K.M., Sequeira, S.J., Larsen, M., Identification of a mechanochemical checkpoint and negative feedback loop regulating branching morphogenesis (2009) Dev Biol, 336, pp. 169-182; Ray, S., Yuan, D., Dhulekar, N., Oztan, B., Yener, B., Larsen, M., Cell-based multi-parametric model of cleft progression during submandibular salivary gland branching morphogenesis (2013) PLoS Comput Biol, 9, p. e1003319; Kadoya, Y., Yamashina, S., Cellular dynamics of epithelial clefting during branching morphogenesis of the mouse submandibular gland (2010) Dev Dyn, 239, pp. 1739-1747; Daley, W.P., Gervais, E.M., Centanni, S.W., Gulfo, K.M., Nelson, D.A., Larsen, M., ROCK1-directed basement membrane positioning coordinates epithelial tissue polarity (2012) Development, 139, pp. 411-422; Daley, W.P., Kohn, J.M., Larsen, M., A focal adhesion protein-based mechanochemical checkpoint regulates cleft progression during branching morphogenesis (2011) Dev Dyn, 240, pp. 2069-2083; Joo, E.E., Yamada, K.M., MYPT1 regulates contractility and microtubule acetylation to modulate integrin adhesions and matrix assembly (2014) Nat Commun, 5, p. 3510; Ray, S., Fanti, J.A., Macedo, D.P., Larsen, M., LIM kinase regulation of cytoskeletal dynamics is required for salivary gland branching morphogenesis (2014) Mol Biol Cell, 25, pp. 2393-2407; Miyajima, H., Matsumoto, T., Sakai, T., Yamaguchi, S., An, S.H., Abe, M., Wakisaka, S., Imazato, S., Hydrogel-based biomimetic environment for in vitro modulation of branching morphogenesis (2011) Biomaterials, 32, pp. 6754-6763; Harunaga, J.S., Doyle, A.D., Yamada, K.M., Local and global dynamics of the basement membrane during branching morphogenesis require protease activity and actomyosin contractility (2014) Dev Biol, 394, pp. 197-205; Larsen, M., Wei, C., Yamada, K.M., Cell and fibronectin dynamics during branching morphogenesis (2006) J Cell Sci, 119, pp. 3376-3384; Onodera, T., Sakai, T., Hsu, J.C., Matsumoto, K., Chiorini, J.A., Yamada, K.M., Btbd7 regulates epithelial cell dynamics and branching morphogenesis (2010) Science, 329, pp. 562-565; Enger, T.B., Samad-Zadeh, A., Bouchie, M.P., Skarstein, K., Galtung, H.K., Mera, T., Walker, J., Faustman, D.L., The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's syndrome (2013) Lab Invest, 93, pp. 1203-1218; Haara, O., Fujimori, S., Schmidt-Ullrich, R., Hartmann, C., Thesleff, I., Mikkola, M.L., Ectodysplasin and Wnt pathways are required for salivary gland branching morphogenesis (2011) Development, 138, pp. 2681-2691; Rebustini, I.T., Myers, C., Lassiter, K.S., Surmak, A., Szabova, L., Holmbeck, K., Pedchenko, V., Hoffman, M.P., MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis (2009) Dev Cell, 17, pp. 482-493; Hsu, J.C., Koo, H., Harunaga, J.S., Matsumoto, K., Doyle, A.D., Yamada, K.M., Region-specific epithelial cell dynamics during branching morphogenesis (2013) Dev Dyn, 242, pp. 1066-1077; Carpenter, G.H., Khosravani, N., Ekstrom, J., Osailan, S.M., Paterson, K.P., Proctor, G.B., Altered plasticity of the parasympathetic innervation in the recovering rat submandibular gland following extensive atrophy (2009) Exp Physiol, 94, pp. 213-219; Denny, P.C., Liu, P., Denny, P.A., Evidence of a phenotypically determined ductal cell lineage in mouse salivary glands (1999) Anat Rec, 256, pp. 84-90; Lombaert, I.M., Brunsting, J.F., Wierenga, P.K., Faber, H., Stokman, M.A., Kok, T., Visser, W.H., Coppes, R.P., Rescue of salivary gland function after stem cell transplantation in irradiated glands (2008) PLoS One, 3, p. e2063; Chibly, A.M., Querin, L., Harris, Z., Limesand, K.H., Label-retaining cells in the adult murine salivary glands possess characteristics of adult progenitor cells (2014) PLoS One, 9, p. e107893; Arany, S., Catalan, M.A., Roztocil, E., Ovitt, C.E., Ascl3 knockout and cell ablation models reveal complexity of salivary gland maintenance and regeneration (2011) Dev Biol, 353, pp. 186-193; Bullard, T., Koek, L., Roztocil, E., Kingsley, P.D., Mirels, L., Ovitt, C.E., Ascl3 expression marks a progenitor population of both acinar and ductal cells in mouse salivary glands (2008) Dev Biol, 320, pp. 72-78; Rugel-Stahl, A., Elliott, M.E., Ovitt, C.E., Ascl3 marks adult progenitor cells of the mouse salivary gland (2012) Stem Cell Res, 8, pp. 379-387; Nelson, D.A., Manhardt, C., Kamath, V., Sui, Y., Santamaria-Pang, A., Can, A., Bello, M., Lazare, M., Quantitative single cell analysis of cell population dynamics during submandibular salivary gland development and differentiation (2013) Biol Open, 2, pp. 439-447; Lombaert, I.M., Abrams, S.R., Li, L., Eswarakumar, V.P., Sethi, A.J., Witt, R.L., Hoffman, M.P., Combined KIT and FGFR2b signaling regulates epithelial progenitor expansion during organogenesis (2013) Stem Cell Rep, 1, pp. 604-619; Wang, X., Qi, S., Wang, J., Xia, D., Qin, L., Zheng, Z., Wang, L., Ding, G., Spatial and temporal expression of c-Kit in the development of the murine submandibular gland (2014) J Mol Histol, 45, pp. 381-389; Ghazizadeh, S., Kwak, M., Analysis of histone H2BGFP retention in mouse submandibular gland reveals actively dividing stem cell populations (2014) Stem Cells Dev, , (E published ahead of print); Garcia-Gallastegui, P., Ibarretxe, G., Garcia-Ramirez, J.J., Baladron, V., Aurrekoetxea, M., Nueda, M.L., Naranjo, A.I., Laborda, J., DLK1 regulates branching morphogenesis and parasympathetic innervation of salivary glands through inhibition of NOTCH signalling (2014) Biol Cell, 106, pp. 237-253; Nedvetsky, P.I., Emmerson, E., Finley, J.K., Ettinger, A., Cruz-Pacheco, N., Prochazka, J., Haddox, C.L., Mostov, K.E., Parasympathetic innervation regulates tubulogenesis in the developing salivary gland (2014) Dev Cell, 30, pp. 449-462; Rebustini, I.T., Hayashi, T., Reynolds, A.D., Dillard, M.L., Carpenter, E.M., Hoffman, M.P., MiR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis (2012) Development, 139, pp. 191-202; Patel, V.N., Lombaert, I.M., Cowherd, S.N., Shworak, N.W., Xu, Y., Liu, J., Hoffman, M.P., Hs3st3-modified heparan sulfate controls KIT+ progenitor expansion by regulating 3-O-sulfotransferases (2014) Dev Cell, 29, pp. 662-673; Patel, N., Sharpe, P.T., Miletich, I., Coordination of epithelial branching and salivary gland lumen formation by Wnt and FGF signals (2011) Dev Biol, 358, pp. 156-167; Yamamoto, S., Fukumoto, E., Yoshizaki, K., Iwamoto, T., Yamada, A., Tanaka, K., Suzuki, H., Yuasa, K., Platelet-derived growth factor receptor regulates salivary gland morphogenesis via fibroblast growth factor expression (2008) J Biol Chem, 283, pp. 23139-23149; Hick, A.C., van Eyll, J.M., Cordi, S., Forez, C., Passante, L., Kohara, H., Nagasawa, T., Rousseau, G.G., Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1 (2009) BMC Dev Biol, 9, p. 66; Musselmann, K., Green, J.A., Sone, K., Hsu, J.C., Bothwell, I.R., Johnson, S.A., Harunaga, J.S., Yamada, K.M., Salivary gland gene expression atlas identifies a new regulator of branching morphogenesis (2011) J Dent Res, 90, pp. 1078-1084; Diez-Roux, G., Banfi, S., Sultan, M., Geffers, L., Anand, S., Rozado, D., Magen, A., Peluso, I., A high-resolution anatomical atlas of the transcriptome in the mouse embryo (2011) PLoS Biol, 9, p. e1000582; Yang, H., Wang, H., Shivalila, C.S., Cheng, A.W., Shi, L., Jaenisch, R., One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering (2013) Cell, 154, pp. 1370-1379; Larson, M.H., Gilbert, L.A., Wang, X., Lim, W.A., Weissman, J.S., Qi, L.S., CRISPR interference (CRISPRi) for sequence-specific control of gene expression (2013) Nat Protoc, 8, pp. 2180-2196; Wang, H., Yang, H., Shivalila, C.S., Dawlaty, M.M., Cheng, A.W., Zhang, F., Jaenisch, R., One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering (2013) Cell, 153, pp. 910-918; Sequeira, S.J., Gervais, E.M., Ray, S., Larsen, M., Genetic modification and recombination of salivary gland organ cultures (2013) J Vis Exp, p. e50060; Hsu, J.C., Di Pasquale, G., Harunaga, J.S., Onodera, T., Hoffman, M.P., Chiorini, J.A., Yamada, K.M., Viral gene transfer to developing mouse salivary glands (2012) J Dent Res, 91, pp. 197-202; Weigert, R., Porat-Shliom, N., Amornphimoltham, P., Imaging cell biology in live animals: ready for prime time (2013) J Cell Biol, 201, pp. 969-979; Jones, S.A., Shim, S.H., He, J., Zhuang, X., Fast, three-dimensional super-resolution imaging of live cells (2011) Nat Methods, 8, pp. 499-508",Review,Scopus,2-s2.0-84923008497
"Gilboa L.","Organizing stem cell units in the Drosophila ovary",2015,"Current Opinion in Genetics and Development","32",,,"31","36",,,10.1016/j.gde.2015.01.005,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84922978812&partnerID=40&md5=a2d412d123dceba63cfb9de8b03636cc","Department of Biological Regulation, Weizmann Institute of ScienceRehovot, Israel","Gilboa, L., Department of Biological Regulation, Weizmann Institute of ScienceRehovot, Israel","Organogenesis utilizes processes fundamental to development: cell proliferation, cell differentiation and morphogenesis. Each of these processes is complex in itself; the challenge of studying organogenesis is to determine how all of them integrate to shape organs with recurring precision. This review focuses on the emerging understanding of how synchronized proliferation and differentiation of both somatic and germ cell lineages form 16-20 germ line stem cell (GSC) units in the ovary of Drosophila melanogaster. Recent work demonstrates that the Insulin, ecdysone, Epidermal Growth Factor, Decapentaplegic and Activin signaling pathways are used reiteratively for proliferation and differentiation in both somatic and germ cell lineages. This linkage underlies ovarian coordinated development and provides opportunity for correction mechanisms for stem cell unit numbers. © 2015 Published by Elsevier Ltd.",,"Spradling, A., Developmental genetics of oogenesis (1993) The Development of Drosophila melanogaster, 1, pp. 1-71. , Cold Spring Harbor Laboratory Press; Fuller, M.T., Spradling, A.C., Male and female Drosophila germline stem cells: two versions of immortality (2007) Science, 316, pp. 402-404; Kirilly, D., Xie, T., The Drosophila ovary: an active stem cell community (2007) Cell Res, 17, pp. 15-25; Spradling, A., Fuller, M.T., Braun, R.E., Yoshida, S., Germline stem cells (2011) Cold Spring Harb Perspect Biol, 3, p. a002642; Riechmann, V., Rehorn, K.P., Reuter, R., Leptin, M., The genetic control of the distinction between fat body and gonadal mesoderm in Drosophila (1998) Development, 125, pp. 713-723; Broihier, H.T., Moore, L.A., Van Doren, M., Newman, S., Lehmann, R., Zfh-1 is required for germ cell migration and gonadal mesoderm development in Drosophila (1998) Development, 125, pp. 655-666; Moore, L.A., Broihier, H.T., Van Doren, M., Lunsford, L.B., Lehmann, R., Identification of genes controlling germ cell migration and embryonic gonad formation in Drosophila (1998) Development, 125, pp. 667-678; Boyle, M., DiNardo, S., Specification, migration and assembly of the somatic cells of the Drosophila gonad (1995) Development, 121, pp. 1815-1825; Gilboa, L., Lehmann, R., Soma-germline interactions coordinate homeostasis and growth in the Drosophila gonad (2006) Nature, 443, pp. 97-100; Li, M.A., Alls, J.D., Avancini, R.M., Koo, K., Godt, D., The large Maf factor Traffic Jam controls gonad morphogenesis in Drosophila (2003) Nat Cell Biol, 5, pp. 994-1000; Sahut-Barnola, I., Dastugue, B., Couderc, J.-L., Terminal filament cell organization in the larval ovary of Drosophila melanogaster: ultrastructural observations and pattern of divisions (1996) Roux's Arch Dev Biol, 205, pp. 356-363; Zhu, C.H., Xie, T., Clonal expansion of ovarian germline stem cells during niche formation in Drosophila (2003) Development, 130, pp. 2579-2588; Asaoka, M., Lin, H., Germline stem cells in the Drosophila ovary descend from pole cells in the anterior region of the embryonic gonad (2004) Development, 131, pp. 5079-5089; Green, D.A., Extavour, C.G., Convergent evolution of a reproductive trait through distinct developmental mechanisms in Drosophila (2012) Dev Biol, 372, pp. 120-130; Jenkins, A.B., McCaffery, J.M., Van Doren, M., Drosophila E-cadherin is essential for proper germ cell-soma interaction during gonad morphogenesis (2003) Development, 130, pp. 4417-4426; Lengil, T., Gancz, D., Gilboa, L., Activin signaling balances proliferation and differentiation of ovarian niche precursors and enables adjustment of niche numbers (2015) Development, , (in press, PMID: 25633355); Bartoletti, M., Rubin, T., Chalvet, F., Netter, S., Dos Santos, N., Poisot, E., Paces-Fessy, M., Pret, A.M., Genetic basis for developmental homeostasis of germline stem cell niche number: a network of Tramtrack-Group nuclear BTB factors (2012) PLoS ONE, 7, p. e49958; Bolivar, J., Pearson, J., Lopez-Onieva, L., Gonzalez-Reyes, A., Genetic dissection of a stem cell niche: the case of the Drosophila ovary (2006) Dev Dyn, 235, pp. 2969-2979; Godt, D., Laski, F.A., Mechanisms of cell rearrangement and cell recruitment in Drosophila ovary morphogenesis and the requirement of bric a brac (1995) Development, 121, pp. 173-187; Sahut-Barnola, I., Godt, D., Laski, F.A., Couderc, J.L., Drosophila ovary morphogenesis: analysis of terminal filament formation and identification of a gene required for this process (1995) Dev Biol, 170, pp. 127-135; Song, X., Call, G.B., Kirilly, D., Xie, T., Notch signaling controls germline stem cell niche formation in the Drosophila ovary (2007) Development, 134, pp. 1071-1080; Song, X., Zhu, C.H., Doan, C., Xie, T., Germline stem cells anchored by adherens junctions in the Drosophila ovary niches (2002) Science, 296, pp. 1855-1857; Gancz, D., Gilboa, L., Insulin and target of rapamycin signaling orchestrate the development of ovarian niche-stem cell units in Drosophila (2013) Development, 140, pp. 4145-4154; Gancz, D., Lengil, T., Gilboa, L., Coordinated regulation of niche and stem cell precursors by hormonal signaling (2011) PLoS Biol, 9, p. e2021001; Cohen, E.D., Mariol, M.C., Wallace, R.M., Weyers, J., Kamberov, Y.G., Pradel, J., Wilder, E.L., DWnt4 regulates cell movement and focal adhesion kinase during Drosophila ovarian morphogenesis (2002) Dev Cell, 2, pp. 437-448; King, R.C., (1970) Ovarian Development in Drosophila melanogaster, , Academic Press, New York; Sarikaya, D.P., Belay, A.A., Ahuja, A., Dorta, A., Green, D.A., Extavour, C.G., The roles of cell size and cell number in determining ovariole number in Drosophila (2012) Dev Biol, 363, pp. 279-289; Gilboa, L., Lehmann, R., Repression of primordial germ cell differentiation parallels germ line stem cell maintenance (2004) Curr Biol, 14, pp. 981-986; Kai, T., Spradling, A., Differentiating germ cells can revert into functional stem cells in Drosophila melanogaster ovaries (2004) Nature, 428, pp. 564-569; Wang, Z., Lin, H., Nanos maintains germline stem cell self-renewal by preventing differentiation (2004) Science, 303, pp. 2016-2019; Sato, T., Ueda, S., Niki, Y., Wingless signaling initiates mitosis of primordial germ cells during development in Drosophila (2008) Mech Dev, 125, pp. 498-507; Matsuoka, S., Hiromi, Y., Asaoka, M., Egfr signaling controls the size of the stem cell precursor pool in the Drosophila ovary (2013) Mech Dev, 130, pp. 241-253; Yogev, S., Schejter, E.D., Shilo, B.Z., Drosophila EGFR signalling is modulated by differential compartmentalization of Rhomboid intramembrane proteases (2008) EMBO J, 27, pp. 1219-1230; Gilbert, L.I., Rybczynski, R., Warren, J.T., Control and biochemical nature of the ecdysteroidogenic pathway (2002) Annu Rev Entomol, 47, pp. 883-916; Perissi, V., Rosenfeld, M.G., Controlling nuclear receptors: the circular logic of cofactor cycles (2005) Nat Rev Mol Cell Biol, 6, pp. 542-554; Schubiger, M., Carre, C., Antoniewski, C., Truman, J.W., Ligand-dependent de-repression via EcR/USP acts as a gate to coordinate the differentiation of sensory neurons in the Drosophila wing (2005) Development, 132, pp. 5239-5248; Schubiger, M., Truman, J.W., The RXR ortholog USP suppresses early metamorphic processes in Drosophila in the absence of ecdysteroids (2000) Development, 127, pp. 1151-1159; Hodin, J., Riddiford, L.M., The ecdysone receptor and ultraspiracle regulate the timing and progression of ovarian morphogenesis during Drosophila metamorphosis (1998) Dev Genes Evol, 208, pp. 304-317; Konig, A., Yatsenko, A.S., Weiss, M., Shcherbata, H.R., Ecdysteroids affect Drosophila ovarian stem cell niche formation and early germline differentiation (2011) EMBO J, 30, pp. 1549-1562",Review,Scopus,2-s2.0-84922978812
"Kapoor R., Fanibunda S.E., Desouza L.A., Guha S.K., Vaidya V.A.","Perspectives on thyroid hormone action in adult neurogenesis",2015,"Journal of Neurochemistry","133","5",,"599","616",,,10.1111/jnc.13093,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928017551&partnerID=40&md5=66e8fc4652a3591f67d084514863e831","Department of Biological Sciences, Tata Institute of Fundamental Research, Homi Bhabha RoadMumbai, India","Kapoor, R., Department of Biological Sciences, Tata Institute of Fundamental Research, Homi Bhabha RoadMumbai, India; Fanibunda, S.E., Department of Biological Sciences, Tata Institute of Fundamental Research, Homi Bhabha RoadMumbai, India; Desouza, L.A., Department of Biological Sciences, Tata Institute of Fundamental Research, Homi Bhabha RoadMumbai, India; Guha, S.K., Department of Biological Sciences, Tata Institute of Fundamental Research, Homi Bhabha RoadMumbai, India; Vaidya, V.A., Department of Biological Sciences, Tata Institute of Fundamental Research, Homi Bhabha RoadMumbai, India","Thyroid hormone exhibits profound effects on neural progenitor turnover, survival, maturation, and differentiation during perinatal development. Studies over the past decade have revealed that thyroid hormone continues to retain an important influence on progenitors within the neurogenic niches of the adult mammalian brain. The focus of the current review is to critically examine and summarize the current state of understanding of the role of thyroid hormone in regulating adult neurogenesis within the major neurogenic niches of the subgranular zone in the hippocampus and the subventricular zone lining the lateral ventricles. We review in depth the studies that highlight a role for thyroid hormone, in particular the TRa1 receptor isoform, in regulating progenitor survival and commitment to a neuronal fate. We also discuss putative models for the mechanism of action of thyroid hormone/TRa1 on specific stages of subgranular zone and subventricular zone progenitor development, and highlight potential thyroid hormone responsive target genes that may contribute to the neurogenic effects of thyroid hormone. The effects of thyroid hormone on adult neurogenesis are discussed in the context of a potential role of these effects in the cognitive- and moodrelated consequences of thyroid hormone dysfunction. Finally, we detail hitherto unexplored aspects of the effects of thyroid hormone on adult neurogenesis that provide impetus for future studies to gain a deeper mechanistic insight into the neurogenic effects of thyroid hormone. © 2015 International Society for Neurochemistry.","hippocampus; neural stem cell; progenitor; subgranular zone; subventricular zone; thyroid hormone receptor","Abel, E.D., Ahima, R.S., Boers, M.E., Elmquist, J.K., Wondisford, F.E., Critical role for thyroid hormone receptor beta2 in the regulation of paraventricular thyrotropin-releasing hormone neurons (2001) J. Clin. Invest., 107, pp. 1017-1023; Alisi, A., Spagnuolo, S., Napoletano, S., Spaziani, A., Leoni, S., Thyroid hormones regulate DNA-synthesis and cell-cycle proteins by activation of PKCalpha and p42/44 MAPK in chick embryo hepatocytes (2004) J. Cell. Physiol., 201, pp. 259-265; Alvarez-Buylla, A., Garcia-Verdugo, J.M., Neurogenesis in adult subventricular zone (2002) J. Neurosci., 22, pp. 629-634; Alvarez-Dolado, M., Ruiz, M., Del Rio, J.A., Thyroid hormone regulates reelin and dab1 expression during brain development (1999) J. Neurosci., 19, pp. 6979-6993; Alvarez-Dolado, M., Figueroa, A., Kozlov, S., Sonderegger, P., Furley, A.J., Munoz, A., Thyroid hormone regulates TAG-1 expression in the developing rat brain (2001) Eur. J. Neurosci., 14, pp. 1209-1218; Ambrogini, P., Cuppini, R., Ferri, P., Mancini, C., Ciaroni, S., Voci, A., Gerdoni, E., Gallo, G., Thyroid hormones affect neurogenesis in the dentate gyrus of adult rat (2005) Neuroendocrinology, 81, pp. 244-253; Arrojo Drigo E, R., Fonseca, T.L., Werneck-De-Castro, J.P., Bianco, A.C., Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling (2013) Biochim. Biophys. Acta, 1830, pp. 3956-3964; Ashton, R.S., Conway, A., Pangarkar, C., Bergen, J., Lim, K.I., Shah, P., Bissell, M., Schaffer, D.V., Astrocytes regulate adult hippocampal neurogenesis through ephrin-B signaling (2012) Nat. Neurosci., 15, pp. 1399-1406; Astapova, I., Hollenberg, A.N., The in vivo role of nuclear receptor corepressors in thyroid hormone action (2013) Biochim. Biophys. Acta, 1830, pp. 3876-3881; Attardo, A., Fabel, K., Krebs, J., Haubensak, W., Huttner, W.B., Kempermann, G., Tis21 expression marks not only populations of neurogenic precursor cells but also new postmitotic neurons in adult hippocampal neurogenesis (2010) Cereb. Cortex, 20, pp. 304-314; Axelstad, M., Hansen, P.R., Boberg, J., Bonnichsen, M., Nellemann, C., Lund, S.P., Hougaard, K.S., Hass, U., Developmental neurotoxicity of propylthiouracil (PTU) in rats: Relationship between transient hypothyroxinemia during development and long-lasting behavioural and functional changes (2008) Toxicol. Appl. Pharmacol., 232, pp. 1-13; Baas, D., Bourbeau, D., Sarlieve, L.L., Ittel, M.E., Dussault, J.H., Puymirat, J., Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone (1997) Glia, 19, pp. 324-332; Baldini, I.M., Vita, A., Mauri, M.C., Amodei, V., Carrisi, M., Bravin, S., Cantalamessa, L., Psychopathological and cognitive features in subclinical hypothyroidism (1997) Prog. Neuropsychopharmacol. Biol. Psychiatry, 21, pp. 925-935; Bauer, M., Whybrow, P.C., Thyroid hormone, neural tissue and mood modulation (2001) World J. Biol. Psychiatry, 2, pp. 59-69; Bauer, M., Goetz, T., Glenn, T., Whybrow, P.C., The thyroid-brain interaction in thyroid disorders and mood disorders (2008) J. Neuroendocrinol., 20, pp. 1101-1114; Beard, M.D., MacKay-Sim, A., Loss of sense of smell in adult, hypothyroid mice (1987) Brain Res., 433, pp. 181-189; Berent, D., Zboralski, K., Orzechowska, A., Galecki, P., Thyroid hormones association with depression severity and clinical outcome in patients with major depressive disorder (2014) Mol. Biol. Rep., 41, pp. 2419-2425; Bergh, J.J., Lin, H.Y., Lansing, L., Mohamed, S.N., Davis, F.B., Mousa, S., Davis, P.J., Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis (2005) Endocrinology, 146, pp. 2864-2871; Bernal, J., Thyroid hormone receptors in brain development and function (2007) Nat. Clin. Pract. Endocrinol. Metab., 3, pp. 249-259; Bernal, J., Morte, B., Thyroid hormone receptor activity in the absence of ligand: Physiological and developmental implications (2013) Biochim. Biophys. Acta, 1830, pp. 3893-3899; Bernal, J., Nunez, J., Thyroid hormones and brain development (1995) Eur. J. Endocrinol., 133, pp. 390-398; Bianco, A.C., Minireview: Cracking the metabolic code for thyroid hormone signaling (2011) Endocrinology, 152, pp. 3306-3311; Bianco, A.C., Kim, B.W., Deiodinases: Implications of the local control of thyroid hormone action (2006) J. Clin. Invest., 116, pp. 2571-2579; Billon, N., Tokumoto, Y., Forrest, D., Raff, M., Role of thyroid hormone receptors in timing oligodendrocyte differentiation (2001) Dev. Biol., 235, pp. 110-120; Billon, N., Jolicoeur, C., Tokumoto, Y., Vennstrom, B., Raff, M., Normal timing of oligodendrocyte development depends on thyroid hormone receptor alpha 1 (TRalpha1) (2002) EMBO J., 21, pp. 6452-6460; Bradley, D.J., Towle, H.C., Young, W.S., III, Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system (1992) J. Neurosci., 12, pp. 2288-2302; Brandt, M.D., Jessberger, S., Steiner, B., Kronenberg, G., Reuter, K., Bick-Sander, A., Von Der Behrens, W., Kempermann, G., Transient calretinin expression defines early postmitotic step of neuronal differentiation in adult hippocampal neurogenesis of mice (2003) Mol. Cell Neurosci., 24, pp. 603-613; Braun, S.M., Jessberger, S., Adult neurogenesis: Mechanisms and functional significance (2014) Development, 141, pp. 1983-1986; Brent, G.A., Mechanisms of thyroid hormone action (2012) J. Clin. Invest., 122, pp. 3035-3043; Brunjes, P.C., Schwark, H.D., Greenough, W.T., Olfactory granule cell development in normal and hyperthyroid rats (1982) Brain Res., 281, pp. 149-159; Calza, L., Aloe, L., Giardino, L., Thyroid hormone-induced plasticity in the adult rat brain (1997) Brain Res. Bull., 44, pp. 549-557; Calza, L., Fernandez, M., Giuliani, A., D'Intino, G., Pirondi, S., Sivilia, S., Paradisi, M., Giardino, L., Thyroid hormone and remyelination in adult central nervous system: A lesson from an inflammatory-demyelinating disease (2005) Brain Res. Rev., 48, pp. 339-346; Calza, L., Fernandez, M., Giardino, L., Cellular approaches to central nervous system remyelination stimulation: Thyroid hormone to promote myelin repair via endogenous stem and precursor cells (2010) J. Mol. Endocrinol., 44, pp. 13-23; Cameron, H.A., McKay, R.D., Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus (2001) J. Comp. Neurol., 435, pp. 406-417; Cao, X., Kambe, F., Moeller, L.C., Refetoff, S., Seo, H., Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts (2005) Mol. Endocrinol., 19, pp. 102-112; Capet, C., Jego, A., Denis, P., Is cognitive change related to hypothyroidism reversible with replacement therapy? (2000) Rev. Med. Interne, 21, pp. 672-678; Carlson, D.J., Strait, K.A., Schwartz, H.L., Oppenheimer, J.H., Immunofluorescent localization of thyroid hormone receptor isoforms in glial cells of rat brain (1994) Endocrinology, 135, pp. 1831-1836; Carlson, D.J., Strait, K.A., Schwartz, H.L., Oppenheimer, J.H., Thyroid hormone receptor isoform content in cultured type 1 and type 2 astrocytes (1996) Endocrinology, 137, pp. 911-917; Chassande, O., Do unliganded thyroid hormone receptors have physiological functions? (2003) J. Mol. Endocrinol., 31, pp. 9-20; Chatonnet, F., Guyot, R., Benoit, G., Flamant, F., Genome-wide analysis of thyroid hormone receptors shared and specific functions in neural cells (2013) Proc. Natl Acad. Sci. USA, 110, pp. E766-E775; Chen, C., Zhou, Z., Zhong, M., Thyroid hormone promotes neuronal differentiation of embryonic neural stem cells by inhibiting STAT3 signaling through TRalpha1 (2012) Stem Cells Dev., 21, pp. 2667-2681; Cheng, S.Y., Leonard, J.L., Davis, P.J., Molecular aspects of thyroid hormone actions (2010) Endocr. Rev., 31, pp. 139-170; Chiamolera, M.I., Wondisford, F.E., Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism (2009) Endocrinology, 150, pp. 1091-1096; Cook, C.B., Koenig, R.J., Expression of erbA alpha and beta mRNAs in regions of adult rat brain (1990) Mol. Cell. Endocrinol., 70, pp. 13-20; Cook, C.B., Kakucska, I., Lechan, R.M., Koenig, R.J., Expression of thyroid hormone receptor beta 2 in rat hypothalamus (1992) Endocrinology, 130, pp. 1077-1079; Cooke, G.E., Mullally, S., Correia, N., O'Mara, S.M., Gibney, J., Hippocampal volume is decreased in adults with hypothyroidism (2014) Thyroid, 24, pp. 433-440; Cooper-Kazaz, R., Apter, J.T., Cohen, R., Combined treatment with sertraline and liothyronine in major depression: A randomized, double-blind, placebo-controlled trial (2007) Arch. Gen. Psychiatry, 64, pp. 679-688; D'Arezzo, S., Incerpi, S., Davis, F.B., Acconcia, F., Marino, M., Farias, R.N., Davis, P.J., Rapid nongenomic effects of 3,5,3a-triiodo-L-thyronine on the intracellular pH of L-6 myoblasts are mediated by intracellular calcium mobilization and kinase pathways (2004) Endocrinology, 145, pp. 5694-5703; Darras, V.M., Houbrechts, A.M., Van Herck, S.L., Intracellular thyroid hormone metabolism as a local regulator of nuclear thyroid hormone receptor-mediated impact on vertebrate development (2013) Biochim. Biophys. Acta, pp. 00110-00112. , 1874-9399; Daury, L., Busson, M., Casas, F., Cassar-Malek, I., Wrutniak-Cabello, C., Cabello, G., The triiodothyronine nuclear receptor c-ErbAalpha1 inhibits avian MyoD transcriptional activity in myoblasts (2001) FEBS Lett., 508, pp. 236-240; David, D.J., Wang, J., Samuels, B.A., Rainer, Q., David, I., Gardier, A.M., Hen, R., Implications of the functional integration of adult-born hippocampal neurons in anxiety-depression disorders (2010) Neuroscientist, 16, pp. 578-591; Davis, P.J., Shih, A., Lin, H.Y., Martino, L.J., Davis, F.B., Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR (2000) J. Biol. Chem., 275, pp. 38032-38039; Davis, P.J., Leonard, J.L., Davis, F.B., Mechanisms of nongenomic actions of thyroid hormone (2008) Front. Neuroendocrinol., 29, pp. 211-218; Davis, P.J., Davis, F.B., Lin, H.Y., Mousa, S.A., Zhou, M., Luidens, M.K., Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor (2009) Am. J. Physiol. Endocrinol. Metab., 297, pp. E1238-E1246; Demartini, B., Ranieri, R., Masu, A., Selle, V., Scarone, S., Gambini, O., Depressive symptoms and major depressive disorder in patients affected by subclinical hypothyroidism: A cross-sectional study (2014) J. Nerv. Ment. Dis., 202, pp. 603-607; Dentice, M., Marsili, A., Zavacki, A., Larsen, P.R., Salvatore, D., The deiodinases and the control of intracellular thyroid hormone signaling during cellular differentiation (2013) Biochim. Biophys. Acta, 1830, pp. 3937-3945; Desouza, L.A., Ladiwala, U., Daniel, S.M., Agashe, S., Vaidya, R.A., Vaidya, V.A., Thyroid hormone regulates hippocampal neurogenesis in the adult rat brain (2005) Mol. Cell Neurosci., 29, pp. 414-426; Desouza, L.A., Sathanoori, M., Kapoor, R., Rajadhyaksha, N., Gonzalez, L.E., Kottmann, A.H., Tole, S., Vaidya, V.A., Thyroid hormone regulates the expression of the sonic hedgehog signaling pathway in the embryonic and adult Mammalian brain (2011) Endocrinology, 152, pp. 1989-2000; Dezonne, R.S., Stipursky, J., Araujo, A.P., Nones, J., Pavao, M.S., Porcionatto, M., Gomes, F.C., Thyroid hormone treated astrocytes induce maturation of cerebral cortical neurons through modulation of proteoglycan levels (2013) Front. Cell. Neurosci., 7, p. 125; Dudazy-Gralla, S., Nordstrom, K., Hofmann, P.J., Meseh, D.A., Schomburg, L., Vennstrom, B., Mittag, J., Identification of thyroid hormone response elements in vivo using mice expressing a tagged thyroid hormone receptor alpha1 (2013) Biosci. Rep., 33, p. e00027; Dugbartey, A.T., Neurocognitive aspects of hypothyroidism (1998) Arch. Intern. Med., 158, pp. 1413-1418; Eisch, A.J., Petrik, D., Depression and hippocampal neurogenesis: A road to remission? (2012) Science, 338, pp. 72-75; Eitan, R., Landshut, G., Lifschytz, T., Einstein, O., Ben-Hur, T., Lerer, B., The thyroid hormone, triiodothyronine, enhances fluoxetine-induced neurogenesis in rats: Possible role in antidepressant-augmenting properties (2010) Int. J. Neuropsychopharmacol., 13, pp. 553-561; De Escobar, G.M., Obregon, M.J., Del Rey, F.E., Iodine deficiency and brain development in the first half of pregnancy (2007) Public Health Nutr., 10, pp. 1554-1570; Farioli-Vecchioli, S., Saraulli, D., Costanzi, M., Impaired terminal differentiation of hippocampal granule neurons and defective contextual memory in PC3/Tis21 knockout mice (2009) PLoS ONE, 4, p. e8339; Farwell, A.P., Nonthyroidal illness syndrome (2013) Curr. Opin. Endocrinol. Diabetes Obes., 20, pp. 478-484; Fernandez, M., Pirondi, S., Manservigi, M., Giardino, L., Calza, L., Thyroid hormone participates in the regulation of neural stem cells and oligodendrocyte precursor cells in the central nervous system of adult rat (2004) Eur. J. Neurosci., 20, pp. 2059-2070; Fernandez-Lamo, I., Montero-Pedrazuela, A., Delgado-Garcia, J.M., Guadano-Ferraz, A., Gruart, A., Effects of thyroid hormone replacement on associative learning and hippocampal synaptic plasticity in adult hypothyroid rats (2009) Eur. J. Neurosci., 30, pp. 679-692; Flamant, F., Gauthier, K., Thyroid hormone receptors: The challenge of elucidating isotype-specific functions and cell-specific response (2013) Biochim. Biophys. Acta, 1830, pp. 3900-3907; Forrest, D., Vennstrom, B., Functions of thyroid hormone receptors in mice (2000) Thyroid, 10, pp. 41-52; Forrest, D., Hanebuth, E., Smeyne, R.J., Everds, N., Stewart, C.L., Wehner, J.M., Curran, T., Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: Evidence for tissue-specific modulation of receptor function (1996) EMBO J., 15, pp. 3006-3015; Fundaro, A., Behavioral modifications in relation to hypothyroidism and hyperthyroidism in adult rats (1989) Prog. Neuropsychopharmacol. Biol. Psychiatry, 13, pp. 927-940; Furuya, F., Lu, C., Guigon, C.J., Cheng, S.Y., Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors (2009) Steroids, 74, pp. 628-634; Galea, L.A., Wainwright, S.R., Roes, M.M., Duarte-Guterman, P., Chow, C., Hamson, D.K., Sex, hormones and neurogenesis in the hippocampus: Hormonal modulation of neurogenesis and potential functional implications (2013) J. Neuroendocrinol., 25, pp. 1039-1061; Gao, F.B., Apperly, J., Raff, M., Cell-intrinsic timers and thyroid hormone regulate the probability of cell-cycle withdrawal and differentiation of oligodendrocyte precursor cells (1998) Dev. Biol., 197, pp. 54-66; Gilbert, M.E., Sui, L., Dose-dependent reductions in spatial learning and synaptic function in the dentate gyrus of adult rats following developmental thyroid hormone insufficiency (2006) Brain Res., 1069, pp. 10-22; Giordano, T., Pan, J.B., Casuto, D., Watanabe, S., Arneric, S.P., Thyroid hormone regulation of NGF, NT-3 and BDNF RNA in the adult rat brain (1992) Brain Res. Mol. Brain Res., 16, pp. 239-245; Gomes, F.C., Maia, C.G., De Menezes, J.R., Neto, V.M., Cerebellar astrocytes treated by thyroid hormone modulate neuronal proliferation (1999) Glia, 25, pp. 247-255; Goodman, R.H., Smolik, S., CBP/p300 in cell growth, transformation, and development (2000) Genes Dev., 14, pp. 1553-1577; Grimaldi, A., Buisine, N., Miller, T., Shi, Y.B., Sachs, L.M., Mechanisms of thyroid hormone receptor action during development: Lessons from amphibian studies (2013) Biochim. Biophys. Acta, 1830, pp. 3882-3892; Guissouma, H., Ghaddab-Zroud, R., Seugnet, I., Decherf, S., Demeneix, B., Clerget-Froidevaux, M.S., TR alpha 2 exerts dominant negative effects on hypothalamic Trh transcription in vivo (2014) PLoS ONE, 9, p. e95064; Haggerty, Jr.J.J., Prange, Jr.A.J., Borderline hypothyroidism and depression (1995) Annu. Rev. Med., 46, pp. 37-46; Harvey, C.B., Williams, G.R., Mechanism of thyroid hormone action (2002) Thyroid, 12, pp. 441-446; Henley, W.N., Koehnle, T.J., Thyroid hormones and the treatment of depression: An examination of basic hormonal actions in the mature mammalian brain (1997) Synapse, 27, pp. 36-44; Hernandez, A., Morte, B., Belinchon, M.M., Ceballos, A., Bernal, J., Critical role of types 2 and 3 deiodinases in the negative regulation of gene expression by T(3)in the mouse cerebral cortex (2012) Endocrinology, 153, pp. 2919-2928; Heuer, H., Maier, M.K., Iden, S., Mittag, J., Friesema, E.C., Visser, T.J., Bauer, K., The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations (2005) Endocrinology, 146, pp. 1701-1706; Horn, S., Heuer, H., Thyroid hormone action during brain development: More questions than answers (2010) Mol. Cell. Endocrinol., 315, pp. 19-26; Hoyk, Z., Szilágyi, T., Halász, N., Modulation by thyroid hormones of the development of external plexiform layer in the rat olfactory bulb (1996) Neurobiology, 4, pp. 45-57; Hu, X., Lazar, M.A., Transcriptional repression by nuclear hormone receptors (2000) Trends Endocrinol. Metab., 11, pp. 6-10; Incerpi, S., Luly, P., De Vito, P., Farias, R.N., Short-term effects of thyroid hormones on the Na/H antiport in L-6 myoblasts: High molecular specificity for 3,3a,5-triiodo-L-thyronine (1999) Endocrinology, 140, pp. 683-689; Ito, M., Roeder, R.G., The TRAP/SMCC/Mediator complex and thyroid hormone receptor function (2001) Trends Endocrinol. Metab., 12, pp. 127-134; Jackson, I.M., The thyroid axis and depression (1998) Thyroid, 8, pp. 951-956; Jansen, J., Friesema, E.C., Milici, C., Visser, T.J., Thyroid hormone transporters in health and disease (2005) Thyroid, 15, pp. 757-768; Jepsen, K., Rosenfeld, M.G., Biological roles and mechanistic actions of co-repressor complexes (2002) J. Cell Sci., 115, pp. 689-698; Johanson, I.B., Development of olfactory and thermal responsiveness in hypothyroid and hyperthyroid rat pups (1980) Dev. Psychobiol., 13, pp. 343-341; Kapoor, R., Van Hogerlinden, M., Wallis, K., Ghosh, H., Nordstrom, K., Vennstrom, B., Vaidya, V.A., Unliganded thyroid hormone receptor alpha1 impairs adult hippocampal neurogenesis (2010) FASEB J., 24, pp. 4793-4805; Kapoor, R., Ghosh, H., Nordstrom, K., Vennstrom, B., Vaidya, V.A., Loss of thyroid hormone receptor beta is associated with increased progenitor proliferation and NeuroD positive cell number in the adult hippocampus (2011) Neurosci. Lett., 487, pp. 199-203; Kapoor, R., Desouza, L.A., Nanavaty, I.N., Kernie, S.G., Vaidya, V.A., Thyroid hormone accelerates the differentiation of adult hippocampal progenitors (2012) J. Neuroendocrinol., 24, pp. 1259-1271; Kempermann, G., Jessberger, S., Steiner, B., Kronenberg, G., Milestones of neuronal development in the adult hippocampus (2004) Trends Neurosci., 27, pp. 447-452; Koenig, R.J., Lazar, M.A., Hodin, R.A., Brent, G.A., Larsen, P.R., Chin, W.W., Moore, D.D., Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing (1989) Nature, 337, pp. 659-661; Koibuchi, N., Chin, W.W., Thyroid hormone action and brain development (2000) Trends Endocrinol. Metab., 11, pp. 123-128; Koibuchi, N., Fukuda, H., Chin, W.W., Promoter-specific regulation of the brain-derived neurotropic factor gene by thyroid hormone in the developing rat cerebellum (1999) Endocrinology, 140, pp. 3955-3961; Koromilas, C., Liapi, C., Schulpis, K.H., Kalafatakis, K., Zarros, A., Tsakiris, S., Structural and functional alterations in the hippocampus due to hypothyroidism (2010) Metab. Brain Dis., 25, pp. 339-354; Kulikov, A., Torresani, J., Jeanningros, R., Experimental hypothyroidism increases immobility in rats in the forced swim paradigm (1997) Neurosci. Lett., 234, pp. 111-114; Lai, Y.J., Li, M.Y., Yang, C.Y., Huang, K.H., Tsai, J.C., Wang, T.W., TRIP6 regulates neural stem cell maintenance in the postnatal mammalian subventricular zone (2014) Dev. Dyn., 243, pp. 1130-1142; Laurberg, P., Thyroid function: Thyroid hormones, iodine and the brain-an important concern (2009) Nat. Rev. Endocrinol., 5, pp. 475-476; Lechan, R.M., Qi, Y., Jackson, I.M., Mahdavi, V., Identification of thyroid hormone receptor isoforms in thyrotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus (1994) Endocrinology, 135, pp. 92-100; Lee, S., Privalsky, M.L., Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties (2005) Mol. Endocrinol., 19, pp. 863-878; Lemkine, G.F., Raj, A., Alfama, G., Turque, N., Hassani, Z., Alegria-Prevot, O., Samarut, J., Demeneix, B.A., Adult neural stem cell cycling in vivo requires thyroid hormone and its alpha receptor (2005) FASEB J., 19, pp. 863-865; Leonard, J.L., Farwell, A.P., Thyroid hormone-regulated actin polymerization in brain (1997) Thyroid, 7, pp. 147-151; Lieberwirth, C., Wang, Z., The social environment and neurogenesis in the adult Mammalian brain (2012) Front. Hum. Neurosci., 6, p. 118; Lima, F.R., Trentin, A.G., Rosenthal, D., Chagas, C., Moura Neto, V., Thyroid hormone induces protein secretion and morphological changes in astroglial cells with an increase in expression of glial fibrillary acidic protein (1997) J. Endocrinol., 154, pp. 167-175; Lima, F.R., Goncalves, N., Gomes, F.C., De Freitas, M.S., Moura Neto, V., Thyroid hormone action on astroglial cells from distinct brain regions during development (1998) Int. J. Dev. Neurosci., 16, pp. 19-27; Liu, Y.Y., Brent, G.A., Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation (2010) Trends Endocrinol. Metab., 21, pp. 166-173; Lopez-Juarez, A., Remaud, S., Hassani, Z., Thyroid hormone signaling acts as a neurogenic switch by repressing Sox2 in the adult neural stem cell niche (2012) Cell Stem Cell, 10, pp. 531-543; Ma, D.K., Ming, G.L., Song, H., Glial influences on neural stem cell development: Cellular niches for adult neurogenesis (2005) Curr. Opin. Neurobiol., 15, pp. 514-520; MacKay-Sim, A., Beard, M.D., Hypothyroidism disrupts neural development in the olfactory epithelium of adult mice (1987) Brain Res., 433, pp. 190-198; Malberg, J.E., Eisch, A.J., Nestler, E.J., Duman, R.S., Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus (2000) J. Neurosci., 20, pp. 9104-9110; Manzano, J., Bernal, J., Morte, B., Influence of thyroid hormones on maturation of rat cerebellar astrocytes (2007) Int. J. Dev. Neurosci., 25, pp. 171-179; Martinez, R., Gomes, F.C., Neuritogenesis induced by thyroid hormone-treated astrocytes is mediated by epidermal growth factor/mitogen-activated protein kinase-phosphatidylinositol 3-kinase pathways and involves modulation of extracellular matrix proteins (2002) J. Biol. Chem., 277, pp. 49311-49318; Martinez, R., Gomes, F.C., Proliferation of cerebellar neurons induced by astrocytes treated with thyroid hormone is mediated by a cooperation between cell contact and soluble factors and involves the epidermal growth factor-protein kinase a pathway (2005) J. Neurosci. Res., 80, pp. 341-349; Martinez-Iglesias, O., Garcia-Silva, S., Tenbaum, S.P., Regadera, J., Larcher, F., Paramio, J.M., Vennstrom, B., Aranda, A., Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis (2009) Cancer Res., 69, pp. 501-509; Mellstrom, B., Naranjo, J.R., Santos, A., Gonzalez, A.M., Bernal, J., Independent expression of the alpha and beta c-erbA genes in developing rat brain (1991) Mol. Endocrinol., 5, pp. 1339-1350; Miller, B.R., Hen, R., The current state of the neurogenic theory of depression and anxiety (2014) Curr. Opin. Neurobiol., 30, pp. 51-58; Ming, G.L., Song, H., Adult neurogenesis in the mammalian central nervous system (2005) Annu. Rev. Neurosci., 28, pp. 223-250; Ming, G.L., Song, H., Adult neurogenesis in the mammalian brain: Significant answers and significant questions (2011) Neuron, 70, pp. 687-702; Mohacsik, P., Zeold, A., Bianco, A.C., Gereben, B., Thyroid hormone and the neuroglia: Both source and target (2011) J. Thyroid Res., 2011, p. 215718; Montero-Pedrazuela, A., Venero, C., Lavado-Autric, R., Fernandez-Lamo, I., Garcia-Verdugo, J.M., Bernal, J., Guadano-Ferraz, A., Modulation of adult hippocampal neurogenesis by thyroid hormones: Implications in depressive-like behavior (2006) Mol. Psychiatry, 11, pp. 361-371; Morte, B., Bernal, J., Thyroid hormone action: Astrocyte-neuron communication (2014) Front. Endocrinol., 5, p. 82; Morte, B., Manzano, J., Scanlan, T.S., Vennstrom, B., Bernal, J., Aberrant maturation of astrocytes in thyroid hormone receptor alpha 1 knockout mice reveals an interplay between thyroid hormone receptor isoforms (2004) Endocrinology, 145, pp. 1386-1391; Murata, Y., Multiple isoforms of thyroid hormone receptor: An analysis of their relative contribution in mediating thyroid hormone action (1998) Nagoya J. Med. Sci., 61, pp. 103-115; O'Shea, P.J., Williams, G.R., Insight into the physiological actions of thyroid hormone receptors from genetically modified mice (2002) J. Endocrinol., 175, pp. 553-570; Osterweil, D., Syndulko, K., Cohen, S.N., Pettler-Jennings, P.D., Hershman, J.M., Cummings, J.L., Tourtellotte, W.W., Solomon, D.H., Cognitive function in non-demented older adults with hypothyroidism (1992) J. Am. Geriatr. Soc., 40, pp. 325-335; Palha, J.A., Transthyretin as a thyroid hormone carrier: Function revisited (2002) Clin. Chem. Lab. Med., 40, pp. 1292-1300; Palha, J.A., Fernandes, R., De Escobar, G.M., Episkopou, V., Gottesman, M., Saraiva, M.J., Transthyretin regulates thyroid hormone levels in the choroid plexus, but not in the brain parenchyma: Study in a transthyretin-null mouse model (2000) Endocrinology, 141, pp. 3267-3272; Pascual, A., Aranda, A., Thyroid hormone receptors, cell growth and differentiation (2013) Biochim. Biophys. Acta, 1830, pp. 3908-3916; Paternostro, M.A., Meisami, E., Lack of thyroid hormones but not their excess affects the maturation of olfactory receptor neurons: A quantitative morphologic study in the postnatal rat (1991) Int. J. Dev. Neurosci., 9, pp. 439-452; Paternostro, M.A., Meisami, E., Developmental plasticity of the rat olfactory receptor sheet as shown by complete recovery of surface area and cell number from extensive early hypothyroid growth retardation (1993) Brain Res. Dev. Brain Res., 76, pp. 151-161; Paternostro, M.A., Meisami, E., Marked restoration of density and total number of mature (knob-bearing) olfactory receptor neurons in rats recovering from early hypothyroid-induced growth retardation (1996) Brain Res. Dev. Brain Res., 96, pp. 173-183; Perez-Domper, P., Gradari, S., Trejo, J.L., The growth factors cascade and the dendrito-/synapto-genesis versus cell survival in adult hippocampal neurogenesis: The chicken or the egg (2013) Ageing Res. Rev., 12, pp. 777-785; Pilhatsch, M., Winter, C., Nordstrom, K., Vennstrom, B., Bauer, M., Juckel, G., Increased depressive behaviour in mice harboring the mutant thyroid hormone receptor alpha 1 (2010) Behav. Brain Res., 214, pp. 187-192; Pilhatsch, M., Marxen, M., Winter, C., Smolka, M.N., Bauer, M., Hypothyroidism and mood disorders: Integrating novel insights from brain imaging techniques (2011) Thyroid Res., 4, p. S3; Preau, L., Fini, J.B., Morvan-Dubois, G., Demeneix, B., Thyroid hormone signaling during early neurogenesis and its significance as a vulnerable window for endocrine disruption (2014) Biochim. Biophys. Acta, pp. 00167-00169. , S1874-9399; Privalsky, M.L., The role of corepressors in transcriptional regulation by nuclear hormone receptors (2004) Annu. Rev. Physiol., 66, pp. 315-360; Quignodon, L., Legrand, C., Allioli, N., Thyroid hormone signaling is highly heterogeneous during pre- and postnatal brain development (2004) J. Mol. Endocrinol., 33, pp. 467-476; Remaud, S., Gothie, J.D., Morvan-Dubois, G., Demeneix, B.A., Thyroid hormone signaling and adult neurogenesis in mammals (2014) Front. Endocrinol., 5, p. 62; Richardson, S.J., Lemkine, G.F., Alfama, G., Hassani, Z., Demeneix, B.A., Cell division and apoptosis in the adult neural stem cell niche are differentially affected in transthyretin null mice (2007) Neurosci. Lett., 421, pp. 234-238; Rodriguez-Pena, A., Oligodendrocyte development and thyroid hormone (1999) J. Neurobiol., 40, pp. 497-512; Sakamoto, M., Kageyama, R., Imayoshi, I., The functional significance of newly born neurons integrated into olfactory bulb circuits (2014) Front. Neurosci., 8, p. 121; Salto, C., Kindblom, J.M., Johansson, C., Ablation of TRalpha2 and a concomitant overexpression of alpha1 yields a mixed hypo- and hyperthyroid phenotype in mice (2001) Mol. Endocrinol., 15, pp. 2115-2128; Santarelli, L., Saxe, M., Gross, C., Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants (2003) Science, 301, pp. 805-809; Sarkar, P.K., In quest of thyroid hormone function in mature mammalian brain (2002) Indian J. Exp. Biol., 40, pp. 865-873; Schroeder, A.C., Privalsky, M.L., Thyroid hormones, t3 and t4, in the brain (2014) Front. Endocrinol., 5, p. 40; Schwartz, H.L., Strait, K.A., Ling, N.C., Oppenheimer, J.H., Quantitation of rat tissue thyroid hormone binding receptor isoforms by immunoprecipitation of nuclear triiodothyronine binding capacity (1992) J. Biol. Chem., 267, pp. 11794-11799; Schweizer, U., Kohrle, J., Function of thyroid hormone transporters in the central nervous system (2013) Biochim. Biophys. Acta, 1830, pp. 3965-3973; Seri, B., Garcia-Verdugo, J.M., McEwen, B.S., Alvarez-Buylla, A., Astrocytes give rise to new neurons in the adult mammalian hippocampus (2001) J. Neurosci., 21, pp. 7153-7160; Shiraki, A., Akane, H., Ohishi, T., Wang, L., Morita, R., Suzuki, K., Mitsumori, K., Shibutani, M., Similar distribution changes of GABAergic interneuron subpopulations in contrast to the different impact on neurogenesis between developmental and adult-stage hypothyroidism in the hippocampal dentate gyrus in rats (2012) Arch. Toxicol., 86, pp. 1559-1569; Silva, F.G., Giannocco, G., Santos, M.F., Nunes, M.T., Thyroid hormone induction of actin polymerization in somatotrophs of hypothyroid rats: Potential repercussions in growth hormone synthesis and secretion (2006) Endocrinology, 147, pp. 5777-5785; Sirakov, M., Skah, S., Nadjar, J., Plateroti, M., Thyroid hormone's action on progenitor/stem cell biology: New challenge for a classic hormone? (2013) Biochim. Biophys. Acta, 1830, pp. 3917-3927; Smith, J.W., Evans, A.T., Costall, B., Smythe, J.W., Thyroid hormones, brain function and cognition: A brief review (2002) Neurosci. Biobehav. Rev., 26, pp. 45-60; St Germain, D.L., Galton, V.A., Hernandez, A., Minireview: Defining the roles of the iodothyronine deiodinases: Current concepts and challenges (2009) Endocrinology, 150, pp. 1097-1107; Tagami, T., Yamamoto, H., Moriyama, K., Sawai, K., Usui, T., Shimatsu, A., Naruse, M., The retinoid X receptor binding to the thyroid hormone receptor: Relationship with cofactor binding and transcriptional activity (2009) J. Mol. Endocrinol., 42, pp. 415-428; Taupin, P., BrdU immunohistochemistry for studying adult neurogenesis: Paradigms, pitfalls, limitations, and validation (2007) Brain Res. Rev., 53, pp. 198-214; Tinnikov, A., Nordstrom, K., Thoren, P., Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1 (2002) EMBO J., 21, pp. 5079-5087; Tohyama, K., Kusuhara, H., Sugiyama, Y., Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier (2004) Endocrinology, 145, pp. 4384-4391; Trentin, A.G., Rosenthal, D., Maura Neto, V., Thyroid hormone and conditioned medium effects on astroglial cells from hypothyroid and normal rat brain: Factor secretion, cell differentiation, and proliferation (1995) J. Neurosci. Res., 41, pp. 409-417; Uhl, I., Bez, J.A., Stamm, T., Influence of levothyroxine in augmentation therapy for bipolar depression on central serotonergic function (2014) Pharmacopsychiatry, 47, pp. 180-183; Vadodaria, K.C., Gage, F.H., SnapShot: Adult hippocampal neurogenesis (2014) Cell, 156, p. e1111; Vaidya, V.A., Vadodaria, K.C., Jha, S., Neurotransmitter regulation of adult neurogenesis: Putative therapeutic targets (2007) CNS Neurol. Disord. Drug Targets, 6, pp. 358-374; Venero, C., Guadano-Ferraz, A., Herrero, A.I., Nordstrom, K., Manzano, J., De Escobar, G.M., Bernal, J., Vennstrom, B., Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor alpha1 can be ameliorated by T3 treatment (2005) Genes Dev., 19, pp. 2152-2163; Wallis, K., Dudazy, S., Van Hogerlinden, M., Nordstrom, K., Mittag, J., Vennstrom, B., The thyroid hormone receptor alpha1 protein is expressed in embryonic postmitotic neurons and persists in most adult neurons (2010) Mol. Endocrinol., 24, pp. 1904-1916; Wikstrom, L., Johansson, C., Salto, C., Barlow, C., Campos Barros, A., Baas, F., Forrest, D., Vennstrom, B., Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1 (1998) EMBO J., 17, pp. 455-461; Williams, G.R., Neurodevelopmental and neurophysiological actions of thyroid hormone (2008) J. Neuroendocrinol., 20, pp. 784-794; Willoughby, K.A., McAndrews, M.P., Rovet, J.F., Effects of maternal hypothyroidism on offspring hippocampus and memory (2014) Thyroid, 24, pp. 576-584; Wirth, E.K., Schweizer, U., Kohrle, J., Transport of thyroid hormone in brain (2014) Front. Endocrinol., 5, p. 98; Wu, Y., Koenig, R.J., Gene regulation by thyroid hormone (2000) Trends Endocrinol. Metab., 11, pp. 207-211; Wu, Y., Xu, B., Koenig, R.J., Thyroid hormone response element sequence and the recruitment of retinoid X receptors for thyroid hormone responsiveness (2001) J. Biol. Chem., 276, pp. 3929-3936; Yen, P.M., Physiological and molecular basis of thyroid hormone action (2001) Physiol. Rev., 81, pp. 1097-1142; Yu, T.S., Dandekar, M., Monteggia, L.M., Parada, L.F., Kernie, S.G., Temporally regulated expression of Cre recombinase in neural stem cells (2005) Genesis, 41, pp. 147-153; Zhang, J., Lazar, M.A., The mechanism of action of thyroid hormones (2000) Annu. Rev. Physiol., 62, pp. 439-466; Zhang, L., Blomgren, K., Kuhn, H.G., Cooper-Kuhn, C.M., Effects of postnatal thyroid hormone deficiency on neurogenesis in the juvenile and adult rat (2009) Neurobiol. Dis., 34, pp. 366-374; Zhao, C., Deng, W., Gage, F.H., Mechanisms and functional implications of adult neurogenesis (2008) Cell, 132, pp. 645-660; Zoeller, R.T., Crofton, K.M., Mode of action: Developmental thyroid hormone insufficiency-neurological abnormalities resulting from exposure to propylthiouracil (2005) Crit. Rev. Toxicol., 35, pp. 771-781; Zoeller, R.T., Rovet, J., Timing of thyroid hormone action in the developing brain: Clinical observations and experimental findings (2004) J. Neuroendocrinol., 16, pp. 809-818",Review,Scopus,2-s2.0-84928017551
"Khanafer N., Neuraz A., Benet T., Cour M., Persat F., Labussiere H., Argaud L., Michallet M., Vanhems P.","Acute graft-versus-host disease, invasive aspergillosis and Clostridium difficile colitis after peripheral blood stem cell transplantation: A complex network of causalities and a challenge for prevention",2015,"Anaerobe","33",,,"98","100",,,10.1016/j.anaerobe.2015.02.007,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924548102&partnerID=40&md5=dfcf10e45344fb7952a23c3727430bab","Service d'Hygiène, Epidémiologie et Prévention, Groupement hospitalier Edouard Herriot, Hospices Civils de Lyon, France; Equipe Epidémiologie et Santé Publique, Université de Lyon, Université Lyon 1, France; Service de Réanimation médicale, Groupement hospitalier Edouard Herriot, Hospices Civils de Lyon, France; Service Paludisme, Parasites du sang et Mycologie médicale, Groupement hospitalier Nord, Hospices Civils de Lyon, France; Service d'Hématologie, Groupement hospitalier Lyon Sud, Hospices Civils de Lyon, France","Khanafer, N., Service d'Hygiène, Epidémiologie et Prévention, Groupement hospitalier Edouard Herriot, Hospices Civils de Lyon, France, Equipe Epidémiologie et Santé Publique, Université de Lyon, Université Lyon 1, France; Neuraz, A., Service d'Hygiène, Epidémiologie et Prévention, Groupement hospitalier Edouard Herriot, Hospices Civils de Lyon, France; Bénet, T., Service d'Hygiène, Epidémiologie et Prévention, Groupement hospitalier Edouard Herriot, Hospices Civils de Lyon, France, Equipe Epidémiologie et Santé Publique, Université de Lyon, Université Lyon 1, France; Cour, M., Service de Réanimation médicale, Groupement hospitalier Edouard Herriot, Hospices Civils de Lyon, France; Persat, F., Service Paludisme, Parasites du sang et Mycologie médicale, Groupement hospitalier Nord, Hospices Civils de Lyon, France; Labussière, H., Service d'Hématologie, Groupement hospitalier Lyon Sud, Hospices Civils de Lyon, France; Argaud, L., Service de Réanimation médicale, Groupement hospitalier Edouard Herriot, Hospices Civils de Lyon, France; Michallet, M., Service d'Hématologie, Groupement hospitalier Lyon Sud, Hospices Civils de Lyon, France; Vanhems, P., Service d'Hygiène, Epidémiologie et Prévention, Groupement hospitalier Edouard Herriot, Hospices Civils de Lyon, France, Equipe Epidémiologie et Santé Publique, Université de Lyon, Université Lyon 1, France","Graft-versus-host disease (GVHD) is a known risk factor for invasive aspergillosis (IA), but remains poorly studied in relation to Clostridium difficile infection (CDI). We report a case of a 58-years-old patient who developed an IA within a protected room, CDI and GVHD after allogeneic allogeneic peripheral blood stem cell transplantation (PBSCT). Factors associated with this complex condition in patients receiving allogeneic PBSCT need to be identified. © 2015 Elsevier Ltd.","Bone marrow transplant; Clostridium difficile infection; Environmental transmission; Graft-versus-host disease; Invasive aspergillosis; Nosocomial","Schmid, C., Schleuning, M., Ledderose, G., Tischer, J., Kolb, H.J., Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome (2005) J.Clin. Oncol., 23, pp. 5675-5687; De Pauw, B., Walsh, T.J., Donnelly, J.P., Stevens, D.A., Edwards, J.E., Calandra, T., Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (2008) Clin. Infect. Dis., 46, pp. 1813-1821; Willems, L., Porcher, R., Lafaurie, M., Casin, I., Robin, M., Xhaard, A., Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome (2012) Biol. Blood Marrow Transplant., 18, pp. 1295-1301; Hosokawa, K., Takami, A., Tsuji, M., Araoka, H., Ishiwata, K., Takagi, S., Relative incidences and outcomes of Clostridium difficile infection following transplantation of unrelated cord blood, unrelated bone marrow, and related peripheral blood in adult patients: a single institute study (2014) Transpl. Infect. Dis., 16 (3), pp. 412-420; Dubberke, E.R., Reske, K.A., Srivastava, A., Sadhu, J., Gatti, R., Young, R.M., Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes (2010) Clin. Transplant., 24 (2), pp. 192-198; Callejas-Diaz, A., Gea-Banacloche, J.C., Clostridium difficile: deleterious impact on hematopoietic stem cell transplantation (2014) Curr. Hematol. Malig. Rep., 9 (1), pp. 85-90; Menotti, J., Waller, J., Meunier, O., Letscher-Bru, V., Herbrecht, R., Candolfi, E., Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus (2005) J.Hosp. Infect., 60 (1), pp. 61-68; Alberti, C., Bouakline, A., Ribaud, P., Lacroix, C., Rousselot, P., Leblanc, T., Derouin, F., Aspergillus Study Group. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients (2001) J.Hosp. Infect., 48 (3), pp. 198-206; Zacharioudakis, I.M., Ziakas, P., Mylonakis, E., Clostridium difficile infection in the hematopoietic unit: a meta-analysis of published studies (2014) Biol. Blood Marrow Transpl., 20 (10), pp. 1650-1654; Alonso, C.D., Kamboj, M., Clostridium difficile infection (CDI) in solid organ and hematopoietic stem cell transplant recipients (2014) Curr. Infect. Dis. Rep., 16 (8), p. 414",Article,Scopus,2-s2.0-84924548102
"Tangye S.G.","Advances in IL-21 biology-enhancing our understanding of human disease",2015,"Current Opinion in Immunology","34",,,"107","115",,,10.1016/j.coi.2015.02.010,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925120155&partnerID=40&md5=63c0050e1e6b7cecf61ea63a85771015","Immunology and Immunodeficiency Group, Immunology Research Program, Garvan Institute of Medical ResearchDarlinghurst, NSW, Australia; St Vincent's Clinical School, UNSW AustraliaDarlinghurst, NSW, Australia","Tangye, S.G., Immunology and Immunodeficiency Group, Immunology Research Program, Garvan Institute of Medical ResearchDarlinghurst, NSW, Australia, St Vincent's Clinical School, UNSW AustraliaDarlinghurst, NSW, Australia","Cytokines play critical roles in regulating the development and function of immune cells. Cytokines function by binding specific multimeric receptor complexes and activating intracellular signaling pathways that often involve JAKs and STATs. In addition to contributing to immunity, when production of cytokines is perturbed, they can contribute to disease. IL-21 is a pleiotropic cytokine produced predominantly by CD4+ T cells and NKT cells. Gene-targeting studies in mice and in vitro analyses of human and murine lymphocytes have revealed central roles of IL-21 in regulating effector functions of T cells, NK cells and B cells. However, recent discoveries of loss-of function mutations in IL21 or IL21R in humans have unveiled unexpected roles for IL-21 in immune regulation. This review will focus on recent advances in IL-21 biology that have highlighted its critical role in normal immunity and how dysregulated IL-21 production can lead to immunodeficiency and autoimmune conditions. © 2015 Elsevier Ltd.",,"Leonard, W.J., Cytokines and immunodeficiency diseases (2001) Nat Rev Immunol, 1, pp. 200-208; Buckley, R.H., Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution (2004) Annu Rev Immunol, 22, pp. 625-655; Matthews, D.J., Clark, P.A., Herbert, J., Morgan, G., Armitage, R.J., Kinnon, C., Minty, A., Ferrara, P., Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15 (1995) Blood, 85, pp. 38-42; Recher, M., Berglund, L.J., Avery, D.T., Cowan, M.J., Gennery, A.R., Smart, J., Peake, J., Baxi, S., IL-21 is the primary common gamma chain-binding cytokine required for human B-cell differentiation in vivo (2011) Blood, 118, pp. 6824-6835; Ozaki, K., Kikly, K., Michalovich, D., Young, P.R., Leonard, W.J., Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain (2000) Proc Natl Acad Sci U S A, 97, pp. 11439-11444; Parrish-Novak, J., Dillon, S.R., Nelson, A., Hammond, A., Sprecher, C., Gross, J.A., Johnston, J., West, J., Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function (2000) Nature, 408, pp. 57-63; Asao, H., Okuyama, C., Kumaki, S., Ishii, N., Tsuchiya, S., Foster, D., Sugamura, K., Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex (2001) J Immunol, 167, pp. 1-5; Habib, T., Senadheera, S., Weinberg, K., Kaushansky, K., The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3 (2002) Biochemistry, 41, pp. 8725-8731; Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jager, A., Strom, T.B., Oukka, M., Kuchroo, V.K., IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells (2007) Nature, 448, pp. 484-487; Nurieva, R., Yang, X.O., Martinez, G., Zhang, Y., Panopoulos, A.D., Ma, L., Schluns, K., Jetten, A.M., Essential autocrine regulation by IL-21 in the generation of inflammatory T cells (2007) Nature, 448, pp. 480-483; Wei, L., Laurence, A., Elias, K.M., O'Shea, J.J., IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner (2007) J Biol Chem, 282, pp. 34605-34610; Zhou, L., Ivanov, I.I., Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D.E., Littman, D.R., IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways (2007) Nat Immunol, 8, pp. 967-974; Suto, A., Kashiwakuma, D., Kagami, S., Hirose, K., Watanabe, N., Yokote, K., Saito, Y., Iwamoto, I., Development and characterization of IL-21-producing CD4+ T cells (2008) J Exp Med, 205, pp. 1369-1379; Nurieva, R.I., Chung, Y., Hwang, D., Yang, X.O., Kang, H.S., Ma, L., Wang, Y.H., Tian, Q., Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages (2008) Immunity, 29, pp. 138-149; Ma, C.S., Avery, D.T., Chan, A., Batten, M., Bustamante, J., Boisson-Dupuis, S., Arkwright, P.D., Engelhard, D., Functional STAT3 deficiency compromises the generation of human T follicular helper cells (2012) Blood, 119, pp. 3997-4008; Eto, D., Lao, C., DiToro, D., Barnett, B., Escobar, T.C., Kageyama, R., Yusuf, I., Crotty, S., IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation (2011) PLoS ONE, 6; Luthje, K., Kallies, A., Shimohakamada, Y., G.T, T.B., Light, A., Tarlinton, D.M., Nutt, S.L., The development and fate of follicular helper T cells defined by an IL-21 reporter mouse (2012) Nat Immunol, 13, pp. 491-498; Tangye, S.G., Ma, C.S., Brink, R., Deenick, E.K., The good, the bad and the ugly-TFH cells in human health and disease (2013) Nat Rev Immunol, 13, pp. 412-426; Liu, S.M., King, C., IL-21-producing Th cells in immunity and autoimmunity (2013) J Immunol, 191, pp. 3501-3506; Coquet, J.M., Skak, K., Davis, I.D., Smyth, M.J., Godfrey, D.I., IL-21 modulates activation of NKT cells in patients with stage IV malignant melanoma (2013) Clin Transl Immunol, 2, p. e6; Spolski, R., Leonard, W.J., Interleukin-21: a double-edged sword with therapeutic potential (2014) Nat Rev Drug Discov, 13, pp. 379-395; Di Fusco, D., Izzo, R., Figliuzzi, M.M., Pallone, F., Monteleone, G., IL-21 as a therapeutic target in inflammatory disorders (2014) Expert Opin Ther Targets, 18, pp. 1329-1338; Wurster, A.L., Rodgers, V.L., Satoskar, A.R., Whitters, M.J., Young, D.A., Collins, M., Grusby, M.J., Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells (2002) J Exp Med, 196, pp. 969-977; Pesce, J., Kaviratne, M., Ramalingam, T.R., Thompson, R.W., Urban, J.F., Cheever, A.W., Young, D.A., Wynn, T.A., The IL-21 receptor augments Th2 effector function and alternative macrophage activation (2006) J Clin Invest, 116, pp. 2044-2055; Frohlich, A., Marsland, B.J., Sonderegger, I., Kurrer, M., Hodge, M.R., Harris, N.L., Kopf, M., IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo (2007) Blood, 109, pp. 2023-2031; Vogelzang, A., McGuire, H.M., Yu, D., Sprent, J., Mackay, C.R., King, C., A fundamental role for interleukin-21 in the generation of T follicular helper cells (2008) Immunity, 29, pp. 127-137; Kastirr, I., Maglie, S., Paroni, M., Alfen, J.S., Nizzoli, G., Sugliano, E., Crosti, M.C., Steinfelder, S., IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells (2014) J Immunol, 193, pp. 3322-3331; Attridge, K., Wang, C.J., Wardzinski, L., Kenefeck, R., Chamberlain, J.L., Manzotti, C., Kopf, M., Walker, L.S., IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis (2012) Blood, 119, pp. 4656-4664; Vogelzang, A., McGuire, H.M., Liu, S.M., Gloss, B., Mercado, K., Earls, P., Dinger, M.E., King, C., IL-21 contributes to fatal inflammatory disease in the absence of Foxp3+ T regulatory cells (2014) J Immunol, 192, pp. 1404-1414; Schmitz, I., Schneider, C., Frohlich, A., Frebel, H., Christ, D., Leonard, W.J., Sparwasser, T., Kopf, M., IL-21 restricts virus-driven Treg cell expansion in chronic LCMV infection (2013) PLoS Pathog, 9; Karnowski, A., Chevrier, S., Belz, G.T., Mount, A., Emslie, D., D'Costa, K., Tarlinton, D.M., Corcoran, L.M., B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1 (2012) J Exp Med, 209, pp. 2049-2064; Coquet, J.M., Chakravarti, S., Smyth, M.J., Godfrey, D.I., Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis (2008) J Immunol, 180, pp. 7097-7101; Sonderegger, I., Kisielow, J., Meier, R., King, C., Kopf, M., IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo (2008) Eur J Immunol, 38, pp. 1833-1838; Zeng, R., Spolski, R., Finkelstein, S.E., Oh, S., Kovanen, P.E., Hinrichs, C.S., Pise-Masison, C.A., Restifo, N.P., Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function (2005) J Exp Med, 201, pp. 139-148; Kasaian, M.T., Whitters, M.J., Carter, L.L., Lowe, L.D., Jussif, J.M., Deng, B., Johnson, K.A., Konz, R.F., IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity (2002) Immunity, 16, pp. 559-569; Ma, H.L., Whitters, M.J., Konz, R.F., Senices, M., Young, D.A., Grusby, M.J., Collins, M., Dunussi-Joannopoulos, K., IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma (2003) J Immunol, 171, pp. 608-615; Elsaesser, H., Sauer, K., Brooks, D.G., IL-21 is required to control chronic viral infection (2009) Science, 324, pp. 1569-1572; Frohlich, A., Kisielow, J., Schmitz, I., Freigang, S., Shamshiev, A.T., Weber, J., Marsland, B.J., Kopf, M., IL-21R on T cells is critical for sustained functionality and control of chronic viral infection (2009) Science, 324, pp. 1576-1580; Yi, J.S., Du, M., Zajac, A.J., A vital role for interleukin-21 in the control of a chronic viral infection (2009) Science, 324, pp. 1572-1576; Yi, J.S., Ingram, J.T., Zajac, A.J., IL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infection (2010) J Immunol, 185, pp. 4835-4845; Novy, P., Huang, X., Leonard, W.J., Yang, Y., Intrinsic IL-21 signaling is critical for CD8 T cell survival and memory formation in response to vaccinia viral infection (2011) J Immunol, 186, pp. 2729-2738; Brady, J., Hayakawa, Y., Smyth, M.J., Nutt, S.L., IL-21 induces the functional maturation of murine NK cells (2004) J Immunol, 172, pp. 2048-2058; Smyth, M.J., Wallace, M.E., Nutt, S.L., Yagita, H., Godfrey, D.I., Hayakawa, Y., Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer (2005) J Exp Med, 201, pp. 1973-1985; Wang, G., Tschoi, M., Spolski, R., Lou, Y., Ozaki, K., Feng, C., Kim, G., Hwu, P., In vivo antitumor activity of interleukin 21 mediated by natural killer cells (2003) Cancer Res, 63, pp. 9016-9022; Coquet, J.M., Kyparissoudis, K., Pellicci, D.G., Besra, G., Berzins, S.P., Smyth, M.J., Godfrey, D.I., IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production (2007) J Immunol, 178, pp. 2827-2834; Davis, I.D., Brady, B., Kefford, R.F., Millward, M., Cebon, J., Skrumsager, B.K., Mouritzen, U., Lundsgaard, D., Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial (2009) Clin Cancer Res, 15, pp. 2123-2129; Schmidt, H., Brown, J., Mouritzen, U., Selby, P., Fode, K., Svane, I.M., Cook, G.P., Geertsen, P.F., Safety and clinical effect of subcutaneous human interleukin-21 in patients with metastatic melanoma or renal cell carcinoma: a phase I trial (2010) Clin Cancer Res, 16, pp. 5312-5319; Frederiksen, K.S., Lundsgaard, D., Freeman, J.A., Hughes, S.D., Holm, T.L., Skrumsager, B.K., Petri, A., Davis, I.D., IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma (2008) Cancer Immunol Immunother, 57, pp. 1439-1449; Pene, J., Gauchat, J.F., Lecart, S., Drouet, E., Guglielmi, P., Boulay, V., Delwail, A., Yssel, H., Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells (2004) J Immunol, 172, pp. 5154-5157; Ettinger, R., Sims, G.P., Fairhurst, A.M., Robbins, R., da Silva, Y.S., Spolski, R., Leonard, W.J., Lipsky, P.E., IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells (2005) J Immunol, 175, pp. 7867-7879; Avery, D.T., Bryant, V.L., Ma, C.S., de Waal Malefyt, R., Tangye, S.G., IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4 (2008) J Immunol, 181, pp. 1767-1779; Bryant, V.L., Ma, C.S., Avery, D.T., Li, Y., Good, K.L., Corcoran, L.M., de Waal Malefyt, R., Tangye, S.G., Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells (2007) J Immunol, 179, pp. 8180-8190; Good, K.L., Bryant, V.L., Tangye, S.G., Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21 (2006) J Immunol, 177, pp. 5236-5247; Ozaki, K., Spolski, R., Ettinger, R., Kim, H.P., Wang, G., Qi, C.F., Hwu, P., Roopenian, D.C., Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6 (2004) J Immunol, 173, pp. 5361-5371; Attridge, K., Kenefeck, R., Wardzinski, L., Qureshi, O.S., Wang, C.J., Manzotti, C., Okkenhaug, K., Walker, L.S., IL-21 promotes CD4 T cell responses by phosphatidylinositol 3-kinase-dependent upregulation of CD86 on B cells (2014) J Immunol, 192, pp. 2195-2201; Rodriguez-Bayona, B., Ramos-Amaya, A., Bernal, J., Campos-Caro, A., Brieva, J.A., Cutting edge: IL-21 derived from human follicular helper T cells acts as a survival factor for secondary lymphoid organ, but not for bone marrow, plasma cells (2012) J Immunol, 188, pp. 1578-1581; Avery, D.T., Deenick, E.K., Ma, C.S., Suryani, S., Simpson, N., Chew, G.Y., Chan, T.D., Boisson-Dupuis, S., B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans (2010) J Exp Med, 207, pp. 155-171; Deenick, E.K., Avery, D.T., Chan, A., Berglund, L.J., Ives, M.L., Moens, L., Stoddard, J.L., Tsumura, M., Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells (2013) J Exp Med, 210, pp. 2739-2753; Berglund, L.J., Avery, D.T., Ma, C.S., Moens, L., Deenick, E.K., Bustamante, J., Boisson-Dupuis, S., Arkwright, P.D., IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts (2013) Blood, 122, pp. 3940-3950; Ozaki, K., Spolski, R., Feng, C.G., Qi, C.F., Cheng, J., Sher, A., Morse, H.C., Leonard, W.J., A critical role for IL-21 in regulating immunoglobulin production (2002) Science, 298, pp. 1630-1634; Zotos, D., Coquet, J.M., Zhang, Y., Light, A., D'Costa, K., Kallies, A., Corcoran, L.M., Smyth, M.J., IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism (2010) J Exp Med, 207, pp. 365-378; Bessa, J., Kopf, M., Bachmann, M.F., Cutting edge: IL-21 and TLR signaling regulate germinal center responses in a B cell-intrinsic manner (2010) J Immunol, 184, pp. 4615-4619; Rankin, A.L., MacLeod, H., Keegan, S., Andreyeva, T., Lowe, L., Bloom, L., Collins, M., Guay, H., IL-21 receptor is critical for the development of memory B cell responses (2011) J Immunol, 186, pp. 667-674; Rasheed, M.A., Latner, D.R., Aubert, R.D., Gourley, T., Spolski, R., Davis, C.W., Langley, W.A., Sarkar, S., Interleukin-21 is a critical cytokine for the generation of virus-specific long-lived plasma cells (2013) J Virol, 87, pp. 7737-7746; Hagn, M., Schwesinger, E., Ebel, V., Sontheimer, K., Maier, J., Beyer, T., Syrovets, T., Simmet, T., Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21 (2009) J Immunol, 183, pp. 1838-1845; Yoshizaki, A., Miyagaki, T., DiLillo, D.J., Matsushita, T., Horikawa, M., Kountikov, E.I., Spolski, R., Tedder, T.F., Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions (2012) Nature, 491, pp. 264-268; Herber, D., Brown, T.P., Liang, S., Young, D.A., Collins, M., Dunussi-Joannopoulos, K., IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression (2007) J Immunol, 178, pp. 3822-3830; Bubier, J.A., Sproule, T.J., Foreman, O., Spolski, R., Shaffer, D.J., Morse, H.C., Leonard, W.J., Roopenian, D.C., A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice (2009) Proc Natl Acad Sci U S A, 106, pp. 1518-1523; Rankin, A.L., Guay, H., Herber, D., Bertino, S.A., Duzanski, T.A., Carrier, Y., Keegan, S., Ryan, M., IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice (2012) J Immunol, 188, pp. 1656-1667; Spolski, R., Kashyap, M., Robinson, C., Yu, Z., Leonard, W.J., IL-21 signaling is critical for the development of type I diabetes in the NOD mouse (2008) Proc Natl Acad Sci U S A, 105, pp. 14028-14033; McGuire, H.M., Walters, S., Vogelzang, A., Lee, C.M., Webster, K.E., Sprent, J., Christ, D., King, C., Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models (2011) Diabetes, 60, pp. 867-875; Sutherland, A.P., Van Belle, T., Wurster, A.L., Suto, A., Michaud, M., Zhang, D., Grusby, M.J., von Herrath, M., Interleukin-21 is required for the development of type 1 diabetes in NOD mice (2009) Diabetes, 58, pp. 1144-1155; Van Belle, T.L., Nierkens, S., Arens, R., von Herrath, M.G., Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets (2012) Immunity, 36, pp. 1060-1072; Young, D.A., Hegen, M., Ma, H.L., Whitters, M.J., Albert, L.M., Lowe, L., Senices, M., Leathurby, Y., Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis (2007) Arthritis Rheum, 56, pp. 1152-1163; Wang, L., Yu, C.R., Kim, H.P., Liao, W., Telford, W.G., Egwuagu, C.E., Leonard, W.J., Key role for IL-21 in experimental autoimmune uveitis (2011) Proc Natl Acad Sci U S A, 108, pp. 9542-9547; McPhee, C.G., Bubier, J.A., Sproule, T.J., Park, G., Steinbuck, M.P., Schott, W.H., Christianson, G.J., Roopenian, D.C., IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB. Yaa mice (2013) J Immunol, 191, pp. 4581-4588; Le Coz, C., Joublin, A., Pasquali, J.L., Korganow, A.S., Dumortier, H., Monneaux, F., Circulating TFH subset distribution is strongly affected in lupus patients with an active disease (2013) PLOS ONE, 8; Terrier, B., Costedoat-Chalumeau, N., Garrido, M., Geri, G., Rosenzwajg, M., Musset, L., Klatzmann, D., Cacoub, P., Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus (2012) J Rheumatol, 39, pp. 1819-1828; Wang, L., Zhao, P., Ma, L., Shan, Y., Jiang, Z., Wang, J., Jiang, Y., Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus (2014) J Rheumatol, 41, pp. 1781-1792; Feng, X., Wang, D., Chen, J., Lu, L., Hua, B., Li, X., Tsao, B.P., Sun, L., Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus (2012) PLoS ONE, 7; He, J., Tsai, L.M., Leong, Y.A., Hu, X., Ma, C.S., Chevalier, N., Sun, X., Ding, Y., Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure (2013) Immunity, 39, pp. 770-781; Arroyo-Villa, I., Bautista-Caro, M.B., Balsa, A., Aguado-Acin, P., Bonilla-Hernan, M.G., Plasencia, C., Villalba, A., Martin-Mola, E., Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in Rheumatoid Arthritis (2014) Arthritis Res Ther, 16, p. 500; Liu, R., Wu, Q., Su, D., Che, N., Chen, H., Geng, L., Chen, J., Sun, L., A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis (2012) Arthritis Res Ther, 14, p. R255; Wang, J., Shan, Y., Jiang, Z., Feng, J., Li, C., Ma, L., Jiang, Y., High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis (2013) Clin Exp Immunol, 174, pp. 212-220; Xu, X., Shi, Y., Cai, Y., Zhang, Q., Yang, F., Chen, H., Gu, Y., Yang, T., Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes (2013) PLOS ONE, 8; Kenefeck, R., Wang, C.J., Kapadi, T., Wardzinski, L., Attridge, K., Clough, L.E., Heuts, F., Rosenthal, M., Follicular helper T cell signature in type 1 diabetes (2015) J Clin Invest, 125, pp. 292-303; Sawalha, A.H., Kaufman, K.M., Kelly, J.A., Adler, A.J., Aberle, T., Kilpatrick, J., Wakeland, E.K., Karp, D.R., Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus (2008) Ann Rheum Dis, 67, pp. 458-461; Webb, R., Merrill, J.T., Kelly, J.A., Sestak, A., Kaufman, K.M., Langefeld, C.D., Ziegler, J., Ramsey-Goldman, R., A polymorphism within IL21R confers risk for systemic lupus erythematosus (2009) Arthritis Rheum, 60, pp. 2402-2407; Flanagan, S.E., Haapaniemi, E., Russell, M.A., Caswell, R., Lango Allen, H., De Franco, E., McDonald, T.J., Barton, J., Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease (2014) Nat Genet, 46, pp. 812-814; Milner, J.D., Vogel, T.P., Forbes, L., Ma, C.A., Stray-Pedersen, A., Niemela, J.E., Lyons, J.J., Topcagic, N., Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations (2015) Blood, 125, pp. 591-599; Haapaniemi, E.M., Kaustio, M., Rajala, H.L., van Adrichem, A.J., Kainulainen, L., Glumoff, V., Doffinger, R., Trotta, L., Autoimmunity, hypogammaglobulinemia, lymphoproliferation and mycobacterial disease in patients with dominant activating mutations in STAT3 (2015) Blood, 125, pp. 639-648; Kotlarz, D., Zietara, N., Uzel, G., Weidemann, T., Braun, C.J., Diestelhorst, J., Krawitz, P.M., Puchalka, J., Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome (2013) J Exp Med, 210, pp. 433-443; Stepensky, P., Keller, B., Abuzaitoun, O., Shaag, A., Yaacov, B., Unger, S., Seidl, M., Elpeleg, O., Extending the clinical and immunological phenotype of human Interleukin-21 receptor deficiency (2014) Haematologica; Erman, B., Bilic, I., Hisrchmugl, T., Salzer, E., Ayvaz Ça da, D., Esenboga, S., Akcoren, Z., Boztug, K., Combined immunodeficiency with predominant CD4 lymphopenia and sclerosing cholangitis caused by a novel loss-of-function mutation affecting IL21R (2015) Haematologica, , (in press); Kotlarz, D., Zietara, N., Milner, J.D., Klein, C., Human IL-21 and IL-21R deficiencies: two novel entities of primary immunodeficiency (2014) Curr Opin Pediatr, 26, pp. 704-712; Salzer, E., Kansu, A., Sic, H., Majek, P., Ikinciogullari, A., Dogu, F.E., Prengemann, N.K., Bilic, I., Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency (2014) J Allergy Clin Immunol, 133. , 1651-1659 e1612; Spolski, R., Kim, H.P., Zhu, W., Levy, D.E., Leonard, W.J., IL-21 mediates suppressive effects via its induction of IL-10 (2009) J Immunol, 182, pp. 2859-2867; Kotlarz, D., Beier, R., Murugan, D., Diestelhorst, J., Jensen, O., Boztug, K., Pfeifer, D., Baumann, U., Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy (2012) Gastroenterology, 143, pp. 347-355",Review,Scopus,2-s2.0-84925120155
"Thus K.A., van Halteren A.G.S., de Hond T.A.P., van Dijk M.R., Kloos R.Q.H., Lankester A.C., Bierings M.B., Spierings E.","The number of T cell allo-epitopes associates with CD4+ and CD8+ T-cell infiltration in pediatric cutaneous GVHD",2015,"Cellular Immunology","295","2",,"112","117",,,10.1016/j.cellimm.2015.03.001,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927549440&partnerID=40&md5=265afdf00de3de95654b5288fca3a82f","Laboratory of Translational Immunology, University Medical Center UtrechtUtrecht, Netherlands; Immunology Laboratory/Pediatric Stem Cell Transplantation Unit, Willem Alexander Children's Hospital, Leiden University Medical CenterLeiden, Netherlands; Department of Pathology, University Medical Center UtrechtUtrecht, Netherlands; Department of Hematology and Stem Cell Transplantation, Wilhelmina Children's HospitalUtrecht, Netherlands","Thus, K.A., Laboratory of Translational Immunology, University Medical Center UtrechtUtrecht, Netherlands; van Halteren, A.G.S., Immunology Laboratory/Pediatric Stem Cell Transplantation Unit, Willem Alexander Children's Hospital, Leiden University Medical CenterLeiden, Netherlands; de Hond, T.A.P., Laboratory of Translational Immunology, University Medical Center UtrechtUtrecht, Netherlands; van Dijk, M.R., Department of Pathology, University Medical Center UtrechtUtrecht, Netherlands; Kloos, R.Q.H., Laboratory of Translational Immunology, University Medical Center UtrechtUtrecht, Netherlands; Lankester, A.C., Immunology Laboratory/Pediatric Stem Cell Transplantation Unit, Willem Alexander Children's Hospital, Leiden University Medical CenterLeiden, Netherlands; Bierings, M.B., Department of Hematology and Stem Cell Transplantation, Wilhelmina Children's HospitalUtrecht, Netherlands; Spierings, E., Laboratory of Translational Immunology, University Medical Center UtrechtUtrecht, Netherlands","Risk factors for graft-versus-host disease (GVHD) following allogeneic hematopoietic stem-cell transplantation (HCST) include: HLA mismatches, sex-mismatch, and stem-cell source. We retrospectively analyzed if HLA- and sex-mismatching quantitatively affects the composition of GVHD-induced T-cell infiltrates. We quantified absolute numbers of CD4+ and CD8+ T cells present in tissue sections from skin biopsies of 23 pediatric HSCT-recipients with GVHD. HSCT with a sex-mismatched unrelated donor was associated with an increased number of CD4+ T cells when compared to a sex-matched unrelated donor (. p=. 0.01). The absolute numbers of skin-infiltrating T cells were increased in patients expressing T-cell epitopes derived from the recipient's mismatched HLA, so called predicted indirectly recognizable HLA epitopes (PIRCHE). The combined expression of PIRCHE with a sex-mismatch resulted in the highest number of skin-infiltrating T cells. Our results indicate that an increased number of recipient-specific T-cell epitopes is associated with accumulation of CD4+ and CD8+ T cells in the skin. © 2015 Elsevier Inc.","Allogeneic hematopoietic stem-cell transplantation; Cutaneous graft-versus-host disease; HY; Pediatric; PIRCHE; T cells","Ferrara, J.L., Levine, J.E., Reddy, P., Holler, E., Graft-versus-host disease (2009) Lancet, 373, pp. 1550-1561; Jagasia, M., Arora, M., Flowers, M.E., Chao, N.J., McCarthy, P.L., Cutler, C.S., Urbano-Ispizua, A., Hahn, T., Risk factors for acute GVHD and survival after hematopoietic cell transplantation (2012) Blood, 119, pp. 296-307; Bayraktar, U.D., de, L.M., Saliba, R.M., Maloy, M., Castro-Malaspina, H.R., Chen, J., Rondon, G., Papadopoulos, E.B., Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission (2013) Biol. Blood Marrow Transplant., 19, pp. 898-903; Petersdorf, E.W., Optimal HLA matching in hematopoietic cell transplantation (2008) Curr. Opin. Immunol., 20, pp. 588-593; (2013), http://www.syfpeithi.de/bin/MHCServer.dll/FindYourMotif.htmRossjohn, J., Gras, S., Miles, J.J., Turner, S.J., Godfrey, D.I., McCluskey, J., T cell antigen receptor recognition of antigen-presenting molecules (2014) Annu. Rev. Immunol.; Geneugelijk, K., Thus, K.A., Spierings, E., Predicting alloreactivity in transplantation (2014) J. Immunol. Res., 2014, p. 159479; Otten, H.G., Calis, J.J., Kesmir, C., van Zuilen, A.D., Spierings, E., Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation (2013) Hum. Immunol., 74, pp. 290-296; Thus, K.A., Te Boome, L., Kuball, J., Spierings, E., Indirectly recognized HLA-C mismatches and their potential role in transplant outcome (2014) Front. Immunol., 5, p. 210; Thus, K.A., Ruizendaal, M.T., de Hoop, T.A., Borst, E., van Deutekom, H.W., Te, B.L., Kuball, J., Spierings, E., Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes (2014) Biol. Blood Marrow Transplant., 20, pp. 1705-1710; Goulmy, E., Schipper, R., Pool, J., Blokland, E., Falkenburg, J.H., Vossen, J., Gratwohl, A., van Rood, J.J., Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation (1996) N. Engl. J. Med., 334, pp. 281-285; Spierings, E., Kim, Y.H., Hendriks, M., Borst, E., Sergeant, R., Canossi, A., Oudshoorn, M., Goulmy, E., Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation (2013) Biol. Blood Marrow Transplant., 19, pp. 1244-1253; Kim, Y.H., Faaij, C.M., van Halteren, A.G., Schrama, E., de Jong, T.A., Scholler, J., Egeler, R.M., Spierings, E., In situ detection of HY-specific T cells in acute graft-versus-host disease-affected male skin after sex-mismatched stem cell transplantation (2012) Biol. Blood Marrow Transplant., 18, pp. 381-387; Mutis, T., Gillespie, G., Schrama, E., Falkenburg, J.H., Moss, P., Goulmy, E., Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease (1999) Nat. Med., 5, pp. 839-842; Faaij, C.M., Lankester, A.C., Spierings, E., Hoogeboom, M., Bowman, E.P., Bierings, M., Revesz, T., Annels, N.E., A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease (2006) Br. J. Haematol., 133, pp. 538-549; Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G., Thomas, E.D., Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors (1974) Transplantation, 18, pp. 295-304; Chevallier, P., Robillard, N., Illiaquer, M., Esbelin, J., Mohty, M., Bodin-Bressollette, C., Guillaume, T., Imbert-Marcille, B.M., Characterization of various blood and graft sources: a prospective series (2013) Transfusion, 53, pp. 2020-2026; Korbling, M., Anderlini, P., Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? (2001) Blood, 98, pp. 2900-2908; Amir, A.L., Hagedoorn, R.S., van Luxemburg-Heijs, S.A., Marijt, E.W., Kruisselbrink, A.B., Frederik Falkenburg, J.H., Heemskerk, M.H., Identification of a coordinated CD8 and CD4 T cell response directed against mismatched HLA Class I causing severe acute graft-versus-host disease (2012) Biol. Blood Marrow Transplant., 18, pp. 210-219; Baron, C., Somogyi, R., Greller, L.D., Rineau, V., Wilkinson, P., Cho, C.R., Cameron, M.J., Perreault, C., Prediction of graft-versus-host disease in humans by donor gene-expression profiling (2007) PLoS Med., 4, p. e23",Article,Scopus,2-s2.0-84927549440
"McCulley D., Wienhold M., Sun X.","The pulmonary mesenchyme directs lung development",2015,"Current Opinion in Genetics and Development","32",,,"98","105",,,10.1016/j.gde.2015.01.011,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924942801&partnerID=40&md5=e6620458813e5b18aab34204280b7f66","Laboratory of Genetics, University of Wisconsin-MadisonMadison, WI, United States; Department of Pediatrics, University of Wisconsin-MadisonMadison, WI, United States","McCulley, D., Laboratory of Genetics, University of Wisconsin-MadisonMadison, WI, United States, Department of Pediatrics, University of Wisconsin-MadisonMadison, WI, United States; Wienhold, M., Laboratory of Genetics, University of Wisconsin-MadisonMadison, WI, United States, Department of Pediatrics, University of Wisconsin-MadisonMadison, WI, United States; Sun, X., Laboratory of Genetics, University of Wisconsin-MadisonMadison, WI, United States","Each of the steps of respiratory system development relies on intricate interactions and coordinated development of the lung epithelium and mesenchyme. In the past, more attention has been paid to the epithelium than the mesenchyme. The mesenchyme is a source of specification and morphogenetic signals as well as a host of surprisingly complex cell lineages that are crucial for normal lung development and function. This review highlights recent research focusing on the mesenchyme that has revealed genetic and epigenetic mechanisms of its development in the context of other cell layers during respiratory lineage specification, branching morphogenesis, epithelial differentiation, lineage distinction, vascular development, and alveolar maturation. © 2015 Elsevier Ltd.",,"Morrisey, E.E., Cardoso, W.V., Lane, R.H., Rabinovitch, M., Abman, S.H., Ai, X., Albertine, K.H., Checkley, W., Molecular determinants of lung development (2013) Ann Am Thorac Soc, 10, pp. S12-S16; Domyan, E.T., Sun, X., Patterning and plasticity in development of the respiratory lineage (2011) Dev Dyn, 240, pp. 477-485; Whitsett, J.A., Haitchi, H.M., Maeda, Y., Intersections between pulmonary development and disease (2011) Am J Respir Crit Care Med, 184, pp. 401-406; Peng, T., Morrisey, E.E., Development of the pulmonary vasculature: current understanding and concepts for the future (2013) Pulm Circ, 3, pp. 176-178; Hines, E.A., Sun, X., Tissue crosstalk in lung development (2014) J Cell Biochem, 115, pp. 1469-1477; Herriges, M., Morrisey, E.E., Lung development: orchestrating the generation and regeneration of a complex organ (2014) Development, 141, pp. 502-513; Hogan, B.L., Barkauskas, C.E., Chapman, H.A., Epstein, J.A., Jain, R., Hsia, C.C., Niklason, L., Randell, S.H., Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function (2014) Cell Stem Cell, 15, pp. 123-138; Lazzaro, D., Price, M., de Felice, M., Di Lauro, R., The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain (1991) Development, 113, pp. 1093-1104; Minoo, P., Su, G., Drum, H., Bringas, P., Kimura, S., Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos (1999) Dev Biol, 209, pp. 60-71; Serls, A.E., Doherty, S., Parvatiyar, P., Wells, J.M., Deutsch, G.H., Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung (2005) Development, 132, pp. 35-47; Que, J., Okubo, T., Goldenring, J.R., Nam, K.T., Kurotani, R., Morrisey, E.E., Taranova, O., Hogan, B.L., Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm (2007) Development, 134, pp. 2521-2531; Goss, A.M., Tian, Y., Tsukiyama, T., Cohen, E.D., Zhou, D., Lu, M.M., Yamaguchi, T.P., Morrisey, E.E., Wnt2/2b and beta-catenin signaling are necessary and sufficient to specify lung progenitors in the foregut (2009) Dev Cell, 17, pp. 290-298; Harris-Johnson, K.S., Domyan, E.T., Vezina, C.M., Sun, X., Beta-Catenin promotes respiratory progenitor identity in mouse foregut (2009) Proc Natl Acad Sci U S A, 106, pp. 16287-16292; Okubo, T., Hogan, B.L., Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm (2004) J Biol, 3, p. 11; Domyan, E.T., Ferretti, E., Throckmorton, K., Mishina, Y., Nicolis, S.K., Sun, X., Signaling through BMP receptors promotes respiratory identity in the foregut via repression of Sox2 (2011) Development, 138, pp. 971-981; Que, J., Choi, M., Ziel, J.W., Klingensmith, J., Hogan, B.L., Morphogenesis of the trachea and esophagus: current players and new roles for noggin and Bmps (2006) Differentiation, 74, pp. 422-437; Li, Y., Litingtung, Y., Ten Dijke, P., Chiang, C., Aberrant Bmp signaling and notochord delamination in the pathogenesis of esophageal atresia (2007) Dev Dyn, 236, pp. 746-754; Li, Y., Gordon, J., Manley, N.R., Litingtung, Y., Chiang, C., Bmp4 is required for tracheal formation: a novel mouse model for tracheal agenesis (2008) Dev Biol, 322, pp. 145-155; Chen, F., Desai, T.J., Qian, J., Niederreither, K., Lu, J., Cardoso, W.V., Inhibition of Tgf beta signaling by endogenous retinoic acid is essential for primary lung bud induction (2007) Development, 134, pp. 2969-2979; Chen, F., Cao, Y., Qian, J., Shao, F., Niederreither, K., Cardoso, W.V., A retinoic acid-dependent network in the foregut controls formation of the mouse lung primordium (2010) J Clin Invest, 120, pp. 2040-2048; Rankin, S.A., Gallas, A.L., Neto, A., Gomez-Skarmeta, J.L., Zorn, A.M., Suppression of Bmp4 signaling by the zinc-finger repressors Osr1 and Osr2 is required for Wnt/beta-catenin-mediated lung specification in Xenopus (2012) Development, 139, pp. 3010-3020; Arora, R., Metzger, R.J., Papaioannou, V.E., Multiple roles and interactions of Tbx4 and Tbx5 in development of the respiratory system (2012) PLoS Genet, 8, p. e1002866; Herriges, M.J., Swarr, D.T., Morley, M.P., Rathi, K.S., Peng, T., Stewart, K.M., Morrisey, E.E., Long noncoding RNAs are spatially correlated with transcription factors and regulate lung development (2014) Genes Dev, 28, pp. 1363-1379; Bellusci, S., Grindley, J., Emoto, H., Itoh, N., Hogan, B.L., Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung (1997) Development, 124, pp. 4867-4878; Abler, L.L., Mansour, S.L., Sun, X., Conditional gene inactivation reveals roles for Fgf10 and Fgfr2 in establishing a normal pattern of epithelial branching in the mouse lung (2009) Dev Dyn, 238, pp. 1999-2013; Volckaert, T., Campbell, A., Dill, E., Li, C., Minoo, P., De Langhe, S., Localized Fgf10 expression is not required for lung branching morphogenesis but prevents differentiation of epithelial progenitors (2013) Development, 140, pp. 3731-3742; Izvolsky, K.I., Zhong, L., Wei, L., Yu, Q., Nugent, M.A., Cardoso, W.V., Heparan sulfates expressed in the distal lung are required for Fgf10 binding to the epithelium and for airway branching (2003) Am J Physiol Lung Cell Mol Physiol, 285, pp. L838-L846; Miller, M.F., Cohen, E.D., Baggs, J.E., Lu, M.M., Hogenesch, J.B., Morrisey, E.E., Wnt ligands signal in a cooperative manner to promote foregut organogenesis (2012) Proc Natl Acad Sci U S A, 109, pp. 15348-15353; Miller, M.F., Cohen, E.D., Baggs, J.E., Hogenesch, J.B., Morrisey, E.E., High throughput genomic screen identifies multiple factors that promote cooperative Wnt signaling (2013) PLoS One, 8, p. e55782; Yin, Y., Wang, F., Ornitz, D.M., Mesothelial- and epithelial-derived FGF9 have distinct functions in the regulation of lung development (2011) Development, 138, pp. 3169-3177; Carraro, G., Shrestha, A., Rostkovius, J., Contreras, A., Chao, C.M., El Agha, E., Mackenzie, B., Taketo, M.M., MiR-142-3p balances proliferation and differentiation of mesenchymal cells during lung development (2014) Development, 141, pp. 1272-1281; Alanis, D.M., Chang, D.R., Akiyama, H., Krasnow, M.A., Chen, J., Two nested developmental waves demarcate a compartment boundary in the mouse lung (2014) Nat Commun, 5, p. 3923; Nechiporuk, T., Klezovitch, O., Nguyen, L., Vasioukhin, V., Dlg5 maintains apical aPKC and regulates progenitor differentiation during lung morphogenesis (2013) Dev Biol, 377, pp. 375-384; Yates, L.L., Schnatwinkel, C., Hazelwood, L., Chessum, L., Paudyal, A., Hilton, H., Romero, M.R., Sanderson, J., Scribble is required for normal epithelial cell-cell contacts and lumen morphogenesis in the mammalian lung (2013) Dev Biol, 373, pp. 267-280; Kim, H.Y., Varner, V.D., Nelson, C.M., Apical constriction initiates new bud formation during monopodial branching of the embryonic chicken lung (2013) Development, 140, pp. 3146-3155; Wan, H., Liu, C., Wert, S.E., Xu, W., Liao, Y., Zheng, Y., Whitsett, J.A., CDC42 is required for structural patterning of the lung during development (2013) Dev Biol, 374, pp. 46-57; Kadzik, R.S., Cohen, E.D., Morley, M.P., Stewart, K.M., Lu, M.M., Morrisey, E.E., Wnt ligand/Frizzled 2 receptor signaling regulates tube shape and branch-point formation in the lung through control of epithelial cell shape (2014) Proc Natl Acad Sci U S A, 111, pp. 12444-12449; Metzger, R.J., Klein, O.D., Martin, G.R., Krasnow, M.A., The branching programme of mouse lung development (2008) Nature, 453, pp. 745-750; Shannon, J.M., Nielsen, L.D., Gebb, S.A., Randell, S.H., Mesenchyme specifies epithelial differentiation in reciprocal recombinants of embryonic lung and trachea (1998) Dev Dyn, 212, pp. 482-494; Hines, E.A., Jones, M.K., Verheyden, J.M., Harvey, J.F., Sun, X., Establishment of smooth muscle and cartilage juxtaposition in the developing mouse upper airways (2013) Proc Natl Acad Sci U S A, 110, pp. 19444-19449; Turcatel, G., Rubin, N., Menke, D.B., Martin, G., Shi, W., Warburton, D., Lung mesenchymal expression of Sox9 plays a critical role in tracheal development (2013) BMC Biol, 11, p. 117; Hong, K.U., Reynolds, S.D., Watkins, S., Fuchs, E., Stripp, B.R., Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium (2004) Am J Pathol, 164, pp. 577-588; Hong, K.U., Reynolds, S.D., Watkins, S., Fuchs, E., Stripp, B.R., In vivo differentiation potential of tracheal basal cells: evidence for multipotent and unipotent subpopulations (2004) Am J Physiol Lung Cell Mol Physiol, 286, pp. L643-L649; Rock, J.R., Onaitis, M.W., Rawlins, E.L., Lu, Y., Clark, C.P., Xue, Y., Randell, S.H., Hogan, B.L., Basal cells as stem cells of the mouse trachea and human airway epithelium (2009) Proc Natl Acad Sci U S A, 106, pp. 12771-12775; Peng, T., Tian, Y., Boogerd, C.J., Lu, M.M., Kadzik, R.S., Stewart, K.M., Evans, S.M., Morrisey, E.E., Coordination of heart and lung co-development by a multipotent cardiopulmonary progenitor (2013) Nature, 500, pp. 589-592; Mailleux, A.A., Kelly, R., Veltmaat, J.M., De Langhe, S.P., Zaffran, S., Thiery, J.P., Bellusci, S., Fgf10 expression identifies parabronchial smooth muscle cell progenitors and is required for their entry into the smooth muscle cell lineage (2005) Development, 132, pp. 2157-2166; El Agha, E., Herold, S., Al Alam, D., Quantius, J., MacKenzie, B., Carraro, G., Moiseenko, A., Seeger, W., Fgf10-positive cells represent a progenitor cell population during lung development and postnatally (2014) Development, 141, pp. 296-306; Kumar, M.E., Bogard, P.E., Espinoza, F.H., Menke, D.B., Kingsley, D.M., Krasnow, M.A., Mesenchymal cells, Defining a mesenchymal progenitor niche at single-cell resolution (2014) Science, 346, p. 1258810; Goss, A.M., Tian, Y., Cheng, L., Yang, J., Zhou, D., Cohen, E.D., Morrisey, E.E., Wnt2 signaling is necessary and sufficient to activate the airway smooth muscle program in the lung by regulating myocardin/Mrtf-B and Fgf10 expression (2011) Dev Biol, 356, pp. 541-552; Bell, S.M., Schreiner, C.M., Wert, S.E., Mucenski, M.L., Scott, W.J., Whitsett, J.A., R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis (2008) Development, 135, pp. 1049-1058; Vermot, J., Niederreither, K., Garnier, J.M., Chambon, P., Dolle, P., Decreased embryonic retinoic acid synthesis results in a DiGeorge syndrome phenotype in newborn mice (2003) Proc Natl Acad Sci U S A, 100, pp. 1763-1768; Tiozzo, C., De Langhe, S., Carraro, G., Alam, D.A., Nagy, A., Wigfall, C., Hajihosseini, M.K., Bellusci, S., Fibroblast growth factor 10 plays a causative role in the tracheal cartilage defects in a mouse model of Apert syndrome (2009) Pediatr Res, 66, pp. 386-390; Miller, L.A., Wert, S.E., Clark, J.C., Xu, Y., Perl, A.K., Whitsett, J.A., Role of Sonic hedgehog in patterning of tracheal-bronchial cartilage and the peripheral lung (2004) Dev Dyn, 231, pp. 57-71; Schachtner, S.K., Wang, Y., Scott Baldwin, H., Qualitative and quantitative analysis of embryonic pulmonary vessel formation (2000) Am J Respir Cell Mol Biol, 22, pp. 157-165; deMello, D.E., Sawyer, D., Galvin, N., Reid, L.M., Early fetal development of lung vasculature (1997) Am J Respir Cell Mol Biol, 16, pp. 568-581; Akeson, A.L., Wetzel, B., Thompson, F.Y., Brooks, S.K., Paradis, H., Gendron, R.L., Greenberg, J.M., Embryonic vasculogenesis by endothelial precursor cells derived from lung mesenchyme (2000) Dev Dyn, 217, pp. 11-23; Parera, M.C., van Dooren, M., van Kempen, M., de Krijger, R., Grosveld, F., Tibboel, D., Rottier, R., Distal angiogenesis: a new concept for lung vascular morphogenesis (2005) Am J Physiol Lung Cell Mol Physiol, 288, pp. L141-L149; Lange, A.W., Haitchi, H.M., LeCras, T.D., Sridharan, A., Xu, Y., Wert, S.E., James, J., Whitsett, J.A., Sox17 is required for normal pulmonary vascular morphogenesis (2014) Dev Biol, 387, pp. 109-120; Mujahid, S., Nielsen, H.C., Volpe, M.V., MiR-221 and miR-130a regulate lung airway and vascular development (2013) PLoS One, 8, p. e55911; Cornett, B., Snowball, J., Varisco, B.M., Lang, R., Whitsett, J., Sinner, D., Wntless is required for peripheral lung differentiation and pulmonary vascular development (2013) Dev Biol, 379, pp. 38-52; Jiang, M., Ku, W.Y., Fu, J., Offermanns, S., Hsu, W., Que, J., Gpr177 regulates pulmonary vasculature development (2013) Development, 140, pp. 3589-3594; Bostrom, H., Willetts, K., Pekny, M., Leveen, P., Lindahl, P., Hedstrand, H., Pekna, M., Schalling, M., PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis (1996) Cell, 85, pp. 863-873; Lindahl, P., Karlsson, L., Hellstrom, M., Gebre-Medhin, S., Willetts, K., Heath, J.K., Betsholtz, C., Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development (1997) Development, 124, pp. 3943-3953; Sun, T., Jayatilake, D., Afink, G.B., Ataliotis, P., Nister, M., Richardson, W.D., Smith, H.K., A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth (2000) Development, 127, pp. 4519-4529; Lin, C., Yao, E., Wang, K., Nozawa, Y., Shimizu, H., Johnson, J.R., Chen, J.N., Chuang, P.T., Regulation of Sufu activity by p66beta and Mycbp provides new insight into vertebrate Hedgehog signaling (2014) Genes Dev, 28, pp. 2547-2563; Li, C., Li, M., Li, S., Xing, Y., Yang, C.Y., Li, A., Borok, Z., Minoo, P., Progenitors of secondary crest myofibroblasts are developmentally committed in early lung mesoderm (2015) Stem Cells, 33 (3), pp. 999-1012; Greer, R.M., Miller, J.D., Okoh, V.O., Halloran, B.A., Prince, L.S., Epithelial-mesenchymal co-culture model for studying alveolar morphogenesis (2014) Organogenesis, p. e29198; Rehan, V.K., Sugano, S., Wang, Y., Santos, J., Romero, S., Dasgupta, C., Keane, M.P., Torday, J.S., Evidence for the presence of lipofibroblasts in human lung (2006) Exp Lung Res, 32, pp. 379-393; Rehan, V., Torday, J., Hyperoxia augments pulmonary lipofibroblast-to-myofibroblast transdifferentiation (2003) Cell Biochem Biophys, 38, pp. 239-250; Nicola, T., Ambalavanan, N., Zhang, W., James, M.L., Rehan, V., Halloran, B., Olave, N., Chen, Y.F., Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone (2011) Am J Physiol Lung Cell Mol Physiol, 301, pp. L125-L134; Rehan, V.K., Sakurai, R., Wang, Y., Santos, J., Huynh, K., Torday, J.S., Reversal of nicotine-induced alveolar lipofibroblast-to-myofibroblast transdifferentiation by stimulants of parathyroid hormone-related protein signaling (2007) Lung, 185, pp. 151-159; Ferguson, H.E., Kulkarni, A., Lehmann, G.M., Garcia-Bates, T.M., Thatcher, T.H., Huxlin, K.R., Phipps, R.P., Sime, P.J., Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts (2009) Am J Respir Cell Mol Biol, 41, pp. 722-730; McGowan, S.E., Jackson, S.K., Doro, M.M., Olson, P.J., Peroxisome proliferators alter lipid acquisition and elastin gene expression in neonatal rat lung fibroblasts (1997) Am J Physiol, 273, pp. L1249-L1257; Dasgupta, C., Sakurai, R., Wang, Y., Guo, P., Ambalavanan, N., Torday, J.S., Rehan, V.K., Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone (2009) Am J Physiol Lung Cell Mol Physiol, 296, pp. L1031-L1041; Varisco, B.M., Ambalavanan, N., Whitsett, J.A., Hagood, J.S., Thy-1 signals through PPARgamma to promote lipofibroblast differentiation in the developing lung (2012) Am J Respir Cell Mol Biol, 46, pp. 765-772; Nicola, T., Hagood, J.S., James, M.L., Macewen, M.W., Williams, T.A., Hewitt, M.M., Schwiebert, L., Chen, Y.F., Loss of Thy-1 inhibits alveolar development in the newborn mouse lung (2009) Am J Physiol Lung Cell Mol Physiol, 296, pp. L738-L750",Review,Scopus,2-s2.0-84924942801
"Abudayyeh A., Abdelrahim M.","Current Strategies for Prevention and Management of Stem Cell Transplant-Related Urinary Tract and Voiding Dysfunction",2015,"Current Bladder Dysfunction Reports","10","2",,"109","117",,,10.1007/s11884-015-0289-4,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928889162&partnerID=40&md5=72985fd3f8da1385b78be3b525d70156","Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Unit 1468, 1400 Pressler StreetHouston, TX, United States; Division of Medical Oncology, Duke University School of MedicineDurham, NC, United States","Abudayyeh, A., Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Unit 1468, 1400 Pressler StreetHouston, TX, United States; Abdelrahim, M., Division of Medical Oncology, Duke University School of MedicineDurham, NC, United States","Advances in hematopoietic cell transplantation (HCT) in providing an effective and curative measure for many malignancies have led to further associated complications. Stem cell transplant (SCT) survivors are at increased risk for developing late complications secondary to pre-, peri-, and posttransplantation exposures. There is a lack of knowledge in prevention, treatment, and long-term outcomes associated with the different organ systems affected. We will present urological complications post SCT with the associated risk factors, preventative measures, treatments, and outcomes. Due to the high morbidity and mortality associated with post SCT urological complications, future prospective studies are needed. © 2015, Springer Science+Business Media New York.","BK hemorrhagic cystitis; Bladder dysfunction; Cidofovir; Cystectomy; Post-engraftment hemorrhagic cystitis; Stem cell transplant associated hemorrhagic cystitis","Gatti, R.A., Meuwissen, H.J., Allen, H.D., Hong, R., Good, R.A., Immunological reconstitution of sex-linked lymphopenic immunological deficiency (1968) Lancet, 2 (7583), pp. 1366-1369. , COI: 1:STN:280:DyaF1M%2FmsVSntA%3D%3D, PID: 4177932; Copelan, E.A., Hematopoietic stem-cell transplantation (2006) N Engl J Med, 354 (17), pp. 1813-1826. , COI: 1:CAS:528:DC%2BD28XjvVarsro%3D, PID: 16641398; Socie, G., Stone, J.V., Wingard, J.R., Weisdorf, D., Henslee-Downey, P.J., Bredeson, C., Long-term survival and late deaths after allogeneic bone marrow transplantation. Late effects Working Committee of the International Bone Marrow Transplant Registry (1999) N Engl J Med, 341 (1), pp. 14-21. , COI: 1:STN:280:DyaK1M3psVeltw%3D%3D, PID: 10387937; Wingard, J.R., Majhail, N.S., Brazauskas, R., Wang, Z., Sobocinski, K.A., Jacobsohn, D., Long-term survival and late deaths after allogeneic hematopoietic cell transplantation (2011) J Clin Oncol Off J Am Soc Clin Oncol, 29 (16), pp. 2230-2239; Majhail, N.S., Rizzo, J.D., Lee, S.J., Aljurf, M., Atsuta, Y., Bonfim, C., Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation (2012) Bone Marrow Transplant, 47 (3), pp. 337-341. , COI: 1:STN:280:DC%2BC383ptFOmtw%3D%3D, PID: 22395764; Rizzo, J.D., Wingard, J.R., Tichelli, A., Lee, S.J., Van Lint, M.T., Burns, L.J., Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT) (2006) Bone Marrow Transplant, 37 (3), pp. 249-261. , COI: 1:STN:280:DC%2BD28%2FksFajug%3D%3D, PID: 16435004; Keles, I., Bozkurt, M.F., Cemek, M., Karalar, M., Hazini, A., Alpdagtas, S., Prevention of cyclophosphamide-induced hemorrhagic cystitis by resveratrol: a comparative experimental study with mesna (2014) Int Urol Nephrol, 46 (12), pp. 2301-2310. , COI: 1:CAS:528:DC%2BC2cXhs1OhsrzO, PID: 25248628; Bassi, P.F., Costantini, E., Foley, S., Palea, S., Glycosaminoglycan therapy for bladder diseases: emerging new treatments (2011) Eur Urol Suppl, 10 (6), pp. 451-459. , COI: 1:CAS:528:DC%2BC3MXhtVyrsLrI; Bedi, A., Miller, C.B., Hanson, J.L., Goodman, S., Ambinder, R.F., Charache, P., Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation (1995) J Clin Oncol Off J Am Soc Clin Oncol, 13 (5), pp. 1103-1109. , COI: 1:STN:280:DyaK2M3ls12gsg%3D%3D, This study is of importance because it was a randomized trial to compare mesna with forced diuresis for prophylaxis against HC in 147 BMT recipients. It demonstrated that the development of HC after uroprophylaxis is not a direct result of preparative regimen toxicity, but is etiologically related to the reactivation of BK virus; Droller, M.J., Saral, R., Santos, G., Prevention of cyclophosphamide-induced hemorrhagic cystitis (1982) Urology, 20 (3), pp. 256-258. , COI: 1:STN:280:DyaL3s%2FhslKhtw%3D%3D, PID: 7123717; Mori, Y., Miyamoto, T., Kato, K., Kamezaki, K., Kuriyama, T., Oku, S., Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation (2012) Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 18 (3), pp. 458-465; Alesawi, A.M., El-Hakim, A., Zorn, K.C., Saad, F., Radiation-induced hemorrhagic cystitis (2014) Curr Opin Support Palliat Care, 8 (3), pp. 235-240. , PID: 25004179; Lawton, C.A., Won, M., Pilepich, M.V., Asbell, S.O., Shipley, W.U., Hanks, G.E., Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706 (1991) Int J Radiat Oncol Biol Phys, 21 (4), pp. 935-939. , COI: 1:STN:280:DyaK38%2FhtFSnuw%3D%3D, PID: 1917622; Payne, H., Adamson, A., Bahl, A., Borwell, J., Dodds, D., Heath, C., Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges (2013) BJU Int, 112 (7), pp. 885-897. , COI: 1:CAS:528:DC%2BC3sXhs1elt7nI, PID: 24000900; Denton, A.S., Clarke, N.W., Maher, E.J., Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis (2002) Cochrane Database Syst Rev, 3. , PID: 12137633; Mohty, M., Malard, F., Savani, B.N., High-dose total body irradiation and myeloablative conditioning before allogeneic hematopoietic cell transplantation: time to rethink? (2014) Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant; Ferry, C., Socie, G., Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned? (2003) Exp Hematol, 31 (12), pp. 1182-1186. , COI: 1:CAS:528:DC%2BD3sXps1yjsb0%3D, PID: 14662323; Brock, N., Wilmanns, H., Effect of a cyclic nitrogen mustard-phosphamidester on experimentally induced tumors in rats; chemotherapeutic effect and pharmacological properties of B 518 ASTA (1958) Dtsch Med Wochenschr, 83 (12), pp. 453-458. , COI: 1:CAS:528:DyaG1cXmslyhsA%3D%3D, PID: 13537667; Cox, P.J., Cyclophosphamide cystitis—identification of acrolein as the causative agent (1979) Biochem Pharmacol, 28 (13), pp. 2045-2049. , COI: 1:CAS:528:DyaL3cXjsFE%3D, PID: 475846; Wang, C.C., Weng, T.I., Wu, E.T., Wu, M.H., Yang, R.S., Liu, S.H., Involvement of interleukin-6-regulated nitric oxide synthase in hemorrhagic cystitis and impaired bladder contractions in young rats induced by acrolein, a urinary metabolite of cyclophosphamide (2013) Toxicol Sci Off J Soc Toxicol, 131 (1), pp. 302-310. , COI: 1:CAS:528:DC%2BC3sXktFamtw%3D%3D; Storb, R., Thomas, E.D., Weiden, P.L., Buckner, C.D., Clift, R.A., Fefer, A., Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle (1976) Blood, 48 (6), pp. 817-841. , COI: 1:STN:280:DyaE2s%2Fms1SgsQ%3D%3D, PID: 11859; Hows, J.M., Mehta, A., Ward, L., Woods, K., Perez, R., Gordon, M.Y., Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study (1984) Br J Cancer, 50 (6), pp. 753-756. , COI: 1:STN:280:DyaL2M%2Fks12qsA%3D%3D, PID: 6437430; Stillwell, T.J., Benson, R.C., Jr., Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients (1988) Cancer, 61 (3), pp. 451-457. , COI: 1:STN:280:DyaL1c7gvFahsw%3D%3D, PID: 3338015; Emadi, A., Jones, R.J., Brodsky, R.A., Cyclophosphamide and cancer: golden anniversary. Nature reviews (2009) Clin Oncol, 6 (11), pp. 638-647. , COI: 1:CAS:528:DC%2BD1MXhtlWlsL3K; Leung AY, Mak R, Lie AK, Yuen KY, Cheng VC, Liang R, et al. Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplant. 2002;29(6):509–13. This paper of greatest importance since it is the first time in the literature that HC post SCT was classified in to two patterns of HC based on the time of marrow engraftment. Lower grade (grade 2) pre-engraftment HC contrasted with the prolonged and often serious (grades3 and 4) post-engraftment HC. It also demonstrated a strong association of post-engraftment HC with more serious GVHDSeber, A., Shu, X.O., Defor, T., Sencer, S., Ramsay, N., Risk factors for severe hemorrhagic cystitis following BMT (1999) Bone Marrow Transplant, 23 (1), pp. 35-40. , COI: 1:STN:280:DyaK1M7lsVKmsA%3D%3D, PID: 10037048; Hassan, Z., Management of refractory hemorrhagic cystitis following hematopoietic stem cell transplantation in children (2011) Pediatr Transplant, 15 (4), pp. 348-361. , PID: 21504524; El-Zimaity M, Saliba R, Chan K, Shahjahan M, Carrasco A, Khorshid O, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters. Blood. 2004;103(12):4674–80. This study is of importance because it was one of the first to demonstrate that the donor type and age effect was independent of platelet engraftment, development of graft-versus-host disease (GVHD), source of stem cells, use of anti-thymocyte globulin (ATG) or cyclophosphamide in the regimen, steroid use, or stem cell source in the development of Hemorrhagic cystitis (HC) post allogeneic SCTShepherd, J.D., Pringle, L.E., Barnett, M.J., Klingemann, H.G., Reece, D.E., Phillips, G.L., Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation (1991) J Clin Oncol Off J Am Soc Clin Oncol, 9 (11), pp. 2016-2020. , COI: 1:STN:280:DyaK38%2FksVOitA%3D%3D; Vose, J.M., Reed, E.C., Pippert, G.C., Anderson, J.R., Bierman, P.J., Kessinger, A., Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial (1993) J Clin Oncol Off J Am Soc Clin Oncol, 11 (7), pp. 1306-1310. , COI: 1:STN:280:DyaK3szgtFKltw%3D%3D; Hadjibabaie, M., Alimoghaddam, K., Shamshiri, A.R., Iravani, M., Bahar, B., Mousavi, A., Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation (2008) Urol Oncol, 26 (1), pp. 43-46. , PID: 18190829; Shameem, I.A., Shimabukuro, T., Shirataki, S., Yamamoto, N., Maekawa, T., Naito, K., Hyperbaric oxygen therapy for control of intractable cyclophosphamide-induced hemorrhagic cystitis (1992) Eur Urol, 22 (3), pp. 263-264. , COI: 1:STN:280:DyaK3s7gs1ShtQ%3D%3D, PID: 1468485; Hattori, K., Yabe, M., Matsumoto, M., Kudo, Y., Yasuda, Y., Inoue, H., Successful hyperbaric oxygen treatment of life-threatening hemorrhagic cystitis after allogeneic bone marrow transplantation (2001) Bone Marrow Transplant, 27 (12), pp. 1315-1317. , COI: 1:STN:280:DC%2BD3MvpvVyktQ%3D%3D, PID: 11548852; Hughes, A.J., Schwarer, A.P., Millar, I.L., Hyperbaric oxygen in the treatment of refractory haemorrhagic cystitis (1998) Bone Marrow Transplant, 22 (6), pp. 585-586. , COI: 1:STN:280:DyaK1cvivFeitw%3D%3D, PID: 9758348; Hader, J.E., Marzella, L., Myers, R.A., Jacobs, S.C., Naslund, M.J., Hyperbaric oxygen treatment for experimental cyclophosphamide-induced hemorrhagic cystitis (1993) J Urol, 149 (6), pp. 1617-1621. , COI: 1:STN:280:DyaK3s3nsVOksw%3D%3D, PID: 8501819; La Rosa, A.M., Champlin, R.E., Mirza, N., Gajewski, J., Giralt, S., Rolston, K.V., Adenovirus infections in adult recipients of blood and marrow transplants (2001) Clin Infect Dis Off Publ Infect Dis Soc Am, 32 (6), pp. 871-876; Gardner, S.D., Field, A.M., Coleman, D.V., Hulme, B., New human papovavirus (B.K.) isolated from urine after renal transplantation (1971) Lancet, 1 (7712), pp. 1253-1257. , COI: 1:STN:280:DyaE3M3mtVSqtQ%3D%3D, PID: 4104714; Gardner, S.D., Prevalence in England of antibody to human polyomavirus (B.k.) (1973) Br Med J, 1 (5845), pp. 77-78. , COI: 1:STN:280:DC%2BC3MzpvValuw%3D%3D, PID: 20791873; O’Donnell, P.H., Swanson, K., Josephson, M.A., Artz, A.S., Parsad, S.D., Ramaprasad, C., BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants (2009) Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 15 (9), pp. 1038-1048. , e1; Haines, H.L., Laskin, B.L., Goebel, J., Davies, S.M., Yin, H.J., Lawrence, J., Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation (2011) Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 17 (10), pp. 1512-1519; Khan, H., Oberoi, S., Mahvash, A., Sharma, M., Rondon, G., Alousi, A., Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement (2011) Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 17 (10), pp. 1551-1555; Basara, N., Rasche, F.M., Schwalenberg, T., Wickenhauser, C., Maier, M., Ivovic, J., Hydronephrosis resulting from bilateral ureteral stenosis: a late complication of polyoma BK virus cystitis? (2010) J Transplant; Hirsch, H.H., Knowles, W., Dickenmann, M., Passweg, J., Klimkait, T., Mihatsch, M.J., Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients (2002) N Engl J Med, 347 (7), pp. 488-496. , PID: 12181403; Silva Lde, P., Patah, P.A., Saliba, R.M., Szewczyk, N.A., Gilman, L., Neumann, J., Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type (2010) Haematologica, 95 (7), pp. 1183-1190. , PID: 20410183; Hirsch, H.H., Steiger, J., Polyomavirus BK (2003) Lancet Infect Dis, 3 (10), pp. 611-623. , PID: 14522260; Erard, V., Storer, B., Corey, L., Nollkamper, J., Huang, M.L., Limaye, A., BK virus infection in hematopoietic stem cell transplant recipients: frequency, risk factors, and association with postengraftment hemorrhagic cystitis (2004) Clin Infect Dis Off Publ Infect Dis Soc Am, 39 (12), pp. 1861-1865; Gilis L, Morisset S, Billaud G, Ducastelle-Lepretre S, Labussiere-Wallet H, Nicolini FE, et al. High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2014;49(5):664–70. This paper is classified of greatest importance because the authors investigated the incidence, risk factors, outcome, and financial burden of BKV-HC in 323 consecutive adult patients undergoing allo-HSCT over a 5-year period. In multivariate analysis, patients receiving cord blood units and peripheral blood stem cells represented high-risk subgroups for developing BKV-HC. BKV-HC patients required a significantly longer duration of hospitalization, more RBC, platelet transfusions and greater financial costsAkiyama, H., Kurosu, T., Sakashita, C., Inoue, T., Mori, S., Ohashi, K., Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation (2001) Clin Infect Dis Off Publ Infect Dis Soc Am, 32 (9), pp. 1325-1330. , COI: 1:STN:280:DC%2BD3MzpsFanug%3D%3D; Hirsch, H.H., BK virus: opportunity makes a pathogen (2005) Clin Infect Dis Off Publ Infect Dis Soc Am, 41 (3), pp. 354-360; Ost, L., Lonnqvist, B., Eriksson, L., Ljungman, P., Ringden, O., Hemorrhagic cystitis—a manifestation of graft versus host disease? (1987) Bone Marrow Transplant, 2 (1), pp. 19-25. , COI: 1:STN:280:DyaL1M%2FgtFeqsw%3D%3D, PID: 3139114; Bogdanovic, G., Priftakis, P., Giraud, G., Kuzniar, M., Ferraldeschi, R., Kokhaei, P., Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation (2004) J Clin Microbiol, 42 (11), pp. 5394-5396. , COI: 1:STN:280:DC%2BD2crls1Ggtg%3D%3D, PID: 15528753; Rorije, N.M., Shea, M.M., Satyanarayana, G., Hammond, S.P., Ho, V.T., Baden, L.R., BK virus disease after allogeneic stem cell transplantation: a cohort analysis (2014) Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 20 (4), pp. 564-570; Oshrine, B., Bunin, N., Li, Y., Furth, S., Laskin, B.L., Kidney and bladder outcomes in children with hemorrhagic cystitis and BK virus infection after allogeneic hematopoietic stem cell transplantation (2013) Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 19 (12), pp. 1702-1707; Giraud, G., Bogdanovic, G., Priftakis, P., Remberger, M., Svahn, B.M., Barkholt, L., The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen (2006) Haematologica, 91 (3), pp. 401-404. , PID: 16531266; Asano, Y., Kanda, Y., Ogawa, N., Sakata-Yanagimoto, M., Nakagawa, M., Kawazu, M., Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation (2003) Bone Marrow Transplant, 32 (12), pp. 1175-1179. , COI: 1:STN:280:DC%2BD3srmsFKrtg%3D%3D, PID: 14647272; Fu, H., Xu, L., Liu, D., Zhang, X., Liu, K., Chen, H., Late-onset hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation in patients with advanced leukemia: differences in ATG dosage are key (2013) Int J Hematol, 98 (1), pp. 89-95. , PID: 23632950; Yaghobi, R., Ramzi, M., Dehghani, S., The role of different risk factors in clinical presentation of hemorrhagic cystitis in hematopoietic stem cell transplant recipients (2009) Transplant Proc, 41 (7), pp. 2900-2902. , COI: 1:STN:280:DC%2BD1MnjsFCluw%3D%3D, PID: 19765468; Trotman, J., Nivison-Smith, I., Dodds, A., Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration (1999) Bone Marrow Transplant, 23 (8), pp. 797-801. , COI: 1:STN:280:DyaK1M3ks1WksQ%3D%3D, PID: 10231142; Turkeri, L.N., Lum, L.G., Uberti, J.P., Abella, E., Momin, F., Karanes, C., Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation (1995) J Urol, 153 (3), pp. 637-640. , COI: 1:STN:280:DyaK2M7msFGisg%3D%3D, PID: 7861502; Atkinson, K., Biggs, J.C., Golovsky, D., Concannon, A., Dodds, A., Downs, K., Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients (1991) Bone Marrow Transplant, 7 (5), pp. 351-354. , COI: 1:STN:280:DyaK3MzgtVWruw%3D%3D, PID: 2070143; Ippoliti, C., Przepiorka, D., Mehra, R., Neumann, J., Wood, J., Claxton, D., Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation (1995) Urology, 46 (6), pp. 811-815. , COI: 1:STN:280:DyaK28%2Fpslaitw%3D%3D, PID: 7502421; Cesaro, S., Facchin, C., Tridello, G., Messina, C., Calore, E., Biasolo, M.A., A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation (2008) Bone Marrow Transplant, 41 (4), pp. 363-370. , COI: 1:STN:280:DC%2BD1c7ktFagsQ%3D%3D, PID: 17982496; Ostroff, E.B., Chenault, O.W., Jr., Alum irrigation for the control of massive bladder hemorrhage (1982) J Urol, 128 (5), pp. 929-930. , COI: 1:STN:280:DyaL3s%2Fos1SgtA%3D%3D, PID: 7176055; Efros, M.D., Ahmed, T., Coombe, N., Choudhury, M.S., Urologic complications of high-dose chemotherapy and bone marrow transplantation (1994) Urology, 43 (3), pp. 355-360. , COI: 1:STN:280:DyaK2c7ot1eitw%3D%3D, PID: 8134990; Heaf, J.G., Podenphant, J., Joffe, P., Andersen, J.R., Fugleberg, S., Braendstrup, O., The effect of oral aluminium salts on the bone of non-dialysed uremic patients (1987) Scand J Urol Nephrol, 21 (3), pp. 229-233. , COI: 1:STN:280:DyaL1c7is12hug%3D%3D, PID: 3433024; Praveen, B.V., Sankaranarayanan, A., Vaidyanathan, S., A comparative study of intravesical instillation of 15(s) 15 Me alpha and alum in the management of persistent hematuria of vesical origin (1992) Int J Clin Pharmacol Ther Toxicol, 30 (1), pp. 7-12. , COI: 1:STN:280:DyaK383gtF2ltQ%3D%3D, PID: 1551743; Goswami, A.K., Mahajan, R.K., Nath, R., Sharma, S.K., How safe is 1% alum irrigation in controlling intractable vesical hemorrhage? (1993) J Urol, 149 (2), pp. 264-267. , COI: 1:STN:280:DyaK3s7kvVelsA%3D%3D, PID: 8426397; Bogris, S.L., Johal, N.S., Hussein, I., Duffy, P.G., Mushtaq, I., Is it safe to use aluminum in the treatment of pediatric hemorrhagic cystitis? A case discussion of aluminum intoxication and review of the literature (2009) J Pediatr Hematol Oncol, 31 (4), pp. 285-288. , PID: 19346883; Shoskes, D.A., Radzinski, C.A., Struthers, N.W., Honey, R.J., Aluminum toxicity and death following intravesical alum irrigation in a patient with renal impairment (1992) J Urol, 147 (3), pp. 697-699. , COI: 1:STN:280:DyaK387msleqtA%3D%3D, PID: 1538463; Brown, R.B., A method of management of inoperable carcinoma of the bladder (1968) Br J Urol, 40 (4), p. 489. , COI: 1:STN:280:DyaF1cvhsVWhuw%3D%3D, PID: 4175874; Vicente, J., Rios, G., Caffaratti, J., Intravesical formalin for the treatment of massive hemorrhagic cystitis: retrospective review of 25 cases (1990) Eur Urol, 18 (3), pp. 204-206. , COI: 1:STN:280:DyaK3M%2FosFCksQ%3D%3D, PID: 2261933; Fair, W.R., Formalin in the treatment of massive bladder hemorrhage. Techniques, results, and complications (1974) Urology, 3 (5), pp. 573-576. , COI: 1:STN:280:DyaE2c7ntV2luw%3D%3D, PID: 4830634; Cheuk, D.K., Lee, T.L., Chiang, A.K., Ha, S.Y., Lau, Y.L., Chan, G.C., Risk factors and treatment of hemorrhagic cystitis in children who underwent hematopoietic stem cell transplantation (2007) Transplant Int Off J Eur Soc Organ Transplant, 20 (1), pp. 73-81; Vela-Ojeda, J., Tripp-Villanueva, F., Sanchez-Cortes, E., Ayala-Sanchez, M., Garcia-Ruiz Esparza, M.A., Rosas-Cabral, A., Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant (1999) Bone Marrow Transplant, 24 (12), pp. 1307-1310. , COI: 1:STN:280:DC%2BD3c%2FpsVOhsw%3D%3D, PID: 10627639; Dorticos, E., Pavon, V., Jaime, J.C., Reboredo, M., Lopez Saura, P., Berlanga, J., Successful application of epidermal growth factor for treatment of hemorrhagic cystitis after bone marrow transplantation (2003) Bone Marrow Transplant, 31 (7), pp. 615-616. , COI: 1:STN:280:DC%2BD3s7ntleksw%3D%3D, PID: 12692631; Liu, Y.K., Harty, J.I., Steinbock, G.S., Holt, H.A., Jr., Goldstein, D.H., Amin, M., Treatment of radiation or cyclophosphamide induced hemorrhagic cystitis using conjugated estrogen (1990) J Urol, 144 (1), pp. 41-43. , PID: 2162975; Heath, J.A., Mishra, S., Mitchell, S., Waters, K.D., Tiedemann, K., Estrogen as treatment of hemorrhagic cystitis in children and adolescents undergoing bone marrow transplantation (2006) Bone Marrow Transplant, 37 (5), pp. 523-526. , COI: 1:CAS:528:DC%2BD28Xhs1eqt7g%3D, PID: 16435012; Miller, J., Burfield, G.D., Moretti, K.L., Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis (1994) J Urol, 151 (5), pp. 1348-1350. , COI: 1:STN:280:DyaK2c3htVKntQ%3D%3D, PID: 8158784; Ordemann, R., Naumann, R., Geissler, G., Bornhauser, M., Schuler, U., Ehninger, G., Encouraging results in the treatment of haemorrhagic cystitis with estrogen—report of 10 cases and review of the literature (2000) Bone Marrow Transplant, 25 (9), pp. 981-985. , COI: 1:STN:280:DC%2BD3c3mtFChtA%3D%3D, PID: 10800067; Cesaro, S., Brugiolo, A., Faraci, M., Uderzo, C., Rondelli, R., Favre, C., Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group (2003) Bone Marrow Transplant, 32 (9), pp. 925-931. , COI: 1:STN:280:DC%2BD3svotlSmsg%3D%3D, PID: 14561994; Mohamad Al-Ali, B., Trummer, H., Shamloul, R., Zigeuner, R., Pummer, K., Is treatment of hemorrhagic radiation cystitis with hyperbaric oxygen effective? (2010) Urol Int, 84 (4), pp. 467-470. , PID: 20224264; Chong, K.T., Hampson, N.B., Corman, J.M., Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis (2005) Urology, 65 (4), pp. 649-653. , PID: 15833500; Davis, M., MacDonald, H., Sames, C., Nand, K., Severe cyclophosphamide-induced haemorrhagic cystitis treated with hyperbaric oxygen (2011) N Z Med J, 124 (1340), pp. 48-54. , PID: 21952384; Nakada, T., Nakada, H., Yoshida, Y., Nakashima, Y., Banya, Y., Fujihira, T., Hyperbaric oxygen therapy for radiation cystitis in patients with prostate cancer: a long-term follow-up study (2012) Urol Int, 89 (2), pp. 208-214. , COI: 1:CAS:528:DC%2BC38XhtlGjtLfM, PID: 22797611; Hosokawa, K., Yamazaki, H., Nakamura, T., Yoroidaka, T., Imi, T., Shima, Y., Successful hyperbaric oxygen therapy for refractory BK virus-associated hemorrhagic cystitis after cord blood transplantation (2014) Transplant Infect Dis Off J Transplant Soc, 16 (5), pp. 843-846. , COI: 1:CAS:528:DC%2BC2cXhslCjtLrP; Savva-Bordalo, J., Pinho Vaz, C., Sousa, M., Branca, R., Campilho, F., Resende, R., Clinical effectiveness of hyperbaric oxygen therapy for BK-virus-associated hemorrhagic cystitis after allogeneic bone marrow transplantation (2012) Bone Marrow Transplant, 47 (8), pp. 1095-1098. , COI: 1:CAS:528:DC%2BC38XhtFOks77O, PID: 22080970; Ashrani, A.A., Gabriel, D.A., Gajewski, J.L., Jacobs, D.R., Jr., Weisdorf, D.J., Key, N.S., Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy (2006) Bone Marrow Transplant, 38 (12), pp. 825-828. , COI: 1:CAS:528:DC%2BD28Xht1Cnt7rM, PID: 17133240; Karimi, M., Zakerinia, M., Khojasteh, H.N., Ramzi, M., Ahmad, E., Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation (2004) J Thromb Haemost JTH, 2 (10), pp. 1853-1855. , COI: 1:CAS:528:DC%2BD2cXps1amu7c%3D; Harkensee, C., Vasdev, N., Gennery, A.R., Willetts, I.E., Taylor, C., Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation–a systematic review and evidence-based guidance for clinical management (2008) Br J Haematol, 142 (5), pp. 717-731. , PID: 18540939; Pihusch, M., Bacigalupo, A., Szer, J., von Depka Prondzinski, M., Gaspar-Blaudschun, B., Hyveled, L., Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation (2005) J Thromb Haemost JTH, 3 (9), pp. 1935-1944. , COI: 1:STN:280:DC%2BD2Mvjs1eqsw%3D%3D; Sakuma, H., Satoh, T., Matsumoto, E., Kanno, H., Watanabe, M., Kikuta, A., The clinical effect of factor XIII on drug-induced hemorrhagic cystitis (1994) Rinsho Ketsueki Jpn J Clin Hematol, 35 (3), pp. 279-285. , COI: 1:STN:280:DyaK2c3htVOhsg%3D%3D; Demesmay, K., Tissot, E., Bulabois, C.E., Bertrand, M.A., Racadot, E., Woronoff-Lemsi, M.C., Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases (2002) Transplantation, 74 (8), pp. 1190-1192. , COI: 1:CAS:528:DC%2BD38XovVeitL8%3D, PID: 12438970; Bhaskaran, S., Abu-Arja, R.F., Abusin, G., Cabral, L., Nagle, K., Ahuja, S., Recombinant human keratinocyte growth factor: successful treatment of severe, refractory hemorrhagic cystitis after allogeneic hematopoietic cell transplantation (2014) Bone Marrow Transplant, 49 (12), pp. 1550-1551. , COI: 1:CAS:528:DC%2BC2cXhsFyltbnE, PID: 25243621; Czibere, A., Bruns, I., Graef, T., Fenk, R., Zohren, F., Safaian, N., Treatment of severe hemorrhagic cystitis after allogeneic stem cell transplantation with palifermin, a recombinant human keratinocyte growth factor (2007) Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 13 (7), pp. 872-874. , COI: 1:CAS:528:DC%2BD2sXosVKmuro%3D; Randhawa, P., Farasati, N.A., Shapiro, R., Hostetler, K.Y., Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro (2006) Antimicrob Agents Chemother, 50 (4), pp. 1564-1566. , COI: 1:CAS:528:DC%2BD28XjvFOrtro%3D, PID: 16569886; Held, T.K., Biel, S.S., Nitsche, A., Kurth, A., Chen, S., Gelderblom, H.R., Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir (2000) Bone Marrow Transplant, 26 (3), pp. 347-350. , COI: 1:STN:280:DC%2BD3M%2Fns1OnsA%3D%3D, PID: 10967578; Kwon, H.J., Kang, J.H., Lee, J.W., Chung, N.G., Kim, H.K., Cho, B., Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience (2013) Transplant Infect Dis Off J Transplant Soc, 15 (6), pp. 569-574. , COI: 1:CAS:528:DC%2BC3sXhvVyjurjL; Savona, M.R., Newton, D., Frame, D., Levine, J.E., Mineishi, S., Kaul, D.R., Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant (2007) Bone Marrow Transplant, 39 (12), pp. 783-787. , COI: 1:CAS:528:DC%2BD2sXmtFSjsb4%3D, PID: 17438584; Purves, J.T., Graham, M.L., Ramakumar, S., Application of fibrin glue to damaged bladder mucosa in a case of BK viral hemorrhagic cystitis (2005) Urology, 66 (3), pp. 641-643. , PID: 16140094; Tirindelli, M.C., Flammia, G., Sergi, F., Cerretti, R., Cudillo, L., Picardi, A., Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation (2009) Transfusion, 49 (1), pp. 170-175. , PID: 18954405; Tirindelli, M.C., Flammia, G.P., Bove, P., Cerretti, R., Cudillo, L., De Angelis, G., Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation (2014) Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 20 (10), pp. 1612-1617. , COI: 1:CAS:528:DC%2BC2cXht1Wjs7rF; Gine, E., Rovira, M., Real, I., Burrel, M., Montana, J., Carreras, E., Successful treatment of severe hemorrhagic cystitis after hemopoietic cell transplantation by selective embolization of the vesical arteries (2003) Bone Marrow Transplant, 31 (10), pp. 923-925. , COI: 1:STN:280:DC%2BD3s3is1CmsA%3D%3D, PID: 12748670; Palandri, F., Bonifazi, F., Rossi, C., Falcioni, S., Arpinati, M., Giannini, M.B., Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization (2005) Bone Marrow Transplant, 35 (5), pp. 529-530. , COI: 1:STN:280:DC%2BD2M7jtVylsg%3D%3D, PID: 15665843; Koc, S., Hagglund, H., Ireton, R.C., Perez-Simon, J.A., Collins, S.J., Appelbaum, F.R., Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation (2000) Bone Marrow Transplant, 26 (8), pp. 899-901. , COI: 1:STN:280:DC%2BD3M7itV2itQ%3D%3D, PID: 11081392; Garderet, L., Bittencourt, H., Sebe, P., Kaliski, A., Claisse, J.P., Esperou, H., Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients (2000) Transplantation, 70 (12), pp. 1807-1811. , COI: 1:STN:280:DC%2BD3M%2FptlOgsQ%3D%3D, PID: 11152115; Linder, B.J., Tarrell, R.F., Boorjian, S.A., Cystectomy for refractory hemorrhagic cystitis: contemporary etiology, presentation and outcomes (2014) J Urol, 192 (6), pp. 1687-1692. , PID: 24936722",Review,Scopus,2-s2.0-84928889162
"Mondanizadeh M., Arefian E., Mosayebi G., Saidijam M., Khansarinejad B., Hashemi S.M.","MicroRNA-124 regulates neuronal differentiation of mesenchymal stem cells by targeting Sp1 mRNA",2015,"Journal of Cellular Biochemistry","116","6",,"943","953",,,10.1002/jcb.25045,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926653903&partnerID=40&md5=21a346edd0ce7d96aa812f8146da072f","Research Center for Molecular Medicine, Hamadan University of Medical SciencesHamadan, Iran; Department of Microbiology, School of Biology, University of TehranTehran, Iran; Department of Microbiology and Immunology, Arak University of Medical SciencesArak, Iran; Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical SciencesTehran, Iran","Mondanizadeh, M., Research Center for Molecular Medicine, Hamadan University of Medical SciencesHamadan, Iran; Arefian, E., Department of Microbiology, School of Biology, University of TehranTehran, Iran; Mosayebi, G., Department of Microbiology and Immunology, Arak University of Medical SciencesArak, Iran; Saidijam, M., Research Center for Molecular Medicine, Hamadan University of Medical SciencesHamadan, Iran; Khansarinejad, B., Department of Microbiology and Immunology, Arak University of Medical SciencesArak, Iran; Hashemi, S.M., Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical SciencesTehran, Iran","MicroRNAs play an important role in neuronal development and function. miR-124 is the most abundantly expressed miRNA in the nervous system. Several different mRNA targets have been proposed for miR-124, but the precise function of endogenous miR-124 and its mRNA targets remain to be further elucidated. Specificity protein 1 (Sp1) is a transcription factor that plays key roles in many cell processes including cell cycle. However, this transcription factor is nearly absent in differentiated neurons and a remarkable suppression of Sp1 expression was shown after neurogenesis. Since miR-124 is expressed abundantly in neurons and because Sp1 levels decrease during neurogenesis, it is possible that miR-124 could regulate the expression of Sp1 during neuronal development. Therefore, the aim of the present study was to evaluate the putative targeting of Sp1 by miR-124. Overexpression of miR-124 using a plasmid coding for pri-miR-124 in HEK293 cells decreased the expression of Sp1 mRNA. The results of dual-luciferase reporter assay demonstrated that miR-124 directly targeted the 3′-untranslated regions of Sp1 mRNA. To evaluate whether Sp1 expression was regulated by miR-124 during the process of neuronal differentiation, Adipose-derived mesenchymal stem cells (A-MSCs) were differentiated into neuron-like cells. The results of qPCR analysis showed that with the gradual increase of miR-124 expression during neurogenesis, the expression of Sp1 mRNA decreased accordingly. In summary, this study demonstrated for the first time that miR-124 is able to suppress Sp1 expression, which in turn affected the neuronal differentiation of mesenchymal stem cells. © 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.","CELL DIFFERENTIATION; MicroRNAs; miR-124; NEUROGENESIS; SPECIFIC PROTEIN 1","Abdelrahim, M., Samudio, I., Smith, R., III, Burghardt, R., Safe, S., Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells (2002) J Biol Chem, 277, pp. 28815-28822; Black, A.R., Jensen, D., Lin, S.Y., Azizkhan, J.C., Growth/cell cycle regulation of Sp1 phosphorylation (1999) J Biol Chem, 274, pp. 1207-1215; Cao, X., Pfaff, S.L., Gage, F.H., A functional study of miR-124 in the developing neural tube (2007) Genes Dev, 21, pp. 531-536; Cheng, L.C., Pastrana, E., Tavazoie, M., Doetsch, F., MiR-124 regulates adult neurogenesis in the subventricular zone stem cell niche (2009) Nat Neurosci, 12, pp. 399-408; Clark, A.M., Goldstein, L.D., Tevlin, M., Tavare, S., Shaham, S., Miska, E.A., The microRNA miR-124 controls gene expression in the sensory nervous system of Caenorhabditis elegans (2010) Nucleic Acids Res, 38, pp. 3780-3793; Conaco, C., Otto, S., Han, J.J., Mandel, G., Reciprocal actions of REST and a microRNA promote neuronal identity (2006) Proc Natl Acad Sci USA, 103, pp. 2422-2427; Dong, Q., Cai, N., Tao, T., Zhang, R., Yan, W., Li, R., Zhang, J., Liu, N., An Axis Involving SNAI1, microRNA-128 and SP1 Modulates Glioma Progression (2014) PLoS ONE, 9, p. e98651; Finch, M.L., Marquardt, J.U., Yeoh, G.C., Callus, B.A., Regulation of microRNAs and their role in liver development, regeneration and disease (2014) Int J Biochem Cell Biol; Franke, K., Otto, W., Johannes, S., Baumgart, J., Nitsch, R., Schumacher, S., MiR-124-regulated RhoG reduces neuronal process complexity via ELMO/Dock180/Rac1 and Cdc42 signalling (2012) EMBO J, 31, pp. 2908-2921; Gao, F.B., Context-dependent functions of specific microRNAs in neuronal development (2010) Neural Dev, 5, p. 25; Guttilla, I.K., White, B.A., Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells (2009) J Biol Chem, 284, pp. 23204-23216; Krichevsky, A.M., King, K.S., Donahue, C.P., Khrapko, K., Kosik, K.S., A microRNA array reveals extensive regulation of microRNAs during brain development (2003) RNA, 9, pp. 1274-1281; Krichevsky, A.M., Sonntag, K.C., Isacson, O., Kosik, K.S., Specific microRNAs modulate embryonic stem cell-derived neurogenesis (2006) Stem Cells, 24, pp. 857-864; Kuss, A.W., Chen, W., MicroRNAs in brain function and disease (2008) Curr Neurol Neurosci Rep, 8, pp. 190-197; Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., Tuschl, T., Identification of tissue-specific microRNAs from mouse (2002) Curr Biol, 12, pp. 735-739; Lee, R.C., Feinbaum, R.L., Ambros, V., The C. Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 (1993) Cell, 75, pp. 843-854; Lee, Y., Kim, M., Han, J., Yeom, K.H., Lee, S., Baek, S.H., Kim, V.N., MicroRNA genes are transcribed by RNA polymerase II (2004) EMBO J, 23, pp. 4051-4060; Liang, R., Wang, E., Full-length 3'-untranslated region reporter construction with recombineering (2012) Anal Biochem, 424, pp. 162-167; Lim, L.P., Lau, N.C., Garrett-Engele, P., Grimson, A., Schelter, J.M., Castle, J., Bartel, D.P., Johnson, J.M., Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs (2005) Nature, 433, pp. 769-773; Liu, N.K., Xu, X.M., MicroRNA in central nervous system trauma and degenerative disorders (2011) Physiol Genomics, 43, pp. 571-580; Maiorano, N.A., Mallamaci, A., The pro-differentiating role of miR-124: Indicating the road to become a neuron (2010) RNA Biol, 7, pp. 528-533; Makeyev, E.V., Zhang, J., Carrasco, M.A., Maniatis, T., The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing (2007) Mol Cell, 27, pp. 435-448; Mao, X.R., Moerman-Herzog, A.M., Chen, Y., Barger, S.W., Unique aspects of transcriptional regulation in neurons-nuances in NFkappaB and Sp1-related factors (2009) J Neuroinflammation, 6, p. 16; Mao, X., Yang, S.H., Simpkins, J.W., Barger, S.W., Glutamate receptor activation evokes calpain-mediated degradation of Sp3 and Sp4, the prominent Sp-family transcription factors in neurons (2007) J Neurochem, 100, pp. 1300-1314; Meza-Sosa, K.F., Valle-Garcia, D., Pedraza-Alva, G., Perez-Martinez, L., Role of microRNAs in central nervous system development and pathology (2012) J Neurosci Res, 90, pp. 1-12; Nagata, K., Hama, I., Kiryu-Seo, S., Kiyama, H., MicroRNA-124 is down regulated in nerve-injured motor neurons and it potentially targets mRNAs for KLF6 and STAT3 (2014) Neuroscience, 256, pp. 426-432; Nelson, P.T., Baldwin, D.A., Kloosterman, W.P., Kauppinen, S., Plasterk, R.H., Mourelatos, Z., RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain (2006) RNA, 12, pp. 187-191; Neo, W.H., Yap, K., Lee, S.H., Looi, L.S., Khandelia, P., Neo, S.X., Makeyev, E.V., Su, I.H., MicroRNA miR-124 controls the choice between neuronal and astrocyte differentiation by fine-tuning Ezh2 expression (2014) J Biol Chem, 289, pp. 20788-20801; Pfaffl, M.W., Horgan, G.W., Dempfle, L., Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR (2002) Nucleic Acids Res, 30, p. e36; Qiu, T., Zhou, X., Wang, J., Du, Y., Xu, J., Huang, Z., Zhu, W., Liu, P., MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer (2014) FEBS Lett, 588, pp. 1168-1177; Schratt, G., Greenberg, M., MicroRNA function in the nervous system (2008) MicroRNAs: From Basic Science to Disease Biology, , Appasani K. editor. New York: Cambridge University Press; Sempere, L.F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., Ambros, V., Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation (2004) Genome Biol, 5, p. R13; Smirnova, L., Grafe, A., Seiler, A., Schumacher, S., Nitsch, R., Wulczyn, F.G., Regulation of miRNA expression during neural cell specification (2005) Eur J Neurosci, 21, pp. 1469-1477; Visvanathan, J., Lee, S., Lee, B., Lee, J.W., Lee, S.K., The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development (2007) Genes Dev, 21, pp. 744-749; Yu, J.Y., Chung, K.H., Deo, M., Thompson, R.C., Turner, D.L., MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation (2008) Exp Cell Res, 314, pp. 2618-2633; Zhang, R., Luo, H., Wang, S., Chen, W., Chen, Z., Wang, H.W., Chen, Y., Wang, H., MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1 (2014) Neuro Oncol; Zou, D., Chen, Y., Han, Y., Lv, C., Tu, G., Overexpression of microRNA-124 promotes the neuronal differentiation of bone marrow-derived mesenchymal stem cells (2014) Neural Regen Res, 9, pp. 1241-1248; Zufferey, R., Trono, D., (2001) Production of High-titer Lentiviral Vectorseditor, Current Protocols in Human Genetics, , John Wiley & Sons, Inc",Article,Scopus,2-s2.0-84926653903
"Kaplan N., Razy-Krajka F., Christiaen L.","Regulation and evolution of cardiopharyngeal cell identity and behavior: Insights from simple chordates",2015,"Current Opinion in Genetics and Development","32",,,"119","128",,,10.1016/j.gde.2015.02.008,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925642518&partnerID=40&md5=012169cb8539fc7a5e19c78632ccd9a7","Center for Developmental Genetics, Department of Biology, New York UniversityNew York, NY, United States","Kaplan, N., Center for Developmental Genetics, Department of Biology, New York UniversityNew York, NY, United States; Razy-Krajka, F., Center for Developmental Genetics, Department of Biology, New York UniversityNew York, NY, United States; Christiaen, L., Center for Developmental Genetics, Department of Biology, New York UniversityNew York, NY, United States","The vertebrate heart arises from distinct first and second heart fields. The latter also share a common origin with branchiomeric muscles in the pharyngeal mesoderm and transcription regulators, such as Nkx2-5, Tbx1 and Islet1. Despite significant progress, the complexity of vertebrate embryos has hindered the identification of multipotent cardiopharyngeal progenitors. Here, we summarize recent insights in cardiopharyngeal development gained from ascidian models, among the closest relatives to vertebrates. In a simplified cellular context, progressive fate specification of the ascidian cardiopharyngeal precursors presents striking similarities with their vertebrate counterparts. Multipotent cardiopharyngeal progenitors are primed to activate both the early cardiac and pharyngeal muscles programs, which segregate following asymmetric cells divisions as a result of regulatory cross-antagonisms involving Tbx1 and Nkx2-5 homologs. Activation of Ebf in pharyngeal muscle founder cells triggers both Myogenic Regulatory Factor-associated differentiation and Notch-mediated maintenance of an undifferentiated state in distinct precursors. Cross-species comparisons revealed the deep conservation of the cardiopharyngeal developmental sequence in spite of extreme genome sequence divergence, gene network rewiring and specific morphogenetic differences. Finally, analyses are beginning to uncover the influence of surrounding tissues in determining cardiopharyngeal cell identity and behavior. Thus, ascidian embryos offer a unique opportunity to study gene regulation and cell behaviors at the cellular level throughout cardiopharyngeal morphogenesis and evolution. © 2015 Elsevier Ltd.",,"Bruneau, B.G., The developmental genetics of congenital heart disease (2008) Nature, 451, pp. 943-948; Bruneau, B.G., Signaling and transcriptional networks in heart development and regeneration (2013) Cold Spring Harb Perspect Biol, 5, p. a008292; Evans, S.M., Yelon, D., Conlon, F.L., Kirby, M.L., Myocardial lineage development (2010) Circ Res, 107, pp. 1428-1444; Buckingham, M., Meilhac, S., Zaffran, S., Building the mammalian heart from two sources of myocardial cells (2005) Nat Rev Genet, 6, pp. 826-835; Vincent, S.D., Buckingham, M.E., How to make a heart: the origin and regulation of cardiac progenitor cells (2010) Curr Top Dev Biol, 90, pp. 1-41; Kelly, R.G., The second heart field (2012) Curr Top Dev Biol, 100, pp. 33-65; Meilhac, S.M., Esner, M., Kelly, R.G., Nicolas, J.F., Buckingham, M.E., The clonal origin of myocardial cells in different regions of the embryonic mouse heart (2004) Dev Cell, 6, pp. 685-698; Saga, Y., Miyagawa-Tomita, S., Takagi, A., Kitajima, S., Miyazaki, J., Inoue, T., MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube (1999) Development, 126, pp. 3437-3447; Saga, Y., Kitajima, S., Miyagawa-Tomita, S., Mesp1 expression is the earliest sign of cardiovascular development (2000) Trends Cardiovasc Med, 10, pp. 345-352; Harel, I., Maezawa, Y., Avraham, R., Rinon, A., Ma, H.Y., Cross, J.W., Leviatan, N., Jacob-Hirsch, J., Pharyngeal mesoderm regulatory network controls cardiac and head muscle morphogenesis (2012) Proc Natl Acad Sci U S A, 109, pp. 18839-18844; Lescroart, F., Hamou, W., Francou, A., Theveniau-Ruissy, M., Kelly, R.G., Buckingham, M., Clonal analysis reveals a common origin between nonsomite-derived neck muscles and heart myocardium (2015) Proc Natl Acad Sci U S A; Lescroart, F., Kelly, R.G., Le Garrec, J.F., Nicolas, J.F., Meilhac, S.M., Buckingham, M., Clonal analysis reveals common lineage relationships between head muscles and second heart field derivatives in the mouse embryo (2010) Development, 137, pp. 3269-3279; Nathan, E., Monovich, A., Tirosh-Finkel, L., Harrelson, Z., Rousso, T., Rinon, A., Harel, I., Tzahor, E., The contribution of Islet1-expressing splanchnic mesoderm cells to distinct branchiomeric muscles reveals significant heterogeneity in head muscle development (2008) Development, 135, pp. 647-657; Tirosh-Finkel, L., Elhanany, H., Rinon, A., Tzahor, E., Mesoderm progenitor cells of common origin contribute to the head musculature and the cardiac outflow tract (2006) Development, 133, pp. 1943-1953; Kelly, R.G., Brown, N.A., Buckingham, M.E., The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm (2001) Dev Cell, 1, pp. 435-440; Merscher, S., Funke, B., Epstein, J.A., Heyer, J., Puech, A., Lu, M.M., Xavier, R.J., Factor, S., TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome (2001) Cell, 104, pp. 619-629; Dodou, E., Verzi, M.P., Anderson, J.P., Xu, S.M., Black, B.L., Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development (2004) Development, 131, pp. 3931-3942; Golzio, C., Havis, E., Daubas, P., Nuel, G., Babarit, C., Munnich, A., Vekemans, M., Etchevers, H.C., ISL1 directly regulates FGF10 transcription during human cardiac outflow formation (2012) PLoS ONE, 7, p. e30677; Watanabe, Y., Zaffran, S., Kuroiwa, A., Higuchi, H., Ogura, T., Harvey, R.P., Kelly, R.G., Buckingham, M., Fibroblast growth factor 10 gene regulation in the second heart field by Tbx1, Nkx2-5, and Islet1 reveals a genetic switch for down-regulation in the myocardium (2012) Proc Natl Acad Sci U S A, 109, pp. 18273-18280; Cai, C.L., Liang, X., Shi, Y., Chu, P.H., Pfaff, S.L., Chen, J., Evans, S., Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart (2003) Dev Cell, 5, pp. 877-889; Prall, O.W., Menon, M.K., Solloway, M.J., Watanabe, Y., Zaffran, S., Bajolle, F., Biben, C., Chaulet, H., An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation (2007) Cell, 128, pp. 947-959; Cota, C.D., Segade, F., Davidson, B., Heart genetics in a small package, exploiting the condensed genome of Ciona intestinalis (2014) Brief Funct Genom, 13, pp. 3-14; Davidson, B., Ciona intestinalis as a model for cardiac development (2007) Semin Cell Dev Biol, 18, pp. 16-26; Tolkin, T., Christiaen, L., Development and evolution of the ascidian cardiogenic mesoderm (2012) Curr Top Dev Biol, 100, pp. 107-142; Delsuc, F., Tsagkogeorga, G., Lartillot, N., Philippe, H., Additional molecular support for the new chordate phylogeny (2008) Genesis, 46, pp. 592-604; Putnam, N.H., Butts, T., Ferrier, D.E., Furlong, R.F., Hellsten, U., Kawashima, T., Robinson-Rechavi, M., Yu, J.K., The amphioxus genome and the evolution of the chordate karyotype (2008) Nature, 453, pp. 1064-1071; Satoh, N., Rokhsar, D., Nishikawa, T., Chordate evolution and the three-phylum system (2014) Proc Biol Sci, 281, p. 20141729; Stolfi, A., Christiaen, L., Genetic and genomic toolbox of the chordate Ciona intestinalis (2012) Genetics, 192, pp. 55-66; Simoes-Costa, M.S., Vasconcelos, M., Sampaio, A.C., Cravo, R.M., Linhares, V.L., Hochgreb, T., Yan, C.Y., Xavier-Neto, J., The evolutionary origin of cardiac chambers (2005) Dev Biol, 277, pp. 1-15; Davidson, B., Levine, M., Evolutionary origins of the vertebrate heart: specification of the cardiac lineage in Ciona intestinalis (2003) Proc Natl Acad Sci U S A, 100, pp. 11469-11473; Satou, Y., Imai, K.S., Satoh, N., The ascidian Mesp gene specifies heart precursor cells (2004) Development, 131, pp. 2533-2541; Hirano, T., Nishida, H., Developmental fates of larval tissues after metamorphosis in ascidian Halocynthia roretzi. I. Origin of mesodermal tissues of the juvenile (1997) Dev Biol, 192, pp. 199-210; Davidson, B., Shi, W., Levine, M., Uncoupling heart cell specification and migration in the simple chordate Ciona intestinalis (2005) Development, 132, pp. 4811-4818; Beh, J., Shi, W., Levine, M., Davidson, B., Christiaen, L., FoxF is essential for FGF-induced migration of heart progenitor cells in the ascidian Ciona intestinalis (2007) Development, 134, pp. 3297-3305; Christiaen, L., Davidson, B., Kawashima, T., Powell, W., Nolla, H., Vranizan, K., Levine, M., The transcription/migration interface in heart precursors of Ciona intestinalis (2008) Science, 320, pp. 1349-1352; Davidson, B., Shi, W., Beh, J., Christiaen, L., Levine, M., FGF signaling delineates the cardiac progenitor field in the simple chordate, Ciona intestinalis (2006) Genes Dev, 20, pp. 2728-2738; Stolfi, A., Gainous, T.B., Young, J.J., Mori, A., Levine, M., Christiaen, L., Early chordate origins of the vertebrate second heart field (2010) Science, 329, pp. 565-568; Razy-Krajka, F., Lam, K., Wang, W., Stolfi, A., Joly, M., Bonneau, R., Christiaen, L., Collier/OLF/EBF-dependent transcriptional dynamics control pharyngeal muscle specification from primed cardiopharyngeal progenitors (2014) Dev Cell, 29, pp. 263-276; Wang, W., Razy-Krajka, F., Siu, E., Ketcham, A., Christiaen, L., NK4 antagonizes Tbx1/10 to promote cardiac versus pharyngeal muscle fate in the ascidian second heart field (2013) PLoS Biol, 11, p. e1001725; Stolfi, A., Sasakura, Y., Chalopin, D., Satou, Y., Christiaen, L., Dantec, C., Endo, T., Swalla, B.J., Guidelines for the nomenclature of genetic elements in tunicate genomes (2014) Genesis, 53, pp. 1-14; Stolfi, A., Gandhi, S., Salek, F., Christiaen, L., Tissue-specific genome editing in Ciona embryos by CRISPR/Cas9 (2014) Development, 141, pp. 4115-4120; Imai, K.S., Satoh, N., Satou, Y., A Twist-like bHLH gene is a downstream factor of an endogenous FGF and determines mesenchymal fate in the ascidian embryos (2003) Development, 130, pp. 4461-4472; Kobayashi, K., Yamada, L., Satou, Y., Satoh, N., Differential gene expression in notochord and nerve cord fate segregation in the Ciona intestinalis embryo (2013) Genesis, 51, pp. 647-659; Paige, S.L., Thomas, S., Stoick-Cooper, C.L., Wang, H., Maves, L., Sandstrom, R., Pabon, L., Keller, G., A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development (2012) Cell, 151, pp. 221-232; Wamstad, J.A., Alexander, J.M., Truty, R.M., Shrikumar, A., Li, F., Eilertson, K.E., Ding, H., Capra, J.A., Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage (2012) Cell, 151, pp. 206-220; Liao, J., Aggarwal, V.S., Nowotschin, S., Bondarev, A., Lipner, S., Morrow, B.E., Identification of downstream genetic pathways of Tbx1 in the second heart field (2008) Dev Biol, 316, pp. 524-537; Meedel, T.H., Chang, P., Yasuo, H., Muscle development in Ciona intestinalis requires the b-HLH myogenic regulatory factor gene Ci-MRF (2007) Dev Biol, 302, pp. 333-344; Grifone, R., Jarry, T., Dandonneau, M., Grenier, J., Duprez, D., Kelly, R.G., Properties of branchiomeric and somite-derived muscle development in Tbx1 mutant embryos (2008) Dev Dyn, 237, pp. 3071-3078; Kelly, R.G., Jerome-Majewska, L.A., Papaioannou, V.E., The del22q11.2 candidate gene Tbx1 regulates branchiomeric myogenesis (2004) Hum Mol Genet, 13, pp. 2829-2840; Sambasivan, R., Gayraud-Morel, B., Dumas, G., Cimper, C., Paisant, S., Kelly, R.G., Tajbakhsh, S., Distinct regulatory cascades govern extraocular and pharyngeal arch muscle progenitor cell fates (2009) Dev Cell, 16, pp. 810-821; Mourikis, P., Gopalakrishnan, S., Sambasivan, R., Tajbakhsh, S., Cell-autonomous Notch activity maintains the temporal specification potential of skeletal muscle stem cells (2012) Development, 139, pp. 4536-4548; Vasyutina, E., Lenhard, D.C., Wende, H., Erdmann, B., Epstein, J.A., Birchmeier, C., RBP-J (Rbpsuh) is essential to maintain muscle progenitor cells and to generate satellite cells (2007) Proc Natl Acad Sci U S A, 104, pp. 4443-4448; Harel, I., Nathan, E., Tirosh-Finkel, L., Zigdon, H., Guimaraes-Camboa, N., Evans, S.M., Tzahor, E., Distinct origins and genetic programs of head muscle satellite cells (2009) Dev Cell, 16, pp. 822-832; Green, Y.S., Vetter, M.L., EBF proteins participate in transcriptional regulation of Xenopus muscle development (2011) Dev Biol, 358, pp. 240-250; El-Magd, M.A., Allen, S., McGonnell, I., Otto, A., Patel, K., Bmp4 regulates chick Ebf2 and Ebf3 gene expression in somite development (2013) Dev Growth Differ, 55, pp. 710-722; El-Magd, M.A., Saleh, A.A., El-Aziz, R.M., Salama, M.F., The effect of RA on the chick Ebf1-3 genes expression in somites and pharyngeal arches (2014) Dev Genes Evol, 224, pp. 245-253; Lescroart, F., Chabab, S., Lin, X., Rulands, S., Paulissen, C., Rodolosse, A., Auer, H., Bondue, A., Early lineage restriction in temporally distinct populations of Mesp1 progenitors during mammalian heart development (2014) Nat Cell Biol, 16, pp. 829-840; Devine, W.P., Wythe, J.D., George, M., Koshiba-Takeuchi, K., Bruneau, B.G., Early patterning and specification of cardiac progenitors in gastrulating mesoderm (2014) Elife, p. 3; Chan, S.S., Shi, X., Toyama, A., Arpke, R.W., Dandapat, A., Iacovino, M., Kang, J., Garry, D.J., Mesp1 patterns mesoderm into cardiac, hematopoietic, or skeletal myogenic progenitors in a context-dependent manner (2013) Cell Stem Cell, 12, pp. 587-601; Lescroart, F., Mohun, T., Meilhac, S.M., Bennett, M., Buckingham, M., Lineage tree for the venous pole of the heart: clonal analysis clarifies controversial genealogy based on genetic tracing (2012) Circ Res, 111, pp. 1313-1322; Huynh, T., Chen, L., Terrell, P., Baldini, A., A fate map of Tbx1 expressing cells reveals heterogeneity in the second cardiac field (2007) Genesis, 45, pp. 470-475; Kong, P., Racedo, S.E., Macchiarulo, S., Hu, Z., Carpenter, C., Guo, T., Wang, T., Morrow, B.E., Tbx1 is required autonomously for cell survival and fate in the pharyngeal core mesoderm to form the muscles of mastication (2014) Hum Mol Genet, 23, pp. 4215-4231; Chen, J.Y., Huang, D.Y., Peng, Q.Q., Chi, H.M., Wang, X.Q., Feng, M., The first tunicate from the Early Cambrian of South China (2003) Proc Natl Acad Sci U S A, 100, pp. 8314-8318; Lemaire, P., Unfolding a chordate developmental program, one cell at a time: invariant cell lineages, short-range inductions and evolutionary plasticity in ascidians (2009) Dev Biol, 332, pp. 48-60; Stolfi, A., Lowe, E.K., Racioppi, C., Ristoratore, F., Brown, C.T., Swalla, B.J., Christiaen, L., Divergent mechanisms regulate conserved cardiopharyngeal development and gene expression in distantly related ascidians (2014) Elife, p. 3; Lemaire, P., Smith, W.C., Nishida, H., Ascidians and the plasticity of the chordate developmental program (2008) Curr Biol, 18, pp. R620-R631; Ragkousi, K., Beh, J., Sweeney, S., Starobinska, E., Davidson, B., A single GATA factor plays discrete, lineage specific roles in ascidian heart development (2011) Dev Biol, 352, pp. 154-163; Chiba, S., Sasaki, A., Nakayama, A., Takamura, K., Satoh, N., Development of Ciona intestinalis juveniles (through 2nd ascidian stage) (2004) Zoolog Sci, 21, pp. 285-298; Sasakura, Y., Kanda, M., Ikeda, T., Horie, T., Kawai, N., Ogura, Y., Yoshida, R., Fujiwara, S., Retinoic acid-driven Hox1 is required in the epidermis for forming the otic/atrial placodes during ascidian metamorphosis (2012) Development, 139, pp. 2156-2160; Hoffmann, A.D., Yang, X.H., Burnicka-Turek, O., Bosman, J.D., Ren, X., Steimle, J.D., Vokes, S.A., Moskowitz, I.P., Foxf genes integrate tbx5 and hedgehog pathways in the second heart field for cardiac septation (2014) PLoS Genet, 10, p. e1004604; Islas, J.F., Liu, Y., Weng, K.C., Robertson, M.J., Zhang, S., Prejusa, A., Harger, J., Iyer, D., Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors (2012) Proc Natl Acad Sci U S A, 109, pp. 13016-13021; Woznica, A., Haeussler, M., Starobinska, E., Jemmett, J., Li, Y., Mount, D., Davidson, B., Initial deployment of the cardiogenic gene regulatory network in the basal chordate, Ciona intestinalis (2012) Dev Biol, 368, pp. 127-139; Norton, J., Cooley, J., Islam, A.F., Cota, C.D., Davidson, B., Matrix adhesion polarizes heart progenitor induction in the invertebrate chordate Ciona intestinalis (2013) Development, 140, pp. 1301-1311; Cooley, J., Whitaker, S., Sweeney, S., Fraser, S., Davidson, B., Cytoskeletal polarity mediates localized induction of the heart progenitor lineage (2011) Nat Cell Biol, 13, pp. 952-957; Bowers, S.L.K., Baudino, T.A., Laying the groundwork for growth: cell-cell and cell-ECM interactions in cardiovascular development (2010) Birth Defects Res C - Embryo Today-Rev, 90, pp. 1-7; Ross, R.S., Borg, T.K., Integrins and the myocardium (2001) Circ Res, 88, pp. 1112-1119; Peterkin, T., Gibson, A., Patient, R., Redundancy and evolution of GATA factor requirements in development of the myocardium (2007) Dev Biol, 311, pp. 623-635; Zhao, R., Watt, A.J., Battle, M.A., Li, J.X., Bondow, B.J., Duncan, S.A., Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice (2008) Dev Biol, 317, pp. 614-619; Molkentin, J.D., Lin, Q., Duncan, S.A., Olson, E.N., Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis (1997) Genes Dev, 11, pp. 1061-1072; Kuo, C.T., Morrisey, E.E., Anandappa, R., Sigrist, K., Lu, M.M., Parmacek, M.S., Soudais, C., Leiden, J.M., GATA4 transcription factor is required for ventral morphogenesis and heart tube formation (1997) Genes Dev, 11, pp. 1048-1060; Reiter, J.F., Alexander, J., Rodaway, A., Yelon, D., Patient, R., Holder, N., Stainier, D.Y.R., Gata5 is required for the development of the heart and endoderm in zebrafish (1999) Genes Dev, 13, pp. 2983-2995; Haworth, K.E., Kotecha, S., Mohun, T.J., Latinkic, B.V., GATA4 and GATA5 are essential for heart and liver development in Xenopus embryos (2008) BMC Dev Biol, p. 8; Peterkin, T., Gibson, A., Patient, R., Common genetic control of haemangioblast and cardiac development in zebrafish (2009) Development, 136, pp. 1465-1474; Gline, S., Kaplan, N., Bernadskaya, Y., Abdu, Y., Christiaen, L., Surrounding tissues canalize motile cardiopharyngeal progenitors towards collective polarity and directed migration (2015) Development, 142, pp. 544-554; Diogo, R., Kelly, R.G., Christiaen, L., Levine, M., Ziermann, J.M., Molnar, J., Noden, D.M., Tzahor, E., The cardiopharyngeal field and vertebrate evolution: a new heart for a new head (2015) Nature, , (in press); Christiaen, L., Stolfi, A., Davidson, B., Levine, M., Spatio-temporal intersection of Lhx3 and Tbx6 defines the cardiac field through synergistic activation of Mesp (2009) Dev Biol, 328, pp. 552-560; Tazumi, S., Yabe, S., Uchiyama, H., Paraxial T-box genes, Tbx6 and Tbx1, are required for cranial chondrogenesis and myogenesis (2010) Dev Biol, 346, pp. 170-180; Tazumi, S., Yabe, S., Yokoyama, J., Aihara, Y., Uchiyama, H., PMesogenin1 and 2 function directly downstream of Xtbx6 in Xenopus somitogenesis and myogenesis (2008) Dev Dyn, 237, pp. 3749-3761; Nishiyama, A., Fujiwara, S., RNA interference by expressing short hairpin RNA in the Ciona intestinalis embryo (2008) Dev Growth Differ, 50, pp. 521-529; Sasaki, H., Yoshida, K., Hozumi, A., Sasakura, Y., CRISPR/Cas9-mediated gene knockout in the ascidian Ciona intestinalis (2014) Dev Growth Differ, 56, pp. 499-510; Treen, N., Yoshida, K., Sakuma, T., Sasaki, H., Kawai, N., Yamamoto, T., Sasakura, Y., Tissue-specific and ubiquitous gene knockouts by TALEN electroporation provide new approaches to investigating gene function in Ciona (2014) Development, 141, pp. 481-487; Tsagkogeorga, G., Turon, X., Hopcroft, R.R., Tilak, M.K., Feldstein, T., Shenkar, N., Loya, Y., Delsuc, F., An updated 18S rRNA phylogeny of tunicates based on mixture and secondary structure models (2009) BMC Evol Biol, 9, p. 187",Review,Scopus,2-s2.0-84925642518
"Xia H.-M., Ou Yang G.-Q., Li C.-J., Yang J.-Z., Ma J., Zhang D., Li Y., Li L., Zhang D.-M.","Clauemarazoles A-G, seven carbazole alkaloids from the stems of Clausena emarginata",2015,"Fitoterapia","103",,,"83","89",,,10.1016/j.fitote.2015.03.016,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925812337&partnerID=40&md5=e0cc3b9f37c603797aac0a3311d81c54","State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences, Peking Union Medical CollegeBeijing, China; Shandong Academy of Chinese MedicineJinan, China","Xia, H.-M., State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences, Peking Union Medical CollegeBeijing, China, Shandong Academy of Chinese MedicineJinan, China; Ou Yang, G.-Q., State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences, Peking Union Medical CollegeBeijing, China; Li, C.-J., State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences, Peking Union Medical CollegeBeijing, China; Yang, J.-Z., State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences, Peking Union Medical CollegeBeijing, China; Ma, J., State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences, Peking Union Medical CollegeBeijing, China; Zhang, D., State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences, Peking Union Medical CollegeBeijing, China; Li, Y., State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences, Peking Union Medical CollegeBeijing, China; Li, L., State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences, Peking Union Medical CollegeBeijing, China; Zhang, D.-M., State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences, Peking Union Medical CollegeBeijing, China","Seven new carbazole alkaloids, clauemarazoles A-G, together with 19 known analogues were isolated from the stems of Clausena emarginata. Their structures were established on the basis of spectroscopic analyses, and the absolute configurations of compounds 1a, 1b, 5a, and 5b were confirmed by their ECD spectroscopy. Compounds 4, 13, 15, and 17 exhibited inhibitory abilities on LPS-induced NO production. Compounds 10-12, 20, 22, and 24 displayed hepatoprotective effects against dl-galactosamine-induced damage in WB-F344 cells. © 2015 Elsevier B.V. All rights reserved.","Anti-inflammatory activity; Carbazole alkaloids; Clausena emarginata; Hepatoprotective effects","Maneerat, W., Ritthiwigrom, T., Cheenpracha, S., Promgool, T., Yossathera, K., Deachathai, S., Bioactive carbazole alkaloids from Clausena wallichii roots (2012) J Nat Prod, 75, pp. 741-746; Liu, H., Li, C.J., Yang, J.Z., Ning, N., Si, Y.K., Li, L., Carbazole alkaloids from the stems of Clausena lansium (2012) J Nat Prod, 75, pp. 677-682; Songsiang, U., Thongthoom, T., Boonyarat, C., Yenjai, C., Claurailas A-D, cytotoxic carbazole alkaloids from the roots of Clausena harmandiana (2011) J Nat Prod, 74, pp. 208-212; Chen, S.K., Chen, B.Y., Li, H., (1997) Flora of Reipublicae Popularis Sinicae (Zhongguo Zhiwu Zhi), 43, p. 135. , Science Press Beijing; Xia, H.M., Li, C.J., Yang, J.Z., Ma, J., Chen, X.G., Zhang, D., A,D-seco-limonoids from the stems of Clausena emarginata (2014) J Nat Prod, 77, pp. 784-791; Xia, H.M., Li, C.J., Yang, J.Z., Ma, J., Li, L., Chen, X.G., Anti-inflammatory amide alkaloids from the stems of Clausena emarginata (2014) J Asian Nat Prod Res, 16, pp. 971-975; Zhang, Y., Liu, Y.B., Li, Y., Ma, S.G., Li, L., Qu, J., Sesquiterpenes and alkaloids from the roots of Alangium chinense (2013) J Nat Prod, 76, pp. 1058-1063; Shi, J., Li, C.J., Yang, J.Z., Ma, J., Wang, C., Tang, J., Hepatoprotective coumarins and secoiridoids from Hydrangea paniculata (2014) Fitoterapia, 96, pp. 138-145; Frelek, J., Szczepek, W.J., [Rh < sub > 2 </sub > (OCOCF < sub > 3 </sub >) < sub > 4 </sub > ] as an auxiliary chromophore in chiroptical studies on steroidal alcohols (1999) Tetrahedron Asymmetry, 10, pp. 1507-1520; Jadwiga, F., Klimek, A., Ruskowska, P., Dinuclear transition metal complexes as auxiliary chromophores in chiroptical studies on bioactive compounds (2003) Curr Org Chem, 7, pp. 1081-1104; Ito, C., Ohta, H., Tan, H.T.W., Furukawa, H., Constituents of Clausena excavate. Isolation and structural elucidation of seven new carbazole alkaloids and a new courmarin (1996) Chem Pharm Bull, 44, pp. 2231-2235; Maneerat, W., Laphookhieo, S., Antitumoral alkaloids from Clausena lansium (2010) Heterocycles, 81, pp. 1261-1269; Maneerat, W., Ritthiwigrom, T., Cheenpracha, S., Laphookhieo, S., Carbazole alkaloids andcoumarins from Clausena lansium (2012) Phytochem Lett, 5, pp. 26-28; Shen, D.Y., Chan, Y.Y., Hwang, T.L., Juang, S.H., Huang, S.C., Kuo, P.C., Constituents of the roots of Clausena lansium and their potential anti- inflammatory activity (2014) J Nat Prod, 77, pp. 1215-1223; Wu, T.S., Huang, S.C., Clausine-D and -F, two new 4-prenyl carbazole alkaloids from Clausena excavata (1992) Chem Pharm Bull, 40, pp. 1069-1071; Wu, T.S., Huang, S.C., Wu, P.L., Teng, C.M., Carbazole alkaloids from Clausena excavate and their biological activity (1996) Phytochemistry, 43, pp. 133-140; Lange, G.L., Organ, M.G., Three new carbazole alkaloids isolated from Murraya siamensis (1990) J Nat Prod, 53, pp. 946-952; Wu, T.S., Huang, S.C., Wu, P.L., Kuoh, C.S., Alkaloidal and other constituents from the root bark of Clausena excavate (1999) Phytochemistry, 52, pp. 523-527; Dhan, P., Kanwal, R., Kapil, R.S., Popli, S.P., Chemical constituents of Clausena lansium: Part I. Structure of lansamide-I and lansine (1980) Indian J Chem Sect B, 19 B, pp. 1075-1076; Wen-Shyong, L., McChesney, J.D., El-Feraly, F.S., Carbazole alkaloids from Clausena lansium (1991) Phytochemistry, 30, pp. 523-527; Wu, T.S., Huang, S.C., Lai, J.S., Teng, C.M., Ko, F.N., Kuoh, C.S., Chemical and antiplatelet aggregative investigation of the leaves of Clausena excavata (1993) Phytochemistry, 32, pp. 449-451; Wen-Shyong, L., McChesney, J.D., El-Feraly, F.S., Carbazole alkaloids from Clausena lansium (1991) Phytochemistry, 30, pp. 343-346; Ngadjui, B.T., Ayafor, J.F., Sondengam, B.L., Connolly, J.D., Quinolone and carbazole alkaloids from Clausena anisata (1989) Phytochemistry, 28, pp. 1517-1519; Bhattacharyya, P., Chakraborty, A., Mukonal, a probable biogenetic intermediate of pyranocarbazole alkaloids from Murraya koenigii (1984) Phytochemistry, 23, pp. 471-472",Article,Scopus,2-s2.0-84925812337
"Reagan M.R., Liaw L., Rosen C.J., Ghobrial I.M.","Dynamic interplay between bone and multiple myeloma: Emerging roles of the osteoblast",2015,"Bone","75",,,"161","169",,,10.1016/j.bone.2015.02.021,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924253484&partnerID=40&md5=dee94546bb78a20ac16f7d56df3b72da","Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical SchoolBoston, MA, United States; Maine Medical Center Research InstituteScarborough, ME, United States; Tufts University School of MedicineBoston, MA, United States","Reagan, M.R., Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical SchoolBoston, MA, United States, Maine Medical Center Research InstituteScarborough, ME, United States; Liaw, L., Maine Medical Center Research InstituteScarborough, ME, United States, Tufts University School of MedicineBoston, MA, United States; Rosen, C.J., Maine Medical Center Research InstituteScarborough, ME, United States, Tufts University School of MedicineBoston, MA, United States; Ghobrial, I.M., Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical SchoolBoston, MA, United States","Multiple myeloma is a B-cell malignancy characterized by the unrelenting proliferation of plasma cells. Multiple myeloma causes osteolytic lesions and fractures that do not heal due to decreased osteoblastic and increased osteoclastic activity. However, the exact relationship between osteoblasts and myeloma cells remains elusive. Understanding the interactions between these dynamic bone-forming cells and myeloma cells is crucial to understanding how osteolytic lesions form and persist and how tumors grow within the bone marrow. This review provides a comprehensive overview of basic and translational research focused on the role of osteoblasts in multiple myeloma progression and their relationship to osteolytic lesions. Importantly, current challenges for in vitro studies exploring direct osteoblastic effects on myeloma cells, and gaps in understanding the role of the osteoblast in myeloma progression are delineated. Finally, successes and challenges in myeloma treatment with osteoanabolic therapy (i.e., any treatment that induces increased osteoblastic number or activity) are enumerated. Our goal is to illuminate novel mechanisms by which osteoblasts may contribute to multiple myeloma disease progression and osteolysis to better direct research efforts. Ultimately, we hope this may provide a roadmap for new approaches to the pathogenesis and treatment of multiple myeloma with a particular focus on the osteoblast. © 2015 Elsevier Inc.","Bone; Multiple myeloma; Osteoblasts","Drake, M.T., Unveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance? (2014) J Bone Miner Res, 29, pp. 2529-2533; Kingsley, L.A., Fournier, P.G.J., Chirgwin, J.M., Guise, T.A., Molecular biology of bone metastasis (2007) Mol Cancer Ther, 6, pp. 2609-2617; Guise, T.A., Mohammad, K.S., Clines, G., Stebbins, E.G., Wong, D.H., Higgins, L.S., Basic mechanisms responsible for osteolytic and osteoblastic bone metastases (2006) Clin Cancer Res, 12, pp. 6213s-6216s; Fowler, J.A., Edwards, C.M., Croucher, P.I., Tumor-host cell interactions in the bone disease of myeloma (2011) Bone, 48, pp. 121-128; Kovacic, N., Croucher, P.I., McDonald, M.M., Signaling between tumor cells and the host bone marrow microenvironment (2013) Calcif Tissue Int, 94, pp. 125-139; Taube, T., Beneton, M.N., McCloskey, E.V., Rogers, S., Greaves, M., Kanis, J.A., Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption (1992) Eur J Haematol, 49, pp. 192-198; (2015), https://clinicaltrials.gov/ct2/show/record/NCT01337752, in Patients With Untreated Multiple Myeloma and Renal Insufficiency n.d. (accessed December 18)(2015), https://clinicaltrials.gov/ct2/show/NCT00741377, With an Adaptive, Randomized, Placebo-controlled, Double-blind Phase II, Using Various Repeated IV Doses of BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients With Prio n.d. (accessed January 18)Krevvata, M., Silva, B.C., Manavalan, J.S., Galan-Diez, M., Kode, A., Matthews, B.G., Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts (2014) Blood, 124, pp. 2834-2846; Ng, A.C., Khosla, S., Charatcharoenwitthaya, N., Kumar, S.K., Achenbach, S.J., Holets, M.F., Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS (2011) Blood, 118, pp. 6529-6534; Berenson, J.R., Anderson, K.C., Audell, R.A., Boccia, R.V., Coleman, M., Dimopoulos, M.A., Monoclonal gammopathy of undetermined significance: a consensus statement (2010) Br J Haematol, 150, pp. 28-38; Capulli, M., Paone, R., Rucci, N., Osteoblast and osteocyte: games without frontiers (2014) Arch Biochem Biophys, 561, pp. 3-12; Kronenberg, H.M., Kobayashi, T., (2014) Skeletal Development and Repair. Methods and Protocols, , Springer, London; Kronenberg, H.M., Developmental regulation of the growth plate (2003) Nature, 423, pp. 332-336; Baron, R., Rawadi, G., Roman-Roman, S., Wnt signaling: a key regulator of bone mass (2006) Curr Top Dev Biol, 76, pp. 103-127; Baron, R., Kneissel, M., WNT signaling in bone homeostasis and disease: from human mutations to treatments (2013) Nat Med, 19, pp. 179-192; Colnot, C., Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration (2009) J Bone Miner Res, 24, pp. 274-282; Colnot, C., Zhang, X., Knothe Tate, M.L., Current insights on the regenerative potential of the periosteum: molecular, cellular, and endogenous engineering approaches (2012) J Orthop Res, 30, pp. 1869-1878; Movérare-Skrtic, S., Henning, P., Liu, X., Nagano, K., Saito, H., Börjesson, A.E., Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures (2014) Nat Med, 20, pp. 1279-1288; Stevens, J.R., Miranda-Carboni, G.A., Singer, M.A., Brugger, S.M., Lyons, K.M., Lane, T.F., Wnt10b deficiency results in age-dependent loss of bone mass and progressive reduction of mesenchymal progenitor cells (2010) J Bone Miner Res, 25, pp. 2138-2147; Bennett, C.N., Longo, K.A., Wright, W.S., Suva, L.J., Lane, T.F., Hankenson, K.D., Regulation of osteoblastogenesis and bone mass by Wnt10b (2005) Proc Natl Acad Sci U S A, 102, pp. 3324-3329; Brommage, R., Liu, J., Hansen, G.M., Kirkpatrick, L.L., Potter, D.G., Sands, A.T., High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes (2014) Bone Res, 2, p. 14034; Pritchard, J.M., Giangregorio, L.M., Atkinson, S.A., Beattie, K.A., Inglis, D., Ioannidis, G., Changes in trabecular bone microarchitecture in postmenopausal women with and without type 2 diabetes: a two year longitudinal study (2013) BMC Musculoskelet Disord, 14, p. 114; Reagan, M.R., Mishima, Y., Glavey, S.V., Zhang, Y., Manier, S., Lu, Z.N., Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model (2014) Blood, 124, pp. 3250-3259; Roccaro, A.M., Sacco, A., Purschke, W.G., Moschetta, M., Buchner, K., Maasch, C., SDF-1 inhibition targets the bone marrow niche for cancer therapy (2014) Cell Rep, 9, pp. 118-128; Azab, A.K., Runnels, J.M., Pitsillides, C., Moreau, A.-S., Azab, F., Leleu, X., CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy (2009) Blood, 113, pp. 4341-4351; Takeuchi, K., Abe, M., Hiasa, M., Oda, A., Amou, H., Kido, S., Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth (2010) PLoS ONE, 5, p. e9870; Logothetis, C.J., Lin, S.-H., Osteoblasts in prostate cancer metastasis to bone (2005) Nat Rev Cancer, 5, pp. 21-28; Langley, G.R., Sabean, H.B., Sorger, K., Sclerotic lesions of bone in myeloma (1966) Can Med Assoc J, 94, pp. 940-946; Morán Blanco, L.M., Encinas Rodríguez, C., Multiple myeloma with diffuse osteosclerosis: Distinct from POEMS syndrome (2013) Radiologia, 56, pp. e29-e33; Chen, M., Green, R., Circulating plasma cells with Russell bodies in osteosclerotic myeloma (2013) Blood, 122, p. 160; Kuo, M.C., Shih, L.Y., Primary plasma cell leukemia with extensive dense osteosclerosis: complete remission following combination chemotherapy (1995) Ann Hematol, 71, pp. 147-151; Mulleman, D., Gaxatte, C., Guillerm, G., Leroy, X., Cotten, A., Duquesnoy, B., Multiple myeloma presenting with widespread osteosclerotic lesions (2004) Joint Bone Spine, 71, pp. 79-83; Olechnowicz, S.W.Z., Edwards, C.M., Contributions of the host microenvironment to cancer-induced bone disease (2014) Cancer Res, 74, pp. 1625-1631; Park, D., Spencer, J.A., Koh, B.I., Kobayashi, T., Fujisaki, J., Clemens, T.L., Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration (2012) Cell Stem Cell, 10, pp. 259-272; Kode, A., Manavalan, J.S., Mosialou, I., Bhagat, G., Rathinam, C.V., Luo, N., Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts (2014) Nature, 506, pp. 240-244; Li, X., Pennisi, A., Yaccoby, S., Role of decorin in the antimyeloma effects of osteoblasts (2008) Blood, 112, pp. 159-168; Chen, Z., Orlowski, R.Z., Wang, M., Kwak, L., McCarty, N., Osteoblastic niche supports the growth of quiescent multiple myeloma cells (2014) Blood, 123, pp. 2204-2208; Yaccoby, S., Osteoblastogenesis and tumor growth in myeloma (2010) Leuk Lymphoma, 51, pp. 213-220; Yaccoby, S., Wezeman, M.J., Zangari, M., Walker, R., Cottler-Fox, M., Gaddy, D., Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model (2006) Haematologica, 91, pp. 192-199; Nash, L.A., Sullivan, P.J., Peters, S.J., Ward, W.E., Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway (2014) Mol Nutr Food Res, , [Epub ahead]; Ishtiaq, S., Edwards, S., Sankaralingam, A., Evans, B.A.J., Elford, C., Frost, M.L., The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells (2014) Cytokine, 71, pp. 154-160; Guo, D., Li, Q., Lv, Q., Wei, Q., Cao, S., Gu, J., MiR-27a targets sFRP1 in hFOB cells to regulate proliferation, apoptosis and differentiation (2014) PLoS ONE, 9, p. e91354; Zhang, W., Lee, W.Y., Siegel, D.S., Tolias, P., Zilberberg, J., Patient-specific 3D microfluidic tissue model for multiple myeloma (2014) Tissue Eng Part C Methods, 20, pp. 663-670; Tinhofer, I., Biedermann, R., Krismer, M., Crazzolara, R., Greil, R., A role of TRAIL in killing osteoblasts by myeloma cells (2006) FASEB J, 20, pp. 759-761; Kassen, D., Moore, S., Percy, L., Herledan, G., Bounds, D., Rodriguez-Justo, M., The bone marrow stromal compartment in multiple myeloma patients retains capability for osteogenic differentiation in vitro: defining the stromal defect in myeloma (2014) Br J Haematol, 167, pp. 194-206; Rubin, J., Fan, X., Rahnert, J., Sen, B., Hsieh, C.-L., Murphy, T.C., IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo (2006) Prostate, 66, pp. 789-800; Standal, T., Johnson, R.W., McGregor, N.E., Poulton, I.J., Ho, P.W.M., Martin, T.J., Gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation (2014) J Endocrinol, 223, pp. 181-190; Reagan, M.R., Ghobrial, I.M., Multiple myeloma-mesenchymal stem cells: characterization, origin, and tumor-promoting effects (2012) Clin Cancer Res, 18, pp. 342-349; Fu, R., Liu, H., Zhao, S., Wang, Y., Li, L., Gao, S., Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone disease (2014) Cancer Cell Int, 14, p. 132; Ferrarini, M., Steimberg, N., Ponzoni, M., Belloni, D., Berenzi, A., Girlanda, S., Ex-vivo dynamic 3-D culture of human tissues in the RCCSTM bioreactor allows the study of multiple myeloma biology and response to therapy (2013) PLoS ONE, 8, p. e71613; Narayanan, N.K., Duan, B., Butcher, J.T., Mazumder, A., Narayanan, B.A., Characterization of multiple myeloma clonal cell expansion and stromal Wnt/β-catenin signaling in hyaluronic acid-based 3D hydrogel (2014) In Vivo (Brooklyn), 28, pp. 67-73; Cappariello, A., Maurizi, A., Veeriah, V., Teti, A., The great beauty of the osteoclast (2014) Arch Biochem Biophys, 558, pp. 70-78; Schmiedel, B.J., Scheible, C.A., Nuebling, T., Kopp, H.-G., Wirths, S., Azuma, M., RANKL expression, function, and therapeutic targeting in multiple myeloma and chronic lymphocytic leukemia (2013) Cancer Res, 73, pp. 683-694; Clines, G.A., Guise, T.A., Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone (2005) Endocr Relat Cancer, 12, pp. 549-583; Colaianni, G., Brunetti, G., Faienza, M.F., Colucci, S., Grano, M., Osteoporosis and obesity: role of Wnt pathway in human and murine models (2014) World J Orthop, 5, pp. 242-246; Berendsen, A.D., Olsen, B.R., Osteoblast-adipocyte lineage plasticity in tissue development, maintenance and pathology (2014) Cell Mol Life Sci, 71, pp. 493-497; Zhou, B.O., Yue, R., Murphy, M.M., Peyer, J.G., Morrison, S.J., Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow (2014) Cell Stem Cell, 15, pp. 154-168; Worthley, D.L., Churchill, M., Compton, J.T., Tailor, Y., Rao, M., Si, Y., Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential (2015) Cell, 160, pp. 269-284; Chan, C.K.F., Seo, E.Y., Chen, J.Y., Lo, D., McArdle, A., Sinha, R., Identification and specification of the mouse skeletal stem cell (2015) Cell, 160, pp. 285-298; Pan, S.Y., Johnson, K.C., Ugnat, A.-M., Wen, S.W., Mao, Y., Association of obesity and cancer risk in Canada (2004) Am J Epidemiol, 159, pp. 259-268; Wallin, A., Larsson, S.C., Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies (2011) Eur J Cancer, 47, pp. 1606-1615; Sola, B., Poirot, M., de Medina, P., Bustany, S., Marsaud, V., Silvente-Poirot, S., Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism (2013) Oncotarget, 4, pp. 911-922; Wang, X., Yan, Z., Fulciniti, M., Li, Y., Gkotzamanidou, M., Amin, S.B., Transcription factor-pathway coexpression analysis reveals cooperation between SP1 and ESR1 on dysregulating cell cycle arrest in non-hyperdiploid multiple myeloma (2014) Leukemia, 28, pp. 894-903; Islam, R., Altundag, K., Kurt, M., Altundag, O., Turen, S., Association between obesity and multiple myeloma in postmenopausal women may be attributed to increased aromatization of androgen in adipose tissue (2005) Med Hypotheses, 65, pp. 1001-1002; Hardaway, A.L., Herroon, M.K., Rajagurubandara, E., Podgorski, I., Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases (2014) Cancer Metastasis Rev, 33, pp. 527-543; Caers, J., Deleu, S., Belaid, Z., De Raeve, H., Van Valckenborgh, E., De Bruyne, E., Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells (2007) Leukemia, 21, pp. 1580-1584; Adler, B.J., Kaushansky, K., Rubin, C.T., Obesity-driven disruption of haematopoiesis and the bone marrow niche (2014) Nat Rev Endocrinol, 10, pp. 737-748; Vogl, D.T., Wang, T., Pérez, W.S., Stadtmauer, E.A., Heitjan, D.F., Lazarus, H.M., Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma (2011) Biol Blood Marrow Transplant, 17, pp. 1765-1774; Calvi, L.M., Adams, G.B., Weibrecht, K.W., Weber, J.M., Olson, D.P., Knight, M.C., Osteoblastic cells regulate the haematopoietic stem cell niche (2003) Nature, 425, pp. 841-846; Panaroni, C., Tzeng, Y.-S., Saeed, H., Wu, J.Y., Mesenchymal progenitors and the osteoblast lineage in bone marrow hematopoietic niches (2014) Curr Osteoporos Rep, 12, pp. 22-32; Wang, L., Jin, N., Schmitt, A., Greiner, J., Malcherek, G., Hundemer, M., T cell-based targeted immunotherapies for patients with multiple myeloma (2014) Int J Cancer, 136, pp. 1751-1768; Ramachandran, I.R., Martner, A., Pisklakova, A., Condamine, T., Chase, T., Vogl, T., Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow (2013) J Immunol, 190, pp. 3815-3823; Braga, W.M.T., Atanackovic, D., Colleoni, G.W.B., The role of regulatory T cells and TH17 cells in multiple myeloma (2012) Clin Dev Immunol, 2012, p. 293479; Fu, R., Gao, S., Peng, F., Li, J., Liu, H., Wang, H., Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma (2014) Cancer Cell Int, 14, p. 62; McMillin, D.W., Delmore, J., Weisberg, E., Negri, J.M., Geer, D.C., Klippel, S., Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity (2010) Nat Med, 16, pp. 483-489; Roccaro, A.M., Sacco, A., Maiso, P., Azab, A.K., Tai, Y.-T., Reagan, M., BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression (2013) J Clin Invest, 123, pp. 1542-1555; Reagan, M.R., Kaplan, D.L., Concise review: mesenchymal stem cell tumor-homing: detection methods in disease model systems (2011) Stem Cells, 29, p. 920; Houthuijzen, J.M., Daenen, L.G.M., Roodhart, J.M.L., Voest, E.E., The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression (2012) Br J Cancer, 106, pp. 1901-1906; Azab, F., Vali, S., Abraham, J., Potter, N., Muz, B., de la Puente, P., PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance (2014) Br J Haematol, 165, pp. 89-101; Corre, J., Mahtouk, K., Attal, M., Gadelorge, M., Huynh, A., Fleury-Cappellesso, S., Bone marrow mesenchymal stem cells are abnormal in multiple myeloma (2007) Leukemia, 21, pp. 1079-1088; Birmingham, E., Niebur, G.L., McHugh, P.E., Shaw, G., Barry, F.P., McNamara, L.M., Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche (2012) Eur Cell Mater, 23, pp. 13-27; Sims, N.A., Vrahnas, C., Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts (2014) Arch Biochem Biophys, 561 C, pp. 22-28; Compton, J.T., Lee, F.Y., A review of osteocyte function and the emerging importance of sclerostin (2014) J Bone Joint Surg Am, 96, pp. 1659-1668; Giuliani, N., Ferretti, M., Bolzoni, M., Storti, P., Lazzaretti, M., Dalla Palma, B., Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation (2012) Leukemia, 26, pp. 1391-1401; Delgado-Calle, J., Bellido, T., Roodman, G.D., Role of osteocytes in multiple myeloma bone disease (2014) Curr Opin Support Palliat Care, 8, pp. 407-413; Del Fattore, A., Teti, A., The tight relationship between osteoclasts and the immune system (2012) Inflamm Allergy Drug Targets, 11, pp. 181-187; Andersen, T.L., Sondergaard, T.E., Skorzynska, K.E., Dagnaes-Hansen, F., Plesner, T.L., Hauge, E.M., A physical mechanism for coupling bone resorption and formation in adult human bone (2009) Am J Pathol, 174, pp. 239-247; Jensen, P.R., Andersen, T.L., Hauge, E.-M., Bollerslev, J., Delaissé, J.-M., A joined role of canopy and reversal cells in bone remodeling-lessons from glucocorticoid-induced osteoporosis (2014) Bone, 73 C, pp. 16-23; Andersen, T.L., Søe, K., Sondergaard, T.E., Plesner, T., Delaisse, J.-M., Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells (2010) Br J Haematol, 148, pp. 551-561; Kondoh, S., Inoue, K., Igarashi, K., Sugizaki, H., Shirode-Fukuda, Y., Inoue, E., Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice (2014) Bone, 60, pp. 68-77; Hofbauer, L.C., Rachner, T.D., Coleman, R.E., Jakob, F., Endocrine aspects of bone metastases (2014) Lancet Diabetes Endocrinol, 2, pp. 500-512; Patti, A., Gennari, L., Merlotti, D., Dotta, F., Nuti, R., Endocrine actions of osteocalcin (2013) Int J Endocrinol, 2013, p. 846480; Hu, B., Chen, Y., Usmani, S.Z., Ye, S., Qiang, W., Papanikolaou, X., Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma (2013) PLoS ONE, 8, p. e74191; Swami, A., Reagan, M.R., Basto, P., Mishima, Y., Kamaly, N., Glavey, S., Engineered nanomedicine for myeloma and bone microenvironment targeting (2014) Proc Natl Acad Sci U S A, 111, pp. 10287-10292; Zangari, M., Terpos, E., Zhan, F., Tricot, G., Impact of bortezomib on bone health in myeloma: a review of current evidence (2012) Cancer Treat Rev, 38, pp. 968-980; Daoussis, D., Andonopoulos, A.P., The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling? (2011) Semin Arthritis Rheum, 41, pp. 170-177; Clarke, B.L., Anti-sclerostin antibodies: utility in treatment of osteoporosis (2014) Maturitas, 78, pp. 199-204; Colucci, S., Brunetti, G., Oranger, A., Mori, G., Sardone, F., Specchia, G., Myeloma cells suppress osteoblasts through sclerostin secretion (2011) Blood Cancer J, 1, p. e27; Politou, M.C., Heath, D.J., Rahemtulla, A., Szydlo, R., Anagnostopoulos, A., Dimopoulos, M.A., Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation (2006) Int J Cancer, 119, pp. 1728-1731; Kaiser, M., Mieth, M., Liebisch, P., Oberländer, R., Rademacher, J., Jakob, C., Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma (2008) Eur J Haematol, 80, pp. 490-494; Fulciniti, M., Tassone, P., Hideshima, T., Vallet, S., Nanjappa, P., Ettenberg, S.A., Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma (2009) Blood, 114, pp. 371-379; Zhou, F., Meng, S., Song, H., Claret, F.X., Dickkopf-1 is a key regulator of myeloma bone disease: opportunities and challenges for therapeutic intervention (2013) Blood Rev, 27, pp. 261-267; Yaccoby, S., Ling, W., Zhan, F., Walker, R., Barlogie, B., Shaughnessy, J.D., Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo (2007) Blood, 109, pp. 2106-2111; Garcia-Gomez, A., Ocio, E.M., Crusoe, E., Santamaria, C., Hernández-Campo, P., Blanco, J.F., Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects (2012) PLoS ONE, 7, p. e34914; Silbermann, R., Bolzoni, M., Storti, P., Guasco, D., Bonomini, S., Zhou, D., Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma (2014) Leukemia, 28, pp. 951-954; Vallet, S., Mukherjee, S., Vaghela, N., Hideshima, T., Fulciniti, M., Pozzi, S., Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease (2010) Proc Natl Acad Sci U S A, 107, pp. 5124-5129; Chantry, A.D., Heath, D., Mulivor, A.W., Pearsall, S., Baud'huin, M., Coulton, L., Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo (2010) J Bone Miner Res, 25, pp. 2633-2646; Pennisi, A., Ling, W., Li, X., Khan, S., Wang, Y., Barlogie, B., Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone (2010) PLoS ONE, 5, p. e15233; Jilka, R.L., Molecular and cellular mechanisms of the anabolic effect of intermittent PTH (2007) Bone, 40, pp. 1434-1446; Martin, T.J., Bone biology and anabolic therapies for bone: current status and future prospects (2014) J Bone Metab, 21, pp. 8-20; Walker, R.E., Lawson, M.A., Buckle, C.H., Snowden, J.A., Chantry, A.D., Myeloma bone disease: pathogenesis, current treatments and future targets (2014) Br Med Bull, 111, pp. 117-138; Coleman, R., Gnant, M., Morgan, G., Clezardin, P., Effects of bone-targeted agents on cancer progression and mortality (2012) J Natl Cancer Inst, 104, pp. 1059-1067; Pozzi, S., Raje, N., The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future (2011) Oncologist, 16, pp. 651-662; Mohty, M., Malard, F., Mohty, B., Savani, B., Moreau, P., Terpos, E., The effects of bortezomib on bone disease in patients with multiple myeloma (2014) Cancer, 120, pp. 618-623; (2015), https://clinicaltrials.gov/ct2/show/record/NCT00983346, n.d. (accessed January 04)(2015), https://clinicaltrials.gov/ct2/show/NCT02230917, Tabular View - ClinicalTrials.gov n.d. (accessed January 04)Abdulkadyrov, K.M., Salogub, G.N., Khuazheva, N.K., Sherman, M.L., Laadem, A., Barger, R., Sotatercept in patients with osteolytic lesions of multiple myeloma (2014) Br J Haematol, 165, pp. 814-823; Platt, R.J., Chen, S., Zhou, Y., Yim, M.J., Swiech, L., Kempton, H.R., CRISPR-Cas9 knockin mice for genome editing and cancer modeling (2014) Cell, 159, pp. 440-455; Lu, G., Middleton, R.E., Sun, H., Naniong, M., Ott, C.J., Mitsiades, C.S., The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins (2014) Science, 343, pp. 305-309; Eskildsen, T., Taipaleenmäki, H., Stenvang, J., Abdallah, B.M., Ditzel, N., Nossent, A.Y., MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo (2011) Proc Natl Acad Sci U S A, 108, pp. 6139-6144; Sung, B., Oyajobi, B., Aggarwal, B.B., Plumbagin inhibits osteoclastogenesis and reduces human breast cancer-induced osteolytic bone metastasis in mice through suppression of RANKL signaling (2012) Mol Cancer Ther, 11, pp. 350-359; Roodman, G.D., Genes associate with abnormal bone cell activity in bone metastasis (2012) Cancer Metastasis Rev, 31, pp. 569-578; Zhai, Z., Qu, X., Yan, W., Li, H., Liu, G., Liu, X., Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling (2014) Breast Cancer Res Treat, 144, pp. 33-45; Zinonos, I., Luo, K.-W., Labrinidis, A., Liapis, V., Hay, S., Panagopoulos, V., Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer (2014) Int J Oncol, 45, pp. 532-540",Review,Scopus,2-s2.0-84924253484
"Roberts-Galbraith R.H., Newmark P.A.","On the organ trail: Insights into organ regeneration in the planarian",2015,"Current Opinion in Genetics and Development","32",,,"37","46",,,10.1016/j.gde.2015.01.009,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84923014108&partnerID=40&md5=397286c6bede16f3e9bf55aa7a383e9d","Howard Hughes Medical Institute and Department of Cell and Developmental Biology, University of Illinois at Urbana-ChampaignUrbana, IL, United States","Roberts-Galbraith, R.H., Howard Hughes Medical Institute and Department of Cell and Developmental Biology, University of Illinois at Urbana-ChampaignUrbana, IL, United States; Newmark, P.A., Howard Hughes Medical Institute and Department of Cell and Developmental Biology, University of Illinois at Urbana-ChampaignUrbana, IL, United States","Advances in stem cell biology have led to the derivation of diverse cell types, yet challenges remain in creating complex tissues and functional organs. Unlike humans, some animals regenerate all missing tissues and organs successfully after dramatic injuries. Studies of organisms with exceptional regenerative capacity, like planarians, could complement in vitro studies and reveal mechanistic themes underlying regeneration on the scale of whole organs and tissues. In this review, we outline progress in understanding planarian organ regeneration, with focus on recent studies of the nervous, digestive, and excretory systems. We further examine molecular mechanisms underlying establishment of diverse cell fates from the planarian stem cell pool. Finally, we explore conceptual directions for future studies of organ regeneration in planarians. © 2015 Elsevier Ltd.",,"Brøndsted, H.V., (1969) Planarian Regeneration, , Pergamon Press, Oxford, New York; Newmark, P.A., Sánchez Alvarado, A., Bromodeoxyuridine specifically labels the regenerative stem cells of planarians (2000) Dev Biol, 220, pp. 142-153; Reddien, P.W., Bermange, A.L., Murfitt, K.J., Jennings, J.R., Sánchez Alvarado, A., Identification of genes needed for regeneration, stem cell function, and tissue homeostasis by systematic gene perturbation in planaria (2005) Dev Cell, 8, pp. 635-649; Cebrià, F., Kobayashi, C., Umesono, Y., Nakazawa, M., Mineta, K., Ikeo, K., Gojobori, T., Sánchez Alvarado, A., FGFR-related gene nou-darake restricts brain tissues to the head region of planarians (2002) Nature, 419, pp. 620-624; Sánchez Alvarado, A., Newmark, P.A., Double-stranded RNA specifically disrupts gene expression during planarian regeneration (1999) Proc Natl Acad Sci U S A, 96, pp. 5049-5054; Reddien, P.W., Specialized progenitors and regeneration (2013) Development, 140, pp. 951-957; Rink, J.C., Stem cell systems and regeneration in planaria (2013) Dev Genes Evol, 223, pp. 67-84; Baguñà, J., The planarian neoblast: the rambling history of its origin and some current black boxes (2012) Int J Dev Biol, 56, pp. 19-37; Wagner, D.E., Wang, I.E., Reddien, P.W., Clonogenic neoblasts are pluripotent adult stem cells that underlie planarian regeneration (2011) Science, 332, pp. 811-816; Hayashi, T., Shibata, N., Okumura, R., Kudome, T., Nishimura, O., Tarui, H., Agata, K., Single-cell gene profiling of planarian stem cells using fluorescent activated cell sorting and its ""index sorting"" function for stem cell research (2010) Dev Growth Differ, 52, pp. 131-144; Moritz, S., Stöckle, F., Ortmeier, C., Schmitz, H., Rodríguez-Esteban, G., Key, G., Gentile, L., Heterogeneity of planarian stem cells in the S/G2/M phase (2012) Int J Dev Biol, 56, pp. 117-125; van Wolfswinkel, J.C., Wagner, D.E., Reddien, P.W., Single-cell analysis reveals functionally distinct classes within the planarian stem cell compartment (2014) Cell Stem Cell, 15, pp. 326-339; Forsthoefel, D.J., Newmark, P.A., Emerging patterns in planarian regeneration (2009) Curr Opin Genet Dev, 19, pp. 412-420; Adell, T., Cebrià, F., Saló, E., Gradients in planarian regeneration and homeostasis (2010) Cold Spring Harb Perspect Biol, 2, p. a000505; Umesono, Y., Tasaki, J., Nishimura, Y., Hrouda, M., Kawaguchi, E., Yazawa, S., Nishimura, O., Agata, K., The molecular logic for planarian regeneration along the anterior-posterior axis (2013) Nature, 500, pp. 73-76; Sikes, J.M., Newmark, P.A., Restoration of anterior regeneration in a planarian with limited regenerative ability (2013) Nature, 500, pp. 77-80; Liu, S.Y., Selck, C., Friedrich, B., Lutz, R., Vila-Farre, M., Dahl, A., Brandl, H., Rink, J.C., Reactivating head regrowth in a regeneration-deficient planarian species (2013) Nature, 500, pp. 81-84; Agata, K., Soejima, Y., Kato, K., Kobayashi, C., Umesono, Y., Watanabe, K., Structure of the planarian central nervous system (CNS) revealed by neuronal cell markers (1998) Zoolog Sci, 15, pp. 433-440; Macrae, E.K., Observations on the fine structure of photoreceptor cells in the planarian Dugesia tigrina (1964) J Ultrastruct Res, 10, pp. 334-349; Carpenter, K.S., Morita, M., Best, J.B., Ultrastructure of the photoreceptor of the planarian Dugesia dorotocephala, I. Normal eye (1974) Cell Tissue Res, 148, pp. 143-158; MacRae, E.K., The fine structure of sensory receptor processes in the auricular epithelium of the planarian, Dugesia tigrina (1967) Z Zellforsch Mikrosk Anat, 82, pp. 479-494; Chien, P.K., Koopowitz, H., Ultrastructure of nerve plexus in flatworms. III. The infra-epithelial nervous system (1977) Cell Tissue Res, 176, pp. 335-347; Koopowitz, H., Chien, P., Ultrastructure of nerve plexus in flatworms. II. Sites of synaptic interactions (1975) Cell Tissue Res, 157, pp. 207-216; Baguñà, J., Ballester, R., The nervous system in planarians: Peripheral and gastrodermal plexuses, pharynx innervation, and the relationship between central nervous system structure and the acoelomate organization (1978) J Morphol, p. 155; Nishimura, K., Kitamura, Y., Inoue, T., Umesono, Y., Sano, S., Yoshimoto, K., Inden, M., Shimohama, S., Reconstruction of dopaminergic neural network and locomotion function in planarian regenerates (2007) Dev Neurobiol, 67, pp. 1059-1078; Nishimura, K., Kitamura, Y., Inoue, T., Umesono, Y., Yoshimoto, K., Takeuchi, K., Taniguchi, T., Agata, K., Identification and distribution of tryptophan hydroxylase (TPH)-positive neurons in the planarian Dugesia japonica (2007) Neurosci Res, 59, pp. 101-106; Nishimura, K., Kitamura, Y., Inoue, T., Umesono, Y., Yoshimoto, K., Taniguchi, T., Agata, K., Characterization of tyramine beta-hydroxylase in planarian Dugesia japonica: cloning and expression (2008) Neurochem Int, 53, pp. 184-192; Nishimura, K., Kitamura, Y., Taniguchi, T., Agata, K., Analysis of motor function modulated by cholinergic neurons in planarian Dugesia japonica (2010) Neuroscience, 168, pp. 18-30; Nishimura, K., Kitamura, Y., Umesono, Y., Takeuchi, K., Takata, K., Taniguchi, T., Agata, K., Identification of glutamic acid decarboxylase gene and distribution of GABAergic nervous system in the planarian Dugesia japonica (2008) Neuroscience, 153, pp. 1103-1114; Collins, J.J., Hou, X., Romanova, E.V., Lambrus, B.G., Miller, C.M., Saberi, A., Sweedler, J.V., Newmark, P.A., Genome-wide analyses reveal a role for peptide hormones in planarian germline development (2010) PLoS Biol, 8, p. e1000509; Takeda, H., Nishimura, K., Agata, K., Planarians maintain a constant ratio of different cell types during changes in body size by using the stem cell system (2009) Zoolog Sci, 26, pp. 805-813; Inoue, T., Kumamoto, H., Okamoto, K., Umesono, Y., Sakai, M., Sánchez Alvarado, A., Agata, K., Morphological and functional recovery of the planarian photosensing system during head regeneration (2004) Zoolog Sci, 21, pp. 275-283; Best, J.B., Goodman, A.B., Pigon, A., Fissioning in planarians: control by the brain (1969) Science, 164, pp. 565-566; Agata, K., Umesono, Y., Brain regeneration from pluripotent stem cells in planarian (2008) Philos Trans R Soc Lond B Biol Sci, 363, pp. 2071-2078; Currie, K.W., Pearson, B.J., Transcription factors lhx1/5-1 and pitx are required for the maintenance and regeneration of serotonergic neurons in planarians (2013) Development, 140, pp. 3577-3588; Marz, M., Seebeck, F., Bartscherer, K., A Pitx transcription factor controls the establishment and maintenance of the serotonergic lineage in planarians (2013) Development, 140, pp. 4499-4509; Cowles, M.W., Brown, D.D., Nisperos, S.V., Stanley, B.N., Pearson, B.J., Zayas, R.M., Genome-wide analysis of the bHLH gene family in planarians identifies factors required for adult neurogenesis and neuronal regeneration (2013) Development, 140, pp. 4691-4702; Cowles, M.W., Omuro, K.C., Stanley, B.N., Quintanilla, C.G., Zayas, R.M., COE loss-of-function analysis reveals a genetic program underlying maintenance and regeneration of the nervous system in planarians (2014) PLoS Genet, 10, p. e1004746; Scimone, M.L., Kravarik, K.M., Lapan, S.W., Reddien, P.W., Neoblast specialization in regeneration of the planarian Schmidtea mediterranea (2014) Stem Cell Reports, 3, pp. 339-352; Wenemoser, D., Lapan, S.W., Wilkinson, A.W., Bell, G.W., Reddien, P.W., A molecular wound response program associated with regeneration initiation in planarians (2012) Genes Dev, 26, pp. 988-1002; Pineda, D., Gonzalez, J., Callaerts, P., Ikeo, K., Gehring, W.J., Saló, E., Searching for the prototypic eye genetic network: Sine oculis is essential for eye regeneration in planarians (2000) Proc Natl Acad Sci U S A, 97, pp. 4525-4529; Mannini, L., Rossi, L., Deri, P., Gremigni, V., Salvetti, A., Saló, E., Batistoni, R., Djeyes absent (Djeya) controls prototypic planarian eye regeneration by cooperating with the transcription factor Djsix-1 (2004) Dev Biol, 269, pp. 346-359; Lapan, S.W., Reddien, P.W., Dlx and sp6-9 Control optic cup regeneration in a prototypic eye (2011) PLoS Genet, 7, p. e1002226; Fraguas, S., Barberán, S., Cebrià, F., EGFR signaling regulates cell proliferation, differentiation and morphogenesis during planarian regeneration and homeostasis (2011) Dev Biol, 354, pp. 87-101; Lapan, S.W., Reddien, P.W., Transcriptome analysis of the planarian eye identifies ovo as a specific regulator of eye regeneration (2012) Cell Rep, 2, pp. 294-307; Gurley, K.A., Rink, J.C., Sánchez Alvarado, A., Beta-catenin defines head versus tail identity during planarian regeneration and homeostasis (2008) Science, 319, pp. 323-327; Iglesias, M., Gomez-Skarmeta, J.L., Saló, E., Adell, T., Silencing of Smed-betacatenin1 generates radial-like hypercephalized planarians (2008) Development, 135, pp. 1215-1221; Petersen, C.P., Reddien, P.W., Smed-betacatenin-1 is required for anteroposterior blastema polarity in planarian regeneration (2008) Science, 319, pp. 327-330; Fraguas, S., Barberán, S., Iglesias, M., Rodríguez-Esteban, G., Cebrià, F., Egr-4, a target of EGFR signaling, is required for the formation of the brain primordia and head regeneration in planarians (2014) Development, 141, pp. 1835-1847; Garcia-Corrales, P., Gamo, J., The ultrastructure of the gastrodermal gland cells in the freshwater planarian Dugesia gonocephala s.l (1986) Acta Zool, 67, pp. 43-51; Bowen, I.D., Ryder, T.A., Thompson, J.A., The fine structure of the planarian Polycelis tenuis Iijima, II. The intestine and gastrodermal phagocytosis (1974) Protoplasma, 79, pp. 1-17; Ishii, S., Electron microscopic observations on the Planarian tissues II. The intestine (1965) Fukushima J Med Sci, 12, pp. 67-87; Garcia-Corrales, P., Gamo, J., Ultrastructural changes in the gastrodermal phagocytic cells of the planarian Dugesia gonocephala s.l. during food digestion (Plathelminthes) (1988) Zoomorphology, 108, pp. 109-117; Kobayashi, C., Kobayashi, S., Orii, H., Watanabe, K., Agata, K., Identification of two distinct muscles in the planarian Dugesia japonica by their expression of myosin heavy chain genes (1998) Zool Sci, 15, pp. 861-869; Macrae, E.K., Observations on the fine structure of pharyngeal muscle in the planarian Dugesia tigrina (1963) J Cell Biol, 18, pp. 651-662; Bueno, D., Baguñà, J., Romero, R., Cell-, tissue-, and position-specific monoclonal antibodies against the planarian Dugesia (Girardia) tigrina (1997) Histochem Cell Biol, 107, pp. 139-149; Gurley, K.A., Elliott, S.A., Simakov, O., Schmidt, H.A., Holstein, T.W., Sánchez Alvarado, A., Expression of secreted Wnt pathway components reveals unexpected complexity of the planarian amputation response (2010) Dev Biol, 347, pp. 24-39; Forsthoefel, D.J., Park, A.E., Newmark, P.A., Stem cell-based growth, regeneration, and remodeling of the planarian intestine (2011) Dev Biol, 356, pp. 445-459; Orii, H., Sakurai, T., Watanabe, K., Distribution of the stem cells (neoblasts) in the planarian Dugesia japonica (2005) Dev Genes Evol, 215, pp. 143-157; Forsthoefel, D.J., James, N.P., Escobar, D.J., Stary, J.M., Vieira, A.P., Waters, F.A., Newmark, P.A., An RNAi screen reveals intestinal regulators of branching morphogenesis, differentiation, and stem cell proliferation in planarians (2012) Dev Cell, 23, pp. 691-704; Kobayashi, C., Watanabe, K., Agata, K., The process of pharynx regeneration in planarians (1999) Dev Biol, 211, pp. 27-38; Bueno, D., Espinosa, L., Baguñà, J., Romero, R., Planarian pharynx regeneration in regenerating tail fragments monitored with cell-specific monoclonal antibodies (1997) Dev Genes Evol, 206, pp. 425-434; Ito, H., Saito, Y., Watanabe, K., Orii, H., Epimorphic regeneration of the distal part of the planarian pharynx (2001) Dev Genes Evol, 211, pp. 2-9; Adler, C.E., Seidel, C.W., McKinney, S.A., Sánchez Alvarado, A., Selective amputation of the pharynx identifies a FoxA-dependent regeneration program in planaria (2014) Elife, 3, p. e02238; Kobayashi, C., Nogi, T., Watanabe, K., Agata, K., Ectopic pharynxes arise by regional reorganization after anterior/posterior chimera in planarians (1999) Mech Dev, 89, pp. 25-34; Rink, J.C., Gurley, K.A., Elliott, S.A., Sánchez Alvarado, A., Planarian Hh signaling regulates regeneration polarity and links Hh pathway evolution to cilia (2009) Science, 326, pp. 1406-1410; Nogi, T., Levin, M., Characterization of innexin gene expression and functional roles of gap-junctional communication in planarian regeneration (2005) Dev Biol, 287, pp. 314-335; Cebrià, F., Newmark, P.A., Morphogenesis defects are associated with abnormal nervous system regeneration following roboA RNAi in planarians (2007) Development, 134, pp. 833-837; Ishii, S., The ultrastructure of the protonephridial tubules of the freshwater planarian Bdellocephala brunnea (1980) Cell Tissue Res, 206, pp. 451-458; Ishii, S., The ultrastructure of the protonephridial flame cell of the freshwater planarian Bdellocephala brunnea (1980) Cell Tissue Res, 206, pp. 441-449; McKanna, J.A., Fine structure of the protonephridial system in planaria. I. Flame cells (1968) Z Zellforsch Mikrosk Anat, 92, pp. 509-523; Rink, J.C., Vu, H.T., Sánchez Alvarado, A., The maintenance and regeneration of the planarian excretory system are regulated by EGFR signaling (2011) Development, 138, pp. 3769-3780; McKanna, J.A., Fine structure of the protonephridial system in planaria, II. Ductules, collecting ducts, and osmoregulatory cells (1968) Z Zellforsch Mikrosk Anat, 92, pp. 524-535; Scimone, M.L., Srivastava, M., Bell, G.W., Reddien, P.W., A regulatory program for excretory system regeneration in planarians (2011) Development, 138, pp. 4387-4398; Hay, E.D., Coward, S.J., Fine structure studies on the planarian, Dugesia. I. Nature of the ""neoblast"" and other cell types in noninjured worms (1975) J Ultrastruct Res, 50, pp. 1-21; MacRae, E.K., The fine structure of muscle in a marine turbellarian (1965) Z Zellforsch Mikrosk Anat, 68, pp. 348-362; Morita, M., Electron microscopic studies on planaria, I. Fine structure of muscle fiber in the head of the planarian Dugesia dorotocephala (1965) J Ultrastruct Res, 13, pp. 383-395; Cebrià, F., Vispo, M., Bueno, D., Carranza, S., Newmark, P., Romero, R., Myosin heavy chain gene in Dugesia (G.) tigrina: a tool for studying muscle regeneration in planarians (1996) Int J Dev Biol, SUPPL 1, pp. 177S-178S; Cebrià, F., Vispo, M., Newmark, P., Bueno, D., Romero, R., Myocyte differentiation and body wall muscle regeneration in the planarian Girardia tigrina (1997) Dev Genes Evol, 207, pp. 306-316; Witchley, J.N., Mayer, M., Wagner, D.E., Owen, J.H., Reddien, P.W., Muscle cells provide instructions for planarian regeneration (2013) Cell Rep, 4, pp. 633-641; Skaer, R.J., The origin and continuous replacement of epidermal cells in the planarian Polycelis tenuis (Iijima) (1965) J Embryol Exp Morphol, 13, pp. 129-139; Smales, L.R., Blankespoor, H.D., The epidermis and sensory organs of Dugesia tigrina (Turbellaria: Tricladida). A scanning electron microscope study (1978) Cell Tissue Res, 193, pp. 35-40; Rompolas, P., Patel-King, R.S., King, S.M., Schmidtea mediterranea: a model system for analysis of motile cilia (2009) Methods Cell Biol, 93, pp. 81-98; Morita, M., Best, J.B., Electron microscopic studies of planarian regeneration, II. Changes in epidermis during regeneration (1974) J Exp Zool, 187, pp. 345-373; Chandebois, R., The dynamics of wound closure and its role in the programming of planarian regeneration II-distalization (1980) Dev Growth Differ, 22, pp. 693-704; Morgan, T.H., Growth and regeneration in Planaria lugubris (1901) Arch Entwicklungsmech Org, 13, pp. 179-212; Hyman, L.H., (1951) The Invertebrates: Platyhelminthes and Rhynchocoela, the Acoelomate Bilateria, , McGraw-Hill; Curtis, W.C., The life history, the normal fission, and the reproductive organs of Planaria maculata (1902) Proc Boston Soc Nat Hist, 30, pp. 515-560; Chong, T., Stary, J.M., Wang, Y., Newmark, P.A., Molecular markers to characterize the hermaphroditic reproductive system of the planarian Schmidtea mediterranea (2011) BMC Dev Biol, 11, p. 69; Wang, Y., Zayas, R.M., Guo, T., Newmark, P.A., Nanos function is essential for development and regeneration of planarian germ cells (2007) Proc Natl Acad Sci U S A, 104, pp. 5901-5906; Chong, T., Collins, J.J., Brubacher, J.L., Zarkower, D., Newmark, P.A., A sex-specific transcription factor controls male identity in a simultaneous hermaphrodite (2013) Nat Commun, 4, p. 1814; Newmark, P.A., Wang, Y., Chong, T., Germ cell specification and regeneration in planarians (2008) Cold Spring Harb Symp Quant Biol, 73, pp. 573-581; Cardona, A., Hartenstein, V., Romero, R., Early embryogenesis of planaria: a cryptic larva feeding on maternal resources (2006) Dev Genes Evol, 216, pp. 667-681; Cardona, A., Fernández, J., Solana, J., Romero, R., An in situ hybridization protocol for planarian embryos: monitoring myosin heavy chain gene expression (2005) Dev Genes Evol, 215, pp. 482-488; Cardona, A., Hartenstein, V., Romero, R., The embryonic development of the triclad Schmidtea polychroa (2005) Dev Genes Evol, 215, pp. 109-131; Martín-Durán, J.M., Amaya, E., Romero, R., Germ layer specification and axial patterning in the embryonic development of the freshwater planarian Schmidtea polychroa (2010) Dev Biol, 340, pp. 145-158; Martín-Durán, J.M., Monjo, F., Romero, R., Morphological and molecular development of the eyes during embryogenesis of the freshwater planarian Schmidtea polychroa (2012) Dev Genes Evol, 222, pp. 45-54; Martín-Durán, J.M., Romero, R., Evolutionary implications of morphogenesis and molecular patterning of the blind gut in the planarian Schmidtea polychroa (2011) Dev Biol, 352, pp. 164-176; Monjo, F., Romero, R., Embryonic development of the nervous system in the planarian Schmidtea polychroa (2015) Dev Biol, 397, pp. 305-319; Nishimura, K., Inoue, T., Yoshimoto, K., Taniguchi, T., Kitamura, Y., Agata, K., Regeneration of dopaminergic neurons after 6-hydroxydopamine-induced lesion in planarian brain (2011) J Neurochem, 119, pp. 1217-1231; Oliver, G., Mailhos, A., Wehr, R., Copeland, N.G., Jenkins, N.A., Gruss, P., Six3, a murine homologue of the sine oculis gene, demarcates the most anterior border of the developing neural plate and is expressed during eye development (1995) Development, 121, pp. 4045-4055; Wallis, D.E., Roessler, E., Hehr, U., Nanni, L., Wiltshire, T., Richieri-Costa, A., Gillessen-Kaesbach, G., Muenke, M., Mutations in the homeodomain of the human SIX3 gene cause holoprosencephaly (1999) Nat Genet, 22, pp. 196-198; Cheyette, B.N., Green, P.J., Martin, K., Garren, H., Hartenstein, V., Zipursky, S.L., The Drosophila sine oculis locus encodes a homeodomain-containing protein required for the development of the entire visual system (1994) Neuron, 12, pp. 977-996; Bürglin, T.R., Ruvkun, G., Regulation of ectodermal and excretory function by the C. elegans POU homeobox gene ceh-6 (2001) Development, 128, pp. 779-790; Nakai, S., Sugitani, Y., Sato, H., Ito, S., Miura, Y., Ogawa, M., Nishi, M., Noda, T., Crucial roles of Brn1 in distal tubule formation and function in mouse kidney (2003) Development, 130, pp. 4751-4759; Hauptmann, G., Gerster, T., Combinatorial expression of zebrafish Brn-1- and Brn-2-related POU genes in the embryonic brain, pronephric primordium, and pharyngeal arches (2000) Dev Dyn, 218, pp. 345-358; Horner, M.A., Quintin, S., Domeier, M.E., Kimble, J., Labouesse, M., Mango, S.E., Pha-4, an HNF-3 homolog, specifies pharyngeal organ identity in Caenorhabditis elegans (1998) Genes Dev, 12, pp. 1947-1952; Kalb, J.M., Lau, K.K., Goszczynski, B., Fukushige, T., Moons, D., Okkema, P.G., McGhee, J.D., Pha-4 is Ce-fkh-1, a fork head/HNF-3alpha,beta,gamma homolog that functions in organogenesis of the C. elegans pharynx (1998) Development, 125, pp. 2171-2180; Mango, S.E., Lambie, E.J., Kimble, J., The pha-4 gene is required to generate the pharyngeal primordium of Caenorhabditis elegans (1994) Development, 120, pp. 3019-3031; Robb, S.M., Sánchez Alvarado, A., Identification of immunological reagents for use in the study of freshwater planarians by means of whole-mount immunofluorescence and confocal microscopy (2002) Genesis, 32, pp. 293-298",Review,Scopus,2-s2.0-84923014108
"Donnenberg V.S., Donnenberg A.D.","Stem cell state and the epithelial-to-mesenchymal transition: Implications for cancer therapy",2015,"Journal of Clinical Pharmacology","55","6",,"603","619",,,10.1002/jcph.486,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928897029&partnerID=40&md5=9218851e87a449f0987845442bd24704","Department of Cardiothoracic Surgery, University of Pittsburgh, School of MedicinePittsburgh, PA, United States; University of Pittsburgh, Cancer InstitutePittsburgh, PA, United States; Department of Medicine, University of Pittsburgh, School of MedicinePittsburgh, PA, United States; Hillman Cancer Center Research Pavilion, 5117 Center AvenuePittsburgh, PA, United States","Donnenberg, V.S., Department of Cardiothoracic Surgery, University of Pittsburgh, School of MedicinePittsburgh, PA, United States, University of Pittsburgh, Cancer InstitutePittsburgh, PA, United States; Donnenberg, A.D., University of Pittsburgh, Cancer InstitutePittsburgh, PA, United States, Department of Medicine, University of Pittsburgh, School of MedicinePittsburgh, PA, United States, Hillman Cancer Center Research Pavilion, 5117 Center AvenuePittsburgh, PA, United States","The cancer stem cell paradigm, the epithelial-to-mesenchymal transition and its converse, the mesenchymal-to-epithelial transition, have reached convergence. Implicit in this understanding is the notion that cancer cells can change state, and with such change come bidirectional alterations in motility, proliferative activity, and drug resistance. As such, tumors present a moving target for antineoplastic therapy. This article will review the evolving adult stem cell paradigm and how changes in our understanding of the bidirectional nature of cancer cell differentiation may affect the selection and timing of antineoplastic therapy. The goal is to determine how to best administer therapies potentially targeted against the cancer stem cell state in the context of established treatment regimens, and to evaluate long-term effects beyond tumor regression. © 2015, The American College of Clinical Pharmacology.","Cancer Stem Cell; Cancer Therapy; Epithelial to Mesenchymal Transition; Stem Cell State","Fiala, S., The cancer cell as a stem cell unable to differentiate. A theory of carcinogenesis (1968) Neoplasma., 15 (6), pp. 607-622; Bonnet, D., Dick, J.E., Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell (1997) Nat Med., 3 (7), pp. 730-737; Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., Clarke, M.F., Prospective identification of tumorigenic breast cancer cells (2003) Proc Natl Acad Sci U S A, 100 (7), pp. 3983-3988; Kelly, P.N., Dakic, A., Adams, J.M., Nutt, S.L., Strasser, A., Tumor growth need not be driven by rare cancer stem cells (2007) Science., 317 (5836), p. 337; Kern, S.E., Shibata, D., The fuzzy math of solid tumor stem cells: A perspective (2007) Cancer Res, 67 (19), pp. 8985-8988; Quintana, E., Shackleton, M., Sabel, M.S., Fullen, D.R., Johnson, T.M., Morrison, S.J., Efficient tumour formation by single human melanoma cells (2008) Nature, 456 (7222), pp. 593-598; Donnenberg, A.D., Hicks, J.B., Wigler, M., Donnenberg, V.S., The cancer stem cell: Cell type or cell state? (2013) Cytometry A, 83 A (1), pp. 5-7; Metcalf, D., Concise review: Hematopoietic stem cells and tissue stem cells: Current concepts and unanswered questions (2007) STEM CELLS, 25 (10), pp. 2390-2395; Till, J.E., McCulloch, E.A., Siminovitch, L., A Stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells (1964) Proc Natl Acad Sci U S A, 51, pp. 29-36; Till, J.E., McCulloch, E.A., A Direct Measurement of the radiation sensitivity of normal mouse bone marrow cells (1961) Radiat Res., 14 (2), pp. 213-222; Bradley, T.R., Metcalf, D., Sumner, M., Stanley, R., Characteristics of in vitro colony formation by cells from haemopoietic tissues (1969) Vitro., 4 (1), pp. 22-35; Strauss, L.C., Rowley, S.D., La Russa, V.F., Sharkis, S.J., Stuart, R.K., Civin, C.I., Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells (1986) Exp Hematol., 14 (9), pp. 878-886; Civin, C.I., Banquerigo, M.L., Strauss, L.C., Loken, M.R., Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow (1987) Exp Hematol., 15 (1), pp. 10-17; Civin, C.I., Strauss, L.C., Brovall, C., Fackler, M.J., Schwartz, J.F., Shaper, J.H., Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells (1984) J Immunol., 133 (1), pp. 157-165; Spangrude, G.J., Heimfeld, S., Weissman, I.L., Purification and characterization of mouse hematopoietic stem cells (1988) Science., 241 (4861), pp. 58-62; Berenson, R.J., Andrews, R.G., Bensinger, W.I., Antigen CD34+ marrow cells engraft lethally irradiated baboons (1988) J Clin Invest., 81 (3), pp. 951-955; Berenson, R., Bensinger, W., Hill, R., Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma (1991) Blood., 77 (8), pp. 1717-1722; Uckun, F.M., Regulation of human B-cell ontogeny (1990) Blood., 76 (10), pp. 1908-1923; Civin, C.I., Almeida-Porada, G., Lee, M.J., Olweus, J., Terstappen, L.W., Zanjani, E.D., Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo (1996) Blood., 88 (11), pp. 4102-4109; Goodell, M.A., Rosenzweig, M., Kim, H., Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species (1997) Nat Med., 3 (12), pp. 1337-1345; Dick, J.E., Lapidot, T., Biology of normal and acute myeloid leukemia stem cells (2005) Int J Hematol., 82 (5), pp. 389-396; Craig, W., Kay, R., Cutler, R.L., Lansdorp, P.M., Expression of Thy-1 on human hematopoietic progenitor cells (1993) The Journal of Exp Med., 177 (5), pp. 1331-1342; Berardi, A., Wang, A., Levine, J., Lopez, P., Scadden, D., Functional isolation and characterization of human hematopoietic stem cells (1995) Science., 267 (5194), pp. 104-108; Yin, A.H., Miraglia, S., Zanjani, E.D., AC133, a novel marker for human hematopoietic stem and progenitor cells (1997) Blood., 90 (12), pp. 5002-5012; Petriv, O.I., Kuchenbauer, F., Delaney, A.D., Comprehensive microRNA expression profiling of the hematopoietic hierarchy (2010) Proc Natl Acad Sci U S A., 107 (35), pp. 15443-15448; Christensen, J.L., Weissman, I.L., Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells (2001) Proc Natl Acad Sci U S A, 98 (25), pp. 14541-14546; Brown, R., Herzig, R., Wolff, S., High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy (1990) Blood., 76 (3), pp. 473-479; Kastan, M., Schlaffer, E., Russo, J., Colvin, O., Civin, C., Hilton, J., Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells (1990) Blood., 75 (10), pp. 1947-1950; Yoshida, A., Rzhetsky, A., Hsu, L.C., Chang, C., Human aldehyde dehydrogenase gene family (1998) Eur J Biochem, 251 (3), pp. 549-557; Jones, R.J., Barber, J.P., Vala, M.S., Assessment of aldehyde dehydrogenase in viable cells (1995) Blood., 85 (10), pp. 2742-2746; Ginestier, C., Hur, M.H., Charafe-Jauffret, E., ALDH1 Is a Marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome (2007) Cell Stem Cell., 1 (5), pp. 555-567; Ito, K., Hirao, A., Arai, F., Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells (2004) Nature., 431 (7011), pp. 997-1002; Tothova, Z., Kollipara, R., Huntly, B.J., FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress (2007) Cell., 128 (2), pp. 325-339; Biedler, J.L., Riehm, H., Cellular resistance to actinomycin D in Chinese hamster cells in vitro: Cross-resistance, radioautographic, and cytogenetic studies (1970) Cancer Res., 30 (4), pp. 1174-1184; Ling, V., Thompson, L.H., Reduced permeability in CHO cells as a mechanism of resistance to colchicine (1974) J Cell Physiol., 83 (1), pp. 103-116; Roninson, I.B., Abelson, H.T., Housman, D.E., Howell, N., Varshavsky, A., Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells (1984) Nature., 309 (5969), pp. 626-628; Roninson, I.B., Chin, J.E., Choi, K.G., Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells (1986) Proc Natl Acad Sci U S A., 83 (12), pp. 4538-4542; Gros, P., Croop, J., Roninson, I., Varshavsky, A., Housman, D.E., Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells (1986) Proc Natl Acad Sci U S A, 83 (2), pp. 337-341; Baines, P., Visser, J.W., Analysis and separation of murine bone marrow stem cells by H33342 fluorescence-activated cell sorting (1983) Exp Hematol., 11 (8), pp. 701-708; Mulder, A.H., Visser, J.W., Separation and functional analysis of bone marrow cells separated by rhodamine-123 fluorescence (1987) Exp Hematol., 15 (1), pp. 99-104; Udomsakdi, C., Eaves, C.J., Sutherland, H.J., Lansdorp, P.M., Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123 (1991) Exp Hematol., 19 (5), pp. 338-342; Goodell, M.A., Brose, K., Paradis, G., Conner, A.S., Mulligan, R.C., Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo (1996) J Exp Med., 183 (4), pp. 1797-1806; Mayle, A., Luo, M., Jeong, M., Goodell, M.A., Flow cytometry analysis of murine hematopoietic stem cells (2013) Cytometry A, 83 (1), pp. 27-37; Chaudhary, P.M., Mechetner, E.B., Roninson, I.B., Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes (1992) Blood., 80 (11), pp. 2735-2739; Donnenberg, V.S., Burckart, G.J., Griffith, B.P., Jain, A.B., Zeevi, A., Donnenberg, A.D., P-glycoprotein (P-gp) is upregulated in peripheral T-cell subsets from solid organ transplant recipients (2001) J Clin Pharmacol., 41 (12), pp. 1271-1279; Donnenberg, V.S., Donnenberg, A.D., Multiple drug resistance in cancer revisited: The cancer stem cell hypothesis (2005) J Clin Pharmacol., 45 (8), pp. 872-877; Lum, B.L., Fisher, G.A., Brophy, N.A., Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations (1993) Cancer., 72 (11), pp. 3502-3514; Van Der Holt, B., Löwenberg, B., Burnett, A.K., The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis (2005) Blood., 106, pp. 2646-2654; Vaziri, H., Schachter, F., Uchida, I., Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes (1993) Am J Hum Genet., 52 (4), pp. 661-667; Kunimura, C., Kikuchi, K., Ahmed, N., Shimizu, A., Yasumoto, S., Telomerase activity in a specific cell subset co-expressing integrinbeta1/EGFR but not p75NGFR/bcl2/integrin beta4 in normal human epithelial cells (1998) Oncogene., 17 (2), pp. 187-197; Hiyama, K., Hirai, Y., Kyoizumi, S., Activation of telomerase in human lymphocytes and hematopoietic progenitor cells (1995) J Immunol., 155 (8), pp. 3711-3715; Vaziri, H., Dragowska, W., Allsopp, R.C., Thomas, T.E., Harley, C.B., Lansdorp, P.M., Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age (1994) Proc Natl Acad Sci U S A, 91 (21), pp. 9857-9860; Vardiman, J.W., Chronic myelogenous leukemia, BCR-ABL1+ (2009) Am J Clin Pathol., 132 (2), pp. 250-260; Fialkow, P.J., Jacobson, R.J., Papayannopoulou, T., Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage (1977) Am J Med., 63 (1), pp. 125-130; Hochhaus, A., O'Brien, S.G., Guilhot, F., Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia (2009) Leukemia., 23 (6), pp. 1054-1061; Gambacorti-Passerini, C.B., Gunby, R.H., Piazza, R., Galietta, A., Rostagno, R., Scapozza, L., Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias (2003) Lancet Oncol., 4 (2), pp. 75-85; Graham, S.M., Jørgensen, H.G., Allan, E., Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro (2002) Blood, 99 (1), pp. 319-325; Sloma, I., Jiang, X., Eaves, A.C., Eaves, C.J., Insights into the stem cells of chronic myeloid leukemia (2010) Leukemia., 24 (11), pp. 1823-1833; Gerber, J.M., Qin, L., Kowalski, J., Characterization of chronic myeloid leukemia stem cells (2011) Am J Hematol., 86 (1), pp. 31-37; Hope, K.J., Jin, L., Dick, J.E., Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity (2004) Nat Immunol., 5 (7), pp. 738-743; Hodes, R.J., Hathcock, K.S., Weng, N.P., Telomeres in T and B cells (2002) Nat Rev., 2 (9), pp. 699-706; Shao, H., Xi, L., Raffeld, M., Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: A study of seven cases (2011) Mod Pathol., 24 (11), pp. 1421-1432; Wagers, A.J., Sherwood, R.I., Christensen, J.L., Weissman, I.L., Little evidence for developmental plasticity of adult hematopoietic stem cells (2002) Science., 297 (5590), pp. 2256-2259; Stange Daniel, E., Koo, B.-K., Huch, M., Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium (2013) Cell., 155 (2), pp. 357-368; Tata, P.R., Mou, H., Pardo-Saganta, A., Dedifferentiation of committed epithelial cells into stem cells in vivo (2013) Nature., 503 (7475), pp. 218-223; Donnenberg, V.S., Donnenberg, A.D., Zimmerlin, L., Localization of CD44 and CD90 positive cells to the invasive front of breast tumors (2010) Cytometry B Clin Cytom., 78 (5), pp. 287-301; Donnenberg, V.S., Landreneau, R.J., Pfeifer, M.E., Donnenberg, A.D., Flow cytometric determination of stem/progenitor content in epithelial tissues: An example from nonsmall lung cancer and normal lung (2013) Cytometry A, 83 (1), pp. 141-149; Potten, C.S., Owen, G., Booth, D., Intestinal stem cells protect their genome by selective segregation of template DNA strands (2002) J Cell Sci., 115 (11), pp. 2381-2388; He, X.C., Zhang, J., Tong, W.-G., BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-[beta]-catenin signaling (2004) Nat Genet., 36 (10), pp. 1117-1121; Roth, K.A., Hermiston, M.L., Gordon, J.A., Use of transgenic mice to infer the biological properties of small intestinal stem cells and to examine the lineage relationships of their descendants (1991) Proc Natl Acad Sci U S A, 88, pp. 9407-9411; Vogel, P.M., Georgiade, N.G., Fetter, B.F., Vogel, F.S., McCarty, K.S.J., The correlation of histologic changes in the human breast with the menstrual cycle (1981) Am J Pathol., 104 (1), pp. 23-34; Shackleton, M., Vaillant, F., Simpson, K.J., Generation of a functional mammary gland from a single stem cell (2006) Nature., 439 (7072), pp. 84-88; Stingl, J., Eaves, C.J., Zandieh, I., Emerman, J.T., Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue (2001) Breast Cancer Res Treat, 67 (2), pp. 93-109; Ohyama, M., Terunuma, A., Tock, C.L., Characterization and isolation of stem cell-enriched human hair follicle bulge cells (2006) J Clin Invest., 116 (1), pp. 249-260; Zimmerlin, L., Donnenberg, V.S., Pfeifer, M.E., Stromal vascular progenitors in adult human adipose tissue (2010) Cytometry A., 77 A, pp. 22-30; Feisst, V., Brooks, A.E.S., Chen, C.-J., Dunbar, R., Characterisation of mesenchymal progenitor cell populations directly derived from human dermis Stem Cells Devel., , In press; Donnenberg V S, L., Rubin, J.P., Donnenberg, A.D., Mesenchymal markers on human adipose stem/progenitor cells (2013) Cytometry A, 83 A (1), pp. 134-140; Kusaba, T., Lalli, M., Kramann, R., Kobayashi, A., Humphreys, B.D., Differentiated kidney epithelial cells repair injured proximal tubule (2014) Proc Natl Acad Sci U S A, 111 (4), pp. 1527-1532; Chen, Y., Wong, P.P., Sjeklocha, L., Steer, C.J., Sahin, M.B., Mature hepatocytes exhibit unexpected plasticity by direct dedifferentiation into liver progenitor cells in culture (2012) Hepatology., 55 (2), pp. 563-574; Yoo, C.B., Jones, P.A., Epigenetic therapy of cancer: Past, present and future (2006) Nat Rev Drug Discov., 5 (1), pp. 37-50; Factor Daniel, C., Corradin, O., Zentner Gabriel, E., Epigenomic comparison reveals activation of ""seed"" enhancers during transition from naive to primed pluripotency (2014) Cell Stem Cell., 14 (6), pp. 854-863; Paul, S., Knott, J.G., Epigenetic control of cell fate in mouse blastocysts: The role of covalent histone modifications and chromatin remodeling (2014) Mol Reprod Dev., 81 (2), pp. 171-182; Burney, M.J., Johnston, C., Wong, K.-Y., An epigenetic signature of developmental potential in neural stem cells and early neurons (2013) Stem Cells., 31 (9), pp. 1868-1880; Lee, B.M., Mahadevan, L.C., Stability of histone modifications across mammalian genomes: Implications for ""epigenetic"" marking (2009) J Cell Biochem., 108 (1), pp. 22-34; Wilmut, I., Schnieke, A.E., McWhir, J., Kind, A.J., Campbell, K.H.S., Viable offspring derived from fetal and adult mammalian cells (1997) Nature., 385 (6619), pp. 810-813; Takahashi, K., Tanabe, K., Ohnuki, M., Induction of pluripotent stem cells from adult human fibroblasts by defined factors (2007) Cell., 131 (5), pp. 861-872; Yu, J., Vodyanik, M.A., Smuga-Otto, K., Induced pluripotent stem cell lines derived from human somatic cells (2007) Science., 318 (5858), pp. 1917-1920; Abad, M., Mosteiro, L., Pantoja, C., Reprogramming in vivo produces teratomas and iPS cells with totipotency features (2013) Nature., 502 (7471), pp. 340-345; Fitchett, J.E., Hay, E.D., Medial edge epithelium transforms to mesenchyme after embryonic palatal shelves fuse (1989) Dev Biol., 131 (2), pp. 455-474; Chagraoui, J., Lepage-Noll, A., Anjo, A., Uzan, G., Charbord, P., Fetal liver stroma consists of cells in epithelial-to-mesenchymal transition (2003) Blood., 101 (8), pp. 2973-2982; Rothenpieler, U.W., Dressler, G.R., Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development (1993) Development., 119 (3), pp. 711-720; Kalluri, R., Weinberg, R.A., The basics of epithelial-mesenchymal transition (2009) J Clin Invest., 119 (6), pp. 1420-1428; Yang, J., Mani, S.A., Donaher, J.L., Twist, a Master regulator of morphogenesis, plays an essential role in tumor metastasis (2004) Cell, 117 (7), pp. 927-939; Zagni, C., Chiacchio, U., Rescifina, A., Histone methyltransferase inhibitors: Novel epigenetic agents for cancer treatment (2013) Curr Med Chem., 20 (2), pp. 167-185; Taube, J.H., Malouf, G.G., Lu, E., Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties (2013) Sci Rep., 3, p. 2687; Mitra, A., Satelli, A., Xia, X., Cutrera, J., Mishra, L., Li, S., Cell-surface Vimentin: A mislocalized protein for isolating csVimentin+CD133- novel stem-like hepatocellular carcinoma cells expressing EMT markers (2014) Int J Cancer., , doi: 10.1002/ijc.29382; Jing, Y.-Y., Han, Z.-P., Sun, K., Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide (2012) BMC Med., 10 (1), p. 98; Liu, W.-T., Jing, Y.-Y., Yu, G.-F., Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma (2015) Cancer Lett., 358 (2), pp. 136-143; Satelli, A., Mitra, A., Brownlee, Z., Epithelial-Mesenchymal transitioned circulating tumor cells capture for detecting tumor progression (2015) Clin Cancer Res., 21 (4), pp. 899-906; Satelli, A., Mitra, A., Cutrera, J.J., Universal marker and detection tool for human sarcoma circulating tumor cells (2014) Cancer Res., 74 (6), pp. 1645-1650; Quintana, E., Shackleton, M., Foster, H.R., Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized (2010) Cancer Cell., 18 (5), pp. 510-523; Hoek, K.S., Goding, C.R., Cancer stem cells versus phenotype-switching in melanoma (2010) Pigment Cell Melanoma Res., 23 (6), pp. 746-759; Saez-Ayala, M., Montenegro, M.F., Sanchez-Del Campo, L., Directed phenotype switching as an effective antimelanoma strategy (2013) Cancer Cell., 24 (1), pp. 105-119; Banerji, S., Cibulskis, K., Rangel-Escareno, C., Sequence analysis of mutations and translocations across breast cancer subtypes (2012) Nature., 486 (7403), pp. 405-409; Ince, T.A., Richardson, A.L., Bell, G.W., Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes (2007) Cancer Cell., 12 (2), pp. 160-170; Lu, H., Clauser, K.R., Tam, W.L., A breast cancer stem cell niche supported by juxtacrine signaling from monocytes and macrophages (2014) Nat Biotechnol., 16 (1), pp. 1105-1117; Donnenberg, A.D., Zimmerlin, L., Landreneau, R.J., Luketich, J.D., Donnenberg, V.S., KIT (CD117) expression in a subset of non-small cell lung carcinoma (NSCLC) patients (2012) PloS One., 7 (12), pp. 1-11; Kelloff, G.J., Sigman, C.C., Cancer biomarkers: Selecting the right drug for the right patient (2012) Nat Rev Drug Discov., 11 (3), pp. 201-214; Shoemaker, R.H., The NCI60 human tumour cell line anticancer drug screen (2006) Nat Rev Cancer., 6 (10), pp. 813-823; Burdach, S., Molecular precision chemotherapy: Overcoming resistance to targeted therapies? (2014) Clin Cancer Res., 20 (5), pp. 1064-1066; Druker, B.J., Guilhot, F., O'Brien, S.G., Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia (2006) N Engl J Med., 355 (23), pp. 2408-2417; Demetri, G.D., Von Mehren, M., Blanke, C.D., Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors (2002) N Engl J Med., 347 (7), pp. 472-480; Piccart-Gebhart, M.J., Procter, M., Leyland-Jones, B., Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer (2005) N Engl J Med., 353 (16), pp. 1659-1672; Moja, L., Tagliabue, L., Balduzzi, S., Trastuzumab containing regimens for early breast cancer (2012) Cochrane Database Systematic Rev., 4, p. Cd006243; Pohlmann, P.R., Mayer, I.A., Mernaugh, R., Resistance to trastuzumab in breast cancer (2009) Clin Cancer Res., 15 (24), pp. 7479-7491; Grohar, P.J., Segars, L.E., Yeung, C., Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth (2014) Clin Cancer Res., 20 (5), pp. 1190-1203; Ruden, M., Puri, N., Novel anticancer therapeutics targeting telomerase (2013) Cancer Treat Rev., 39 (5), pp. 444-456; Shay, J.W., Wright, W.E., Telomeres and telomerase in normal and cancer stem cells (2010) FEBS Lett., 584 (17), pp. 3819-3825; Pecot, C.V., Calin, G.A., Coleman, R.L., Lopez-Berestein, G., Sood, A.K., RNA interference in the clinic: Challenges and future directions (2011) Nat Rev Cancer., 11 (1), pp. 59-67; Tabernero, J., Shapiro, G.I., Lorusso, P.M., First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement (2013) Cancer Discov., 3 (4), pp. 406-417; Yang, D., Sun, Y., Hu, L., Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer (2013) Cancer Cell., 23 (2), pp. 186-199; Katz, T.A., Huang, Y., Davidson, N.E., Jankowitz, R.C., Epigenetic reprogramming in breast cancer: From new targets to new therapies (2014) Ann Med., 46 (6), pp. 397-408; Akhtar-Zaidi, B., Cowper-Sallari, R., Corradin, O., Epigenomic enhancer profiling defines a signature of colon cancer (2012) Science., 336 (6082), pp. 736-739; Grignani, F., De Matteis, S., Nervi, C., Fusion proteins of the retinoic acid receptor-[alpha] recruit histone deacetylase in promyelocytic leukaemia (1998) Nature., 391 (6669), pp. 815-818; Tallman, M.S., Andersen, J.W., Schiffer, C.A., All-trans-retinoic acid in acute promyelocytic leukemia (1997) N Engl J Med., 337 (15), pp. 1021-1028; Scales, S.J., De Sauvage, F.J., Mechanisms of Hedgehog pathway activation in cancer and implications for therapy (2009) Trends Pharmacol Sci., 30 (6), pp. 303-312; Amakye, D., Jagani, Z., Dorsch, M., Unraveling the therapeutic potential of the Hedgehog pathway in cancer (2013) Nat Med., 19 (11), pp. 1410-1422; Kwon, H.-Y., Kim, S.-J., Kim, C.-H., Triptolide downregulates human GD3 synthase (hST8Sia I) gene expression in SK-MEL-2 human melanoma cells (2010) Exp Mol Med., 42, pp. 849-855; Chugh, R., Sangwan, V., Patil, S.P., A preclinical evaluation of minnelide as a therapeutic agent against pancreatic cancer (2012) Sci Transl Med., 4 (156), p. 156ra139; Liu, L., Salnikov, A.V., Bauer, N., Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation (2014) Int J Cancer, 134 (10), pp. 2489-2503; Sangwan, V., Saluja, A.K., Mechanism of action of the anti-cancer agent, triptolide (2012) Nutraceuticals and Cancer, pp. 135-150. , Sarkar F.H. ed. Dordrecht Heidelberg, London, New York: Springer; Yu, A.L., Gilman, A.L., Ozkaynak, M.F., Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma (2010) N Engl J Med, 363 (14), pp. 1324-1334; Sarkar, T.R., Battula, V.L., Werden, S.J., GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer (2014) Oncogene, p. 0; Pecora, A.L., Rizvi, N., Cohen, G.I., Phase i Trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers (2002) J Clin Oncol, 20 (9), pp. 2251-2266; Lichty, B.D., Breitbach, C.J., Stojdl, D.F., Bell, J.C., Going viral with cancer immunotherapy (2014) Nat Rev Cancer, 14 (8), pp. 559-567; Albelda, S.M., Thorne, S.H., Giving oncolytic vaccinia virus more BiTE (2014) Mol Ther., 22 (1), pp. 6-8; Dienstmann, R., Rodon, J., Serra, V., Tabernero, J., Picking the point of inhibition: A comparative review of PI3K/AKT/mTOR pathway inhibitors (2014) Mol Cancer Ther., 13 (5), pp. 1021-1031; Ellard, S.L., Clemons, M., Gelmon, K.A., Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163 (2009) J Clin Oncol., 27 (27), pp. 4536-4541; Gulhati, P., Bowen, K.A., Liu, J., MTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways (2011) Cancer Res, 71 (9), pp. 3246-3256; Rothwell, P.M., Wilson, M., Price, J.F., Belch, J.F.F., Meade, T.W., Mehta, Z., Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials (2012) Lancet., 379 (9826), pp. 1591-1601; Algra, A.M., Rothwell, P.M., Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic comparison of evidence from observational studies versus randomised trials (2012) Lancet Oncol, 13 (5), pp. 518-527; Rothwell, P.M., Price, J.F., Fowkes, F.G., Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials (2012) Lancet., 379 (9826), pp. 1602-1612; Krug, L.M., Crapanzano, J.P., Azzoli, C.G., Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein (2005) Cancer., 103 (10), pp. 2128-2131; Kajstura, J., Rota, M., Hall, S.R., Evidence for human lung stem cells (2011) N Engl J Med., 364 (19), pp. 1795-1806; Martens, J.H.A., Brinkman, A.B., Simmer, F., PML-RARα/RXR alters the epigenetic landscape in acute promyelocytic leukemia (2010) Cancer Cell., 17 (2), pp. 173-185; Fetahu, I.S., Höbaus, J., Kállay, E., Vitamin D and the epigenome (2014) Front Physiol, 5, p. 164; Valeri, N., Vannini, I., Fanini, F., Calore, F., Adair, B., Fabbri, M., Epigenetics, miRNAs, and human cancer: A new chapter in human gene regulation (2009) Mamm Genome., 20 (910), pp. 573-580; Omenetti, A., Porrello, A., Jung, Y., Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans (2008) J Clin Invest, 118 (10), pp. 3331-3342; Goldbach-Mansky, R., Wilson, M., Fleischmann, R., Comparison of Tripterygium wilfordii hook f versus sulfasalazine in the treatment of rheumatoid arthritis: A randomized trial (2009) Ann Intern Med., 151 (4), pp. 229-240; Masferrer, J.L., Leahy, K.M., Koki, A.T., Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors (2000) Cancer Res, 60 (5), pp. 1306-1311; Erpenbeck, L., Schön, M.P., Deadly Allies: The Fatal Interplay between Platelets and Metastasizing Cancer Cells; Donnenberg, V.S., Landreneau, R.J., Donnenberg, A.D., Tumorigenic stem and progenitor cells: Implications for the therapeutic index of anti-cancer agents (2007) J Control Release, 122 (3), pp. 385-391; Baer, C., Squadrito, M.L., Iruela-Arispe, M.L., De Palma, M., Reciprocal interactions between endothelial cells and macrophages in angiogenic vascular niches (2013) Exp Cell Res., 319 (11), pp. 1626-1634; Larue, L., Bellacosa, A., Epithelial-mesenchymal transition in development and cancer: Role of phosphatidylinositol 3[prime] kinase//AKT pathways Oncogene, 24 (50), pp. 7443-7454; Onoyama, M., Kitadai, Y., Tanaka, Y., Combining molecular targeted drugs to inhibit both cancer cells and activated stromal cells in gastric cancer (2013) Neoplasia., 15 (12), pp. 1391-1399; Karnoub, A.E., Dash, A.B., Vo, A.P., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis (2007) Nature., 449 (7162), pp. 557-563; El-Haibi, C.P., Bell, G.W., Zhang, J., Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy (2012) Proc Natl Acad Sci U S A., 109 (43), pp. 17460-17465; Kolb, H., Schattenberg, A., Goldman, J., Graft-versus-leukemia Effect of Donor Lymphocyte Transfusions in Marrow Grafted Patients; Porter, D.L., Levine, B.L., Kalos, M., Bagg, A., June, C.H., Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia (2011) N Engl J Med., 365 (8), pp. 725-733; Thakur, A., Lum, L.G., Cancer therapy with bispecific antibodies: Clinical experience (2010) Curr Opin Mol Ther., 12 (3), pp. 340-349",Review,Scopus,2-s2.0-84928897029
"Park J.-R., Kim E., Yang J., Lee H., Hong S.-H., Woo H.-M., Park S.-M., Na S., Yang S.-R.","Isolation of human dermis derived mesenchymal stem cells using explants culture method: expansion and phenotypical characterization",2015,"Cell and Tissue Banking","16","2",,"209","218",,,10.1007/s10561-014-9471-8,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928998571&partnerID=40&md5=1c876a6a85c777054c807c8d13525819","Department of Thoracic and Cardiovascular Surgery, School of Medicine, Kangwon National UniversityChuncheon, South Korea; Department of Pulmonary Medicine, School of Medicine, Kangwon National UniversityChuncheon, South Korea; College of Veterinary Medicine, Kangwon National UniversityChuncheon, South Korea; School of Medicine, Stem Cell Institute, Kangwon National University, 1 Kangwondaehak-gilChuncheon, Gangwon, South Korea; Institute of Medical Science, Kangwon National UniversityChuncheon, South Korea; Department of Obstetrics and Gynecology, School of Medicine, Kangwon National UniversityChuncheon, South Korea","Park, J.-R., Department of Thoracic and Cardiovascular Surgery, School of Medicine, Kangwon National UniversityChuncheon, South Korea, School of Medicine, Stem Cell Institute, Kangwon National University, 1 Kangwondaehak-gilChuncheon, Gangwon, South Korea, Institute of Medical Science, Kangwon National UniversityChuncheon, South Korea; Kim, E., Department of Thoracic and Cardiovascular Surgery, School of Medicine, Kangwon National UniversityChuncheon, South Korea, School of Medicine, Stem Cell Institute, Kangwon National University, 1 Kangwondaehak-gilChuncheon, Gangwon, South Korea; Yang, J., Department of Thoracic and Cardiovascular Surgery, School of Medicine, Kangwon National UniversityChuncheon, South Korea, School of Medicine, Stem Cell Institute, Kangwon National University, 1 Kangwondaehak-gilChuncheon, Gangwon, South Korea; Lee, H., Department of Thoracic and Cardiovascular Surgery, School of Medicine, Kangwon National UniversityChuncheon, South Korea, School of Medicine, Stem Cell Institute, Kangwon National University, 1 Kangwondaehak-gilChuncheon, Gangwon, South Korea; Hong, S.-H., Department of Pulmonary Medicine, School of Medicine, Kangwon National UniversityChuncheon, South Korea, School of Medicine, Stem Cell Institute, Kangwon National University, 1 Kangwondaehak-gilChuncheon, Gangwon, South Korea; Woo, H.-M., College of Veterinary Medicine, Kangwon National UniversityChuncheon, South Korea, School of Medicine, Stem Cell Institute, Kangwon National University, 1 Kangwondaehak-gilChuncheon, Gangwon, South Korea; Park, S.-M., Department of Thoracic and Cardiovascular Surgery, School of Medicine, Kangwon National UniversityChuncheon, South Korea, School of Medicine, Stem Cell Institute, Kangwon National University, 1 Kangwondaehak-gilChuncheon, Gangwon, South Korea; Na, S., Department of Obstetrics and Gynecology, School of Medicine, Kangwon National UniversityChuncheon, South Korea; Yang, S.-R., Department of Thoracic and Cardiovascular Surgery, School of Medicine, Kangwon National UniversityChuncheon, South Korea, School of Medicine, Stem Cell Institute, Kangwon National University, 1 Kangwondaehak-gilChuncheon, Gangwon, South Korea","Recent studies have reported that stem cells can be isolated from a wide range of tissues including bone marrow, fatty tissue, adipose tissue and placenta. Moreover, several studies also suggest that skin dermis could serve as a source of stem cells, but are of unclear phenotype. Therefore, we isolated and investigated to determine the potential of stem cell within human skin dermis. We isolated cells from human dermis, termed here as human dermis-derived mesenchymal stem cells (hDMSCs) which is able to be isolated by using explants culture method. Our method has an advantage over the enzymatic method as it is easier, less expensive and less cell damage. hDMSCs were maintained in basal culture media and proliferation potential was measured. hDMSCs were highly proliferative and successfully expanded with no additional growth factor. In addition, hDMSCs revealed normal karyotype and expressed high levels of CD90, CD73 and CD105 while did not express the surface markers for CD34, CD45 and HLA-DR. Also, we confirmed that hDMSCs possess the capacity to differentiate into multiple lineage including adipocyte, osteocyte, chondrocyte and precursor of hepatocyte lineage. Considering these results, we suggest that hDMSCs might be a valuable source of stem cells and could potentially be a useful source of clinical application. © 2014, Springer Science+Business Media Dordrecht.","Differentiation potential; Explants culture method; Human dermis; Mesenchymal stem cells","Crigler, L., Kazhanie, A., Yoon, T.J., Zakhari, J., Anders, J., Taylor, B., Virador, V.M., Isolation of a mesenchymal cell population from murine dermis that contains progenitors of multiple cell lineages (2007) FASEB J, 21, pp. 2050-2063. , COI: 1:CAS:528:DC%2BD2sXnvVags7s%3D, PID: 17384147; Dhanasekaran, M., Indumathi, S., Poojitha, R., Kanmani, A., Rajkumar, J.S., Sudarsanam, D., Plasticity and banking potential of cultured adipose tissue derived mesenchymal stem cells (2013) Cell Tissue Bank, 14, pp. 303-315. , COI: 1:STN:280:DC%2BC38nislaksg%3D%3D, PID: 22581232; Gao, Y., Bai, C., Xiong, H., Li, Q., Shan, Z., Huang, L., Ma, Y., Guan, W., Isolation and characterization of chicken dermis-derived mesenchymal stem/progenitor cells (2013) Biomed Res Int, 2013, p. 626258. , PID: 23984389; Giordano, A., Galderisi, U., Marino, I.R., From the laboratory bench to the patient’s bedside: an update on clinical trials with mesenchymal stem cells (2007) J Cell Physiol, 211, pp. 27-35. , COI: 1:CAS:528:DC%2BD2sXis12jt7o%3D, PID: 17226788; Herzog, E.L., Chai, L., Krause, D.S., Plasticity of marrow-derived stem cells (2003) Blood, 102, pp. 3483-3493. , COI: 1:CAS:528:DC%2BD3sXptVymsbg%3D, PID: 12893756; Huard, J., Cao, B., Qu-Petersen, Z., Muscle-derived stem cells: potential for muscle regeneration (2003) Birth Defects Res C Embryo Today, 69, pp. 230-237. , COI: 1:CAS:528:DC%2BD3sXntFygsLs%3D, PID: 14671776; Kanazawa, H., Fujimoto, Y., Teratani, T., Iwasaki, J., Kasahara, N., Negishi, K., Tsuruyama, T., Kobayashi, E., Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model (2011) PLoS ONE, 6, p. 19195. , COI: 1:CAS:528:DC%2BC3MXlslGmtrg%3D, PID: 21559442; Kheolamai, P., Dickson, A.J., Liver-enriched transcription factors are critical for the expression of hepatocyte marker genes in mES-derived hepatocyte-lineage cells (2009) BMC Mol Biol, 10, p. 35. , PID: 19389256; Kim, S.W., Han, H., Chae, G.T., Lee, S.H., Bo, S., Yoon, J.H., Lee, Y.S., Kang, K.S., Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger’s disease and ischemic limb disease animal model (2006) Stem Cells, 24, pp. 1620-1626. , PID: 16497946; Li, Y., Chen, J., Chen, X.G., Wang, L., Gautam, S.C., Xu, Y.X., Katakowski, M., Chopp, M., Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery (2002) Neurology, 59, pp. 514-523. , COI: 1:STN:280:DC%2BD38vls1Sgug%3D%3D, PID: 12196642; Ogawa, R., Mizuno, H., Watanabe, A., Migita, M., Shimada, T., Hyakusoku, H., Osteogenic and chondrogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice (2004) Biochem Biophys Res Commun, 313, pp. 871-877. , COI: 1:CAS:528:DC%2BD2cXosFaq, PID: 14706623; Park, J.R., Jung, J.W., Lee, Y.S., Kang, K.S., The roles of Wnt antagonists Dkk1 and sFRP4 during adipogenesis of human adipose tissue-derived mesenchymal stem cells (2008) Cell Prolif, 41, pp. 859-874. , COI: 1:CAS:528:DC%2BD1MXmt1yguw%3D%3D, PID: 19040566; Park, S.B., Seo, K.W., So, A.Y., Seo, M.S., Yu, K.R., Kang, S.K., Kang, K.S., SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC (2012) Cell Death Differ, 19, pp. 534-545. , COI: 1:CAS:528:DC%2BC38XitlGqtb8%3D, PID: 22015605; Pountos, I., Corscadden, D., Emery, P., Giannoudis, P.V., Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application (2007) Injury, 38, pp. 23-33. , PID: 18224734; Riekstina, U., Cakstina, I., Parfejevs, V., Hoogduijn, M., Jankovskis, G., Muiznieks, I., Muceniece, R., Ancans, J., Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis (2009) Stem Cell Rev, 5, pp. 378-386. , COI: 1:CAS:528:DC%2BC3cXjtlalsA%3D%3D, PID: 20058201; Shiojiri, N., Lemire, J.M., Fausto, N., Cell lineages and oval cell progenitors in rat liver development (1991) Cancer Res, 51, pp. 2611-2620. , COI: 1:CAS:528:DyaK3MXktVGks7o%3D, PID: 1708696; Snykers, S., De Kock, J., Rogiers, V., Vanhaecke, T., In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art (2009) Stem Cells, 27, pp. 577-605. , COI: 1:CAS:528:DC%2BD1MXkvVKgurw%3D, PID: 19056906; Studeny, M., Marini, F.C., Dembinski, J.L., Zompetta, C., Cabreira-Hansen, M., Bekele, B.N., Champlin, R.E., Andreeff, M., Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents (2004) J Natl Cancer Inst, 96, pp. 1593-1603. , COI: 1:CAS:528:DC%2BD2cXhtVeqs7nM, PID: 15523088; Tilghman, S.M., Belayew, A., Transcriptional control of the murine albumin/alpha-fetoprotein locus during development (1982) Proc Natl Acad Sci USA, 79, pp. 5254-5257. , COI: 1:CAS:528:DyaL38XlvFeqsbo%3D, PID: 6182563; Toma, J.G., Akhavan, M., Fernandes, K.J., Barnabe-Heider, F., Sadikot, A., Kaplan, D.R., Miller, F.D., Isolation of multipotent adult stem cells from the dermis of mammalian skin (2001) Nat Cell Biol, 3, pp. 778-784. , COI: 1:CAS:528:DC%2BD3MXmvF2lsrk%3D, PID: 11533656; Tuli, R., Seghatoleslami, M.R., Tuli, S., Wang, M.L., Hozack, W.J., Manner, P.A., Danielson, K.G., Tuan, R.S., A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone (2003) Mol Biotechnol, 23, pp. 37-49. , COI: 1:CAS:528:DC%2BD3sXntlynug%3D%3D, PID: 12611268; Vaculik, C., Schuster, C., Bauer, W., Iram, N., Pfisterer, K., Kramer, G., Reinisch, A., Elbe-Burger, A., Human dermis harbors distinct mesenchymal stromal cell subsets (2012) J Invest Dermatol, 132, pp. 563-574. , COI: 1:CAS:528:DC%2BC3MXhsVSktbrM, PID: 22048731; Yen, B.L., Huang, H.I., Chien, C.C., Jui, H.Y., Ko, B.S., Yao, M., Shun, C.T., Chen, Y.C., Isolation of multipotent cells from human term placenta (2005) Stem Cells, 23, pp. 3-9. , COI: 1:CAS:528:DC%2BD2MXhtVygurY%3D, PID: 15625118; Yu, B.D., Mukhopadhyay, A., Wong, C., Skin and hair: models for exploring organ regeneration (2008) Hum Mol Genet, 17, pp. 54-59. , COI: 1:CAS:528:DC%2BD1cXoslCms74%3D, PID: 18632698; Yu, K.R., Lee, J.Y., Kim, H.S., Hong, I.S., Choi, S.W., Seo, Y., Kang, I., Kang, K.S., A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging (2014) PLoS ONE, 9, p. 102426. , PID: 25090227; Yucel, G., Altindag, B., Gomez-Ospina, N., Rana, A., Panagiotakos, G., Lara, M.F., Dolmetsch, R., Oro, A.E., State-dependent signaling by Cav1.2 regulates hair follicle stem cell function (2013) Genes Dev, 27, pp. 1217-1222. , COI: 1:CAS:528:DC%2BC3sXhtVWmtr3F, PID: 23752588; Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Benhaim, P., Hedrick, M.H., Multilineage cells from human adipose tissue: implications for cell-based therapies (2001) Tissue Eng, 7, pp. 211-228. , COI: 1:CAS:528:DC%2BD3MXjsFShtro%3D, PID: 11304456",Article,Scopus,2-s2.0-84928998571
"Wu Y., Shen Y., Kang K., Zhang Y., Ao F., Wan Y., Song J.","Effects of estrogen on growth and smooth muscle differentiation of vascular wall-resident CD34+ stem/progenitor cells",2015,"Atherosclerosis","240","2",,"453","461",,,10.1016/j.atherosclerosis.2015.04.008,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928029313&partnerID=40&md5=13136a04aea2d79538ed9f5ee0f69d33","Department of Anatomy and Embryology, Wuhan University School of Basic Medical Sciences, 135 Donghu RoadWuhan, Hubei, China; Department of Physiology, Wuhan University School of Basic Medical Sciences, 135 Donghu RoadWuhan, Hubei, China","Wu, Y., Department of Anatomy and Embryology, Wuhan University School of Basic Medical Sciences, 135 Donghu RoadWuhan, Hubei, China; Shen, Y., Department of Physiology, Wuhan University School of Basic Medical Sciences, 135 Donghu RoadWuhan, Hubei, China; Kang, K., Department of Anatomy and Embryology, Wuhan University School of Basic Medical Sciences, 135 Donghu RoadWuhan, Hubei, China; Zhang, Y., Department of Anatomy and Embryology, Wuhan University School of Basic Medical Sciences, 135 Donghu RoadWuhan, Hubei, China; Ao, F., Department of Anatomy and Embryology, Wuhan University School of Basic Medical Sciences, 135 Donghu RoadWuhan, Hubei, China; Wan, Y., Department of Physiology, Wuhan University School of Basic Medical Sciences, 135 Donghu RoadWuhan, Hubei, China; Song, J., Department of Anatomy and Embryology, Wuhan University School of Basic Medical Sciences, 135 Donghu RoadWuhan, Hubei, China","Objectives: To investigate the effects of estrogen on growth and smooth muscle cell (SMC)-differentiation of vascular wall-resident CD34+ stem/progenitor cells (VRS/Pcs). Methods and Results: The existence of CD34+ VRS/Pcs was confirmed by immunohistochemistry in the adventitia of arteries of young (2-month-old) and old (24-month-old) female SD rats with less CD34+ adventitial cells detected in the old. The VRS/Pcs isolated from young animals were grown in Stem cell growth medium or induced to differentiate into SMC with PDGF-BB in the presence or absence of 17β-estrodiol (E<inf>2</inf>). Flow cytometry, RT-qPCR and Western blot showed that E<inf>2</inf> promoted Brdu incorporation of the CD34+ VRS/Pcs growing in Stem cell growth medium; but when the cells were incubated in PDGF-BB, the hormone enhanced their expression of SMC marker SM22. ChIP and IP assays showed that E<inf>2</inf> significantly promoted the binding of pELK1-SRF complex to the promoter of c-fos gene in CD34+ VRS/Pcs growing in the Stem cell growth medium; but when the cells were stimulated with PDGF-BB, an E<inf>2</inf>-enhanced binding of myocardin-SRF to the promoter of SM22 gene was found with enhanced expression of SRC3 and its binding to myocardin. The effects of E<inf>2</inf> above could be blocked by the estrogen receptor antagonist ICI 182,780 or inhibited by SRF-siRNA. Conclusion: Estrogen has dual effects on CD34+ VRS/Pcs. For the undifferentiated VRS/Pcs, it accelerates their proliferation by enhancing binding of pELK1-SRF complex to c-fos gene while for the differentiating VRS/Pcs, it promotes their differentiation to SMC through a mechanism of SRC3-mediated interaction of myocardin-SRF complex with SM22 gene. © 2015 Elsevier Ireland Ltd.","Differentiation; Estrogen; Proliferation; Vascular wall-resident stem/progenitor cells","Lobo, R.A., What the future holds for women after menopause: where we have been, where we are, and where we want to go (2014) Climacteric, pp. 1-6; Chamley-Campbell, J., Campbell, G.R., Ross, R., The smooth muscle cell in culture (1979) Physiol. Rev., 1 (59), pp. 1-61; Campbell, J.H., Campbell, G.R., Smooth muscle phenotypic modulation-a personal experience (2012) Arterioscler. Thromb. Vasc. Biol., 8 (32), pp. 1784-1789; Kudryavtseva, O., Aalkjaer, C., Matchkov, V.V., Vascular smooth muscle cell phenotype is defined by Ca2+-dependent transcription factors (2013) FEBS J., 21 (280), pp. 5488-5499; Shen, J., White, M., Husband, A.J., Hambly, B.D., Bao, S., Phytoestrogen derivatives differentially inhibit arterial neointimal proliferation in a mouse model (2006) Eur. J. Pharmacol., (548), pp. 123-128; Rhee, C.Y., Spaet, T.H., Stemerman, M.B., Lajam, F., Shiang, H.H., Caruso, E., Litwak, R.S., Estrogen suppression of surgically induced vascular intimal hyperplasia in rabbits (1977) J.Lab. Clin. Med., 1 (90), pp. 77-84; Foegh, M.L., Asotra, S., Howell, M.H., Ramwell, P.W., Estradiol inhibition of arterial neointimal hyperplasia after balloon injury (1994) J.Vasc. Surg., 4 (19), pp. 722-726; Cheng, L.P., Kuwahara, M., Jacobsson, J., Foegh, M.L., Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts (1991) Transplantation, 6 (52), pp. 967-972; Ling, S., Dai, A., Dilley, R.J., Jones, M., Simpson, E., Komesaroff, P.A., Sudhir, K., Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells: insights from the aromatase-knockout mouse (2004) Circulation, 4 (109), pp. 537-543; Keyes, L.E., Moore, L.G., Walchak, S.J., Dempsey, E.C., Pregnancy-stimulated growth of vascular smooth muscle cells: importance of protein kinase C-dependent synergy between estrogen and platelet-derived growth factor (1996) J.Cell. Physiol., 1 (166), pp. 22-32; Farhat, M.Y., Vargas, R., Dingaan, B., Ramwell, P.W., Invitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium (1992) Br. J. Pharmacol., 3 (107), pp. 679-683; Song, J., Wan, Y., Rolfe, B.E., Campbell, J.H., Campbell, G.R., Effect of estrogen on vascular smooth muscle cells is dependent upon cellular phenotype (1998) Atherosclerosis, 1 (140), pp. 97-104; Zhu, C., Zhang, L., Zheng, Y., Xu, J., Song, J., Rolfe, B.E., Campbell, J.H., Effects of estrogen on stress-induced premature senescence of vascular smooth muscle cells: a novel mechanism for the ""time window theory"" of menopausal hormone therapy (2011) Atherosclerosis, 2 (215), pp. 294-300; Zhang, L., Zhu, C., Zhang, X., Wan, Y., Song, J., Dual effects of estrogen on vascular smooth muscle cells: receptor-mediated proliferative vs. metabolite-induced pro-senescent actions (2011) Steroids, 3 (76), pp. 309-316; Hu, Y., Zhang, Z., Torsney, E., Afzal, A.R., Davison, F., Metzler, B., Xu, Q., Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice (2004) J.Clin. Invest, 9 (113), pp. 1258-1265; Tang, Z., Wang, A., Yuan, F., Yan, Z., Liu, B., Chu, J.S., Helms, J.A., Li, S., Differentiation of multipotent vascular stem cells contributes to vascular diseases (2012) Nat. Commun., p. 875; Tsai, T.N., Kirton, J.P., Campagnolo, P., Zhang, L., Xiao, Q., Zhang, Z., Wang, W., Xu, Q., Contribution of stem cells to neointimal formation of decellularized vessel grafts in a novel mouse model (2012) Am. J. Pathol., 1 (181), pp. 362-373; Yang, S., Eto, H., Kato, H., Doi, K., Kuno, S., Kinoshita, K., Ma, H., Yoshimura, K., Comparative characterization of stromal vascular cells derived from three types of vascular wall and adipose tissue (2013) Tissue Eng. Part A, (19), pp. 2724-2734; Askarinam, A., James, A.W., Zara, J.N., Goyal, R., Corselli, M., Pan, A., Liang, P., Soo, C., Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with Nel-like molecule I protein (2013) Tissue Eng. Part A, (19), pp. 1386-1397; Smith, A.G., Nichols, J., Robertson, M., Rathjen, P.D., Differentiation inhibiting activity (DIA/LIF) and mouse development (1992) Dev. Biol., 2 (151), pp. 339-351; Diao, Y., Wang, X., Wu, Z., SOCS1, SOCS3, and PIAS1 promote myogenic differentiation by inhibiting the leukemia inhibitory factor-induced JAK1/STAT1/STAT3 pathway (2009) Mol. Cell. Biol., 18 (29), pp. 5084-5093; Wang, Z., Wang, D.Z., Hockemeyer, D., McAnally, J., Nordheim, A., Olson, E.N., Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression (2004) Nature, 6979 (428), pp. 185-189; Duan, R., Xie, W., Burghardt, R.C., Safe, S., Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1 (2001) J.Biol. Chem., 15 (276), pp. 11590-11598; Altucci, L., Addeo, R., Cicatiello, L., Dauvois, S., Parker, M.G., Truss, M., Beato, M., Weisz, A., 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells (1996) Oncogene, 11 (12), pp. 2315-2324; Foster, J.S., Wimalasena, J., Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells (1996) Mol. Endocrinol., 5 (10), pp. 488-498; Ang, E.Z., Nguyen, H.T., Sim, H.L., Putti, T.C., Lim, L.H., Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells (2009) Mol. Cancer Res., 2 (7), pp. 266-274; Paruthiyil, S., Parmar, H., Kerekatte, V., Cunha, G.R., Firestone, G.L., Leitman, D.C., Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest (2004) Cancer Res., 1 (64), pp. 423-428; Chen, J., Iverson, D., Estrogen in obesity-associated colon cancer: friend or foe? protecting postmenopausal women but promoting late-stage colon cancer (2012) Cancer Causes Control, 11 (23), pp. 1767-1773; Sun, H., Wang, H., Hu, S., Effects of estrogen on diverse stem cells and relevant intracellular mechanisms (2010) Sci. China Life Sci., 5 (53), pp. 542-547; Reynolds, B.A., Weiss, S., Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system (1992) Science, 5052 (255), pp. 1707-1710; Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Anversa, P., Adult cardiac stem cells are multipotent and support myocardial regeneration (2003) Cell, 6 (114), pp. 763-776; Nakayama, H., Enzan, H., Miyazaki, E., Kuroda, N., Toi, M., Hiroi, M., Yasui, W., Presence of vascular adventitial fibroblastic cells in diffuse-type gastric carcinomas (2004) J.Clin. Pathol., 9 (57), pp. 970-972; Torsney, E., Mandal, K., Halliday, A., Jahangiri, M., Xu, Q., Characterisation of progenitor cells in human atherosclerotic vessels (2007) Atherosclerosis, 2 (191), pp. 259-264; Zengin, E., Chalajour, F., Gehling, U.M., Ito, W.D., Treede, H., Lauke, H., Weil, J., Ergun, S., Vascular wall resident progenitor cells: a source for postnatal vasculogenesis (2006) Development, 8 (133), pp. 1543-1551; Han, G., White, R.E., G-protein-coupled estrogen receptor as a new therapeutic target for treating coronary artery disease (2014) World J. Cardiol., 6 (6), pp. 367-375; Haas, E., Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity (2009) Circ. Res., 104 (3), pp. 288-291; Gros, R., Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation (2013) Am. J. Physiol. Cell. Physiol., 304 (6), pp. C532-C540; Li, F., Activation of GPER induces differentiation and inhibition of coronary artery smooth muscle cell proliferation (2013) PLoS One, 8 (6), p. e64771; Gros, R., GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone (2011) Hypertension, 57 (3), pp. 442-451; Ding, Q., Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30 (2009) Am. J. Physiol. Cell. Physiol., 297 (5), pp. C1178-C1187; Li, H.J., Haque, Z., Lu, Q., Li, L., Karas, R., Mendelsohn, M., Steroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiation (2007) Proc. Natl. Acad. Sci. U. S. A., 10 (104), pp. 4065-4070",Article,Scopus,2-s2.0-84928029313
"Konishi S., Teramachi Y., Shimomura S., Tonomura W., Tajima S., Tabata Y.","Cellular aggregate capture by fluidic manipulation device highly compatible with micro-well-plates",2015,"Biomedical Microdevices","17","3",,"","",6,,10.1007/s10544-015-9953-x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927656251&partnerID=40&md5=73b5a189c6f7128040c2d3302ed20ee9","Department of Mechanical Engineering, Ritsumeikan University, 1-1-1 Noji-higashiKusatsu, Shiga, Japan; Graduate School of Science and Engineering, Ritsumeikan University, 1-1-1 Noji-higashiKusatsu, Shiga, Japan; Institute for Frontier Medical Sciences, Kyoto University, 53 Kawara-cho Shogoin, Sakyo-kuKyoto, Japan","Konishi, S., Department of Mechanical Engineering, Ritsumeikan University, 1-1-1 Noji-higashiKusatsu, Shiga, Japan; Teramachi, Y., Graduate School of Science and Engineering, Ritsumeikan University, 1-1-1 Noji-higashiKusatsu, Shiga, Japan; Shimomura, S., Graduate School of Science and Engineering, Ritsumeikan University, 1-1-1 Noji-higashiKusatsu, Shiga, Japan; Tonomura, W., Department of Mechanical Engineering, Ritsumeikan University, 1-1-1 Noji-higashiKusatsu, Shiga, Japan; Tajima, S., Institute for Frontier Medical Sciences, Kyoto University, 53 Kawara-cho Shogoin, Sakyo-kuKyoto, Japan; Tabata, Y., Institute for Frontier Medical Sciences, Kyoto University, 53 Kawara-cho Shogoin, Sakyo-kuKyoto, Japan","This paper proposes a capture device to manipulate and transport a cellular aggregate in a micro-well. A cellular aggregate (a few hundreds μm in diameter) is currently manipulated by a pipette. The manual manipulation by a pipette has problems; low reliability, low throughput, and difficulty in confirmation of task completion. We took into account of compatibility with existing methods such as a micro-well-plate and designed for the capture device of a cellular aggregate in a micro-well. A newly developed capture device flows and carries a cellular aggregate from a bottom of a well to a trap of the capture device. We designed a curved surface at the bottom of the capture device to form a space to act as a channel between the inner wall of the micro-well. This paper presents concept, design, fabrication, and of the proposed cellular aggregate capture, followed by successful experimental results. © 2015, Springer Science+Business Media New York.","Capture; Cellular aggregate; Fluidic manipulation; Micro-well-plate; uTAS","Augustsson, P., Persson, J., Ekstrom, S., Ohlin, M., Laurell, T., Decomplexing biofluids using microchip based acoustophoresis (2009) Lab Chip, 9, pp. 810-818; Drury, J.L., Mooney, D.J., Hydrogels for tissue engineering: scaffold design variables and applications (2003) Biomaterials, 24, pp. 4337-4351; Hartgerink, J.D., Beniash, E., Stupp, S.I., Self-assembly and mineralization of peptide-amphiphile nanofibers (2001) Science, 294, pp. 1684-1688; Hosseinkhani, H., Azzam, T., Kobayashi, H., Hiraokae, Y., Shimokawa, H., Dombb, A.J., Tabata, Y., Combination of 3D tissue engineered scaffold and non-viral gene carrier enhance in vitro DNA expression of mesenchymal stem cells (2006) Biomaterials, 27, pp. 4269-4278; Huang, S.B., Wu, M.H., Lin, Y.H., Hsieh, C.H., Yang, C.L., Lin, H.C., Tseng, C.P., Lee, G.B., High-purity and label-free isolation of circulating tumor cells (CTCs) in a microfluidic platform by using optically-induced-dielectrophoretic (ODEP) force (2013) Lab Chip, 13, pp. 1371-1383; Kurosawa, H., Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells (2007) Soc. Biotechnol, pp. 389-398; Li, W.J., Tuli, R., Okafor, C., Derfoul, A., Danielson, K.G., Hall, D.J., Tuan, R.S., A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells (2005) Biomaterials, 26, pp. 599-609; Moon, H.S., Kwon, K., Kim, S.I., Han, H., Sohn, J., Lee, S., Jung, H.I., Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP) (2011) Lab Chip, 11, pp. 1118-1125; Nishijima, T., Ikeuchi, M., Ikuta, K., Pneumatically actuated spheroid culturing lab-on-a-chip for combinatorial analysis of embryonic body (2012) Proc IEEE MEMS, pp. 92-95; Sakai, S., Ito, S., Ogushi, Y., Hashimoto, I., Hosoda, N., Sawae, Y., Kawakami, K., Enzymatically fabricated and degradable microcapsules for production of multicellular spheroids with well-defined diameters of less than 150 μm (2009) Biomaterials, 30, pp. 5937-5942; Solchaga, L.A., Dennis, J.E., Goldberg, V.M., Caplan, A.I., Hyaluronic acid-based polymers as cell carriers for tissue-engineered repair of bone and cartilage (1999) J. Orthop. Res., 17, pp. 205-213; Tung, Y.C., Hsiao, A.Y., Allen, S.G., Torisawa, Y., Ho, M., Takayama, S., High-throughput 3D spheroid culture and drug testing a 384 hanging drop array (2011) Analyst, 136, pp. 473-478; Vepari, C.P., Kaplan, D.L., Covalently immobilized enzyme gradients within three-dimensional porous scaffolds (2006) Biotechnol. Bioeng, pp. 1130-1137; Vigolo, D., Rusconi, R., Stone, H.A., Piazza, R., Thermophoresis: microfluidics characterization and separation (2010) Soft Matter, 6, pp. 3489-3493; Yoshimoto, H., Shin, Y.M., Terai, H., Vacanti, J.P., A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering (2003) Biomaterials, 24, pp. 2077-2082; Zengerle, R., Hoffmann, J., Roth, G., Strohmeier, O., Fiebach, A.R., Drechsel, L., Zhang, S., Von Stetten, F., Microfludic apps on standard lab-instruments (2012) Proc. MicroTAS, pp. 239-241",Article,Scopus,2-s2.0-84927656251
"Li Y., Li F., Zhang C., Gao B., Tan P., Mi B., Zhang Y., Cheng H., Liao H., Huo K., Xiong W.","The dimension of titania nanotubes influences implant success for osteoclastogenesis and osteogenesis patients",2015,"Journal of Nanoscience and Nanotechnology","15","6",,"4136","4142",,,10.1166/jnn.2015.9602,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920742385&partnerID=40&md5=7a4511497e4f8908d11f58209203eff2","Department of Orthopedics, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Key State Laboratory Breeding Base of Refractories and Ceramics, School of Materials and Metallurgy, Wuhan University of Science and TechnologyWuhan, China; Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and TechnologyWuhan, China","Li, Y., Department of Orthopedics, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Li, F., Department of Orthopedics, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Zhang, C., Key State Laboratory Breeding Base of Refractories and Ceramics, School of Materials and Metallurgy, Wuhan University of Science and TechnologyWuhan, China; Gao, B., Key State Laboratory Breeding Base of Refractories and Ceramics, School of Materials and Metallurgy, Wuhan University of Science and TechnologyWuhan, China; Tan, P., Department of Orthopedics, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Mi, B., Department of Orthopedics, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Zhang, Y., Department of Orthopedics, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Cheng, H., Department of Orthopedics, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Liao, H., Department of Orthopedics, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Huo, K., Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and TechnologyWuhan, China; Xiong, W., Department of Orthopedics, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China","Implants that can inhibit osteoclastogenesis and enhance osteogenesis are desirable for osteoporosis patients. In this study, titania nanotube (Ti-NT) materials, having nanotube diameters of 30, 80, and 120 nm, were produced separately by anodization at 10, 40, and 60 V, respectively. The introduction of Ti-NTs to titanium substrates significantly reduced the formation and activity of osteoclasts on samples. With the enlargement of the nanotube diameter, the osteoclasts number, tartrate-resistant acid phosphatase staining and activity, and related gene expressions of osteoclasts were further reduced. Osteogenic ability was enhanced by increasing the nanotube diameter. Thus, larger-diameter nanotube implants, such as NT60, were better able to inhibit bone absorption and enhance bone formation to prevent implant loss and failure, especially for osteoporosis patients. © 2015 American Scientific Publishers All rights reserved.","Mesenchymal Stem Cells; Nanotube Dimension; Osteoclasts; Osteoporosis; Titania Nanotube","Elsubeihi, E.S., Zarb, G.A., (2002) J. Can. Dent. Assoc., 68, p. 103; Yamazaki, M., Shirota, T., Tokugawa, Y., Motohashi, M., Ohno, K., Michi, K., Yamaguchi, A., (1999) Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 87, p. 411; Rachner, T.D., Khosla, S., Hofbauer, L.C., (2011) Lancet, 377, p. 1276; Chen, Z.X., Takao, Y., Wang, W.X., Matsubara, T., Ren, L.M., (2009) Biomed. Mater., 4, p. 065003; Yu, W.Q., Qiu, J., Xu, L., Zhang, F.Q., (2009) Biomed. Mater., 4, p. 065012; Kim, H.M., Chae, W.P., Chang, K.W., Chun, S., Kim, S., Jeong, Y., Kang, I.K., (2010) J. Biomed. Mater. Res. B Appl. Biomater., 94, p. 380; Kim, J.H., Cho, K.P., Chung, Y.S., Kim, O.S., Chung, S.S., Lee, K.K., Lee, D.J., Kim, Y.J., (2010) J. Nanosci. Nanotechnol., 10, p. 3581; Park, J., Bauer, S., Schlegel, K.A., Neukam, F.W., Von Der Mark, K., Schmuki, P., (2009) Small, 5, p. 666; Nalwa, H.S., (2004) Handbook of Organic-inorganic Hybrid Materials and Nanocomposites, 1. , American Scientific Publishers, Los Angeles, CA; Nalwa, H.S., (2004) Encyclopedia of Nanoscience and Nanotechnology, 1. , American Scientific Publishers, Los Angeles, CA; Gurzawska, K., Svava, R., Jorgensen, N.R., Gotfredsen, K., (2012) J. Biomed. Nanotechnol., 8, p. 1012; Rivera-Chacon, D.M., Alvarado-Velez, M., Acevedo-Morantes, C.Y., Singh, S.P., Gultepe, E., Nagesha, D., Sridhar, S., Ramirez-Vick, J.E., (2013) J. Biomed. Nanotechnol., 9, p. 1092; Wang, L.N., Lin, L.X., Lin, C.J., Shen, C., Shinbine, A., Luo, J.L., (2013) J. Nanosci. Nanotechnol., 13, p. 5316; Oh, S.H., Finones, R.R., Daraio, C., Chen, L.H., Jin, S., (2005) Biomaterials, 26, p. 4938; Park, J., Bauer, S., Von Der Mark, K., Schmuki, P., (2007) Nano Lett., 7, p. 1686; Valencia, S., Gretzer, C., Cooper, L.F., (2009) Int. J. Oral Maxillofac Implants, 24, p. 38; Duarte, P.M., Cesar Neto, J.B., Goncalves, P.F., Sallum, E.A., Nociti, F., (2003) J. Implant Dent., 12, p. 340; Li, Y., Zou, S., Wang, D., Feng, G., Bao, C., Hu, J., (2010) Biomaterials, 31, p. 3266; Zhao, L., Wang, H., Huo, K., Zhang, X., Wang, W., Zhang, Y., Wu, Z., Chu, P.K., (2013) Biomaterials, 34, p. 19; Shin, C.S., Her, S.J., Kim, J.A., Kim, D.H., Kim, S.W., Kim, S.Y., Kim, H.S., Civitelli, R., (2005) J. Bone. Miner. Res., 20, p. 2200; Brinkmann, J., Hefti, T., Schlottig, F., Spencer, N.D., Hall, H., (2012) Biointerphases, 7, p. 34; Lindunger, A., MacKay, C.A., Ek-Rylander, B., Andersson, G., Marks, S.C., Jr., (1990) Bone Miner., 10, p. 109; Gregory, C.A., Gunn, W.G., Peister, A., Prockop, D.J., (2004) Anal. Biochem., 329, p. 77; Oh, S., Brammer, K.S., Li, Y.S., Teng, D., Engler, A.J., Chien, S., Jin, S., (2009) Proc. Natl. Acad. Sci. USA, 106, p. 2130; Popat, K.C., Leoni, L., Grimes, C.A., Desai, T.A., (2007) Biomaterials, 28, p. 3188; Wang, N., Li, H.Y., Lu, W.L., Li, J.H., Wang, J.S., Zhang, Z.T., Liu, Y.R., (2011) Biomaterials, 32, p. 6900; Bjursten, L.M., Rasmusson, L., Oh, S., Smith, G.C., Brammer, K.S., Jin, S., (2010) J. Biomed. Mater. Res. A, 92, p. 1218; Xing, L., Xiu, Y., Boyce, B.F., World, J., (2012) Orthop., 3, p. 212; Vignery, A., (2008) Methods Mol. Biol., 475, p. 149; Helming, L., Gordon, S., (2009) Trends Cell Biol., 19, p. 514; Narita, N., Kobayashi, Y., Nakamura, H., Maeda, K., Ishihara, A., Mizoguchi, T., Usui, Y., Saito, N., (2009) Nano Lett., 9, p. 1406; Ye, S., Jiang, Y., Zhang, H., Wang, Y., Wu, Y., Hou, Z., Zhang, Q., (2012) J. Nanosci. Nanotechnol., 12, p. 2101; Gross, K.A., Muller, D., Lucas, H., Haynes, D.R., (2012) Acta Biomater., 8, p. 1948; Webster, T.J., Ergun, C., Doremus, R.H., Siegel, R.W., Bizios, R., (2001) Biomaterials, 22, p. 1327; Zhao, L., Wang, H., Huo, K., Cui, L., Zhang, W., Ni, H., Zhang, Y., Chu, P.K., (2011) Biomaterials, 32, p. 5706; Huo, K., Zhang, X., Wang, H., Zhao, L., Liu, X., Chu, P.K., (2013) Biomaterials, 34, p. 3467; Yu, W.Q., Jiang, X.Q., Zhang, F.Q., Xu, L., (2010) J. Biomed. Mater. Res. A, 94, p. 1012",Article,Scopus,2-s2.0-84920742385
"Goncalves C., Martins-Neves S.R., Paiva-Oliveira D., Oliveira V.E.B., Fontes-Ribeiro C., Gomes C.M.F.","Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins",2015,"Life Sciences","130",, 14332,"47","56",,,10.1016/j.lfs.2015.03.009,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927731861&partnerID=40&md5=88510c1edff3e09518262f1c5fa7ae85","Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Az. de Sta. CombaCelas, Coimbra, Portugal; Center of Investigation in Environment, Faculty of Medicine, University of CoimbraCoimbra, Portugal","Gonçalves, C., Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Az. de Sta. CombaCelas, Coimbra, Portugal; Martins-Neves, S.R., Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Az. de Sta. CombaCelas, Coimbra, Portugal; Paiva-Oliveira, D., Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Az. de Sta. CombaCelas, Coimbra, Portugal; Oliveira, V.E.B., Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Az. de Sta. CombaCelas, Coimbra, Portugal; Fontes-Ribeiro, C., Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Az. de Sta. CombaCelas, Coimbra, Portugal; Gomes, C.M.F., Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Az. de Sta. CombaCelas, Coimbra, Portugal, Center of Investigation in Environment, Faculty of Medicine, University of CoimbraCoimbra, Portugal","Abstract Aims: Osteosarcoma is the most common pediatric bone malignancy with high propensity to metastasize and relapse. Emerging evidence suggest that osteosarcoma is sustained by a subset of self-renewing cancer stemlike cells (CSCs) relying on mechanisms to evade apoptosis and survive in response to drugs-induced DNA damage. We proposed to decipher the mechanisms underlying the resistance of CSCs to doxorubicin-induced apoptosis. Mainmethods: CSCs were isolated using a sphere-forming assay and tested for sensitivity to doxorubicin-induced apoptosis, using MTT cell viability and BrdU proliferation assays, TUNEL staining and caspases 3/7 activity. Bcl-2 family proteins were analyzed by Western blot. Doxorubicin uptakewas determined by confocal microscopy and bioluminescence imaging. Key findings: We showed that osteosarcoma sphere stem-like cells expressed the multidrug-related efflux transporters P-glycoprotein and BCRP and are highly resistant to doxorubicin-induced apoptosis. Conversely after exposure to doxorubicin, these cells displayed an up-regulation of the anti-apoptotic proteins Bcl-2 and Bcl-xLwith concomitant down-regulation of Bak and decreased caspase 3/7 activity. Inhibition of drug efflux transporters enhanced the cellular uptake of doxorubicin, being encompassed by an up-regulation the pro-apoptotic protein Bak and suppression of Bcl-2, favoring the commitment of CSCs towards apoptosis. Significance: These results seemingly suggest that the high apoptotic threshold of CSCs to doxorubicin-induced cell dead stimuli is mainly dependent on the drug concentration reaching tumor cells that are governed by efflux transporter activity. Therefore, modulation of these transporters may be effective in potentiating the proapoptotic effects of doxorubicin, and emerges as an attractive strategy to sensitize osteosarcoma CSCs to chemotherapy. © 2015 Elsevier Inc. All rights reserved.","Apoptosis; BCRP; Cancer stem cells; Chemoresistance; Doxorubicin; Osteosarcoma; P-glycoprotein","Longhi, A., Errani, C., De Paolis, M., Mercuri, M., Bacci, G., Primary bone osteosarcoma in the pediatric age: state of the art (2006) Cancer Treat. Rev., 32, pp. 423-436; Marina, N., Gebhardt, M., Teot, L., Gorlick, R., Biology and therapeutic advances for pediatric osteosarcoma (2004) Oncologist, 9, pp. 422-441; Gatta, G., Capocaccia, R., Stiller, C., Kaatsch, P., Berrino, F., Terenziani, M., The Eurocare Working Group, Childhood cancer survival trends in europe: a EUROCARE Working Group Study (2005) J. Clin. Oncol., 23, pp. 3742-3751; Ferrari, S., Briccoli, A., Mercuri, M., Bertoni, F., Picci, P., Tienghi, A., Del Prever, A.B., Bacci, G., Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival (2003) J. Clin. Oncol., 21, pp. 710-715; Visvader, J.E., Lindeman, G.J., Cancer stem cells: current status and evolving complexities (2012) Cell Stem Cell, 10, pp. 717-728; Diehn, M., Cho, R.W., Clarke, M.F., Therapeutic implications of the cancer stem cell hypothesis (2009) Semin. Radiat. Oncol., 19, pp. 78-86; Martins-Neves, S., Lopes, A., Do Carmo, A., Paiva, A., Simoes, P., Abrunhosa, A., Gomes, C., Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line (2012) BMC Cancer, 12, p. 139; Honoki, K., Fujji, H., Kubo, A., Kido, A., Mori, T., Tanaka, Y., Tsujiuchi, T., Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance (2010) Oncol. Rep., 24, pp. 501-505; Tirino, V., Desiderio, V., Paino, F., De Rosa, A., Papaccio, F., Fazioli, F., Pirozzi, G., Papaccio, G., Human primary bone sarcomas contain CD133 + cancer stem cells displaying high tumorigenicity in vivo (2011) FASEB J., 25, pp. 2022-2030; Mccubrey, J.A., Abrams, S.L., Fitzgerald, T.L., Cocco, L., Martelli, A.M., Montalto, G., Cervello, M., Steelman, L.S., Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis (2014) Adv. Biol. Regul., pp. 1-27; Takebe, N., Harris, P.J., Warren, R.Q., Ivy, S.P., Targeting cancer stem cells by inhibiting Wnt, notch, and hedgehog pathways (2011) Nat. Rev. Clin. Oncol., 8, pp. 97-106; Fulda, S., Regulation of apoptosis pathways in cancer stem cells (2013) Cancer Lett., 338, pp. 168-173; Lowe, S.W., Cepero, E., Evan, G., Intrinsic tumour suppression (2004) Nature, 432, pp. 307-315; Tsang, W.P., Chau, S.P.Y., Kong, S.K., Fung, K.P., Kwok, T.T., Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis (2003) Life Sci., 73, pp. 2047-2058; Dembinski, J., Krauss, S., Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma (2009) Clin. Exp. Metastasis, 26, pp. 611-623; Kelly, P.N., Strasser, A., The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy (2011) Cell Death Differ., 18, pp. 1414-1424; Yip, K.W., Reed, J.C., Bcl-2 family proteins and cancer (2008) Oncogene, 27, pp. 6398-6406; Reya, T., Duncan, A.W., Ailles, L., Domen, J., Scherer, D.C., Willert, K., Hintz, L., Weissman, I.L., A role for Wnt signalling in self-renewal of haematopoietic stem cells (2003) Nature, 423, pp. 409-414; Kemper, K., Rodermond, H., Colak, S., Grandela, C., Medema, J., Targeting colorectal cancer stem cells with inducible caspase-9 (2012) Apoptosis, 17, pp. 528-537; Tagscherer, K.E., Fassl, A., Campos, B., Farhadi, M., Kraemer, A., Bock, B.C., Macher-Goeppinger, S., Roth, W., Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins (2008) Oncogene, 27, pp. 6646-6656; Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I., Lu, L., Yu, J., Analysis of gene expression and chemoresistance of CD133 + cancer stem cells in glioblastoma (2006) Mol. Cancer, 5, p. 67; Johnstone, R.W., Cretney, E., Smyth, M.J., P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death (1999) Blood, 93, pp. 1075-1085; Gao, M.Q., Choi, Y.P., Kang, S., Youn, J.H., Cho, N.H., CD24 + cells from hierarchically organized ovarian cancer are enriched in cancer stem cells (2010) Oncogene, 29, pp. 2672-2680; Naumov, G., Townson, J., MacDonald, I., Wilson, S., Bramwell, V., Groom, A., Chambers, A., Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases (2003) Breast Cancer Res. Treat., 82, pp. 199-206; Panaretakis, T., Pokrovskaja, K., Shoshan, M.C., Grandér, D., Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin (2002) J. Biol. Chem., 277, pp. 44317-44326; Wang, G.Q., Gastman, B.R., Wieckowski, E., Goldstein, L.A., Gambotto, A., Kim, T.H., Fang, B., Rabinowich, H., A role for mitochondrial Bak in apoptotic response to anticancer drugs (2001) J. Biol. Chem., 276, pp. 34307-34317; Castilla, C., Congregado, B., Chinchón, D., Torrubia, F.J., Japón, M.A., Sáez, C., Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak (2006) Endocrinology, 147, pp. 4960-4967; Konopleva, M., Zhao, S., Hu, W., Jiang, S., Snell, V., Weidner, D., Jackson, C.E., Andreeff, M., The anti-apoptotic genes Bcl-XL and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34 + cells (2002) Brit. J. Haematol., 118, pp. 521-534; Gottesman, M.M., Fojo, T., Bates, S.E., Multidrug resistance in cancer: role of ATP-dependent transporters (2002) Nat. Rev. Cancer, 2, pp. 48-58; Moitra, K., Lou, H., Dean, M., Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development (2011) Clin. Pharmacol. Ther., 89, pp. 491-502; Gomes, C.M.F., Van Paassen, H., Romeo, S., Welling, M.M., Feitsma, R.I.J., Abrunhosa, A.J., Botelho, M.F., Cleton-Jansen, A.M., Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies (2006) Nucl. Med. Biol., 33, pp. 831-840; Serra, M., Pasello, M., Manara, M.C., Scotlandi, K., Ferrari, S., Bertoni, F., Mercuri, M., Smeland, S., May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol (2006) Int. J. Oncol., 29, pp. 1459-1468; Cheng, J.Q., Lindsley, C.W., Cheng, G.Z., Yang, H., Nicosia, S.V., The Akt/PKB pathway: molecular target for cancer drug discovery (2005) Oncogene, 24, pp. 7482-7492; Opel, D., Westhoff, M.A., Bender, A., Braun, V., Debatin, K.M., Fulda, S., Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis (2008) Cancer Res., 68, pp. 6271-6280; Marklein, D., Graab, U., Naumann, I., Yan, T., Ridzewski, R., Nitzki, F., Rosenberger, A., Ahn, H., PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells (2012) PLoS ONE, 7; Imai, Y., Yoshimori, M., Fukuda, K., Yamagishi, H., Ueda, Y., The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocation (2012) Oncol. Rep., 27, pp. 1703-1709",Article,Scopus,2-s2.0-84927731861
"Adli M., Parlak M., Li Y., El-Dahr S.S.","Epigenetic states of nephron progenitors and epithelial differentiation",2015,"Journal of Cellular Biochemistry","116","6",,"893","902",,,10.1002/jcb.25048,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926635119&partnerID=40&md5=83066f82325216d9d40de7b91a8124fc","Department of Biochemistry and Molecular Genetics, University of Virginia, School of Medicine, 1340 Jefferson Park AveCharlottesville, VA, United States; Department of Pediatrics, Tulane University, School of Medicine, 1430 Tulane AvenueNew Orleans, LA, United States","Adli, M., Department of Biochemistry and Molecular Genetics, University of Virginia, School of Medicine, 1340 Jefferson Park AveCharlottesville, VA, United States; Parlak, M., Department of Biochemistry and Molecular Genetics, University of Virginia, School of Medicine, 1340 Jefferson Park AveCharlottesville, VA, United States; Li, Y., Department of Pediatrics, Tulane University, School of Medicine, 1430 Tulane AvenueNew Orleans, LA, United States; El-Dahr, S.S., Department of Pediatrics, Tulane University, School of Medicine, 1430 Tulane AvenueNew Orleans, LA, United States","In mammals, formation of new nephrons ends perinatally due to consumption of mesenchymal progenitor cells. Premature depletion of progenitors due to prematurity or postnatal loss of nephrons due to injury causes chronic kidney disease and hypertension. Intensive efforts are currently invested in designing regenerative strategies to form new nephron progenitors from pluripotent cells, which upon further differentiation provide a potential source of new nephrons. To know if reprogramed renal cells can maintain their identity and fate requires knowledge of the epigenetic states of native nephron progenitors and their progeny. In this article, we summarize current knowledge and gaps in the epigenomic landscape of the developing kidney. We now know that Pax2/PTIP/H3K4 methyltransferase activity provides the initial epigenetic specification signal to the metanephric mesenchyme. During nephrogenesis, the cap mesenchyme housing nephron progenitors is enriched in bivalent chromatin marks; as tubulogenesis proceeds, the tubular epithelium acquires H3K79me2. The latter mark is uniquely induced during epithelial differentiation. Analysis of histone landscapes in clonal metanephric mesenchyme cell lines and in Wilms tumor and normal fetal kidney has revealed that promoters of poised nephrogenesis genes carry bivalent histone signatures in progenitors. Differentiation or stimulation of Wnt signaling promotes resolution of bivalency; this does not occur in Wilms tumor cells consistent with their developmental arrest. The use of small cell number ChIP-Seq should facilitate the characterization of the chromatin landscape of the metanephric mesenchyme and various nephron compartments during nephrogenesis. Only then we will know if stem and somatic cell reprogramming into kidney progenitors recapitulates normal development. J. Cell. Biochem. 116: 893-902, 2015. © 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.","CHROMATIN SIGNATURE; EPIGENETICS; KIDNEY DEVELOPMENT; NEPHROGENESIS; NEPHRON PROGENITORS","Abdel-Wahab, O., Adli, M., Lafave, L.M., Gao, J., Hricik, T., Shih, A.H., Pandey, S., Levine, R.L., ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression (2012) Cancer Cell, 22, pp. 180-193; Adli, M., Bernstein, B.E., Whole-genome chromatin profiling from limited numbers of cells using nano-ChIP-seq (2011) Nat Protoc, 6, pp. 1656-1668; Adli, M., Zhu, J., Bernstein, B.E., Genome-wide chromatin maps derived from limited numbers of hematopoietic progenitors (2010) Nat Methods, 7, pp. 615-618; Aiden, A.P., Rivera, M.N., Rheinbay, E., Ku, M., Coffman, E.J., Truong, T.T., Vargas, S.O., Bernstein, B.E., Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network (2010) Cell Stem Cell, 6, pp. 591-602; Barak, H., Huh, S.H., Chen, S., Jeanpierre, C., Martinovic, J., Parisot, M., Bole-Feysot, C., Kopan, R., FGF9 and FGF20 maintain the stemness of nephron progenitors in mice and man (2012) Dev Cell, 22, pp. 1191-1207; Barski, A., Cuddapah, S., Cui, K., Roh, T.Y., Schones, D.E., Wang, Z., Wei, G., Zhao, K., High-resolution profiling of histone methylations in the human genome (2007) Cell, 129, pp. 823-837; Berdasco, M., Esteller, M., Aberrant epigenetic landscape in cancer: How cellular identity goes awry (2010) Dev Cell, 19, pp. 698-711; Berger, S.L., Kouzarides, T., Shiekhattar, R., Shilatifard, A., An operational definition of epigenetics (2009) Genes Dev, 23, pp. 781-783; Bernstein, B.E., Stamatoyannopoulos, J.A., Costello, J.F., Ren, B., Milosavljevic, A., Meissner, A., Kellis, M., Thomson, J.A., The NIH roadmap epigenomics mapping consortium (2010) Nat Biotechnol, 28, pp. 1045-1048; Biron, V.L., Mcmanus, K.J., Hu, N., Hendzel, M.J., Underhill, D.A., Distinct dynamics and distribution of histone methyl-lysine derivatives in mouse development (2004) Dev Biol, 276, pp. 337-351; Boyle, S.C., Kim, M., Valerius, M.T., Mcmahon, A.P., Kopan, R., Notch pathway activation can replace the requirement for Wnt4 and Wnt9b in mesenchymal-to-epithelial transition of nephron stem cells (2011) Development, 138, pp. 4245-4254; Brower, V., Epigenetics: Unravelling the cancer code (2011) Nature, 471, pp. S12-S13; Buenrostro, J.D., Giresi, P.G., Zaba, L.C., Chang, H.Y., Greenleaf, W.J., Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position (2013) Nat Methods, 10, pp. 1213-1218; Carroll, T.J., Park, J.S., Hayashi, S., Majumdar, A., Mcmahon, A.P., Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system (2005) Dev Cell, 9, pp. 283-292; Cheng, J., Kapranov, P., Drenkow, J., Dike, S., Brubaker, S., Patel, S., Long, J., Gingeras, T.R., Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution (2005) Science, 308, pp. 1149-1154; Cho, Y.W., Hong, T., Hong, S., Guo, H., Yu, H., Kim, D., Guszczynski, T., Ge, K., PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex (2007) J Biol Chem, 282, pp. 20395-20406; Consortium, E.P., Bernstein, B.E., Birney, E., Dunham, I., Green, E.D., Gunter, C., Snyder, M., An integrated encyclopedia of DNA elements in the human genome (2012) Nature, 489, pp. 57-74; Costantini, F., Kopan, R., Patterning a complex organ: Branching morphogenesis and nephron segmentation in kidney development (2010) Dev Cell, 18, pp. 698-712; Dawson, M.A., Kouzarides, T., Huntly, B.J., Targeting epigenetic readers in cancer (2012) N Engl J Med, 367, pp. 647-657; Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., Guernec, G., Guigo, R., The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression (2012) Genome Res, 22, pp. 1775-1789; Dressler, G.R., Patterning and early cell lineage decisions in the developing kidney: The role of Pax genes (2011) Pediatr Nephrol, 26, pp. 1387-1394; Dressler, G.R., Patel, S.R., Epigenetics in kidney development and renal disease (2015) Transl Res, 165, pp. 166-176; Ernst, J., Kheradpour, P., Mikkelsen, T.S., Shoresh, N., Ward, L.D., Epstein, C.B., Zhang, X., Bernstein, B.E., Mapping and analysis of chromatin state dynamics in nine human cell types (2011) Nature, 473, pp. 43-49; Heintzman, N.D., Hon, G.C., Hawkins, R.D., Kheradpour, P., Stark, A., Harp, L.F., Ye, Z., Ren, B., Histone modifications at human enhancers reflect global cell-type-specific gene expression (2009) Nature, 459, pp. 108-112; Karner, C.M., Das, A., Ma, Z., Self, M., Chen, C., Lum, L., Oliver, G., Carroll, T.J., Canonical Wnt9b signaling balances progenitor cell expansion and differentiation during kidney development (2011) Development, 138, pp. 1247-1257; Kobayashi, A., Valerius, M.T., Mugford, J.W., Carroll, T.J., Self, M., Oliver, G., Mcmahon, A.P., Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development (2008) Cell Stem Cell, 3, pp. 169-181; Koesters, R., Niggli, F., Von Knebel, D., Stallmach, M., Nuclear accumulation of beta-catenin protein in Wilms' tumours dagger (2003) J Pathol, 199, pp. 68-76; Kohli, R.M., Zhang, Y., TET enzymes, TDG and the dynamics of DNA demethylation (2013) Nature, 502, pp. 472-479; Kriaucionis, S., Heintz, N., The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain (2009) Science, 324, pp. 929-930; Landt, S.G., Marinov, G.K., Kundaje, A., Kheradpour, P., Pauli, F., Batzoglou, S., Bernstein, B.E., Snyder, M., ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia (2012) Genome Res, 22, pp. 1813-1831; Lara-Astiaso, D., Weiner, A., Lorenzo-Vivas, E., Zaretsky, I., Jaitin, D.A., David, E., Keren-Shaul, H., Amit, I., Immunogenetics. Chromatin state dynamics during blood formation (2014) Science, 345, pp. 943-949; Lee, J.T., Bartolomei, M.S., X-inactivation, imprinting, and long noncoding RNAs in health and disease (2013) Cell, 152, pp. 1308-1323; Lister, R., Pelizzola, M., Dowen, R.H., Hawkins, R.D., Hon, G., Tonti-Filippini, J., Nery, J.R., Ecker, J.R., Human DNA methylomes at base resolution show widespread epigenomic differences (2009) Nature, 462, pp. 315-322; Lister, R., Mukamel, E.A., Nery, J.R., Urich, M., Puddifoot, C.A., Johnson, N.D., Lucero, J., Ecker, J.R., Global epigenomic reconfiguration during mammalian brain development (2013) Science, 341, p. 1237905; Lister, R., Pelizzola, M., Kida, Y.S., Hawkins, R.D., Nery, J.R., Hon, G., Antosiewicz-Bourget, J., Ecker, J.R., Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells (2011) Nature, 471, pp. 68-73; Luco, R.F., Pan, Q., Tominaga, K., Blencowe, B.J., Pereira-Smith, O.M., Misteli, T., Regulation of alternative splicing by histone modifications (2010) Science, 327, pp. 996-1000; Matoba, S., Liu, Y., Lu, F., Iwabuchi, K.A., Shen, L., Inoue, A., Zhang, Y., Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation (2014) Cell, 159, pp. 884-895; Mclaughlin, N., Wang, F., Saifudeen, Z., El-Dahr, S.S., In situ histone landscape of nephrogenesis (2014) Epigenetics, 9, pp. 222-235; Mclaughlin, N., Yao, X., Li, Y., Saifudeen, Z., El-Dahr, S.S., Histone signature of metanephric mesenchyme cell lines (2013) Epigenetics, 8, pp. 970-978; Mercer, T.R., Dinger, M.E., Mattick, J.S., Long non-coding RNAs: Insights into functions (2009) Nat Rev Genet, 10, pp. 155-159; Onder, T.T., Kara, N., Cherry, A., Sinha, A.U., Zhu, N., Bernt, K.M., Cahan, P., Daley, G.Q., Chromatin-modifying enzymes as modulators of reprogramming (2012) Nature, 483, pp. 598-602; Park, J.S., Ma, W., O'brien, L.L., Chung, E., Guo, J.J., Cheng, J.G., Valerius, M.T., Mcmahon, A.P., Six2 and Wnt regulate self-renewal and commitment of nephron progenitors through shared gene regulatory networks (2012) Dev cell, 23, pp. 637-651; Patel, S.R., Dressler, G.R., The genetics and epigenetics of kidney development (2013) Semin Nephrol, 33, pp. 314-326; Patel, S.R., Kim, D., Levitan, I., Dressler, G.R., The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex (2007) Dev Cell, 13, pp. 580-592; Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S.A., Flynn, R.A., Wysocka, J., A unique chromatin signature uncovers early developmental enhancers in humans (2011) Nature, 470, pp. 279-283; Rinn, J.L., Kertesz, M., Wang, J.K., Squazzo, S.L., Xu, X., Brugmann, S.A., Goodnough, L.H., Chang, H.Y., Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs (2007) Cell, 129, pp. 1311-1323; Rivera, M.N., Kim, W.J., Wells, J., Driscoll, D.R., Brannigan, B.W., Han, M., Kim, J.C., Haber, D.A., An X chromosome gene, WTX, is commonly inactivated in Wilms tumor (2007) Science, 315, pp. 642-645; Self, M., Lagutin, O.V., Bowling, B., Hendrix, J., Cai, Y., Dressler, G.R., Oliver, G., Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney (2006) EMBO J, 25, pp. 5214-5228; Shankaranarayanan, P., Mendoza-Parra, M.A., Walia, M., Wang, L., Li, N., Trindade, L.M., Gronemeyer, H., Single-tube linear DNA amplification (LinDA) for robust ChIP-seq (2011) Nat Methods, 8, pp. 565-567; Shen, H., Laird, P.W., Interplay between the cancer genome and epigenome (2013) Cell, 153, pp. 38-55; Shen, X., Orkin, S.H., Glimpses of the epigenetic landscape (2009) Cell Stem Cell, 4, pp. 1-2; Strahl, B.D., Allis, C.D., The language of covalent histone modifications (2000) Nature, 403, pp. 41-45; Surendran, K., Kopan, R., Chromatin-based mechanisms of renal epithelial differentiation (2011) J Am Soc Nephrol: JASN, 22, pp. 1208-1212; Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Rao, A., Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 (2009) Science, 324, pp. 930-935; Tan, M., Luo, H., Lee, S., Jin, F., Yang, J.S., Montellier, E., Buchou, T., Zhao, Y., Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification (2011) Cell, 146, pp. 1016-1028; Thurman, R.E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M.T., Haugen, E., Sheffield, N.C., Stamatoyannopoulos, J.A., The accessible chromatin landscape of the human genome (2012) Nature, 489, pp. 75-82; Torres, M., Gomez-Pardo, E., Dressler, G.R., Gruss, P., Pax-2 controls multiple steps of urogenital development (1995) Development, 121, pp. 4057-4065; Wu, H., Zhang, Y., Reversing DNA methylation: Mechanisms, genomics, and biological functions (2014) Cell, 156, pp. 45-68; Xu, C.R., Cole, P.A., Meyers, D.J., Kormish, J., Dent, S., Zaret, K.S., Chromatin ""prepattern"" and histone modifiers in a fate choice for liver and pancreas (2011) Science, 332, pp. 963-966; Zhao, J., Sun, B.K., Erwin, J.A., Song, J.J., Lee, J.T., Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome (2008) Science, 322, pp. 750-756; Zhou, V.W., Goren, A., Bernstein, B.E., Charting histone modifications and the functional organization of mammalian genomes (2011) Nat Rev Genet, 12, pp. 7-18; Zhu, J., Adli, M., Zou, J.Y., Verstappen, G., Coyne, M., Zhang, X., Durham, T., Bernstein, B.E., Genome-wide chromatin state transitions associated with developmental and environmental cues (2013) Cell, 152, pp. 642-654",Article,Scopus,2-s2.0-84926635119
"Li L.-M., Han M., Khang G., Tabata Y., Gao J.-Q.","Design of cell niches for the regulation of stem cell fate in central nervous tissue regeneration",2015,"Materials Letters","148",,,"96","98",,,10.1016/j.matlet.2015.02.079,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924041801&partnerID=40&md5=3efa9e5ae8e407a33ce0223b37bc3fb9","Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China; Department of Polymer Nano Sci Tech, Chonbuk National UniversityJeonju, South Korea; Department of Biomaterials, Institute for Frontier Medical Sciences, Kyoto UniversityKyoto, Japan","Li, L.-M., Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China; Han, M., Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China; Khang, G., Department of Polymer Nano Sci Tech, Chonbuk National UniversityJeonju, South Korea; Tabata, Y., Department of Biomaterials, Institute for Frontier Medical Sciences, Kyoto UniversityKyoto, Japan; Gao, J.-Q., Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China","Cell therapy based on biomaterials and stem cells has made outstanding performance in central nervous tissue engineering. To stimulate stem cell behavior and obtain maximum functional recovery, researchers have paid great effort to elucidate the function of stem cell microenvironments. However, optimum scaffold conditions vary among biomaterials and cells. During the development in scaffolds, stem cells detect different aspects of scaffold signals and change their behavior accordingly, where as the synergism of scaffold biochemical and geometric properties are usually neglected by current reports. To provide a reference for scaffold designs based on specific types of biomaterials and stem cells, we performed this review to make discussion on the function of the geometric properties of scaffolds with reference to the corresponding biomaterials. © 2015 Elsevier B.V. All rights reserved.","Central nervous system; Neural differentiation; Scaffold; Stem cell","Garrey, W.E., Townsend, S.E., Neural responses and reactions of the heart of a human embryo (1948) Am J Phys: Cell Physiol, 152, pp. 219-224; Benetato, G., Baciu, I., Budai, R., Petru-Miulescu, V., Neumann, E., Mechanism of nervous regulation of immuno-biological processes; Role of the CNS in the activity of the sessile phagocyte system (1955) Buletin Stiintific Sectiunea de Stiinte Medicale Academia Republicii Populare Romine, 7, pp. 349-366; Presl, J., Horsky, J., Henzl, M., Effect of a prolonged cyclic administration of progesterone in oligomenorrhea and role of the CNS (1961) Ceska Gynekologie/Ceska Lekarska Spolecnost J Ev Purkyne, 26, pp. 572-577; Stahel, P.F., Vanderheiden, T., Finn, M.A., Management strategies for acute spinal cord injury: Current options and future perspectives (2012) Curr Opin Crit Care, 18, pp. 651-660; Zhorow, I.S., Significance of the functional level of the CNS in the postoperative period (1958) Der Anaesthesist, 7, pp. 107-110; An, Y., Tsang, K.K., Zhang, H., Potential of stem cell based therapy and tissue engineering in the regeneration of the central nervous system (2006) Biomed Mater, 1, pp. R38-R44; Varma, A.K., Das, A., Gt, W., Barry, J., Vertegel, A.A., Ray, S.K., Spinal cord injury: A review of current therapy, future treatments, and basic science frontiers (2013) Neurochem Res, 38, pp. 895-905; Yazdani, S.O., Hafizi, M., Zali, A.R., Atashi, A., Ashrafi, F., Seddighi, A.S., Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury (2013) Cytotherapy, 15, pp. 782-791; Nehrer, S., Breinan, H.A., Ramappa, A., Young, G., Shortkroff, S., Louie, L.K., Matrix collagen type and pore size influence behaviour of seeded canine chondrocytes (1997) Biomaterials, 18, pp. 769-776; O'Brien, F.J., Harley, B.A., Yannas, I.V., Gibson, L.J., The effect of pore size on cell adhesion in collagen-GAG scaffolds (2005) Biomaterials, 26, pp. 433-441; Ahn, G., Park, J.H., Kang, T., Lee, J.W., Kang, H.W., Cho, D.W., Effect of pore architecture on oxygen diffusion in 3D scaffolds for tissue engineering (2010) J Biomech Eng, 132, p. 104506; Hejcl, A., Ruzicka, J., Kapcalova, M., Turnovcova, K., Krumbholcova, E., Pradny, M., Adjusting the chemical and physical properties of hydrogels leads to improved stem cell survival and tissue ingrowth in spinal cord injury reconstruction: A comparative study of four methacrylate hydrogels (2013) Stem Cells Dev, 22, pp. 2794-2805; Kim, B.S., Mooney, D.J., Development of biocompatible synthetic extracellular matrices for tissue engineering (1998) Trends Biotechnol, 16, pp. 224-230; Ji, C., Khademhosseini, A., Dehghani, F., Enhancing cell penetration and proliferation in chitosan hydrogels for tissue engineering applications (2011) Biomaterials, 32, pp. 9719-9729; Li, H., Wijekoon, A., Leipzig, N.D., 3D differentiation of neural stem cells in macroporous photopolymerizable hydrogel scaffolds (2012) PLoS One, 7, p. e48824; Zamani, F., Amani-Tehran, M., Latifi, M., Shokrgozar, M.A., Zaminy, A., Promotion of spinal cord axon regeneration by 3D nanofibrous core-sheath scaffolds (2014) J Biomed Mater Res A, 102, pp. 506-513; Gros, T., Sakamoto, J.S., Blesch, A., Havton, L.A., Tuszynski, M.H., Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds (2010) Biomaterials, 31, pp. 6719-6729; Peyton, S.R., Kalcioglu, Z.I., Cohen, J.C., Runkle, A.P., Van Vliet, K.J., Lauffenburger, D.A., Marrow-derived stem cell motility in 3D synthetic scaffold is governed by geometry along with adhesivity and stiffness (2011) Biotechnol Bioeng, 108, pp. 1181-1193; Kim, H.Y., Kim, H.N., Lee, S.J., Song, J.E., Kwon, S.Y., Chung, J.W., Effect of pore sizes of PLGA scaffolds on mechanical properties and cell behaviour for nucleus pulposus regeneration in vivo (2014) J Tissue Eng Regen Med; Wang, G., Ao, Q., Gong, K., Wang, A., Zheng, L., Gong, Y., The effect of topology of chitosan biomaterials on the differentiation and proliferation of neural stem cells (2010) Acta Biomater, 6, pp. 3630-3639; Gao, M., Lu, P., Bednark, B., Lynam, D., Conner, J.M., Sakamoto, J., Templated agarose scaffolds for the support of motor axon regeneration into sites of complete spinal cord transection (2013) Biomaterials, 34, pp. 1529-1536; Sheets, K., Wunsch, S., Ng, C., Nain, A.S., Shape-dependent cell migration and focal adhesion organization on suspended and aligned nanofiber scaffolds (2013) Acta Biomater, 9, pp. 7169-7177; Liu, T., Houle, J.D., Xu, J., Chan, B.P., Chew, S.Y., Nanofibrous collagen nerve conduits for spinal cord repair (2012) Tissue Eng Part A, 18, pp. 1057-1066; Subramanian, A., Krishnan, U.M., Sethuraman, S., Fabrication, characterization and in vitro evaluation of aligned PLGA-PCL nanofibers for neural regeneration (2012) Ann Biomed Eng, 40, pp. 2098-2110; Chung, T.W., Liu, D.Z., Wang, S.Y., Wang, S.S., Enhancement of the growth of human endothelial cells by surface roughness at nanometer scale (2003) Biomaterials, 24, pp. 4655-4661; Chun, Y.W., Khang, D., Haberstroh, K.M., Webster, T.J., The role of polymer nanosurface roughness and submicron pores in improving bladder urothelial cell density and inhibiting calcium oxalate stone formation (2009) Nanotechnology, 20, p. 085104; Zamani, F., Amani-Tehran, M., Latifi, M., Shokrgozar, M.A., The influence of surface nanoroughness of electrospun PLGA nanofibrous scaffold on nerve cell adhesion and proliferation (2013) J Mater Sci Mater Med, 24, pp. 1551-1560; Weigel, S., Osterwalder, T., Tobler, U., Yao, L., Wiesli, M., Lehnert, T., Surface microstructures on planar substrates and textile fibers guide neurite outgrowth: A scaffold solution to push limits of critical nerve defect regeneration? (2012) PLoS One, 7, p. e50714; Donoghue, P.S., Lamond, R., Boomkamp, S.D., Sun, T., Gadegaard, N., Riehle, M.O., The development of a epsilon-polycaprolactone scaffold for central nervous system repair (2013) Tissue Eng Part A, 19, pp. 497-507; Beduer, A., Vieu, C., Arnauduc, F., Sol, J.C., Loubinoux, I., Vaysse, L., Engineering of adult human neural stem cells differentiation through surface micropatterning (2012) Biomaterials, 33, pp. 504-514",Article,Scopus,2-s2.0-84924041801
"Nair G., Hebrok M.","Islet formation in mice and men: Lessons for the generation of functional insulin-producing β-cells from human pluripotent stem cells",2015,"Current Opinion in Genetics and Development","32",,,"171","180",,,10.1016/j.gde.2015.03.004,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928163419&partnerID=40&md5=c4648f0d9b7383ab625caad1973ad57b","Diabetes Center, Department of Medicine, University of CaliforniaSan Francisco, CA, United States","Nair, G., Diabetes Center, Department of Medicine, University of CaliforniaSan Francisco, CA, United States; Hebrok, M., Diabetes Center, Department of Medicine, University of CaliforniaSan Francisco, CA, United States","The Islets of Langerhans are crucial 'micro-organs' embedded in the glandular exocrine pancreas that regulate nutrient metabolism. They not only synthesize, but also secrete endocrine hormones in a modulated fashion in response to physiologic metabolic demand. These highly sophisticated structures with intricate organization of multiple cell types, namely endocrine, vascular, neuronal and mesenchymal cells, have evolved to perform this task to perfection over time. Not surprisingly, islet architecture and function are dissimilar between humans and typically studied model organisms, such as rodents and zebrafish. Further, recent findings also suggest noteworthy differences in human islet development from that in mouse, including delayed appearance and gradual resolution of key differentiation markers, a single-phase of endocrine differentiation, and prenatal association of developing islets with neurovascular milieu. In light of these findings, it is imperative that a systematic study is undertaken to compare islet development between human and mouse. Illuminating inter-species differences in islet development will likely be critical in furthering our pursuit to generate an unlimited supply of truly functional and fully mature β-cells from human pluripotent stem cell (hPSC) sources for therapeutic purposes. © 2015 Elsevier Ltd.",,"Kushner, J.A., MacDonald, P.E., Atkinson, M.A., Stem cells to insulin secreting cells: two steps forward and now a time to pause? (2014) Cell Stem Cell, 15, pp. 535-536; Pagliuca, F.W., Melton, D.A., How to make a functional β-cell (2013) Development, 140, pp. 2472-2483; Hay, C.W., Docherty, K., Comparative analysis of insulin gene promoters: implications for diabetes research (2006) Diabetes, 55, pp. 3201-3213; McCulloch, L.J., van de Bunt, M., Braun, M., GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: Implications for understanding genetic association signals at this locus (2011) Mol Genet Metab, 104, pp. 648-653; De Vos, A., Heimberg, H., Quartier, E., Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression (1995) J Clin Invest, 96, pp. 2489-2495; Peschke, E., Bähr, I., Mühlbauer, E., Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon (2013) Int J Mol Sci, 14, pp. 6981-7015; McDonald, T.J., Tu, E., Brenner, S., Canine, human, and rat plasma insulin responses to galanin administration: species response differences (1994) Am J Physiol Endocrinol Metab, 266, pp. E612-E617; Fiaschi-Taesch, N., Bigatel, T.A., Sicari, B., Survey of the human pancreatic β-cell G1/S proteome reveals a potential therapeutic role for Cdk-6 and cyclin D1 in enhancing human β-cell replication and function in vivo (2009) Diabetes, 58, pp. 882-893; Steiner, D.J., Kim, A., Miller, K., Pancreatic islet plasticity: interspecies comparison of islet architecture and composition (2010) Islets, 2, pp. 135-145; Shih, H.P., Wang, A., Sander, M., Pancreas organogenesis: from lineage determination to morphogenesis (2013) Ann Rev Cell Dev Biol, 29, pp. 81-105; Hebrok, M., Hedgehog signaling in pancreas development (2003) Mech Dev, 120, pp. 45-57; Jennings, R.E., Berry, A.A., Kirkwood-Wilson, R., Development of the human pancreas from foregut to endocrine commitment (2013) Diabetes, 62, pp. 3514-3522; Shaw-Smith, C., De Franco, E., Allen, H.L., GATA4 mutations are a cause of neonatal and childhood-onset diabetes (2014) Diabetes, 63, pp. 2888-2894; Eifes, S., Chudasama, K.K., Molnes, J., A novel GATA6 mutation in a child with congenital heart malformation and neonatal diabetes (2013) Clin Case Rep, 1, pp. 86-90; Weedon, M.N., Cebola, I., Patch, A.-M., Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis (2014) Nat Genet, 46, pp. 61-64; De León, D.D.S.C., Permanent neonatal diabetes mellitus (2008) GeneReviews® [Internet], , University of Washington, Seattle, Seattle (WA), 1993-2014 [updated 23.01.14], R.A. Pagon, M.P. Adam, H.H. Ardinger (Eds.); Ye, F., Duvillié, B., Scharfmann, R., Fibroblast growth factors 7 and 10 are expressed in the human embryonic pancreatic mesenchyme and promote the proliferation of embryonic pancreatic epithelial cells (2005) Diabetologia, 48, pp. 277-281; Zhou, Q., Law, A.C., Rajagopal, J., A multipotent progenitor domain guides pancreatic organogenesis (2007) Dev Cell, 13, pp. 103-114; Schaffer, A.E., Freude, K.K., Nelson, S.B., Nkx6 transcription factors and Ptf1a function as antagonistic lineage determinants in multipotent pancreatic progenitors (2010) Dev Cell, 18, pp. 1022-1029; Kesavan, G., Sand, F.W., Greiner, T.U., Cdc42-mediated tubulogenesis controls cell specification (2009) Cell, 139, pp. 791-801; Villasenor, A., Chong, D.C., Henkemeyer, M., Epithelial dynamics of pancreatic branching morphogenesis (2010) Development (Cambridge, England), 137, pp. 4295-4305; Gradwohl, G., Dierich, A., LeMeur, M., Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas (2000) Proc Natl Acad Sci, 97, pp. 1607-1611; Rubio-Cabezas, O., Jensen, J.N., Hodgson, M.I., Permanent neonatal diabetes and enteric anendocrinosis associated with biallelic mutations in NEUROG3 (2011) Diabetes, 60, pp. 1349-1353; Villasenor, A., Chong, D.C., Cleaver, O., Biphasic Ngn3 expression in the developing pancreas (2008) Dev Dyn, 237, pp. 3270-3279; Salisbury, R.J., Blaylock, J., Berry, A.A., The window period of NEUROGENIN3 during human gestation (2014) Islets, 6, p. e954436; Afelik, S., Qu, X., Hasrouni, E., Notch-mediated patterning and cell fate allocation of pancreatic progenitor cells (2012) Development, 139, pp. 1744-1753; Shih, H.P., Kopp, J.L., Sandhu, M., A notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation (2012) Development, 139, pp. 2488-2499; Hu, H., Zhou, L., Awadallah, A., Significance of notch1-signaling pathway in human pancreatic development and carcinogenesis (2013) Appl Immunohistochem Mol Morphol, 21, pp. 242-247; Mastracci, T.L., Sussel, L., The endocrine pancreas: insights into development, differentiation, and diabetes (2012) Wiley Interdiscip Rev: Dev Biol, 1, pp. 609-628; Johansson, K.A., Dursun, U., Jordan, N., Temporal control of Neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types (2007) Dev Cell, 12, pp. 457-465; Desgraz, R., Herrera, P.L., Pancreatic neurogenin 3-expressing cells are unipotent islet precursors (2009) Development, 136, pp. 3567-3574; Mastracci, T.L., Anderson, K.R., Papizan, J.B., Regulation of Neurod1 contributes to the lineage potential of neurogenin3+ endocrine precursor cells in the pancreas (2013) PLoS Genet, 9, p. e1003278; Schwitzgebel, V.M., Scheel, D.W., Conners, J.R., Expression of neurogenin3 reveals an islet cell precursor population in the pancreas (2000) Development, 127, pp. 3533-3542; Piper, K., Brickwood, S., Turnpenny, L., Beta cell differentiation during early human pancreas development (2004) J Endocrinol, 181, pp. 11-23; Jeon, J., Correa-Medina, M., Ricordi, C., Endocrine cell clustering during human pancreas development (2009) J Histochem Cytochem, 57, pp. 811-824; Nelson, S.B., Schaffer, A.E., Sander, M., The transcription factors Nkx6.1 and Nkx6.2 possess equivalent activities in promoting beta-cell fate specification in Pdx1+ pancreatic progenitor cells (2007) Development, 134, pp. 2491-2500; McDonald, E., Li, J., Krishnamurthy, M., SOX9 regulates endocrine cell differentiation during human fetal pancreas development (2012) Int J Biochem Cell Biol, 44, pp. 72-83; Nef, S., Verma-Kurvari, S., Merenmies, J., Testis determination requires insulin receptor family function in mice (2003) Nature, 426, pp. 291-295; Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits apcmin/+tumors, and regulates Sox9 (2008) Endocrinology, 149, pp. 261-267; Bocian-Sobkowska, J., Zabel, M., Wozniak, W., Polyhormonal aspect of the endocrine cells of the human fetal pancreas (1999) Histochem Cell Biol, 112, pp. 147-153; Riedel, M.J., Asadi, A., Wang, R., Immunohistochemical characterisation of cells co-producing insulin and glucagon in the developing human pancreas (2012) Diabetologia, 55, pp. 372-381; Anderson, S.J., Seeberger, K.L., Ellis, C.E., Immunohistochemical characterization of insulin, glucagon, PDX1, SOX17 and NGN3 expression in human fetal pancreatic development (2013) J Stem Cell Res Ther, 3, p. 148; Sarkar, S.A., Kobberup, S., Wong, R., Global gene expression profiling and histochemical analysis of the developing human fetal pancreas (2008) Diabetologia, 51, pp. 285-297; Herrera, P.L., Adult insulin-and glucagon-producing cells differentiate from two independent cell lineages (2000) Development, 127, pp. 2317-2322; Cabrera, O., Berman, D.M., Kenyon, N.S., The unique cytoarchitecture of human pancreatic islets has implications for islet cell function (2006) Proc Natl Acad Sci USA, 103, pp. 2334-2339; Brissova, M., Fowler, M.J., Nicholson, W.E., Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy (2005) J Histochem Cytochem, 53, pp. 1087-1097; Orci, L., The microanatomy of the islets of Langerhans (1976) Metabolism, 25, pp. 1303-1313; Bosco, D., Armanet, M., Morel, P., Unique arrangement of α- and β-cells in human islets of langerhans (2010) Diabetes, 59, pp. 1202-1210; Kilimnik, G., Jo, J., Periwal, V., Quantification of islet size and architecture (2012) Islets, 4, pp. 167-172; Wojtusciszyn, A., Armanet, M., Morel, P., Insulin secretion from human beta cells is heterogeneous and dependent on cell-to-cell contacts (2008) Diabetologia, 51, pp. 1843-1852; Huypens, P., Ling, Z., Pipeleers, D., Glucagon receptors on human islet cells contribute to glucose competence of insulin release (2000) Diabetologia, 43, pp. 1012-1019; Robb, P., The development of the islets of langerhans in the human foetus (1961) Exp Physiol, 46, pp. 335-343; Gregg, B., Moore, P., Demozay, D., Formation of a human beta-cell population within pancreatic islets is set early in life (2012) J Clin Endocrinol Metab, 97, pp. 3197-3206; Hang, Y., Stein, R., MafA and MafB activity in pancreatic β cells (2011) Trends Endocrinol Metab, 22, pp. 364-373; Blum, B., Hrvatin, S., Schuetz, C., Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3 (2012) Nat Biotech, 30, pp. 261-264; Hang, Y., Yamamoto, T., Benninger, R.K.P., The MafA transcription factor becomes essential to islet β-cells soon after birth (2014) Diabetes, 63, pp. 1994-2005; Busiah, K., Verkarre, V., Cavé, H., Human pancreas endocrine cell populations and activating ABCC8 mutations (2014) Horm Res Paediat, 82, pp. 59-64; Polak, M., Cave, H., Neonatal diabetes mellitus: a disease linked to multiple mechanisms (2007) Orphanet J Rare Dis, 2, p. 12; Carvalho, C.P.F., Barbosa, H.C.L., Britan, A., Beta cell coupling and connexin expression change during the functional maturation of rat pancreatic islets (2010) Diabetologia, 53, pp. 1428-1437; Reinert, R.B., Cai, Q., Hong, J.-Y., Vascular endothelial growth factor coordinates islet innervation via vascular scaffolding (2014) Development, 141, pp. 1480-1491; Roost, M., van Iperen, L., de Melo Bernardo, A., Lymphangiogenesis and angiogenesis during human fetal pancreas development (2014) Vascular Cell, 6, p. 22; Rodriguez-Diaz, R., Abdulreda, M.H., Formoso, A.L., Autonomic axons in the human endocrine pancreas show unique innervation patterns (2011) Cell Metab, 14, pp. 45-54; Proshchina, A.E., Krivova, Y.S., Barabanov, V.M., Ontogeny of neuro-insular complexes and islets innervation in the human pancreas (2014) Front Endocrinol, p. 5; Borden, P., Houtz, J., Leach Steven, D., Sympathetic innervation during development is necessary for pancreatic islet architecture and functional maturation (2013) Cell Rep, 4, pp. 287-301; Hrvatin, S., O'Donnell, C.W., Deng, F., Differentiated human stem cells resemble fetal, not adult, β cells (2014) Proc Natl Acad Sci, 111, pp. 3038-3043; Pagliuca, F.W., Millman, J.R., Gürtler, M., Generation of functional human pancreatic β cells in vitro (2014) Cell, 159, pp. 428-439; Rezania, A., Bruin, J.E., Arora, P., Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells (2014) Nat Biotech, 32, pp. 1121-1133; Kuo, C.T., Morrisey, E.E., Anandappa, R., GATA4 transcription factor is required for ventral morphogenesis and heart tube formation (1997) Gene Dev, 11, pp. 1048-1060; Kanai-Azuma, M., Kanai, Y., Gad, J.M., Depletion of definitive gut endoderm in Sox17-null mutant mice (2002) Development, 129, pp. 2367-2379; Rodredguez, S., GATA believe it: new essential regulators of pancreas development (2012) J Clin Invest, 122, pp. 3469-3471",Review,Scopus,2-s2.0-84928163419
"Yea K., Xie J., Zhang H., Zhang W., Lerner R.A.","Selection of multiple agonist antibodies from intracellular combinatorial libraries reveals that cellular receptors are functionally pleiotropic",2015,"Current Opinion in Chemical Biology","26",,,"1","7",,,10.1016/j.cbpa.2015.01.002,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84921508928&partnerID=40&md5=f9cf76e4b55bca8c4d30492ba8b5732a","Department of Cell and Molecular Biology, The Scripps Research InstituteLa Jolla, CA, United States; Shanghai Institute for Advanced Immunological Studies, ShanghaiTech UniversityShanghai, China","Yea, K., Shanghai Institute for Advanced Immunological Studies, ShanghaiTech UniversityShanghai, China; Xie, J., Department of Cell and Molecular Biology, The Scripps Research InstituteLa Jolla, CA, United States; Zhang, H., Department of Cell and Molecular Biology, The Scripps Research InstituteLa Jolla, CA, United States; Zhang, W., Department of Cell and Molecular Biology, The Scripps Research InstituteLa Jolla, CA, United States; Lerner, R.A., Department of Cell and Molecular Biology, The Scripps Research InstituteLa Jolla, CA, United States","The main purpose of this perspective is to build on the unexpected outcomes of previous laboratory experiments using antibody agonists to raise questions concerning how activation of a given receptor can be involved in inducing differentiation of cells along different pathways some of which may even derive from different lineages. While not yet answered, the question illustrates how the advent of agonists not present in nature may give a different dimension to the important problem of signal transduction. Thus, if one studies a natural agonist-receptor system one can learn details about its signal transduction pathway. However, if one has a set of orthogonal agonists, one may learn about the yet undiscovered potential of the system that, in the end, may necessitate refinements to the currently used models. Thus, we wonder why receptors conventionally linked to a given pathway induce a different pattern of differentiation when agonized in another way. © 2014 Published by Elsevier Ltd.",,"Xie, J., Zhang, H., Yea, K., Lerner, R.A., Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells (2013) Proc Natl Acad Sci U S A, 110, pp. 8099-8104; Yea, K., Zhang, H., Xie, J., Jones, T.M., Yang, G., Song, B.D., Lerner, R.A., Converting stem cells to dendritic cells by agonist antibodies from unbiased morphogenic selections (2013) Proc Natl Acad Sci U S A, 110, pp. 14966-14971; Zhang, H., Yea, K., Xie, J., Ruiz, D., Wilson, I.A., Lerner, R.A., Selecting agonists from single cells infected with combinatorial antibody libraries (2013) Chem Biol, 20, pp. 734-741; Zhang, H., Wilson, I.A., Lerner, R.A., Selection of antibodies that regulate phenotype from intracellular combinatorial antibody libraries (2012) Proc Natl Acad Sci U S A, 109, pp. 15728-15733; Abbonante, V., Gruppi, C., Rubel, D., Gross, O., Moratti, R., Balduini, A., Discoidin domain receptor 1 protein is a novel modulator of megakaryocyte-collagen interactions (2013) J Biol Chem, 288, pp. 16738-16746; Hidalgo-Carcedo, C., Hooper, S., Chaudhry, S.I., Williamson, P., Harrington, K., Leitinger, B., Sahai, E., Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by ddr1 and the cell polarity regulators par3 and par6 (2011) Nat Cell Biol, 13, pp. 49-58; Masuda, T., Watanabe, K., Sakuma, C., Ikenaka, K., Ono, K., Yaginuma, H., Netrin-1 acts as a repulsive guidance cue for sensory axonal projections toward the spinal cord (2008) J Neurosci, 28, pp. 10380-10385; Serafini, T., Colamarino, S.A., Leonardo, E.D., Wang, H., Beddington, R., Skarnes, W.C., Tessier-Lavigne, M., Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system (1996) Cell, 87, pp. 1001-1014; Przyborski, S.A., Knowles, B.B., Ackerman, S.L., Embryonic phenotype of unc5h3 mutant mice suggests chemorepulsion during the formation of the rostral cerebellar boundary (1998) Development, 125, pp. 41-50; Ackerman, S.L., Kozak, L.P., Przyborski, S.A., Rund, L.A., Boyer, B.B., Knowles, B.B., The mouse rostral cerebellar malformation gene encodes an unc-5-like protein (1997) Nature, 386, pp. 838-842; Theilgaard-Monch, K., Raaschou-Jensen, K., Schjodt, K., Heilmann, C., Vindelov, L., Jacobsen, N., Dickmeiss, E., Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts (2003) Bone Marrow Transpl, 32, pp. 1125-1133; Bar-Shavit, Z., The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell (2007) J Cell Biochem, 102, pp. 1130-1139; Kogawa, M., Hisatake, K., Atkins, G.J., Findlay, D.M., Enoki, Y., Sato, T., Gray, P.C., Kato, N., The paired-box homeodomain transcription factor pax6 binds to the upstream region of the trap gene promoter and suppresses receptor activator of nf-kappab ligand (rankl)-induced osteoclast differentiation (2013) J Biol Chem, 288, pp. 31299-31312; Okabe, S., Hirokawa, N., Actin dynamics in growth cones (1991) J Neurosci, 11, pp. 1918-1929; Letourneau, P.C., Differences in the organization of actin in the growth cones compared with the neurites of cultured neurons from chick embryos (1983) J Cell Biol, 97, pp. 963-973; Goedert, M., Crowther, R.A., Garner, C.C., Molecular characterization of microtubule-associated proteins tau and map2 (1991) Trends Neurosci, 14, pp. 193-199; Nunez, J., Immature and mature variants of map2 and tau proteins and neuronal plasticity (1988) Trends Neurosci, 11, pp. 477-479; Chao, H.T., Chen, H., Samaco, R.C., Xue, M., Chahrour, M., Yoo, J., Neul, J.L., Ekker, M., Dysfunction in gaba signalling mediates autism-like stereotypies and Rett syndrome phenotypes (2010) Nature, 468, pp. 263-269; White, R.B., Thomas, M.G., Moving beyond tyrosine hydroxylase to define dopaminergic neurons for use in cell replacement therapies for Parkinson's disease (2012) CNS Neurol Disord Drug Targets, 11, pp. 340-349",Article,Scopus,2-s2.0-84921508928
"Kim S.H., Kim S.H., Jung Y.","TGF-β3 encapsulated PLCL scaffold by a supercritical CO2-HFIP co-solvent system for cartilage tissue engineering",2015,"Journal of Controlled Release","206",,,"101","107",,,10.1016/j.jconrel.2015.03.026,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925762593&partnerID=40&md5=ef4e75dacbbcf7d9893f1b3e673e9d82","Center for Biomaterials, Biomedical Research Institute, Korea Institute of Science and Technology, P.O. Box 131Cheongryang, Seoul, South Korea; NBIT, KU-KIST Graduate School of Converging Science and Technology, Korea University, 145, Anam-roSeongbuk-gu, Seoul, South Korea; Korea University of Science and Technology, 113 GwahangnoYuseong-gu, Daejeon, South Korea","Kim, S.H., Center for Biomaterials, Biomedical Research Institute, Korea Institute of Science and Technology, P.O. Box 131Cheongryang, Seoul, South Korea, NBIT, KU-KIST Graduate School of Converging Science and Technology, Korea University, 145, Anam-roSeongbuk-gu, Seoul, South Korea; Kim, S.H., Center for Biomaterials, Biomedical Research Institute, Korea Institute of Science and Technology, P.O. Box 131Cheongryang, Seoul, South Korea, NBIT, KU-KIST Graduate School of Converging Science and Technology, Korea University, 145, Anam-roSeongbuk-gu, Seoul, South Korea, Korea University of Science and Technology, 113 GwahangnoYuseong-gu, Daejeon, South Korea; Jung, Y., Center for Biomaterials, Biomedical Research Institute, Korea Institute of Science and Technology, P.O. Box 131Cheongryang, Seoul, South Korea, Korea University of Science and Technology, 113 GwahangnoYuseong-gu, Daejeon, South Korea","Mimicking the native tissue microenvironment is critical for effective tissue regeneration. Mechanical cues and sustained biological cues are important factors, particularly in load-bearing tissues such as articular cartilage or bone. Carriers including hydrogels and nanoparticles have been investigated to achieve sustained release of protein drugs. However, it is difficult to apply such carriers alone as scaffolds for cartilage regeneration because of their weak mechanical properties, and they must be combined with other biomaterials that have adequate mechanical strength. In this study, we developed the multifunctional scaffold which has similar mechanical properties to those of native cartilage and encapsulates TGF-β3 for chondrogenesis. In our previous work, we confirmed that poly(lactide-co-caprolacton) (PLCL) did not foam when exposed to supercritical CO2 below 45 °C. Here, we used a supercritical carbon dioxide (scCO2)-1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) co-solvent system to facilitate processing under mild conditions because high temperature causes protein denaturation and decreases bioactivity of the protein. This processing made it possible to fabricate a TGF-β3 encapsulated elastic porous PLCL scaffold at 37 °C. We investigated the tissue regeneration efficiency of the TGF-β3 encapsulated PLCL scaffold using human adipose-derived stem cells (ADSCs) in vitro and in vivo (Groups; i. PLCL scaffold + Fibrin gel + TGF-β3, ii. TGF-β3 encapsulated PLCL scaffold + Fibrin gel, iii. TGF-β3 encapsulated PLCL scaffold). We evaluated the chondrogenic abilities of the scaffolds at 4, 8, and 12 weeks after subcutaneous implantation of the constructs in immune-deficient mice. Based on TGF-β3 release studies, we confirmed that TGF-β3 molecules were released by 8 weeks and remained in the PLCL matrix. Explants of TGF-β3 encapsulated scaffolds by a co-solvent system exhibited distinct improvement in the compressive E-modulus and deposition of extracellular matrix. Furthermore, long-term delivery of TGF-β3 formed a hyaline cartilage-specific lacunae structure and prevented the hypertrophy of differentiated chondrocytes. TGF-β3 encapsulated PLCL scaffolds would be useful as functional scaffolds for cartilage tissue engineering. © 2015 Elsevier B.V. All rights reserved.","Cartilage regeneration; Mechano-active scaffold; PLCL; Supercritical carbon dioxide foaming; TGF-β3","Ghezzi, C.E., Marelli, B., Donelli, I., Alessandrino, A., Freddi, G., Nazhat, S.N., The role of physiological mechanical cues on mesenchymal stem cell differentiation in an airway tract-like dense collagen-silk fibroin construct (2014) Biomaterials, 35, pp. 6236-6247; Juhasz, T., Matta, C., Somogyi, C., Katona, E., Takacs, R., Soha, R.F., Mechanical loading stimulates chondrogenesis via the PKA/CREB-Sox9 and PP2A pathways in chicken micromass cultures (2014) Cell. Signal., 26, pp. 468-482; Kelly, D.J., Prendergast, P.J., Mechano-regulation of stem cell differentiation and tissue regeneration in osteochondral defects (2005) J. Biomech., 38, pp. 1413-1422; Wu, W., Allen, R.A., Wang, Y., Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery (2009) Nat. Med., 18, pp. 1148-1153; Jung, Y., Park, M.S., Lee, J.W., Kim, Y.H., Kim, S.H., Cartilage regeneration with highly-elastic three-dimensional scaffolds prepared from biodegradable poly(l-lactide-co-epsilon-caprolactone) (2008) Biomaterials, 29, pp. 4630-4636; Re'Em, T., Kaminer-Israeli, Y., Ruvinov, E., Cohen, S., Chondrogenesis of hMSC in affinity-bound TGF-beta scaffolds (2012) Biomaterials, 33, pp. 751-761; Merceron, C., Portron, S., Vignes-Colombeix, C., Rederstorff, E., Masson, M., Lesoeur, J., Pharmacological modulation of human mesenchymal stem cell chondrogenesis by a chemically oversulfated polysaccharide of marine origin: Potential application to cartilage regenerative medicine (2012) Stem Cells, 30, pp. 471-480; Davies, O.R., Lewis, A.L., Whitaker, M.J., Tai, H., Shakesheff, K.M., Howdle, S.M., Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering (2008) Adv. Drug Deliv. Rev., 60, pp. 373-387; Barry, J.J., Silva, M.M., Popov, V.K., Shakesheff, K.M., Howdle, S.M., Supercritical carbon dioxide: Putting the fizz into biomaterials (2006) Philos. Transact. A Math. Phys. Eng. Sci., 364, pp. 249-261; Hile, D.D., Amirpour, M.L., Akgerman, A., Pishko, M.V., Active growth factor delivery from poly(d,l-lactide-co-glycolide) foams prepared in supercritical CO(2) (2000) J. Control. Release, 66, pp. 177-185; Kanczler, J.M., Ginty, P.J., Barry, J.J., Clarke, N.M., Howdle, S.M., Shakesheff, K.M., The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation (2008) Biomaterials, 29, pp. 1892-1900; Kim, S.H., Jung, Y., Kim, S.H., A biocompatible tissue scaffold produced by supercritical fluid processing for cartilage tissue engineering (2013) Tissue Eng. Part C Methods, 19, pp. 181-188; Jeong, S.I., Kim, B.S., Kang, S.W., Kwon, J.H., Lee, Y.M., Kim, S.H., In vivo biocompatibilty and degradation behavior of elastic poly(L-lactide-co-epsilon-caprolactone) scaffolds (2004) Biomaterials, 25, pp. 5939-5946; Jung, Y., Chung, Y.I., Kim, S.H., Tae, G., Kim, Y.H., Rhie, J.W., In situ chondrogenic differentiation of human adipose tissue-derived stem cells in a TGF-beta1 loaded fibrin-poly(lactide-caprolactone) nanoparticulate complex (2009) Biomaterials, 30, pp. 4657-4664; Tai, H., Mather, M.L., Howard, D., Wang, W., White, L.J., Crowe, J.A., Control of pore size and structure of tissue engineering scaffolds produced by supercritical fluid processing (2007) Eur. Cell. Mater., 14, pp. 64-77; Frolov, A.I., Kiselev, M.G., Prediction of cosolvent effect on solvation free energies and solubilities of organic compounds in supercritical carbon dioxide based on fully atomistic molecular simulations (2014) J. Phys. Chem. B, 118, pp. 11769-11780; Domingo, C., Vega, A., Fanovich, M.A., Elvira, C., Subra, P., Behavior of poly (methyl methacrylate)-based systems in supercritical CO2 and CO2 plus cosolvent: Solubility measurements and process assessment (2003) J. Appl. Polym. Sci., 90, pp. 3652-3659; Argemi, A., Vega, A., Subra-Paternault, P., Saurina, J., Characterization of azacytidine/poly(L-lactic) acid particles prepared by supercritical antisolvent precipitation (2009) J. Pharm. Biomed. Anal., 50, pp. 847-852; Argemi, A., Vega, A., Subra-Paternault, P., Saurina, J., Characterization of azacytidine/poly(L-lactic) acid particles prepared by supercritical antisolvent precipitation (2009) J. Pharm. Biomed. Anal., 50, pp. 847-852; Cai, J.Y., Huang, D.C., Wang, Z.X., Dang, B.L., Wang, Q.L., Su, X.G., Preparation of ibuprofen/EC-PVP sustained-release composite particles by supercritical CO2 anti-solvent technology (2012) Yao Xue Xue Bao, 47, pp. 791-796; Lu, L., Peter, S.J., Lyman, M.D., Lai, H.L., Leite, S.M., Tamada, J.A., In vitro and in vivo degradation of porous poly(dl-lactic-co-glycolic acid) foams (2000) Biomaterials, 21, pp. 1837-1845; Park, J.S., Yang, H.J., Woo, D.G., Yang, H.N., Na, K., Park, K.H., Chondrogenic differentiation of mesenchymal stem cells embedded in a scaffold by long-term release of TGF-beta 3 complexed with chondroitin sulfate (2010) J. Biomed. Mater. Res. A, 92, pp. 806-816; Bian, L., Zhai, D.Y., Tous, E., Rai, R., Mauck, R.L., Burdick, J.A., Enhanced MSC chondrogenesis following delivery of TGF-beta3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo (2011) Biomaterials, 32, pp. 6425-6434; Kim, M., Erickson, I.E., Choudhury, M., Pleshko, N., Mauck, R.L., Transient exposure to TGF-beta3 improves the functional chondrogenesis of MSC-laden hyaluronic acid hydrogels (2012) J. Mech. Behav. Biomed. Mater., 11, pp. 92-101; Jurvelin, J.S., Buschmann, M.D., Hunziker, E.B., Mechanical anisotropy of the human knee articular cartilage in compression, Proceedings of the Institution of Mechanical Engineers Part H (2003) J. Eng. Med., 217, pp. 215-219; Mueller, M.B., Fischer, M., Zellner, J., Berner, A., Dienstknecht, T., Prantl, L., Hypertrophy in mesenchymal stem cell chondrogenesis: Effect of TGF-beta isoforms and chondrogenic conditioning (2010) Cells Tissues Organs, 192, pp. 158-166",Article,Scopus,2-s2.0-84925762593
"Bostad M., Olsen C.E., Peng Q., Berg K., Hogset A., Selbo P.K.","Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy",2015,"Journal of Controlled Release","206",,,"37","48",,,10.1016/j.jconrel.2015.03.008,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924940611&partnerID=40&md5=9062aa86dc5d5e699b147d6f24ad066b","Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Postboks 4953Nydalen, Oslo, Norway; Cancer Stem Cell Innovation Center (SFI-CAST), Institute for Cancer Research, Norwegian Radium HospitalOslo, Norway; Department of Pathology, Norwegian Radium Hospital, Oslo University HospitalOslo, Norway; PCI Biotech ASLysaker, Norway","Bostad, M., Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Postboks 4953Nydalen, Oslo, Norway, Cancer Stem Cell Innovation Center (SFI-CAST), Institute for Cancer Research, Norwegian Radium HospitalOslo, Norway; Olsen, C.E., Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Postboks 4953Nydalen, Oslo, Norway, Cancer Stem Cell Innovation Center (SFI-CAST), Institute for Cancer Research, Norwegian Radium HospitalOslo, Norway; Peng, Q., Department of Pathology, Norwegian Radium Hospital, Oslo University HospitalOslo, Norway; Berg, K., Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Postboks 4953Nydalen, Oslo, Norway; Høgset, A., Cancer Stem Cell Innovation Center (SFI-CAST), Institute for Cancer Research, Norwegian Radium HospitalOslo, Norway, PCI Biotech ASLysaker, Norway; Selbo, P.K., Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Postboks 4953Nydalen, Oslo, Norway, Cancer Stem Cell Innovation Center (SFI-CAST), Institute for Cancer Research, Norwegian Radium HospitalOslo, Norway","The cancer stem cell (CSC) marker CD133 is an attractive target to improve antitumor therapy. We have used photochemical internalization (PCI) for the endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin (PCIAC133-saporin). PCI employs an endocytic vesicle-localizing photosensitizer, which generates reactive oxygen species upon light-activation causing a rupture of the vesicle membranes and endosomal escape of entrapped drugs. Here we show that AC133-saporin co-localizes with the PCI-photosensitizer TPCS2a, which upon light exposure induces cytosolic release of AC133-saporin. PCI of picomolar levels of AC133-saporin in colorectal adenocarcinoma WiDr cells blocked cell proliferation and induced 100% inhibition of cell viability and colony forming ability at the highest light doses, whereas no cytotoxicity was obtained in the absence of light. Efficient PCI-based CD133-targeting was in addition demonstrated in the stem-cell-like, triple negative breast cancer cell line MDA-MB-231 and in the aggressive malignant melanoma cell line FEMX-1, whereas no enhanced targeting was obtained in the CD133-negative breast cancer cell line MCF-7. PCIAC133-saporin induced mainly necrosis and a minimal apoptotic response based on assessing cleavage of caspase-3 and PARP, and the TUNEL assay. PCIAC133-saporin resulted in S phase arrest and reduced LC3-II conversion compared to control treatments. Notably, co-treatment with Bafilomycin A1 and PCIAC133-saporin blocked LC3-II conversion, indicating a termination of the autophagic flux in WiDr cells. For the first time, we demonstrate laser-controlled targeting of CD133 in vivo. After only one systemic injection of AC133-saporin and TPCS2a, a strong anti-tumor response was observed after PCIAC133-saporin. The present PCI-based endosomal escape technology represents a minimally invasive strategy for spatio-temporal, light-controlled targeting of CD133 + cells in localized primary tumors or metastasis. © 2015 Elsevier B.V.","Autophagy; Cancer stem cells; Cancer therapy; CD133; Controlled drug delivery; Endosomal escape; Immunotoxin; Photochemical internalization; Photodynamic therapy; Targeting","Reya, T., Morrison, S.J., Clarke, M.F., Weissman, I.L., Stem cells, cancer, and cancer stem cells (2001) Nature, 414, pp. 105-111; O'Brien, C.A., Pollett, A., Gallinger, S., Dick, J.E., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice (2007) Nature, 445, pp. 106-110; Ricci-Vitiani, L., Lombardi, D.G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., De, M.R., Identification and expansion of human colon-cancer-initiating cells (2007) Nature, 445, pp. 111-115; Todaro, M., Alea, M.P., Di Stefano, A.B., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Stassi, G., Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4 (2007) Cell Stem Cell, 1, pp. 389-402; Liu, T.J., Sun, B.C., Zhao, X.L., Zhao, X.M., Sun, T., Gu, Q., Yao, Z., Liu, N., CD133 + cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer (2013) Oncogene, 32, pp. 544-553; Swaminathan, S.K., Roger, E., Toti, U., Niu, L., Ohlfest, J.R., Panyam, J., CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer (2013) J. Control. Release, 171, pp. 280-287; Rappa, G., Fodstad, O., Lorico, A., The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma (2008) Stem Cells, 26, pp. 3008-3017; Hermann, P.C., Huber, S.L., Herrler, T., Aicher, A., Ellwart, J.W., Guba, M., Bruns, C.J., Heeschen, C., Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer (2007) Cell Stem Cell, 1, pp. 313-323; Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Dirks, P.B., Identification of human brain tumour initiating cells (2004) Nature, 432, pp. 396-401; Bao, S., Wu, Q., McLendon, R.E., Hao, Y., Shi, Q., Hjelmeland, A.B., Dewhirst, M.W., Rich, J.N., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response (2006) Nature, 444, pp. 756-760; Curley, M.D., Therrien, V.A., Cummings, C.L., Sergent, P.A., Koulouris, C.R., Friel, A.M., Roberts, D.J., Foster, R., CD133 expression defines a tumor initiating cell population in primary human ovarian cancer (2009) Stem Cells, 27, pp. 2875-2883; Skubitz, A.P., Taras, E.P., Boylan, K.L., Waldron, N.N., Oh, S., Panoskaltsis-Mortari, A., Vallera, D.A., Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression (2013) Gynecol. Oncol., 130, pp. 579-587; Galizia, G., Gemei, M., Del, V.L., Zamboli, A., Di, N.R., Mirabelli, P., Salvatore, F., Lieto, E., Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer (2012) Arch. Surg., 147, pp. 18-24; Horst, D., Kriegl, L., Engel, J., Kirchner, T., Jung, A., CD133 expression is an independent prognostic marker for low survival in colorectal cancer (2008) Br. J. Cancer, 99, pp. 1285-1289; Kojima, M., Ishii, G., Atsumi, N., Fujii, S., Saito, N., Ochiai, A., Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study (2008) Cancer Sci., 99, pp. 1578-1583; Aomatsu, N., Yashiro, M., Kashiwagi, S., Takashima, T., Ishikawa, T., Ohsawa, M., Wakasa, K., Hirakawa, K., CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer (2012) PLoS One, 7, p. e45865; Lomonaco, S.L., Finniss, S., Xiang, C., Decarvalho, A., Umansky, F., Kalkanis, S.N., Mikkelsen, T., Brodie, C., The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells (2009) Int. J. Cancer, 125, pp. 717-722; Wei, M.F., Chen, M.W., Chen, K.C., Lou, P.J., Lin, S.Y., Hung, S.C., Hsiao, M., Shieh, M.J., Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cells (2014) Autophagy, 10, pp. 1179-1192; Yin, A.H., Miraglia, S., Zanjani, E.D., Almeida-Porada, G., Ogawa, M., Leary, A.G., Olweus, J., Buck, D.W., AC133, a novel marker for human hematopoietic stem and progenitor cells (1997) Blood, 90, pp. 5002-5012; Bostad, M., Berg, K., Hogset, A., Skarpen, E., Stenmark, H., Selbo, P.K., Photochemical internalization (PCI) of immunotoxins targeting CD133 is specific and highly potent at femtomolar levels in cells with cancer stem cell properties (2013) J. Control. Release, 168, pp. 317-326; Bostad, M., Kausberg, M., Weyergang, A., Olsen, C.E., Berg, K., Hogset, A., Selbo, P.K., Light-triggered, efficient cytosolic release of IM7-saporin targeting the putative cancer stem cell marker CD44 by photochemical internalization (2014) Mol. Pharm., 11, pp. 2764-2776; Lund, K., Bostad, M., Skarpen, E., Braunagel, M., Kiprijanov, S., Krauss, S., Duncan, A., Selbo, P.K., The novel EpCAM-targeting monoclonal antibody 3-17I linked to saporin is highly cytotoxic after photochemical internalization in breast, pancreas and colon cancer cell lines (2014) MAbs, 6, pp. 1038-1050; Selbo, P.K., Weyergang, A., Høgset, A., Norum, O.J., Berstad, M.B., Vikdal, M., Berg, K., Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules (2010) J. Control. Release, 148, pp. 2-12; Stratford, E.W., Bostad, M., Castro, R., Skarpen, E., Berg, K., Hogset, A., Myklebost, O., Selbo, P.K., Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity (2013) Biochim. Biophys. Acta, 1830, pp. 4235-4243; Berg, K., Folini, M., Prasmickaite, L., Selbo, P.K., Bonsted, A., Engesaeter, B.O., Zaffaroni, N., Hogset, A., Photochemical internalization: A new tool for drug delivery (2007) Curr. Pharm. Biotechnol., 8, pp. 362-372; Berg, K., Weyergang, A., Prasmickaite, L., Bonsted, A., Hogset, A., Strand, M.T., Wagner, E., Selbo, P.K., Photochemical internalization (PCI): A technology for drug delivery (2010) Methods Mol. Biol., 635, pp. 133-145; (2013) An Open-label, Single Arm, Multi-centre, Phase II Study to Evaluate the Safety and Efficacy of PC-A11 with Superficial and Interstitial Laser Light Application in Patients with Recurrent Head and Neck Squamous Cell Carcinoma Unsuitable for Surgery and Radiotherapy, , http://ClinicalTrials.govIdentifier:NCT01606566; (2013) A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients with Cholangiocarcinomas, , http://ClinicalTrials.govIdentifier:NCT01900158; Weyergang, A., Selbo, P.K., Berstad, M.E., Bostad, M., Berg, K., Photochemical internalization of tumor-targeted protein toxins (2011) Lasers Surg. Med., 43, pp. 721-733; Selbo, P.K., Rosenblum, M.G., Cheung, L.H., Zhang, W., Berg, K., Multi-modality therapeutics with potent anti-tumor effects: Photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel (2009) PLoS One, 4, p. e6691; Yip, W.L., Weyergang, A., Berg, K., Tonnesen, H.H., Selbo, P.K., Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells (2007) Mol. Pharm., 4, pp. 241-251; Selbo, P.K., Sivam, G., Fodstad, O., Sandvig, K., Berg, K., Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31-gelonin (2000) Int. J. Cancer, 87, pp. 853-859; Berstad, M.B., Cheung, L.H., Berg, K., Peng, Q., Fremstedal, A., Patzke, S., Weyergang, A., Design of an EGFR-targeting toxin for photochemical delivery; In vitro and in vivo selectivity and efficacy (2015) Oncogene; Woodhams, J., Lou, P.J., Selbo, P.K., Mosse, A., Oukrif, D., Macrobert, A., Novelli, M., Bown, S.G., Intracellular re-localisation by photochemical internalisation enhances the cytotoxic effect of gelonin - Quantitative studies in normal rat liver (2010) J. Control. Release, 142, pp. 347-353; Stirpe, F., Ribosome-inactivating proteins (2004) Toxicon, 44, pp. 371-383; Polito, L., Bortolotti, M., Mercatelli, D., Battelli, M.G., Bolognesi, A., Saporin-S6: A useful tool in cancer therapy (2013) Toxins (Basel), 5, pp. 1698-1722; Yamaizumi, M., Mekada, E., Uchida, T., Okada, Y., One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell (1978) Cell, 15, pp. 245-250; Selbo, P.K., Weyergang, A., Bonsted, A., Bown, S.G., Berg, K., Photochemical internalization of therapeutic macromolecular agents: A novel strategy to kill multidrug-resistant cancer cells (2006) J. Pharmacol. Exp. Ther., 319, pp. 604-612; Selbo, P.K., Sivam, G., Fodstad, O., Sandvig, K., Berg, K., In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy (2001) Int. J. Cancer, 92, pp. 761-766; Dittfeld, C., Dietrich, A., Peickert, S., Hering, S., Baumann, M., Grade, M., Ried, T., Kunz-Schughart, L.A., CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116 (2009) Radiother. Oncol., 92, pp. 353-361; Noodt, B.B., Berg, K., Stokke, T., Peng, Q., Nesland, J.M., Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light (1999) Br. J. Cancer, 79, pp. 72-81; Reiners, Jr.J.J., Agostinis, P., Berg, K., Oleinick, N.L., Kessel, D., Assessing autophagy in the context of photodynamic therapy (2010) Autophagy, 6, pp. 7-18; Noodt, B.B., Berg, K., Stokke, T., Peng, Q., Nesland, J.M., Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX (1996) Br. J. Cancer, 74, pp. 22-29; Oleinick, N.L., Morris, R.L., Belichenko, I., The role of apoptosis in response to photodynamic therapy: What, where, why, and how (2002) Photochem. Photobiol. Sci., 1, pp. 1-21; Agostinis, P., Berg, K., Cengel, K.A., Foster, T.H., Girotti, A.W., Gollnick, S.O., Hahn, S.M., Golab, J., Photodynamic therapy of cancer: An update (2011) CA Cancer J. Clin., 61, pp. 250-281; Berg, K., Moan, J., Photodynamic effects of Photofrin II on cell division in human NHIK 3025 cells (1988) Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 53, pp. 797-811; Berg, K., Moan, J., Bommer, J.C., Winkelman, J.W., Cellular inhibition of microtubule assembly by photoactivated sulphonated meso-tetraphenylporphines (1990) Int. J. Radiat. Biol., 58, pp. 475-487; Dewaele, M., Martinet, W., Rubio, N., Verfaillie, T., De Witte, P.A., Piette, J., Agostinis, P., Autophagy pathways activated in response to PDT contribute to cell resistance against ROS damage (2011) J. Cell. Mol. Med., 15, pp. 1402-1414; Chen, H., Luo, Z., Dong, L., Tan, Y., Yang, J., Feng, G., Wu, M., Wang, H., CD133/prominin-1-mediated autophagy and glucose uptake beneficial for hepatoma cell survival (2013) PLoS One, 8, p. e56878; Waldron, N.N., Kaufman, D.S., Oh, S., Inde, Z., Hexum, M.K., Ohlfest, J.R., Vallera, D.A., Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer (2011) Mol. Cancer Ther., 10, pp. 1829-1838; Hogset, A., Prasmickaite, L., Selbo, P.K., Hellum, M., Engesaeter, B.O., Bonsted, A., Berg, K., Photochemical internalisation in drug and gene delivery (2004) Adv. Drug Deliv. Rev., 56, pp. 95-115; Selbo, P.K., Weyergang, A., Eng, M.S., Bostad, M., Maelandsmo, G.M., Hogset, A., Berg, K., Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug (2012) J. Control. Release, 159, pp. 197-203; Irollo, E., Pirozzi, G., CD133: To be or not to be, is this the real question? (2013) Am. J. Transl. Res., 5, pp. 563-581; Swaminathan, S.K., Olin, M.R., Forster, C.L., Cruz, K.S., Panyam, J., Ohlfest, J.R., Identification of a novel monoclonal antibody recognizing CD133 (2010) J. Immunol. Methods, 361, pp. 110-115; Kemper, K., Sprick, M.R., De Bree, M., Scopelliti, A., Vermeulen, L., Hoek, M., Zeilstra, J., Medema, J.P., The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation (2010) Cancer Res., 70, pp. 719-729; Mak, A.B., Nixon, A.M., Kittanakom, S., Stewart, J.M., Chen, G.I., Curak, J., Gingras, A.C., Moffat, J., Regulation of CD133 by HDAC6 promotes beta-catenin signaling to suppress cancer cell differentiation (2012) Cell Rep., 2, pp. 951-963; Norum, O.J., Gaustad, J.V., Angell-Petersen, E., Rofstad, E.K., Peng, Q., Giercksky, K.E., Berg, K., Photochemical internalization of bleomycin is superior to photodynamic therapy due to the therapeutic effect in the tumor periphery (2009) Photochem. Photobiol., 85, pp. 740-749",Article,Scopus,2-s2.0-84924940611
"Lei Q., Chen J., Huang W., Wu D., Lin H., Lai Y.","Proteomic analysis of the effect of extracellular calcium ions on human mesenchymal stem cells: Implications for bone tissue engineering",2015,"Chemico-Biological Interactions","233",,,"139","146",,,10.1016/j.cbi.2015.03.021,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927555749&partnerID=40&md5=31766e5ebd367ecc43ebc41d2fa67a6a","Department of Oral Implantology, Affiliated Stomatological Hospital of Fujian Medical UniversityFuzhou, Fujian, China; Department of Stomatology, Affiliated Provincial Governmental Hospital of Fujian Health CollegeFuzhou, Fujian, China; Department of Stomatology, Xiamen Medical CollegeXiamen, Fujian, China","Lei, Q., Department of Oral Implantology, Affiliated Stomatological Hospital of Fujian Medical UniversityFuzhou, Fujian, China; Chen, J., Department of Oral Implantology, Affiliated Stomatological Hospital of Fujian Medical UniversityFuzhou, Fujian, China; Huang, W., Department of Oral Implantology, Affiliated Stomatological Hospital of Fujian Medical UniversityFuzhou, Fujian, China; Wu, D., Department of Oral Implantology, Affiliated Stomatological Hospital of Fujian Medical UniversityFuzhou, Fujian, China; Lin, H., Department of Stomatology, Affiliated Provincial Governmental Hospital of Fujian Health CollegeFuzhou, Fujian, China; Lai, Y., Department of Stomatology, Xiamen Medical CollegeXiamen, Fujian, China","Human mesenchymal stem cells-bone marrow (BM-hMSCs) are considered as the most suitable seed cells for bone tissue engineering. Calcium ions (Ca2+) forms an important component of a number of commercial bone substitutes and support materials. For efficient bone tissue engineering, it is crucial to explore the effect of extracellular Ca2+ on the growth and differentiation of BM-hMSCs, and to understand their molecular mechanisms. Therefore, in the present study, BM-hMSCs were cultivated in serum free growth medium or serum free growth medium with additional 4 or 6 mM Ca2+ for 3 weeks, following which, the proliferation and osteoblastic differentiation of these cells were evaluated. Differentially expressed proteins were established using iTRAQ labeling coupled with nano-LC-MS/MS. Our data revealed that Ca2+ significantly promoted the proliferation of BM-hMSCs in the early stage. Furthermore, Ca2+ showed osteoinduction properties. MAPKs signaling pathway might participate in the osteogenic differentiation of BM-hMSCs caused by Ca2+. Certain newly found proteins could be potentially important for the osteogenic differentiation of BM-hMSCs and may be associated with osteogenesis. © 2015 Elsevier Ireland Ltd. All rights reserved.","Ca2+; iTRAQ; MSC; Osteogenic differentiation; Proteomics","Braghirolli, D.I., Zamboni, F., Chagastelles, P.C., Moura, D.J., Saffi, J., Henriques, J.A., Pilger, D.A., Pranke, P., Bio-electrospraying of human mesenchymal stem cells: An alternative for tissue engineering (2013) Biomicrofluidics, 7 (4), p. 44130; Im, J.Y., Min, W.K., You, C., Kim, H.O., Jin, H.K., Bae, J.S., Bone regeneration of mouse critical-sized calvarial defects with human mesenchymal stem cells in scaffold (2013) Lab. Anim. Res., 29 (4), pp. 196-203; Jung, S., Panchalingam, K.M., Wuerth, R.D., Rosenberg, L., Behie, L.A., Large-scale production of human mesenchymal stem cells for clinical applications (2012) Biotechnol. Appl. Biochem., 59 (2), pp. 106-120; Zomorodian, E., Baghaban Eslaminejad, M., Mesenchymal stem cells as a potent cell source for bone regeneration (2012) Stem Cells Int., 2012, p. 980353; Zhang, J., Luo, X., Barbieri, D., Barradas, A.M., De Bruijn, J.D., Van Blitterswijk, C.A., Yuan, H., The size of surface microstructures as an osteogenic factor in calcium phosphate ceramics (2014) Acta Biomater., 10 (7), pp. 3254-3263; Barradas, A.M., Monticone, V., Hulsman, M., Danoux, C., Femandes, H., Tahmasebi Birgani, Z., Barrere-De Groot, F., De Boer, J., Molecular mechanisms of biomaterial-driven osteogenic differentiation in human mesenchymal stromal cells (2013) Integr. Biol. (Camb.), 5 (7), pp. 920-931; Barradas, A.M., Femandes, H.A., Groen, N., Chai, Y.C., Schrooten, J., Van De Peppel, J., Van Leeuwen, J.P., De Boer, J., A calcium-induced signaling cascade leading to osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells (2012) Biomaterials, 33 (11), pp. 3205-3215; Martino, N.A., Reshkin, S.J., Ciani, E., Dell'Aquila, M.E., Calcium-sensing receptor-mediated osteogenic and early-stage neurogenic differentiation in umbilical cord matrix mesenchymal stem cells from a large animal model (2014) PLoS ONE, 9 (11), p. e111533; Nakamura, S., Matsumoto, T., Sasaki, J., Egusa, H., Lee, K.Y., Nakano, T., Sohmura, T., Nakahira, A., Effect of calcium ion concentrations on osteogenic differentiation and hematopoietic stem cell niche-related protein expression in osteoblasts (2010) Tissue Eng. Part A, 16 (8), pp. 2467-2473; Zieske, L.R., A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies (2006) J. Exp. Bot., 57 (7), pp. 1501-1508; Evans, C., Noirel, J., Ow, S.Y., Salim, M., Pereira-Medrano, A.G., Couto, N., Pandhal, J., Wright, P.C., An insight into iTRAQ: Where do we stand now? (2012) Anal. Bioanal. Chem., 404 (4), pp. 1011-1027; Solmesky, L., Lefler, S., Jacob-Hirsch, J., Bulvik, S., Rechavi, G., Weil, M., Serum free cultured bone marrow mesenchymal stem cells as a platform to characterize the effects of specific molecules (2010) PLoS ONE, 5 (9); Choudhary, S., Kumar, A., Kale, R.K., Raisz, L.G., Pilbeam, C.C., Extracellular calcium induces COX-2 in osteoblasts via a PKA pathway (2004) Biochem. Biophys. Res. Commun., 322 (2), pp. 395-402; Dvorak, M.M., Riccardi, D., Ca2+ as an extracellular signal in bone (2004) Cell Calcium, 35 (3), pp. 249-255; Dvorak, M.M., Siddiqua, A., Ward, D.T., Carter, D.H., Dallas, S.L., Nemeth, E.F., Riccardi, D., Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones (2004) Proc. Natl. Acad. Sci. U.S.A., 101 (14), pp. 5140-5145; Siddappa, R., Mulder, W., Steeghs, I., Van De Klundert, C., Fernandes, H., Liu, J., Arends, R., De Boer, J., CAMP/PKA signaling inhibits osteogenic differentiation and bone formation in rodent models (2009) Tissue Eng. Part A, 15 (8), pp. 2135-2143; Zhao, H., Liang, X., Zhong, H., Zhang, C.J., He, F., Involvement of store-operated calcium channels and receptor-operated calcium channels in Ca(2+)-sensing receptor-evoked extracellular Ca(2+) influx and NO generation in human umbilical vein endothelial cells (2013) Sheng Li Xue Bao, 65 (5), pp. 553-561; Davis, F.M., Parsonage, M.T., Cabot, P.J., Parat, M.O., Thompson, E.W., Roberts-Thomson, S.J., Monteith, G.R., Assessment of gene expression of intracellular calcium channels, pumps and exchangers with epidermal growth factor-induced epithelial-mesenchymal transition in a breast cancer cell line (2013) Cancer Cell Int., 13 (1), p. 76; Di Tomo, P., Pipino, C., Lanuti, P., Morabito, C., Pierdomenico, L., Sirolli, V., Bonomini, M., Pandolfi, A., Calcium sensing receptor expression in ovine amniotic fluid mesenchymal stem cells and the potential role of R-568 during osteogenic differentiation (2013) PLoS ONE, 8 (9), p. e73816; Ben Azouna, N., Jenhani, F., Regaya, Z., Berraeis, L., Ben Othman, T., Ducrocq, E., Domenech, J., Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: Comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum (2012) Stem Cell Res. Ther., 3 (1), p. 6; Barradas, A.M., Fernandes, H.A., Groen, N., Chai, Y.C., Schrooten, J., Van De Peppel, J., Van Leeuwen, J.P., De Boer, J., A calcium-induced signaling cascade leading to osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells (2012) Biomaterials, 33 (11), pp. 3205-3215; Wen, L., Wang, Y., Wang, H., Kong, L., Zhang, L., Chen, X., Ding, Y., L-type calcium channels play a crucial role in the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells (2012) Biochem. Biophys. Res. Commun., 424 (3), pp. 439-445; Katz, S., Boland, R., Santillan, G., Modulation of ERK 1/2 and p38 MAPK signaling pathways by ATP in osteoblasts: Involvement of mechanical stress-activated calcium influx, PKC and Src activation (2006) Int. J. Biochem. Cell Biol., 38 (12), pp. 2082-2091; Schieffer, B., Paxton, W.G., Chai, Q., Marrero, M.B., Bernstein, K.E., Angiotensin II controls p21ras activity via pp60c-src (1996) J. Biol. Chem., 271 (17), pp. 10329-10333; Hobson, S.A., Wright, J., Lee, F., McNeil, S.E., Bilderback, T., Rodland, K.D., Activation of the MAP kinase cascade by exogenous calcium-sensing receptor (2003) Mol. Cell. Endocrinol., 200 (12), pp. 189-198; Sneddon, W.B., Liu, F., Gesek, F.A., Friedman, P.A., Obligate mitogen-activated protein kinase activation in parathyroid hormone stimulation of calcium transport but not calcium signaling (2000) Endocrinology, 141 (11), pp. 4185-4193; Marshall, C.J., Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation (1995) Cell, 80 (2), pp. 179-185; Agell, N., Bachs, O., Rocamora, N., Villalonga, P., Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin (2002) Cell. Signal., 14 (8), pp. 649-654; Arnsdorf, E.J., Tummala, P., Kwon, R.Y., Jacobs, C.R., Mechanically induced osteogenic differentiation - The role of RhoA, ROCKII and cytoskeletal dynamics (2009) J. Cell Sci., 122 (PART 4), pp. 546-553; Grellier, M., Bareille, R., Bourget, C., Amedee, J., Responsiveness of human bone marrow stromal cells to shear stress (2009) J. Tissue Eng. Regen. Med., 3 (4), pp. 302-309; Sharp, L.A., Lee, Y.W., Goldstein, A.S., Effect of low-frequency pulsatile flow on expression of osteoblastic genes by bone marrow stromal cells (2009) Ann. Biomed. Eng., 37 (3), pp. 445-453; Riddle, R.C., Taylor, A.F., Genetos, D.C., Donahue, H.J., MAP kinase and calcium signaling mediate fluid flow-induced human mesenchymal stem cell proliferation (2006) Am. J. Physiol. Cell Physiol., 290 (3), pp. C776-784; Kern, B., Shen, J., Starbuck, M., Karsenty, G., Cbfa1 contributes to the osteoblast-specific expression of type i collagen genes (2001) J. Biol. Chem., 276 (10), pp. 7101-7107; Soltanoff, C.S., Yang, S., Chen, W., Li, Y.P., Signaling networks that control the lineage commitment and differentiation of bone cells (2009) Crit. Rev. Eukaryot. Gene Expr., 19 (1), pp. 1-46; Resh, M.D., Fyn, a Src family tyrosine kinase (1998) Int. J. Biochem. Cell Biol., 30 (11), pp. 1159-1162; Van Der Geer, P., Wiley, S., Gish, G.D., Pawson, T., The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions (1996) Curr. Biol., 6 (11), pp. 1435-1444; Sato, K., Gotoh, N., Otsuki, T., Kakumoto, M., Aoto, M., Tokmakov, A.A., Shibuya, M., Fukami, Y., Tyrosine residues 239 and 240 of Shc are phosphatidylinositol 4,5-bisphosphate-dependent phosphorylation sites by c-Src (1997) Biochem. Biophys. Res. Commun., 240 (2), pp. 399-404; Buday, L., Downward, J., Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor (1993) Cell, 73 (3), pp. 611-620; Van Biesen, T., Hawes, B.E., Luttrell, D.K., Krueger, K.M., Touhara, K., Porfiri, E., Sakaue, M., Lefkowitz, R.J., Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway (1995) Nature, 376 (6543), pp. 781-784; Krawczyk, P., Matuszyk, J., The mechanism of phospholipase Cgamma1 activation (2011) Postepy Hig. Med. Dosw. (Online), 65, pp. 470-477; Ren, Y., Yu, L., Fan, J., Rui, Z., Hua, Z., Zhang, Z., Zhang, N., Yin, G., Phosphorylation of GIT1 tyrosine 321 is required for association with FAK at focal adhesions and for PDGF-activated migration of osteoblasts (2012) Mol. Cell. Biochem., 365 (12), pp. 109-118; Rui, Z., Li, X., Fan, J., Ren, Y., Yuan, Y., Hua, Z., Zhang, N., Yin, G., GIT1Y321 phosphorylation is required for ERK1/2- and PDGF-dependent VEGF secretion from osteoblasts to promote angiogenesis and bone healing (2012) Int. J. Mol. Med., 30 (4), pp. 819-825; Zhang, N., Cai, W., Yin, G., Nagel, D.J., Berk, B.C., GIT1 is a novel MEK1-ERK1/2 scaffold that localizes to focal adhesions (2010) Cell Biol. Int., 34 (1), pp. 41-47; Peng, H., Dara, L., Li, T.W., Zheng, Y., Yang, H., Tomasi, M.L., Tomasi, I., Lu, S.C., MAT2B-GIT1 interplay activates MEK1/ERK 1 and 2 to induce growth in human liver and colon cancer (2013) Hepatology, 57 (6), pp. 2299-2313; Higuchi, C., Nakamura, N., Yoshikawa, H., Itoh, K., Transient dynamic actin cytoskeletal change stimulates the osteoblastic differentiation (2009) J. Bone Miner. Metab., 27 (2), pp. 158-167; Visser, R., Arrabal, P.M., Santos-Ruiz, L., Fernandez-Barranco, R., Becerra, J., Cifuentes, M., A collagen-targeted biomimetic RGD peptide to promote osteogenesis (2014) Tissue Eng. Part A, 20 (12), pp. 34-44; Wang, X., Liao, S., Nelson, E.R., Schmalzigaug, R., Spurney, R.F., Guilak, F., Premont, R.T., Gesty-Palmer, D., The cytoskeletal regulatory scaffold protein GIT2 modulates mesenchymal stem cell differentiation and osteoblastogenesis (2012) Biochem. Biophys. Res. Commun., 425 (2), pp. 407-412; Alves, R.D., Eijken, M., Swagemakers, S., Chiba, H., Titulaer, M.K., Burgers, P.C., Luider, T.M., Van Leeuwen, J.P., Proteomic analysis of human osteoblastic cells: Relevant proteins and functional categories for differentiation (2010) J. Proteome Res., 9 (9), pp. 4688-4700; Marie, P.J., Targeting integrins to promote bone formation and repair (2013) Nat. Rev. Endocrinol., 9 (5), pp. 288-295; Nielbo, S., Thomsen, J.K., Graversen, J.H., Jensen, P.H., Etzerodt, M., Poulsen, F.M., Thogersen, H.C., Structure of the plasminogen kringle 4 binding calcium-free form of the C-type lectin-like domain of tetranectin (2004) Biochemistry, 43 (27), pp. 8636-8643; Iba, K., Durkin, M.E., Johnsen, L., Hunziker, E., Damgaard-Pedersen, K., Zhang, H., Engvall, E., Wewer, U.M., Mice with a targeted deletion of the tetranectin gene exhibit a spinal deformity (2001) Mol. Cell. Biol., 21 (22), pp. 7817-7825; Larsen, K.H., Frederiksen, C.M., Burns, J.S., Abdallah, B.M., Kassem, M., Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity (2010) J. Bone Miner. Res., 25 (4), pp. 796-808; Iba, K., Chiba, H., Yamashita, T., Ishii, S., Sawada, N., Phase-independent inhibition by retinoic acid of mineralization correlated with loss of tetranectin expression in a human osteoblastic cell line (2001) Cell Struct. Funct., 26 (4), pp. 227-233; Iba, K., Sawada, N., Nuka, S., Chiba, H., Obata, H., Isomura, H., Satoh, M., Mori, M., Phase-dependent effects of transforming growth factor beta 1 on osteoblastic markers of human osteoblastic cell line sV-HFO during mineralization (1996) Bone, 19 (4), pp. 363-369; Aldea, D., Hanna, P., Munoz, D., Espinoza, J., Torrejon, M., Sachs, L., Buisine, N., Marcellini, S., Evolution of the vertebrate bone matrix: An expression analysis of the network forming collagen paralogues in amphibian osteoblasts (2013) J. Exp. Zool. B Mol. Dev. Evol., 320 (6), pp. 375-384; Takeshita, S., Kikuno, R., Tezuka, K., Amann, E., Osteoblast-specific factor 2: Cloning of a putative bone adhesion protein with homology with the insect protein fasciclin i (1993) Biochem. J., 294 (PART 1), pp. 271-278; Coutu, D.L., Wu, J.H., Monette, A., Rivard, G.E., Blostein, M.D., Galipeau, J., Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells (2008) J. Biol. Chem., 283 (26), pp. 17991-18001; Conway, S.J., Izuhara, K., Kudo, Y., Litvin, J., Markwald, R., Ouyang, G., Arron, J.R., Kudo, A., The role of periostin in tissue remodeling across health and disease (2014) Cell. Mol. Life Sci., 71 (7), pp. 1279-1288; Merle, B., Garnero, P., The multiple facets of periostin in bone metabolism (2012) Osteoporos. Int., 23 (4), pp. 1199-1212; Thapa, N., Lee, B.H., Kim, I.S., TGFBIp/betaig-h3 protein: A versatile matrix molecule induced by TGF-beta (2007) Int. J. Biochem. Cell Biol., 39 (12), pp. 2183-2194; Romanos, G.E., Asnani, K.P., Hingorani, D., Deshmukh, V.L., PERIOSTIN: Role in formation and maintenance of dental tissues (2014) J. Cell. Physiol., 229 (1), pp. 1-5",Article,Scopus,2-s2.0-84927555749
"Bahadur R.K.C., Cezary K., Hasan U.","Additive nanocomplexes of cationic lipopolymers for improved non-viral gene delivery to mesenchymal stem cells",2015,"Journal of Materials Chemistry B","3","19",,"3972","3982",,,10.1039/c4tb02101k,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928954801&partnerID=40&md5=d6ca460847b303ac3f624fdf84401981","Department of Chemical and Material Engineering, Faculty of Engineering, University of Alberta, 2-021 RTFEdmonton, AB, Canada; Department of Biomedical Engineering, Faculty of Medicine, University of AlbertaEdmonton, AB, Canada; Faculty of Pharmacy and Pharmaceutical Sciences, University of AlbertaEdmonton, AB, Canada","Bahadur, R.K.C., Department of Chemical and Material Engineering, Faculty of Engineering, University of Alberta, 2-021 RTFEdmonton, AB, Canada; Cezary, K., Department of Chemical and Material Engineering, Faculty of Engineering, University of Alberta, 2-021 RTFEdmonton, AB, Canada; Hasan, U., Department of Chemical and Material Engineering, Faculty of Engineering, University of Alberta, 2-021 RTFEdmonton, AB, Canada, Department of Biomedical Engineering, Faculty of Medicine, University of AlbertaEdmonton, AB, Canada, Faculty of Pharmacy and Pharmaceutical Sciences, University of AlbertaEdmonton, AB, Canada","It has been challenging to modify primary cells with non-viral gene delivery. Herein, we developed a ternary nano-formulation for gene delivery to umbilical cord blood and bone marrow derived mesenchymal stem cells (MSC) by using lipid-modified small (1.2 kDa) molecular weight polyethylenimine (PEI1.2). Linoleic acid (LA) was end-capped with carboxyl functionality by coupling with mercaptopropionic acid through thio-ester linkage, and then grafted onto PEI1.2 via N-acylation. The thio-ester LA grafted PEI1.2 (PEI-tLA) displayed a significantly lower (up to 6-fold) DNA binding capability and a higher propensity to dissociate upon polyanionic challenge. The dissociation ability of the complexes was further enhanced by incorporating hyaluronic acid (HA) into plasmid DNA (pDNA) complexes of PEI-tLA. The HA incorporation influenced the surface charge of complexes more so than the hydrodynamic size, but it clearly increased the propensity for dissociation upon a polyanionic challenge. The PEI-tLAs were less toxic on MSC and displayed significantly higher transgene expression in MSC than conventional PEI-LA. Ternary complexes of with HA (pDNA/HA = 2, w/w) further enhanced the efficiency of PEI-tLAs of low (∼2 lipid/PEI) lipid substitution, which was comparable to or higher than commercial transfection reagents. We conclude that PEI-tLA of low lipid substitution can be employed as a gene carrier to design supersensitive nano-formulations. © The Royal Society of Chemistry.2015.",,"Pallini, R., Ricci-Vitiani, L., Banna, G.L., Signore, M., Lombardi, D., Todaro, M., Stassi, G., De Maria, R., (2008) Clin. Cancer Res., 14, pp. 8205-8212; Studeny, M., Marini, F.C., Champlin, R.E., Zompetta, C., Fidler, I.J., Andreeff, M., (2002) Cancer Res., 62, pp. 3603-3608; Nakamura, K., Ito, Y., Kawano, Y., Kurozumi, K., Kobune, M., Tsuda, H., Bizen, A., Hamada, H., (2004) Gene Ther., 11, pp. 1155-1164; Borlongan, C.V., Kaneko, Y., Maki, M., Yu, S.J., Ali, M., Allickson, J.G., Sanberg, C.D., Sanberg, P.R., (2010) Stem Cells Dev., 19, pp. 439-452; Kim, S.M., Lim, J.Y., Park, S.I., Jeong, C.H., Oh, J.H., Jeong, M., Oh, W., Jeun, S.S., (2008) Cancer Res., 68, pp. 9614-9623; Altaner, C., (2008) Cancer Lett., 270, pp. 191-201; Baksh, D., Song, L., Tuan, R.S., (2004) J. Cell. Mol. Med., 8, pp. 301-316; Salem, H.K., Thiemermann, C., (2010) Stem Cells, 28, pp. 585-596; Uchibori, R., Tsukahara, T., Mizuguchi, H., Saga, Y., Urabe, M., Mizukami, H., Kume, A., Ozawa, K., (2013) Cancer Res., 73, pp. 364-372; Ryu, C.H., Park, S.H., Park, S.A., Kim, S.M., Lim, J.Y., Jeong, C.H., Yoon, W.S., Jeun, S.S., (2011) Hum. Gene Ther., 22, pp. 733-743; Cihova, M., Altanerova, V., Altaner, C., (2011) Mol. Pharmaceutics, 8, pp. 1480-1487; Takahashi, Y., Nishikawa, M., Takakura, Y., (2009) Adv. Drug Delivery Rev., 61, pp. 760-766; Hoon Jeong, J., Christensen, L.V., Yockman, J.W., Zhong, Z., Engbersen, J.F., Jong Kim, W., Feijen, J., Wan Kim, S., (2007) Biomaterials, 28, pp. 1912-1917; Dehousse, V., Garbacki, N., Colige, A., Evrard, B., (2010) Biomaterials, 31, pp. 1839-1849; Breunig, M., Hozsa, C., Lungwitz, U., Watanabe, K., Umeda, I., Kato, H., Goepferich, A., (2008) J. Controlled Release, 130, pp. 57-63; Gwak, S.J., Kim, B.S., (2008) Biotechnol. Lett., 30, pp. 1177-1182; Mintzer, M.A., Simanek, E.E., (2009) Chem. Rev., 109, pp. 259-302; Zintchenko, A., Philipp, A., Dehshahri, A., Wagner, E., (2008) Bioconjugate Chem., 19, pp. 1448-1455; Lungwitz, U., Breunig, M., Blunk, T., Gopferich, A., (2005) Eur. J. Pharm. Biopharm., 60, pp. 247-266; Iwai, M., Harada, Y., Tanaka, S., Muramatsu, A., Mori, T., Kashima, K., Imanishi, J., Mazda, O., (2002) Biochem. Biophys. Res. Commun., 291, pp. 48-54; Aigner, A., Fischer, D., Merdan, T., Brus, C., Kissel, T., Czubayko, F., (2002) Gene Ther., 9, pp. 1700-1707; Kircheis, R., Wightman, L., Wagner, E., (2001) Adv. Drug Delivery Rev., 53, pp. 341-358; Moghimi, S.M., Symonds, P., Murray, J.C., Hunter, A.C., Debska, G., Szewczyk, A., (2005) Mol. Ther., 11, pp. 990-995; Kang, H.C., Lee, M., Bae, Y.H., (2005) Crit. Rev. Eukaryotic Gene Expression, 15, pp. 317-342; Neamnark, A., Suwantong, O., Bahadur, R.K., Hsu, C.Y., Supaphol, P., Uludag, H., (2009) Mol. Pharmaceutics, 6, pp. 1798-1815; Park, K., Hong, S.W., Hur, W., Lee, M.Y., Yang, J.A., Kim, S.W., Yoon, S.K., Hahn, S.K., (2011) Biomaterials, 32, pp. 4951-4958; Mahato, R.I., Lee, M., Han, S., Maheshwari, A., Kim, S.W., (2001) Mol. Ther., 4, pp. 130-138; Bajaj, A., Kondaiah, P., Bhattacharya, S., (2008) Bioconjugate Chem., 19, pp. 1640-1651; Kim, W.J., Chang, C.W., Lee, M., Kim, S.W., (2007) J. Controlled Release, 118, pp. 357-363; Kim, D., Lee, D., Jang, Y.L., Chae, S.Y., Choi, D., Jeong, J.H., Kim, S.H., (2012) Eur. J. Pharm. Biopharm., 81, pp. 14-23; Wang, Y., Mostafa, N.Z., Hsu, C.Y., Rose, L., Kucharki, C., Yan, J., Jiang, H., Uludag, H., (2013) J. Surg. Res., 183, pp. 8-17; Gary, D.J., Puri, N., Won, Y.Y., (2007) J. Controlled Release, 121, pp. 64-73; Danielsen, S., Maurstad, G., Stokke, B.T., (2005) Biopolymers, 77, pp. 86-97; Bolcato-Bellemin, A.L., Bonnet, M.E., Creusat, G., Erbacher, P., Behr, J.P., (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 16050-16055; Schaffer, D.V., Fidelman, N.A., Dan, N., Lauffenburger, D.A., (2000) Biotechnol. Bioeng., 67, pp. 598-606; Chang Kang, H., Bae, Y.H., (2011) Biomaterials, 32, pp. 4914-4924; Fischer, D., Bieber, T., Li, Y., Elsasser, H.P., Kissel, T., (1999) Pharm. Res., 16, pp. 1273-1279; Bahadur, K.C., Landry, B., Aliabadi, H.M., Lavasanifar, A., Uludag, H., (2011) Acta Biomater., 7, pp. 2209-2217; Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D.A., Torchilin, V.P., Jain, R.K., (1995) Cancer Res., 55, pp. 3752-3756; Lin, Y.L., Jiang, G., Birrell, L.K., El-Sayed, M.E., (2010) Biomaterials, 31, pp. 7150-7166; Neu, M., Fischer, D., Kissel, T., (2005) J. Gene Med., 7, pp. 992-1009; Bahadur, K.C.R., Thapa, B., Xu, P., (2012) Macromol. Biosci., 12, pp. 637-646; Xu, P., Quick, G.K., Yeo, Y., (2009) Biomaterials, 30, pp. 5834-5843; Jiang, G., Min, S.H., Kim, M.N., Lee, D.C., Lim, M.J., Yeom, Y.I., (2006) Yaoxue Xuebao, 41, pp. 439-445; Kunath, K., Von Harpe, A., Fischer, D., Petersen, H., Bickel, U., Voigt, K., Kissel, T., (2003) J. Controlled Release, 89, pp. 113-125; Tong, J., Luxenhofer, R., Yi, X., Jordan, R., Kabanov, A.V., (2010) Mol. Pharmaceutics, 7, pp. 984-992; Marquez-Curtis, L.A., Gul-Uludag, H., Xu, P., Chen, J., Janowska-Wieczorek, A., (2013) Cytotherapy, 15, pp. 840-849; Jiang, H., Secretan, C., Gao, T., Bagnall, K., Korbutt, G., Lakey, J., Jomha, N.M., (2006) Stud. Health Technol. Inform., 123, pp. 467-472",Article,Scopus,2-s2.0-84928954801
"Romero R., Chubb L., Travers J.K., Gonzales T.R., Ehrhart N.P., Kipper M.J.","Coating cortical bone allografts with periosteum-mimetic scaffolds made of chitosan, trimethyl chitosan, and heparin",2015,"Carbohydrate Polymers","122",,,"144","151",,,10.1016/j.carbpol.2015.01.015,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84921688994&partnerID=40&md5=67ade3acc8c7e1cf00682d897098cf75","School of Biomedical Engineering, Colorado State UniversityFort Collins, CO, United States; Department of Clinical Sciences, Colorado State UniversityFort Collins, CO, United States; Department of Chemical and Biological Engineering, Colorado State University, 1370 Campus DeliveryFort Collins, CO, United States","Romero, R., School of Biomedical Engineering, Colorado State UniversityFort Collins, CO, United States; Chubb, L., Department of Clinical Sciences, Colorado State UniversityFort Collins, CO, United States; Travers, J.K., Department of Chemical and Biological Engineering, Colorado State University, 1370 Campus DeliveryFort Collins, CO, United States; Gonzales, T.R., Department of Chemical and Biological Engineering, Colorado State University, 1370 Campus DeliveryFort Collins, CO, United States; Ehrhart, N.P., School of Biomedical Engineering, Colorado State UniversityFort Collins, CO, United States, Department of Clinical Sciences, Colorado State UniversityFort Collins, CO, United States; Kipper, M.J., School of Biomedical Engineering, Colorado State UniversityFort Collins, CO, United States, Department of Chemical and Biological Engineering, Colorado State University, 1370 Campus DeliveryFort Collins, CO, United States","Bone allografts have very limited healing leading to high rates of failure from non-union, fracture, and infection. The limited healing of bone allografts is due in large part to devitalization and removal of the periosteum, which removes osteogenic cells and osteoinductive signals. Here we report techniques for directly coating cortical bone with tissue scaffolds, and evaluate the scaffolds' capacity to support osteoprogenitor cells. Three types of coatings are investigated: N,N,N-trimethyl chitosan-heparin polyelectrolyte multilayers, freeze-dried porous chitosan foam coatings, and electrospun chitosan nanofibers. The freeze-dried and electrospun scaffolds are also further modified with polyelectrolyte multilayers. All of the scaffolds are durable to subsequent aqueous processing, and are cytocompatible with adipose-derived stem cells. Alkaline phosphatase and receptor activator of nuclear factor kappa-B ligand expression at days 7 and 21 suggest that these scaffolds support an osteoprogenitor phenotype. These scaffolds could serve as periosteum mimics, deliver osteoprogenitor cells, and improve bone allograft healing. © 2015 Elsevier Ltd.","Adipose-derived stem cell; Bone allograft; Bone tissue engineering; Chitosan; Heparin; Periosteum","Almodóvar, J., Mower, J., Banerjee, A., Sarkar, A.K., Ehrhart, N.P., Kipper, M.J., Chitosan-heparin polyelectrolyte multilayers on cortical bone: Periosteum-mimetic, cytophilic, antibacterial coatings (2013) Biotechnology and Bioengineering, 110 (2), pp. 609-618; Almodoívar, J., Bacon, S., Gogolski, J., Kisiday, J.D., Kipper, M.J., Polysaccharide-based polyelectrolyte multilayer surface coatings can enhance mesenchymal stem cell response to adsorbed growth factors (2010) Biomacromolecules, 11, pp. 2629-2639; Almodoívar, J., Kipper, M.J., Coating electrospun chitosan nanofibers with polyelectrolyte multilayers using the polysaccharides heparin and N,N,N-trimethyl chitosan (2011) Macromolecular Bioscience, 11 (1), pp. 72-76; Almodoívar, J., Place, L.W., Gogolski, J., Erickson, K., Kipper, M.J., Layer-by-layer assembly of polysaccharide-based polyelectrolyte multilayers: A spectroscopic study of hydrophilicity, composition, and ion pairing (2011) Biomacromolecules, 12 (7), pp. 2755-2765; Aubin, J.E., Advances in the osteoblast lineage (1998) Biochemistry and Cell Biology, 76 (6), pp. 899-910; Azad, A.K., Sermsintham, N., Chandrkrachang, S., Stevens, W.F., Chitosan membrane as a wound-healing dressing: Characterization and clinical application (2004) Journal of Biomedical Materials Research, B: Applied Biomaterials, 69 (2), pp. 216-222; Bauer, T.W., Muschler, G.F., Bone graft materials: An overview of the basic science (2000) Clinical Orthopaedics and Related Research, (371), pp. 10-27; Benoit, D.S.W., Anseth, K.S., Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation (2005) Acta Biomaterialia, 1 (4), pp. 461-470; Biagini, G., Bertani, A., Muzzarelli, R.A.A., Damadei, A., Dibenedetto, G., Belligolli, A., Wound management with N-carboxybutyl chitosan (1991) Biomaterials, 12 (3), pp. 281-286; Boyce, B.F., Xing, L., Functions of RANKL/RANK/OPG in bone modeling and remodeling (2008) Archives of Biochemistry and Biophysics, 473 (2), pp. 139-146; Bucholz, R.W., Nonallograft osteoconductive bone graft substitutes (2002) Clinical Orthopaedics and Related Research, (395), pp. 44-52; Colnot, C., Zhang, X., Knothe Tate, M.L., Current insights on the regenerative potential of the periosteum: Molecular, cellular, and endogenous engineering approaches (2012) Journal of Orthopaedic Research, 30 (12), pp. 1869-1878; Costa-Pinto, A.R., Reis, R.L., Neves, N.M., Scaffolds based bone tissue engineering: The role of chitosan (2011) Tissue Engineering, B: Reviews, 17 (5), pp. 331-347; De Britto, D., Assis, O.B.G., A novel method for obtaining a quaternary salt of chitosan (2007) Carbohydrate Polymers, 69 (2), pp. 305-310; Follmann, H.D.M., Martins, A.F., Gerola, A.P., Burgo, T.A.L., Nakamura, C.V., Rubira, A.F., Antiadhesive and antibacterial multilayer films via layer-by-layer assembly of tmc/heparin complexes (2012) Biomacromolecules, 13 (11), pp. 3711-3722; Hastings, J., Bioluminescence (2012) Cell Physiology Source Book: Essentials of Membrane Biophysics, pp. 925-947. , N. Sperelakis, Academic Press Boston, MA; Hoffman, M.D., Benoit, D.S.W., Emerging ideas: Engineering the periosteum: Revitalizing allografts by mimicking autograft healing (2013) Clinical Orthopaedics and Related Research, 471 (3), pp. 721-726; Hoffman, M.D., Van Hove, A.H., Benoit, D.S., Degradable hydrogels for spatiotemporal control of mesenchymal stem cells localized at decellularized bone allografts (2014) Acta Biomaterialia, 10 (8), pp. 3431-3441; Hoffman, M.D., Xie, C., Zhang, X., Benoit, D.S.W., The effect of mesenchymal stem cells delivered via hydrogel-based tissue engineered periosteum on bone allograft healing (2013) Biomaterials, 34 (35), pp. 8887-8898; Ito, H., Koefoed, M., Tiyapatanaputi, P., Gromov, K., Goater, J.J., Carmouche, J., Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy (2005) Nature Medicine, 11 (3), pp. 291-297; Jahangir, A.A., Nunley, R.M., Mehta, S., Sharan, A., (2008) Bone-graft Substitutes in Orthopaedic Surgery, , AAOS Now: American Academy of Orthopaedic Surgeons Rockford, IL; Jia, Z., Shen, D., Xu, W., Synthesis and antibacterial activities of quaternary ammonium salt of chitosan (2001) Carbohydrate Research, 333 (1), pp. 1-6; Jiang, T., Deng, M., James, R., Nair, L.S., Laurencin, C.T., Micro- and nanofabrication of chitosan structures for regenerative engineering (2014) Acta Biomaterialia, 10 (4), pp. 1632-1645; Kang, J.M., Han, M., Park, I.S., Jung, Y., Kim, S.H., Kim, S.-H., Adhesion and differentiation of adipose-derived stem cells on a substrate with immobilized fibroblast growth factor (2012) Acta Biomaterialia, 8 (5), pp. 1759-1767; Kang, Y.Q., Ren, L.L., Yang, Y.Z., Engineering vascularized bone grafts by integrating a biomimetic periosteum and beta-TCP scaffold (2014) ACS Applied Materials & Interfaces, 6 (12), pp. 9622-9633; Kim, M., Kim, Y.H., Tae, G., Human mesenchymal stem cell culture on heparin-based hydrogels and the modulation of interactions by gel elasticity and heparin amount (2013) Acta Biomaterialia, 9 (8), pp. 7833-7844; Koefoed, M., Ito, H., Gromov, K., Reynolds, D.G., Awad, H.A., Rubery, P.T., Biological effects of rAAV-caAlk2 coating on structural allograft healing (2005) Molelcular Therapy, 12 (2), pp. 212-218; Loke, W.K., Lau, S.K., Yong, L.L., Khor, E., Sum, C.K., Wound dressing with sustained anti-microbial capability (2000) Journal of Biomedical Materials Research, 53 (1), pp. 8-17; Long, T., Zhu, Z., Awad, H.A., Schwarz, E.M., Hilton, M.J., Dong, Y., The effect of mesenchymal stem cell sheets on structural allograft healing of critical sized femoral defects in mice (2014) Biomaterials, 35 (9), pp. 2752-2759; Lyu, S., Huang, C., Yang, H., Zhang, X., Electrospun fibers as a scaffolding platform for bone tissue repair (2013) Journal of Orthopaedic Research, 31 (9), pp. 1382-1389; Molinaro, G., Leroux, J.-C., Damas, J., Adam, A., Biocompatibility of thermosensitive chitosan-based hydrogels: An in vivo experimental approach to injectable biomaterials (2002) Biomaterials, 23 (13), pp. 2717-2722; Muzzarelli, R.A.A., Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone (2009) Carbohydrate Polymers, 76 (2), pp. 167-182; Nordtveit, R.J., Vårum, K.M., Smidsrød, O., Degradation of partially N-acetylated chitosans with hen egg white and human lysozyme (1996) Carbohydrate Polymers, 29 (2), pp. 163-167; Ogilvie, C.M., Crawford, E.A., Hosalkar, H.S., King, J.J., Lackman, R.D., Long-term results for limb salvage with osteoarticular allograft reconstruction (2009) Clinical Orthopaedics and Related Research, 467 (10), pp. 2685-2690; Ouyang, H.W., Cao, T., Zou, X.H., Heng, B.C., Wang, L.L., Song, X.H., Mesenchymal stem cell sheets revitalize nonviable dense grafts: Implications for repair of large-bone and tendon defects (2006) Transplantation, 82 (2), pp. 170-174; Park, I.-S., Han, M., Rhie, J.-W., Kim, S.H., Jung, Y., Kim, I.H., The correlation between human adipose-derived stem cells differentiation and cell adhesion mechanism (2009) Biomaterials, 30 (36), pp. 6835-6843; Place, L.W., Kelly, S.M., Kipper, M.J., Synthesis and characterization of proteoglycan-mimetic graft copolymers with tunable glycosaminoglycan density (2014) Biomacromolecules, 15 (10), pp. 3772-3780; Place, L.W., Sekyi, M., Kipper, M.J., Aggrecan-mimetic, glycosaminoglycan-containing nanoparticles for growth factor stabilization and delivery (2014) Biomacromolecules, 15 (2), pp. 680-689; Shi, X., Fujie, T., Saito, A., Takeoka, S., Hou, Y., Shu, Y., Periosteum-mimetic structures made from freestanding microgrooved nanosheets (2014) Advanced Materials, 26 (20), pp. 3290-3296; Shin, S.Y., Park, H.N., Kim, K.H., Lee, M.H., Choi, Y.S., Park, Y.J., Biological evaluation of chitosan nanofiber membrane for guided bone regeneration (2005) Journal of Periodontology, 76 (10), pp. 1778-1784; Tessmar, J.K., Göpferich, A.M., Matrices and scaffolds for protein delivery in tissue engineering (2007) Advanced Drug Delivery Reviews, 59 (4), pp. 274-291; Tomihata, K., Ikada, Y., In vitro and in vivo degradation of films of chitin and its deacetylated derivatives (1997) Biomaterials, 18 (7), pp. 567-575; Ueno, H., Yamada, H., Tanaka, I., Kaba, N., Matsuura, M., Okumura, M., Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs (1999) Biomaterials, 20 (15), pp. 1407-1414; Vandevord, P.J., Matthew, H.W.T., Desilva, S.P., Mayton, L., Wu, B., Wooley, P.H., Evaluation of the biocompatibility of a chitosan scaffold in mice (2002) Journal of Biomedical Materials Research, 59 (3), pp. 585-590; Volpato, F.Z., Almodóvar, J., Erickson, K., Popat, K.C., Migliaresi, C., Kipper, M.J., Preservation of FGF-2 bioactivity using heparin-based nanoparticles, and their delivery from electrospun chitosan fibers (2012) Acta Biomaterialia, 8 (4), pp. 1551-1559; Vårum, K.M., Myhr, M.M., Hjerde, R.J.N., Smidsrød, O., In vitro degradation rates of partially N-acetylated chitosans in human serum (1997) Carbohydrate Research, 299 (12), pp. 99-101; Xie, C., Reynolds, D., Awad, H., Rubery, P.T., Pelled, G., Gazit, D., Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering (2007) Tissue Engineering, 13 (3), pp. 435-445; Xu, Y., Malladi, P., Wagner, D.R., Longaker, M.T., Adipose-derived mesenchymal cells as a potential cell source for skeletal regeneration (2005) Current Opinion in Molecular Therapeutics, 7 (4), pp. 300-305; Yazici, C., Yanoso, L., Xie, C., Reynolds, D.G., Samulski, R.J., Samulski, J., The effect of surface demineralization of cortical bone allograft on the properties of recombinant adeno-associated virus coatings (2008) Biomaterials, 29 (28), pp. 3882-3887; Zhang, X., Awad, H.A., O'Keefe, R.J., Guldberg, R.E., Schwarz, E.M., A perspective: Engineering periosteum for structural bone graft healing (2008) Clinical Orthopaedics and Related Research, 466 (8), pp. 1777-1787; Zhang, X., Xie, C., Lin, A.S.P., Ito, H., Awad, H., Lieberman, J.R., Periosteal progenitor cell fate in segmental cortical bone graft transplantations: Implications for functional tissue engineering (2005) Journal of Bone and Mineral Research, 20 (12), pp. 2124-2137; Zhou, Y., Chen, F., Ho, S.T., Woodruff, M.A., Lim, T.M., Hutmacher, D.W., Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts (2007) Biomaterials, 28 (5), pp. 814-824; Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H., Human adipose tissue is a source of multipotent stem cells (2002) Molecular Biology of the Cell, 13 (12), pp. 4279-4295; Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Multilineage cells from human adipose tissue: Implications for cell-based therapies (2001) Tissue Engineering, 7 (2), pp. 211-228",Article,Scopus,2-s2.0-84921688994
"Yang H.N., Park J.S., Jeon S.Y., Park K.-H.","Carboxymethylcellulose (CMC) formed nanogels with branched poly(ethyleneimine) (bPEI) for inhibition of cytotoxicity in human MSCs as a gene delivery vehicles",2015,"Carbohydrate Polymers","122",,,"265","275",,,10.1016/j.carbpol.2014.12.073,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84921782676&partnerID=40&md5=846e0577f5909bc2f3a81506342c690b","Department of Biomedical Science, College of Life Science, CHA University, 3F, Yatap Acecore, 502 Yatap-dong Bundang-guSeongam-si, South Korea","Yang, H.N., Department of Biomedical Science, College of Life Science, CHA University, 3F, Yatap Acecore, 502 Yatap-dong Bundang-guSeongam-si, South Korea; Park, J.S., Department of Biomedical Science, College of Life Science, CHA University, 3F, Yatap Acecore, 502 Yatap-dong Bundang-guSeongam-si, South Korea; Jeon, S.Y., Department of Biomedical Science, College of Life Science, CHA University, 3F, Yatap Acecore, 502 Yatap-dong Bundang-guSeongam-si, South Korea; Park, K.-H., Department of Biomedical Science, College of Life Science, CHA University, 3F, Yatap Acecore, 502 Yatap-dong Bundang-guSeongam-si, South Korea","Specific vehicles are necessary for safe and efficient gene transfection into cells. Nano-type hydrogels (nanogel) comprising carboxymethylcellulose (CMC) complexed with branched type cationic poly(ethleneimine) (bPEI) were used as gene delivery vehicles. When complexes of CMC and bPEI were used in vitro, CMC showed nano-gel type properties, as shown by the results of a viscosity test, and bPEI showed low cytotoxicity comparing to bPEI alone. Together, these properties are shown to maintain high gene transfection efficiency. In viability experiments using three types of adult stem cells, cell viability varied depending on the branch form of PEI and whether or not it is in a complex with CMC. The gene delivery efficacy showed that the CMC nanogel complexed with bPEI (CMC-bPEI) showed more uptaking and gene transfection ability in hMSCs comparing to bPEI alone. In osteogenesis, the CMC-bPEI complexed with OSX pDNA showed more easy internalization than bPEI alone complexed with OSX pDNA in hMSCs. Specific genes and proteins related in osteogenic differentiation were expressed in hMSCs when the CMC-bPEI complexed with OSX pDNA was used. © 2015 Elsevier Ltd. All rights reserved.","Adult stem cells; Branched PEI; CMC; Genes; Nanogel","Burakowska, E., Zimmerman, S.C., Haag, R., Photoresponsive crosslinked hyperbranched polyglycerols as smart nanocarriers for guest binding and controlled release (2009) Small, 5, pp. 2199-2204; Chacko, R.T., Ventura, J., Zhuang, J., Thayumanavan, S., Polymer nanogels: A versatile nanoscopic drug delivery platform (2009) Advanced Drug Delivery Reviews, 25, pp. 451-457; Du, J.Z., Sun, T.M., Song, W.J., Wy, J., Wang, J., A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoralcell uptake and drug delivery (2010) Angewandte Chemie International Edition, 49, pp. 3621-3626. , in English; Fan, L.H., Zhang, Z.J., Yu, X.Y., Xue, Y.X., Tan, T.W., Self-surface assembly of cellulosomes with two miniscaffoldins on Saccharomyces cerevisiae for cellulosic ethanol production (2012) Proceedings of the National Academy of Sciences of the United States of America, 109, pp. 13260-13265; Hoyer, J., Neundorf, I., Peptide vectors for the nonviral delivery of nucleic acids (2012) Accounts of Chemical Research, 45, pp. 1048-1056; Hsu, S.H., Ho, T.T., Tseng, T.C., Nanoparticle uptake and gene transfer efficiency for MSCs on chitosan and chitosan-hyaluronan substrates (2012) Biomaterials, 33, pp. 3639-3650; Jung, S.H., Kim, S.K., Jung, S.H., Kim, E.H., Cho, S.H., Jeong, K.S., Increased stability in plasma and enhanced cellular uptake of thermally denatured albumin-coated liposomes (2010) Colloids and Surfaces B: Biointerfaces, 76, pp. 434-440; Kim, K.S., Lee, J.Y., Kang, Y.M., Kim, E.S., Kim, C.H., Min, B.H., Electrostatic crosslinked in situ-forming in vivo scaffold for rat bone marrow mesenchymal stem cells (2009) Tissue Engineering: Part A, 15, pp. 3201-3209; Kim, K.S., Kang, Y.M., Lee, J.Y., Kim, E.S., Kim, C.H., Min, B.H., Injectable CMC/PEI gel as an in vivo scaffold for demineralized bone matrix (2009) Bio-Medical Materials and Engineering, 19, pp. 381-390; Lee, V.Y., Havenstrite, K., Tjio, M., McNeil, M., Blau, H.M., Miller, R.D., Nanogel star polymer architectures: A nanoparticle platform for modular programmable macromolecular self-assembly, intercellular transport, and dual-mode cargo delivery (2011) Advanced Materials, 23, pp. 4509-4515; Lee, J.H., Lee, H., Joung, Y.K., Jung, K.H., Choi, J.H., Lee, D.H., The use of low molecular weight heparin-pluronic nanogels to impede liver fibrosis by inhibition the TGF-β/Smad signaling pathway (2011) Biomaterials, 32, pp. 1438-1445; Li, F., Bae, B.C., Na, K., Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: Synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against HeLa cells (2010) Bioconjugate Chemistry, 21, pp. 1312-1320; Li, L.L., Zhang, R., Yin, L., Zheng, K., Qin, W., Selvin, P.R., Biomimetic surface engineering of lanthanide-doped upconversion nanoparticles as versatile bioprobes (2012) Angewandte Chemie International Edition, 51, pp. 6121-6125. , in English; Lim, Y.T., Shim, S.M., Noh, Y.W., Lee, K.S., Choi, D.Y., Uyama, H., Bioderived polyelectrolyte nanogels for robust antigen loading and vaccine adjuvant effects (2011) Small, 7, pp. 3281-3286; Liu, H., Wang, H., Yang, W., Cheng, Y., Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost (2012) Journal of the American Chemical Society, 134, pp. 17680-17687; Luo, Y.L., Shiao, Y.S., Huang, Y.F., Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy (2011) ACS Nano, 5, pp. 7796-7804; Maia, J., Santos, T., Aday, S., Agasse, F., Cortes, L., Malva, J.O., Controlling the neuronal differentiation of stem cells by the intracellular delivery of retinoic acid-loaded nanoparticles (2011) ACS Nano, 5, pp. 97-106; Orelma, H., Filpponen, I., Johansson, L.S., Laine, J., Rojas, O.J., Modification of cellulose films by adsorption of CMC and chitosan for controlled attachment of biomolecules (2011) Biomacromolecules, 12, pp. 4311-4318; Peng, C.H., Cherng, J.Y., Chiou, G.Y., Chen, Y.C., Chien, C.H., Kao, C.L., Delivery of Oct4 and SirT1 with cationic polyurethanes-short branch PEI to aged retinal pigment epithelium (2011) Biomaterials, 32, pp. 9077-9088; Sakurada, K., McDonald, F.M., Shimada, F., Regenerative medicine and stem cell based drug discovery (2008) Angewandte Chemie International Edition, 47, pp. 5718-5738. , in English; Shah, P.P., Desai, P.R., Patel, A.R., Singh, M.S., Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs (2012) Biomaterials, 33, pp. 1607-1617; Smith, M.H., Lyon, L.A., Multifunctional nanogels for siRNA delivery (2012) Accounts of Chemical Research, 45, pp. 985-993; Sousa, A.A., Morgan, J.T., Brown, P.H., Adams, A., Jayasekara, M.P., Zhang, G., Synthesis, characterization, and direct intracellular imaging of ultrasmall and uniform glutathione-coated gold nanoparticles (2012) Small, 8, pp. 2277-2286; Wen, Y., Guo, Z., Du, Z., Fang, R., Wu, H., Zeng, X., Serum tolerance and endosomal escape capacity of histidine-modified pDNA-loaded complexes based on polyamidoamine dendrimer derivatives (2012) Biomaterials, 33, pp. 8111-8121; Wu, W., Shen, J., Gai, Z., Hong, K., Banerjee, P., Zhou, S., Multi-functional core-shell hybrid nanogels for pH-dependent magnetic manipulation, fluorescent pH-sensing, and drug delivery (2011) Biomaterials, 32, pp. 9876-9887; Xiong, Y., Liu, J., Wang, Y., Wang, H., Wang, R., One-step synthesis of thermosensitive nanogels based on highly cross-linked poly(ionic liquid)s (2012) Angewandte Chemie International Edition, 51, pp. 9114-9118. , in English; Xiong, M.H., Bao, Y., Yang, X.Z., Wang, Y.C., Sun, B., Wang, J., Lipasesensitive polymeric triple-layered nanogel for on-demand drug delivery (2012) Journal of the American Chemical Society, 134, pp. 4355-4362; Yang, M., Lai, S.K., Wang, Y.Y., Zhong, W., Happe, C., Zhang, M., Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus (2011) Angewandte Chemie International Edition, 50, pp. 2597-2600. , in English",Article,Scopus,2-s2.0-84921782676
"Patel D.K., Rana D., Aswal V.K., Srivastava S., Roy P., Maiti P.","Influence of graphene on self-assembly of polyurethane and evaluation of its biomedical properties",2015,"Polymer (United Kingdom)","65",,,"183","192",,,10.1016/j.polymer.2015.03.076,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927613803&partnerID=40&md5=94069da32533196977c5376123e73b70","School of Material Science and Technology, Indian Institute of Technology (Banaras Hindu University)Varanasi, India; Industrial Membrane Research Institute, Department of Chemical and Biological Engineering, University of Ottawa, 161 Louis Pasteur St.Ottawa, ON, Canada; Solid State Physics Division, Bhabha Atomic Research CentreTrombay, Mumbai, India; Department of Biotechnology, Indian Institute of Technology RoorkeeRoorkee, India","Patel, D.K., School of Material Science and Technology, Indian Institute of Technology (Banaras Hindu University)Varanasi, India; Rana, D., Industrial Membrane Research Institute, Department of Chemical and Biological Engineering, University of Ottawa, 161 Louis Pasteur St.Ottawa, ON, Canada; Aswal, V.K., Solid State Physics Division, Bhabha Atomic Research CentreTrombay, Mumbai, India; Srivastava, S., Department of Biotechnology, Indian Institute of Technology RoorkeeRoorkee, India; Roy, P., Department of Biotechnology, Indian Institute of Technology RoorkeeRoorkee, India; Maiti, P., School of Material Science and Technology, Indian Institute of Technology (Banaras Hindu University)Varanasi, India","Novel aliphatic polyurethane (PU) nanohybrids have been prepared using varying amount of graphene by dispersing it in the early stage of polymerization (in situ) and achieved uniform distribution throughout the matrix, required for the improvement of properties. The alteration of self-assembly in presence of graphene have been explored through X-ray diffraction, small angle neutron scattering, atomic force and optical microscopy in the length scale of nanometer, tens of nanometer, hundreds of nanometer and micron range, respectively, indicating the layer by layer self-assembly of polymer and graphene in nanohybrids. The cause of self-assembly has been studied through spectroscopic techniques like FTIR and UV-vis measurements revealing strong interaction between polymer chain (both hard and soft segments) and graphene which is further confirmed from the depression of melting point and decrease in heat of fusion with increasing graphene content in the nanohybrids. The toughness of nanohybrids in solid state improves considerably as compared to pure PU and the mechanical strength in liquid state also dramatically increases with graphene content showing a dip at a particular frequency depending on the strength of self-assembly (greater for higher graphene content nanohybrid) followed by its reformation at higher frequency. Sustained drug release has been achieved in presence of graphene explaining the phenomena from the greater tortuousity in nanohybrids arising from the 2-D graphene and small but uniform cluster size of self-assembly as compared to pure PU. The suitability of the developed nanohybrids has been testified for its use in biomedical arena by checking the complete biocompatibility of the nanohybrids as compared to pure PU using bone marrow derived mesenchymal stem cells. © 2015 Elsevier Ltd. All rights reserved.","Controlled drug release; Polyurethane; Self-assembly","Howard, G.T., (2002) Int Biodeterior Biodegr, 49, pp. 245-252; Ciardelli, G., Rechichi, A., Cerrai, P., Tricoli, M., Barbani, N., Giusti, P., (2004) Macromol Symp, 218, pp. 261-271; Mishra, A., Purkayastha, B.P.D., Roy, J.K., Aswal, V.K., Maiti, P., (2010) Macromolecules, 43, pp. 9928-9936; Mishra, A., Aswal, V.K., Maiti, P., (2010) J Phys Chem B, 114, pp. 5292-5300; Peppas, N.A., Langer, R., (1999) Science, 284, pp. 1143-1146; Lendlein, A., Jiang, H.Y., Junger, O., Langer, R., (2005) Nature, 434, pp. 879-882; Mishra, A., Purkayastha, B.P.D., Roy, J.K., Aswal, V.K., Maiti, P., (2012) J Phys Chem C, 116, pp. 2260-2270; Zilg, C., Thomson, R., Mülhaupt, R., Finter, J., (1999) Adv Mater, 11, pp. 49-52; Lendlein, A., Langer, R., (2002) Science, 296, pp. 1673-1676; Gordon, R.F., (1994) Proc. of the Int. Conf. on Shape Memory and Superelastic Technologies, 1st, Pacific Grove, CA, March 7-10, pp. 115-120. , A.R. Pelton, D. Hodgson, T. Duerig, MIAS Monterey, CA; Rana, S., Karak, N., Cho, J.W., Kim, Y.H., (2008) Nanotechnology, 19, p. 8. , 495707; Li, F., Qi, L., Yang, J., Xu, M., Luo, X., Ma, D., (2000) J Appl Polym Sci, 75, pp. 68-77; Moniruzzaman, M., Winey, K.I., (2006) Macromolecules, 39, pp. 5194-5205; Kim, H., Abdala, A.A., Macosko, C.W., (2010) Macromolecules, 43, pp. 6515-6530; Kuan, H.C., Ma, C.C.M., Chang, W.P., Yuen, S.M., Wu, H.H., Lee, T.M., (2005) Compos Sci Technol, 65, pp. 1703-1710; Cho, J.W., Kim, J.W., Jung, Y.C., Goo, N.S., (2005) Macromol Rapid Commun, 26, pp. 412-416; Gu, X., Wu, J., Mather, P.T., (2011) Biomacromolecules, 12, pp. 3066-3077; Novoselov, K.S., Geim, S.V., Morozov, S.V., Jiang, D., Zhang, Y., Dubonos, S.V., (2004) Science, 306, pp. 666-669; Lalit, S., Henrard, L., (2006) Phys Rev Lett, 97, p. 4. , 036803; Shen, H., Zhang, L., Liu, M., Zhang, Z., (2012) Theranostics, 2, pp. 283-294; Wang, X., Hu, Y., Song, L., Yang, H., Xing, W., Lu, H., (2011) J Mater Chem, 21, pp. 4222-4227; Kim, H., Miura, Y., Macosko, C.W., (2010) Chem Mater, 22, pp. 3441-3450; Choi, J.T., Dao, T.D., Oh, K.M., Lee, H.I., Jeong, H.M., Kim, B.K., (2012) Smart Mater Struct, 21, p. 9. , 075017; Lee, W.C., Lim, C.H.Y.X., Shi, H., Tang, L.A.L., Wang, Y., Lim, C.T., Loh, K.P., (2011) ACS Nano, 5, pp. 7334-7341; Srivastava, S., Bedi, U., Roy, P., (2012) Mol Cell Endocrin, 361, pp. 153-164; Cao, Y.W., Feng, J.C., Wu, P.Y., (2010) Carbon, 48, pp. 3834-3839; Prosa, T.J., Winokur, M.J., Moulton, J., Smith, P., Heeger, A.J., (1992) Macromolecules, 25, pp. 4364-4372; Raghu, A.V., Lee, Y.R., Jeong, H.M., Shin, C.M., (2008) Macromol Chem Phys, 209, pp. 2487-2493; Nguyen, D.A., Lee, Y.R., Raghu, A.V., Jeong, H.M., Shin, C.M., Kim, B.K., (2009) Polym Int, 58, pp. 412-417; Liang, J., Huang, Y., Zhang, L., Wang, Y., Ma, Y., Guo, T., (2009) Adv Funct Mater, 19, pp. 2297-2302; Rogulska, M., Kultys, A., Podkos̈cielny, W., (2007) Eur Polym J, 43, pp. 1402-1414; Gilman, J.W., Jackson, C.L., Morgan, A.B., Harris, Jr.R., Manias, E., Giannelis, E.P., (2000) Chem Mater, 12, pp. 1866-1873; Singh, N.K., Singh, S.K., Dash, D., Purkayastha, B.P.D., Roy, J.K., Maiti, P., (2012) J Mater Chem, 22, pp. 17853-17863; Schierholz, J.M., Steinhauser, H., Rump, A.F.E., Berkels, R., Pulverer, G., (1997) Biomaterials, 18, pp. 839-844; Kwok, C.S., Horbett, T.A., Ranter, B.D., (1999) J Control Release, 62, pp. 301-311; Depan, D., Kumar, A.P., Singh, R.P., (2009) Acta Biomater, 5, pp. 93-100; Zhu, S., Zhang, J., Qiao, C., Tang, S., Li, Y., Yuan, W., (2011) Chem Commun, 47, pp. 6858-6860; Nayak, T.R., Andersen, H., Makam, V.S., Khaw, C., Bae, S., Xu, X., (2011) ACS Nano, 5, pp. 4670-4678; Leenaerts, O., Partoens, B., Peeters, F.M., (2009) Phys Rev B, 79, p. 5. , 235440; Kalbacova, M., Broz, A., Kong, J., Kalbac, M., (2010) Carbon, 48, pp. 4323-4329",Article,Scopus,2-s2.0-84927613803
"Gurruchaga H., Ciriza J., Saenz Del Burgo L., Rodriguez-Madoz J.R., Santos E., Prosper F., Hernandez R.M., Orive G., Pedraz J.L.","Cryopreservation of microencapsulated murine mesenchymal stem cells genetically engineered to secrete erythropoietin",2015,"International Journal of Pharmaceutics","485","1-2", 14683,"15","24",,,10.1016/j.ijpharm.2015.02.047,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925115535&partnerID=40&md5=16a60b7db7955c0f3bb3e974eef63610","NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, University of the Basque Country, UPV/EHUVitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, CIBER-BBNVitoria-Gasteiz, Spain; Division of Oncology, Foundation for Applied Medical Research, University of NavarraPamplona, Spain; Hematology and Cell Therapy, Clinica Universidad de Navarra, University of NavarraPamplona, Spain","Gurruchaga, H., NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, University of the Basque Country, UPV/EHUVitoria-Gasteiz, Spain, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, CIBER-BBNVitoria-Gasteiz, Spain; Ciriza, J., NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, University of the Basque Country, UPV/EHUVitoria-Gasteiz, Spain, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, CIBER-BBNVitoria-Gasteiz, Spain; Saenz Del Burgo, L., NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, University of the Basque Country, UPV/EHUVitoria-Gasteiz, Spain, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, CIBER-BBNVitoria-Gasteiz, Spain; Rodriguez-Madoz, J.R., Division of Oncology, Foundation for Applied Medical Research, University of NavarraPamplona, Spain; Santos, E., NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, University of the Basque Country, UPV/EHUVitoria-Gasteiz, Spain, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, CIBER-BBNVitoria-Gasteiz, Spain; Prosper, F., Hematology and Cell Therapy, Clinica Universidad de Navarra, University of NavarraPamplona, Spain; Hernández, R.M., NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, University of the Basque Country, UPV/EHUVitoria-Gasteiz, Spain, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, CIBER-BBNVitoria-Gasteiz, Spain; Orive, G., NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, University of the Basque Country, UPV/EHUVitoria-Gasteiz, Spain, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, CIBER-BBNVitoria-Gasteiz, Spain; Pedraz, J.L., NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, University of the Basque Country, UPV/EHUVitoria-Gasteiz, Spain, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, CIBER-BBNVitoria-Gasteiz, Spain","Abstract The ability to cryopreserve and store for long term the structure and function of therapeutic cells and tissues plays a pivotal role in clinical medicine. In fact, it is an essential pre-requisite for the commercial and clinical application of stem cells since preserves cells at low temperature and creates a reserve for future uses. This requisite may also affect the encapsulated stem cells. Several parameters should be considered on encapsulated cell cryopreservation such as the time and temperature during the cryopreservation process, or the cryoprotectant solutions used. In this study, we have compared the influence of penetrating and nonpenetrating cryoprotectants on the viability and functionality of encapsulated mesenchymal stem cells genetically modified to secrete erythropoeitin. Several cryoprotectant solutions combining DMSO, glycerol and trehalose at different concentrations were studied. Although almost no differences among the studied cryoprotectant solutions were observed on the differentiation potential of encapsulated mesenchymal stem cells, the penetrating cryoprotectant DMSO at a concentration of 10% displayed the best viability and erythropoietin secretion profile compared to the other cryoprotectant solutions. These results were confirmed after subcutaneous implantation of thawed encapsulated mesenchymal stem cells secreting erythropoeitin on Balb/c mice. The hematocrit levels of these animals increased to similar levels of those detected on animals transplanted with noncryopreserved encapsulated cells. Therefore, DMSO 10% represents the most suitable cryoprotectant solution among the solutions here studied, for encapsulated mesenchymal stem cells cryopreservation and its translation into the clinic. Similar studies should be performed for the encapsulation of other cell types before they can be translated into the clinic. © 2015 Elsevier B.V. All rights reserved.","Cryopreservation; Mesenchymal stem cells; Microencapsulation; Nanotechnology","Anderson, J.M., Rodriguez, A., Chang, D.T., Foreign body reaction to biomaterials (2008) Semin Immunol., 20, pp. 86-100; Beattie, G.M., Crowe, J.H., Lopez, A.D., Cirulli, V., Ricordi, C., Hayek, A., Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage (1997) Diabetes, 46, pp. 519-523; Cui, J.H., Cao, Q.R., Choi, Y.J., Lee, K.H., Lee, B.J., Effect of additives on the viability of bifidobacteria loaded in alginate poly-l-lysine microparticles during the freeze-drying process (2006) Arch. Pharm. Res., 29, pp. 707-711; Dang, S.M., Gerecht-Nir, S., Chen, J., Itskovitz-Eldor, J., Zandstra, P.W., Controlled, scalable embryonic stem cell differentiation culture (2004) Stem Cells, 22, pp. 275-282; De Castro, M., Orive, G., Hernandez, R.M., Gascon, A.R., Pedraz, J.L., Comparative study of microcapsules elaborated with three polycations (PLL, PDL, PLO) for cell immobilization (2005) J. Microencapsul., 22, pp. 303-315; De Vos, P., Fass, M.M., Strand, B., Calafiore, R., Alginate-based microcapsules for immunoisolation of pancreatic islets (2006) Biomaterials, 27, pp. 5603-5617; Fahy, G.M., Theoretical considerations for oocyte cryopreservation by freezing (2007) Reprod. Biomed. Online, 14, pp. 709-714; Garate, A., Murua, A., Orive, G., Hernandez, R.M., Pedraz, J.L., Stem cells in alginate bioscaffolds (2012) Ther. Deliv., 3, pp. 761-774; Gebler, A., Zabel, O., Seliger, B., The immunomodulatory capacity of mesenchymal stem cells (2012) Trends Mol. Med., 18, pp. 128-134; Gerecht, S., Burdick, J.A., Ferreira, L.S., Townsend, S.A., Langer, R., Vunjak-Novakovic, G., Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 11298-11303; Ginis, I., Grinblat, B., Shirvan, M.H., Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium (2012) Tissue Eng. Part C, 18, pp. 453-463; Goren, A., Dahan, N., Goren, E., Baruch, L., Machluf, M., Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy (2010) FASEB J., 24, pp. 22-31; Holt, W.V., Head, M.F., North, R.D., Freeze-induced membrane damage in ram spermatozoa is manifested after thawing: observations with experimental cryomicroscopy (1992) Biol. Reprod., 46, pp. 1086-1094; Hunt, C.J., Cryopreservation of human stem cells for clinical application: a review (2011) Transfus. Med. Hemother., 38, pp. 107-123; Ieropoli, S., Masullo, P., Santo Mdo, E., Sansone, G.I., Effects of extender composition, cooling rate and freezing on the fertilisation viability of spermatozoa of the Pacific oyster (Crassostrea gigas) (2004) Cryobiology, 49, pp. 250-257; Kobayashi, T., Harb, G., Rajotte, R.V., Korbutt, G.S., Mallett, A.G., Arefanian, H., Mok, D., Rayat, G.R., Immune mechanisms associated with the rejection of encapsulated neonatal porcine islet xenografts (2006) Xenotransplantation, 13, pp. 547-559; Li, Z., Leung, M., Hopper, R., Ellenbogen, R., Zhang, M., Feeder-free self-renewal of human embryonic stem cells in 3D porous natural polymer scaffolds (2010) Biomaterials, 31, pp. 404-412; Lim, F., Sun, A.M., Microencapsulated islets as bioartificial endocrine pancreas (1980) Science, 210, pp. 908-910; Lovelock, J.E., Bishop, M.W., Prevention of freezing damage to living cells by dimethyl sulphoxide (1959) Nature, 183, pp. 1394-1395; Maccario, R., Podesta, M., Moretta, A., Cometa, A., Comoli, P., Montagna, D., Daudt, L., Locatelli, F., Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype (2005) Haematologica, 90, pp. 516-525; Mauerer, A., Lee, G., Changes in the amide I FT-IR bands of poly-l-lysine on spray-drying from alpha-helix, beta-sheet or random coil conformations (2006) Eur. J. Pharm. Biopharm., 62, pp. 131-142; Da Silva Meirelles, L., Fontes, A.M., Covas, D.T., Caplan, A.I., Mechanisms involved in the therapeutic properties of mesenchymal stem cells (2009) Cytokine Growth Factor Rev., 20, pp. 419-427; Murua, A., De Castro, M., Orive, G., Hernandez, R.M., Pedraz, J.L., In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-l-lysine-alginate microcapsules (2007) Biomacromolecules, 8, pp. 3302-3307; Murua, A., Orive, G., Hernandez, R.M., Pedraz, J.L., Cryopreservation based on freezing protocols for the long-term storage of microencapsulated myoblasts (2009) Biomaterials, 30, pp. 3495-3501; Murua, A., Orive, G., Hernandez, R.M., Pedraz, J.L., Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression (2009) J. Control. Release, 137, pp. 174-178; Nauta, A.J., Kruisselbrink, A.B., Lurvink, E., Willemze, R., Fibbe, W.E., Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells (2006) J. Immunol., 177, pp. 2080-2087; Orive, G., De Castro, M., Ponce, S., Hernandez, R.M., Gascon, A.R., Bosch, M., Alberch, J., Pedraz, J.L., Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules (2005) Mol. Ther., 12, pp. 283-289; Orive, G., Santso, E., Pedraz, J.L., Hernandezd, R.M., Application of cell encapsulation for controlled delivery of biological therapeutics (2013) Adv. Drug Deliv. Rev., 67-68, pp. 3-14; Polge, C., Smith, A.U., Parkes, A.S., Revival of spermatozoa after vitrification and dehydration at low temperatures (1949) Nature, 164, p. 666; Ponce, S., Orive, G., Hernandez, R.M., Gascon, A.R., Canals, J.M., Munoz, M.T., Pedraz, J.L., In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules (2006) J. Control. Release, 116, pp. 28-34; Pravdyuk, A.I., Petrenko, Y.A., Fuller, B.J., Petrenko, A.Y., Cryopreservation of alginate encapsulated mesenchymal stromal cells (2013) Cryobiology, 66, pp. 215-222; Riazantsev, V.V., Gulevskii, A.K., Effectiveness of the cryoprotective effect of glycerol and polyethylene glycol on plasma membranes (1987) Ukr. Biokhim. Zh., 59, pp. 97-99; Sershen, Berjak, P., Pammenter, N.W., Wesley-Smith, J., Rate of dehydration, state of subcellular organisation and nature of cryoprotection are critical factors contributing to the variable success of cryopreservation: studies on recalcitrant zygotic embryos of Haemanthus montanus (2012) Protoplasma, 249, pp. 171-186; Shevde, L.A., Riker, A.I., Current concepts in biobanking: development and implementation of a tissue repository (2009) Front. Biosci. (School Ed.), 1, pp. 188-193; Shi, M., Liu, Z.W., Wang, F.S., Immunomodulatory properties and therapeutic application of mesenchymal stem cells (2011) Clin. Exp. Immunol., 164, pp. 1-8; Siti-Ismail, N., Bishop, A.E., Polak, J.M., Mantalaris, A., The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance (2008) Biomaterials, 29, pp. 3946-3952; Smillie, J.A., Munro, A.C., Wood, G.C., Mitchell, R., Cryopreservation of human platelets with polyvinylpyrrolidone (1981) Transfusion, 21, pp. 552-556; Son, J.H., Kim, K.H., Nam, Y.K., Park, J.K., Kim, S.K., Optimization of cryoprotectants for cryopreservation of rat hepatocyte (2004) Biotechnol. Lett., 26, pp. 829-833; Soon-Shiong, P., Heintz, R.E., Merideth, N., Yao, Q.X., Yao, Z., Zheng, T., Murphy, M., Harris, M., Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation (1994) Lancet, 343, pp. 950-951; Spuch, C., Antequera, D., Portero, A., Orive, G., Hernandez, R.M., Molina, J.A., Bermejo-Pareja, F., Carro, E., The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease (2010) Biomaterials, 31, pp. 5608-5618; Szurek, E.A., Eroglu, A., Comparison and avoidance of toxicity of penetrating cryoprotectants (2011) PLoS One, 6; Tasdemir, U., Buyukleblebici, S., Tuncer, P.B., Coskun, E., Ozgurtas, T., Aydin, F.N., Buyukleblebici, O., Gurcan, I.S., Effects of various cryoprotectants on bull sperm quality, DNA integrity and oxidative stress parameters (2013) Cryobiology, 66, pp. 38-42; Trusal, L.R., Guzman, A.W., Baker, C.J., Characterization of freeze-thaw induced ultrastructural damage to endothelial cells in vitro (1984) In Vitro, 20, pp. 353-364; Wikstrom, J., Elomaa, M., Nevala, L., Raikkonen, J., Heljo, P., Urtti, A., Yliperttula, M., Viability of freeze dried microencapsulated human retinal pigment epithelial cells (2012) Eur. J. Pharm. Sci., 47, pp. 520-526; Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Thomson, J.A., Induced pluripotent stem cell lines derived from human somatic cells (2007) Science, 318, pp. 1917-1920",Article,Scopus,2-s2.0-84925115535
"Hutchinson T.E., Zhong W., Chebolu S., Wilson S.M., Darmani N.A.","L-type calcium channels contribute to 5-HT3-receptor-evoked CaMKIIα and ERK activation and induction of emesis in the least shrew (Cryptotis parva)",2015,"European Journal of Pharmacology","755",,,"110","118",,,10.1016/j.ejphar.2015.02.042,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925395414&partnerID=40&md5=2496634fdd46f3304738f0f491fcdbbe","Department of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, 309 E. Second Street PomonaPomona, CA, United States; Center for Perinatal Biology, Loma Linda University School of MedicineLoma Linda, CA, United States","Hutchinson, T.E., Department of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, 309 E. Second Street PomonaPomona, CA, United States; Zhong, W., Department of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, 309 E. Second Street PomonaPomona, CA, United States; Chebolu, S., Department of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, 309 E. Second Street PomonaPomona, CA, United States; Wilson, S.M., Center for Perinatal Biology, Loma Linda University School of MedicineLoma Linda, CA, United States; Darmani, N.A., Department of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, 309 E. Second Street PomonaPomona, CA, United States","Activation of serotonergic 5-HT3 receptors by its selective agonist 2-methyl serotonin (2-Me-5-HT) induces vomiting, which is sensitive to selective antagonists of both 5-HT3 receptors (palonosetron) and L-type calcium channels (LTCC) (amlodipine or nifedipine). Previously we demonstrated that 5-HT3 receptor activation also causes increases in a palonosetron-sensitive manner in: i) intracellular Ca2+ concentration, ii) attachment of calmodulin (CaM) to 5-HT3 receptor, and iii) phosphorylation of Ca2+/calmodulin-dependent protein kinase IIα (CaMKIIα) and extracellular-signal-regulated kinase 1/2 (ERK1/2). Here, we investigate the role of the short-acting LTCC blocker nifedipine on 2-Me-5-HT-evoked intracellular Ca2+ increase and on downstream intracellular emetic signaling, which have been shown to be coupled with 2-Me-5-HT's emetic effects in the least shrew. Using the cell-permeant Ca2+ indicator fluo-4 AM, here we present evidence for the contribution of Ca2+ influx through LTCCs (sensitive to nifedipine) in 2-Me-5-HT (1 μM) -evoked rise in cytosolic Ca2+ levels in least shrew brainstem slices. Nifedipine pretreatment (10 mg/kg, s.c.) also suppressed 2-Me-5-HT-evoked interaction of 5-HT3 receptors with CaM as well as phosphorylation of CaMKIIα and ERK1/2 in the least shrew brainstem, and 5-HT3 receptors -CaM colocalization in jejunum of the small intestine. In vitro exposure of isolated enterochromaffin cells of the small intestine to 2-Me-5-HT (1 μM) caused CaMKIIα phosphorylation, which was also abrogated by nifedipine pretreatment (0.1 μM). In addition, pretreatment with the CaMKII inhibitor KN62 (10 mg/kg, i.p.) suppressed emesis and also the activation of CaMKIIα, and ERK in brainstem caused by 2-Me-5-HT (5 mg/kg, i.p.). This study provides further mechanistic explanation for our published findings that nifedipine can dose-dependently protect shrews from 2-Me-5-HT-induced vomiting. © 2015 Elsevier B.V. All rights reserved.","5-HT3 receptor; Area postrema; Calcium-induced calcium release; CaMKII; Colocalization; Emesis; Enterochromaffin cells; ERK1/2; Intestine; L-type calcium channel; mmunoprecipitation","Albertino, D., Alijandro, S., Manuel, P., Paula, S., Paula, C., Patricio S-Da, S., Jorge, P., Acute hypotensive, natriuretic, and hormonal effects of nifedipine in salt-sensitive and salt-resistent black normotensive and hypertensive subjects (1999) J. Cardiovasc. Pharmacol., 34, pp. 346-353; Brooks, I.M., Tavalin, S.J., Ca2+/calmodulin-dependent protein kinase II inhibitors disrupt AKAP79-dependent PKC signaling to GluA1 AMPA receptors (2011) J. Biol. Chem, 286, pp. 6697-6706; Churchfield, S., (1990) The Natural History of Shrews, , Cornell Univ. Press, Comstock Publishing Associates Ithaca, NY; Croom, K.F., Wellington, K., Modified-release nifedipine: A review of the use of modified-release formulations in the treatment of hypertension and angina pectoris (2006) Drugs, 66, pp. 497-528; Darmani, N.A., Crim, J.L., Janoyan, J.J., Abad, J., Ramirez, J., A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: Evidence from the least shrew (2009) Brain Res., 1248, pp. 40-58; Darmani, N.A., Johnson, J.C., Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis (2004) Eur. J. Pharmacol., 488, pp. 201-212; Darmani, N.A., Ray, A.P., Evidence for a re-evaluation of the neurochemical and anatomical bases of chemotherapy-induced vomiting (2009) Chem. Rev., 109, pp. 3158-3199; Darmani, N.A., Zhao, W., Ahmad, B., The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew) (1999) J. Neural Transm., 106, pp. 1045-1061; Darmani, N.A., Zhong, W., Chebolu, S., Vaezi, M., Alkam, T., Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT3 receptor antagonist palonosetron in the least shrew (Cryptotis parva) (2014) Eur. J. Pharmacol., 722, pp. 2-12; Darmani, N.A., Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: A new experimental model of emesis (1998) J. Neural Transm., 105, pp. 1143-1154; Darmani, N.A., Dey, D., Chebolu, S., Amos, B., Kandpal, R., Alkam, T., Cisplatin causes over-expression of tachykinin NK(1) receptors and increases ERK1/2- and PKA-phosphorylation during peak immediate- and delayed-phase emesis in the least shrew (Cryptotis parva) brainstem (2013) Eur. J. Pharmacol., 698, pp. 161-169; Gustin, R.M., Shonesy, B.C., Robinson, S.L., Rentz, T.J., Baucum, A.J., II, Jalan-Sakrikar, N., Winder, D.G., Colbran, R.J., Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice (2011) Mol. Cell. Neurosci., 47, pp. 286-292; Hannon, J., Hoyer, D., Molecular biology of 5-HT receptors (2008) Behav. Brain Res., 195, pp. 198-213; Hargreaves, A.C., Gunthorpe, M.J., Taylor, C.W., Lummis, S.C., Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels (1996) Mol. Pharmacol., 50, pp. 1284-1294; Homma, K., Kitamura, Y., Ogawa, H., Oka, K., Serotonin induces the increase in intracellular Ca2+ that enhances neutrite outgrowth in PC12 cells via activation of 5-HT3 receptors and voltage-gated calcium channels (2006) J. Neurosci. Res., 84, pp. 316-325; Hudmon, A., Schulman, H., Neuronal Ca2+/calmodulin-dependent protein kinase II: The role of structure and autoregulation in cellular function (2002) Annu. Rev. Biochem., 71, pp. 473-510; Jin, D.Z., Guo, M.L., Xue, B., Fibuch, E.E., Choe, E.S., Mao, L.M., Wang, J.Q., Phosphorylation and feedback regulation of metabotropic glutamate receptor 1 by calcium/calmodulin-dependent protein kinase II (2013) J. Neurosci., 33, pp. 3402-3412; Johnston, K.D., Lu, Z., Rudd, J.A., Looking beyond 5-HT(3) receptors: A review of the wider role of serotonin in the pharmacology of nausea and vomiting (2014) Eur. J. Pharmacol., 722, pp. 13-25; Kovalevskaya, N.V., Van De Waterbeemd, M., Bokhovchuk, F.M., Bate, N., Bindels, R.J., Hoenderop, J.G., Vuister, G.W., Structural analysis of calmodulin binding to ion channels demonstrates the role of its plasticity in regulation (2013) Pflug. Arch., 465, pp. 1507-1519; Labasque, M., Reiter, E., Becamel, C., Bockaert, J., Marin, P., Physical interaction of calmodulin with the 5-hydroxytryptamine2C receptor C-terminus is essential for G protein-independent, arrestin-dependent receptor signaling (2008) Mol. Biol. Cell, 19, pp. 4640-4650; Lomax, R.B., Gallego, S., Novalbos, J., García, A.G., Warhurst, G., L-Type calcium channels in enterochromaffin cells from guinea pig and human duodenal crypts: An in situ study (1999) Gastroenterology, 117, pp. 1363-1369; Machu, T.K., Coultrap, S.J., Waugh, M.D., Hamilton, M.E., Mutation of putative phosphorylation sites in the 5-hydroxytryptamine3 receptor does not eliminate its modulation by ethanol (1999) Alcohol. Clin. Exp. Res., 23, pp. 12-17; Minami, M., Endo, T., Hirafuji, M., Hamaue, N., Liu, Y., Hiroshige, T., Nemoto, M., Yoshioka, M., Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity (2003) Pharmacol. Ther., 99, pp. 149-165; Minami, M., Taguchi, S., Kikuchi, T., Endo, T., Hamaue, N., Hiroshige, T., Liu, Y., Hirafuji, M., Effects of fluvoxamine, a selective serotonin re-uptake inhibitor, on serotonin release from the mouse isolated ileum (2003) Res. Commun. Mol. Pathol. Pharmacol., 113-114, pp. 115-131; Mockett, B.G., Guévremont, D., Wutte, M., Hulme, S.R., Williams, J.M., Abraham, W.C., Calcium/calmodulin-dependent protein kinase II mediates group i metabotropic glutamate receptor-dependent protein synthesis and long-term depression in rat hippocampus (2011) J. Neurosci., 31, pp. 7380-7391; Okazaki, K., Ishikawa, T., Inui, M., Tada, M., Goshima, K., Okamoto, T., Hidaka, H., KN-62, a specific Ca++/calmodulin-dependent protein kinase inhibitor, reversibly depresses the rate of beating of cultured fetal mouse cardiac myocytes (1994) J. Pharmacol. Exp. Ther, 270, pp. 1319-1324; Racké, K., Reimann, A., Schwörer, H., Kilbinger, H., Regulation of 5-HT release from enterochromaffin cells (1996) Behav. Brain Res., 73, pp. 83-87; Ray, A.P., Chebolu, S., Darmani, N.A., Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva) (2009) Pharmacol. Biochem. Behav., 94, pp. 211-218; Rondé, P., Nichols, R.A., 5-HT3 receptors induce rises in cytosolic and nuclear calcium in NG108-15 cells via calcium-induced calcium release (1997) Cell Calcium., 22, pp. 357-365; Sam, T.S., Cheng, J.T., Johnston, K.D., Kan, K.K., Ngan, M.P., Rudd, J.A., Wai, M.K., Yeung, J.H., Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew) (2003) Eur. J. Pharmacol., 472, pp. 135-145; Takenouchi, T., Munekata, E., Serotonin increases cytoplasmic Ca2+ concentration in PC12h cells: Effect of tachykinin peptides (1998) Neurosci. Lett., 246, pp. 141-144; Torii, Y., Saito, H., Matsuki, N., 5-Hydroxytryptamine is emetogenic in the house musk shrew, Suncus murinus (1991) Naunyn Schmiedebergs Arch Pharmacol., 344, pp. 564-567; Trudeau, M.C., Zagotta, W.N., Calcium/calmodulin modulation of olfactory and rod cyclic nucleotide-gated ion channels (2003) J. Biol. Chem., 278, pp. 18705-18708; Turner, J.H., Gelasco, A.K., Raymond, J.R., Calmodulin interacts with the third intracellular loop of the serotonin 5-hydroxytryptamine1A receptor at two distinct sites: Putative role in receptor phosphorylation by protein kinase C (2004) J. Biol. Chem., 279, pp. 17027-17037; Turner, J.H., Raymond, J.R., Interaction of calmodulin with the serotonin 5-hydroxytryptamine 2A receptor. A putative regulator of G protein coupling and receptor phosphorylation by protein kinase C (2005) J. Biol. Chem., 280, pp. 30741-30750; Ueno, S., Matsuki, N., Saito, H., Suncus murinus: A new experimental model in emesis research (1987) Life Sci., 41, pp. 513-518; Van Driessche, A., Sermijn, E., Paemeleire, K., Van Coster, R., Vogelaers, D., Cyclic vomiting syndrome: Case report and short review of the literature (2012) Acta Clin. Belg., 67, pp. 123-126; Wong, E.H.F., Clark, R., Leung, E., Loury, D., Binhaus, D.W., Jakeman, L., Parnes, H., Eglen, R.M., The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro (1995) Br. J. Pharmacol., 114, pp. 851-859; Young, K.A., Caldwell, J.H., Modulation of skeletal and cardiac voltage-gated sodium channels by calmodulin (2005) J. Physiol., 565, pp. 349-370; Zhong, W., Chebolu, S., Darmani, N.A., Broad-spectrum antiemetic efficacy of the L-type calcium channel blocker amlodipine in the least shrew (Cryptotis parva) (2014) Pharmacol. Biochem. Behav., 120, pp. 124-132; Zhong, W., Hutchinson, T.E., Chebolu, S., Darmani, N.A., Serotonin 5-HT3 receptor-mediated vomiting occurs via the activation of Ca2+/CaMKII-dependent ERK1/2 signaling in the least shrew (Cryptotis parva) (2014) PLoS One, 9, p. e104718",Article,Scopus,2-s2.0-84925395414
"Wang P.-Y., Lee H.H.-C., Higuchi A., Ling Q.-D., Lin H.-R., Li H.-F., Suresh Kumar S., Chang Y., Alarfaj A.A., Munusamy M.A., Chen D.-C., Hsu S.-T., Wang H.-C., Hsiao H.-Y., Wu G.-J.","Pluripotency maintenance of amniotic fluid-derived stem cells cultured on biomaterials",2015,"Journal of Materials Chemistry B","3","18",,"3858","3869",,,10.1039/c5tb00447k,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928962848&partnerID=40&md5=b4d522c4f6b40c25dbc6bea7a4d51414","Department of Chemical and Materials Engineering, National Central University, No. 300 Jhongda RDJhongli Taoyuan, Taiwan; Department of Surgery, Cathay General Hospital, No. 280 Section 4 Ren'ai RoadTaipei, Taiwan; Graduate Institute of Translational and Interdisciplinary Medicine, National Central University, No. 300 Jhongda RDJhongli Taoyuan, Taiwan; Department of Botany and Microbiology, King Saud UniversityRiyadh, Saudi Arabia; Nano Medical Engineering Laboratory, RIKEN 2-1 Hirosawa WakoSaitama, Japan; Institute of Systems Biology and Bioinformatics, National Central University, No. 300 Jhongda RDJhongli Taoyuan, Taiwan; Cathay Medical Research Institute, Cathay General Hospital, No. 32 Ln 160 Jian-Cheng RoadHsi-Chi City Taipei, Taiwan; Department of Medical Microbiology and Parasitology, Universities Putra MalaysiaSerdang Slangor, Malaysia; Department of Chemical Engineering, RandD Center for Membrane Technology, Chung Yuan Christian University, 200 Chung-Bei RdChungli Taoyuan, Taiwan; Department of Obstetrics, Gynaecology Taiwan Landseed Hospital, 77 Kuangtai RoadPingjen City Taoyuan, Taiwan; Department of Internal, Medicine Taiwan Landseed Hospital, 77 Kuangtai RoadPingjen City Taoyuan, Taiwan; Hungchi Women and Children's Hospital, No. 233 Yuanhua RdJhongli Taoyuan, Taiwan; Material and Chemical Research Laboratories, Industrial Technology Research Institute, No. 321 Sec. 2 Guangfu Rd East Dist.Hsinchu, Taiwan; Graduate Institute of Medical Sciences, Department of Obstetrics and Gynecology, Tri-Service General HospitalTaipei 114, Taiwan","Wang, P.-Y., Department of Chemical and Materials Engineering, National Central University, No. 300 Jhongda RDJhongli Taoyuan, Taiwan; Lee, H.H.-C., Department of Surgery, Cathay General Hospital, No. 280 Section 4 Ren'ai RoadTaipei, Taiwan, Graduate Institute of Translational and Interdisciplinary Medicine, National Central University, No. 300 Jhongda RDJhongli Taoyuan, Taiwan; Higuchi, A., Department of Chemical and Materials Engineering, National Central University, No. 300 Jhongda RDJhongli Taoyuan, Taiwan, Department of Botany and Microbiology, King Saud UniversityRiyadh, Saudi Arabia, Nano Medical Engineering Laboratory, RIKEN 2-1 Hirosawa WakoSaitama, Japan; Ling, Q.-D., Institute of Systems Biology and Bioinformatics, National Central University, No. 300 Jhongda RDJhongli Taoyuan, Taiwan, Cathay Medical Research Institute, Cathay General Hospital, No. 32 Ln 160 Jian-Cheng RoadHsi-Chi City Taipei, Taiwan; Lin, H.-R., Department of Chemical and Materials Engineering, National Central University, No. 300 Jhongda RDJhongli Taoyuan, Taiwan; Li, H.-F., Department of Chemical and Materials Engineering, National Central University, No. 300 Jhongda RDJhongli Taoyuan, Taiwan; Suresh Kumar, S., Department of Medical Microbiology and Parasitology, Universities Putra MalaysiaSerdang Slangor, Malaysia; Chang, Y., Department of Chemical Engineering, RandD Center for Membrane Technology, Chung Yuan Christian University, 200 Chung-Bei RdChungli Taoyuan, Taiwan; Alarfaj, A.A., Department of Botany and Microbiology, King Saud UniversityRiyadh, Saudi Arabia; Munusamy, M.A., Department of Botany and Microbiology, King Saud UniversityRiyadh, Saudi Arabia; Chen, D.-C., Department of Obstetrics, Gynaecology Taiwan Landseed Hospital, 77 Kuangtai RoadPingjen City Taoyuan, Taiwan; Hsu, S.-T., Department of Internal, Medicine Taiwan Landseed Hospital, 77 Kuangtai RoadPingjen City Taoyuan, Taiwan; Wang, H.-C., Hungchi Women and Children's Hospital, No. 233 Yuanhua RdJhongli Taoyuan, Taiwan; Hsiao, H.-Y., Material and Chemical Research Laboratories, Industrial Technology Research Institute, No. 321 Sec. 2 Guangfu Rd East Dist.Hsinchu, Taiwan; Wu, G.-J., Graduate Institute of Medical Sciences, Department of Obstetrics and Gynecology, Tri-Service General HospitalTaipei 114, Taiwan","The stem cell fates of pluripotency and differentiation are regulated by not only soluble biological cues but also insoluble biochemical cues (i.e., extracellular matrix (ECM)) and the physical cues of cell culture biomaterials (i.e., elasticity). We investigated the maintenance of pluripotency and the differentiation lineages of human amniotic fluid-derived stem cells (hAFSCs) cultured on poly(vinyl alcohol-co-itaconic acid) (PVA) hydrogels grafted with several types of ECM and corresponding oligopeptides in expansion medium. hAFSCs cultured on soft PVA hydrogels (12.2 kPa) that were grafted with oligopeptides derived from fibronectin and vitronectin showed high pluripotency, which was evaluated by Oct4, Sox2 and Nanog expression. The hAFSCs grown on soft PVA hydrogels (12.2 kPa) grafted with each oligopeptide showed higher pluripotency, as assessed by Oct4 and Nanog expression, than hAFSCs grown on stiff PVA hydrogels (25.3 kPa) grafted with the same oligopeptides and a much higher pluripotency than those grown on rigid tissue-culture polystyrene dishes. Soft biomaterials appeared to be adequate to maintain the pluripotency of hAFSCs. Surprisingly, hAFSCs that showed higher pluripotency on PVA hydrogels grafted with oligopeptides derived from fibronectin and vitronectin also expressed higher levels of early differentiation markers for three germ layers in expansion medium. This result suggests that hAFSCs are heterogeneous and that this population contains highly pluripotent stem cells and stem cells that can be easily differentiated. © 2015 The Royal Society of Chemistry.",,"Higuchi, A., Ling, Q.D., Hsu, S.T., Umezawa, A., (2012) Chem. Rev., 112, pp. 4507-4540; Tyndall, A., (2014) Nat. Rev. Rheumatol., 10, pp. 117-124; Barry, F., Murphy, M., (2013) Nat. Rev. Rheumatol., 9, pp. 584-594; Leri, A., Anversa, P., (2013) Nat. Rev. Cardiol., 10, pp. 372-373; Bianco, P., Cao, X., Frenette, P.S., Mao, J.J., Robey, P.G., Simmons, P.J., Wang, C.Y., (2013) Nat. Med., 19, pp. 35-42; Bai, L., Lennon, D.P., Caplan, A.I., Dechant, A., Hecker, J., Kranso, J., Zaremba, A., Miller, R.H., (2012) Nat. Neurosci., 15, pp. 862-870; Guan, M., Yao, W., Liu, R., Lam, K.S., Nolta, J., Jia, J., Panganiban, B., Lane, N.E., (2012) Nat. Med., 18, pp. 456-462; Higuchi, A., Ling, Q.D., Chang, Y., Hsu, S.T., Umezawa, A., (2013) Chem. Rev., 113, pp. 3297-3328; Stock, P., Bruckner, S., Ebensing, S., Hempel, M., Dollinger, M.M., Christ, B., (2010) Nat. Protoc., 5, pp. 617-627; Krampera, M., Marconi, S., Pasini, A., Galie, M., Rigotti, G., Mosna, F., Tinelli, M., Bonetti, B., (2007) Bone, 40, pp. 382-390; Ye, Y., Zeng, Y.M., Wan, M.R., Lu, X.F., (2011) Cell Biochem. Biophys., 59, pp. 179-184; Long, X., Olszewski, M., Huang, W., Kletzel, M., (2005) Stem Cells Dev., 14, pp. 65-69; Li, J., Zhu, L., Qu, X., Lin, R., Liao, L., Wang, J., Wang, S., Zhao, R.C., (2013) Stem Cells Dev., 22, pp. 1576-1587; Dave, S.D., Vanikar, A.V., Trivedi, H.L., (2013) Appl. Biochem. Biotechnol., 170, pp. 962-971; Timper, K., Seboek, D., Eberhardt, M., Linscheid, P., Christ-Crain, M., Keller, U., Muller, B., Zulewski, H., (2006) Biochem. Biophys. Res. Commun., 341, pp. 1135-1140; Xie, Q.P., Huang, H., Xu, B., Dong, X., Gao, S.L., Zhang, B., Wu, Y.L., (2009) Differentiation, 77, pp. 483-491; Higuchi, A., Ling, Q.D., Ko, Y.A., Chang, Y., Umezawa, A., (2011) Chem. Rev., 111, pp. 3021-3035; Higuchi, A., Ling, Q.D., Kumar, S., Munusamy, M., Alarfaj, A.A., Umezawa, A., Wu, G.J., (2014) Prog. Polym. Sci., 39, pp. 1348-1374; McMurray, R.J., Gadegaard, N., Tsimbouri, P.M., Burgess, K.V., McNamara, L.E., Tare, R., Murawski, K., Dalby, M.J., (2011) Nat. Mater., 10, pp. 637-644; Engler, A.J., Sen, S., Sweeney, H.L., Discher, D.E., (2006) Cell, 126, pp. 677-689; Chowdhury, F., Li, Y., Poh, Y.C., Yokohama-Tamaki, T., Wang, N., Tanaka, T.S., (2010) PLoS One, 5, p. e15655; Sun, Y., Villa-Diaz, L.G., Lam, R.H., Chen, W., Krebsbach, P.H., Fu, J., (2012) PLoS One, 7, p. e37178; Winer, J.P., Janmey, P.A., McCormick, M.E., Funaki, M., (2009) Tissue Eng., Part A, 15, pp. 147-154; Kumar, S.S., Hsiao, J.H., Ling, Q.D., Dulinska-Molak, I., Chen, G.P., Chang, Y., Chen, Y.H., Higuchi, A., (2013) Biomaterials, 34, pp. 7632-7644; Higuchi, A., Huang, S.C., Shen, P.Y., Ling, Q.D., Zhao, J.K., Chang, Y., Wang, H.C., Hsu, S.T., (2011) Curr. Nanosci., 7, pp. 893-901; Kellogg, R.A., Gomez-Sjoberg, R., Leyrat, A.A., Tay, S., (2014) Nat. Protoc., 9, pp. 1713-1726; Chen, D.C., Chen, L.Y., Ling, Q.D., Wu, M.H., Wang, C.T., Kumar, S.S., Chang, Y., Higuchi, A., (2014) Biomaterials, 35, pp. 4278-4287; Lu, H.E., Tsai, M.S., Yang, Y.C., Yuan, C.C., Wang, T.H., Lin, X.Z., Tseng, C.P., Hwang, S.M., (2011) Exp. Cell Res., 317, pp. 1895-1903; Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S., (2007) Cell, 131, pp. 861-872; Zheng, Z., Jian, J., Zhang, X.L., Zara, J.N., Yin, W., Chiang, M., Liu, Y., Soo, C., (2012) Biomaterials, 33, pp. 5821-5831; Tse, J.R., Engler, A.J., (2011) PLoS One, 6, p. e15978; Banerjee, A., Arha, M., Choudhary, S., Ashton, R.S., Bhatia, S.R., Schaffer, D.V., Kane, R.S., (2009) Biomaterials, 30, pp. 4695-4699; Wang, L.S., Boulaire, J., Chan, P.P.Y., Chung, J.E., Kurisawa, M., (2010) Biomaterials, 31, pp. 8608-8616; Du, J., Chen, X., Liang, X., Zhang, G., Xu, J., He, L., Zhan, Q., Yang, C., (2011) Proc. Natl. Acad. Sci. U. S. A., 108, pp. 9466-9471; Lanniel, M., Huq, E., Allen, S., Buttery, L., Williams, P.M., Alexander, M.R., (2011) Soft Matter, 7, pp. 6501-6514; Saha, K., Keung, A.J., Irwin, E.F., Li, Y., Little, L., Schaffer, D.V., Healy, K.E., (2008) Biophys. J., 95, pp. 4426-4438; Pek, Y.S., Wan, A.C.A., Ying, J.Y., (2010) Biomaterials, 31, pp. 385-391; Banks, J.M., Mozdzen, L.C., Harley, B.A.C., Bailey, R.C., (2014) Biomaterials, 35, pp. 8951-8959; Young, D.A., Choi, Y.S., Engler, A.J., Christman, K.L., (2013) Biomaterials, 34, pp. 8581-8588; Li, Z., Gong, Y.W., Sun, S.J., Du, Y., Lu, D.Y., Liu, X.F., Long, M., (2013) Biomaterials, 34, pp. 7616-7625; Zouani, O.F., Kalisky, J., Ibarboure, E., Durrieu, M.C., (2013) Biomaterials, 34, pp. 2157-2166; Wang, L.S., Du, C., Chung, J.E., Kurisawa, M., (2012) Acta Biomater., 8, pp. 1826-1837; Gilbert, P.M., Havenstrite, K.L., Magnusson, K.E., Sacco, A., Leonardi, N.A., Kraft, P., Nguyen, N.K., Blau, H.M., (2010) Science, 329, pp. 1078-1081; Melkoumian, Z., Weber, J.L., Weber, D.M., Fadeev, A.G., Zhou, Y., Dolley-Sonneville, P., Yang, J., Brandenberger, R., (2010) Nat. Biotechnol., 28, pp. 606-610",Article,Scopus,2-s2.0-84928962848
"Chen M.-M., Zhao G.-W., He P., Jiang Z.-L., Xi X., Xu S.-H., Ma D.-M., Wang Y., Li Y.-C., Wang G.-H.","Improvement in the neural stem cell proliferation in rats treated with modified ""shengyu"" decoction may contribute to the neurorestoration",2015,"Journal of Ethnopharmacology","165",,,"9","19",,,10.1016/j.jep.2015.02.037,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924261091&partnerID=40&md5=9a1faade61d6118ee95840da942b8053","Department of Neurophysiology and Neuropharmacology, Institute of Nautical Medicine, Nantong University, 9 Seyuan RoadChongchuan District, Nantong, Jiangsu, China; Department of Neurosurgery, People's Hospital of NingxiaYinchuan, Ningxia, China; Department of Neurosurgery and Chinese Medicine, People's Hospital of NantongJiangsu, China; Department of Neurology, People's Hospital of GaochengHebei, China","Chen, M.-M., Department of Neurophysiology and Neuropharmacology, Institute of Nautical Medicine, Nantong University, 9 Seyuan RoadChongchuan District, Nantong, Jiangsu, China; Zhao, G.-W., Department of Neurophysiology and Neuropharmacology, Institute of Nautical Medicine, Nantong University, 9 Seyuan RoadChongchuan District, Nantong, Jiangsu, China, Department of Neurology, People's Hospital of GaochengHebei, China; He, P., Department of Neurosurgery, People's Hospital of NingxiaYinchuan, Ningxia, China; Jiang, Z.-L., Department of Neurophysiology and Neuropharmacology, Institute of Nautical Medicine, Nantong University, 9 Seyuan RoadChongchuan District, Nantong, Jiangsu, China; Xi, X., Department of Neurosurgery and Chinese Medicine, People's Hospital of NantongJiangsu, China; Xu, S.-H., Department of Neurosurgery, People's Hospital of NingxiaYinchuan, Ningxia, China; Ma, D.-M., Department of Neurosurgery, People's Hospital of NingxiaYinchuan, Ningxia, China; Wang, Y., Department of Neurosurgery and Chinese Medicine, People's Hospital of NantongJiangsu, China; Li, Y.-C., Department of Neurosurgery, People's Hospital of NingxiaYinchuan, Ningxia, China; Wang, G.-H., Department of Neurophysiology and Neuropharmacology, Institute of Nautical Medicine, Nantong University, 9 Seyuan RoadChongchuan District, Nantong, Jiangsu, China","Ethnopharmacological relevance ""Shengyu"" decoction, a traditional Chinese medicine, has been used to treat diseases with deficit in ""qi"" and ""blood"". The modified ""Shengyu"" decoction (MSD) used in the present study was designed to treat traumatic brain injury (TBI) on the basis of the ""Shengyu"" decoction, in which additional four herbs were added. Many ingredients in these herbs have been demonstrated to be effective for the treatment of brain injury. The present study was performed to evaluate the neurorestorative effect and the underlying mechanisms of MSD on the rat brain after a TBI. Materials and methods TBI was induced in the right cerebral cortex of adult rats using Feeney's weight-drop method. Intragastrical administration of MSD (1.0 ml/200 g) was begun 6 h after TBI. The neurological functions and neuronal loss in the cortex and hippocampus were determined. The levels of nerve growth-related factors GDNF, NGF, NCAM, TN-C, and Nogo-A and the number of GFAP+/GDNF+, BrdU+/nestin+, BrdU+/NeuN+ immunoreactive cells in the brain ipsilateral to TBI were also measured. Moreover, the influences of MSD on these variables were observed at the same time. Results We found that treatment with MSD in TBI rats ameliorated the neurological functions and alleviated neuronal loss. MSD treatment elevated the expression of GDNF, NGF, NCAM, and TN-C, and inhibited the expression of Nogo-A. Moreover, MSD treatment increased the number of GFAP+/GDNF+, BrdU+/nestin+, and BrdU+/NeuN+ immunoreactive cells in the cortex and hippocampus. Conclusion The present results suggest that MSD treatment in TBI rats could improve the proliferation of neural stem/progenitor cells and differentiation into neurons, which may facilitate neural regeneration and tissue repair and thus contribute to the recovery of neurological functions. These effects of modified ""Shengyu"" decoction may provide a foundation for the use of MSD as a prescription of medicinal herbs in the traditional medicine to treat brain injuries in order to improve the neurorestoration. © 2015 Elsevier Ireland Ltd. All rights reserved.","""Shengyu"" decoction; Medicinal herbs; Neurorestoration; Rat; Traditional medicine; Traumaticbraininjury","Abaskharoun, M., Bellemare, M., Lau, E., Margolis, R.U., Glypican-1, phosphacan/receptor protein-tyrosine phosphatase-ζ/β and its ligand, tenascin-C, are expressed by neural stem cells and neural cells derived from embryonic stem cells (2010) ASN Neuro, 2, p. e00039; Allen, S.J., Watson, J.J., Shoemark, D.K., Barua, N.U., Patel, N.K., GDNF, NGF and BDNF as therapeutic options for neurodegeneration (2013) Pharmacology & Therapeutics, 138, pp. 155-175; Boutin, C., Schmitz, B., Cremer, H., Diestel, S., NCAM expression induces neurogenesis in vivo (2009) European Journal of Neuroscience, 30, pp. 1209-1218; Chang, H.M., But, P.P.H., (2001) Pharmacology and Applications of Chinese Materia Medica, , World Scientific Publishing Co. Pte. Ltd. Singapore; Chiu, S.C., Hung, H.S., Lin, S.Z., Chiang, E., Liu, D.D., Therapeutic potential of olfactory ensheathing cells in neurodegenerative diseases (2009) Journal of Molecular Medicine, 87, pp. 1179-1189; Corrigan, J.D., Selassie, A.W., Orman, J.A., The epidemiology of traumatic brain injury (2010) The Journal of Head Trauma Rehabilitation, 25, pp. 72-80; Dong, H., Gao, Z., Rong, H., Jin, M., Zhang, X., β-asarone reverses chronic unpredictable mild stress-induced depression-like behavior and promotes hippocampal neurogenesis in rats (2014) Molecules, 19, pp. 5634-5649; Duan, S.R., Wang, J., Teng, W., Xu, R., Expression of nestin and glial-derived neurotrophic factor in human endogenous neural stem cells following ischemia (2010) Neurological Research, 32, pp. 835-840; Feeney, D.M., Boyeson, M.G., Linn, R.T., Murray, H.M., Dail, W.G., Responses to cortical injury: I. Methodology and local effects of contusions in the rat (1981) Brain Research, 211, pp. 67-77; Feigin, V.L., Theadom, A., Barker-Collo, S., Starkey, N.J., McPherson, K., Kahan, M., Dowell, A., Ameratunga, S., Incidence of traumatic brain injury in New Zealand: A population-based study (2013) The Lancet Neurology, 12, pp. 53-64. , BIONIC Study Group; Gean, A.D., Fischbein, N.J., Head trauma (2010) Neuroimaging Clinics of North America, 20, pp. 527-556; Gögel, S., Gubernator, M., Minger, S.L., Progress and prospects: Stem cells and neurological diseases (2011) Gene Therapy, 18, pp. 1-6; Guo, G., Li, B., Wang, Y., Shan, A., Shen, W., Yuan, L., Zhong, S., Effects of salvianolic acid B on proliferation, neurite outgrowth and differentiation of neural stem cells derived from the cerebral cortex of embryonic mice (2010) Science China Life Sciences, 53, pp. 653-662; Hannila, S.S., Kawaja, M.D., Nerve growth factor-induced growth of sympathetic axons into the optic tract of mature mice is enhanced by an absence of p75NTR expression (1999) Journal of Neurobiology, 39, pp. 51-66; Hu, B.Y., Liu, X.J., Qiang, R., Jiang, Z.L., Xu, L.H., Wang, G.H., Li, X., Peng, B., Treatment with ginseng total saponins improves the neurorestoration of rat after traumatic brain injury (2014) Journal of Ethnopharmacology, 155, pp. 1243-1255; Hyder, A.A., Wunderlich, C.A., Puvanachandra, P., Gururaj, G., Kobusingye, O.C., The impact of traumatic brain injuries: A global perspective (2007) NeuroRehabilitation, 22, pp. 341-353; Jablonska, A., Lukomska, B., Stroke induced brain changes: Implications for stem cell transplantation (2011) Acta Neurobiologiae Experimentalis, 71, pp. 74-85; Ji, Y.B., Yu, L., Kong, Q., Ma, H.T., Wang, X.J., Sun, A.X., Zhang, G.J., Jiang, H., (2005) Pharmacology and Applications of Compound Chinese Materia Medica, , China Medical Science Press Beijing, China; Leker, R.R., Fate and manipulations of endogenous neural stem cells following brain ischemia (2009) Expert Opinion on Biological Therapy, 9, pp. 1117-1125; Liang, W., Ge, S., Yang, L., Yang, M., Ye, Z., Yan, M., Du, J., Luo, Z., Ginsenosides Rb1 and Rg1 promote proliferation and expression of neurotrophic factors in primary Schwann cell cultures (2010) Brain Research, 1357, pp. 19-25; Liu, J.W., Tian, S.J., De Barry, J., Luu, B., Panaxadiol glycosides that induce neuronal differentiation in neurosphere stem cells (2007) Journal of Natural Products, 70, pp. 1329-1334; Liu, G.S., Zang, S.H., (2004) Secret Book of Orchid Chamber, 3. , Science and Technology Press Tianjin, China; Meiners, S., Mercado, M.L., Nur-E-Kamal, M.S., Geller, H.M., Tenascin-C contains domains that independently regulate neurite outgrowth and neurite guidance (1999) The Journal of Neuroscience, 19, pp. 8443-8453; Pernet, V., Schwab, M.E., The role of Nogo-A in axonal plasticity, regrowth and repair (2012) Cell & Tissue Research, 349, pp. 97-104; Picard-Riera, N., Nait-Oumesmar, B., Baron-Van Evercooren, A., Endogenous adult neural stem cells: Limits and potential to repair the injured central nervous system (2004) Journal of Neuroscience Research, 76, pp. 223-231; Rice, A.C., Khaldi, A., Harvey, H.B., Salman, N.J., White, F., Fillmore, H., Bullock, M.R., Proliferation and neuronal differentiation of mitotically active cells following traumatic brain injury (2003) Experimental Neurology, 183, pp. 406-417; Richardson, R.M., Singh, A., Sun, D., Fillmore, H.L., Dietrich, D.W., Bullock, M.R., Stem cell biology in traumatic brain injury: Effects of injury and strategies for repair (2010) Journal of Neurosurgery, 112, pp. 1125-1138; Richardson, R.M., Sun, D., Bullock, M.R., Neurogenesis after traumatic brain injury (2007) Neurosurgery Clinics of North America., 18, pp. 169-181; Rigato, F., Garwood, J., Calco, V., Heck, N., Faivre-Sarrailh, C., Faissner, A., Tenascin-C promotes neurite outgrowth of embryonic hippocampal neurons through the alternatively spliced fibronectin type III BD domains via activation of the cell adhesion molecule F3/contactin (2002) The Journal of Neuroscience, 22, pp. 6596-6609; Rovegno, M., Soto, P.A., Sáez, J.C., Von Bernhardi, R., Biological mechanisms involved in the spread of traumatic brain damage (2012) Medicina Intensiva, 36, pp. 37-44; Schmid, R.S., Maness, P.F., L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth (2008) Current Opinion in Neurobiology, 18, pp. 245-250; Shear, D.A., Tate, C.C., Tate, M.C., Archer, D.R., Laplaca, M.C., Stein, D.G., Dunbar, G.L., Stem cell survival and functional outcome after traumatic brain injury is dependent on transplant timing and location (2011) Restorative Neurology and Neuroscience, 29, pp. 215-225; Shen, L.H., Zhang, J.T., Ginsenoside Rg1 promotes proliferation of hippocampal progenitor cells (2004) Neurological Research, 26, pp. 422-428; Shen, L.H., Zhang, J.T., NMDA receptor and iNOS are involved in the effects of ginsenoside Rg1 on hippocampal neurogenesis in ischemic gerbils (2007) Neurological Research, 29, pp. 270-273; Sun, D., Colello, R.J., Daugherty, W.P., Kwon, T.H., McGinn, M.J., Harvey, H.B., Bullock, M.R., Cell proliferation and neuronal differentiation in the dentate gyrus in juvenile and adult rats following traumatic brain injury (2005) Journal of Neurotrauma, 22, pp. 95-105; Tian, Y., Liu, Y., Chen, X., Zhang, H., Shi, Q., Zhang, J., Yang, P., Tetramethylpyrazine promotes proliferation and differentiation of neural stem cells from rat brain in hypoxic condition via mitogen-activated protein kinases pathway in vitro (2010) Neuroscience Letters, 474, pp. 26-31; Tohda, C., Tamura, T., Matsuyama, S., Komatsu, K., Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus (2006) British Journal of Pharmacology, 149, pp. 532-541; Vaquero, J., Zurita, M., Functional recovery after severe CNS trauma: Current perspectives for cell therapy with bone marrow stromal cells (2010) Progress in Neurobiology, 93, pp. 341-349; Walsh, G.S., Krol, K.M., Crutcher, K.A., Kawaja, M.D., Enhanced neurotrophin-induced axon growth in myelinated portions of the CNS in mice lacking the p75 neurotrophin receptor (1999) The Journal of Neuroscience, 19, pp. 4155-4168; Wang, Z.J., Nie, B.M., Chen, H.Z., Lu, Y., Panaxynol induces neurite outgrowth in PC12D cells via cAMP- and MAP kinase-dependent mechanisms (2006) Chemico-Biological Interactions, 159, pp. 58-64; Wang, T., Xiong, J.Q., Ren, X.B., Sun, W., The role of Nogo-A in neuroregeneration: A review (2012) Brain Research Bulletin, 87, pp. 499-503; Wu, Q., Golden Mirror of Medicine (1957) Correction of Drugs in the Prescriptions from Famous Doctors, 3. , People's Medical Publishing House Co. Ltd. Beijing, China; Xiao, X., Liu, Y., Qi, C., Qiu, F., Chen, X., Zhang, J., Yang, P., Neuroprotection and enhanced neurogenesis by tetramethylpyrazine in adult rat brain after focal ischemia (2010) Neurological Research, 32, pp. 547-555; Xin, J., Zhang, J., Yang, Y., Deng, M., Xie, X., Radix Angelica Sinensis that contains the component Z-ligustilide promotes adult neurogenesis to mediate recovery from cognitive impairment (2013) Current Neurovascular Research, 10, pp. 304-315; Xiong, Y., Mahmood, A., Chopp, M., Neurorestorative treatments for traumatic brain injury (2010) Discovery Medicine, 10, pp. 434-442; Xiong, Y., Mahmood, A., Chopp, M., Angiogenesis, neurogenesis and brain recovery of function (2010) Current Opinion in Investigational Drugs, 11, pp. 298-308; Yoneyama, M., Shiba, T., Hasebe, S., Ogita, K., Adult neurogenesis is regulated by endogenous factors produced during neurodegeneration (2011) Journal of Pharmacological Sciences, 115, pp. 425-432; Zhang, X., Chen, J., The mechanism of astragaloside IV promoting sciatic nerve regeneration (2013) Neural Regeneration Research, 8, pp. 2256-2265; Zhao, G.W., Wang, Y., Li, Y.C., Jiang, Z.L., Sun, L., Xi, X., He, P., Ke, K.F., The neuroprotective effect of modified ""shengyu"" decoction is mediated through an anti-inflammatory mechanism in the rat after traumatic brain injury (2014) Journal of Ethnopharmacology, 151, pp. 694-703; Zheng, G.Q., Cheng, W., Wang, Y., Wang, X.M., Zhao, S.Z., Zhou, Y., Liu, S.J., Wang, X.T., Ginseng total saponins enhance neurogenesis after focal cerebral ischemia (2011) Journal of Ethnopharmacology, 133, pp. 724-728",Article,Scopus,2-s2.0-84924261091
"Ribeiro T.G., Nascimento A.M., Henriques B.O., Chavez-Fumagalli M.A., Franca J.R., Duarte M.C., Lage P.S., Andrade P.H.R., Lage D.P., Rodrigues L.B., Costa L.E., Martins V.T., Faraco A.A.G., Coelho E.A.F., Castilho R.O.","Antileishmanial activity of standardized fractions of Stryphnodendron obovatum (Barbatimão) extract and constituent compounds",2015,"Journal of Ethnopharmacology","165",,,"238","242",,,10.1016/j.jep.2015.02.047,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925436629&partnerID=40&md5=7095aa4853946ad7b99683b3702d8f67","Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Programa de Pos-Graduacao em Ciencias da Saude: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Departamento de Patologia Clínica, COLTEC, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil","Ribeiro, T.G., Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Nascimento, A.M., Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Henriques, B.O., Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Chávez-Fumagalli, M.A., Programa de Pos-Graduacao em Ciencias da Saude: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Franca, J.R., Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Duarte, M.C., Programa de Pos-Graduacao em Ciencias da Saude: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Lage, P.S., Programa de Pos-Graduacao em Ciencias da Saude: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Andrade, P.H.R., Departamento de Patologia Clínica, COLTEC, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Lage, D.P., Departamento de Patologia Clínica, COLTEC, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Rodrigues, L.B., Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Costa, L.E., Programa de Pos-Graduacao em Ciencias da Saude: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Martins, V.T., Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Faraco, A.A.G., Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil, Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Coelho, E.A.F., Programa de Pos-Graduacao em Ciencias da Saude: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil, Departamento de Patologia Clínica, COLTEC, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil; Castilho, R.O., Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil, Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Minas Gerais, Brazil","Ethnopharmacological relevance Stryphnodendron obovatum Benth. is a Brazilian tree used to treat skin ulceration, promote wound healing, and inhibit the growth of protozoa, including Trypanosoma and Leishmania species. Bioguided fractionation of the ethanol extract of S. obovatum stem bark was performed, and antileishmanial and antioxidant activities of the standardized fractions were analyzed. Materials and methods Stationary-phase Leishmania amazonensis promastigotes, murine macrophages, and human red blood cells (RBCs) were exposed to plant extract, standardized fractions or isolated compounds for 48 h at 37 °C to evaluate their antiparasitic activity and cytotoxicity. The 2,2-diphenyl-1-picryl-hidrazyl assay was used to evaluate antioxidant activity. Results The S. obovatum extract and fractions showed antileishmanial and antioxidant activity; however, the organic fraction (OF) showed the best efficacy. We identified gallic acid, gallocatechin, epigallocatechin, catechin, and epigallocatechin gallate in the OF fraction. These compounds effectively inhibited L. amazonensis activity, with gallic acid, gallocatechin, and epigallocatechin gallate showing the highest selectivity. Furthermore, the evaluated compounds had no significant effect on murine macrophages and human RBCs. Conclusions The compounds present in the S. obovatum plant bark ethanol extract may provide an alternative therapeutic approach for L. amazonensis treatment. © 2015 Published by Elsevier Ireland Ltd.","Antioxidant; Cerrado; Gallic acid; Gallocatechin; Leishmania amazonensis; Tannins","Alvar, J., Vélez, I.D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., Den Boer, M., Leishmaniasis worldwide and global estimates of its incidence (2012) PLoS ONE, 7, p. e35671; Bocedi, A., Dawood, K.F., Fabrini, R., Federici, G., Gradoni, L., Pedersen, J.Z., Ricci, G., Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites (2010) FASEB J., 24, pp. 1035-1042; Coelho, E.A.F., Tavares, C.A.P., Carvalho, F.A.A., Chaves, K.F., Teixeira, K.N., Rodrigues, R.C., Charest, H., Fernandes, A.P., Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection (2003) Infect. Immun., 71, pp. 3988-3994; Colotti, G., Ilari, A., Polyamine metabolism in Leishmania: From arginine to trypanothione (2011) Amino Acids, 40, pp. 269-285; Costa, D.F.G., Franca, J.R., Ribeiro, T.G., Kaplan, M.A.C., Faraco, A.A.G., Castilho, R.O., Development and characterization of polymeric nanoparticles as Barbatimão (Stryphnodendron obovatum) standardized fraction (2013) Adv. Biosci. Biotechnol., 4, pp. 89-92; Desjeux, P., Leishmaniasis: Current situation and new perspectives (2004) Comp. Immunol. Microbiol. Infect. Dis., 27, pp. 305-318; Farias, K.S., Santos, T.S.N., Paiva, M.R.A.B., Almeida, S.M.L., Guedes, P.T., Vianna, C.A., Favaro, S.P., Castilho, R.O., Antioxidant properties of species from the Brazilian cerrado by different assays (2013) Braz. J. Med. Plants, 15, pp. 520-528; Heby, O., Persson, L., Rentala, M., Targeting the polyamine biosynthetic enzymes: A promising approach to therapy of African sleeping sickness, Chagas disease, and leishmaniasis (2007) Amino Acids, 33, pp. 359-366; Inacio, J.D.F., Canto-Cavalheiro, M.M., Menna-Barreto, R.F.S., Almeida-Amaral, E.E., Mitochondrial damage contribute to epigallocatechin-3-gallate induced death in Leishmania amazonensis (2012) Exp. Parasitol., 132, pp. 151-155; Kedzierski, L., Sakthianandeswaren, A., Curtis, J.M., Andrews, P.C., Junk, P.C., Kedzierska, K., Leishmaniasis: Current treatment and prospect for new drugs and vaccines (2009) Curr. Med. Chem., 16, pp. 599-614; Kolodziej, H., Kayser, O., Kiderlen, A.F., Ito, H., Hatano, T., Yoshida, T., Foo, L.Y., Antileishmanial activity of hydrolyzable tannins and their modulatory effects on nitric oxide and tumour necrosis factor-α release in macrophages in vitro (2001) Planta Med., 9, pp. 825-832; Kolodziej, H., Kiderlen, A.F., Antileishmanial activity and immune modulatory effects of tannins and related compounds on Leishmania parasitised RAW 264.7 cells (2005) Phytochemistry, 66, pp. 2056-2071; Lage, P.S., Andrade, P.H.D., Lopes, A.D.S., Chávez-Fumagalli, M.A., Valadares, D.G., Duarte, M.C., Pagliara-Lage, D., Coelho, E.A., Strychnos pseudoquina and its purified compounds present an effective in vitro antileishmanial activity (2013) Evid.-Based Complement. Altern. Med., 2013, p. 304354; Lopes, G.C., Sanches, A.C., Nakamura, C.V., Dias Filho, B.P., Hernandes, L., Mello, J.C.P., Influence of extracts of Stryphnodendron polyphyllum Mart and Stryphnodendron obovatum Benth. on the cicatrisation of cutaneous wounds in rats (2005) J. Ethnopharmacol., 99, pp. 265-272; Luize, P.S., Tiuman, T.S., Morello, L.G., Maza, P.K., Ueda-Nakamura, T., Dias-Filho, B.P., Cortez, D.A.G., Nakamura, C.V., Effects of medicinal extracts on growth of Leishmania (L.) amazonensis and Trypanosoma cruzi (2005) Braz. J. Pharm. Sci., 41, pp. 1-10; Mello, J.C.P., Petereit, F., Nahrstedt, A., A dimeric proanthocyanidin from Stryphnodendron adstringens (1999) Phytochemistry, 51, pp. 1105-1107; Nascimento, A.M.D., Guedes, P.T., Castilho, R.O., Vianna-Soares, C.D., Stryphnodendron adstringens (Mart.) Coville (Fabaceae) proanthocyanidins quantitation by RP-HPLC (2013) Braz. J. Pharm. Sci, 49, pp. 549-558; Okuda, T., Systematics and health effects of chemically distinct tannins in medicinal plants (2005) Phytochemistry, 66, pp. 2012-2031; Oliveira, D.R., Júnior, W.S.F., Bitu, V.C.N., Pinheiro, P.G., Menezes, C.D.A., Junior, F.E.B., Albuquerque, U.P., Menezes, I.R.A., Ethnopharmacological study of Stryphnodendron rotundifolium in two communities in the semi-arid region of northeastern Brazil (2014) Braz. J.Pharmacogn., 24, pp. 124-132; Oliveira, L.F., Schubach, A.O., Martins, M.M., Passos, S.L., Oliveira, R.V., Marzochi, M.C., Andrade, C.A., Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World (2011) Acta Trop., 118, pp. 87-96; Reis, M.B.D., Manjolin, L.C., Maquiaveli, C.C., Santos-Filho, O.A., Silva, E.R., Inhibition of Leishmania (Leishmania) amazonensis and Rat Arginases by Green Tea EGCG, (+)-Catechin and (-)-Epicatechin: A Comparative Structural Analysis of Enzyme-Inhibitor Interactions (2013) PLoS ONE, 8, p. e78387; Ribeiro, T.G., Chávez-Fumagalli, M.A., Valadares, D.G., França, J.R., Rodrigues, L.B., Lage, P.S., Duarte, M.C., Castilho, R.O., Antileishmanial activity and cytotoxicity of Brazilian plants (2014) Exp. Parasitol., 143, pp. 60-68; Ribeiro, T.G., Chávez-Fumagalli, M.A., Valadares, D.G., França, J.R., Rodrigues, L.B., Duarte, M.C., Lage, P.S., Faraco, A.A.G., Novel target using nanoparticles: Approach to develop an effective antileishmanial drug delivery system (2014) Int. J. Nanomed., 9, pp. 877-890; Saklani, A., Kutty, S.K., Plant-derived compounds in clinical trials (2008) Drug Discov. Today, 13, pp. 161-171; Sanches, A.C.C., Lopes, G.C., Toledo, C.E.M., Sacramento, L.V.S., Sakuragui, C.M., Mello, J.C.P., Estudo Morfológico Comparativo das Cascas e Folhas de Stryphnodendron adstringens, S. polyphyllum e S. obovatum- Leguminosae (2007) Lat. Am. J. Pharm., 26, pp. 362-368; Silva, M.F.D., Zampieri, R.A., Muxel, S.M., Beverley, S.M., Floeter-Winter, L.M., Leishmania amazonensis arginase compartmentalization in the glycosome is important for parasite infectivity (2012) PLoS ONE, 7, p. e34022; Souza, T.M., Severi, J.A., Silva, V.Y.A., Santos, E., Pietro, R.C.L., Bioprospection of antioxidant and antimicrobial activities in the bark of Stryphnodendron adstringens (Mart.) Coville (Leguminosae-Mimosoideae) (2007) Revista de Ciências Farmacêuticas Básica e Aplicada, 28, pp. 221-226; Tarascou, I., Souquet, J.M., Mazauric, J.P., Carrillo, S., Coq, S., Canon, F., Fulcrand, H., Cheynier, V., The hidden face of food phenolic composition (2010) Arch. Biochemis. Biophys., 501, pp. 16-22; Tasdemir, D., Kaiser, M., Brun, R., Yardley, V., Schmidt, T.J., Tosun, F., Rüedi, P., Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: In vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies (2006) Antimicrob. Agents Chemother., 50, pp. 1352-1364; Tepe, B., Degerli, S., Arslana, S., Malatyali, E., Sarikurkcu, C., Determination of chemical profile, antioxidant, DNA damage protection and antiamoebic activities of Teucrium polium and Stachys iberica (2011) Fitoterapia, 82, pp. 237-246; Wagner, H., Bladt, S., Zgainski, E.M., (1984) Plant Drug Analysis: A Thin Layer Chromatography Atlas, pp. 1-320. , Berlin, Springer Verlag Berlin; (2010) Control of the Leishmaniasis, pp. 1-186. , WHOE World Health Organization Technical Report Series no. 949",Article,Scopus,2-s2.0-84925436629
"Nembo E.N., Atsamo A.D., Nguelefack T.B., Kamanyi A., Hescheler J., Nguemo F.","In vitro chronotropic effects of Erythrina senegalensis DC (Fabaceae) aqueous extract on mouse heart slice and pluripotent stem cell-derived cardiomyocytes",2015,"Journal of Ethnopharmacology","165",,,"163","172",,,10.1016/j.jep.2015.02.002,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924358924&partnerID=40&md5=ebac726b082e182dc863912bf9652a43","Institute of Neurophysiology, University of CologneCologne, Germany; Laboratory of Animal Physiology and Phytopharmacology, Faculty of Science, University of Dschang, P.O. Box 67Dschang, Cameroon","Nembo, E.N., Institute of Neurophysiology, University of CologneCologne, Germany; Atsamo, A.D., Laboratory of Animal Physiology and Phytopharmacology, Faculty of Science, University of Dschang, P.O. Box 67Dschang, Cameroon; Nguelefack, T.B., Laboratory of Animal Physiology and Phytopharmacology, Faculty of Science, University of Dschang, P.O. Box 67Dschang, Cameroon; Kamanyi, A., Laboratory of Animal Physiology and Phytopharmacology, Faculty of Science, University of Dschang, P.O. Box 67Dschang, Cameroon; Hescheler, J., Institute of Neurophysiology, University of CologneCologne, Germany; Nguemo, F., Institute of Neurophysiology, University of CologneCologne, Germany","Ethnopharmacological relevance: Erythrina senegalensis DC (Fabaceae) bark is commonly used in sub-Saharan traditional medicine for the treatment of many diseases including gastrointestinal disorders and cardiovascular diseases. In this study, we investigated the effect of the aqueous extract of the stem bark of Erythrina senegalensis on the contractile properties of mouse ventricular slices and human induced pluripotent stem (hiPS) cell-derived cardiomyocytes. We also investigated the cytotoxic effect of the extract on mouse embryonic stem (ES) cells differentiating into cardiomyocytes (CMs). Materials and methods: We used well-established electrophysiological technologies to assess the effect of Erythrina senegalensis aqueous extract (ESAE) on the beating activity of mouse ventricular slices, mouse ES and hiPS cell-derived CMs. To study the cytotoxic effect of our extract, differentiating mouse ES cells were exposed to different concentrations of ESAE. EB morphology was assessed by microscopy at different stages of differentiation whereas cell viability was measured by flow cytometry, fluorometry and immunocytochemistry. The electrical activity of CMs and heart slices were respectively captured by the patch clamp technique and microelectrode array (MEA) method following ESAE acute exposure. Results: Our findings revealed that ESAE exhibits a biphasic chronotropic activity on mouse ventricular slices with an initial low dose (0.001 and 0.01 μg/mL) decrease in beating activity followed by a corresponding significant increase in chronotropic activity at higher doses above 10 μg/mL. The muscarinic receptor blocker, atropine abolished the negative chronotropic activity of ESAE, while propranolol successfully blocked its positive chronotropic activity. ESAE showed a significant dose-dependent positive chronotropic activity on hiPS cell-derived CMs. Also, though not significantly, ESAE decreased cell viability and increased total caspase-3/7 activity of mouse ES cells in a concentration-dependent manner. Conclusion: Erythrina senegalensis aqueous extract exhibits a biphasic chronotropic effect on mouse heart and a positive chronotropic activity on hiPS cell-derived CMs, suggesting a possible mechanism through muscarinic and β-adrenergic receptor pathways. Also, ESAE is not cytotoxic on mouse ES cells at concentrations up to 100 μg/mL. © 2015 Elsevier Ireland Ltd. All rights reserved.","Cardiomyocytes; Chronotropy; Erythrina senegalensis; Heart slice; Microelectrode arrays; Patch-clamp technique; Stem cells","Anago, E., Lagnika, L., Gbenou, J., Loko, F., Moudachirou, M., Sanni, A., Antibacterial activity and phytochemical study of six medicinal plants used in Benin (2011) Pakistan Journal of Biological Sciences, 14, pp. 449-455; Atsamo, A.D., Nene-Bi, A.S., Kouakou, K.L., Fofié, C.K., Nyadjeu, P., Watcho, P., Datté, J.Y., Nguelefack, T.B., Cardiovascular and antioxidant effects of the methanol extract from the stem bark of Erythrina Senegalensis DC (Fabaceae) (2013) Journal of Physiology and Pharmacology Advances, 3, pp. 110-120; Atsamo, A.D., Nguelefack, T.B., Datte, J.Y., Kamanyi, A., Acute and subchronic oral toxicity assessment of the aqueous extract from the stem bark of Erythrina senegalensis DC (Fabaceae) in rodents (2011) Journal of Ethnopharmacology, 134, pp. 697-702; Bussek, A., Schmidt, M., Bauriedl, J., Ravens, U., Wettwer, E., Lohmann, H., Cardiac tissue slices with prolonged survival for in vitro drug safety screening (2012) Journal of Pharmacological and Toxicological Methods, 66, pp. 145-151; Chandler, K.J., Barrier, M., Jeffay, S., Nichols, H.P., Kleinstreuer, N.C., Singh, A.V., Reif, D.M., Knudsen, T.B., Evaluation of 309 environmental chemicals using a mouse embryonic stem cell adherent cell differentiation and cytotoxicity assay. (2011) PloS One, 6, p. e18540; Chin, Y.W., Balunas, M.J., Chai, H.B., Kinghorn, A.D., Drug discovery from natural sources (2006) American Association of Pharmaceutical Scientists Journal, 8, pp. E239-E253; Deshmukh, R.S., Kovacs, K.A., Dinnyes, A., Drug discovery models and toxicity testing using embryonic and induced pluripotent stem-cell-derived cardiac and neuronal cells (2012) Stem Cells International, 2012, p. 379569; Donfack, J., Njayou, F., Rodrigue, T., Chuisseu, D., Tchana, N., Finzi, V., Tchounguep, M., Moundipa, F., Study of a hepatoprotective and antioxidant fraction from Erythrina Senegalensis stem bark extract: In vitro and in vivo (2008) Pharmacologyonline, 1, pp. 120-130; Doughari, J.H., Evaluation of antimicrobial potentials of stem bark extracts of Erythrina senegalensis (2010) African Journal of Microbiology Research, 4, pp. 1836-1841; Fatima, A., Kaifeng, S., Dittmann, S., Xu, G., Gupta, M.K., Linke, M., Zechner, U., Saric, T., The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome Type 3 patients (2013) PLoS One, 8, p. e83005; Festag, M., Viertel, B., Steinberg, P., Sehner, C., An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds (2007) Toxicology in Vitro, 21, pp. 1631-1640; Fleischmann, M., Bloch, W., Kolossov, E., Andressen, C., Muller, M., Brem, G., Hescheler, J., Fleischmann, B.K., Cardiac specific expression of the green fluorescent protein during early murine embryonic development (1998) Federation of European Biochemical Societies Letters, 440, pp. 370-376; Genschow, E., Spielmann, H., Scholz, G., Pohl, I., Seiler, A., Clemann, N., Bremer, S., Becker, K., Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests (2004) Alternatives to Laboratory Animals, 32, pp. 209-244; Genschow, E., Spielmann, H., Scholz, G., Seiler, A., Brown, N., Piersma, A., Brady, M., Becker, K., The ECVAM international validation study on in vitro embryotoxicity tests: Results of the definitive phase and evaluation of prediction models. European centre for the validation of alternative methods (2002) Alternatives to Laboratory Animals, 30, pp. 151-176; Goldberg, N.D., Haddox, M.K., Nicol, S.E., Glass, D.B., Sanford, C.H., Kuehl, F.A., Jr., Estensen, R., Biologic regulation through opposing influences of cyclic GMP and cyclic AMP: The Yin Yang hypothesis (1975) Advances in Cyclic Nucleotide Research, 5, pp. 307-330; Greenhough, S., Medine, C.N., Hay, D.C., Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening (2010) Toxicology, 278, pp. 250-255; Gurib-Fakim, A., Medicinal plants: Traditions of yesterday and drugs of tomorrow (2006) Molecular Aspects of Medicine, 27, pp. 1-93; Harvey, R., Muscarinic receptor agonists and antagonists: Effects on cardiovascular function (2012) Muscarinic Receptors, pp. 299-316. , A.D. Fryer, A. Christopoulos, N.M. Nathanson (Eds.), Springer Berlin Heidelberg; Hoskins, C., Wang, L., Cheng, W.P., Cuschieri, A., Dilemmas in the reliable estimation of the in-vitro cell viability in magnetic nanoparticle engineering: Which tests and what protocols? (2012) Nanoscale Research Letters, 7, p. 77; Johnstone, A.F.M., Gross, G.W., Weiss, D.G., Schroeder, O.H.U., Gramowski, A., Shafer, T.J., Microelectrode arrays: A physiologically based neurotoxicity testing platform for the 21st century (2010) Neurotoxicology, 31, pp. 331-350; Kolossov, E., Bostani, T., Roell, W., Breitbach, M., Pillekamp, F., Nygren, J.M., Sasse, P., Fleischmann, B.K., Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium (2006) Journal of Experimental Medicine, 203, pp. 2315-2327; Kone, W.M., Solange, K.N., Dosso, M., Assessing sub-Saharan Erythrina for efficacy: Traditional uses, biological activities and phytochemistry (2011) Pakistan Journal of Biological Sciences, 14, pp. 560-571; Mordwinkin, N.M., Burridge, P.W., Wu, J.C., A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards (2013) Journal of Cardiovascular Translational Research, 6, pp. 22-30; Mummery, C., Ward, D., Van Den Brink, C.E., Bird, S.D., Doevendans, P.A., Opthof, T., Brutel De La Riviere, A., Pera, M., Cardiomyocyte differentiation of mouse and human embryonic stem cells (2002) Journal of Anatomy, 200, pp. 233-242; Nembo, E.N., Dimo, T., Bopda, O.S.M., Hescheler, J., Nguemo, F., The proliferative and chronotropic effects of Brillantaisia nitens Lindau (Acanthaceae) extracts on pluripotent stem cells and their cardiomyocytes derivatives (2014) Journal of Ethnopharmacology, 156, pp. 73-81; Nene-Bi, S.A., Soro, T.Y., Zahoui, O.S., Traore, F., Pharmacological effects of the roots and the stem barks extracts of Erythrina senegalensis DC (Fabaceae) in mammalians (2013) International Journal of Pharmacognosy and Phytochemical Research, 14, pp. 254-258; Nguemo, F., Sasse, P., Fleischmann, B.K., Kamanyi, A., Schunkert, H., Hescheler, J., Reppel, M., Modulation of L-type Ca(2+) channel current density and inactivation by beta-adrenergic stimulation during murine cardiac embryogenesis (2009) Basic Research in Cardiology, 104, pp. 295-306; Nguemo, F., Semmler, J., Reppel, M., Hescheler, J., Modulation of L-type calcium current by intracellular magnesium in differentiating cardiomyocytes derived from induced pluripotent stem cells (2014) Stem Cells and Development, 23, pp. 1316-1327; Noori, S., Seri, I., Neonatal blood pressure support: The use of inotropes, lusitropes, and other vasopressor agents (2012) Clinics in Perinatology, 39, pp. 221-238; Obidah, W., Badung, H.L., Ajuji, J., Peter, H., Bello, H., Effects of Erythrina senegalensis aqueous leaf extract in rats (2014) American Journal of Research Communicationcan Journal of Research Communication, 2, pp. 179-185; Olshansky, B., Sabbah, H.N., Hauptman, P.J., Colucci, W.S., Parasympathetic nervous system and heart failure: Pathophysiology and potential implications for therapy (2008) Circulation, 118, pp. 863-871; Pfannkuche, K., Liang, H., Hannes, T., Xi, J., Fatima, A., Nguemo, F., Matzkies, M., Reppel, M., Cardiac myocytes derived from murine reprogrammed fibroblasts: Intact hormonal regulation, cardiac ion channel expression and development of contractility (2009) Cellular Physiology and Biochemistry, 24, pp. 73-86; Pillekamp, F., Reppel, M., Dinkelacker, V., Duan, Y., Jazmati, N., Bloch, W., Brockmeier, K., Koehling, R., Establishment and characterization of a mouse embryonic heart slice preparation (2005) Cellular Physiology and Biochemistry, 16, pp. 127-132; Rodeh, H.J., Eisel, D., Frost, I., (2000) Apoptosis, Cell Death and Cell Proliferation, pp. 2-6. , Mannheim: Roche Diagnostics GmbH 3rd ed; Rungarunlert, S., Techakumphu, M., Pirity, M.K., Dinnyes, A., Embryoid body formation from embryonic and induced pluripotent stem cells: Benefits of bioreactors (2009) World Journal of Stem Cells, 1, pp. 11-21; (2010) Atropine. Clinical Pharmacology, , http://www.rxlist.com/script/main/rxlist.asp?articlekey=65543&pf=3&page=6, assessed 29.08.2014; Sachinidis, A., Fleischmann, B.K., Kolossov, E., Wartenberg, M., Sauer, H., Hescheler, J., Cardiac specific differentiation of mouse embryonic stem cells (2003) Cardiovascular Research, 58, pp. 278-291; Steinberg, S.F., The molecular basis for distinct β-adrenergic receptor subtype actions in cardiomyocytes (1999) Circulation Research, 85, pp. 1101-1111; Tepongning, R.N., Yerbanga, S.R., Dori, G.U., Lucantoni, L., Lupidi, G., Habluetzel, A., In vivo efficacy and toxicity studies on Erythrina senegalensis and Khaya ivorensis used as herbal remedies for malaria prevention in cameroon (2013) European J of Medicinal Plants, 3, pp. 454-464; Togola, A., Austarheim, I., Theis, A., Diallo, D., Paulsen, B.S., Ethnopharmacological uses of Erythrina senegalensis: A comparison of three areas in mali, and a link between traditional knowledge and modern biological science (2008) Journal of Ethnobiology and Ethnomedicine, 4, p. 6; Udem, S.C., Obidoa, O., Asuzu, I.U., Acute and chronic toxicity studies of Erythrina senegalensis DC stem bark extract in mice (2010) Comparative Clinical Pathology, 19, pp. 275-282; Wakawa, H., Hauwa, M., Protective effect of Erythrina senegalensis (DC) leaf extract on carbon tetrachloride-induced liver injury in rats (2013) Asian Journal of Biological Sciences, 6, pp. 234-238; Yoshida, Y., Yamanaka, S., Recent stem cell advances: Induced pluripotent stem cells for disease modeling and stem cell-based regeneration (2010) Circulation, 122, pp. 80-87",Article,Scopus,2-s2.0-84924358924
"Park B.-K., Park Y.-C., Jung I.C., Kim S.-H., Choi J.J., Do M., Kim S.Y., Jin M.","Gamisasangja-tang suppresses pruritus and atopic skin inflammation in the NC/Nga murine model of atopic dermatitis",2015,"Journal of Ethnopharmacology","165",,,"54","60",,,10.1016/j.jep.2015.02.040,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924273080&partnerID=40&md5=8c1d7d962160a4f5ff54c597047a7a7d","Laboratory of Pharmacology, College of Korean Medicine, Daejeon UniversityDaejeon, South Korea; Department of Internal Medicine, Daejeon Korean Medicine Hospital, Daejeon UniversityDaejeon, South Korea; Department of Neuropsychiatry, Dunsan Korean Medicine Hospital, Daejeon UniversityDaejeon, South Korea; Institute of Traditional Medicine and Bioscience, Daejeon UniversityDaejeon, South Korea; College of Pharmacy, Gachon UniversityIncheon, South Korea","Park, B.-K., Laboratory of Pharmacology, College of Korean Medicine, Daejeon UniversityDaejeon, South Korea; Park, Y.-C., Department of Internal Medicine, Daejeon Korean Medicine Hospital, Daejeon UniversityDaejeon, South Korea; Jung, I.C., Department of Neuropsychiatry, Dunsan Korean Medicine Hospital, Daejeon UniversityDaejeon, South Korea; Kim, S.-H., Institute of Traditional Medicine and Bioscience, Daejeon UniversityDaejeon, South Korea; Choi, J.J., Institute of Traditional Medicine and Bioscience, Daejeon UniversityDaejeon, South Korea; Do, M., College of Pharmacy, Gachon UniversityIncheon, South Korea; Kim, S.Y., College of Pharmacy, Gachon UniversityIncheon, South Korea; Jin, M., Laboratory of Pharmacology, College of Korean Medicine, Daejeon UniversityDaejeon, South Korea","Ethnopharmacological relevance Gamisasangja-tang (GST) is a traditional herbal formula prescribed for patients with intractable pruritus in association with various inflammatory skin diseases. To evaluate the effects of GST on pruritic skin inflammation and investigate its cellular and molecular mechanisms. Materials and methods We orally administered GST to NC/Nga (NC) mice, an animal model of atopic dermatitis. Scratching frequency and the dermatitis index were evaluated, and histological examination was performed using hematoxylin and eosin and toluidine blue staining. The levels of interleukin (IL)-31 and T-helper cell type 2 (TH2) cytokines were determined in both the dorsal skin and cultured splenocytes by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. The serum levels of chemokines and immunoglobulin E (IgE) were determined by ELISA. Changes in the inflammatory cell population were analyzed by a hemocytometer. Results GST significantly lowered scratching frequency and inhibited increases in dermatitis index, thickness of epidermis/dermis and infiltration of chemokine (C-C motif) receptor 3 (CCR3)+ and cluster of differentiation (CD)117+/FcεRIα (Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide)+ cells in atopic skin. Both IL-31 mRNA expression and production were significantly reduced by GST, which was accomrease in the levels of IL-4, IL-5, and IL-13. Further, GST treatment suppressed the secretion of eotaxin, TARC (thymus and activation-regulated chemokine), IgE, and increases in the number of basophils and eosinophils in the blood. Conclusion GST may have potential as an effective treatment for pruritic skin disease such as atopic dermatitis. © 2015 Elsevier Ireland Ltd. All rights reserved.","Atopicskin inflammation; Gamisasangja-tang (GST); IL-31; NC/Nga murine model; Pruritus","Ahn, K.S., Sim, W.S., Kim, I.H., Decursin: A cytotoxic agent and protein kinase C activator from the root of Angelica gigas (1996) Planta Medica, 62, pp. 7-9; Akdis, C.A., Akdis, M., Trautmann, A., Blaser, K., Immune regulation in atopic dermatitis (2000) Current Opinion in Immunology, 12, pp. 641-646; Basnet, P., Yasuda, I., Kumagai, N., Tohda, C., Nojima, H., Kuraishi, Y., Komatsu, K., Inhibition of itch-scratch response by fruits of Cnidium monnieri in mice (2001) Biological Pharmaceutical Bulletin, 24, pp. 1012-1015; Berke, R., Singh, A., Guralnick, M., Atopic dermatitis: An overview (2012) American Family Physician, 86, pp. 35-42; Bilsborough, J., Leung, D.Y., Maurer, M., Howell, M., Boguniewicz, M., Yao, L., Storey, H., Gross, J.A., IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis (2006) Journal of Allergy and Clinical Immunology, 117, pp. 418-425; Buddenkotte, J., Steinhoff, M., Pathophysiology and therapy of pruritus in allergic and atopic diseases (2010) Allergy, 65, pp. 805-821; Cevikbas, F., Wang, X., Akiyama, T., Kempkes, C., Savinko, T., Antal, A., Kukova, G., Steinhoff, M., A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1 (2014) Journal of Allergy and Clinical Immunology, 133, pp. 448-460; Chen, S., (1983) Wai-ke-zheng-zong, p. 245. , Ren-min-wei-sheng-chu-ban-she Beijing; Cho, W.I., Choi, J.B., Lee, K., Chung, M.S., Pyun, Y.R., Antimicrobial activity of torilin isolated from Torilis japonica fruit against Bacillus subtilis (2008) Journal of Food Science, 73, pp. M37-46; Lee, C.-W., Han, J., Lee, M.-Y., Jung, I.-C., Jin, M., Kim, S.-H., Park, Y.-C., Genotoxicity study of GST extract (2014) Korean Journal of Oriental Physiology & Pathology, 28, pp. 621-629; Cornelissen, C., Luscher-Firzlaff, J., Baron, J.M., Luscher, B., Signaling by IL-31 and functional consequences (2012) European Journal of Cell Biology, 91, pp. 552-566; Darsow, U., Pfab, F., Valet, M., Huss-Marp, J., Behrendt, H., Ring, J., Stander, S., Pruritus and atopic dermatitis (2011) Clinical Reviews in Allergy & Immunology, 41, pp. 237-244; Dillon, S.R., Sprecher, C., Hammond, A., Bilsborough, J., Rosenfeld-Franklin, M., Presnell, S.R., Haugen, H.S., Gross, J.A., Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice (2004) Nature Immunology, 5, pp. 752-760; Ge, F., Ke, C., Tang, W., Yang, X., Tang, C., Qin, G., Xu, R., Ye, Y., Isolation of chlorogenic acids and their derivatives from Stemona japonica by preparative HPLC and evaluation of their anti-AIV (H5N1) activity in vitro (2007) Phytochemical Analysis, 18, pp. 213-218; Homey, B., Steinhoff, M., Ruzicka, T., Leung, D.Y., Cytokines and chemokines orchestrate atopic skin inflammation (2006) Journal of Allergy and Clinical Immunology, 118, pp. 178-189; Han, J.-M., Hong, J.-H., Lee, H.-Y., Jung, I.-C., Jin, M., Kim, S.-H., Park, Y.-C., Single oral dose toxicity test and four weeks repeated oral dose determination test of GST in Sprague-Dawley rats (2013) Journal of Korea Oriental Internal Medicine, 34, pp. 349-361; Kabashima, K., New concept of the pathogenesis of atopic dermatitis: Interplay among the barrier, allergy, and pruritus as a trinity (2013) Journal of Dermatological Science, 70, pp. 3-11; Kang, S.Y., Kim, Y.C., Decursinol and decursin protect primary cultured rat cortical cells from glutamate-induced neurotoxicity (2007) Journal of Pharmacy and Pharmacology, 59, pp. 863-870; Kawata, Y., Kizu, H., Tomimori, T., Studies on the constituents of Clematis species. VII. Triterpenoid saponins from the roots of Clematis terniflora DC. Var. Robusta Tamura (1998) Chemical and Pharmaceutical Bulletin, 46, pp. 1891-1900; Kim, D.W., Park, J.Y., Na, G.Y., Lee, S.J., Lee, W.J., Correlation of clinical features and skin barrier function in adolescent and adult patients with atopic dermatitis (2006) International Journal of Dermatology, 45, pp. 698-701; Kim, H., Lee, M.R., Lee, G.S., An, W.G., Cho, S.I., Effect of Sophora flavescens Aiton extract on degranulation of mast cells and contact dermatitis induced by dinitrofluorobenzene in mice (2012) Journal of Ethnopharmacology, 142, pp. 253-258; Kim, J., Lee, I., Seo, J., Jung, M., Kim, Y., Yim, N., Bae, K., Vitexin, orientin and other flavonoids from Spirodela polyrhiza inhibit adipogenesis in 3T3-L1 cells (2010) Phytotherapy Research, 24, pp. 1543-1548; Leung, D.Y., Boguniewicz, M., Howell, M.D., Nomura, I., Hamid, Q.A., New insights into atopic dermatitis (2004) Journal of Clinical Investigation, 113, pp. 651-657; Leung, D.Y., Hirsch, R.L., Schneider, L., Moody, C., Takaoka, R., Li, S.H., Meyerson, L.A., Hanifin, J.M., Thymopentin therapy reduces the clinical severity of atopic dermatitis (1990) Journal of Allergy and Clinical Immunology, 85, pp. 927-933; Ley, K., Molecular mechanisms of leukocyte recruitment in the inflammatory process (1996) Cardiovascular Research, 32, pp. 733-742; Lin, Z., Huang, C.F., Liu, X.S., Jiang, J., In vitro anti-tumour activities of quinolizidine alkaloids derived from Sophora flavescens Ait (2011) Basic Clinical Pharmacology and Toxicology, 108, pp. 304-309; Madan, V., Griffiths, C.E., Systemic ciclosporin and tacrolimus in dermatology (2007) Dermatology and Therapy, 20, pp. 239-250; Matsuda, H., Tomohiro, N., Ido, Y., Kubo, M., Anti-allergic effects of cnidii monnieri fructus (dried fruits of Cnidium monnieri) and its major component, osthol (2002) Biological and Pharmaceutical Bulletin, 25, pp. 809-812; Matsuda, H., Watanabe, N., Geba, G.P., Sperl, J., Tsudzuki, M., Hiroi, J., Matsumoto, M., Ra, C., Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice (1997) International Immunology, 9, pp. 461-466; Neis, M.M., Peters, B., Dreuw, A., Wenzel, J., Bieber, T., Mauch, C., Krieg, T., Hermanns, H.M., Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis (2006) Journal of Allergy and Clinical Immunology, 118, pp. 930-937; Nobbe, S., Dziunycz, P., Muhleisen, B., Bilsborough, J., Dillon, S.R., French, L.E., Hofbauer, G.F., IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis (2012) Acta Dermato-Venereologica, 92, pp. 24-28; Novak, N., Bieber, T., Leung, D.Y., Immune mechanisms leading to atopic dermatitis (2003) Journal of Allergy and Clinical Immunology, 112, pp. S128-139; Oh, H., Kim, J.S., Song, E.K., Cho, H., Kim, D.H., Park, S.E., Lee, H.S., Kim, Y.C., Sesquiterpenes with hepatoprotective activity from Cnidium monnieri on tacrine-induced cytotoxicity in Hep G2 cells (2002) Planta Medica, 68, pp. 748-749; Park, B.K., Park, S., Park, J.B., Park, M.C., Min, T.S., Jin, M., Omega-3 fatty acids suppress Th2-associated cytokine gene expressions and GATA transcription factors in mast cells (2013) Jornal of Nutritional Biochemistry, 24, pp. 868-876; Park, B.K., Park, Y.C., Jung, I.C., Kim, S.H., Choi, J.E., Park, S., Choi, J.J., Jin, M., Oral administration of SSC201, a medicinal herbal formula, suppresses atopic dermatitis-like skin lesions (2014) Journal of Medicinal Food, 17, pp. 496-504; Park, Y.C., Jin, M., Kim, S.H., Kim, M.H., Namgung, U., Yeo, Y., Effects of inhalable microparticle of flower of Lonicera japonica in a mouse model of COPD (2014) Journal of Ethnopharmacology, 151, pp. 123-130; Qiao, X., He, W.N., Xiang, C., Han, J., Wu, L.J., Guo, D.A., Ye, M., Qualitative and quantitative analyses of flavonoids in Spirodela polyrrhiza by high-performance liquid chromatography coupled with mass spectrometry (2011) Phytochemical Analysis, 22, pp. 475-483; Raap, U., Weissmantel, S., Gehring, M., Eisenberg, A.M., Kapp, A., Folster-Holst, R., IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis (2012) Pediatric Allergy and Immunology, 23, pp. 285-288; Raap, U., Wichmann, K., Bruder, M., Stander, S., Wedi, B., Kapp, A., Werfel, T., Correlation of IL-31 serum levels with severity of atopic dermatitis (2008) Journal of Allergy and Clinical Immunology, 122, pp. 421-423; Sallusto, F., Lanzavecchia, A., Mackay, C.R., Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses (1998) Immunology Today, 19, pp. 568-574; Schofield, M., Calhoun, K.H., Immunology of allergy (2011) Otolaryngologic Clinics of North America, 44, pp. 591-601. , viii; Seo, C.S., Lee, M.Y., Shin, I.S., Lee, J.A., Ha, H., Shin, H.K., Spirodela polyrhiza (L.) Sch. Ethanolic extract inhibits LPS-induced inflammation in RAW264.7 cells (2012) Immunopharmacology and Immunotoxicology, 34, pp. 794-802; Simon, D., Braathen, L.R., Simon, H.U., Eosinophils and atopic dermatitis (2004) Allergy, 59, pp. 561-570; Sonkoly, E., Muller, A., Lauerma, A.I., Pivarcsi, A., Soto, H., Kemeny, L., Alenius, H., Homey, B., IL-31: A new link between T cells and pruritus in atopic skin inflammation (2006) Journal of Allergy and Clinical Immunology, 117, pp. 411-417; Stander, S., Steinhoff, M., Pathophysiology of pruritus in atopic dermatitis: An overview (2002) Experimental Dermatology, 11, pp. 12-24; Yang, X.Z., Zhu, J.Y., Tang, C.P., Ke, C.Q., Lin, G., Cheng, T.Y., Rudd, J.A., Ye, Y., Alkaloids from roots of Stemona sessilifolia and their antitussive activities (2009) Planta Medica, 75, pp. 174-177; Yang, Z., Yin, R., Cong, Y., Zhou, E., Wei, Z., Liu, Z., Cao, Y., Zhang, N., Oxymatrine lightened the inflammatory response of LPS-induced mastitis in mice through affecting NF-kappaB and MAPKs signaling pathways (2014) Inflammation, 37, pp. 2047-2055; Kim, Y.-H., Kim, J.-Y., Han, J., Lee, H.-Y., Jung, I.-C., Jin, M., Kim, S.-H., Park, Y.-C., A thirteen week repeated oral dose toxicity test and a four week recovery test of GST in Sprague-Dawley rats (2014) Journal of Korea Oriental Internal Medicine, 35, pp. 223-243",Article,Scopus,2-s2.0-84924273080
"Liu J., Jia D.-Y., Cai S.-Z., Li C.-P., Zhang M.-S., Zhang Y.-Y., Yan C.-H., Wang Y.-P.","Mitochondria defects are involved in lead-acetate-induced adult hematopoietic stem cell decline",2015,"Toxicology Letters","235","1",,"37","44",,,10.1016/j.toxlet.2015.03.007,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925844579&partnerID=40&md5=4bcdd6ae6433d19940380a38e383ae0f","Chengdu Research Institute of Reproduction and Infertility, Chengdu Women and Children's Central Hospital, Chongqing Medical UniversityChengdu, Sichuan, China; Institute of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical UniversityChongqing, China; Department of Neonatology, The Children's Hospital of Soochow University, No. 303 Jingde Rd.Suzhou, Jiangsu, China; MOE-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of MedicineShanghai, China","Liu, J., Chengdu Research Institute of Reproduction and Infertility, Chengdu Women and Children's Central Hospital, Chongqing Medical UniversityChengdu, Sichuan, China; Jia, D.-Y., Institute of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical UniversityChongqing, China; Cai, S.-Z., Department of Neonatology, The Children's Hospital of Soochow University, No. 303 Jingde Rd.Suzhou, Jiangsu, China; Li, C.-P., Institute of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical UniversityChongqing, China; Zhang, M.-S., Institute of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical UniversityChongqing, China; Zhang, Y.-Y., Institute of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical UniversityChongqing, China; Yan, C.-H., MOE-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of MedicineShanghai, China; Wang, Y.-P., Institute of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical UniversityChongqing, China","Occupational high-grade lead exposure has been reduced in recent decades as a result of increased regulation. However, environmental lead exposure remains widespread, and is associated with severe toxicity implicated in human diseases. We performed oral intragastric administration of various dose lead acetate to adult Sprague Dawley rats to define the role of lead exposure in hematopoietic stem cells (HSCs) function, and to clarify its underlying mechanism. Lead acetate-exposed rats exhibited developmental abnormalities in myeloid and lymphoid lineages, and a significant decline in immune functions. It also showed HSCs functional decline associated with senescent phenotype with low grade lead acetate exposure or apoptotic phenotype with relative higher grade dose exposure. Mechanistic exploration showed a significant increase in reactive oxygen species (ROS) in the lead acetate-exposed CD90+CD45- compartment, which correlated with functional defects in cellular mitochondria. Furthermore, in vivo treatment with the antioxidant vitamin C led to reversion of the CD90+CD45- compartment functional decline. These results indicate that lead acetate perturbs the hematopoietic balance of adult HSCs, associated with cellular mitochondria defects, increased intracellular ROS generation. © 2015 Elsevier Ireland Ltd.","Apoptosis; Hematopoietic stem cell; Lead-acetate (PbAc); Mitochondria defect; Reactive oxygen species (ROS); Senescence","Ahamed, M., Siddiqui, M.K., Environmental lead toxicity and nutritional factors (2007) Clin. Nutr., 26, pp. 400-408; Ahamed, M., Siddiqui, M.K., Low level lead exposure and oxidative stress: current opinions (2007) Clin. Chim. Acta, 383, pp. 57-64; Baranowska-Bosiacka, I., Gutowska, I., Rybicka, M., Nowacki, P., Chlubek, D., Neurotoxicity of lead. Hypothetical molecular mechanisms of synaptic function disorders (2012) Neurol. Neurochir. Pol., 46, pp. 569-578; Bellinger, D.C., Lead (2004) Pediatrics, 113, pp. 1016-1022; Canfield, R.L., Henderson, C.R., Cory-Slechta, D.A., Cox, C., Jusko, T.A., Lanphear, B.P., Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter (2003) N. Engl. J. Med., 348, pp. 1517-1526; Castagnola, C., Visser, J., Boersma, W., van Bekkum, D.W., Purification of rat pluripotent hemopoietic stem cells (1982) Stem Cells, 1, pp. 250-260; Chen, H., Li, Y., Tollefsbol, T.O., Cell senescence culturing methods (2013) Methods Mol Biol., 1048, pp. 1-10; Droge, W., Free radicals in the physiological control of cell function (2002) Physiol. Rev., 82, pp. 47-95; Fadrowski, J.J., Abraham, A.G., Navas-Acien, A., Guallar, E., Weaver, V.M., Furth, S.L., Blood lead level and measured glomerular filtration rate in children with chronic kidney disease (2013) Environ. Health Perspect., 121, pp. 965-970; Flora, G., Gupta, D., Tiwari, A., Toxicity of lead: a review with recent updates (2012) Interdiscip. Toxicol., pp. 47-58; Flora, S.J., Arsenic-induced oxidative stress and its reversibility (2011) Free Radic. Biol. Med., 51, pp. 257-281; Guidotti, T.L., McNamara, J., Moses, M.S., The interpretation of trace element analysis in body fluids (2008) Indian J. Med. Res., 128, pp. 524-532; Gutowska, I., Baranowska-Bosiacka, I., Siwiec, E., Szczuko, M., Kolasa, A., Kondarewicz, A., Rybicka, M., Stachowska, E., Lead enhances fluoride influence on apoptosis processes in liver cell line HepG2 (2013) Toxicol. Ind. Health, 2013; Ito, K., Hirao, A., Arai, F., Takubo, K., Matsuoka, S., Miyamoto, K., Ohmura, M., Suda, T., Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells (2006) Nat. Med., 12, pp. 446-451; Janzen, V., Forkert, R., Fleming, H.E., Saito, Y., Waring, M.T., Dombkowski, D.M., Cheng, T., Scadden, D.T., Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a (2006) Nature, 443, pp. 421-426; Kamata, T., Roles of Nox1 and other Nox isoforms in cancer development (2009) Cancer Sci., 100, pp. 1382-1388; Katsuyama, M., Matsuno, K., Yabe-Nishimura, C., Physiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme (2012) J. Clin. Biochem. Nutr., 50, pp. 9-22; Kishi, R., Ikeda, T., Miyake, H., Uchino, E., Tsuzuki, T., Inoue, K., Effects of low lead exposure on neuro-behavioral function in the rat (1983) Arch. Environ. Health, 38, pp. 25-33; Ksiazek, K., Passos, J.F., Olijslagers, S., von Zglinicki, T., Mitochondrial dysfunction is a possible cause of accelerated senescence of mesothelial cells exposed to high glucose (2008) Biochem. Biophys. Res. Commun., 366, pp. 793-799; McCarthy, K.F., Hale, M.L., Fehnel, P.L., Purification and analysis of rat hematopoietic stem cells by flow cytometry (1987) Cytometry, 8, pp. 296-305; Osterode, W., Barnas, U., Geissler, K., Dose dependent reduction of erythroid progenitor cells and inappropriate erythropoietin response in exposure to lead: new aspects of anaemia induced by lead (1999) Occup. Environ. Med., 56, pp. 106-109; Piomelli, S., Childhood lead poisoning (2002) Pediatr. Clin. North Am., 49, pp. 1285-1304; Purton, L.E., Scadden, D.T., Limiting factors in murine hematopoietic stem cell assays (2007) Cell Stem Cell, 1, pp. 263-270; Rastogi, S.K., Renal effects of environmental and occupational lead exposure (2008) Indian J. Occup. Environ. Med., 12, pp. 103-106; Seo, J., Lee, B.K., Jin, S.U., Park, J.W., Kim, Y.T., Ryeom, H.K., Lee, J., Chang, Y., Lead-induced impairments in the neural processes related to working memory function (2014) PLoS One, 9, p. e105308; Sinha, K., Das, J., Pal, P.B., Sil, P.C., Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis (2013) Arch. Toxicol., 87, pp. 1157-1180; Spiteller, G., The important role of lipid peroxidation processes in aging and age dependent diseases (2007) Mol. Biotechnol., 37, pp. 5-12; Spivey, A., The weight of lead. Effects add up in adults (2007) Environ. Health Perspect., 115, pp. 30-36; Taniguchi Ishikawa, E., Gonzalez-Nieto, D., Ghiaur, G., Dunn, S.K., Ficker, A.M., Murali, B., Madhu, M., Cancelas, J.A., Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells (2012) Proc. Natl. Acad. Sci. U. S. A., 109, pp. 9071-9076; Toews, A.D., Kolber, A., Hayward, J., Krigman, M.R., Morell, P., Experimental lead encephalopathy in the suckling rat: concentration of lead in cellular fractions enriched in brain capillaries (1978) Brain Res., 147, pp. 131-138; Toplan, S., Ozcelik, D., Gulyasar, T., Akyolcu, M.C., Changes in hemorheological parameters due to lead exposure in female rats (2004) J. Trace Elem. Med. Biol., 18, pp. 179-182; ul Haq, N., Tabassum, S., Anjum, R., Fatima, B., Lead, hypertension, and chronic renal failure (2013) J. Ayub Med. Coll. Abbottabad, 25, pp. 96-99; Wannhoff, A., Bolck, B., Kubler, A.C., Bloch, W., Reuther, T., Oxidative and nitrosative stress and apoptosis in oral mucosa cells after ex vivo exposure to lead and benzo[a]pyrene (2013) Toxicol. In Vitro, 27, pp. 915-921; Yu, S., Qin, W., Zhuang, G., Zhang, X., Chen, G., Liu, W., Monitoring oxidative stress and DNA damage induced by heavy metals in yeast expressing a redox-sensitive green fluorescent protein (2009) Curr. Microbiol., 58, pp. 504-510; van Deursen, J.M., The role of senescent cells in ageing (2014) Nature, 509, pp. 439-446",Article,Scopus,2-s2.0-84925844579
"Tamura A., Matsunobu T., Mizutari K., Niwa K., Kurioka T., Kawauchi S., Satoh S., Hiroi S., Satoh Y., Nibuya M., Tamura R., Shiotani A.","Low-level laser therapy for prevention of noise-induced hearing loss in rats",2015,"Neuroscience Letters","595",,,"81","86",,,10.1016/j.neulet.2015.03.031,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927517628&partnerID=40&md5=7c9ece01bfcc884a2a677431788d974e","Department of Otolaryngology-Head and Neck Surgery, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan; Division of Biomedical Information Sciences, National Defense Medical College Research Institute, 3-2 NamikiTokorozawa, Saitama, Japan; Department of Pathology and Laboratory Medicine, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan; Department of Anesthesiology, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan; Department of Psychiatry, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan; Department of Physiology, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan","Tamura, A., Department of Otolaryngology-Head and Neck Surgery, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan; Matsunobu, T., Department of Otolaryngology-Head and Neck Surgery, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan; Mizutari, K., Department of Otolaryngology-Head and Neck Surgery, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan; Niwa, K., Department of Otolaryngology-Head and Neck Surgery, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan; Kurioka, T., Department of Otolaryngology-Head and Neck Surgery, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan; Kawauchi, S., Division of Biomedical Information Sciences, National Defense Medical College Research Institute, 3-2 NamikiTokorozawa, Saitama, Japan; Satoh, S., Division of Biomedical Information Sciences, National Defense Medical College Research Institute, 3-2 NamikiTokorozawa, Saitama, Japan; Hiroi, S., Department of Pathology and Laboratory Medicine, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan; Satoh, Y., Department of Anesthesiology, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan; Nibuya, M., Department of Psychiatry, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan; Tamura, R., Department of Physiology, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan; Shiotani, A., Department of Otolaryngology-Head and Neck Surgery, National Defense Medical College, 3-2 NamikiTokorozawa, Saitama, Japan","Noninvasive low-level laser therapy (LLLT) is neuroprotective, but the mechanism of this effect is not fully understood. In this study, the use of LLLT as a novel treatment for noise-induced hearing loss (NIHL) is investigated. Sprague-Dawley rats were exposed to intense noise and their right ears were irradiated with an 808nm diode laser at an output power density of 110 or 165mW/cm2 for a 30min period for 5 consecutive days. Measurement of the auditory brainstem response revealed an accelerated recovery of auditory function in the groups treated with LLLT compared with the non-treatment group at days 2, 4, 7 and 14 after noise exposure. Morphological observations also revealed a significantly higher outer hair cell survival rate in the LLLT groups. Immunohistochemical analyses for inducible nitric oxide synthase (iNOS) and cleaved caspase-3 were used to examine oxidative stress and apoptosis. Strong immunoreactivities were observed in the inner ear tissues of the non-treatment group, whereas these signals were decreased in the LLLT group at 165mW/cm2 power density. Our findings suggest that LLLT has cytoprotective effects against NIHL via the inhibition of iNOS expression and apoptosis. © 2015 Elsevier Ireland Ltd.","Cleaved caspase-3; Inducible nitric oxide synthase; Low-level laser therapy; Noise-induced hearing loss","Hultcrantz, E., Angelborg, C., Beausang-Linder, M., Noise and cochlear blood flow (1979) Arch.Otorhinolaryngol., 224, pp. 103-106; Axelsson, A., Dengerink, H., The effects of noise on histological measures of the cochlear vasculature and red blood cells (1987) Hear Res., 31, pp. 183-191; Ohlemiller, K.K., Wright, J.S., Dugan, L.L., Early elevation of cochlear reactive oxygen species following noise exposure (1999) Audiol. Neurootol., 4, pp. 229-236; Ohinata, Y., Miller, J.M., Altschuler, R.A., J Schacht, Intense noise induces formation of vasoactive lipid peroxidation products in the cochlea (2000) Brain Res., 878, pp. 163-173; Masuda, M., Nagashima, R., Kanzaki, S., Fujioka, M., Ogita, K., Ogawa, K., Nuclear factor-kappa B nuclear translocation in the cochlea of mice following acoustic overstimulation (2006) Brain Res., 1068, pp. 237-247; Nicotera, T., Hu, B.H., Henderson, D., The caspase pathway in noise-induced apoptosis of the chinchilla cochlea (2003) J. Assoc. Res. Otolaryngol., 4, pp. 466-477; Huang, Y.Y., Chen, A.C., Carroll, J.D., Hamblin, M.R., Biphasic dose response in low level light therapy (2009) Dose Response, 7, pp. 358-383; Tata, D.B., Waynant, R.W., Laser therapy: A review of its mechanism of action and potential medical application (2011) Laser Photonics Rev., 5, pp. 1-12; Streeter, J., Taboada, L.D., Oron, U., Mechanisms of action of light therapy for stroke and acute myocardial infarction (2004) Mitochondrion, 4, pp. 569-576; Conlan, M.J., Rapley, J.W., Cobb, C.M., Biostimulation of wound healing by low-energy laser irradiation, A review (1996) J. Clin. Periodontol., 23, pp. 492-496; Uozumi, Y., Nawashiro, H., Sato, S., Kawauchi, S., Shima, K., Kikuchi, M., Targeted increase in cerebral blood flow by transcranial near-infrared laser irradiation (2010) Lasers Surg. Med., 42, pp. 566-576; Leung, M.C.P., Lo, S.C.L., Siu, F.K.W., So, K.F., Treatment of experimentally induced transient cerebral ischemia with low energy laser inhibits nitric oxide synthase activity and up-regulates the expression of transforming growth factor-beta 1 (2002) Lasers Surg. Med., 31, pp. 283-288; Gomes, L.E., Dalmarco, E.M., Andre, E.S., The brain-derived neurotrophic factor nerve growth factor, nurotrophin-3, and induced nitric oxide synthase expressions after low-level laser therapy in an axonotmesis experimental model (2012) Photomed. Laser Surg., 30, pp. 642-647; Rhee, C.K., Bahk, C.W., Kim, S.H., Ahn, J.C., Jung, J.Y., Chung, P.S., Suh, M.W., Effect of low-level laser treatment on cochlea hair-cell recovery after acute acoustic trauma (2012) J. Biomed. Opt., 17, p. 068002; Tanaka, K., Takemoto, T., Sugahara, K., Okuda, T., Mikuriya, T., Takeno, K., Hashimoto, M., Yamashita, H., Post-exposure administration of edaravone attenuates noise-induced hearing loss (2005) Eur. J. Pharmacol., 522, pp. 116-121; Inai, S., Watanabe, K., Okubo, K., Inducible nitric oxide synthase participates in cochlear damage after acoustic stimulation in Guinea pigs (2012) J. Nippon Med. Sch., 79, pp. 121-128; Hsu, W.C., Wang, J.D., Hsu, C.J., Lee, S.Y., Th. Yeh Expression of connexin 26 in the lateral wall of the rat cochlea after acoustic trauma (2004) Acta Otolaryngol., 124, pp. 459-463; Takumida, M., Anniko, M., DM Zhang, Pharmacological models for inner ear therapy with emphasis on nitric oxide (2001) Acta Otolaryngol., 121, pp. 16-20; Takumida, M., Anniko, M., Nitric oxide in the inner ear (2002) Curr. Opin. Neurol., 15, pp. 11-15; Teggi, R., Bellini, C., Fabiano, B., Bussi, M., Efficacy of low-level laser therapy in Ménière's disease: a pilot study of 10 patients (2008) Photomed. Laser Surg., 26, pp. 349-353; Salahaldin, A.H., Abdulhadi, K., Najjar, N., Bener, A., Low-level laser therapy in patients with complaints of tinnitus: A clinical study (2012) ISRN Otolaryngol., 2012, p. 132060",Article,Scopus,2-s2.0-84927517628
"Yang Y., Yang Y., Yang X., Zhu H., Guo Q., Chen X., Zhang H., Cheng H., Sun X.","Autophagy and its function in radiosensitivity",2015,"Tumor Biology",,,,"","",9,,10.1007/s13277-015-3496-x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928966879&partnerID=40&md5=f656c76acad9d5141b5a6063e2920e4a","Department of Radiotherapy, The First Affiliated Hospital of Nanjing Medical UniversityNanjing, Jiangsu Province, China; Department of Oncology, People’s Hospital of TaizhouTaizhou, Jiangsu Province, China; Department of Synthetic Internal Medicine, The First Affiliated Hospital of Nanjing Medical UniversityNanjing, Jiangsu Province, China","Yang, Y., Department of Radiotherapy, The First Affiliated Hospital of Nanjing Medical UniversityNanjing, Jiangsu Province, China; Yang, Y., Department of Radiotherapy, The First Affiliated Hospital of Nanjing Medical UniversityNanjing, Jiangsu Province, China; Yang, X., Department of Radiotherapy, The First Affiliated Hospital of Nanjing Medical UniversityNanjing, Jiangsu Province, China; Zhu, H., Department of Radiotherapy, The First Affiliated Hospital of Nanjing Medical UniversityNanjing, Jiangsu Province, China; Guo, Q., Department of Radiotherapy, The First Affiliated Hospital of Nanjing Medical UniversityNanjing, Jiangsu Province, China, Department of Oncology, People’s Hospital of TaizhouTaizhou, Jiangsu Province, China; Chen, X., Department of Radiotherapy, The First Affiliated Hospital of Nanjing Medical UniversityNanjing, Jiangsu Province, China; Zhang, H., Department of Radiotherapy, The First Affiliated Hospital of Nanjing Medical UniversityNanjing, Jiangsu Province, China; Cheng, H., Department of Synthetic Internal Medicine, The First Affiliated Hospital of Nanjing Medical UniversityNanjing, Jiangsu Province, China; Sun, X., Department of Radiotherapy, The First Affiliated Hospital of Nanjing Medical UniversityNanjing, Jiangsu Province, China","Autophagy differs from apoptosis and is independent of phagocytes by the appearance of autophagosomes, autolysosomes, and complete nuclei in the cell. This process significantly contributes to the antineoplastic effects of radiation. Radiation is an important strategy in cancer treatment; however, many types of cancer show radioresistance. The effects of radiotherapy are affected by factors, including the degree of tumor tissue hypoxia, the ability to repair DNA damage, and the presence of cancer stem cells. We review the relationships among autophagy, the three factors in cancer radiation, and the possible underlying molecular mechanisms. The therapeutic implications of these relationships and mechanisms in clinical settings are also discussed. © 2015 International Society of Oncology and BioMarkers (ISOBM)","Autophagy; Cancer stem cells; DNA damage; Hypoxia; Radiosensitivity",,Article in Press,Scopus,2-s2.0-84928966879
"Li P., Liu F., Wu C., Jiang W., Zhao G., Liu L., Bai T., Wang L., Jiang Y., Guo L., Qi X., Kou J., Fan R., Hao D., Lan S., Li Y., Liu J.Y.","Feasibility of human hair follicle-derived mesenchymal stem cells/CultiSpher®-G constructs in regenerative medicine",2015,"Cell and Tissue Research",,,,"","",18,,10.1007/s00441-015-2182-z,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928974710&partnerID=40&md5=269f0a85263d187cd3fb88ff4475a209","Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China; Department of Analytical Chemistry, School of Pharmaceutical Sciences, Jilin UniversityChangchun, Jilin, China; Department of Toxicology, School of Preventive Medicine, Jilin UniversityChangchun, Jilin, China; Harbin Veterinary Research Institute, CAAS-Michigan State University Joint Laboratory of Innate Immunity, State Key Laboratory of Veterinary Biotechnology, Chinese Academy of Agricultural Sciences, Maduan Street 427, Nangang DistrictHarbin, China; Department of Pathology, Jilin Cancer HospitalChangchun, Jilin, China","Li, P., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China, Department of Toxicology, School of Preventive Medicine, Jilin UniversityChangchun, Jilin, China; Liu, F., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China; Wu, C., Harbin Veterinary Research Institute, CAAS-Michigan State University Joint Laboratory of Innate Immunity, State Key Laboratory of Veterinary Biotechnology, Chinese Academy of Agricultural Sciences, Maduan Street 427, Nangang DistrictHarbin, China; Jiang, W., Department of Analytical Chemistry, School of Pharmaceutical Sciences, Jilin UniversityChangchun, Jilin, China; Zhao, G., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China; Liu, L., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China; Bai, T., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China; Wang, L., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China; Jiang, Y., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China; Guo, L., Department of Pathology, Jilin Cancer HospitalChangchun, Jilin, China; Qi, X., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China; Kou, J., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China; Fan, R., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China; Hao, D., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China; Lan, S., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China; Li, Y., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China; Liu, J.Y., Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin UniversityChangchun, Jilin, China, Department of Toxicology, School of Preventive Medicine, Jilin UniversityChangchun, Jilin, China","The use of human mesenchymal stem cells (hMSCs) in cell therapies has increased the demand for strategies that allow efficient cell scale-up. Preliminary data on the three-dimensional (3D) spinner culture describing the potential use of microcarriers for hMSCs culture scale-up have been reported. We exploited a rich source of autologous stem cells (human hair follicle) and demonstrated the robust in vitro long-term expansion of human hair follicle-derived mesenchymal stem cells (hHF-MSCs) by using CultiSpher®-G microcarriers. We analyzed the feasibility of 3D culture by using hHF-MSCs/CultiSpher®-G microcarrier constructs for its potential applicability in regenerative medicine by comparatively analyzing the performance of hHF-MSCs adhered to the CultiSpher®-G microspheres in 3D spinner culture and those grown on the gelatin-coated plastic dishes (2D culture), using various assays. We showed that the hHF-MSCs seeded at various densities quickly adhered to and proliferated well on the microspheres, thus generating at least hundreds of millions of hHF-MSCs on 1 g of CultiSpher®-G within 12 days. This resulted in a cumulative cell expansion of greater than 26-fold. Notably, the maximum and average proliferation rates in 3D culture were significantly greater than that of the 2D culture. However, the hHF-MSCs from both the cultures retained surface marker and nestin expression, proliferation capacity and differentiation potentials toward adipocytes, osteoblasts and smooth muscle cells and showed no significant differences as evidenced by Edu incorporation, cell cycle, colony formation, apoptosis, biochemical quantification and qPCR assays. © 2015 Springer-Verlag Berlin Heidelberg","3D cell culture; CultiSpher®-G microbeads; Hair follicle mesenchymal stem cells; Long-term expansion; Spinner culture",,Article in Press,Scopus,2-s2.0-84928974710
"Hashimoto H., Kitano S., Ueda R., Ito A., Tada K., Fuji S., Yamashita T., Tomura D., Nukaya I., Mineno J., Fukuda T., Mori S., Takaue Y., Heike Y.","Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation",2015,"International Journal of Hematology",,,,"","",10,,10.1007/s12185-015-1801-5,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928940615&partnerID=40&md5=76f2a730d1e06d30a9015978679254f6","Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Division of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Center for Cell and Gene Therapy, Takara Bio Inc, Seta 3-4-1Otsu, Shiga, Japan; Division of Hematology and Oncology, St. Luke’s International Hospital, 9-1 Akashi-cho, Chou-kuTokyo, Japan; Research Planning and Management Department, St. Luke’s International Hospital, 9-1 Akashi-cho, Chou-kuTokyo, Japan; Immunotherapy and Cell Therapy Service, St. Luke’s International University and Hospital, 9-1 Akashi-cho, Chou-kuTokyo, Japan","Hashimoto, H., Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Kitano, S., Division of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan, Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Ueda, R., Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Ito, A., Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Tada, K., Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan, Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Fuji, S., Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Yamashita, T., Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Tomura, D., Center for Cell and Gene Therapy, Takara Bio Inc, Seta 3-4-1Otsu, Shiga, Japan; Nukaya, I., Center for Cell and Gene Therapy, Takara Bio Inc, Seta 3-4-1Otsu, Shiga, Japan; Mineno, J., Center for Cell and Gene Therapy, Takara Bio Inc, Seta 3-4-1Otsu, Shiga, Japan; Fukuda, T., Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Mori, S., Division of Hematology and Oncology, St. Luke’s International Hospital, 9-1 Akashi-cho, Chou-kuTokyo, Japan; Takaue, Y., Research Planning and Management Department, St. Luke’s International Hospital, 9-1 Akashi-cho, Chou-kuTokyo, Japan; Heike, Y., Immunotherapy and Cell Therapy Service, St. Luke’s International University and Hospital, 9-1 Akashi-cho, Chou-kuTokyo, Japan","The infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene (TK-cells) is a promising strategy for the treatment of hematologic malignancies relapsing after allogeneic hematopoietic stem cell transplantation. Here we report the results of a phase I clinical trial designed to examine the feasibility, safety, and efficacy of donor lymphocyte infusion (DLI) of TK-cells. Three patients (two with malignant lymphomas, one with acute myeloid leukemia) were enrolled in the trial and received a single DLI of 1 × 107 or 5 × 107 TK-cells/kg. No local or systemic toxicity related to the gene-transfer procedure was observed. Two patients achieved stable disease. No patient had severe graft-versus-host disease requiring systemic steroid and/or ganciclovir administration. TK-cells were detected in the peripheral blood of all three patients by PCR, but did not persist longer than 28 days. Analysis of cytotoxic T lymphocyte activity detected no immune response against TK-cells by the recipient’s own T cells. Flow cytometric analysis showed low proliferative activity and cytotoxic function of TK-cells. In conclusion, DLI of TK-cells was safely performed in all three patients. Our analysis suggests the probable cause of rapid disappearance of TK-cells to be insufficient in vivo expansion of TK-cells in these patients. © 2015 The Japanese Society of Hematology","Allogeneic hematopoietic stem cell transplantation; Donor lymphocyte infusion; Hematologic malignancy; Herpes simplex virus thymidine kinase suicide gene",,Article in Press,Scopus,2-s2.0-84928940615
"Delhommeau F.","Effect of mutation order on myeloproliferative neoplasms",2015,"The New England journal of medicine","372","19",,"1865","",,,10.1056/NEJMc1503143#SA1,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84929046059&partnerID=40&md5=71538a1ebc9de23635e2eecc48e486e4",,"Delhommeau, F.",[No abstract available],,,Letter,Scopus,2-s2.0-84929046059
"Shi L., Rui Y.-F., Li G., Wang C.","Alterations of tendons in diabetes mellitus: what are the current findings?",2015,"International Orthopaedics",,,,"","",9,,10.1007/s00264-015-2775-x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928964046&partnerID=40&md5=a9732de9641b700acbf26df06c9137a1","Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, 87 Ding Jia QiaoNanjing, Jiangsu, China; Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong KongHong Kong, SAR, China; Program of Stem Cell and Regeneration, School of Biomedical Science, and Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong KongHong Kong, SAR, China","Shi, L., Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, 87 Ding Jia QiaoNanjing, Jiangsu, China; Rui, Y.-F., Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, 87 Ding Jia QiaoNanjing, Jiangsu, China; Li, G., Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong KongHong Kong, SAR, China, Program of Stem Cell and Regeneration, School of Biomedical Science, and Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong KongHong Kong, SAR, China; Wang, C., Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, 87 Ding Jia QiaoNanjing, Jiangsu, China","As a connective tissue, tendon connects the muscle and bone, and plays the key role in the locomotor system. Some previous studies have shown the pathological alternations in diabetic tendons, which might result in the structural and functional changes, and even accelerate the process of diabetic foot. In this review, we examined the current findings of the diabetic tendons in the form of various aspects, and summarized the clinical presentation, imaging, biomechanical, histopathological, cellular and molecular abnormalities in the diabetic tendons. The progress of diabetic tendon damage is complicated and the main hypotheses include the excessive accumulation of AGEs, the altered inflammatory response, neovascularization and insensitive neuropathy. However, the cellular and molecular mechanisms of these alterations are still ambiguous. Tendon stem/progenitor cells (TSPCs) have been discovered to play important roles in both tendon physiology and tendon pathology. Recently, we identified TSPCs from patellar tendons in our well-established diabetic rat model and found impaired tenogenic differentiation potential of these cells. We proposed a new hypothesis that the impaired cell functions of diabetic TSPCs might be the underlying cellular and molecular mechanism of the diabetic tendon alternations. These findings should be helpful to establish a better therapeutic strategy for diabetic tendon repair and regeneration. © 2015 SICOT aisbl","Diabetes mellitus; Tendon repair and regeneration; Tendon stem/progenitor cells",,Article in Press,Scopus,2-s2.0-84928964046
"Zong S., Zeng G., Fang Y., Peng J., Zou B., Gao T., Zhao J.","The effects of α-zearalanol on the proliferation of bone-marrow-derived mesenchymal stem cells and their differentiation into osteoblasts",2015,"Journal of Bone and Mineral Metabolism",,,,"","",10,,10.1007/s00774-015-0659-1,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928964164&partnerID=40&md5=82717dba88f365aee5ac33ea11b0ab56","Department of Spine Osteopathia, The First Affiliated Hospital of Guangxi Medical UniversityNanning, Guangxi, China; College of Public Hygiene, Guangxi Medical UniversityNanning, Guangxi, China; Graduate School, Guangxi Medical UniversityNanning, Guangxi, China; Department of Osteopathia, The First Affiliated Hospital of Guangxi Medical University, No. 22 Shuangyong RoadNanning, Guangxi, China","Zong, S., Department of Spine Osteopathia, The First Affiliated Hospital of Guangxi Medical UniversityNanning, Guangxi, China; Zeng, G., College of Public Hygiene, Guangxi Medical UniversityNanning, Guangxi, China; Fang, Y., Graduate School, Guangxi Medical UniversityNanning, Guangxi, China; Peng, J., Graduate School, Guangxi Medical UniversityNanning, Guangxi, China; Zou, B., Graduate School, Guangxi Medical UniversityNanning, Guangxi, China; Gao, T., Graduate School, Guangxi Medical UniversityNanning, Guangxi, China; Zhao, J., Department of Osteopathia, The First Affiliated Hospital of Guangxi Medical University, No. 22 Shuangyong RoadNanning, Guangxi, China","The aim of this study was to explore the effects of α-zearalanol (α-ZAL) on the proliferation of mouse bone-marrow-derived mesenchymal stem cells (BMSCs) and their differentiation into osteoblasts. Six- to eight-week-old BALB/C mice were used either as recipients or as bone marrow donors. BMSCs were isolated and collected using a differential adhesion method, with use of 10 % fetal bovine serum and Iscove’s modified Dulbecco’s medium. After the third generation, the BMSCs were randomly placed into the following subgroups: a control group, an osteogenic medium (OM) group, a 17β-estradiol group, an α-ZAL 10−7 mol/L group, an α-ZAL 10−6 mol/L group, and an α-ZAL 10−5 mol/L group. Flow cytometry was used to identify the BMSCs collected from the bone marrow. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test was performed, and markers of the osteoblasts were measured in the different subgroups. In addition, expression of osteoprotegerin and expression of receptor activator of nuclear factor κB ligand were examined using Western blot. In contrast to the control and OM groups, BMSCs in the α-ZAL groups exhibited long fusiform shapes, and contact inhibition was observed when the cells were closely packed. After induction, the BMSCs grew well and exhibited triangular, star, polygonal, or irregular shapes. Clumps and multiple cells were evident. The trends of the proliferation and differentiation for the control, OM, 17β-estradiol, and α-ZAL groups were similar. Compared with the control and OM groups, in the α-ZAL groups the expression levels of alkaline phosphatase, procollagen type I N-terminal propeptide, bone morphogenetic protein 2, and osteocalcin were significantly increased (p < 0.05). In addition, α-ZAL inhibited osteoclastogenesis by increasing the expression of osteoprotegerin and decreasing the expression of nuclear factor κB ligand. In conclusion, α-ZAL can increase the proliferation of BMSCs and their differentiation into osteoblasts and can effectively suppress osteoclastogenesis. © 2015 The Japanese Society for Bone and Mineral Research and Springer Japan","Bone-marrow-derived mesenchymal stem cells; Nuclear factor κB; Osteoblast; Osteoprotegerin; α-Zearalanol",,Article in Press,Scopus,2-s2.0-84928964164
"Park J., Kim I.Y., Patel M., Moon H.J., Hwang S.-J., Jeong B.","2D and 3D Hybrid Systems for Enhancement of Chondrogenic Differentiation of Tonsil-Derived Mesenchymal Stem Cells",2015,"Advanced Functional Materials","25","17",,"2573","2582",,,10.1002/adfm.201500299,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928729909&partnerID=40&md5=42c675eb71671249c0c917b74dd9f3df","Department of Chemistry and Nano Science, Ewha Global Top 5 Research Program, Ewha Womans University Seodaemun-gu, 52 Ewhayeodae-gilSeoul, South Korea","Park, J., Department of Chemistry and Nano Science, Ewha Global Top 5 Research Program, Ewha Womans University Seodaemun-gu, 52 Ewhayeodae-gilSeoul, South Korea; Kim, I.Y., Department of Chemistry and Nano Science, Ewha Global Top 5 Research Program, Ewha Womans University Seodaemun-gu, 52 Ewhayeodae-gilSeoul, South Korea; Patel, M., Department of Chemistry and Nano Science, Ewha Global Top 5 Research Program, Ewha Womans University Seodaemun-gu, 52 Ewhayeodae-gilSeoul, South Korea; Moon, H.J., Department of Chemistry and Nano Science, Ewha Global Top 5 Research Program, Ewha Womans University Seodaemun-gu, 52 Ewhayeodae-gilSeoul, South Korea; Hwang, S.-J., Department of Chemistry and Nano Science, Ewha Global Top 5 Research Program, Ewha Womans University Seodaemun-gu, 52 Ewhayeodae-gilSeoul, South Korea; Jeong, B., Department of Chemistry and Nano Science, Ewha Global Top 5 Research Program, Ewha Womans University Seodaemun-gu, 52 Ewhayeodae-gilSeoul, South Korea","2D/3D hybrid cell culture systems are constructed by increasing the temperature of the thermogelling poly(ethylene glycol)-poly(l-alanine) diblock copolymer (PEG-l-PA) aqueous solution in which tonsil tissue-derived mesenchymal stem cells and graphene oxide (GO) or reduced graphene oxide (rGO) are suspended, to 37 'C. The cells exhibit spherical cell morphologies in 2D/3D hybrid culture systems of GO/PEG-l-PA and rGO/PEG-l-PA by using the growth medium. The cell proliferations are 30%-50% higher in the rGO/PEG-l-PA hybrid system than in the GO/PEG-l-PA hybrid system. When chondrogenic culture media enriched with TGF-β3 is used in the 2D/3D hybrid systems, cells extensively aggregate, and the expression of chondrogenic biomarkers of SOX 9, COL II A1, COL II, and COL X significantly increases in the GO/PEG-l-PA 2D/3D hybrid system as compared with the PEG-l-PA 3D systems and rGO/PEG-l-PA 2D/3D hybrid system, suggesting that the GO/PEG-l-PA 2D/3D hybrid system can be an excellent candidate as a chondrogenic differentiation platform of the stem cell. This paper also suggests that a 2D/3D hybrid system prepared by incorporating 2D materials with various surface biofunctionalities in the in situ forming 3D hydrogel matrix can be a new cell culture system. © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.","cell cultures; graphene oxide; hybrids; thermogel; tonsil-derived mesenchymal stem cells","Grichnik, J.M., Burch, J.A., Schulteis, R.D., Shan, S., Liu, J., Darrow, T.L., Vervaert, C.E., Seigler, H.F., (2006) J. Invest. Dermatol., 126, p. 142; Bozic, I., Nowak, M.A., (2013) Science, 342, p. 938; Lutolf, M.P., Gilbert, P.M., Blau, H.M., (2009) Nature, 462, p. 433; Murphy, W.L., McDevitt, T.C., Engler, A.J., (2014) Nat. Mater., 13, p. 547; Dawson, E., Mapili, G., Erickson, K., Taqvi, S., Roy, K., (2008) Adv. Drug Deliv. Rev., 60, p. 215; Lyssiotis, C.A., Lairson, L.L., Boitano, A.E., Wurdak, H., Zhu, S., Schultz, P.G., (2011) Angew. Chem., Int. Ed., 50, p. 200; Kim, B., Park, I., Hoshiba, T., Jiang, H., Choi, Y., Akaike, T., Cho, C., (2011) Prog. Polym. Sci., 36, p. 238; Zouani, O.F., Chanseau, C., Brouilluad, B., Bareille, R., Deliane, F., Foulc, M., Mehdi, A., Durrieu, M., (2012) J. Cell Sci., 125, p. 1217; Watari, S., Hayashi, K., Wood, J.A., Russell, P., Nealy, P.F., Murphy, C.J., Genetos, D.C., (2012) Biomaterials, 33, p. 128; Engler, A.J., Sen, S., Sweeney, H.L., Discher, D.E., (2006) Cell, 126, p. 677; Benoit, D.S.W., Schwartz, M.P., Durney, A.R., Anseth, K.S., (2008) Nat. Mater., 7, p. 816; Mathieu, P.S., Loboa, E.G., (2012) Tissue Eng. Part B, 18, p. 436; Tuli, R., Tuli, S., Nandi, S., Huang, X., Manner, P.A., Hozack, W.J., Manner, P.A., Tuan, R.S., (2003) Stem Cells, 21, p. 681; Baharvand, H., Hashemi, S.M., Ashtiani, S.K., Farrokhi, A., (2006) Int. J. Dev. Biol., 50, p. 645; Callahan, L.A.S., Xie, S., Barker, I.A., Zheng, J., Reneker, D.H., Dove, A.P., Becker, M.L., (2013) Biomaterials, 34, p. 9089; Christopherson, G.T., Song, H., Mao, H.Q., (2009) Biomaterials, 30, p. 556; Petersen, O.W., Ronnovjessen, L., Howlett, A.R., Bissell, M.J., (1992) Proc. Natl. Acad. Sci. USA., 89, p. 9064; Choi, B.G., Park, M.H., Cho, S.H., Joo, M.K., Oh, H.J., Kim, E.H., Park, K., Jeong, B., (2010) Biomaterials, 31, p. 9266; Lee, W.C., Lim, C.H., Shi, H., Tang, L.A., Wang, Y., Lim, C.T., Loh, K.P., (2011) ACS Nano, 5, p. 7334; Ku, S.H., Park, C.B., (2013) Biomaterials, 34, p. 2017; Yoon, H.H., Bhang, S.H., Kim, T., Yu, T., Hyeon, T., Kim, B.S., (2014) Adv. Funct. Mater., 24, p. 6455; Ko, D.Y., Shinde, U.P., Yeon, B., Jeong, B., (2013) Prog. Polym. Sci., 38, p. 672; Yu, L., Ding, J., (2008) Chem. Soc. Rev., 37, p. 1473; Park, M.H., Yu, Y., Moon, H.J., Ko, D.Y., Kim, H.S., Lee, H., Ryu, K.H., Jeong, B., (2014) Adv. Healthcare Mater., 3, p. 1782; Kim, S.J., Park, M.H., Moon, H.J., Park, J.H., Ko, D.Y., Jeong, B., (2014) ACS Appl. Mater. Interfaces, 6, p. 17034; Janjanin, S., Djouad, F., Shanti, R.M., Baksh, D., Gollapudi, K., Prgomet, D., Rackwitz, L., Tuan, R.S., (2008) Arthiritis Res. Ther., 10, p. R83; Ryu, K.H., Cho, K.A., Park, H.S., Kim, J.Y., Woo, S.Y., Jo, I.H., Choi, Y.H., Kim, H.S., (2012) Cytotherapy, 14, p. 1193; Sakaguchi, Y., Sekiya, I., Yagishita, K., Muneta, T., (2005) Arthritis Rheum., 52, p. 2521; Janjanin, S., Djouad, F., Shanti, R.M., Baksh, D., Gollapudi, K., Prgomet, D., Rackwitz, L., Tuan, R.S., (2008) Arthritis Res. Ther., 10, p. R83; Kim, H.S., Woo, S.Y., Ryu, K.H., Cho, K.A., Jo, I.H., Park, Y.S., (2013) WIPO, , Patent WO A1; Joo, M.K., Ko, D.Y., Jeong, S.J., Park, M.H., Shinde, U.P., Jeong, B., (2013) Soft Matter, 9, p. 8014; Ding, W., Lin, S., Lin, J., Zhang, L., (2008) J. Phys. Chem. B, 112, p. 776; Choi, Y.Y., Joo, M.K., Sohn, Y.S., Jeong, B., (2008) Soft Matter, 4, p. 2383; Yu, L., Zhang, Z., Ding, J., (2011) Biomacromolecules, 12, p. 1290; Yang, C., Ni, X., Li, J., (2009) J. Mater. Chem., 19, p. 3755; Ahn, S., Monge, E.C., Song, S.C., (2009) Langmuir, 25, p. 2407; Ferrari, A.C., Robertson, J., (2000) Phys. Rev. B, 61, p. 14095; Pan, D., Wang, S., Zhao, B., Wu, M., Zhang, H., Wang, Y., Jiao, Z., (2009) Chem. Mater., 21, p. 3136; Volkmer, E., Leicht, U., Moritz, M., Schwarz, C., Wiese, H., Milz, S., Matthias, P., Schieker, M., (2013) J. Mater. Sci.: Mater. Med., 24, p. 2223; Yeon, B., Park, M.H., Moon, H.J., Kim, S.J., Cheon, Y.W., Jeong, B., (2013) Biomacromolecules, 14, p. 3256; Bosnakovski, D., Mizuno, M., Kim, G., Takagi, S., Okumura, M., Fujinaga, T., (2006) Biotechnol. Bioeng., 93, p. 1152; Vivien, D., Galera, P., Lebrun, E., Loyau, G., Pujol, J.P., (1990) J. Cell Physiol., 143, p. 534; Attisano, L., Wrana, J.L., (2002) Science, 296, p. 1646; Kye, E.J., Kim, S.J., Park, M.P., Moon, H.J., Ryu, K.H., Jeong, B., (2014) Biomacromolecules, 15, p. 2180; Park, M.H., Choi, B.G., Jeong, B., (2012) Adv. Funct. Mater., 22, p. 5118; Motoyama, M., Deie, M., Kanaya, A., Nishimori, M., Miyamoto, A., Yanada, S., Adachi, N., Ochi, M., (2010) J. Biomed. Mater. Res. A, 92, p. 196; Yoon, H.H., Bhang, S.H., Shin, J.Y., Shin, J.H., Kim, B.S., (2012) Tissue Eng., 18, p. 1949; Gandavarapu, N.R., Mariner, P.D., Wchwartz, M.P., Anseth, K.S., (2013) Acta Biomater., 9, p. 4525; Li, D., Müller, M.B., Gilje, S., Kaner, R.B., Wallace, G.G., (2008) Nat. Nanotechnol., 3, p. 101; Stankovich, S., Dikin, D.A., Piner, R.D., Kohlhaas, K.A., Kleinhammes, A., Jia, Y., Wu, Y., Ruoff, R.S., (2007) Carbon, 45, p. 1558",Article,Scopus,2-s2.0-84928729909
"Park J., Kim Y.S., Ryu S., Kang W.S., Park S., Han J., Jeong H.C., Hong B.H., Ahn Y., Kim B.-S.","Graphene potentiates the myocardial repair efficacy of mesenchymal stem cells by stimulating the expression of angiogenic growth factors and gap junction protein",2015,"Advanced Functional Materials","25","17",,"2590","2600",,,10.1002/adfm.201500365,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928795584&partnerID=40&md5=83c9472a4c153b1bfb28e08d537ee006","School of Chemical and Biological Engineering, Seoul National UniversitySeoul, South Korea; Department of Cardiology, Chonnam National University HospitalGwangju, South Korea; Interdisciplinary Program of Bioengineering, Seoul National UniversitySeoul, South Korea; Department of Chemistry, Seoul National UniversitySeoul, South Korea; Bio-MAX Institute, Engineering Research Institute, Seoul National UniversitySeoul, South Korea","Park, J., School of Chemical and Biological Engineering, Seoul National UniversitySeoul, South Korea; Kim, Y.S., Department of Cardiology, Chonnam National University HospitalGwangju, South Korea; Ryu, S., Interdisciplinary Program of Bioengineering, Seoul National UniversitySeoul, South Korea; Kang, W.S., Department of Cardiology, Chonnam National University HospitalGwangju, South Korea; Park, S., Department of Chemistry, Seoul National UniversitySeoul, South Korea; Han, J., School of Chemical and Biological Engineering, Seoul National UniversitySeoul, South Korea; Jeong, H.C., Department of Cardiology, Chonnam National University HospitalGwangju, South Korea; Hong, B.H., Department of Chemistry, Seoul National UniversitySeoul, South Korea; Ahn, Y., Department of Cardiology, Chonnam National University HospitalGwangju, South Korea; Kim, B.-S., School of Chemical and Biological Engineering, Seoul National UniversitySeoul, South Korea, Bio-MAX Institute, Engineering Research Institute, Seoul National UniversitySeoul, South Korea","Stem cell therapy has emerged as a potential modality for myocardial infarction treatment. Mesenchymal stem cells (MSCs) exert reparative actions in the injured myocardium mainly through the secretion of paracrine factors. In addition, the overexpression of connexin 43 (Cx43), a gap junction protein, promotes cardiac repair and function restoration. It is known that MSCs in a spheroid form, which have enhanced cell-cell interaction, exhibit enhanced expression of paracrine factors and Cx43. However, cell-extracellular matrix (ECM) interactions, which also contribute to growth factor expression, are very limited in MSC spheroids. Reduced graphene oxide (RGO) shows high affinity toward ECM proteins, such as fibronectin (FN), and high electrical conductivity. In this study, by incorporating FN-adsorbed RGO flakes into MSC spheroids, it is possible to enhance the cell-ECM interactions and, subsequently, the paracrine factor expression in the MSCs in spheroids. Cx43 is also upregulated likely due to the enhanced paracrine factor expression and electrical conductivity of RGO. The injection of MSC-RGO hybrid spheroids into the infarcted hearts enhances cardiac repair compared with the injection of RGO flakes or MSC spheroids. This study demonstrates that RGO can effectively improve the therapeutic efficacy of MSCs for ischemic heart diseases. © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.","gap junction; graphene; growth factors; myocardial infarction; spheroids","Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S.M., Li, B., Pickel, J., Anversa, P., (2001) Nature, 410, p. 701; Zhou, B., Honor, L.B., He, H.M., Ma, Q., Oh, J.H., Butterfield, C., Lin, R.Z., Pu, W.T., (2011) J. Clin. Invest., 121, p. 1894; Nagaya, N., Kangawa, K., Itoh, T., Iwase, T., Murakami, S., Miyahara, Y., Fujii, T., Kitamura, S., (2005) Circulation, 112, p. 1128; Kinnaird, T., Stabile, E., Burnett, M.S., Lee, C.W., Barr, S., Fuchs, S., Epstein, S.E., (2004) Circ. Res., 94, p. 678; Gnecchi, M., He, H., Noiseux, N., Liang, O.D., Zhang, L., Morello, F., Mu, H., Dzau, V.J., (2006) FASEB J., 20, p. 661; Gandia, C., Arminan, A., Garcia-Verdugo, J.M., Lledo, E., Ruiz, A., Minana, M.D., Sanchez-Torrijos, J., Sepulveda, P., (2008) Stem Cells, 26, p. 638; De Jong, S., Van Veen, T.A., Van Rijen, H.V., De Bakker, J.M., (2011) J. Cardiovasc. Pharmacol., 57, p. 630; Roell, W., Lewalter, T., Sasse, P., Tallini, Y.N., Choi, B.R., Breitbach, M., Doran, R., Fleischmann, B.K., (2007) Nature, 450, p. 819; Wang, D.G., Zhang, F.X., Shen, W.Z., Chen, M.L., Yang, B., Zhang, Y.Z., Cao, K.J., (2011) Int. J. Cardiol., 152, p. 314; Chang, M.G., Tung, L., Sekar, R.B., Chang, C.Y., Cysyk, J., Dong, P., Marban, E., Abraham, M.R., (2006) Circulation, 113, p. 1832; Hahn, J.Y., Cho, H.J., Kang, H.J., Kim, T.S., Kim, M.H., Chung, J.H., Bae, J.W., Kim, H.S., (2008) J. Am. Coll. Cardiol., 51, p. 933; Potapova, I.A., Gaudette, G.R., Brink, P.R., Robinson, R.B., Rosen, M.R., Cohen, I.S., Doronin, S.V., (2007) Stem Cells, 25, p. 1761; Hsu, S.H., Huang, G.S., Lin, S.Y.F., Feng, F., Ho, T.T., Liao, Y.C., (2012) Tissue Eng. Part A, 18, p. 67; Lee, E.J., Park, S.J., Kang, S.K., Kim, G.H., Kang, H.J., Lee, S.W., Leo, H.B., Kim, H.S., (2012) Mol. Ther., 20, p. 1424; Doble, B.W., Kardami, E., (1995) Mol. Cell. Biochem., 143, p. 81; Wang, M., Cai, J., Huang, F., Zhu, M., Zhang, Q., Yang, T., Zhang, X., Xu, W., (2015) Int. J. Mol. Med., 35, p. 367; Yoon, H.H., Bhang, S.H., Kim, T., Yu, T., Hyeon, T., Kim, B.-S., (2014) Adv. Funct. Mater., 24, p. 6455; Yamada, K., Green, K.G., Samarel, A.M., Saffitz, J.E., (2005) Circ. Res., 97, p. 346; Kim, K.S., Zhao, Y., Jang, H., Lee, S.Y., Kim, J.M., Ahn, J.H., Kim, P., Hong, B.H., (2009) Nature, 457, p. 706; Chung, C., Kim, Y.K., Shin, D., Ryoo, S.R., Hong, B.H., Min, D.H., (2013) Acc. Chem. Res., 46, p. 2211; Kharaziha, M., Shin, S.R., Nikkhah, M., Topkaya, S.N., Masoumi, N., Annabi, N., Dokmeci, M.R., Khademhosseini, A., (2014) Biomaterials, 35, p. 7346; Lee, W.C., Lim, C.H.Y.X., Shi, H., Tang, L.A.L., Wang, Y., Lim, C.T., Loh, K.P., (2011) ACS Nano, 5, p. 7334; Lee, W.C., Lim, C.H., Shi, H., Tang, L.A., Wang, Y., Lim, C.T., Loh, K.P., (2011) ACS Nano, 5, p. 7334; Sheta, E.A., Harding, M.A., Conaway, M.R., Theodorescu, D., (2000) J. Natl. Cancer Inst., 92, p. 1065; Pimentel, R.C., Yamada, K.A., Kleber, A.G., Saffitz, J.E., (2002) Circ. Res., 90, p. 671; Moon, I.K., Lee, J., Ruoff, R.S., Lee, H., (2010) Nat. Commun., 1, p. 73; Mu, Q., Su, G., Li, L., Gilbertson, B.O., Yu, L.H., Zhang, Q., Sun, Y.-P., Yan, B., (2012) ACS Appl. Mater. Interfaces, 4, p. 2259; Schrepfer, S., Deuse, T., Reichenspurner, H., Fischbein, M.P., Robbins, R.C., Pelletier, M.P., (2007) Transplant. Proc., 39, p. 573; Datta, S.S., Strachan, D.R., Khamis, S.M., Johnson, A.T.C., (2008) Nano Lett., 8, p. 1912; Liao, K.H., Lin, Y.S., Macosko, C.W., Haynes, C.L., (2011) ACS Appl. Mater. Interfaces, 3, p. 2607; Shi, X.T., Chang, H.X., Chen, S., Lai, C., Khademhosseini, A., Wu, H.K., (2012) Adv. Funct. Mater., 22, p. 751; Seo, J., Lee, J.S., Lee, K., Kim, D., Yang, K., Shin, S., Mahata, C., Lee, T., (2014) Adv. Mater.; Hanks, S.K., Calalb, M.B., Harper, M.C., Patel, S.K., (1992) Proc. Natl. Acad. Sci. U.S.A., 89, p. 8487; Garcia, A.J., Boettiger, D., (1999) Biomaterials, 20, p. 2427; Fogerty, F.J., Akiyama, S.K., Yamada, K.M., Mosher, D.F., (1990) J. Cell Biol., 111, p. 699; Toutant, M., Costa, A., Studler, J.M., Kadare, G., Carnaud, M., Girault, J.A., (2002) Mol. Cell. Biol., 22, p. 7731; Mitra, S.K., Schlaepfer, D.D., (2006) Curr. Opin. Cell Biol., 18, p. 516; Bhang, S.H., Cho, S.W., Lim, J.M., Kang, J.M., Lee, T.J., Yang, H.S., Song, Y.S., Kim, B.S., (2009) Stem Cells, 27, p. 1976; Ma, N., Stamm, C., Kaminski, A., Li, W., Kleine, H.D., Muller-Hilke, B., Zhang, L., Steinhoff, G., (2005) Cardiovasc. Res., 66, p. 45; Bhang, S.H., Cho, S.W., La, W.G., Lee, T.J., Yang, H.S., Sun, A.Y., Baek, S.H., Kim, B.S., (2011) Biomaterials, 32, p. 2734; Wang, C.C., Chen, C.H., Hwang, S.M., Lin, W.W., Huang, C.H., Lee, W.Y., Chang, Y., Sung, H.W., (2009) Stem Cells, 27, p. 724; Pinto, J.M.B., Boyden, P.A., (1999) Cardiovasc. Res., 42, p. 284; Khan, R., Sheppard, R., (2006) Immunology, 118, p. 10; Poelzing, S., Rosenbaum, D.S., (2004) Am. J. Physiol. Heart Circ. Physiol., 287, p. H1762; Gutstein, D.E., Morley, G.E., Tamaddon, H., Vaidya, D., Schneider, M.D., Chen, J., Chien, K.R., Fishman, G.I., (2001) Circ. Res., 88, p. 333; O'Quinn, M.P., Palatinus, J.A., Harris, B.S., Hewett, K.W., Gourdie, R.G., (2011) Circ. Res., 108, p. 704; You, J.-O., Rafat, M., Ye, G.J.C., Auguste, D.T., (2011) Nano Lett., 11, p. 3643; Gomez-Navarro, C., Weitz, R.T., Bittner, A.M., Scolari, M., Mews, A., Burghard, M., Kern, K., (2007) Nano Lett., 7, p. 3499; Vuluga, D., Thomassin, J.M., Molenberg, I., Huynen, I., Gilbert, B., Jerome, C., Alexandre, M., Detrembleur, C., (2011) Chem. Commun., 47, p. 2544; Kim, Y.S., Ahn, Y., Kwon, J.S., Cho, Y.K., Jeong, M.H., Cho, J.G., Park, J.C., Kang, J.C., (2012) Cells Tissues Organs, 195, p. 428; Czyz, J., Irmer, U., Schulz, G., Mindermann, A., Hulser, D.F., (2000) Exp. Cell Res., 255, p. 40; Grzelczak, M., Perez-Juste, J., Mulvaney, P., Liz-Marzan, L.M., (2008) Chem. Soc. Rev., 37, p. 1783; Li, Z., Ravaine, V., Ravaine, S., Garrigue, P., Kuhn, A., (2007) Adv. Funct. Mater., 17, p. 618; Chithrani, B.D., Ghazani, A.A., Chan, W.C., (2006) Nano Lett., 6, p. 662; Behfar, A., Yamada, S., Crespo-Diaz, R., Nesbitt, J.J., Rowe, L.A., Perez-Terzic, C., Gaussin, V., Terzic, A., (2010) J. Am. Coll. Cardiol., 56, p. 721; Jin, J., Zhao, Y., Tan, X., Guo, C., Yang, Z., Miao, D., (2011) PLoS One, 6, p. e21005; Noiseux, N., Gnecchi, M., Lopez-Ilasaca, M., Zhang, L., Solomon, S.D., Deb, A., Dzau, V.J., Pratt, R.E., (2006) Mol. Ther., 14, p. 840; Yang, K., Wan, J., Zhang, S., Zhang, Y., Lee, S.T., Liu, Z., (2011) ACS Nano, 5, p. 516; Li, Y., Feng, L., Shi, X., Wang, X., Yang, Y., Yang, K., Liu, T., Liu, Z., (2014) Small, 10, p. 1544; Thomas, S.P., Kucera, J.P., Bircher-Lehmann, L., Rudy, Y., Saffitz, J.E., Kleber, A.G., (2003) Circ. Res., 92, p. 1209; Jalife, J., Morley, G.E., Vaidya, D., (1999) J. Cardiovasc. Electrophysiol., 10, p. 1649; Hummers, W.S., Offeman, R.E., (1958) J. Am. Chem. Soc., 80, p. 1339; Del Duca, D., Werbowetski, T., Del Maestro, R.F., (2004) J. Neurooncol., 67, p. 295",Article,Scopus,2-s2.0-84928795584
"Xia P., Wang X., Lin Q., Li X.","Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis",2015,"International Orthopaedics",,,,"","",10,,10.1007/s00264-015-2785-8,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928974474&partnerID=40&md5=38a6e5c34a2c22fcf3c7e09e96124bb1","Department of Rehabilitation Medicine, Nanjing First Hospital, Nanjing Medical UniversityNanjing, China","Xia, P., Department of Rehabilitation Medicine, Nanjing First Hospital, Nanjing Medical UniversityNanjing, China; Wang, X., Department of Rehabilitation Medicine, Nanjing First Hospital, Nanjing Medical UniversityNanjing, China; Lin, Q., Department of Rehabilitation Medicine, Nanjing First Hospital, Nanjing Medical UniversityNanjing, China; Li, X., Department of Rehabilitation Medicine, Nanjing First Hospital, Nanjing Medical UniversityNanjing, China","Objective: The purpose of this study was to access the efficacy of mesenchymal stem cells (MSCs) injection in the treatment of knee osteoarthritis (OA). Methods: Studies were identified from databases (Pubmed, Embase, Cochrane Library, Biosis Previews, ClincalTrials.gov, CBMdisc) searched to December 2014 using a battery of keywords. We included randomized controlled and controlled clinical trials of people with knee OA comparing the outcomes of pain and function for those receiving MSCs injection with those receiving no MSCs injection. Two reviewers independently selected studies, extracted relevant data and assessed study quality. Data were pooled and meta-analyses were performed. Results: Seven randomized controlled and controlled clinical trials, studying a total of 314 participants with a diagnosis of knee OA were included. Overall, MSCs injection has no significant effect on pain [weighted mean difference (WMD) (95 % confidence interval (CI)) [−1.33(−3.08, 0.41), P = 0.13], and tends to improve self-reported physical function [standardized mean difference (SMD) (CI) = 2.35(0.92, 3.77), P = 0.001] at the last follow-up. But results from two high quality trials (94 patients) show a positive effect of MSCs injection on pain [WMD(CI) = −0.49 (−0.79, −0.19), P = 0.001]. Heterogeneity observed between studies regarding the effect of MSCs injection on pain and function was explained by the difference of follow-up time, outcome measures, control group, the source and dose of MSCs. The quality of evidence supporting these effect estimates was rated as low. Conclusion: MSCs injection could be potentially efficacious for decreasing pain and may improve physical function in patients with knee OA. The findings of this review should be confirmed using methodologically rigorous and adequately powered clinical trials. © 2015 SICOT aisbl","Knee; Mesenchymal stem cells (MSCs); Meta-analysis; Osteoarthritis (OA)",,Article in Press,Scopus,2-s2.0-84928974474
"Beloor J., Ramakrishna S., Nam K., Seon Choi C., Kim J., Kim S.H., Cho H.J., Shin H.S., Kim H., Kim S.W., Lee S.-K., Kumar P.","Effective gene delivery into human stem cells with a cell-targeting peptide-modified bioreducible polymer",2015,"Small","11","17",,"2069","2079",,,10.1002/smll.201402933,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928948601&partnerID=40&md5=d06babc42d54048116a4b335826e4699","Department of Internal Medicine, Section of Infectious Diseases, Yale University School of MedicineNew Haven, CT, United States; Department of Bioengineering, Institute of Nano Science and Technology, Hanyang UniversitySeoul, South Korea; Graduate School of Biomedical Science and Engineering, College of Medicine, Hanyang UniversitySeoul, South Korea; Center for Controlled Chemical Delivery, Department of Pharmaceutics and Pharmaceutical Chemistry, University of UtahSalt Lake City, UT, United States","Beloor, J., Department of Internal Medicine, Section of Infectious Diseases, Yale University School of MedicineNew Haven, CT, United States, Graduate School of Biomedical Science and Engineering, College of Medicine, Hanyang UniversitySeoul, South Korea; Ramakrishna, S., Center for Controlled Chemical Delivery, Department of Pharmaceutics and Pharmaceutical Chemistry, University of UtahSalt Lake City, UT, United States; Nam, K., Center for Controlled Chemical Delivery, Department of Pharmaceutics and Pharmaceutical Chemistry, University of UtahSalt Lake City, UT, United States; Seon Choi, C., Department of Internal Medicine, Section of Infectious Diseases, Yale University School of MedicineNew Haven, CT, United States, Center for Controlled Chemical Delivery, Department of Pharmaceutics and Pharmaceutical Chemistry, University of UtahSalt Lake City, UT, United States; Kim, J., Department of Bioengineering, Institute of Nano Science and Technology, Hanyang UniversitySeoul, South Korea; Kim, S.H., Department of Bioengineering, Institute of Nano Science and Technology, Hanyang UniversitySeoul, South Korea; Cho, H.J., Department of Bioengineering, Institute of Nano Science and Technology, Hanyang UniversitySeoul, South Korea; Shin, H.S., Department of Bioengineering, Institute of Nano Science and Technology, Hanyang UniversitySeoul, South Korea; Kim, H., Graduate School of Biomedical Science and Engineering, College of Medicine, Hanyang UniversitySeoul, South Korea; Kim, S.W., Center for Controlled Chemical Delivery, Department of Pharmaceutics and Pharmaceutical Chemistry, University of UtahSalt Lake City, UT, United States; Lee, S.-K., Department of Bioengineering, Institute of Nano Science and Technology, Hanyang UniversitySeoul, South Korea; Kumar, P., Department of Internal Medicine, Section of Infectious Diseases, Yale University School of MedicineNew Haven, CT, United States","Stem cells are poorly permissive to non-viral gene transfection reagents. In this study, we explored the possibility of improving gene delivery into human embryonic (hESC) and mesenchymal (hMSC) stem cells by synergizing the activity of a cell-binding ligand with a polymer that releases nucleic acids in a cytoplasm-responsive manner. A 29 amino acid long peptide, RVG, targeting the nicotinic acetylcholine receptor (nAchR) was identified to bind both hMSC and H9-derived hESC. Conjugating RVG to a redox-sensitive biodegradable dendrimer-type arginine-grafted polymer (PAM-ABP) enabled nanoparticle formation with plasmid DNA without altering the environment-sensitive DNA release property and favorable toxicity profile of the parent polymer. Importantly, RVG-PAM-ABP quantitatively enhanced transfection into both hMSC and hESC compared to commercial transfection reagents like Lipofectamine 2000 and Fugene. 60% and 50% of hMSC and hESC were respectively transfected, and at increased levels on a per cell basis, without affecting pluripotency marker expression. RVG-PAM-ABP is thus a novel bioreducible, biocompatible, non-toxic, synthetic gene delivery system for nAchR-expressing stem cells. Our data also demonstrates that a cell-binding ligand like RVG can cooperate with a gene delivery system like PAM-ABP to enable transfection of poorly-permissive cells. The potentiation of gene delivery by combining the activities of a nicotinic acetylcholine receptor-binding peptide RVG and a polymer PAM-ABP that releases nucleic acids in a cytoplasm-responsive manner are detailed. RVG-engrafted PAM-ABP quantitatively and qualitatively enhances plasmid DNA transfection into human mesenchymal and embryonic stem cells by synergizing ligand-mediated cellular entry with the environment-sensitive release property of the bioreducible polymer. © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.",,"Zwaka, T.P., 4.Use of Genetically Modifi ed Stem Cells in Experimental Gene Therapies (2009) Stem Cell Information, pp. 45-52. , http://stemcells.nih.gov/info/Regenerative_Medicine/Pages/2006Chapter4.aspx, [Online], p; Yu, J., Thomson, J.A., Embryonic Stem Cells (2010) Stem Cell Information, pp. 1-12. , http://stemcells.nih.gov/info/Regenerative_Medicine/Pages/2006Chapter1.aspx, [World Wide Web site] [Online] National Institutes of Health, U.S. Department of Health and Human Services: Bethesda, MD; Li, M., Suzuki, K., Kim, N.Y., Liu, G.H., Izpisua Belmonte, J.C., (2014) J Biol Chem, 289, pp. 4594-4599; Manjunath, N., Yi, G., Dang, Y., Shankar, P., (2013) Viruses, 5, pp. 2748-2766; Yi, Y., Noh, M.J., Lee, K.H., (2011) Curr Gene Ther, 11, pp. 218-228; Nayerossadat, N., Maedeh, T., Ali, P.A., (2012) Adv Biomed Res, 1, p. 27; Seo, S.J., Kim, T.H., Choi, S.J., Park, J.H., Wall, I.B., Kim, H.W., (2013) Nanomedicine (Lond), 8, pp. 1875-1891; Santos, J.L., Pandita, D., Rodrigues, J., Pego, A.P., Granja, P.L., Tomas, H., (2011) Curr Gene Ther, 11, pp. 46-57; Boura, J.S., Santos, F.D., Gimble, J.M., Cardoso, C.M., Madeira, C., Cabral, J.M., Silva, C.L., (2013) Hum Gene Ther Methods, 24, pp. 38-48; Eiges, R., Schuldiner, M., Drukker, M., Yanuka, O., Itskovitz-Eldor, J., Benvenisty, N., (2001) Curr Biol, 11, pp. 514-518; Hamm, A., Krott, N., Breibach, I., Blindt, R., Bosserhoff, A.K., (2002) Tissue Eng, 8, pp. 235-245; Hoelters, J., Ciccarella, M., Drechsel, M., Geissler, C., Gulkan, H., Bocker, W., Schieker, M., Neth, P., (2005) J Gene Med, 7, pp. 718-728; Madeira, C., Mendes, R.D., Ribeiro, S.C., Boura, J.S., Aires-Barros, M.R., Da Silva, C.L., Cabral, J.M., (2010) J Biomed Biotechnol, 2010, p. 735349; Vanderbyl, S., Macdonald, G.N., Sidhu, S., Gung, L., Telenius, A., Perez, C., Perkins, E., (2004) Stem Cells, 22, pp. 324-333; Wang, W., Li, W., Ou, L., Flick, E., Mark, P., Nesselmann, C., Lux, C.A., Ma, N., (2011) J Cell Mol Med, 15, pp. 1989-1998; Siemen, H., Nix, M., Endl, E., Koch, P., Itskovitz-Eldor, J., Brustle, O., (2005) Stem Cells Dev, 14, pp. 378-383; Liew, A., Andre, F.M., Lesueur, L.L., De Menorval, M.A., O'Brien, T., Mir, L.M., (2013) Hum Gene Ther Methods, 24, pp. 289-297; Kim, S.S., Ye, C., Kumar, P., Chiu, I., Subramanya, S., Wu, H., Shankar, P., Manjunath, N., (2010) Mol Ther, 18, pp. 993-1001; Kumar, P., Ban, H.S., Kim, S.S., Wu, H., Pearson, T., Greiner, D.L., Laouar, A., Shankar, P., (2008) Cell, 134, pp. 577-586; Kumar, P., Wu, H., McBride, J.L., Jung, K.E., Kim, M.H., Davidson, B.L., Lee, S.K., Manjunath, N., (2007) Nature, 448, pp. 39-43; Lentz, T.L., (1990) J Mol Recognit, 3, pp. 82-88; Lentz, T.L., Hawrot, E., Wilson, P.T., (1987) Proteins, 2, pp. 298-307; Leonard, S., Bertrand, D., (2001) Nicotine Tob Res, 3, pp. 203-223; Hoogduijn, M.J., Cheng, A., Genever, P.G., (2009) Stem Cells Dev, 18, pp. 103-112; Landgraf, D., Barth, M., Layer, P.G., Sperling, L.E., (2010) Chem Biol Interact, 187, pp. 115-119; Lin, W., Hirata, N., Sekino, Y., Kanda, Y., (2012) Curr Drug Targets, 13, pp. 656-665; Paraoanu, L.E., Steinert, G., Koehler, A., Wessler, I., Layer, P.G., (2007) Life Sci, 80, pp. 2375-2379; Resende, R.R., Adhikari, A., (2009) Cell Commun Signal, 7, p. 20; Schraufstatter, I.U., Discipio, R.G., Khaldoyanidi, S.K., (2009) J Stem Cells, 4, pp. 203-215; Wessler, I., Kirkpatrick, C.J., (2008) Br J Pharmacol, 154, pp. 1558-1571; Liu, J., Jones, K.L., Sumer, H., Verma, P.J., (2009) Mol Reprod Dev, 76, pp. 580-586; Strulovici, Y., Leopold, P.L., O'Connor, T.P., Pergolizzi, R.G., Crystal, R.G., (2007) Mol Ther, 15, pp. 850-866; Bianco, P., Riminucci, M., Gronthos, S., Robey, P.G., (2001) Stem Cells, 19, pp. 180-192; Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Marshak, D.R., (1999) Science, 284, pp. 143-147; Yu, J., Huang, N.F., Wilson, K.D., Velotta, J.B., Huang, M., Li, Z., Lee, A., Wu, J.C., (2009) PLoS One, 4, p. e7040; Nam, H.Y., Nam, K., Lee, M., Kim, S.W., Bull, D.A., (2012) J Control Release, 160, pp. 592-600; Kim, S.H., Jeong, J.H., Kim, T.I., Kim, S.W., Bull, D.A., (2009) Mol Pharm, 6, pp. 718-726; Kim, T.I., Ou, M., Lee, M., Kim, S.W., (2009) Biomaterials, 30, pp. 658-664; Son, S., Namgung, R., Kim, J., Singha, K., Kim, W.J., (2012) Acc Chem Res, 45, pp. 1100-1112; Khalil, I.A., Kogure, K., Akita, H., Harashima, H., (2006) Pharmacol Rev, 58, pp. 32-45; Yue, Y., Wu, C., (2013) Biomaterials Science, 1, pp. 152-170; Delyagina, E., Schade, A., Scharfenberg, D., Skorska, A., Lux, C., Li, W., Steinhoff, G., (2013) Nanomedicine (Lond); Malakooty Poor, E., Baghaban Eslaminejad, M., Gheibi, N., Bagheri, F., Atyabi, F., (2013) Artif Cells Nanomed Biotechnol; Deng, W., Fu, M., Cao, Y., Cao, X., Wang, M., Yang, Y., Qu, R., Yu, J., (2013) Nanomedicine, 9, pp. 1181-1191; Deng, W.W., Cao, X., Wang, M., Yang, Y., Su, W.Y., Wei, Y.W., Ou-Yang, Z., Xu, X.M., (2012) Small, 8, pp. 441-451; Vallier, L., Rugg-Gunn, P.J., Bouhon, I.A., Andersson, F.K., Sadler, A.J., Pedersen, R.A., (2004) Stem Cells, 22, pp. 2-11; Lee, S.K., Siefert, A., Beloor, J., Fahmy, T.M., Kumar, P., (2012) Methods Enzymol, 502, pp. 91-122",Article,Scopus,2-s2.0-84928948601
"Pirraco R.P., Reis R.L.","Tissue Engineering: New Tools for Old Problems",2015,"Stem Cell Reviews and Reports",,,,"","",3,,10.1007/s12015-015-9593-9,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928721607&partnerID=40&md5=c1844bc31bbde0060d5ab4f9d05168bb","3B’s Research Group – Biomaterials, Biodegradables and Biomimetics, University of Minho, AvePark, Zona Industrial da Gandra, S. Cláudio do BarcoGuimarães, Portugal; ICVS/3B’s - PT Government Associate LaboratoryBraga/Guimarães, Portugal","Pirraco, R.P., 3B’s Research Group – Biomaterials, Biodegradables and Biomimetics, University of Minho, AvePark, Zona Industrial da Gandra, S. Cláudio do BarcoGuimarães, Portugal, ICVS/3B’s - PT Government Associate LaboratoryBraga/Guimarães, Portugal; Reis, R.L., 3B’s Research Group – Biomaterials, Biodegradables and Biomimetics, University of Minho, AvePark, Zona Industrial da Gandra, S. Cláudio do BarcoGuimarães, Portugal, ICVS/3B’s - PT Government Associate LaboratoryBraga/Guimarães, Portugal",[No abstract available],"Biomaterials; Gene editing; Graphene; Scaffold-free; Stem cells; Tissue Engineering",,Article in Press,Scopus,2-s2.0-84928721607
"Karabon L., Markiewicz M., Partyka A., Pawlak-Adamska E., Tomkiewicz A., Dzierzak-Mietla M., Kyrcz-Krzemien S., Frydecka I.","A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation",2015,"Immunogenetics",,,,"","",10,,10.1007/s00251-015-0840-7,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928710749&partnerID=40&md5=c8e4d2bb5f3b8ccbadd283aa2415bc76","Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Science, R. Weigl 12Wroclaw, Poland; Department and Clinic of Urology, Wroclaw Medical University, Borowska 213Wroclaw, Poland; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Dabrowskiego 25Katowice, Poland","Karabon, L., Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Science, R. Weigl 12Wroclaw, Poland, Department and Clinic of Urology, Wroclaw Medical University, Borowska 213Wroclaw, Poland; Markiewicz, M., Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Dabrowskiego 25Katowice, Poland; Partyka, A., Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Science, R. Weigl 12Wroclaw, Poland; Pawlak-Adamska, E., Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Science, R. Weigl 12Wroclaw, Poland; Tomkiewicz, A., Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Science, R. Weigl 12Wroclaw, Poland; Dzierzak-Mietla, M., Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Dabrowskiego 25Katowice, Poland; Kyrcz-Krzemien, S., Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Dabrowskiego 25Katowice, Poland; Frydecka, I., Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Science, R. Weigl 12Wroclaw, Poland","T cell activation plays a crucial role in the development of acute graft versus host disease (aGvHD). Cytotoxic T cell antigen-4 (CTLA-4) is a co-inhibitory molecule that negatively regulates T cell activation, differentiation, and proliferation. Single-nucleotide polymorphisms (SNPs) in CTLA-4 gene may affect its function. Inconsistent observations have been reported regarding the associations of CTLA-4 SNPs with complications after hematopoietic stem cell transplantation (HSCT). Moreover, the majority of the observations were focused on the donors’ SNPs. Recently, a few studies have shown that recipients’ genetic variations in the CTLA-4 gene might influence HSCT results. The aim of our study was to determine the influence of the CTLA-4 gene polymorphisms of the donors and the recipients on the outcome of HSCT. Altogether, 312 donor-recipient pairs were genotyped for the CTLA-4c.49A>G (rs231775) and CT60G>A (rs3087243) SNPs using the TaqMan®SNP Genotyping Assays. In this study, it was shown that the recipients’ CT60G>A[GG] genotype, the myeloablative conditioning regimen, and HSCT from an unrelated donor were independent aGvHD risk factors (odds ratio (OR) 2.63, 95 % confidence intervals (95 % CI) 1.45–4.59, p = 0.001; OR 2.68, 95 % CI 1.65–4.07, p = 0.00003; and OR 1.87, 95 % CI 1.02–3.24, p = 0.04, respectively). Moreover, haplotype analysis revealed that possessing allele A in both of the SNPs decreased the risk of aGvHD approximately 1.5-fold (RR 0.69, p = 0.008). Our data suggest that the CT60G>A[GG] genotype in the recipient has an impact on aGvHD development, especially in patients receiving transplants from unrelated donors together with the myeloablative conditioning regimen. © 2015 The Author(s)","Acute graft versus host disease; CTLA-4; Gene polymorphism; Hematopoietic stem cell transplantation",,Article in Press,Scopus,2-s2.0-84928710749
"Abe H., Tanaka T., Kimura M., Mizukami S., Imatanaka N., Akahori Y., Yoshida T., Shibutani M.","Developmental exposure to cuprizone reduces intermediate-stage progenitor cells and cholinergic signals in the hippocampal neurogenesis in rat offspring",2015,"Toxicology Letters","234","3",,"180","193",,,10.1016/j.toxlet.2015.01.022,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924749657&partnerID=40&md5=206d8ecc1c3d9cdd6c9cd24737635953","Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shiTokyo, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shiGifu, Japan; Chemicals Evaluation and Research Institute, 1-4-25 Koraku, Bunkyo-kuTokyo, Japan","Abe, H., Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shiTokyo, Japan, Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shiGifu, Japan; Tanaka, T., Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shiTokyo, Japan, Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shiGifu, Japan; Kimura, M., Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shiTokyo, Japan, Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shiGifu, Japan; Mizukami, S., Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shiTokyo, Japan, Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shiGifu, Japan; Imatanaka, N., Chemicals Evaluation and Research Institute, 1-4-25 Koraku, Bunkyo-kuTokyo, Japan; Akahori, Y., Chemicals Evaluation and Research Institute, 1-4-25 Koraku, Bunkyo-kuTokyo, Japan; Yoshida, T., Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shiTokyo, Japan; Shibutani, M., Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shiTokyo, Japan","The exposure to cuprizone (CPZ) leads to demyelination in the central nervous system in rodents. To examine the developmental effects of CPZ exposure on hippocampal neurogenesis, pregnant rats were treated with 0, 0.1 or 0.4% CPZ in the diet from gestational day 6 to day 21 after delivery. On postnatal day 21, male offspring had a decreased density of new glue2+ oligodendrocyte progenitor cells in the dentate hilus and in the area of the cerebellar medulla in the presence of 0.4% CPZ. With regard to neurogenesis-related parameters, offspring had decreased T box brain 2+ progenitor cells and increased apoptotic cells, as detected by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling, which was accompanied by the up-regulation of Casp12 and Bcl2l11 in the subgranular zone, and increased reelin+ interneurons in the dentate hilus. In addition, the density of phosphorylated TrkB+ interneurons decreased in the dentate hilus, which was accompanied by transcript down-regulation of Bdnf and Chrna7 in the dentate gyrus. Moreover, granule cells expressing gene products of immediate-early genes, i.e., Arc and Fos, decreased. These results suggest that maternal exposure to 0.4% CPZ decreases proliferative type-2 progenitor cells via endoplasmic reticulum stress-mediated apoptosis and inhibition of cholinergic signals to intermediate-stage progenitor cells following reduced oligodendrocyte production and suppression of the brain-derived neurotrophic factor signaling cascade. Increases in reelin-expressing interneurons may compensate for impaired granule cell migration and/or correct positioning due to decreased immediate-early gene-mediated neuronal plasticity. However, all observed fluctuations disappeared at the adult stage, suggesting that CPZ-induced developmental neurotoxicity was reversible. © 2015 Elsevier Ireland Ltd.","Brain-derived neurotrophic factor; Cholinergic signals; Cuprizone (CPZ); Hippocampal dentate gyrus; Neurogenesis","Adamo, A.M., Paez, P.M., Escobar Cabrera, O.E., Wolfson, M., Franco, P.G., Pasquini, J.M., Soto, E.F., Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin (2006) Exp. Neurol., 198, pp. 519-529; Akane, H., Shiraki, A., Imatanaka, N., Akahori, Y., Itahashi, M., Ohishi, T., Mitsumori, K., Shibutani, M., Glycidol induces axonopathy by adult-stage exposure and aberration of hippocampal neurogenesis affecting late-stage differentiation by developmental exposure in rats (2013) Toxicol. Sci., 134, pp. 140-154; Akane, H., Saito, F., Yamanaka, H., Shiraki, A., Imatanaka, N., Akahori, Y., Morita, R., Shibutani, M., Methacarn as a whole brain fixative for gene and protein expression analyses of specific brain regions in rats (2013) J. Toxicol. Sci., 38, pp. 431-443; Amaral, D.G., Kurz, J., An analysis of the origins of the cholinergic and noncholinergic septal projections to the hippocampal formation of the rat (1985) J. Comp. Neurol., 240, pp. 37-59; Bath, K.G., Mandairon, N., Jing, D., Rajagopal, R., Kapoor, R., Chen, Z.Y., Lee, F.S., Variant brain-derived neurotrophic factor (Val66Met) alters adult olfactory bulb neurogenesis and spontaneous olfactory discrimination (2008) J. Neurosci., 28, pp. 2383-2393; Breunig, J.J., Silbereis, J., Vaccarino, F.M., Sestan, N., Rakic, P., Notch regulates cell fate and dendrite morphology of newborn neurons in the postnatal dentate gyrus (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 20558-20563; Carlton, W.W., Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity (1967) Life Sci., 6, pp. 11-19; Dawson, M.R., Levine, J.M., Reynolds, R., NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors? (2000) J. Neurosci. Res., 61, pp. 471-479; D'Arcangelo, G., Nakajima, K., Miyata, T., Ogawa, M., Mikoshiba, K., Curran, T., Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody (1997) J. Neurosci., 17, pp. 23-31; Drake, C.T., Milner, T.A., Patterson, S.L., Ultrastructural localization of full-length trkB immunoreactivity in rat hippocampus suggests multiple roles in modulating activity-dependent synaptic plasticity (1999) J. Neurosci., 19, pp. 8009-8026; Fang, F., Zhang, H., Zhang, Y., Xu, H., Huang, Q., Adilijiang, A., Wang, J., Li, X.M., Antipsychotics promote the differentiation of oligodendrocyte progenitor cells by regulating oligodendrocyte lineage transcription factors 1 and 2 (2013) Life Sci., 93, pp. 429-434; Ferencz, I., Kokaia, M., Keep, M., Elmer, E., Metsis, M., Kokaia, Z., Lindvall, O., Effects of cholinergic denervation on seizure development and neurotrophin messenger RNA regulation in rapid hippocampal kindling (1997) Neuroscience, 80, pp. 389-399; Freund, T.F., Buzsáki, G., Interneurons of the hippocampus (1996) Hippocampus, 6, pp. 347-470; Gong, C., Wang, T.W., Huang, H.S., Parent, J.M., Reelin regulates neuronal progenitor migration in intact and epileptic hippocampus (2007) J. Neurosci., 27, pp. 1803-1811; Gould, E., How widespread is adult neurogenesis in mammals? (2007) Nat. Rev. Neurosci., 8, pp. 481-488; Gregg, J.R., Herring, N.R., Naydenov, A.V., Hanlin, R.P., Konradi, C., Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats (2009) Schizophr. Res., 113, pp. 277-287; Guzowski, J.F., Insights into immediate-early gene function in hippocampal memory consolidation using antisense oligonucleotide and fluorescent imaging approaches (2002) Hippocampus, 12, pp. 86-104; Hartfuss, E., Galli, R., Heins, N., Götz, M., Characterization of CNS precursor subtypes and radial glia (2001) Dev. Biol., 229, pp. 15-30; Hodge, R.D., Kowalczyk, T.D., Wolf, S.A., Encinas, J.M., Rippey, C., Enikolopov, G., Kempermann, G., Hevner, R.F., Intermediate progenitors in adult hippocampal neurogenesis: Tbr2 expression and coordinate regulation of neuronal output (2008) J. Neurosci., 28, pp. 3707-3717; Itahashi, M., Wang, L., Shiraki, A., Abe, H., Tanaka, T., Murakami, T., Yoshida, T., Shibutani, M., N-methyl-N-nitrosourea during late gestation results in concomitant but reversible progenitor cell reduction and delayed neurogenesis in the hippocampus of rats (2014) Toxicol. Lett., 226, pp. 285-293; Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., Kohsaka, S., Microglia-specific localisation of a novel calcium binding protein, Iba1 (1998) Brain Res. Mol. Brain Res., 57, pp. 1-9; Itou, Y., Nochi, R., Kuribayashi, H., Saito, Y., Hisatsune, T., Cholinergic activation of hippocampal neural stem cells in aged dentate gyrus (2011) Hippocampus, 1, pp. 446-459; Kanno, T., Sasaki, S., Yamada, N., Kawasako, K., Tsuchitani, M., Hexachlorophene and cuprizone induce the spongy change of the developing rat brain by different mechanisms: the role of 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) (2012) J. Vet. Med. Sci., 74, pp. 837-843; Kempermann, G., Jessberger, S., Steiner, B., Kronenberg, G., Milestones of neuronal development in the adult hippocampus (2004) Trends Neurosci., 27, pp. 447-452; Knipper, M., da Penha Berzaghi, M., Blöchl, A., Breer, H., Thoenen, H., Lindholm, D., Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus (1994) Eur. J. Neurosci., 6, pp. 668-671; Knoth, R., Singec, I., Ditter, M., Pantazis, G., Capetian, P., Meyer, R.P., Horvat, V., Kempermann, G., Murine features of neurogenesis in the human hippocampus across the lifespan from 0 to 100 years (2010) PLoS One, 5, p. e8809; Komoly, S., Jeyasingham, M.D., Pratt, O.E., Lantos, P.L., Decrease in oligodendrocyte carbonic anhydrase activity preceding myelin degeneration in cuprizone induced demyelination (1987) J. Neurol. Sci., 79, pp. 141-148; Koutsoudaki, P.N., Skripuletz, T., Gudi, V., Moharregh-Khiabani, D., Hildebrandt, H., Trebst, C., Stangel, M., Demyelination of the hippocampus is prominent in the cuprizone model (2009) Neurosci. Lett., 451, pp. 83-88; Lapchak, P.A., Araujo, D.M., Hefti, F., Cholinergic regulation of hippocampal brain-derived neurotrophic factor mRNA expression: evidence from lesion and chronic cholinergic drug treatment studies (1993) Neuroscience, 52, pp. 575-585; Levey, A.I., Edmunds, S.M., Koliatsos, V., Wiley, R.G., Heilman, C.J., Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation (1995) J. Neurosci., 15, pp. 4077-4092; Liu, Q., Huang, Y., Shen, J., Steffensen, S., Wu, J., Functional #20*21#2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid β peptides (2012) BMC Neurosci., 13, p. 155; Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-δδCT method (2001) Methods, 25, pp. 402-408; Matsushima, G.K., Morell, P., The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system (2001) Brain Pathol., 11, pp. 107-116; McDonald, H.Y., Wojtowicz, J.M., Dynamics of neurogenesis in the dentate gyrus of adult rats (2005) Neurosci. Lett., 385, pp. 70-75; Morishima, N., Nakanishi, K., Tsuchiya, K., Shibata, T., Seiwa, E., Translocation of Bim to the endoplasmic reticulum (ER) mediates ER stress signaling for activation of caspase-12 during ER stress-induced apoptosis (2004) J. Biol. Chem., 26, pp. 50375-50381; Nagy, Z., Westerberg, H., Klingberg, T., Maturation of white matter is associated with the development of cognitive functions during childhood (2004) J. Cogn. Neurosci., 16, pp. 1227-1233; Nahm, W.K., Noebels, J.L., Nonobligate role of early or sustained expression of immediate-early gene proteins c-fos, c-jun, and Zif/268 in hippocampal mossy fiber sprouting (1998) J. Neurosci., 18, pp. 9245-9255; O'Connor, L., Strasser, A., O'Reilly, L.A., Hausmann, G., Adams, J.M., Cory, S., Huang, D.C., Bim: a novel member of the Bcl-2 family that promotes apoptosis (1998) EMBO J., 15, pp. 384-395; Ogawa, B., Wang, L., Ohishi, T., Taniai, E., Akane, H., Suzuki, K., Mitsumori, K., Shibutani, M., Reversible aberration of neurogenesis targeting late-stage progenitor cells in the hippocampal dentate gyrus of rat offspring after maternal exposure to acrylamide (2012) Arch. Toxicol., 86, pp. 779-790; Ohishi, T., Wang, L., Ogawa, B., Fujisawa, K., Taniai, E., Hayashi, H., Mitsumori, K., Shibutani, M., No effect of sustained systemic growth retardation on the distribution of Reelin-expressing interneurons in the neuron-producing hippocampal dentate gyrus in rats (2010) Reprod. Toxicol., 30, pp. 591-599; Peterson, R.E., Bollier, M.E., Spectrophotometric determination of serum copper with biscyclohexanoneoxalyldihydrazone (1955) Anal. Chem., 27, pp. 1195-1197; Pujadas, L., Gruart, A., Bosch, C., Delgado, L., Teixeira, C.M., Rossi, D., de Lecea, L., Soriano, E., Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation (2010) J. Neurosci., 30, pp. 4636-4649; Saegusa, Y., Woo, G.H., Fujimoto, H., Kemmochi, S., Shimamoto, K., Hirose, M., Mitsumori, K., Shibutani, M., Sustained production of reelin-expressing interneurons in the hippocampal dentate hilus after developmental exposure to anti-thyroid agents in rats (2010) Reprod. Toxicol., 29, pp. 407-414; Sairanen, M., Lucas, G., Ernfors, P., Castren, M., Castren, E., Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus (2005) J. Neurosci., 25, pp. 1089-1094; Scharfman, H., Goodman, J., Macleod, A., Phani, S., Antonelli, C., Croll, S., Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats (2005) Exp. Neurol., 192, pp. 348-356; Seguela, P., Wadiche, J., Dineley-Miller, K., Dani, J.A., Patrick, J.W., Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium (1993) J. Neurosci., 13, pp. 596-604; Shimohama, S., Greenwald, D.L., Shafron, D.H., Akaika, A., Maeda, T., Kaneko, S., Kimura, J., Meyer, E.M., Nicotinic α7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage (1998) Brain Res., 779, pp. 359-363; Shiraki, A., Akane, H., Ohishi, T., Wang, L., Morita, R., Suzuki, K., Mitsumori, K., Shibutani, M., Similar distribution changes of GABAergic interneuron subpopulations in contrast to the different impact on neurogenesis between developmental and adult-stage hypothyroidism in the hippocampal dentate gyrus in rats (2012) Arch. Toxicol., 86, pp. 1559-1569; Skripuletz, T., Lindner, M., Kotsiari, A., Garde, N., Fokuhl, J., Linsmeier, F., Trebst, C., Stangel, M., Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent (2008) Am. J. Pathol., 172, pp. 1053-1061; Skripuletz, T., Bussmann, J.H., Gudi, V., Koutsoudaki, P.N., Pul, R., Moharregh-Khiabani, D., Lindner, M., Stangel, M., Cerebellar cortical demyelination in the murine cuprizone model (2010) Brain Pathol., 20, pp. 301-312; Takimoto, N., Wang, L., Itahashi, M., Ogawa, T., Segawa, R., Hara, S., Murakami, T., Shibutani, M., Maternal single injection of N-methyl-N-nitrosourea to cause microcephaly in offspring induces transient aberration of hippocampal neurogenesis in mice (2014) Toxicol. Lett., 226, pp. 20-27; Toni, N., Laplagne, D.A., Zhao, C., Lombardi, G., Ribak, C.E., Gage, F.H., Schinder, A.F., Neurons born in the adult dentate gyrus form functional synapses with target cells (2008) Nat. Neurosci., 11, pp. 901-907; Wada, E., Wada, K., Boulter, J., Deneris, E., Heinemann, S., Patrick, J., Swanson, L.W., Distribution of α2, α3, α4, and β2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat (1989) J. Comp. Neurol., 284, pp. 314-335; Xu, H., Yang, H.J., Zhang, Y., Clough, R., Browning, R., Li, X.M., Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone (2009) Behav. Neurosci., 123, pp. 418-429; Yoneda, T., Imaizumi, K., Oono, K., Yui, D., Gomi, F., Katayama, T., Tohyama, M., Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress (2001) J. Biol. Chem., 276, pp. 13935-13940",Article,Scopus,2-s2.0-84924749657
"Li Y., Wen Y., Wang L., Liang W., Xu L., Ren S., Zou Z., Zuo X., Fan C., Huang Q., Liu G., Jia N.","Analysis of telomerase activity based on a spired DNA tetrahedron TS primer",2015,"Biosensors and Bioelectronics","67",,,"364","369",,,10.1016/j.bios.2014.08.056,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84922221299&partnerID=40&md5=3cb2852dcaa58979f66382556a21f3c0","Laboratory of Biometrology, Division of Chemistry and Ionizing Radiation Measurement Technology, Shanghai Institute of Measurement and Testing TechnologyShanghai, China; Laboratory of Physical Biology, Shanghai Institute of Applied Physics, Chinese Academy of SciencesShanghai, China; Department of Chemistry, College of Life and Environmental Sciences, Shanghai Normal University, 100 Guilin RoadShanghai, China","Li, Y., Laboratory of Biometrology, Division of Chemistry and Ionizing Radiation Measurement Technology, Shanghai Institute of Measurement and Testing TechnologyShanghai, China; Wen, Y., Laboratory of Biometrology, Division of Chemistry and Ionizing Radiation Measurement Technology, Shanghai Institute of Measurement and Testing TechnologyShanghai, China; Wang, L., Department of Chemistry, College of Life and Environmental Sciences, Shanghai Normal University, 100 Guilin RoadShanghai, China; Liang, W., Laboratory of Biometrology, Division of Chemistry and Ionizing Radiation Measurement Technology, Shanghai Institute of Measurement and Testing TechnologyShanghai, China; Xu, L., Laboratory of Biometrology, Division of Chemistry and Ionizing Radiation Measurement Technology, Shanghai Institute of Measurement and Testing TechnologyShanghai, China; Ren, S., Laboratory of Biometrology, Division of Chemistry and Ionizing Radiation Measurement Technology, Shanghai Institute of Measurement and Testing TechnologyShanghai, China; Zou, Z., Laboratory of Biometrology, Division of Chemistry and Ionizing Radiation Measurement Technology, Shanghai Institute of Measurement and Testing TechnologyShanghai, China; Zuo, X., Laboratory of Physical Biology, Shanghai Institute of Applied Physics, Chinese Academy of SciencesShanghai, China; Fan, C., Laboratory of Physical Biology, Shanghai Institute of Applied Physics, Chinese Academy of SciencesShanghai, China; Huang, Q., Laboratory of Physical Biology, Shanghai Institute of Applied Physics, Chinese Academy of SciencesShanghai, China; Liu, G., Laboratory of Biometrology, Division of Chemistry and Ionizing Radiation Measurement Technology, Shanghai Institute of Measurement and Testing TechnologyShanghai, China; Jia, N., Department of Chemistry, College of Life and Environmental Sciences, Shanghai Normal University, 100 Guilin RoadShanghai, China","The development of sensitive telomerase biosensors is hindered by the restricted accessibility of telomere strand (TS) primer and the limited enzyme reaction space, which is mainly confined by the vertical distance. In this work, we designed an electrochemical telomerase biosensor based on a spired DNA tetrahedron TS primer (STTS). By adding a rigid dsDNA spire onto the top of the DNA tetrahedron, we successfully regulated the distance between the TS primer and the surface, and thus greatly facilitated the telomerase elongation on surface. The signal-to-noise ratio was 2 times higher than TSP without the spire structure. The limit of detection was calculated to be lower than 10 HeLa cells, which is at least 2 magnitudes lower than other surface extension-based electrochemical telomerase sensors without amplification. The practicability of STTS sensor was also demonstrated by analysing various other cell lines including cancer cells, stem cells of high telomerase activity and somatic cells of low telomerase activity. © 2014 Elsevier B.V.","Cancer; DNA nano-structure; Electrochemical biosensor; Spired DNA tetrahedron TS primer; Telomerase activity","Ak, A., Basaran, A., Dikmen, M., Cosan, D.T., Degirmenci, I., Gunes, H.V., (2011) Balk. Med. J., 28 (3), pp. 293-299; Blackburn, E.H., (1991) Nature, 350 (6319), pp. 569-573; Blackburn, E.H., (1994) Cell, 77 (5), pp. 621-623; Blasco, M.A., (2005) Nat. Rev. Genet., 6 (8), pp. 611-622; Eskiocak, U., Ozkan-Ariksoysal, D., Ozsoz, M., Oktem, H.A., (2007) Anal. Chem., 79 (22), pp. 8807-8811; Fu, W., Begley, J.G., Killen, M.W., Mattson, M.P., (1999) J. Biol. Chem., 274 (11), pp. 7264-7271; Greider, C.W., Blackburn, E.H., (1989) Nature, 337 (6205), pp. 331-337; Harley, C.B., (2008) Nat. Rev. Cancer, 8 (3), pp. 167-179; Harley, C.B., Futcher, A.B., Greider, C.W., (1990) Nature, 345 (6274), pp. 458-460; Kim, K.W., Shin, Y., Perera, A.P., Liu, Q., Kee, J.S., Han, K., Yoon, Y.J., Park, M.K., (2013) Biosens. Bioelectron., 45, pp. 152-157; Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Shay, J.W., (1994) Science, 266 (5193), pp. 2011-2015; Lee, M.S., Blackburn, E.H., (1993) Mol. Cell Biol., 13 (10), pp. 6586-6599; Li, Y., Li, X., Ji, X., Li, X., (2011) Biosens. Bioelectron., 26 (10), pp. 4095-4098; Li, Y., Liu, B., Li, X., Wei, Q., (2010) Biosens. Bioelectron., 25 (11), pp. 2543-2547; Lin, M., Wen, Y., Li, L., Pei, H., Liu, G., Song, H., Zuo, X., Huang, Q., (2014) Anal. Chem., 86 (5), pp. 2285-2288; Liu, G., Chen, H., Peng, H., Song, S., Gao, J., Lu, J., Ding, M., Fan, C., (2011) Biosens. Bioelectron., 28, pp. 308-313; Liu, G., Lao, R., Xu, L., Xu, Q., Li, L., Zhang, M., Song, S., Fan, C., (2012) Biosens. Bioelectron., 42 C, pp. 516-521; Liu, G., Sun, C., Li, D., Song, S., Mao, B., Fan, C., Tian, Z., (2010) Adv. Mater., 22 (19), pp. 2148-2150; Liu, G., Wan, Y., Gau, V., Zhang, J., Wang, L., Song, S., Fan, C., (2008) J. Am. Chem. Soc., 130, pp. 6820-6825; Pavlov, V., Willner, I., Dishon, A., Kotler, M., (2004) Biosens. Bioelectron., 20 (5), pp. 1011-1021; Pei, H., Lu, N., Wen, Y., Song, S., Liu, Y., Yan, H., Fan, C., (2010) Adv. Mater., 22, pp. 4754-4758; Rothacker, J., Ramsay, R.G., Ciznadija, D., Gras, E., Neylon, C.B., Elwood, N.J., Bouchier-Hayes, D., Nice, E.C., (2007) Electrophoresis, 28 (23), pp. 4435-4446; Sato, S., Kondo, H., Nojima, T., Takenaka, S., (2005) Anal. Chem., 77 (22), pp. 7304-7309; Shao, Z.Y., Liu, Y.X., Xiao, H., Li, G.X., (2008) Electrochem. Commun., 10 (10), pp. 1502-1504; Takahashi, A., Higashino, F., Aoyagi, M., Yoshida, K., Itoh, M., Kyo, S., Ohno, T., Shindoh, M., (2003) Cancer Res., 63 (23), pp. 8338-8344; Weizmann, Y., Patolsky, F., Katz, E., Willner, I., (2004) ChemBioChem, 5 (7), pp. 943-948; Wen, Y., Liu, G., Pei, H., Li, L., Xu, Q., Liang, W., Li, Y., Fan, C., (2013) Methods, 64, pp. 276-282; Wen, Y., Pei, H., Wan, Y., Su, Y., Huang, Q., Song, S., Fan, C., (2011) Anal. Chem., 83, pp. 7418-7423; Xiao, Y., Dane, K.Y., Uzawa, T., Csordas, A., Qian, J., Soh, H.T., Daugherty, P.S., Plaxco, K.W., (2010) J. Am. Chem. Soc., 132 (43), pp. 15299-15307; Yang, W., Zhu, X., Liu, Q., Lin, Z., Qiu, B., Chen, G., (2011) Chem. Commun., 47 (11), pp. 3129-3131; Yi, Z., Wang, H.B., Chen, K., Gao, Q., Tang, H., Yu, R.Q., Chu, X., (2014) Biosens. Bioelectron., 53, pp. 310-315; Yu, G.L., Bradley, J.D., Attardi, L.D., Blackburn, E.H., (1990) Nature, 344 (6262), pp. 126-132; Zheng, G., Daniel, W.L., Mirkin, C.A., (2008) J. Am. Chem. Soc., 130 (30), pp. 9644-9645; Zhou, X., Xing, D., (2012) Chem. Soc. Rev., 41 (13), pp. 4643-4656",Article,Scopus,2-s2.0-84922221299
"Hu N., Wang T., Wang Q., Zhou J., Zou L., Su K., Wu J., Wang P.","High-performance beating pattern function of human induced pluripotent stem cell-derived cardiomyocyte-based biosensors for hERG inhibition recognition",2015,"Biosensors and Bioelectronics","67",,,"146","153",,1,10.1016/j.bios.2014.07.080,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84922273996&partnerID=40&md5=7ead6dee74918c4184c2efaa0f27f763","Biosensor National Special Laboratory, Key Laboratory for Biomedical Engineering of Education Ministry, Department of Biomedical Engineering, Zhejiang UniversityHangzhou, China; ACEA Biosciences (Hangzhou) Co., Ltd., High Throughput Drug Screening Center, Xihu Technology and Economy ParkHangzhou, China","Hu, N., Biosensor National Special Laboratory, Key Laboratory for Biomedical Engineering of Education Ministry, Department of Biomedical Engineering, Zhejiang UniversityHangzhou, China; Wang, T., Biosensor National Special Laboratory, Key Laboratory for Biomedical Engineering of Education Ministry, Department of Biomedical Engineering, Zhejiang UniversityHangzhou, China; Wang, Q., Biosensor National Special Laboratory, Key Laboratory for Biomedical Engineering of Education Ministry, Department of Biomedical Engineering, Zhejiang UniversityHangzhou, China; Zhou, J., Biosensor National Special Laboratory, Key Laboratory for Biomedical Engineering of Education Ministry, Department of Biomedical Engineering, Zhejiang UniversityHangzhou, China; Zou, L., Biosensor National Special Laboratory, Key Laboratory for Biomedical Engineering of Education Ministry, Department of Biomedical Engineering, Zhejiang UniversityHangzhou, China; Su, K., Biosensor National Special Laboratory, Key Laboratory for Biomedical Engineering of Education Ministry, Department of Biomedical Engineering, Zhejiang UniversityHangzhou, China; Wu, J., ACEA Biosciences (Hangzhou) Co., Ltd., High Throughput Drug Screening Center, Xihu Technology and Economy ParkHangzhou, China; Wang, P., Biosensor National Special Laboratory, Key Laboratory for Biomedical Engineering of Education Ministry, Department of Biomedical Engineering, Zhejiang UniversityHangzhou, China","High-throughput and high clinical relevance methods are demanded to predict the drug-induced cardiotoxicity in pharmaceutical and biotechnology industries to effectively decrease late-stage drug attrition. In this study, human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) were integrated into an interdigital impedance sensor array to fabricate a high performance iPSC-CM-based biosensor array with high-throughput and high-consistency beating pattern. Typical withdrawal approved drugs (astemizole, sertindole, cisapride, and droperidol) with hERG inhibition and positive control E-4031 were employed to determine the beating pattern function. From the results, it can be concluded that this iPSC-CM-based biosensor array can specifically differentiate the hERG inhibitors from the non-hERG inhibition compounds through beating pattern function. © 2014 Elsevier B.V.","Beating pattern function; Drug cardiotoxicity assessment; HERG inhibitor recognition; Human iPSC-CM-based biosensor array; Impedance detection technology","Abassi, Y.A., Xi, B., Li, N., Ouyang, W., Seiler, A., Watzele, M., Kettenhofen, R., Kolossov, E., (2012) Br. J. Pharmacol., 165 (5), pp. 1424-1441; Bers, D.M., (2002) Nature, 415 (6868), pp. 198-205; Bowes, J., Brown, A.J., Hamon, J., Jarolimek, W., Sridhar, A., Waldron, G., Whitebread, S., (2012) Nat. Rev. Drug Discov., 11 (12), pp. 909-922; Cohen, J., Babiarz, J., Abrams, R., Guo, L., Kameoka, S., Chiao, E., Taunton, J., Kolaja, K., (2011) Toxicol. Appl. Pharmacol., 257 (1), pp. 74-83; Fermini, B., Fossa, A.A., (2003) Nat. Rev. Drug Discov., 2 (6), pp. 439-447; Gonzalez, R., Lee, J.W., Schultz, P.G., (2011) Angew. Chem. Int. Ed., 50 (47), pp. 11181-11185; Hancox, J.C., McPate, M.J., El Harchi, A., (2008) Pharmacol. Therapeut., 119 (2), pp. 118-132; Hu, N., Wang, T., Cao, J., Su, K., Zhou, J., Wu, J., Wang, P., (2013) Sens. Actuators B: Chem., 185, pp. 238-244; Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Hammerman, H., (2011) Nature, 471 (7337), pp. 225-229; Jeyaraj, D., Haldar, S.M., Wan, X., McCauley, M.D., Ripperger, J.A., Hu, K., Lu, Y., Ficker, E., (2012) Nature, 483 (7387), pp. 96-99; Jonsson, M.K., Wang, Q.-D., Becker, B., (2011) Assay Drug Dev. Technol., 9 (6), pp. 589-599; Kiss, L., Bennett, P.B., Uebele, V.N., Koblan, K.S., Kane, S.A., Neagle, B., Schroeder, K., (2003) Assay Drug Dev. Technol., 1 (1), pp. 127-135; Kola, I., Landis, J., (2004) Nat. Rev. Drug Discov., 3 (8), pp. 711-716; Liu, Q., Huang, H., Cai, H., Xu, Y., Li, Y., Li, R., Wang, P., (2007) Biosens. Bioelectron., 22 (6), pp. 810-815; Lyssiotis, C.A., Lairson, L.L., Boitano, A.E., Wurdak, H., Zhu, S., Schultz, P.G., (2011) Angew. Chem. Int. Ed., 50 (1), pp. 200-242; Meyer, T., Sartipy, P., Blind, F., Leisgen, C., Guenther, E., (2007) Expert Opin. Drug Metab, 3 (4), pp. 507-517; Nattel, S., Carlsson, L., (2006) Nat. Rev. Drug Discov., 5 (12), pp. 1034-1049; Navarrete, E.G., Liang, P., Lan, F., Sanchez-Freire, V., Simmons, C., Gong, T., Sharma, A., Lee, A.S., (2013) Circulation, 128 (26), pp. S3-S13; Oinuma, H., Miyake, K., Yamanaka, M., Nomoto, K., Katoh, H., Sawada, K., Shino, M., Hamano, S., (1990) J. Med. Chem., 33 (3), pp. 903-905; Plowright, A.T., Engkvist, O., Gill, A., Knerr, L., Wang, Q.D., (2014) Angew. Chem. Int. Ed., 53 (16), pp. 4056-4075; Sakurada, K., McDonald, F.M., Shimada, F., (2008) Angew. Chem. Int. Ed., 47 (31), pp. 5718-5738; Sanguinetti, M.C., Tristani-Firouzi, M., (2006) Nature, 440 (7083), pp. 463-469; Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., Jones, J.M., (1998) Science, 282 (5391), pp. 1145-1147; Volders, P.G., Vos, M.A., Szabo, B., Sipido, K.R., de Groot, S.M., Gorgels, A.P., Wellens, H.J., Lazzara, R., (2000) Cardiovasc. Res., 46 (3), pp. 376-392; Wang, T., Hu, N., Cao, J., Wu, J., Su, K., Wang, P., (2013) Biosens. Bioelectron., 49 (0), pp. 9-13; Yap, Y.G., Camm, A.J., (2003) Heart, 89 (11), pp. 1363-1372",Article,Scopus,2-s2.0-84922273996
"Tran T.D.N., Yao S., Hsu W.H., Gimble J.M., Bunnell B.A., Cheng H.","Arginine vasopressin inhibits adipogenesis in human adipose-derived stem cells",2015,"Molecular and Cellular Endocrinology","406",,,"1","9",,,10.1016/j.mce.2015.02.009,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84923369824&partnerID=40&md5=5e616270f1329c53e8f148d0bec0dd84","Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State UniversityBaton Rouge, LA, United States; Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State UniversityAmes, IA, United States; Stem Cell Biology Laboratory, Pennington Biomedical Research Center, Louisiana State UniversityBaton Rouge, LA, United States; Department of Pharmacology, Tulane Center for Stem Cell Research and Regenerative Medicine, Div. of Regenerative Med.of Tulane National Primate Research Center, Tulane Univ. Health Sci. CenterNew Orleans, LA, United States; LaCell LLC, 340 Building Louisiana State University CampusBaton Rouge, LA, United States","Tran, T.D.N., Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State UniversityBaton Rouge, LA, United States; Yao, S., Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State UniversityBaton Rouge, LA, United States; Hsu, W.H., Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State UniversityAmes, IA, United States; Gimble, J.M., Stem Cell Biology Laboratory, Pennington Biomedical Research Center, Louisiana State UniversityBaton Rouge, LA, United States, LaCell LLC, 340 Building Louisiana State University CampusBaton Rouge, LA, United States; Bunnell, B.A., Department of Pharmacology, Tulane Center for Stem Cell Research and Regenerative Medicine, Div. of Regenerative Med.of Tulane National Primate Research Center, Tulane Univ. Health Sci. CenterNew Orleans, LA, United States; Cheng, H., Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State UniversityBaton Rouge, LA, United States","Intracellular Ca2+ signaling is important for stem cell differentiation and there is evidence it may coordinate the process. Arginine vasopressin (AVP) is a neuropeptide hormone secreted mostly from the posterior pituitary gland and increases Ca2+ signals mainly via V1 receptors. However, the role of AVP in adipogenesis of human adipose-derived stem cells (hASCs) is unknown. In this study, we identified the V1a receptor gene in hASCs and demonstrated that AVP stimulation increased intracellular Ca2+ concentration during adipogenesis. This effect was mediated via V1a receptors, Gq-proteins and the PLC-IP3 pathway. These Ca2+ signals were due to endoplasmic reticulum release and influx from the extracellular space. Furthermore, AVP supplementation to the adipogenic medium decreased the number of adipocytes and adipocyte marker genes during differentiation. The effect of AVP on adipocyte formation was reversed by the V1a receptor blocker V2255. These findings suggested that AVP may function to inhibit adipocyte differentiation. © 2015 Elsevier Ireland Ltd.","Arginine vasopressin; Ca2+ signaling; Differentiation; Human adipose-derived stem cells","Ang, V.T., Jenkins, J.S., Neurohypophysial hormones in the adrenal medulla (1984) J. Clin. Endocrinol. Metab, 58, pp. 688-691; Angelini, C., (2014) Multiple Symmetric Lipomatosis, Genetic Neuromuscular Disorders, pp. 251-254. , Springer; Aoyagi, T., Birumachi, J., Hiroyama, M., Fujiwara, Y., Sanbe, A., Yamauchi, J., Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice (2007) Endocrinology, 148, pp. 2075-2084; Boston, B.A., Cone, R.D., Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line (1996) Endocrinology, 137, pp. 2043-2050; Bourin, P., Bunnell, B.A., Casteilla, L., Dominici, M., Katz, A.J., March, K.L., Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) (2013) Cytotherapy, 15, pp. 641-648; Camp, H.S., Tafuri, S.R., Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase (1997) J. Biol. Chem, 272, pp. 10811-10816; Chiu, T., Wu, S.S., Santiskulvong, C., Tangkijvanich, P., Yee, H.F., Rozengurt, E., Vasopressin-mediated mitogenic signaling in intestinal epithelial cells (2002) Am. J. Physiol. Cell Physiol, 282, pp. C434-C450; Coiro, V., Chiodera, P., Effect of obesity and weight loss on the arginine vasopressin response to insulin-induced hypoglycaemia (1987) Clin. Endocrinol. (Oxf), 27, pp. 253-258; Dolmetsch, R.E., Xu, K., Lewis, R.S., Calcium oscillations increase the efficiency and specificity of gene expression (1998) Nature, 392, pp. 933-936; Draznin, B., Sussman, K.E., Eckel, R.H., Kao, M., Yost, T., Sherman, N.A., Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia (1988) J. Clin. Invest, 82, pp. 1848-1852; Enhorning, S., Leosdottir, M., Wallstrom, P., Gullberg, B., Berglund, G., Wirfalt, E., Relation between human vasopressin 1a gene variance, fat intake, and diabetes (2009) Am. J. Clin. Nutr, 89, pp. 400-406; Gassanov, N., Jankowski, M., Danalache, B., Wang, D., Grygorczyk, R., Hoppe, U.C., Arginine vasopressin-mediated cardiac differentiation: insights into the role of its receptors and nitric oxide signaling (2007) J. Biol. Chem, 282, pp. 11255-11265; Grazzini, E., Lodboerer, A.M., Perez-Martin, A., Joubert, D., Guillon, G., Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla (1996) Endocrinology, 137, pp. 3906-3914; Gutkowska, J., Miszkurka, M., Danalache, B., Gassanov, N., Wang, D., Jankowski, M., Functional arginine vasopressin system in early heart maturation (2007) Am. J. Physiol. Heart Circ. Physiol, 293, pp. H2262-H2270; He, Y.P., Zhao, L.Y., Zheng, Q.S., Liu, S.W., Zhao, X.Y., Lu, X.L., Arginine vasopressin stimulates proliferation of adult rat cardiac fibroblasts via protein kinase C-extracellular signal-regulated kinase 1/2 pathway (2008) Sheng Li Xue Bao, 60, pp. 333-340; Hew-Butler, T., Noakes, T.D., Soldin, S.J., Verbalis, J.G., Acute changes in arginine vasopressin, sweat, urine and serum sodium concentrations in exercising humans: does a coordinated homeostatic relationship exist? (2010) Br. J. Sports Med, 44, pp. 710-715; Hiroyama, M., Aoyagi, T., Fujiwara, Y., Birumachi, J., Shigematsu, Y., Kiwaki, K., Hypermetabolism of fat in V1a vasopressin receptor knockout mice (2007) Mol. Endocrinol, 21, pp. 247-258; Inder, W.J., Hellemans, J., Swanney, M.P., Prickett, T.C., Donald, R.A., Prolonged exercise increases peripheral plasma ACTH, CRH, and AVP in male athletes (1998) J. Appl. Physiol, 85, pp. 835-841; Jaiswal, R.K., Jaiswal, N., Bruder, S.P., Mbalaviele, G., Marshak, D.R., Pittenger, M.F., Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase (2000) J. Biol. Chem, 275, pp. 9645-9652; Jessop, D.S., Murphy, D., Larsen, P.J., Thymic vasopressin (AVP) transgene expression in rats: a model for the study of thymic AVP hyper-expression in T cell differentiation (1995) J. Neuroimmunol, 62, pp. 85-90; Kapur, N., Mignery, G.A., Banach, K., Cell cycle-dependent calcium oscillations in mouse embryonic stem cells (2007) Am. J. Physiol. Cell Physiol, 292, pp. C1510-C1518; Kasson, B.G., Meidan, R., Hsueh, A.J., Identification and characterization of arginine vasopressin-like substances in the rat testis (1985) J. Biol. Chem, 260, pp. 5302-5307; Kawano, S., Shoji, S., Ichinose, S., Yamagata, K., Tagami, M., Hiraoka, M., Characterization of Ca(2+) signaling pathways in human mesenchymal stem cells (2002) Cell Calcium, 32, pp. 165-174; Kawano, S., Otsu, K., Kuruma, A., Shoji, S., Yanagida, E., Muto, Y., ATP autocrine/paracrine signaling induces calcium oscillations and NFAT activation in human mesenchymal stem cells (2006) Cell Calcium, 39, pp. 313-324; Keegan, B.P., Akerman, B.L., Pequeux, C., North, W.G., Provasopressin expression by breast cancer cells: implications for growth and novel treatment strategies (2006) Breast Cancer Res. Treat, 95, pp. 265-277; Koshimizu, T.A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., Tanoue, A., Vasopressin V1a and V1b receptors: from molecules to physiological systems (2012) Physiol. Rev, 92, pp. 1813-1864; Kotchen, T.A., Obesity-related hypertension?: weighing the evidence (2008) Hypertension, 52, pp. 801-802; Kotova, P.D., Sysoeva, V.Y., Rogachevskaja, O.A., Bystrova, M.F., Kolesnikova, A.S., Tyurin-Kuzmin, P.A., Functional expression of adrenoreceptors in mesenchymal stromal cells derived from the human adipose tissue (2014) Biochim. Biophys. Acta, 1843 (9), pp. 1899-1908; Kuchler, S., Perwitz, N., Schick, R.R., Klein, J., Westphal, S., Arginine-vasopressin directly promotes a thermogenic and pro-inflammatory adipokine expression profile in brown adipocytes (2010) Regul. Pept, 164, pp. 126-132; Lagumdzija, A., Bucht, E., Stark, A., Hulting, A.L., Petersson, M., Arg-vasopressin increases proliferation of human osteoblast-like cells and decreases production of interleukin-6 and macrophage colony-stimulating factor (2004) Regul. Pept, 121, pp. 41-48; Laycock, J.F., (2010) Perspectives on Vasopressin, , Imperial College Press; Lee, B., Yang, C., Chen, T.H., al-Azawi, N., Hsu, W.H., Effect of AVP and oxytocin on insulin release: involvement of V1b receptors (1995) Am. J. Physiol, 269, pp. E1095-E1100; Lin, F., Ribar, T.J., Means, A.R., The Ca2+/calmodulin-dependent protein kinase kinase, CaMKK2, inhibits preadipocyte differentiation (2011) Endocrinology, 152, pp. 3668-3679; Liu, Q., Cen, L., Zhou, H., Yin, S., Liu, G., Liu, W., The role of the extracellular signal-related kinase signaling pathway in osteogenic differentiation of human adipose-derived stem cells and in adipogenic transition initiated by dexamethasone (2009) Tissue Eng. Part A., 15, pp. 3487-3497; Markwick, A.J., Lolait, S.J., Funder, J.W., Immunoreactive arginine vasopressin in the rat thymus (1986) Endocrinology, 119, pp. 1690-1696; Nakamura, K., Aoyagi, T., Hiroyama, M., Kusakawa, S., Mizutani, R., Sanbe, A., Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance (2009) Eur. J. Pharmacol, 613, pp. 182-188; Nakamura, Y., Haneda, T., Osaki, J., Miyata, S., Kikuchi, K., Hypertrophic growth of cultured neonatal rat heart cells mediated by vasopressin V(1A) receptor (2000) Eur. J. Pharmacol, 391, pp. 39-48; Nervi, C., Benedetti, L., Minasi, A., Molinaro, M., Adamo, S., Arginine-vasopressin induces differentiation of skeletal myogenic cells and up-regulation of myogenin and Myf-5 (1995) Cell Growth Differ, 6, pp. 81-89; Peinelt, C., Vig, M., Koomoa, D.L., Beck, A., Nadler, M.J., Koblan-Huberson, M., Amplification of CRAC current by STIM1 and CRACM1 (Orai1) (2006) Nat. Cell Biol, 8, pp. 771-773; Pequeux, C., Breton, C., Hendrick, J.C., Hagelstein, M.T., Martens, H., Winkler, R., Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling (2002) Cancer Res, 62, pp. 4623-4629; Prakriya, M., Feske, S., Gwack, Y., Srikanth, S., Rao, A., Hogan, P.G., Orai1 is an essential pore subunit of the CRAC channel (2006) Nature, 443, pp. 230-233; Resende, R.R., Adhikari, A., da Costa, J.L., Lorencon, E., Ladeira, M.S., Guatimosim, S., Influence of spontaneous calcium events on cell-cycle progression in embryonal carcinoma and adult stem cells (2010) Biochim. Biophys. Acta, 1803, pp. 246-260; Schaeffer, J.M., Liu, J., Hsueh, A.J., Yen, S.S., Presence of oxytocin and arginine vasopressin in human ovary, oviduct, and follicular fluid (1984) J. Clin. Endocrinol. Metab, 59, pp. 970-973; Serradeil-Le Gal, C., Herbert, J.M., Delisee, C., Schaeffer, P., Raufaste, D., Garcia, C., Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells (1995) Am. J. Physiol, 268, pp. H404-H410; Shi, H., Halvorsen, Y.D., Ellis, P.N., Wilkison, W.O., Zemel, M.B., Role of intracellular calcium in human adipocyte differentiation (2000) Physiol. Genomics, 3, pp. 75-82; Sugden, M.C., Ball, A.J., Ilic, V., Williamson, D.H., Stimulation of [1-14C]oleate oxidation to 14CO2 in isolated rat hepatocytes by vasopressin: effects of Ca2 (1980) FEBS Lett, 116, pp. 37-40; Sukhonthachit, P., Aekplakorn, W., Hudthagosol, C., Sirikulchayanonta, C., The association between obesity and blood pressure in Thai public school children (2014) BMC Public Health, 14, p. 729; Sun, S., Liu, Y., Lipsky, S., Cho, M., Physical manipulation of calcium oscillations facilitates osteodifferentiation of human mesenchymal stem cells (2007) FASEB J., 21, pp. 1472-1480; Syed, N., Martens, C.A., Hsu, W.H., Arginine vasopressin increases glutamate release and intracellular Ca2+ concentration in hippocampal and cortical astrocytes through two distinct receptors (2007) J. Neurochem, 103, pp. 229-237; Tahara, A., Tsukada, J., Tomura, Y., Suzuki, T., Yatsu, T., Shibasaki, M., Effect of vasopressin on type IV collagen production in human mesangial cells (2008) Regul. Pept, 147, pp. 60-66; Tahara, A., Tsukada, J., Tomura, Y., Yatsu, T., Shibasaki, M., Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells (2008) Pharmacol. Res, 57, pp. 142-150; Thibonnier, M., Bayer, A.L., Simonson, M.S., Kester, M., Multiple signaling pathways of V1-vascular vasopressin receptors of A7r5 cells (1991) Endocrinology, 129, pp. 2845-2856; Thibonnier, M., Berti-Mattera, L.N., Dulin, N., Conarty, D.M., Mattera, R., Signal transduction pathways of the human V1-vascular, V2-renal, V3-pituitary vasopressin and oxytocin receptors (1998) Prog. Brain Res, 119, pp. 147-161; Thorgeirsson, T.E., Gudbjartsson, D.F., Sulem, P., Besenbacher, S., Styrkarsdottir, U., Thorleifsson, G., A common biological basis of obesity and nicotine addiction (2013) Transl. Psychiatry, 3, p. e308; Todorova, M.G., Fuentes, E., Soria, B., Nadal, A., Quesada, I., Lysophosphatidic acid induces Ca2+ mobilization and c-Myc expression in mouse embryonic stem cells via the phospholipase C pathway (2009) Cell. Signal, 21, pp. 523-528; Toschi, A., Severi, A., Coletti, D., Catizone, A., Musaro, A., Molinaro, M., Skeletal muscle regeneration in mice is stimulated by local overexpression of V1a-vasopressin receptor (2011) Mol. Endocrinol, 25, pp. 1661-1673; Yibchok-anun, S., Abu-Basha, E.A., Yao, C.Y., Panichkriangkrai, W., Hsu, W.H., The role of arginine vasopressin in diabetes-associated increase in glucagon secretion (2004) Regul. Pept, 122, pp. 157-162; Yibchok-Anun, S., Cheng, H., Heine, P.A., Hsu, W.H., Characterization of receptors mediating AVP- and OT-induced glucagon release from the rat pancreas (1999) Am. J. Physiol, 277, pp. E56-E62; Yu, G., Floyd, Z.E., Wu, X., Hebert, T., Halvorsen, Y.D., Buehrer, B.M., Adipogenic differentiation of adipose-derived stem cells (2011) Methods Mol. Biol, 702, pp. 193-200; Yu, L., Moriguchi, T., Souma, T., Takai, J., Satoh, H., Morito, N., GATA2 regulates body water homeostasis through maintaining aquaporin 2 expression in renal collecting ducts (2014) Mol. Cell. Biol, 34, pp. 1929-1941",Article,Scopus,2-s2.0-84923369824
"Yang Y., Adachi K., Sheridan M.A., Alexenko A.P., Schust D.J., Schulz L.C., Ezashi T., Roberts R.M.","Heightened potency of human pluripotent stem cell lines created by transient BMP4 exposure",2015,"Proceedings of the National Academy of Sciences of the United States of America","112","18",,"E2337","E2346",,,10.1073/pnas.1504778112,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928946673&partnerID=40&md5=0d5fe440bd2ec54380c533d5c9ab62f6","Division of Animal Sciences, Bond Life Sciences Center, University of MissouriColumbia, MO, United States; Department of Obstetrics, Gynecology, and Women's Health, University of MissouriColumbia, MO, United States; Department of Biochemistry, University of MissouriColumbia, MO, United States","Yang, Y., Division of Animal Sciences, Bond Life Sciences Center, University of MissouriColumbia, MO, United States; Adachi, K., Department of Obstetrics, Gynecology, and Women's Health, University of MissouriColumbia, MO, United States; Sheridan, M.A., Department of Biochemistry, University of MissouriColumbia, MO, United States; Alexenko, A.P., Division of Animal Sciences, Bond Life Sciences Center, University of MissouriColumbia, MO, United States; Schust, D.J., Department of Obstetrics, Gynecology, and Women's Health, University of MissouriColumbia, MO, United States; Schulz, L.C., Department of Obstetrics, Gynecology, and Women's Health, University of MissouriColumbia, MO, United States; Ezashi, T., Division of Animal Sciences, Bond Life Sciences Center, University of MissouriColumbia, MO, United States; Roberts, R.M., Division of Animal Sciences, Bond Life Sciences Center, University of MissouriColumbia, MO, United States, Department of Biochemistry, University of MissouriColumbia, MO, United States","Human pluripotent stem cells (PSCs) show epiblast-type pluripotency that is maintained with ACTIVIN/FGF2 signaling. Here, we report the acquisition of a unique stem cell phenotype by both human ES cells (hESCs) and induced pluripotent stem cells (iPSCs) in response to transient (24-36 h) exposure to bone morphogenetic protein 4 (BMP4) plus inhibitors of ACTIVIN signaling (A83-01) and FGF2 (PD173074), followed by trypsin dissociation and recovery of colonies capable of growing on a gelatin substratum in standard medium for human PSCs at low but not high FGF2 concentrations. The self-renewing cell lines stain weakly for CDX2 and strongly for NANOG, can be propagated clonally on either Matrigel or gelatin, and are morphologically distinct from human PSC progenitors on either substratum but still meet standard in vitro criteria for pluripotency. They form well-differentiated teratomas in immune-compromised mice that secrete human chorionic gonadotropin (hCG) into the host mouse and include small areas of trophoblast-like cells. The cells have a distinct transcriptome profile from the human PSCs from which they were derived (including higher expression of NANOG, LEFTY1, and LEFTY2). In nonconditioned medium lacking FGF2, the colonies spontaneously differentiated along multiple lineages, including trophoblast. They responded to PD173074 in the absence of both FGF2 and BMP4 by conversion to trophoblast, and especially syncytiotrophoblast, whereas an A83-01/PD173074 combination favored increased expression of HLA-G, a marker of extravillous trophoblast. Together, these data suggest that the cell lines exhibit totipotent potential and that BMP4 can prime human PSCs to a self-renewing alternative state permissive for trophoblast development. The results may have implications for regulation of lineage decisions in the early embryo. © 2015, National Academy of Sciences. All rights reserved.","Biological sciences; Developmental biology; Pluripotent stem cells; Totipotent; Trophoblast","Nichols, J., Smith, A., Naive and primed pluripotent states (2009) Cell Stem Cell, 4 (6), pp. 487-492; Brons, I.G., Derivation of pluripotent epiblast stem cells from mammalian embryos (2007) Nature, 448 (7150), pp. 191-195; Tesar, P.J., New cell lines from mouse epiblast share defining features with human embryonic stem cells (2007) Nature, 448 (7150), pp. 196-199; Greber, B., Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells (2010) Cell Stem Cell, 6 (3), pp. 215-226; Vallier, L., Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways (2009) PLoS ONE, 4 (6), p. e6082; Vallier, L., Alexander, M., Pedersen, R.A., Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells (2005) J Cell Sci, 118 (19), pp. 4495-4509; Vallier, L., Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells (2009) Stem Cells, 27 (11), pp. 2655-2666; Xu, R.H., NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs (2008) Cell Stem Cell, 3 (2), pp. 196-206; Schenke-Layland, K., Collagen IV induces trophoectoderm differentiation of mouse embryonic stem cells (2007) Stem Cells, 25 (6), pp. 1529-1538; He, S., Pant, D., Schiffmacher, A., Meece, A., Keefer, C.L., Lymphoid enhancer factor 1-mediated Wnt signaling promotes the initiation of trophoblast lineage differentiation in mouse embryonic stem cells (2008) Stem Cells, 26 (4), pp. 842-849; Hayashi, Y., BMP4 induction of trophoblast from mouse embryonic stem cells in defined culture conditions on laminin (2010) In Vitro Cell Dev Biol Anim, 46 (5), pp. 416-430; Harun, R., Cytotrophoblast stem cell lines derived from human embryonic stem cells and their capacity to mimic invasive implantation events (2006) Hum Reprod, 21 (6), pp. 1349-1358; Gerami-Naini, B., Trophoblast differentiation in embryoid bodies derived from human embryonic stem cells (2004) Endocrinology, 145 (4), pp. 1517-1524; Chen, G., Trophoblast differentiation defect in human embryonic stem cells lacking PIG-A and GPI-anchored cell-surface proteins (2008) Cell Stem Cell, 2 (4), pp. 345-355; Douglas, G.C., VandeVoort, C.A., Kumar, P., Chang, T.C., Golos, T.G., Trophoblast stem cells: Models for investigating trophectoderm differentiation and placental development (2009) Endocr Rev, 30 (3), pp. 228-240; Drukker, M., Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells (2012) Nat Biotechnol, 30 (6), pp. 531-542; Li, Y., BMP4-directed trophoblast differentiation of human embryonic stem cells is mediated through a ΔNp63+ cytotrophoblast stem cell state (2013) Development, 140 (19), pp. 3965-3976; Marchand, M., Transcriptomic signature of trophoblast differentiation in a human embryonic stem cell model (2011) Biol Reprod, 84 (6), pp. 1258-1271; Schulz, L.C., Human embryonic stem cells as models for trophoblast differentiation (2008) Placenta, 29, pp. S10-S16; Sudheer, S., Bhushan, R., Fauler, B., Lehrach, H., Adjaye, J., FGF inhibition directs BMP4-mediated differentiation of human embryonic stem cells to syncytiotrophoblast (2012) Stem Cells Dev, 21 (16), pp. 2987-3000; Das, P., Effects of fgf2 and oxygen in the bmp4-driven differentiation of trophoblast from human embryonic stem cells (2007) Stem Cell Res (Amst), 1 (1), pp. 61-74; Erb, T.M., Paracrine and epigenetic control of trophectoderm differentiation from human embryonic stem cells: The role of bone morphogenic protein 4 and histone deacetylases (2011) Stem Cells Dev, 20 (9), pp. 1601-1614; Xu, R.H., BMP4 initiates human embryonic stem cell differentiation to trophoblast (2002) Nat Biotechnol, 20 (12), pp. 1261-1264; Lichtner, B., Knaus, P., Lehrach, H., Adjaye, J., BMP10 as a potent inducer of trophoblast differentiation in human embryonic and induced pluripotent stem cells (2013) Biomaterials, 34 (38), pp. 9789-9802; Amita, M., Complete and unidirectional conversion of human embryonic stem cells to trophoblast by BMP4 (2013) Proc Natl Acad Sci USA, 110 (13), pp. E1212-E1221; Telugu, B.P., Comparison of extravillous trophoblast cells derived from human embryonic stem cells and from first trimester human placentas (2013) Placenta, 34 (7), pp. 536-543; Bai, Q., Dissecting the first transcriptional divergence during human embryonic development (2012) Stem Cell Rev, 8 (1), pp. 150-162; Ying, Q.L., Nichols, J., Chambers, I., Smith, A., BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3 (2003) Cell, 115 (3), pp. 281-292; Hassani, S.N., Inhibition of TGFβ signaling promotes ground state pluripotency (2014) Stem Cell Rev, 10 (1), pp. 16-30; Bernardo, A.S., BRACHYURY and CDX2 mediate BMP-induced differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages (2011) Cell Stem Cell, 9 (2), pp. 144-155; Roberts, R.M., Differentiation of trophoblast cells from human embryonic stem cells: To be or not to be? (2014) Reproduction, 147 (5), pp. D1-D12; Ludwig, T., Thompson, J.A., Defined, feeder-independent medium for human embryonic stem cell culture (2007) Curr Protoc Stem Cell Biol, , Chapter 1:Unit 1C.2; Chan, E.M., Yates, F., Boyer, L.F., Schlaeger, T.M., Daley, G.Q., Enhanced plating efficiency of trypsin-adapted human embryonic stem cells is reversible and independent of trisomy 12/17 (2008) Cloning Stem Cells, 10 (1), pp. 107-118; Sánchez, L., Maintenance of human embryonic stem cells in media conditioned by human mesenchymal stem cells obviates the requirement of exogenous basic fibroblast growth factor supplementation (2012) Tissue Eng Part C Methods, 18 (5), pp. 387-396; Tanaka, S., Derivation and culture of mouse trophoblast stem cells in vitro (2006) Methods Mol Biol, 329, pp. 35-44; Tanaka, S., Kunath, T., Hadjantonakis, A.K., Nagy, A., Rossant, J., Promotion of trophoblast stem cell proliferation by FGF4 (1998) Science, 282 (5396), pp. 2072-2075; Müller, F.J., A bioinformatic assay for pluripotency in human cells (2011) Nat Methods, 8 (4), pp. 315-317; Roberts, R.M., Fisher, S.J., Trophoblast stem cells (2011) Biol Reprod, 84 (3), pp. 412-421; Kidder, B.L., Palmer, S., Examination of transcriptional networks reveals an important role for TCFAP2C, SMARCA4, and EOMES in trophoblast stem cell maintenance (2010) Genome Res, 20 (4), pp. 458-472; Ralston, A., Gata3 regulates trophoblast development downstream of Tead4 and in parallel to Cdx2 (2010) Development, 137 (3), pp. 395-403; Chen, Y., Blair, K., Smith, A., Robust self-renewal of rat embryonic stem cells requires fine-tuning of glycogen synthase kinase-3 inhibition (2013) Stem Cell Rev, 1 (3), pp. 209-217; Hong, J., A focused microarray for screening rat embryonic stem cell lines (2013) Stem Cells Dev, 22 (3), pp. 431-443; Rajendran, G., Inhibition of protein kinase C signaling maintains rat embryonic stem cell pluripotency (2013) J Biol Chem, 288 (34), pp. 24351-24362; Niakan, K.K., Eggan, K., Analysis of human embryos from zygote to blastocyst reveals distinct gene expression patterns relative to the mouse (2013) Dev Biol, 375 (1), pp. 54-64; Berg, D.K., Trophectoderm lineage determination in cattle (2011) Dev Cell, 20 (2), pp. 244-255; Chen, L., Cross-regulation of the Nanog and Cdx2 promoters (2009) Cell Res, 19 (9), pp. 1052-1061; Surani, A., Tischler, J., Stem cells: A sporadic super state (2012) Nature, 487 (7405), pp. 43-45; Singh, A.M., Hamazaki, T., Hankowski, K.E., Terada, N., A heterogeneous expression pattern for Nanog in embryonic stem cells (2007) Stem Cells, 25 (10), pp. 2534-2542; Macfarlan, T.S., Embryonic stem cell potency fluctuates with endogenous retrovirus activity (2012) Nature, 487 (7405), pp. 57-63; Torres-Padilla, M.E., Parfitt, D.E., Kouzarides, T., Zernicka-Goetz, M., Histone arginine methylation regulates pluripotency in the early mouse embryo (2007) Nature, 445 (7124), pp. 214-218; Abad, M., Reprogramming in vivo produces teratomas and iPS cells with totipotency features (2013) Nature, 502 (7471), pp. 340-345; Benirschke, K., (2012) Pathology of the Human Placenta, , Springer, New York; Regelson, W., Have we found the ""definitive cancer biomarker""? The diagnostic and therapeutic implications of human chorionic gonadotropin-beta expression as a key to malignancy (1995) Cancer, 76 (8), pp. 1299-1301; Butler, S.A., Iles, R.K., Ectopic human chorionic gonadotropin beta secretion by epithelial tumors and human chorionic gonadotropin beta-induced apoptosis in Kaposi's sarcoma: Is there a connection? (2003) Clin Cancer Res, 9 (13), pp. 4666-4673; Stenman, U.H., Alfthan, H., Hotakainen, K., Human chorionic gonadotropin in cancer (2004) Clin Biochem, 37 (7), pp. 549-561; Itinteang, T., A placental chorionic villous mesenchymal core cellular origin for infantile haemangioma (2011) J Clin Pathol, 64 (10), pp. 870-874; Clark, B.Z., Beriwal, S., Dabbs, D.J., Bhargava, R., Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas (2014) Am J Clin Pathol, 142 (1), pp. 64-71; Yang, P., Abnormal oxidative stress responses in fibroblasts from preeclampsia infants (2014) PLoS ONE, 9 (7), p. e103110; Graham, S.J., BMP signalling regulates the pre-implantation development of extra-embryonic cell lineages in the mouse embryo (2014) Nat Commun, 5, p. 5667; Chu, G.C., Dunn, N.R., Anderson, D.C., Oxburgh, L., Robertson, E.J., Differential requirements for Smad4 in TGFbeta-dependent patterning of the early mouse embryo (2004) Development, 131 (15), pp. 3501-3512; Okita, K., A more efficient method to generate integration-free human iPS cells (2011) Nat Methods, 8 (5), pp. 409-412; Lee, K., Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency (2014) Proc Natl Acad Sci USA, 111 (20), pp. 7260-7265; Ludwig, T.E., Feeder-independent culture of human embryonic stem cells (2006) Nat Methods, 3 (8), pp. 637-646; Amit, M., Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture (2000) Dev Biol, 227 (2), pp. 271-278; Ezashi, T., Das, P., Roberts, R.M., Low O2 tensions and the prevention of differentiation of hES cells (2005) Proc Natl Acad Sci USA, 102 (13), pp. 4783-4788; Xu, R.H., In vitro induction of trophoblast from human embryonic stem cells (2006) Methods Mol Med, 121, pp. 189-202",Article,Scopus,2-s2.0-84928946673
"Kikuchihara Y., Abe H., Tanaka T., Kato M., Wang L., Ikarashi Y., Yoshida T., Shibutani M.","Relationship between brain accumulation of manganese and aberration of hippocampal adult neurogenesis after oral exposure to manganese chloride in mice",2015,"Toxicology","331",,,"24","34",,,10.1016/j.tox.2015.02.005,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925965939&partnerID=40&md5=36a473dd608f1d476a0b02b056280357","Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-choFuchu-shi, Tokyo, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 YanagidoGifu-shi, Gifu, Japan; Division of Environmental Chemistry, National Institute of Health Sciences, 1-18-1 KamiyogaSetagaya-ku, Tokyo, Japan","Kikuchihara, Y., Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-choFuchu-shi, Tokyo, Japan; Abe, H., Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-choFuchu-shi, Tokyo, Japan, Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 YanagidoGifu-shi, Gifu, Japan; Tanaka, T., Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-choFuchu-shi, Tokyo, Japan, Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 YanagidoGifu-shi, Gifu, Japan; Kato, M., Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-choFuchu-shi, Tokyo, Japan; Wang, L., Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-choFuchu-shi, Tokyo, Japan; Ikarashi, Y., Division of Environmental Chemistry, National Institute of Health Sciences, 1-18-1 KamiyogaSetagaya-ku, Tokyo, Japan; Yoshida, T., Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-choFuchu-shi, Tokyo, Japan; Shibutani, M., Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-choFuchu-shi, Tokyo, Japan","We previously found persistent aberration of hippocampal adult neurogenesis, along with brain manganese (Mn) accumulation, in mouse offspring after developmental exposure to 800-ppm dietary Mn. Reduction of parvalbumin (Pvalb)+ γ-aminobutyric acid (GABA)-ergic interneurons in the hilus of the dentate gyrus along with promoter region hypermethylation are thought to be responsible for this aberrant neurogenesis. The present study was conducted to examine the relationship between the induction of aberrant neurogenesis and brain Mn accumulation after oral Mn exposure as well as the responsible mechanism in young adult animals. We used two groups of mice with 28- or 56-day exposure periods to oral MnCl2·xH2O at 800ppm as Mn, a dose sufficient to lead to aberrant neurogenesis after developmental exposure. A third group of mice received intravenous injections of Mn at 5-mg/kg body weight once weekly for 28 days. The 28-day oral Mn exposure did not cause aberrations in neurogenesis. In contrast, 56-day oral exposure caused aberrations in neurogenesis suggestive of reductions in type 2b and type 3 progenitor cells and immature granule cells in the dentate subgranular zone. Brain Mn accumulation in 56-day exposed cases, as well as in directly Mn-injected cases occurred in parallel with reduction of Pvalb+ GABAergic interneurons in the dentate hilus, suggesting that this may be responsible for aberrant neurogenesis. For reduction of Pvalb+ interneurons, suppression of brain-derived neurotrophic factor-mediated signaling of mature granule cells may occur via suppression of c-Fos-mediated neuronal plasticity due to direct Mn-toxicity rather than promoter region hypermethylation of Pvalb. © 2015 Elsevier Ireland Ltd.","BDNF; GABAergic interneuron; Hippocampal adult neurogenesis; Manganese","Akane, H., Shiraki, A., Imatanaka, N., Akahori, Y., Itahashi, M., Ohishi, T., Mitsumori, K., Shibutani, M., Glycidol induces axonopathy by adult-stage exposure and aberration of hippocampal neurogenesis affecting late-stage differentiation by developmental exposure in rats (2013) Toxicol. Sci., 134, pp. 140-154; Akane, H., Saito, F., Shiraki, A., Takeyoshi, M., Imatanaka, N., Itahashi, M., Murakami, T., Shibutani, M., Downregulation of immediate-early genes linking to suppression of neuronal plasticity in rats after 28-day exposure to glycidol (2014) Toxicol. Appl. Pharmacol., 279, pp. 150-162; Aschner, M., Erikson, K.M., Herrero Hernández, E., Tjalkens, R., Manganese and its role in Parkinson's disease: from transport to neuropathology (2009) Neuromol. Med., 11, pp. 252-266; Ascoli, G.A., Alonso-Nanclares, L., Anderson, S.A., Barrionuevo, G., Benavides-Piccione, R., Burkhalter, A., Buzsáki, G., Yuste, R., Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex (2008) Nat. Rev. Neurosci., 9, pp. 557-568; Bates, R.C., Stith, B.J., Stevens, K.E., Adams, C.E., Reduced CHRNA7 expression in C3H mice is associated with increases in hippocampal parvalbumin and glutamate decarboxylase-67 (GAD67) as well as altered levels of GABA(A) receptor subunits (2014) Neuroscience, 273, pp. 52-64; Bath, K.G., Mandairon, N., Jing, D., Rajagopal, R., Kapoor, R., Chen, Z.Y., Lee, F.S., Variant brain-derived neurotrophic factor (Val66Met) alters adult olfactory bulb neurogenesis and spontaneous olfactory discrimination (2008) J. Neurosci., 28, pp. 2383-2393; Batista-Brito, R., Machold, R., Klein, C., Fishell, G., Gene expression in cortical interneuron precursors is prescient of their mature function (2008) Cereb. Cortex, 18, pp. 2306-2317; Black, I.B., Trophic regulation of synaptic plasticity (1999) J. Neurobiol., 41, pp. 108-118; Borgstahl, G.E., Parge, H.E., Hickey, M.J., Beyer, W.F., Hallewell, R.A., Tainer, J.A., The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles (1992) Cell, 71, pp. 107-118; Breunig, J.J., Silbereis, J., Vaccarino, F.M., Sestan, N., Rakic, P., Notch regulates cell fate and dendrite morphology of newborn neurons in the postnatal dentate gyrus (2007) Proc. Natl. Acad. Sci., 104, pp. 20558-20563; Dobson, A.W., Erikson, K.M., Aschner, M., Manganese neurotoxicity (2004) Ann. N. Y. Acad. Sci., 1012, pp. 115-128; Dorman, D.C., Struve, M.F., Vitarella, D., Byerly, F.L., Goetz, J., Miller, R., Neurotoxicity of manganese chloride in neonatal and adult CD rats following subchronic (21-day) high-dose oral exposure (2000) J. Appl. Toxicol., 20, pp. 179-187; Dugan, L.L., Ali, S.S., Shekhtman, G., Roberts, A.J., Lucero, J., Quick, K.L., Behrens, M.M., IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase (2009) PLoS One, 4, p. e5518; Hack, I., Hellwig, S., Junghans, D., Brunne, B., Bock, H.H., Zhao, S., Frotscher, M., Divergent roles of ApoER2 and Vldlr in the migration of cortical neurons (2007) Development, 134, pp. 3883-3891; Hodge, R.D., Kowalczyk, T.D., Wolf, S.A., Encinas, J.M., Rippey, C., Enikolopov, G., Kempermann, G., Hevner, R.F., Intermediate progenitors in adult hippocampal neurogenesis: Tbr2 expression and coordinate regulation of neuronal output (2008) J. Neurosci., 28, pp. 3707-3717; Kádár, E., Huguet, G., Aldavert-Vera, L., Morgado-Bernal, I., Segura-Torres, P., Intracranial self stimulation upregulates the expression of syn-aptic plasticity related genes and Arc protein expression in rat hippocampus (2013) Genes Brain Behav., 12, pp. 771-779; Karpova, N.N., Lindholm, J.S., Kulesskaya, N., Onishchenko, N., Vahter, M., Popova, D., Ceccatelli, S., Castrén, E., TrkB overexpression in mice buffers against memory deficits and depression-like behavior but not all anxiety- and stress-related symptoms induced by developmental exposure to methylmercury (2014) Front. Behav. Neurosci., 8, p. 315; Kempermann, G., Gast, D., Kronenberg, G., Yamaguchi, M., Gage, F.H., Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice (2003) Development, 130, pp. 391-399; Kitazawa, M., Anantharam, V., Yang, Y., Hirata, Y., Kanthasamy, A., Kanthasamy, A.G., Activation of protein kinase C delta by proteolytic cleavage contributes to manganese-induced apoptosis in dopaminergic cells: protective role of Bcl-2 (2005) Biochem. Pharmacol., 69, pp. 133-146; Knoth, R., Singec, I., Ditter, M., Pantazis, G., Capetian, P., Meyer, R.P., Horvat, V., Kempermann, G., Murine features of neurogenesis in the human hippocampus across the lifespan from 0 to 100 years (2010) PLoS One, 5, p. e8809; Kubota, Y., Kawaguchi, Y., Three classes of GABAergic interneurons in neocortex and neostriatum (1994) Jpn. J. Physiol., 44, pp. S145-S148; Liu, Y., Namba, T., Liu, J., Suzuki, R., Shioda, S., Seki, T., Glial fibrillary acidic protein-expressing neural progenitors give rise to immature neurons via early intermediate progenitors expressing both glial fibrillary acidic protein and neuronal markers in the adult hippocampus (2009) Neuroscience, 166, pp. 241-251; Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-δδC T method (2001) Methods, 25, pp. 402-408; Lönnerdal, B., Keen, C.L., Bell, J.G., Sandström, B., Manganese uptake and retention: Experimental animal and human studies (1987) Nutritional Bioavailability of Manganese. ACS Symposium Series, 354, pp. 9-20. , American Chemical Society; Lönnerdal, B., Manganese nutrition of infants (1994) Manganese in Health and Disease, pp. 175-191. , CRC Press, Boca Raton, FL, D.J. Klimis-Tavantzis (Ed.); Lussier, A.L., Caruncho, H.J., Kalynchuk, L.E., Repeated exposure to corticosterone but not restraint, decreases the number of reelin-positive cells in the adult rat hippocampus (2009) Neurosci. Lett., 460, pp. 170-174; Mena, I., The role of manganese in human disease (1974) Ann. Clin. Lab. Sci., 4, pp. 487-491; Montaron, M.F., Koehl, M., Lemaire, V., Drapeau, E., Abrous, D.N., Le Moal, M., Environmentally induced long-term structural changes: cues for functional orientation and vulnerabilities (2004) Neurotox. Res., 6, pp. 571-580; Nacher, J., Varea, E., Blasco-Ibañez, J.M., Castillo-Gomez, E., Crespo, C., Martinez-Guijarro, F.J., McEwen, B.S., Expression of the transcription factor Pax 6 in the adult rat dentate gyrus (2005) J. Neurosci. Res., 81, pp. 753-761; Nahm, W.K., Noebels, J.L., Nonobligate role of early or sustained expression of immediate-early gene proteins c-fos, c-jun, and Zif/268 in hippocampal mossy fiber sprouting (1998) J. Neurosci., 18, pp. 9245-9255; Ohishi, T., Wang, L., Akane, H., Shiraki, A., Goto, K., Ikarashi, Y., Suzuki, K., Shibutani, M., Reversible aberration of neurogenesis affecting late-stage differentiation in the hippocampal dentate gyrus of rat offspring after maternal exposure to manganese chloride (2012) Reprod. Toxicol., 34, pp. 408-419; Ohtani, Y., Miyata, M., Hashimoto, K., Tabata, T., Kishimoto, Y., Fukaya, M., Kase, D., Aiba, A., The synaptic targeting of mGluR1 by its carboxyl-terminal domain is crucial for cerebellar function (2014) J. Neurosci., 34, pp. 2702-2712; Priya, A., Johar, K., Nair, B., Wong-Riley, M.T., Nuclear respiratory factor 2 regulates the transcription of AMPA receptor subunit GluA2 (Gria2) (2014) Biochim. Biophys. Acta, 1843, pp. 3018-3028; Reichel, C.M., Wacan, J.J., Farley, C.M., Stanley, B.J., Crawford, C.A., McDougall, S.A., Postnatal manganese exposure attenuates cocaine-induced locomotor activity and reduces dopamine transporters in adult male rats (2006) Neurotoxicol. Teratol., 28, pp. 323-332; Roels, H., Meiers, G., Delos, M., Ortega, I., Lauwerys, R., Buchet, J.P., Lison, D., Influence of the route of administration and the chemical form (MnCl2, MnO2) on the absorption and cerebral distribution of manganese in rats (1997) Arch. Toxicol., 71, pp. 223-230; Saegusa, Y., Woo, G.H., Fujimoto, H., Kemmochi, S., Shimamoto, K., Hirose, M., Mitsumori, K., Shibutani, M., Sustained production of Reelin-expressing interneurons in the hippocampal dentate hilus after developmental exposure to anti-thyroid agents in rats (2010) Reprod. Toxicol., 29, pp. 407-414; Sairanen, M., Lucas, G., Ernfors, P., Castren, M., Castren, E., Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus (2005) J. Neurosci., 25, pp. 1089-1094; Scharfman, H., Goodman, J., Macleod, A., Phani, S., Antonelli, C., Croll, S., Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats (2005) Exp. Neurol., 192, pp. 348-356; Schlief, M.L., West, T., Craig, A.M., Holtzman, D.M., Gitlin, J.D., Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 14919-14924; Shibutani, M., Uneyama, C., Miyazaki, K., Toyoda, K., Hirose, M., Methacarn fixation: a novel tool for analysis of gene expressions in paraffin-embedded tissue specimens (2000) Lab. Invest., 80, pp. 199-208; Song, J., Sun, J., Moss, J., Wen, Z., Sun, G.J., Hsu, D., Zhong, C., Song, H., Parvalbumin interneurons mediate neuronal circuitry-neurogenesis coupling in the adult hippocampus (2013) Nat. Neurosci., 16, pp. 1728-1730; Stansfield, K.H., Bichell, T.J., Bowman, A.B., Guilarte, T.R., BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity (2014) J. Neurochem., 131, pp. 655-666; Tarabeux, J., Kebir, O., Gauthier, J., Hamdan, F.F., Xiong, L., Piton, A., Spiegelman, D., Krebs, M.O., Rare mutations in N-methyl-d-aspartate glutamate receptors in autism spectrum disorders and schizophrenia (2011) Transl. Psychiatry, 1, p. e55; Torrente, M., Colomina, M.T., Domingo, J.L., Behavioral effects of adult rats concurrently exposed to high doses of oral manganese and restraint stress (2005) Toxicology, 211, pp. 59-69; Tozuka, Y., Fukuda, S., Namba, T., Seki, T., Hisatsune, T., GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells (2005) Neuron, 47, pp. 803-815; Vezér, T., Kurunczi, A., Náray, M., Papp, A., Nagymajtényi, L., Behavioral effects of subchronic inorganic manganese exposure in rats (2007) Am. J. Ind. Med., 50, pp. 841-852; Wang, L., Ohishi, T., Shiraki, A., Morita, R., Akane, H., Ikarashi, Y., Mitsumori, K., Shibutani, M., Developmental exposure to manganese chloride induces sustained aberration of neurogenesis in the hippocampal dentate gyrus of mice (2012) Toxicol. Sci., 127, pp. 508-521; Wang, L., Shiraki, A., Itahashi, M., Akane, H., Abe, H., Mitsumori, K., Shibutani, M., Aberration in epigenetic gene regulation in hippocampal neurogenesis by developmental exposure to manganese chloride in mice (2013) Toxicol. Sci., 136, pp. 154-165; Waterhouse, E.G., An, J.J., Orefice, L.L., Baydyuk, M., Liao, G.Y., Zheng, K., Lu, B., Xu, B., BDNF promotes differentiation and maturation of adult-born neurons through GABAergic transmission (2012) J. Neurosci., 32, pp. 14318-14330; Wilking, J.A., Hesterberg, K.G., Crouch, E.L., Homanics, G.E., Stitzel, J.A., Chrna4 A529 knock-in mice exhibit altered nicotine sensitivity (2010) Pharmacogenet. Genomics, 20, pp. 121-130; Williams, J.M., Milatovic, D., Gore, J.C., Aschner, M., Avison, M.J., Chronic exposure to manganese alters brain responses to amphetamine: a pharmacological magnetic resonance imaging study (2010) Toxicol. Sci., 114, pp. 310-322; Zhao, C., Deng, W., Gage, F.H., Mechanisms and functional implications of adult neurogenesis (2008) Cell, 132, pp. 645-660",Article,Scopus,2-s2.0-84925965939
"Altmeppen H.C., Prox J., Krasemann S., Puig B., Kruszewski K., Dohler F., Bernreuther C., Hoxha A., Linsenmeier L., Sikorska B., Liberski P.P., Bartsch U., Saftig P., Glatze M.","The sheddase ADAM10 is a potent modulator of prion disease",2015,"eLife","2015","4",,"1","50",,,10.7554/eLife.04260,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84922956711&partnerID=40&md5=defdd28c4c704c47ba595683e18d8bbe","Institute of Neuropathology, University Medical Center Hamburg-EppendorfHamburg, Germany; Institute of Biochemistry, Christian Albrechts UniversityKiel, Germany; Department of Ophthalmology, University Medical Center Hamburg-EppendorfHamburg, Germany; Department of Molecular Pathology and Neuropathology, Medical UniversityLodz, Poland","Altmeppen, H.C., Institute of Neuropathology, University Medical Center Hamburg-EppendorfHamburg, Germany; Prox, J., Institute of Biochemistry, Christian Albrechts UniversityKiel, Germany; Krasemann, S., Institute of Neuropathology, University Medical Center Hamburg-EppendorfHamburg, Germany; Puig, B., Institute of Neuropathology, University Medical Center Hamburg-EppendorfHamburg, Germany; Kruszewski, K., Department of Ophthalmology, University Medical Center Hamburg-EppendorfHamburg, Germany; Dohler, F., Institute of Neuropathology, University Medical Center Hamburg-EppendorfHamburg, Germany; Bernreuther, C., Institute of Neuropathology, University Medical Center Hamburg-EppendorfHamburg, Germany; Hoxha, A., Institute of Neuropathology, University Medical Center Hamburg-EppendorfHamburg, Germany; Linsenmeier, L., Institute of Neuropathology, University Medical Center Hamburg-EppendorfHamburg, Germany; Sikorska, B., Department of Molecular Pathology and Neuropathology, Medical UniversityLodz, Poland; Liberski, P.P., Department of Molecular Pathology and Neuropathology, Medical UniversityLodz, Poland; Bartsch, U., Department of Ophthalmology, University Medical Center Hamburg-EppendorfHamburg, Germany; Saftig, P., Institute of Biochemistry, Christian Albrechts UniversityKiel, Germany; Glatze, M., Institute of Neuropathology, University Medical Center Hamburg-EppendorfHamburg, Germany","The prion protein (PrPC) is highly expressed in the nervous system and critically involved in prion diseases where it misfolds into pathogenic PrPSc. Moreover, it has been suggested as a receptor mediating neurotoxicity in common neurodegenerative proteinopathies such as Alzheimer’s disease. PrPC is shed at the plasma membrane by the metalloprotease ADAM10 yet the impact of this on prion disease remains enigmatic. Employing conditional knockout mice, we show that depletion of ADAM10 in forebrain neurons leads to posttranslational increase of PrPC levels. Upon prion infection of these mice, clinical, biochemical, and morphological data reveal that lack of ADAM10 significantly reduces incubation times and increases PrPSc formation. In contrast, spatiotemporal analysis indicates that absence of shedding impairs spread of prion pathology. Our data support a dual role for ADAM10 mediated shedding and highlight the role of proteolytic processing in prion disease. © 2015, eLife Sciences Publications Ltd. All rights reserved.","ADAM10; Neurodegeneration; Prion disease; Proteolytic processing; Shedding","Ader, M., Schachner, M., Bartsch, U., Transplantation of neural precursor cells into the dysmyelinated CNS of mutant mice deficient in the myelin-associated glycoprotein and Fyn tyrosine kinase (2001) Eur J Neurosci, 14, pp. 561-566; Aguzzi, A., Baumann, F., Bremer, J., The prion's elusive reason for being (2008) Annu Rev Neurosci, 31, pp. 439-477; Aguzzi, A., Heppner, F.L., Heikenwalder, M., Prinz, M., Mertz, K., Seeger, H., Glatzel, M., Immune system and peripheral nerves in propagation of prions to CNS (2003) Br Med Bull, 66, pp. 141-159; Akhtar, S., Grizenkova, J., Wenborn, A., Hummerich, H., Fernandez De Marco, M., Brandner, S., Collinge, J., Lloyd, S.E., Sod1 deficiency reduces incubation time in mouse models of prion disease (2013) Plos ONE, 8; Alais, S., Simoes, S., Baas, D., Lehmann, S., Raposo, G., Darlix, J.L., Leblanc, P., Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles (2008) Biol Cell, 100, pp. 603-615; Altmeppen, H.C., Prox, J., Puig, B., Dohler, F., Falker, C., Krasemann, S., Glatzel, M., Roles of endoproteolytic alpha-cleavage and shedding of the prion protein in neurodegeneration (2013) FEBS J, 280, pp. 4338-4347; Altmeppen, H.C., Prox, J., Puig, B., Kluth, M.A., Bernreuther, C., Thurm, D., Jorissen, E., De Strooper, B., Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo (2011) Mol Neurodegener, 6, 36p; Altmeppen, H.C., Puig, B., Dohler, F., Thurm, D.K., Falker, C., Krasemann, S., Glatzel, M., Proteolytic processing of the prion protein in health and disease (2012) Am J Neurodegener Dis, 1, pp. 15-31; Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., Tapella, L., Borsello, T., Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein (2010) Proc Natl Acad Sci U S A, 107, pp. 2295-2300; Barron, R.M., Campbell, S.L., King, D., Bellon, A., Chapman, K.E., Williamson, R.A., Manson, J.C., High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo (2007) J Biol Chem, 282, pp. 35878-35886; Barron, R.M., Thomson, V., King, D., Shaw, J., Melton, D.W., Manson, J.C., Transmission of murine scrapie to P101L transgenic mice (2003) J Gen Virol, 84, pp. 3165-3172; Baumann, F., Tolnay, M., Brabeck, C., Pahnke, J., Kloz, U., Niemann, H.H., Heikenwalder, M., Aguzzi, A., Lethal recessive myelin toxicity of prion protein lacking its central domain (2007) Embo J, 26, pp. 538-547; Beland, M., Motard, J., Barbarin, A., Roucou, X., PrP(C) homodimerization stimulates the production of PrPC cleaved fragments PrPN1 and PrPC1 (2012) J Neurosci, 32, pp. 13255-13263; Benilova, I., De Strooper, B., Prion protein in Alzheimer's pathogenesis: A hot and controversial issue (2010) EMBO Mol Med, 2, pp. 289-290; Bessen, R.A., Shearin, H., Martinka, S., Boharski, R., Lowe, D., Wilham, J.M., Caughey, B., Wiley, J.A., Prion shedding from olfactory neurons into nasal secretions (2010) Plos Pathog, 6; Borchelt, D.R., Rogers, M., Stahl, N., Telling, G., Prusiner, S.B., Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor (1993) Glycobiology, 3, pp. 319-329; Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Aguzzi, A., Normal host prion protein necessary for scrapie-induced neurotoxicity (1996) Nature, 379, pp. 339-343; Bremer, J., Baumann, F., Tiberi, C., Wessig, C., Fischer, H., Schwarz, P., Steele, A.D., Weis, J., Axonal prion protein is required for peripheral myelin maintenance (2010) Nat Neurosci, 13, pp. 310-318; Bueler, H.R., Aguzzi, A., Sailer, A., Greiner, R.A., Autenried, P., Aguet, M., Weissmann, C., Mice devoid of PrP are resistant to scrapie (1993) Cell, 73, pp. 1339-1347; Bueler, H.R., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.P., Dearmond, S.J., Prusiner, S.B., Weissmann, C., Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein (1992) Nature, 356, pp. 577-582; Burwinkel, M., Schwarz, A., Riemer, C., Schultz, J., Van Landeghem, F., Baier, M., Rapid disease development in scrapie-infected mice deficient for CD40 ligand (2004) EMBO Rep, 5 (5), pp. 527-531; Calella, A.M., Farinelli, M., Nuvolone, M., Mirante, O., Moos, R., Falsig, J., Mansuy, I.M., Aguzzi, A., Prion protein and Abeta-related synaptic toxicity impairment (2010) EMBO Mol Med, 2, pp. 306-314; Campbell, L., Gill, A.C., McGovern, G., Jalland, C.M., Hopkins, J., Tranulis, M.A., Hunter, N., Goldmann, W., The PrP(C) C1 fragment derived from the ovine A136R154R171PRNP allele is highly abundant in sheep brain and inhibits fibrillisation of full-length PrP(C) protein in vitro (2013) Biochim Biophys Acta, 1832, pp. 826-836; Casanova, E., Fehsenfeld, S., Mantamadiotis, T., Lemberger, T., Greiner, E., Stewart, A.F., Schutz, G., A CamKIIalpha iCre BAC allows brain-specific gene inactivation (2001) Genesis, 31, pp. 37-42; Chen, C., Lv, Y., Zhang, B.Y., Zhang, J., Shi, Q., Wang, J., Tian, C., Ren, K., Apparent Reduction of ADAM10 in Scrapie-Infected Cultured Cells and in the Brains of Scrapie-Infected Rodents (2014) Mol Neurobiol; Chen, S.G., Teplow, D.B., Parchi, P., Teller, J.K., Gambetti, P., Autilio-Gambetti, L., Truncated forms of the human prion protein in normal brain and in prion diseases (1995) J Biol Chem, 270, pp. 19173-19180; Chesebro, B., Race, B., Meade-White, K., Lacasse, R., Race, R., Klingeborn, M., Striebel, J., Jeffrey, M., Fatal transmissible amyloid encephalopathy: A new type of prion disease associated with lack of prion protein membrane anchoring (2010) Plos Pathog, 6; Chesebro, B., Trifilo, M., Race, R., Meade-White, K., Teng, C., Lacasse, R., Raymond, L., Priola, S., Anchorless prion protein results in infectious amyloid disease without clinical scrapie (2005) Science, 308, pp. 1435-1439; Conti, L., Pollard, S.M., Gorba, T., Reitano, E., Toselli, M., Biella, G., Sun, Y., Cattaneo, E., Niche-independent symmetrical self-renewal of a mammalian tissue stem cell (2005) Plos Biol, 3; Dohler, F., Sepulveda-Falla, D., Krasemann, S., Altmeppen, H., Schluter, H., Hildebrand, D., Zerr, I., Glatzel, M., High molecular mass assemblies of amyloid-beta oligomers bind prion protein in patients with Alzheimer's disease (2014) Brain, 137, pp. 873-886; Endres, K., Mitteregger, G., Kojro, E., Kretzschmar, H., Fahrenholz, F., Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo (2009) Neurobiol Dis, 36, pp. 233-241; Falsig, J., Sonati, T., Herrmann, U.S., Saban, D., Li, B., Arroyo, K., Ballmer, B., Aguzzi, A., Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures (2012) Plos Pathog, 8; Fischer, M., Rulicke, T., Raeber, A., Sailer, A., Moser, M., Oesch, B., Brandner, S., Weissmann, C., Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie (1996) EMBO J, 15, pp. 1255-1264; Fluharty, B.R., Biasini, E., Stravalaci, M., Sclip, A., Diomede, L., Balducci, C., La Vitola, P., Forloni, G., An N-terminal fragment of the prion protein binds to amyloid-beta oligomers and inhibits their neurotoxicity in vivo (2013) J Biol Chem, 288, pp. 7857-7866; Glatzel, M., Giger, O., Seeger, H., Aguzzi, A., Variant Creutzfeldt-jakob disease: Between lymphoid organs and brain (2004) Trends Microbiol, 12, pp. 51-53; Glatzel, M., Heppner, F.L., Albers, K.M., Aguzzi, A., Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion (2001) Neuron, 31, pp. 25-34; Gousset, K., Schiff, E., Langevin, C., Marijanovic, Z., Caputo, A., Browman, D.T., Chenouard, N., Enninga, J., Prions hijack tunnelling nanotubes for intercellular spread (2009) Nat Cell Biol, 11, pp. 328-336; Grizenkova, J., Akhtar, S., Brandner, S., Collinge, J., Lloyd, S.E., Microglial Cx3cr1 knockout reduces prion disease incubation time in mice (2014) BMC Neurosci, 15, 44p; Grizenkova, J., Akhtar, S., Hummerich, H., Tomlinson, A., Asante, E.A., Wenborn, A., Fizet, J., Fisher, E.M., Overexpression of the Hspa13 (Stch) gene reduces prion disease incubation time in mice (2012) Proc Natl Acad Sci U S A, 109, pp. 13722-13727; Guillot-Sestier, M.V., Sunyach, C., Druon, C., Scarzello, S., Checler, F., The alpha-secretase-derived N- terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo (2009) J Biol Chem, 284, pp. 35973-35986; Guillot-Sestier, M.V., Sunyach, C., Ferreira, S.T., Marzolo, M.P., Bauer, C., Thevenet, A., Checler, F., Alpha- Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid beta (Abeta)-associated cell death (2012) J Biol Chem, 287, pp. 5021-5032; Harris, D.A., Huber, M.T., Van Dijken, P., Shyng, S.L., Chait, B.T., Wang, R., Processing of a cellular prion protein: Identification of N- and C-terminal cleavage sites (1993) Biochemistry, 32, pp. 1009-1016; Hartmann, D., De Strooper, B., Serneels, L., Craessaerts, K., Herreman, A., Annaert, W., Umans, L., Figura, K., The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts (2002) Hum Mol Genet, 11, pp. 2615-2624; Heiseke, A., Schobel, S., Lichtenthaler, S.F., Vorberg, I., Groschup, M.H., Kretzschmar, H., Schatzl, H.M., Nunziante, M., The novel sorting nexin SNX33 interferes with cellular PrP formation by modulation of PrP shedding (2008) Traffic, 9, pp. 1116-1129; Jeffrey, M., Fraser, J.R., Tubulovesicular particles occur early in the incubation period of murine scrapie (2000) Acta Neuropathol, 99, pp. 525-528; Jorissen, E., Prox, J., Bernreuther, C., Weber, S., Schwanbeck, R., Serneels, L., Snellinx, A., Tesseur, I., The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex (2010) J Neurosci, 30, pp. 4833-4844; Jung, G., Sun, J., Petrowitz, B., Riecken, K., Kruszewski, K., Jankowiak, K., Kunst, F., Fehse, B., Genetically modified neural stem cells for a local and sustained delivery of neuroprotective factors to the dystrophic mouse retina (2013) Stem Cells Transl Med, 2, pp. 1001-1010; Kessels, H.W., Nguyen, L.N., Nabavi, S., Malinow, R., The prion protein as a receptor for amyloid- beta (2010) Nature, 466, pp. E3-E4. , discussion E4-5; Kim, J.I., Surewicz, K., Gambetti, P., Surewicz, W.K., The role of glycophosphatidylinositol anchor in the amplification of the scrapie isoform of prion protein in vitro (2009) FEBS Lett, 583, pp. 3671-3675; Kocisko, D.A., Come, J.H., Priola, S.A., Chesebro, B., Raymond, G.J., Lansbury, P.T., Caughey, B., Cell-free formation of protease-resistant prion protein (1994) Nature, 370, pp. 471-474; Krasemann, S., Neumann, M., Szalay, B., Stocking, C., Glatzel, M., Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrP(Sc) and prion infectivity (2013) J Gen Virol, 94, pp. 453-463; Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., Fahrenholz, F., Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease (1999) Proc Natl Acad Sci U S A, 96, pp. 3922-3927; Larson, M., Sherman, M.A., Amar, F., Nuvolone, M., Schneider, J.A., Bennett, D.A., Aguzzi, A., Lesne, S.E., The complex PrP(C)-Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer's disease (2012) J Neurosci, 32, pp. 16857a-16871a; Lasmezas, C.I., Deslys, J.P., Robain, O., Jaegly, A., Beringue, V., Peyrin, J.M., Fournier, J.G., Dormont, D., Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein (1997) Science, 275, pp. 402-405; Lauren, J., Gimbel, D.A., Nygaard, H.B., Gilbert, J.W., Strittmatter, S.M., Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers (2009) Nature, 457, pp. 1128-1132; Leblanc, P., Alais, S., Porto-Carreiro, I., Lehmann, S., Grassi, J., Raposo, G., Darlix, J.L., Retrovirus infection strongly enhances scrapie infectivity release in cell culture (2006) Embo J, 25, pp. 2674-2685; Lee, A.M., Paulsson, J.F., Cruite, J., Aya, A.A., Trifilo, M.J., Oldstone, M.B., Extraneural manifestations of prion infection in GPI-anchorless transgenic mice (2011) Virology, 411, pp. 1-8; Lee, M.S., Kwon, Y.T., Li, M., Peng, J., Friedlander, R.M., Tsai, L.H., Neurotoxicity induces cleavage of p35 to p25 by calpain (2000) Nature, 405, pp. 360-364; Lewis, V., Hill, A.F., Haigh, C.L., Klug, G.M., Masters, C.L., Lawson, V.A., Collins, S.J., Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection (2009) J Neuropathol Exp Neurol, 68, pp. 1125-1135; Liang, J., Wang, W., Sorensen, D., Medina, S., Ilchenko, S., Kiselar, J., Surewicz, W.K., Kong, Q., Cellular prion protein regulates its own alpha-cleavage through ADAM8 in skeletal muscle (2012) J Biol Chem, 287, pp. 16510-16520; Liberski, P.P., Sikorska, B., Hauw, B.J., Kopp, N., Streichenberger, N., Giraud, P., Boellaard, J., Ironside, J., Ultrastructural characteristics (Or evaluation) of Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies or prion diseases (2010) Ultrastruct Pathol, 34, pp. 351-361; Liberski, P.P., Sikorska, B., Hauw, B.J., Kopp, N., Streichenberger, N., Giraud, P., Budka, H., Brown, P., Tubulovesicular structures are a consistent (And unexplained) finding in the brains of humans with prion diseases (2008) Virus Res, 132, pp. 226-228; Linden, R., Martins, V.R., Prado, M.A., Cammarota, M., Izquierdo, I., Brentani, R.R., Physiology of the prion protein (2008) Physiol Rev, 88, pp. 673-728; Mabbott, N.A., Mackay, F., Minns, F., Bruce, M.E., Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie [letter] (2000) Nat Med, 6, pp. 719-720; Mallucci, G., Dickinson, A., Linehan, J., Klohn, P.C., Brandner, S., Collinge, J., Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis (2003) Science, 302, pp. 871-874; Mange, A., Beranger, F., Peoc'h, K., Onodera, T., Frobert, Y., Lehmann, S., Alpha- and beta- cleavages of the amino-terminus of the cellular prion protein (2004) Biol Cell, 96, pp. 125-132; Marella, M., Lehmann, S., Grassi, J., Chabry, J., Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release (2002) J Biol Chem, 277; Mays, C.E., Coomaraswamy, J., Watts, J.C., Yang, J., Ko, K.W., Strome, B., Mercer, B.R., Westaway, D., Endoproteolytic processing of the mammalian prion glycoprotein family (2014) Febs J, 281, pp. 862-876; McDonald, A.J., Dibble, J.P., Evans, E.G., Millhauser, G.L., A new paradigm for enzymatic control of alpha-cleavage and beta-cleavage of the prion protein (2014) J Biol Chem, 289, pp. 803-813; Meier, P., Genoud, N., Prinz, M., Maissen, M., Rulicke, T., Zurbriggen, A., Raeber, A.J., Aguzzi, A., Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease (2003) Cell, 113, pp. 49-60; Mouillet-Richard, S., Ermonval, M., Chebassier, C., Laplanche, J.L., Lehmann, S., Launay, J.M., Kellermann, O., Signal transduction through prion protein (2000) Science, 289, pp. 1925-1928; Nieznanski, K., Choi, J.K., Chen, S., Surewicz, K., Surewicz, W.K., Soluble Prion Protein Inhibits Amyloid- beta (Abeta) Fibrillization and Toxicity (2012) J Biol Chem, 287, pp. 33104-33108; Oliveira-Martins, J.B., Yusa, S., Calella, A.M., Bridel, C., Baumann, F., Dametto, P., Aguzzi, A., Unexpected tolerance of alpha-cleavage of the prion protein to sequence variations (2010) Plos One, 5; Ostapchenko, V.G., Beraldo, F.H., Guimaraes, A.L., Mishra, S., Guzman, M., Fan, J., Martins, V.R., Prado, M.A., Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease (2013) J Neurochem, 127 (3), pp. 415-425; Parizek, P., Roeckl, C., Weber, J., Flechsig, E., Aguzzi, A., Raeber, A.J., Similar turnover and shedding of the cellular prion protein in primary lymphoid and neuronal cells (2001) J Biol Chem, 276, pp. 44627-44632; Parkin, E.T., Watt, N.T., Turner, A.J., Hooper, N.M., Dual mechanisms for shedding of the cellular prion protein (2004) J Biol Chem, 279, pp. 11170-11178; Perini, F., Vidal, R., Ghetti, B., Tagliavini, F., Frangione, B., Prelli, F., PrP27-30 is a normal soluble prion protein fragment released by human platelets (1996) Biochem Biophys Res Commun, 223, pp. 572-577; Piccardo, P., Manson, J.C., King, D., Ghetti, B., Barron, R.M., Accumulation of prion protein in the brain that is not associated with transmissible disease (2007) Proc Natl Acad Sci U S A, 104, pp. 4712-4717; Polymenidou, M., Moos, R., Scott, M., Sigurdson, C., Shi, Y.Z., Yajima, B., Hafner-Bratkovic, I., Wuthrich, K., The POM monoclonals: A comprehensive set of antibodies to non-overlapping prion protein epitopes (2008) Plos ONE, 3; Pradines, E., Hernandez-Rapp, J., Villa-Diaz, A., Dakowski, C., Ardila-Osorio, H., Haik, S., Schneider, B., Torres, J.M., Pathogenic prions deviate PrP(C) signaling in neuronal cells and impair A-beta clearance (2013) Cell Death Dis, 4; Pressmar, S., Ader, M., Richard, G., Schachner, M., Bartsch, U., The fate of heterotopically grafted neural precursor cells in the normal and dystrophic adult mouse retina (2001) Invest Ophthalmol Vis Sci, 42, pp. 3311-3319; Prinz, M., Heikenwalder, M., Junt, T., Schwarz, P., Glatzel, M., Heppner, F.L., Fu, Y.X., Aguzzi, A., Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion (2003) Nature, 425, pp. 957-962; Prox, J., Bernreuther, C., Altmeppen, H., Grendel, J., Glatzel, M., D'hooge, R., Stroobants, S., Willem, M., Postnatal Disruption of the Disintegrin/Metalloproteinase ADAM10 in Brain Causes Epileptic Seizures, Learning Deficits, Altered Spine Morphology, and Defective Synaptic Functions (2013) J Neurosci, 33, pp. 12915-12928; Prox, J., Bernreuther, C., Altmeppen, H., Grendel, J., Glatzel, M., D'hooge, R., Stroobants, S., Willem, M., Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions (2013) J Neurosci, 33, pp. 12915-12928; Prusiner, S.B., Novel proteinaceous infectious particles cause scrapie (1982) Science, 216, pp. 136-144; Resenberger, U.K., Harmeier, A., Woerner, A.C., Goodman, J.L., Muller, V., Krishnan, R., Vabulas, R.M., Hartl, F.U., The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication (2011) EMBO J, 30, pp. 2057-2070; Richard, I., Ader, M., Sytnyk, V., Dityatev, A., Richard, G., Schachner, M., Bartsch, U., Electroporation- based gene transfer for efficient transfection of neural precursor cells (2005) Brain Res Mol Brain Res, 138, pp. 182-190; Sandberg, M.K., Al-Doujaily, H., Sharps, B., Clarke, A.R., Collinge, J., Prion propagation and toxicity in vivo occur in two distinct mechanistic phases (2011) Nature, 470, pp. 540-542; Schneider, B., Mutel, V., Pietri, M., Ermonval, M., Mouillet-Richard, S., Kellermann, O., NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells (2003) Proc Natl Acad Sci U S A, 100, pp. 13326-13331; Schonbeck, U., Libby, P., The CD40/CD154 receptor/ligand dyad (2001) Cell Mol Life Sci, 58, pp. 4-43; Shearin, H., Bessen, R.A., Axonal and transynaptic spread of prions (2014) J Virol; Shmerling, D., Hegyi, I., Fischer, M., Blattler, T., Brandner, S., Gotz, J., Rulicke, T., Von Mering, C., Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions (1998) Cell, 93, pp. 203-214; Silveira, J.R., Raymond, G.J., Hughson, A.G., Race, R.E., Sim, V.L., Hayes, S.F., Caughey, B., The most infectious prion protein particles (2005) Nature, 437, pp. 257-261; Sonati, T., Reimann, R.R., Falsig, J., Baral, P.K., O'connor, T., Hornemann, S., Yaganoglu, S., Wieland, B., The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein (2013) Nature, 501, pp. 102-106; Stohr, J., Watts, J.C., Legname, G., Oehler, A., Lemus, A., Nguyen, H.O., Sussman, J., Prusiner, S.B., Spontaneous generation of anchorless prions in transgenic mice (2011) Proc Natl Acad Sci U S A, 108, pp. 21223-21228; Tagliavini, F., Prelli, F., Porro, M., Salmona, M., Bugiani, O., Frangione, B., A soluble form of prion protein in human cerebrospinal fluid: Implications for prion-related encephalopathies (1992) Biochem Biophys Res Commun, 184, pp. 1398-1404; Taylor, D.R., Parkin, E.T., Cocklin, S.L., Ault, J.R., Ashcroft, A.E., Turner, A.J., Hooper, N.M., Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein (2009) J Biol Chem, 284, pp. 22590-22600; Turnbaugh, J.A., Unterberger, U., Saa, P., Massignan, T., Fluharty, B.R., Bowman, F.P., Miller, M.B., Harris, D.A., The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc) (2012) J Neurosci, 32, pp. 8817-8830; Tveit, H., Lund, C., Olsen, C.M., Ersdal, C., Prydz, K., Harbitz, I., Tranulis, M.A., Proteolytic processing of the ovine prion protein in cell cultures (2005) Biochem Biophys Res Commun, 337, pp. 232-240; Um, J.W., Nygaard, H.B., Heiss, J.K., Kostylev, M.A., Stagi, M., Vortmeyer, A., Wisniewski, T., Strittmatter, S.M., Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons (2012) Nat Neurosci, 15, pp. 1227-1235; Vincent, B., Paitel, E., Saftig, P., Frobert, Y., Hartmann, D., De Strooper, B., Grassi, J., Checler, F., The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein (2001) J Biol Chem, 276, pp. 37743-37746; Weber, S., Saftig, P., Ectodomain shedding and ADAMs in development (2012) Development, 139; Weber, S., Wetzel, S., Prox, J., Lehmann, T., Schneppenheim, J., Donners, M., Saftig, P., Regulation of adult hematopoiesis by the a disintegrin and metalloproteinase 10 (ADAM10) (2013) Biochem Biophys Res Commun, 442, pp. 234-241; Westergard, L., Turnbaugh, J.A., Harris, D.A., A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation (2011) J Biol Chem, 286, pp. 44234-44242; Wik, L., Klingeborn, M., Willander, H., Linne, T., Separate mechanisms act concurrently to shed and release the prion protein from the cell (2012) Prion, 6, pp. 498-509; Yang, P., Baker, K.A., Hagg, T., The ADAMs family: Coordinators of nervous system development, plasticity and repair (2006) Prog Neurobiol, 79, pp. 73-94; Yuan, J., Zhan, Y.A., Abskharon, R., Xiao, X., Martinez, M.C., Zhou, X., Kneale, G., Surewicz, W.K., Recombinant human prion protein inhibits prion propagation in vitro (2013) Sci Rep, 3, p. 2911; Yusa, S., Oliveira-Martins, J.B., Sugita-Konishi, Y., Kikuchi, Y., Cellular prion protein: From physiology to pathology (2012) Viruses, 4, pp. 3109-3131",Article,Scopus,2-s2.0-84922956711
"Dametti S., Faravelli I., Ruggieri M., Ramirez A., Nizzardo M., Corti S.","Experimental Advances Towards Neural Regeneration from Induced Stem Cells to Direct In Vivo Reprogramming",2015,"Molecular Neurobiology",,,,"","",8,,10.1007/s12035-015-9181-7,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928809526&partnerID=40&md5=0952da1f4db940f7ee894a7f2dcef10f","Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), Neurology Unit, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Via Francesco Sforza 35Milan, Italy","Dametti, S., Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), Neurology Unit, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Via Francesco Sforza 35Milan, Italy; Faravelli, I., Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), Neurology Unit, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Via Francesco Sforza 35Milan, Italy; Ruggieri, M., Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), Neurology Unit, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Via Francesco Sforza 35Milan, Italy; Ramirez, A., Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), Neurology Unit, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Via Francesco Sforza 35Milan, Italy; Nizzardo, M., Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), Neurology Unit, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Via Francesco Sforza 35Milan, Italy; Corti, S., Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), Neurology Unit, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Via Francesco Sforza 35Milan, Italy","Neuronal loss is a common substrate of many neurological diseases that still lack effective treatments and highly burden lives of affected individuals. The discovery of self-renewing stem cells within the central nervous system (CNS) has opened the doors to the possibility of using the plasticity of CNS as a potential strategy for the development of regenerative therapies after injuries. The role of neural progenitor cells appears to be crucial, but insufficient in reparative processes after damage. In addition, the mechanisms that regulate these events are still largely unknown. Stem cell-based therapeutic approaches have primarily focused on the use of either induced pluripotent stem cells or induced neural stem cells as sources for cell transplantation. More recently, in vivo direct reprogramming of endogenous CNS cells into multipotent neural stem/progenitor cells has been proposed as an alternative strategy that could overcome the limits connected with both the invasiveness of exogenous cell transplantation and the technical issues of in vitro reprogramming (i.e., the time requested and the limited available amount of directly induced neuronal cells). In this review, we aim to highlight the recent studies on in vivo direct reprogramming, focusing on astrocytes conversion to neurons or to neural stem/precursors cells, in the perspective of future therapeutic purposes for neurological disorders. © 2015 Springer Science+Business Media New York","In vivo reprogramming; Neural stem cells; Neuronal loss; Regeneration",,Article in Press,Scopus,2-s2.0-84928809526
"Chen J.L., Zhang W., Liu Z.Y., Heng B.C., Ouyang H.W., Dai X.S.","Physical regulation of stem cells differentiation into teno-lineage: current strategies and future direction",2015,"Cell and Tissue Research","360","2",,"195","207",,,10.1007/s00441-014-2077-4,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928555987&partnerID=40&md5=c27cdf7aae4eae00494a6aefa7b68160","Mailbox #39 Center for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, 866 Yu Hang Tang RoadHangzhou, China; Zhejiang Provincial Key Lab for Tissue Engineering and Regenerative MedicineHangzhou, China; Department of Biosystems Science & Engineering, ETH-Zurich, Mattenstrasse 26Basel, Switzerland; Department of Sports Medicine, School of Medicine, Zhejiang UniversityHangzhou, China; Department of Orthopedics, Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jie Fang RoadHangzhou, China","Chen, J.L., Mailbox #39 Center for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, 866 Yu Hang Tang RoadHangzhou, China, Zhejiang Provincial Key Lab for Tissue Engineering and Regenerative MedicineHangzhou, China; Zhang, W., Mailbox #39 Center for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, 866 Yu Hang Tang RoadHangzhou, China, Zhejiang Provincial Key Lab for Tissue Engineering and Regenerative MedicineHangzhou, China; Liu, Z.Y., Mailbox #39 Center for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, 866 Yu Hang Tang RoadHangzhou, China, Zhejiang Provincial Key Lab for Tissue Engineering and Regenerative MedicineHangzhou, China; Heng, B.C., Department of Biosystems Science & Engineering, ETH-Zurich, Mattenstrasse 26Basel, Switzerland; Ouyang, H.W., Mailbox #39 Center for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, 866 Yu Hang Tang RoadHangzhou, China, Zhejiang Provincial Key Lab for Tissue Engineering and Regenerative MedicineHangzhou, China, Department of Sports Medicine, School of Medicine, Zhejiang UniversityHangzhou, China; Dai, X.S., Department of Orthopedics, Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jie Fang RoadHangzhou, China","Tendon injuries are commonly encountered in the clinic, disrupting the patient’s normal work/life routine and damaging the career life of athletes. Currently, there is still no effective treatment for tendon injury. Tendon tissue engineering appears to be a promising route for tendon repair and regeneration. However, current strategies utilized in research are still far away from clinical applications due to unsuccessful cellular differentiation to tendon/tenocytes. In this review, we focus on the current physical strategies (mechanical stimulation and extracellular matrix topography) and evaluate their roles in precise and stepwise tendon differentiation. A systematic comprehension of normal tendon development process by structure, gene profile and physical microenvironment analysis is likely suggestive for stepwise tenocyte differentiation. © 2015, Springer-Verlag Berlin Heidelberg.","Extracellular matrix topography; Mechanical stimulation; Stepwise differentiation; Tendon development; Tendon differentiation","Abousleiman, R.I., Reyes, Y., McFetridge, P., Sikavitsas, V., Tendon tissue engineering using cell-seeded umbilical veins cultured in a mechanical stimulator (2009) Tissue Eng Part A, 15, pp. 787-795. , COI: 1:CAS:528:DC%2BD1MXktVGrsb8%3D, PID: 18991488; Alberton, P., Popov, C., Pragert, M., Kohler, J., Shukunami, C., Schieker, M., Docheva, D., Conversion of human bone marrow-derived mesenchymal stem cells into tendon progenitor cells by ectopic expression of scleraxis (2012) Stem Cells Dev, 21, pp. 846-858. , COI: 1:CAS:528:DC%2BC38XkvV2rsLg%3D, PID: 21988170; Altman, G.H., Horan, R.L., Martin, I., Farhadi, J., Stark, P.R., Volloch, V., Richmond, J.C., Kaplan, D.L., Cell differentiation by mechanical stress (2002) FASEB J, 16, pp. 270-272. , COI: 1:CAS:528:DC%2BD38XhsVCjsb8%3D, PID: 11772952; Ansorge, H.L., Adams, S., Birk, D.E., Soslowsky, L.J., Mechanical, compositional, and structural properties of the post-natal mouse Achilles tendon (2011) Ann Biomed Eng, 39, pp. 1904-1913. , PID: 21431455; Awad, H.A., Butler, D.L., Harris, M.T., Ibrahim, R.E., Wu, Y., Young, R.G., Kadiyala, S., Boivin, G.P., In vitro characterization of mesenchymal stem cell-seeded collagen scaffolds for tendon repair: effects of initial seeding density on contraction kinetics (2000) J Biomed Mater Res, 51, pp. 233-240. , COI: 1:CAS:528:DC%2BD3cXjvFygsbc%3D, PID: 10825223; Bagnaninchi, P.O., Yang, Y., El, H.A., Maffulli, N., Tissue engineering for tendon repair (2007) Br J Sports Med, 41. , PID: 17062654, discussion e10; Barberi, T., Bradbury, M., Dincer, Z., Panagiotakos, G., Socci, N.D., Studer, L., Derivation of engraftable skeletal myoblasts from human embryonic stem cells (2007) Nat Med, 13, pp. 642-648. , COI: 1:CAS:528:DC%2BD2sXkvVOhu78%3D, PID: 17417652; Barboni, B., Curini, V., Russo, V., Mauro, A., Di Giacinto, O., Marchisio, M., Alfonsi, M., Mattioli, M., Indirect co-culture with tendons or tenocytes can program amniotic epithelial cells towards stepwise tenogenic differentiation (2012) PLoS ONE, 7. , COI: 1:CAS:528:DC%2BC38XivVKjs7o%3D, PID: 22348033; (2014) Tissue Eng Part A, , Barsby T, Bavin EP, Guest DJ (2014) Three-dimensional culture and transforming growth factor Beta3 synergistically promote tenogenic differentiation of equine embryo-derived stem cells. (in press); Bi, Y., Ehirchiou, D., Kilts, T.M., Inkson, C.A., Embree, M.C., Sonoyama, W., Li, L., Young, M.F., Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche (2007) Nat Med, 13, pp. 1219-1227. , COI: 1:CAS:528:DC%2BD2sXhtFagsbrP, PID: 17828274; Brent, A.E., Schweitzer, R., Tabin, C.J., A somitic compartment of tendon progenitors (2003) Cell, 113, pp. 235-248. , COI: 1:CAS:528:DC%2BD3sXjtlOqsL0%3D, PID: 12705871; Butler, D.L., Juncosa, N., Dressler, M.R., Functional efficacy of tendon repair processes (2004) Annu Rev Biomed Eng, 6, pp. 303-329. , COI: 1:CAS:528:DC%2BD2cXns1yitbo%3D, PID: 15255772; (2014) Adv Healthc Mater, , Caliari SR, Harley BA (2014) Structural and biochemical modification of a collagen scaffold to selectively enhance MSC tenogenic, chondrogenic, and osteogenic differentiation. (in press); Cardwell, R.D., (2012) Dahlgren LA, , Goldstein AS: Electrospun fibre diameter, not alignment, affects mesenchymal stem cell differentiation into the tendon/ligament lineage. J Tissue Eng Regen Med; Chai, W., Ni, M., Rui, Y.F., Zhang, K.Y., Zhang, Q., Xu, L.L., Chan, K.M., Wang, Y., Effect of growth and differentiation factor 6 on the tenogenic differentiation of bone marrow-derived mesenchymal stem cells (2013) Chin Med J (Engl), 126, pp. 1509-1516. , COI: 1:CAS:528:DC%2BC3sXhtVahs7zN; Chen, Y.J., Huang, C.H., Lee, I.C., Lee, Y.T., Chen, M.H., Young, T.H., Effects of cyclic mechanical stretching on the mRNA expression of tendon/ligament-related and osteoblast-specific genes in human mesenchymal stem cells (2008) Connect Tissue Res, 49, pp. 7-14. , COI: 1:CAS:528:DC%2BD1cXit1CltL0%3D, PID: 18293173; Chen, X., Song, X.H., Yin, Z., Zou, X.H., Wang, L.L., Hu, H., Cao, T., Ouyang, H.W., Stepwise differentiation of human embryonic stem cells promotes tendon regeneration by secreting fetal tendon matrix and differentiation factors (2009) Stem Cells, 27, pp. 1276-1287. , COI: 1:CAS:528:DC%2BD1MXovFartbo%3D, PID: 19489094; Chen, J.L., Yin, Z., Shen, W.L., Chen, X., Heng, B.C., Zou, X.H., Ouyang, H.W., Efficacy of hESC-MSCs in knitted silk-collagen scaffold for tendon tissue engineering and their roles (2010) Biomaterials, 31, pp. 9438-9451. , COI: 1:CAS:528:DC%2BC3cXhtlygtrfP, PID: 20870282; Chen, H., Rui, Y.F., Wang, C., Are bone marrow mesenchymal stem cells-induced tenogenic progenitor cells identical to tendon progenitor cells? (2012) Stem Cells Dev, 21, pp. 844-845. , COI: 1:CAS:528:DC%2BC38XkvV2rsLo%3D, PID: 22150136; Chen, L., Dong, S.W., Tao, X., Liu, J.P., Tang, K.L., Xu, J.Z., Autologous platelet-rich clot releasate stimulates proliferation and inhibits differentiation of adult rat tendon stem cells towards nontenocyte lineages (2012) J Int Med Res, 40, pp. 1399-1409. , COI: 1:STN:280:DC%2BC38bmtlehtA%3D%3D, PID: 22971491; Chen, X., Yin, Z., Chen, J.L., Shen, W.L., Liu, H.H., Tang, Q.M., Fang, Z., Ouyang, H.W., Force and scleraxis synergistically promote the commitment of human ES cells derived MSCs to tenocytes (2012) Sci Rep, 2, p. 977. , PID: 23243495; Cheng, X., Tsao, C., Sylvia, V.L., Cornet, D., Nicolella, D.P., Bredbenner, T.L., Christy, R.J., Platelet-derived growth-factor-releasing aligned collagen-nanoparticle fibers promote the proliferation and tenogenic differentiation of adipose-derived stem cells (2014) Acta Biomater, 10, pp. 1360-1369. , COI: 1:CAS:528:DC%2BC3sXitVSgsrzK, PID: 24291329; Czaplewski, S.K., Tsai, T.L., Duenwald-Kuehl, S.E., Vanderby, R.J., Li, W.J., Tenogenic differentiation of human induced pluripotent stem cell-derived mesenchymal stem cells dictated by properties of braided submicron fibrous scaffolds (2014) Biomaterials, 35, pp. 6907-6917. , COI: 1:CAS:528:DC%2BC2cXos1elsb8%3D, PID: 24875762; D’Amour, K.A., Bang, A.G., Eliazer, S., Kelly, O.G., Agulnick, A.D., Smart, N.G., Moorman, M.A., Baetge, E.E., Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells (2006) Nat Biotechnol, 24, pp. 1392-1401. , PID: 17053790; Darabi, R., Gehlbach, K., Bachoo, R.M., Kamath, S., Osawa, M., Kamm, K.E., Kyba, M., Perlingeiro, R.C., Functional skeletal muscle regeneration from differentiating embryonic stem cells (2008) Nat Med, 14, pp. 134-143. , COI: 1:CAS:528:DC%2BD1cXhs1KhsLc%3D, PID: 18204461; Darabi, R., Arpke, R.W., Irion, S., Dimos, J.T., Grskovic, M., Kyba, M., Perlingeiro, R.C., Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice (2012) Cell Stem Cell, 10, pp. 610-619. , COI: 1:CAS:528:DC%2BC38Xms12msbs%3D, PID: 22560081; Ezura, Y., Chakravarti, S., Oldberg, A., Chervoneva, I., Birk, D.E., Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons (2000) J Cell Biol, 151, pp. 779-788. , COI: 1:CAS:528:DC%2BD3cXotFens7w%3D, PID: 11076963; Farng, E., Urdaneta, A.R., Barba, D., Esmende, S., McAllister, D.R., The effects of GDF-5 and uniaxial strain on mesenchymal stem cells in 3-D culture (2008) Clin Orthop Relat Res, 466, pp. 1930-1937. , PID: 18535869; Goh, J.C., Ouyang, H.W., Teoh, S.H., Chan, C.K., Lee, E.H., Tissue-engineering approach to the repair and regeneration of tendons and ligaments (2003) Tissue Eng, 9, pp. 31-44. , COI: 1:CAS:528:DC%2BD3sXnvF2lsLo%3D, PID: 14511469; Goudenege, S., Lebel, C., Huot, N.B., Dufour, C., Fujii, I., Gekas, J., Rousseau, J., Tremblay, J.P., Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation (2012) Mol Ther, 20, pp. 2153-2167. , COI: 1:CAS:528:DC%2BC38XhtlGqtb7J, PID: 22990676; Hankemeier, S., Keus, M., Zeichen, J., Jagodzinski, M., Barkhausen, T., Bosch, U., Krettek, C., Van Griensven, M., Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2: potential implications for tissue engineering of tendons and ligaments (2005) Tissue Eng, 11, pp. 41-49. , COI: 1:CAS:528:DC%2BD2MXhs12rt70%3D, PID: 15738660; Hannafin, J.A., Arnoczky, S.P., Hoonjan, A., Torzilli, P.A., Effect of stress deprivation and cyclic tensile loading on the material and morphologic properties of canine flexor digitorum profundus tendon: an in vitro study (1995) J Orthop Res, 13, pp. 907-914. , COI: 1:STN:280:DyaK287ksVGkuw%3D%3D, PID: 8544028; Hay, D.C., Zhao, D., Fletcher, J., Hewitt, Z.A., McLean, D., Urruticoechea-Uriguen, A., Black, J.R., Cui, W., Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo (2008) Stem Cells, 26, pp. 894-902. , COI: 1:CAS:528:DC%2BD1cXmtFKltb4%3D, PID: 18238852; Helm, G.A., Li, J.Z., Alden, T.D., Hudson, S.B., Beres, E.J., Cunningham, M., Mikkelsen, M.M., Kallmes, D.F., A light and electron microscopic study of ectopic tendon and ligament formation induced by bone morphogenetic protein-13 adenoviral gene therapy (2001) J Neurosurg, 95, pp. 298-307. , COI: 1:CAS:528:DC%2BD3MXmtVOlu7o%3D, PID: 11780901; Juncosa-Melvin, N., Shearn, J.T., Boivin, G.P., Gooch, C., Galloway, M.T., West, J.R., Nirmalanandhan, V.S., Butler, D.L., Effects of mechanical stimulation on the biomechanics and histology of stem cell-collagen sponge constructs for rabbit patellar tendon repair (2006) Tissue Eng, 12, pp. 2291-2300. , COI: 1:CAS:528:DC%2BD28XptlOht7k%3D, PID: 16968169; Kalson, N.S., Holmes, D.F., Kapacee, Z., Otermin, I., Lu, Y., Ennos, R.A., Canty-Laird, E.G., Kadler, K.E., An experimental model for studying the biomechanics of embryonic tendon: evidence that the development of mechanical properties depends on the actinomyosin machinery (2010) Matrix Biol, 29, pp. 678-689. , COI: 1:CAS:528:DC%2BC3cXhsVyhsL3P, PID: 20736063; Ker, E.D., Nain, A.S., Weiss, L.E., Wang, J., Suhan, J., Amon, C.H., Campbell, P.G., Bioprinting of growth factors onto aligned sub-micron fibrous scaffolds for simultaneous control of cell differentiation and alignment (2011) Biomaterials, 32, pp. 8097-8107. , COI: 1:CAS:528:DC%2BC3MXhtVyhu7nF, PID: 21820736; Kishore, V., Bullock, W., Sun, X., Van Dyke, W.S., Akkus, O., Tenogenic differentiation of human MSCs induced by the topography of electrochemically aligned collagen threads (2012) Biomaterials, 33, pp. 2137-2144. , COI: 1:CAS:528:DC%2BC38Xnt1ehug%3D%3D, PID: 22177622; Koh, K.P., Rao, A., DNA methylation and methylcytosine oxidation in cell fate decisions (2013) Curr Opin Cell Biol, 25, pp. 152-161. , COI: 1:CAS:528:DC%2BC3sXktVOltb8%3D, PID: 23498662; Kuo, C.K., Tuan, R.S., Mechanoactive tenogenic differentiation of human mesenchymal stem cells (2008) Tissue Eng Part A, 14, pp. 1615-1627. , COI: 1:CAS:528:DC%2BD1cXht1SlsLnJ, PID: 18759661; Laflamme, M.A., Chen, K.Y., Naumova, A.V., Muskheli, V., Fugate, J.A., Dupras, S.K., Reinecke, H., Murry, C.E., Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts (2007) Nat Biotechnol, 25, pp. 1015-1024. , COI: 1:CAS:528:DC%2BD2sXhtVWksLvE, PID: 17721512; Lee, I.C., Wang, J.H., Lee, Y.T., Young, T.H., The differentiation of mesenchymal stem cells by mechanical stress or/and co-culture system (2007) Biochem Biophys Res Commun, 352, pp. 147-152. , COI: 1:CAS:528:DC%2BD28Xht1Oht7rM, PID: 17107659; Liden, M., Movin, T., Ejerhed, L., Papadogiannakis, N., Blomen, E., Hultenby, K., Kartus, J., A histological and ultrastructural evaluation of the patellar tendon 10 years after reharvesting its central third (2008) Am J Sports Med, 36, pp. 781-788. , PID: 18192494; Liu, C.F., Aschbacher-Smith, L., Barthelery, N.J., Dyment, N., Butler, D., Wylie, C., Spatial and temporal expression of molecular markers and cell signals during normal development of the mouse patellar tendon (2012) Tissue Eng Part A, 18, pp. 598-608. , COI: 1:CAS:528:DC%2BC38Xjt1WiurY%3D, PID: 21939397; Lovati, A.B., Corradetti, B., Cremonesi, F., Bizzaro, D., Consiglio, A.L., Tenogenic differentiation of equine mesenchymal progenitor cells under indirect co-culture (2012) Int J Artif Organs, 35, pp. 996-1005. , COI: 1:CAS:528:DC%2BC3sXhsF2lsLnE, PID: 23065882; Lui, P.P., Rui, Y.F., Ni, M., Chan, K.M., Tenogenic differentiation of stem cells for tendon repair-what is the current evidence? (2011) J Tissue Eng Regen Med, 5, pp. 144-163. , COI: 1:CAS:528:DC%2BC3MXhtVejtLvI, PID: 21548133; Luo, Q., Song, G., Song, Y., Xu, B., Qin, J., Shi, Y., Indirect co-culture with tenocytes promotes proliferation and mRNA expression of tendon/ligament related genes in rat bone marrow mesenchymal stem cells (2009) Cytotechnology, 61, pp. 1-10. , PID: 19842053; Ma, D.K., Marchetto, M.C., Guo, J.U., Ming, G., Gage, F.H., Song, H., Epigenetic choreographers of neurogenesis in the adult mammalian brain (2010) Nat Neurosci, 13, pp. 1338-1344. , COI: 1:CAS:528:DC%2BC3cXhtlegs77N, PID: 20975758; Maffulli, N., Wong, J., Almekinders, L.C., Types and epidemiology of tendinopathy (2003) Clin Sports Med, 22, pp. 675-692. , PID: 14560540; Mazzocca, A.D., McCarthy, M.B., Chowaniec, D., Cote, M.P., Judson, C.H., Apostolakos, J., Solovyova, O., Arciero, R.A., Bone marrow-derived mesenchymal stem cells obtained during arthroscopic rotator cuff repair surgery show potential for tendon cell differentiation after treatment with insulin (2011) Arthroscopy, 27, pp. 1459-1471. , PID: 21978434; Mikic, B., Multiple effects of GDF-5 deficiency on skeletal tissues: implications for therapeutic bioengineering (2004) Ann Biomed Eng, 32, pp. 466-476. , PID: 15095821; Mikic, B., Rossmeier, K., Bierwert, L., Identification of a tendon phenotype in GDF6 deficient mice (2009) Anat Rec (Hoboken), 292, pp. 396-400; Min, H.K., Oh, S.H., Lee, J.M., Im, G.I., Lee, J.H., Porous membrane with reverse gradients of PDGF-BB and BMP-2 for tendon-to-bone repair: in vitro evaluation on adipose-derived stem cell differentiation (2014) Acta Biomater, 10, pp. 1272-1279. , COI: 1:CAS:528:DC%2BC2cXhtlGmtrg%3D, PID: 24370639; Morita, Y., Watanabe, S., Ju, Y., Xu, B., Determination of optimal cyclic uniaxial stretches for stem cell-to-tenocyte differentiation under a wide range of mechanical stretch conditions by evaluating gene expression and protein synthesis levels (2013) Acta Bioeng Biomech, 15, pp. 71-79. , PID: 24215499; Ni, M., Rui, Y., Chen, Q., Wang, Y., Li, G., Effect of growth differentiation factor 7 on tenogenic differentiation of bone marrow mesenchymal stem cells of rat in vitro (2011) Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 25, pp. 1103-1109. , COI: 1:CAS:528:DC%2BC38XkvFSntA%3D%3D, PID: 21991820; Nistor, G.I., Totoiu, M.O., Haque, N., Carpenter, M.K., Keirstead, H.S., Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation (2005) Glia, 49, pp. 385-396. , PID: 15538751; Noth, U., Schupp, K., Heymer, A., Kall, S., Jakob, F., Schutze, N., Baumann, B., Hendrich, C., Anterior cruciate ligament constructs fabricated from human mesenchymal stem cells in a collagen type I hydrogel (2005) Cytotherapy, 7, pp. 447-455. , COI: 1:STN:280:DC%2BD2MrlvF2hsQ%3D%3D, PID: 16236634; Oldershaw, R.A., Baxter, M.A., Lowe, E.T., Bates, N., Grady, L.M., Soncin, F., Brison, D.R., Kimber, S.J., Directed differentiation of human embryonic stem cells toward chondrocytes (2010) Nat Biotechnol, 28, pp. 1187-1194. , COI: 1:CAS:528:DC%2BC3cXhtlahu7jM, PID: 20967028; Omae, H., Zhao, C., Sun, Y.L., An, K.N., Amadio, P.C., Multilayer tendon slices seeded with bone marrow stromal cells: a novel composite for tendon engineering (2009) J Orthop Res, 27, pp. 937-942. , COI: 1:CAS:528:DC%2BD1MXot12rsb8%3D, PID: 19105224; Park, A., Hogan, M.V., Kesturu, G.S., James, R., Balian, G., Chhabra, A.B., Adipose-derived mesenchymal stem cells treated with growth differentiation factor-5 express tendon-specific markers (2010) Tissue Eng Part A, 16, pp. 2941-2951. , COI: 1:CAS:528:DC%2BC3cXhtVOhsr7M, PID: 20575691; Petrigliano, F.A., English, C.S., Barba, D., Esmende, S., Wu, B.M., McAllister, D.R., The effects of local bFGF release and uniaxial strain on cellular adaptation and gene expression in a 3D environment: implications for ligament tissue engineering (2007) Tissue Eng, 13, pp. 2721-2731. , COI: 1:CAS:528:DC%2BD2sXht1OrurbK, PID: 17727336; (2014) J Tissue Eng Regen Med, , Qiu Y, Lei J, Koob TJ, Temenoff JS (2014) Cyclic tension promotes fibroblastic differentiation of human MSCs cultured on collagen-fibre scaffolds. (in press); (2013) Cell Tissue Res, , Raabe O, Shell K, Fietz D, Freitag C, Ohrndorf A, Christ HJ, Wenisch S, Arnhold S (2013) Tenogenic differentiation of equine adipose-tissue-derived stem cells under the influence of tensile strain, growth differentiation factors and various oxygen tensions. (in press); Rui, Y.F., Lui, P.P., Ni, M., Chan, L.S., Lee, Y.W., Chan, K.M., Mechanical loading increased BMP-2 expression which promoted osteogenic differentiation of tendon-derived stem cells (2011) J Orthop Res, 29, pp. 390-396. , COI: 1:CAS:528:DC%2BC3MXis1Cisbs%3D, PID: 20882582; Sahoo, S., Ouyang, H., Goh, J.C., Tay, T.E., Toh, S.L., Characterization of a novel polymeric scaffold for potential application in tendon/ligament tissue engineering (2006) Tissue Eng, 12, pp. 91-99. , COI: 1:CAS:528:DC%2BD28XhslCjtLc%3D, PID: 16499446; Sahoo, S., Ang, L.T., Cho-Hong, G.J., Toh, S.L., Bioactive nanofibers for fibroblastic differentiation of mesenchymal precursor cells for ligament/tendon tissue engineering applications (2010) Differentiation, 79, pp. 102-110. , COI: 1:CAS:528:DC%2BC3cXjsFGitb4%3D, PID: 19963313; Sahoo, S., Toh, S.L., Goh, J.C., A bFGF-releasing silk/PLGA-based biohybrid scaffold for ligament/tendon tissue engineering using mesenchymal progenitor cells (2010) Biomaterials, 31, pp. 2990-2998. , COI: 1:CAS:528:DC%2BC3cXit1SgtLw%3D, PID: 20089300; Sassoon, A.A., Ozasa, Y., Chikenji, T., Sun, Y.L., Larson, D.R., Maas, M.L., Zhao, C., Amadio, P.C., Skeletal muscle and bone marrow derived stromal cells: a comparison of tenocyte differentiation capabilities (2012) J Orthop Res, 30, pp. 1710-1718. , PID: 22511232; Schneider, P.R., Buhrmann, C., Mobasheri, A., Matis, U., Shakibaei, M., Three-dimensional high-density co-culture with primary tenocytes induces tenogenic differentiation in mesenchymal stem cells (2011) J Orthop Res, 29, pp. 1351-1360. , COI: 1:CAS:528:DC%2BC3MXos1ars74%3D, PID: 21437969; Schweitzer, R., Chyung, J.H., Murtaugh, L.C., Brent, A.E., Rosen, V., Olson, E.N., Lassar, A., Tabin, C.J., Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments (2001) Development, 128, pp. 3855-3866. , COI: 1:CAS:528:DC%2BD3MXnvVejs7c%3D, PID: 11585810; Sharma, R.I., Snedeker, J.G., Paracrine interactions between mesenchymal stem cells affect substrate driven differentiation toward tendon and bone phenotypes (2012) PLoS ONE, 7. , COI: 1:CAS:528:DC%2BC38XjtFSqu7s%3D, PID: 22355373; Shi, Y., Fu, Y., Tong, W., Geng, Y., Lui, P.P., Tang, T., Zhang, X., Dai, K., Uniaxial mechanical tension promoted osteogenic differentiation of rat tendon-derived stem cells (rTDSCs) via the Wnt5a-RhoA pathway (2012) J Cell Biochem, 113, pp. 3133-3142. , COI: 1:CAS:528:DC%2BC38XhtFKlsL%2FN, PID: 22615126; Shukunami, C., Takimoto, A., Oro, M., Hiraki, Y., Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes (2006) Dev Biol, 298, pp. 234-247. , COI: 1:CAS:528:DC%2BD28XpvFeksb4%3D, PID: 16876153; Song, G., Luo, Q., Xu, B., Ju, Y., Mechanical stretch-induced changes in cell morphology and mRNA expression of tendon/ligament-associated genes in rat bone-marrow mesenchymal stem cells (2010) Mol Cell Biomech, 7, pp. 165-174. , PID: 21141679; Storm, E.E., Kingsley, D.M., Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family (1996) Development, 122, pp. 3969-3979. , COI: 1:CAS:528:DyaK2sXhtVyjsr4%3D, PID: 9012517; Tan, Q., Lui, P.P., Rui, Y.F., Wong, Y.M., Comparison of potentials of stem cells isolated from tendon and bone marrow for musculoskeletal tissue engineering (2012) Tissue Eng Part A, 18, pp. 840-851. , COI: 1:CAS:528:DC%2BC38XkvVSnur4%3D, PID: 22011320; Tang, S.W., Tong, W.Y., Shen, W., Yeung, K.W., Lam, Y.W., Stringent requirement for spatial arrangement of extracellular matrix in supporting cell morphogenesis and differentiation (2014) BMC Cell Biol, 15, p. 10. , PID: 24661496; Tong, W.Y., Shen, W., Yeung, C.W., Zhao, Y., Cheng, S.H., Chu, P.K., Chan, D., Lam, Y.W., Functional replication of the tendon tissue microenvironment by a bioimprinted substrate and the support of tenocytic differentiation of mesenchymal stem cells (2012) Biomaterials, 33, pp. 7686-7698. , COI: 1:CAS:528:DC%2BC38XhtVKnurbP, PID: 22818988; Violini, S., Ramelli, P., Pisani, L.F., Gorni, C., Mariani, P., Horse bone marrow mesenchymal stem cells express embryo stem cell markers and show the ability for tenogenic differentiation by in vitro exposure to BMP-12 (2009) BMC Cell Biol, 10, p. 29. , PID: 19383177; Wang, J., Ye, R., Wei, Y., Wang, H., Xu, X., Zhang, F., Qu, J., Zhang, H., The effects of electrospun TSF nanofiber diameter and alignment on neuronal differentiation of human embryonic stem cells (2012) J Biomed Mater Res A, 100, pp. 632-645. , PID: 22213384; Wang, T., Gardiner, B.S., Lin, Z., Rubenson, J., Kirk, T.B., Wang, A., Xu, J., Zheng, M.H., Bioreactor design for tendon/ligament engineering (2013) Tissue Eng Part B, 19, pp. 133-146. , COI: 1:CAS:528:DC%2BC3sXjsFeksbY%3D; Wang, T., Lin, Z., Day, R.E., Gardiner, B., Landao-Bassonga, E., Rubenson, J., Kirk, T.B., Zheng, M.H., Programmable mechanical stimulation influences tendon homeostasis in a bioreactor system (2013) Biotechnol Bioeng, 110, pp. 1495-1507. , COI: 1:CAS:528:DC%2BC3sXhvFWgt7g%3D, PID: 23242991; Wei, X., Mao, Z., Hou, Y., Lin, L., Xue, T., Chen, L., Wang, H., Yu, C., Local administration of TGFbeta-1/VEGF165 gene-transduced bone mesenchymal stem cells for Achilles allograft replacement of the anterior cruciate ligament in rabbits (2011) Biochem Biophys Res Commun, 406, pp. 204-210. , COI: 1:CAS:528:DC%2BC3MXjtFKjtrg%3D, PID: 21303664; Xu, B., Song, G., Ju, Y., Effect of focal adhesion kinase on the regulation of realignment and tenogenic differentiation of human mesenchymal stem cells by mechanical stretch (2011) Connect Tissue Res, 52, pp. 373-379. , COI: 1:CAS:528:DC%2BC3MXhtFOmt77J, PID: 21401419; Xu, B., Song, G., Ju, Y., Li, X., Song, Y., Watanabe, S., RhoA/ROCK, cytoskeletal dynamics, and focal adhesion kinase are required for mechanical stretch-induced tenogenic differentiation of human mesenchymal stem cells (2012) J Cell Physiol, 227, pp. 2722-2729. , COI: 1:CAS:528:DC%2BC38Xisl2rur0%3D, PID: 21898412; Yan, Y., Yang, D., Zarnowska, E.D., Du, Z., Werbel, B., Valliere, C., Pearce, R.A., Zhang, S.C., Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells (2005) Stem Cells, 23, pp. 781-790. , COI: 1:CAS:528:DC%2BD2MXlslCltb8%3D, PID: 15917474; Yang, F., Murugan, R., Wang, S., Ramakrishna, S., Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering (2005) Biomaterials, 26, pp. 2603-2610. , COI: 1:CAS:528:DC%2BD2cXhtVChsrzF, PID: 15585263; Yang, G., Rothrauff, B.B., Lin, H., Gottardi, R., Alexander, P.G., Tuan, R.S., Enhancement of tenogenic differentiation of human adipose stem cells by tendon-derived extracellular matrix (2013) Biomaterials, 34, pp. 9295-9306. , COI: 1:CAS:528:DC%2BC3sXhsVCmsrzO, PID: 24044998; Yin, Z., Chen, X., Chen, J.L., Shen, W.L., Hieu, N.T., Gao, L., Ouyang, H.W., The regulation of tendon stem cell differentiation by the alignment of nanofibers (2010) Biomaterials, 31, pp. 2163-2175. , COI: 1:CAS:528:DC%2BC3cXpsV2hsQ%3D%3D, PID: 19995669; Yin, Z., Chen, X., Zhu, T., Hu, J.J., Song, H.X., Shen, W.L., Jiang, L.Y., Ouyang, H.W., The effect of decellularized matrices on human tendon stem/progenitor cell differentiation and tendon repair (2013) Acta Biomater, 9, pp. 9317-9329. , COI: 1:CAS:528:DC%2BC3sXht1GgtbjM, PID: 23896565; Zhang, J., Wang, J.H., Mechanobiological response of tendon stem cells: implications of tendon homeostasis and pathogenesis of tendinopathy (2010) J Orthop Res, 28, pp. 639-643. , PID: 19918904; Zhang, J., Wang, J.H., Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes (2010) Am J Sports Med, 38, pp. 2477-2486. , PID: 20802092; Zhang, J., Wang, J.H., The effects of mechanical loading on tendons–an in vivo and in vitro model study (2013) PLoS ONE, 8. , COI: 1:CAS:528:DC%2BC3sXhtlGjur%2FF, PID: 23977130; Zhang, G., Ezura, Y., Chervoneva, I., Robinson, P.S., Beason, D.P., Carine, E.T., Soslowsky, L.J., Birk, D.E., Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development (2006) J Cell Biochem, 98, pp. 1436-1449. , COI: 1:CAS:528:DC%2BD28XnvFWkurw%3D, PID: 16518859; Zhang, L., Tran, N., Chen, H.Q., Kahn, C.J., Marchal, S., Groubatch, F., Wang, X., Time-related changes in expression of collagen types I and III and of tenascin-C in rat bone mesenchymal stem cells under co-culture with ligament fibroblasts or uniaxial stretching (2008) Cell Tissue Res, 332, pp. 101-109. , COI: 1:CAS:528:DC%2BD1cXjsF2ms7w%3D, PID: 18196274",Review,Scopus,2-s2.0-84928555987
"Zhang Y., Zhang X., Huang J., Dong Q.","Wnt signaling regulation of stem-like properties in human lung adenocarcinoma cell lines",2015,"Medical Oncology","32","5",,"","",10,,10.1007/s12032-015-0596-9,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926295241&partnerID=40&md5=575f7e65fcb19ce8cdecbb662995bab1","Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, 25/Ln 2200 Xietu RoadShanghai, China; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, 241 Huaihai Road (West)Shanghai, China","Zhang, Y., Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, 25/Ln 2200 Xietu RoadShanghai, China; Zhang, X., Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, 241 Huaihai Road (West)Shanghai, China; Huang, J., Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, 241 Huaihai Road (West)Shanghai, China; Dong, Q., Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, 25/Ln 2200 Xietu RoadShanghai, China","The refractory pulmonary adenocarcinoma is characterized by its metastasis and resistance to cytotoxic agents. While the underlying molecular mechanism is unclear, the property of chemoresistance may mainly lie in the presence of highly resistant cancer stem cells. We examined the function of Wnt/β-catenin signaling in maintaining cancer stem cells (CSCs) in lung adenocarcinoma. Lentivirus-mediated knockdown of β-catenin expression accelerated cell cycle. Subsequently, β-catenin knockdown PC9 cells improve the sensitivity to chemotherapy. Further focusing on Wnt signal by administrating PP and EGFR-TKIs as Wnt antagonists can decrease metastasis and induce apoptosis. Collectively, these results indicate that Wnt signaling pathway plays an essential role in maintaining highly resistant CSCs, regulation of cell cycle, metastasis and apoptosis in lung adenocarcinoma. © 2015, Springer Science+Business Media New York.","Apoptosis; Drug resistance; Metastasis; Stem-like property; Wnt signaling","Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., Cancer statistics, 2006 (2006) CA Cancer J Clin, 56 (2), pp. 106-130. , PID: 16514137; Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C., Parkin, D.M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 (2010) Int J Cancer, 127 (12), pp. 2893-2917. , COI: 1:CAS:528:DC%2BC3cXhtlWhs7fO, PID: 21351269; Stewart, D.J., Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer (2010) Crit Rev Oncol Hematol, 75 (3), pp. 173-234. , PID: 20047843; Liu, Y.P., Yang, C.J., Huang, M.S., Yeh, C.T., Wu, A.T., Lee, Y.C., Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling (2013) Cancer Res, 73 (1), pp. 406-416. , COI: 1:CAS:528:DC%2BC3sXjs1aitA%3D%3D, PID: 23135908; Morrison, R., Schleicher, S.M., Sun, Y., Niermann, K.J., Kim, S., Spratt, D.E., Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis (2011) J Oncol, 2011, p. 941876. , PID: 20981352; Reya, T., Morrison, S.J., Clarke, M.F., Weissman, I.L., Stem cells, cancer, and cancer stem cells (2001) Nature, 414 (6859), pp. 105-111. , COI: 1:CAS:528:DC%2BD3MXot1ahs7c%3D, PID: 11689955; Rivera, C., Rivera, S., Loriot, Y., Vozenin, M.C., Deutsch, E., Lung cancer stem cell: new insights on experimental models and preclinical data (2011) J Oncol, 2011, p. 549181. , PID: 21209720; O’Flaherty, J.D., Barr, M., Fennell, D., Richard, D., Reynolds, J., O’Leary, J., The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy (2012) J Thorac Oncol, 7 (12), pp. 1880-1890. , PID: 23154562; Eyler, C.E., Rich, J.N., Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis (2008) J Clin Oncol, 26 (17), pp. 2839-2845. , COI: 1:CAS:528:DC%2BD1cXotlCmsr4%3D, PID: 18539962; Visvader, J.E., Lindeman, G.J., Cancer stem cells in solid tumours: accumulating evidence and unresolved questions (2008) Nat Rev Cancer, 8 (10), pp. 755-768. , COI: 1:CAS:528:DC%2BD1cXhtFCrtb3K, PID: 18784658; Visvader, J.E., Lindeman, G.J., Cancer stem cells: current status and evolving complexities (2012) Cell Stem Cell, 10 (6), pp. 717-728. , COI: 1:CAS:528:DC%2BC38XosFCitLc%3D, PID: 22704512; Schoenhals, M., Kassambara, A., De Vos, J., Hose, D., Moreaux, J., Klein, B., Embryonic stem cell markers expression in cancers (2009) Biochem Biophys Res Commun, 383 (2), pp. 157-162. , COI: 1:CAS:528:DC%2BD1MXltFWntbs%3D, PID: 19268426; Chiou, S.H., Wang, M.L., Chou, Y.T., Chen, C.J., Hong, C.F., Hsieh, W.J., Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation (2010) Cancer Res, 70 (24), pp. 10433-10444. , COI: 1:CAS:528:DC%2BC3cXhsFGrtL3M, PID: 21159654; Zhang, Q., Taguchi, A., Schliekelman, M., Wong, C.H., Chin, A., Kuick, R., Comprehensive proteomic profiling of aldehyde dehydrogenases in lung adenocarcinoma cell lines (2011) Int J Proteomics, 2011, p. 145010. , PID: 22110949; Corominas-Faja, B., Oliveras-Ferraros, C., Cuyas, E., Segura-Carretero, A., Joven, J., Martin-Castillo, B., Stem cell-like ALDH (bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin (2013) Cell Cycle, 12 (21), pp. 3390-3404. , COI: 1:CAS:528:DC%2BC2cXhs1Wlu70%3D, PID: 24047698; Chang, A., Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC (2011) Lung Cancer, 71 (1), pp. 3-10. , PID: 20951465; Harris-Johnson, K.S., Domyan, E.T., Vezina, C.M., Sun, X., Beta-catenin promotes respiratory progenitor identity in mouse foregut (2009) Proc Natl Acad Sci USA, 106 (38), pp. 16287-16292. , COI: 1:CAS:528:DC%2BD1MXht1KqtbjI, PID: 19805295; Singh, S., Trevino, J., Bora-Singhal, N., Coppola, D., Haura, E., Altiok, S., EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer (2012) Mol Cancer, 11, p. 73. , PID: 23009336; Lee, S.H., Koo, B.S., Kim, J.M., Huang, S., Rho, Y.S., Bae, W.J., Wnt/beta-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4 (2014) J Pathol, 234 (1), pp. 99-107. , COI: 1:CAS:528:DC%2BC2cXhtlGgsrvI, PID: 24871033; Prud’homme, G.J., Cancer stem cells and novel targets for antitumor strategies (2012) Curr Pharm Des, 18 (19), pp. 2838-2849. , PID: 22390767; Teng, Y., Wang, X., Wang, Y., Ma, D., Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells (2010) Biochem Biophys Res Commun, 392 (3), pp. 373-379. , COI: 1:CAS:528:DC%2BC3cXitVGqurc%3D, PID: 20074550; Thorne, C.A., Hanson, A.J., Schneider, J., Tahinci, E., Orton, D., Cselenyi, C.S., Small-molecule inhibition of Wnt signaling through activation of casein kinase 1 alpha (2010) Nat Chem Biol, 6 (11), pp. 829-836. , COI: 1:CAS:528:DC%2BC3cXht1elu7zO, PID: 20890287; Xu, W., Lacerda, L., Debeb, B.G., Atkinson, R.L., Solley, T.N., Li, L., The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer (2013) PLoS One, 8 (8), p. 71508. , COI: 1:CAS:528:DC%2BC3sXhsVWhsbfO, PID: 24013655; Dolnikov, A., Xu, N., Shen, S., Song, E., Holmes, T., Klamer, G., GSK-3 beta inhibition promotes early engraftment of ex vivo-expanded haematopoietic stem cells (2014) Cell Prolif, 47 (2), pp. 113-123. , COI: 1:CAS:528:DC%2BC2cXktlKltb4%3D, PID: 24517125; Kim, K.A., Wagle, M., Tran, K., Zhan, X., Dixon, M.A., Liu, S., R-Spondin family members regulate the Wnt pathway by a common mechanism (2008) Mol Biol Cell, 19 (6), pp. 2588-2596. , COI: 1:CAS:528:DC%2BD1cXntV2rtL0%3D, PID: 18400942; Dembinski, J.L., Krauss, S., Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma (2009) Clin Exp Metastasis, 26 (7), pp. 611-623. , COI: 1:CAS:528:DC%2BD1MXhsVWls7%2FM, PID: 19421880; Naujok, O., Lentes, J., Diekmann, U., Davenport, C., Lenzen, S., Cytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors (2014) BMC Res Notes, 7, p. 273. , PID: 24779365; Zhang, X.Y., Zheng, B.Q., Han, B.H., Huang, J.S., Geng, Q., Xu, H.L., Lung adenocarcinoma stem cell phenotypes and their correlation with patient prognosis (2009) Zhonghua Zhong Liu Za Zhi, 31 (11), pp. 836-840. , PID: 20137348; Yin, X., Li, Y.W., Jin, J.J., Zhou, Y., Ren, Z.G., Qiu, S.J., The clinical and prognostic implications of pluripotent stem cell gene expression in hepatocellular carcinoma (2013) Oncol Lett, 5 (4), pp. 1155-1162. , COI: 1:CAS:528:DC%2BC3sXms1Kit7g%3D, PID: 23599755; Paul, I., Bhattacharya, S., Chatterjee, A., Ghosh, M.K., Current understanding on EGFR and Wnt/beta-catenin signaling in glioma and their possible crosstalk (2013) Genes Cancer, 4 (11-12), pp. 427-446. , COI: 1:CAS:528:DC%2BC2cXhsVGktbbO, PID: 24386505; Georgopoulos, N.T., Kirkwood, L.A., Southgate, J., A novel bidirectional positive-feedback loop between Wnt-beta-catenin and EGFR-ERK plays a role in context-specific modulation of epithelial tissue regeneration (2014) J Cell Sci, 127, pp. 2967-2982. , COI: 1:CAS:528:DC%2BC2cXht1emt7vM, PID: 24816560; Okudela, K., Woo, T., Mitsui, H., Tajiri, M., Masuda, M., Ohashi, K., Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and beta-catenin, in primary lung adenocarcinoma—their prognostic significance (2012) Pathol Int, 62 (12), pp. 792-801. , COI: 1:CAS:528:DC%2BC38XhvVOrtL%2FO, PID: 23252868; Cortes-Dericks, L., Galetta, D., Spaggiari, L., Schmid, R.A., Karoubi, G., High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals (2012) Eur J Cardiothorac Surg, 41 (6), pp. 173-181. , PID: 22529186; Moore, N., Houghton, J., Lyle, S., Slow-cycling therapy-resistant cancer cells (2012) Stem Cells Dev, 21 (10), pp. 1822-1830. , COI: 1:CAS:528:DC%2BC38XptFWlsrc%3D, PID: 21973238; Bragado, P., Estrada, Y., Sosa, M.S., Avivar-Valderas, A., Cannan, D., Genden, E., Analysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties (2012) PLoS One, 7 (1), p. 29974. , COI: 1:CAS:528:DC%2BC38XitVGhtbg%3D, PID: 22276135; Immervoll, H., Hoem, D., Sakariassen, P.O., Steffensen, O.J., Molven, A., Expression of the “stem cell marker” CD133 in pancreas and pancreatic ductal adenocarcinomas (2008) BMC Cancer, 8, p. 48. , PID: 18261235",Article,Scopus,2-s2.0-84926295241
"Ng S.K., Higashimori H., Tolman M., Yang Y.","Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis",2015,"Experimental Neurology","267",,,"115","122",,,10.1016/j.expneurol.2015.03.004,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924956494&partnerID=40&md5=6e0f6dcc72dee866373f035754c187e4","Department of Neuroscience, Tufts University School of Medicine, 136 Harrison AveBoston, MA, United States; Neuroscience Program, Tufts Sackler School of Graduate Biomedical Sciences, 136 Harrison AveBoston, MA, United States","Ng, S.K., Department of Neuroscience, Tufts University School of Medicine, 136 Harrison AveBoston, MA, United States; Higashimori, H., Department of Neuroscience, Tufts University School of Medicine, 136 Harrison AveBoston, MA, United States; Tolman, M., Department of Neuroscience, Tufts University School of Medicine, 136 Harrison AveBoston, MA, United States, Neuroscience Program, Tufts Sackler School of Graduate Biomedical Sciences, 136 Harrison AveBoston, MA, United States; Yang, Y., Department of Neuroscience, Tufts University School of Medicine, 136 Harrison AveBoston, MA, United States, Neuroscience Program, Tufts Sackler School of Graduate Biomedical Sciences, 136 Harrison AveBoston, MA, United States","Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disease in which the majority of upper and lower motor neurons are degenerated. Despite intensive efforts to identify drug targets and develop neuroprotective strategies, effective therapeutics for ALS remains unavailable. The identification and characterization of novel targets and pathways remain crucial in the development of ALS therapeutics. Adenosine is a major neuromodulator that actively regulates synaptic transmission. Interestingly, adenosine levels are significantly elevated in the cerebrospinal fluid (CSF) of progressing human ALS patients. In the current study, we showed that adenosine 2a receptor (A2aR), but not adenosine 1 receptor (A1R), is highly enriched in spinal (motor) neurons. A2aR expression is also selectively increased at the symptomatic onset in the spinal cords of SOD1G93A mice and end-stage human ALS spinal cords. Interestingly, we found that direct adenosine treatment is sufficient to induce embryonic stem cell-derived motor neuron (ESMN) cell death in cultures. Subsequent pharmacological inhibition and partial genetic ablation of A2aR (A2aR+/-) significantly protect ESMN from SOD1G93A+ astrocyte-induced cell death and delay disease progression of SOD1G93A mice. Taken together, our results provide compelling novel evidence that A2aR-mediated adenosine signaling contributes to the selective spinal motor neuron degeneration observed in the SOD1G93A mouse model of ALS. © 2015 Elsevier Inc.","A2a receptor; Adenosine; Amyotrophic lateral sclerosis (ALS); Astrocyte; KW6002; Motor neuron","Aoyama, S., Kase, H., Borrelli, E., Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist (2000) J. Neurosci., 20, pp. 5848-5852; Armentero, M.T., Pinna, A., Ferre, S., Lanciego, J.L., Muller, C.E., Franco, R., Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease (2011) Pharmacol. Ther., 132, pp. 280-299; Azevedo, F.A., Carvalho, L.R., Grinberg, L.T., Farfel, J.M., Ferretti, R.E., Leite, R.E., Jacob Filho, W., Herculano-Houzel, S., Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain (2009) J. Comp. Neurol., 513, pp. 532-541; Bairam, A., Joseph, V., Lajeunesse, Y., Kinkead, R., Altered expression of adenosine A1 and A2A receptors in the carotid body and nucleus tractus solitarius of adult male and female rats following neonatal caffeine treatment (2009) Brain Res., 1287, pp. 74-83; Blutstein, T., Haydon, P.G., The importance of astrocyte-derived purines in the modulation of sleep (2013) Glia, 61, pp. 129-139; Boillee, S., Yamanaka, K., Lobsiger, C.S., Copeland, N.G., Jenkins, N.A., Kassiotis, G., Kollias, G., Cleveland, D.W., Onset and progression in inherited ALS determined by motor neurons and microglia (2006) Science, 312, pp. 1389-1392; Boison, D., Chen, J.F., Fredholm, B.B., Adenosine signaling and function in glial cells (2010) Cell Death Differ., 17, pp. 1071-1082; Bruijn, L.I., Houseweart, M.K., Kato, S., Anderson, K.L., Anderson, S.D., Ohama, E., Reaume, A.G., Cleveland, D.W., Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1 (1998) Science, 281, pp. 1851-1854; Brundege, J.M., Dunwiddie, T.V., Role of adenosine as a modulator of synaptic activity in the central nervous system (1997) Adv. Pharmacol., 39, pp. 353-391; Burnstock, G., The past, present and future of purine nucleotides as signalling molecules (1997) Neuropharmacology, 36, pp. 1127-1139; Cahoy, J.D., Emery, B., Kaushal, A., Foo, L.C., Zamanian, J.L., Christopherson, K.S., Xing, Y., Barres, B.A., A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function (2008) J. Neurosci., 28, pp. 264-278; Chen, J.F., Huang, Z., Ma, J., Zhu, J., Moratalla, R., Standaert, D., Moskowitz, M.A., Schwarzschild, M.A., A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice (1999) J. Neurosci., 19, pp. 9192-9200; Choca, J.I., Proudfit, H.K., Green, R.D., Identification of A1 and A2 adenosine receptors in the rat spinal cord (1987) J. Pharmacol. Exp. Ther., 242, pp. 905-910; Clement, A.M., Nguyen, M.D., Roberts, E.A., Garcia, M.L., Boillee, S., Rule, M., McMahon, A.P., Cleveland, D.W., Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice (2003) Science, 302, pp. 113-117; Cleveland, D.W., Rothstein, J.D., From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS (2001) Nat. Rev. Neurosci., 2, pp. 806-819; DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., Boxer, A.L., Baker, M., Rutherford, N.J., Nicholson, A.M., Rademakers, R., Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS (2011) Neuron, 72, pp. 245-256; Doyle, J.P., Dougherty, J.D., Heiman, M., Schmidt, E.F., Stevens, T.R., Ma, G., Bupp, S., Heintz, N., Application of a translational profiling approach for the comparative analysis of CNS cell types (2008) Cell, 135, pp. 749-762; Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Deng, H.X., Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation (1994) Science, 264, pp. 1772-1775; Halassa, M.M., Florian, C., Fellin, T., Munoz, J.R., Lee, S.Y., Abel, T., Haydon, P.G., Frank, M.G., Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss (2009) Neuron, 61, pp. 213-219; Higashimori, H., Morel, L., Huth, J., Lindemann, L., Dulla, C., Taylor, A., Freeman, M., Yang, Y., Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X mouse (2013) Hum. Mol. Genet., 22, pp. 2041-2054; Ilieva, H., Polymenidou, M., Cleveland, D.W., Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond (2009) J. Cell Biol., 187, pp. 761-772; Kang, S.H., Li, Y., Fukaya, M., Lorenzini, I., Cleveland, D.W., Ostrow, L.W., Rothstein, J.D., Bergles, D.E., Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis (2013) Nat. Neurosci., 16, pp. 571-579; Kawamata, H., Ng, S.K., Diaz, N., Burstein, S., Morel, L., Osgood, A., Sider, B., Yang, Y., Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis (2014) J. Neurosci., 34, pp. 2331-2348; Latini, S., Pedata, F., Adenosine in the central nervous system: release mechanisms and extracellular concentrations (2001) J. Neurochem., 79, pp. 463-484; Ledent, C., Vaugeois, J.M., Schiffmann, S.N., Pedrazzini, T., El Yacoubi, M., Vanderhaeghen, J.J., Costentin, J., Parmentier, M., Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor (1997) Nature, 388, pp. 674-678; Lupica, C.R., Proctor, W.R., Dunwiddie, T.V., Presynaptic inhibition of excitatory synaptic transmission by adenosine in rat hippocampus: analysis of unitary EPSP variance measured by whole-cell recording (1992) J. Neurosci., 12, pp. 3753-3764; Miyazaki, N., Nakatsuka, T., Takeda, D., Nohda, K., Inoue, K., Yoshida, M., Adenosine modulates excitatory synaptic transmission and suppresses neuronal death induced by ischaemia in rat spinal motoneurones (2008) Pflugers Arch., 457, pp. 441-451; Mojsilovic-Petrovic, J., Jeong, G.B., Crocker, A., Arneja, A., David, S., Russell, D.S., Kalb, R.G., Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors (2006) J. Neurosci., 26, pp. 9250-9263; Morelli, M., Carta, A.R., Kachroo, A., Schwarzschild, M.A., Pathophysiological roles for purines: adenosine, caffeine and urate (2010) Prog. Brain Res., 183, pp. 183-208; Nam, H.W., Bruner, R.C., Choi, D.S., Adenosine signaling in striatal circuits and alcohol use disorders (2013) Mol. Cell, 36, pp. 195-202; Nascimento, F., Pousinha, P.A., Correia, A.M., Gomes, R., Sebastiao, A.M., Ribeiro, J.A., Adenosine A2A receptors activation facilitates neuromuscular transmission in the pre-symptomatic phase of the SOD1(G93A) ALS mice, but not in the symptomatic phase (2014) PLoS One, 9, p. e104081; Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Lee, V.M., Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis (2006) Science, 314, pp. 130-133; Potenza, R.L., Armida, M., Ferrante, A., Pezzola, A., Matteucci, A., Puopolo, M., Popoli, P., Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis (2013) J. Neurosci. Res., 91, pp. 585-592; Renton, A.E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J.R., Schymick, J.C., Traynor, B.J., A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD (2011) Neuron, 72, pp. 257-268; Renton, A.E., Chio, A., Traynor, B.J., State of play in amyotrophic lateral sclerosis genetics (2014) Nat. Neurosci., 17, pp. 17-23; Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Deng, H.X., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis (1993) Nature, 362, pp. 59-62; Sawynok, J., Adenosine receptor activation and nociception (1998) Eur. J. Pharmacol., 347, pp. 1-11; Trussell, L.O., Jackson, M.B., Adenosine-activated potassium conductance in cultured striatal neurons (1985) Proc. Natl. Acad. Sci. U. S. A., 82, pp. 4857-4861; Vincenzi, F., Corciulo, C., Targa, M., Casetta, I., Gentile, M., Granieri, E., Borea, P.A., Varani, K., A2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients (2013) Amyotroph. Lateral Scler Frontotemporal Degener., 14, pp. 406-413; Xu, K., Bastia, E., Schwarzschild, M., Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease (2005) Pharmacol. Ther., 105, pp. 267-310; Yamanaka, K., Chun, S.J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D.H., Takahashi, R., Cleveland, D.W., Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis (2008) Nat. Neurosci., 11, pp. 251-253; Yang, Y., Vidensky, S., Jin, L., Jie, C., Lorenzini, I., Frankl, M., Rothstein, J.D., Molecular comparison of GLT1+ and ALDH1L1+ astrocytes in vivo in astroglial reporter mice (2011) Glia, 59, pp. 200-207; Yoshida, Y., Une, F., Utatsu, Y., Nomoto, M., Furukawa, Y., Maruyama, Y., Machigashira, N., Osame, M., Adenosine and neopterin levels in cerebrospinal fluid of patients with neurological disorders (1999) Intern. Med., 38, pp. 133-139; Zhai, J., Zhou, W., Li, J., Hayworth, C.R., Zhang, L., Misawa, H., Klein, R., Kalb, R.G., The in vivo contribution of motor neuron TrkB receptors to mutant SOD1 motor neuron disease (2011) Hum. Mol. Genet., 20, pp. 4116-4131",Article,Scopus,2-s2.0-84924956494
"Lin X., Zhong M.-L., Li M., Li L.-H., Yin Q.-S., Zhang Y., Ning C.-Y.","Effects of different lengths of Ti nanorods topography on mesenchymal stem cell growth and proliferation",2015,"Journal of Nanoscience and Nanotechnology","15","5",,"3893","3899",,1,10.1166/jnn.2015.9275,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84920749631&partnerID=40&md5=8593700364c1cdc83abacb212a919ee1","Southern Medical UniversityGuangzhou, Guangdong, China; Department of Orthopedics, Liu Hua Qiao HospitalGuangzhou, Guangdong, China; School of Materials Science and Engineering, South China University of TechnologyGuangzhou, China","Lin, X., Southern Medical UniversityGuangzhou, Guangdong, China; Zhong, M.-L., School of Materials Science and Engineering, South China University of TechnologyGuangzhou, China; Li, M., Department of Orthopedics, Liu Hua Qiao HospitalGuangzhou, Guangdong, China; Li, L.-H., Department of Orthopedics, Liu Hua Qiao HospitalGuangzhou, Guangdong, China; Yin, Q.-S., Department of Orthopedics, Liu Hua Qiao HospitalGuangzhou, Guangdong, China; Zhang, Y., Department of Orthopedics, Liu Hua Qiao HospitalGuangzhou, Guangdong, China; Ning, C.-Y., School of Materials Science and Engineering, South China University of TechnologyGuangzhou, China","Total hip and knee arthroplasty have being successfully performed in world-wide in recent years. However, poor osseointegration between implant (polish surface) and host bone tissue is one of the main causes for aseptic loosening in Ti-based materials and result in failure. Fabricating nanotopography is a promising method to improve cell behaviors and promote osseointegration. Ti nanorods array of vary lengths have been produced via selective corrosion of Ti substrate using electrochemical anodization technique on titanium surface. In this study, we investigated the murine bone mesenchymal stem cell (MSC) behaviors in response to these different lengths of nanorods. The result showed that the nanorod of 100 nm length increased MSCs adhesion and proliferation. Increased elongation of cytoskeleton actin was also observed on 100 nm height, which resulted in substantially up-regulation of alkaline phosphatase (ALP) activity, suggesting greater bone-forming ability than control Ti. The Ti nanorods of 100 nm length may be a promising implant surface to improve the osseointegration. © 2015 American Scientific Publishers All rights reserved Printed in the United States of America.","MSC; Nanorod; Nanostructure; Titanium","Durmus, N.G., Webster, T.J., (2012) Nanomedicine (Lond.), 7, p. 791; Prokopetz, J.J., Losina, E., Bliss, R.L., Wright, J., Baron, J.A., Katz, J.N., (2012) BMC Musculoskelet Disord., 13, p. 251; Sundfeldt, M., Carlsson, L.V., Johansson, C.B., Thomsen, P., Gretzer, C., (2006) Acta Orthop., 77, p. 177; Yadav, S.K., Khan, Z.A., Mishra, B., (2013) Rev. Nanosci. Nanotechnol., 2, p. 127; Kim, J.U., Jeong, Y.H., Choe, H.C., (2013) J. Nanosci. Nanotechnol., 13, p. 1876; Christensen, S.L., Padoms, J.D., Chatt, A., Zhang, P., (2013) Rev. Nanosci. Nanotechnol., 2, p. 63; Dalby, M.J., Riehle, M.O., Yarwood, S.J., Wikinson, C.D., Curtis, A.S., (2003) Exp. Cell. Res., 284, p. 274; Cavalcanti-Adam, E.A., Micoulet, A., Blümmel, J., Auernheimer, J., Kessler, H., Spatz, J.P., (2006) Eur. J. Cell Biol., 85, p. 219; Dalby, M.J., Giannaras, D., Riehle, M.O., Gadegaard, N., Affrossman, S., Curtis, A.S., (2004) Biomaterials, 25, p. 77; Dalby, M.J., Riehle, M.O., Johnstone, H.J., Affrossman, S., Curtis, A.S., (2002) Tissue. Eng., 8, p. 1099; Chen, C.C., Fang, D., Luo, Z.P., (2012) Rev. Nanosci. Nanotechnol., 1, p. 229; Huang, S.S., Ning, C.Y., Peng, W.T., Huang, D., (2012) Electrochem. Commun., 17, p. 14; Allen, M.J., (2003) Vet. Clin. Pathol., 32, p. 101; Heidi, A., Ronald, M., Leo, I., Etienne, H., Maria, J., (2005) Biomaterials, 26, p. 4964; Webster, T.J., Erqun, C., Doremus, R.H., Sieqel, R.W., Bizios, R., (2000) Biomaterials, 21, p. 1803; Zhao, L., Mei, S., Wang, W., Chu, P.K., Wu, Z., Zhang, Y., (2010) Biomaterials, 31, p. 2055; Wang, M., Castro, J.N., Li, J., Keidar, M., Zhang, G.L., (2012) J. Nanosci. Nanotechnol., 12, p. 1; Yang, S.W., Lee, K., Kim, B.H., (2013) J. Nanosci. Nanotechnol., 13, p. 698; Wojciak-Stothard, B., Madeja, Z., Korohoda, W., Curtis, A.S., Wilkinson, C.D., (1995) Cell Biol. Int., 19, p. 485; Dalby, M.J., Kayser, M.V., Bonfield, W., Disilvio, L., (2002) Biomaterials, 23, p. 681; Xu, L.P., Pan, F., Yu, G.N., Yang, L., Zhang, E.L., Yang, K., (2009) Biomaterials, 30, p. 1512; Oh, S.H., Finones, R.R., Daraio, C., Chen, L.H., Jin, S., (2005) Biomaterials, 26, p. 4938; Popat, K.C., Chatvanichkul, K.L., Barnes, G.L., Latempa, T.J., Grimes, C.A., Desai, T.A., (2006) J. Biomed. Mater. Res. A, 80, p. 955; Oh, S., Daraio, C., Chen, L.H., Pisanic, T.R., Fiñones, R.R., Jin, S., (2006) J. Biomed. Mater. Res. A, 78, p. 97; Oh, S., Jin, S., (2006) Mater. Sci. Eng. C, 26, p. 1301; Anselme, K., (2000) Biomaterials, 21, p. 667; Ide, N., Lau, B.H., (2001) J. Nutr., 131, p. 1020s; Sjöström, T., Dalby, M.J., Hart, A., Tare, R., Oreffo, R.O., Su, B., (2009) Acta Biomater., 5, p. 1433; Oh, S., Brammer, K.S., Li, J.Y., Teng, D., Engler, A.J., Chien, S., Jin, S., (2009) Proc. Natl. Acad. Sci. USA, 106, p. E61; Mcnamara, L.E., Mcmurray, R.J., Biggs, M.J., Kantawong, F., Oreffo, R.O., Dalby, M.J., (2010) J. Tissue. Eng., 2010, p. 1; Anselme, K., Davidson, P., Popa, A.M., Giazzon, M., Liley, M., Ploux, L., (2010) Acta Biomater., 6, p. 3824",Article,Scopus,2-s2.0-84920749631
"Yang C., Jin K., Tong Y., Cho W.C.","Therapeutic potential of cancer stem cells",2015,"Medical Oncology","32","6",,"","",10,,10.1007/s12032-015-0619-6,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928685888&partnerID=40&md5=b5ba7e9e5500947d0225362cdfb9cad3","Department of Otorhinolaryngology, Head and Neck Surgery, Xiangya Hospital, Central South UniversityChangsha, Hunan, China; Department of Pharmacology and Neuroscience, University of North Texas Health Science CenterFort Worth, TX, United States; Department of Neurology, Changsha Central HospitalChangsha, Hunan, China; Department of Clinical Oncology, Queen Elizabeth HospitalKowloon, Hong Kong","Yang, C., Department of Otorhinolaryngology, Head and Neck Surgery, Xiangya Hospital, Central South UniversityChangsha, Hunan, China; Jin, K., Department of Pharmacology and Neuroscience, University of North Texas Health Science CenterFort Worth, TX, United States; Tong, Y., Department of Neurology, Changsha Central HospitalChangsha, Hunan, China; Cho, W.C., Department of Clinical Oncology, Queen Elizabeth HospitalKowloon, Hong Kong","Cancer stem cells (CSCs) play an important role in cancer growth, self-renewal, metastasis, recurrence and radio/chemotherapy. However, the underlying mechanisms remain elusive. In this review, we explore the roles of CSCs in cancer’s relapse and progression and discuss the biomarkers of CSCs to predict clinical outcome and their diagnostic potential. The different approaches of CSC therapies are also reviewed, including cytotoxic, radiation, differentiation and targeting signaling pathways. We also discuss the challenge of targeting CSCs in cancer therapy. In addition, non-coding RNAs in CSC therapies are also discussed. © 2015, Springer Science+Business Media New York.","Cancer stem cells; Epithelial–mesenchymal transition; Signaling pathway; Therapeutics","Huang, E.H., Hynes, M.J., Zhang, T., Ginestier, C., Dontu, G., Appelman, H., Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis (2009) Cancer Res, 69 (8), pp. 3382-3389. , COI: 1:CAS:528:DC%2BD1MXksV2hsb0%3D, PID: 19336570; Bonnet, D., Dick, J.E., Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell (1997) Nat Med, 3 (7), pp. 730-737. , COI: 1:CAS:528:DyaK2sXkt1GrtLY%3D, PID: 9212098; Zhang, S., Balch, C., Chan, M.W., Lai, H.C., Matei, D., Schilder, J.M., Identification and characterization of ovarian cancer-initiating cells from primary human tumors (2008) Cancer Res, 68 (11), pp. 4311-4320. , COI: 1:CAS:528:DC%2BD1cXmsFKmuro%3D, PID: 18519691; Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Identification of human brain tumour initiating cells (2004) Nature, 432 (7015), pp. 396-401. , COI: 1:CAS:528:DC%2BD2cXpvVCjtbY%3D, PID: 15549107; Li, C., Heidt, D.G., Dalerba, P., Burant, C.F., Zhang, L., Adsay, V., Identification of pancreatic cancer stem cells (2007) Cancer Res, 67 (3), pp. 1030-1037. , COI: 1:CAS:528:DC%2BD2sXht1yns70%3D, PID: 17283135; Ginestier, C., Hur, M.H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome (2007) Cell Stem Cell, 1 (5), pp. 555-567. , COI: 1:CAS:528:DC%2BD2sXhsVahtrvF, PID: 18371393; Qin, J., Liu, X., Laffin, B., Chen, X., Choy, G., Jeter, C.R., The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration (2012) Cell Stem Cell, 10 (5), pp. 556-569. , COI: 1:CAS:528:DC%2BC38Xms12ms70%3D, PID: 22560078; Yang, Z.F., Ngai, P., Ho, D.W., Yu, W.C., Ng, M.N., Lau, C.K., Identification of local and circulating cancer stem cells in human liver cancer (2008) Hepatology, 47 (3), pp. 919-928. , COI: 1:CAS:528:DC%2BD1cXktVOhs7w%3D, PID: 18275073; Oonishi, K., Cui, X., Hirakawa, H., Fujimori, A., Kamijo, T., Yamada, S., Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells (2012) Radiother Oncol, 105 (2), pp. 258-265. , COI: 1:CAS:528:DC%2BC38XhvVCrsr7O, PID: 23017870; Xue, Z., Yan, H., Li, J., Liang, S., Cai, X., Chen, X., Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line (2012) J Cell Biochem, 113 (1), pp. 302-312. , COI: 1:CAS:528:DC%2BC3MXhs1Cgt73O, PID: 21913215; Adikrisna, R., Tanaka, S., Muramatsu, S., Aihara, A., Ban, D., Ochiai, T., Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents (2012) Gastroenterology, 143 (1), pp. 234-245. , COI: 1:CAS:528:DC%2BC38XptFansbc%3D, PID: 22510202; Fan, X., Khaki, L., Zhu, T.S., Soules, M.E., Talsma, C.E., Gul, N., NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts (2010) Stem Cells (Dayton, Ohio), 28 (1), pp. 5-16. , COI: 1:CAS:528:DC%2BC3cXis1WqsLY%3D; Chang, W.W., Lin, R.J., Yu, J., Chang, W.Y., Fu, C.H., Lai, A.C., The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stemprogenitors (2013) Breast Cancer Res BCR, 15 (3), p. 39. , COI: 1:CAS:528:DC%2BC3sXhtVGqtb%2FO; Suva, M.L., Rheinbay, E., Gillespie, S.M., Patel, A.P., Wakimoto, H., Rabkin, S.D., Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells (2014) Cell, 157 (3), pp. 580-594. , COI: 1:CAS:528:DC%2BC2cXmtVClurw%3D, PID: 24726434; Chan, C.H., Morrow, J.K., Li, C.F., Gao, Y., Jin, G., Moten, A., Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression (2013) Cell, 154 (3), pp. 556-568. , COI: 1:CAS:528:DC%2BC3sXht1WkurvI, PID: 23911321; Metellus, P., Nanni-Metellus, I., Delfino, C., Colin, C., Tchogandjian, A., Coulibaly, B., Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution (2011) Ann Surg Oncol, 18 (10), pp. 2937-2945. , PID: 21479688; Giampieri, R., Scartozzi, M., Loretelli, C., Piva, F., Mandolesi, A., Lezoche, G., Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients (2013) PLoS One, 8 (9), p. 72843. , COI: 1:CAS:528:DC%2BC3sXhsVCrsrfM, PID: 24023782; Artells, R., Moreno, I., Diaz, T., Martinez, F., Gel, B., Navarro, A., Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients (2010) Eur J Cancer, 46 (3), pp. 642-649. , COI: 1:CAS:528:DC%2BC3cXhtlWrs7w%3D, PID: 20005089; Gottschling, S., Jensen, K., Warth, A., Herth, F.J., Thomas, M., Schnabel, P.A., Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer and associated with poor prognosis (2013) Eur Respir J, 41 (3), pp. 656-663. , COI: 1:CAS:528:DC%2BC3sXlsVCitLo%3D, PID: 22743677; Liu, Z., Li, Q., Li, K., Chen, L., Li, W., Hou, M., Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells (2013) Oncogene, 32 (36), pp. 4203-4213. , COI: 1:CAS:528:DC%2BC38XhsVKks7bP, PID: 23045275; Mustjoki, S., Richter, J., Barbany, G., Ehrencrona, H., Fioretos, T., Gedde-Dahl, T., Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients (2013) Leukemia, 27 (7), pp. 1520-1526. , COI: 1:CAS:528:DC%2BC3sXhtFSiu7vE, PID: 23328954; Pollard, S.M., Yoshikawa, K., Clarke, I.D., Danovi, D., Stricker, S., Russell, R., Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens (2009) Cell Stem Cell, 4 (6), pp. 568-580. , COI: 1:CAS:528:DC%2BD1MXnt1Ggtbg%3D, PID: 19497285; Zhao, X., Zhao, Y.J., Lin, Q., Yu, L., Liu, Z., Lindsay, H., Cytogenetic landscape of paired neurospheres and traditional monolayer cultures in pediatric malignant brain tumors (2014) Neuro-oncology; Pece, S., Tosoni, D., Confalonieri, S., Mazzarol, G., Vecchi, M., Ronzoni, S., Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content (2010) Cell, 140 (1), pp. 62-73. , COI: 1:CAS:528:DC%2BC3cXkvVWiur0%3D, PID: 20074520; Choi, J.W., Kim, J.K., Choi, M., Kim, Y.R., Yun, S.H., In vivo imaging of Lgr5-positive cell populations using confocal laser endomicroscopy during early colon tumorigenesis (2014) Endoscopy, 46 (12), pp. 1110-1116. , PID: 25216325; Yilmaz, O.H., Valdez, R., Theisen, B.K., Guo, W., Ferguson, D.O., Wu, H., Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells (2006) Nature, 441 (7092), pp. 475-482. , COI: 1:CAS:528:DC%2BD28XkvVykurY%3D, PID: 16598206; Sachlos, E., Risueno, R.M., Laronde, S., Shapovalova, Z., Lee, J.H., Russell, J., Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells (2012) Cell, 149 (6), pp. 1284-1297. , COI: 1:CAS:528:DC%2BC38XnslSisb0%3D, PID: 22632761; Grimm, M., Krimmel, M., Polligkeit, J., Alexander, D., Munz, A., Kluba, S., ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma (2012) Eur J Cancer, 48 (17), pp. 3186-3197. , COI: 1:CAS:528:DC%2BC38XpvFOqtr0%3D, PID: 22784549; Frank, N.Y., Margaryan, A., Huang, Y., Schatton, T., Waaga-Gasser, A.M., Gasser, M., ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma (2005) Cancer Res, 65 (10), pp. 4320-4333. , COI: 1:CAS:528:DC%2BD2MXktlSmt7Y%3D, PID: 15899824; Wurth, R., Pattarozzi, A., Gatti, M., Bajetto, A., Corsaro, A., Parodi, A., Metformin selectively affects human glioblastoma tumor-initiating cell viability: a role for metformin-induced inhibition of Akt (2013) Cell Cycle (Georgetown, Tex), 12 (1), pp. 145-156. , COI: 1:CAS:528:DC%2BC3sXisVKrsbo%3D; Guzman, M.L., Li, X., Corbett, C.A., Rossi, R.M., Bushnell, T., Liesveld, J.L., Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8) (2007) Blood, 110 (13), pp. 4436-4444. , COI: 1:CAS:528:DC%2BD1cXot1Wn, PID: 17785584; Bao, S., Wu, Q., McLendon, R.E., Hao, Y., Shi, Q., Hjelmeland, A.B., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response (2006) Nature, 444 (7120), pp. 756-760. , COI: 1:CAS:528:DC%2BD28Xht1OntbzP, PID: 17051156; Xu, Y., Stamenkovic, I., Yu, Q., CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma (2010) Cancer Res, 70 (6), pp. 2455-2464. , COI: 1:CAS:528:DC%2BC3cXjtFygtb0%3D, PID: 20197461; Androutsellis-Theotokis, A., Leker, R.R., Soldner, F., Hoeppner, D.J., Ravin, R., Poser, S.W., Notch signalling regulates stem cell numbers in vitro and in vivo (2006) Nature, 442 (7104), pp. 823-826. , COI: 1:CAS:528:DC%2BD28XotFKmsLs%3D, PID: 16799564; Kwon, C., Cheng, P., King, I.N., Andersen, P., Shenje, L., Nigam, V., Notch post-translationally regulates beta-catenin protein in stem and progenitor cells (2011) Nat Cell Biol, 13 (10), pp. 1244-1251. , COI: 1:CAS:528:DC%2BC3MXhtFylsLvO, PID: 21841793; Wang, S., Sdrulla, A.D., diSibio, G., Bush, G., Nofziger, D., Hicks, C., Notch receptor activation inhibits oligodendrocyte differentiation (1998) Neuron, 21 (1), pp. 63-75. , PID: 9697852; Nicolas, M., Wolfer, A., Raj, K., Kummer, J.A., Mill, P., van Noort, M., Notch1 functions as a tumor suppressor in mouse skin (2003) Nat Genet, 33 (3), pp. 416-421. , COI: 1:CAS:528:DC%2BD3sXhsV2kurs%3D, PID: 12590261; Tonon, G., Modi, S., Wu, L., Kubo, A., Coxon, A.B., Komiya, T., t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway (2003) Nat Genet, 33 (2), pp. 208-213. , COI: 1:CAS:528:DC%2BD3sXnsFSkug%3D%3D, PID: 12539049; Pannuti, A., Foreman, K., Rizzo, P., Osipo, C., Golde, T., Osborne, B., Targeting notch to target cancer stem cells (2010) Clin Cancer Res, 16 (12), pp. 3141-3152. , COI: 1:CAS:528:DC%2BC3cXntlKru70%3D, PID: 20530696; Hovinga, K.E., Shimizu, F., Wang, R., Panagiotakos, G., Van Der Heijden, M., Moayedpardazi, H., Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate (2010) Stem Cells (Dayton, Ohio), 28 (6), pp. 1019-1029. , COI: 1:CAS:528:DC%2BC3cXptlWlt70%3D; Wang, J., Wakeman, T.P., Lathia, J.D., Hjelmeland, A.B., Wang, X.F., White, R.R., Notch promotes radioresistance of glioma stem cells (2010) Stem Cells (Dayton, Ohio), 28 (1), pp. 17-28. , COI: 1:CAS:528:DC%2BC3cXis1Wqsb8%3D; Huelsken, J., Vogel, R., Erdmann, B., Cotsarelis, G., Birchmeier, W., Beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin (2001) Cell, 105 (4), pp. 533-545. , COI: 1:CAS:528:DC%2BD3MXksFektLg%3D, PID: 11371349; MacDonald, B.T., Tamai, K., He, X., Wnt/beta-catenin signaling: components, mechanisms, and diseases (2009) Dev Cell, 17 (1), pp. 9-26. , COI: 1:CAS:528:DC%2BD1MXpsV2msb8%3D, PID: 19619488; Willert, K., Brown, J.D., Danenberg, E., Duncan, A.W., Weissman, I.L., Reya, T., Wnt proteins are lipid-modified and can act as stem cell growth factors (2003) Nature, 423 (6938), pp. 448-452. , COI: 1:CAS:528:DC%2BD3sXjvFalt7c%3D, PID: 12717451; Greco, V., Chen, T., Rendl, M., Schober, M., Pasolli, H.A., Stokes, N., A two-step mechanism for stem cell activation during hair regeneration (2009) Cell Stem Cell, 4 (2), pp. 155-169. , COI: 1:CAS:528:DC%2BD1MXitFSjtLY%3D, PID: 19200804; Sokol, S.Y., Maintaining embryonic stem cell pluripotency with Wnt signaling (2011) Development, 138 (20), pp. 4341-4350. , COI: 1:CAS:528:DC%2BC3MXhsV2nt7nK, PID: 21903672; Polakis, P., The many ways of Wnt in cancer (2007) Curr Opin Genet Dev, 17 (1), pp. 45-51. , COI: 1:CAS:528:DC%2BD2sXnslOnsw%3D%3D, PID: 17208432; Fearon, E.R., PARsing the phrase “all in for Axin”-Wnt pathway targets in cancer (2009) Cancer Cell, 16 (5), pp. 366-368. , COI: 1:CAS:528:DC%2BD1MXhsFKltbzL, PID: 19878868; Barker, N., Clevers, H., Mining the Wnt pathway for cancer therapeutics (2006) Nat Rev Drug Discov, 5 (12), pp. 997-1014. , COI: 1:CAS:528:DC%2BD28Xht1Kju7vK, PID: 17139285; Fodde, R., Brabletz, T., Wnt/beta-catenin signaling in cancer stemness and malignant behavior (2007) Curr Opin Cell Biol, 19 (2), pp. 150-158. , COI: 1:CAS:528:DC%2BD2sXjt1Slu7s%3D, PID: 17306971; Arend, R.C., Londono-Joshi, A.I., Straughn, J.M., Jr., Buchsbaum, D.J., The Wnt/beta-catenin pathway in ovarian cancer: a review (2013) Gynecol Oncol, 131 (3), pp. 772-779. , COI: 1:CAS:528:DC%2BC3sXhs1Ortb7F, PID: 24125749; Mao, J., Fan, S., Ma, W., Fan, P., Wang, B., Zhang, J., Roles of Wnt/beta-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment (2014) Cell Death Dis, 5, p. 1039. , COI: 1:CAS:528:DC%2BC2cXhsl2gsL0%3D, PID: 24481453; Xia, H., Cheung, W.K., Sze, J., Lu, G., Jiang, S., Yao, H., miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling (2010) J Biol Chem, 285 (47), pp. 36995-37004. , COI: 1:CAS:528:DC%2BC3cXhsVWgsrnI, PID: 20826811; Han, M., Liu, M., Wang, Y., Chen, X., Xu, J., Sun, Y., Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN (2012) PLoS One, 7 (6), p. 39520. , COI: 1:CAS:528:DC%2BC38XpsFyitbw%3D, PID: 22761812; Li, J., Zhou, B.P., Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters (2011) BMC Cancer, 11, p. 49. , PID: 21284870; Vlahos, C.J., Matter, W.F., Hui, K.Y., Brown, R.F., A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) (1994) J Biol Chem, 269 (7), pp. 5241-5248. , COI: 1:CAS:528:DyaK2cXjtFGit78%3D, PID: 8106507; Palomero, T., Sulis, M.L., Cortina, M., Real, P.J., Barnes, K., Ciofani, M., Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia (2007) Nat Med, 13 (10), pp. 1203-1210. , COI: 1:CAS:528:DC%2BD2sXhtFagsb3F, PID: 17873882; Trinh, X.B., Tjalma, W.A., Vermeulen, P.B., Van den Eynden, G., Van der Auwera, I., Van Laere, S.J., The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer (2009) Br J Cancer, 100 (6), pp. 971-978. , COI: 1:CAS:528:DC%2BD1MXjt1Gjsbk%3D, PID: 19240722; Wang, J., Lu, Y., Koch, A.E., Zhang, J., Taichman, R.S., CXCR6 induces prostate cancer progression by the AKT mammalian target of rapamycin signaling pathway (2008) Cancer Res, 68 (24), pp. 10367-10376. , COI: 1:CAS:528:DC%2BD1cXhsV2itLzM, PID: 19074906; Chen, B., Xue, Z., Yang, G., Shi, B., Yang, B., Yan, Y., Akt-signal integration is involved in the differentiation of embryonal carcinoma cells (2013) PLoS One, 8 (6), p. 64877. , COI: 1:CAS:528:DC%2BC3sXpvFKhs70%3D, PID: 23762260; Aldaz, B., Sagardoy, A., Nogueira, L., Guruceaga, E., Grande, L., Huse, J.T., Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells (2013) PLoS One, 8 (10), p. 77098. , COI: 1:CAS:528:DC%2BC3sXhs1KiurvL, PID: 24155920; Rampazzo, E., Persano, L., Pistollato, F., Moro, E., Frasson, C., Porazzi, P., Wnt activation promotes neuronal differentiation of glioblastoma (2013) Cell Death Dis, 4, p. 500. , COI: 1:CAS:528:DC%2BC3sXhtVyrsrrP, PID: 23429286; He, J., Liu, Y., Zhu, T., Zhu, J., Dimeco, F., Vescovi, A.L., CD90 is identified as a marker for cancer stem cells in primary high-grade gliomas using tissue microarrays (2012) Mol Cell Proteomics MCP, 11 (6), p. 111 010744; Gupta, P.B., Onder, T.T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R.A., Identification of selective inhibitors of cancer stem cells by high-throughput screening (2009) Cell, 138 (4), pp. 645-659. , COI: 1:CAS:528:DC%2BD1MXhsVCjs73E, PID: 19682730; Campos, B., Wan, F., Farhadi, M., Ernst, A., Zeppernick, F., Tagscherer, K.E., Differentiation therapy exerts antitumor effects on stem-like glioma cells (2010) Clin Cancer Res, 16 (10), pp. 2715-2728. , COI: 1:CAS:528:DC%2BC3cXlvF2iu7o%3D, PID: 20442299; Azzi, S., Bruno, S., Giron-Michel, J., Clay, D., Devocelle, A., Croce, M., Differentiation therapy: targeting human renal cancer stem cells with interleukin 15 (2011) J Natl Cancer Inst, 103 (24), pp. 1884-1898. , COI: 1:CAS:528:DC%2BC3MXhs12ht7fK, PID: 22043039; Kugel, J.F., Goodrich, J.A., Non-coding RNAs: key regulators of mammalian transcription (2012) Trends Biochem Sci, 37 (4), pp. 144-151. , COI: 1:CAS:528:DC%2BC38XlsFGgsrc%3D, PID: 22300815; Tsai, M.C., Spitale, R.C., Chang, H.Y., Long intergenic noncoding RNAs: new links in cancer progression (2011) Cancer Res, 71 (1), pp. 3-7. , COI: 1:CAS:528:DC%2BC3MXovF2l, PID: 21199792; Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., let-7 regulates self renewal and tumorigenicity of breast cancer cells (2007) Cell, 131 (6), pp. 1109-1123. , COI: 1:CAS:528:DC%2BD1cXksFGgtQ%3D%3D, PID: 18083101; Shimono, Y., Zabala, M., Cho, R.W., Lobo, N., Dalerba, P., Qian, D., Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells (2009) Cell, 138 (3), pp. 592-603. , COI: 1:CAS:528:DC%2BD1MXhsVChs7bP, PID: 19665978; Song, S.J., Poliseno, L., Song, M.S., Ala, U., Webster, K., Ng, C., MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling (2013) Cell, 154 (2), pp. 311-324. , COI: 1:CAS:528:DC%2BC3sXhtVGrtb3F, PID: 23830207; Song, S.J., Ito, K., Ala, U., Kats, L., Webster, K., Sun, S.M., The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation (2013) Cell Stem Cell, 13 (1), pp. 87-101. , COI: 1:CAS:528:DC%2BC3sXhtVGrsrfO, PID: 23827711; Hwang, W.L., Jiang, J.K., Yang, S.H., Huang, T.S., Lan, H.Y., Teng, H.W., MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells (2014) Nat Cell Biol, 16 (3), pp. 268-280. , COI: 1:CAS:528:DC%2BC2cXivFamsbY%3D, PID: 24561623; Cui, T.X., Kryczek, I., Zhao, L., Zhao, E., Kuick, R., Roh, M.H., Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2 (2013) Immunity, 39 (3), pp. 611-621. , COI: 1:CAS:528:DC%2BC3sXhtl2ksbzO, PID: 24012420; Chang, C.J., Chao, C.H., Xia, W., Yang, J.Y., Xiong, Y., Li, C.W., p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs (2011) Nat Cell Biol, 13 (3), pp. 317-323. , COI: 1:CAS:528:DC%2BC3MXisFKntrg%3D, PID: 21336307; Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M.J., Kenzelmann-Broz, D., A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response (2010) Cell, 142 (3), pp. 409-419. , COI: 1:CAS:528:DC%2BC3cXpvFKrtrg%3D, PID: 20673990; Loewer, S., Cabili, M.N., Guttman, M., Loh, Y.H., Thomas, K., Park, I.H., Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells (2010) Nat Genet, 42 (12), pp. 1113-1117. , COI: 1:CAS:528:DC%2BC3cXhtl2jsbzE, PID: 21057500; Gupta, R.A., Shah, N., Wang, K.C., Kim, J., Horlings, H.M., Wong, D.J., Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis (2010) Nature, 464 (7291), pp. 1071-1076. , COI: 1:CAS:528:DC%2BC3cXkslaru7w%3D, PID: 20393566; Sun, M., Liu, X.H., Wang, K.M., Nie, F.Q., Kong, R., Yang, J.S., Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition (2014) Molecular cancer., 13, p. 68. , PID: 24655544; Luo, M., Li, Z., Wang, W., Zeng, Y., Liu, Z., Qiu, J., Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression (2013) Cancer Lett, 333 (2), pp. 213-221. , COI: 1:CAS:528:DC%2BC3sXisVSqtLg%3D, PID: 23354591; Bolton-Gillespie, E., Schemionek, M., Klein, H.U., Flis, S., Hoser, G., Lange, T., Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells (2013) Blood, 121 (20), pp. 4175-4183. , COI: 1:CAS:528:DC%2BC3sXot1Kjt7g%3D, PID: 23543457; Nieborowska-Skorska, M., Kopinski, P.K., Ray, R., Hoser, G., Ngaba, D., Flis, S., Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors (2012) Blood, 119 (18), pp. 4253-4263. , COI: 1:CAS:528:DC%2BC38XmvV2rt74%3D, PID: 22411871; de Sousa, E.M.F., Colak, S., Buikhuisen, J., Koster, J., Cameron, K., de Jong, J.H., Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients (2011) Cell Stem Cell, 9 (5), pp. 476-485; Peter, M.E., Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression (2009) Cell Cycle (Georgetown, Tex), 8 (6), pp. 843-852. , COI: 1:CAS:528:DC%2BD1MXlvFWis7k%3D; Yang, X., Lin, X., Zhong, X., Kaur, S., Li, N., Liang, S., Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells (2010) Cancer Res, 70 (22), pp. 9463-9472. , COI: 1:CAS:528:DC%2BC3cXhsVWmsLnF, PID: 21045151; Kong, D., Heath, E., Chen, W., Cher, M.L., Powell, I., Heilbrun, L., Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM (2012) PLoS One, 7 (3), p. 33729. , COI: 1:CAS:528:DC%2BC38XkvVyitb8%3D, PID: 22442719; Dillman, R.O., Cornforth, A.N., Depriest, C., McClay, E.F., Amatruda, T.T., de Leon, C., Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanoma (2012) J Immunother, 35 (8), pp. 641-649. , PID: 22996370; Kreso, A., van Galen, P., Pedley, N.M., Lima-Fernandes, E., Frelin, C., Davis, T., Self-renewal as a therapeutic target in human colorectal cancer (2014) Nat Med, 20 (1), pp. 29-36. , COI: 1:CAS:528:DC%2BC3sXhvVGqs7rJ, PID: 24292392; Curry, J.M., Tuluc, M., Whitaker-Menezes, D., Ames, J.A., Anantharaman, A., Butera, A., Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer (2013) Cell Cycle (Georgetown, Tex), 12 (9), pp. 1371-1384. , COI: 1:CAS:528:DC%2BC3sXovFelsrg%3D; Le, X.F., Arachchige-Don, A.S., Mao, W., Horne, M.C., Bast, R.C., Jr., Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells (2007) Mol Cancer Ther, 6 (11), pp. 2843-2857. , COI: 1:CAS:528:DC%2BD2sXhtlWkt7nP, PID: 18025271; Yang, C., Peng, J., Jiang, W., Zhang, Y., Chen, X., Wu, X., mTOR activation in immature cells of primary nasopharyngeal carcinoma and anti-tumor effect of rapamycin in vitro and in vivo (2013) Cancer Lett, 341 (2), pp. 186-194. , COI: 1:CAS:528:DC%2BC3sXhtlCgt77M, PID: 23933173; Kemper, K., Prasetyanti, P.R., De Lau, W., Rodermond, H., Clevers, H., Medema, J.P., Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells (2012) Stem Cells (Dayton, Ohio), 30 (11), pp. 2378-2386. , COI: 1:CAS:528:DC%2BC38XhvVWgsbnO; Lacy, M.Q., Alsina, M., Fonseca, R., Paccagnella, M.L., Melvin, C.L., Yin, D., Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 Receptor monoclonal antibody CP-751,871 in patients with multiple myeloma (2008) J Clin Oncol, 26 (19), pp. 3196-3203. , COI: 1:CAS:528:DC%2BD1cXptlKgtb8%3D, PID: 18474873; Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation (2011) Cell, 144 (5), pp. 646-674. , COI: 1:CAS:528:DC%2BC3MXjsFeqtrk%3D, PID: 21376230; Lonardo, E., Frias-Aldeguer, J., Hermann, P.C., Heeschen, C., Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness (2012) Cell Cycle (Georgetown, Tex), 11 (7), pp. 1282-1290. , COI: 1:CAS:528:DC%2BC38XnsVSqsrY%3D; Calabrese, C., Poppleton, H., Kocak, M., Hogg, T.L., Fuller, C., Hamner, B., A perivascular niche for brain tumor stem cells (2007) Cancer Cell, 11 (1), pp. 69-82. , COI: 1:CAS:528:DC%2BD2sXhtFClsLY%3D, PID: 17222791; Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., Kirchner, T., Opinion: migrating cancer stem cells—an integrated concept of malignant tumour progression (2005) Nat Rev Cancer, 5 (9), pp. 744-749. , COI: 1:CAS:528:DC%2BD2MXpsleksLw%3D, PID: 16148886; Yu, X., Jiang, X., Li, H., Guo, L., Jiang, W., Lu, S.H., miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1 (2014) Stem Cells Dev, 23 (6), pp. 576-585. , COI: 1:CAS:528:DC%2BC2cXjsFGntrg%3D, PID: 24219349; Park, S.M., Gaur, A.B., Lengyel, E., Peter, M.E., The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 (2008) Genes Dev, 22 (7), pp. 894-907. , COI: 1:CAS:528:DC%2BD1cXksVGktL4%3D, PID: 18381893; Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells (2008) EMBO Rep, 9 (6), pp. 582-589. , COI: 1:CAS:528:DC%2BD1cXmsFykt7Y%3D, PID: 18483486",Review,Scopus,2-s2.0-84928685888
"Signolet J., Hendrich B.","The function of chromatin modifiers in lineage commitment and cell fate specification",2015,"FEBS Journal","282","9",,"1692","1702",,1,10.1111/febs.13132,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928485442&partnerID=40&md5=dce6a24f430ce75a9775805e2d0fd010","Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of CambridgeCambridge, United Kingdom; Department of Biochemistry, University of Cambridge, United Kingdom","Signolet, J., Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of CambridgeCambridge, United Kingdom; Hendrich, B., Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of CambridgeCambridge, United Kingdom, Department of Biochemistry, University of Cambridge, United Kingdom","Proteins that modify the structure of chromatin are known to be important for various aspects of metazoan biology including development, disease and possibly ageing. Yet functional details of why these proteins are important, i.e. how their action influences a given biological process, are lacking. While it is now possible to describe the biochemistry of how these proteins remodel chromatin, their chromatin binding profiles in cell lines, or gene expression changes upon loss of a given protein, in very few cases has this easily translated into an understanding of how the function of that protein actually influences a developmental process. Given that many chromatin modifying proteins will largely exert their influence through control of gene expression, it is useful to consider developmental processes as changes in the gene regulatory network (GRN), with each cell type exhibiting a unique gene expression profile. In this essay we consider the impact of two abundant and highly conserved chromatin modifying complexes, namely the nucleosome remodelling and deacetylation (NuRD) complex and the polycomb repressive complex 2 (PRC2), on the change in GRNs associated with lineage commitment during early mammalian development. We propose that while the NuRD complex limits the stability of cell states and defines the developmental trajectory between two stable states, PRC2 activity is important for stabilizing a new GRN once established. Although these two complexes display different biochemical activities, chromatin binding profiles and mutant phenotypes, we propose a model to explain how they cooperate to facilitate the transition through cell states that is development. Chromatin modifying proteins play essential roles during metazoan development. Considering developmental processes as changes in a cell's gene regulatory network, we propose a model to explain how two abundant and highly conserved chromatin modifying complexes cooperate to facilitate the transition through cell states that is development. © 2014 The Authors.","development; gene expression; gene regulatory network; NuRD; polycomb; stem cells","Nichols, J., Smith, A., Pluripotency in the embryo and in culture (2012) Cold Spring Harb Perspect Biol, 4; Daley, G.Q., Scadden, D.T., Prospects for stem cell-based therapy (2008) Cell, 132, pp. 544-548; Ferreira, L.M., Mostajo-Radji, M.A., How induced pluripotent stem cells are redefining personalized medicine (2013) Gene, 520, pp. 1-6; Pourquie, O., Bruneau, B., Gotz, M., Keller, G., Smith, A., Stem cells and regeneration: a special issue (2013) Development (Cambridge, England), 140, p. 2445; Clapier, C.R., Cairns, B.R., The biology of chromatin remodeling complexes (2009) Annu Rev Biochem, 78, pp. 273-304; Iyer, V.R., Nucleosome positioning: bringing order to the eukaryotic genome (2012) Trends Cell Biol, 22, pp. 250-256; Struhl, K., Segal, E., Determinants of nucleosome positioning (2013) Nat Struct Mol Biol, 20, pp. 267-273; O'Shaughnessy, A., Hendrich, B., CHD4 in the DNA-damage response and cell cycle progression: not so NuRDy now (2013) Biochem Soc Trans, 41, pp. 777-782; Lessard, J.A., Crabtree, G.R., Chromatin regulatory mechanisms in pluripotency (2010) Annu Rev Cell Dev Biol, 26, pp. 503-532; Laugesen, A., Helin, K., Chromatin repressive complexes in stem cells, development, and cancer (2014) Cell Stem Cell, 14, pp. 735-751; Paul, S., Knott, J.G., Epigenetic control of cell fate in mouse blastocysts: the role of covalent histone modifications and chromatin remodeling (2014) Mol Reprod Dev, 81, pp. 171-182; Bird, A., DNA methylation patterns and epigenetic memory (2002) Genes Dev, 16, pp. 6-21; Wray, J., Kalkan, T., Smith, A.G., The ground state of pluripotency (2010) Biochem Soc Trans, 38, pp. 1027-1032; Ying, Q.L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., Smith, A., The ground state of embryonic stem cell self-renewal (2008) Nature, 453, pp. 519-523; Canham, M.A., Sharov, A.A., Ko, M.S., Brickman, J.M., Functional heterogeneity of embryonic stem cells revealed through translational amplification of an early endodermal transcript (2010) PLoS Biol, 8; Chambers, I., Silva, J., Colby, D., Nichols, J., Nijmeijer, B., Robertson, M., Vrana, J., Smith, A., Nanog safeguards pluripotency and mediates germline development (2007) Nature, 450, pp. 1230-1234; Kalmar, T., Lim, C., Hayward, P., Munoz-Descalzo, S., Nichols, J., Garcia-Ojalvo, J., Martinez Arias, A., Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells (2009) PLoS Biol, 7; Wu, J., Tzanakakis, E.S., Deconstructing stem cell population heterogeneity: single-cell analysis and modeling approaches (2013) Biotechnol Adv, 31, pp. 1047-1062; Martinez Arias, A., Brickman, J.M., Gene expression heterogeneities in embryonic stem cell populations: origin and function (2011) Curr Opin Cell Biol, 23, pp. 650-656; Raj, A., Van Oudenaarden, A., Nature, nurture, or chance: stochastic gene expression and its consequences (2008) Cell, 135, pp. 216-226; Kobayashi, T., Mizuno, H., Imayoshi, I., Furusawa, C., Shirahige, K., Kageyama, R., The cyclic gene Hes1 contributes to diverse differentiation responses of embryonic stem cells (2009) Genes Dev, 23, pp. 1870-1875; Huang, S., Reprogramming cell fates: reconciling rarity with robustness (2009) BioEssays, 31, pp. 546-560; Arriaga, E.A., Determining biological noise via single cell analysis (2009) Anal Bioanal Chem, 393, pp. 73-80; Huang, S., Non-genetic heterogeneity of cells in development: more than just noise (2009) Development (Cambridge, England), 136, pp. 3853-3862; Maheshri, N., O'Shea, E.K., Living with noisy genes: how cells function reliably with inherent variability in gene expression (2007) Annu Rev Biophys Biomol Struct, 36, pp. 413-434; Elowitz, M.B., Levine, A.J., Siggia, E.D., Swain, P.S., Stochastic gene expression in a single cell (2002) Science (New York, NY), 297, pp. 1183-1186; Newman, J.R., Ghaemmaghami, S., Ihmels, J., Breslow, D.K., Noble, M., Derisi, J.L., Weissman, J.S., Single-cell proteomic analysis of S. cerevisiae reveals the architecture of biological noise (2006) Nature, 441, pp. 840-846; Raser, J.M., O'Shea, E.K., Control of stochasticity in eukaryotic gene expression (2004) Science (New York, NY), 304, pp. 1811-1814; Morelli, M.J., Allen, R.J., Wolde, P.R., Effects of macromolecular crowding on genetic networks (2011) Biophys J, 101, pp. 2882-2891; Faddah, D.A., Wang, H., Cheng, A.W., Katz, Y., Buganim, Y., Jaenisch, R., Single-cell analysis reveals that expression of nanog is biallelic and equally variable as that of other pluripotency factors in mouse ESCs (2013) Cell Stem Cell, 13, pp. 23-29; Filipczyk, A., Gkatzis, K., Fu, J., Hoppe, P.S., Lickert, H., Anastassiadis, K., Schroeder, T., Biallelic expression of nanog protein in mouse embryonic stem cells (2013) Cell Stem Cell, 13, pp. 12-13; Miyanari, Y., Torres-Padilla, M.E., Control of ground-state pluripotency by allelic regulation of Nanog (2012) Nature, 483, pp. 470-473; Niwa, H., Ogawa, K., Shimosato, D., Adachi, K., A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells (2009) Nature, 460, pp. 118-122; Reynolds, N., Latos, P., Hynes-Allen, A., Loos, R., Leaford, D., O'Shaughnessy, A., Mosaku, O., Kalkan, T., NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment (2012) Cell Stem Cell, 10, pp. 583-594; Toyooka, Y., Shimosato, D., Murakami, K., Takahashi, K., Niwa, H., Identification and characterization of subpopulations in undifferentiated ES cell culture (2008) Development (Cambridge, England), 135, pp. 909-918; Wray, J., Kalkan, T., Gomez-Lopez, S., Eckardt, D., Cook, A., Kemler, R., Smith, A., Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation (2011) Nat Cell Biol, 13, pp. 838-845; Hayashi, K., Lopes, S.M., Tang, F., Surani, M.A., Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states (2008) Cell Stem Cell, 3, pp. 391-401; Huang, S., Cell lineage determination in state space: a systems view brings flexibility to dogmatic canonical rules (2010) PLoS Biol, 8; Chang, H.H., Hemberg, M., Barahona, M., Ingber, D.E., Huang, S., Transcriptome-wide noise controls lineage choice in mammalian progenitor cells (2008) Nature, 453, pp. 544-547; Huang, S., Ernberg, I., Kauffman, S., Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective (2009) Semin Cell Dev Biol, 20, pp. 869-876; Wang, J., Xu, L., Wang, E., Huang, S., The potential landscape of genetic circuits imposes the arrow of time in stem cell differentiation (2010) Biophys J, 99, pp. 29-39; Levy, S.F., Siegal, M.L., Network hubs buffer environmental variation in Saccharomyces cerevisiae (2008) PLoS Biol, 6, p. e264; Lu, R., Markowetz, F., Unwin, R.D., Leek, J.T., Airoldi, E.M., Macarthur, B.D., Lachmann, A., Boyer, L.A., Systems-level dynamic analyses of fate change in murine embryonic stem cells (2009) Nature, 462, pp. 358-362; Ng, H.H., Surani, M.A., The transcriptional and signalling networks of pluripotency (2011) Nat Cell Biol, 13, pp. 490-496; Ahringer, J., NuRD and SIN3 histone deacetylase complexes in development (2000) Trends Genet, 16, pp. 351-356; Allen, H.F., Wade, P.A., Kutateladze, T.G., The NuRD architecture (2013) Cell Mol Life Sci, 70, pp. 3513-3524; McDonel, P., Costello, I., Hendrich, B., Keeping things quiet: roles of NuRD and Sin3 co-repressor complexes during mammalian development (2009) Int J Biochem Cell Biol, 41, pp. 108-116; Reynolds, N., O'Shaughnessy, A., Hendrich, B., Transcriptional repressors: multifaceted regulators of gene expression (2013) Development (Cambridge, England), 140, pp. 505-512; Shimbo, T., Du, Y., Grimm, S.A., Dhasarathy, A., Mav, D., Shah, R.R., Shi, H., Wade, P.A., MBD3 localizes at promoters, gene bodies and enhancers of active genes (2013) PLoS Genet, 9; Baubec, T., Ivanek, R., Lienert, F., Schubeler, D., Methylation-dependent and -independent genomic targeting principles of the MBD protein family (2013) Cell, 153, pp. 480-492; Gunther, K., Rust, M., Leers, J., Boettger, T., Scharfe, M., Jarek, M., Bartkuhn, M., Renkawitz, R., Differential roles for MBD2 and MBD3 at methylated CpG islands, active promoters and binding to exon sequences (2013) Nucleic Acids Res, 41, pp. 3010-3021; Kaji, K., Caballero, I.M., MacLeod, R., Nichols, J., Wilson, V.A., Hendrich, B., The NuRD component Mbd3 is required for pluripotency of embryonic stem cells (2006) Nat Cell Biol, 8, pp. 285-292; Narlikar, G.J., Sundaramoorthy, R., Owen-Hughes, T., Mechanisms and functions of ATP-dependent chromatin-remodeling enzymes (2013) Cell, 154, pp. 490-503; Morris, S.A., Baek, S., Sung, M.H., John, S., Wiench, M., Johnson, T.A., Schiltz, R.L., Hager, G.L., Overlapping chromatin-remodeling systems collaborate genome wide at dynamic chromatin transitions (2014) Nat Struct Mol Biol, 21, pp. 73-81; Kaji, K., Nichols, J., Hendrich, B., Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells (2007) Development (Cambridge, England), 134, pp. 1123-1132; Latos, P.A., Helliwell, C., Mosaku, O., Dudzinska, D.A., Stubbs, B., Berdasco, M., Esteller, M., Hendrich, B., NuRD-dependent DNA methylation prevents ES cells from accessing a trophectoderm fate (2012) Biol Open, 1, pp. 341-352; Zhu, D., Fang, J., Li, Y., Zhang, J., Mbd3, a component of NuRD/Mi-2 complex, helps maintain pluripotency of mouse embryonic stem cells by repressing trophectoderm differentiation (2009) PLoS One, 4; Dos Santos, R.L., Tosti, L., Radzisheuskaya, A., Caballero, I.M., Kaji, K., Hendrich, B., Silva, J.C., MBD3/NuRD facilitates induction of pluripotency in a context-dependent manner (2014) Cell Stem Cell, 15, pp. 102-110; Kashiwagi, M., Morgan, B.A., Georgopoulos, K., The chromatin remodeler Mi-2beta is required for establishment of the basal epidermis and normal differentiation of its progeny (2007) Development (Cambridge, England), 134, pp. 1571-1582; Yoshida, T., Hazan, I., Zhang, J., Ng, S.Y., Naito, T., Snippert, H.J., Heller, E.J., Williams, C.J., The role of the chromatin remodeler Mi-2{beta} in hematopoietic stem cell self-renewal and multilineage differentiation (2008) Genes Dev, 22, pp. 1174-1189; Mazumdar, A., Wang, R.A., Mishra, S.K., Adam, L., Bagheri-Yarmand, R., Mandal, M., Vadlamudi, R.K., Kumar, R., Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor (2001) Nat Cell Biol, 3, pp. 30-37; Schmitt, C., Tonnelle, C., Dalloul, A., Chabannon, C., Debre, P., Rebollo, A., Aiolos and Ikaros: regulators of lymphocyte development, homeostasis and lymphoproliferation (2002) Apoptosis, 7, pp. 277-284; Bowen, N.J., Fujita, N., Kajita, M., Wade, P.A., Mi-2/NuRD: multiple complexes for many purposes (2004) Biochim Biophys Acta, 1677, pp. 52-57; Fujita, N., Jaye, D.L., Kajita, M., Geigerman, C., Moreno, C.S., Wade, P.A., MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer (2003) Cell, 113, pp. 207-219; Faust, C., Schumacher, A., Holdener, B., Magnuson, T., The eed mutation disrupts anterior mesoderm production in mice (1995) Development (Cambridge, England), 121, pp. 273-285; O'Carroll, D., Erhardt, S., Pagani, M., Barton, S.C., Surani, M.A., Jenuwein, T., The polycomb-group gene Ezh2 is required for early mouse development (2001) Mol Cell Biol, 21, pp. 4330-4336; Pasini, D., Bracken, A.P., Jensen, M.R., Lazzerini Denchi, E., Helin, K., Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity (2004) EMBO J, 23, pp. 4061-4071; Margueron, R., Reinberg, D., The Polycomb complex PRC2 and its mark in life (2011) Nature, 469, pp. 343-349; Voigt, P., LeRoy, G., Drury, W.J., III, Zee, B.M., Son, J., Beck, D.B., Young, N.L., Reinberg, D., Asymmetrically modified nucleosomes (2012) Cell, 151, pp. 181-193; Azuara, V., Perry, P., Sauer, S., Spivakov, M., Jorgensen, H.F., John, R.M., Gouti, M., Merkenschlager, M., Chromatin signatures of pluripotent cell lines (2006) Nat Cell Biol, 8, pp. 532-538; Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., Plath, K., A bivalent chromatin structure marks key developmental genes in embryonic stem cells (2006) Cell, 125, pp. 315-326; Mikkelsen, T.S., Ku, M., Jaffe, D.B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Koche, R.P., Genome-wide maps of chromatin state in pluripotent and lineage-committed cells (2007) Nature, 448, pp. 553-560; Pan, G., Tian, S., Nie, J., Yang, C., Ruotti, V., Wei, H., Jonsdottir, G.A., Thomson, J.A., Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells (2007) Cell Stem Cell, 1, pp. 299-312; Faust, C., Lawson, K.A., Schork, N.J., Thiel, B., Magnuson, T., The Polycomb-group gene eed is required for normal morphogenetic movements during gastrulation in the mouse embryo (1998) Development (Cambridge, England), 125, pp. 4495-4506; Pasini, D., Bracken, A., Hansen, J., Capillo, M., Helin, K., The polycomb group protein Suz12 Is required for embryonic stem cell differentiation (2007) Mol Cell Biol, 27, pp. 3769-3779; Williams, R.R., Azuara, V., Perry, P., Sauer, S., Dvorkina, M., Jorgensen, H., Roix, J., Merkenschlager, M., Neural induction promotes large-scale chromatin reorganisation of the Mash1 locus (2006) J Cell Sci, 119, pp. 132-140; Chamberlain, S.J., Yee, D., Magnuson, T., Polycomb repressive complex 2 is dispensable for maintenance of embryonic stem cell pluripotency (2008) Stem Cells, 26, pp. 1496-1505; Shen, X., Liu, Y., Hsu, Y.J., Fujiwara, Y., Kim, J., Mao, X., Yuan, G., Orkin, S.H., EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency (2008) Mol Cell, 32, pp. 491-502; Marks, H., Kalkan, T., Menafra, R., Denissov, S., Jones, K., Hofemeister, H., Nichols, J., Smith, A., The transcriptional and epigenomic foundations of ground state pluripotency (2012) Cell, 149, pp. 590-604; Denissov, S., Hofemeister, H., Marks, H., Kranz, A., Ciotta, G., Singh, S., Anastassiadis, K., Stewart, A.F., Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant (2014) Development (Cambridge, England), 141, pp. 526-537; Hu, D., Garruss, A.S., Gao, X., Morgan, M.A., Cook, M., Smith, E.R., Shilatifard, A., The Mll2 branch of the COMPASS family regulates bivalent promoters in mouse embryonic stem cells (2013) Nat Struct Mol Biol, 20, pp. 1093-1097; Riising, E.M., Comet, I., Leblanc, B., Wu, X., Johansen, J.V., Helin, K., Gene silencing triggers polycomb repressive complex 2 recruitment to CpG islands genome wide (2014) Mol Cell, 55, pp. 347-360; Boyer, L.A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L.A., Lee, T.I., Levine, S.S., Ray, M.K., Polycomb complexes repress developmental regulators in murine embryonic stem cells (2006) Nature, 441, pp. 349-353; Bienz, M., Muller, J., Transcriptional silencing of homeotic genes in Drosophila (1995) BioEssays, 17, pp. 775-784; White, R.A., Lehmann, R., A gap gene, hunchback, regulates the spatial expression of Ultrabithorax (1986) Cell, 47, pp. 311-321; Struhl, G., Akam, M., Altered distributions of Ultrabithorax transcripts in extra sex combs mutant embryos of Drosophila (1985) EMBO J, 4, pp. 3259-3264; Kehle, J., Beuchle, D., Treuheit, S., Christen, B., Kennison, J.A., Bienz, M., Müller, J., dMi-2, a hunchback-interacting protein that functions in Polycomb repression (1998) Science (New York, NY), 282, pp. 1897-1900; Unhavaithaya, Y., Shin, T.H., Miliaras, N., Lee, J., Oyama, T., Mello, C.C., MEP-1 and a homolog of the NURD complex component Mi-2 act together to maintain germline-soma distinctions in C. elegans (2002) Cell, 111, pp. 991-1002; Eshed, Y., Baum, S.F., Bowman, J.L., Distinct mechanisms promote polarity establishment in carpels of Arabidopsis (1999) Cell, 99, pp. 199-209; Ogas, J., Cheng, J.C., Sung, Z.R., Somerville, C., Cellular differentiation regulated by gibberellin in the Arabidopsis thaliana pickle mutant (1997) Science (New York, NY), 277, pp. 91-94; Ogas, J., Kaufmann, S., Henderson, J., Somerville, C., PICKLE is a CHD3 chromatin-remodeling factor that regulates the transition from embryonic to vegetative development in Arabidopsis (1999) Proc Natl Acad Sci USA, 96, pp. 13839-13844; Ferrari, K.J., Scelfo, A., Jammula, S., Cuomo, A., Barozzi, I., Stutzer, A., Fischle, W., Pasini, D., Polycomb-dependent H3K27me1 and H3K27me2 regulate active transcription and enhancer fidelity (2014) Mol Cell, 53, pp. 49-62; Morey, L., Helin, K., Polycomb group protein-mediated repression of transcription (2010) Trends Biochem Sci, 35, pp. 323-332; Reynolds, N., Salmon-Divon, M., Dvinge, H., Hynes-Allen, A., Balasooriya, G., Leaford, D., Behrens, A., Hendrich, B., NuRD-mediated deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression (2012) EMBO J, 31, pp. 593-605; Morey, L., Brenner, C., Fazi, F., Villa, R., Gutierrez, A., Buschbeck, M., Nervi, C., Di Croce, L., MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks (2008) Mol Cell Biol, 28, pp. 5912-5923; Halley, J.D., Burden, F.R., Winkler, D.A., Stem cell decision making and critical-like exploratory networks (2009) Stem Cell Res, 2, pp. 165-177; Torres-Sosa, C., Huang, S., Aldana, M., Criticality is an emergent property of genetic networks that exhibit evolvability (2012) PLoS Comput Biol, 8; Balazsi, G., Van Oudenaarden, A., Collins, J.J., Cellular decision making and biological noise: from microbes to mammals (2011) Cell, 144, pp. 910-925",Article,Scopus,2-s2.0-84928485442
"Alimperti S., Andreadis S.T.","CDH2 and CDH11 act as regulators of stem cell fate decisions",2015,"Stem Cell Research","14","3",,"270","282",,,10.1016/j.scr.2015.02.002,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924710551&partnerID=40&md5=524834a4510b24237b5bbaf07ebe5202","Bioengineering Laboratory, Department of Chemical and Biological Engineering, University at Buffalo, State University of New YorkAmherst, NY, United States; Center of Excellence in Bioinformatics and Life SciencesBuffalo, NY, United States","Alimperti, S., Bioengineering Laboratory, Department of Chemical and Biological Engineering, University at Buffalo, State University of New YorkAmherst, NY, United States; Andreadis, S.T., Bioengineering Laboratory, Department of Chemical and Biological Engineering, University at Buffalo, State University of New YorkAmherst, NY, United States, Center of Excellence in Bioinformatics and Life SciencesBuffalo, NY, United States","Accumulating evidence suggests that the mechanical and biochemical signals originating from cell-cell adhesion are critical for stem cell lineage specification. In this review, we focus on the role of cadherin mediated signaling in development and stem cell differentiation, with emphasis on two well-known cadherins, cadherin-2 (CDH2) (N-cadherin) and cadherin-11 (CDH11) (OB-cadherin). We summarize the existing knowledge regarding the role of CDH2 and CDH11 during development and differentiation in vivo and in vitro. We also discuss engineering strategies to control stem cell fate decisions by fine-tuning the extent of cell-cell adhesion through surface chemistry and microtopology. These studies may be greatly facilitated by novel strategies that enable monitoring of stem cell specification in real time. We expect that better understanding of how intercellular adhesion signaling affects lineage specification may impact biomaterial and scaffold design to control stem cell fate decisions in three-dimensional context with potential implications for tissue engineering and regenerative medicine. © 2015.",,"Agarwal, S.K., Brenner, M.B., Role of adhesion molecules in synovial inflammation (2006) Curr. Opin. Rheumatol., 18, pp. 268-276; Alimperti, S., Lei, P., Tian, J., Andreadis, S.T., A novel lentivirus for quantitative assessment of gene knockdown in stem cell differentiation (2012) Gene Ther., 19, pp. 1123-1132; Alimperti, S., You, H., George, T., Agarwal, S.K., Andreadis, S.T., Cadherin-11 regulates both mesenchymal stem cell differentiation into smooth muscle cells and the development of contractile function in vivo (2014) J. Cell Sci., 127, pp. 2627-2638; Alimperti, S., Lei, P., Wen, Y., Tian, J., Campbell, A.M., Andreadis, S.T., Serum-free spheroid suspension culture maintains mesenchymal stem cell proliferation and differentiation potential (2014) Biotechnol. Prog., 30, pp. 974-983; Anastasiadis, P.Z., Reynolds, A.B., The p120 catenin family: complex roles in adhesion, signaling and cancer (2000) J. Cell Sci., 113, pp. 1319-1334; Anastasiadis, P.Z., Moon, S.Y., Thoreson, M.A., Mariner, D.J., Crawford, H.C., Zheng, Y., Reynolds, A.B., Inhibition of RhoA by p120 catenin (2000) Nat. Cell Biol., 2, pp. 637-644; Augello, A., Tasso, R., Negrini, S.M., Cancedda, R., Pennesi, G., Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis (2007) Arthritis Rheum., 56, pp. 1175-1186; Baraniak, P.R., McDevitt, T.C., Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential (2012) Cell Tissue Res., 347, pp. 701-711; Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Hoffman, R., Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo (2002) Exp. Hematol., 30, pp. 42-48; Bartosh, T.J., Ylostalo, J.H., Mohammadipoor, A., Bazhanov, N., Coble, K., Claypool, K., Lee, R.H., Prockop, D.J., Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties (2010) Proc. Natl. Acad. Sci. U. S. A., 107, pp. 13724-13729; Becker, S.F., Mayor, R., Kashef, J., Cadherin-11 mediates contact inhibition of locomotion during Xenopus neural crest cell migration (2013) PLoS ONE, 8, p. e85717; Bixby, J.L., Grunwald, G.B., Bookman, R.J., Ca2+ influx and neurite growth in response to purified N-cadherin and laminin (1994) J. Cell Biol., 127, pp. 1461-1475; Boggon, T.J., Murray, J., Chappuis-Flament, S., Wong, E., Gumbiner, B.M., Shapiro, L., C-cadherin ectodomain structure and implications for cell adhesion mechanisms (2002) Science, 296, pp. 1308-1313; Borghi, N., James Nelson, W., Intercellular adhesion in morphogenesis: molecular and biophysical considerations (2009) Curr. Top. Dev. Biol., 89, pp. 1-32; Boscher, C., Mege, R.M., Cadherin-11 interacts with the FGF receptor and induces neurite outgrowth through associated downstream signalling (2008) Cell. Signal., 20, pp. 1061-1072; Braga, V.M., Cell-cell adhesion and signalling (2002) Curr. Opin. Cell Biol., 14, pp. 546-556; Brasch, J., Harrison, O.J., Honig, B., Shapiro, L., Thinking outside the cell: how cadherins drive adhesion (2012) Trends Cell Biol., 22, pp. 299-310; Brieva, T.A., Moghe, P.V., Engineering the hepatocyte differentiation-proliferation balance by acellular cadherin micropresentation (2004) Tissue Eng., 10, pp. 553-564; Brieva, T.A., Moghe, P.V., Exogenous cadherin microdisplay can interfere with endogenous signaling and reprogram gene expression in cultured hepatocytes (2004) Biotechnol. Bioeng., 85, pp. 283-292; Buxboim, A., Discher, D.E., Stem cells feel the difference (2010) Nat. Methods, 7, pp. 695-697; Buxboim, A., Ivanovska, I.L., Discher, D.E., Matrix elasticity, cytoskeletal forces and physics of the nucleus: how deeply do cells 'feel' outside and in? (2010) J. Cell Sci., 123, pp. 297-308; Cavallaro, U., Dejana, E., Adhesion molecule signalling: not always a sticky business (2011) Nat. Rev. Mol. Cell Biol., 12, pp. 189-197; Chang, S.K., Noss, E.H., Chen, M., Gu, Z., Townsend, K., Grenha, R., Leon, L., Brenner, M.B., Cadherin-11 regulates fibroblast inflammation (2011) Proc. Natl. Acad. Sci. U. S. A., 108, pp. 8402-8407; Charest, J.L., Jennings, J.M., King, W.P., Kowalczyk, A.P., Garcia, A.J., Cadherin-mediated cell-cell contact regulates keratinocyte differentiation (2009) J. Investig. Dermatol., 129, pp. 564-572; Charrasse, S., Meriane, M., Comunale, F., Blangy, A., Gauthier-Rouviere, C., N-cadherin-dependent cell-cell contact regulates Rho GTPases and beta-catenin localization in mouse C2C12 myoblasts (2002) J. Cell Biol., 158, pp. 953-965; Cheng, S.L., Lecanda, F., Davidson, M.K., Warlow, P.M., Zhang, S.F., Zhang, L., Suzuki, S., Civitelli, R., Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation (1998) J. Bone Miner. Res., 13, pp. 633-644; Chin, V.I., Taupin, P., Sanga, S., Scheel, J., Gage, F.H., Bhatia, S.N., Microfabricated platform for studying stem cell fates (2004) Biotechnol. Bioeng., 88, pp. 399-415; Chopra, A., Tabdanov, E., Patel, H., Janmey, P.A., Kresh, J.Y., Cardiac myocyte remodeling mediated by N-cadherin-dependent mechanosensing (2011) Am. J. Physiol. Heart Circ. Physiol., 300, pp. H1252-H1266; Dander, E., Lucchini, G., Vinci, P., Introna, M., Masciocchi, F., Perseghin, P., Balduzzi, A., D'Amico, G., Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring (2012) Leukemia, 26, pp. 1681-1684; Debiais, F., Lemonnier, J., Hay, E., Delannoy, P., Caverzasio, J., Marie, P.J., Fibroblast growth factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts (2001) J. Cell. Biochem., 81, pp. 68-81; Derycke, L.D., Bracke, M.E., N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling (2004) Int. J. Dev. Biol., 48, pp. 463-476; Di Benedetto, A., Watkins, M., Grimston, S., Salazar, V., Donsante, C., Mbalaviele, G., Radice, G.L., Civitelli, R., N-cadherin and cadherin 11 modulate postnatal bone growth and osteoblast differentiation by distinct mechanisms (2010) J. Cell Sci., 123, pp. 2640-2648; Diamond, M.E., Sun, L., Ottaviano, A.J., Joseph, M.J., Munshi, H.G., Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium (2008) J. Cell Sci., 121, pp. 2197-2207; Discher, D.E., Janmey, P., Wang, Y.L., Tissue cells feel and respond to the stiffness of their substrate (2005) Science, 310, pp. 1139-1143; Dvir-Ginzberg, M., Gamlieli-Bonshtein, I., Agbaria, R., Cohen, S., Liver tissue engineering within alginate scaffolds: effects of cell-seeding density on hepatocyte viability, morphology, and function (2003) Tissue Eng., 9, pp. 757-766; Engler, A.J., Griffin, M.A., Sen, S., Bonnemann, C.G., Sweeney, H.L., Discher, D.E., Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments (2004) J. Cell Biol., 166, pp. 877-887; Engler, A.J., Sen, S., Sweeney, H.L., Discher, D.E., Matrix elasticity directs stem cell lineage specification (2006) Cell, 126, pp. 677-689; Engler, A.J., Sweeney, H.L., Discher, D.E., Schwarzbauer, J.E., Extracellular matrix elasticity directs stem cell differentiation (2007) J. Musculoskelet Neuronal Interact., 7, p. 335; Evans, S.F., Docheva, D., Bernecker, A., Colnot, C., Richter, R.P., Knothe Tate, M.L., Solid-supported lipid bilayers to drive stem cell fate and tissue architecture using periosteum derived progenitor cells (2013) Biomaterials, 34, pp. 1878-1887; Ferrari, S.L., Traianedes, K., Thorne, M., Lafage-Proust, M.H., Genever, P., Cecchini, M.G., Behar, V., Suva, L.J., A role for N-cadherin in the development of the differentiated osteoblastic phenotype (2000) J. Bone Miner. Res., 15, pp. 198-208; Gao, L., McBeath, R., Chen, C.S., Stem cell shape regulates a chondrogenic versus myogenic fate through Rac1 and N-cadherin (2010) Stem Cells, 28, pp. 564-572; Garcia-Castro, M.I., Vielmetter, E., Bronner-Fraser, M., N-Cadherin, a cell adhesion molecule involved in establishment of embryonic left-right asymmetry (2000) Science, 288, pp. 1047-1051; Gavard, J., Marthiens, V., Monnet, C., Lambert, M., Mege, R.M., N-Cadherin activation substitutes for the cell contact control in cell cycle arrest and myogenic differentiation: involvement of p120 and beta-catenin (2004) J. Biol. Chem., 279, pp. 36795-36802; Gilbert, P.M., Havenstrite, K.L., Magnusson, K.E., Sacco, A., Leonardi, N.A., Kraft, P., Nguyen, N.K., Blau, H.M., Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture (2010) Science, 329, pp. 1078-1081; Goldring, M.B., Tsuchimochi, K., Ijiri, K., The control of chondrogenesis (2006) J. Cell. Biochem., 97, pp. 33-44; Gray, D.S., Liu, W.F., Shen, C.J., Bhadriraju, K., Nelson, C.M., Chen, C.S., Engineering amount of cell-cell contact demonstrates biphasic proliferative regulation through RhoA and the actin cytoskeleton (2008) Exp. Cell Res., 314, pp. 2846-2854; Griffin, M.A., Sen, S., Sweeney, H.L., Discher, D.E., Adhesion-contractile balance in myocyte differentiation (2004) J. Cell Sci., 117, pp. 5855-5863; Grosheva, I., Shtutman, M., Elbaum, M., Bershadsky, A.D., P120 catenin affects cell motility via modulation of activity of Rho-family GTPases: a link between cell-cell contact formation and regulation of cell locomotion (2001) J. Cell Sci., 114, pp. 695-707; Guilak, F., Cohen, D.M., Estes, B.T., Gimble, J.M., Liedtke, W., Chen, C.S., Control of stem cell fate by physical interactions with the extracellular matrix (2009) Cell Stem Cell, 5, pp. 17-26; Guillot, C., Lecuit, T., Mechanics of epithelial tissue homeostasis and morphogenesis (2013) Science, 340, pp. 1185-1189; Gumbiner, B.M., Cell adhesion: the molecular basis of tissue architecture and morphogenesis (1996) Cell, 84, pp. 345-357; Gupta, N., Su, X., Popov, B., Lee, J.W., Serikov, V., Matthay, M.A., Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice (2007) J. Immunol., 179, pp. 1855-1863; Halbleib, J.M., Nelson, W.J., Cadherins in development: cell adhesion, sorting, and tissue morphogenesis (2006) Genes Dev., 20, pp. 3199-3214; Harris, T.J., Tepass, U., Adherens junctions: from molecules to morphogenesis (2010) Nat. Rev. Mol. Cell Biol., 11, pp. 502-514; Hatanaka, K., Lanahan, A.A., Murakami, M., Simons, M., Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2 (2012) PLoS ONE, 7, p. e37600; Hatta, K., Takeichi, M., Expression of N-cadherin adhesion molecules associated with early morphogenetic events in chick development (1986) Nature, 320, pp. 447-449; Hinz, B., Gabbiani, G., Mechanisms of force generation and transmission by myofibroblasts (2003) Curr. Opin. Biotechnol., 14, pp. 538-546; Hinz, B., Celetta, G., Tomasek, J.J., Gabbiani, G., Chaponnier, C., Alpha-smooth muscle actin expression upregulates fibroblast contractile activity (2001) Mol. Biol. Cell, 12, pp. 2730-2741; Hinz, B., Mastrangelo, D., Iselin, C.E., Chaponnier, C., Gabbiani, G., Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation (2001) Am. J. Pathol., 159, pp. 1009-1020; Hinz, B., Pittet, P., Smith-Clerc, J., Chaponnier, C., Meister, J.J., Myofibroblast development is characterized by specific cell-cell adherens junctions (2004) Mol. Biol. Cell, 15, pp. 4310-4320; Horwitz, E.M., Gordon, P.L., Koo, W.K., Marx, J.C., Neel, M.D., McNall, R.Y., Muul, L., Hofmann, T., Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 8932-8937; Hoschuetzky, H., Aberle, H., Kemler, R., Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor (1994) J. Cell Biol., 127, pp. 1375-1380; Hosokawa, K., Arai, F., Yoshihara, H., Iwasaki, H., Nakamura, Y., Gomei, Y., Suda, T., Knockdown of N-cadherin suppresses the long-term engraftment of hematopoietic stem cells (2010) Blood, 116, pp. 554-563; Hosokawa, K., Arai, F., Yoshihara, H., Iwasaki, H., Hembree, M., Yin, T., Nakamura, Y., Suda, T., Cadherin-based adhesion is a potential target for niche manipulation to protect hematopoietic stem cells in adult bone marrow (2010) Cell Stem Cell, 6, pp. 194-198; Jia, J., Zhang, W., Liu, J.Y., Chen, G., Liu, H., Zhong, H.Y., Liu, B., Zhao, Y.F., Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma (2012) PLoS ONE, 7, p. e51549; Kadowaki, M., Nakamura, S., Machon, O., Krauss, S., Radice, G.L., Takeichi, M., N-Cadherin mediates cortical organization in the mouse brain (2007) Dev. Biol., 304, pp. 22-33; Kawaguchi, J., Azuma, Y., Hoshi, K., Kii, I., Takeshita, S., Ohta, T., Ozawa, H., Kudo, A., Targeted disruption of cadherin-11 leads to a reduction in bone density in calvaria and long bone metaphyses (2001) J. Bone Miner. Res., 16, pp. 1265-1271; Kawaguchi, J., Kii, I., Sugiyama, Y., Takeshita, S., Kudo, A., The transition of cadherin expression in osteoblast differentiation from mesenchymal cells: consistent expression of cadherin-11 in osteoblast lineage (2001) J. Bone Miner. Res., 16, pp. 260-269; Kiel, M.J., Acar, M., Radice, G.L., Morrison, S.J., Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance (2009) Cell Stem Cell, 4, pp. 170-179; Kii, I., Amizuka, N., Shimomura, J., Saga, Y., Kudo, A., Cell-cell interaction mediated by cadherin-11 directly regulates the differentiation of mesenchymal cells into the cells of the osteo-lineage and the chondro-lineage (2004) J. Bone Miner. Res., 19, pp. 1840-1849; Kimura, Y., Matsunami, H., Inoue, T., Shimamura, K., Uchida, N., Ueno, T., Miyazaki, T., Takeichi, M., Cadherin-11 expressed in association with mesenchymal morphogenesis in the head, somite, and limb bud of early mouse embryos (1995) Dev. Biol., 169, pp. 347-358; Kovacs, E.M., Goodwin, M., Ali, R.G., Paterson, A.D., Yap, A.S., Cadherin-directed actin assembly: E-cadherin physically associates with the Arp2/3 complex to direct actin assembly in nascent adhesive contacts (2002) Curr. Biol., 12, pp. 379-382; Kovacs, E.M., Ali, R.G., McCormack, A.J., Yap, A.S., E-cadherin homophilic ligation directly signals through Rac and phosphatidylinositol 3-kinase to regulate adhesive contacts (2002) J. Biol. Chem., 277, pp. 6708-6718; Kuijpers, K.A., Heesakkers, J.P., Jansen, C.F., Schalken, J.A., Cadherin-11 is expressed in detrusor smooth muscle cells and myofibroblasts of normal human bladder (2007) Eur. Urol., 52, pp. 1213-1221; Ladoux, B., Anon, E., Lambert, M., Rabodzey, A., Hersen, P., Buguin, A., Silberzan, P., Mege, R.M., Strength dependence of cadherin-mediated adhesions (2010) Biophys. J., 98, pp. 534-542; Lambert, M., Padilla, F., Mege, R.M., Immobilized dimers of N-cadherin-Fc chimera mimic cadherin-mediated cell contact formation: contribution of both outside-in and inside-out signals (2000) J. Cell Sci., 113, pp. 2207-2219; Lecanda, F., Cheng, S.L., Shin, C.S., Davidson, M.K., Warlow, P., Avioli, L.V., Civitelli, R., Differential regulation of cadherins by dexamethasone in human osteoblastic cells (2000) J. Cell. Biochem., 77, pp. 499-506; Levental, K.R., Yu, H., Kass, L., Lakins, J.N., Egeblad, M., Erler, J.T., Fong, S.F., Weaver, V.M., Matrix crosslinking forces tumor progression by enhancing integrin signaling (2009) Cell, 139, pp. 891-906; Li, Y., Chen, J., Zhang, C.L., Wang, L., Lu, D., Katakowski, M., Gao, Q., Chopp, M., Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells (2005) Glia, 49, pp. 407-417; Li, L., Bennett, S.A., Wang, L., Role of E-cadherin and other cell adhesion molecules in survival and differentiation of human pluripotent stem cells (2012) Cell Adhes. Migr., 6, pp. 59-70; Lira, C.B., Chu, K., Lee, Y.C., Hu, M.C., Lin, S.H., Expression of the extracellular domain of OB-cadherin as an Fc fusion protein using bicistronic retroviral expression vector (2008) Protein Expr. Purif., 61, pp. 220-226; Luegmayr, E., Glantschnig, H., Varga, F., Klaushofer, K., The organization of adherens junctions in mouse osteoblast-like cells (MC3T3-E1) and their modulation by triiodothyronine and 1,25-dihydroxyvitamin D3 (2000) Histochem. Cell Biol., 113, pp. 467-478; Luo, Y., Kostetskii, I., Radice, G.L., N-Cadherin is not essential for limb mesenchymal chondrogenesis (2005) Dev. Dyn., 232, pp. 336-344; Manabe, T., Togashi, H., Uchida, N., Suzuki, S.C., Hayakawa, Y., Yamamoto, M., Yoda, H., Chisaka, O., Loss of cadherin-11 adhesion receptor enhances plastic changes in hippocampal synapses and modifies behavioral responses (2000) Mol. Cell. Neurosci., 15, pp. 534-546; Marie, P.J., Role of N-cadherin in bone formation (2002) J. Cell. Physiol., 190, pp. 297-305; Marthiens, V., Gavard, J., Lambert, M., Mege, R.M., Cadherin-based cell adhesion in neuromuscular development (2002) Biol. Cell., 94, pp. 315-326; Marthiens, V., Padilla, F., Lambert, M., Mege, R.M., Complementary expression and regulation of cadherins 6 and 11 during specific steps of motoneuron differentiation (2002) Mol. Cell. Neurosci., 20, pp. 458-475; Martin, T.A., Mansel, R., Jiang, W.G., Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells (2001) Clin. Cancer Res., 7, pp. 734-737; McBeath, R., Pirone, D.M., Nelson, C.M., Bhadriraju, K., Chen, C.S., Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment (2004) Dev. Cell, 6, pp. 483-495; Mertsching, H., Walles, T., Hofmann, M., Schanz, J., Knapp, W.H., Engineering of a vascularized scaffold for artificial tissue and organ generation (2005) Biomaterials, 26, pp. 6610-6617; Moharil, J., Lei, P., Gaile, D., Andreadis, S.T., (2015) Lentiviral microarrays for high throughput monitoring MSC differentiation along the myogenic lineage, , (submitted for publication); Monahan, T.S., Andersen, N.D., Panossian, H., Kalish, J.A., Daniel, S., Shrikhande, G.V., Ferran, C., Logerfo, F.W., A novel function for cadherin 11/osteoblast-cadherin in vascular smooth muscle cells: modulation of cell migration and proliferation (2007) J. Vasc. Surg., 45, pp. 581-589; Myers, T.J., Granero-Molto, F., Longobardi, L., Li, T., Yan, Y., Spagnoli, A., Mesenchymal stem cells at the intersection of cell and gene therapy (2010) Expert. Opin. Biol. Ther., 10, pp. 1663-1679; Nakazora, S., Matsumine, A., Iino, T., Hasegawa, M., Kinoshita, A., Uemura, K., Niimi, R., Sudo, A., The cleavage of N-cadherin is essential for chondrocyte differentiation (2010) Biochem. Biophys. Res. Commun., 400, pp. 493-499; Napolitano, A.P., Dean, D.M., Man, A.J., Youssef, J., Ho, D.N., Rago, A.P., Lech, M.P., Morgan, J.R., Scaffold-free three-dimensional cell culture utilizing micromolded nonadhesive hydrogels (2007) Biotechniques, 43 (494), pp. 496-500; Nelson, C.M., Liu, W.F., Chen, C.S., Manipulation of cell-cell adhesion using bowtie-shaped microwells (2007) Methods Mol. Biol., 370, pp. 1-10; Ng, M.R., Besser, A., Danuser, G., Brugge, J.S., Substrate stiffness regulates cadherin-dependent collective migration through myosin-II contractility (2012) J. Cell Biol., 199, pp. 545-563; Niessen, C.M., Gumbiner, B.M., Cadherin-mediated cell sorting not determined by binding or adhesion specificity (2002) J. Cell Biol., 156, pp. 389-399; Noren, N.K., Liu, B.P., Burridge, K., Kreft, B., P120 catenin regulates the actin cytoskeleton via Rho family GTPases (2000) J. Cell Biol., 150, pp. 567-580; Noren, N.K., Niessen, C.M., Gumbiner, B.M., Burridge, K., Cadherin engagement regulates Rho family GTPases (2001) J. Biol. Chem., 276, pp. 33305-33308; Norotte, C., Marga, F.S., Niklason, L.E., Forgacs, G., Scaffold-free vascular tissue engineering using bioprinting (2009) Biomaterials, 30, pp. 5910-5917; Oberlender, S.A., Tuan, R.S., Spatiotemporal profile of N-cadherin expression in the developing limb mesenchyme (1994) Cell Adhes. Commun., 2, pp. 521-537; Ortiz, L.A., Dutreil, M., Fattman, C., Pandey, A.C., Torres, G., Go, K., Phinney, D.G., Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 11002-11007; Ouyang, M., Lu, S., Kim, T., Chen, C.E., Seong, J., Leckband, D.E., Wang, F., Wang, Y., N-cadherin regulates spatially polarized signals through distinct p120ctn and beta-catenin-dependent signalling pathways (2013) Nat. Commun., 4, p. 1589; Padilla, F., Broders, F., Nicolet, M., Mege, R.M., Cadherins M, 11, and 6 expression patterns suggest complementary roles in mouse neuromuscular axis development (1998) Mol. Cell. Neurosci., 11, pp. 217-233; Padmashali, R.M., Andreadis, S.T., Engineering fibrinogen-binding VSV-G envelope for spatially- and cell-controlled lentivirus delivery through fibrin hydrogels (2011) Biomaterials, 32, pp. 3330-3339; Padmashali, R.M., Mistriotis, P., Liang, M.S., Andreadis, S.T., Lentiviral arrays for live-cell dynamic monitoring of gene and pathway activity during stem cell differentiation (2014) Mol. Ther., 22, pp. 1971-1982; Pece, S., Gutkind, J.S., Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation (2000) J. Biol. Chem., 275, pp. 41227-41233; Peglion, F., Llense, F., Etienne-Manneville, S., Adherens junction treadmilling during collective migration (2014) Nat. Cell Biol., 16, pp. 639-651; Pittet, P., Lee, K., Kulik, A.J., Meister, J.J., Hinz, B., Fibrogenic fibroblasts increase intercellular adhesion strength by reinforcing individual OB-cadherin bonds (2008) J. Cell Sci., 121, pp. 877-886; Place, E.S., Evans, N.D., Stevens, M.M., Complexity in biomaterials for tissue engineering (2009) Nat. Mater., 8, pp. 457-470; Pokutta, S., Herrenknecht, K., Kemler, R., Engel, J., Conformational changes of the recombinant extracellular domain of E-cadherin upon calcium binding (1994) Eur. J. Biochem., 223, pp. 1019-1026; Quintana, L., zur Nieden, N.I., Semino, C.E., Morphogenetic and regulatory mechanisms during developmental chondrogenesis: new paradigms for cartilage tissue engineering (2009) Tissue Eng. B Rev., 15, pp. 29-41; Radice, G.L., Rayburn, H., Matsunami, H., Knudsen, K.A., Takeichi, M., Hynes, R.O., Developmental defects in mouse embryos lacking N-cadherin (1997) Dev. Biol., 181, pp. 64-78; Raut, S.D., Lei, P., Padmashali, R.M., Andreadis, S.T., Fibrin-mediated lentivirus gene transfer: implications for lentivirus microarrays (2010) J. Control. Release, 144, pp. 213-220; Redies, C., Cadherins in the central nervous system (2000) Prog. Neurobiol., 61, pp. 611-648; Redmer, T., Diecke, S., Grigoryan, T., Quiroga-Negreira, A., Birchmeier, W., Besser, D., E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming (2011) EMBO Rep., 12, pp. 720-726; Reynolds, A.B., Carnahan, R.H., Regulation of cadherin stability and turnover by p120ctn: implications in disease and cancer (2004) Semin. Cell Dev. Biol., 15, pp. 657-663; Riehl, R., Johnson, K., Bradley, R., Grunwald, G.B., Cornel, E., Lilienbaum, A., Holt, C.E., Cadherin function is required for axon outgrowth in retinal ganglion cells in vivo (1996) Neuron, 17, pp. 837-848; Rossant, J., Tam, P.P., Blastocyst lineage formation, early embryonic asymmetries and axis patterning in the mouse (2009) Development, 136, pp. 701-713; Rougon, G., Hobert, O., New insights into the diversity and function of neuronal immunoglobulin superfamily molecules (2003) Annu. Rev. Neurosci., 26, pp. 207-238; Schiele, N.R., Koppes, R.A., Chrisey, D.B., Corr, D.T., Engineering cellular fibers for musculoskeletal soft tissues using directed self-assembly (2013) Tissue Eng. A, 19, pp. 1223-1232; Schneider, D.J., Wu, M., Le, T.T., Cho, S.H., Brenner, M.B., Blackburn, M.R., Agarwal, S.K., Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-beta production and epithelial to mesenchymal transition (2012) FASEB J., 26, pp. 503-512; Shapiro, L., Weis, W.I., Structure and biochemistry of cadherins and catenins (2009) Cold Spring Harb. Perspect. Biol., 1, p. a003053; Shay-Salit, A., Shushy, M., Wolfovitz, E., Yahav, H., Breviario, F., Dejana, E., Resnick, N., VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 9462-9467; Shen, X., Kramer, R.H., Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor (2004) Am. J. Pathol., 165, pp. 1315-1329; Shih, W., Yamada, S., N-Cadherin as a key regulator of collective cell migration in a 3D environment (2012) Cell Adhes. Migr., 6, pp. 513-517; Shih, W., Yamada, S., N-Cadherin-mediated cell-cell adhesion promotes cell migration in a three-dimensional matrix (2012) J. Cell Sci., 125, pp. 3661-3670; Shin, C.S., Lecanda, F., Sheikh, S., Weitzmann, L., Cheng, S.L., Civitelli, R., Relative abundance of different cadherins defines differentiation of mesenchymal precursors into osteogenic, myogenic, or adipogenic pathways (2000) J. Cell. Biochem., 78, pp. 566-577; Simonneau, L., Kitagawa, M., Suzuki, S., Thiery, J.P., Cadherin 11 expression marks the mesenchymal phenotype: towards new functions for cadherins? (1995) Cell Adhes. Commun., 3, pp. 115-130; Smutny, M., Yap, A.S., Neighborly relations: cadherins and mechanotransduction (2010) J. Cell Biol., 189, pp. 1075-1077; Stepniak, E., Radice, G.L., Vasioukhin, V., Adhesive and signaling functions of cadherins and catenins in vertebrate development (2009) Cold Spring Harb. Perspect. Biol., 1, p. a002949; Stevens, K.R., Kreutziger, K.L., Dupras, S.K., Korte, F.S., Regnier, M., Muskheli, V., Nourse, M.B., Murry, C.E., Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 16568-16573; Suva, L.J., Towler, D.A., Harada, S., Gaub, M.P., Rodan, G.A., Characterization of retinoic acid- and cell-dependent sequences which regulate zif268 gene expression in osteoblastic cells (1994) Mol. Endocrinol., 8, pp. 1507-1520; Suzuki, S.C., Inoue, T., Kimura, Y., Tanaka, T., Takeichi, M., Neuronal circuits are subdivided by differential expression of type-II classic cadherins in postnatal mouse brains (1997) Mol. Cell. Neurosci., 9, pp. 433-447; Takeichi, M., Cadherin cell adhesion receptors as a morphogenetic regulator (1991) Science, 251, pp. 1451-1455; Tang, J., Peng, R., Ding, J., The regulation of stem cell differentiation by cell-cell contact on micropatterned material surfaces (2010) Biomaterials, 31, pp. 2470-2476; Theisen, C.S., Wahl, J.K., Johnson, K.R., Wheelock, M.J., NHERF links the N-cadherin/catenin complex to the platelet-derived growth factor receptor to modulate the actin cytoskeleton and regulate cell motility (2007) Mol. Biol. Cell, 18, pp. 1220-1232; Thompson, S.A., Blazeski, A., Copeland, C.R., Cohen, D.M., Chen, C.S., Reich, D.M., Tung, L., Acute slowing of cardiac conduction in response to myofibroblast coupling to cardiomyocytes through N-cadherin (2014) J. Mol. Cell. Cardiol., 68, pp. 29-37; Tian, J., Andreadis, S.T., Independent and high-level dual-gene expression in adult stem-progenitor cells from a single lentiviral vector (2009) Gene Ther., 16, pp. 874-884; Tian, J., Alimperti, S., Lei, P., Andreadis, S.T., Lentiviral microarrays for real-time monitoring of gene expression dynamics (2010) Lab Chip, 10, pp. 1967-1975; Tomita, K., van Bokhoven, A., van Leenders, G.J., Ruijter, E.T., Jansen, C.F., Bussemakers, M.J., Schalken, J.A., Cadherin switching in human prostate cancer progression (2000) Cancer Res., 60, pp. 3650-3654; Trappmann, B., Gautrot, J.E., Connelly, J.T., Strange, D.G., Li, Y., Oyen, M.L., Cohen Stuart, M.A., Huck, W.T., Extracellular-matrix tethering regulates stem-cell fate (2012) Nat. Mater., 11, pp. 642-649; Treiser, M.D., Yang, E.H., Gordonov, S., Cohen, D.M., Androulakis, I.P., Kohn, J., Chen, C.S., Moghe, P.V., Cytoskeleton-based forecasting of stem cell lineage fates (2010) Proc. Natl. Acad. Sci. U. S. A., 107, pp. 610-615; Tuan, R.S., Cellular signaling in developmental chondrogenesis: N-cadherin, Wnts, and BMP-2 (2003) J. Bone Joint Surg. Am., pp. 137-141; Tufan, A.C., Tuan, R.S., Wnt regulation of limb mesenchymal chondrogenesis is accompanied by altered N-cadherin-related functions (2001) FASEB J., 15, pp. 1436-1438; Tufan, A.C., Daumer, K.M., DeLise, A.M., Tuan, R.S., AP-1 transcription factor complex is a target of signals from both WnT-7a and N-cadherin-dependent cell-cell adhesion complex during the regulation of limb mesenchymal chondrogenesis (2002) Exp. Cell Res., 273, pp. 197-203; Tufan, A.C., Daumer, K.M., Tuan, R.S., Frizzled-7 and limb mesenchymal chondrogenesis: effect of misexpression and involvement of N-cadherin (2002) Dev. Dyn., 223, pp. 241-253; Tzima, E., Irani-Tehrani, M., Kiosses, W.B., Dejana, E., Schultz, D.A., Engelhardt, B., Cao, G., Schwartz, M.A., A mechanosensory complex that mediates the endothelial cell response to fluid shear stress (2005) Nature, 437, pp. 426-431; Wakitani, S., Imoto, K., Yamamoto, T., Saito, M., Murata, N., Yoneda, M., Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees (2002) Osteoarthr. Cartil., 10, pp. 199-206; Wang, L., Li, Y., Chen, X., Chen, J., Gautam, S.C., Xu, Y., Chopp, M., MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture (2002) Hematology, 7, pp. 113-117; Wang, X., Song, W., Kawazoe, N., Chen, G., The osteogenic differentiation of mesenchymal stem cells by controlled cell-cell interaction on micropatterned surfaces (2013) J. Biomed. Mater. Res. A, 101, pp. 3388-3395; Wen, J.H., Vincent, L.G., Fuhrmann, A., Choi, Y.S., Hribar, K.C., Taylor-Weiner, H., Chen, S., Engler, A.J., Interplay of matrix stiffness and protein tethering in stem cell differentiation (2014) Nat. Mater., 13, pp. 979-987; Wendt, M.K., Smith, J.A., Schiemann, W.P., Transforming growth factor-beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression (2010) Oncogene, 29, pp. 6485-6498; Williams, E.J., Furness, J., Walsh, F.S., Doherty, P., Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin (1994) Neuron, 13, pp. 583-594; Williams, G., Williams, E.J., Doherty, P., Dimeric versions of two short N-cadherin binding motifs (HAVDI and INPISG) function as N-cadherin agonists (2002) J. Biol. Chem., 277, pp. 4361-4367; Woods, A., Wang, G., Dupuis, H., Shao, Z., Beier, F., Rac1 signaling stimulates N-cadherin expression, mesenchymal condensation, and chondrogenesis (2007) J. Biol. Chem., 282, pp. 23500-23508; Xu, L., Meng, F., Ni, M., Lee, Y., Li, G., N-Cadherin regulates osteogenesis and migration of bone marrow-derived mesenchymal stem cells (2012) Mol. Biol. Rep.; Yang, X., Chrisman, H., Weijer, C.J., PDGF signalling controls the migration of mesoderm cells during chick gastrulation by regulating N-cadherin expression (2008) Development, 135, pp. 3521-3530; Yap, A.S., Kovacs, E.M., Direct cadherin-activated cell signaling: a view from the plasma membrane (2003) J. Cell Biol., 160, pp. 11-16; Yonemura, S., Cadherin-actin interactions at adherens junctions (2011) Curr. Opin. Cell Biol., 23, pp. 515-522; You, H., Padmashali, R.M., Ranganathan, A., Lei, P., Girnius, N., Davis, R.J., Andreadis, S.T., JNK regulates compliance-induced adherens junctions formation in epithelial cells and tissues (2013) J. Cell Sci., 126, pp. 2718-2729; Zeisberg, M., Neilson, E.G., Biomarkers for epithelial-mesenchymal transitions (2009) J. Clin. Invest., 119, pp. 1429-1437; Zhang, Y., Zhou, Y., Zhu, J., Dong, S., Li, C., Xiang, Q., Effect of a novel recombinant protein of fibronectinIII7-10/cadherin 11 EC1-2 on osteoblastic adhesion and differentiation (2009) Biosci. Biotechnol. Biochem., 73, pp. 1999-2006",Review,Scopus,2-s2.0-84924710551
"Lin H.-Y., Liou C.-W., Chen S.-D., Hsu T.-Y., Chuang J.-H., Wang P.-W., Huang S.-T., Tiao M.-M., Chen J.-B., Lin T.-K., Chuang Y.-C.","Mitochondrial transfer from Wharton's jelly-derived mesenchymal stem cells to mitochondria-defective cells recaptures impaired mitochondrial function",2015,"Mitochondrion","22",,,"31","44",,,10.1016/j.mito.2015.02.006,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924959263&partnerID=40&md5=b450686316d6e90ac940ec6faf65623f","Department of Biological Sciences, National Sun Yat-Sen UniversityKaohsiung, Taiwan; Department of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Division of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Center of Parkinson's Disease, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Department of Chinese Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Department of Nephrology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Center for Translational Research in Biomedical Sciences, Kaohsiung Chang Gung Memorial HospitalKaohsiung, Taiwan","Lin, H.-Y., Department of Biological Sciences, National Sun Yat-Sen UniversityKaohsiung, Taiwan, Department of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Center of Parkinson's Disease, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Center for Translational Research in Biomedical Sciences, Kaohsiung Chang Gung Memorial HospitalKaohsiung, Taiwan; Liou, C.-W., Department of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Center of Parkinson's Disease, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Chen, S.-D., Department of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Center of Parkinson's Disease, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Center for Translational Research in Biomedical Sciences, Kaohsiung Chang Gung Memorial HospitalKaohsiung, Taiwan; Hsu, T.-Y., Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Chuang, J.-H., Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Division of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Wang, P.-W., Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Huang, S.-T., Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Department of Chinese Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Tiao, M.-M., Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Chen, J.-B., Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Department of Nephrology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Lin, T.-K., Department of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Center of Parkinson's Disease, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan; Chuang, Y.-C., Department of Biological Sciences, National Sun Yat-Sen UniversityKaohsiung, Taiwan, Department of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Center of Parkinson's Disease, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineKaohsiung, Taiwan, Center for Translational Research in Biomedical Sciences, Kaohsiung Chang Gung Memorial HospitalKaohsiung, Taiwan","Adult mesenchymal stem cell (MSC)-conducted mitochondrial transfer has been recently shown to rescue cellular bioenergetics and prevent cell death caused by mitochondrial dysfunction. Wharton's jelly-derived MSCs (WJMSCs) harvested from postpartum umbilical cords are an accessible and abundant source of stem cells. This study aimed to determine the capability of WJMSCs to transfer their own mitochondria and rescue impaired oxidative phosphorylation (OXPHOS) and bioenergetics caused by mitochondrial DNA defects. To do this, WJMSCs were co-cultured with mitochondrial DNA (mtDNA)-depleted ρ0 cells and the recapture of mitochondrial function was evaluated. WJMSCs were shown to be capable of transferring their own mitochondria into ρ0 cells and underwent interorganellar mixture within these cells. Permissive culture media (BrdU-containing and pyruvate- and uridine-free) sieved out a survival cell population from the co-cultured WJMSCs (BrdU-sensitive) and ρ0 cells (pyruvate/uridine-free). The survival cells had mtDNA identical to that of WJMSCs, whereas they expressed cellular markers identical to that of ρ0 cells. Importantly, these ρ0-plus -WJMSC-mtDNA (ρ+W) cells recovered the expression of mtDNA-encoded proteins and exhibited functional oxygen consumption and respiratory control, as well as the activity of electron transport chain (ETC) complexes I, II, III and IV. In addition, ETC complex V-inhibitor-sensitive ATP production and metabolic shifting were also recovered. Furthermore, cellular behaviors including attachment-free proliferation, aerobic viability and OXPHOS-reliant cellular motility were also regained after mitochondrial transfer by WJMSCs. The therapeutic effect of WJMSCs-derived mitochondrial transfer was able to stably sustain for at least 45 passages. In conclusion, this study suggests that WJMSCs may serve as a potential therapeutic strategy for diseases linked to mitochondrial dysfunction through the donation of healthy mitochondria to cells with genetic mitochondrial defects. © 2015 Elsevier B.V.","Mitochondrial dysfunction; Mitochondrial transfer; Wharton's jelly mesenchymal stem cell","Acquistapace, A., Bru, T., Lesault, P.F., Figeac, F., Coudert, A.E., le Coz, O., Christov, C., Rodriguez, A.M., Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer (2011) Stem Cells, 29, pp. 812-824; Baksh, D., Yao, R., Tuan, R.S., Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow (2007) Stem Cells, 25, pp. 1384-1392; Beal, M.F., Mitochondria take center stage in aging and neurodegeneration (2005) Ann. Neurol., 58, pp. 495-505; Boquest, A.C., Noer, A., Collas, P., Epigenetic programming of mesenchymal stem cells from human adipose tissue (2006) Stem Cell Rev., 2, pp. 319-329; Brandon, M.C., Lott, M.T., Nguyen, K.C., Spolim, S., Navathe, S.B., Baldi, P., Wallace, D.C., MITOMAP: a human mitochondrial genome database-2004 update (2005) Nucleic Acids Res., 33, pp. D611-613; Chang, J.C., Liu, K.H., Chuang, C.S., Su, H.L., Wei, Y.H., Kuo, S.J., Liu, C.S., Treatment of human cells derived from MERRF syndrome by peptide-mediated mitochondrial delivery (2013) Cytotherapy, 15, pp. 1580-1596; Chen, M.Y., Lie, P.C., Li, Z.L., Wei, X., Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells (2009) Exp. Hematol., 37, pp. 629-640; Cho, Y.M., Kim, J.H., Kim, M., Park, S.J., Koh, S.H., Ahn, H.S., Kang, G.H., Lee, H.K., Mesenchymal stem cells transfer mitochondria to the cells with virtually no mitochondrial function but not with pathogenic mtDNA mutations (2012) PLoS One, 7, p. e32778; Conconi, M.T., Burra, P., Di Liddo, R., Calore, C., Turetta, M., Bellini, S., Bo, P., Parnigotto, P.P., CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential (2006) Int. J. Mol. Med., 18, pp. 1089-1096; Cselenyak, A., Pankotai, E., Horvath, E.M., Kiss, L., Lacza, Z., Mesenchymal stem cells rescue cardiomyoblasts from cell death in an in vitro ischemia model via direct cell-to-cell connections (2010) BMC Cell Biol., 11, p. 29; Evans, M.D., Dizdaroglu, M., Cooke, M.S., Oxidative DNA damage and disease: induction, repair and significance (2004) Mutat. Res., 567, pp. 1-61; Figeac, F., Lesault, P.F., Le Coz, O., Damy, T., Souktani, R., Trebeau, C., Schmitt, A., Rodriguez, A.M., Nanotubular crosstalk with distressed cardiomyocytes stimulates the paracrine repair function of mesenchymal stem cells (2014) Stem Cells, 32, pp. 216-230; Gohil, V.M., Sheth, S.A., Nilsson, R., Wojtovich, A.P., Lee, J.H., Perocchi, F., Chen, W., Mootha, V.K., Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis (2010) Nat. Biotechnol., 28, pp. 249-255; Hematti, P., Role of mesenchymal stromal cells in solid organ transplantation (2008) Transplant. Rev. (Orlando), 22, pp. 262-273; Heytler, P.G., Uncouplers of oxidative phosphorylation (1979) Methods Enzymol., 55, pp. 442-462; Hirko, A.C., Dallasen, R., Jomura, S., Xu, Y., Modulation of inflammatory responses after global ischemia by transplanted umbilical cord matrix stem cells (2008) Stem Cells, 26, pp. 2893-2901; Honda, H.M., Korge, P., Weiss, J.N., Mitochondria and ischemia/reperfusion injury (2005) Ann. N. Y. Acad. Sci., 1047, pp. 248-258; Islam, M.N., Das, S.R., Emin, M.T., Wei, M., Sun, L., Westphalen, K., Rowlands, D.J., Bhattacharya, J., Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury (2012) Nat. Med., 18, pp. 759-765; Karahuseyinoglu, S., Cinar, O., Kilic, E., Kara, F., Akay, G.G., Demiralp, D.O., Tukun, A., Can, A., Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys (2007) Stem Cells, 25, pp. 319-331; Kern, S., Eichler, H., Stoeve, J., Kluter, H., Bieback, K., Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue (2006) Stem Cells, 24, pp. 1294-1301; Kim, D.W., Staples, M., Shinozuka, K., Pantcheva, P., Kang, S.D., Borlongan, C.V., Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications (2013) Int. J. Mol. Sci., 14, pp. 11692-11712; Kimura, R., Ishikawa, C., Rokkaku, T., Janknecht, R., Mori, N., Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells (1813) Biochim. Biophys. Acta, 2011, pp. 1543-1553; King, M.P., Attardi, G., Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation (1989) Science, 246, pp. 500-503; Kroemer, G., Galluzzi, L., Brenner, C., Mitochondrial membrane permeabilization in cell death (2007) Physiol. Rev., 87, pp. 99-163; Lin, T.K., Liou, C.W., Chen, S.D., Chuang, Y.C., Tiao, M.M., Wang, P.W., Chen, J.B., Chuang, J.H., Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease (2009) Chang Gung Med. J., 32, pp. 589-599; Lin, T.K., Lin, H.Y., Chen, S.D., Chuang, Y.C., Chuang, J.H., Wang, P.W., Huang, S.T., Liou, C.W., The creation of cybrids harboring mitochondrial haplogroups in the Taiwanese population of ethnic Chinese background: an extensive in vitro tool for the study of mitochondrial genomic variations (2012) Oxidative Med. Cell. Longev., 2012, p. 824275; Lund, R.D., Wang, S., Lu, B., Girman, S., Holmes, T., Sauve, Y., Messina, D.J., Mistry, S.K., Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease (2007) Stem Cells, 25, pp. 602-611; Matsunoshita, Y., Ijiri, K., Ishidou, Y., Nagano, S., Yamamoto, T., Nagao, H., Komiya, S., Setoguchi, T., Suppression of osteosarcoma cell invasion by chemotherapy is mediated by urokinase plasminogen activator activity via up-regulation of EGR1 (2011) PLoS One, 6, p. e16234; Mitchell, K.E., Weiss, M.L., Mitchell, B.M., Martin, P., Davis, D., Morales, L., Helwig, B., Medicetty, S., Matrix cells from Wharton's jelly form neurons and glia (2003) Stem Cells, 21, pp. 50-60; Noer, A., Boquest, A.C., Collas, P., Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence (2007) BMC Cell Biol., 8, p. 18; Rojewski, M.T., Weber, B.M., Schrezenmeier, H., Phenotypic characterization of mesenchymal stem cells from various tissues (2008) Transfus. Med. Hemother., 35, pp. 168-184; Spees, J.L., Olson, S.D., Whitney, M.J., Prockop, D.J., Mitochondrial transfer between cells can rescue aerobic respiration (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 1283-1288; Tiao, M.M., Liou, C.W., Huang, L.T., Wang, P.W., Lin, T.K., Chen, J.B., Chou, Y.M., Chuang, J.H., Associations of mitochondrial haplogroups b4 and e with biliary atresia and differential susceptibility to hydrophobic bile acid (2013) PLoS Genet., 9, p. e1003696; Wang, H.S., Hung, S.C., Peng, S.T., Huang, C.C., Wei, H.M., Guo, Y.J., Fu, Y.S., Chen, C.C., Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord (2004) Stem Cells, 22, pp. 1330-1337; Weng, S.W., Kuo, H.M., Chuang, J.H., Lin, T.K., Huang, H.L., Lin, H.Y., Liou, C.W., Wang, P.W., Study of insulin resistance in cybrid cells harboring diabetes-susceptible and diabetes-protective mitochondrial haplogroups (2013) Mitochondrion, 13, pp. 888-897; Yang, C.C., Shih, Y.H., Ko, M.H., Hsu, S.Y., Cheng, H., Fu, Y.S., Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord (2008) PLoS One, 3, p. e3336; Yang, X., Zhang, M., Zhang, Y., Li, W., Yang, B., Mesenchymal stem cells derived from Wharton jelly of the human umbilical cord ameliorate damage to human endometrial stromal cells (2011) Fertil. Steril., 96, pp. 1029-1036; Zhang, J., Nuebel, E., Wisidagama, D.R., Setoguchi, K., Hong, J.S., Van Horn, C.M., Imam, S.S., Teitell, M.A., Measuring energy metabolism in cultured cells, including human pluripotent stem cells and differentiated cells (2012) Nat. Protoc., 7, pp. 1068-1085",Article,Scopus,2-s2.0-84924959263
"Scelfo A., Piunti A., Pasini D.","The controversial role of the Polycomb group proteins in transcription and cancer: How much do we not understand Polycomb proteins?",2015,"FEBS Journal","282","9",,"1703","1722",,1,10.1111/febs.13112,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928535677&partnerID=40&md5=5ce38780c77c7edee1a973d57a5589e0","Department of Experimental Oncology, European Institute of Oncology (IEO), Via Adamello 16Milan, Italy","Scelfo, A., Department of Experimental Oncology, European Institute of Oncology (IEO), Via Adamello 16Milan, Italy; Piunti, A., Department of Experimental Oncology, European Institute of Oncology (IEO), Via Adamello 16Milan, Italy; Pasini, D., Department of Experimental Oncology, European Institute of Oncology (IEO), Via Adamello 16Milan, Italy","Polycomb group proteins (PcGs) are a large protein family that includes diverse biochemical features assembled together in two large multiprotein complexes. These complexes maintain gene transcriptional repression in a cell type specific manner by modifying the surrounding chromatin to control development, differentiation and cell proliferation. PcGs are also involved in several diseases. PcGs are often directly or indirectly implicated in cancer development for which they have been proposed as potential targets for cancer therapeutic strategies. However, in the last few years a series of discoveries about the basic properties of PcGs and the identification of specific genetic alterations affecting specific Polycomb proteins in different tumours have converged to challenge old dogmas about PcG biological and molecular functions. In this review, we analyse these new data in the context of the old knowledge, highlighting the controversies and providing new models of interpretation and ideas that will perhaps bring some order among apparently contradicting observations. Polycomb group proteins (PcGs) assemble two large complexes with different biochemical features ensuring gene transcriptional repression in a cell-type specific manner by modifying the surrounding chromatin. PcGs control development, differentiation, cell proliferation and are involved in cancer onset. This review analyzes new evidences challenging old dogmas about PcG functions, highlighting the controversies and providing new models to interpret PcG activities. © 2014 FEBS.","Cancer; Chromatin; Epigenetics; Histone modifications; Polycomb; PRC1; PRC2; Transcriptional regulation","Lewis, E.B., A gene complex controlling segmentation in Drosophila (1978) Nature, 276, pp. 565-570; Van Lohuizen, M., Verbeek, S., Scheijen, B., Wientjens, E., Van Der Gulden, H., Berns, A., Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging (1991) Cell, 65, pp. 737-752; Haupt, Y., Alexander, W.S., Barri, G., Klinken, S.P., Adams, J.M., Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice (1991) Cell, 65, pp. 753-763; Schumacher, A., Magnuson, T., Murine Polycomb- and trithorax-group genes regulate homeotic pathways and beyond (1997) Trends Genet, 13, pp. 167-170; Piunti, A., Pasini, D., Epigenetic factors in cancer development: polycomb group proteins (2011) Future Oncol, 7, pp. 57-75; Schwartz, Y.B., Pirrotta, V., A new world of Polycombs: unexpected partnerships and emerging functions (2013) Nat Rev Genet, 14, pp. 853-864; Gao, Z., Zhang, J., Bonasio, R., Strino, F., Sawai, A., Parisi, F., Kluger, Y., Reinberg, D., PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes (2012) Mol Cell, 45, pp. 344-356; De Napoles, M., Mermoud, J.E., Wakao, R., Tang, Y.A., Endoh, M., Appanah, R., Nesterova, T.B., Vidal, M., Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation (2004) Dev Cell, 7, pp. 663-676; Endoh, M., Endo, T.A., Endoh, T., Fujimura, Y., Ohara, O., Toyoda, T., Otte, A.P., Vidal, M., Polycomb group proteins Ring1A/B are functionally linked to the core transcriptional regulatory circuitry to maintain ES cell identity (2008) Development, 135, pp. 1513-1524; Margueron, R., Reinberg, D., The Polycomb complex PRC2 and its mark in life (2011) Nature, 469, pp. 343-349; Ferrari, K.J., Scelfo, A., Jammula, S., Cuomo, A., Barozzi, I., Stutzer, A., Fischle, W., Pasini, D., Polycomb-dependent H3K27me1 and H3K27me2 regulate active transcription and enhancer fidelity (2014) Mol Cell, 53, pp. 49-62; Cao, R., Tsukada, Y., Zhang, Y., Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing (2005) Mol Cell, 20, pp. 845-854; Elderkin, S., Maertens, G.N., Endoh, M., Mallery, D.L., Morrice, N., Koseki, H., Peters, G., Hiom, K., A phosphorylated form of Mel-18 targets the Ring1B histone H2A ubiquitin ligase to chromatin (2007) Mol Cell, 28, pp. 107-120; Pasini, D., Bracken, A.P., Jensen, M.R., Lazzerini Denchi, E., Helin, K., Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity (2004) EMBO J, 23, pp. 4061-4071; Cao, R., Zhang, Y., SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex (2004) Mol Cell, 15, pp. 57-67; Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R.S., Zhang, Y., Role of histone H3 lysine 27 methylation in Polycomb-group silencing (2002) Science, 298, pp. 1039-1043; Orlando, V., Paro, R., Mapping Polycomb-repressed domains in the bithorax complex using in vivo formaldehyde cross-linked chromatin (1993) Cell, 75, pp. 1187-1198; Simon, J.A., Kingston, R.E., Occupying chromatin: Polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put (2013) Mol Cell, 49, pp. 808-824; Laugesen, A., Helin, K., Chromatin repressive complexes in stem cells, development, and cancer (2014) Cell Stem Cell, 14, pp. 735-751; Mousavi, K., Zare, H., Wang, A.H., Sartorelli, V., Polycomb protein Ezh1 promotes RNA polymerase II elongation (2012) Mol Cell, 45, pp. 255-262; Frangini, A., Sjoberg, M., Roman-Trufero, M., Dharmalingam, G., Haberle, V., Bartke, T., Lenhard, B., Dillon, N., The aurora B kinase and the polycomb protein ring1B combine to regulate active promoters in quiescent lymphocytes (2013) Mol Cell, 51, pp. 647-661; Tavares, L., Dimitrova, E., Oxley, D., Webster, J., Poot, R., Demmers, J., Bezstarosti, K., Koide, H., RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3 (2012) Cell, 148, pp. 664-678; Wu, X., Johansen, J.V., Helin, K., Fbxl10/Kdm2b recruits polycomb repressive complex 1 to CpG islands and regulates H2A ubiquitylation (2013) Mol Cell, 49, pp. 1134-1146; Pasini, D., Cloos, P.A., Walfridsson, J., Olsson, L., Bukowski, J.P., Johansen, J.V., Bak, M., Helin, K., JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells (2010) Nature, 464, pp. 306-310; He, J., Shen, L., Wan, M., Taranova, O., Wu, H., Zhang, Y., Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes (2013) Nat Cell Biol, 15, pp. 373-384; Sparmann, A., Van Lohuizen, M., Polycomb silencers control cell fate, development and cancer (2006) Nat Rev Cancer, 6, pp. 846-856; Czermin, B., Melfi, R., Mccabe, D., Seitz, V., Imhof, A., Pirrotta, V., Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites (2002) Cell, 111, pp. 185-196; Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., Reinberg, D., Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein (2002) Genes Dev, 16, pp. 2893-2905; Margueron, R., Li, G., Sarma, K., Blais, A., Zavadil, J., Woodcock, C.L., Dynlacht, B.D., Reinberg, D., Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms (2008) Mol Cell, 32, pp. 503-518; Ketel, C.S., Andersen, E.F., Vargas, M.L., Suh, J., Strome, S., Simon, J.A., Subunit contributions to histone methyltransferase activities of fly and worm polycomb group complexes (2005) Mol Cell Biol, 25, pp. 6857-6868; Faust, C., Schumacher, A., Holdener, B., Magnuson, T., The eed mutation disrupts anterior mesoderm production in mice (1995) Development, 121, pp. 273-285; O'carroll, D., Erhardt, S., Pagani, M., Barton, S.C., Surani, M.A., Jenuwein, T., The polycomb-group gene Ezh2 is required for early mouse development (2001) Mol Cell Biol, 21, pp. 4330-4336; Mohn, F., Weber, M., Rebhan, M., Roloff, T.C., Richter, J., Stadler, M.B., Bibel, M., Schubeler, D., Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors (2008) Mol Cell, 30, pp. 755-766; Lee, T.I., Jenner, R.G., Boyer, L.A., Guenther, M.G., Levine, S.S., Kumar, R.M., Chevalier, B., Isono, K., Control of developmental regulators by Polycomb in human embryonic stem cells (2006) Cell, 125, pp. 301-313; Bracken, A.P., Dietrich, N., Pasini, D., Hansen, K.H., Helin, K., Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions (2006) Genes Dev, 20, pp. 1123-1136; Boyer, L.A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L.A., Lee, T.I., Levine, S.S., Ray, M.K., Polycomb complexes repress developmental regulators in murine embryonic stem cells (2006) Nature, 441, pp. 349-353; Margueron, R., Justin, N., Ohno, K., Sharpe, M.L., Son, J., Drury, W.J., III, Voigt, P., De Marco, V., Role of the polycomb protein EED in the propagation of repressive histone marks (2009) Nature, 461, pp. 762-767; Hansen, K.H., Bracken, A.P., Pasini, D., Dietrich, N., Gehani, S.S., Monrad, A., Rappsilber, J., Helin, K., A model for transmission of the H3K27me3 epigenetic mark (2008) Nat Cell Biol, 10, pp. 1291-1300; Lewis, P.W., Muller, M.M., Koletsky, M.S., Cordero, F., Lin, S., Banaszynski, L.A., Garcia, B.A., Allis, C.D., Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma (2013) Science, 340, pp. 857-861; Van Aller, G.S., Pappalardi, M.B., Ott, H.M., Diaz, E., Brandt, M., Schwartz, B.J., Miller, W.H., Verma, S.K., Long residence time inhibition of EZH2 in activated polycomb repressive complex 2 (2014) ACS Chem Biol, 9, pp. 622-629; Piunti, A., Rossi, A., Cerutti, A., Albert, M., Jammula, S., Scelfo, A., Cedrone, L., Koseki, H., Polycomb proteins control proliferation and transformation independently of cell cycle checkpoints by regulating DNA replication (2014) Nat Commun, 5, p. 3649; Ku, M., Koche, R.P., Rheinbay, E., Mendenhall, E.M., Endoh, M., Mikkelsen, T.S., Presser, A., Chi, A.S., Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains (2008) PLoS Genet, 4; Kizer, K.O., Phatnani, H.P., Shibata, Y., Hall, H., Greenleaf, A.L., Strahl, B.D., A novel domain in Set2 mediates RNA polymerase II interaction and couples histone H3 K36 methylation with transcript elongation (2005) Mol Cell Biol, 25, pp. 3305-3316; Li, B., Howe, L., Anderson, S., Yates, J.R., III, Workman, J.L., The Set2 histone methyltransferase functions through the phosphorylated carboxyl-terminal domain of RNA polymerase II (2003) J Biol Chem, 278, pp. 8897-8903; Li, J., Moazed, D., Gygi, S.P., Association of the histone methyltransferase Set2 with RNA polymerase II plays a role in transcription elongation (2002) J Biol Chem, 277, pp. 49383-49388; Xiao, T., Hall, H., Kizer, K.O., Shibata, Y., Hall, M.C., Borchers, C.H., Strahl, B.D., Phosphorylation of RNA polymerase II CTD regulates H3 methylation in yeast (2003) Genes Dev, 17, pp. 654-663; McCabe, M.T., Graves, A.P., Ganji, G., Diaz, E., Halsey, W.S., Jiang, Y., Smitheman, K.N., Allen, K.E., Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27) (2012) Proc Natl Acad Sci USA, 109, pp. 2989-2994; Sneeringer, C.J., Scott, M.P., Kuntz, K.W., Knutson, S.K., Pollock, R.M., Richon, V.M., Copeland, R.A., Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas (2010) Proc Natl Acad Sci USA, 107, pp. 20980-20985; Tie, F., Banerjee, R., Stratton, C.A., Prasad-Sinha, J., Stepanik, V., Zlobin, A., Diaz, M.O., Harte, P.J., CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing (2009) Development, 136, pp. 3131-3141; Kim, H., Kang, K., Kim, J., AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2 (2009) Nucleic Acids Res, 37, pp. 2940-2950; Sarma, K., Margueron, R., Ivanov, A., Pirrotta, V., Reinberg, D., Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo (2008) Mol Cell Biol, 28, pp. 2718-2731; Cao, R., Wang, H., He, J., Erdjument-Bromage, H., Tempst, P., Zhang, Y., Role of hPHF1 in H3K27 methylation and Hox gene silencing (2008) Mol Cell Biol, 28, pp. 1862-1872; Walker, E., Chang, W.Y., Hunkapiller, J., Cagney, G., Garcha, K., Torchia, J., Krogan, N.J., Stanford, W.L., Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation (2010) Cell Stem Cell, 6, pp. 153-166; Zhang, Z., Jones, A., Sun, C.W., Li, C., Chang, C.W., Joo, H.Y., Dai, Q., Guo, Y., PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming (2011) Stem Cells, 29, pp. 229-240; Boulay, G., Rosnoblet, C., Guerardel, C., Angrand, P.O., Leprince, D., Functional characterization of human Polycomb-like 3 isoforms identifies them as components of distinct EZH2 protein complexes (2011) Biochem J, 434, pp. 333-342; Wang, S., Robertson, G.P., Zhu, J., A novel human homologue of Drosophila polycomblike gene is up-regulated in multiple cancers (2004) Gene, 343, pp. 69-78; Ballare, C., Lange, M., Lapinaite, A., Martin, G.M., Morey, L., Pascual, G., Liefke, R., Gozani, O., Phf19 links methylated Lys36 of histone H3 to regulation of Polycomb activity (2012) Nat Struct Mol Biol, 19, pp. 1257-1265; Brien, G.L., Gambero, G., O'connell, D.J., Jerman, E., Turner, S.A., Egan, C.M., Dunne, E.J., Piao, L., Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation (2012) Nat Struct Mol Biol, 19, pp. 1273-1281; Li, G., Margueron, R., Ku, M., Chambon, P., Bernstein, B.E., Reinberg, D., Jarid2 and PRC2, partners in regulating gene expression (2010) Genes Dev, 24, pp. 368-380; Landeira, D., Sauer, S., Poot, R., Dvorkina, M., Mazzarella, L., Jorgensen, H.F., Pereira, C.F., Spivakov, M., Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators (2010) Nat Cell Biol, 12, pp. 618-624; Shen, X., Kim, W., Fujiwara, Y., Simon, M.D., Liu, Y., Mysliwiec, M.R., Yuan, G.C., Orkin, S.H., Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells (2009) Cell, 139, pp. 1303-1314; Peng, J.C., Valouev, A., Swigut, T., Zhang, J., Zhao, Y., Sidow, A., Wysocka, J., Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells (2009) Cell, 139, pp. 1290-1302; Cao, Q., Wang, X., Zhao, M., Yang, R., Malik, R., Qiao, Y., Poliakov, A., Chen, W., The central role of EED in the orchestration of polycomb group complexes (2014) Nat Commun, 5, p. 3127; Vandamme, J., Volkel, P., Rosnoblet, C., Le Faou, P., Angrand, P.O., Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells (2011) Mol Cell Proteomics, 10, p. M110002642; Wang, H., Wang, L., Erdjument-Bromage, H., Vidal, M., Tempst, P., Jones, R.S., Zhang, Y., Role of histone H2A ubiquitination in Polycomb silencing (2004) Nature, 431, pp. 873-878; Levine, S.S., Weiss, A., Erdjument-Bromage, H., Shao, Z., Tempst, P., Kingston, R.E., The core of the polycomb repressive complex is compositionally and functionally conserved in flies and humans (2002) Mol Cell Biol, 22, pp. 6070-6078; Morey, L., Aloia, L., Cozzuto, L., Benitah, S.A., Di Croce, L., RYBP and Cbx7 define specific biological functions of polycomb complexes in mouse embryonic stem cells (2013) Cell Rep, 3, pp. 60-69; Blackledge, N.P., Farcas, A.M., Kondo, T., King, H.W., Mcgouran, J.F., Hanssen, L.L., Ito, S., Koseki, Y., Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation (2014) Cell, 157, pp. 1445-1459; Barrero, M.J., Izpisua Belmonte, J.C., Polycomb complex recruitment in pluripotent stem cells (2013) Nat Cell Biol, 15, pp. 348-350; He, J., Kallin, E.M., Tsukada, Y., Zhang, Y., The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b) (2008) Nat Struct Mol Biol, 15, pp. 1169-1175; Blackledge, N.P., Zhou, J.C., Tolstorukov, M.Y., Farcas, A.M., Park, P.J., Klose, R.J., CpG islands recruit a histone H3 lysine 36 demethylase (2010) Mol Cell, 38, pp. 179-190; Trojer, P., Cao, A.R., Gao, Z., Li, Y., Zhang, J., Xu, X., Li, G., Tempst, P., L3MBTL2 protein acts in concert with PcG protein-mediated monoubiquitination of H2A to establish a repressive chromatin structure (2011) Mol Cell, 42, pp. 438-450; Qin, J., Whyte, W.A., Anderssen, E., Apostolou, E., Chen, H.H., Akbarian, S., Bronson, R.T., Young, R.A., The polycomb group protein L3mbtl2 assembles an atypical PRC1-family complex that is essential in pluripotent stem cells and early development (2012) Cell Stem Cell, 11, pp. 319-332; Ang, Y.S., Tsai, S.Y., Lee, D.F., Monk, J., Su, J., Ratnakumar, K., Ding, J., Chang, B., Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network (2011) Cell, 145, pp. 183-197; Trievel, R.C., Shilatifard, A., WDR5, a complexed protein (2009) Nat Struct Mol Biol, 16, pp. 678-680; Amati, B., Dalton, S., Brooks, M.W., Littlewood, T.D., Evan, G.I., Land, H., Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max (1992) Nature, 359, pp. 423-426; Attwooll, C., Oddi, S., Cartwright, P., Prosperini, E., Agger, K., Steensgaard, P., Wagener, C., Helin, K., A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner (2005) J Biol Chem, 280, pp. 1199-1208; Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D.M., Nakatani, Y., A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells (2002) Science, 296, pp. 1132-1136; Hayakawa, T., Nakayama, J., Physiological roles of class I HDAC complex and histone demethylase (2011) J Biomed Biotechnol, 2011, p. 129383; Sabin, L.R., Delas, M.J., Hannon, G.J., Dogma derailed: the many influences of RNA on the genome (2013) Mol Cell, 49, pp. 783-794; Lee, J.T., Davidow, L.S., Warshawsky, D., Tsix, a gene antisense to Xist at the X-inactivation centre (1999) Nat Genet, 21, pp. 400-404; Zhao, J., Sun, B.K., Erwin, J.A., Song, J.J., Lee, J.T., Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome (2008) Science, 322, pp. 750-756; Da Rocha, S.T., Boeva, V., Escamilla-Del-Arenal, M., Ancelin, K., Granier, C., Matias, N.R., Sanulli, S., Picard, C., Jarid2 Is Implicated in the Initial Xist-Induced Targeting of PRC2 to the Inactive X Chromosome (2014) Mol Cell, 53, pp. 301-316; Bernstein, E., Duncan, E.M., Masui, O., Gil, J., Heard, E., Allis, C.D., Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin (2006) Mol Cell Biol, 26, pp. 2560-2569; Rinn, J.L., Kertesz, M., Wang, J.K., Squazzo, S.L., Xu, X., Brugmann, S.A., Goodnough, L.H., Segal, E., Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs (2007) Cell, 129, pp. 1311-1323; Tsai, M.C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J.K., Lan, F., Shi, Y., Chang, H.Y., Long noncoding RNA as modular scaffold of histone modification complexes (2010) Science, 329, pp. 689-693; Schorderet, P., Duboule, D., Structural and functional differences in the long non-coding RNA hotair in mouse and human (2011) PLoS Genet, 7; Yap, K.L., Li, S., Munoz-Cabello, A.M., Raguz, S., Zeng, L., Mujtaba, S., Gil, J., Zhou, M.M., Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a (2010) Mol Cell, 38, pp. 662-674; Zhao, J., Ohsumi, T.K., Kung, J.T., Ogawa, Y., Grau, D.J., Sarma, K., Song, J.J., Lee, J.T., Genome-wide identification of polycomb-associated RNAs by RIP-seq (2010) Mol Cell, 40, pp. 939-953; Davidovich, C., Zheng, L., Goodrich, K.J., Cech, T.R., Promiscuous RNA binding by Polycomb repressive complex 2 (2013) Nat Struct Mol Biol, 20, pp. 1250-1257; Kanhere, A., Viiri, K., Araujo, C.C., Rasaiyaah, J., Bouwman, R.D., Whyte, W.A., Pereira, C.F., Bell, G.W., Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2 (2010) Mol Cell, 38, pp. 675-688; Kaneko, S., Son, J., Shen, S.S., Reinberg, D., Bonasio, R., PRC2 binds active promoters and contacts nascent RNAs in embryonic stem cells (2013) Nat Struct Mol Biol, 20, pp. 1258-U275; Kaneko, S., Bonasio, R., Saldana-Meyer, R., Yoshida, T., Son, J., Nishino, K., Umezawa, A., Reinberg, D., Interactions between JARID2 and Noncoding RNAs Regulate PRC2 Recruitment to Chromatin (2014) Mol Cell, 53, pp. 290-300; Busturia, A., Bienz, M., Silencers in abdominal-B, a homeotic Drosophila gene (1993) EMBO J, 12, pp. 1415-1425; Mohd-Sarip, A., Cleard, F., Mishra, R.K., Karch, F., Verrijzer, C.P., Synergistic recognition of an epigenetic DNA element by Pleiohomeotic and a Polycomb core complex (2005) Genes Dev, 19, pp. 1755-1760; Sengupta, A.K., Kuhrs, A., Muller, J., General transcriptional silencing by a Polycomb response element in Drosophila (2004) Development, 131, pp. 1959-1965; Schwartz, Y.B., Kahn, T.G., Nix, D.A., Li, X.Y., Bourgon, R., Biggin, M., Pirrotta, V., Genome-wide analysis of Polycomb targets in Drosophila melanogaster (2006) Nat Genet, 38, pp. 700-705; Tolhuis, B., De Wit, E., Muijrers, I., Teunissen, H., Talhout, W., Van Steensel, B., Van Lohuizen, M., Genome-wide profiling of PRC1 and PRC2 Polycomb chromatin binding in Drosophila melanogaster (2006) Nat Genet, 38, pp. 694-699; Vella, P., Barozzi, I., Cuomo, A., Bonaldi, T., Pasini, D., Yin Yang 1 extends the Myc-related transcription factors network in embryonic stem cells (2012) Nucleic Acids Res, 40, pp. 3403-3418; Hoskins, R.A., Landolin, J.M., Brown, J.B., Sandler, J.E., Takahashi, H., Lassmann, T., Yu, C., Wan, K.H., Genome-wide analysis of promoter architecture in Drosophila melanogaster (2011) Genome Res, 21, pp. 182-192; Klose, R.J., Cooper, S., Farcas, A.M., Blackledge, N.P., Brockdorff, N., Chromatin sampling-an emerging perspective on targeting polycomb repressor proteins (2013) PLoS Genet, 9; Dietrich, N., Lerdrup, M., Landt, E., Agrawal-Singh, S., Bak, M., Tommerup, N., Rappsilber, J., Hansen, K., REST-mediated recruitment of polycomb repressor complexes in mammalian cells (2012) PLoS Genet, 8; Ren, X., Kerppola, T.K., REST interacts with Cbx proteins and regulates polycomb repressive complex 1 occupancy at RE1 elements (2011) Mol Cell Biol, 31, pp. 2100-2110; Yu, M., Mazor, T., Huang, H., Huang, H.T., Kathrein, K.L., Woo, A.J., Chouinard, C.R., Moran, T.B., Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors (2012) Mol Cell, 45, pp. 330-343; Herranz, N., Pasini, D., Diaz, V.M., Franci, C., Gutierrez, A., Dave, N., Escriva, M., Helin, K., Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor (2008) Mol Cell Biol, 28, pp. 4772-4781; Villa, R., Pasini, D., Gutierrez, A., Morey, L., Occhionorelli, M., Vire, E., Nomdedeu, J.F., Minucci, S., Role of the polycomb repressive complex 2 in acute promyelocytic leukemia (2007) Cancer Cell, 11, pp. 513-525; Boukarabila, H., Saurin, A.J., Batsche, E., Mossadegh, N., Van Lohuizen, M., Otte, A.P., Pradel, J., Duprez, E., The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation (2009) Genes Dev, 23, pp. 1195-1206; Riising, E.M., Comet, I., Leblanc, B., Wu, X., Johansen, J.V., Helin, K., Gene silencing triggers polycomb repressive complex 2 recruitment to CpG Islands genome wide (2014) Mol Cell, 55, pp. 347-360; Jermann, P., Hoerner, L., Burger, L., Schubeler, D., Short sequences can efficiently recruit histone H3 lysine 27 trimethylation in the absence of enhancer activity and DNA methylation (2014) Proc Natl Acad Sci USA, 111, pp. E3415-E3421; Cooper, S., Dienstbier, M., Hassan, R., Schermelleh, L., Sharif, J., Blackledge, N.P., De Marco, V., Klose, R., Targeting polycomb to pericentric heterochromatin in embryonic stem cells reveals a role for H2AK119u1 in PRC2 recruitment (2014) Cell Rep, 7, pp. 1456-1470; Levine, S.S., King, I.F., Kingston, R.E., Division of labor in polycomb group repression (2004) Trends Biochem Sci, 29, pp. 478-485; Fischle, W., Wang, Y., Jacobs, S.A., Kim, Y., Allis, C.D., Khorasanizadeh, S., Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains (2003) Genes Dev, 17, pp. 1870-1881; Min, J., Zhang, Y., Xu, R.M., Structural basis for specific binding of Polycomb chromodomain to histone H3 methylated at Lys 27 (2003) Genes Dev, 17, pp. 1823-1828; Wysocka, J., Swigut, T., Milne, T.A., Dou, Y., Zhang, X., Burlingame, A.L., Roeder, R.G., Allis, C.D., WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development (2005) Cell, 121, pp. 859-872; Farcas, A.M., Blackledge, N.P., Sudbery, I., Long, H.K., McGouran, J.F., Rose, N.R., Lee, S., Sheahan, T.W., KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands (2012) eLife, 1; Kalb, R., Latwiel, S., Baymaz, H.I., Jansen, P.W., Muller, C.W., Vermeulen, M., Muller, J., Histone H2A monoubiquitination promotes histone H3 methylation in Polycomb repression (2014) Nat Struct Mol Biol, 21, pp. 569-571; Francis, N.J., Kingston, R.E., Woodcock, C.L., Chromatin compaction by a polycomb group protein complex (2004) Science, 306, pp. 1574-1577; Bantignies, F., Roure, V., Comet, I., Leblanc, B., Schuettengruber, B., Bonnet, J., Tixier, V., Cavalli, G., Polycomb-dependent regulatory contacts between distant Hox loci in Drosophila (2011) Cell, 144, pp. 214-226; Endoh, M., Endo, T.A., Endoh, T., Isono, K., Sharif, J., Ohara, O., Toyoda, T., Bickmore, W.A., Histone H2A mono-ubiquitination is a crucial step to mediate PRC1-dependent repression of developmental genes to maintain ES cell identity (2012) PLoS Genet, 8; Francis, N.J., Saurin, A.J., Shao, Z., Kingston, R.E., Reconstitution of a functional core polycomb repressive complex (2001) Mol Cell, 8, pp. 545-556; Yuan, W., Wu, T., Fu, H., Dai, C., Wu, H., Liu, N., Li, X., Niu, T., Dense chromatin activates Polycomb repressive complex 2 to regulate H3 lysine 27 methylation (2012) Science, 337, pp. 971-975; Breiling, A., Turner, B.M., Bianchi, M.E., Orlando, V., General transcription factors bind promoters repressed by Polycomb group proteins (2001) Nature, 412, pp. 651-655; Min, I.M., Waterfall, J.J., Core, L.J., Munroe, R.J., Schimenti, J., Lis, J.T., Regulating RNA polymerase pausing and transcription elongation in embryonic stem cells (2011) Genes Dev, 25, pp. 742-754; Brookes, E., De Santiago, I., Hebenstreit, D., Morris, K.J., Carroll, T., Xie, S.Q., Stock, J.K., Nozaki, N., Polycomb associates genome-wide with a specific RNA polymerase II variant, and regulates metabolic genes in ESCs (2012) Cell Stem Cell, 10, pp. 157-170; Stock, J.K., Giadrossi, S., Casanova, M., Brookes, E., Vidal, M., Koseki, H., Brockdorff, N., Pombo, A., Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells (2007) Nat Cell Biol, 9, pp. 1428-1435; Boyer, L.A., Lee, T.I., Cole, M.F., Johnstone, S.E., Levine, S.S., Zucker, J.P., Guenther, M.G., Jenner, R.G., Core transcriptional regulatory circuitry in human embryonic stem cells (2005) Cell, 122, pp. 947-956; Chamberlain, S.J., Yee, D., Magnuson, T., Polycomb repressive complex 2 is dispensable for maintenance of embryonic stem cell pluripotency (2008) Stem Cells, 26, pp. 1496-1505; Pasini, D., Bracken, A.P., Hansen, J.B., Capillo, M., Helin, K., The polycomb group protein Suz12 is required for embryonic stem cell differentiation (2007) Mol Cell Biol, 27, pp. 3769-3779; Posfai, E., Kunzmann, R., Brochard, V., Salvaing, J., Cabuy, E., Roloff, T.C., Liu, Z., Vidal, M., Polycomb function during oogenesis is required for mouse embryonic development (2012) Genes Dev, 26, pp. 920-932; Shen, X., Liu, Y., Hsu, Y.J., Fujiwara, Y., Kim, J., Mao, X., Yuan, G.C., Orkin, S.H., EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency (2008) Mol Cell, 32, pp. 491-502; Akasaka, T., Van Lohuizen, M., Van Der Lugt, N., Mizutani-Koseki, Y., Kanno, M., Taniguchi, M., Vidal, M., Koseki, H., Mice doubly deficient for the Polycomb Group genes Mel18 and Bmi1 reveal synergy and requirement for maintenance but not initiation of Hox gene expression (2001) Development, 128, pp. 1587-1597; Morey, L., Pascual, G., Cozzuto, L., Roma, G., Wutz, A., Benitah, S.A., Di Croce, L., Nonoverlapping functions of the Polycomb group Cbx family of proteins in embryonic stem cells (2012) Cell Stem Cell, 10, pp. 47-62; O'loghlen, A., Munoz-Cabello, A.M., Gaspar-Maia, A., Wu, H.A., Banito, A., Kunowska, N., Racek, T., Lavial, F., MicroRNA regulation of Cbx7 mediates a switch of Polycomb orthologs during ESC differentiation (2012) Cell Stem Cell, 10, pp. 33-46; Forzati, F., Federico, A., Pallante, P., Abbate, A., Esposito, F., Malapelle, U., Sepe, R., Scarfo, M., CBX7 is a tumor suppressor in mice and humans (2012) J Clin Investig, 122, pp. 612-623; Bracken, A.P., Helin, K., Polycomb group proteins: navigators of lineage pathways led astray in cancer (2009) Nat Rev Cancer, 9, pp. 773-784; Wang, S., He, F., Xiong, W., Gu, S., Liu, H., Zhang, T., Yu, X., Chen, Y., Polycomblike-2-deficient mice exhibit normal left-right asymmetry (2007) Dev Dyn, 236, pp. 853-861; Voncken, J.W., Roelen, B.A., Roefs, M., De Vries, S., Verhoeven, E., Marino, S., Deschamps, J., Van Lohuizen, M., Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition (2003) Proc Natl Acad Sci USA, 100, pp. 2468-2473; Hisada, K., Sanchez, C., Endo, T.A., Endoh, M., Roman-Trufero, M., Sharif, J., Koseki, H., Vidal, M., RYBP represses endogenous retroviruses and preimplantation- and germ line-specific genes in mouse embryonic stem cells (2012) Mol Cell Biol, 32, pp. 1139-1149; Katoh-Fukui, Y., Tsuchiya, R., Shiroishi, T., Nakahara, Y., Hashimoto, N., Noguchi, K., Higashinakagawa, T., Male-to-female sex reversal in M33 mutant mice (1998) Nature, 393, pp. 688-692; Koren, A., Mccarroll, S.A., Random replication of the inactive X chromosome (2014) Genome Res, 24, pp. 64-69; Akasaka, T., Kanno, M., Balling, R., Mieza, M.A., Taniguchi, M., Koseki, H., A role for mel-18, a Polycomb group-related vertebrate gene, during theanteroposterior specification of the axial skeleton (1996) Development, 122, pp. 1513-1522; Van Der Lugt, N.M., Domen, J., Linders, K., Van Roon, M., Robanus-Maandag, E., Te Riele, H., Van Der Valk, M., Van Lohuizen, M., Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene (1994) Genes Dev, 8, pp. 757-769; Su, I.H., Basavaraj, A., Krutchinsky, A.N., Hobert, O., Ullrich, A., Chait, B.T., Tarakhovsky, A., Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement (2003) Nat Immunol, 4, pp. 124-131; Xie, H., Xu, J., Hsu, J.H., Nguyen, M., Fujiwara, Y., Peng, C., Orkin, S.H., Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner (2014) Cell Stem Cell, 14, pp. 68-80; Park, I.K., Qian, D., Kiel, M., Becker, M.W., Pihalja, M., Weissman, I.L., Morrison, S.J., Clarke, M.F., Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells (2003) Nature, 423, pp. 302-305; Klauke, K., Radulovic, V., Broekhuis, M., Weersing, E., Zwart, E., Olthof, S., Ritsema, M., Helin, K., Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation (2013) Nat Cell Biol, 15, pp. 353-362; Wang, L., Jin, Q., Lee, J.E., Su, I.H., Ge, K., Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis (2010) Proc Natl Acad Sci USA, 107, pp. 7317-7322; Caretti, G., Di Padova, M., Micales, B., Lyons, G.E., Sartorelli, V., The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation (2004) Genes Dev, 18, pp. 2627-2638; Ezhkova, E., Pasolli, H.A., Parker, J.S., Stokes, N., Su, I.H., Hannon, G., Tarakhovsky, A., Fuchs, E., Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells (2009) Cell, 136, pp. 1122-1135; Helin, K., Dhanak, D., Chromatin proteins and modifications as drug targets (2013) Nature, 502, pp. 480-488; Baylin, S.B., Jones, P.A., A decade of exploring the cancer epigenome - biological and translational implications (2011) Nat Rev Cancer, 11, pp. 726-734; Prinjha, R., Tarakhovsky, A., Chromatin targeting drugs in cancer and immunity (2013) Genes Dev, 27, pp. 1731-1738; Mochizuki-Kashio, M., Wendt, G.R., Iwama, A., Tumor suppressor function of the polycomb group genes (2012) Cell Cycle, 11, pp. 2043-2044; Hock, H., A complex Polycomb issue: the two faces of EZH2 in cancer (2012) Genes Dev, 26, pp. 751-755; Lund, K., Adams, P.D., Copland, M., EZH2 in normal and malignant hematopoiesis (2014) Leukemia, 28, pp. 44-49; Xu, F., Li, X., The role of histone methyltransferase EZH2 in myelodysplastic syndromes (2012) Expert Rev Hematol, 5, pp. 177-185; Score, J., Hidalgo-Curtis, C., Jones, A.V., Winkelmann, N., Skinner, A., Ward, D., Zoi, K., Dohner, K., Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms (2012) Blood, 119, pp. 1208-1213; Puda, A., Milosevic, J.D., Berg, T., Klampfl, T., Harutyunyan, A.S., Gisslinger, B., Rumi, E., Elena, C., Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies (2012) Am J Hematol, 87, pp. 245-250; Ueda, T., Sanada, M., Matsui, H., Yamasaki, N., Honda, Z.I., Shih, L.Y., Mori, H., Honda, H., EED mutants impair polycomb repressive complex 2 in myelodysplastic syndrome and related neoplasms (2012) Leukemia, 26, pp. 2557-2560; Ntziachristos, P., Tsirigos, A., Van Vlierberghe, P., Nedjic, J., Trimarchi, T., Flaherty, M.S., Ferres-Marco, D., Siegle, J., Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia (2012) Nat Med, 18, pp. 298-301; Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S.L., Payne-Turner, D., Easton, J., Rusch, M., The genetic basis of early T-cell precursor acute lymphoblastic leukaemia (2012) Nature, 481, pp. 157-163; Simon, C., Chagraoui, J., Krosl, J., Gendron, P., Wilhelm, B., Lemieux, S., Boucher, G., Lambert, R., A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia (2012) Genes Dev, 26, pp. 651-656; Herrera-Merchan, A., Arranz, L., Ligos, J.M., De Molina, A., Dominguez, O., Gonzalez, S., Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease (2012) Nat Commun, 3, p. 623; Neff, T., Sinha, A.U., Kluk, M.J., Zhu, N., Khattab, M.H., Stein, L., Xie, H., Armstrong, S.A., Polycomb repressive complex 2 is required for MLL-AF9 leukemia (2012) Proc Natl Acad Sci USA, 109, pp. 5028-5033; Kim, W., Bird, G.H., Neff, T., Guo, G., Kerenyi, M.A., Walensky, L.D., Orkin, S.H., Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer (2013) Nat Chem Biol, 9, pp. 643-650; Shi, J., Wang, E., Zuber, J., Rappaport, A., Taylor, M., Johns, C., Lowe, S.W., Vakoc, C.R., The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia (2013) Oncogene, 32, pp. 930-938; Abdel-Wahab, O., Adli, M., LaFave, L.M., Gao, J., Hricik, T., Shih, A.H., Pandey, S., Koche, R., ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression (2012) Cancer Cell, 22, pp. 180-193; Sashida, G., Harada, H., Matsui, H., Oshima, M., Yui, M., Harada, Y., Tanaka, S., Saraya, A., Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation (2014) Nat Commun, 5, p. 4177; Smith, L.L., Yeung, J., Zeisig, B.B., Popov, N., Huijbers, I., Barnes, J., Wilson, A.J., Gil, J., Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells (2011) Cell Stem Cell, 8, pp. 649-662; Tan, J., Jones, M., Koseki, H., Nakayama, M., Muntean, A.G., Maillard, I., Hess, J.L., CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis (2011) Cancer Cell, 20, pp. 563-575; Gil, J., Bernard, D., Martinez, D., Beach, D., Polycomb CBX7 has a unifying role in cellular lifespan (2004) Nat Cell Biol, 6, pp. 67-72; Bernard, D., Martinez-Leal, J.F., Rizzo, S., Martinez, D., Hudson, D., Visakorpi, T., Peters, G., Gil, J., CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus (2005) Oncogene, 24, pp. 5543-5551; Scott, C.L., Gil, J., Hernando, E., Teruya-Feldstein, J., Narita, M., Martinez, D., Visakorpi, T., Peters, G., Role of the chromobox protein CBX7 in lymphomagenesis (2007) Proc Natl Acad Sci USA, 104, pp. 5389-5394; Gargiulo, G., Cesaroni, M., Serresi, M., De Vries, N., Hulsman, D., Bruggeman, S.W., Lancini, C., Van Lohuizen, M., In vivo RNAi screen for BMI1 targets identifies TGF-beta/BMP-ER stress pathways as key regulators of neural- and malignant glioma-stem cell homeostasis (2013) Cancer Cell, 23, pp. 660-676; Yang, M.H., Hsu, D.S., Wang, H.W., Wang, H.J., Lan, H.Y., Yang, W.H., Huang, C.H., Tai, S.K., Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition (2010) Nat Cell Biol, 12, pp. 982-992; Nacerddine, K., Beaudry, J.B., Ginjala, V., Westerman, B., Mattiroli, F., Song, J.Y., Van Der Poel, H., Cornelissen-Steijger, P., Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer (2012) J Clin Invest, 122, pp. 1920-1932; Jacobs, J.J., Scheijen, B., Voncken, J.W., Kieboom, K., Berns, A., Van Lohuizen, M., Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF (1999) Genes Dev, 13, pp. 2678-2690; Jacobs, J.J., Kieboom, K., Marino, S., Depinho, R.A., Van Lohuizen, M., The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus (1999) Nature, 397, pp. 164-168; Bracken, A.P., Kleine-Kohlbrecher, D., Dietrich, N., Pasini, D., Gargiulo, G., Beekman, C., Theilgaard-Monch, K., Marine, J.C., The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells (2007) Genes Dev, 21, pp. 525-530; Dietrich, N., Bracken, A.P., Trinh, E., Schjerling, C.K., Koseki, H., Rappsilber, J., Helin, K., Hansen, K.H., Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus (2007) EMBO J, 26, pp. 1637-1648; Smith, K.S., Chanda, S.K., Lingbeek, M., Ross, D.T., Botstein, D., Van Lohuizen, M., Cleary, M.L., Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1 (2003) Mol Cell, 12, pp. 393-400; Mallen-St Clair, J., Soydaner-Azeloglu, R., Lee, K.E., Taylor, L., Livanos, A., Pylayeva-Gupta, Y., Miller, G., Bar-Sagi, D., EZH2 couples pancreatic regeneration to neoplastic progression (2012) Genes Dev, 26, pp. 439-444; Serrano, M., The INK4a/ARF locus in murine tumorigenesis (2000) Carcinogenesis, 21, pp. 865-869; Dawson, M.A., Kouzarides, T., Cancer epigenetics: from mechanism to therapy (2012) Cell, 150, pp. 12-27; Morin, R.D., Johnson, N.A., Severson, T.M., Mungall, A.J., An, J., Goya, R., Paul, J.E., Kuchenbauer, F., Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin (2010) Nat Genet, 42, pp. 181-185; Yap, D.B., Chu, J., Berg, T., Schapira, M., Cheng, S.W., Moradian, A., Morin, R.D., Boyle, M., Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation (2011) Blood, 117, pp. 2451-2459; Knutson, S.K., Wigle, T.J., Warholic, N.M., Sneeringer, C.J., Allain, C.J., Klaus, C.R., Sacks, J.D., Song, J., A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells (2012) Nat Chem Biol, 8, pp. 890-896; McCabe, M.T., Ott, H.M., Ganji, G., Korenchuk, S., Thompson, C., Van Aller, G.S., Liu, Y., Diaz, E., EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations (2012) Nature, 492, pp. 108-112; Qi, W., Chan, H., Teng, L., Li, L., Chuai, S., Zhang, R., Zeng, J., Lin, Y., Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation (2012) Proc Natl Acad Sci USA, 109, pp. 21360-21365; Caganova, M., Carrisi, C., Varano, G., Mainoldi, F., Zanardi, F., Germain, P.L., George, L., Talukder, A.K., Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis (2013) J Clin Investig, 123, pp. 5009-5022; Beguelin, W., Popovic, R., Teater, M., Jiang, Y., Bunting, K.L., Rosen, M., Shen, H., Ezponda, T., EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation (2013) Cancer Cell, 23, pp. 677-692; Lee, S.C., Phipson, B., Hyland, C.D., Leong, H.S., Allan, R.S., Lun, A., Hilton, D.J., Smyth, G.K., Polycomb repressive complex 2 (PRC2) suppresses Emu-myc lymphoma (2013) Blood, 122, pp. 2654-2663; Crea, F., Hurt, E.M., Farrar, W.L., Clinical significance of Polycomb gene expression in brain tumors (2010) Mol Cancer, 9, p. 265; Abdouh, M., Facchino, S., Chatoo, W., Balasingam, V., Ferreira, J., Bernier, G., BMI1 sustains human glioblastoma multiforme stem cell renewal (2009) J Neurosci, 29, pp. 8884-8896; Suva, M.L., Riggi, N., Janiszewska, M., Radovanovic, I., Provero, P., Stehle, J.C., Baumer, K., Cironi, L., EZH2 is essential for glioblastoma cancer stem cell maintenance (2009) Cancer Res, 69, pp. 9211-9218; Bruggeman, S.W., Hulsman, D., Tanger, E., Buckle, T., Blom, M., Zevenhoven, J., Van Tellingen, O., Van Lohuizen, M., Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma (2007) Cancer Cell, 12, pp. 328-341; Wu, G., Broniscer, A., McEachron, T.A., Lu, C., Paugh, B.S., Becksfort, J., Qu, C., Washington University Pediatric Cancer Genome Project, Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas (2012) Nat Genet, 44, pp. 251-253; Schwartzentruber, J., Korshunov, A., Liu, X.Y., Jones, D.T., Pfaff, E., Jacob, K., Sturm, D., Tonjes, M., Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma (2012) Nature, 482, pp. 226-231; Chan, K.M., Fang, D., Gan, H., Hashizume, R., Yu, C., Schroeder, M., Gupta, N., Jenkins, R., The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression (2013) Genes Dev, 27, pp. 985-990; Kim, E., Kim, M., Woo, D.H., Shin, Y., Shin, J., Chang, N., Oh, Y.T., Nakano, I., Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells (2013) Cancer Cell, 23, pp. 839-852; De Raedt, T., Beert, E., Pasmant, E., Luscan, A., Brems, H., Ortonne, N., Helin, K., Kehrer-Sawatzki, H., PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies (2014) Nature, 514, pp. 247-251",Article,Scopus,2-s2.0-84928535677
"Raulf A., Horder H., Tarnawski L., Geisen C., Ottersbach A., Roll W., Jovinge S., Fleischmann B.K., Hesse M.","Transgenic systems for unequivocal identification of cardiac myocyte nuclei and analysis of cardiomyocyte cell cycle status",2015,"Basic Research in Cardiology","110","3",,"","",18,,10.1007/s00395-015-0489-2,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928738908&partnerID=40&md5=cc4d8920c8cc65e59245a86e507bdb7f","Institute of Physiology I, Life and Brain Center, University of Bonn, Sigmund-Freud-Strasse 25Bonn, Germany; Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund UniversityLund, Sweden; DeVos Cardiovascular Research Program, Van Andel Institute/Spectrum HealthGrand Rapids, United States; Department of Cardiac Surgery, University of BonnBonn, Germany; Pharma Center BonnBonn, Germany","Raulf, A., Institute of Physiology I, Life and Brain Center, University of Bonn, Sigmund-Freud-Strasse 25Bonn, Germany, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund UniversityLund, Sweden, DeVos Cardiovascular Research Program, Van Andel Institute/Spectrum HealthGrand Rapids, United States, Department of Cardiac Surgery, University of BonnBonn, Germany, Pharma Center BonnBonn, Germany; Horder, H., Institute of Physiology I, Life and Brain Center, University of Bonn, Sigmund-Freud-Strasse 25Bonn, Germany, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund UniversityLund, Sweden, DeVos Cardiovascular Research Program, Van Andel Institute/Spectrum HealthGrand Rapids, United States, Department of Cardiac Surgery, University of BonnBonn, Germany, Pharma Center BonnBonn, Germany; Tarnawski, L., Institute of Physiology I, Life and Brain Center, University of Bonn, Sigmund-Freud-Strasse 25Bonn, Germany, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund UniversityLund, Sweden, DeVos Cardiovascular Research Program, Van Andel Institute/Spectrum HealthGrand Rapids, United States, Department of Cardiac Surgery, University of BonnBonn, Germany, Pharma Center BonnBonn, Germany; Geisen, C., Institute of Physiology I, Life and Brain Center, University of Bonn, Sigmund-Freud-Strasse 25Bonn, Germany, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund UniversityLund, Sweden, DeVos Cardiovascular Research Program, Van Andel Institute/Spectrum HealthGrand Rapids, United States, Department of Cardiac Surgery, University of BonnBonn, Germany, Pharma Center BonnBonn, Germany; Ottersbach, A., Institute of Physiology I, Life and Brain Center, University of Bonn, Sigmund-Freud-Strasse 25Bonn, Germany, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund UniversityLund, Sweden, DeVos Cardiovascular Research Program, Van Andel Institute/Spectrum HealthGrand Rapids, United States, Department of Cardiac Surgery, University of BonnBonn, Germany, Pharma Center BonnBonn, Germany; Röll, W., Institute of Physiology I, Life and Brain Center, University of Bonn, Sigmund-Freud-Strasse 25Bonn, Germany, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund UniversityLund, Sweden, DeVos Cardiovascular Research Program, Van Andel Institute/Spectrum HealthGrand Rapids, United States, Department of Cardiac Surgery, University of BonnBonn, Germany, Pharma Center BonnBonn, Germany; Jovinge, S., Institute of Physiology I, Life and Brain Center, University of Bonn, Sigmund-Freud-Strasse 25Bonn, Germany, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund UniversityLund, Sweden, DeVos Cardiovascular Research Program, Van Andel Institute/Spectrum HealthGrand Rapids, United States, Department of Cardiac Surgery, University of BonnBonn, Germany, Pharma Center BonnBonn, Germany; Fleischmann, B.K., Institute of Physiology I, Life and Brain Center, University of Bonn, Sigmund-Freud-Strasse 25Bonn, Germany, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund UniversityLund, Sweden, DeVos Cardiovascular Research Program, Van Andel Institute/Spectrum HealthGrand Rapids, United States, Department of Cardiac Surgery, University of BonnBonn, Germany, Pharma Center BonnBonn, Germany; Hesse, M., Institute of Physiology I, Life and Brain Center, University of Bonn, Sigmund-Freud-Strasse 25Bonn, Germany, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund UniversityLund, Sweden, DeVos Cardiovascular Research Program, Van Andel Institute/Spectrum HealthGrand Rapids, United States, Department of Cardiac Surgery, University of BonnBonn, Germany, Pharma Center BonnBonn, Germany","Even though the mammalian heart has been investigated for many years, there are still uncertainties in the fields of cardiac cell biology and regeneration with regard to exact fractions of cardiomyocytes (CMs) at different developmental stages, their plasticity after cardiac lesion and also their basal turnover rate. A main shortcoming is the accurate identification of CM and the demonstration of CM division. Therefore, an in vivo model taking advantage of a live reporter-based identification of CM nuclei and their cell cycle status is needed. In this technical report, we describe the generation and characterization of embryonic stem cells and transgenic mice expressing a fusion protein of human histone 2B and the red fluorescence protein mCherry under control of the CM specific αMHC promoter. This fluorescence label allows unequivocal identification and quantitation of CM nuclei and nuclearity in isolated cells and native tissue slices. In ventricles of adults, we determined a fraction of <20 % CMs and binucleation of 77–90 %, while in atria a CM fraction of 30 % and a binucleation index of 14 % were found. We combined this transgenic system with the CAG-eGFP-anillin transgene, which identifies cell division and established a novel screening assay for cell cycle-modifying substances in isolated, postnatal CMs. Our transgenic live reporter-based system enables reliable identification of CM nuclei and determination of CM fractions and nuclearity in heart tissue. In combination with CAG-eGFP-anillin-mice, the cell cycle status of CMs can be monitored in detail enabling screening for proliferation-inducing substances in vitro and in vivo. © 2015, The Author(s).","Cardiac myocyte; Cell cycle; Genetically altered mice; miRNA; Proliferation","Ang, K.L., Shenje, L.T., Reuter, S., Soonpaa, M.H., Rubart, M., Field, L.J., Galinanes, M., Limitations of conventional approaches to identify myocyte nuclei in histologic sections of the heart (2010) Am J Physiol Cell Physiol, 298, pp. 1603-1609. , COI: 1:CAS:528:DC%2BC3cXnvFamsL8%3D, PID: 20457832; Banerjee, I., Fuseler, J.W., Price, R.L., Borg, T.K., Baudino, T.A., Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse (2007) Am J Physiol Heart Circ Physiol, 293, pp. 1883-1891. , COI: 1:CAS:528:DC%2BD2sXhtVOqtrnM, PID: 17604329; Baudino, T.A., Carver, W., Giles, W., Borg, T.K., Cardiac fibroblasts: friend or foe? (2006) Am J Physiol Heart Circ Physiol, 291, pp. 1015-1026. , COI: 1:CAS:528:DC%2BD28XhtVSksrrJ, PID: 16617141; Bergmann, O., Bhardwaj, R.D., Bernard, S., Zdunek, S., Barnabe-Heider, F., Walsh, S., Zupicich, J., Frisen, J., Evidence for cardiomyocyte renewal in humans (2009) Science, 324, pp. 98-102. , COI: 1:CAS:528:DC%2BD1MXjvVajsbc%3D, PID: 19342590; Bergmann, O., Jovinge, S., Isolation of cardiomyocyte nuclei from post-mortem tissue (2012) J Vis Exp, 65, p. 4205; Bergmann, O., Zdunek, S., Alkass, K., Druid, H., Bernard, S., Frisen, J., Identification of cardiomyocyte nuclei and assessment of ploidy for the analysis of cell turnover (2011) Exp Cell Res, 317, pp. 188-194. , COI: 1:CAS:528:DC%2BC3cXhsV2jur3P, PID: 20828558; Bersell, K., Arab, S., Haring, B., Kuhn, B., Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury (2009) Cell, 138, pp. 257-270. , COI: 1:CAS:528:DC%2BD1MXhtVSgtrzF, PID: 19632177; Brodsky, V.Y., Chernyaev, A.L., Vasilyeva, I.A., Variability of the cardiomyocyte ploidy in normal human hearts (1991) Virchows Arch B Cell Pathol Incl Mol Pathol, 61, pp. 289-294. , PID: 1685821; Engel, F.B., Hsieh, P.C., Lee, R.T., Keating, M.T., FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction (2006) Proc Natl Acad Sci USA, 103, pp. 15546-15551. , COI: 1:CAS:528:DC%2BD28XhtFCjtLbP, PID: 17032753; Eulalio, A., Mano, M., Dal, F.M., Zentilin, L., Sinagra, G., Zacchigna, S., Giacca, M., Functional screening identifies miRNAs inducing cardiac regeneration (2012) Nature, 492, pp. 376-381. , COI: 1:CAS:528:DC%2BC38Xhslynu7jO, PID: 23222520; Georgakopoulos, D., Kass, D.A., Estimation of parallel conductance by dual-frequency conductance catheter in mice (2000) Am J Physiol Heart Circ Physiol, 279, pp. 443-450. , COI: 1:CAS:528:DC%2BD3cXltlyqsr4%3D, PID: 10899085; George, S.H., Gertsenstein, M., Vintersten, K., Korets-Smith, E., Murphy, J., Stevens, M.E., Haigh, J.J., Nagy, A., Developmental and adult phenotyping directly from mutant embryonic stem cells (2007) Proc Natl Acad Sci USA, 104, pp. 4455-4460. , COI: 1:CAS:528:DC%2BD2sXjsFKgtb8%3D, PID: 17360545; Gilsbach, R., Preissl, S., Gruning, B.A., Schnick, T., Burger, L., Benes, V., Wurch, A., Hein, L., Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease (2014) Nat Commun, 5, p. 5288. , COI: 1:CAS:528:DC%2BC2cXitVShs7zF, PID: 25335909; Herget, G.W., Neuburger, M., Plagwitz, R., Adler, C.P., DNA content, ploidy level and number of nuclei in the human heart after myocardial infarction (1997) Cardiovasc Res, 36, pp. 45-51. , COI: 1:STN:280:DyaK1c%2Fns12kuw%3D%3D, PID: 9415271; Hesse, M., Raulf, A., Pilz, G.A., Haberlandt, C., Klein, A.M., Jabs, R., Zaehres, H., Fleischmann, B.K., Direct visualization of cell division using high-resolution imaging of M-phase of the cell cycle (2012) Nat Commun, 3, p. 1076. , PID: 23011130; Heusch, G., Libby, P., Gersh, B., Yellon, D., Bohm, M., Lopaschuk, G., Opie, L., Cardiovascular remodelling in coronary artery disease and heart failure (2014) Lancet, 383, pp. 1933-1943. , PID: 24831770; Hosoda, T., D’Amario, D., Cabral-Da-Silva, M.C., Zheng, H., Padin-Iruegas, M.E., Ogorek, B., Ferreira-Martins, J., Leri, A., Clonality of mouse and human cardiomyogenesis in vivo (2009) Proc Natl Acad Sci USA, 106, pp. 17169-17174. , COI: 1:CAS:528:DC%2BD1MXhtlaksL3M, PID: 19805158; Hsieh, P.C., Segers, V.F., Davis, M.E., MacGillivray, C., Gannon, J., Molkentin, J.D., Robbins, J., Lee, R.T., Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury (2007) Nat Med, 13, pp. 970-974. , COI: 1:CAS:528:DC%2BD2sXos1Cjsbk%3D, PID: 17660827; Jesty, S.A., Steffey, M.A., Lee, F.K., Breitbach, M., Hesse, M., Reining, S., Lee, J.C., Kotlikoff, M.I., c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart (2012) Proc Natl Acad Sci USA, 109, pp. 13380-13385. , COI: 1:CAS:528:DC%2BC38XhsVaitLfN, PID: 22847442; Jugdutt, B.I., Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? (2003) Circulation, 108, pp. 1395-1403. , PID: 12975244; Li, F., Wang, X., Capasso, J.M., Gerdes, A.M., Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development (1996) J Mol Cell Cardiol, 28, pp. 1737-1746. , COI: 1:CAS:528:DyaK28XlsF2jtLs%3D, PID: 8877783; Lyons, G.E., Schiaffino, S., Sassoon, D., Barton, P., Buckingham, M., Developmental regulation of myosin gene expression in mouse cardiac muscle (1990) J Cell Biol, 111, pp. 2427-2436. , COI: 1:CAS:528:DyaK3cXmtVyrt7o%3D, PID: 2277065; Meckert, P.C., Rivello, H.G., Vigliano, C., Gonzalez, P., Favaloro, R., Laguens, R., Endomitosis and polyploidization of myocardial cells in the periphery of human acute myocardial infarction (2005) Cardiovasc Res, 67, pp. 116-123. , COI: 1:CAS:528:DC%2BD2MXltFSrtbg%3D, PID: 15949475; Mollova, M., Bersell, K., Walsh, S., Savla, J., Das, L.T., Park, S.Y., Silberstein, L.E., Kuhn, B., Cardiomyocyte proliferation contributes to heart growth in young humans (2013) Proc Natl Acad Sci USA, 110, pp. 1446-1451. , COI: 1:CAS:528:DC%2BC3sXhvFKku70%3D, PID: 23302686; Nag, A.C., Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution (1980) Cytobios, 28, pp. 41-61. , COI: 1:STN:280:DyaL3M%2FktlaksQ%3D%3D, PID: 7428441; Nagy, A., Rossant, J., Nagy, R., Bramow-Newerly, W., Roder, J.C., Derivation of completely cell culture-derived mice from early-passage embryonic stem cells (1993) Proc Natl Acad Sci USA, 90, pp. 8424-8428. , COI: 1:STN:280:DyaK3szptFeltA%3D%3D, PID: 8378314; Nowotschin, S., Eakin, G.S., Hadjantonakis, A.K., Live-imaging fluorescent proteins in mouse embryos: multi-dimensional, multi-spectral perspectives (2009) Trends Biotechnol, 27, pp. 266-276. , COI: 1:CAS:528:DC%2BD1MXltVyns74%3D, PID: 19339068; Oberpriller, J.O., Oberpriller, J.C., Aafedt, B.C., Changes in binucleation and cellular dimensions of rat left atrial myocytes after induced left ventricular infarction (1987) Am J Anat, 179, pp. 285-290. , COI: 1:STN:280:DyaL2szitlShtg%3D%3D, PID: 2957910; Olivetti, G., Cigola, E., Maestri, R., Corradi, D., Lagrasta, C., Gambert, S.R., Anversa, P., Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart (1996) J Mol Cell Cardiol, 28, pp. 1463-1477. , COI: 1:CAS:528:DyaK28Xks1WmsL0%3D, PID: 8841934; Porrello, E.R., Mahmoud, A.I., Simpson, E., Hill, J.A., Richardson, J.A., Olson, E.N., Sadek, H.A., Transient regenerative potential of the neonatal mouse heart (2011) Science, 331, pp. 1078-1080. , COI: 1:CAS:528:DC%2BC3MXit1eitrs%3D, PID: 21350179; Roell, W., Fan, Y., Xia, Y., Stoecker, E., Sasse, P., Kolossov, E., Bloch, W., Fleischmann, B.K., Cellular cardiomyoplasty in a transgenic mouse model (2002) Transplantation, 73, pp. 462-465. , PID: 11884945; Rumyantsev, P.P., Ultrastructural reorganization, DNA synthesis and mitotic division of myocytes in atria of rats with left ventricle infarction. An electron microscopic and autoradiographic study (1974) Virchows Arch B Cell Pathol, 15, pp. 357-378. , COI: 1:STN:280:DyaE2c3otFGltw%3D%3D, PID: 4210798; Senyo, S.E., Steinhauser, M.L., Pizzimenti, C.L., Yang, V.K., Cai, L., Wang, M., Wu, T.D., Lee, R.T., Mammalian heart renewal by pre-existing cardiomyocytes (2013) Nature, 493, pp. 433-436. , COI: 1:CAS:528:DC%2BC38XhslyntbfN, PID: 23222518; Sohal, D.S., Nghiem, M., Crackower, M.A., Witt, S.A., Kimball, T.R., Tymitz, K.M., Penninger, J.M., Molkentin, J.D., Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein (2001) Circ Res, 89, pp. 20-25. , COI: 1:CAS:528:DC%2BD3MXltlSltr0%3D, PID: 11440973; Soonpaa, M.H., Field, L.J., Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts (1997) Am J Physiol, 272, pp. 220-226. , COI: 1:CAS:528:DyaK2sXht1Wmsb0%3D, PID: 9038941; Soonpaa, M.H., Field, L.J., Survey of studies examining mammalian cardiomyocyte DNA synthesis (1998) Circ Res, 83, pp. 15-26. , COI: 1:CAS:528:DyaK1cXks1Kksbs%3D, PID: 9670914; Soonpaa, M.H., Kim, K.K., Pajak, L., Franklin, M., Field, L.J., Cardiomyocyte DNA synthesis and binucleation during murine development (1996) Am J Physiol, 271, pp. 2183-2189. , COI: 1:CAS:528:DyaK28XntFyrsLo%3D, PID: 8945939; Soonpaa, M.H., Koh, G.Y., Klug, M.G., Field, L.J., Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium (1994) Science, 264, pp. 98-101. , COI: 1:STN:280:DyaK2c7ovVOiuw%3D%3D, PID: 8140423; Stegemann, M., Meyer, R., Haas, H.G., Robert-Nicoud, M., The cell surface of isolated cardiac myocytes—a light microscope study with use of fluorochrome-coupled lectins (1990) J Mol Cell Cardiol, 22, pp. 787-803. , COI: 1:CAS:528:DyaK3cXmt1yhtbY%3D, PID: 2231745; Tumbar, T., Guasch, G., Greco, V., Blanpain, C., Lowry, W.E., Rendl, M., Fuchs, E., Defining the epithelial stem cell niche in skin (2004) Science, 303, pp. 359-363. , COI: 1:CAS:528:DC%2BD2cXjtFGmsg%3D%3D, PID: 14671312; Uosaki, H., Magadum, A., Seo, K., Fukushima, H., Takeuchi, A., Nakagawa, Y., Moyes, K.W., Yamashita, J.K., Identification of chemicals inducing cardiomyocyte proliferation in developmental stage-specific manner with pluripotent stem cells (2013) Circ Cardiovasc Genet, 6, pp. 624-633. , COI: 1:CAS:528:DC%2BC3sXhvFyrtLrM, PID: 24141057; Vliegen, H.W., van der, L.A., Cornelisse, C.J., Eulderink, F., Myocardial changes in pressure overload-induced left ventricular hypertrophy. A study on tissue composition, polyploidization and multinucleation (1991) Eur Heart J, 12, pp. 488-494. , COI: 1:STN:280:DyaK3M3ptlWnsQ%3D%3D, PID: 1829680; Walsh, S., Ponten, A., Fleischmann, B.K., Jovinge, S., Cardiomyocyte cell cycle control and growth estimation in vivo—an analysis based on cardiomyocyte nuclei (2010) Cardiovasc Res, 86, pp. 365-373. , COI: 1:CAS:528:DC%2BC3cXmtFKqt7g%3D, PID: 20071355; Zaruba, M.M., Soonpaa, M., Reuter, S., Field, L.J., Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts (2010) Circulation, 121, pp. 1992-2000. , COI: 1:CAS:528:DC%2BC3cXlvVakur8%3D, PID: 20421520",Article,Scopus,2-s2.0-84928738908
"Ogata K., Katagiri W., Osugi M., Kawai T., Sugimura Y., Hibi H., Nakamura S., Ueda M.","Evaluation of the therapeutic effects of conditioned media from mesenchymal stem cells in a rat bisphosphonate-related osteonecrosis of the jaw-like model",2015,"Bone","74",,,"95","105",,,10.1016/j.bone.2015.01.011,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84921712475&partnerID=40&md5=30446839d5b1c66f9b46b2e91c2a3fd6","Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Higashi-ku, 3-1-1 MaidashiFukuoka, Japan; Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Aichi 65 Tsurumai-choShowa-ku, Nagoya, Japan","Ogata, K., Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Higashi-ku, 3-1-1 MaidashiFukuoka, Japan, Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Aichi 65 Tsurumai-choShowa-ku, Nagoya, Japan; Katagiri, W., Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Aichi 65 Tsurumai-choShowa-ku, Nagoya, Japan; Osugi, M., Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Aichi 65 Tsurumai-choShowa-ku, Nagoya, Japan; Kawai, T., Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Aichi 65 Tsurumai-choShowa-ku, Nagoya, Japan; Sugimura, Y., Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Aichi 65 Tsurumai-choShowa-ku, Nagoya, Japan; Hibi, H., Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Aichi 65 Tsurumai-choShowa-ku, Nagoya, Japan; Nakamura, S., Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Higashi-ku, 3-1-1 MaidashiFukuoka, Japan; Ueda, M., Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Aichi 65 Tsurumai-choShowa-ku, Nagoya, Japan","Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is defined as an exposed necrotic bone in the oral cavity that does not heal after appropriate intervention for >. 8. weeks with present or previous bisphosphonate treatment in the absence of radiotherapy. Until now, although several risk factors, including invasive dental procedures, infection, mechanical trauma to the jawbone, and concomitant use of immunosuppressive and chemotherapy drugs have been implicated in the etiology of BRONJ, its underlying mechanisms and treatments remain largely unknown. A study recently showed that intravenous administration of mesenchymal stem cells (MSCs) improved BRONJ, and it was hypothesized that paracrine effects by secretomes from MSCs are the main constituent. Here we used rat BRONJ models to examine the therapeutic effects with serum-free conditioned media from human MSCs (MSC-CM), including various secretomes. We showed that MSC-CM has protected rat MSCs and rat osteoclasts. MSC-CM enhanced the expression of osteogenic-related genes and neovascularization-related genes by real-time reverse-transcriptase polymerase chain reaction analysis in in vitro study. In in vivo study, 5-week-old Wistar/ST male rats received zoledronate (35. μg/kg/week) and dexamethasone (1. mg/kg/day) subcutaneously for 2. weeks. Unilateral maxillary molars were then extracted. Two weeks later, rats were divided into non-treatment, serum-free Dulbecco's modified Eagle's medium, and MSC-CM groups. In the MSC-CM group, the open alveolar sockets in 63% of the rats with BRONJ healed with complete soft tissue coverage and socket bones, whereas the exposed necrotic bone with inflamed soft tissue remained in the other groups. Histological analysis showed new bone formation and the appearance of osteoclasts in the MSC-CM group. Osteoclasts were significantly reduced in the non-treatment group. Thus, we concluded that the antiapoptotic and antiinflammatory effects of MSC-CM dramatically regulated the turnover of local bone and indicated therapeutic effects on BRONJ. © 2015 Elsevier Inc.","Bisphosphonate-related osteonecrosis; Conditioned media; Osteoclasts; Osteogenesis; Paracrine effects; Secretome","Lipton, A., New therapeutic agents for the treatment of bone diseases (2005) Expert Opin Biol Ther, 5, pp. 817-832; Berenson, J.R., Hillner, B.E., Kyle, R.A., Anderson, K., Lipton, A., Yee, G.C., American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma (2002) J Clin Oncol, 20, pp. 3719-3736; Lipton, A., Theriault, R.L., Hortobagyi, G.N., Simeone, J., Knight, R.D., Mellars, K., Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long-term follow-up of two randomized, placebo-controlled trials (2000) Cancer, 88, pp. 1082-1090; Berenson, J.R., Rosen, L.S., Howell, A., Porter, L., Coleman, R.E., Morley, W., Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases (2001) Cancer, 91, pp. 1191-1200; Marx, R.E., Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic (2003) J Oral Maxillofac Surg, 61, pp. 1115-1117; Silverman, S.L., Landesberg, R., Osteonecrosis of the jaw and the role of bisphosphonates: a critical review (2009) Am J Med, 122, pp. 33-45; Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D.D., Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure (1991) J Clin Invest, 88, pp. 2095-2105; Fujita, H., Kurokawa, K., Ogino, T., Ono, M., Yamamoto, M., Oka, T., Effect of risedronate on osteoblast differentiation, expression of receptor activator of NF-kappa B ligand and apoptosis in mesenchymal stem cells (2011) Basic Clin Pharmacol Toxicol, 109, pp. 78-84; Patntirapong, S., Singhatanadgit, W., Chanruangvanit, C., Lavanrattanakul, K., Satravaha, Y., Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition (2012) J Oral Pathol Med, 41, pp. 713-720; Basso, F.G., Turrioni, A.P.S., Hebling, J., Costa, C.A.D., Effects of zoledronic acid on odontoblast-like cells (2013) Arch Oral Biol, 58, pp. 467-473; Bagan, J., Scully, C., Sabater, V., Jimenez, Y., Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): a concise update (2009) Oral Oncol, 45, pp. 551-554; Wimalawansa, S.J., Insight into bisphosphonate-associated osteomyelitis of the jaw: pathophysiology, mechanisms and clinical management (2008) Expert Opin Drug Saf, 7, pp. 491-512; Ross, J.R., Saunders, Y., Edmonds, P.M., Patel, S., Broadley, K.E., Johnston, S.R.D., Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer (2003) BMJ, 327, pp. 469-472; Marx, R.E., Sawatari, Y., Fortin, M., Broumand, V., Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment (2005) J Oral Maxillofac Surg, 63, pp. 1567-1575; Kuehn, B.M., Reports of adverse events from bone drugs prompt caution (2006) JAMA, 295, pp. 2833-2836; Wilkinson, G.S., Kuo, Y.-F., Freeman, J.L., Goodwin, J.S., Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis (2007) J Natl Cancer Inst, 99, pp. 1016-1024; Woo, S.B., Hellstein, J.W., Kalmar, J.R., Systematic review: bisphosphonates and osteonecrosis of the jaws (2006) Ann Intern Med, 144, pp. 753-761; Kikuiri, T., Kim, I., Yamaza, T., Akiyama, K., Zhang, Q., Li, Y., Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice (2010) J Bone Miner Res, 25; Cella, L., Oppici, A., Arbasi, M., Moretto, M., Piepoli, M., Vallisa, D., Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw (2011) Head Face Med, 7; Spaeth, E.L., Dembinski, J.L., Sasser, A.K., Watson, K., Klopp, A., Hall, B., Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression (2009) PLoS One, 4; Rosland, G.V., Svendsen, A., Torsvik, A., Sobala, E., McCormack, E., Immervoll, H., Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation (2009) Cancer Res, 69, pp. 5331-5339; Ide, C., Nakai, Y., Nakano, N., Seo, T.-B., Yamada, Y., Endo, K., Bone marrow stromal cell transplantation for treatment of sub-acute spinal cord injury in the rat (2010) Brain Res, 1332, pp. 32-47; Hung, S.-C., Pochampally, R.R., Chen, S.-C., Hsu, S.-C., Prockop, D.J., Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis (2007) Stem Cells, 25, pp. 2363-2370; Oskowitz, A., McFerrin, H., Gutschow, M., Carter, M.L., Pochampally, R., Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic (2011) Stem Cell Res, 6, pp. 215-225; Osugi, M., Katagiri, W., Yoshimi, R., Inukai, T., Hibi, H., Ueda, M., Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects (2012) Tissue Eng Part A, 18, pp. 1479-1489; Katagiri, W., Osugi, M., Kawai, T., Ueda, M., Novel cell-free regeneration of bone using stem cell-derived growth factors (2013) Int J Oral Maxillofac Implants, 28, pp. 1009-1016; Inukai, T., Katagiri, W., Yoshimi, R., Osugi, M., Kawai, T., Hibi, H., Novel application of stem cell-derived factors for periodontal regeneration (2013) Biochem Biophys Res Commun, 430, pp. 763-768; Ando, Y., Matsubara, K., Ishikawa, J., Fujio, M., Shohara, R., Hibi, H., Stem cell-conditioned medium accelerates distraction osteogenesis through multiple regenerative mechanisms (2014) Bone, 61, pp. 82-90; Chen, L.W., Tredget, E.E., Wu, P.Y.G., Wu, Y.J., Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing (2008) PLoS One, 3, p. 12; Kinnaird, T., Stabile, E., Burnett, M.S., Shou, M., Lee, C.W., Barr, S., Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms (2004) Circulation, 109, pp. 1543-1549; Sonis, S.T., Watkins, B.A., Lyng, G.D., Lerman, M.A., Anderson, K.C., Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients (2009) Oral Oncol, 45, pp. 164-172; Lopez-Jornet, P., Camacho-Alonso, F., Molina-Minano, F., Gomez-Garcia, F., Vicente-Ortega, V., An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats (2010) J Oral Pathol Med, 39, pp. 697-702; Senel, F.C., Duman, M.K., Muci, E., Cankaya, M., Pampu, A.A., Ersoz, S., Jaw bone changes in rats after treatment with zoledronate and pamidronate (2010) Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 109, pp. 385-391; Yamamoto-Silva, F.P., Bradaschia-Correa, V., Lima, L., Arana-Chavez, V.E., Ultrastructural and immunohistochemical study of early repair of alveolar sockets after the extraction of molars from alendronate-treated rats (2013) Microsc Res Tech, 76, pp. 633-640; Azizi, S.A., Stokes, D., Augelli, B.J., DiGirolamo, C., Prockop, D.J., Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats - similarities to astrocyte grafts (1998) Proc Natl Acad Sci U S A, 95, pp. 3908-3913; Hokugo, A., Christensen, R., Chung, E.M., Sung, E.C., Felsenfeld, A.L., Sayre, J.W., Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats (2010) J Bone Miner Res, 25, pp. 1337-1349; Wislet-Gendebien, S., Leprince, P., Moonen, G., Rogister, B., Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells (2003) J Cell Sci, 116, pp. 3295-3302; Gibson, U.E.M., Heid, C.A., Williams, P.M., A novel method for real time quantitative RT PCR (1996) Genome Res, 6, pp. 995-1001; Heid, C.A., Stevens, J., Livak, K.J., Williams, P.M., Real time quantitative PCR (1996) Genome Res, 6, pp. 986-994; Kawamoto, T., Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants (2003) Arch Histol Cytol, 66, pp. 123-143; Ruggiero, S.L., Drew, S.J., Osteonecrosis of the jaws and bisphosphonate therapy (2007) J Dent Res, 86, pp. 1013-1021; Giuliani, N., Pedrazzoni, M., Passeri, G., Girasole, G., Bisphosphonates inhibit IL-6 production by human osteoblast-like cells (1998) Scand J Rheumatol, 27, pp. 38-41; Viereck, V., Emons, G., Lauck, V., Frosch, K.H., Blaschke, S., Grundker, C., Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts (2002) Biochem Biophys Res Commun, 291, pp. 680-686; Kim, M.S., Day, C.J., Morrison, N.A., MCP-1 is induced by receptor activator of nuclear factor-kappa B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation (2005) J Biol Chem, 280, pp. 16163-16169; Tsubaki, M., Satou, T., Itoh, T., Imano, M., Yanae, M., Kato, C., Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2 (2012) Mol Cell Endocrinol, 361, pp. 219-231; Fournier, P., Boissier, S., Filleur, S., Guglielmi, J., Cabon, F., Colombel, M., Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats (2002) Cancer Res, 62, pp. 6538-6544; Kobayashi, Y., Hiraga, T., Ueda, A., Wang, L.Y., Matsumoto-Nakano, M., Hata, K., Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice (2010) J Bone Miner Res, 28, pp. 165-175; Li, Y., Yu, X., Lin, S., Li, X., Zhang, S., Song, Y.-H., Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells (2007) Biochem Biophys Res Commun, 356, pp. 780-784; Kaigler, D., Krebsbach, P.H., Polverini, P.J., Mooney, D.J., Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells (2003) Tissue Eng, 9, pp. 95-103; Cetiner, S., Sucak, G.T., Kahraman, S.A., Aki, S.Z., Kocakahyaoglu, B., Gultekin, S.E., Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid (2009) J Bone Miner Res, 27, pp. 435-443; Klopp, A.H., Lacerda, L., Gupta, A., Debeb, B.G., Solley, T., Li, L., Mesenchymal stem cells promote mammosphere formation and decrease e-cadherin in normal and malignant breast cells (2010) PLoS One, 5 (8), p. e12180; Mandel, K., Yang, Y., Schambach, A., Glage, S., Otte, A., Hass, R., Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo (2013) Stem Cells Dev, 22, pp. 3114-3127; Li, X., Ling, W., Khan, S., Yaccoby, S., Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth (2012) J Bone Miner Res, 27, pp. 1635-1648; Atsuta, I., Liu, S., Miura, Y., Akiyama, K., Chen, C., An, Y., Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway (2013) Stem Cell Res Ther, 4 (5), p. 111",Article,Scopus,2-s2.0-84921712475
"Rao T.N., Marks-Bluth J., Sullivan J., Gupta M.K., Chandrakanthan V., Fitch S.R., Ottersbach K., Jang Y.C., Piao X., Kulkarni R.N., Serwold T., Pimanda J.E., Wagers A.J.","High-level Gpr56 expression is dispensable for the maintenance and function of hematopoietic stem and progenitor cells in mice",2015,"Stem Cell Research","14","3",,"307","322",,,10.1016/j.scr.2015.02.001,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925969923&partnerID=40&md5=01b27d8a9682f8ff4b7a20ef2f0d6e5e","Howard Hughes Medical Institute, United States; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard UniversityCambridge, MA, United States; Joslin Diabetes CenterBoston, MA, United States; Harvard Medical SchoolBoston, MA, United States; Lowy Cancer Research Centre, University of New South WalesSydney, NSW, Australia; Prince of Wales Clinical School, University of New South WalesSydney, NSW, Australia; Department of Haematology, Cambridge Institute for Medical Research University of CambridgeCambridge, United Kingdom; Wellcome Trust - Medical Research Council Stem Cell Institute, University of CambridgeCambridge, United Kingdom; Division of Newborn Medicine, Boston Children's Hospital, Harvard Medical SchoolMA, United States","Rao, T.N., Howard Hughes Medical Institute, United States, Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard UniversityCambridge, MA, United States, Joslin Diabetes CenterBoston, MA, United States, Harvard Medical SchoolBoston, MA, United States; Marks-Bluth, J., Lowy Cancer Research Centre, University of New South WalesSydney, NSW, Australia, Prince of Wales Clinical School, University of New South WalesSydney, NSW, Australia; Sullivan, J., Howard Hughes Medical Institute, United States, Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard UniversityCambridge, MA, United States, Joslin Diabetes CenterBoston, MA, United States, Harvard Medical SchoolBoston, MA, United States; Gupta, M.K., Joslin Diabetes CenterBoston, MA, United States, Harvard Medical SchoolBoston, MA, United States; Chandrakanthan, V., Lowy Cancer Research Centre, University of New South WalesSydney, NSW, Australia, Prince of Wales Clinical School, University of New South WalesSydney, NSW, Australia; Fitch, S.R., Department of Haematology, Cambridge Institute for Medical Research University of CambridgeCambridge, United Kingdom, Wellcome Trust - Medical Research Council Stem Cell Institute, University of CambridgeCambridge, United Kingdom; Ottersbach, K., Department of Haematology, Cambridge Institute for Medical Research University of CambridgeCambridge, United Kingdom, Wellcome Trust - Medical Research Council Stem Cell Institute, University of CambridgeCambridge, United Kingdom; Jang, Y.C., Howard Hughes Medical Institute, United States, Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard UniversityCambridge, MA, United States, Joslin Diabetes CenterBoston, MA, United States, Harvard Medical SchoolBoston, MA, United States; Piao, X., Division of Newborn Medicine, Boston Children's Hospital, Harvard Medical SchoolMA, United States; Kulkarni, R.N., Joslin Diabetes CenterBoston, MA, United States, Harvard Medical SchoolBoston, MA, United States; Serwold, T., Joslin Diabetes CenterBoston, MA, United States, Harvard Medical SchoolBoston, MA, United States; Pimanda, J.E., Lowy Cancer Research Centre, University of New South WalesSydney, NSW, Australia, Prince of Wales Clinical School, University of New South WalesSydney, NSW, Australia; Wagers, A.J., Howard Hughes Medical Institute, United States, Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard UniversityCambridge, MA, United States, Joslin Diabetes CenterBoston, MA, United States, Harvard Medical SchoolBoston, MA, United States","Blood formation by hematopoietic stem cells (HSCs) is regulated by a still incompletely defined network of general and HSC-specific regulators. In this study, we analyzed the role of G-protein coupled receptor 56 (. Gpr56) as a candidate HSC regulator based on its differential expression in quiescent relative to proliferating HSCs and its common targeting by core HSC regulators. Detailed expression analysis revealed that Gpr56 is abundantly expressed by HSPCs during definitive hematopoiesis in the embryo and in the adult bone marrow, but its levels are reduced substantially as HSPCs differentiate. However, despite enriched expression in HSPCs, Gpr56-deficiency did not impair HSPC maintenance or function during steady-state or myeloablative stress-induced hematopoiesis. Gpr56-deficient HSCs also responded normally to physiological and pharmacological mobilization signals, despite the reported role of this GPCR as a regulator of cell adhesion and migration in neuronal cells. Moreover, Gpr56-deficient bone marrow engrafted with equivalent efficiency as wild-type HSCs in primary recipients; however, their reconstituting ability was reduced when subjected to serial transplantation. These data indicate that although GPR56 is abundantly and selectively expressed by primitive HSPCs, its high level expression is largely dispensable for steady-state and regenerative hematopoiesis. © 2015.",,"Bagger, F.O., Rapin, N., Theilgaard-Monch, K., Kaczkowski, B., Jendholm, J., Winther, O., Porse, B., HemaExplorer: a web server for easy and fast visualization of gene expression in normal and malignant hematopoiesis (2012) Blood, 119 (26), pp. 6394-6395. , (Epub 2012/06/30. PubMed PMID: 22745298); Beck, D., Thoms, J.A., Perera, D., Schutte, J., Unnikrishnan, A., Knezevic, K., Kinston, S.J., Pimanda, J.E., Genome-wide analysis of transcriptional regulators in human HSPCs reveals a densely interconnected network of coding and noncoding genes (2013) Blood, 122 (14), pp. e12-e22. , (Epub 2013/08/27. PubMed PMID: 23974199); Chambers, S.M., Boles, N.C., Lin, K.Y., Tierney, M.P., Bowman, T.V., Bradfute, S.B., Chen, A.J., Goodell, M.A., Hematopoietic fingerprints: an expression database of stem cells and their progeny (2007) Cell Stem Cell, 1 (5), pp. 578-591. , (Epub 2008/03/29. PubMed PMID: 18371395); Dar, A., Kollet, O., Lapidot, T., Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice (2006) Exp. Hematol., 34 (8), pp. 967-975. , (Epub 2006/07/26, PubMed PMID: 16863903); Ehninger, A., Trumpp, A., The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in (2011) J. Exp. Med., 208 (3), pp. 421-428; Fitch, S.R., Kimber, G.M., Wilson, N.K., Parker, A., Mirshekar-Syahkal, B., Gottgens, B., Medvinsky, A., Ottersbach, K., Signaling from the sympathetic nervous system regulates hematopoietic stem cell emergence during embryogenesis (2012) Cell Stem Cell, 11 (4), pp. 554-566. , (Epub 2012/10/09. PubMed PMID: 23040481); Forsberg, E.C., Passegue, E., Prohaska, S.S., Wagers, A.J., Koeva, M., Stuart, J.M., Weissman, I.L., Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells (2010) PLoS One, 5 (1), p. e8785. , (PubMed PMID: 20098702); Gazit, R., Garrison, B.S., Rao, T.N., Shay, T., Costello, J., Ericson, J., Kim, F., Rossi, D.J., Transcriptome analysis identifies regulators of hematopoietic stem and progenitor cells (2013) Stem Cell Rep., 1 (3), pp. 266-280. , (Epub 2013/12/10. PubMed PMID: 24319662; PubMed Central PMCID: PMC3849420); Greenbaum, A.M., Link, D.C., Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization (2011) Leukemia, 25 (2), pp. 211-217. , (Epub 2010/11/17, PubMed PMID: 21079612); Iguchi, T., Sakata, K., Yoshizaki, K., Tago, K., Mizuno, N., Itoh, H., Orphan G protein-coupled receptor GPR56 regulates neural progenitor cell migration via a G alpha 12/13 and Rho pathway (2008) J. Biol. Chem., 283 (21), pp. 14469-14478. , (Epub 2008/04/02. PubMed PMID: 18378689); Ivanova, N.B., Dimos, J.T., Schaniel, C., Hackney, J.A., Moore, K.A., Lemischka, I.R., A stem cell molecular signature (2002) Science, 298 (5593), pp. 601-604. , (PubMed PMID: 12228721); Jeong, S.J., Luo, R., Li, S., Strokes, N., Piao, X., Characterization of G protein-coupled receptor 56 protein expression in the mouse developing neocortex (2012) J. Comp. Neurol., 520 (13), pp. 2930-2940. , (Epub 2012/02/22. PubMed PMID: 22351047); Kiel, M.J., Yilmaz, O.H., Iwashita, T., Terhorst, C., Morrison, S.J., SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells (2005) Cell, 121 (7), pp. 1109-1121. , (PubMed PMID: 15989959); Kim, Y.J., Huh, J.W., Kim, D.S., Bae, M.I., Lee, J.R., Ha, H.S., Ahn, K., Kim, H.S., Molecular characterization of the DYX1C1 gene and its application as a cancer biomarker (2009) J. Cancer Res. Clin. Oncol., 135 (2), pp. 265-270. , (Epub 2008/07/12, PubMed PMID: 18618141); Kinzer-Ursem, T.L., Linderman, J.J., Both ligand- and cell-specific parameters control ligand agonism in a kinetic model of g protein-coupled receptor signaling (2007) PLoS Comput. Biol., 3 (1), p. e6. , (Epub 2007/01/16, PubMed PMID: 17222056); Koirala, S., Jin, Z., Piao, X., Corfas, G., GPR56-regulated granule cell adhesion is essential for rostral cerebellar development (2009) J. Neurosci. Off. J. Soc. Neurosci., 29 (23), pp. 7439-7449. , (Epub 2009/06/12. PubMed PMID: 19515912); Kriegel, M.A., Sefik, E., Hill, J.A., Wu, H.J., Benoist, C., Mathis, D., Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice (2011) Proc. Natl. Acad. Sci. U. S. A., 108 (28), pp. 11548-11553. , (PubMed PMID: 21709219); Laird, D.J., von Andrian, U.H., Wagers, A.J., Stem cell trafficking in tissue development, growth, and disease (2008) Cell, 132 (4), pp. 612-630. , (PubMed PMID: 18295579); Langenhan, T., Aust, G., Hamann, J., Sticky signaling-adhesion class G protein-coupled receptors take the stage (2013) Sci. Signal., 6 (276), p. re3. , (Epub 2013/05/23. PubMed PMID: 23695165); Levesque, J.P., Winkler, I.G., Hierarchy of immature hematopoietic cells related to blood flow and niche (2011) Curr. Opin. Hematol., 18 (4), pp. 220-225. , (Epub 2011/04/27. PubMed PMID: 21519242); Li, S., Jin, Z., Koirala, S., Bu, L., Xu, L., Hynes, R.O., Walsh, C.A., Piao, X., GPR56 regulates pial basement membrane integrity and cortical lamination (2008) J. Neurosci. Off. J. Soc. Neurosci., 28 (22), pp. 5817-5826. , (Epub 2008/05/30. PubMed PMID: 18509043); Ling, K.W., Ottersbach, K., van Hamburg, J.P., Oziemlak, A., Tsai, F.Y., Orkin, S.H., Ploemacher, R., Dzierzak, E., GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells (2004) J. Exp. Med., 200 (7), pp. 871-882. , (PubMed PMID: 15466621); Luo, R., Jeong, S.J., Jin, Z., Strokes, N., Li, S., Piao, X., G protein-coupled receptor 56 and collagen III, a receptor-ligand pair, regulates cortical development and lamination (2011) Proc. Natl. Acad. Sci. U. S. A., 108 (31), pp. 12925-12930. , (Epub 2011/07/20. PubMed PMID: 21768377); Luo, B., Lam, B.S., Lee, S.H., Wey, S., Zhou, H., Wang, M., Chen, S.Y., Lee, A.S., The endoplasmic reticulum chaperone protein GRP94 is required for maintaining hematopoietic stem cell interactions with the adult bone marrow niche (2011) PLoS One, 6 (5), p. e20364. , (Epub 2011/06/08, PONE-D-11-02406 [pii]. PubMed PMID: 21647226); Neben, S., Marcus, K., Mauch, P., Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor (1993) Blood, 81 (7), pp. 1960-1967. , (PubMed PMID: 7681707); Orkin, S.H., Zon, L.I., Hematopoiesis: an evolving paradigm for stem cell biology (2008) Cell, 132 (4), pp. 631-644. , (PubMed PMID: 18295580); Passegue, E., Wagers, A.J., Giuriato, S., Anderson, W.C., Weissman, I.L., Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates (2005) J. Exp. Med., 202 (11), pp. 1599-1611. , (PubMed PMID: 16330818); Piao, X., Hill, R.S., Bodell, A., Chang, B.S., Basel-Vanagaite, L., Straussberg, R., Dobyns, W.B., Walsh, C.A., G protein-coupled receptor-dependent development of human frontal cortex (2004) Science, 303 (5666), pp. 2033-2036. , (Epub 2004/03/27. PubMed PMID: 15044805); Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R.C., Melton, D.A., ""Stemness"": transcriptional profiling of embryonic and adult stem cells (2002) Science, 298 (5593), pp. 597-600. , (PubMed PMID: 12228720); Riddell, J., Gazit, R., Garrison, B.S., Guo, G., Saadatpour, A., Mandal, P.K., Ebina, W., Rossi, D.J., Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors (2014) Cell, 157 (3), pp. 549-564. , (Epub 2014/04/29. PubMed PMID: 24766805); Saito, Y., Kaneda, K., Suekane, A., Ichihara, E., Nakahata, S., Yamakawa, N., Nagai, K., Morishita, K., Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR56 (2013) Leukemia, 27 (8), pp. 1637-1649. , (Epub 2013/03/13. PubMed PMID: 23478665); Schepers, K., Hsiao, E.C., Garg, T., Scott, M.J., Passegue, E., Activated Gs signaling in osteoblastic cells alters the hematopoietic stem cell niche in mice (2012) Blood, 120 (17), pp. 3425-3435. , (Epub 2012/08/04. PubMed PMID: 22859604); Schnell, F.J., Zoller, A.L., Patel, S.R., Williams, I.R., Kersh, G.J., Early growth response gene 1 provides negative feedback to inhibit entry of progenitor cells into the thymus (2006) J. Immunol., 176 (8), pp. 4740-4747. , (Epub 2006/04/06. PubMed PMID: 16585567); Shashidhar, S., Lorente, G., Nagavarapu, U., Nelson, A., Kuo, J., Cummins, J., Nikolich, K., Foehr, E.D., GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion (2005) Oncogene, 24 (10), pp. 1673-1682. , (Epub 2005/01/28. PubMed PMID: 15674329); Solaimani Kartalaei, P., Yamada-Inagawa, T., Vink, C.S., de Pater, E., van der Linden, R., Marks-Bluth, J., van der Sloot, A., Dzierzak, E., Whole-transcriptome analysis of endothelial to hematopoietic stem cell transition reveals a requirement for Gpr56 in HSC generation (2015) J. Exp. Med., 212 (1), pp. 93-106. , PubMed PMID: 25547674); Venezia, T.A., Merchant, A.A., Ramos, C.A., Whitehouse, N.L., Young, A.S., Shaw, C.A., Goodell, M.A., Molecular signatures of proliferation and quiescence in hematopoietic stem cells (2004) PLoS Biol., 2 (10), p. e301. , (PubMed PMID: 15459755); Venkatakrishnan, A.J., Deupi, X., Lebon, G., Tate, C.G., Schertler, G.F., Babu, M.M., Molecular signatures of G-protein-coupled receptors (2013) Nature, 494 (7436), pp. 185-194. , (Epub 2013/02/15. PubMed PMID: 23407534); Wang, L.D., Wagers, A.J., Dynamic niches in the origination and differentiation of haematopoietic stem cells (2011) Nat. Rev. Mol. Cell Biol., 12 (10), pp. 643-655. , (Epub 2011/09/03. nrm3184 [pii]. PubMed PMID: 21886187); Wilson, N.K., Foster, S.D., Wang, X., Knezevic, K., Schutte, J., Kaimakis, P., Chilarska, P.M., Gottgens, B., Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators (2010) Cell Stem Cell, 7 (4), pp. 532-544. , (Epub 2010/10/05. PubMed PMID: 20887958); Wright, D.E., Bowman, E.P., Wagers, A.J., Butcher, E.C., Weissman, I.L., Hematopoietic stem cells are uniquely selective in their migratory response to chemokines (2002) J. Exp. Med., 195 (9), pp. 1145-1154. , (PubMed PMID: 11994419); Wu, M.P., Doyle, J.R., Barry, B., Beauvais, A., Rozkalne, A., Piao, X., Lawlor, M.W., Gussoni, E., G-protein coupled receptor 56 promotes myoblast fusion through serum response factor- and nuclear factor of activated T-cell-mediated signalling but is not essential for muscle development in vivo (2013) FEBS J., 280 (23), pp. 6097-6113. , (Epub 2013/10/10. PubMed PMID: 24102982)",Article,Scopus,2-s2.0-84925969923
"Ekthuwapranee K., Sotthibundhu A., Govitrapong P.","Melatonin attenuates methamphetamine-induced inhibition of proliferation of adult rat hippocampal progenitor cells in vitro",2015,"Journal of Pineal Research","58","4",,"418","428",,,10.1111/jpi.12225,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926484137&partnerID=40&md5=b91dff13202957bab289999bdfdae36a","Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol UniversitySalaya, Nakornpathom, Thailand; Center for Neuroscience and Department of Pharmacology, Faculty of Science, Mahidol UniversityNakornpathom, Thailand","Ekthuwapranee, K., Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol UniversitySalaya, Nakornpathom, Thailand; Sotthibundhu, A., Center for Neuroscience and Department of Pharmacology, Faculty of Science, Mahidol UniversityNakornpathom, Thailand; Govitrapong, P., Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol UniversitySalaya, Nakornpathom, Thailand, Center for Neuroscience and Department of Pharmacology, Faculty of Science, Mahidol UniversityNakornpathom, Thailand","Methamphetamine (METH) is an extremely addictive stimulatory drug. A recent study suggested that METH may cause an impairment in the proliferation of hippocampal neural progenitor cells, but the underlying mechanism of this effect remains unknown. Blood and cerebrospinal levels of melatonin derive primarily from the pineal gland, and that performs many biological functions. Our previous study demonstrated that melatonin promotes the proliferation of progenitor cells originating from the hippocampus. In this study, hippocampal progenitor cells from adult Wistar rats were used to determine the effects of METH on cell proliferation and the mechanisms underlying these effects. We investigated the effects of melatonin on the METH-induced alteration in cell proliferation. The results demonstrated that 500 μm METH induced a decrease (63.0%) in neurosphere cell proliferation and altered the expression of neuronal phenotype markers in the neurosphere cell population. Moreover, METH induced an increase in the protein expression of the tumor suppressor p53 (124.4%) and the cell cycle inhibitor p21CIP1 (p21) (128.1%), resulting in the accumulation of p21 in the nucleus. We also found that METH altered the expression of the N-methyl-d-aspartate (NMDA) receptor subunits NR2A (79.6%) and NR2B (126.7%) and Ca2+/calmodulin-dependent protein kinase II (CAMKII) (74.0%). In addition, pretreatment with 1 μm melatonin attenuated the effects induced by METH treatment. According to these results, we concluded that METH induces a reduction in cell proliferation by upregulating the cell cycle regulators p53/p21 and promoting the accumulation of p21 in the nucleus and that melatonin ameliorates these negative effects of METH. © 2015 John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.","adult neurogenesis; hippocampus; melatonin; methamphetamine; N-methyl- d -aspartate receptor; proliferation","Kita, T., Wagner, G.C., Nakashima, T., Current research on methamphetamine-induced neurotoxicity: Animal models of monoamine disruption (2003) J Pharmacol Sci, 92, pp. 178-195; Hart, C.L., Marvin, C.B., Silver, R., Is cognitive functioning impaired in methamphetamine users? A critical review (2012) Neuropsychopharmacology, 37, pp. 586-608; Tolliver, B.K., Price, K.L., Baker, N.L., Impaired cognitive performance in subjects with methamphetamine dependence during exposure to neutral versus methamphetamine-related cues (2012) Am J Drug Alcohol Abuse, 38, pp. 251-259; Belcher, A.M., Feinstein, E.M., O'Dell, S.J., Methamphetamine influences on recognition memory: Comparison of escalating and single-day dosing regimens (2008) Neuropsychopharmacology, 33, pp. 1453-1463; Reichel, C.M., Ramsey, L.A., Schwendt, M., Methamphetamine-induced changes in the object recognition memory circuit (2012) Neuropharmacology, 62, pp. 1119-1126; Deng, W., Aimone, J.B., Gage, F.H., New neurons and new memories: How does adult hippocampal neurogenesis affect learning and memory? (2010) Nat Rev Neurosci, 11, pp. 339-350; Pan, Y.W., Storm, D.R., Xia, Z., Role of adult neurogenesis in hippocampus-dependent memory, contextual fear extinction and remote contextual memory: New insights from ERK5 MAP kinase (2013) Neurobiol Learn Mem, 105, pp. 81-92; Marques-Torrejon, M.A., Porlan, E., Banito, A., Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expression (2013) Cell Stem Cell, 12, pp. 88-100; Lee, T.K., Man, K., Poon, R.T., Disruption of p53-p21/WAF1 cell cycle pathway contributes to progression and worse clinical outcome of hepatocellular carcinoma (2004) Oncol Rep, 12, pp. 25-31; Kachnic, L.A., Wu, B., Wunsch, H., The ability of p53 to activate downstream genes p21(WAF1/cip1) and MDM2, and cell cycle arrest following DNA damage is delayed and attenuated in scid cells deficient in the DNA-dependent protein kinase (1999) J Biol Chem, 274, pp. 13111-13117; Fotedar, R., Fitzgerald, P., Rousselle, T., P21 contains independent binding sites for cyclin and cdk2: Both sites are required to inhibit cdk2 kinase activity (1996) Oncogene, 12, pp. 2155-2164; Venkatesan, A., Uzasci, L., Chen, Z., Impairment of adult hippocampal neural progenitor proliferation by methamphetamine: Role for nitrotyrosination (2011) Mol Brain, 4, p. 28; Cajochen, C., Krauchi, K., Wirz-Justice, A., Role of melatonin in the regulation of human circadian rhythms and sleep (2003) J Neuroendocrinol, 15, pp. 432-437; Srinivasan, V., Pandi-Perumal, S.R., Trahkt, I., Melatonin and melatonergic drugs on sleep: Possible mechanisms of action (2009) Int J Neurosci, 119, pp. 821-846; Herrera, E.A., Macchiavello, R., Montt, C., Melatonin improves cerebrovascular function and decreases oxidative stress in chronically hypoxic lambs (2014) J Pineal Res, 57, pp. 33-42; Zhang, H.M., Zhang, Y., Melatonin: A well-documented antioxidant with conditional pro-oxidant actions (2014) J Pineal Res, 57, pp. 131-146; Tocharus, C., Puriboriboon, Y., Junmanee, T., Melatonin enhances adult rat hippocampal progenitor cell proliferation via ERK signaling pathway through melatonin receptor (2014) Neuroscience, 275 C, pp. 314-321; Sotthibundhu, A., Phansuwan-Pujito, P., Govitrapong, P., Melatonin increases proliferation of cultured neural stem cells obtained from adult mouse subventricular zone (2010) J Pineal Res, 49, pp. 291-300; Ramirez-Rodriguez, G., Klempin, F., Babu, H., Melatonin modulates cell survival of new neurons in the hippocampus of adult mice (2009) Neuropsychopharmacology, 34, pp. 2180-2191; Tocharus, C., Puriboriboon, Y., Junmanee, T., Melatonin enhances adult rat hippocampal progenitor cell proliferation via ERK signaling pathway through melatonin receptor (2014) Neuroscience, 275, pp. 314-321; Louis, S.A., Mak, C.K., Reynolds, B.A., Methods to culture, differentiate, and characterize neural stem cells from the adult and embryonic mouse central nervous system (2013) Methods Mol Biol, 946, pp. 479-506; Kee, N., Sivalingam, S., Boonstra, R., The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis (2002) J Neurosci Methods, 115, pp. 97-105; Zinchuk, V., Zinchuk, O., Okada, T., Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: Pushing pixels to explore biological phenomena (2007) Acta Histochem Cytochem, 40, pp. 101-111; Dunn, K.W., Kamocka, M.M., McDonald, J.H., A practical guide to evaluating colocalization in biological microscopy (2011) Am J Physiol Cell Physiol, 300, pp. C723-C742; Mahoney, J.J., III, Jackson, B.J., Kalechstein, A.D., Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline (2011) Prog Neuropsychopharmacol Biol Psychiatry, 35, pp. 459-465; Leuner, B., Gould, E., Shors, T.J., Is there a link between adult neurogenesis and learning? (2006) Hippocampus, 16, pp. 216-224; Recinto, P., Samant, A.R., Chavez, G., Levels of neural progenitors in the hippocampus predict memory impairment and relapse to drug seeking as a function of excessive methamphetamine self-administration (2012) Neuropsychopharmacology, 37, pp. 1275-1287; Bento, A.R., Baptista, S., Malva, J.O., Methamphetamine exerts toxic effects on subventricular zone stem/progenitor cells and inhibits neuronal differentiation (2011) Rejuvenation Res, 14, pp. 205-214; Yuan, C.J., Quiocho, J.M., Kim, A., Extended access methamphetamine decreases immature neurons in the hippocampus which results from loss and altered development of neural progenitors without altered dynamics of the S-phase of the cell cycle (2011) Pharmacol Biochem Behav, 100, pp. 98-108; Baptista, S., Bento, A.R., Goncalves, J., Neuropeptide y promotes neurogenesis and protection against methamphetamine-induced toxicity in mouse dentate gyrus-derived neurosphere cultures (2012) Neuropharmacology, 62, pp. 2413-2423; Chen, M., Pereira-Smith, O.M., Tominaga, K., Loss of the chromatin regulator MRG15 limits neural stem/progenitor cell proliferation via increased expression of the p21 Cdk inhibitor (2011) Stem Cell Res, 7, pp. 75-88; Malik, S., Saha, R., Seth, P., Involvement of extracellular signal-regulated kinase (ERK1/2)-p53-p21 axis in mediating neural stem/progenitor cell cycle arrest in co-morbid HIV-drug abuse exposure (2014) J Neuroimmune Pharmacol, 9, pp. 340-353; Mirzayans, R., Scott, A., Andrais, B., Ultraviolet light exposure triggers nuclear accumulation of p21(WAF1) and accelerated senescence in human normal and nucleotide excision repair-deficient fibroblast strains (2008) J Cell Physiol, 215, pp. 55-67; Hwang, C.Y., Lee, C., Kwon, K.S., Extracellular signal-regulated kinase 2-dependent phosphorylation induces cytoplasmic localization and degradation of p21Cip1 (2009) Mol Cell Biol, 29, pp. 3379-3389; Reiter, R.J., Tan, D.X., Kim, S.J., Delivery of pineal melatonin to the brain and SCN: Role of canaliculi, cerebrospinal fluid, tanycytes and Virchow-Robin perivascular spaces (2014) Brain Struct Funct, 219, pp. 1873-1887; Gesing, A., Jagiela, J., Lewinski, A., Melatonin does not affect p21 expression in rat thyroid follicular cells (2003) Neuro Endocrinol Lett, 24, pp. 310-313; Ekthuwapranee, K., Sotthibundhu, A., Tocharus, C., Melatonin ameliorates dexamethasone-induced inhibitory effects on the proliferation of cultured progenitor cells obtained from adult rat hippocampus (2015) J Steroid Biochem Mol Biol, 145, pp. 38-48; Mandyam, C.D., Wee, S., Crawford, E.F., Varied access to intravenous methamphetamine self-administration differentially alters adult hippocampal neurogenesis (2008) Biol Psychiatry, 64, pp. 958-965; Robson, M.J., Turner, R.C., Naser, Z.J., SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation (2014) Exp Neurol, 254, pp. 180-189; Permpoonputtana, K., Mukda, S., Govitrapong, P., Effect of melatonin on d -amphetamine-induced neuroglial alterations in postnatal rat hippocampus and prefrontal cortex (2012) Neurosci Lett, 524, pp. 1-4; Bannerman, D.M., Sprengel, R., Sanderson, D.J., Hippocampal synaptic plasticity, spatial memory and anxiety (2014) Nat Rev Neurosci, 15, pp. 181-192; Simoes, P.F., Silva, A.P., Pereira, F.C., Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory (2007) Neuroscience, 150, pp. 433-441; Kitayama, T., Yoneyama, M., Tamaki, K., Regulation of neuronal differentiation by N-methyl- d -aspartate receptors expressed in neural progenitor cells isolated from adult mouse hippocampus (2004) J Neurosci Res, 76, pp. 599-612; Li, M., Zhang, D.Q., Wang, X.Z., NR2B-containing NMDA receptors promote neural progenitor cell proliferation through CaMKIV/CREB pathway (2011) Biochem Biophys Res Commun, 411, pp. 667-672; Hu, M., Sun, Y.J., Zhou, Q.G., Negative regulation of neurogenesis and spatial memory by NR2B-containing NMDA receptors (2008) J Neurochem, 106, pp. 1900-1913; Watanabe, K., Kanno, T., Oshima, T., The NMDA receptor NR2A subunit regulates proliferation of MKN45 human gastric cancer cells (2008) Biochem Biophys Res Commun, 367, pp. 487-490; Suemaru, J., Akiyama, K., Tanabe, Y., Methamphetamine decreases calcium-calmodulin dependent protein kinase II activity in discrete rat brain regions (2000) Synapse, 36, pp. 155-166; Jayanthi, S., McCoy, M.T., Chen, B., Methamphetamine downregulates striatal glutamate receptors via diverse epigenetic mechanisms (2014) Biol Psychiatry, 76, pp. 47-56; Baydas, G., Ozer, M., Yasar, A., Melatonin improves learning and memory performances impaired by hyperhomocysteinemia in rats (2005) Brain Res, 1046, pp. 187-194; Tongjaroenbuangam, W., Ruksee, N., Mahanam, T., Melatonin attenuates dexamethasone-induced spatial memory impairment and dexamethasone-induced reduction of synaptic protein expressions in the mouse brain (2013) Neurochem Int, 63, pp. 482-491; Coras, R., Siebzehnrubl, F.A., Pauli, E., Low proliferation and differentiation capacities of adult hippocampal stem cells correlate with memory dysfunction in humans (2010) Brain, 133, pp. 3359-3372",Article,Scopus,2-s2.0-84926484137
"Pioli P.D., Chen X., Weis J.J., Weis J.H.","Fatal autoimmunity results from the conditional deletion of Snai2 and Snai3",2015,"Cellular Immunology","295","1",,"1","18",,,10.1016/j.cellimm.2015.02.009,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84923367026&partnerID=40&md5=d9998a94cc0b31cccb0eedd1aad1a192","Division of Cell Biology and Immunology, Department of Pathology, University of Utah School of MedicineSalt Lake City, UT, United States","Pioli, P.D., Division of Cell Biology and Immunology, Department of Pathology, University of Utah School of MedicineSalt Lake City, UT, United States; Chen, X., Division of Cell Biology and Immunology, Department of Pathology, University of Utah School of MedicineSalt Lake City, UT, United States; Weis, J.J., Division of Cell Biology and Immunology, Department of Pathology, University of Utah School of MedicineSalt Lake City, UT, United States; Weis, J.H., Division of Cell Biology and Immunology, Department of Pathology, University of Utah School of MedicineSalt Lake City, UT, United States","Transcriptional regulation of gene expression is a key component of orchestrating proper immune cell development and function. One strategy for maintaining these transcriptional programs has been the evolution of transcription factor families with members possessing overlapping functions. Using the germ line deletion of Snai2 combined with the hematopoietic specific deletion of Snai3, we report that these factors function redundantly to preserve the development of B and T cells. Such animals display severe lymphopenia, alopecia and dermatitis as well as profound autoimmunity manifested by the production of high levels of autoantibodies as early as 3weeks of age and die by 30days after birth. Autoantibodies included both IgM and IgG isotypes and were reactive against cytoplasmic and membranous components. A regulatory T cell defect contributed to the autoimmune response in that adoptive transfer of wild type regulatory T cells alleviated symptoms of autoimmunity. Additionally, transplantation of Snai2/Snai3 double deficient bone marrow into Snai2 sufficient Rag2-/- recipients resulted in autoantibody generation. The results demonstrated that appropriate expression of Snai2 and Snai3 in cells of hematopoietic derivation plays an important role in development and maintenance of immune tolerance. © 2015 Elsevier Inc.","Autoantibody; Autoimmunity; Genetic deficiency; Lymphocytes; Snail transcription factors","Scott, E.W., Fisher, R.C., Olson, M.C., Kehrli, E.W., Simon, M.C., Singh, H., PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors (1997) Immunity, 6, pp. 437-447; Fontenot, J.D., Rasmussen, J.P., Williams, L.M., Dooley, J.L., Farr, A.G., Rudensky, A.Y., Regulatory T cell lineage specification by the forkhead transcription factor foxp3 (2005) Immunity, 22, pp. 329-341; Sakaguchi, S., Regulatory T Cells: key controllers of immunologic self-tolerance (2000) Cell, 101, pp. 455-458; Fujiwara, Y., Chang, A.N., Williams, A.M., Orkin, S.H., Functional overlap of GATA-1 and GATA-2 in primitive hematopoietic development (2004) Blood, 103, pp. 583-585; Manzanares, M., Locascio, A., Nieto, M.A., The increasing complexity of the Snail gene superfamily in metazoan evolution (2001) Trends Genet., 17, pp. 178-181; Manzanares, M., Blanco, M.J., Nieto, M.A., Snail3 orthologues in vertebrates: divergent members of the Snail zinc-finger gene family (2004) Dev. Genes. Evol., 214, pp. 47-53; Barrallo-Gimeno, A., Nieto, M.A., Evolutionary history of the Snail/Scratch superfamily (2009) Trends Genet., 25, pp. 248-252; Kataoka, H., Murayama, T., Yokode, M., Mori, S., Sano, H., Ozaki, H., A novel snail-related transcription factor Smuc regulates basic helix-loop-helix transcription factor activities via specific E-box motifs (2000) Nucleic Acids Res., 28, pp. 626-633; Soleimani, V.D., Yin, H., Jahani-Asl, A., Ming, H., Kockx, C.E., van Ijcken, W.F., Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis (2012) Mol. Cell, 47, pp. 457-468; Ferrari-Amorotti, G., Fragliasso, V., Esteki, R., Prudente, Z., Soliera, A.R., Cattelani, S., Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion (2013) Cancer Res., 73, pp. 235-245; Herranz, N., Pasini, D., Diaz, V.M., Franci, C., Gutierrez, A., Dave, N., Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor (2008) Mol. Cell. Biol., 28, pp. 4772-4781; Peinado, H., Ballestar, E., Esteller, M., Cano, A., Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex (2004) Mol. Cell. Biol., 24, pp. 306-319; Chen, Y., Gridley, T., Compensatory regulation of the Snai1 and Snai2 genes during chondrogenesis (2013) J. Bone Miner. Res., 28, pp. 1412-1421; Barrallo-Gimeno, A., Nieto, M.A., The Snail genes as inducers of cell movement and survival: implications in development and cancer (2005) Development, 132, pp. 3151-3161; Pioli, P.D., Weis, J.H., Snail transcription factors in hematopoietic cell development: a model of functional redundancy (2014) Exp. Hematol., 42, pp. 425-430; Lomeli, H., Starling, C., Gridley, T., Epiblast-specific Snai1 deletion results in embryonic lethality due to multiple vascular defects (2009) BMC Res. Notes, 2, p. 22; Carver, E.A., Jiang, R., Lan, Y., Oram, K.F., Gridley, T., The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition (2001) Mol. Cell. Biol., 21, pp. 8184-8188; Perez-Losada, J., Sanchez-Martin, M., Rodriguez-Garcia, A., Sanchez, M.L., Orfao, A., Flores, T., Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway (2002) Blood, 100, pp. 1274-1286; Bradley, C.K., Norton, C.R., Chen, Y., Han, X., Booth, C.J., Yoon, J.K., The snail family gene snai3 is not essential for embryogenesis in mice (2013) PLoS ONE, 8, p. e65344; Pioli, P.D., Dahlem, T.J., Weis, J.J., Weis, J.H., Deletion of Snai2 and Snai3 results in impaired physical development compounded by lymphocyte deficiency (2013) PLoS ONE, 8, p. e69216; Anderson, G., Takahama, Y., Thymic epithelial cells: working class heroes for T cell development and repertoire selection (2012) Trends Immunol., 33, pp. 256-263; Pioli, P.D., Debnath, I., Weis, J.J., Weis, J.H., Zfp318 regulates IgD expression by abrogating transcription termination within the Ighm/Ighd locus (2014) J. Immunol.; Cho, S., Spangrude, G.J., Enrichment of functionally distinct mouse hematopoietic progenitor cell populations using CD62L (2011) J. Immunol., 187, pp. 5203-5210; Perry, S.S., Wang, H., Pierce, L.J., Yang, A.M., Tsai, S., Spangrude, G.J., L-selectin defines a bone marrow analog to the thymic early T-lineage progenitor (2004) Blood, 103, pp. 2990-2996; Leonardo, S.M., Josephson, J.A., Hartog, N.L., Gauld, S.B., Altered B cell development and anergy in the absence of Foxp3 (2010) J. Immunol., 185, pp. 2147-2156; Hibbs, M.L., Tarlinton, D.M., Armes, J., Grail, D., Hodgson, G., Maglitto, R., Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease (1995) Cell, 83, pp. 301-311; Gu, Y., Jensen, P.E., Chen, X., Immunodeficiency and autoimmunity in H2-O-deficient mice (2013) J. Immunol., 190, pp. 126-137; Ando, T., Xiao, W., Gao, P., Namiranian, S., Matsumoto, K., Tomimori, Y., Critical role for mast cell Stat5 activity in skin inflammation (2014) Cell Rep., 6, pp. 366-376; Huter, E.N., Natarajan, K., Torgerson, T.R., Glass, D.D., Shevach, E.M., Autoantibodies in scurfy mice and IPEX patients recognize keratin 14 (2010) J. Invest. Dermatol., 130, pp. 1391-1399; Aschermann, S., Lehmann, C.H., Mihai, S., Schett, G., Dudziak, D., Nimmerjahn, F., B cells are critical for autoimmune pathology in Scurfy mice (2013) Proc. Natl. Acad. Sci. U.S.A., 110, pp. 19042-19047; Bennett, C.L., Ochs, H.D., IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena (2001) Curr. Opin. Pediatr., 13, pp. 533-538; Bennett, C.L., Christie, J., Ramsdell, F., Brunkow, M.E., Ferguson, P.J., Whitesell, L., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 (2001) Nat. Genet., 27, pp. 20-21; Ouyang, W., Beckett, O., Ma, Q., Paik, J.H., DePinho, R.A., Li, M.O., Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells (2010) Nat. Immunol., 11, pp. 618-627; Miyazaki, M., Miyazaki, K., Chen, S., Itoi, M., Miller, M., Lu, L.F., Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease (2014) Nat. Immunol., 15, pp. 767-776; Komatsu, N., Hori, S., Full restoration of peripheral Foxp3+ regulatory T cell pool by radioresistant host cells in scurfy bone marrow chimeras (2007) Proc. Natl. Acad. Sci. U.S.A., 104, pp. 8959-8964; Nagasawa, T., Microenvironmental niches in the bone marrow required for B-cell development (2006) Nat. Rev. Immunol., 6, pp. 107-116; Lai, A.Y., Kondo, M., Identification of a bone marrow precursor of the earliest thymocytes in adult mouse (2007) Proc. Natl. Acad. Sci. U.S.A., 104, pp. 6311-6316; Nakamura, K., Kouro, T., Kincade, P.W., Malykhin, A., Maeda, K., Coggeshall, K.M., Src homology 2-containing 5-inositol phosphatase (SHIP) suppresses an early stage of lymphoid cell development through elevated interleukin-6 production by myeloid cells in bone marrow (2004) J. Exp. Med., 199, pp. 243-254; Wu, W.S., Heinrichs, S., Xu, D., Garrison, S.P., Zambetti, G.P., Adams, J.M., Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma (2005) Cell, 123, pp. 641-653; Kim, S., Yao, J., Suyama, K., Qian, X., Qian, B.Z., Bandyopadhyay, S., Slug promotes survival during metastasis through suppression of puma-mediated apoptosis (2014) Cancer Res., 74, pp. 3695-3706; Arienti, C., Tesei, A., Carloni, S., Ulivi, P., Romeo, A., Ghigi, G., SLUG silencing increases radiosensitivity of melanoma cells in vitro (2013) Cell. Oncol., 36, pp. 131-139; Chen, Y., Gridley, T., The SNAI1 and SNAI2 proteins occupy their own and each other's promoter during chondrogenesis (2013) Biochem. Biophys. Res. Commun., 435, pp. 356-360",Article,Scopus,2-s2.0-84923367026
"Ueda R., Fuji S., Mori S.-I., Hiramoto N., Hashimoto H., Tanaka T., Tada K., Kobayashi Y., Morikawa N., Shinohara A., Okinaka K., Maeshima A.M., Kurosawa S., Kim S.-W., Yamashita T., Fukuda T.","Characteristics and outcomes of patients diagnosed with norovirus gastroenteritis after allogeneic hematopoietic stem cell transplantation based on immunochromatography",2015,"International Journal of Hematology",,,,"","",8,,10.1007/s12185-015-1804-2,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928656764&partnerID=40&md5=49651172b41e6751ceaced2d59cb58c0","Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Department of Hemato-Oncology, St. Luke’s International HospitalTokyo, Japan; Pathology and Clinical Laboratory Division, National Cancer Center HospitalTokyo, Japan","Ueda, R., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Fuji, S., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Mori, S.-I., Department of Hemato-Oncology, St. Luke’s International HospitalTokyo, Japan; Hiramoto, N., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Hashimoto, H., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Tanaka, T., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Tada, K., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Kobayashi, Y., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Morikawa, N., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Shinohara, A., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Okinaka, K., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Maeshima, A.M., Pathology and Clinical Laboratory Division, National Cancer Center HospitalTokyo, Japan; Kurosawa, S., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Kim, S.-W., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Yamashita, T., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan; Fukuda, T., Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-kuTokyo, Japan","Norovirus gastroenteritis (NV-GE) is a highly transmittable disease that can lead to fatal outcomes in vulnerable populations including patients after hematopoietic stem cell transplantation (HSCT). Prompt detection of NV is therefore important for HSCT recipients. Immunochromatography (IC) can be used to easily and rapidly diagnose NV-GE by detecting NV antigens. In this study, we examined 642 stool specimens in patients who developed diarrhea after allogeneic HSCT between January 2007 and June 2011. NV was detected in 10 of 350 (2.9 %) HSCT recipients. The median onset of symptoms was 36 days (range 3–93) after HSCT. The median duration of symptoms was 42 days (3–135). A second or subsequent allogeneic HSCT was associated with a higher incidence of NV-GE (P = 0.034). Of four patients who underwent colonoscopy, two showed intestinal graft-versus-host disease (GVHD) histopathology, whereas the other two showed no evidence of GVHD, and thus no need for intensified immunosuppression. None of the patients died of NV-GE. In conclusion, IC may be useful in the differential diagnosis of diarrhea after allogeneic HSCT, and could enable the appropriate adjustment of immunosuppressive drugs and prompt preventive measures. © 2015 The Japanese Society of Hematology","Allogeneic hematopoietic stem cell transplantation; Immunochromatgraphy; Norovirus gastroenteritis",,Article in Press,Scopus,2-s2.0-84928656764
"Chung M.-M., Chen Y.-L., Pei D., Cheng Y.-C., Sun B., Nicol C.J., Yen C.-H., Chen H.-M., Liang Y.-J., Chiang M.-C.","The neuroprotective role of metformin in advanced glycation end product treated human neural stem cells is AMPK-dependent",2015,"Biochimica et Biophysica Acta - Molecular Basis of Disease","1852","5",,"720","731",,,10.1016/j.bbadis.2015.01.006,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84922364445&partnerID=40&md5=e30abf2f979c686119ce368414c1411c","Department of Internal Medicine, Cardinal Tien Hospital, School of Medicine, Fu-Jen Catholic UniversityNew Taipei City, Taiwan; Department of Pathology, Cardinal Tien Hospital, School of Medicine, Fu-Jen Catholic UniversityNew Taipei City, Taiwan; Department of Biochemistry and Molecular Biology, Chang Gung UniversityTao Yuan, Taiwan; Institute of Neuroscience, Zhejiang University School of MedicineZhejiang, China; Department of Pathology and Molecular Medicine, Cancer Biology and Genetics Division, Cancer Research Institute, Queen's UniversityKingston, ON, Canada; Department of Biomedical and Molecular Sciences (Pharmacology and Toxicology), Queen's UniversityKingston, ON, Canada; Department of International Business, Ming Chuan UniversityTaipei, Taiwan; Graduate Institute of Applied Science and Engineering, Fu Jen Catholic UniversityNew Taipei City, Taiwan; Department of Life Science, Fu Jen Catholic UniversityNew Taipei City, Taiwan","Chung, M.-M., Department of Internal Medicine, Cardinal Tien Hospital, School of Medicine, Fu-Jen Catholic UniversityNew Taipei City, Taiwan; Chen, Y.-L., Department of Pathology, Cardinal Tien Hospital, School of Medicine, Fu-Jen Catholic UniversityNew Taipei City, Taiwan; Pei, D., Department of Internal Medicine, Cardinal Tien Hospital, School of Medicine, Fu-Jen Catholic UniversityNew Taipei City, Taiwan; Cheng, Y.-C., Department of Biochemistry and Molecular Biology, Chang Gung UniversityTao Yuan, Taiwan; Sun, B., Institute of Neuroscience, Zhejiang University School of MedicineZhejiang, China; Nicol, C.J., Department of Pathology and Molecular Medicine, Cancer Biology and Genetics Division, Cancer Research Institute, Queen's UniversityKingston, ON, Canada, Department of Biomedical and Molecular Sciences (Pharmacology and Toxicology), Queen's UniversityKingston, ON, Canada; Yen, C.-H., Department of International Business, Ming Chuan UniversityTaipei, Taiwan; Chen, H.-M., Graduate Institute of Applied Science and Engineering, Fu Jen Catholic UniversityNew Taipei City, Taiwan, Department of Life Science, Fu Jen Catholic UniversityNew Taipei City, Taiwan; Liang, Y.-J., Department of Life Science, Fu Jen Catholic UniversityNew Taipei City, Taiwan; Chiang, M.-C., Department of Life Science, Fu Jen Catholic UniversityNew Taipei City, Taiwan","Diabetic neuronal damage results from hyperglycemia followed by increased formation of advanced glycosylation end products (AGEs), which leads to neurodegeneration, although the molecular mechanisms are still not well understood. Metformin, one of the most widely used anti-diabetic drugs, exerts its effects in part by activation of AMP-activated protein kinase (AMPK). AMPK is a critical evolutionarily conserved enzyme expressed in the liver, skeletal muscle and brain, and promotes cellular energy homeostasis and biogenesis by regulating several metabolic processes. While the mechanisms of AMPK as a metabolic regulator are well established, the neuronal role for AMPK is still unknown. In the present study, human neural stem cells (hNSCs) exposed to AGEs had significantly reduced cell viability, which correlated with decreased AMPK and mitochondria associated gene/protein (PGC1α, NRF-1 and Tfam) expressions, as well as increased activation of caspase 3 and 9 activities. Metformin prevented AGEs induced cytochrome c release from mitochondria into cytosol in the hNSCs. Co-treatment with metformin significantly abrogated the AGE-mediated effects in hNSCs. Metformin also significantly rescued hNSCs from AGE-mediated mitochondrial deficiency (lower ATP, D-loop level, mitochondrial mass, maximal respiratory function, COX activity, and mitochondrial membrane potential). Furthermore, co-treatment of hNSCs with metformin significantly blocked AGE-mediated reductions in the expression levels of several neuroprotective genes (PPARγ, Bcl-2 and CREB). These findings extend our understanding of the molecular mechanisms of both AGE-induced neuronal toxicity, and AMPK-dependent neuroprotection by metformin. This study further suggests that AMPK may be a potential therapeutic target for treating diabetic neurodegeneration. © 2015 Elsevier B.V.","AGEs; AMPK; HNSCs; Metformin","Butterfield, D.A., Di Domenico, F., Barone, E., Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain (2014) Biochim. Biophys. Acta, 1842, pp. 1693-1706; McCall, A.L., The impact of diabetes on the CNS (1992) Diabetes, 41, pp. 557-570; Thomas, V.S., Darvesh, S., MacKnight, C., Rockwood, K., Estimating the prevalence of dementia in elderly people: a comparison of the Canadian study of health and aging and national population health survey approaches (2001) Int. Psychogeriatr., 13, pp. 169-175; Arnold, S.E., Lucki, I., Brookshire, B.R., Carlson, G.C., Browne, C.A., Kazi, H., Bang, S., Kim, S.F., High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice (2014) Neurobiol. Dis., 67, pp. 79-87; Ott, A., Stolk, R.P., van Harskamp, F., Pols, H.A., Hofman, A., Breteler, M.M., Diabetes mellitus and the risk of dementia: the Rotterdam study (1999) Neurology, 53, pp. 1937-1942; Peila, R., Rodriguez, B.L., Launer, L.J., Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study (2002) Diabetes, 51, pp. 1256-1262; Arvanitakis, Z., Wilson, R.S., Bienias, J.L., Evans, D.A., Bennett, D.A., Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function (2004) Arch. Neurol., 61, pp. 661-666; den Heijer, T., Vermeer, S.E., van Dijk, E.J., Prins, N.D., Koudstaal, P.J., Hofman, A., Breteler, M.M., Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI (2003) Diabetologia, 46, pp. 1604-1610; Stewart, R., Liolitsa, D., Type 2 diabetes mellitus, cognitive impairment and dementia (1999) Diabet. Med., 16, pp. 93-112; Magistretti, P.J., Pellerin, L., Cellular mechanisms of brain energy metabolism. Relevance to functional brain imaging and to neurodegenerative disorders (1996) Ann. N. Y. Acad. Sci., 777, pp. 380-387; Duarte, A.I., Candeias, E., Correia, S.C., Santos, R.X., Carvalho, C., Cardoso, S., Placido, A., Moreira, P.I., Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration (2013) Biochim. Biophys. Acta, 1832, pp. 527-541; Nelson, P.T., Smith, C.D., Abner, E.A., Schmitt, F.A., Scheff, S.W., Davis, G.J., Keller, J.N., Markesbery, W.R., Human cerebral neuropathology of type 2 diabetes mellitus (2009) Biochim. Biophys. Acta, 1792, pp. 454-469; Yamagishi, S., Takeuchi, M., Inagaki, Y., Nakamura, K., Imaizumi, T., Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy (2003) Int. J. Clin. Pharmacol. Res., 23, pp. 129-134; Yamagishi, S., Imaizumi, T., Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy (2005) Curr. Pharm. Des., 11, pp. 2279-2299; Wang, S.H., Sun, Z.L., Guo, Y.J., Yuan, Y., Li, L., PPARgamma-mediated advanced glycation end products regulation of neural stem cells (2009) Mol. Cell. Endocrinol., 307, pp. 176-184; Yamagishi, S., Nakamura, K., Matsui, T., Ueda, S., Fukami, K., Okuda, S., Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications (2008) Expert Opin. Investig. Drugs, 17, pp. 983-996; Ruggiero-Lopez, D., Lecomte, M., Moinet, G., Patereau, G., Lagarde, M., Wiernsperger, N., Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation (1999) Biochem. Pharmacol., 58, pp. 1765-1773; Steinberg, G.R., Kemp, B.E., AMPK in health and disease (2009) Physiol. Rev., 89, pp. 1025-1078; Fogarty, S., Hardie, D.G., Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer (2010) Biochim. Biophys. Acta, 1804, pp. 581-591; Sun, W., Lee, T.S., Zhu, M., Gu, C., Wang, Y., Zhu, Y., Shyy, J.Y., Statins activate AMP-activated protein kinase in vitro and in vivo (2006) Circulation, 114, pp. 2655-2662; Rahbar, S., Natarajan, R., Yerneni, K., Scott, S., Gonzales, N., Nadler, J.L., Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation (2000) Clin. Chim. Acta, 301, pp. 65-77; Ronnett, G.V., Ramamurthy, S., Kleman, A.M., Landree, L.E., Aja, S., AMPK in the brain: its roles in energy balance and neuroprotection (2009) J. Neurochem., 109, pp. 17-23; Carling, D., The AMP-activated protein kinase cascade-a unifying system for energy control (2004) Trends Biochem. Sci., 29, pp. 18-24; Hardie, D.G., Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status (2003) Endocrinology, 144, pp. 5179-5183; Shin, S.M., Cho, I.J., Kim, S.G., Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3beta inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway (2009) Mol. Pharmacol., 76, pp. 884-895; Choi, S.L., Kim, S.J., Lee, K.T., Kim, J., Mu, J., Birnbaum, M.J., Soo Kim, S., Ha, J., The regulation of AMP-activated protein kinase by H(2)O(2) (2001) Biochem. Biophys. Res. Commun., 287, pp. 92-97; Salt, I.P., Johnson, G., Ashcroft, S.J., Hardie, D.G., AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release (1998) Biochem. J., 335, pp. 533-539; Arsikin, K., Kravic-Stevovic, T., Jovanovic, M., Ristic, B., Tovilovic, G., Zogovic, N., Bumbasirevic, V., Harhaji-Trajkovic, L., Autophagy-dependent and -independent involvement of AMP-activated protein kinase in 6-hydroxydopamine toxicity to SH-SY5Y neuroblastoma cells (2012) Biochim. Biophys. Acta, 1822, pp. 1826-1836; Melemedjian, O.K., Asiedu, M.N., Tillu, D.V., Sanoja, R., Yan, J., Lark, A., Khoutorsky, A., Price, T.J., Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain (2011) Mol. Pain, 7, p. 70; Zhang, B.B., Zhou, G., Li, C., AMPK: an emerging drug target for diabetes and the metabolic syndrome (2009) Cell Metab., 9, pp. 407-416; Salminen, A., Kaarniranta, K., AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network (2012) Ageing Res. Rev., 11, pp. 230-241; Salminen, A., Kaarniranta, K., Haapasalo, A., Soininen, H., Hiltunen, M., AMP-activated protein kinase: a potential player in Alzheimer's disease (2011) J. Neurochem., 118, pp. 460-474; Dulovic, M., Jovanovic, M., Xilouri, M., Stefanis, L., Harhaji-Trajkovic, L., Kravic-Stevovic, T., Paunovic, V., Trajkovic, V., The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro (2014) Neurobiol. Dis., 63, pp. 1-11; Ferretta, A., Gaballo, A., Tanzarella, P., Piccoli, C., Capitanio, N., Nico, B., Annese, T., Cocco, T., Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease (2014) Biochim. Biophys. Acta, 1842, pp. 902-915; Chakraborty, A., Chowdhury, S., Bhattacharyya, M., Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients (2011) Diabetes Res. Clin. Pract., 93, pp. 56-62; Salminen, A., Hyttinen, J.M., Kaarniranta, K., AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan (2011) J. Mol. Med. (Berl.), 89, pp. 667-676; Chiang, M.C., Lin, H., Cheng, Y.C., Yen, C.H., Huang, R.N., Lin, K.H., Beta-adrenoceptor pathway enhances mitochondrial function in human neural stem cells via rotary cell culture system (2012) J. Neurosci. Methods, 207, pp. 130-136; Chiang, M.C., Cheng, Y.C., Chen, H.M., Liang, Y.J., Yen, C.H., Rosiglitazone promotes neurite outgrowth and mitochondrial function in N2A cells via PPARgamma pathway (2014) Mitochondrion, 14, pp. 7-17; Chiang, M.C., Cheng, Y.C., Lin, K.H., Yen, C.H., PPARgamma regulates the mitochondrial dysfunction in human neural stem cells with tumor necrosis factor alpha (2013) Neuroscience, 229, pp. 118-129; Chiang, M.C., Chern, Y., Huang, R.N., PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease (2012) Neurobiol. Dis., 45, pp. 322-328; Chiang, M.C., Chern, Y., Juo, C.G., The dysfunction of hepatic transcriptional factors in mice with Huntington's disease (2011) Biochim. Biophys. Acta, 1812, pp. 1111-1120; Ramasamy, R., Vannucci, S.J., Yan, S.S., Herold, K., Yan, S.F., Schmidt, A.M., Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation (2005) Glycobiology, 15, pp. 16R-28R; Srikanth, V., Maczurek, A., Phan, T., Steele, M., Westcott, B., Juskiw, D., Munch, G., Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease (2011) Neurobiol. Aging, 32, pp. 763-777; Yan, S.F., Yan, S.D., Ramasamy, R., Schmidt, A.M., Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation (2009) Ann. Med., 41, pp. 408-422; Ishibashi, Y., Yamagishi, S., Matsui, T., Ohta, K., Tanoue, R., Takeuchi, M., Ueda, S., Okuda, S., Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level (2012) Metab. Clin. Exp., 61, pp. 1067-1072; Gasic-Milenkovic, J., Loske, C., Munch, G., Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y (2003) J. Alzheimers Dis., 5, pp. 25-30; Chang, P.C., Chong, L.Y., Tsai, S.C., Lim, L.P., Aminoguanidine inhibits the AGE-RAGE axis to modulate the induction of periodontitis but has limited effects on the progression and recovery of experimental periodontitis: a preliminary study (2014) J. Periodontol., 85, pp. 729-739; Thornalley, P.J., Use of aminoguanidine (pimagedine) to prevent the formation of advanced glycation endproducts (2003) Arch. Biochem. Biophys., 419, pp. 31-40; Green, D.R., Reed, J.C., Mitochondria and apoptosis (1998) Science, 281, pp. 1309-1312; Naseer, M.I., Ullah, I., Narasimhan, M.L., Lee, H.Y., Bressan, R.A., Yoon, G.H., Yun, D.J., Kim, M.O., Neuroprotective effect of osmotin against ethanol-induced apoptotic neurodegeneration in the developing rat brain (2014) Cell Death Dis., 5, p. e1150; Saito, M., Chakraborty, G., Mao, R.F., Wang, R., Cooper, T.B., Vadasz, C., Ethanol alters lipid profiles and phosphorylation status of AMP-activated protein kinase in the neonatal mouse brain (2007) J. Neurochem., 103, pp. 1208-1218; Shirwany, N.A., Zou, M.H., AMPK: a cellular metabolic and redox sensor. A minireview (2014) Front Biosci., 19, pp. 447-474; Scarpulla, R.C., Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network (2011) Biochim. Biophys. Acta, 1813, pp. 1269-1278; Jager, S., Handschin, C., St-Pierre, J., Spiegelman, B.M., AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 12017-12022; Puigserver, P., Spiegelman, B.M., Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator (2003) Endocr. Rev., 24, pp. 78-90; Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Spiegelman, B.M., Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 (1999) Cell, 98, pp. 115-124; Pagel-Langenickel, I., Bao, J., Joseph, J.J., Schwartz, D.R., Mantell, B.S., Xu, X., Raghavachari, N., Sack, M.N., PGC-1alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle (2008) J. Biol. Chem., 283, pp. 22464-22472; Jimenez-Flores, L.M., Lopez-Briones, S., Macias-Cervantes, M.H., Ramirez-Emiliano, J., Perez-Vazquez, V., A PPARgamma, NF-kappaB and AMPK-dependent mechanism may be involved in the beneficial effects of curcumin in the diabetic db/db mice liver (2014) Molecules, 19, pp. 8289-8302; Alrashed, F., Calay, D., Thornton, C., Bauer, A., Kiprianos, A., Haskard, D., Boyle, J., Mason, J., P179Celecoxib-mediated activation of an AMPK-CREB-Nrf2 dependent pathway: a novel mechanism for endothelial cytoprotection in chronic systemic inflammation (2014) Cardiovasc. Res., 103, pp. S31-S32; Xu, J.N., Zeng, C., Zhou, Y., Peng, C., Zhou, Y.F., Xue, Q., Metformin inhibits StAR expression in human endometrial stromal cells via AMPK-mediated disruption of CREB-CRTC2 complex formation (2014) J. Clin. Endocrinol. Metab., 99, pp. 2795-2803; Hamdulay, S.S., Wang, B., Calay, D., Kiprianos, A.P., Cole, J., Dumont, O., Dryden, N., Mason, J.C., Synergistic therapeutic vascular cytoprotection against complement-mediated injury induced via a PKCalpha-AMPK-, and CREB-dependent pathway (2014) J. Immunol., 192, pp. 4316-4327; Moran, C., Sanz-Rodriguez, A., Jimenez-Pacheco, A., Martinez-Villareal, J., McKiernan, R.C., Jimenez-Mateos, E.M., Mooney, C., Engel, T., Bmf upregulation through the AMP-activated protein kinase pathway may protect the brain from seizure-induced cell death (2013) Cell Death Dis., 4, p. e606; Kuhla, B., Loske, C., Garcia De Arriba, S., Schinzel, R., Huber, J., Munch, G., Differential effects of ""advanced glycation endproducts"" and beta-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y (2004) J. Neural Transm., 111, pp. 427-439; de Arriba, S.G., Stuchbury, G., Yarin, J., Burnell, J., Loske, C., Munch, G., Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells-protection by carbonyl scavengers (2007) Neurobiol. Aging, 28, pp. 1044-1050; Wareski, P., Vaarmann, A., Choubey, V., Safiulina, D., Liiv, J., Kuum, M., Kaasik, A., PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons (2009) J. Biol. Chem., 284, pp. 21379-21385; Kamal, A., Biessels, G.J., Duis, S.E., Gispen, W.H., Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing (2000) Diabetologia, 43, pp. 500-506; Ullah, I., Ullah, N., Naseer, M.I., Lee, H.Y., Kim, M.O., Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neurons (2012) BMC Neurosci., 13, p. 11; El-Mir, M.Y., Detaille, D.R.V.G., Delgado-Esteban, M., Guigas, B., Attia, S., Fontaine, E., Almeida, A., Leverve, X., Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons (2008) J. Mol. Neurosci., 34, pp. 77-87. , MN; Reznick, R.M., Zong, H., Li, J., Morino, K., Moore, I.K., Yu, H.J., Liu, Z.X., Shulman, G.I., Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis (2007) Cell Metab., 5, pp. 151-156; Price, N.L., Gomes, A.P., Ling, A.J., Duarte, F.V., Martin-Montalvo, A., North, B.J., Agarwal, B., Sinclair, D.A., SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function (2012) Cell Metab., 15, pp. 675-690; Chowdhury, S.K., Smith, D.R., Fernyhough, P., The role of aberrant mitochondrial bioenergetics in diabetic neuropathy (2013) Neurobiol. Dis., 51, pp. 56-65; Choi, J., Chandrasekaran, K., Inoue, T., Muragundla, A., Russell, J.W., PGC-1alpha regulation of mitochondrial degeneration in experimental diabetic neuropathy (2014) Neurobiol. Dis., 64, pp. 118-130; Horvath, T.L., Erion, D.M., Elsworth, J.D., Roth, R.H., Shulman, G.I., Andrews, Z.B., GPA protects the nigrostriatal dopamine system by enhancing mitochondrial function (2011) Neurobiol. Dis., 43, pp. 152-162; Suwa, M., Egashira, T., Nakano, H., Sasaki, H., Kumagai, S., Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo (2006) J. Appl. Physiol., 101, pp. 1685-1692; Hardie, D.G., AMPK: positive and negative regulation, and its role in whole-body energy homeostasis (2014) Curr. Opin. Cell Biol., 33 C, pp. 1-7; Godoy, J.A., Rios, J.A., Zolezzi, J.M., Braidy, N., Inestrosa, N.C., Signaling pathway cross talk in Alzheimer's disease (2014) Cell Commun. Signal., 12, p. 23",Article,Scopus,2-s2.0-84922364445
"Gude N., Joyo E., Toko H., Quijada P., Villanueva M., Hariharan N., Sacchi V., Truffa S., Joyo A., Voelkers M., Alvarez R., Sussman M.A.","Notch activation enhances lineage commitment and protective signaling in cardiac progenitor cells",2015,"Basic Research in Cardiology","110","3",,"","",15,,10.1007/s00395-015-0488-3,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928603444&partnerID=40&md5=51280ad984aadf4ae7fc2505e2811118","Heart Institute, and Biology Department, SDSU Integrated Regenerative Research Institute, Life Sciences North, 426, 5500 Campanile DriveSan Diego, CA, United States","Gude, N., Heart Institute, and Biology Department, SDSU Integrated Regenerative Research Institute, Life Sciences North, 426, 5500 Campanile DriveSan Diego, CA, United States; Joyo, E., Heart Institute, and Biology Department, SDSU Integrated Regenerative Research Institute, Life Sciences North, 426, 5500 Campanile DriveSan Diego, CA, United States; Toko, H., Heart Institute, and Biology Department, SDSU Integrated Regenerative Research Institute, Life Sciences North, 426, 5500 Campanile DriveSan Diego, CA, United States; Quijada, P., Heart Institute, and Biology Department, SDSU Integrated Regenerative Research Institute, Life Sciences North, 426, 5500 Campanile DriveSan Diego, CA, United States; Villanueva, M., Heart Institute, and Biology Department, SDSU Integrated Regenerative Research Institute, Life Sciences North, 426, 5500 Campanile DriveSan Diego, CA, United States; Hariharan, N., Heart Institute, and Biology Department, SDSU Integrated Regenerative Research Institute, Life Sciences North, 426, 5500 Campanile DriveSan Diego, CA, United States; Sacchi, V., Heart Institute, and Biology Department, SDSU Integrated Regenerative Research Institute, Life Sciences North, 426, 5500 Campanile DriveSan Diego, CA, United States; Truffa, S., Heart Institute, and Biology Department, SDSU Integrated Regenerative Research Institute, Life Sciences North, 426, 5500 Campanile DriveSan Diego, CA, United States; Joyo, A., Heart Institute, and Biology Department, SDSU Integrated Regenerative Research Institute, Life Sciences North, 426, 5500 Campanile DriveSan Diego, CA, United States; Voelkers, M., Heart Institute, and Biology Department, SDSU Integrated Regenerative Research Institute, Life Sciences North, 426, 5500 Campanile DriveSan Diego, CA, United States; Alvarez, R., Heart Institute, and Biology Department, SDSU Integrated Regenerative Research Institute, Life Sciences North, 426, 5500 Campanile DriveSan Diego, CA, United States; Sussman, M.A., Heart Institute, and Biology Department, SDSU Integrated Regenerative Research Institute, Life Sciences North, 426, 5500 Campanile DriveSan Diego, CA, United States","Phase I clinical trials applying autologous progenitor cells to treat heart failure have yielded promising results; however, improvement in function is modest, indicating a need to enhance cardiac stem cell reparative capacity. Notch signaling plays a crucial role in cardiac development, guiding cell fate decisions that underlie myocyte and vessel differentiation. The Notch pathway is retained in the adult cardiac stem cell niche, where level and duration of Notch signal influence proliferation and differentiation of cardiac progenitors. In this study, Notch signaling promotes growth, survival and differentiation of cardiac progenitor cells into smooth muscle lineages in vitro. Cardiac progenitor cells expressing tamoxifen-regulated intracellular Notch1 (CPCeK) are significantly larger and proliferate more slowly than control cells, exhibit elevated mTORC1 and Akt signaling, and are resistant to oxidative stress. Vascular smooth muscle and cardiomyocyte markers increase in CPCeK and are augmented further upon ligand-mediated induction of Notch signal. Paracrine signals indicative of growth, survival and differentiation increase with Notch activity, while markers of senescence are decreased. Adoptive transfer of CPCeK into infarcted mouse myocardium enhances preservation of cardiac function and reduces infarct size relative to hearts receiving control cells. Greater capillary density and proportion of vascular smooth muscle tissue in CPCeK-treated hearts indicate improved vascularization. Finally, we report a previously undescribed signaling mechanism whereby Notch activation stimulates CPC growth, survival and differentiation via mTORC1 and paracrine factor expression. Taken together, these findings suggest that regulated Notch activation potentiates the reparative capacity of CPCs in the treatment of cardiac disease. © 2015, Springer-Verlag Berlin Heidelberg.","Cardiac progenitor; Differentiation; Notch signaling; Paracrine; Survival","Androutsellis-Theotokis, A., Leker, R.R., Soldner, F., Hoeppner, D.J., Ravin, R., Poser, S.W., Rueger, M.A., McKay, R.D., Notch signalling regulates stem cell numbers in vitro and in vivo (2006) Nature, 442, pp. 823-826. , COI: 1:CAS:528:DC%2BD28XotFKmsLs%3D, PID: 16799564; Avolio, E., Meloni, M., Spencer, H.L., Riu, F., Katare, R., Mangialardi, G., Oikawa, A., Madeddu, P.R., Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair (2015) Circ Res, , PID: 25801898; Bolli, R., Chugh, A.R., D’Amario, D., Loughran, J.H., Stoddard, M.F., Ikram, S., Beache, G.M., Anversa, P., Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial (2011) Lancet, 378, pp. 1847-1857. , PID: 22088800; Boni, A., Urbanek, K., Nascimbene, A., Hosoda, T., Zheng, H., Delucchi, F., Amano, K., Leri, A., Notch1 regulates the fate of cardiac progenitor cells (2008) Proc Natl Acad Sci USA, 105, pp. 15529-15534. , COI: 1:CAS:528:DC%2BD1cXht1Gnt73L, PID: 18832173; Buas, M.F., Kabak, S., Kadesch, T., The Notch effector Hey1 associates with myogenic target genes to repress myogenesis (2010) J Biol Chem, 285, pp. 1249-1258. , COI: 1:CAS:528:DC%2BC3cXkvFai, PID: 19917614; Campa, V.M., Gutierrez-Lanza, R., Cerignoli, F., Diaz-Trelles, R., Nelson, B., Tsuji, T., Barcova, M., Mercola, M., Notch activates cell cycle reentry and progression in quiescent cardiomyocytes (2008) J Cell Biol, 183, pp. 129-141. , COI: 1:CAS:528:DC%2BD1cXht1Cht77F, PID: 18838555; Chen, L., Ashraf, M., Wang, Y., Zhou, M., Zhang, J., Qin, G., Rubinstein, J., Tang, Y., The role of Notch 1 activation in cardiosphere derived cell differentiation (2012) Stem Cells Dev, 21, pp. 2122-2129. , COI: 1:CAS:528:DC%2BC38XhtFOhtrnK, PID: 22239539; Chen, V.C., Stull, R., Joo, D., Cheng, X., Keller, G., Notch signaling respecifies the hemangioblast to a cardiac fate (2008) Nat Biotechnol, 26, pp. 1169-1178. , COI: 1:CAS:528:DC%2BD1cXht1aisrrJ, PID: 18820686; Chugh, A.R., Beache, G.M., Loughran, J.H., Mewton, N., Elmore, J.B., Kajstura, J., Pappas, P., Bolli, R., Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance (2012) Circulation, 126, pp. 54-64. , COI: 1:CAS:528:DC%2BC38XhtlCitbvF, PID: 22965994; Croquelois, A., Domenighetti, A.A., Nemir, M., Lepore, M., Rosenblatt-Velin, N., Radtke, F., Pedrazzini, T., Control of the adaptive response of the heart to stress via the Notch1 receptor pathway (2008) J Exp Med, 205, pp. 3173-3185. , COI: 1:CAS:528:DC%2BD1MXosFGq, PID: 19064701; D’Amario, D., Leone, A.M., Iaconelli, A., Luciani, N., Gaudino, M., Kannappan, R., Manchi, M., Crea, F., Growth properties of cardiac stem cells are a novel biomarker of patients’ outcome after coronary bypass surgery (2014) Circulation, 129, pp. 157-172. , PID: 24249720; de la Pompa, J.L., Epstein, J.A., Coordinating tissue interactions: Notch signaling in cardiac development and disease (2012) Dev Cell, 22, pp. 244-254. , PID: 22340493; Fischer, K.M., Cottage, C.T., Wu, W., Din, S., Gude, N.A., Avitabile, D., Quijada, P., Sussman, M.A., Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase (2009) Circulation, 120, pp. 2077-2087. , COI: 1:CAS:528:DC%2BD1MXhsVaksrrN, PID: 19901187; Flaherty, M.P., Kamerzell, T.J., Dawn, B., Wnt signaling and cardiac differentiation (2012) Prog Mol Biol Transl Sci, 111, pp. 153-174. , COI: 1:CAS:528:DC%2BC38XhvVSjtLbO, PID: 22917230; Fransioli, J., Bailey, B., Gude, N.A., Cottage, C.T., Muraski, J.A., Emmanuel, G., Wu, W., Sussman, M.A., Evolution of the c-kit-positive cell response to pathological challenge in the myocardium (2008) Stem Cells, 26, pp. 1315-1324. , COI: 1:CAS:528:DC%2BD1cXnsFCgtbo%3D, PID: 18308948; Gnecchi, M., He, H., Liang, O.D., Melo, L.G., Morello, F., Mu, H., Noiseux, N., Dzau, V.J., Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells (2005) Nat Med, 11, pp. 367-368. , COI: 1:CAS:528:DC%2BD2MXivFChurc%3D, PID: 15812508; Gnecchi, M., Zhang, Z., Ni, A., Dzau, V.J., Paracrine mechanisms in adult stem cell signaling and therapy (2008) Circ Res, 103, pp. 1204-1219. , COI: 1:CAS:528:DC%2BD1cXhtlKrt7bF, PID: 19028920; Gude, N.A., Emmanuel, G., Wu, W., Cottage, C.T., Fischer, K., Quijada, P., Muraski, J.A., Sussman, M.A., Activation of Notch-mediated protective signaling in the myocardium (2008) Circ Res, 102, pp. 1025-1035. , COI: 1:CAS:528:DC%2BD1cXltlSnsLo%3D, PID: 18369158; Guentchev, M., McKay, R.D., Notch controls proliferation and differentiation of stem cells in a dose-dependent manner (2006) Eur J Neurosci, 23, pp. 2289-2296. , PID: 16706837; Heusch, G., SCIPIO brings new momentum to cardiac cell therapy (2011) Lancet, 378, pp. 1827-1828. , PID: 22088799; High, F.A., Epstein, J.A., The multifaceted role of Notch in cardiac development and disease (2008) Nat Rev Genet, 9, pp. 49-61. , COI: 1:CAS:528:DC%2BD2sXhsVCgt7vL, PID: 18071321; High, F.A., Lu, M.M., Pear, W.S., Loomes, K.M., Kaestner, K.H., Epstein, J.A., Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development (2008) Proc Natl Acad Sci USA, 105, pp. 1955-1959. , COI: 1:CAS:528:DC%2BD1cXitl2ntbY%3D, PID: 18245384; Hong, K.U., Li, Q.H., Guo, Y., Patton, N.S., Moktar, A., Bhatnagar, A., Bolli, R., A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice (2013) Basic Res Cardiol, 108, p. 346. , PID: 23549981; Hu, S., Yan, G., Xu, H., He, W., Liu, Z., Ma, G., Hypoxic preconditioning increases survival of cardiac progenitor cells via the pim-1 kinase-mediated anti-apoptotic effect (2014) Circ J, 78, pp. 724-731. , COI: 1:CAS:528:DC%2BC2cXntlGjs7s%3D, PID: 24401608; Huang, C., Gu, H., Yu, Q., Manukyan, M.C., Poynter, J.A., Wang, M., Sca-1 + cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion (2011) PLoS One, 6, p. 29246. , COI: 1:CAS:528:DC%2BC38Xis1ajsg%3D%3D, PID: 22195033; Hurlbut, G.D., Kankel, M.W., Lake, R.J., Artavanis-Tsakonas, S., Crossing paths with Notch in the hyper-network (2007) Curr Opin Cell Biol, 19, pp. 166-175. , COI: 1:CAS:528:DC%2BD2sXjt1Slu7k%3D, PID: 17317139; Jain, R., Rentschler, S., Epstein, J.A., Notch and cardiac outflow tract development (2010) Ann N Y Acad Sci, 1188, pp. 184-190. , COI: 1:CAS:528:DC%2BC3cXksVKgt74%3D, PID: 20201902; Johnson, A.M., Kartha, C.C., Proliferation of murine c-kit(pos) cardiac stem cells stimulated with IGF-1 is associated with Akt-1 mediated phosphorylation and nuclear export of FoxO3a and its effect on downstream cell cycle regulators (2014) Growth Factors, 32, pp. 53-62. , COI: 1:CAS:528:DC%2BC2cXkvVCqsLo%3D, PID: 24580070; Kishore, R., Verma, S.K., Mackie, A.R., Vaughan, E.E., Abramova, T.V., Aiko, I., Krishnamurthy, P., Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts (2013) PLoS One, 8, p. 60161. , COI: 1:CAS:528:DC%2BC3sXmtVelsL4%3D, PID: 23560074; Konstandin, M.H., Toko, H., Gastelum, G.M., Quijada, P., De La Torre, A., Quintana, M., Collins, B., Sussman, M.A., Fibronectin is essential for reparative cardiac progenitor cell response after myocardial infarction (2013) Circ Res, 113, pp. 115-125. , COI: 1:CAS:528:DC%2BC3sXhtVKgtL%2FI, PID: 23652800; Koyanagi, M., Bushoven, P., Iwasaki, M., Urbich, C., Zeiher, A.M., Dimmeler, S., Notch signaling contributes to the expression of cardiac markers in human circulating progenitor cells (2007) Circ Res, 101, pp. 1139-1145. , COI: 1:CAS:528:DC%2BD2sXhtlahurjI, PID: 17967789; Kratsios, P., Catela, C., Salimova, E., Huth, M., Berno, V., Rosenthal, N., Mourkioti, F., Distinct roles for cell-autonomous Notch signaling in cardiomyocytes of the embryonic and adult heart (2010) Circ Res, 106, pp. 559-572. , COI: 1:CAS:528:DC%2BC3cXitFCksL8%3D, PID: 20007915; Kurpinski, K., Lam, H., Chu, J., Wang, A., Kim, A., Tsay, E., Agrawal, S., Li, S., Transforming growth factor-beta and Notch signaling mediate stem cell differentiation into smooth muscle cells (2010) Stem Cells, 28, pp. 734-742. , COI: 1:CAS:528:DC%2BC3cXms1yisLs%3D, PID: 20146266; Li, Y., Hiroi, Y., Ngoy, S., Okamoto, R., Noma, K., Wang, C.Y., Wang, H.W., Liao, J.K., Notch1 in bone marrow-derived cells mediates cardiac repair after myocardial infarction (2011) Circulation, 123, pp. 866-876. , COI: 1:CAS:528:DC%2BC3MXisFWlsbY%3D, PID: 21321153; Liu, Z.J., Li, Y., Tan, Y., Xiao, M., Zhang, J., Radtke, F., Velazquez, O.C., Inhibition of fibroblast growth by Notch1 signaling is mediated by induction of Wnt11-dependent WISP-1 (2012) PLoS One, 7, p. 38811. , COI: 1:CAS:528:DC%2BC38XovVejt7Y%3D, PID: 22715413; Makkar, R.R., Smith, R.R., Cheng, K., Malliaras, K., Thomson, L.E., Berman, D., Czer, L.S., Marban, E., Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial (2012) Lancet, 379, pp. 895-904. , PID: 22336189; Malliaras, K., Makkar, R.R., Smith, R.R., Cheng, K., Wu, E., Bonow, R.O., Marban, L., Marban, E., Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction) (2014) J Am Coll Cardiol, 63, pp. 110-122. , PID: 24036024; Manderfield, L.J., High, F.A., Engleka, K.A., Liu, F., Li, L., Rentschler, S., Epstein, J.A., Notch activation of Jagged1 contributes to the assembly of the arterial wall (2012) Circulation, 125, pp. 314-323. , PID: 22147907; Mohsin, S., Khan, M., Nguyen, J., Alkatib, M., Siddiqi, S., Hariharan, N., Wallach, K., Sussman, M.A., Rejuvenation of human cardiac progenitor cells with Pim-1 kinase (2013) Circ Res, 113, pp. 1169-1179. , COI: 1:CAS:528:DC%2BC3sXhs1Gqu73F, PID: 24044948; Mohsin, S., Khan, M., Toko, H., Bailey, B., Cottage, C.T., Wallach, K., Nag, D., Sussman, M.A., Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair (2012) J Am Coll Cardiol, 60, pp. 1278-1287. , COI: 1:CAS:528:DC%2BC38XhsVCjsb3J, PID: 22841153; Mohsin, S., Siddiqi, S., Collins, B., Sussman, M.A., Empowering adult stem cells for myocardial regeneration (2011) Circ Res, 109, pp. 1415-1428. , COI: 1:CAS:528:DC%2BC3MXhsF2jsrvN, PID: 22158649; Nemir, M., Metrich, M., Plaisance, I., Lepore, M., Cruchet, S., Berthonneche, C., Sarre, A., Pedrazzini, T., The Notch pathway controls fibrotic and regenerative repair in the adult heart (2012) Eur Heart J, , PID: 23166366; Nurzynska, D., Di Meglio, F., Romano, V., Miraglia, R., Sacco, A.M., Latino, F., Bancone, C., Castaldo, C., Cardiac primitive cells become committed to a cardiac fate in adult human heart with chronic ischemic disease but fail to acquire mature phenotype: genetic and phenotypic study (2013) Basic Res Cardiol, 108, p. 320. , PID: 23224139; Oie, E., Sandberg, W.J., Ahmed, M.S., Yndestad, A., Laerum, O.D., Attramadal, H., Aukrust, P., Eiken, H.G., Activation of Notch signaling in cardiomyocytes during post-infarction remodeling (2010) Scand Cardiovasc J, 44, pp. 359-366. , COI: 1:CAS:528:DC%2BC3cXhsVekt7vJ, PID: 20799913; Pedrazzini, T., Control of cardiogenesis by the notch pathway (2007) Trends Cardiovasc Med, 17, pp. 83-90. , COI: 1:CAS:528:DC%2BD2sXjvFGgtbs%3D, PID: 17418369; Pei, H., Yu, Q., Xue, Q., Guo, Y., Sun, L., Hong, Z., Han, H., Tao, L., Notch1 cardioprotection in myocardial ischemia/reperfusion involves reduction of oxidative/nitrative stress (2013) Basic Res Cardiol, 108, p. 373. , PID: 23989801; Quijada, P., Sussman, M.A., Making it stick: chasing the optimal stem cells for cardiac regeneration (2014) Expert Rev Cardiovasc Ther, 12, pp. 1275-1288. , COI: 1:CAS:528:DC%2BC2cXhsl2msbrM, PID: 25340282; Rogers, T.B., Pati, S., Gaa, S., Riley, D., Khakoo, A.Y., Patel, S., Wardlow, R.D., 2nd, Lederer, W.J., Mesenchymal stem cells stimulate protective genetic reprogramming of injured cardiac ventricular myocytes (2011) J Mol Cell Cardiol, 50, pp. 346-356. , COI: 1:CAS:528:DC%2BC3MXhtlart7Y%3D, PID: 20837021; Sacchi, V., Mittermayr, R., Hartinger, J., Martino, M.M., Lorentz, K.M., Wolbank, S., Hofmann, A., Banfi, A., Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164 (2014) Proc Natl Acad Sci USA, 111, pp. 6952-6957. , COI: 1:CAS:528:DC%2BC2cXntFGisbw%3D, PID: 24778233; Sanada, F., Kim, J., Czarna, A., Chan, N.Y., Signore, S., Ogorek, B., Isobe, K., Leri, A., c-Kit-positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the aging myopathy (2014) Circ Res, 114, pp. 41-55. , COI: 1:CAS:528:DC%2BC2cXhs1KlsA%3D%3D, PID: 24170267; Siddiqi, S., Sussman, M.A., Cell and gene therapy for severe heart failure patients: the time and place for Pim-1 kinase (2013) Expert Rev Cardiovasc Ther, 11, pp. 949-957. , COI: 1:CAS:528:DC%2BC3sXhtlChs7jJ, PID: 23984924; Tierney, M.T., Aydogdu, T., Sala, D., Malecova, B., Gatto, S., Puri, P.L., Latella, L., Sacco, A., STAT3 signaling controls satellite cell expansion and skeletal muscle repair (2014) Nat Med, 20, pp. 1182-1186. , COI: 1:CAS:528:DC%2BC2cXhsFKms7vK, PID: 25194572; Urbanek, K., Cabral-da-Silva, M.C., Ide-Iwata, N., Maestroni, S., Delucchi, F., Zheng, H., Ferreira-Martins, J., Leri, A., Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart (2010) Circ Res, 107, pp. 429-441. , COI: 1:CAS:528:DC%2BC3cXpvVSnsr0%3D, PID: 20558824; Urbanek, K., Cesselli, D., Rota, M., Nascimbene, A., De Angelis, A., Hosoda, T., Bearzi, C., Leri, A., Stem cell niches in the adult mouse heart (2006) Proc Natl Acad Sci USA, 103, pp. 9226-9231. , COI: 1:CAS:528:DC%2BD28XmsVWjtrg%3D, PID: 16754876; Urbanek, K., Rota, M., Cascapera, S., Bearzi, C., Nascimbene, A., De Angelis, A., Hosoda, T., Anversa, P., Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival (2005) Circ Res, 97, pp. 663-673. , COI: 1:CAS:528:DC%2BD2MXhtVeqsrbJ, PID: 16141414; Williams, A.R., Hatzistergos, K.E., Addicott, B., McCall, F., Carvalho, D., Suncion, V., Morales, A.R., Hare, J.M., Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction (2013) Circulation, 127, pp. 213-223. , PID: 23224061; Yuan, Z.R., Kobayashi, N., Kohsaka, T., Human Jagged 1 mutants cause liver defect in Alagille syndrome by overexpression of hepatocyte growth factor (2006) J Mol Biol, 356, pp. 559-568. , COI: 1:CAS:528:DC%2BD28XotVKkuw%3D%3D, PID: 16403414",Article,Scopus,2-s2.0-84928603444
"Sohi G., Dilworth F.J.","Noncoding RNAs as epigenetic mediators of skeletal muscle regeneration",2015,"FEBS Journal","282","9",,"1630","1646",,1,10.1111/febs.13170,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928481379&partnerID=40&md5=f645f70630c78808acc4c3d1d84f37e5","Sprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, 501 Smyth Rd, Mailbox 511Ottawa, ON, Canada; Department of Cellular and Molecular Medicine, University of Ottawa, Canada","Sohi, G., Sprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, 501 Smyth Rd, Mailbox 511Ottawa, ON, Canada; Dilworth, F.J., Sprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, 501 Smyth Rd, Mailbox 511Ottawa, ON, Canada, Department of Cellular and Molecular Medicine, University of Ottawa, Canada","Skeletal muscle regeneration is a well-characterized biological process in which resident adult stem cells must undertake a series of cell-fate decisions to ensure efficient repair of the damaged muscle fibers while also maintaining the stem cell niche. Satellite cells, the main stem cell contributing to the repaired muscle fiber, are maintained in a quiescent state in healthy muscle. Upon injury, the satellite cells become activated, and proliferate to expand the muscle progenitor cell population before returning to the quiescent state or differentiating to become myofibers. Importantly, the determination of cell fate is controlled at the epigenetic level in response to environmental cues. In this review, we discuss our current understanding of the role played by noncoding RNAs (both miRNAs and long-noncoding RNAs) in the epigenetic control of muscle regeneration. Muscle regeneration is mediated by satellite cells, a population of stem cells that must undertake a cell fate decision to either repair damaged muscle fibers or self-renew to maintain the satellite cell niche. This determination of cell fate is controlled at the epigenetic level. Here, we discuss the role played by noncoding RNAs in the epigenetic control of muscle regeneration. © 2014 FEBS.","differentiation; epigenetics; gene expression; lncRNAs; miRNAs; MyoD; myogenesis; myoMiRs; satellite cells; skeletal muscle","Crick, F., Central dogma of molecular biology (1970) Nature, 227, pp. 561-563; Michalak, P., RNA world - the dark matter of evolutionary genomics (2006) J Evol Biol, 19, pp. 1768-1774; Velculescu, V.E., Zhang, L., Vogelstein, B., Kinzler, K.W., Serial analysis of gene expression (1995) Science, 270, pp. 484-487; Wei, C.L., Ng, P., Chiu, K.P., Wong, C.H., Ang, C.C., Lipovich, L., Liu, E.T., Ruan, Y., 5′ Long serial analysis of gene expression (LongSAGE) and 3′ LongSAGE for transcriptome characterization and genome annotation (2004) Proc Natl Acad Sci USA, 101, pp. 11701-11706; Matsumura, H., Reuter, M., Kruger, D.H., Winter, P., Kahl, G., Terauchi, R., SuperSAGE (2008) Methods Mol Biol, 387, pp. 55-70; Shiraki, T., Kondo, S., Katayama, S., Waki, K., Kasukawa, T., Kawaji, H., Kodzius, R., Arakawa, T., Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage (2003) Proc Natl Acad Sci USA, 100, pp. 15776-15781; Mortazavi, A., Williams, B.A., McCue, K., Schaeffer, L., Wold, B., Mapping and quantifying mammalian transcriptomes by RNA-Seq (2008) Nat Methods, 5, pp. 621-628; Djebali, S., Davis, C.A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Schlesinger, F., Landscape of transcription in human cells (2012) Nature, 489, pp. 101-108; Bushati, N., Cohen, S.M., microRNA functions (2007) Annu Rev Cell Dev Biol, 23, pp. 175-205; Ha, M., Kim, V.N., Regulation of microRNA biogenesis (2014) Nat Rev Mol Cell Biol, 15, pp. 509-524; Bartel, D.P., MicroRNAs: genomics, biogenesis, mechanism, and function (2004) Cell, 116, pp. 281-297; Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Kim, S., The nuclear RNase III Drosha initiates microRNA processing (2003) Nature, 425, pp. 415-419; Lund, E., Guttinger, S., Calado, A., Dahlberg, J.E., Kutay, U., Nuclear export of microRNA precursors (2004) Science, 303, pp. 95-98; Ruby, J.G., Jan, C.H., Bartel, D.P., Intronic microRNA precursors that bypass Drosha processing (2007) Nature, 448, pp. 83-86; Schraivogel, D., Meister, G., Import routes and nuclear functions of Argonaute and other small RNA-silencing proteins (2014) Trends Biochem Sci, 39, pp. 420-431; Liu, J., Carmell, M.A., Rivas, F.V., Marsden, C.G., Thomson, J.M., Song, J.J., Hammond, S.M., Hannon, G.J., Argonaute2 is the catalytic engine of mammalian RNAi (2004) Science, 305, pp. 1437-1441; Diederichs, S., Haber, D.A., Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression (2007) Cell, 131, pp. 1097-1108; Matsui, M., Chu, Y., Zhang, H., Gagnon, K.T., Shaikh, S., Kuchimanchi, S., Manoharan, M., Janowski, B.A., Promoter RNA links transcriptional regulation of inflammatory pathway genes (2013) Nucleic Acids Res, 41, pp. 10086-10109; Kim, D.H., Saetrom, P., Snove, O., Jr., Rossi, J.J., MicroRNA-directed transcriptional gene silencing in mammalian cells (2008) Proc Natl Acad Sci USA, 105, pp. 16230-16235; O'Rourke, J.R., Georges, S.A., Seay, H.R., Tapscott, S.J., McManus, M.T., Goldhamer, D.J., Swanson, M.S., Harfe, B.D., Essential role for Dicer during skeletal muscle development (2007) Dev Biol, 311, pp. 359-368; Guttman, M., Amit, I., Garber, M., French, C., Lin, M.F., Feldser, D., Huarte, M., Cassady, J.P., Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals (2009) Nature, 458, pp. 223-227; Mercer, T.R., Mattick, J.S., Structure and function of long noncoding RNAs in epigenetic regulation (2013) Nat Struct Mol Biol, 20, pp. 300-307; Kapranov, P., Drenkow, J., Cheng, J., Long, J., Helt, G., Dike, S., Gingeras, T.R., Examples of the complex architecture of the human transcriptome revealed by RACE and high-density tiling arrays (2005) Genome Res, 15, pp. 987-997; Dieci, G., Fiorino, G., Castelnuovo, M., Teichmann, M., Pagano, A., The expanding RNA polymerase III transcriptome (2007) Trends Genet, 23, pp. 614-622; Kapranov, P., Cheng, J., Dike, S., Nix, D.A., Duttagupta, R., Willingham, A.T., Stadler, P.F., Hofacker, I.L., RNA maps reveal new RNA classes and a possible function for pervasive transcription (2007) Science, 316, pp. 1484-1488; Cabili, M.N., Trapnell, C., Goff, L., Koziol, M., Tazon-Vega, B., Regev, A., Rinn, J.L., Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses (2011) Genes Dev, 25, pp. 1915-1927; Batista, P.J., Chang, H.Y., Long noncoding RNAs: cellular address codes in development and disease (2013) Cell, 152, pp. 1298-1307; Van Heesch, S., Van Iterson, M., Jacobi, J., Boymans, S., Essers, P.B., De Bruijn, E., Hao, W., Simonis, M., Extensive localization of long noncoding RNAs to the cytosol and mono- and polyribosomal complexes (2014) Genome Biol, 15, p. R6; Cesana, M., Cacchiarelli, D., Legnini, I., Santini, T., Sthandier, O., Chinappi, M., Tramontano, A., Bozzoni, I., A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA (2011) Cell, 147, pp. 358-369; Wang, Y., Xu, Z., Jiang, J., Xu, C., Kang, J., Xiao, L., Wu, M., Liu, H., Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal (2013) Dev Cell, 25, pp. 69-80; Penny, G.D., Kay, G.F., Sheardown, S.A., Rastan, S., Brockdorff, N., Requirement for Xist in X chromosome inactivation (1996) Nature, 379, pp. 131-137; Nagano, T., Mitchell, J.A., Sanz, L.A., Pauler, F.M., Ferguson-Smith, A.C., Feil, R., Fraser, P., The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin (2008) Science, 322, pp. 1717-1720; Chu, C., Qu, K., Zhong, F.L., Artandi, S.E., Chang, H.Y., Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions (2011) Mol Cell, 44, pp. 667-678; Plath, K., Fang, J., Mlynarczyk-Evans, S.K., Cao, R., Worringer, K.A., Wang, H., De La Cruz, C.C., Zhang, Y., Role of histone H3 lysine 27 methylation in X inactivation (2003) Science, 300, pp. 131-135; Bertani, S., Sauer, S., Bolotin, E., Sauer, F., The noncoding RNA Mistral activates Hoxa6 and Hoxa7 expression and stem cell differentiation by recruiting MLL1 to chromatin (2011) Mol Cell, 43, pp. 1040-1046; Zhao, J., Ohsumi, T.K., Kung, J.T., Ogawa, Y., Grau, D.J., Sarma, K., Song, J.J., Lee, J.T., Genome-wide identification of polycomb-associated RNAs by RIP-seq (2010) Mol Cell, 40, pp. 939-953; Tripathi, V., Ellis, J.D., Shen, Z., Song, D.Y., Pan, Q., Watt, A.T., Freier, S.M., Bubulya, P.A., The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation (2010) Mol Cell, 39, pp. 925-938; Barry, G., Briggs, J.A., Vanichkina, D.P., Poth, E.M., Beveridge, N.J., Ratnu, V.S., Nayler, S.P., Bredy, T.W., The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing (2014) Mol Psychiatry, 19, pp. 486-494; Liz, J., Portela, A., Soler, M., Gomez, A., Ling, H., Michlewski, G., Calin, G.A., Esteller, M., Regulation of pri-miRNA processing by a long noncoding RNA transcribed from an ultraconserved region (2014) Mol Cell, 55, pp. 138-147; Xiang, J.F., Yin, Q.F., Chen, T., Zhang, Y., Zhang, X.O., Wu, Z., Zhang, S., Lu, X., Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus (2014) Cell Res, 24, pp. 513-531; Cabianca, D.S., Casa, V., Bodega, B., Xynos, A., Ginelli, E., Tanaka, Y., Gabellini, D., A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy (2012) Cell, 149, pp. 819-831; Wang, K.C., Yang, Y.W., Liu, B., Sanyal, A., Corces-Zimmerman, R., Chen, Y., Lajoie, B.R., Gupta, R.A., A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression (2011) Nature, 472, pp. 120-124; Mao, Y.S., Sunwoo, H., Zhang, B., Spector, D.L., Direct visualization of the co-transcriptional assembly of a nuclear body by noncoding RNAs (2011) Nat Cell Biol, 13, pp. 95-101; Yang, L., Lin, C., Liu, W., Zhang, J., Ohgi, K.A., Grinstein, J.D., Dorrestein, P.C., Rosenfeld, M.G., ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs (2011) Cell, 147, pp. 773-788; Beltran, M., Puig, I., Pena, C., Garcia, J.M., Alvarez, A.B., Pena, R., Bonilla, F., De Herreros, A.G., A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition (2008) Genes Dev, 22, pp. 756-769; Carrieri, C., Cimatti, L., Biagioli, M., Beugnet, A., Zucchelli, S., Fedele, S., Pesce, E., Santoro, C., Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat (2012) Nature, 491, pp. 454-457; Yoon, J.H., Abdelmohsen, K., Srikantan, S., Yang, X., Martindale, J.L., De, S., Huarte, M., Gorospe, M., LincRNA-p21 suppresses target mRNA translation (2012) Mol Cell, 47, pp. 648-655; Kretz, M., Siprashvili, Z., Chu, C., Webster, D.E., Zehnder, A., Qu, K., Lee, C.S., Chow, J., Control of somatic tissue differentiation by the long non-coding RNA TINCR (2013) Nature, 493, pp. 231-235; Gong, C., Maquat, L.E., lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3′ UTRs via Alu elements (2011) Nature, 470, pp. 284-288; Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W.J., Pandolfi, P.P., A coding-independent function of gene and pseudogene mRNAs regulates tumour biology (2010) Nature, 465, pp. 1033-1038; Hansen, T.B., Wiklund, E.D., Bramsen, J.B., Villadsen, S.B., Statham, A.L., Clark, S.J., Kjems, J., miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA (2011) EMBO J, 30, pp. 4414-4422; Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Munschauer, M., Circular RNAs are a large class of animal RNAs with regulatory potency (2013) Nature, 495, pp. 333-338; Franco-Zorrilla, J.M., Valli, A., Todesco, M., Mateos, I., Puga, M.I., Rubio-Somoza, I., Leyva, A., Paz-Ares, J., Target mimicry provides a new mechanism for regulation of microRNA activity (2007) Nat Genet, 39, pp. 1033-1037; Hansen, T.B., Jensen, T.I., Clausen, B.H., Bramsen, J.B., Finsen, B., Damgaard, C.K., Kjems, J., Natural RNA circles function as efficient microRNA sponges (2013) Nature, 495, pp. 384-388; Mauro, A., Satellite cell of skeletal muscle fibers (1961) J Biophys Biochem Cytol, 9, pp. 493-495; Montarras, D., L'Honore, A., Buckingham, M., Lying low but ready for action: the quiescent muscle satellite cell (2013) FEBS J, 280, pp. 4036-4050; Kuang, S., Kuroda, K., Le Grand, F., Rudnicki, M.A., Asymmetric self-renewal and commitment of satellite stem cells in muscle (2007) Cell, 129, pp. 999-1010; Le Grand, F., Jones, A.E., Seale, V., Scime, A., Rudnicki, M.A., Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells (2009) Cell Stem Cell, 4, pp. 535-547; Segalés, J., Perdiguero, E., Muñoz-Cánoves, P., Epigenetic control of adult skeletal muscle stem cell functions (2014) FEBS J, 282, pp. 1571-1588; Aziz, A., Sebastian, S., Dilworth, F.J., The origin and fate of muscle satellite cells (2012) Stem Cell Rev, 8, pp. 609-622; McKinnell, I.W., Ishibashi, J., Le Grand, F., Punch, V.G., Addicks, G.C., Greenblatt, J.F., Dilworth, F.J., Rudnicki, M.A., Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex (2008) Nat Cell Biol, 10, pp. 77-84; Crist, C.G., Montarras, D., Buckingham, M., Muscle satellite cells are primed for myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by microRNA-31 in mRNP granules (2012) Cell Stem Cell, 11, pp. 118-126; Liu, L., Cheung, T.H., Charville, G.W., Hurgo, B.M., Leavitt, T., Shih, J., Brunet, A., Rando, T.A., Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging (2013) Cell Rep, 4, pp. 189-204; Reimann, J., Brimah, K., Schroder, R., Wernig, A., Beauchamp, J.R., Partridge, T.A., Pax7 distribution in human skeletal muscle biopsies and myogenic tissue cultures (2004) Cell Tissue Res, 315, pp. 233-242; Cheung, T.H., Quach, N.L., Charville, G.W., Liu, L., Park, L., Edalati, A., Yoo, B., Rando, T.A., Maintenance of muscle stem-cell quiescence by microRNA-489 (2012) Nature, 482, pp. 524-528; Sato, T., Yamamoto, T., Sehara-Fujisawa, A., miR-195/497 induce postnatal quiescence of skeletal muscle stem cells (2014) Nat Commun, 5, p. 4597; Kedersha, N., Anderson, P., Mammalian stress granules and processing bodies (2007) Methods Enzymol, 431, pp. 61-81; Buchan, J.R., Parker, R., Eukaryotic stress granules: the ins and outs of translation (2009) Mol Cell, 36, pp. 932-941; Legnini, I., Morlando, M., Mangiavacchi, A., Fatica, A., Bozzoni, I., A feedforward regulatory loop between HuR and the long noncoding RNA linc-MD1 controls early phases of myogenesis (2014) Mol Cell, 53, pp. 506-514; Figueroa, A., Cuadrado, A., Fan, J., Atasoy, U., Muscat, G.E., Munoz-Canoves, P., Gorospe, M., Munoz, A., Role of HuR in skeletal myogenesis through coordinate regulation of muscle differentiation genes (2003) Mol Cell Biol, 23, pp. 4991-5004; Cammas, A., Sanchez, B.J., Lian, X.J., Dormoy-Raclet, V., Van Der Giessen, K., De Silanes, I.L., Ma, J., Gorospe, M., Destabilization of nucleophosmin mRNA by the HuR/KSRP complex is required for muscle fibre formation (2014) Nat Commun, 5, p. 4190; Siegel, A.L., Kuhlmann, P.K., Cornelison, D.D., Muscle satellite cell proliferation and association: new insights from myofiber time-lapse imaging (2011) Skelet Muscle, 1, p. 7; Ciarapica, R., Russo, G., Verginelli, F., Raimondi, L., Donfrancesco, A., Rota, R., Giordano, A., Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma (2009) Cell Cycle, 8, pp. 172-175; Granjon, A., Gustin, M.P., Rieusset, J., Lefai, E., Meugnier, E., Guller, I., Cerutti, C., Rabasa-Lhoret, R., The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway (2009) Diabetes, 58, pp. 2555-2564; Dmitriev, P., Barat, A., Polesskaya, A., O'Connell, M.J., Robert, T., Dessen, P., Walsh, T.A., Carnac, G., Simultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes (2013) BMC Genom, 14, p. 265; Chen, J.F., Mandel, E.M., Thomson, J.M., Wu, Q., Callis, T.E., Hammond, S.M., Conlon, F.L., Wang, D.Z., The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation (2006) Nat Genet, 38, pp. 228-233; Yin, H., Pasut, A., Soleimani, V.D., Bentzinger, C.F., Antoun, G., Thorn, S., Seale, P., Grosveld, F., MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16 (2013) Cell Metab, 17, pp. 210-224; Trajkovski, M., Ahmed, K., Esau, C.C., Stoffel, M., MyomiR-133 regulates brown fat differentiation through Prdm16 (2012) Nat Cell Biol, 14, pp. 1330-1335; Huang, M.B., Xu, H., Xie, S.J., Zhou, H., Qu, L.H., Insulin-like growth factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis (2011) PLoS One, 6; Zhou, L., Wang, L., Lu, L., Jiang, P., Sun, H., Wang, H., A novel target of microRNA-29, Ring1 and YY1-binding protein (Rybp), negatively regulates skeletal myogenesis (2012) J Biol Chem, 287, pp. 25255-25265; Winbanks, C.E., Wang, B., Beyer, C., Koh, P., White, L., Kantharidis, P., Gregorevic, P., TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4 (2011) J Biol Chem, 286, pp. 13805-13814; Choi, M.C., Ryu, S., Hao, R., Wang, B., Kapur, M., Fan, C.M., Yao, T.P., HDAC4 promotes Pax7-dependent satellite cell activation and muscle regeneration (2014) EMBO Rep, 15, pp. 1175-1183; Lu, L., Zhou, L., Chen, E.Z., Sun, K., Jiang, P., Wang, L., Su, X., Wang, H., A Novel YY1-miR-1 regulatory circuit in skeletal myogenesis revealed by genome-wide prediction of YY1-miRNA network (2012) PLoS One, 7; Lu, L., Sun, K., Chen, X., Zhao, Y., Wang, L., Zhou, L., Sun, H., Wang, H., Genome-wide survey by ChIP-seq reveals YY1 regulation of lincRNAs in skeletal myogenesis (2013) EMBO J, 32, pp. 2575-2588; Wang, H., Garzon, R., Sun, H., Ladner, K.J., Singh, R., Dahlman, J., Cheng, A., Chandler, D.S., NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma (2008) Cancer Cell, 14, pp. 369-381; Liu, Q.C., Zha, X.H., Faralli, H., Yin, H., Louis-Jeune, C., Perdiguero, E., Pranckeviciene, E., Brand, M., Comparative expression profiling identifies differential roles for Myogenin and p38alpha MAPK signaling in myogenesis (2012) J Mol Cell Biol, 4, pp. 386-397; Singh, K., Dilworth, F.J., Differential modulation of cell cycle progression distinguishes members of the myogenic regulatory factor family of transcription factors (2013) FEBS J, 280, pp. 3991-4003; Cao, Y., Yao, Z., Sarkar, D., Lawrence, M., Sanchez, G.J., Parker, M.H., Macquarrie, K.L., Ruzzo, W.L., Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming (2010) Dev Cell, 18, pp. 662-674; Yan, B., Guo, J.T., Zhu, C.D., Zhao, L.H., Zhao, J.L., miR-203b: a novel regulator of MyoD expression in tilapia skeletal muscle (2013) J Exp Biol, 216, pp. 447-451; Ge, Y., Sun, Y., Chen, J., IGF-II is regulated by microRNA-125b in skeletal myogenesis (2011) J Cell Biol, 192, pp. 69-81; Gagan, J., Dey, B.K., Layer, R., Yan, Z., Dutta, A., MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation (2011) J Biol Chem, 286, pp. 19431-19438; Dey, B.K., Gagan, J., Dutta, A., miR-206 and -486 induce myoblast differentiation by downregulating Pax7 (2011) Mol Cell Biol, 31, pp. 203-214; Hirai, H., Verma, M., Watanabe, S., Tastad, C., Asakura, Y., Asakura, A., MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3 (2010) J Cell Biol, 191, pp. 347-365; Mousavi, K., Zare, H., Dell'orso, S., Grontved, L., Gutierrez-Cruz, G., Derfoul, A., Hager, G.L., Sartorelli, V., eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci (2013) Mol Cell, 51, pp. 606-617; Dey, B.K., Pfeifer, K., Dutta, A., The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration (2014) Genes Dev, 28, pp. 491-501; Caretti, G., Schiltz, R.L., Dilworth, F.J., Di Padova, M., Zhao, P., Ogryzko, V., Fuller-Pace, F.V., Sartorelli, V., The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation (2006) Dev Cell, 11, pp. 547-560; O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V., Mendell, J.T., c-Myc-regulated microRNAs modulate E2F1 expression (2005) Nature, 435, pp. 839-843; Sylvestre, Y., De Guire, V., Querido, E., Mukhopadhyay, U.K., Bourdeau, V., Major, F., Ferbeyre, G., Chartrand, P., An E2F/miR-20a autoregulatory feedback loop (2007) J Biol Chem, 282, pp. 2135-2143; Nagel, S., Venturini, L., Przybylski, G.K., Grabarczyk, P., Schmidt, C.A., Meyer, C., Drexler, H.G., Scherr, M., Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia (2009) Leuk Lymphoma, 50, pp. 101-108; Tschop, K., Conery, A.R., Litovchick, L., Decaprio, J.A., Settleman, J., Harlow, E., Dyson, N., A kinase shRNA screen links LATS2 and the pRB tumor suppressor (2011) Genes Dev, 25, pp. 814-830; Liu, X., Cheng, Y., Chen, X., Yang, J., Xu, L., Zhang, C., MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2 (2011) J Biol Chem, 286, pp. 42371-42380; Perdiguero, E., Ruiz-Bonilla, V., Gresh, L., Hui, L., Ballestar, E., Sousa-Victor, P., Baeza-Raja, B., Esteller, M., Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation (2007) EMBO J, 26, pp. 1245-1256; Zhang, D., Li, X., Chen, C., Li, Y., Zhao, L., Jing, Y., Liu, W., Xia, H., Attenuation of p38-mediated miR-1/133 expression facilitates myoblast proliferation during the early stage of muscle regeneration (2012) PLoS One, 7; Jash, S., Dhar, G., Ghosh, U., Adhya, S., Role of the mTORC1 complex in satellite cell activation by RNA-induced mitochondrial restoration: dual control of cyclin D1 through microRNAs (2014) Mol Cell Biol, 34, pp. 3594-3606; Schiaffino, S., Reggiani, C., Fiber types in mammalian skeletal muscles (2011) Physiol Rev, 91, pp. 1447-1531; Van Rooij, E., Quiat, D., Johnson, B.A., Sutherland, L.B., Qi, X., Richardson, J.A., Kelm, R.J., Jr., Olson, E.N., A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance (2009) Dev Cell, 17, pp. 662-673; Sakakibara, I., Santolini, M., Ferry, A., Hakim, V., Maire, P., Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype (2014) PLoS Genet, 10; Watts, R., Johnsen, V.L., Shearer, J., Hittel, D.S., Myostatin-induced inhibition of the long noncoding RNA Malat1 is associated with decreased myogenesis (2013) Am J Physiol Cell Physiol, 304, pp. C995-C1001; Leucci, E., Patella, F., Waage, J., Holmstrom, K., Lindow, M., Porse, B., Kauppinen, S., Lund, A.H., microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus (2013) Sci Rep, 3, p. 2535; Grishok, A., Biology and mechanisms of short RNAs in Caenorhabditis elegans (2013) Adv Genet, 83, pp. 1-69; Place, R.F., Li, L.C., Pookot, D., Noonan, E.J., Dahiya, R., MicroRNA-373 induces expression of genes with complementary promoter sequences (2008) Proc Natl Acad Sci USA, 105, pp. 1608-1613; Zardo, G., Ciolfi, A., Vian, L., Starnes, L.M., Billi, M., Racanicchi, S., Maresca, C., Noguera, N., Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression (2012) Blood, 119, pp. 4034-4046; Francia, S., Michelini, F., Saxena, A., Tang, D., De Hoon, M., Anelli, V., Mione, M., D'Adda Di Fagagna, F., Site-specific DICER and DROSHA RNA products control the DNA-damage response (2012) Nature, 488, pp. 231-235; Ameyar-Zazoua, M., Rachez, C., Souidi, M., Robin, P., Fritsch, L., Young, R., Morozova, N., Andrau, J.C., Argonaute proteins couple chromatin silencing to alternative splicing (2012) Nat Struct Mol Biol, 19, pp. 998-1004; Gilbert, L.A., Larson, M.H., Morsut, L., Liu, Z., Brar, G.A., Torres, S.E., Stern-Ginossar, N., Doudna, J.A., CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes (2013) Cell, 154, pp. 442-451; Kwon, C., Han, Z., Olson, E.N., Srivastava, D., MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling (2005) Proc Natl Acad Sci USA, 102, pp. 18986-18991; Sayed, D., Hong, C., Chen, I.Y., Lypowy, J., Abdellatif, M., MicroRNAs play an essential role in the development of cardiac hypertrophy (2007) Circ Res, 100, pp. 416-424; Pan, Z., Sun, X., Ren, J., Li, X., Gao, X., Lu, C., Zhang, Y., Wang, H., miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models (2012) PLoS One, 7; Zhao, Y., Samal, E., Srivastava, D., Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis (2005) Nature, 436, pp. 214-220; Chen, J.F., Tao, Y., Li, J., Deng, Z., Yan, Z., Xiao, X., Wang, D.Z., microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7 (2010) J Cell Biol, 190, pp. 867-879; Lu, T.Y., Lin, B., Li, Y., Arora, A., Han, L., Cui, C., Coronnello, C., Yang, L., Overexpression of microRNA-1 promotes cardiomyocyte commitment from human cardiovascular progenitors via suppressing WNT and FGF signaling pathways (2013) J Mol Cell Cardiol, 63, pp. 146-154; Tritsch, E., Mallat, Y., Lefebvre, F., Diguet, N., Escoubet, B., Blanc, J., De Windt, L.J., Li, Z., An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart (2013) Cardiovasc Res, 98, pp. 372-380; Kukreti, H., Amuthavalli, K., Harikumar, A., Sathiyamoorthy, S., Feng, P.Z., Anantharaj, R., Tan, S.L., Sriram, S., Muscle-specific microRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasone-mediated atrophy (2013) J Biol Chem, 288, pp. 6663-6678; Ai, J., Zhang, R., Gao, X., Niu, H.F., Wang, N., Xu, Y., Li, Y., Pan, Z.W., Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly (2012) Cardiovasc Res, 95, pp. 385-393; Ali, R., Huang, Y., Maher, S.E., Kim, R.W., Giordano, F.J., Tellides, G., Geirsson, A., miR-1 mediated suppression of Sorcin regulates myocardial contractility through modulation of Ca2+ signaling (2012) J Mol Cell Cardiol, 52, pp. 1027-1037; Qian, L., Wythe, J.D., Liu, J., Cartry, J., Vogler, G., Mohapatra, B., Otway, R.T., Maillet, M., Tinman/Nk2-5 acts via miR-1 and upstream of Cdc42 to regulate heart function across species (2011) J Cell Biol, 193, pp. 1181-1196; Xie, C., Huang, H., Sun, X., Guo, Y., Hamblin, M., Ritchie, R.P., Garcia-Barrio, M.T., Chen, Y.E., MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4 (2011) Stem Cells Dev, 20, pp. 205-210; Li, Q., Song, X.W., Zou, J., Wang, G.K., Kremneva, E., Li, X.Q., Zhu, N., Yuan, W.J., Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy (2010) J Cell Sci, 123, pp. 2444-2452; Elia, L., Contu, R., Quintavalle, M., Varrone, F., Chimenti, C., Russo, M.A., Cimino, V., Catalucci, D., Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions (2009) Circulation, 120, pp. 2377-2385; Yan, D., Dong Xda, E., Chen, X., Wang, L., Lu, C., Wang, J., Qu, J., Tu, L., MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development (2009) J Biol Chem, 284, pp. 29596-29604; Tang, Y., Zheng, J., Sun, Y., Wu, Z., Liu, Z., Huang, G., MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2 (2009) Int Heart J, 50, pp. 377-387; Ikeda, S., He, A., Kong, S.W., Lu, J., Bejar, R., Bodyak, N., Lee, K.H., Golub, T.R., MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes (2009) Mol Cell Biol, 29, pp. 2193-2204; Terentyev, D., Belevych, A.E., Terentyeva, R., Martin, M.M., Malana, G.E., Kuhn, D.E., Abdellatif, M., Gyorke, S., miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2 (2009) Circ Res, 104, pp. 514-521; Gagan, J., Dey, B.K., Layer, R., Yan, Z., Dutta, A., Notch3 and Mef2c proteins are mutually antagonistic via Mkp1 protein and miR-1/206 microRNAs in differentiating myoblasts (2012) J Biol Chem, 287, pp. 40360-40370; Liu, N., Bezprozvannaya, S., Williams, A.H., Qi, X., Richardson, J.A., Bassel-Duby, R., Olson, E.N., microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart (2008) Genes Dev, 22, pp. 3242-3254; Care, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., Bang, M.L., Dalton, N.D., MicroRNA-133 controls cardiac hypertrophy (2007) Nat Med, 13, pp. 613-618; Feng, Y., Niu, L.L., Wei, W., Zhang, W.Y., Li, X.Y., Cao, J.H., Zhao, S.H., A feedback circuit between miR-133 and the ERK1/2 pathway involving an exquisite mechanism for regulating myoblast proliferation and differentiation (2013) Cell Death Dis, 4, p. e934; Liu, W., Bi, P., Shan, T., Yang, X., Yin, H., Wang, Y.X., Liu, N., Kuang, S., miR-133a regulates adipocyte browning in vivo (2013) PLoS Genet, 9; Li, Q., Lin, X., Yang, X., Chang, J., NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression (2010) Am J Physiol Heart Circ Physiol, 298, pp. H1340-H1347; Horie, T., Ono, K., Nishi, H., Iwanaga, Y., Nagao, K., Kinoshita, M., Kuwabara, Y., Kita, T., MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes (2009) Biochem Biophys Res Commun, 389, pp. 315-320; Duisters, R.F., Tijsen, A.J., Schroen, B., Leenders, J.J., Lentink, V., Der Van Made, I., Herias, V., Barenbrug, P., miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling (2009) Circ Res, 104, pp. 170-178. , 6p following 178; Boutz, P.L., Chawla, G., Stoilov, P., Black, D.L., MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development (2007) Genes Dev, 21, pp. 71-84; Anderson, C., Catoe, H., Werner, R., MIR-206 regulates connexin43 expression during skeletal muscle development (2006) Nucleic Acids Res, 34, pp. 5863-5871; Amirouche, A., Tadesse, H., Miura, P., Belanger, G., Lunde, J.A., Cote, J., Jasmin, B.J., Converging pathways involving microRNA-206 and the RNA-binding protein KSRP control post-transcriptionally utrophin A expression in skeletal muscle (2014) Nucleic Acids Res, 42, pp. 3982-3997; Winbanks, C.E., Beyer, C., Hagg, A., Qian, H., Sepulveda, P.V., Gregorevic, P., miR-206 represses hypertrophy of myogenic cells but not muscle fibers via inhibition of HDAC4 (2013) PLoS One, 8; Maciotta, S., Meregalli, M., Cassinelli, L., Parolini, D., Farini, A., Fraro, G.D., Gandolfi, F., Gabellini, D., Hmgb3 is regulated by microRNA-206 during muscle regeneration (2012) PLoS One, 7; Limana, F., Esposito, G., D'arcangelo, D., Di Carlo, A., Romani, S., Melillo, G., Mangoni, A., Germani, A., HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3 (2011) PLoS One, 6; Shan, Z.X., Lin, Q.X., Deng, C.Y., Zhu, J.N., Mai, L.P., Liu, J.L., Fu, Y.H., Zhang, Y.Y., miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes (2010) FEBS Lett, 584, pp. 3592-3600; Zhang, Y., Wang, Y., Wang, X., Zhang, Y., Eisner, G.M., Asico, L.D., Jose, P.A., Zeng, C., Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21 (2011) J Hypertens, 29, pp. 1560-1568; Small, E.M., O'Rourke, J.R., Moresi, V., Sutherland, L.B., Mcanally, J., Gerard, R.D., Richardson, J.A., Olson, E.N., Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486 (2010) Proc Natl Acad Sci USA, 107, pp. 4218-4223; Wang, J., Jia, Z., Zhang, C., Sun, M., Wang, W., Chen, P., Ma, K., Zhou, C., miR-499 protects cardiomyocytes from H 2O 2-induced apoptosis via its effects on Pdcd4 and Pacs2 (2014) RNA Biol, 11, pp. 339-350; Li, X., Wang, J., Jia, Z., Cui, Q., Zhang, C., Wang, W., Chen, P., Zhou, C., MiR-499 regulates cell proliferation and apoptosis during late-stage cardiac differentiation via Sox6 and cyclin D1 (2013) PLoS One, 8; Ling, T.Y., Wang, X.L., Chai, Q., Lau, T.W., Koestler, C.M., Park, S.J., Daly, R.C., Wu, L.Q., Regulation of the SK3 channel by microRNA-499-potential role in atrial fibrillation (2013) Heart Rhythm, 10, pp. 1001-1009",Article,Scopus,2-s2.0-84928481379
"Kleist C., Sandra-Petrescu F., Jiga L., Dittmar L., Mohr E., Greil J., Mier W., Becker L.E., Lang P., Opelz G., Terness P.","Generation of suppressive blood cells for control of allograft rejection",2015,"Clinical science (London, England : 1979)","128","9",,"593","607",,,10.1042/CS20140258,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927170726&partnerID=40&md5=ee9a27d7acf39635bb684016970ae7a9","*Department of Transplantation Immunology, Institute for Immunology, University of Heidelberg, 69120 Heidelberg, Germany; *Department of Transplantation Immunology, Institute for Immunology, University of Heidelberg, 69120 Heidelberg, Germany; †Department of Vascular Surgery, Division of Reconstructive Microsurgery, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania; *Department of Transplantation Immunology, Institute for Immunology, University of Heidelberg, 69120 Heidelberg, Germany; *Department of Transplantation Immunology, Institute for Immunology, University of Heidelberg, 69120 Heidelberg, Germany; ‡Department of Hematology and Oncology, Center for Child and Adolescent Medicine, University of Heidelberg, 69120 Heidelberg, Germany; §Department of Radiology, Division of Nuclear Medicine, University of Heidelberg, 69120 Heidelberg, Germany; ║Department of Internal Medicine I, Division of Nephrology, University of Heidelberg, 69120 Heidelberg, Germany; ¶Department of Pediatric Oncology, Children's University Hospital, University of Tuebingen, 72076 Tuebingen, Germany; *Department of Transplantation Immunology, Institute for Immunology, University of Heidelberg, 69120 Heidelberg, Germany; *Department of Transplantation Immunology, Institute for Immunology, University of Heidelberg, 69120 Heidelberg, Germany","Kleist, C., *Department of Transplantation Immunology, Institute for Immunology, University of Heidelberg, 69120 Heidelberg, Germany; Sandra-Petrescu, F., *Department of Transplantation Immunology, Institute for Immunology, University of Heidelberg, 69120 Heidelberg, Germany; Jiga, L., †Department of Vascular Surgery, Division of Reconstructive Microsurgery, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania; Dittmar, L., *Department of Transplantation Immunology, Institute for Immunology, University of Heidelberg, 69120 Heidelberg, Germany; Mohr, E., *Department of Transplantation Immunology, Institute for Immunology, University of Heidelberg, 69120 Heidelberg, Germany; Greil, J., ‡Department of Hematology and Oncology, Center for Child and Adolescent Medicine, University of Heidelberg, 69120 Heidelberg, Germany; Mier, W., §Department of Radiology, Division of Nuclear Medicine, University of Heidelberg, 69120 Heidelberg, Germany; Becker, L.E., ║Department of Internal Medicine I, Division of Nephrology, University of Heidelberg, 69120 Heidelberg, Germany; Lang, P., ¶Department of Pediatric Oncology, Children's University Hospital, University of Tuebingen, 72076 Tuebingen, Germany; Opelz, G., *Department of Transplantation Immunology, Institute for Immunology, University of Heidelberg, 69120 Heidelberg, Germany; Terness, P., *Department of Transplantation Immunology, Institute for Immunology, University of Heidelberg, 69120 Heidelberg, Germany","Our previous studies in rats showed that incubation of monocytic dendritic cells (DCs) with the chemotherapeutic drug mitomycin C (MMC) renders the cells immunosuppressive. Donor-derived MMC-DCs injected into the recipient prior to transplantation prolonged heart allograft survival. Although the generation of DCs is labour-intensive and time-consuming, peripheral blood mononuclear cells (PBMCs) can be easily harvested. In the present study, we analyse under which conditions DCs can be replaced by PBMCs and examine their mode of action. When injected into rats, MMC-incubated donor PBMCs (MICs) strongly prolonged heart allograft survival. Removal of monocytes from PBMCs completely abrogated their suppressive effect, indicating that monocytes are the active cell population. Suppression of rejection was donor-specific. The injected MICs migrated into peripheral lymphoid organs and led to an increased number of regulatory T-cells (Tregs) expressing cluster of differentiation (CD) markers CD4 and CD25 and forkhead box protein 3 (FoxP3). Tolerance could be transferred to syngeneic recipients with blood or spleen cells. Depletion of Tregs from tolerogenic cells abrogated their suppressive effect, arguing for mediation of immunosuppression by CD4⁺CD25⁺FoxP3⁺ Tregs. Donor-derived MICs also prolonged kidney allograft survival in pigs. MICs generated from donor monocytes were applied for the first time in humans in a patient suffering from therapy-resistant rejection of a haploidentical stem cell transplant. We describe, in the present paper, a simple method for in vitro generation of suppressor blood cells for potential use in clinical organ transplantation. Although the case report does not allow us to draw any conclusion about their therapeutic effectiveness, it shows that MICs can be easily generated and applied in humans.",,,Article,Scopus,2-s2.0-84927170726
"Werneburg S., Buettner F.F.R., Muhlenhoff M., Hildebrandt H.","Polysialic acid modification of the synaptic cell adhesion molecule SynCAM 1 in human embryonic stem cell-derived oligodendrocyte precursor cells",2015,"Stem Cell Research","14","3",,"339","346",,,10.1016/j.scr.2015.03.001,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926346207&partnerID=40&md5=3a701e906fcab5c488a97020eed31a2f","Institute for Cellular Chemistry, Hannover Medical School, Carl-Neuberg-Straße 1Hannover, Germany; Center for Systems Neuroscience (ZSN), Bünteweg 2Hannover, Germany","Werneburg, S., Institute for Cellular Chemistry, Hannover Medical School, Carl-Neuberg-Straße 1Hannover, Germany, Center for Systems Neuroscience (ZSN), Bünteweg 2Hannover, Germany; Buettner, F.F.R., Institute for Cellular Chemistry, Hannover Medical School, Carl-Neuberg-Straße 1Hannover, Germany; Mühlenhoff, M., Institute for Cellular Chemistry, Hannover Medical School, Carl-Neuberg-Straße 1Hannover, Germany; Hildebrandt, H., Institute for Cellular Chemistry, Hannover Medical School, Carl-Neuberg-Straße 1Hannover, Germany, Center for Systems Neuroscience (ZSN), Bünteweg 2Hannover, Germany","Oligodendrocyte precursor cells (OPCs) are the progenitors of myelinating oligodendrocytes in brain development and repair. Successful myelination depends on the control of adhesiveness during OPC migration and axon contact formation. The decoration of cell surface proteins with the glycan polysialic acid (polySia) is a key regulatory element of OPC interactions during development and under pathological conditions. By far the major protein carrier of polySia is the neural cell adhesion molecule NCAM, but recently, polysialylation of the synaptic cell adhesion molecule SynCAM 1 has been detected in the developing mouse brain. In mice, polySia-SynCAM 1 is associated with cells expressing NG2, a marker of a heterogeneous precursor cell population, which is the primary source for oligodendrocytes in development and myelin repair but can also give rise to astrocytes and possibly neurons. It is not yet clear if polySia-SynCAM 1 is expressed by OPCs and its occurrence in humans is elusive. By generating uniform human embryonic stem cell-derived OPC cultures, we demonstrate that polySia is present on human OPCs but down-regulated during differentiation into myelin basic protein-positive oligodendrocytes. PolySia on NCAM resides on the isoforms NCAM-180 and NCAM-140, and SynCAM 1 is identified as a novel polySia acceptor in human OPCs. © 2015.",,"Al Saraireh, Y.M., Sutherland, M., Springett, B.R., Freiberger, F., Ribeiro, M.G., Loadman, P.M., Errington, R.J., Falconer, R.A., Pharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migration (2013) PLoS One, 8, p. e73366; Back, S.A., Luo, N.L., Borenstein, N.S., Levine, J.M., Volpe, J.J., Kinney, H.C., Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury (2001) J. Neurosci., 21, pp. 1302-1312; Bartsch, U., Kirchhoff, F., Schachner, M., Highly sialylated N-CAM is expressed in adult mouse optic nerve and retina (1990) J. Neurocytol., 19, pp. 550-565; Bergles, D.E., Roberts, J.D., Somogyi, P., Jahr, C.E., Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus (2000) Nature, 405, pp. 187-191; Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, X., Kavalali, E.T., Sudhof, T.C., SynCAM, a synaptic adhesion molecule that drives synapse assembly (2002) Science, 297, pp. 1525-1531; Brocco, M.A., Frasch, A.C., Interfering polysialyltransferase ST8SiaII/STX mRNA inhibits neurite growth during early hippocampal development (2006) FEBS Lett., 580, pp. 4723-4726; Charles, P., Hernandez, M.P., Stankoff, B., Aigrot, M.S., Colin, C., Rougon, G., Zalc, B., Lubetzki, C., Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule (2000) Proc. Natl. Acad. Sci. U. S. A., 97, pp. 7585-7590; Charles, P., Reynolds, R., Seilhean, D., Rougon, G., Aigrot, M.S., Niezgoda, A., Zalc, B., Lubetzki, C., Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? (2002) Brain, 125, pp. 1972-1979; Cox, E.T., Brennaman, L.H., Gable, K.L., Hamer, R.M., Glantz, L.A., LaMantia, A.S., Lieberman, J.A., Jarskog, L.F., Developmental regulation of neural cell adhesion molecule in human prefrontal cortex (2009) Neuroscience, 162, pp. 96-105; Czepiel, M., Leicher, L., Becker, K., Boddeke, E., Copray, S., Overexpression of polysialylated neural cell adhesion molecule improves the migration capacity of induced pluripotent stem cell-derived oligodendrocyte precursors (2014) Stem Cells Transl. Med., 3, pp. 1100-1109; De Biase, L.M., Nishiyama, A., Bergles, D.E., Excitability and synaptic communication within the oligodendrocyte lineage (2010) J. Neurosci., 30, pp. 3600-3611; Douvaras, P., Wang, J., Zimmer, M., Hanchuk, S., O'Bara, M.A., Sadiq, S., Sim, F.J., Fossati, V., Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells (2014) Stem Cell Rep., 3, pp. 250-259; Dubois-Dalcq, M., Williams, A., Stadelmann, C., Stankoff, B., Zalc, B., Lubetzki, C., From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases (2008) Brain, 131, pp. 1686-1700; Etxeberria, A., Mangin, J.M., Aguirre, A., Gallo, V., Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum (2010) Nat. Neurosci., 13, pp. 287-289; Fewou, S.N., Ramakrishnan, H., Bussow, H., Gieselmann, V., Eckhardt, M., Down-regulation of polysialic acid is required for efficient myelin formation (2007) J. Biol. Chem., 282, pp. 16700-16711; Fogel, A.I., Stagi, M., Perez, D., Biederer, T., Lateral assembly of the immunoglobulin protein SynCAM 1 controls its adhesive function and instructs synapse formation (2011) EMBO J., 30, pp. 4728-4738; Fox, I.J., Daley, G.Q., Goldman, S.A., Huard, J., Kamp, T.J., Trucco, M., Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease (2014) Science, 345, p. 1247391; Franklin, R.J., Ffrench-Constant, C., Remyelination in the CNS: from biology to therapy (2008) Nat. Rev. Neurosci., 9, pp. 839-855; Galuska, S.P., Rollenhagen, M., Kaup, M., Eggers, K., Oltmann-Norden, I., Schiff, M., Hartmann, M., Geyer, H., Synaptic cell adhesion molecule SynCAM 1 is a target for polysialylation in postnatal mouse brain (2010) Proc. Natl. Acad. Sci. U. S. A., 107, pp. 10250-10255; Glaser, T., Brose, C., Franceschini, I., Hamann, K., Smorodchenko, A., Zipp, F., Dubois-Dalcq, M., Brustle, O., Neural cell adhesion molecule polysialylation enhances the sensitivity of embryonic stem cell-derived neural precursors to migration guidance cues (2007) Stem Cells, 25, pp. 3016-3025; Goldman, S.A., Nedergaard, M., Windrem, M.S., Glial progenitor cell-based treatment and modeling of neurological disease (2012) Science, 338, pp. 491-495; Hildebrandt, H., Becker, C., Glüer, S., Rösner, H., Gerardy-Schahn, R., Rahmann, H., Polysialic acid on the neural cell adhesion molecule correlates with expression of polysialyltransferases and promotes neuroblastoma cell growth (1998) Cancer Res., 58, pp. 779-784; Hildebrandt, H., Mühlenhoff, M., Gerardy-Schahn, R., Polysialylation of NCAM (2010) Adv. Exp. Med. Biol., 663, pp. 95-109; Hu, B.Y., Du, Z.W., Li, X.J., Ayala, M., Zhang, S.C., Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects (2009) Development, 136, pp. 1443-1452; Hu, B.Y., Du, Z.W., Zhang, S.C., Differentiation of human oligodendrocytes from pluripotent stem cells (2009) Nat. Protoc., 4, pp. 1614-1622; Karadottir, R., Cavelier, P., Bergersen, L.H., Attwell, D., NMDA receptors are expressed in oligodendrocytes and activated in ischaemia (2005) Nature, 438, pp. 1162-1166; Kasper, B.T., Koppolu, S., Mahal, L.K., Insights into miRNA regulation of the human glycome (2014) Biochem. Biophys. Res. Commun., 445, pp. 774-779; Keirstead, H.S., Nistor, G., Bernal, G., Totoiu, M., Cloutier, F., Sharp, K., Steward, O., Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury (2005) J. Neurosci., 25, pp. 4694-4705; Konze, S.A., van Diepen, L., Schroder, A., Olmer, R., Moller, H., Pich, A., Weissmann, R., Buettner, F.F., Cleavage of E-cadherin and beta-catenin by calpain affects Wnt signaling and spheroid formation in suspension cultures of human pluripotent stem cells (2014) Mol. Cell. Proteomics, 13, pp. 990-1007; Kukley, M., Capetillo-Zarate, E., Dietrich, D., Vesicular glutamate release from axons in white matter (2007) Nat. Neurosci., 10, pp. 311-320; Kukley, M., Nishiyama, A., Dietrich, D., The fate of synaptic input to NG2 glial cells: neurons specifically downregulate transmitter release onto differentiating oligodendroglial cells (2010) J. Neurosci., 30, pp. 8320-8331; Martins, M., Rosa, A., Guedes, L.C., Fonseca, B.V., Gotovac, K., Violante, S., Mestre, T., Oliveira, S.A., Convergence of miRNA expression profiling, alpha-synuclein interaction and GWAS in Parkinson's disease (2011) PLoS One, 6, p. e25443; Mühlenhoff, M., Eckhardt, M., Bethe, A., Frosch, M., Gerardy-Schahn, R., Polysialylation of NCAM by a single enzyme (1996) Curr. Biol., 6, pp. 1188-1191; Mühlenhoff, M., Rollenhagen, M., Werneburg, S., Gerardy-Schahn, R., Hildebrandt, H., Polysialic acid: versatile modification of NCAM, SynCAM 1 and neuropilin-2 (2013) Neurochem. Res., 38, pp. 1134-1143; Nait-Oumesmar, B., Decker, L., Lachapelle, F., Avellana-Adalid, V., Bachelin, C., Van Evercooren, A.B., Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination (1999) Eur. J. Neurosci., 11, pp. 4357-4366; Nait-Oumesmar, B., Picard-Riera, N., Kerninon, C., Decker, L., Seilhean, D., Hoglinger, G.U., Hirsch, E.C., Baron-van, E.A., Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 4694-4699; Nait-Oumesmar, B., Vignais, L., Duhamel-Clerin, E., Avellana-Adalid, V., Rougon, G., Baron-van, E.A., Expression of the highly polysialylated neural cell adhesion molecule during postnatal myelination and following chemically induced demyelination of the adult mouse spinal cord (1995) Eur. J. Neurosci., 7, pp. 480-491; Nishiyama, A., Komitova, M., Suzuki, R., Zhu, X., Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity (2009) Nat. Rev. Neurosci., 10, pp. 9-22; Nistor, G.I., Totoiu, M.O., Haque, N., Carpenter, M.K., Keirstead, H.S., Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation (2005) Glia, 49, pp. 385-396; Oltmann-Norden, I., Galuska, S.P., Hildebrandt, H., Geyer, R., Gerardy-Schahn, R., Geyer, H., Mühlenhoff, M., Impact of the polysialyltransferases ST8SiaII and ST8SiaIV on polysialic acid synthesis during postnatal mouse brain development (2008) J. Biol. Chem., 283, pp. 1463-1471; Picard-Riera, N., Decker, L., Delarasse, C., Goude, K., Nait-Oumesmar, B., Liblau, R., Pham-Dinh, D., Evercooren, A.B., Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 13211-13216; Rollenhagen, M., Buettner, F.F., Reismann, M., Jirmo, A.C., Grove, M., Behrens, G.M., Gerardy-Schahn, R., Muhlenhoff, M., Polysialic acid on neuropilin-2 is exclusively synthesized by the polysialyltransferase ST8SiaIV and attached to mucin-type O-glycans located between the b2 and c domain (2013) J. Biol. Chem., 288, pp. 22880-22892; Rollenhagen, M., Kuckuck, S., Ulm, C., Hartmann, M., Galuska, S.P., Geyer, R., Geyer, H., Mühlenhoff, M., Polysialylation of the synaptic cell adhesion molecule 1 (SynCAM 1) depends exclusively on the polysialyltransferase ST8SiaII in vivo (2012) J. Biol. Chem., 287, pp. 35170-35180; Rutishauser, U., Polysialic acid in the plasticity of the developing and adult vertebrate nervous system (2008) Nat. Rev. Neurosci., 9, pp. 26-35; Schiff, M., Weinhold, B., Grothe, C., Hildebrandt, H., NCAM and polysialyltransferase profiles match dopaminergic marker gene expression but polysialic acid is dispensable for development of the midbrain dopamine system (2009) J. Neurochem., 110, pp. 1661-1673; Schnaar, R.L., Gerardy-Schahn, R., Hildebrandt, H., Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration (2014) Physiol. Rev., 94, pp. 461-518; Sharp, J., Frame, J., Siegenthaler, M., Nistor, G., Keirstead, H.S., Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury (2010) Stem Cells, 28, pp. 152-163; Sim, F.J., Windrem, M.S., Goldman, S.A., Fate determination of adult human glial progenitor cells (2009) Neuron Glia Biol., 5, pp. 45-55; Solozobova, V., Wyvekens, N., Pruszak, J., Lessons from the embryonic neural stem cell niche for neural lineage differentiation of pluripotent stem cells (2012) Stem Cell Rev., 8, pp. 813-829; Stagi, M., Fogel, A.I., Biederer, T., SynCAM 1 participates in axo-dendritic contact assembly and shapes neuronal growth cones (2010) Proc. Natl. Acad. Sci. U. S. A., 107, pp. 7568-7573; Sternberger, N.H., Itoyama, Y., Kies, M.W., Webster, H., Immunocytochemical method to identify basic protein in myelin-forming oligodendrocytes of newborn rat C.N.S (1978) J. Neurocytol., 7, pp. 251-263; Stummeyer, K., Dickmanns, A., Mühlenhoff, M., Gerardy-Schahn, R., Ficner, R., Crystal structure of the polysialic acid-degrading endosialidase of bacteriophage K1F (2005) Nat. Struct. Mol. Biol., 12, pp. 90-96; Trotter, J., Bitter-Suermann, D., Schachner, M., Differentiation-regulated loss of the polysialylated embryonic form and expression of the different polypeptides of the neural cell adhesion molecule by cultured oligodendrocytes and myelin (1989) J. Neurosci. Res., 22, pp. 369-383; Trotter, J., Karram, K., Nishiyama, A., NG2 cells: properties, progeny and origin (2010) Brain Res. Rev., 63, pp. 72-82; Wang, C., Rougon, G., Kiss, J.Z., Requirement of polysialic acid for the migration of the O-2A glial progenitor cell from neurohypophyseal explants (1994) J. Neurosci., 14, pp. 4446-4457; Wang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., Maherali, N., Goldman, S.A., Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination (2013) Cell Stem Cell, 12, pp. 252-264; Wolswijk, G., Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord (2002) Brain, 125, pp. 338-349; Zhang, H., Vutskits, L., Calaora, V., Durbec, P., Kiss, J.Z., A role for the polysialic acid-neural cell adhesion molecule in PDGF-induced chemotaxis of oligodendrocyte precursor cells (2004) J. Cell Sci., 117, pp. 93-103",Article,Scopus,2-s2.0-84926346207
"Easley C.A., Bradner J.M., Moser A., Rickman C.A., McEachin Z.T., Merritt M.M., Hansen J.M., Caudle W.M.","Assessing reproductive toxicity of two environmental toxicants with a novel in vitro human spermatogenic model",2015,"Stem Cell Research","14","3",,"347","355",,,10.1016/j.scr.2015.03.002,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926350200&partnerID=40&md5=d1c02a83fd8a93ff33ef93e50a06be26","Laboratory of Translational Cell Biology, Department of Cell Biology, Emory University School of MedicineAtlanta, GA, United States; Department of Environmental Health, Rollins School of Public Heath, Emory UniversityAtlanta, GA, United States; Division of Pulmonology, Department of Pediatrics, Emory University School of MedicineAtlanta, GA, United States; Center for Neurodegenerative Disease, Emory University School of MedicineAtlanta, GA, United States; Wallace H. Coulter Department of Biomedical Engineering, Georgia Tech College of EngineeringAtlanta, GA, United States","Easley, C.A., IV, Laboratory of Translational Cell Biology, Department of Cell Biology, Emory University School of MedicineAtlanta, GA, United States; Bradner, J.M., Department of Environmental Health, Rollins School of Public Heath, Emory UniversityAtlanta, GA, United States, Center for Neurodegenerative Disease, Emory University School of MedicineAtlanta, GA, United States; Moser, A., Laboratory of Translational Cell Biology, Department of Cell Biology, Emory University School of MedicineAtlanta, GA, United States; Rickman, C.A., Laboratory of Translational Cell Biology, Department of Cell Biology, Emory University School of MedicineAtlanta, GA, United States; McEachin, Z.T., Laboratory of Translational Cell Biology, Department of Cell Biology, Emory University School of MedicineAtlanta, GA, United States, Wallace H. Coulter Department of Biomedical Engineering, Georgia Tech College of EngineeringAtlanta, GA, United States; Merritt, M.M., Laboratory of Translational Cell Biology, Department of Cell Biology, Emory University School of MedicineAtlanta, GA, United States; Hansen, J.M., Division of Pulmonology, Department of Pediatrics, Emory University School of MedicineAtlanta, GA, United States; Caudle, W.M., Department of Environmental Health, Rollins School of Public Heath, Emory UniversityAtlanta, GA, United States, Center for Neurodegenerative Disease, Emory University School of MedicineAtlanta, GA, United States","Environmental influences and insults by reproductive toxicant exposure can lead to impaired spermatogenesis or infertility. Understanding how toxicants disrupt spermatogenesis is critical for determining how environmental factors contribute to impaired fertility. While current animal models are available, understanding of the reproductive toxic effects on human fertility requires a more robust model system. We recently demonstrated that human pluripotent stem cells can differentiate into spermatogonial stem cells/spermatogonia, primary and secondary spermatocytes, and haploid spermatids; a model that mimics many aspects of human spermatogenesis. Here, using this model system, we examine the effects of 2-bromopropane (2-BP) and 1,2,dibromo-3-chloropropane (DBCP) on in vitro human spermatogenesis. 2-BP and DBCP are non-endocrine disrupting toxicants that are known to impact male fertility. We show that acute treatment with either 2-BP or DBCP induces a reduction in germ cell viability through apoptosis. 2-BP and DBCP affect viability of different cell populations as 2-BP primarily reduces spermatocyte viability, whereas DBCP exerts a much greater effect on spermatogonia. Acute treatment with 2-BP or DBCP also reduces the percentage of haploid spermatids. Both 2-BP and DBCP induce reactive oxygen species (ROS) formation leading to an oxidized cellular environment. Taken together, these results suggest that acute exposure with 2-BP or DBCP causes human germ cell death in vitro by inducing ROS formation. This system represents a unique platform for assessing human reproductive toxicity potential of various environmental toxicants in a rapid, efficient, and unbiased format. © 2015.",,"Agarwal, A., Virk, G., Ong, C., du Plessis, S.S., Effect of oxidative stress on male reproduction (2014) World J. Mens Health, 32, pp. 1-17; Aitken, R.J., Roman, S.D., Antioxidant systems and oxidative stress in the testes (2008) Oxidative Med. Cell. Longev., 1, pp. 15-24; Amann, R.P., Berndtson, W.E., Assessment of procedures for screening agents for effects on male reproduction: effects of dibromochloropropane (DBCP) on the rat (1986) Fundam. Appl. Toxicol., 7, pp. 244-255; NTP-CERHR monograph on the potential human reproductive and developmental effects of 2-bromopropane (2-BP) (2003) NTP CERHR MON, pp. 1-311; 1,2-Dibromo-3-chloropropane (2011) Report on carcinogens: carcinogen profiles, 12, pp. 134-135. , U.S. Dept. of Health and Human Services, Public Health Service, National Toxicology Program; Baird, L., Dinkova-Kostova, A.T., The cytoprotective role of the Keap1-Nrf2 pathway (2011) Arch. Toxicol., 85, pp. 241-272; Bjorge, C., Wiger, R., Holme, J.A., Brunborg, G., Andersen, R., Dybing, E., Soderlund, E.J., In vitro toxicity of 1,2-dibromo-3-chloropropane (DBCP) in different testicular cell types from rats (1995) Reprod. Toxicol., 9, pp. 461-473; Boekelheide, K., Darney, S.P., Daston, G.P., David, R.M., Luderer, U., Olshan, A.F., Sanderson, W.T., Woskie, S., NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of 2-bromopropane (2004) Reprod. Toxicol., 18, pp. 189-217; Bucay, N., Yebra, M., Cirulli, V., Afrikanova, I., Kaido, T., Hayek, A., Montgomery, A.M., A novel approach for the derivation of putative primordial germ cells and sertoli cells from human embryonic stem cells (2009) Stem Cells, 27, pp. 68-77; Campion, S., Catlin, N., Heger, N., McDonnell, E.V., Pacheco, S.E., Saffarini, C., Sandrof, M.A., Boekelheide, K., Male reprotoxicity and endocrine disruption (2012) EXS, 101, pp. 315-360; Easley, C., Ben-Yehudah, A., Redinger, C.J., Oliver, S.L., Varum, S.T., Eisinger, V.M., Carlisle, D.L., Schatten, G.P., MTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells (2010) Cell. Reprogram., 12, pp. 263-273; Easley, C., Phillips, B.T., McGuire, M.M., Barringer, J.M., Valli, H., Hermann, B.P., Simerly, C.R., Schatten, G.P., Direct differentiation of human pluripotent stem cells into haploid spermatogenic cells (2012) Cell Rep., 2, pp. 440-446; Eguizabal, C., Montserrat, N., Vassena, R., Barragan, M., Garreta, E., Garcia-Quevedo, L., Vidal, F., Izpisua Belmonte, J.C., Complete meiosis from human induced pluripotent stem cells (2011) Stem Cells, 29, pp. 1186-1195; Ehmcke, J., Wistuba, J., Schlatt, S., Spermatogonial stem cells: questions, models and perspectives (2006) Hum. Reprod. Update, 12, pp. 275-282; Fukunaga, N., Teramura, T., Onodera, Y., Takehara, T., Fukuda, K., Hosoi, Y., Leukemia inhibitory factor (LIF) enhances germ cell differentiation from primate embryonic stem cells (2010) Cell. Reprogram., 12, pp. 369-376; Geijsen, N., Horoschak, M., Kim, K., Gribnau, J., Eggan, K., Daley, G.Q., Derivation of embryonic germ cells and male gametes from embryonic stem cells (2004) Nature, 427, pp. 148-154; Holme, J.A., Soderlund, E.J., Brunborg, G., Lag, M., Nelson, S.D., Dybing, E., DNA damage and cell death induced by 1,2-dibromo-3-chloropropane (DBCP) and structural analogs in monolayer culture of rat hepatocytes: 3-aminobenzamide inhibits the toxicity of DBCP (1991) Cell Biol. Toxicol., 7, pp. 413-432; Ichihara, G., Ding, X., Yu, X., Wu, X., Kamijima, M., Peng, S., Jiang, X., Takeuchi, Y., Occupational health survey on workers exposed to 2-bromopropane at low concentrations (1999) Am. J. Ind. Med., 35, pp. 523-531; Kapp, R.W., Picciano, D.J., Jacobson, C.B., Y-chromosomal nondisjunction in dibromochloropropane-exposed workmen (1979) Mutat. Res., 64, pp. 47-51; Kee, K., Angeles, V.T., Flores, M., Nguyen, H.N., Reijo Pera, R.A., Human DAZL, DAZ and BOULE genes modulate primordial germ-cell and haploid gamete formation (2009) Nature, 462, pp. 222-225; Kelce, W.R., Raisbeck, M.F., Ganjam, V.K., Gonadotoxic effects of 2-hexanone and 1,2-dibromo-3-chloropropane on the enzymatic activity of rat testicular 17 alpha-hydroxylase/C17,20-lyase (1990) Toxicol. Lett., 52, pp. 331-338; Kim, Y., Jung, K., Hwang, T., Jung, G., Kim, H., Park, J., Kim, J., Moon, Y., Hematopoietic and reproductive hazards of Korean electronic workers exposed to solvents containing 2-bromopropane (1996) Scand. J. Work Environ. Health, 22, pp. 387-391; Kim, Y., Park, J., Moon, Y., Hematopoietic and reproductive toxicity of 2-bromopropane, a recently introduced substitute for chlorofluorocarbons (1999) Toxicol. Lett., 108, pp. 309-313; Lamkanfi, M., Kanneganti, T.D., Caspase-7: a protease involved in apoptosis and inflammation (2010) Int. J. Biochem. Cell Biol., 42, pp. 21-24; Maiorino, M., Ursini, F., Oxidative stress, spermatogenesis and fertility (2002) Biol. Chem., 383, pp. 591-597; Meistrich, M.L., Wilson, G., Shuttlesworth, G.A., Porter, K.L., Dibromochloropropane inhibits spermatogonial development in rats (2003) Reprod. Toxicol., 17, pp. 263-271; Panula, S., Medrano, J.V., Kee, K., Bergstrom, R., Nguyen, H.N., Byers, B., Wilson, K.D., Reijo Pera, R.A., Human germ cell differentiation from fetal- and adult-derived induced pluripotent stem cells (2011) Hum. Mol. Genet., 20, pp. 752-762; Park, T.S., Galic, Z., Conway, A.E., Lindgren, A., van Handel, B.J., Magnusson, M., Richter, L., Clark, A.T., Derivation of primordial germ cells from human embryonic and induced pluripotent stem cells is significantly improved by coculture with human fetal gonadal cells (2009) Stem Cells, 27, pp. 783-795; Potashnik, G., Porath, A., Dibromochloropropane (DBCP): a 17-year reassessment of testicular function and reproductive performance (1995) J. Occup. Environ. Med., 37, pp. 1287-1292; Slutsky, M., Levin, J.L., Levy, B.S., Azoospermia and oligospermia among a large cohort of DBCP applicators in 12 countries (1999) Int. J. Occup. Environ. Health, 5, pp. 116-122; Son, H.Y., Kim, Y.B., Kang, B.H., Cho, S.W., Ha, C.S., Roh, J.K., Effects of 2-bromopropane on spermatogenesis in the Sprague-Dawley rat (1999) Reprod. Toxicol., 13, pp. 179-187; Teramoto, S., Saito, R., Aoyama, H., Shirasu, Y., Dominant lethal mutation induced in male rats by 1,2-dibromo-3-chloropropane (DBCP) (1980) Mutat. Res., 77, pp. 71-78; Teramura, T., Takehara, T., Kawata, N., Fujinami, N., Mitani, T., Takenoshita, M., Matsumoto, K., Hosoi, Y., Primate embryonic stem cells proceed to early gametogenesis in vitro (2007) Cloning Stem Cells, 9, pp. 144-156; Tilgner, K., Atkinson, S.P., Golebiewska, A., Stojkovic, M., Lako, M., Armstrong, L., Isolation of primordial germ cells from differentiating human embryonic stem cells (2008) Stem Cells, 26, pp. 3075-3085; Tomerlin, J.R., The US Food Quality Protection Act-policy implications of variability and consumer risk (2000) Food Addit. Contam., 17, pp. 641-648; West, F.D., Mumaw, J.L., Gallegos-Cardenas, A., Young, A., Stice, S.L., Human haploid cells differentiated from meiotic competent clonal germ cell lines that originated from embryonic stem cells (2011) Stem Cells Dev., 20, pp. 1079-1088; Whorton, D., Milby, T.H., Krauss, R.M., Stubbs, H.A., Testicular function in DBCP exposed pesticide workers (1979) J. Occup. Med., 21, pp. 161-166; Wu, X., Faqi, A.S., Yang, J., Ding, X., Jiang, X., Chahoud, I., Male reproductive toxicity and beta-luteinizing hormone gene expression in sexually mature and immature rats exposed to 2-bromopropane (1999) Hum. Exp. Toxicol., 18, pp. 683-690; Yamauchi, K., Hasegawa, K., Chuma, S., Nakatsuji, N., Suemori, H., In vitro germ cell differentiation from cynomolgus monkey embryonic stem cells (2009) PLoS One, 4, p. e5338; Yu, I.J., Chung, Y.H., Lim, C.H., Maeng, S.H., Lee, J.Y., Kim, H.Y., Lee, S.J., Moon, Y.H., Reproductive toxicity of 2-bromopropane in Sprague Dawley rats (1997) Scand. J. Work Environ. Health, 23, pp. 281-288",Article,Scopus,2-s2.0-84926350200
"Kwan A., Hu D., Song M., Gomes H., Brown D.R., Bourque T., Gonzalez-Espinosa D., Lin Z., Cowan M.J., Puck J.M.","Successful newborn screening for SCID in the Navajo Nation",2015,"Clinical Immunology","158","1",,"29","34",,,10.1016/j.clim.2015.02.015,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925424134&partnerID=40&md5=500200555cd975f5b59e1503ed77a856","Allergy Immunology and Blood and Marrow Transplant Division, Department of Pediatrics, Benioff Children's Hospital and University of California San FranciscoSan Francisco, CA, United States; Department of Pediatrics, Tuba City Regional Health Care CenterTuba City, AZ, United States; Department of Pediatrics, Chinle Comprehensive Health Care FacilityChinle, AZ, United States; Research and Development, PerkinElmer Genetics Inc.Bridgeville, PA, United States","Kwan, A., Allergy Immunology and Blood and Marrow Transplant Division, Department of Pediatrics, Benioff Children's Hospital and University of California San FranciscoSan Francisco, CA, United States; Hu, D., Department of Pediatrics, Tuba City Regional Health Care CenterTuba City, AZ, United States; Song, M., Department of Pediatrics, Tuba City Regional Health Care CenterTuba City, AZ, United States; Gomes, H., Department of Pediatrics, Chinle Comprehensive Health Care FacilityChinle, AZ, United States; Brown, D.R., Department of Pediatrics, Tuba City Regional Health Care CenterTuba City, AZ, United States; Bourque, T., Department of Pediatrics, Chinle Comprehensive Health Care FacilityChinle, AZ, United States; Gonzalez-Espinosa, D., Allergy Immunology and Blood and Marrow Transplant Division, Department of Pediatrics, Benioff Children's Hospital and University of California San FranciscoSan Francisco, CA, United States; Lin, Z., Research and Development, PerkinElmer Genetics Inc.Bridgeville, PA, United States; Cowan, M.J., Allergy Immunology and Blood and Marrow Transplant Division, Department of Pediatrics, Benioff Children's Hospital and University of California San FranciscoSan Francisco, CA, United States; Puck, J.M., Allergy Immunology and Blood and Marrow Transplant Division, Department of Pediatrics, Benioff Children's Hospital and University of California San FranciscoSan Francisco, CA, United States","Newborn screening (NBS) for severe combined immunodeficiency (SCID) identifies affected infants before the onset of life-threatening infections, permitting optimal treatment. Navajo Native Americans have a founder mutation in the DNA repair enzyme Artemis, resulting in frequent Artemis SCID (SCID-A). A pilot study at 2 Navajo hospitals assessed the feasibility of SCID NBS in this population. Dried blood spots from 1800 infants were assayed by PCR for T-cell receptor excision circles (TRECs), a biomarker for naïve T cells. Starting in February 2012, TREC testing transitioned to standard care throughout the Navajo Area Indian Health Service, and a total of 7900 infants were screened through July 2014. One infant had low TRECs and was diagnosed with non-SCID T lymphopenia, while 4 had undetectable TRECs due to SCID-A, all of whom were referred for hematopoietic cell transplantation. This report establishes the incidence of SCID-A and demonstrates effectiveness of TREC NBS in the Navajo. © 2015 Elsevier Inc.","Artemis; Navajo; Newborn screening; Primary immunodeficiency; SCID; TREC","Al-Herz, W., Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency (2011) Front. Immunol., 2, p. 54; Verbsky, J., Thakar, M., Routes, J., The Wisconsin approach to newborn screening for severe combined immunodeficiency (2012) J. Allergy Clin. Immunol., 129 (3), pp. 622-627; Kwan, A., Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2years (2013) J. Allergy Clin. Immunol., 132 (1), pp. 140-150 e7; Kwan, A., Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States (2014) JAMA, 312 (7), pp. 729-738; Dvorak, C.C., The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901 (2013) J. Clin. Immunol., 33 (7), pp. 1156-1164; Pai, S.Y., Transplantation outcomes for severe combined immunodeficiency, 2000-2009 (2014) New Engl. J. Med., 371 (5), pp. 434-446; Dvorak, C.C., Cowan, M.J., Radiosensitive severe combined immunodeficiency disease (2010) Immunol. Allergy Clin. N. Am., 30 (1), pp. 125-142; de Villartay, J.P., Human and animal models of V(D)J recombination deficiency (2003) Curr. Opin. Immunol., 15 (5), pp. 592-598; Murphy, S., Gene enrichment in an American Indian population: an excess of severe combined immunodeficiency disease (1980) Lancet, 2 (8193), pp. 502-505; Li, L., A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking Native Americans (2002) J. Immunol., 168 (12), pp. 6323-6329; Cheek, L.W., The Navajo long walk (2004) Look West Series, p. 64. , Rio Nuevo Publishers, Tucson; Jones, J.F., Severe combined immunodeficiency among the Navajo. I. Characterization of phenotypes, epidemiology, and population genetics (1991) Hum. Biol., 63 (5), pp. 669-682; Li, L., Prenatal diagnosis and carrier detection for Athabascan severe combined immunodeficiency disease (2002) Prenat. Diagn., 22 (9), pp. 763-768; Douek, D.C., Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution (2000) Lancet, 355 (9218), pp. 1875-1881; Chan, K., Puck, J.M., Development of population-based newborn screening for severe combined immunodeficiency (2005) J. Allergy Clin. Immunol., 115 (2), pp. 391-398; O'Marcaigh, A.S., Maternal mosaicism for a novel interleukin-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency in a Navajo kindred (1997) J. Clin. Immunol., 17 (1), pp. 29-33; Howell, R.R., (2011) Report on Newborn Screening for Severe Combined Immunodeficiency 2011, , http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/recommendations/correspondence/severeimmunodeficiency.pdf, Secretary's Advisory Committee on Heritable Disorders in Newborns and Children. Last accessed August 12, 2014; Hannon, W.H., (2013) Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline, , Clinical and Laboratory Standards Institute, Wayne, PA; Kwong, P.C., Oral and genital ulceration: a unique presentation of immunodeficiency in Athabascan-speaking American Indian children with severe combined immunodeficiency (1999) Arch. Dermatol., 135 (8), pp. 927-931; Tarini, B.A., Waiving informed consent in newborn screening research: balancing social value and respect (2008) Am. J. Med. Genet. C: Semin. Med. Genet., 148 C (1), pp. 23-30; Botkin, J.R., Parental permission for pilot newborn screening research: guidelines from the NBSTRN (2014) Pediatrics, 133 (2), pp. e410-e417; Feuchtbaum, L., Cunningham, G., Sciortino, S., Questioning the need for informed consent: A case study of California's experience with a pilot newborn screening research project (2007) J. Empir. Res. Hum. Res. Ethics, 2 (3), pp. 3-14; Bakare, N., Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS) (2010) Vaccine, 28 (40), pp. 6609-6612",Article,Scopus,2-s2.0-84925424134
"DeFilipp Z., Khoury H.J.","Management of Advanced-Phase Chronic Myeloid Leukemia",2015,"Current Hematologic Malignancy Reports",,,,"","",9,,10.1007/s11899-015-0249-2,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928672579&partnerID=40&md5=e6692db5db68711eda505a6560b9ebe6","Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, 1365 Clifton Road NE C5010Atlanta, GA, United States; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, 1365 Clifton Road NE C1152Atlanta, GA, United States","DeFilipp, Z., Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, 1365 Clifton Road NE C5010Atlanta, GA, United States; Khoury, H.J., Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, 1365 Clifton Road NE C1152Atlanta, GA, United States","The management of chronic myeloid leukemia (CML) in accelerated or blast phase (advanced phase) remains a significant challenge despite the introduction of very effective tyrosine kinase inhibitors (TKIs). The biology of advanced-phase CML is complex and engages several pathways that are not optimally targeted by TKIs. Allogeneic stem cell transplantation remains the only potentially curative therapy, but the effectiveness of this conventional approach is limited. New strategies are required to improve the outlook for these patients. © 2015 Springer Science+Business Media New York","Accelerated phase; Advanced-phase; Allogeneic stem cell transplantation; Blast phase; Chronic myeloid leukemia; Tyrosine kinase inhibitors",,Article in Press,Scopus,2-s2.0-84928672579
"Mead B., Berry M., Logan A., Scott R.A.H., Leadbeater W., Scheven B.A.","Stem cell treatment of degenerative eye disease",2015,"Stem Cell Research","14","3",,"243","257",,,10.1016/j.scr.2015.02.003,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924267865&partnerID=40&md5=d85c43f484029ed24adac260f2d3a2e3","Neurotrauma Research Group, Neurobiology Section, School of Clinical and Experimental Medicine, University of Birmingham, United Kingdom; School of Dentistry, University of Birmingham, United Kingdom","Mead, B., Neurotrauma Research Group, Neurobiology Section, School of Clinical and Experimental Medicine, University of Birmingham, United Kingdom, School of Dentistry, University of Birmingham, United Kingdom; Berry, M., Neurotrauma Research Group, Neurobiology Section, School of Clinical and Experimental Medicine, University of Birmingham, United Kingdom; Logan, A., Neurotrauma Research Group, Neurobiology Section, School of Clinical and Experimental Medicine, University of Birmingham, United Kingdom; Scott, R.A.H., Neurotrauma Research Group, Neurobiology Section, School of Clinical and Experimental Medicine, University of Birmingham, United Kingdom; Leadbeater, W., Neurotrauma Research Group, Neurobiology Section, School of Clinical and Experimental Medicine, University of Birmingham, United Kingdom; Scheven, B.A., School of Dentistry, University of Birmingham, United Kingdom","Stem cell therapies are being explored extensively as treatments for degenerative eye disease, either for replacing lost neurons, restoring neural circuits or, based on more recent evidence, as paracrine-mediated therapies in which stem cell-derived trophic factors protect compromised endogenous retinal neurons from death and induce the growth of new connections. Retinal progenitor phenotypes induced from embryonic stem cells/induced pluripotent stem cells (ESCs/iPSCs) and endogenous retinal stem cells may replace lost photoreceptors and retinal pigment epithelial (RPE) cells and restore vision in the diseased eye, whereas treatment of injured retinal ganglion cells (RGCs) has so far been reliant on mesenchymal stem cells (MSC). Here, we review the properties of non-retinal-derived adult stem cells, in particular neural stem cells (NSCs), MSC derived from bone marrow (BMSC), adipose tissues (ADSC) and dental pulp (DPSC), together with ESC/iPSC and discuss and compare their potential advantages as therapies designed to provide trophic support, repair and replacement of retinal neurons, RPE and glia in degenerative retinal diseases. We conclude that ESCs/iPSCs have the potential to replace lost retinal cells, whereas MSC may be a useful source of paracrine factors that protect RGC and stimulate regeneration of their axons in the optic nerve in degenerate eye disease. NSC may have potential as both a source of replacement cells and also as mediators of paracrine treatment. © 2015.",,"Aanismaa, R., Hautala, J., Vuorinen, A., Miettinen, S., Narkilahti, S., Human dental pulp stem cells differentiate into neural precursors but not into mature functional neurons (2012) Stem Cell Discov., 2, pp. 85-91; Abematsu, M., Tsujimura, K., Yamano, M., Saito, M., Kohno, K., Kohyama, J., Namihira, M., Nakashima, K., Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury (2010) J. Clin. Invest., 120, pp. 3255-3266; Ahmad, I., Tang, L., Pham, H., Identification of neural progenitors in the adult mammalian eye (2000) Biochem. Biophys. Res. Commun., 270, pp. 517-521; Ahmed, Z., Kalinski, H., Berry, M., Almasieh, M., Ashush, H., Slager, N., Brafman, A., Logan, A., Ocular neuroprotection by siRNA targeting caspase-2 (2011) Cell Death Dis., 2, p. e173; Anghileri, E., Marconi, S., Pignatelli, A., Cifelli, P., Galie, M., Sbarbati, A., Krampera, M., Bonetti, B., Neuronal differentiation potential of human adipose-derived mesenchymal stem cells (2008) Stem Cells Dev., 17, pp. 909-916; Arboleda, D., Forostyak, S., Jendelova, P., Marekova, D., Amemori, T., Pivonkova, H., Masinova, K., Sykova, E., Transplantation of predifferentiated adipose-derived stromal cells for the treatment of spinal cord injury (2011) Cell. Mol. Neurobiol., 31, pp. 1113-1122; Arnhold, S., Absenger, Y., Klein, H., Addicks, K., Schraermeyer, U., Transplantation of bone marrow-derived mesenchymal stem cells rescue photoreceptor cells in the dystrophic retina of the rhodopsin knockout mouse. Graefe's archive for clinical and experimental ophthalmology=Albrecht von Graefes Archiv fur klinische und experimentelle (2007) Ophthalmologie, 245, pp. 414-422; Arthur, A., Rychkov, G., Shi, S., Koblar, S.A., Gronthos, S., Adult human dental pulp stem cells differentiate toward functionally active neurons under appropriate environmental cues (2008) Stem Cells, 26, pp. 1787-1795; Ballios, B.G., Clarke, L., Coles, B.L.K., Shoichet, M.S., Van Der Kooy, D., The adult retinal stem cell is a rare cell in the ciliary epithelium whose progeny can differentiate into photoreceptors (2012) Biol. Open, 1 (3), pp. 237-246; Banin, E., Obolensky, A., Idelson, M., Hemo, I., Reinhardtz, E., Pikarsky, E., Ben-Hur, T., Reubinoff, B., Retinal incorporation and differentiation of neural precursors derived from human embryonic stem cells (2006) Stem Cells, 24, pp. 246-257; Barde, Y.-A., Trophic factors and neuronal survival (1989) Neuron, 2, pp. 1525-1534; Berkelaar, M., Clarke, D.B., Wang, Y.C., Bray, G.M., Aguayo, A.J., Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats (1994) J. Neurosci., 14, pp. 4368-4374; Berry, M., Ahmed, Z., Lorber, B., Douglas, M., Logan, A., Regeneration of axons in the visual system (2008) Restor. Neurol. Neurosci., 26, pp. 147-174; Bharti, K., Miller, S.S., Arnheiter, H., The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells (2011) Pigment Cell Melanoma Res., 24, pp. 21-34; Bohm, M.R.R., Pfrommer, S., Chiwitt, C., Bruckner, M., Melkonyan, H., Thanos, S., Crystallin-beta-b2-overexpressing NPCs support the survival of injured retinal ganglion cells and photoreceptors in rats (2012) Invest. Ophthalmol. Vis. Sci., 53, pp. 8265-8279; Butowt, R., von Bartheld, C.S., Connecting the dots: trafficking of neurotrophins, lectins and diverse pathogens by binding to the neurotrophin receptor p75(NTR) (2003) Eur. J. Neurosci., 17, pp. 673-680; Canola, K., Angénieux, B., Tekaya, M., Quiambao, A., Naash, M.I., Munier, F.L., Schorderet, D.F., Arsenijevic, Y., Retinal stem cells transplanted into models of late stages of retinitis pigmentosa preferentially adopt a glial or a retinal ganglion cell fate (2007) Invest. Ophthalmol. Vis. Sci., 48, pp. 446-454; Cao, Q.L., Zhang, Y.P., Howard, R.M., Walters, W.M., Tsoulfas, P., Whittemore, S.R., Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage (2001) Exp. Neurol., 167, pp. 48-58; Carr, A.J., Vugler, A., Lawrence, J., Chen, L.L., Ahmado, A., Chen, F.K., Semo, M., Coffey, P.J., Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay (2009) Mol. Vis., 15, pp. 283-295; Carr, A.J., Vugler, A.A., Hikita, S.T., Lawrence, J.M., Gias, C., Chen, L.L., Buchholz, D.E., Coffey, P.J., Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat (2009) Plos One, 4, p. e8152; Chacko, D.M., Das, A.V., Zhao, X., James, J., Bhattacharya, S., Ahmad, I., Transplantation of ocular stem cells: the role of injury in incorporation and differentiation of grafted cells in the retina (2003) Vis. Res., 43, pp. 937-946; Chen, H., Weber, A.J., Brain-derived neurotrophic factor reduces TrkB protein and mRNA in the normal retina and following optic nerve crush in adult rats (2004) Brain Res., 1011, pp. 99-106; Chen, Q., Long, Y., Yuan, X., Zou, L., Sun, J., Chen, S., Perez-Polo, J.R., Yang, K., Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors (2005) J. Neurosci. Res., 80, pp. 611-619; Chen, M., Xiang, Z., Cai, J., The anti-apoptotic and neuro-protective effects of human umbilical cord blood mesenchymal stem cells (hUCB-MSCs) on acute optic nerve injury is transient (2013) Brain Res., 1532, pp. 63-75; Cho, S.-R., Kim, Y.R., Kang, H.-S., Yim, S.H., C-i, P., Min, Y.H., Lee, B.H., Lim, J.-B., Functional recovery after the transplantation of neurally differentiated mesenchymal stem cells derived from bone barrow in a rat model of spinal cord injury (2009) Cell Transplant., 18, pp. 1359-1368; Clarke, L., Ballios, B.G., van der Kooy, D., Generation and clonal isolation of retinal stem cells from human embryonic stem cells (2012) Eur. J. Neurosci., 36, pp. 1951-1959; Cuenca, N., Fernandez-Sanchez, L., McGill, T.J., Lu, B., Wang, S.M., Lund, R., Huhn, S., Capela, A., Phagocytosis of photoreceptor outer segments by transplanted human neural stem cells as a neuroprotective mechanism in retinal degeneration (2013) Invest. Ophthalmol. Vis. Sci., 54, pp. 6745-6756; Cummings, B.J., Uchida, N., Tamaki, S.J., Salazar, D.L., Hooshmand, M., Summers, R., Gage, F.H., Anderson, A.J., Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 14069-14074; da Cruz, L., Chen, F.K., Ahmado, A., Greenwood, J., Coffey, P., RPE transplantation and its role in retinal disease (2007) Prog. Retin. Eye Res., 26, pp. 598-635; Dawbarn, D., Allen, S.J., Neurotrophins and neurodegeneration (2003) Neuropathol. Appl. Neurobiol., 29, pp. 211-230; Del Debbio, C.B., Peng, X., Xiong, H., Ahmad, I., Adult ciliary epithelial stem cells generate functional neurons and differentiate into both early and late born retinal neurons under non-cell autonomous influences (2013) BMC Neurosci., 14, p. 130; Dormady, S.P., Bashayan, O., Dougherty, R., Zhang, X.M., Basch, R.S., Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment (2001) J. Hematother. Stem Cell Res., 10, pp. 125-140; Dougherty, K.D., Dreyfus, C.F., Black, I.B., Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury (2000) Neurobiol. Dis., 7, pp. 574-585; Eiraku, M., Takata, N., Ishibashi, H., Kawada, M., Sakakura, E., Okuda, S., Sekiguchi, K., Sasai, Y., Self-organizing optic-cup morphogenesis in three-dimensional culture (2011) Nature, 472, pp. 51-56; Fang, C.-Z., Yang, Y.-J., Wang, Q.-H., Yao, Y., Zhang, X.-Y., He, X.-H., Intraventricular injection of human dental pulp stem cells improves hypoxic-ischemic brain damage in neonatal rats (2013) Plos One, 8, p. e66748; Faulkner, J.R., Herrmann, J.E., Woo, M.J., Tansey, K.E., Doan, N.B., Sofroniew, M.V., Reactive astrocytes protect tissue and preserve function after spinal cord injury (2004) J. Neurosci., 24, pp. 2143-2155; Fischer, A.J., Neural regeneration in the chick retina (2005) Prog. Retin. Eye Res., 24, pp. 161-182; Flachsbarth, K., Kruszewski, K., Jung, G., Jankwiak, W., Riecken, K., Wagenfeld, L., Richard, G., Bartsch, U., Neural stem cell-based intraocular administration of ciliary neurotrophic factor attentuates the loss of axotomized ganglion cells in adult mice (2014) Invest. Ophthalmol. Vis. Sci., 55, pp. 7029-7039; Gale, Z., Cooper, P.R., Scheven, B.A.A., Effects of glial cell line-derived neurotrophic factor on dental pulp cells (2011) J. Dent. Res., 90, pp. 1240-1245; Ghorbanian, M.T., Haji Ghasem Kashani, M., Lashkarblouki, T., Hosseinpour, L., Mirzaiyan, L., Characterization of in vitro cultured bone marrow and adipose tissue-derived mesenchymal stem cells and their ability to express neurotrophic factors (2012) Cell Biol. Int., 36 (12), pp. 1239-1249; Gonzalez-Cordero, A., West, E.L., Pearson, R.A., Duran, Y., Carvalho, L.S., Chu, C.J., Naeem, A., Ali, R.R., Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina (2013) Nat. Biotechnol., 31, pp. 741-747; Grozdanic, S.D., Ast, A.M., Lazic, T., Kwon, Y.H., Kardon, R.H., Sonea, I.M., Sakaguchi, D.S., Morphological integration and functional assessment of transplanted neural progenitor cells in healthy and acute ischemic rat eyes (2006) Exp. Eye Res., 82, pp. 597-607; Gu, Y.L., Yin, L.W., Zhang, Z., Liu, J., Liu, S.J., Zhang, L.F., Wang, T.H., Neurotrophin expressions in neural stem cells grafted acutely to transected spinal cord of adult rats linked to functional improvement (2012) Cell. Mol. Neurobiol., 32, pp. 1089-1097; Haddad-Mashadrizeh, A., Bahrami, A.R., Matin, M.M., Edalatmanesh, M.A., Zomorodipour, A., Gardaneh, M., Farshchian, M., Momeni-Moghaddam, M., Human adipose-derived mesenchymal stem cells can survive and integrate into the adult rat eye following xenotransplantation (2013) Xenotransplantation, 20, pp. 165-176; Hambright, D., Park, K.Y., Brooks, M., McKay, R., Swaroop, A., Nasonkin, I.O., Long-term survival and differentiation of retinal neurons derived from human embryonic stem cell lines in un-immunosuppressed mouse retina (2012) Mol. Vis., 18, pp. 920-936; Harper, M.M., Grozdanic, S.D., Blits, B., Kuehn, M.H., Zamzow, D., Buss, J.E., Kardon, R.H., Sakaguchi, D.S., Transplantation of BDNF-secreting mesenchymal stem cells provides neuroprotection in chronically hypertensive rat eyes (2011) Invest. Ophthalmol. Vis. Sci., 52, pp. 4506-4515; He, B.-L., Ba, Y.-C., Wang, X.-Y., Liu, S.-J., Ou, S., Liu, G.-D., Gu, Y.-L., Wang, T.-H., BDNF expression with functional improvement in transected spinal cord treated with neural stem cells in adult rats (2012) Neuropeptides, 47 (1), pp. 1-7; Hertz, J., Qu, B., Hu, Y., Patel, R.D., Valenzuela, D.A., Goldberg, J.L., Survival and integration of developing and progenitor-derived retinal ganglion cells following transplantation (2014) Cell Transplant., 23, pp. 855-872; Hill, A.J., Zwart, I., Tam, H.H., Chan, J., Navarrete, C., Jen, L.S., Navarrete, R., Human umbilical cord blood-derived mesenchymal stem cells do not differentiate into neural cell types or integrate into the retina after intravitreal grafting in neonatal rats (2009) Stem Cells Dev., 18, pp. 399-409; Huang, A.H.-C., Snyder, B.R., Cheng, P.-H., Chan, A.W.S., Putative dental pulp-derived stem/stromal cells promote proliferation and differentiation of endogenous neural cells in the hippocampus of mice (2008) Stem Cells, 26, pp. 2654-2663; Ikeda, H., Osakada, F., Watanabe, K., Mizuseki, K., Haraguchi, T., Miyoshi, H., Kamiya, D., Sasai, Y., Generation of Rx+/Pax6+ neural retinal precursors from embryonic stem cells (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 11331-11336; Ishizaka, R., Hayashi, Y., Iohara, K., Sugiyama, M., Murakami, M., Yamamoto, T., Fukuta, O., Nakashima, M., Stimulation of angiogenesis, neurogenesis and regeneration by side population cells from dental pulp (2013) Biomaterials, 34, pp. 1888-1897; Jeong, S.W., Chu, K., Jung, K.H., Kim, S.U., Kim, M., Roh, J.K., Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage (2003) Stroke, 34, pp. 2258-2263; Jiang, L.Q., Streilein, J.W., Immune privilege extended to allogeneic tumor cells in the vitreous cavity (1991) Invest. Ophthalmol. Vis. Sci., 32, pp. 224-228; Jiang, Y., Ding, Q., Xie, X., Libby, R.T., Lefebvre, V., Gan, L., Transcription factors SOX4 and SOX11 function redundantly to regulate the development of mouse retinal ganglion cells (2013) J. Biol. Chem., 288, pp. 18429-18438; Johnson, T.V., Bull, N.D., Hunt, D.P., Marina, N., Tomarev, S.I., Martin, K.R., Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma (2010) Invest. Ophthalmol. Vis. Sci., 51, pp. 2051-2059; Johnson, T.V., Dekorver, N.W., Levasseur, V.A., Osborne, A., Tassoni, A., Lorber, B., Heller, J.P., Tomarev, S.I., Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome (2013) Brain, 137, pp. 503-519; Jones, L.L., Oudega, M., Bunge, M.B., Tuszynski, M.H., Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury (2001) J. Physiol., 533, pp. 83-89; Jung, G.L., Sun, J., Petrowitz, B., Riecken, K., Kruszewski, K., Jankowiak, W., Kunst, F., Bartsch, U., Genetically modified neural stem cells for a local and sustained delivery of neuroprotective factors to the dystrophic mouse retina (2013) Stem Cells Transl. Med., 2, pp. 1001-1010; Kalbermatten, D.F., Schaakxs, D., Kingham, P.J., Wiberg, M., Neurotrophic activity of human adipose stem cells isolated from deep and superficial layers of abdominal fat (2011) Cell Tissue Res., 344, pp. 251-260; Kang, S.K., Lee, D.H., Bae, Y.C., Kim, H.K., Baik, S.Y., Jung, J.S., Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats (2003) Exp. Neurol., 183, pp. 355-366; Kang, K.N., Kim da, Y., Yoon, S.M., Lee, J.Y., Lee, B.N., Kwon, J.S., Seo, H.W., Kim, M.S., Tissue engineered regeneration of completely transected spinal cord using human mesenchymal stem cells (2012) Biomaterials, 33, pp. 4828-4835; Karaoz, E., Demircan, P.C., Saglam, O., Aksoy, A., Kaymaz, F., Duruksu, G., Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells (2011) Histochem. Cell Biol., 136, pp. 455-473; Kiraly, M., Porcsalmy, B., Pataki, A., Kadar, K., Jelitai, M., Molnar, B., Hermann, P., Varga, G., Simultaneous PKC and cAMP activation induces differentiation of human dental pulp stem cells into functionally active neurons (2009) Neurochem. Int., 55, pp. 323-332; Kiraly, M., Kadar, K., Horvathy, D.B., Nardai, P., Racz, G.Z., Lacza, Z., Varga, G., Gerber, G., Integration of neuronally predifferentiated human dental pulp stem cells into rat brain in vivo (2011) Neurochem. Int., 59, pp. 371-381; Ko, M.L., Hu, D.N., Ritch, R., Sharma, S.C., The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma (2000) Invest. Ophthalmol. Vis. Sci., 41, pp. 2967-2971; Ko, M.L., Hu, D.N., Ritch, R., Sharma, S.C., Chen, C.F., Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats (2001) Neurosci. Lett., 305, pp. 139-142; Kode, J.A., Mukherjee, S., Joglekar, M.V., Hardikar, A.A., Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration (2009) Cytotherapy, 11, pp. 377-391; Lamb, T.M., Knecht, A.K., Smith, W.C., Stachel, S.E., Economides, A.N., Stahl, N., Yancopolous, G.D., Harland, R.M., Neural induction by the secreted polypeptide noggin (1993) Science, 262, pp. 713-718; Lamba, D.A., Reh, T.A., Microarray characterization of human embryonic stem cell-derived retinal cultures (2011) Invest. Ophthalmol. Vis. Sci., 52, pp. 4897-4906; Lamba, D.A., Karl, M.O., Ware, C.B., Reh, T.A., Efficient generation of retinal progenitor cells from human embryonic stem cells (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 12769-12774; Lamba, D.A., Gust, J., Reh, T.A., Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice (2009) Cell Stem Cell, 4, pp. 73-79; Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., Ringden, O., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells (2004) Lancet, 363, pp. 1439-1441; Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., DCEGB, M., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study (2008) Lancet, 371, pp. 1579-1586; Lee, J.Y., Shin, J.M., Yeum, C.E., Chae, G.T., Chun, M.H., Oh, S.J., Intravitreal delivery of mesenchymal stem cells loaded onto hydrogel affects the regulatory expression of endogenous NGF and BDNF in ischemic rat retina (2012) Tissue Eng. Regen. Med., 9, pp. 249-258; Leong, W.K., Henshall, T.L., Arthur, A., Kremer, K.L., Lewis, M.D., Helps, S.C., Field, J., Koblar, S.A., Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms (2012) Stem Cells Transl. Med., 1, pp. 177-187; Levkovitch-Verbin, H., Sadan, O., Vander, S., Rosner, M., Barhum, Y., Melamed, E., Offen, D., Melamed, S., Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection (2010) Invest. Ophthalmol. Vis. Sci., 51, pp. 6394-6400; Li, G.R., Deng, X.L., Sun, H., Chung, S.S., Tse, H.F., Lau, C.P., Ion channels in mesenchymal stem cells from rat bone marrow (2006) Stem Cells, 24, pp. 1519-1528; Liao, J.L., Yu, J., Huang, K., Hu, J., Diemer, T., Ma, Z., Dvash, T., Fan, G., Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells (2010) Hum. Mol. Genet., 19, pp. 4229-4238; Liu, B., Hunter, D.J., Rooker, S., Chan, A., Paulus, Y.M., Leucht, P., Nusse, Y., Helms, J.A., Wnt signaling promotes Muller cell proliferation and survival after injury (2013) Invest. Ophthalmol. Vis. Sci., 54, pp. 444-453; Logan, A., Ahmed, Z., Baird, A., Gonzalez, A.M., Berry, M., Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury (2006) Brain, 129, pp. 490-502; Lu, P., Jones, L.L., Snyder, E.Y., Tuszynski, M.H., Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury (2003) Exp. Neurol., 181, pp. 115-129; Lu, P., Blesch, A., Tuszynski, M.H., Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? (2004) J. Neurosci. Res., 77, pp. 174-191; Lu, P., Yang, H., Jones, L.L., Filbin, M.T., Tuszynski, M.H., Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury (2004) J. Neurosci., 24, pp. 6402-6409; Lu, B., Malcuit, C., Wang, S., Girman, S., Francis, P., Lemieux, L., Lanza, R., Lund, R., Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration (2009) Stem Cells, 27, pp. 2126-2135; Lu, B., Wang, S., Girman, S., McGill, T., Ragaglia, V., Lund, R., Human adult bone marrow-derived somatic cells rescue vision in a rodent model of retinal degeneration (2010) Exp. Eye Res., 91, pp. 449-455; Lu, P., Wang, Y., Graham, L., McHale, K., Gao, M., Wu, D., Brock, J., Tuszynski, M.H., Long-distance growth and connectivity of neural stem cells after severe spinal cord injury (2012) Cell, 150, pp. 1264-1273; Lu, B., Morgans, C.W., Girman, S., Luo, J., Zhao, J., Du, H., Lim, S., Wang, S., Neural stem cells derived by small molecules preserve vision (2013) Transl. Vis. Sci. Technol., 2, p. 1; Machalińska, A., Kawa, M., Pius-Sadowska, E., Stepniewski, J., Nowak, W., Rogińska, D., Kaczyńska, K., Machaliński, B., Long-term neuroprotective effects of NT-4-engineered mesenchymal stem cells injected intravitreally in a mouse model of acute retinal injury (2013) Invest. Ophthalmol. Vis. Sci., 54, pp. 8292-8305; Martin, P.J., Uberti, J.P., Soiffer, R.J., Klingemann, H., Waller, E.K., Daly, A., Herrmann, R.P., Kebriaei, P., Prochymal (R) improves response rates in patients with steroid-refractory acute graft-versus-host disease involving the liver and gut: results of a randomized, placebo-controlled, multicentre phase III trial in GvHD (2010) Bone Marrow Transplant., 45, p. S17; Martino, G., Pluchino, S., The therapeutic potential of neural stem cells (2006) Nat. Rev. Neurosci., 7, pp. 395-406; McGill, T.J., Cottam, B., Lu, B., Wang, S., Girman, S., Tian, C., Huhn, S.L., Capela, A., Transplantation of human central nervous system stem cells - neuroprotection in retinal degeneration (2012) Eur. J. Neurosci., 35, pp. 468-477; Mead, B., Logan, A., Berry, M., Leadbeater, W., Scheven, B.A., Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury (2013) Invest. Ophthalmol. Vis. Sci., 54, pp. 7544-7556; Mead, B., Logan, A., Berry, M., Leadbeater, W., Scheven, B.A., Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adipose-derived mesenchymal stem cells (2014) Plos One, 9, p. e109305; Mellough, C.B., Cui, Q., Spalding, K.L., Symons, N.A., Pollett, M.A., Snyder, E.Y., Macklis, J.D., Harvey, A.R., Fate of multipotent neural precursor cells transplanted into mouse retina selectively depleted of retinal ganglion cells (2004) Exp. Neurol., 186, pp. 6-19; Mendel, T.A., Clabough, E.B., Kao, D.S., Demidova-Rice, T.N., Durham, J.T., Zotter, B.C., Seaman, S.A., Yates, P.A., Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy (2013) Plos One, 8, p. e65691; Mey, J., Thanos, S., Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo (1993) Brain Res., 602, pp. 304-317; Meyer, J.S., Katz, M.L., Maruniak, J.A., Kirk, M.D., Embryonic stem cell-derived neural progenitors incorporate into degenerating retina and enhance survival of host photoreceptors (2006) Stem Cells, 24, pp. 274-283; Meyer, J.S., Shearer, R.L., Capowski, E.E., Wright, L.S., Wallace, K.A., McMillan, E.L., Zhang, S.C., Gamm, D.M., Modeling early retinal development with human embryonic and induced pluripotent stem cells (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 16698-16703; Morgan-Warren, P.J., Berry, M., Ahmed, Z., Scott, R.A., Logan, A., Exploiting mTOR signaling: a novel translatable treatment strategy for traumatic optic neuropathy? (2013) Invest. Ophthalmol. Vis. Sci., 54, pp. 6903-6916; Nakano, T., Ando, S., Takata, N., Kawada, M., Muguruma, K., Sekiguchi, K., Saito, K., Sasai, Y., Self-formation of optic cups and storable stratified neural retina from human ESCs (2012) Cell Stem Cell, 10, pp. 771-785; Neuhuber, B., Gallo, G., Howard, L., Kostura, L., Mackay, A., Fischer, I., Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype (2004) J. Neurosci. Res., 77, pp. 192-204; Nishida, A., Takahashi, M., Tanihara, H., Nakano, I., Takahashi, J.B., Mizoguchi, A., Ide, C., Honda, Y., Incorporation and differentiation of hippocampus-derived neural stem cells transplanted in injured adult rat retina (2000) Invest. Ophthalmol. Vis. Sci., 41, pp. 4268-4274; Nosrat, C.A., Fried, K., Lindskog, S., Olson, L., Cellular expression of neurotrophin mRNAs during tooth development (1997) Cell Tissue Res., 290, pp. 569-580; Nosrat, I.V., Widenfalk, J., Olson, L., Nosrat, C.A., Dental pulp cells produce neurotrophic factors, interact with trigeminal neurons in vitro, and rescue motoneurons after spinal cord injury (2001) Dev. Biol., 238, pp. 120-132; Ooto, S., Akagi, T., Kageyama, R., Akita, J., Mandai, M., Honda, Y., Takahashi, M., Potential for neural regeneration after neurotoxic injury in the adult mammalian retina (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 13654-13659; Osakada, F., Ooto, S., Akagi, T., Mandai, M., Akaike, A., Takahashi, M., Wnt signaling promotes regeneration in the retina of adult mammals (2007) J. Neurosci., 27, pp. 4210-4219; Osakada, F., Ikeda, H., Mandai, M., Wataya, T., Watanabe, K., Yoshimura, N., Akaike, A., Takahashi, M., Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells (2008) Nat. Biotechnol., 26, pp. 215-224; Osakada, F., Ikeda, H., Sasai, Y., Takahashi, M., Stepwise differentiation of pluripotent stem cells into retinal cells (2009) Nat. Protoc., 4, pp. 811-824; Osakada, F., Jin, Z.B., Hirami, Y., Ikeda, H., Danjyo, T., Watanabe, K., Sasai, Y., Takahashi, M., In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction (2009) J. Cell Sci., 122, pp. 3169-3179; Pakulska, M.M., Ballios, B.G., Shoichet, M.S., Injectable hydrogels for central nervous system therapy (2012) Biomed. Mater., 7, p. 024101; Park, K.K., Liu, K., Hu, Y., Smith, P.D., Wang, C., Cai, B., Xu, B., He, Z., Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway (2008) Science, 322, pp. 963-966; Park, S.S., Bauer, G., Abedi, M., Pontow, S., Panorgias, A., Jonnal, R., Zawadzki, R.J., Nolta, J., Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings (2015) Invest. Ophthalmol. Vis. Sci., 56, pp. 81-89; Pera, E.M., Wessely, O., Li, S.Y., De Robertis, E.M., Neural and head induction by insulin-like growth factor signals (2001) Dev. Cell, 1, pp. 655-665; Phillips, M.J., Wallace, K.A., Dickerson, S.J., Miller, M.J., Verhoeven, A.D., Martin, J.M., Wright, L.S., Gamm, D.M., Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses (2012) Invest. Ophthalmol. Vis. Sci., 53, pp. 2007-2019; Pierdomenico, L., Bonsi, L., Calvitti, M., Rondelli, D., Arpinati, M., Chirumbolo, G., Becchetti, E., Bagnara, G.P., Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp (2005) Transplantation, 80, pp. 836-842; Puissant, N., Barreau, C., Bourin, P., Clavel, C., Corre, J., Bousquet, C., Taureau, C., Blancher, A., Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells (2005) Brit. J. Haematol., 129, pp. 118-129; Pyle, A.D., Lock, L.F., Donovan, P.J., Neurotrophins mediate human embryonic stem cell survival (2006) Nat. Biotechnol., 24, pp. 344-350; Reichenbach, A., Bringmann, A., New functions of Muller cells (2013) Glia, 61, pp. 651-678; Reynolds, J., Lamba, D.A., Human embryonic stem cell applications for retinal degenerations (2013) Exp. Eye Res., 123, pp. 151-160; Richardson, P.M., McGuinness, U.M., Aguayo, A.J., Axons from CNS neurons regenerate into PNS grafts (1980) Nature, 284, pp. 264-265; Riess, P., Zhang, C., Saatman, K.E., Laurer, H.L., Longhi, L.G., Raghupathi, R., Lenzlinger, P.M., McIntosh, T.K., Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury (2002) Neurosurgery, 51, pp. 1043-1052. , (Discussion 1052-1044); Sakai, K., Yamamoto, A., Matsubara, K., Nakamura, S., Naruse, M., Yamagata, M., Sakamoto, K., Ueda, M., Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms (2012) J. Clin. Investig., 122, pp. 80-90; Salero, E., Blenkinsop, T.A., Corneo, B., Harris, A., Rabin, D., Stern, J.H., Temple, S., Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives (2012) Cell Stem Cell, 10, pp. 88-95; Sandvig, A., Berry, M., Barrett, L.B., Butt, A., Logan, A., Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration (2004) Glia, 46, pp. 225-251; Schwartz, S.D., Hubschman, J.P., Heilwell, G., Franco-Cardenas, V., Pan, C.K., Ostrick, R.M., Mickunas, E., Lanza, R., Embryonic stem cell trials for macular degeneration: a preliminary report (2012) Lancet, 379, pp. 713-720; Schwartz, S.D., Regillo, C.D., Lam, B.L., Eliott, D., Rosenfeld, P.J., Gregori, N.Z., Hubschman, J.P., Lanza, R., Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies (2014) Lancet; Sieving, P.A., Caruso, R.C., Tao, W., Coleman, H.R., Thompson, D.J., Fullmer, K.R., Bush, R.A., Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 3896-3901; Singer, N.G., Caplan, A.I., Mesenchymal stem cells: mechanisms of inflammation (2011) Annu. Rev. Pathol., 6, pp. 457-478; Singh, T., Prabhakar, S., Gupta, A., Anand, A., Recruitment of stem cells into the injured retina after laser injury (2012) Stem Cells Dev., 21, pp. 448-454; Siqueira, R.C., Messias, A., Voltarelli, J.C., Scott, I.U., Jorge, R., Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinaldystrophy: a phase I trial (2011) Retina, 31, pp. 1207-1214; Sofroniew, M.V., Howe, C.L., Mobley, W.C., Nerve growth factor signaling, neuroprotection, and neural repair (2001) Annu. Rev. Neurosci., 24, pp. 1217-1281; Sommerfeld, M.T., Schweigreiter, R., Barde, Y.A., Hoppe, E., Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB (2000) J. Biol. Chem., 275, pp. 8982-8990; Strauss, O., The retinal pigment epithelium in visual function (2005) Physiol. Rev., 85, pp. 845-881; Sugitani, S., Tsuruma, K., Ohno, Y., Kuse, Y., Yamauchi, M., Egashira, Y., Yoshimura, S., Hara, H., The potential neuroprotective effect of human adipose stem cells conditioned medium against light-induced retinal damage (2013) Exp. Eye Res., 116, pp. 254-264; Sun, F., Park, K.K., Belin, S., Wang, D., Lu, T., Chen, G., Zhang, K., He, Z., Sustained axon regeneration induced by co-deletion of PTEN and SOCS3 (2011) Nature, 480, pp. 372-375; Tamaki, Y., Nakahara, T., Ishikawa, H., Sato, S., In vitro analysis of mesenchymal stem cells derived from human teeth and bone marrow (2012) Odontology, 101 (2), pp. 121-132; Tropepe, V., Coles, B.L., Chiasson, B.J., Horsford, D.J., Elia, A.J., McInnes, R.R., van der Kooy, D., Retinal stem cells in the adult mammalian eye (2000) Science, 287, pp. 2032-2036; Tsuruma, K., Yamauchi, M., Sugitani, S., Otsuka, T., Ohno, Y., Nagahara, Y., Ikegame, Y., Hara, H., Progranulin, a major secreted protein of mouse adipose-derived stem cells, inhibits light-induced retinal degeneration (2014) Stem Cells Transl. Med., 3, pp. 42-53; Tucker, B.A., Park, I.H., Qi, S.D., Klassen, H.J., Jiang, C., Yao, J., Redenti, S., Young, M.J., Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice (2011) Plos One, 6, p. e18992; Tzameret, A., Sher, I., Belkin, M., Treves, A.J., Meir, A., Nagler, A., Levkovitch-Verbin, H., Rotenstreich, Y., Transplantation of human bone marrow mesenchymal stem cells as a thin subretinal layer ameliorates retinal degeneration in a rat model of retinal dystrophy (2014) Exp. Eye Res., 118, pp. 135-144; Vallières, L., Sawchenko, P.E., Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity (2003) J. Neurosci., 23, pp. 5197-5207; Vugler, A., Carr, A.J., Lawrence, J., Chen, L.L., Burrell, K., Wright, A., Lundh, P., Coffey, P., Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation (2008) Exp. Neurol., 214, pp. 347-361; Wang, H.C., Brown, J., Alayon, H., Stuck, B.E., Transplantation of quantum dot-labelled bone marrow-derived stem cells into the vitreous of mice with laser-induced retinal injury: survival, integration and differentiation (2010) Vis. Res., 50, pp. 665-673; West, E.L., Pearson, R.A., Tschernutter, M., Sowden, J.C., MacLaren, R.E., Ali, R.R., Pharmacological disruption of the outer limiting membrane leads to increased retinal integration of transplanted photoreceptor precursors (2008) Exp. Eye Res., 86, pp. 601-611; Wilkins, A., Kemp, K., Ginty, M., Hares, K., Mallam, E., Scolding, N., Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro (2009) Stem Cell Res., 3, pp. 63-70; Wilson, S.W., Houart, C., Early steps in the development of the forebrain (2004) Dev. Cell, 6, pp. 167-181; Wright, L.S., Phillips, M.J., Pinilla, I., Hei, D., Gamm, D.M., Induced pluripotent stem cells as custom therapeutics for retinal repair: progress and rationale (2014) Exp. Eye Res., 123, pp. 161-172; Xu, H., Sta Iglesia, D.D., Kielczewski, J.L., Valenta, D.F., Pease, M.E., Zack, D.J., Quigley, H.A., Characteristics of progenitor cells derived from adult ciliary body in mouse, rat, and human eyes (2007) Invest. Ophthalmol. Vis. Sci., 48, pp. 1674-1682; Yañez, R., Lamana, M.L., García-Castro, J., Colmenero, I., Ramírez, M., Bueren, J.A., Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease (2006) Stem Cells, 24, pp. 2582-2591; Ye, C.Q., Yuan, X.D., Liu, H., Cai, Y.A., Ou, Y., Ultrastructure of neuronal-like cells differentiated from adult adipose-derived stromal cells (2010) Neural. Regen. Res., 5, pp. 1456-1463; Yu, S., Tanabe, T., Dezawa, M., Ishikawa, H., Yoshimura, N., Effects of bone marrow stromal cell injection in an experimental glaucoma model (2006) Biochem. Biophys. Res. Commun., 344, pp. 1071-1079; Yu, H., Vu, T.H., Cho, K.S., Guo, C., Chen, D.F., Mobilizing endogenous stem cells for retinal repair (2014) Transl. Res., 163, pp. 387-398; Zhang, Y., Wang, W., Effects of bone marrow mesenchymal stem cell transplantation on light-damaged retina (2010) Invest. Ophthalmol. Vis. Sci., 51, pp. 3742-3748; Zhang, R., Zhang, H., Xu, L., Ma, K., Wallrapp, C., Jonas, J.B., Neuroprotective effect of intravitreal cell-based glucagon-like peptide-1 production in the optic nerve crush model (2011) Acta Ophthalmol., 89, pp. e320-e326; Zhou, Z., Chen, Y., Zhang, H., Min, S., Yu, B., He, B., Jin, A., Comparison of mesenchymal stem cells from human bone marrow and adipose tissue for the treatment of spinal cord injury (2013) Cytotherapy, 15 (4), pp. 434-448; Zwart, I., Hill, A.J., Al-Allaf, F., Shah, M., Girdlestone, J., Sanusi, A.B., Mehmet, H., Jen, L.S., Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model (2009) Exp. Neurol., 216, pp. 439-448",Review,Scopus,2-s2.0-84924267865
"Wiedenmann T., Ehrhardt S., Cerny D., Hildebrand D., Klein S., Heeg K., Kubatzky K.F.","Erythropoietin acts as an anti-inflammatory signal on murine mast cells",2015,"Molecular Immunology","65","1",,"68","76",,,10.1016/j.molimm.2015.01.011,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84921832204&partnerID=40&md5=7d5cd92e7b153cf96312c26824a6b41e","Universitätsklinikum Heidelberg, Zentrum für Infektiologie, Medizinische Mikrobiologie und Hygiene, Germany","Wiedenmann, T., Universitätsklinikum Heidelberg, Zentrum für Infektiologie, Medizinische Mikrobiologie und Hygiene, Germany; Ehrhardt, S., Universitätsklinikum Heidelberg, Zentrum für Infektiologie, Medizinische Mikrobiologie und Hygiene, Germany; Cerny, D., Universitätsklinikum Heidelberg, Zentrum für Infektiologie, Medizinische Mikrobiologie und Hygiene, Germany; Hildebrand, D., Universitätsklinikum Heidelberg, Zentrum für Infektiologie, Medizinische Mikrobiologie und Hygiene, Germany; Klein, S., Universitätsklinikum Heidelberg, Zentrum für Infektiologie, Medizinische Mikrobiologie und Hygiene, Germany; Heeg, K., Universitätsklinikum Heidelberg, Zentrum für Infektiologie, Medizinische Mikrobiologie und Hygiene, Germany; Kubatzky, K.F., Universitätsklinikum Heidelberg, Zentrum für Infektiologie, Medizinische Mikrobiologie und Hygiene, Germany","Recently it was found that the erythropoietin receptor (EpoR) is expressed on innate immune cells, such as dendritic cells and macrophages. We found that murine bone marrow-derived mast cells express the EpoR and that its expression is increased under hypoxic conditions. Interestingly, Epo stimulation of the cells did not activate signal transducer and activator of transcription molecules, nor did we find differences in the expression of typical STAT-dependent genes, the proliferation rate, and the ability to differentiate or to protect the cells from apoptosis. Instead, we demonstrate that stimulation of mast cells with Epo leads to phosphorylation of the receptor tyrosine kinase c-kit. We hypothesize that this is due to the formation of a receptor complex between the EpoR and c-kit. The common beta chain of the IL-3 receptor family, which was described as part of the tissue protective receptor (TPR) on other non-erythroid cells, however is not activated. To investigate whether the EpoR/c-kit complex has tissue protective properties, cells were treated with the Toll-like receptor ligand LPS. Combined Epo and LPS treatment downregulated the inflammatory response of the cells as detected by a decrease in IL-6 and TNF-α secretion. © 2015 Elsevier Ltd.","Bone marrow-derived mast cells; Erythropoietin; Hypoxia; Pro-inflammatory cytokines; Stem cell factor receptor; Toll-like receptor","Arcasoy, M.O., Non-erythroid effects of erythropoietin (2010) Haematologica, 95, pp. 1803-1805; Baynes, R.D., Reddy, G.K., Shih, Y.J., Skikne, B.S., Cook, J.D., Serum form of the erythropoietin receptor identified by a sequence-specific peptide antibody (1993) Blood, 82, pp. 2088-2095; Bittorf, T., Seiler, J., Ludtke, B., Buchse, T., Jaster, R., Brock, J., Activation of STAT5 during EPO-directed suppression of apoptosis (2000) Cell. Signal., 12, pp. 23-30; Blake, T.J., Jenkins, B.J., D'Andrea, R.J., Gonda, T.J., Functional cross-talk between cytokine receptors revealed by activating mutations in the extracellular domain of the beta-subunit of the GM-CSF receptor (2002) J. Leukoc. Biol., 72, pp. 1246-1255; Brines, M., Cerami, A., Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response (2008) J. Intern. Med., 264, pp. 405-432; Brines, M., Cerami, A., The receptor that tames the innate immune response (2012) Mol. Med., 18, pp. 486-496; Brines, M., Cerami, A., Erythropoietin and engineered innate repair activators (2013) Methods Mol. Biol., 982, pp. 1-12; Brines, M., Grasso, G., Fiordaliso, F., Sfacteria, A., Ghezzi, P., Fratelli, M., Latini, R., Cerami, A., Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 14907-14912; Broudy, V.C., Lin, N.L., Buhring, H.J., Komatsu, N., Kavanagh, T.J., Analysis of c-kit receptor dimerization by fluorescence resonance energy transfer (1998) Blood, 91, pp. 898-906; Byts, N., Siren, A.L., Erythropoietin: a multimodal neuroprotective agent (2009) Exp. Transl. Stroke Med., 1, p. 4; Chateauvieux, S., Grigorakaki, C., Morceau, F., Dicato, M., Diederich, M., Erythropoietin, erythropoiesis and beyond (2011) Biochem. Pharmacol., 82, pp. 1291-1303; Chin, H., Wakao, H., Miyajima, A., Kamiyama, R., Miyasaka, N., Miura, O., Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3 (1997) Blood, 89, pp. 4327-4336; Constantinescu, S.N., Ghaffari, S., Lodish, H.F., The erythropoietin receptor: structure, activation and intracellular signal transduction (1999) Trends Endocrinol. Metab., 10, pp. 18-23; Elliott, S., Sinclair, A., Collins, H., Rice, L., Jelkmann, W., Progress in detecting cell-surface protein receptors: the erythropoietin receptor example (2014) Ann. Hematol., 93, pp. 181-192; Erickson-Miller, C.L., Pelus, L.M., Lord, K.A., Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation (2000) Stem Cells, 18, pp. 366-373; Hanazono, Y., Sasaki, K., Nitta, H., Yazaki, Y., Hirai, H., Erythropoietin induces tyrosine phosphorylation of the beta chain of the GM-CSF receptor (1995) Biochem. Biophys. Res. Commun., 208, pp. 1060-1066; Hellewell, S.C., Yan, E.B., Alwis, D.S., Bye, N., Morganti-Kossmann, M.C., Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor (2013) J. Neuroinflamm., 10, p. 156; Huang, H., Li, Y., Mechanisms controlling mast cell and basophil lineage decisions (2014) Curr. Allergy Asthma Rep., 14, p. 457; Huang, L.J., Constantinescu, S.N., Lodish, H.F., The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor (2001) Mol. Cell, 8, pp. 1327-1338; Isogai, R., Takahashi, M., Aisu, K., Horiuti, Y., Aragane, Y., Kawada, A., Tezuka, T., The receptor for erythropoietin is present on cutaneous mast cells (2006) Arch. Dermatol. Res., 297, pp. 389-394; Jacobs-Helber, S.M., Penta, K., Sun, Z., Lawson, A., Sawyer, S.T., Distinct signaling from stem cell factor and erythropoietin in HCD57 cells (1997) J. Biol. Chem., 272, pp. 6850-6853; Jegalian, A.G., Wu, H., Differential roles of SOCS family members in EpoR signal transduction (2002) J. Interferon Cytokine Res., 22, pp. 853-860; Jelkmann, W., Physiology and pharmacology of erythropoietin (2013) Transfus. Med. Hemother., 40, pp. 302-309; Jubinsky, P.T., Krijanovski, O.I., Nathan, D.G., Tavernier, J., Sieff, C.A., The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor (1997) Blood, 90, pp. 1867-1873; Karasuyama, H., Melchers, F., Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors (1988) Eur. J. Immunol., 18, pp. 97-104; Krantz, S.B., Erythropoietin (1991) Blood, 77, pp. 419-434; Kumral, A., Baskin, H., Yesilirmak, D.C., Ergur, B.U., Aykan, S., Genc, S., Genc, K., Ozkan, H., Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain (2007) Neonatology, 92, pp. 269-278; Lifshitz, L., Prutchi-Sagiv, S., Avneon, M., Gassmann, M., Mittelman, M., Neumann, D., Non-erythroid activities of erythropoietin: functional effects on murine dendritic cells (2009) Mol. Immunol., 46, pp. 713-721; Lifshitz, L., Tabak, G., Gassmann, M., Mittelman, M., Neumann, D., Macrophages as novel target cells for erythropoietin (2010) Haematologica, 95, pp. 1823-1831; Lin, C.S., Lim, S.K., D'Agati, V., Costantini, F., Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis (1996) Genes Dev., 10, pp. 154-164; Lisowska, K.A., Debska-Slizien, A., Bryl, E., Rutkowski, B., Witkowski, J.M., Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment (2010) Artif. Organs, 34, pp. 654-662; Luo, B., Jiang, M., Yang, X., Zhang, Z., Xiong, J., Schluesener, H.J., Zhang, Z., Wu, Y., Erythropoietin is a hypoxia inducible factor-induced protective molecule in experimental autoimmune neuritis (2013) Biochim. Biophys. Acta, 1832, pp. 1260-1270; Lutz, M.B., Kukutsch, N., Ogilvie, A.L., Rossner, S., Koch, F., Romani, N., Schuler, G., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow (1999) J. Immunol. Methods, 223, pp. 77-92; Masuda, S., Nagao, M., Takahata, K., Konishi, Y., Gallyas, F., Tabira, T., Sasaki, R., Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells (1993) J. Biol. Chem., 268, pp. 11208-11216; Mitra, A., Bansal, S., Wang, W., Falk, S., Zolty, E., Schrier, R.W., Erythropoietin ameliorates renal dysfunction during endotoxaemia (2007) Nephrol. Dial. Transpl., 22, pp. 2349-2353; Motoyama, N., Kimura, T., Takahashi, T., Watanabe, T., Nakano, T., Bcl-x prevents apoptotic cell death of both primitive and definitive erythrocytes at the end of maturation (1999) J. Exp. Med., 189, pp. 1691-1698; Munugalavadla, V., Kapur, R., Role of c-Kit and erythropoietin receptor in erythropoiesis (2005) Crit. Rev. Oncol. Hematol., 54, pp. 63-75; Nairz, M., Schroll, A., Moschen, A.R., Sonnweber, T., Theurl, M., Theurl, I., Taub, N., Weiss, G., Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways (2011) Immunity, 34, pp. 61-74; Nairz, M., Sonnweber, T., Schroll, A., Theurl, I., Weiss, G., The pleiotropic effects of erythropoietin in infection and inflammation (2012) Microbes Infect., 14, pp. 238-246; Ogunshola, O.O., Bogdanova, A.Y., Erythropoietin and engineered innate repair activators (2013) Methods Mol. Biol., 982, pp. 13-42; Prutchi Sagiv, S., Lifshitz, L., Orkin, R., Mittelman, M., Neumann, D., Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator? (2008) Exp. Hematol., 36, pp. 1682-1690; Ray, P., Krishnamoorthy, N., Oriss, T.B., Ray, A., Signaling of c-kit in dendritic cells influences adaptive immunity (2010) Ann. N.Y. Acad. Sci., 1183, pp. 104-122; Ribatti, D., Crivellato, E., Nico, B., Guidolin, D., Gassmann, M., Djonov, V., Mast cells and macrophages in duodenal mucosa of mice overexpressing erythropoietin (2009) J. Anat., 215, pp. 548-554; Rich, I.N., Heit, W., Kubanek, B., Extrarenal erythropoietin production by macrophages (1982) Blood, 60, pp. 1007-1018; Rocchetta, F., Solini, S., Mister, M., Mele, C., Cassis, P., Noris, M., Remuzzi, G., Aiello, S., Erythropoietin enhances immunostimulatory properties of immature dendritic cells (2011) Clin. Exp. Immunol., 165, pp. 202-210; Scott, C.L., Robb, L., Papaevangeliou, B., Mansfield, R., Nicola, N.A., Begley, C.G., Reassessment of interactions between hematopoietic receptors using common beta-chain and interleukin-3-specific receptor beta-chain-null cells: no evidence of functional interactions with receptors for erythropoietin, granulocyte colony-stimulating factor, or stem cell factor (2000) Blood, 96, pp. 1588-1590; Shurtz-Swirski, R., Kristal, B., Shasha, S.M., Shapiro, G., Geron, R., Sela, S., Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in continuous ambulatory dialysis patients (2002) Nephron, 91, pp. 759-761; von Lindern, M., Schmidt, U., Beug, H., Control of erythropoiesis by erythropoietin and stem cell factor: a novel role for Bruton's tyrosine kinase (2004) Cell Cycle, 3, pp. 876-879; Wu, H., Klingmuller, U., Acurio, A., Hsiao, J.G., Lodish, H.F., Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation (1997) Proc. Natl. Acad. Sci. U. S. A., 94, pp. 1806-1810; Wu, H., Klingmuller, U., Besmer, P., Lodish, H.F., Interaction of the erythropoietin and stem-cell-factor receptors (1995) Nature, 377, pp. 242-246; Wu, H., Liu, X., Jaenisch, R., Lodish, H.F., Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor (1995) Cell, 83, pp. 59-67",Article,Scopus,2-s2.0-84921832204
"Karabon L., Markiewicz M., Kosmaczewska A., Partyka A., Pawlak-Adamska E., Tomkiewicz A., Ciszak L., Jagoda K., Dzierzak-Mietla M., Kyrcz-Krzemien S., Frydecka I.","Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation",2015,"Immunology Letters","165","1",,"52","59",,,10.1016/j.imlet.2015.03.011,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927557337&partnerID=40&md5=f07f44749fba63c402ecb8287706090b","Department of Experimental Therapy, L. Hirszfeld Institute of Immunology and Experimental Therapy, R Weigl St 12Wroclaw, Poland; Department and Clinic of Urology, Wroclaw Medical University, Borowska St 213Wroclaw, Poland; School of Medicine in Katowice, Medical University of Silesia, Dabrowskiego St 25Katowice, Poland","Karabon, L., Department of Experimental Therapy, L. Hirszfeld Institute of Immunology and Experimental Therapy, R Weigl St 12Wroclaw, Poland, Department and Clinic of Urology, Wroclaw Medical University, Borowska St 213Wroclaw, Poland; Markiewicz, M., School of Medicine in Katowice, Medical University of Silesia, Dabrowskiego St 25Katowice, Poland; Kosmaczewska, A., Department of Experimental Therapy, L. Hirszfeld Institute of Immunology and Experimental Therapy, R Weigl St 12Wroclaw, Poland; Partyka, A., Department of Experimental Therapy, L. Hirszfeld Institute of Immunology and Experimental Therapy, R Weigl St 12Wroclaw, Poland; Pawlak-Adamska, E., Department of Experimental Therapy, L. Hirszfeld Institute of Immunology and Experimental Therapy, R Weigl St 12Wroclaw, Poland; Tomkiewicz, A., Department of Experimental Therapy, L. Hirszfeld Institute of Immunology and Experimental Therapy, R Weigl St 12Wroclaw, Poland; Ciszak, L., Department of Experimental Therapy, L. Hirszfeld Institute of Immunology and Experimental Therapy, R Weigl St 12Wroclaw, Poland; Jagoda, K., School of Medicine in Katowice, Medical University of Silesia, Dabrowskiego St 25Katowice, Poland; Dzierzak-Mietla, M., School of Medicine in Katowice, Medical University of Silesia, Dabrowskiego St 25Katowice, Poland; Kyrcz-Krzemien, S., School of Medicine in Katowice, Medical University of Silesia, Dabrowskiego St 25Katowice, Poland; Frydecka, I., Department of Experimental Therapy, L. Hirszfeld Institute of Immunology and Experimental Therapy, R Weigl St 12Wroclaw, Poland","Background: Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an inhibitory T cells' receptor essential for maintaining T cell homeostasis and immunotolerance. The role of the co-stimulatory pathway in development of aGvHD has been studied mostly in animal models. To the best of our knowledge, there are no published data on the role of CTLA-4 in pathogenesis of aGvHD after hematopoietic stem cell transplantation (HSCT) in humans. Therefore the aim of our study was to determine the association of CTLA-4 mRNA and proteins level in HSCT donor-recipient pairs, prior to and after HSCT, with aGvHD risk. Methods: Total CTLA-4 mRNA level in 51 donor-recipient pairs prior to and 56 days after HSCT was determined using real time PCR techniques, while membrane (m) and cytoplasmic (c) CTLA-4 expression in CD3+ cells were measured by flow cytometry in 40 donor-recipient pairs at the same time points. Results: We found an association between the risk of aGvHD and high pre-transplant CTLA-4 mRNA expression level both in recipients and in donors, stronger in recipients (OR = 2.02, CI95% 1.39-3.01), and less pronounced in donors (OR = 1.57, CI95% 1.18-2.0). Moreover, we showed that proportion of CD3+ cells positive for mCTLA-4 in recipients prior to HSCT positively correlated with increased risk of aGvHD (OR = 1.175, CI95% 1.024-1.311, p = 0.018). Conclusion: Our results indicate that both donor and recipient CTLA-4 mRNA as well as recipient membrane protein expression levels measured before transplantation may be considered as prognostic factors for aGvHD development. © 2015.","Acute graft vs host disease; CTLA-4; Hematopoietic stem cell transplantation; MRNA expression level; Protein expression level","Ferrara, J.L., Advances in the clinical management of GVHD (2008) Best Pract. Res. Clin. Haematol., 21, pp. 677-682; Frauwirth, K.A., Thompson, C.B., Activation and inhibition of lymphocytes by costimulation (2002) J. Clin. Invest., 109, pp. 295-299; Walunas, T.L., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Green, J.M., CTLA-4 can function as a negative regulator of T cell activation (1994) Immunity, 1, pp. 405-413; Valk, E., Rudd, C.E., Schneider, H., CTLA-4 trafficking and surface expression (2008) Trends Immunol., 29, pp. 272-279; Li, J., Semple, K., Suh, W.K., Liu, C., Chen, F., Blazar, B.R., Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice (2011) Biol. Blood Marrow Transplant., 17, pp. 962-969; Blazar, B.R., Taylor, P.A., Panoskaltsis-Mortari, A., Sharpe, A.H., Vallera, D.A., Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells (1999) J. Immunol., 162, pp. 6368-6377; Yu, X.Z., Albert, M.H., Martin, P.J., Anasetti, C., CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens (2004) J. Clin. Invest., 113, pp. 1624-1630; Kurtz, J., Raval, F., Vallot, C., Der, J., Sykes, M., CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance (2009) Blood, 113, pp. 3475-3484; Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J., 1994 consensus conference on acute GVHD grading (1995) Bone Marrow Transplant., 15, pp. 825-828; Kosmaczewska, A., Bocko, D., Ciszak, L., Wlodarska-Polinska, I., Kornafel, J., Szteblich, A., Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progression (2012) Pathol. Oncol. Res., 18, pp. 479-489; Chomczynski, P., A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples (1993) Biotechniques, 15, pp. 532-537; Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method (2001) Methods, 25, pp. 402-408; Rousseeuw, P.J., Croux, C., Alternatives to the median absolute deviation (1993) JASA, 88, pp. 1273-1283; Efron, B., Bootstrap methods: another look at the jackknife (1979) Ann. Statist., 7, pp. 1-26; Fuji, S., Kim, S.W., Fukuda, T., Mori, S., Yamasaki, S., Morita-Hoshi, Y., Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation (2008) Biol. Blood Marrow Transplant., 14, pp. 510-517; Jordan, W.J., Brookes, P.A., Szydlo, R.M., Goldman, J.M., Lechler, R.I., Ritter, M.A., IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantation (2004) Blood, 103, pp. 717-724; Magenau, J.M., Qin, X., Tawara, I., Rogers, C.E., Kitko, C., Schlough, M., Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease (2010) Biol. Blood Marrow Transplant., 16, pp. 907-914; Jordan, K.K., Christensen, I.J., Heilmann, C., Sengelov, H., Muller, K.G., Pretransplant C-reactive protein as a prognostic marker in allogeneic stem cell transplantation (2013) Scand. J. Immunol.; Kataoka, K., Nannya, Y., Hangaishi, A., Imai, Y., Chiba, S., Takahashi, T., Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation (2009) Biol. Blood Marrow Transplant., 15, pp. 195-204; Lv, M., Ye, H.G., Zhao, X.S., Zhao, X.Y., Chang, Y.J., Liu, D.H., Ceruloplasmin is a potential biomarker for aGvHD following allogeneic hematopoietic stem cell transplantation (2013) PLOS ONE, 8, p. e58735; Wierzbicka, D., Gromadzka, G., Ceruloplasmin, hephaestin and zyklopen: the three multicopper oxidases important for human iron metabolism (2014) Postepy. Hig. Med. Dosw., 68, pp. 912-924; Cuzzola, M., Fiasche, M., Iacopino, P., Messina, G., Martino, M., Console, G., A molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host disease (2012) Haematologica, 97, pp. 1532-1538; Kosmaczewska, A., Bilinska, M., Ciszak, L., Noga, L., Pawlak, E., Szteblich, A., Different patterns of activation markers expression and CD4+ T-cell responses to ex vivo stimulation in patients with clinically quiescent multiple sclerosis (MS) (2007) J. Neuroimmunol., 189, pp. 137-146; Fowler, D.H., Foley, J., Whit-Shan, H.J., Odom, J., Castro, K., Steinberg, S.M., Clinical cytokine storm as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease (2004) Clin. Gastroenterol. Hepatol., 2, pp. 237-245; Symington, F.W., Symington, B.E., Liu, P.Y., Viguet, H., Santhanam, U., Sehgal, P.B., The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation (1992) Transplantation, 54, pp. 457-462; Antin, J.H., Ferrara, J.L., Cytokine dysregulation and acute graft-versus-host disease (1992) Blood, 80, pp. 2964-2968",Article,Scopus,2-s2.0-84927557337
"Rinaldi L., Benitah S.A.","Epigenetic regulation of adult stem cell function",2015,"FEBS Journal","282","9",,"1589","1604",,1,10.1111/febs.12946,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928550323&partnerID=40&md5=09b5293dfb01fce27309e514e5223842","Centre for Genomic RegulationBarcelona, Spain; Universitat Pompeu FabraBarcelona, Spain; Institute for Research in Biomedicine (IRB Barcelona), C/ Baldiri Reixac 10Barcelona, Spain; Catalan Institution for Research and Advanced StudiesBarcelona, Spain","Rinaldi, L., Centre for Genomic RegulationBarcelona, Spain, Universitat Pompeu FabraBarcelona, Spain, Institute for Research in Biomedicine (IRB Barcelona), C/ Baldiri Reixac 10Barcelona, Spain; Benitah, S.A., Institute for Research in Biomedicine (IRB Barcelona), C/ Baldiri Reixac 10Barcelona, Spain, Catalan Institution for Research and Advanced StudiesBarcelona, Spain","Understanding the cellular and molecular mechanisms that specify cell lineages throughout development, and that maintain tissue homeostasis during adulthood, is paramount towards our understanding of why we age or develop pathologies such as cancer. Epigenetic mechanisms ensure that genetically identical cells acquire different fates during embryonic development and are therefore essential for the proper progression of development. How they do so is still a matter of intense investigation, but there is sufficient evidence indicating that they act in a concerted manner with inductive signals and tissue-specific transcription factors to promote and stabilize fate changes along the three germ layers during development. In consequence, it is generally hypothesized that epigenetic mechanisms are also required for the continuous maintenance of cell fate during adulthood. However, in vivo models in which different epigenetic factors have been depleted in different tissues do not show overt changes in cell lineage, thus not strongly supporting this view. Instead, the function of some of these factors appears to be primarily associated with tissue functionality, and a strong causal relationship has been established between their misregulation and a diseased state. In this review, we summarize our current knowledge of the role of epigenetic factors in adult stem cell function and tissue homeostasis. Epigenetic mechanisms ensure that lineages are acquired during development. It is therefore hypothesized that they also maintain cell fates during adulthood. However, perturbation of epigenetic factors in adult tissues affects homeostasis instead of eliciting overt changes in cell identity. Here, we summarize current knowledge of the role of epigenetic factors in adult stem cells and homeostasis. © 2014 FEBS.","adult stem cells; ageing and cancer; epigenetic regulators; lineage commitment; tissue homeostasis","Blanpain, C., Simons, B.D., Unravelling stem cell dynamics by lineage tracing (2013) Nat Rev Mol Cell Biol, 14, pp. 489-502; Li, L., Clevers, H., Coexistence of quiescent and active adult stem cells in mammals (2010) Science, 327, pp. 542-545; Solanas, G., Benitah, S.A., Regenerating the skin: a task for the heterogeneous stem cell pool and surrounding niche (2013) Nat Rev Mol Cell Biol, 14, pp. 737-748; Rios, A.C., Fu, N.Y., Lindeman, G.J., Visvader, J.E., In situ identification of bipotent stem cells in the mammary gland (2015) Nature, 506, pp. 322-327; Doucet, Y.S., Woo, S.-H., Ruiz, M.E., Owens, D.M., The Touch dome defines an epidermal niche specialized for mechanosensory signaling (2013) Cell Rep, 3, pp. 1759-1765; Van Keymeulen, A., Rocha, A.S., Ousset, M., Beck, B., Bouvencourt, G., Rock, J., Sharma, N., Blanpain, C., Distinct stem cells contribute to mammary gland development and maintenance (2012) Nature, 479, pp. 189-193; Gage, F.H., Temple, S., Perspective (2013) Neuron, 80, pp. 588-601; Bernstein, B.E., Meissner, A., Lander, E.S., The mammalian epigenome (2007) Cell, 128, pp. 669-681; Sauvageau, M., Sauvageau, G., Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer (2010) Cell Stem Cell, 7, pp. 299-313; Luis, N.M., Morey, L., Di Croce, L., Benitah, S.A., Polycomb in stem cells: PRC1 branches out (2012) Cell Stem Cell, 11, pp. 16-21; Richly, H., Aloia, L., Di Croce, L., Roles of the polycomb group proteins in stem cells and cancer (2011) Cell Death Dis, 2, pp. e204-e207; Schwartz, Y.B., Pirrotta, V., Polycomb silencing mechanisms and the management of genomic programmes (2007) Nat Rev Genet, 8, pp. 9-22; Surface, L.E., Thornton, S.R., Boyer, L.A., Polycomb group proteins set the stage for early lineage commitment (2010) Cell Stem Cell, 7, pp. 288-298; Aloia, L., Di Stefano, B., Sessa, A., Morey, L., Santanach, A., Gutierrez, A., Cozzuto, L., Broccoli, V., Zrf1 is required to establish and maintain neural progenitor identity (2014) Genes Dev, 28, pp. 182-197; Simon, J.A., Kingston, R.E., Occupying chromatin: polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put (2013) Mol Cell, 49, pp. 808-824; Blackledge, N.P., Farcas, A.M., Kondo, T., King, H.W., McGouran, J.F., Hanssen, L.L.P., Ito, S., Koseki, Y., Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation (2014) Cell, 157, pp. 1445-1459; Morey, L., Pascual, G., Cozzuto, L., Roma, G., Wutz, A., Benitah, S.A., Di Croce, L., Nonoverlapping functions of the polycomb group Cbx family of proteins in embryonic stem cells (2012) Cell Stem Cell, 10, pp. 47-62; Morey, L., Aloia, L., Cozzuto, L., Benitah, S.A., Di Croce, L., RYBP and Cbx7 define specific biological functions of polycomb complexes in mouse embryonic stem cells (2013) Cell Rep, 3, pp. 60-69; O'Loghlen, A., Muñoz-Cabello, A.M., Gaspar-Maia, A., Wu, H.-A., Banito, A., Kunowska, N., Racek, T., Lavial, F., MicroRNA regulation of Cbx7 mediates a switch of polycomb orthologs during ESC differentiation (2012) Cell Stem Cell, 10, pp. 33-46; Cooper, S., Dienstbier, M., Hassan, R., Schermelleh, L., Sharif, J., Blackledge, N.P., De Marco, V., Klose, R., Targeting polycomb to pericentric heterochromatin in embryonic stem cells reveals a role for H2AK119u1 in PRC2 recruitment (2014) Cell Rep, 7, pp. 1456-1470; Mousavi, K., Zare, H., Wang, A.H., Sartorelli, V., Polycomb protein Ezh1 promotes RNA polymerase II elongation (2012) Mol Cell, 45, pp. 255-262; Wen, B., Wu, H., Shinkai, Y., Irizarry, R.A., Feinberg, A.P., Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells (2009) Nat Genet, 41, pp. 246-250; Tachibana, M., G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis (2002) Genes Dev, 16, pp. 1779-1791; Schuettengruber, B., Martinez, A.-M., Iovino, N., Cavalli, G., Trithorax group proteins: switching genes on and keeping them active (2011) Nat Rev Mol Cell Biol, 12, pp. 799-814; Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S.A., Flynn, R.A., Wysocka, J., A unique chromatin signature uncovers early developmental enhancers in humans (2012) Nature, 470, pp. 279-283; McMahon, K.A., Hiew, S.Y.L., Hadjur, S., Veiga-Fernandes, H., Menzel, U., Price, A.J., Kioussis, D., Brady, H.J.M., MLL has a critical role in fetal and adult hematopoietic stem cell self-renewal (2007) Cell Stem Cell, 1, pp. 338-345; Wu, S.C., Zhang, Y., Active DNA demethylation: many roads lead to Rome (2010) Nat Rev Mol Cell Biol, 11, pp. 607-620; Wu, H., Zhang, Y., Reversing DNA methylation: mechanisms, genomics, and biological functions (2014) Cell, 156, pp. 45-68; Seisenberger, S., Andrews, S., Krueger, F., Arand, J., Walter, J., Santos, F., Popp, C., Reik, W., The dynamics of genome-wide DNA methylation reprogramming in mouse primordial germ cells (2012) Mol Cell, 48, pp. 849-862; Watanabe, D., Suetake, I., Tada, T., Tajima, S., Stage- and cell-specific expression of Dnmt3a and Dnmt3b during embryogenesis (2002) Mech Dev, 118, pp. 187-190; Okano, M., Bell, D.W., Haber, D.A., Li, E., DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development (1999) Cell, 99, pp. 247-257; Neri, F., Krepelova, A., Incarnato, D., Maldotti, M., Parlato, C., Galvagni, F., Matarese, F., Oliviero, S., Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs (2013) Cell, 155, pp. 121-134; Blasco, M.A., The epigenetic regulation of mammalian telomeres (2007) Nat Rev Genet, 8, pp. 299-309; Gonzalo, S., Jaco, I., Fraga, M.F., Chen, T., Li, E., Esteller, M., Blasco, M.A., DNA methyltransferases control telomere length and telomere recombination in mammalian cells (2006) Nat Cell Biol, 8, pp. 416-424; Bird, A., DNA methylation patterns and epigenetic memory (2002) Genes Dev, 16, pp. 6-21; Bock, C., Beerman, I., Lien, W.-H., Smith, Z.D., Gu, H., Boyle, P., Gnirke, A., Meissner, A., DNA methylation dynamics during in vivo differentiation of blood and skin stem cells (2012) Mol Cell, 47, pp. 633-647; Kaaij, L.T., Van De Wetering, M., Fang, F., Decato, B., Molaro, A., Van De Werken, H.J., Van Es, J.H., De Laat, W., DNA methylation dynamics during intestinal stem cell differentiation reveals enhancers driving gene expression in the villus (2013) Genome Biol, 14, p. R50; Sharif, J., Muto, M., Takebayashi, S.-I., Suetake, I., Iwamatsu, A., Endo, T.A., Shinga, J., Okamura, K., The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA (2007) Nature, 450, pp. 908-912; Bostick, M., Kim, J.K., Esteve, P.-O., Clark, A., Pradhan, S., Jacobsen, S.E., UHRF1 plays a role in maintaining DNA methylation in mammalian cells (2007) Science, 317, pp. 1760-1764; Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Aravind, L., Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 (2009) Science, 324, pp. 930-935; Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Vanderwinden, J.-M., The polycomb group protein EZH2 directly controls DNA methylation (2005) Nature, 439, pp. 871-874; Li, E., Bestor, T.H., Jaenisch, R., Targeted mutation of the DNA methyltransferase gene results in embryonic lethality (1992) Cell, 69, pp. 915-926; Hnisz, D., Abraham, B.J., Lee, T.I., Lau, A., Saint-André, V., Sigova, A.A., Hoke, H.A., Young, R.A., Super-enhancers in the control of cell identity and disease (2013) Cell, 155, pp. 934-947; Whyte, W.A., Orlando, D.A., Hnisz, D., Abraham, B.J., Lin, C.Y., Kagey, M.H., Rahl, P.B., Young, R.A., Master transcription factors and mediator establish super-enhancers at key cell identity genes (2013) Cell, 153, pp. 307-319; Heintzman, N.D., Stuart, R.K., Hon, G., Fu, Y., Ching, C.W., Hawkins, R.D., Barrera, L.O., Ching, K.A., Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome (2007) Nat Genet, 39, pp. 311-318; Hon, G.C., Rajagopal, N., Shen, Y., McCleary, D.F., Yue, F., Dang, M.D., Ren, B., Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues (2013) Nat Genet, 45, pp. 1198-1206; Plank, J.L., Dean, A., Enhancer function: mechanistic and genome-wide insights come together (2014) Mol Cell, 55, pp. 5-14; Wilson, A., Trumpp, A., Bone-marrow haematopoietic-stem-cell niches (2006) Nat Rev Immunol, 6, pp. 93-106; Yang, L., Identification of Lin-Sca1 + kit+CD34 + Flt3 - short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients (2005) Blood, 105, pp. 2717-2723; Ding, X., Lin, Q., Ensenat-Waser, R., Rose-John, S., Zenke, M., Polycomb group protein Bmi1 promotes hematopoietic cell development from embryonic stem cells (2012) Stem Cells Dev, 21, pp. 121-132; Oguro, H., Iwama, A., Morita, Y., Kamijo, T., Van Lohuizen, M., Nakauchi, H., Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice (2006) J Exp Med, 203, pp. 2247-2253; Majewski, I.J., Ritchie, M.E., Phipson, B., Corbin, J., Pakusch, M., Ebert, A., Busslinger, M., Smyth, G.K., Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells (2010) Blood, 116, pp. 731-739; Lessard, J., Sauvageau, G., Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells (2003) Nature, 423, pp. 255-260; Oguro, H., Yuan, J., Ichikawa, H., Ikawa, T., Yamazaki, S., Kawamoto, H., Nakauchi, H., Iwama, A., Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1 (2010) Cell Stem Cell, 6, pp. 279-286; Iwama, A., Oguro, H., Negishi, M., Kato, Y., Morita, Y., Tsukui, H., Ema, H., Koseki, H., Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1 (2004) Immunity, 21, pp. 843-851; Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., Plath, K., A bivalent chromatin structure marks key developmental genes in embryonic stem cells (2006) Cell, 125, pp. 315-326; Klauke, K., Radulović, V., Broekhuis, M., Weersing, E., Zwart, E., Olthof, S., Ritsema, M., Helin, K., Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation (2013) Nat Cell Biol, 15, pp. 353-362; Majewski, I.J., Blewitt, M.E., De Graaf, C.A., McManus, E.J., Bahlo, M., Hilton, A.A., Hyland, C.D., Metcalf, D., Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activity (2008) PLoS Biol, 6, p. e93; Xie, H., Xu, J., Hsu, J.H., Nguyen, M., Fujiwara, Y., Peng, C., Orkin, S.H., Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner (2014) Cell Stem Cell, 14, pp. 68-80; Hidalgo, I., Herrera-Merchan, A., Ligos, J.M., Carramolino, L., Nunez, J., Martinez, F., Dominguez, O., González, S., Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest (2012) Cell Stem Cell, 11, pp. 649-662; Cao, Q., Wang, X., Zhao, M., Yang, R., Malik, R., Qiao, Y., Poliakov, A., Chen, W., The central role of EED in the orchestration of polycomb group complexes (2014) Nat Commun, 5, pp. 1-13; Hodges, E., Molaro, A., Dos Santos, C.O., Thekkat, P., Song, Q., Uren, P.J., Park, J., McCombie, W.R., Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment (2011) Mol Cell, 44, pp. 17-28; Bröske, A.-M., Vockentanz, L., Kharazi, S., Huska, M.R., Mancini, E., Scheller, M., Kuhl, C., Jaenisch, R., DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction (2009) Nat Genet, 41, pp. 1207-1215; Trowbridge, J.J., Snow, J.W., Kim, J., Orkin, S.H., DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells (2009) Cell Stem Cell, 5, pp. 442-449; Tadokoro, Y., Ema, H., Okano, M., Li, E., Nakauchi, H., De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells (2007) J Exp Med, 204, pp. 715-722; Challen, G.A., Sun, D., Jeong, M., Luo, M., Jelinek, J., Berg, J.S., Bock, C., Xi, Y., Dnmt3a is essential for hematopoietic stem cell differentiation (2012) Nat Genet, 44, pp. 23-31; Jeong, M., Sun, D., Luo, M., Huang, Y., Challen, G.A., Rodriguez, B., Zhang, X., Hannah, R., Large conserved domains of low DNA methylation maintained by Dnmt3a (2014) Nat Genet, 46, pp. 17-23; Sun, D., Luo, M., Jeong, M., Rodriguez, B., Xia, Z., Hannah, R., Wang, H., Chen, R., Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal (2014) Cell Stem Cell, 14, pp. 673-688; Chen, X., Skutt-Kakaria, K., Davison, J., Ou, Y.L., Choi, E., Malik, P., Loeb, K., Torok-Storb, B., G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitment (2012) Genes Dev, 26, pp. 2499-2511; Lehnertz, B., Pabst, C., Su, L., Miller, M., Liu, F., Yi, L., Zhang, R., Kirschner, J., The methyltransferase G9a regulates HoxA9-dependent transcription in AML (2014) Genes Dev, 28, pp. 317-327; Shilatifard, A., The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis (2012) Annu Rev Biochem, 81, pp. 65-95; Mishra, B.P., Zaffuto, K.M., Artinger, E.L., Org, T., Mikkola, H.K.A., Cheng, C., Djabali, M., Ernst, P., The histone methyltransferase activityof MLL1 is dispensable for hematopoiesis and leukemogenesis (2014) Cell Rep, 7, pp. 1239-1247; Blanpain, C., Fuchs, E., Epidermal homeostasis: a balancing act of stem cells in the skin (2009) Nat Rev Mol Cell Biol, 10, pp. 207-217; Frye, M., Benitah, S.A., Chromatin regulators in mammalian epidermis (2012) Semin Cell Dev Biol, 23, pp. 897-905; Jones, P.H., Watt, F.M., Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression (1993) Cell, 73, pp. 713-724; Mejetta, S., Morey, L., Pascual, G., Kuebler, B., Mysliwiec, M.R., Lee, Y., Shiekhattar, R., Benitah, S.A., Jarid2 regulates mouse epidermal stem cell activation and differentiation (2011) EMBO J, 30, pp. 3635-3646; Sen, G.L., Webster, D.E., Barragan, D.I., Chang, H.Y., Khavari, P.A., Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3 (2008) Genes Dev, 22, pp. 1865-1870; Ezhkova, E., Pasolli, H.A., Parker, J.S., Stokes, N., Su, I.-H., Hannon, G., Tarakhovsky, A., Fuchs, E., Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells (2009) Cell, 136, pp. 1122-1135; Ezhkova, E., Lien, W.H., Stokes, N., Pasolli, H.A., Silva, J.M., Fuchs, E., EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair (2011) Genes Dev, 25, pp. 485-498; Luis, N.M., Morey, L., Mejetta, S., Pascual, G., Janich, P., Kuebler, B., Cozutto, L., Frye, M., Regulation of human epidermal stem cell proliferation and senescence requires polycomb-dependent and -independent functions of Cbx4 (2011) Cell Stem Cell, 9, pp. 233-246; Lee, K., Adhikary, G., Balasubramanian, S., Gopalakrishnan, R., McCormick, T., Dimri, G.P., Eckert, R.L., Rorke, E.A., Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis (2007) J Invest Dermatol, 128, pp. 9-17; Vanbokhoven, H., Melino, G., Candi, E., Declercq, W., p63, a story of mice and men (2011) J Invest Dermatol, 131, pp. 1196-1207; Driskell, I., Oda, H., Blanco, S., Nascimento, E., Humphreys, P., Frye, M., The histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin (2012) EMBO J, 31, pp. 616-629; LeBoeuf, M., Terrell, A., Trivedi, S., Sinha, S., Epstein, J.A., Olson, E.N., Morrisey, E.E., Millar, S.E., Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells (2010) Dev Cell, 19, pp. 807-818; Keyes, W.M., Pecoraro, M., Aranda, V., Vernersson-Lindahl, E., Li, W., Vogel, H., Guo, X., Enikolopov, G., DeltaNp63alpha is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis (2011) Cell Stem Cell, 8, pp. 164-176; Mardaryev, A.N., Gdula, M.R., Yarker, J.L., Emelianov, V.N., Poterlowicz, K., Sharov, A.A., Sharova, T.Y., Botchkarev, V.A., p63 and Brg1 control developmentally regulated higher-order chromatin remodelling at the epidermal differentiation complex locus in epidermal progenitor cells (2014) Development, 141, pp. 101-111; Fessing, M.Y., Mardaryev, A.N., Gdula, M.R., Sharov, A.A., Sharova, T.Y., Rapisarda, V., Gordon, K.B., Ferone, G., p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis (2011) J Cell Biol, 194, pp. 825-839; Watt, F.M., Frye, M., Benitah, S.A., MYC in mammalian epidermis: how can an oncogene stimulate differentiation? (2008) Nat Rev Cancer, 8, pp. 234-242; Varlakhanova, N.V., Knoepfler, P.S., Acting locally and globally: Myc's ever-expanding roles on chromatin (2009) Cancer Res, 69, pp. 7487-7490; Arnold, I., Watt, F.M., c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny (2001) Curr Biol, 11, pp. 558-568; Frye, M., Gardner, C., Li, E.R., Arnold, I., Watt, F.M., Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment (2003) Development, 130, pp. 2793-2808; Nascimento, E.M., Cox, C.L., MacArthur, S., Hussain, S., Trotter, M., Blanco, S., Suraj, M., Benitah, S.A., The opposing transcriptional functions of Sin3a and c-Myc are required to maintain tissue homeostasis (2011) Nat Cell Biol, 13, pp. 1395-1405; Rao, G., Alland, L., Guida, P., Schreiber-Agus, N., Chen, K., Chin, L., Rochelle, J.M., DePinho, R.A., Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1 (1996) Oncogene, 12, pp. 1165-1172; Laherty, C.D., Yang, W.M., Sun, J.M., Davie, J.R., Seto, E., Eisenman, R.N., Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression (1997) Cell, 89, pp. 349-356; Hassig, C.A., Fleischer, T.C., Billin, A.N., Schreiber, S.L., Ayer, D.E., Histone deacetylase activity is required for full transcriptional repression by mSin3A (1997) Cell, 89, pp. 341-347; Sen, G.L., Reuter, J.A., Webster, D.E., Zhu, L., Khavari, P.A., DNMT1 maintains progenitor function in self-renewing somatic tissue (2010) Nature, 463, pp. 563-567; Li, J., Jiang, T.-X., Hughes, M.W., Wu, P., Widelitz, R.B., Fan, G., Chuong, C.-M., Progressive alopecia reveals decreasing stem cell activation probability during aging of mice with epidermal deletion of DNA methyltransferase 1 (2012) J Invest Dermatol, 132, pp. 2681-2690; Schaefer, A., Sampath, S.C., Intrator, A., Min, A., Gertler, T.S., Surmeier, D.J., Tarakhovsky, A., Greengard, P., Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex (2009) Neuron, 64, pp. 678-691; Maze, I., Chaudhury, D., Dietz, D.M., Von Schimmelmann, M., Kennedy, P.J., Lobo, M.K., Sillivan, S.E., Sun, H., G9a influences neuronal subtype specification in striatum (2014) Nat Neurosci, 17, pp. 533-539; Molofsky, A.V., He, S., Bydon, M., Morrison, S.J., Pardal, R., Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways (2005) Genes Dev, 19, pp. 1432-1437; Molofsky, A.V., Pardal, R., Iwashita, T., Park, I.-K., Clarke, M.F., Morrison, S.J., Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation (2003) Nature, 425, pp. 962-967; Pereira, J.D., Sansom, S.N., Smith, J., Dobenecker, M.-W., Tarakhovsky, A., Livesey, F.J., Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex (2010) Proc Natl Acad Sci USA, 107, pp. 15957-15962; Yu, Y.L., Chou, R.H., Chen, L.T., Shyu, W.C., Hsieh, S.C., Wu, C.S., Zeng, H.J., Hung, S.C., EZH2 Regulates neuronal differentiation of mesenchymal stem cells through PIP5K1C-dependent calcium signaling (2011) J Biol Chem, 286, pp. 9657-9667; Watanabe, D., Uchiyama, K., Hanaoka, K., Transition of mouse de novo methyltransferases expression from Dnmt3b to Dnmt3a during neural progenitor cell development (2006) Neuroscience, 142, pp. 727-737; Fan, G., Martinowich, K., Chin, M.H., He, F., Fouse, S.D., Hutnick, L., Hattori, D., Wu, H., DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling (2005) Development, 132, pp. 3345-3356; Wu, H., Coskun, V., Tao, J., Xie, W., Ge, W., Yoshikawa, K., Li, E., Sun, Y.E., Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes (2010) Science, 329, pp. 444-448; Feng, J., Zhou, Y., Campbell, S.L., Le, T., Li, E., Sweatt, J.D., Silva, A.J., Fan, G., Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons (2010) Nat Neurosci, 13, pp. 423-430; Moarefi, A.H., Chédin, F., ICF syndrome mutations cause a broad spectrum of biochemical defects in DNMT3B-mediated de novo DNA methylation (2011) J Mol Biol, 409, pp. 758-772; Jin, B., Tao, Q., Peng, J., Soo, H.M., Wu, W., Ying, J., Fields, C.R., Qiu, J., DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function (2007) Hum Mol Genet, 17, pp. 690-709; Weemaes, C.M., Van Tol, M.J., Wang, J., Van Ostaijen-Ten Dam, M.M., Van Eggermond, M.C., Thijssen, P.E., Aytekin, C., Davies, E.G., Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects (2013) Eur J Hum Genet, 21, pp. 1219-1225; Kinney, S.M., Chin, H.G., Vaisvila, R., Bitinaite, J., Zheng, Y., Esteve, P.O., Feng, S., Pradhan, S., Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes (2011) J Biol Chem, 286, pp. 24685-24693; Kim, M., Park, Y.K., Kang, T.W., Lee, S.H., Rhee, Y.H., Park, J.L., Kim, H.J., Kim, S.Y., Dynamic changes in DNA methylation and hydroxymethylation when hES cells undergo differentiation toward a neuronal lineage (2014) Hum Mol Genet, 23, pp. 657-667; Kriaucionis, S., Heintz, N., The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain (2009) Science, 324, pp. 929-930; Hahn, M.A., Qiu, R., Wu, X., Li, A.X., Zhang, H., Wang, J., Jui, J., Pfeifer, G.P., Dynamics of 5-hydroxymethylcytosine and chromatin marks in mammalian neurogenesis (2013) Cell Rep, 3, pp. 291-300; Zhang, R.-R., Cui, Q.-Y., Murai, K., Lim, Y.C., Smith, Z.D., Jin, S., Ye, P., Wu, H.-P., Tet1 regulates adult hippocampal neurogenesis and cognition (2013) Cell Stem Cell, 13, pp. 237-245; Mauro, A., Satellite cell of skeletal muscle fibers (1961) J Biophys Biochem Cytol, 9, pp. 493-495; Péault, B., Rudnicki, M., Torrente, Y., Cossu, G., Tremblay, J.P., Partridge, T., Gussoni, E., Huard, J., Stem and progenitor cells in skeletal muscle development, maintenance, and therapy (2007) Mol Ther, 15, pp. 867-877; Brack, A.S., Rando, T.A., Tissue-specific stem cells: lessons from the skeletal muscle satellite cell (2012) Cell Stem Cell, 10, pp. 504-514; Caretti, G., Di Padova, M., Micales, B., Lyons, G.E., Sartorelli, V., The polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation (2004) Genes Dev, 18, pp. 2627-2638; Stojic, L., Jasencakova, Z., Prezioso, C., Stützer, A., Bodega, B., Pasini, D., Klingberg, R., Puri, P.L., Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells (2011) Epigenetics Chromatin, 4, p. 16; Asp, P., Blum, R., Vethantham, V., Parisi, F., Micsinai, M., Cheng, J., Bowman, C., Dynlacht, B.D., Genome-wide remodeling of the epigenetic landscape during myogenic differentiation (2011) Proc Natl Acad Sci USA, 108, pp. E149-E158; Robson, L.G., Di Foggia, V., Radunovic, A., Bird, K., Zhang, X., Marino, S., Bmi1 is expressed in postnatal myogenic satellite cells, controls their maintenance and plays an essential role in repeated muscle regeneration (2011) PLoS One, 6; Sousa-Victor, P., Gutarra, S., García-Prat, L., Rodriguez-Ubreva, J., Ortet, L., Ruiz-Bonilla, V., Jardí, M., Serrano, A.L., Geriatric muscle stem cells switch reversible quiescence into senescence (2014) Nature, 506, pp. 316-321; Tsumagari, K., Baribault, C., Terragni, J., Varley, K.E., Gertz, J., Pradhan, S., Badoo, M., Crawford, G.E., Early de novo DNA methylation and prolonged demethylation in the muscle lineage (2013) Epigenetics, 8, pp. 317-332; Wang, L., Xu, S., Lee, J.-E., Baldridge, A., Grullon, S., Peng, W., Ge, K., Histone H3K9 methyltransferase G9a represses PPARc expression and adipogenesis (2012) EMBO J, 32, pp. 45-59; Lee, J., Saha, P.K., Yang, Q.H., Lee, S., Park, J.Y., Suh, Y., Lee, S.-K., Chan, L., Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis (2008) Proc Natl Acad Sci USA, 105, pp. 19229-19234; Sheaffer, K.L., Kim, R., Aoki, R., Elliott, E.N., Schug, J., Burger, L., Schübeler, D., Kaestner, K.H., DNA methylation is required for the control of stem cell differentiation in the small intestine (2014) Genes Dev, 28, pp. 652-664; Lin, H., Yamada, Y., Nguyen, S., Linhart, H., Jackson-Grusby, L., Meissner, A., Meletis, K., Jaenisch, R., Suppression of intestinal neoplasia by deletion of Dnmt3b (2006) Mol Cell Biol, 26, pp. 2976-2983; Linhart, H.G., Lin, H., Yamada, Y., Moran, E., Steine, E.J., Gokhale, S., Lo, G., He, T., Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing (2007) Genes Dev, 21, pp. 3110-3122; Kim, T.-H., Li, F., Ferreiro-Neira, I., Ho, L.-L., Luyten, A., Nalapareddy, K., Long, H., Shivdasani, R.A., Broadly permissive intestinal chromatin underlies lateral inhibition and cell plasticity (2014) Nature, 506, pp. 511-515; Shen, H., Laird, P.W., Interplay between the cancer genome and epigenome (2013) Cell, 153, pp. 38-55; Horvath, S., DNA methylation age of human tissues and cell types (2013) Genome Biol, 14, p. R115; Ernst, T., Chase, A.J., Score, J., Hidalgo-Curtis, C.E., Bryant, C., Jones, A.V., Waghorn, K., Reiter, A., Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders (2010) Nat Genet, 42, pp. 722-726; Lohr, J.G., Stojanov, P., Lawrence, M.S., Auclair, D., Chapuy, B., Sougnez, C., Cruz-Gordillo, P., Slager, S.L., Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing (2012) Proc Natl Acad Sci USA, 109, pp. 3879-3884; McCabe, M.T., Graves, A.P., Ganji, G., Diaz, E., Halsey, W.S., Jiang, Y., Smitheman, K.N., Allen, K.E., Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27) (2012) Proc Natl Acad Sci USA, 109, pp. 2989-2994; Nikoloski, G., Langemeijer, S.M.C., Kuiper, R.P., Knops, R., Massop, M., Tönnissen, E., Van Der Heijden, A., De Witte, T., Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes (2010) Nat Genet, 42, pp. 665-667; McCabe, M.T., Ott, H.M., Ganji, G., Korenchuk, S., Thompson, C., Van Aller, G.S., Liu, Y., Diaz, E., EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations (2013) Nature, 492, pp. 108-112; Kim, W., Bird, G.H., Neff, T., Guo, G., Kerenyi, M.A., Walensky, L.D., Orkin, S.H., Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer (2013) Nat Chem Biol, 9, pp. 643-650",Article,Scopus,2-s2.0-84928550323
"Worsham M.J., Chitale D., Chen K.M., Datta I., Divine G.","Cell signaling events differentiate ER-negative subtypes from ER-positive breast cancer",2015,"Medical Oncology","32","5",,"","",8,,10.1007/s12032-015-0565-3,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925811349&partnerID=40&md5=f418bf31dcdd64d6c3fcfb997a7a70f9","Department of Otolaryngology, Henry Ford Hospital, 1Ford Place, 1DDetroit, MI, United States; Department of Pathology, Henry Ford HospitalDetroit, MI, United States; Department Public Health Sciences, Henry Ford HospitalDetroit, MI, United States","Worsham, M.J., Department of Otolaryngology, Henry Ford Hospital, 1Ford Place, 1DDetroit, MI, United States; Chitale, D., Department of Pathology, Henry Ford HospitalDetroit, MI, United States; Chen, K.M., Department of Otolaryngology, Henry Ford Hospital, 1Ford Place, 1DDetroit, MI, United States; Datta, I., Department Public Health Sciences, Henry Ford HospitalDetroit, MI, United States; Divine, G., Department Public Health Sciences, Henry Ford HospitalDetroit, MI, United States","Currently available markers routinely used in clinical practice are of limited value to patients with estrogen receptor-negative (ER−) breast cancer [basal-like and HER2neu-positive (HER+)], an aggressive subtype. Our aim was to uncover molecular pathways and signaling networks exposed by differentially methylated genes informative of the biology of ER− breast cancer (BC) subtypes versus ER-positive (ER+). Whole-genome methylation array analysis was carried out using the Illumina Infinium HumanMethylation27 BeadChip on 14 primary BC: five ER+, four triple-negative (TNBC), and five ER−HER2+. Degree of methylation was calculated as a β-value (ranging from 0 to 1), and M-values [log (β/(1 − β)] were used for significance tests. To identify methylated genes associated with ER− subtypes (TNBC and ER−HER2+) and distinct from ER+, a weighted algorithm, developed to increase statistical rigor, called out genes in which methylation changed dramatically between ER+ and ER− subtypes. Differentially methylated gene lists examined using Ingenuity Pathway Analysis called out canonical pathways and networks with clues to biological distinctiveness as well as relatedness between ER− subtypes as compared to ER+ BC. The study highlights the interplay of ER− subtype-specific genes and their signaling pathways as potential putative fingerprints in refining classification of BC subtypes and as potential biological markers designed to hit multiple targets. © 2015, Springer Science+Business Media New York.","Breast cancers subtypes; Canonical pathways; Differential methylation; Networks","Perou, C.M., Sorlie, T., Eisen, M.B., Molecular portraits of human breast tumours (2000) Nature, 406 (6797), pp. 747-752. , COI: 1:CAS:528:DC%2BD3cXmt1CnsLw%3D, PID: 10963602; Sorlie, T., Perou, C.M., Tibshirani, R., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications (2001) Proc Natl Acad Sci USA, 98 (19), pp. 10869-10874. , COI: 1:CAS:528:DC%2BD3MXntVGmsbo%3D, PID: 11553815; Sorlie, T., Tibshirani, R., Parker, J., Repeated observation of breast tumor subtypes in independent gene expression data sets (2003) Proc Natl Acad Sci USA, 100 (14), pp. 8418-8423. , COI: 1:CAS:528:DC%2BD3sXlsFGntLk%3D, PID: 12829800; Dent, R., Trudeau, M., Pritchard, K.I., Triple-negative breast cancer: clinical features and patterns of recurrence (2007) Clin Cancer Res Off J Am Assoc Cancer Res, 13, pp. 4429-4434; Bertucci, F., Finetti, P., Cervera, N., How basal are triple-negative breast cancers? International journal of cancer (2008) J Int du cancer, 123 (1), pp. 236-240. , COI: 1:CAS:528:DC%2BD1cXmtlantbg%3D; Cleator, S., Heller, W., Coombes, R.C., Triple-negative breast cancer: therapeutic options (2007) Lancet Oncol, 8 (3), pp. 235-244. , PID: 17329194; Kreike, B., van Kouwenhove, M., Horlings, H., Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas (2007) Breast Cancer Res BCR, 9 (5), p. R65; Nielsen, T.O., Hsu, F.D., Jensen, K., Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma (2004) Clin Cancer Res Off J Am Assoc Cancer Res, 10 (16), pp. 5367-5374. , COI: 1:CAS:528:DC%2BD2cXmvFSlt7k%3D; Benjamini, Y.H.Y., On the adaptive control of the false discovery rate in multiple testing with independent statistics (2000) J Educ Behav Stat, 25 (1), pp. 60-83; Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing (1995) J R Stat Soc Series B (Methodological), 57 (1), pp. 289-300; Worsham, M.J., Chen, K.M., Ghanem, T., Stephen, J.K., Divine, G., Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC (2013) Otolaryngol Head Neck Surg, 149 (3), pp. 409-416; Lehmann, B.D., Bauer, J.A., Chen, X., Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies (2011) J Clin Investig, 121 (7), pp. 2750-2767. , COI: 1:CAS:528:DC%2BC3MXovVKgu78%3D, PID: 21633166; Masuda, H., Baggerly, K.A., Wang, Y., Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes (2013) Clin Cancer Res, 19 (19), pp. 5533-5540. , COI: 1:CAS:528:DC%2BC3sXhsFynsL7P, PID: 23948975; Parker, J.S., Mullins, M., Cheang, M.C., Supervised risk predictor of breast cancer based on intrinsic subtypes (2009) J Clin Oncol Off J Am Soc Clin Oncol, 27 (8), pp. 1160-1167; Dowsett, M., Sestak, I., Lopez-Knowles, E., Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy (2013) J Clin Oncol, 31 (22), pp. 2783-2790. , PID: 23816962; Filipits, M., Nielsen, T.O., Rudas, M., The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer (2014) Clin Cancer Res, 20 (5), pp. 1298-1305. , COI: 1:CAS:528:DC%2BC2cXks1Ohu78%3D, PID: 24520097; Cancer Genome Atlas, N., Comprehensive molecular portraits of human breast tumours (2012) Nature, 490 (7418), pp. 61-70; Curtis, C., Shah, S.P., Chin, S.F., The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups (2012) Nature, 486 (7403), pp. 346-352. , COI: 1:CAS:528:DC%2BC38XlslSnsL8%3D, PID: 22522925; Stephens, P.J., Tarpey, P.S., Davies, H., The landscape of cancer genes and mutational processes in breast cancer (2012) Nature, 486 (7403), pp. 400-404. , COI: 1:CAS:528:DC%2BC38XovFyrsrs%3D, PID: 22722201; Dedeurwaerder, S., Fumagalli, D., Fuks, F., Unravelling the epigenomic dimension of breast cancers (2011) Curr Opin Oncol, 23 (6), pp. 559-565. , PID: 21946247; Parsons, D.W., Jones, S., Zhang, X., An integrated genomic analysis of human glioblastoma multiforme (2008) Science, 321 (5897), pp. 1807-1812. , COI: 1:CAS:528:DC%2BD1cXhtFCrtLrE, PID: 18772396; Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008) Nature, 455 (7216), pp. 1061-1068; Vaske, C.J., Benz, S.C., Sanborn, J.Z., Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM (2010) Bioinformatics, 26 (12), pp. i237-i245. , COI: 1:CAS:528:DC%2BC3cXnsVOltbk%3D, PID: 20529912; Trusolino, L., Comoglio, P.M., Scatter-factor and semaphorin receptors: cell signalling for invasive growth (2002) Nat Rev Cancer, 2 (4), pp. 289-300. , COI: 1:CAS:528:DC%2BD38XivFGqt7g%3D, PID: 12001990; Comoglio, P.M., Trusolino, L., Invasive growth: from development to metastasis (2002) J Clin Investig, 109 (7), pp. 857-862. , COI: 1:CAS:528:DC%2BD38Xis1Kjurc%3D, PID: 11927611; Biankin, A.V., Waddell, N., Kassahn, K.S., Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes (2012) Nature, 491 (7424), pp. 399-405. , COI: 1:CAS:528:DC%2BC38XhsFOmt7jN, PID: 23103869; Mehlen, P., Delloye-Bourgeois, C., Chedotal, A., Novel roles for Slits and netrins: axon guidance cues as anticancer targets? Nature reviews (2011) Cancer, 11 (3), pp. 188-197. , COI: 1:CAS:528:DC%2BC3MXitVClurc%3D, PID: 21326323; Kim, J., Chu, J., Shen, X., Wang, J., Orkin, S.H., An extended transcriptional network for pluripotency of embryonic stem cells (2008) Cell, 132 (6), pp. 1049-1061. , COI: 1:CAS:528:DC%2BD1cXkt1WqsLg%3D, PID: 18358816; Dontu, G., Al-Hajj, M., Abdallah, W.M., Clarke, M.F., Wicha, M.S., Stem cells in normal breast development and breast cancer (2003) Cell Prolif, 36, pp. 59-72. , COI: 1:CAS:528:DC%2BD3sXpsFChtr0%3D, PID: 14521516; Honeth, G., Bendahl, P.O., Ringner, M., The CD44+/CD24- phenotype is enriched in basal-like breast tumors (2008) Breast Cancer Res BCR, 10 (3), p. R53; Wright, M.H., Calcagno, A.M., Salcido, C.D., Carlson, M.D., Ambudkar, S.V., Varticovski, L., Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics (2008) Breast Cancer Res BCR, 10 (1), p. R10; Gong, H., Wu, T.T., Clarke, E.M., Pathway-gene identification for pancreatic cancer survival via doubly regularized Cox regression (2014) BMC Syst Biol, 8, p. S3; Tauber, S., Jais, A., Jeitler, M., Transcriptome analysis of human cancer reveals a functional role of heme oxygenase-1 in tumor cell adhesion (2010) Mol cancer, 9, p. 200. , PID: 20667089; Jozkowicz, A., Was, H., Dulak, J., Heme oxygenase-1 in tumors: Is it a false friend? (2007) Antioxid Redox Signal, 9 (12), pp. 2099-2117. , COI: 1:CAS:528:DC%2BD2sXht1GrsLzJ, PID: 17822372; Januchowski, R., Zawierucha, P., Rucinski, M., Nowicki, M., Zabel, M., Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line (2014) BioMed Res Int, 2014, p. 365867. , PID: 24804215; Conway, K., Edmiston, S.N., May, R., DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival (2014) Breast Cancer Res BCR, 16 (5), p. 450; Stefansson, O.A., Moran, S., Gomez, A., A DNA methylation-based definition of biologically distinct breast cancer subtypes (2014) Mol oncol, , PID: 25468711",Article,Scopus,2-s2.0-84925811349
"Lv Y., Yang L., Wang F.","Chemoradiation therapy reduces aldehyde dehydrogenase 1 expression in cervical cancer but does not improve patient survival",2015,"Medical Oncology","32","5",,"","",6,,10.1007/s12032-015-0597-8,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926305908&partnerID=40&md5=846526042040fc66a327f0f500108634","Department of Radiotherapy, The First Affiliated Hospital of Anhui Medical University, 281 Jixi RoadHefei, Anhui, China","Lv, Y., Department of Radiotherapy, The First Affiliated Hospital of Anhui Medical University, 281 Jixi RoadHefei, Anhui, China; Yang, L., Department of Radiotherapy, The First Affiliated Hospital of Anhui Medical University, 281 Jixi RoadHefei, Anhui, China; Wang, F., Department of Radiotherapy, The First Affiliated Hospital of Anhui Medical University, 281 Jixi RoadHefei, Anhui, China","Aldehyde dehydrogenase 1 (ALDH-1) is a cancer stem cell marker whose overexpression can predict the prognosis of several human cancers. In this study, we assessed ALDH-1 expression in cervical cancer tissues and investigated the usefulness of ALDH-1 expression levels for the prediction of patient response to chemoradiation therapy and survival. Tissue samples from 74 patients were examined via immunostaining with ALDH-1 antibody before and after chemoradiation therapy. Twenty-nine of the 74 cervical cancer cases exhibited ALDH-1 expression (39.19 %) in the pre-treatment tissue samples; however, only 19 of these 39 cases exhibited ALDH-1 expression (48.72 %) in post-treatment tissue samples, indicating that chemoradiotherapy eliminated the ALDH-1 positive tumor stem cells in cervical cancer. However, patient disease-free survival was not associated with ALDH-1 expression (11.78 ± 1.95 vs. 12.50 ± 1.91 months in ALDH-1-positive and -negative tumors, respectively). This study indicates that the reduction of the cancer stem cell population via chemoradiotherapy may not be sufficient to improve patient survival. Thus, the clinical value of ALDH-1 expression in cervical cancer may need to be re-examined. © 2015, Springer Science+Business Media New York.","ALDH-1; Biomarker; Cervical cancer; Prognosis; Treatment response","Duenas-Gonzalez, A., Lizano, M., Candelaria, M., Cetina, L., Arce, C., Cervera, E., Epigenetics of cervical cancer. An overview and therapeutic perspectives (2005) Mol Cancer, 4, p. 38. , PID: 16248899; Aggarwal, P., Cervical cancer: can it be prevented? (2014) World J Clin Oncol, 5, pp. 775-780. , PID: 25302177; Kitchener, H.C., Denton, K., Soldan, K., Crosbie, E.J., Developing role of hpv in cervical cancer prevention (2013) BMJ, 347, p. 4781. , PID: 23926316; Ibeanu, O.A., Molecular pathogenesis of cervical cancer (2011) Cancer Biol Ther, 11, pp. 295-306. , COI: 1:CAS:528:DC%2BC3MXivFWhurk%3D, PID: 21239888; McGraw, S.L., Ferrante, J.M., Update on prevention and screening of cervical cancer (2014) World J Clin Oncol, 5, pp. 744-752. , PID: 25302174; Gadducci, A., Guerrieri, M.E., Greco, C., Tissue biomarkers as prognostic variables of cervical cancer (2013) Crit Rev Oncol Hematol, 86, pp. 104-129. , PID: 23031678; Shukla, S., Meeran, S.M., Epigenetics of cancer stem cells: pathways and therapeutics (2014) Biochim Biophys Acta, 1840, pp. 3494-3502. , COI: 1:CAS:528:DC%2BC2cXhsFyns7bO, PID: 25240776; Liao, W.T., Ye, Y.P., Deng, Y.J., Bian, X.W., Ding, Y.Q., Metastatic cancer stem cells: from the concept to therapeutics (2014) Am J Stem Cells, 3, pp. 46-62. , COI: 1:CAS:528:DC%2BC2cXhvFais7bJ, PID: 25232505; Vlashi, E., Pajonk, F., Cancer stem cells, cancer cell plasticity and radiation therapy (2015) Semin Cancer Biol, 31C, pp. 28-35. , PID: 25025713; Warnock, G.L., Callahan, D., Ellis, D.K., Rajotte, R.V., Twenty-four-hour hypothermic storage of the canine pancreas before islet isolation (1989) Transplant Proc, 21, pp. 2646-2647. , COI: 1:STN:280:DyaL1M3gsVGnsg%3D%3D, PID: 2495657; Friedman, G.K., Cassady, K.A., Beierle, E.A., Markert, J.M., Gillespie, G.Y., Targeting pediatric cancer stem cells with oncolytic virotherapy (2012) Pediatr Res, 71, pp. 500-510. , COI: 1:CAS:528:DC%2BC38XksVajtL8%3D, PID: 22430386; Prud’homme, G.J., Cancer stem cells and novel targets for antitumor strategies (2012) Curr Pharm Des, 18, pp. 2838-2849. , PID: 22390767; Walsh, N., Dowling, P., O’Donovan, N., Henry, M., Meleady, P., Clynes, M., Aldehyde dehydrogenase 1a1 and gelsolin identified as novel invasion-modulating factors in conditioned medium of pancreatic cancer cells (2008) J Proteomics, 71, pp. 561-571. , COI: 1:CAS:528:DC%2BD1cXhtlyktrfP, PID: 18848913; Barley, K., Dracheva, S., Byne, W., Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder (2009) Schizophr Res, 112, pp. 54-64. , PID: 19447584; Kastan, M.B., Schlaffer, E., Russo, J.E., Colvin, O.M., Civin, C.I., Hilton, J., Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells (1990) Blood, 75, pp. 1947-1950. , COI: 1:CAS:528:DyaK3cXktlKkurc%3D, PID: 2337669; Cai, Y., Wang, Y., Zheng, Z., Wang, J., Yao, W., Ma, J., Predictors of reducing sexual and reproductive risk behaviors based on the information-motivation-behavioral skills (imb) model among unmarried rural-to-urban female migrants in shanghai, china (2013) PLoS One, 8, p. 62787. , COI: 1:CAS:528:DC%2BC3sXnsVKgsrs%3D, PID: 23646145; Lynge, E., Rygaard, C., Baillet, M.V., Dugue, P.A., Sander, B.B., Bonde, J., Rebolj, M., Cervical cancer screening at crossroads (2014) Apmis, 122, pp. 667-673. , PID: 25046198; Kreso, A., Dick, J.E., Evolution of the cancer stem cell model (2014) Cell Stem Cell, 14, pp. 275-291. , COI: 1:CAS:528:DC%2BC2cXjvFWju7c%3D, PID: 24607403; Lopez, J., Valdez-Morales, F.J., Benitez-Bribiesca, L., Cerbon, M., Carranca, A.G., Normal and cancer stem cells of the human female reproductive system (2013) Reprod Biol Endocrinol, 11, p. 53. , PID: 23782518; Butof, R., Dubrovska, A., Baumann, M., Clinical perspectives of cancer stem cell research in radiation oncology (2013) Radiother Oncol, 108, pp. 388-396. , PID: 23830466; Dittmer, J., Rody, A., Cancer stem cells in breast cancer (2013) Histol Histopathol, 28, pp. 827-838. , COI: 1:CAS:528:DC%2BC3sXhsVeku73I, PID: 23468411; Zhou, C., Sun, B., The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis (2014) Oral Oncol, 50, pp. 1144-1148. , COI: 1:CAS:528:DC%2BC2cXhsFGgs7fN, PID: 25264224; Yao, T., Wu, Z., Liu, Y., Rao, Q., Lin, Z., Aldehyde dehydrogenase 1 (aldh1) positivity correlates with poor prognosis in cervical cancer (2014) J Int Med Res, 42, pp. 1038-1042. , PID: 24827824; Wang, L., Guo, H., Lin, C., Yang, L., Wang, X., Enrichment and characterization of cancer stemlike cells from a cervical cancer cell line (2014) Mol Med Rep, 9, pp. 2117-2123. , COI: 1:CAS:528:DC%2BC2cXptlSjtrY%3D, PID: 24676900; Li, J., Yao, Y.S., Dong, Q., Dong, Y.H., Liu, J.J., Yang, L.S., Huang, F., Characterization and factors associated with sleep quality among rural elderly in china (2013) Arch Gerontol Geriatr, 56, pp. 237-243. , PID: 22906471; Rao, Q.X., Yao, T.T., Zhang, B.Z., Lin, R.C., Chen, Z.L., Zhou, H., Wang, L.J., Lin, Z.Q., Expression and functional role of aldh1 in cervical carcinoma cells (2012) Asian Pac J Cancer Prev, 13, pp. 1325-1331. , PID: 22799327; Siegel, R., Naishadham, D., Jemal, A., Cancer statistics, 2013 (2013) CA Cancer J Clin, 63, pp. 11-30. , PID: 23335087; Hirohashi, Y., Torigoe, T., Inoda, S., Takahashi, A., Morita, R., Nishizawa, S., Tamura, Y., Sato, N., Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells (2010) Immunotherapy, 2, pp. 201-211. , COI: 1:CAS:528:DC%2BC3cXivVCjsrk%3D, PID: 20635928; Pearce, D.J., Taussig, D., Simpson, C., Allen, K., Rohatiner, A.Z., Lister, T.A., Bonnet, D., Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples (2005) Stem Cells, 23, pp. 752-760. , COI: 1:CAS:528:DC%2BD2MXlslCltLY%3D, PID: 15917471; Yoshida, A., Rzhetsky, A., Hsu, L.C., Chang, C., Human aldehyde dehydrogenase gene family (1998) Eur J Biochem, 251, pp. 549-557. , COI: 1:CAS:528:DyaK1cXhtVKktLY%3D, PID: 9490025; Islam, M.O., Kanemura, Y., Tajria, J., Mori, H., Kobayashi, S., Shofuda, T., Miyake, J., Okano, H., Characterization of abc transporter abcb1 expressed in human neural stem/progenitor cells (2005) FEBS Lett, 579, pp. 3473-3480. , COI: 1:CAS:528:DC%2BD2MXlvVWrtr8%3D, PID: 15950972; Shinohara, T., Avarbock, M.R., Brinster, R.L., Beta1- and alpha6-integrin are surface markers on mouse spermatogonial stem cells (1999) Proc Natl Acad Sci USA, 96, pp. 5504-5509. , COI: 1:CAS:528:DyaK1MXjtFCnsbg%3D, PID: 10318913; Danet, G.H., Luongo, J.L., Butler, G., Lu, M.M., Tenner, A.J., Simon, M.C., Bonnet, D.A., C1qrp defines a new human stem cell population with hematopoietic and hepatic potential (2002) Proc Natl Acad Sci USA, 99, pp. 10441-10445. , COI: 1:CAS:528:DC%2BD38Xmt1Chsr4%3D, PID: 12140365; Suzuki, A., Zheng, Y.W., Fukao, K., Nakauchi, H., Taniguchi, H., Liver repopulation by c-met-positive stem/progenitor cells isolated from the developing rat liver (2004) Hepatogastroenterology, 51, pp. 423-426. , COI: 1:CAS:528:DC%2BD2cXmt1Gnsb0%3D, PID: 15086173",Article,Scopus,2-s2.0-84926305908
"Segales J., Perdiguero E., Munoz-Canoves P.","Epigenetic control of adult skeletal muscle stem cell functions",2015,"FEBS Journal","282","9",,"1571","1588",,1,10.1111/febs.13065,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928494154&partnerID=40&md5=0ac688277ee98b1f0234f904bf88b8af","Department of Experimental and Health Sciences, Pompeu Fabra University, Center for Networked Biomedical Research on Neurodegenerative DiseasesBarcelona, Spain; Instituciõ Catalana de Recerca i Estudis AvançatsBarcelona, Spain","Segalés, J., Department of Experimental and Health Sciences, Pompeu Fabra University, Center for Networked Biomedical Research on Neurodegenerative DiseasesBarcelona, Spain; Perdiguero, E., Department of Experimental and Health Sciences, Pompeu Fabra University, Center for Networked Biomedical Research on Neurodegenerative DiseasesBarcelona, Spain; Muñoz-Cánoves, P., Department of Experimental and Health Sciences, Pompeu Fabra University, Center for Networked Biomedical Research on Neurodegenerative DiseasesBarcelona, Spain, Instituciõ Catalana de Recerca i Estudis AvançatsBarcelona, Spain","Skeletal muscle regeneration in the adult (de novo myogenesis) depends on a resident population of muscle stem cells (satellite cells) that are normally quiescent. In response to injury or stress, satellite cells are activated and expand as myoblast cells that differentiate and fuse to form new muscle fibers or return to quiescence to maintain the stem cell pool (self-renewal). Satellite cell-dependent myogenesis is a well-characterized multi-step process orchestrated by muscle-specific transcription factors, such as Pax3/Pax7 and members of the MyoD family of muscle regulatory factors, and epigenetically controlled by mechanisms such as DNA methylation, covalent modification of histones and non-coding RNAs. Recent results from next-generation genome-wide sequencing have increased our understanding about the highly intricate layers of epigenetic regulation involved in satellite cell maintenance, activation, differentiation and self-renewal, and their cross-talk with the muscle-specific transcriptional machinery. Satellite cell-dependent myogenesis is a well-characterized multi-step process orchestrated by muscle-specific transcription factors, such as Pax3/Pax7 and members of the MyoD family of muscle regulatory factors and epigenetically controlled by mechanisms such as DNA methylation and covalent modification of histones. Recent results from genome-wide sequencing have increased our understanding about this epigenetic regulation involved in satellite cell maintenance, activation, differentiation, and self-renewal. © 2014 FEBS.","chromatin modifications; DNA methylation; epigenetic regulation; histone code; muscle stem cell; myogenesis; satellite cells; signal transduction; skeletal muscle; transcription factors","Buckingham, M., Myogenic progenitor cells and skeletal myogenesis in vertebrates (2006) Curr Opin Genet Dev, 16, pp. 525-532; Sambasivan, R., Tajbakhsh, S., Skeletal muscle stem cell birth and properties (2007) Semin Cell Dev Biol, 18, pp. 870-882; Kuang, S., Gillespie, M.A., Rudnicki, M.A., Niche regulation of muscle satellite cell self-renewal and differentiation (2008) Cell Stem Cell, 2, pp. 22-31; Soleimani, V.D., Punch, V.G., Kawabe, Y., Jones, A.E., Palidwor, G.A., Porter, C.J., Cross, J.W., Van, I.W.F., Transcriptional dominance of Pax7 in adult myogenesis is due to high-affinity recognition of homeodomain motifs (2012) Dev Cell, 22, pp. 1208-1220; Lepper, C., Conway, S.J., Fan, C.M., Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements (2009) Nature, 460, pp. 627-631; Gunther, S., Kim, J., Kostin, S., Lepper, C., Fan, C.M., Braun, T., Myf5-positive satellite cells contribute to Pax7-dependent long-term maintenance of adult muscle stem cells (2013) Cell Stem Cell, 13, pp. 590-601; Von Maltzahn, J., Jones, A.E., Parks, R.J., Rudnicki, M.A., Pax7 is critical for the normal function of satellite cells in adult skeletal muscle (2013) Proc Natl Acad Sci USA, 110, pp. 16474-16479; Bulut-Karslioglu, A., Perrera, V., Scaranaro, M., De La Rosa-Velazquez, I.A., Van De Nobelen, S., Shukeir, N., Popow, J., Pagani, M., A transcription factor-based mechanism for mouse heterochromatin formation (2012) Nat Struct Mol Biol, 19, pp. 1023-1030; Gopinath, S.D., Rando, T.A., Stem cell review series: Aging of the skeletal muscle stem cell niche (2008) Aging Cell, 7, pp. 590-598; Giordani, L., Puri, P.L., Epigenetic control of skeletal muscle regeneration: Integrating genetic determinants and environmental changes (2013) FEBS J, 280, pp. 4014-4025; Judson, R.N., Zhang, R.H., Rossi, F.M., Tissue-resident mesenchymal stem/progenitor cells in skeletal muscle: Collaborators or saboteurs? (2013) FEBS J, 280, pp. 4100-4108; Pannerec, A., Formicola, L., Besson, V., Marazzi, G., Sassoon, D.A., Defining skeletal muscle resident progenitors and their cell fate potentials (2013) Development, 140, pp. 2879-2891; Pannerec, A., Marazzi, G., Sassoon, D., Stem cells in the hood: the skeletal muscle niche (2012) Trends Mol Med, 18, pp. 599-606; Lluis, F., Ballestar, E., Suelves, M., Esteller, M., Munoz-Canoves, P., E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription (2005) EMBO J, 24, pp. 974-984; Wu, Z., Woodring, P., Bhakta, K., Tamura, K., Wen, F., Feramisco, J.R., Karin, M., Puri, P.L., p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps (2000) Mol Cell Biol, 20, pp. 3951-3964; Cuenda, A., Cohen, P., Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis (1999) J Biol Chem, 274, pp. 4341-4346; Guasconi, V., Puri, P.L., Chromatin: the interface between extrinsic cues and the epigenetic regulation of muscle regeneration (2009) Trends Cell Biol, 19, pp. 286-294; Keren, A., Tamir, Y., Bengal, E., The p38 MAPK signaling pathway: a major regulator of skeletal muscle development (2006) Mol Cell Endocrinol, 252, pp. 224-230; Ornatsky, O.I., Cox, D.M., Tangirala, P., Andreucci, J.J., Quinn, Z.A., Wrana, J.L., Prywes, R., Mcdermott, J.C., Post-translational control of the MEF2A transcriptional regulatory protein (1999) Nucleic Acids Res, 27, pp. 2646-2654; Perdiguero, E., Ruiz-Bonilla, V., Gresh, L., Hui, L., Ballestar, E., Sousa-Victor, P., Baeza-Raja, B., Esteller, M., Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation (2007) EMBO J, 7, pp. 1245-1256; Serra, C., Palacios, D., Mozzetta, C., Forcales, S.V., Morantte, I., Ripani, M., Jones, D.R., Simone, C., Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation (2007) Mol Cell, 28, pp. 200-213; Suelves, M., Lluis, F., Ruiz, V., Nebreda, A.R., Munoz-Canoves, P., Phosphorylation of MRF4 transactivation domain by p38 mediates repression of specific myogenic genes (2004) EMBO J, 23, pp. 365-375; Lluis, F., Perdiguero, E., Nebreda, A.R., Munoz-Canoves, P., Regulation of skeletal muscle gene expression by p38 MAP kinases (2006) Trends Cell Biol, 16, pp. 36-44; Zetser, A., Gredinger, E., Bengal, E., p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor (1999) J Biol Chem, 274, pp. 5193-5200; Sartorelli, V., Caretti, G., Mechanisms underlying the transcriptional regulation of skeletal myogenesis (2005) Curr Opin Genet Dev, 15, pp. 528-535; Perdiguero, E., Sousa-Victor, P., Ballestar, E., Munoz-Canoves, P., Epigenetic regulation of myogenesis (2009) Epigenetics, 4, pp. 541-550; Buckingham, M., Rigby, P.W., Gene regulatory networks and transcriptional mechanisms that control myogenesis (2014) Dev Cell, 28, pp. 225-238; Tapscott, S.J., The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription (2005) Development, 132, pp. 2685-2695; Mckinnell, I.W., Ishibashi, J., Le Grand, F., Punch, V.G., Addicks, G.C., Greenblatt, J.F., Dilworth, F.J., Rudnicki, M.A., Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex (2008) Nat Cell Biol, 10, pp. 77-84; Olguin, H.C., Olwin, B.B., Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal (2004) Dev Biol, 275, pp. 375-388; Zammit, P.S., Golding, J.P., Nagata, Y., Hudon, V., Partridge, T.A., Beauchamp, J.R., Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? (2004) J Cell Biol, 166, pp. 347-357; Olguin, H.C., Yang, Z., Tapscott, S.J., Olwin, B.B., Reciprocal inhibition between Pax7 and muscle regulatory factors modulates myogenic cell fate determination (2007) J Cell Biol, 177, pp. 769-779; Kuang, S., Kuroda, K., Le Grand, F., Rudnicki, M.A., Asymmetric self-renewal and commitment of satellite stem cells in muscle (2007) Cell, 129, pp. 999-1010; Hu, P., Geles, K.G., Paik, J.H., Depinho, R.A., Tjian, R., Codependent activators direct myoblast-specific MyoD transcription (2008) Dev Cell, 15, pp. 534-546; Puri, P.L., Sartorelli, V., Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications (2000) J Cell Physiol, 185, pp. 155-173; Buas, M.F., Kabak, S., Kadesch, T., Inhibition of myogenesis by Notch: evidence for multiple pathways (2009) J Cell Physiol, 218, pp. 84-93; Buas, M.F., Kabak, S., Kadesch, T., The notch effector Hey1 associates with myogenic target genes to repress myogenesis (2010) J Biol Chem, 285, pp. 1249-1258; Soleimani, V.D., Yin, H., Jahani-Asl, A., Ming, H., Kockx, C.E., Van Ijcken, W.F., Grosveld, F., Rudnicki, M.A., Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis (2012) Mol Cell, 47, pp. 457-468; Siles, L., Sanchez-Tillo, E., Lim, J.W., Darling, D.S., Kroll, K.L., Postigo, A., ZEB1 imposes a temporary stage-dependent inhibition of muscle gene expression and differentiation via CtBP-mediated transcriptional repression (2013) Mol Cell Biol, 33, pp. 1368-1382; Blum, R., Vethantham, V., Bowman, C., Rudnicki, M., Dynlacht, B.D., Genome-wide identification of enhancers in skeletal muscle: the role of MyoD1 (2012) Genes Dev, 26, pp. 2763-2779; Blum, R., Dynlacht, B.D., The role of MyoD1 and histone modifications in the activation of muscle enhancers (2013) Epigenetics, 8, pp. 778-784; Rampalli, S., Li, L., Mak, E., Ge, K., Brand, M., Tapscott, S.J., Dilworth, F.J., p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation (2007) Nat Struct Mol Biol, 14, pp. 1150-1156; Palacios, D., Mozzetta, C., Consalvi, S., Caretti, G., Saccone, V., Proserpio, V., Marquez, V.E., Forcales, S.V., TNF/p38alpha/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration (2010) Cell Stem Cell, 7, pp. 455-469; Berkes, C.A., Bergstrom, D.A., Penn, B.H., Seaver, K.J., Knoepfler, P.S., Tapscott, S.J., Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential (2004) Mol Cell, 14, pp. 465-477; Croissant, J.D., Kim, J.H., Eichele, G., Goering, L., Lough, J., Prywes, R., Schwartz, R.J., Avian serum response factor expression restricted primarily to muscle cell lineages is required for alpha-actin gene transcription (1996) Dev Biol, 177, pp. 250-264; Kim, J.R., Kee, H.J., Kim, J.Y., Joung, H., Nam, K.I., Eom, G.H., Choe, N., Kook, H., Enhancer of polycomb1 acts on serum response factor to regulate skeletal muscle differentiation (2009) J Biol Chem, 284, pp. 16308-16316; Deato, M.D., Tjian, R., Switching of the core transcription machinery during myogenesis (2007) Genes Dev, 21, pp. 2137-2149; Deato, M.D., Marr, M.T., Sottero, T., Inouye, C., Hu, P., Tjian, R., MyoD targets TAF3/TRF3 to activate myogenin transcription (2008) Mol Cell, 32, pp. 96-105; Lolis, A.A., Londhe, P., Beggs, B.C., Byrum, S.D., Tackett, A.J., Davie, J.K., Myogenin recruits the histone chaperone facilitates chromatin transcription (FACT) to promote nucleosome disassembly at muscle-specific genes (2013) J Biol Chem, 288, pp. 7676-7687; Cao, Y., Yao, Z., Sarkar, D., Lawrence, M., Sanchez, G.J., Parker, M.H., Macquarrie, K.L., Ruzzo, W.L., Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming (2010) Dev Cell, 18, pp. 662-674; Macquarrie, K.L., Yao, Z., Fong, A.P., Diede, S.J., Rudzinski, E.R., Hawkins, D.S., Tapscott, S.J., Comparison of genome-wide binding of MyoD in normal human myogenic cells and rhabdomyosarcomas identifies regional and local suppression of promyogenic transcription factors (2013) Mol Cell Biol, 33, pp. 773-784; Macquarrie, K.L., Yao, Z., Fong, A.P., Tapscott, S.J., Genome-wide binding of the basic helix-loop-helix myogenic inhibitor musculin has substantial overlap with MyoD: implications for buffering activity (2013) Skelet Muscle, 3, p. 26; Narlikar, G.J., Fan, H.Y., Kingston, R.E., Cooperation between complexes that regulate chromatin structure and transcription (2002) Cell, 108, pp. 475-487; Kadam, S., Emerson, B.M., Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes (2003) Mol Cell, 11, pp. 377-389; Schuettengruber, B., Martinez, A.M., Iovino, N., Cavalli, G., Trithorax group proteins: Switching genes on and keeping them active (2011) Nat Rev Mol Cell Biol, 12, pp. 799-814; Heintzman, N.D., Stuart, R.K., Hon, G., Fu, Y., Ching, C.W., Hawkins, R.D., Barrera, L.O., Ching, K.A., Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome (2007) Nat Genet, 39, pp. 311-318; Herz, H.M., Mohan, M., Garruss, A.S., Liang, K., Takahashi, Y.H., Mickey, K., Voets, O., Shilatifard, A., Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4 (2012) Genes Dev, 26, pp. 2604-2620; Hu, D., Gao, X., Morgan, M.A., Herz, H.M., Smith, E.R., Shilatifard, A., The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers (2013) Mol Cell Biol, 33, pp. 4745-4754; Strahl, B.D., Allis, C.D., The language of covalent histone modifications (2000) Nature, 403, pp. 41-45; Dilworth, F.J., Blais, A., Epigenetic regulation of satellite cell activation during muscle regeneration (2011) Stem Cell Res Ther, 2, p. 18; Sun, Z.W., Allis, C.D., Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast (2002) Nature, 418, pp. 104-108; Minsky, N., Shema, E., Field, Y., Schuster, M., Segal, E., Oren, M., Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells (2008) Nat Cell Biol, 10, pp. 483-488; Kim, J., Guermah, M., Mcginty, R.K., Lee, J.S., Tang, Z., Milne, T.A., Shilatifard, A., Roeder, R.G., RAD6-Mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells (2009) Cell, 137, pp. 459-471; Vethantham, V., Yang, Y., Bowman, C., Asp, P., Lee, J.H., Skalnik, D.G., Dynlacht, B.D., Dynamic loss of H2B ubiquitylation without corresponding changes in H3K4 trimethylation during myogenic differentiation (2012) Mol Cell Biol, 32, pp. 1044-1055; Simone, C., SWI/SNF: The crossroads where extracellular signaling pathways meet chromatin (2006) J Cell Physiol, 207, pp. 309-314; De La Serna, I.L., Ohkawa, Y., Imbalzano, A.N., Chromatin remodelling in mammalian differentiation: Lessons from ATP-dependent remodellers (2006) Nat Rev Genet, 7, pp. 461-473; Bestor, T.H., The DNA methyltransferases of mammals (2000) Hum Mol Genet, 9, pp. 2395-2402; Hendrich, B., Bird, A., Identification and characterization of a family of mammalian methyl-CpG binding proteins (1998) Mol Cell Biol, 18, pp. 6538-6547; Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D.J., Jacobs, I., Epigenetic stem cell signature in cancer (2007) Nat Genet, 39, pp. 157-158; Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Reubinoff, B.E., Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer (2007) Nat Genet, 39, pp. 232-236; Lande-Diner, L., Zhang, J., Ben-Porath, I., Amariglio, N., Keshet, I., Hecht, M., Azuara, V., Cedar, H., Role of DNA methylation in stable gene repression (2007) J Biol Chem, 282, pp. 12194-12200; Geiman, T.M., Sankpal, U.T., Robertson, A.K., Zhao, Y., Zhao, Y., Robertson, K.D., DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system (2004) Biochem Biophys Res Commun, 318, pp. 544-555; Taylor, S.M., Jones, P.A., Changes in phenotypic expression in embryonic and adult cells treated with 5-azacytidine (1982) J Cell Physiol, 111, pp. 187-194; Kriaucionis, S., Heintz, N., The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain (2009) Science, 324, pp. 929-930; Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Aravind, L., Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 (2009) Science, 324, pp. 930-935; Jin, S.G., Kadam, S., Pfeifer, G.P., Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine (2010) Nucleic Acids Res, 38, p. e125; Ficz, G., Branco, M.R., Seisenberger, S., Santos, F., Krueger, F., Hore, T.A., Marques, C.J., Reik, W., Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation (2011) Nature, 473, pp. 398-402; Ito, S., D'alessio, A.C., Taranova, O.V., Hong, K., Sowers, L.C., Zhang, Y., Role of tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification (2010) Nature, 466, pp. 1129-1133; Goljanek-Whysall, K., Sweetman, D., Munsterberg, A.E., microRNAs in skeletal muscle differentiation and disease (2012) Clin Sci, 123, pp. 611-625; Sweetman, D., Goljanek, K., Rathjen, T., Oustanina, S., Braun, T., Dalmay, T., Munsterberg, A., Specific requirements of MRFs for the expression of muscle specific microRNAs, miR-1, miR-206 and miR-133 (2008) Dev Biol, 321, pp. 491-499; Sebastian, S., Sreenivas, P., Sambasivan, R., Cheedipudi, S., Kandalla, P., Pavlath, G.K., Dhawan, J., MLL5, a trithorax homolog, indirectly regulates H3K4 methylation, represses cyclin A2 expression, and promotes myogenic differentiation (2009) Proc Natl Acad Sci USA, 106, pp. 4719-4724; Liu, L., Cheung, T.H., Charville, G.W., Hurgo, B.M., Leavitt, T., Shih, J., Brunet, A., Rando, T.A., Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging (2013) Cell Rep, 4, pp. 189-204; Guenther, M.G., Levine, S.S., Boyer, L.A., Jaenisch, R., Young, R.A., A chromatin landmark and transcription initiation at most promoters in human cells (2007) Cell, 130, pp. 77-88; Mikkelsen, T.S., Ku, M., Jaffe, D.B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Koche, R.P., Genome-wide maps of chromatin state in pluripotent and lineage-committed cells (2007) Nature, 448, pp. 553-560; Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., Plath, K., A bivalent chromatin structure marks key developmental genes in embryonic stem cells (2006) Cell, 125, pp. 315-326; Marks, H., Kalkan, T., Menafra, R., Denissov, S., Jones, K., Hofemeister, H., Nichols, J., Smith, A., The transcriptional and epigenomic foundations of ground state pluripotency (2012) Cell, 149, pp. 590-604; Cheung, T.H., Rando, T.A., Molecular regulation of stem cell quiescence (2013) Nat Rev Mol Cell Biol, 14, pp. 329-340; Lien, W.H., Guo, X., Polak, L., Lawton, L.N., Young, R.A., Zheng, D., Fuchs, E., Genome-wide maps of histone modifications unwind in vivo chromatin states of the hair follicle lineage (2011) Cell Stem Cell, 9, pp. 219-232; Rodgers, J.T., King, K.Y., Brett, J.O., Cromie, M.J., Charville, G.W., Maguire, K.K., Brunson, C., Tsai, C.R., mTORC1 controls the adaptive transition of quiescent stem cells from G to G (2014) Nature, 510, pp. 393-396; Juan, A.H., Derfoul, A., Feng, X., Ryall, J.G., Dell'orso, S., Pasut, A., Zare, H., Sartorelli, V., Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells (2011) Genes Dev, 25, pp. 789-794; Woodhouse, S., Pugazhendhi, D., Brien, P., Pell, J.M., Ezh2 maintains a key phase of muscle satellite cell expansion but does not regulate terminal differentiation (2013) J Cell Sci, 126, pp. 565-579; Kamminga, L.M., Bystrykh, L.V., De Boer, A., Houwer, S., Douma, J., Weersing, E., Dontje, B., De Haan, G., The polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion (2006) Blood, 107, pp. 2170-2179; Hidalgo, I., Herrera-Merchan, A., Ligos, J.M., Carramolino, L., Nunez, J., Martinez, F., Dominguez, O., Gonzalez, S., Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest (2012) Cell Stem Cell, 11, pp. 649-662; Fujimaki, S., Hidaka, R., Asashima, M., Takemasa, T., Kuwabara, T., Wnt protein-mediated satellite cell conversion in adult and aged mice following voluntary wheel running (2014) J Biol Chem, 289, pp. 7399-7412; Sousa-Victor, P., Gutarra, S., Garcia-Prat, L., Rodriguez-Ubreva, J., Ortet, L., Ruiz-Bonilla, V., Jardi, M., Serrano, A.L., Geriatric muscle stem cells switch reversible quiescence into senescence (2014) Nature, 506, pp. 316-321; Taylor, S.M., Jones, P.A., Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine (1979) Cell, 17, pp. 771-779; Lassar, A.B., Buskin, J.N., Lockshon, D., Hauschka, S.D., Weintraub, H., Davis, R.L., Apone, S., MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer (1989) Cell, 58, pp. 823-831; Palacios, D., Puri, P.L., The epigenetic network regulating muscle development and regeneration (2006) J Cell Physiol, 207, pp. 1-11; Hupkes, M., Jonsson, M.K., Scheenen, W.J., Van Rotterdam, W., Sotoca, A.M., Van Someren, E.P., Van Der Heyden, M.A., Bauerschmidt, S., Epigenetics: DNA demethylation promotes skeletal myotube maturation (2011) FASEB J, 25, pp. 3861-3872; Montesano, A., Luzi, L., Senesi, P., Terruzzi, I., Modulation of cell cycle progression by 5-azacytidine is associated with early myogenesis induction in murine myoblasts (2013) Int J Biol Sci, 9, pp. 391-402; Palacios, D., Summerbell, D., Rigby, P.W., Boyes, J., Interplay between DNA methylation and transcription factor availability: Implications for developmental activation of the mouse Myogenin gene (2010) Mol Cell Biol, 30, pp. 3805-3815; Fuso, A., Ferraguti, G., Grandoni, F., Ruggeri, R., Scarpa, S., Strom, R., Lucarelli, M., Early demethylation of non-CpG, CpC-rich, elements in the myogenin 5′-flanking region: A priming effect on the spreading of active demethylation (2010) Cell Cycle, 9, pp. 3965-3976; Oikawa, Y., Omori, R., Nishii, T., Ishida, Y., Kawaichi, M., Matsuda, E., The methyl-CpG-binding protein CIBZ suppresses myogenic differentiation by directly inhibiting myogenin expression (2011) Cell Res, 21, pp. 1578-1590; Vire, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Vanderwinden, J.M., The Polycomb group protein EZH2 directly controls DNA methylation (2006) Nature, 439, pp. 871-874; Terragni, J., Zhang, G., Sun, Z., Pradhan, S., Song, L., Crawford, G.E., Lacey, M., Ehrlich, M., Notch signaling genes: Myogenic DNA hypomethylation and 5-hydroxymethylcytosine (2014) Epigenetics, 9, pp. 842-850; Schuettengruber, B., Chourrout, D., Vervoort, M., Leblanc, B., Cavalli, G., Genome regulation by polycomb and trithorax proteins (2007) Cell, 128, pp. 735-745; Pietersen, A.M., Van Lohuizen, M., Stem cell regulation by polycomb repressors: Postponing commitment (2008) Curr Opin Cell Biol, 20, pp. 201-207; Caretti, G., Di Padova, M., Micales, B., Lyons, G.E., Sartorelli, V., The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation (2004) Genes Dev, 18, pp. 2627-2638; Mal, A., Harter, M.L., MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis (2003) Proc Natl Acad Sci USA, 100, pp. 1735-1739; Mal, A.K., Histone methyltransferase Suv39 h1 represses MyoD-stimulated myogenic differentiation (2006) EMBO J, 25, pp. 3323-3334; Ling, B.M., Bharathy, N., Chung, T.K., Kok, W.K., Li, S., Tan, Y.H., Rao, V.K., Walsh, M.J., Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation (2012) Proc Natl Acad Sci USA, 109, pp. 841-846; Luo, S.W., Zhang, C., Zhang, B., Kim, C.H., Qiu, Y.Z., Du, Q.S., Mei, L., Xiong, W.C., Regulation of heterochromatin remodelling and myogenin expression during muscle differentiation by FAK interaction with MBD2 (2009) EMBO J, 28, pp. 2568-2582; Cheng, J., Blum, R., Bowman, C., Hu, D., Shilatifard, A., Shen, S., Dynlacht, B.D., A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers (2014) Mol Cell, 53, pp. 979-992; Lu, J., Mckinsey, T.A., Zhang, C.L., Olson, E.N., Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases (2000) Mol Cell, 6, pp. 233-244; Puri, P.L., Iezzi, S., Stiegler, P., Chen, T.T., Schiltz, R.L., Muscat, G.E., Giordano, A., Sartorelli, V., Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis (2001) Mol Cell, 8, pp. 885-897; Fulco, M., Schiltz, R.L., Iezzi, S., King, M.T., Zhao, P., Kashiwaya, Y., Hoffman, E., Sartorelli, V., Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state (2003) Mol Cell, 12, pp. 51-62; Di Padova, M., Caretti, G., Zhao, P., Hoffman, E.P., Sartorelli, V., MyoD acetylation influences temporal patterns of skeletal muscle gene expression (2007) J Biol Chem, 282, pp. 37650-37659; Jin, J., Cai, Y., Li, B., Conaway, R.C., Workman, J.L., Conaway, J.W., Kusch, T., In and out: Histone variant exchange in chromatin (2005) Trends Biochem Sci, 30, pp. 680-687; Happel, N., Doenecke, D., Histone H1 and its isoforms: Contribution to chromatin structure and function (2009) Gene, 431, pp. 1-12; Lee, H., Habas, R., Abate-Shen, C., MSX1 cooperates with histone H1b for inhibition of transcription and myogenesis (2004) Science, 304, pp. 1675-1678; Blais, A., Dynlacht, B.D., E2F-associated chromatin modifiers and cell cycle control (2007) Curr Opin Cell Biol, 19, pp. 658-662; Blais, A., Van Oevelen, C.J., Margueron, R., Acosta-Alvear, D., Dynlacht, B.D., Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit (2007) J Cell Biol, 179, pp. 1399-1412; Ait-Si-Ali, S., Guasconi, V., Fritsch, L., Yahi, H., Sekhri, R., Naguibneva, I., Robin, P., Harel-Bellan, A., A Suv39 h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells (2004) EMBO J, 23, pp. 605-615; Sambasivan, R., Cheedipudi, S., Pasupuleti, N., Saleh, A., Pavlath, G.K., Dhawan, J., The small chromatin-binding protein p8 coordinates the association of anti-proliferative and pro-myogenic proteins at the myogenin promoter (2009) J Cell Sci, 122, pp. 3481-3491; Seenundun, S., Rampalli, S., Liu, Q.C., Aziz, A., Palii, C., Hong, S., Blais, A., Dilworth, F.J., UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis (2010) EMBO J, 29, pp. 1401-1411; Wang, A.H., Zare, H., Mousavi, K., Wang, C., Moravec, C.E., Sirotkin, H.I., Ge, K., Sartorelli, V., The histone chaperone Spt6 coordinates histone H3K27 demethylation and myogenesis (2013) EMBO J, 32, pp. 1075-1086; Stojic, L., Jasencakova, Z., Prezioso, C., Stutzer, A., Bodega, B., Pasini, D., Klingberg, R., Puri, P.L., Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells (2011) Epigenetics Chromatin, 4, p. 16; Mousavi, K., Zare, H., Wang, A.H., Sartorelli, V., Polycomb protein Ezh1 promotes RNA polymerase II elongation (2012) Mol Cell, 45, pp. 255-262; Choi, J., Jang, H., Kim, H., Kim, S.T., Cho, E.J., Youn, H.D., Histone demethylase LSD1 is required to induce skeletal muscle differentiation by regulating myogenic factors (2010) Biochem Biophys Res Commun, 401, pp. 327-332; Verrier, L., Escaffit, F., Chailleux, C., Trouche, D., Vandromme, M., A new isoform of the histone demethylase JMJD2A/KDM4A is required for skeletal muscle differentiation (2011) PLoS Genet, 7; Asp, P., Blum, R., Vethantham, V., Parisi, F., Micsinai, M., Cheng, J., Bowman, C., Dynlacht, B.D., Genome-wide remodeling of the epigenetic landscape during myogenic differentiation (2011) Proc Natl Acad Sci USA, 108, pp. E149-E158; Tao, Y., Neppl, R.L., Huang, Z.P., Chen, J., Tang, R.H., Cao, R., Zhang, Y., Wang, D.Z., The histone methyltransferase Set7/9 promotes myoblast differentiation and myofibril assembly (2011) J Cell Biol, 194, pp. 551-565; Polesskaya, A., Naguibneva, I., Fritsch, L., Duquet, A., Ait-Si-Ali, S., Robin, P., Vervisch, A., Harel-Bellan, A., CBP/p300 and muscle differentiation: No HAT, no muscle (2001) EMBO J, 20, pp. 6816-6825; Dilworth, F.J., Seaver, K.J., Fishburn, A.L., Htet, S.L., Tapscott, S.J., In vitro transcription system delineates the distinct roles of the coactivators pCAF and p300 during MyoD/E47-dependent transactivation (2004) Proc Natl Acad Sci USA, 101, pp. 11593-11598; Simone, C., Forcales, S.V., Hill, D.A., Imbalzano, A.N., Latella, L., Puri, P.L., p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci (2004) Nat Genet, 36, pp. 738-743; Forcales, S.V., Albini, S., Giordani, L., Malecova, B., Cignolo, L., Chernov, A., Coutinho, P., Williams, R., Signal-dependent incorporation of MyoD-BAF60c into Brg1-based SWI/SNF chromatin-remodelling complex (2012) EMBO J, 31, pp. 301-316; Albini, S., Coutinho, P., Malecova, B., Giordani, L., Savchenko, A., Forcales, S.V., Puri, P.L., Epigenetic reprogramming of human embryonic stem cells into skeletal muscle cells and generation of contractile myospheres (2013) Cell Rep, 3, pp. 661-670; Flowers, S., Nagl, Jr.N.G., Beck, Jr.G.R., Moran, E., Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation (2009) J Biol Chem, 284, pp. 10067-10075; Dacwag, C.S., Ohkawa, Y., Pal, S., Sif, S., Imbalzano, A.N., The protein arginine methyltransferase Prmt5 is required for myogenesis because it facilitates ATP-dependent chromatin remodeling (2007) Mol Cell Biol, 27, pp. 384-394; Dacwag, C.S., Bedford, M.T., Sif, S., Imbalzano, A.N., Distinct protein arginine methyltransferases promote ATP-dependent chromatin remodeling function at different stages of skeletal muscle differentiation (2009) Mol Cell Biol, 29, pp. 1909-1921; Lange, M., Kaynak, B., Forster, U.B., Tonjes, M., Fischer, J.J., Grimm, C., Schlesinger, J., Krueger, T., Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex (2008) Genes Dev, 22, pp. 2370-2384; Cuadrado, A., Corrado, N., Perdiguero, E., Lafarga, V., Munoz-Canoves, P., Nebreda, A.R., Essential role of p18Hamlet/SRCAP-mediated histone H2A.Z chromatin incorporation in muscle differentiation (2010) EMBO J, 29, pp. 2014-2025; Eapen, S.A., Netherton, S.J., Sarker, K.P., Deng, L., Chan, A., Riabowol, K., Bonni, S., Identification of a novel function for the chromatin remodeling protein ING2 in muscle differentiation (2012) PLoS One, 7; Hernandez-Hernandez, J.M., Mallappa, C., Nasipak, B.T., Oesterreich, S., Imbalzano, A.N., The Scaffold attachment factor b1 (Safb1) regulates myogenic differentiation by facilitating the transition of myogenic gene chromatin from a repressed to an activated state (2013) Nucleic Acids Res, 41, pp. 5704-5716; Yang, C.C., Liu, H., Chen, S.L., Wang, T.H., Hsieh, C.L., Huang, Y., Chen, S.J., Chin-Ming Tan, B., Epigenetic silencing of myogenic gene program by Myb-binding protein 1a suppresses myogenesis (2012) EMBO J, 31, pp. 1739-1751",Article,Scopus,2-s2.0-84928494154
"Fraineau S., Palii C.G., Allan D.S., Brand M.","Epigenetic regulation of endothelial-cell-mediated vascular repair",2015,"FEBS Journal","282","9",,"1605","1629",,1,10.1111/febs.13183,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928490734&partnerID=40&md5=a8e92a1d779b04a9bba4cb09f7217824","Sprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research InstituteOttawa, ON, Canada; Department of Cellular and Molecular Medicine, University of Ottawa, Canada; Ottawa Institute of Systems Biology, Canada","Fraineau, S., Sprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research InstituteOttawa, ON, Canada, Department of Cellular and Molecular Medicine, University of Ottawa, Canada, Ottawa Institute of Systems Biology, Canada; Palii, C.G., Sprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research InstituteOttawa, ON, Canada, Ottawa Institute of Systems Biology, Canada; Allan, D.S., Sprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research InstituteOttawa, ON, Canada; Brand, M., Sprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research InstituteOttawa, ON, Canada, Department of Cellular and Molecular Medicine, University of Ottawa, Canada, Ottawa Institute of Systems Biology, Canada","Maintenance of vascular integrity is essential for the prevention of vascular disease and for recovery following cardiovascular, cerebrovascular and peripheral vascular events including limb ischemia, heart attack and stroke. Endothelial stem/progenitor cells have recently gained considerable interest due to their potential use in stem cell therapies to mediate revascularization after ischemic injury. Therefore, there is an urgent need to understand fundamental mechanisms regulating vascular repair in specific cell types to develop new beneficial therapeutic interventions. In this review, we highlight recent studies demonstrating that epigenetic mechanisms (including post-translational modifications of DNA and histones as well as non-coding RNA-mediated processes) play essential roles in the regulation of endothelial stem/progenitor cell functions through modifying chromatin structure. Furthermore, we discuss the potential of using small molecules that modulate the activities of epigenetic enzymes to enhance the vascular repair function of endothelial cells and offer insight on potential strategies that may accelerate clinical applications. Endothelial stem/progenitor cells have gained considerable interest due to their potential use in stem cell therapies to mediate revascularization after ischemic injury. We highlight studies demonstrating that epigenetic mechanisms are essential for endothelial cell functions. Furthermore, we discuss the use of epigenetic drugs to enhance the vascular repair function of endothelial cells and propose potential strategies to accelerate clinical applications. © 2014 FEBS.","DNA methylation; endothelial progenitors; epigenetic drugs; epigenetics; histone acetylation; histone methylation; non-coding RNAs; stem cell therapy; transcription factors; vascular ischemic disease","Rama, P., Matuska, S., Paganoni, G., Spinelli, A., De Luca, M., Pellegrini, G., Limbal stem-cell therapy and long-term corneal regeneration (2010) N Engl J Med, 363, pp. 147-155; Tsubota, K., Satake, Y., Kaido, M., Shinozaki, N., Shimmura, S., Bissen-Miyajima, H., Shimazaki, J., Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation (1999) N Engl J Med, 340, pp. 1697-1703; Schwartz, S.D., Hubschman, J.P., Heilwell, G., Franco-Cardenas, V., Pan, C.K., Ostrick, R.M., Mickunas, E., Lanza, R., Embryonic stem cell trials for macular degeneration: a preliminary report (2012) Lancet, 379, pp. 713-720; Ohnishi, K., Semi, K., Yamamoto, T., Shimizu, M., Tanaka, A., Mitsunaga, K., Okita, K., Maeda, T., Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation (2014) Cell, 156, pp. 663-677; Fadini, G.P., Losordo, D., Dimmeler, S., Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use (2012) Circ Res, 110, pp. 624-637; Shantsila, E., Watson, T., Lip, G.Y., Endothelial progenitor cells in cardiovascular disorders (2007) J Am Coll Cardiol, 49, pp. 741-752; Callum, K., Bradbury, A., ABC of arterial and venous disease: acute limb ischaemia (2000) BMJ, 320, pp. 764-767; Creager, M.A., Kaufman, J.A., Conte, M.S., Clinical practice. Acute limb ischemia (2012) N Engl J Med, 366, pp. 2198-2206; Leeper, N.J., Hunter, A.L., Cooke, J.P., Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells (2010) Circulation, 122, pp. 517-526; Asahara, T., Murohara, T., Sullivan, A., Silver, M., Van Der Zee, R., Li, T., Witzenbichler, B., Isner, J.M., Isolation of putative progenitor endothelial cells for angiogenesis (1997) Science, 275, pp. 964-967; Ingram, D.A., Mead, L.E., Tanaka, H., Meade, V., Fenoglio, A., Mortell, K., Pollok, K., Yoder, M.C., Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood (2004) Blood, 104, pp. 2752-2760; Lin, Y., Weisdorf, D.J., Solovey, A., Hebbel, R.P., Origins of circulating endothelial cells and endothelial outgrowth from blood (2000) J Clin Invest, 105, pp. 71-77; Medina, R.J., O'Neill, C.L., Sweeney, M., Guduric-Fuchs, J., Gardiner, T.A., Simpson, D.A., Stitt, A.W., Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities (2010) BMC Med Genomics, 3, p. 18; Critser, P.J., Yoder, M.C., Endothelial colony-forming cell role in neoangiogenesis and tissue repair (2010) Curr Opin Organ Transplant, 15, pp. 68-72; Lee, S.H., Lee, J.H., Asahara, T., Kim, Y.S., Jeong, H.C., Ahn, Y., Jung, J.S., Kwon, S.M., Genistein promotes endothelial colony-forming cell (ECFC) bioactivities and cardiac regeneration in myocardial infarction (2014) PLoS One, 9; Bouvard, C., Gafsou, B., Dizier, B., Galy-Fauroux, I., Lokajczyk, A., Boisson-Vidal, C., Fischer, A.M., Helley, D., alpha6-integrin subunit plays a major role in the proangiogenic properties of endothelial progenitor cells (2010) Arterioscler Thromb Vasc Biol, 30, pp. 1569-1575; Saif, J., Schwarz, T.M., Chau, D.Y., Henstock, J., Sami, P., Leicht, S.F., Hermann, P.C., Shakesheff, K.M., Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization (2010) Arterioscler Thromb Vasc Biol, 30, pp. 1897-1904; Schwarz, T.M., Leicht, S.F., Radic, T., Rodriguez-Araboalaza, I., Hermann, P.C., Berger, F., Saif, J., Aicher, A., Vascular incorporation of endothelial colony-forming cells is essential for functional recovery of murine ischemic tissue following cell therapy (2012) Arterioscler Thromb Vasc Biol, 32, pp. e13-e21; Palii, C.G., Vulesevic, B., Fraineau, S., Pranckeviciene, E., Griffith, A.J., Chu, A., Faralli, H., Sun, J., Trichostatin A enhances vascular repair by injected human endothelial progenitors through increasing the expression of TAL1-dependent genes (2014) Cell Stem Cell, 14, pp. 644-657; Moubarik, C., Guillet, B., Youssef, B., Codaccioni, J.L., Piercecchi, M.D., Sabatier, F., Lionel, P., Velly, L., Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke (2011) Stem Cell Rev, 7, pp. 208-220; Ward, M.R., Stewart, D.J., Kutryk, M.J., Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives (2007) Catheter Cardiovasc Interv, 70, pp. 983-998; Medina, R.J., O'Neill, C.L., Humphreys, M.W., Gardiner, T.A., Stitt, A.W., Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy (2010) Invest Ophthalmol Vis Sci, 51, pp. 5906-5913; Alphonse, R.S., Vadivel, A., Fung, M., Shelley, W.C., Critser, P.J., Ionescu, L., O'Reilly, M., Eaton, F., Existence, functional impairment, and lung repair potential of endothelial colony-forming cells in oxygen-induced arrested alveolar growth (2014) Circulation, 129, pp. 2144-2157; Marcelo, K.L., Goldie, L.C., Hirschi, K.K., Regulation of endothelial cell differentiation and specification (2013) Circ Res, 112, pp. 1272-1287; Park, C., Kim, T.M., Malik, A.B., Transcriptional regulation of endothelial cell and vascular development (2013) Circ Res, 112, pp. 1380-1400; De Val, S., Black, B.L., Transcriptional control of endothelial cell development (2009) Dev Cell, 16, pp. 180-195; Kubo, H., Alitalo, K., The bloody fate of endothelial stem cells (2003) Genes Dev, 17, pp. 322-329; De Val, S., Key transcriptional regulators of early vascular development (2011) Arterioscler Thromb Vasc Biol, 31, pp. 1469-1475; Kume, T., Specification of arterial, venous, and lymphatic endothelial cells during embryonic development (2010) Histol Histopathol, 25, pp. 637-646; Rössig, L., Urbich, C., Brühl, T., Dernbach, E., Heeschen, C., Chavakis, E., Sasaki, K., Seeger, F., Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells (2005) J Exp Med, 201, pp. 1825-1835; Song, Y., Li, X., Wang, D., Fu, C., Zhu, Z., Zou, M.H., Zhu, Y., Transcription factor Krüppel-like factor 2 plays a vital role in endothelial colony forming cells differentiation (2013) Cardiovasc Res, 99, pp. 514-524; Li, B., Carey, M., Workman, J.L., The role of chromatin during transcription (2007) Cell, 128, pp. 707-719; Klose, R.J., Zhang, Y., Regulation of histone methylation by demethylimination and demethylation (2007) Nat Rev Mol Cell Biol, 8, pp. 307-318; Kouzarides, T., Chromatin modifications and their function (2007) Cell, 128, pp. 693-705; Cedar, H., Bergman, Y., Linking DNA methylation and histone modification: patterns and paradigms (2009) Nat Rev Genet, 10, pp. 295-304; Rando, O.J., Chang, H.Y., Genome-wide views of chromatin structure (2009) Annu Rev Biochem, 78, pp. 245-271; Fish, J.E., Matouk, C.C., Rachlis, A., Lin, S., Tai, S.C., D'Abreo, C., Marsden, P.A., The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code (2005) J Biol Chem, 280, pp. 24824-24838; Fish, J.E., Marsden, P.A., Endothelial nitric oxide synthase: insight into cell-specific gene regulation in the vascular endothelium (2006) Cell Mol Life Sci, 63, pp. 144-162; Fish, J.E., Yan, M.S., Matouk, C.C., St Bernard, R., Ho, J.J., Gavryushova, A., Srivastava, D., Marsden, P.A., Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones (2010) J Biol Chem, 285, pp. 810-826; Chan, Y., Fish, J.E., D'Abreo, C., Lin, S., Robb, G.B., Teichert, A.M., Karantzoulis-Fegaras, F., Marsden, P.A., The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation (2004) J Biol Chem, 279, pp. 35087-35100; Goretti, E., Wagner, D.R., Devaux, Y., Regulation of endothelial progenitor cell function by micrornas (2013) Minerva Cardioangiol, 61, pp. 591-604; Eken, S.M., Jin, H., Chernogubova, E., Maegdefessel, L., Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction (2013) J Diabetes Res, 2013, p. 834727; Division of Cardiology, Role of microRNAs in endothelial progenitor cells: implication for cardiac repair (2014) J Stem Cells, 9, pp. 107-115. , Luxembourg, L.xembourg, C. H., Luxembourg, L.xembourg, Luxembourg, L. o. C. R. P. R. C.-H. L. & Luxembourg, D. o. C. C. H. L; Meng, S., Cao, J.T., Zhang, B., Zhou, Q., Shen, C.X., Wang, C.Q., Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1 (2012) J Mol Cell Cardiol, 53, pp. 64-72; Zhang, J., Zhang, Z., Zhang, D.Y., Zhu, J., Zhang, T., Wang, C., microRNA 126 inhibits the transition of endothelial progenitor cells to mesenchymal cells via the PIK3R2-PI3K/Akt signalling pathway (2013) PLoS One, 8; Meng, S., Cao, J., Zhang, X., Fan, Y., Fang, L., Wang, C., Lv, Z., Li, Y., Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3 (2013) PLoS One, 8; Xu, Q., Meng, S., Liu, B., Li, M.Q., Li, Y., Fang, L., Li, Y.G., MicroRNA-130a regulates autophagy of endothelial progenitor cells through Runx3 (2014) Clin Exp Pharmacol Physiol, 41, pp. 351-357; Zhu, S., Deng, S., Ma, Q., Zhang, T., Jia, C., Zhuo, D., Yang, F., Dykxhoorn, D.M., MicroRNA-10A∗ and MicroRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2 (2013) Circ Res, 112, pp. 152-164; Chang, T.Y., Huang, T.S., Wang, H.W., Chang, S.J., Lo, H.H., Chiu, Y.L., Wang, Y.L., Chan, C.H., miRNome traits analysis on endothelial lineage cells discloses biomarker potential circulating microRNAs which affect progenitor activities (2014) BMC Genom, 15, p. 802; Kaikkonen, M.U., Lam, M.T., Glass, C.K., Non-coding RNAs as regulators of gene expression and epigenetics (2011) Cardiovasc Res, 90, pp. 430-440; Robb, G.B., Carson, A.R., Tai, S.C., Fish, J.E., Singh, S., Yamada, T., Scherer, S.W., Marsden, P.A., Post-transcriptional regulation of endothelial nitric-oxide synthase by an overlapping antisense mRNA transcript (2004) J Biol Chem, 279, pp. 37982-37996; Fish, J.E., Matouk, C.C., Yeboah, E., Bevan, S.C., Khan, M., Patil, K., Ohh, M., Marsden, P.A., Hypoxia-inducible expression of a natural cis-antisense transcript inhibits endothelial nitric-oxide synthase (2007) J Biol Chem, 282, pp. 15652-15666; Li, K., Blum, Y., Verma, A., Liu, Z., Pramanik, K., Leigh, N.R., Chun, C.Z., Garnaas, M.K., A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo (2010) Blood, 115, pp. 133-139; Yan, M.S., Matouk, C.C., Marsden, P.A., Epigenetics of the vascular endothelium (2010) J Appl Physiol (1985), 109, pp. 916-926; Kohli, R.M., Zhang, Y., TET enzymes, TDG and the dynamics of DNA demethylation (2013) Nature, 502, pp. 472-479; Banerjee, S., Bacanamwo, M., DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells (2010) Exp Cell Res, 316, pp. 172-180; Shirodkar, A.V., St Bernard, R., Gavryushova, A., Kop, A., Knight, B.J., Yan, M.S., Man, H.S., Oettgen, P., A mechanistic role for DNA methylation in endothelial cell (EC)-enriched gene expression: relationship with DNA replication timing (2013) Blood, 121, pp. 3531-3540; Lagarkova, M.A., Volchkov, P.Y., Philonenko, E.S., Kiselev, S.L., Efficient differentiation of hESCs into endothelial cells in vitro is secured by epigenetic changes (2008) Cell Cycle, 7, pp. 2929-2935; Lagarkova, M.A., Shutova, M.V., Bogomazova, A.N., Vassina, E.M., Glazov, E.A., Zhang, P., Rizvanov, A.A., Kiselev, S.L., Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale (2010) Cell Cycle, 9, pp. 937-946; Ohtani, K., Vlachojannis, G.J., Koyanagi, M., Boeckel, J.N., Urbich, C., Farcas, R., Bonig, H., Dimmeler, S., Epigenetic regulation of endothelial lineage committed genes in pro-angiogenic hematopoietic and endothelial progenitor cells (2011) Circ Res, 109, pp. 1219-1229; Marks, P.A., Xu, W.S., Histone deacetylase inhibitors: potential in cancer therapy (2009) J Cell Biochem, 107, pp. 600-608; Marks, P.A., Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions (2010) Biochim Biophys Acta, 1799, pp. 717-725; Roth, S.Y., Denu, J.M., Allis, C.D., Histone acetyltransferases (2001) Annu Rev Biochem, 70, pp. 81-120; Smith, B.C., Denu, J.M., Chemical mechanisms of histone lysine and arginine modifications (2009) Biochim Biophys Acta, 1789, pp. 45-57; Kuo, M.H., Allis, C.D., Roles of histone acetyltransferases and deacetylases in gene regulation (1998) BioEssays, 20, pp. 615-626; Gray, S.G., Ekström, T.J., The human histone deacetylase family (2001) Exp Cell Res, 262, pp. 75-83; Guarani, V., Deflorian, G., Franco, C.A., Krüger, M., Phng, L.K., Bentley, K., Toussaint, L., Schmidt, M.H., Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase (2011) Nature, 473, pp. 234-238; Potente, M., Dimmeler, S., Emerging roles of SIRT1 in vascular endothelial homeostasis (2008) Cell Cycle, 7, pp. 2117-2122; De Ruijter, A.J., Van Gennip, A.H., Caron, H.N., Kemp, S., Van Kuilenburg, A.B., Histone deacetylases (HDACs): characterization of the classical HDAC family (2003) Biochem J, 370, pp. 737-749; Bolden, J.E., Peart, M.J., Johnstone, R.W., Anticancer activities of histone deacetylase inhibitors (2006) Nat Rev Drug Discov, 5, pp. 769-784; Lf, C., Fischle, W., Verdin, E., Greene, W.C., Duration of nuclear NF-kappaB action regulated by reversible acetylation (2001) Science, 293, pp. 1653-1657; Crosson, C.E., Mani, S.K., Husain, S., Alsarraf, O., Menick, D.R., Inhibition of histone deacetylase protects the retina from ischemic injury (2010) Invest Ophthalmol Vis Sci, 51, pp. 3639-3645; Zhang, Z., Qin, X., Tong, N., Zhao, X., Gong, Y., Shi, Y., Wu, X., Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation (2012) Exp Eye Res, 94, pp. 98-108; Granger, A., Abdullah, I., Huebner, F., Stout, A., Wang, T., Huebner, T., Epstein, J.A., Gruber, P.J., Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice (2008) FASEB J, 22, pp. 3549-3560; Illi, B., Scopece, A., Nanni, S., Farsetti, A., Morgante, L., Biglioli, P., Capogrossi, M.C., Gaetano, C., Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress (2005) Circ Res, 96, pp. 501-508; Chen, W., Bacanamwo, M., Harrison, D.G., Activation of p300 histone acetyltransferase activity is an early endothelial response to laminar shear stress and is essential for stimulation of endothelial nitric-oxide synthase mRNA transcription (2008) J Biol Chem, 283, pp. 16293-16298; Kaur, H., Chen, S., Xin, X., Chiu, J., Khan, Z.A., Chakrabarti, S., Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300 (2006) Diabetes, 55, pp. 3104-3111; Wei, J.Q., Shehadeh, L.A., Mitrani, J.M., Pessanha, M., Slepak, T.I., Webster, K.A., Bishopric, N.H., Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300 (2008) Circulation, 118, pp. 934-946; Shehadeh, L.A., Sharma, S., Pessanha, M., Wei, J.Q., Liu, J., Yuan, H., Rodrigues, C.O., Bishopric, N.H., MicroRNA-20a constrains p300-driven myocardial angiogenic transcription by direct targeting of p300 (2013) PLoS One, 8; Arany, Z., Huang, L.E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M.A., Bunn, H.F., Livingston, D.M., An essential role for p300/CBP in the cellular response to hypoxia (1996) Proc Natl Acad Sci USA, 93, pp. 12969-12973; Chiu, J.J., Chien, S., Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives (2011) Physiol Rev, 91, pp. 327-387; Hahn, C., Schwartz, M.A., Mechanotransduction in vascular physiology and atherogenesis (2009) Nat Rev Mol Cell Biol, 10, pp. 53-62; Chiu, J.J., Usami, S., Chien, S., Vascular endothelial responses to altered shear stress: pathologic implications for atherosclerosis (2009) Ann Med, 41, pp. 19-28; Traub, O., Berk, B.C., Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force (1998) Arterioscler Thromb Vasc Biol, 18, pp. 677-685; Lee, D.Y., Lee, C.I., Lin, T.E., Lim, S.H., Zhou, J., Tseng, Y.C., Chien, S., Chiu, J.J., Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow (2012) Proc Natl Acad Sci USA, 109, pp. 1967-1972; Gan, Y., Shen, Y.H., Wang, J., Wang, X., Utama, B., Wang, X.L., Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase (2005) J Biol Chem, 280, pp. 16467-16475; Hyndman, K.A., Ho, D.H., Sega, M.F., Pollock, J.S., Histone deacetylase 1 reduces NO production in endothelial cells via lysine deacetylation of NO synthase 3 (2014) Am J Physiol Heart Circ Physiol, 307, p. 5; Nishida, K., Harrison, D.G., Navas, J.P., Fisher, A.A., Dockery, S.P., Uematsu, M., Nerem, R.M., Murphy, T.J., Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase (1992) J Clin Invest, 90, pp. 2092-2096; Fleming, I., Busse, R., Signal transduction of eNOS activation (1999) Cardiovasc Res, 43, pp. 532-541; Zeng, L., Zhang, Y., Chien, S., Liu, X., Shyy, J.Y., The role of p53 deacetylation in p21Waf1 regulation by laminar flow (2003) J Biol Chem, 278, pp. 24594-24599; Pandey, D., Sikka, G., Bergman, Y., Kim, J.H., Ryoo, S., Romer, L., Berkowitz, D., Transcriptional regulation of endothelial arginase 2 by histone deacetylase 2 (2014) Arterioscler Thromb Vasc Biol, 34, pp. 1556-1566; Fan, J., Alsarraf, O., Dahrouj, M., Platt, K.A., Chou, C.J., Rice, D.S., Crosson, C.E., Inhibition of HDAC2 protects the retina from ischemic injury (2013) Invest Ophthalmol Vis Sci, 54, pp. 4072-4080; Xiao, Q., Zeng, L., Zhang, Z., Margariti, A., Ali, Z.A., Channon, K.M., Xu, Q., Hu, Y., Sca-1+ progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury (2006) Arterioscler Thromb Vasc Biol, 26, pp. 2244-2251; Zeng, L., Xiao, Q., Margariti, A., Zhang, Z., Zampetaki, A., Patel, S., Capogrossi, M.C., Xu, Q., HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells (2006) J Cell Biol, 174, pp. 1059-1069; Zampetaki, A., Zeng, L., Margariti, A., Xiao, Q., Li, H., Zhang, Z., Pepe, A.E., DeFalco, E., Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow (2010) Circulation, 121, pp. 132-142; Zeng, L., Wang, G., Ummarino, D., Margariti, A., Xu, Q., Xiao, Q., Wang, W., Mayr, M., Histone deacetylase 3 unconventional splicing mediates endothelial-to-mesenchymal transition through transforming growth factor β2 (2013) J Biol Chem, 288, pp. 31853-31866; Chang, S., McKinsey, T.A., Zhang, C.L., Richardson, J.A., Hill, J.A., Olson, E.N., Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development (2004) Mol Cell Biol, 24, pp. 8467-8476; Chang, S., Young, B.D., Li, S., Qi, X., Richardson, J.A., Olson, E.N., Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10 (2006) Cell, 126, pp. 321-334; Wang, S., Li, X., Parra, M., Verdin, E., Bassel-Duby, R., Olson, E.N., Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7 (2008) Proc Natl Acad Sci USA, 105, pp. 7738-7743; Sun, X., Wei, L., Chen, Q., Terek, R.M., HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity (2009) J Biol Chem, 284, pp. 21881-21890; Urbich, C., Rössig, L., Kaluza, D., Potente, M., Boeckel, J.N., Knau, A., Diehl, F., Zeiher, A.M., HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells (2009) Blood, 113, pp. 5669-5679; Ha, C.H., Wang, W., Jhun, B.S., Wong, C., Hausser, A., Pfizenmaier, K., McKinsey, T.A., Jin, Z.G., Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis (2008) J Biol Chem, 283, pp. 14590-14599; Kwon, I.S., Wang, W., Xu, S., Jin, Z.G., Histone deacetylase 5 interacts with Krüppel-like factor 2 and inhibits its transcriptional activity in endothelium (2014) Cardiovasc Res, 104, pp. 127-137; Illi, B., Dello Russo, C., Colussi, C., Rosati, J., Pallaoro, M., Spallotta, F., Rotili, D., Martelli, F., Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling (2008) Circ Res, 102, pp. 51-58; Mottet, D., Bellahcène, A., Pirotte, S., Waltregny, D., Deroanne, C., Lamour, V., Lidereau, R., Castronovo, V., Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis (2007) Circ Res, 101, pp. 1237-1246; Turtoi, A., Mottet, D., Matheus, N., Dumont, B., Peixoto, P., Hennequière, V., Deroanne, C., Bellahcène, A., The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells (2012) Angiogenesis, 15, pp. 543-554; Margariti, A., Zampetaki, A., Xiao, Q., Zhou, B., Karamariti, E., Martin, D., Yin, X., Zhang, Z., Histone deacetylase 7 controls endothelial cell growth through modulation of beta-catenin (2010) Circ Res, 106, pp. 1202-1211; Margariti, A., Xiao, Q., Zampetaki, A., Zhang, Z., Li, H., Martin, D., Hu, Y., Xu, Q., Splicing of HDAC7 modulates the SRF-myocardin complex during stem-cell differentiation towards smooth muscle cells (2009) J Cell Sci, 122, pp. 460-470; Ha, C.H., Jhun, B.S., Kao, H.Y., Jin, Z.G., VEGF stimulates HDAC7 phosphorylation and cytoplasmic accumulation modulating matrix metalloproteinase expression and angiogenesis (2008) Arterioscler Thromb Vasc Biol, 28, pp. 1782-1788; Yu, D., Chen, W., Ren, J., Zhang, T., Yang, K., Wu, G., Liu, H., VEGF-PKD1-HDAC7 signaling promotes endothelial progenitor cell migration and tube formation (2014) Microvasc Res, 91, pp. 66-72; Kaluza, D., Kroll, J., Gesierich, S., Manavski, Y., Boeckel, J.N., Doebele, C., Zelent, A., Augustin, H.G., Histone deacetylase 9 promotes angiogenesis by targeting the antiangiogenic microRNA-17-92 cluster in endothelial cells (2013) Arterioscler Thromb Vasc Biol, 33, pp. 533-543; Kaluza, D., Kroll, J., Gesierich, S., Yao, T.P., Boon, R.A., Hergenreider, E., Tjwa, M., Augustin, H.G., Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin (2011) EMBO J, 30, pp. 4142-4156; Potente, M., Ghaeni, L., Baldessari, D., Mostoslavsky, R., Rossig, L., Dequiedt, F., Haendeler, J., Alt, F.W., SIRT1 controls endothelial angiogenic functions during vascular growth (2007) Genes Dev, 21, pp. 2644-2658; Mattagajasingh, I., Kim, C.S., Naqvi, A., Yamamori, T., Hoffman, T.A., Jung, S.B., DeRicco, J., Irani, K., SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase (2007) Proc Natl Acad Sci USA, 104, pp. 14855-14860; Hou, J., Chong, Z.Z., Shang, Y.C., Maiese, K., Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation (2010) Curr Neurovasc Res, 7, pp. 95-112; Zu, Y., Liu, L., Lee, M.Y., Xu, C., Liang, Y., Man, R.Y., Vanhoutte, P.M., Wang, Y., SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells (2010) Circ Res, 106, pp. 1384-1393; Vassallo, P.F., Simoncini, S., Ligi, I., Chateau, A.L., Bachelier, R., Robert, S., Morere, J., Marcelli, M., Accelerated senescence of cord blood endothelial progenitor cells in premature neonates is driven by SIRT1 decreased expression (2014) Blood, 123, pp. 2116-2126; Cloos, P.A., Christensen, J., Agger, K., Helin, K., Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease (2008) Genes Dev, 22, pp. 1115-1140; Zhou, V.W., Goren, A., Bernstein, B.E., Charting histone modifications and the functional organization of mammalian genomes (2011) Nat Rev Genet, 12, pp. 7-18; Calo, E., Wysocka, J., Modification of enhancer chromatin: what, how, and why? (2013) Mol Cell, 49, pp. 825-837; Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., Plath, K., A bivalent chromatin structure marks key developmental genes in embryonic stem cells (2006) Cell, 125, pp. 315-326; Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S.A., Flynn, R.A., Wysocka, J., A unique chromatin signature uncovers early developmental enhancers in humans (2011) Nature, 470, pp. 279-283; Gifford, C.A., Ziller, M.J., Gu, H., Trapnell, C., Donaghey, J., Tsankov, A., Shalek, A.K., Issner, R., Transcriptional and epigenetic dynamics during specification of human embryonic stem cells (2013) Cell, 153, pp. 1149-1163; Voigt, P., Tee, W.W., Reinberg, D., A double take on bivalent promoters (2013) Genes Dev, 27, pp. 1318-1338; Varier, R.A., Timmers, H.T., Histone lysine methylation and demethylation pathways in cancer (2011) Biochim Biophys Acta, 1815, pp. 75-89; Eissenberg, J.C., Shilatifard, A., Histone H3 lysine 4 (H3K4) methylation in development and differentiation (2010) Dev Biol, 339, pp. 240-249; Ernst, P., Vakoc, C.R., WRAD: enabler of the SET1-family of H3K4 methyltransferases (2012) Brief Funct Genomics, 11, pp. 217-226; Ernst, P., Mabon, M., Davidson, A.J., Zon, L.I., Korsmeyer, S.J., An Mll-dependent Hox program drives hematopoietic progenitor expansion (2004) Curr Biol, 14, pp. 2063-2069; Ernst, P., Fisher, J.K., Avery, W., Wade, S., Foy, D., Korsmeyer, S.J., Definitive hematopoiesis requires the mixed-lineage leukemia gene (2004) Dev Cell, 6, pp. 437-443; Hess, J.L., Yu, B.D., Li, B., Hanson, R., Korsmeyer, S.J., Defects in yolk sac hematopoiesis in Mll-null embryos (1997) Blood, 90, pp. 1799-1806; Diehl, F., Rössig, L., Zeiher, A.M., Dimmeler, S., Urbich, C., The histone methyltransferase MLL is an upstream regulator of endothelial-cell sprout formation (2007) Blood, 109, pp. 1472-1478; Li, Q., Shi, L., Gui, B., Yu, W., Wang, J., Zhang, D., Han, X., Shang, Y., Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14 (2011) Cancer Res, 71, pp. 6899-6908; Pojoga, L.H., Williams, J.S., Yao, T.M., Kumar, A., Raffetto, J.D., Do Nascimento, G.R., Reslan, O.M., Shi, Y., Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension (2011) Am J Physiol Heart Circ Physiol, 301, pp. H1862-H1871; Wang, G.G., Allis, C.D., Chi, P., Chromatin remodeling and cancer. Part I: Covalent histone modifications (2007) Trends Mol Med, 13, pp. 363-372; Black, J.C., Van Rechem, C., Whetstine, J.R., Histone lysine methylation dynamics: establishment, regulation, and biological impact (2012) Mol Cell, 48, pp. 491-507; Snowden, A.W., Gregory, P.D., Case, C.C., Pabo, C.O., Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo (2002) Curr Biol, 12, pp. 2159-2166; Varambally, S., Dhanasekaran, S.M., Zhou, M., Barrette, T.R., Kumar-Sinha, C., Sanda, M.G., Ghosh, D., Otte, A.P., The polycomb group protein EZH2 is involved in progression of prostate cancer (2002) Nature, 419, pp. 624-629; Kleer, C.G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S.A., Ghosh, D., Hayes, D.F., EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells (2003) Proc Natl Acad Sci USA, 100, pp. 11606-11611; Tonini, T., D'Andrilli, G., Fucito, A., Gaspa, L., Bagella, L., Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements (2008) J Cell Physiol, 214, pp. 295-300; Richter, G.H., Plehm, S., Fasan, A., Rössler, S., Unland, R., Bennani-Baiti, I.M., Hotfilder, M., Mossbrugger, I., EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation (2009) Proc Natl Acad Sci USA, 106, pp. 5324-5329; Lu, C., Han, H.D., Mangala, L.S., Ali-Fehmi, R., Newton, C.S., Ozbun, L., Armaiz-Pena, G.N., Munkarah, A., Regulation of tumor angiogenesis by EZH2 (2010) Cancer Cell, 18, pp. 185-197; Smits, M., Mir, S.E., Nilsson, R.J., Van Der Stoop, P.M., Niers, J.M., Marquez, V.E., Cloos, J., Noske, D.P., Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2 (2011) PLoS One, 6; Dreger, H., Ludwig, A., Weller, A., Stangl, V., Baumann, G., Meiners, S., Stangl, K., Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells (2012) Hypertension, 60, pp. 1176-1183; Mitic, T., Caporali, A., Floris, I., Meloni, M., Marchetti, M., Urrutia, R., Angelini, G.D., Emanueli, C., EZH2 modulates angiogenesis in vitro and in a mouse model of limb ischemia (2015) Mol Ther, 23, pp. 32-42; Dalgliesh, G.L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Latimer, C., Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes (2010) Nature, 463, pp. 360-363; Agger, K., Cloos, P.A., Christensen, J., Pasini, D., Rose, S., Rappsilber, J., Issaeva, I., Helin, K., UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development (2007) Nature, 449, pp. 731-734; Zhang, Q.H., Ye, M., Wu, X.Y., Ren, S.X., Zhao, M., Zhao, C.J., Fu, G., Lu, G., Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells (2000) Genome Res, 10, pp. 1546-1560; Hu, M., Sun, X.J., Zhang, Y.L., Kuang, Y., Hu, C.Q., Wu, W.L., Shen, S.H., He, F., Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling (2010) Proc Natl Acad Sci USA, 107, pp. 2956-2961; Khan, C., Pathe, N., Fazal, S., Lister, J., Rossetti, J.M., Azacitidine in the management of patients with myelodysplastic syndromes (2012) Ther Adv Hematol, 3, pp. 355-373; Derissen, E.J., Beijnen, J.H., Schellens, J.H., Concise drug review: azacitidine and decitabine (2013) Oncologist, 18, pp. 619-624; Dhanak, D., Jackson, P., Development and classes of epigenetic drugs for cancer (2014) Biochem Biophys Res Commun, 455, pp. 58-69; Rafehi, H., Balcerczyk, A., Lunke, S., Kaspi, A., Ziemann, M., Kn, H., Okabe, J., Khan, A.W., Vascular histone deacetylation by pharmacological HDAC inhibition (2014) Genome Res, 24, pp. 1271-1284; Iordache, F., Buzila, C., Constantinescu, A., Andrei, E., Maniu, H., Histone deacetylase (HDAC) inhibitors down-regulate endothelial lineage commitment of umbilical cord blood derived endothelial progenitor cells (2012) Int J Mol Sci, 13, pp. 15074-15085; Rössig, L., Li, H., Fisslthaler, B., Urbich, C., Fleming, I., Förstermann, U., Zeiher, A.M., Dimmeler, S., Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis (2002) Circ Res, 91, pp. 837-844; Gan, Y., Shen, Y.H., Utama, B., Wang, J., Coselli, J., Wang, X.L., Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells (2006) Biochem Biophys Res Commun, 340, pp. 29-34; Thaler, F., Minucci, S., Next generation histone deacetylase inhibitors: the answer to the search for optimized epigenetic therapies? (2011) Expert Opin Drug Discov, 6, pp. 393-404; Ria, R., Catacchio, I., Berardi, S., De Luisi, A., Caivano, A., Piccoli, C., Ruggieri, V., Nico, B., HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target (2014) Clin Cancer Res, 20, pp. 847-858; Michaelis, M., Michaelis, U.R., Fleming, I., Suhan, T., Cinatl, J., Blaheta, R.A., Hoffmann, K., Nau, H., Valproic acid inhibits angiogenesis in vitro and in vivo (2004) Mol Pharmacol, 65, pp. 520-527; Michaelis, M., Suhan, T., Michaelis, U.R., Beek, K., Rothweiler, F., Tausch, L., Werz, O., Nau, H., Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells (2006) Cell Death Differ, 13, pp. 446-453; Dokmanovic, M., Clarke, C., Marks, P.A., Histone deacetylase inhibitors: overview and perspectives (2007) Mol Cancer Res, 5, pp. 981-989; Lee, M.G., Wynder, C., Schmidt, D.M., McCafferty, D.G., Shiekhattar, R., Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications (2006) Chem Biol, 13, pp. 563-567; Konovalov, S., Garcia-Bassets, I., Analysis of the levels of lysine-specific demethylase 1 (LSD1) mRNA in human ovarian tumors and the effects of chemical LSD1 inhibitors in ovarian cancer cell lines (2013) J Ovarian Res, 6, p. 75; Schenk, T., Chen, W.C., Göllner, S., Howell, L., Jin, L., Hebestreit, K., Klein, H.U., Mills, K., Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia (2012) Nat Med, 18, pp. 605-611; Shi, L., Cui, S., Engel, J.D., Tanabe, O., Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction (2013) Nat Med, 19, pp. 291-294; Glazer, R.I., Hartman, K.D., Knode, M.C., Richard, M.M., Chiang, P.K., Tseng, C.K., Marquez, V.E., 3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60 (1986) Biochem Biophys Res Commun, 135, pp. 688-694; Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P.L., Karuturi, R.K., Yu, Q., Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells (2007) Genes Dev, 21, pp. 1050-1063; Miranda, T.B., Cortez, C.C., Yoo, C.B., Liang, G., Abe, M., Kelly, T.K., Marquez, V.E., Jones, P.A., DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation (2009) Mol Cancer Ther, 8, pp. 1579-1588; McCabe, M.T., Ott, H.M., Ganji, G., Korenchuk, S., Thompson, C., Van Aller, G.S., Liu, Y., Diaz, E., EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations (2012) Nature, 492, pp. 108-112; Verma, S.K., Tian, X., LaFrance, L.V., Duquenne, C., Suarez, D.P., Newlander, K.A., Romeril, S.P., Brackley, J.A., Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2 (2012) ACS Med Chem Lett, 3, pp. 1091-1096; Knutson, S.K., Wigle, T.J., Warholic, N.M., Sneeringer, C.J., Allain, C.J., Klaus, C.R., Sacks, J.D., Song, J., A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells (2012) Nat Chem Biol, 8, pp. 890-896; Amatangelo, M.D., Garipov, A., Li, H., Conejo-Garcia, J.R., Speicher, D.W., Zhang, R., Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition (2013) Cell Cycle, 12, pp. 2113-2119; Béguelin, W., Popovic, R., Teater, M., Jiang, Y., Bunting, K.L., Rosen, M., Shen, H., Ezponda, T., EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation (2013) Cancer Cell, 23, pp. 677-692; Mozzetta, C., Pontis, J., Fritsch, L., Robin, P., Portoso, M., Proux, C., Margueron, R., Ait-Si-Ali, S., The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing (2014) Mol Cell, 53, pp. 277-289; Han, H., Yang, X., Pandiyan, K., Liang, G., Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells (2013) PLoS One, 8; Fiskus, W., Sharma, S., Shah, B., Portier, B.P., Devaraj, S.G., Liu, K., Iyer, S.P., Bhalla, K.N., Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells (2014) Leukemia, 28, pp. 2155-2164",Article,Scopus,2-s2.0-84928490734
"Pripuzova N.S., Getie-Kebtie M., Grunseich C., Sweeney C., Malech H., Alterman M.A.","Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis",2015,"Stem Cell Research","14","3",,"323","338",,,10.1016/j.scr.2015.01.009,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925947361&partnerID=40&md5=87968065b4153bc5f681fc21377ccd63","Tumor Vaccine and Biotechnology Branch, Division of Cellular and Gene Therapies, FDA, Center for Biologics Evaluation and ResearchBethesda, MD, United States; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthBethesda, MD, United States; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of HealthBethesda, MD, United States","Pripuzova, N.S., Tumor Vaccine and Biotechnology Branch, Division of Cellular and Gene Therapies, FDA, Center for Biologics Evaluation and ResearchBethesda, MD, United States; Getie-Kebtie, M., Tumor Vaccine and Biotechnology Branch, Division of Cellular and Gene Therapies, FDA, Center for Biologics Evaluation and ResearchBethesda, MD, United States; Grunseich, C., Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthBethesda, MD, United States; Sweeney, C., Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of HealthBethesda, MD, United States; Malech, H., Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of HealthBethesda, MD, United States; Alterman, M.A., Tumor Vaccine and Biotechnology Branch, Division of Cellular and Gene Therapies, FDA, Center for Biologics Evaluation and ResearchBethesda, MD, United States","The emergence of new methods for reprogramming of adult somatic cells into induced pluripotent stem cells (iPSC) led to the development of new approaches in drug discovery and regenerative medicine. Investigation of the molecular mechanisms underlying the self-renewal, expansion and differentiation of human iPSC (hiPSC) should lead to improvements in the manufacture of safe and reliable cell therapy products. The goal of our study was qualitative and quantitative proteomic characterizations of hiPSC by means of electrospray ionization (ESI)-MSe and MALDI-TOF/TOF mass spectrometry (MS). Proteomes of hiPSCs of different somatic origins: fibroblasts and peripheral blood CD34+ cells, reprogrammed by the same technique, were compared with the original somatic cells and hESC. Quantitative proteomic comparison revealed approximately 220 proteins commonly up-regulated in all three pluripotent stem cell lines compared to the primary cells. Expression of 21 proteins previously reported as pluripotency markers was up-regulated in both hiPSCs (8 were confirmed by Western blot). A number of novel candidate marker proteins with the highest fold-change difference between hiPSCs/hESC and somatic cells discovered by MS were confirmed by Western blot. A panel of 22 candidate marker proteins of hiPSC was developed and expression of these proteins was confirmed in 8 additional hiPSC lines. © 2015.",,"Bachy, I., Franck, M.C., Li, L., Abdo, H., Pattyn, A., Ernfors, P., The transcription factor Cux2 marks development of an A-delta sublineage of TrkA sensory neurons (2011) Dev. Biol., 360, pp. 77-86; Bar-Nur, O., Russ, H.A., Efrat, S., Benvenisty, N., Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells (2011) Cell Stem Cell, 9, pp. 17-23; Benevento, M., Munoz, J., Role of mass spectrometry-based proteomics in the study of cellular reprogramming and induced pluripotent stem cells (2012) Expert Rev. Proteomics, 9, pp. 379-399; Bock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z.D., Ziller, M., Meissner, A., Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines (2011) Cell, 144, pp. 439-452; Bodnar, W.M., Blackburn, R.K., Krise, J.M., Moseley, M.A., Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage (2003) J. Am. Soc. Mass Spectrom., 14 (9), pp. 971-979; Bradley, E., Bieberich, E., Mivechi, N.F., Tangpisuthipongsa, D., Wang, G., Regulation of embryonic stem cell pluripotency by heat shock protein 90 (2012) Stem Cells, 30, pp. 1624-1633; Chen, H., Chuang, C.Y., Lee, W.C., Huang, H.P., Wu, H.C., Ho, H.N., Chen, Y.J., Kuo, H.C., Surface marker epithelial cell adhesion molecule and E-cadherin facilitate the identification and selection of induced pluripotent stem cells (2011) Stem Cell Rev., 7, pp. 722-735; Chin, M.H., Mason, M.J., Xie, W., Volinia, S., Singer, M., Peterson, C., Ambartsumyan, G., Lowry, W.E., Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures (2009) Cell Stem Cell, 5, pp. 111-123; Conforto, T.L., Zhang, Y., Sherman, J., Waxman, D.J., Impact of CUX2 on the female mouse liver transcriptome: activation of female-biased genes and repression of male-biased genes (2012) Mol. Cell. Biol., 32, pp. 4611-4627; Cubelos, B., Sebastian-Serrano, A., Beccari, L., Calcagnotto, M.E., Cisneros, E., Kim, S., Dopazo, A., Nieto, M., Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex (2010) Neuron, 66, pp. 523-535; Folmes, C.D., Arrell, D.K., Zlatkovic-Lindor, J., Martinez-Fernandez, A., Perez-Terzic, C., Nelson, T.J., Terzic, A., Metabolome and metaboproteome remodeling in nuclear reprogramming (2013) Cell Cycle, 12, pp. 2355-2365; Ghosh, Z., Wilson, K.D., Wu, Y., Hu, S., Quertermous, T., Wu, J.C., Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells (2010) PLoS One, 5, p. e8975; Grunseich, C., Zukosky, K., Kats, I.R., Ghosh, L., Harmison, G.G., Bott, L.C., Rinaldi, C., Fischbeck, K.H., Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients (2014) Neurobiol. Dis., 70, pp. 12-20; Heller, M., Mattou, H., Menzel, C., Yao, X., Trypsin catalyzed 16O-to-18O exchange for comparative proteomics: tandem mass spectrometry comparison using MALDI-TOF, ESI-QTOF, and ESI-ion trap mass spectrometers (2003) J. Am. Soc. Mass Spectrom., 14 (7), pp. 704-718; Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Daley, G.Q., Epigenetic memory in induced pluripotent stem cells (2010) Nature, 467, pp. 285-290; Kim, S.Y., Kim, M.J., Jung, H., Kim, W.K., Kwon, S.O., Son, M.J., Jang, I.S., Bae, K.H., Comparative proteomic analysis of human somatic cells, induced pluripotent stem cells, and embryonic stem cells (2012) Stem Cells Dev., 21, pp. 1272-1286; Lee, S.B., Seo, D., Choi, D., Park, K.Y., Holczbauer, A., Marquardt, J.U., Conner, E.A., Thorgeirsson, S.S., Contribution of hepatic lineage stage-specific donor memory to the differential potential of induced mouse pluripotent stem cells (2012) Stem Cells, 30, pp. 997-1007; Liu, J., Yang, T., Liu, Y., Zhang, H., Wang, K., Liu, M., Chen, G., Xiao, X., Kruppel-like factor 4 inhibits the expression of interleukin-1 beta in lipopolysaccharide-induced RAW264.7 macrophages (2012) FEBS Lett., 586, pp. 834-840; Loh, Y.H., Agarwal, S., Park, I.H., Urbach, A., Huo, H., Heffner, G.C., Kim, K., Daley, G.Q., Generation of induced pluripotent stem cells from human blood (2009) Blood, 113, pp. 5476-5479; Loh, Y.H., Hartung, O., Li, H., Guo, C., Sahalie, J.M., Manos, P.D., Urbach, A., Daley, G.Q., Reprogramming of T cells from human peripheral blood (2010) Cell Stem Cell, 7, pp. 15-19; Lowry, W.E., Richter, L., Yachechko, R., Pyle, A.D., Tchieu, J., Sridharan, R., Clark, A.T., Plath, K., Generation of human induced pluripotent stem cells from dermal fibroblasts (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 2883-2888; Ma, H., Morey, R., O'Neil, R.C., He, Y., Daughtry, B., Schultz, M.D., Hariharan, M., Mitalipov, S., Abnormalities in human pluripotent cells due to reprogramming mechanisms (2014) Nature, 511, pp. 177-183; Marchetto, M.C., Yeo, G.W., Kainohana, O., Marsala, M., Gage, F.H., Muotri, A.R., Transcriptional signature and memory retention of human-induced pluripotent stem cells (2009) PLoS One, 4, p. e7076; Menendez, J.A., Vellon, L., Oliveras-Ferraros, C., Cufi, S., Vazquez-Martin, A., MTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging (2011) Cell Cycle, 10, pp. 3658-3677; Merling, R.K., Sweeney, C.L., Choi, U., De Ravin, S.S., Myers, T.G., Otaizo-Carrasquero, F., Pan, J., Malech, H.L., Transgene-free iPSCs generated from small volume peripheral blood non-mobilized CD34+ cells (2013) Blood, 121, pp. e98-e107; Mindaye, S.T., Ra, M., Lo Surdo, J., Bauer, S.R., Alterman, M.A., Improved proteomic profiling of the cell surface of culture-expanded human bone marrow multipotent stromal cells (2013) J. Proteomics, 78, pp. 1-14; Mindaye, S.T., Ra, M., Lo Surdo, J.L., Bauer, S.R., Alterman, M.A., Global proteomic signature of undifferentiated human bone marrow stromal cells: evidence for donor-to-donor proteome heterogeneity (2013) Stem Cell Res., 11, pp. 793-805; Montserrat, N., Ramirez-Bajo, M.J., Xia, Y., Sancho-Martinez, I., Moya-Rull, D., Miquel-Serra, L., Yang, S., Campistol, J.M., Generation of induced pluripotent stem cells from human renal proximal tubular cells with only two transcription factors, OCT4 and SOX2 (2012) J. Biol. Chem., 287, pp. 24131-24138; Muller, G., Tarasov, K.V., Gundry, R.L., Boheler, K.R., Human ESC/iPSC-based ""omics"" and bioinformatics for translational research (2012) Drug Discov. Today Dis. Model., 9, pp. e161-e170; Munoz, J., Low, T.Y., Kok, Y.J., Chin, A., Frese, C.K., Ding, V., Choo, A., Heck, A.J., The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells (2011) Mol. Syst. Biol., 7, p. 550; Oguro-Okano, M., Griesmann, G.E., Wieben, E.D., Slaymaker, S.J., Snutch, T.P., Lennon, V.A., Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma (1992) Mayo Clin. Proc., 67, pp. 1150-1159; Phanstiel, D.H., Brumbaugh, J., Wenger, C.D., Tian, S., Probasco, M.D., Bailey, D.J., Swaney, D.L., Coon, J.J., Proteomic and phosphoproteomic comparison of human ES and iPS cells (2011) Nat. Methods, 8, pp. 821-827; Prieto, I., Pezzi, N., Buesa, J.M., Kremer, L., Barthelemy, I., Carreiro, C., Roncal, F., Barbero, J.L., STAG2 and Rad21 mammalian mitotic cohesins are implicated in meiosis (2002) EMBO Rep., 3, pp. 543-550; Raman, M., Earnest, S., Zhang, K., Zhao, Y., Cobb, M.H., TAO kinases mediate activation of p38 in response to DNA damage (2007) EMBO J., 26, pp. 2005-2014; Roche, S., D'Ippolito, G., Gomez, L.A., Bouckenooghe, T., Lehmann, S., Montero-Menei, C.N., Schiller, P.C., Comparative analysis of protein expression of three stem cell populations: models of cytokine delivery system in vivo (2013) Int. J. Pharm., 440, pp. 72-82; Rowe, H.M., Kapopoulou, A., Corsinotti, A., Fasching, L., Macfarlan, T.S., Tarabay, Y., Viville, S., Trono, D., TRIM28 repression of retrotransposon-based enhancers is necessary to preserve transcriptional dynamics in embryonic stem cells (2013) Genome Res., 23, pp. 452-461. , (1); Sarkar, P., Collier, T.S., Randall, S.M., Muddiman, D.C., Rao, B.M., The subcellular proteome of undifferentiated human embryonic stem cells (2012) Proteomics, 12, pp. 421-430; Schlafli, P., Borter, E., Spielmann, P., Wenger, R.H., The PAS-domain kinase PASKIN: a new sensor in energy homeostasis (2009) Cell. Mol. Life Sci., 66, pp. 876-883; Seki, Y., Kurisaki, A., Watanabe-Susaki, K., Nakajima, Y., Nakanishi, M., Arai, Y., Shiota, K., Asashima, M., TIF1beta regulates the pluripotency of embryonic stem cells in a phosphorylation-dependent manner (2010) Proc. Natl. Acad. Sci. U. S. A., 107, pp. 10926-10931; Silva, J.C., Denny, R., Dorschel, C.A., Gorenstein, M., Kass, I.J., Li, G.Z., McKenna, T., Geromanos, S., Quantitative proteomic analysis by accurate mass retention time pairs (2005) Anal. Chem., 77, pp. 2187-2200; Silva, J.C., Gorenstein, M.V., Li, G.Z., Vissers, J.P., Geromanos, S.J., Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition (2006) Mol. Cell. Proteomics, 5, pp. 144-156; Sommer, C.A., Stadtfeld, M., Murphy, G.J., Hochedlinger, K., Kotton, D.N., Mostoslavsky, G., Induced pluripotent stem cell generation using a single lentiviral stem cell cassette (2009) Stem Cells, 27, pp. 543-549; Son, Y.S., Park, J.H., Kang, Y.K., Park, J.S., Choi, H.S., Lim, J.Y., Lee, J.E., Hong, H.J., Heat shock 70-kDa protein 8 isoform 1 is expressed on the surface of human embryonic stem cells and downregulated upon differentiation (2005) Stem Cells, 23, pp. 1502-1513; Sridharan, R., Gonzales-Cope, M., Chronis, C., Bonora, G., McKee, R., Huang, C., Patel, S., Plath, K., Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1gamma in reprogramming to pluripotency (2013) Nat. Cell Biol., 15, pp. 872-882; Staerk, J., Dawlaty, M.M., Gao, Q., Maetzel, D., Hanna, J., Sommer, C.A., Mostoslavsky, G., Jaenisch, R., Reprogramming of human peripheral blood cells to induced pluripotent stem cells (2010) Cell Stem Cell, 7, pp. 20-24; Stapels, M.D., Barofsky, D.F., Complementary use of MALDI and ESI for the HPLC-MS/MS analysis of DNA-binding proteins (2004) Anal. Chem., 76 (18), pp. 5423-5430; Sudhir, P.R., Kumari, M.P., Hsu, W.T., Massiot, J., Chen, C.H., Kuo, H.C., Quantitative proteomics of protein complexes and their implications for cell reprograming and pluripotency (2013) J. Proteome Res., 12, pp. 5878-5890; Sugawara, T., Nishino, K., Umezawa, A., Akutsu, H., Investigating cellular identity and manipulating cell fate using induced pluripotent stem cells (2012) Stem Cell Res. Ther., 3, p. 8; Sweeney, C.L., Merling, R.K., Choi, U., Priel, D.L., Kuhns, D.B., Wang, H., Malech, H.L., Generation of functionally mature neutrophils from induced pluripotent stem cells (2014) Methods Mol. Biol., 1124, pp. 189-206; Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S., Induction of pluripotent stem cells from adult human fibroblasts by defined factors (2007) Cell, 131, pp. 861-872; Vazquez-Martin, A., Corominas-Faja, B., Cufi, S., Vellon, L., Oliveras-Ferraros, C., Menendez, O.J., Joven, J., Menendez, J.A., The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells (2013) Cell Cycle, 12, pp. 207-218; Westhorpe, F.G., Diez, M.A., Gurden, M.D., Tighe, A., Taylor, S.S., Re-evaluating the role of Tao1 in the spindle checkpoint (2010) Chromosoma, 119, pp. 371-379; Wolf, D., Goff, S.P., TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells (2007) Cell, 131, pp. 46-57; Xu, X., Duan, S., Yi, F., Ocampo, A., Liu, G.H., Izpisua Belmonte, J.C., Mitochondrial regulation in pluripotent stem cells (2013) Cell Metab., 18 (3), pp. 325-332; Yamana, R., Iwasaki, M., Wakabayashi, M., Nakagawa, M., Yamanaka, S., Ishihama, Y., Rapid and deep profiling of human induced pluripotent stem cell proteome by one-shot NanoLC-MS/MS analysis with meter-scale monolithic silica columns (2013) J. Proteome Res., 12, pp. 214-221; Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Thomson, J.A., Induced pluripotent stem cell lines derived from human somatic cells (2007) Science, 318, pp. 1917-1920; Yustein, J.T., Xia, L., Kahlenburg, J.M., Robinson, D., Templeton, D., Kung, H.J., Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38 (2003) Oncogene, 22, pp. 6129-6141; Zhang, J., Khvorostov, I., Hong, J.S., Oktay, Y., Vergnes, L., Nuebel, E., Wahjudi, P.N., Teitell, M.A., UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells (2011) EMBO J., 30, pp. 4860-4873; Zou, J., Sweeney, C.L., Chou, B.K., Choi, U., Pan, J., Wang, H., Dowey, S.N., Malech, H.L., Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting (2011) Blood, 117, pp. 5561-5572",Article,Scopus,2-s2.0-84925947361
"Manohar R., Li Y., Fohrer H., Guzik L., Stolz D.B., Chandran U.R., LaFramboise W.A., Lagasse E.","Identification of a candidate stem cell in human gallbladder",2015,"Stem Cell Research","14","3",,"258","269",,,10.1016/j.scr.2014.12.003,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924428496&partnerID=40&md5=de4c3d36f33fa61f01ad5b2aafdfd851","McGowan Institute for Regenerative Medicine, Department of Pathology, University of Pittsburgh School of MedicinePittsburgh, PA, United States; Center for Biological Imaging, Department of Cell Biology and Physiology, University of Pittsburgh School of MedicinePittsburgh, PA, United States; Department of Biomedical Informatics, University of Pittsburgh School of MedicinePittsburgh, PA, United States; University of Pittsburgh Cancer Institute, Hillman Cancer CenterPittsburgh, PA, United States; Clinical Genomics Facility, University of Pittsburgh School of MedicinePittsburgh, PA, United States","Manohar, R., McGowan Institute for Regenerative Medicine, Department of Pathology, University of Pittsburgh School of MedicinePittsburgh, PA, United States; Li, Y., McGowan Institute for Regenerative Medicine, Department of Pathology, University of Pittsburgh School of MedicinePittsburgh, PA, United States; Fohrer, H., McGowan Institute for Regenerative Medicine, Department of Pathology, University of Pittsburgh School of MedicinePittsburgh, PA, United States; Guzik, L., McGowan Institute for Regenerative Medicine, Department of Pathology, University of Pittsburgh School of MedicinePittsburgh, PA, United States; Stolz, D.B., Center for Biological Imaging, Department of Cell Biology and Physiology, University of Pittsburgh School of MedicinePittsburgh, PA, United States; Chandran, U.R., Department of Biomedical Informatics, University of Pittsburgh School of MedicinePittsburgh, PA, United States, University of Pittsburgh Cancer Institute, Hillman Cancer CenterPittsburgh, PA, United States; LaFramboise, W.A., University of Pittsburgh Cancer Institute, Hillman Cancer CenterPittsburgh, PA, United States, Clinical Genomics Facility, University of Pittsburgh School of MedicinePittsburgh, PA, United States; Lagasse, E., McGowan Institute for Regenerative Medicine, Department of Pathology, University of Pittsburgh School of MedicinePittsburgh, PA, United States","There are currently no reports of identification of stem cells in human gallbladder. The differences between human gallbladder and intrahepatic bile duct (IHBD) cells have also not been explored. The goals of this study were to evaluate if human fetal gallbladder contains a candidate stem cell population and if fetal gallbladder cells are distinct from fetal IHBD cells. We found that EpCAM+CD44+CD13. + cells represent the cell population most enriched for clonal self-renewal from primary gallbladder. Primary EpCAM+CD44+CD13. + cells gave rise to EpCAM+CD44+CD13. + and EpCAM+CD44+CD13. - cells in vitro, and gallbladder cells expanded in vitro exhibited short-term engraftment in vivo. Last, we found that CD13, CD227, CD66, CD26 and CD49b were differentially expressed between gallbladder and IHBD cells cultured in vitro indicating clear phenotypic differences between the two cell populations. Microarray analyses of expanded cultures confirmed that both cell types have unique transcriptional profiles with predicted functional differences in lipid, carbohydrate, nucleic acid and drug metabolism.In conclusion, we have isolated a distinct clonogenic population of epithelial cells from primary human fetal gallbladder with stem cell characteristics and found it to be unique compared to IHBD cells. © 2015 The Authors.",,"Auth, M.K., Keitzer, R.A., Scholz, M., Blaheta, R.A., Hottenrott, E.C., Herrmann, G., Encke, A., Establishment and immunological characterization of cultured human gallbladder epithelial cells (1993) Hepatology, 18, pp. 546-555; Balzar, M., Winter, M.J., de Boer, C.J., Litvinov, S.V., The biology of the 17-1A antigen (Ep-CAM) (1999) J. Mol. Med., 77, pp. 699-712; Barker, N., Ridgway, R.A., van Es, J.H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Crypt stem cells as the cells-of-origin of intestinal cancer (2009) Nature, 457, pp. 608-611; Bassett, M.D., Murray, K.F., Biliary atresia: recent progress (2008) J. Clin. Gastroenterol., 42, pp. 720-729; Baum, C.M., Weissman, I.L., Tsukamoto, A.S., Buckle, A.M., Peault, B., Isolation of a candidate human hematopoietic stem-cell population (1992) Proc. Natl. Acad. Sci. U. S. A., 89, pp. 2804-2808; Blankenberg, T.A., Lund, J.K., Ruebner, B.H., Normal and abnormal development of human intrahepatic bile ducts. An immunohistochemical perspective (1991) Perspect. Pediatr. Pathol., 14, pp. 143-167; Buisine, M.P., Devisme, L., Degand, P., Dieu, M.C., Gosselin, B., Copin, M.C., Aubert, J.P., Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. II. Duodenum and liver, gallbladder, and pancreas (2000) J. Histochem. Cytochem., 48, pp. 1667-1676; Cardinale, V., Wang, Y., Carpino, G., Alvaro, D., Reid, L., Gaudio, E., Multipotent stem cells in the biliary tree (2010) Ital. J. Anat. Embryol., 115, pp. 85-90; Cicalese, A., Bonizzi, G., Pasi, C.E., Faretta, M., Ronzoni, S., Giulini, B., Brisken, C., The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells (2009) Cell, 138, pp. 1083-1095; de Boer, C.J., van Krieken, J.H., Janssen-van Rhijn, C.M., Litvinov, S.V., Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver (1999) J. Pathol., 188, pp. 201-206; Ehmann, U.K., Peterson, W.D., Misfeldt, D.S., To grow mouse mammary epithelial cells in culture (1984) J. Cell Biol., 98, pp. 1026-1032; Fazekas de St, G., The evaluation of limiting dilution assays (1982) J. Immunol. Methods, 49, pp. R11-R23; Frizzell, R.A., Heintze, K., Transport functions of the gallbladder (1980) Int. Rev. Physiol., 21, pp. 221-247; Hand, B.H., Anatomy and function of the extrahepatic biliary system (1973) Clin. Gastroenterol., 2, pp. 3-29; Haraguchi, N., Ishii, H., Mimori, K., Tanaka, F., Ohkuma, M., Kim, H.M., Akita, H., CD13 is a therapeutic target in human liver cancer stem cells (2010) J. Clin. Invest., 120, pp. 3326-3339; Hickey, R.D., Galivo, F., Schug, J., Brehm, M.A., Haft, A., Wang, Y., Benedetti, E., Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogramming (2013) Stem Cell Res., 11, pp. 503-515; Hirschfield, G.M., Heathcote, E.J., Gershwin, M.E., Pathogenesis of cholestatic liver disease and therapeutic approaches (2010) Gastroenterology, 139, pp. 1481-1496; Hoerl, B.J., Vroman, B.T., Kasperbauer, J.L., LaRusso, N.F., Scott, R.E., Biological characteristics of primary cultures of human gallbladder epithelial cells (1992) Lab. Investig., 66, pp. 243-250; Huch, M., Dorrell, C., Boj, S.F., van Es, J.H., Li, V.S., van de Wetering, M., Sato, T., In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration (2013) Nature, 494, pp. 247-250; Kakinuma, S., Ohta, H., Kamiya, A., Yamazaki, Y., Oikawa, T., Okada, K., Nakauchi, H., Analyses of cell surface molecules on hepatic stem/progenitor cells in mouse fetal liver (2009) J. Hepatol., 51, pp. 127-138; Kamiya, A., Kakinuma, S., Yamazaki, Y., Nakauchi, H., Enrichment and clonal culture of progenitor cells during mouse postnatal liver development in mice (2009) Gastroenterology, 137, pp. 1114-1126. , (1126 e1111-1114); Kobayashi, K., Kan, M., Yamane, I., Ishii, M., Toyota, T., Primary culture of human gallbladder epithelial cells (1991) Gastroenterol. Jpn., 26, pp. 363-369; Koprowski, H., Steplewski, Z., Mitchell, K., Herlyn, M., Herlyn, D., Fuhrer, P., Colorectal carcinoma antigens detected by hybridoma antibodies (1979) Somatic Cell Genet., 5, pp. 957-971; Kuver, R., Savard, C.E., Lee, S.K., Haigh, W.G., Lee, S.P., Murine gallbladder epithelial cells can differentiate into hepatocyte-like cells in vitro (2007) Am. J. Physiol. Gastrointest. Liver Physiol., 293, pp. G944-G955; Lagasse, E., Cancer stem cells with genetic instability: the best vehicle with the best engine for cancer (2008) Gene Ther., 15, pp. 136-142; Lamote, J., Willems, G., DNA synthesis, cell proliferation index in normal and abnormal gallbladder epithelium (1997) Microsc. Res. Tech., 38, pp. 609-615; Lee, S.P., Savard, C.E., Kuver, R., Gallbladder epithelial cells that engraft in mouse liver can differentiate into hepatocyte-like cells (2009) Am. J. Pathol., 174, pp. 842-853; MacFadyen, B.V., Vecchio, R., Ricardo, A.E., Mathis, C.R., Bile duct injury after laparoscopic cholecystectomy. The United States experience (1998) Surg. Endosc., 12, pp. 315-321; Manohar, R., Komori, J., Guzik, L., Stolz, D.B., Chandran, U.R., Laframboise, W.A., Lagasse, E., Identification and expansion of a unique stem cell population from adult mouse gallbladder (2011) Hepatology, 54, pp. 1830-1841; Miller, G., Jarnagin, W.R., Gallbladder carcinoma (2008) Eur. J. Surg. Oncol., 34, pp. 306-312; Moll, R., Franke, W.W., Schiller, D.L., Geiger, B., Krepler, R., The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells (1982) Cell, 31, pp. 11-24; Momburg, F., Moldenhauer, G., Hammerling, G.J., Moller, P., Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues (1987) Cancer Res., 47, pp. 2883-2891; Nakanuma, Y., Katayanagi, K., Kawamura, Y., Yoshida, K., Monolayer and three-dimensional cell culture and living tissue culture of gallbladder epithelium (1997) Microsc. Res. Tech., 39, pp. 71-84; Nakanuma, Y., Tsuneyama, K., Harada, K., Pathology and pathogenesis of intrahepatic bile duct loss (2001) J. Hepatobiliary Pancreat. Surg., 8, pp. 303-315; Okada, K., Kamiya, A., Ito, K., Yanagida, A., Ito, H., Kondou, H., Nishina, H., Prospective isolation and characterization of bipotent progenitor cells in early mouse liver development (2011) Stem Cells Dev., 21, pp. 1124-1133; Okumura, H., Sakamoto, K., Nakano, G., Ikeda, H., Nagashima, K., Nagamachi, Y., Yuasa, Y., Long-term maintenance of human gall-bladder epithelia as xenografts following explant organ culture (1988) Nippon Geka Gakkai Zasshi, 89, pp. 388-393; Portincasa, P., Palasciano, G., Svelto, M., Calamita, G., Aquaporins in the hepatobiliary tract. Which, where and what they do in health and disease (2008) Eur. J. Clin. Investig., 38, pp. 1-10; Roskams, T., Desmet, V., Embryology of extra- and intrahepatic bile ducts, the ductal plate (2008) Anat. Rec. (Hoboken), 291, pp. 628-635; Sasaki, M., Nakanuma, Y., Terada, T., Kim, Y.S., Biliary epithelial expression of MUC1, MUC2, MUC3 and MUC5/6 apomucins during intrahepatic bile duct development and maturation. An immunohistochemical study (1995) Am. J. Pathol., 147, pp. 574-579; Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N., Stange, D.E., van Es, J.H., Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche (2009) Nature, 459, pp. 262-265; Shackleton, M., Vaillant, F., Simpson, K.J., Stingl, J., Smyth, G.K., Asselin-Labat, M.L., Wu, L., Generation of a functional mammary gland from a single stem cell (2006) Nature, 439, pp. 84-88; Shi, C., Tian, R., Wang, M., Wang, X., Jiang, J., Zhang, Z., Li, X., CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma (2010) Cancer Biol. Ther., 10, pp. 1182-1190; Shi, C.J., Gao, J., Wang, M., Wang, X., Tian, R., Zhu, F., Shen, M., CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity (2011) World J. Gastroenterol., 17, pp. 2965-2971; Shiojiri, N., Development and differentiation of bile ducts in the mammalian liver (1997) Microsc. Res. Tech., 39, pp. 328-335; Spence, J.R., Lange, A.W., Lin, S.C., Kaestner, K.H., Lowy, A.M., Kim, I., Whitsett, J.A., Sox17 regulates organ lineage segregation of ventral foregut progenitor cells (2009) Dev. Cell, 17, pp. 62-74; Stingl, J., Eirew, P., Ricketson, I., Shackleton, M., Vaillant, F., Choi, D., Li, H.I., Purification and unique properties of mammary epithelial stem cells (2006) Nature, 439, pp. 993-997; Tremblay, K.D., Zaret, K.S., Distinct populations of endoderm cells converge to generate the embryonic liver bud and ventral foregut tissues (2005) Dev. Biol., 280, pp. 87-99; Tsuchiya, A., Heike, T., Baba, S., Fujino, H., Umeda, K., Matsuda, Y., Nomoto, M., Long-term culture of postnatal mouse hepatic stem/progenitor cells and their relative developmental hierarchy (2007) Stem Cells, 25, pp. 895-902; Uchida, N., Buck, D.W., He, D., Reitsma, M.J., Masek, M., Phan, T.V., Tsukamoto, A.S., Direct isolation of human central nervous system stem cells (2000) Proc. Natl. Acad. Sci. U. S. A., 97, pp. 14720-14725; Wagers, A.J., Weissman, I.L., Plasticity of adult stem cells (2004) Cell, 116, pp. 639-648; Zaret, K.S., Grompe, M., Generation and regeneration of cells of the liver and pancreas (2008) Science, 322, pp. 1490-1494; Zheng, Y.W., Taniguchi, H., Diversity of hepatic stem cells in the fetal and adult liver (2003) Semin. Liver Dis., 23, pp. 337-348",Article,Scopus,2-s2.0-84924428496
"Zhao Y.-H., Lv X., Liu Y.-L., Zhao Y., Li Q., Chen Y.-J., Zhang M.","Hydrostatic pressure promotes the proliferation and osteogenic/chondrogenic differentiation of mesenchymal stem cells: The roles of RhoA and Rac1",2015,"Stem Cell Research","14","3",,"283","296",,,10.1016/j.scr.2015.02.006,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925016252&partnerID=40&md5=84297495d598e98fcf6bb6e760e89d7e","State Key Laboratory of Military Stomatology, Department of General Dentistry and Emergency, School of Stomatology, Fourth Military Medical University, No. 145 West Changle RoadXi'an, China","Zhao, Y.-H., State Key Laboratory of Military Stomatology, Department of General Dentistry and Emergency, School of Stomatology, Fourth Military Medical University, No. 145 West Changle RoadXi'an, China; Lv, X., State Key Laboratory of Military Stomatology, Department of General Dentistry and Emergency, School of Stomatology, Fourth Military Medical University, No. 145 West Changle RoadXi'an, China; Liu, Y.-L., State Key Laboratory of Military Stomatology, Department of General Dentistry and Emergency, School of Stomatology, Fourth Military Medical University, No. 145 West Changle RoadXi'an, China; Zhao, Y., State Key Laboratory of Military Stomatology, Department of General Dentistry and Emergency, School of Stomatology, Fourth Military Medical University, No. 145 West Changle RoadXi'an, China; Li, Q., State Key Laboratory of Military Stomatology, Department of General Dentistry and Emergency, School of Stomatology, Fourth Military Medical University, No. 145 West Changle RoadXi'an, China; Chen, Y.-J., State Key Laboratory of Military Stomatology, Department of General Dentistry and Emergency, School of Stomatology, Fourth Military Medical University, No. 145 West Changle RoadXi'an, China; Zhang, M., State Key Laboratory of Military Stomatology, Department of General Dentistry and Emergency, School of Stomatology, Fourth Military Medical University, No. 145 West Changle RoadXi'an, China","Our previous studies have shown that hydrostatic pressure can serve as an active regulator for bone marrow mesenchymal stem cells (BMSCs). The current work further investigates the roles of cytoskeletal regulatory proteins Ras homolog gene family member A (RhoA) and Ras-related C3 botulinum toxin substrate 1 (Rac1) in hydrostatic pressure-related effects on BMSCs. Flow cytometry assays showed that the hydrostatic pressure promoted cell cycle initiation in a RhoA- and Rac1-dependent manner. Furthermore, fluorescence assays confirmed that RhoA played a positive and Rac1 displayed a negative role in the hydrostatic pressure-induced F-actin stress fiber assembly. Western blots suggested that RhoA and Rac1 play central roles in the pressure-inhibited ERK phosphorylation, and Rac1 but not RhoA was involved in the pressure-promoted JNK phosphorylation. Finally, real-time polymerase chain reaction (PCR) experiments showed that pressure promoted the expression of osteogenic marker genes in BMSCs at an early stage of osteogenic differentiation through the up-regulation of RhoA activity. Additionally, the PCR results showed that pressure enhanced the expression of chondrogenic marker genes in BMSCs during chondrogenic differentiation via the up-regulation of Rac1 activity. Collectively, our results suggested that RhoA and Rac1 are critical to the pressure-induced proliferation and differentiation, the stress fiber assembly, and MAPK activation in BMSCs. © 2015.",,"Alford, J.W., Cole, B.J., Cartilage restoration, part 1: basic science, historical perspective, patient evaluation, and treatment options (2005) Am. J. Sports Med., 33 (2), pp. 295-306; Amano, M., Ito, M., Kimura, K., Fukata, Y., Chihara, K., Nakano, T., Matsuura, Y., Kaibuchi, K., Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase) (1996) J. Biol. Chem., 271 (34), pp. 20246-20249; Angele, P., Yoo, J.U., Smith, C., Mansour, J., Jepsen, K.J., Nerlich, M., Johnstone, B., Cyclic hydrostatic pressure enhances the chondrogenic phenotype of human mesenchymal progenitor cells differentiated in vitro (2003) J. Orthop. Res., 21 (3), pp. 451-457; Burridge, K., Wennerberg, K., Rho and Rac take center stage (2004) Cell, 116 (2), pp. 167-179; Carter, D.R., Wong, M., The role of mechanical loading histories in the development of diarthrodial joints (1988) J. Orthop. Res., 6 (6), pp. 804-816; Carter, D.R., Beaupre, G.S., Giori, N.J., Helms, J.A., Mechanobiology of skeletal regeneration (1998) Clin. Orthop. Relat. Res., (355), pp. S41-S55; Chen, Y.J., Zhang, M., Wang, J.J., Study on the effects of mechanical pressure to the ultrastructure and secretion ability of mandibular condylar chondrocytes (2007) Arch. Oral Biol., 52 (2), pp. 173-181; Chowdhury, F., Na, S., Li, D., Poh, Y.C., Tanaka, T.S., Wang, F., Wang, N., Material properties of the cell dictate stress-induced spreading and differentiation in embryonic stem cells (2010) Nat. Mater., 9 (1), pp. 82-88; Darling, E.M., Guilak, F., A neural network model for cell classification based on single-cell biomechanical properties (2008) Tissue Eng. Part A, 14 (9), pp. 1507-1515; De Croos, J.N., Dhaliwal, S.S., Grynpas, M.D., Pilliar, R.M., Kandel, R.A., Cyclic compressive mechanical stimulation induces sequential catabolic and anabolic gene changes in chondrocytes resulting in increased extracellular matrix accumulation (2006) Matrix Biol., 25 (6), pp. 323-331; Dezawa, M., Kanno, H., Hoshino, M., Cho, H., Matsumoto, N., Itokazu, Y., Tajima, N., Ide, C., Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation (2004) J. Clin. Invest., 113 (12), pp. 1701-1710; Discher, D.E., Mooney, D.J., Zandstra, P.W., Growth factors, matrices, and forces combine and control stem cells (2009) Science, 324 (5935), pp. 1673-1677; Dulic, V., Lees, E., Reed, S.I., Association of human cyclin E with a periodic G1-S phase protein kinase (1992) Science, 257 (5078), pp. 1958-1961; Etienne-Manneville, S., Hall, A., Rho GTPases in cell biology (2002) Nature, 420 (6916), pp. 629-635; Farndale, R.W., Buttle, D.J., Barrett, A.J., Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue (1986) Biochim. Biophys. Acta, 883 (2), pp. 173-177; Gray, M.L., Pizzanelli, A.M., Grodzinsky, A.J., Lee, R.C., Mechanical and physiochemical determinants of the chondrocyte biosynthetic response (1988) J. Orthop. Res., 6 (6), pp. 777-792; Hamel, M., Kanyi, D., Cipolle, M.D., Lowe-Krentz, L., Active stress kinases in proliferating endothelial cells associated with cytoskeletal structures (2006) Endothelium, 13 (3), pp. 157-170; Hangody, L., Fules, P., Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience (2003) J. Bone Joint Surg. Am., pp. 25-32; Henderson, J.H., Carter, D.R., Mechanical induction in limb morphogenesis: the role of growth-generated strains and pressures (2002) Bone, 31 (6), pp. 645-653; Hu, W., Bellone, C.J., Baldassare, J.J., RhoA stimulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity (1999) J. Biol. Chem., 274 (6), pp. 3396-3401; Hu, Y.L., Li, S., Miao, H., Tsou, T.C., del Pozo, M.A., Chien, S., Roles of microtubule dynamics and small GTPase Rac in endothelial cell migration and lamellipodium formation under flow (2002) J. Vasc. Res., 39 (6), pp. 465-476; Hunter, C.J., Imler, S.M., Malaviya, P., Nerem, R.M., Levenston, M.E., Mechanical compression alters gene expression and extracellular matrix synthesis by chondrocytes cultured in collagen I gels (2002) Biomaterials, 23 (4), pp. 1249-1259; Hunziker, E.B., Growth-factor-induced healing of partial-thickness defects in adult articular cartilage (2001) Osteoarthritis Cartilage, 9 (1), pp. 22-32; Ingber, D.E., Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology (2002) Circ. Res., 91 (10), pp. 877-887; Jin, S., Ray, R.M., Johnson, L.R., Rac1 mediates intestinal epithelial cell apoptosis via JNK (2006) Am. J. Physiol. Gastrointest. Liver Physiol., 291 (6), pp. G1137-G1147; Johnstone, B., Alini, M., Cucchiarini, M., Dodge, G.R., Eglin, D., Guilak, F., Madry, H., Stoddart, M.J., Tissue engineering for articular cartilage repair-the state of the art (2013) Eur. Cell Mater., 25, pp. 248-267; Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J.W., Elledge, S., Nishimoto, T., Roberts, J.M., Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle (1992) Science, 257 (5077), pp. 1689-1694; Kukekov, N.V., Xu, Z., Greene, L.A., Direct interaction of the molecular scaffolds POSH and JIP is required for apoptotic activation of JNKs (2006) J. Biol. Chem., 281 (22), pp. 15517-15524; Liu, J., Zhao, Z., Li, J., Zou, L., Shuler, C., Zou, Y., Huang, X., Wang, J., Hydrostatic pressures promote initial osteodifferentiation with ERK1/2 not p38 MAPK signaling involved (2009) J. Cell. Biochem., 107 (2), pp. 224-232; Loboa, E.G., Beaupre, G.S., Carter, D.R., Mechanobiology of initial pseudarthrosis formation with oblique fractures (2001) J. Orthop. Res., 19 (6), pp. 1067-1072; Luk, J.M., Wang, P.P., Lee, C.K., Wang, J.H., Fan, S.T., Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models (2005) J. Immunol. Methods, 305 (1), pp. 39-47; Luu, Y.K., Capilla, E., Rosen, C.J., Gilsanz, V., Pessin, J.E., Judex, S., Rubin, C.T., Mechanical stimulation of mesenchymal stem cell proliferation and differentiation promotes osteogenesis while preventing dietary-induced obesity (2009) J. Bone Miner. Res., 24 (1), pp. 50-61; Masuda, M., Fujiwara, K., The biased lamellipodium development and microtubule organizing center position in vascular endothelial cells migrating under the influence of fluid flow (1993) Biol. Cell., 77 (3), pp. 237-245; Masuda, M., Fujiwara, K., Morphological responses of single endothelial cells exposed to physiological levels of fluid shear stress (1993) Front. Med. Biol. Eng., 5 (2), pp. 79-87; Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M., Sherr, C.J., Kato, J.Y., D-type cyclin-dependent kinase activity in mammalian cells (1994) Mol. Cell. Biol., 14 (3), pp. 2066-2076; Matthews, B.D., Overby, D.R., Mannix, R., Ingber, D.E., Cellular adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension and mechanosensitive ion channels (2006) J. Cell Sci., 119, pp. 508-518; McBeath, R., Pirone, D.M., Nelson, C.M., Bhadriraju, K., Chen, C.S., Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment (2004) Dev. Cell, 6 (4), pp. 483-495; McConnell, B.B., Gregory, F.J., Stott, F.J., Hara, E., Peters, G., Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes (1999) Mol. Cell. Biol., 19 (3), pp. 1981-1989; Mengistu, M., Brotzman, H., Ghadiali, S., Lowe-Krentz, L., Fluid shear stress-induced JNK activity leads to actin remodeling for cell alignment (2011) J. Cell. Physiol., 226 (1), pp. 110-121; Mettouchi, A., Klein, S., Guo, W., Lopez-Lago, M., Lemichez, E., Westwick, J.K., Giancotti, F.G., Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle (2001) Mol. Cell, 8 (1), pp. 115-127; Miyanishi, K., Trindade, M.C., Lindsey, D.P., Beaupre, G.S., Carter, D.R., Goodman, S.B., Schurman, D.J., Smith, R.L., Dose- and time-dependent effects of cyclic hydrostatic pressure on transforming growth factor-beta3-induced chondrogenesis by adult human mesenchymal stem cells in vitro (2006) Tissue Eng., 12 (8), pp. 2253-2262; Miyanishi, K., Trindade, M.C., Lindsey, D.P., Beaupre, G.S., Carter, D.R., Goodman, S.B., Schurman, D.J., Smith, R.L., Effects of hydrostatic pressure and transforming growth factor-beta 3 on adult human mesenchymal stem cell chondrogenesis in vitro (2006) Tissue Eng., 12 (6), pp. 1419-1428; Olson, M.F., Paterson, H.F., Marshall, C.J., Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1 (1998) Nature, 394 (6690), pp. 295-299; Outerbridge, H.K., Outerbridge, A.R., Outerbridge, R.E., The use of a lateral patellar autologous graft for the repair of a large osteochondral defect in the knee (1995) J. Bone Joint Surg. Am., 77 (1), pp. 65-72; Panseri, S., Russo, A., Cunha, C., Bondi, A., Di Martino, A., Patella, S., Kon, E., Osteochondral tissue engineering approaches for articular cartilage and subchondral bone regeneration (2012) Knee Surg. Sports Traumatol. Arthrosc., 20 (6), pp. 1182-1191; Parry, D., Bates, S., Mann, D.J., Peters, G., Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product (1995) EMBO J., 14 (3), pp. 503-511; Parry, D., Mahony, D., Wills, K., Lees, E., Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors (1999) Mol. Cell. Biol., 19 (3), pp. 1775-1783; Riddle, R.C., Taylor, A.F., Genetos, D.C., Donahue, H.J., MAP kinase and calcium signaling mediate fluid flow-induced human mesenchymal stem cell proliferation (2006) Am. J. Physiol. Cell Physiol., 290 (3), pp. C776-C784; Sanders, L.C., Matsumura, F., Bokoch, G.M., de Lanerolle, P., Inhibition of myosin light chain kinase by p21-activated kinase (1999) Science, 283 (5410), pp. 2083-2085; Shapiro, F., Koide, S., Glimcher, M.J., Cell origin and differentiation in the repair of full-thickness defects of articular cartilage (1993) J. Bone Joint Surg. Am., 75 (4), pp. 532-553; Shifrin, Y., Arora, P.D., Ohta, Y., Calderwood, D.A., McCulloch, C.A., The role of FilGAP-filamin A interactions in mechanoprotection (2009) Mol. Biol. Cell, 20 (5), pp. 1269-1279; Smith, G.D., Richardson, J.B., Brittberg, M., Erggelet, C., Verdonk, R., Knutsen, G., Ashton, B.A., Harrison, P.E., Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint (2003) J. Bone Joint Surg. Am., (12), pp. 2487-2488. , (author reply 2488); Stanton, L.A., Underhill, T.M., Beier, F., MAP kinases in chondrocyte differentiation (2003) Dev. Biol., 263 (2), pp. 165-175; Steadman, J.R., Miller, B.S., Karas, S.G., Schlegel, T.F., Briggs, K.K., Hawkins, R.J., The microfracture technique in the treatment of full-thickness chondral lesions of the knee in National Football League players (2003) J. Knee Surg., 16 (2), pp. 83-86; Thompson, W.R., Rubin, C.T., Rubin, J., Mechanical regulation of signaling pathways in bone (2012) Gene, 503 (2), pp. 179-193; Vidal, A., Millard, S.S., Miller, J.P., Koff, A., Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status (2002) J. Biol. Chem., 277 (19), pp. 16433-16440; Wagner, D.R., Lindsey, D.P., Li, K.W., Tummala, P., Chandran, S.E., Smith, R.L., Longaker, M.T., Beaupre, G.S., Hydrostatic pressure enhances chondrogenic differentiation of human bone marrow stromal cells in osteochondrogenic medium (2008) Ann. Biomed. Eng., 36 (5), pp. 813-820; Wang, N., Tolic-Norrelykke, I.M., Chen, J., Mijailovich, S.M., Butler, J.P., Fredberg, J.J., Stamenovic, D., Cell prestress. I. Stiffness and prestress are closely associated in adherent contractile cells (2002) Am. J. Physiol. Cell Physiol., 282 (3), pp. C606-C616; Weber, J.D., Hu, W., Jefcoat, S.C., Raben, D.M., Baldassare, J.J., Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27 (1997) J. Biol. Chem., 272 (52), pp. 32966-32971; Wei, H.W., Sun, S.S., Jao, S.H., Yeh, C.R., Cheng, C.K., The influence of mechanical properties of subchondral plate, femoral head and neck on dynamic stress distribution of the articular cartilage (2005) Med. Eng. Phys., 27 (4), pp. 295-304; Welsh, C.F., Roovers, K., Villanueva, J., Liu, Y., Schwartz, M.A., Assoian, R.K., Timing of cyclin D1 expression within G1 phase is controlled by Rho (2001) Nat. Cell Biol., 3 (11), pp. 950-957; Woods, A., Beier, F., RhoA/ROCK signaling regulates chondrogenesis in a context-dependent manner (2006) J. Biol. Chem., 281 (19), pp. 13134-13140; Woods, A., Wang, G., Beier, F., RhoA/ROCK signaling regulates Sox9 expression and actin organization during chondrogenesis (2005) J. Biol. Chem., 280 (12), pp. 11626-11634; Woods, A., Wang, G., Dupuis, H., Shao, Z., Beier, F., Rac1 signaling stimulates N-cadherin expression, mesenchymal condensation, and chondrogenesis (2007) J. Biol. Chem., 282 (32), pp. 23500-23508; Yang, C., Patel, K., Harding, P., Sorokin, A., Glass, W.F., Regulation of TGF-beta1/MAPK-mediated PAI-1 gene expression by the actin cytoskeleton in human mesangial cells (2007) Exp. Cell Res., 313 (6), pp. 1240-1250; Yousefian, J., Firouzian, F., Shanfeld, J., Ngan, P., Lanese, R., Davidovitch, Z., A new experimental model for studying the response of periodontal ligament cells to hydrostatic pressure (1995) Am. J. Orthod. Dentofacial Orthop., 108 (4), pp. 402-409; Zeiter, S., Lezuo, P., Ito, K., Effect of TGF beta1, BMP-2 and hydraulic pressure on chondrogenic differentiation of bovine bone marrow mesenchymal stromal cells (2009) Biorheology, 46 (1), pp. 45-55; Zhang, M., Wang, J.J., Chen, Y.J., Effects of mechanical pressure on intracellular calcium release channel and cytoskeletal structure in rabbit mandibular condylar chondrocytes (2006) Life Sci., 78 (21), pp. 2480-2487; Zhang, Z., Messana, J., Hwang, N.S., Elisseeff, J.H., Reorganization of actin filaments enhances chondrogenic differentiation of cells derived from murine embryonic stem cells (2006) Biochem. Biophys. Res. Commun., 348 (2), pp. 421-427; Zhang, M., Chen, F.M., Wang, A.H., Chen, Y.J., Lv, X., Wu, S., Zhao, R.N., Estrogen and its receptor enhance mechanobiological effects in compressed bone mesenchymal stem cells (2012) Cells Tissues Organs, 195 (5), pp. 400-413",Article,Scopus,2-s2.0-84925016252
"Sworder B.J., Yoshizawa S., Mishra P.J., Cherman N., Kuznetsov S.A., Merlino G., Balakumaran A., Robey P.G.","Molecular profile of clonal strains of human skeletal stem/progenitor cells with different potencies",2015,"Stem Cell Research","14","3",,"297","306",,,10.1016/j.scr.2015.02.005,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925458168&partnerID=40&md5=68107a16e31c601ef8cf5589d48d36e6","Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human ServicesBethesda, MD, United States; Boston University School of MedicineBoston, MA, United States; Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human ServicesBethesda, MD, United States","Sworder, B.J., Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human ServicesBethesda, MD, United States, Boston University School of MedicineBoston, MA, United States; Yoshizawa, S., Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human ServicesBethesda, MD, United States; Mishra, P.J., Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human ServicesBethesda, MD, United States; Cherman, N., Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human ServicesBethesda, MD, United States; Kuznetsov, S.A., Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human ServicesBethesda, MD, United States; Merlino, G., Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human ServicesBethesda, MD, United States; Balakumaran, A., Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human ServicesBethesda, MD, United States; Robey, P.G., Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human ServicesBethesda, MD, United States","Bone marrow stromal cells (BMSCs, also known as bone marrow-derived mesenchymal stem cells) are fibroblastic reticular cells, a subset of which is composed of multipotent skeletal stem cells (SSCs). SSCs/BMSCs are able to recreate a bone/marrow organ in vivo. To determine differences between clonogenic multipotent SSCs and similarly clonogenic but non-multipotent BMSCs, we established single colony-derived strains (SCDSs, initiated by individual Colony Forming Unit-Fibroblasts) and determined their differentiation capacity by vivo transplantation. In this series of human SCDSs (N = 24), 20.8% formed fibrous tissue (F), 66.7% formed bone (B), and 12.5% formed a bone/marrow organ, and thus were multipotent (M). RNA isolated from 12 SCDSs just prior to transplantation was analyzed by microarray. Although highly similar, there was variability from one SCDS to another, and SCDSs did not strictly segregate into the three functional groups (F, B or M) by unsupervised hierarchical clustering. We then compared 3 F-SCDSs to 3 M-SCDSs that did segregate. Genes associated with skeletogenesis, osteoblastogeneis, hematopoiesis, and extracellular matrix were over-represented in M-SCDSs compared with F-SCDSs. These results highlight the heterogeneity of SSCs/BMSCs, even between functionally similar SCDSs, but also indicate that differences can be detected that may shed light on the character of the SSC. © 2015.",,"Al-Nbaheen, M., Vishnubalaji, R., Ali, D., Bouslimi, A., Al-Jassir, F., Megges, M., Prigione, A., Aldahmash, A., Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential (2013) Stem Cell Rev., 9, pp. 32-43; Balakumaran, A., Pawelczyk, E., Ren, J., Sworder, B., Chaudhry, A., Sabatino, M., Stroncek, D., Robey, P.G., Superparamagnetic iron oxide nanoparticles labeling of bone marrow stromal (mesenchymal) cells does not affect their ""stemness"" (2010) PLoS One, 5, p. e11462; Bianco, P., Bone and the hematopoietic niche: a tale of two stem cells (2011) Blood, 117, pp. 5281-5288; Bianco, P., Robey, P.G., Skeletal stem cells (2004) Handbook of Adult and Fetal Stem Cells, pp. 415-424. , San Diego, Academic Press, R.P. Lanza (Ed.); Bianco, P., Robey, P.G., Simmons, P.J., Mesenchymal stem cells: revisiting history, concepts, and assays (2008) Cell Stem Cell, 2, pp. 313-319; Delorme, B., Ringe, J., Pontikoglou, C., Gaillard, J., Langonne, A., Sensebe, L., Noel, D., Charbord, P., Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity (2009) Stem Cells, 27, pp. 1142-1151; Dieudonne, S.C., Xu, T., Chou, J.Y., Kuznetsov, S.A., Satomura, K., Mankani, M., Fedarko, N.S., Young, M.F., Immortalization and characterization of bone marrow stromal fibroblasts from a patient with a loss of function mutation in the estrogen receptor-alpha gene (1998) J. Bone Miner. Res., 13, pp. 598-608; Digirolamo, C.M., Stokes, D., Colter, D., Phinney, D.G., Class, R., Prockop, D.J., Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate (1999) Br. J. Haematol., 107, pp. 275-281; Fedarko, N.S., Bianco, P., Vetter, U., Robey, P.G., Human bone cell enzyme expression and cellular heterogeneity: correlation of alkaline phosphatase enzyme activity with cell cycle (1990) J. Cell. Physiol., 144, pp. 115-121; Friedenstein, A.J., Precursor cells of mechanocytes (1976) Int. Rev. Cytol., 47, pp. 327-359; Friedenstein, A.J., Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo (1980) Hamatol. Bluttransfus., 25, pp. 19-29; Friedenstein, A.J., Osteogenic stem cells in the bone marrow (1990) Bone and Mineral Research, pp. 243-272. , London, Elsevier, J.N.M. Heersche, J.A. Kanis (Eds.); Friedenstein, A.J., Chailakhyan, R.K., Latsinik, N.V., Panasyuk, A.F., Keiliss-Borok, I.V., Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo (1974) Transplantation, 17, pp. 331-340; Gronthos, S., Zannettino, A.C., Hay, S.J., Shi, S., Graves, S.E., Kortesidis, A., Simmons, P.J., Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow (2003) J. Cell Sci., 116, pp. 1827-1835; Guo, G., Luc, S., Marco, E., Lin, T.W., Peng, C., Kerenyi, M.A., Beyaz, S., Das, P.P., Mapping cellular hierarchy by single-cell analysis of the cell surface repertoire (2013) Cell Stem Cell, 13, pp. 492-505; Krebsbach, P.H., Kuznetsov, S.A., Satomura, K., Emmons, R.V., Rowe, D.W., Robey, P.G., Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts (1997) Transplantation, 63, pp. 1059-1069; Kuznetsov, S.A., Krebsbach, P.H., Satomura, K., Kerr, J., Riminucci, M., Benayahu, D., Robey, P.G., Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo (1997) J. Bone Miner. Res., 12, pp. 1335-1347; Kuznetsov, S.A., Riminucci, M., Ziran, N., Tsutsui, T.W., Corsi, A., Calvi, L., Kronenberg, H.M., Bianco, P., The interplay of osteogenesis and hematopoiesis: expression of a constitutively active PTH/PTHrP receptor in osteogenic cells perturbs the establishment of hematopoiesis in bone and of skeletal stem cells in the bone marrow (2004) J. Cell Biol., 167, pp. 1113-1122; Larsen, K.H., Frederiksen, C.M., Burns, J.S., Abdallah, B.M., Kassem, M., Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity (2010) J. Bone Miner. Res., 25, pp. 796-808; Lymperi, S., Ferraro, F., Scadden, D.T., The HSC niche concept has turned 31. Has our knowledge matured? (2010) Ann. N. Y. Acad. Sci., 1192, pp. 12-18; Maes, C., Kobayashi, T., Selig, M.K., Torrekens, S., Roth, S.I., Mackem, S., Carmeliet, G., Kronenberg, H.M., Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels (2010) Dev. Cell, 19, pp. 329-344; Mankani, M.H., Kuznetsov, S.A., Avila, N.A., Kingman, A., Robey, P.G., Bone formation in transplants of human bone marrow stromal cells and hydroxyapatite-tricalcium phosphate: prediction with quantitative CT in mice (2004) Radiology, 230, pp. 369-376; Mendez-Ferrer, S., Michurina, T.V., Ferraro, F., Mazloom, A.R., Macarthur, B.D., Lira, S.A., Scadden, D.T., Frenette, P.S., Mesenchymal and haematopoietic stem cells form a unique bone marrow niche (2010) Nature, 466, pp. 829-834; Menicanin, D., Bartold, P.M., Zannettino, A.C., Gronthos, S., Identification of a common gene expression signature associated with immature clonal mesenchymal cell populations derived from bone marrow and dental tissues (2010) Stem Cells Dev., 19, pp. 1501-1510; Muraglia, A., Cancedda, R., Quarto, R., Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model (2000) J. Cell Sci., 113, pp. 1161-1166; Neumuller, R.A., Knoblich, J.A., Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancer (2009) Genes Dev., 23, pp. 2675-2699; Owen, M., Friedenstein, A.J., Stromal stem cells: marrow-derived osteogenic precursors (1988) Ciba Found. Symp., 136, pp. 42-60; Papadimitropoulos, A., Piccinini, E., Brachat, S., Braccini, A., Wendt, D., Barbero, A., Jacobi, C., Martin, I., Expansion of human mesenchymal stromal cells from fresh bone marrow in a 3D scaffold-based system under direct perfusion (2014) PLoS One, 9, p. e102359; Pavlin, D., Lichtler, A.C., Bedalov, A., Kream, B.E., Harrison, J.R., Thomas, H.F., Gronowicz, G.A., Rowe, D.W., Differential utilization of regulatory domains within the alpha 1(I) collagen promoter in osseous and fibroblastic cells (1992) J. Cell Biol., 116, pp. 227-236; Phinney, D.G., Kopen, G., Righter, W., Webster, S., Tremain, N., Prockop, D.J., Donor variation in the growth properties and osteogenic potential of human marrow stromal cells (1999) J. Cell. Biochem., 75, pp. 424-436; Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Marshak, D.R., Multilineage potential of adult human mesenchymal stem cells (1999) Science, 284, pp. 143-147; Robey, P.G., Kuznetsov, S.A., Riminucci, M., Bianco, P., Bone marrow stromal cell assays: in vitro and in vivo (2014) Methods Mol. Biol., 1130, pp. 279-293; Russell, K.C., Phinney, D.G., Lacey, M.R., Barrilleaux, B.L., Meyertholen, K.E., O'Connor, K.C., In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment (2010) Stem Cells, 28, pp. 788-798; Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Piersanti, S., Saggio, I., Tagliafico, E., Riminucci, M., Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment (2007) Cell, 131, pp. 324-336; Satomura, K., Derubeis, A.R., Fedarko, N.S., Ibaraki-O'Connor, K., Kuznetsov, S.A., Rowe, D.W., Young, M.F., Gehron Robey, P., Receptor tyrosine kinase expression in human bone marrow stromal cells (1998) J. Cell. Physiol., 177, pp. 426-438; Yoshida, C.A., Furuichi, T., Fujita, T., Fukuyama, R., Kanatani, N., Kobayashi, S., Satake, M., Komori, T., Core-binding factor beta interacts with Runx2 and is required for skeletal development (2002) Nat. Genet., 32, pp. 633-638; Zhang, M., Xuan, S., Bouxsein, M.L., von Stechow, D., Akeno, N., Faugere, M.C., Malluche, H., Efstratiadis, A., Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization (2002) J. Biol. Chem., 277, pp. 44005-44012",Article,Scopus,2-s2.0-84925458168
"Mtaweh H., Bell M.J.","Management of Pediatric Traumatic Brain Injury",2015,"Current Treatment Options in Neurology","17","5",,"","",13,,10.1007/s11940-015-0348-3,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927616575&partnerID=40&md5=d0a72c233dc8ff0486d2da43f0140d23","Department of Critical Care Medicine, The Hospital for Sick Children, 555 University AveToronto, ON, Canada; Department of Critical Care Medicine, University of Pittsburgh, 3434 Fifth AvenuePittsburgh, PA, United States; Department of Neurological Surgery, University of Pittsburgh, 3434 Fifth AvenuePittsburgh, PA, United States; Safar Center for Resuscitation Research, University of Pittsburgh, 3434 Fifth AvenuePittsburgh, United States","Mtaweh, H., Department of Critical Care Medicine, The Hospital for Sick Children, 555 University AveToronto, ON, Canada; Bell, M.J., Department of Critical Care Medicine, University of Pittsburgh, 3434 Fifth AvenuePittsburgh, PA, United States, Department of Neurological Surgery, University of Pittsburgh, 3434 Fifth AvenuePittsburgh, PA, United States, Safar Center for Resuscitation Research, University of Pittsburgh, 3434 Fifth AvenuePittsburgh, United States","Pediatric severe traumatic brain injury continues to be a major cause of disability and death. Rapid initial airway and hemodynamic stabilization is critical, followed by the need for immediate recognition of intracranial pathology that requires neurosurgical intervention. Intracranial hypertension and cerebral hypoperfusion have been recognized as major insults after trauma and management should be directed at preventing both. Sedation with opioids, moderate hyperventilation to arterial carbon dioxide level of 35–40 mmHg, hyperosmolar therapy with 3 % saline or mannitol, normothermia, and cerebrospinal fluid drainage continue to be the cornerstones of initial management of intracranial hypertension (intracranial pressure >20 mmHg). Refractory intracranial hypertension is treated with high-dose barbiturate therapy to achieve medical burst suppression on electroencephalography and decompressive craniectomy. In addition, those children require antiepileptic medications for seizure prophylaxis, adequate nutritional management, and early physical therapy and rehabilitation referrals. Most of the evidence for care of children with brain injury comes from center-specific practice and experience rather than objective data. This lack of evidence provides the ground for ongoing research; nevertheless, outcomes after traumatic brain injury continue to show improvement. © 2015, Springer Science+Business Media New York.","Children; Intracranial pressure; Pediatric head injury; Pediatric neurocritical care; Traumatic brain injury","Faul, M.D.X.L., Wald, W.M., (2010) Traumatic brain injury in the United States: emergency department visits, hospitalizations and death 2002–2006, , Centers for Disease Control and Prevention, National Center for Injury Prevention, Atlanta:; Stanley, R.M., Bonsu, B.K., Zhao, W., Ehrlich, P.F., Rogers, A.J., Xiang, H., US estimates of hospitalized children with severe traumatic brain injury: implications for clinical trials (2012) Pediatrics, 129 (1), pp. e24-e30. , PID: 22184643; Pineda, J.A., Leonard, J.R., Mazotas, I.G., Noetzel, M., Limbrick, D.D., Keller, M.S., Effect of implementation of a paediatric neurocritical care programme on outcomes after severe traumatic brain injury: a retrospective cohort study (2013) Lancet Neurol, 12 (1), pp. 45-52. , PID: 23200264, This study provides evidence for the importance of a pediatric neurocritical care program; Adelson, P.D., Bratton, S.L., Carney, N.A., Chesnut, R.M., du Coudray, H.E., Goldstein, B., Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents. Chapter 1: introduction (2003) Pediatr Crit Care Med: J Soc Crit Care Med World Fed Pediatr IntensCrit Care Soc, 4, pp. S2-S4; Kochanek, P.M., Carney, N., Adelson, P.D., Ashwal, S., Bell, M.J., Bratton, S., Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents—second edition (2012) Pediatr Crit Care Med: J Soc Crit Care Med World Fed Pediatr IntensCrit Care Soc, 13, pp. S1-S82. , This is the most recently updated guidelines for the management of traumatic brain injury in children; Adelson, P.D., Pineda, J., Bell, M.J., Abend, N.S., Berger, R.P., Giza, C.C., Common data elements for pediatric traumatic brain injury: recommendations from the working group on demographics and clinical assessment (2012) J Neurotrauma, 29 (4), pp. 639-653. , PID: 21939389; Berger, R.P., Beers, S.R., Papa, L., Bell, M., Pediatric TBI CDE Biospecimens and Biomarkers Workgroup, Common data elements for pediatric traumatic brain injury: recommendations from the biospecimens and biomarkers workgroup (2012) J Neurotrauma, 29 (4), pp. 672-677. , PID: 22106839; McCauley, S.R., Wilde, E.A., Anderson, V.A., Bedell, G., Beers, S.R., Campbell, T.F., Recommendations for the use of common outcome measures in pediatric traumatic brain injury research (2012) J Neurotrauma, 29 (4), pp. 678-705. , PID: 21644810; Duhaime, A.C., Gean, A.D., Haacke, E.M., Hicks, R., Wintermark, M., Mukherjee, P., Common data elements in radiologic imaging of traumatic brain injury (2010) Arch Phys Med Rehabil, 91 (11), pp. 1661-1666. , PID: 21044709; Levi, L., Guilburd, J.N., Linn, S., Feinsod, M., The association between skull fracture, intracranial pathology and outcome in pediatric head injury (1991) Br J Neurosurg, 5 (6), pp. 617-625. , COI: 1:STN:280:DyaK387is1amsA%3D%3D, PID: 1772608; Stein, S.C., Spettell, C., Young, G., Ross, S.E., Delayed and progressive brain injury in closed-head trauma: radiological demonstration (1993) Neurosurgery, 32 (1), pp. 25-30. , COI: 1:STN:280:DyaK3s7jtlCjtA%3D%3D, PID: 8421553, discussion -1; Figaji, A.A., Zwane, E., Thompson, C., Fieggen, A.G., Argent, A.C., Le Roux, P.D., Brain tissue oxygen tension monitoring in pediatric severe traumatic brain injury. Part 1: relationship with outcome (2009) Childs Nerv System: ChNS: Off J Int Soc Pediatr Neurosurg, 25 (10), pp. 1325-1333; Figaji, A.A., Zwane, E., Thompson, C., Fieggen, A.G., Argent, A.C., Le Roux, P.D., Brain tissue oxygen tension monitoring in pediatric severe traumatic brain injury. Part 2: relationship with clinical, physiological, and treatment factors (2009) Childs Nerv System: ChNS: Off J Int Soc Pediatr Neurosurg, 25 (10), pp. 1335-1343; McLaughlin, M.R., Marion, D.W., Cerebral blood flow and vasoresponsivity within and around cerebral contusions (1996) J Neurosurg, 85 (5), pp. 871-876. , COI: 1:STN:280:DyaK2s%2FkvV2qtA%3D%3D, PID: 8893726; Adelson, P.D., Ragheb, J., Kanev, P., Brockmeyer, D., Beers, S.R., Brown, S.D., Phase II clinical trial of moderate hypothermia after severe traumatic brain injury in children (2005) Neurosurgery, 56 (4), pp. 740-754. , PID: 15792513, discussion -54; Pfenninger, J., Santi, A., Severe traumatic brain injury in children—are the results improving? (2002) Swiss Med Wkly, 132 (9-10), pp. 116-120. , PID: 12045999; White, J.R., Farukhi, Z., Bull, C., Christensen, J., Gordon, T., Paidas, C., Predictors of outcome in severely head-injured children (2001) Crit Care Med, 29 (3), pp. 534-540. , COI: 1:STN:280:DC%2BD3M3ptVyntQ%3D%3D, PID: 11373416; Chambers, I.R., Jones, P.A., Lo, T.Y., Forsyth, R.J., Fulton, B., Andrews, P.J., Critical thresholds of intracranial pressure and cerebral perfusion pressure related to age in paediatric head injury (2006) J Neurol Neurosurg Psychiatry, 77 (2), pp. 234-240. , COI: 1:STN:280:DC%2BD28%2FjtlGitA%3D%3D, PID: 16103043; Allen, B.B., Chiu, Y.L., Gerber, L.M., Ghajar, J., Greenfield, J.P., Age-specific cerebral perfusion pressure thresholds and survival in children and adolescents with severe traumatic brain injury (2014) Pediatr Crit Care Med: J Soc Crit Care Med World Fed Pediatr IntensCrit Care Soc, 15 (1), pp. 62-70. , This is the first study to attempt and determine the age related differences in cerebral perfusion pressures in children; Stippler, M., Ortiz, V., Adelson, P.D., Chang, Y.F., Tyler-Kabara, E.C., Wisniewski, S.R., Brain tissue oxygen monitoring after severe traumatic brain injury in children: relationship to outcome and association with other clinical parameters (2012) J Neurosurg Pediatr, 10 (5), pp. 383-391. , PID: 22978637; Mehta, A., Kochanek, P.M., Tyler-Kabara, E., Adelson, P.D., Wisniewski, S.R., Berger, R.P., Relationship of intracranial pressure and cerebral perfusion pressure with outcome in young children after severe traumatic brain injury (2010) Dev Neurosci, 32 (5-6), pp. 413-419. , COI: 1:CAS:528:DC%2BC3MXhvFCisLc%3D, PID: 20847542; Roberts, D.J., Hall, R.I., Kramer, A.H., Robertson, H.L., Gallagher, C.N., Zygun, D.A., Sedation for critically ill adults with severe traumatic brain injury: a systematic review of randomized controlled trials (2011) Crit Care Med, 39 (12), pp. 2743-2751. , COI: 1:CAS:528:DC%2BC3MXhsV2ls7%2FO, PID: 22094498; Sperry, R.J., Bailey, P.L., Reichman, M.V., Peterson, J.C., Petersen, P.B., Pace, N.L., Fentanyl and sufentanil increase intracranial pressure in head trauma patients (1992) Anesthesiology, 77 (3), pp. 416-420. , COI: 1:STN:280:DyaK38zptFKqtg%3D%3D, PID: 1306051; Lauer, K.K., Connolly, L.A., Schmeling, W.T., Opioid sedation does not alter intracranial pressure in head injured patients (1997) Can J Anaesth, 44 (9), pp. 929-933. , COI: 1:STN:280:DyaK2svltVGltQ%3D%3D, PID: 9305555; Albanese, J., Viviand, X., Potie, F., Rey, M., Alliez, B., Martin, C., Sufentanil, fentanyl, and alfentanil in head trauma patients: a study on cerebral hemodynamics (1999) Crit Care Med, 27 (2), pp. 407-411. , COI: 1:STN:280:DyaK1M7ntlelsQ%3D%3D, PID: 10075068; de Nadal, M., Munar, F., Poca, M.A., Sahuquillo, J., Garnacho, A., Rossello, J., Cerebral hemodynamic effects of morphine and fentanyl in patients with severe head injury: absence of correlation to cerebral autoregulation (2000) Anesthesiology, 92 (1), pp. 11-19. , PID: 10638893; Colton K, Yang S, Hu PF, Chen HH, Bonds B, Scalea TM et al. Intracranial pressure response after pharmacologic treatment of intracranial hypertension. J Trauma Acute Care Surg. 2014;77(1):47–53; discussion. doi:Papazian, L., Albanese, J., Thirion, X., Perrin, G., Durbec, O., Martin, C., Effect of bolus doses of midazolam on intracranial pressure and cerebral perfusion pressure in patients with severe head injury (1993) Br J Anaesth, 71 (2), pp. 267-271. , COI: 1:STN:280:DyaK2c7mvVyktQ%3D%3D, PID: 8123405; Sandiumenge Camps, A., Sanchez-Izquierdo Riera, J.A., Toral Vazquez, D., Sa Borges, M., Peinado Rodriguez, J., Alted Lopez, E., Midazolam and 2% propofol in long-term sedation of traumatized critically ill patients: efficacy and safety comparison (2000) Crit Care Med, 28 (11), pp. 3612-3619. , COI: 1:STN:280:DC%2BD3M%2Flt1GjtA%3D%3D, PID: 11098962; Sanchez-Izquierdo-Riera, J.A., Caballero-Cubedo, R.E., Perez-Vela, J.L., Ambros-Checa, A., Cantalapiedra-Santiago, J.A., Alted-Lopez, E., Propofol versus midazolam: safety and efficacy for sedating the severe trauma patient (1998) Anesth Analg, 86 (6), pp. 1219-1224. , COI: 1:CAS:528:DyaK1cXjvValsrc%3D, PID: 9620508; Gu, J.W., Yang, T., Kuang, Y.Q., Huang, H.D., Kong, B., Shu, H.F., Comparison of the safety and efficacy of propofol with midazolam for sedation of patients with severe traumatic brain injury: a meta-analysis (2014) J Crit Care, 29 (2), pp. 287-290. , COI: 1:CAS:528:DC%2BC3sXitVSgs7rL, PID: 24360821; Roberts, I., Sydenham, E., Barbiturates for acute traumatic brain injury (2012) Cochrane Database Syst Rev, 12, p. CD000033. , PID: 23235573, This Cochrane review summarizes the evidence for barbiturates in adult traumatic brain injury; Pittman, T., Bucholz, R., Williams, D., Efficacy of barbiturates in the treatment of resistant intracranial hypertension in severely head-injured children (1989) Pediatr Neurosci, 15 (1), pp. 13-17. , COI: 1:STN:280:DyaK3c3ltFGisw%3D%3D, PID: 2635769; Mellion, S.A., Bennett, K.S., Ellsworth, G.L., Moore, K., Riva-Cambrin, J., Metzger, R.R., High-dose barbiturates for refractory intracranial hypertension in children with severe traumatic brain injury (2013) Pediatr Crit Care Med: J Soc Crit Care Med World Fed Pediatr IntensCrit Care Soc, 14 (3), pp. 239-247; Spitzfaden, A.C., Jimenez, D.F., Tobias, J.D., Propofol for sedation and control of intracranial pressure in children (1999) Pediatr Neurosurg, 31 (4), pp. 194-200. , COI: 1:STN:280:DC%2BD3c7mvVCntA%3D%3D, PID: 10705929; Pinaud, M., Lelausque, J.N., Chetanneau, A., Fauchoux, N., Menegalli, D., Souron, R., Effects of propofol on cerebral hemodynamics and metabolism in patients with brain trauma (1990) Anesthesiology, 73 (3), pp. 404-409. , COI: 1:STN:280:DyaK3czmsFanuw%3D%3D, PID: 2118315; Kelly, D.F., Goodale, D.B., Williams, J., Herr, D.L., Chappell, E.T., Rosner, M.J., Propofol in the treatment of moderate and severe head injury: a randomized, prospective double-blinded pilot trial (1999) J Neurosurg, 90 (6), pp. 1042-1052. , COI: 1:CAS:528:DyaK1MXjvVeisLk%3D, PID: 10350250; Gooding, J.M., Weng, J.T., Smith, R.A., Berninger, G.T., Kirby, R.R., Cardiovascular and pulmonary responses following etomidate induction of anesthesia in patients with demonstrated cardiac disease (1979) Anesth Analg, 58 (1), pp. 40-41. , COI: 1:STN:280:DyaE1M7mtlGltw%3D%3D, PID: 571221; Moss, E., Powell, D., Gibson, R.M., McDowall, D.G., Effect of etomidate on intracranial pressure and cerebral perfusion pressure (1979) Br J Anaesth, 51 (4), pp. 347-352. , COI: 1:STN:280:DyaE1M3jt1Srug%3D%3D, PID: 465257; Bramwell, K.J., Haizlip, J., Pribble, C., VanDerHeyden, T.C., Witte, M., The effect of etomidate on intracranial pressure and systemic blood pressure in pediatric patients with severe traumatic brain injury (2006) Pediatr Emerg Care, 22 (2), pp. 90-93. , PID: 16481923; Gibbs, J.M., The effect of intravenous ketamine on cerebrospinal fluid pressure (1972) Br J Anaesth, 44 (12), pp. 1298-1302. , COI: 1:STN:280:DyaE3s%2FptVGksA%3D%3D, PID: 4650346; Ben Yehuda, Y., Watemberg, N., Ketamine increases opening cerebrospinal pressure in children undergoing lumbar puncture (2006) J Child Neurol, 21 (6), pp. 441-443. , PID: 16948925; Wyte, S.R., Shapiro, H.M., Turner, P., Harris, A.B., Ketamine-induced intracranial hypertension (1972) Anesthesiology, 36 (2), pp. 174-176. , COI: 1:STN:280:DyaE387gvVWntA%3D%3D, PID: 5059108; Bourgoin, A., Albanese, J., Leone, M., Sampol-Manos, E., Viviand, X., Martin, C., Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients (2005) Crit Care Med, 33 (5), pp. 1109-1113. , COI: 1:CAS:528:DC%2BD2MXkt1ahsLg%3D, PID: 15891344; Bar-Joseph, G., Guilburd, Y., Tamir, A., Guilburd, J.N., Effectiveness of ketamine in decreasing intracranial pressure in children with intracranial hypertension (2009) J Neurosurg Pediatr, 4 (1), pp. 40-46. , PID: 19569909; Chin, K.H., Bell, M.J., Wisniewski, S.R., Goundappa, B.G., Kochanek, P.M., Beers, S.R., Effect of administration of neuromuscular blocking agents in children with severe traumatic brain injury on acute complication rates and outcomes: a secondary analysis from a randomized, controlled trial of therapeutic hypothermia (2015) Pediatr Crit Care Med: J Soc Crit Care Med World Fed Pediatr IntensCrit Care Soc, , This study reviews the effects of neuromuscular blockade administration in pediatric traumatic brain injury on complications and outcomes; Adelson, P.D., Wisniewski, S.R., Beca, J., Brown, S.D., Bell, M., Muizelaar, J.P., Comparison of hypothermia and normothermia after severe traumatic brain injury in children (Cool Kids): a phase 3, randomised controlled trial (2013) Lancet Neurol, 12 (6), pp. 546-553. , PID: 23664370, This study is the most recent prospective trial investigating the effect of hypothermia on neurologic outcome after traumatic brain injury; Hsiang, J.K., Chesnut, R.M., Crisp, C.B., Klauber, M.R., Blunt, B.A., Marshall, L.F., Early, routine paralysis for intracranial pressure control in severe head injury: is it necessary? (1994) Crit Care Med, 22 (9), pp. 1471-1476. , COI: 1:STN:280:DyaK2czktV2ltQ%3D%3D, PID: 8062572; Sanfilippo, F., Santonocito, C., Veenith, T., Astuto, M., Maybauer, M.O., The role of neuromuscular blockade in patients with traumatic brain injury: a systematic review (2014) Neurocrit Care, , A review summarizing the literature for use of muscle relaxants; Annegers, J.F., Hauser, W.A., Coan, S.P., Rocca, W.A., A population-based study of seizures after traumatic brain injuries (1998) N Engl J Med, 338 (1), pp. 20-24. , COI: 1:STN:280:DyaK1c%2FmvF2nsw%3D%3D, PID: 9414327; Muizelaar, J.P., Lutz, H.A., 3rd, Becker, D.P., Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients (1984) J Neurosurg, 61 (4), pp. 700-706. , COI: 1:STN:280:DyaL2c3ptFKhsg%3D%3D, PID: 6432972; Diringer MN, Scalfani MT, Zazulia AR, Videen TO, Dhar R, Powers WJ. Effect of mannitol on cerebral blood volume in patients with head injury. Neurosurgery. 2012;70(5):1215–8; discussion 9. doi:. This paper provides the evidence for mannitol’s effect on cerebral blood volume and intracranial pressureBouma, G.J., Muizelaar, J.P., Cerebral blood flow, cerebral blood volume, and cerebrovascular reactivity after severe head injury (1992) J Neurotrauma, 9, pp. S333-S348. , PID: 1588625; Wakai, A., McCabe, A., Roberts, I., Schierhout, G., Mannitol for acute traumatic brain injury (2013) Cochrane Database Syst Rev, 8, p. CD001049. , PID: 23918314, This review summarizes the efficacy of mannitol in treatment of intracranial hypertension; Schwartz, M.L., Tator, C.H., Rowed, D.W., Reid, S.R., Meguro, K., Andrews, D.F., The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol (1984) Can J Neurol Sci, 11 (4), pp. 434-440. , COI: 1:STN:280:DyaL2M%2FpvVyruw%3D%3D, PID: 6440704; Vialet, R., Albanese, J., Thomachot, L., Antonini, F., Bourgouin, A., Alliez, B., Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol (2003) Crit Care Med, 31 (6), pp. 1683-1687. , COI: 1:CAS:528:DC%2BD3sXlvVSltL0%3D, PID: 12794404; Mangat, H.S., Chiu, Y.L., Gerber, L.M., Alimi, M., Ghajar, J., Hartl, R., Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury (2015) J Neurosurg, 122 (1), pp. 202-210. , PID: 25380107, This study provides the evidence for the efficacy of hypertonic saline in intracranial pressure reduction; Fisher, B., Thomas, D., Peterson, B., Hypertonic saline lowers raised intracranial pressure in children after head trauma (1992) J Neurosurg Anesthesiol, 4 (1), pp. 4-10. , COI: 1:STN:280:DC%2BD2M3msVGmug%3D%3D, PID: 15815431; Simma, B., Burger, R., Falk, M., Sacher, P., Fanconi, S., A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer’s solution versus hypertonic saline (1998) Crit Care Med, 26 (7), pp. 1265-1270. , COI: 1:STN:280:DyaK1czjsVCmtg%3D%3D, PID: 9671379; Arndt, D.H., Lerner, J.T., Matsumoto, J.H., Madikians, A., Yudovin, S., Valino, H., Subclinical early posttraumatic seizures detected by continuous EEG monitoring in a consecutive pediatric cohort (2013) Epilepsia, 54 (10), pp. 1780-1788. , PID: 24032982, This study demonstrates the frequency of posttraumatic seizures in pediatrics; Lewis, R.J., Yee, L., Inkelis, S.H., Gilmore, D., Clinical predictors of post-traumatic seizures in children with head trauma (1993) Ann Emerg Med, 22 (7), pp. 1114-1118. , COI: 1:STN:280:DyaK3s3pslOmtA%3D%3D, PID: 8517559; Kloti, J., Fanconi, S., Zachmann, M., Zaugg, H., Dexamethasone therapy and cortisol excretion in severe pediatric head injury (1987) Childs Nerv System: ChNS: Off J Int Soc Pediatr Neurosurg, 3 (2), pp. 103-105. , COI: 1:STN:280:DyaL2szgtFGitA%3D%3D; Fanconi, S., Kloti, J., Meuli, M., Zaugg, H., Zachmann, M., Dexamethasone therapy and endogenous cortisol production in severe pediatric head injury (1988) Intensive Care Med, 14 (2), pp. 163-166. , COI: 1:STN:280:DyaL1c7pvVOltA%3D%3D, PID: 3361022; Stringer, W.A., Hasso, A.N., Thompson, J.R., Hinshaw, D.B., Jordan, K.G., Hyperventilation-induced cerebral ischemia in patients with acute brain lesions: demonstration by xenon-enhanced CT (1993) AJNR Am J Neuroradiol, 14 (2), pp. 475-484. , COI: 1:STN:280:DyaK3s3gs1yhuw%3D%3D, PID: 8456732; Muizelaar, J.P., Marmarou, A., DeSalles, A.A., Ward, J.D., Zimmerman, R.S., Li, Z., Cerebral blood flow and metabolism in severely head-injured children. Part 1: relationship with GCS score, outcome, ICP, and PVI (1989) J Neurosurg, 71 (1), pp. 63-71. , COI: 1:STN:280:DyaL1M3ptlahug%3D%3D, PID: 2738643; Curry, R., Hollingworth, W., Ellenbogen, R.G., Vavilala, M.S., Incidence of hypo- and hypercarbia in severe traumatic brain injury before and after 2003 pediatric guidelines (2008) Pediatr Crit Care Med: J Soc Crit Care Med World Fed Pediatr IntensCrit Care Soc, 9 (2), pp. 141-146; Hutchison, J.S., Ward, R.E., Lacroix, J., Hebert, P.C., Barnes, M.A., Bohn, D.J., Hypothermia therapy after traumatic brain injury in children (2008) N Engl J Med, 358 (23), pp. 2447-2456. , COI: 1:CAS:528:DC%2BD1cXmvFKmtLc%3D, PID: 18525042; Taylor, A., Butt, W., Rosenfeld, J., Shann, F., Ditchfield, M., Lewis, E., A randomized trial of very early decompressive craniectomy in children with traumatic brain injury and sustained intracranial hypertension (2001) Childs Nerv System: ChNS: Off J Int Soc Pediatr Neurosurg, 17 (3), pp. 154-162. , COI: 1:STN:280:DC%2BD3MvgvFSgtA%3D%3D; Skoglund, T.S., Eriksson-Ritzen, C., Jensen, C., Rydenhag, B., Aspects on decompressive craniectomy in patients with traumatic head injuries (2006) J Neurotrauma, 23 (10), pp. 1502-1509. , PID: 17020484; Jagannathan, J., Okonkwo, D.O., Dumont, A.S., Ahmed, H., Bahari, A., Prevedello, D.M., Outcome following decompressive craniectomy in children with severe traumatic brain injury: a 10-year single-center experience with long-term follow up (2007) J Neurosurg, 106, pp. 268-275. , PID: 17465359; Briassoulis, G., Filippou, O., Kanariou, M., Papassotiriou, I., Hatzis, T., Temporal nutritional and inflammatory changes in children with severe head injury fed a regular or an immune-enhancing diet: a randomized, controlled trial (2006) Pediatr Crit Care Med: J Soc Crit Care Med World Fed Pediatr IntensCrit Care Soc, 7 (1), pp. 56-62; Michaud, L.J., Rivara, F.P., Longstreth, W.T., Jr., Grady, M.S., Elevated initial blood glucose levels and poor outcome following severe brain injuries in children (1991) J Trauma, 31 (10), pp. 1356-1362. , COI: 1:STN:280:DyaK38%2Fks1Wqsg%3D%3D, PID: 1942143; Cochran, A., Scaife, E.R., Hansen, K.W., Downey, E.C., Hyperglycemia and outcomes from pediatric traumatic brain injury (2003) J Trauma, 55 (6), pp. 1035-1038. , PID: 14676647; Smith, R.L., Lin, J.C., Adelson, P.D., Kochanek, P.M., Fink, E.L., Wisniewski, S.R., Relationship between hyperglycemia and outcome in children with severe traumatic brain injury (2012) Pediatr Crit Care Med: J Soc Crit Care Med World Fed Pediatr IntensCrit Care Soc, 13 (1), pp. 85-91",Review,Scopus,2-s2.0-84927616575
"Leung H.W., Moerkamp A.T., Padmanabhan J., Ng S.-W., Goumans M.-J., Choo A.","MAb C19 targets a novel surface marker for the isolation of human cardiac progenitor cells from human heart tissue and differentiated hESCs",2015,"Journal of Molecular and Cellular Cardiology","82",,,"228","237",,,10.1016/j.yjmcc.2015.02.016,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926462984&partnerID=40&md5=0d25e6ea0b91f55f52cc1b6b1dd5898a","Bioprocessing Technology Institute, Agency for Science, Technology and Research (A STAR), Singapore; NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore; Department of Molecular Cell Biology, Leiden University Medical CentreLeiden, Netherlands; Department of Bioengineering, National University of Singapore, Singapore","Leung, H.W., Bioprocessing Technology Institute, Agency for Science, Technology and Research (A STAR), Singapore, NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore; Moerkamp, A.T., Department of Molecular Cell Biology, Leiden University Medical CentreLeiden, Netherlands; Padmanabhan, J., Bioprocessing Technology Institute, Agency for Science, Technology and Research (A STAR), Singapore; Ng, S.-W., Bioprocessing Technology Institute, Agency for Science, Technology and Research (A STAR), Singapore; Goumans, M.-J., Department of Molecular Cell Biology, Leiden University Medical CentreLeiden, Netherlands; Choo, A., Bioprocessing Technology Institute, Agency for Science, Technology and Research (A STAR), Singapore, Department of Bioengineering, National University of Singapore, Singapore","Aims: Cardiac progenitor cells (CPCs) have been isolated from adult and developing hearts using an anti-mouse Sca-1 antibody. However, the absence of a human Sca-1 homologue has hampered the clinical application of the CPCs. Therefore, we generated novel monoclonal antibodies (mAbs) specifically raised against surface markers expressed by resident human CPCs. Here, we explored the suitability of one of these mAbs, mAb C19, for the identification, isolation and characterization of CPCs from fetal heart tissue and differentiating cultures of human embryonic stem cells (hESCs). Methods & results: Using whole-cell immunization, mAbs were raised against Sca-1. + CPCs and screened for reactivity to various CPC lines by flow cytometry. mAb C19 was found to be specific for Sca-1. + CPCs, with high cell surface binding capabilities. mAb C19 stained small stem-like cells in cardiac tissue sections. Moreover, during differentiation of hESCs towards cardiomyocytes, a transient population of cells with mAb C19 reactivity was identified and isolated using magnetic-activated cell sorting. Their cell fate was tracked and found to improve cardiomyocyte purity from hESC-derived cultures. mAb C19. + CPCs, from both hESC differentiation and fetal heart tissues, were maintained and expanded in culture, while retaining their CPC-like characteristics and their ability to further differentiate into cardiomyocytes by stimulation with TGFβ1. Finally, gene expression profiling of these mAb C19. + CPCs suggested a highly angiogenic nature, which was further validated by cell-based angiogenesis assays. Conclusion: mAb C19 is a new surface marker for the isolation of multipotent CPCs from both human heart tissues and differentiating hESCs. © 2015 Elsevier Ltd.","Cardiomyocyte differentiation; HESC differentiation; Monoclonal antibodies; Multipotent; Resident cardiac progenitor cells; Sca-1","Reinecke, H., Minami, E., Zhu, W.-Z., Laflamme, M.A., Cardiogenic differentiation and transdifferentiation of progenitor cells (2008) Circ Res, 103, pp. 1058-1071; Bollini, S., Smart, N., Riley, P.R., Resident cardiac progenitor cells: at the heart of regeneration (2011) J Mol Cell Cardiol, 50, pp. 296-303; Smits, A.M., van Vliet, P., Metz, C.H., Korfage, T., Sluijter, J.P., Doevendans, P.A., Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology (2009) Nat Protoc, 4, pp. 232-243; Goumans, M.-J., de Boer, T.P., Smits, A.M., van Laake, L.W., van Vliet, P., Metz, C.H.G., TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro (2007) Stem Cell Res, 1, pp. 138-149; De Boer, T.P., van Veen, T.A.B., Jonsson, M.K.B., Kok, B.G.J.M., Metz, C.H.G., Sluijter, J.P.G., Human cardiomyocyte progenitor cell-derived cardiomyocytes display a maturated electrical phenotype (2010) J Mol Cell Cardiol, 48, pp. 254-260; Smits, A.M., van Laake, L.W., den Ouden, K., Schreurs, C., Szuhai, K., van Echteld, C.J., Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium (2009) Cardiovasc Res, 83, pp. 527-535; Holmes, C., Stanford, W.L., Concise review: stem cell antigen-1: expression, function, and enigma (2007) STEM CELLS, 25, pp. 1339-1347; Keller, G., Embryonic stem cell differentiation: emergence of a new era in biology and medicine (2005) Genes Dev, 19, pp. 1129-1155; Huber, T.L., Dissecting hematopoietic differentiation using the embryonic stem cell differentiation model (2010) Int J Dev Biol, 54, pp. 991-1002; Yang, L., Soonpaa, M.H., Adler, E.D., Roepke, T.K., Kattman, S.J., Kennedy, M., Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population (2008) Nature, 453, pp. 524-528; Choo, A., Padmanabhan, J., Chin, A., Fong, W.J., Oh, S.K.W., Immortalized feeders for the scale-up of human embryonic stem cells in feeder and feeder-free conditions (2006) J Biotechnol, 122, pp. 130-141; Lecina, M., Ting, S., Choo, A., Reuveny, S., Oh, S., Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures (2010) Tissue Eng Part C Methods, 16, pp. 1609-1619; Huang, D.W., Sherman, B.T., Lempicki, R.A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources (2008) Nat Protoc, 4, pp. 44-57; Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Human cardiac stem cells (2007) Proc Natl Acad Sci, 104, pp. 14068-14073; Munoz, J., Low, T.Y., Kok, Y.J., Chin, A., Frese, C.K., Ding, V., The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells (2011) Mol Syst Biol, 7, p. 550; Oh, H., Bradfute, S.B., Gallardo, T.D., Nakamura, T., Gaussin, V., Mishina, Y., Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction (2003) Proc Natl Acad Sci U S A, 100, pp. 12313-12318; Panayi, G.S., Corrigall, V.M., Henderson, B., Stress cytokines: pivotal proteins in immune regulatory networks: opinion (2004) Curr Opin Immunol, 16, pp. 531-534; Quinones, Q.J., de Ridder, G.G., Pizzo, S.V., GRP78: a chaperone with diverse roles beyond the endoplasmic reticulum (2008) Histol Histopathol, 23, pp. 1409-1416; Barnes, J.A., Smoak, I.W., Glucose-regulated protein 78 (GRP78) is elevated in embryonic mouse heart and induced following hypoglycemic stress (2000) Anat Embryol, 202, pp. 67-74; Mao, C., Tai, W.-C., Bai, Y., Poizat, C., Lee, A.S., In vivo regulation of Grp78/BiP transcription in the embryonic heart: role of the endoplasmic reticulum stress response element and GATA-4 (2006) J Biol Chem, 281, pp. 8877-8887; Hardy, B., Raiter, A., Peptide-binding heat shock protein GRP78 protects cardiomyocytes from hypoxia-induced apoptosis (2010) J Mol Med, 88, pp. 1157-1167; Adamczyk, B., Tharmalingam, T., Rudd, P.M., Glycans as cancer biomarkers (2012) Biochim Biophys Acta Gen Subj, 1820, pp. 1347-1353; Lanctot, P.M., Gage, F.H., Varki, A.P., The glycans of stem cells (2007) Curr Opin Chem Biol, 11, pp. 373-380; Nairn, A.V., Aoki, K., dela, R.M., Porterfield, M., Lim, J.-M., Kulik, M., Regulation of glycan structures in murine embryonic stem cells: combined transcript profiling of glycan-related genes and glycan structural analysis (2012) J Biol Chem, 287, pp. 37835-37856; Peng, J., Jiang, J., Wang, W., Qi, X., Sun, X.-L., Wu, Q., Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes (2011) Biochem Biophys Res Commun, 411, pp. 593-598; Menasché, P., Alfieri, O., Janssens, S., McKenna, W., Reichenspurner, H., Trinquart, L., The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial first randomized placebo-controlled study of myoblast transplantation (2008) Circulation, 117, pp. 1189-1200; Psaltis, P.J., Zannettino, A.C.W., Worthley, S.G., Gronthos, S., Concise review: mesenchymal stromal cells: potential for cardiovascular repair (2008) STEM CELLS, 26, pp. 2201-2210; Tang, X.-L., Rokosh, G., Sanganalmath, S.K., Yuan, F., Sato, H., Mu, J., Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction (2010) Circulation, 121, pp. 293-305; Yoon, C.-H., Koyanagi, M., Iekushi, K., Seeger, F., Urbich, C., Zeiher, A.M., Mechanism of improved cardiac function after bone marrow mononuclear cell therapy role of cardiovascular lineage commitment (2010) Circulation, 121, pp. 2001-2011; Den Haan, M.C., Grauss, R.W., Smits, A.M., Winter, E.M., van Tuyn, J., Pijnappels, D.A., Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts (2012) J Cell Mol Med, 16, pp. 1508-1521; Li, T.-S., Cheng, K., Malliaras, K., Smith, R.R., Zhang, Y., Sun, B., Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells (2012) J Am Coll Cardiol, 59, pp. 942-953",Article,Scopus,2-s2.0-84926462984
"Puri D., Gala H., Mishra R., Dhawan J.","High-wire act: The poised genome and cellular memory",2015,"FEBS Journal","282","9",,"1675","1691",,1,10.1111/febs.13165,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928524398&partnerID=40&md5=ada70b265e6b9e4dd40ee8eae087befa","Council of Scientific and Industrial Research-Centre for Cellular and Molecular BiologyHyderabad, India; Institute for Stem Cell Biology and Regenerative Medicine, National Center for Biological Sciences, GKVK Post, Bellary RoadBangalore, India; Max Planck Institute of Immuno-biology and EpigeneticsFreiburg, Germany","Puri, D., Council of Scientific and Industrial Research-Centre for Cellular and Molecular BiologyHyderabad, India, Max Planck Institute of Immuno-biology and EpigeneticsFreiburg, Germany; Gala, H., Council of Scientific and Industrial Research-Centre for Cellular and Molecular BiologyHyderabad, India, Institute for Stem Cell Biology and Regenerative Medicine, National Center for Biological Sciences, GKVK Post, Bellary RoadBangalore, India; Mishra, R., Institute for Stem Cell Biology and Regenerative Medicine, National Center for Biological Sciences, GKVK Post, Bellary RoadBangalore, India; Dhawan, J., Council of Scientific and Industrial Research-Centre for Cellular and Molecular BiologyHyderabad, India, Institute for Stem Cell Biology and Regenerative Medicine, National Center for Biological Sciences, GKVK Post, Bellary RoadBangalore, India","Emerging evidence aided by genome-wide analysis of chromatin and transcriptional states has shed light on the mechanisms by which stem cells achieve cellular memory. The epigenetic and transcriptional plasticity governing stem cell behavior is highlighted by the identification of 'poised' genes, which permit cells to maintain readiness to undertake alternate developmental fates. This review focuses on two crucial mechanisms of gene poising: bivalent chromatin marks and RNA polymerase II stalling. We provide the context for these mechanisms by exploring the current consensus on the regulation of chromatin states, especially in quiescent adult stem cells, where poised genes are critical for recapitulating developmental choices, leading to regenerative function. Epigenetic and transcriptional plasticity governs stem cell behavior. The discovery of 'poised' genes suggests mechanisms that permit cells to maintain readiness for alternate developmental fates. This review focuses on two key mechanisms of gene poising: bivalent chromatin marks and RNA Polymerase II stalling, in the context of stem cell memory. © 2014 FEBS.","bivalent chromatin; Ezh2; H3K27; H3K4; poising; PRC2; quiescence; RNA Pol II; stem cells","Luger, K., Rechsteiner, T.J., Flaus, A.J., Waye, M.M., Richmond, T.J., Characterization of nucleosome core particles containing histone proteins made in bacteria (1997) J Mol Biol, 272, pp. 301-311; Kouzarides, T., SnapShot: Histone-modifying enzymes (2007) Cell, 128, p. 802; Tan, M., Luo, H., Lee, S., Jin, F., Yang, J.S., Montellier, E., Buchou, T., Rajagopal, N., Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification (2011) Cell, 146, pp. 1016-1028; Wang, Y., Fischle, W., Cheung, W., Jacobs, S., Khorasanizadeh, S., Allis, C.D., Beyond the double helix: writing and reading the histone code (2004) Novartis Found Symp, 259, pp. 3-17. , discussion 17-21, 163-169; Jenuwein, T., Allis, C.D., Translating the histone code (2001) Science, 293, pp. 1074-1080; Ernst, J., Kheradpour, P., Mikkelsen, T.S., Shoresh, N., Ward, L.D., Epstein, C.B., Zhang, X., Coyne, M., Mapping and analysis of chromatin state dynamics in nine human cell types (2011) Nature, 473, pp. 43-49; De Souza, N., The ENCODE project (2012) Nat Methods, 9, p. 1046; Kouzarides, T., Chromatin modifications and their function (2007) Cell, 128, pp. 693-705; Weber, C.M., Henikoff, S., Histone variants: dynamic punctuation in transcription (2014) Genes Dev, 28, pp. 672-682; Smith, Z.D., Meissner, A., DNA methylation: roles in mammalian development (2013) Nat Rev Genet, 14, pp. 204-220; Azuara, V., Perry, P., Sauer, S., Spivakov, M., Jørgensen, H.F., John, R.M., Gouti, M., Merkenschlager, M., Chromatin signatures of pluripotent cell lines (2006) Nat Cell Biol, 8, pp. 532-538; Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., Plath, K., A bivalent chromatin structure marks key developmental genes in embryonic stem cells (2006) Cell, 125, pp. 315-326; Mikkelsen, T.S., Ku, M., Jaffe, D.B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Koche, R.P., Genome-wide maps of chromatin state in pluripotent and lineage-committed cells (2007) Nature, 448, pp. 553-560; Mohn, F., Weber, M., Rebhan, M., Roloff, T.C., Richter, J., Stadler, M.B., Bibel, M., Schubeler, D., Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors (2008) Mol Cell, 30, pp. 755-766; Pan, G., Tian, S., Nie, J., Yang, C., Ruotti, V., Wei, H., Jonsdottir, G.A., Thomson, J.A., Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells (2007) Cell Stem Cell, 1, pp. 299-312; Zhao, X.D., Han, X., Chew, J.L., Liu, J., Chiu, K.P., Choo, A., Orlov, Y.L., Kuznetsov, V.A., Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells (2007) Cell Stem Cell, 1, pp. 286-298; Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors (2006) Cell, 126, pp. 663-676; Barski, A., Cuddapah, S., Cui, K., Roh, T.Y., Schones, D.E., Wang, Z., Wei, G., Zhao, K., High-resolution profiling of histone methylations in the human genome (2007) Cell, 129, pp. 823-837; Alder, O., Lavial, F., Helness, A., Brookes, E., Pinho, S., Chandrashekran, A., Arnaud, P., Azuara, V., Ring1B and Suv39 h1 delineate distinct chromatin states at bivalent genes during early mouse lineage commitment (2010) Development, 137, pp. 2483-2492; Vastenhouw, N.L., Zhang, Y., Woods, I.G., Imam, F., Regev, A., Liu, X.S., Rinn, J., Schier, A.F., Chromatin signature of embryonic pluripotency is established during genome activation (2010) Nature, 464, pp. 922-926; Sachs, M., Onodera, C., Blaschke, K., Ebata, K.T., Song, J.S., Ramalho-Santos, M., Bivalent chromatin marks developmental regulatory genes in the mouse embryonic germline in vivo (2013) Cell Rep, 3, pp. 1777-1784; Rodriguez, J., Munoz, M., Vives, L., Frangou, C.G., Groudine, M., Peinado, M.A., Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells (2008) Proc Natl Acad Sci USA, 105, pp. 19809-19814; Bapat, S.A., Jin, V., Berry, N., Balch, C., Sharma, N., Kurrey, N., Zhang, S., Li, M., Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells (2010) Epigenetics, 5, pp. 716-729; Chapman-Rothe, N., Curry, E., Zeller, C., Liber, D., Stronach, E., Gabra, H., Ghaem-Maghami, S., Brown, R., Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells (2013) Oncogene, 32, pp. 4586-4592; Ohm, J.E., McGarvey, K.M., Yu, X., Cheng, L., Schuebel, K.E., Cope, L., Mohammad, H.P., Yu, W., A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing (2007) Nat Genet, 39, pp. 237-242; Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D.J., Jacobs, I., Epigenetic stem cell signature in cancer (2007) Nat Genet, 39, pp. 157-158; Voigt, P., Tee, W.W., Reinberg, D., A double take on bivalent promoters (2013) Genes Dev, 27, pp. 1318-1338; Swigut, T., Wysocka, J., H3K27 demethylases, at long last (2007) Cell, 131, pp. 29-32; Agger, K., Cloos, P.A., Christensen, J., Pasini, D., Rose, S., Rappsilber, J., Issaeva, I., Helin, K., UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development (2007) Nature, 449, pp. 731-734; De Santa, F., Totaro, M.G., Prosperini, E., Notarbartolo, S., Testa, G., Natoli, G., The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing (2007) Cell, 130, pp. 1083-1094; Lan, F., Bayliss, P.E., Rinn, J.L., Whetstine, J.R., Wang, J.K., Chen, S., Iwase, S., Canaani, E., A histone H3 lysine 27 demethylase regulates animal posterior development (2007) Nature, 449, pp. 689-694; Nottke, A., Colaiacovo, M.P., Shi, Y., Developmental roles of the histone lysine demethylases (2009) Development, 136, pp. 879-889; Lee, M.G., Villa, R., Trojer, P., Norman, J., Yan, K.P., Reinberg, D., Di Croce, L., Shiekhattar, R., Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination (2007) Science, 318, pp. 447-450; Chen, S., Ma, J., Wu, F., Xiong, L.-J., Ma, H., Xu, W., Lv, R., Gygi, S.P., The histone H3 Lys 27 demethylase JMJD3 regulates gene expression by impacting transcriptional elongation (2012) Genes Dev, 26, pp. 1364-1375; Pasini, D., Hansen, K.H., Christensen, J., Agger, K., Cloos, P.A., Helin, K., Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2 (2008) Genes Dev, 22, pp. 1345-1355; Lagarou, A., Mohd-Sarip, A., Moshkin, Y.M., Chalkley, G.E., Bezstarosti, K., Demmers, J.A., Verrijzer, C.P., dKDM2 couples histone H2A ubiquitylation to histone H3 demethylation during Polycomb group silencing (2008) Genes Dev, 22, pp. 2799-2810; Voigt, P., Leroy, G., Drury, W.J., Zee, B.M., Son, J., Beck, D.B., Young, N.L., Reinberg, D., Asymmetrically modified nucleosomes (2012) Cell, 151, pp. 181-193; Cui, K., Zang, C., Roh, T.Y., Schones, D.E., Childs, R.W., Peng, W., Zhao, K., Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation (2009) Cell Stem Cell, 4, pp. 80-93; Paige, S.L., Thomas, S., Stoick-Cooper, C.L., Wang, H., Maves, L., Sandstrom, R., Pabon, L., Keller, G., A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development (2012) Cell, 151, pp. 221-232; Lien, W.H., Guo, X., Polak, L., Lawton, L.N., Young, R.A., Zheng, D., Fuchs, E., Genome-wide maps of histone modifications unwind in vivo chromatin states of the hair follicle lineage (2011) Cell Stem Cell, 9, pp. 219-232; Hammoud, S.S., Nix, D.A., Zhang, H., Purwar, J., Carrell, D.T., Cairns, B.R., Distinctive chromatin in human sperm packages genes for embryo development (2009) Nature, 460, pp. 473-478; Puri, D., Dhawan, J., Mishra, R.K., The paternal hidden agenda: Epigenetic inheritance through sperm chromatin (2010) Epigenetics, 5, pp. 386-391; Mauro, A., Satellite cell of skeletal muscle fibers (1961) J Biophys Biochem Cytol, 9, pp. 493-495; Schultz, E., Gibson, M.C., Champion, T., Satellite cells are mitotically quiescent in mature mouse muscle: an EM and radioautographic study (1978) J Exp Zool, 206, pp. 451-456; Aziz, A., Liu, Q.C., Dilworth, F.J., Regulating a master regulator: establishing tissue-specific gene expression in skeletal muscle (2010) Epigenetics, 5, pp. 691-695; Sartorelli, V., Juan, A.H., Sculpting chromatin beyond the double helix: epigenetic control of skeletal myogenesis (2011) Curr Top Dev Biol, 96, pp. 57-83; Saccone, V., Puri, P.L., Epigenetic regulation of skeletal myogenesis (2010) Organogenesis, 6, pp. 48-53; Asp, P., Blum, R., Vethantham, V., Parisi, F., Micsinai, M., Cheng, J., Bowman, C., Dynlacht, B.D., Genome-wide remodeling of the epigenetic landscape during myogenic differentiation (2011) Proc Natl Acad Sci USA, 108, pp. E149-E158; Blais, A., Tsikitis, M., Acosta-Alvear, D., Sharan, R., Kluger, Y., Dynlacht, B.D., An initial blueprint for myogenic differentiation (2005) Genes Dev, 19, pp. 553-569; Cao, Y., Yao, Z., Sarkar, D., Lawrence, M., Sanchez, G.J., Parker, M.H., MacQuarrie, K.L., Ruzzo, W.L., Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming (2010) Dev Cell, 18, pp. 662-674; Woodhouse, S., Pugazhendhi, D., Brien, P., Pell, J.M., Ezh2 maintains a key phase of muscle satellite cell expansion but does not regulate terminal differentiation (2013) J Cell Sci, 126, pp. 565-579; Liu, L., Cheung, T.H., Charville, G.W., Hurgo, B.M., Leavitt, T., Shih, J., Brunet, A., Rando, T.A., Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging (2013) Cell Rep, 4, pp. 189-204; Fukada, S., Uezumi, A., Ikemoto, M., Masuda, S., Segawa, M., Tanimura, N., Yamamoto, H., Takeda, S., Molecular signature of quiescent satellite cells in adult skeletal muscle (2007) Stem Cells, 25, pp. 2448-2459; Akkers, R.C., Van Heeringen, S.J., Jacobi, U.G., Janssen-Megens, E.M., Francoijs, K.J., Stunnenberg, H.G., Veenstra, G.J., A hierarchy of H3K4me3 and H3K27me3 acquisition in spatial gene regulation in Xenopus embryos (2009) Dev Cell, 17, pp. 425-434; Schuettengruber, B., Ganapathi, M., Leblanc, B., Portoso, M., Jaschek, R., Tolhuis, B., Van Lohuizen, M., Cavalli, G., Functional anatomy of polycomb and trithorax chromatin landscapes in Drosophila embryos (2009) PLoS Biol, 7, p. e13; Gan, Q., Schones, D.E., Ho Eun, S., Wei, G., Cui, K., Zhao, K., Chen, X., Monovalent and unpoised status of most genes in undifferentiated cell-enriched Drosophila testis (2010) Genome Biol, 11, p. R42; Schmitges, F.W., Prusty, A.B., Faty, M., Stutzer, A., Lingaraju, G.M., Aiwazian, J., Sack, R., Zhou, S., Histone methylation by PRC2 is inhibited by active chromatin marks (2011) Mol Cell, 42, pp. 330-341; Young, N.L., Dimaggio, P.A., Plazas-Mayorca, M.D., Baliban, R.C., Floudas, C.A., Garcia, B.A., High throughput characterization of combinatorial histone codes (2009) Mol Cell Proteomics, 8, pp. 2266-2284; Roh, T.Y., Cuddapah, S., Cui, K., Zhao, K., The genomic landscape of histone modifications in human T cells (2006) Proc Natl Acad Sci USA, 103, pp. 15782-15787; Brookes, E., De Santiago, I., Hebenstreit, D., Morris, K.J., Carroll, T., Xie, S.Q., Stock, J.K., Nozaki, N., Polycomb associates genome-wide with a specific RNA polymerase II variant, and regulates metabolic genes in ESCs (2012) Cell Stem Cell, 10, pp. 157-170; Seenundun, S., Rampalli, S., Liu, Q.C., Aziz, A., Palii, C., Hong, S., Blais, A., Dilworth, F.J., UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis (2010) EMBO J, 29, pp. 1401-1411; Creyghton, M.P., Markoulaki, S., Levine, S.S., Hanna, J., Lodato, M.A., Sha, K., Young, R.A., Boyer, L.A., H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment (2008) Cell, 135, pp. 649-661; Talbert, P.B., Henikoff, S., Histone variants-ancient wrap artists of the epigenome (2010) Nat Rev Mol Cell Biol, 11, pp. 264-275; Ku, M., Jaffe, J.D., Koche, R.P., Rheinbay, E., Endoh, M., Koseki, H., Carr, S.A., Bernstein, B.E., H2A.Z landscapes and dual modifications in pluripotent and multipotent stem cells underlie complex genome regulatory functions (2012) Genome Biol, 13, p. R85; Orlando, D.A., Guenther, M.G., Frampton, G.M., Young, R.A., CpG island structure and trithorax/polycomb chromatin domains in human cells (2012) Genomics, 100, pp. 320-326; Mozzetta, C., Pontis, J., Fritsch, L., Robin, P., Portoso, M., Proux, C., Margueron, R., Ait-Si-Ali, S., The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing (2014) Mol Cell, 53, pp. 277-289; Bilodeau, S., Kagey, M.H., Frampton, G.M., Rahl, P.B., Young, R.A., SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state (2009) Genes Dev, 23, pp. 2484-2489; Yuan, P., Han, J., Guo, G., Orlov, Y.L., Huss, M., Loh, Y.H., Yaw, L.P., Ng, H.H., Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells (2009) Genes Dev, 23, pp. 2507-2520; Karmodiya, K., Krebs, A.R., Oulad-Abdelghani, M., Kimura, H., Tora, L., H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells (2012) BMC Genom, 13, p. 424; Hattori, N., Niwa, T., Kimura, K., Helin, K., Ushijima, T., Visualization of multivalent histone modification in a single cell reveals highly concerted epigenetic changes on differentiation of embryonic stem cells (2013) Nucleic Acids Res, 41, pp. 7231-7239; Kim, T.H., Barrera, L.O., Zheng, M., Qu, C., Singer, M.A., Richmond, T.A., Wu, Y., Ren, B., A high-resolution map of active promoters in the human genome (2005) Nature, 436, pp. 876-880; Zeitlinger, J., Stark, A., Kellis, M., Hong, J.W., Nechaev, S., Adelman, K., Levine, M., Young, R.A., RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo (2007) Nat Genet, 39, pp. 1512-1516; Core, L.J., Waterfall, J.J., Lis, J.T., Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters (2008) Science, 322, pp. 1845-1848; Guenther, M.G., Levine, S.S., Boyer, L.A., Jaenisch, R., Young, R.A., A chromatin landmark and transcription initiation at most promoters in human cells (2007) Cell, 130, pp. 77-88; Muse, G.W., Gilchrist, D.A., Nechaev, S., Shah, R., Parker, J.S., Grissom, S.F., Zeitlinger, J., Adelman, K., RNA polymerase is poised for activation across the genome (2007) Nat Genet, 39, pp. 1507-1511; Nechaev, S., Fargo, D.C., Dos Santos, G., Liu, L., Gao, Y., Adelman, K., Global analysis of short RNAs reveals widespread promoter-proximal stalling and arrest of Pol II in Drosophila (2010) Science, 327, pp. 335-338; Rahl, P.B., Lin, C.Y., Seila, A.C., Flynn, R.A., McCuine, S., Burge, C.B., Sharp, P.A., Young, R.A., c-Myc regulates transcriptional pause release (2010) Cell, 141, pp. 432-445; Gilmour, D.S., Lis, J.T., RNA polymerase II interacts with the promoter region of the noninduced hsp70 gene in Drosophila melanogaster cells (1986) Mol Cell Biol, 6, pp. 3984-3989; Krumm, A., Meulia, T., Brunvand, M., Groudine, M., The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region (1992) Genes Dev, 6, pp. 2201-2213; Plet, A., Eick, D., Blanchard, J.M., Elongation and premature termination of transcripts initiated from c-fos and c-myc promoters show dissimilar patterns (1995) Oncogene, 10, pp. 319-328; Rasmussen, E.B., Lis, J.T., In vivo transcriptional pausing and cap formation on three Drosophila heat shock genes (1993) Proc Natl Acad Sci USA, 90, pp. 7923-7927; Rougvie, A.E., Lis, J.T., The RNA polymerase II molecule at the 5′ end of the uninduced hsp70 gene of D. melanogaster is transcriptionally engaged (1988) Cell, 54, pp. 795-804; Strobl, L.J., Eick, D., Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo (1992) EMBO J, 11, pp. 3307-3314; Guo, J., Price, D.H., RNA polymerase II transcription elongation control (2013) Chem Rev, 113, pp. 8583-8603; Adelman, K., Lis, J.T., Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans (2012) Nat Rev Genet, 13, pp. 720-731; Lagha, M., Bothma, J.P., Esposito, E., Ng, S., Stefanik, L., Tsui, C., Johnston, J., Zeitlinger, J., Paused Pol II coordinates tissue morphogenesis in the Drosophila embryo (2013) Cell, 153, pp. 976-987; Boettiger, A.N., Levine, M., Synchronous and stochastic patterns of gene activation in the Drosophila embryo (2009) Science, 325, pp. 471-473; Danko, C.G., Hah, N., Luo, X., Martins, A.L., Core, L., Lis, J.T., Siepel, A., Kraus, W.L., Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells (2013) Mol Cell, 50, pp. 212-222; Luo, Z., Lin, C., Guest, E., Garrett, A.S., Mohaghegh, N., Swanson, S., Marshall, S., Shilatifard, A., The super elongation complex family of RNA polymerase II elongation factors: gene target specificity and transcriptional output (2012) Mol Cell Biol, 32, pp. 2608-2617; Luo, Z., Lin, C., Shilatifard, A., The super elongation complex (SEC) family in transcriptional control (2012) Nat Rev Mol Cell Biol, 13, pp. 543-547; Liu, L., Xu, Y., He, M., Zhang, M., Cui, F., Lu, L., Yao, M., Zhuang, Q., Transcriptional pause release is a rate-limiting step for somatic cell reprogramming (2014) Cell Stem Cell, 15, pp. 574-588; Lin, C.-H., Lin, C., Tanaka, H., Fero, M.L., Eisenman, R.N., Gene regulation and epigenetic remodeling in murine embryonic stem cells by c-Myc (2009) PLoS One, 4; Brookes, E., Pombo, A., Modifications of RNA polymerase II are pivotal in regulating gene expression states (2009) EMBO Rep, 10, pp. 1213-1219; Gaertner, B., Johnston, J., Chen, K., Wallaschek, N., Paulson, A., Garruss, A.S., Gaudenz, K., Zeitlinger, J., Poised RNA polymerase II changes over developmental time and prepares genes for future expression (2012) Cell Rep, 2, pp. 1670-1683; Ku, M., Koche, R.P., Rheinbay, E., Mendenhall, E.M., Endoh, M., Mikkelsen, T.S., Presser, A., Chi, A.S., Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains (2008) PLoS Genet, 4; Min, I.M., Waterfall, J.J., Core, L.J., Munroe, R.J., Schimenti, J., Lis, J.T., Regulating RNA polymerase pausing and transcription elongation in embryonic stem cells (2011) Genes Dev, 25, pp. 742-754; Narita, T., Yamaguchi, Y., Yano, K., Sugimoto, S., Chanarat, S., Wada, T., Kim, D., Inukai, N., Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex (2003) Mol Cell Biol, 23, pp. 1863-1873; Lim, P.S., Hardy, K., Bunting, K.L., Ma, L., Peng, K., Chen, X., Shannon, M.F., Defining the chromatin signature of inducible genes in T cells (2009) Genome Biol, 10, p. R107; Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S.A., Flynn, R.A., Wysocka, J., A unique chromatin signature uncovers early developmental enhancers in humans (2011) Nature, 470, pp. 279-283; Zentner, G.E., Tesar, P.J., Scacheri, P.C., Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions (2011) Genome Res, 21, pp. 1273-1283; Creyghton, M.P., Cheng, A.W., Welstead, G.G., Kooistra, T., Carey, B.W., Steine, E.J., Hanna, J., Sharp, P.A., Histone H3K27ac separates active from poised enhancers and predicts developmental state (2010) Proc Natl Acad Sci USA, 107, pp. 21931-21936; O'Neill, L.P., Turner, B.M., Immunoprecipitation of native chromatin: NChIP (2003) Methods, 31, pp. 76-82; Carey, M.F., Peterson, C.L., Smale, S.T., Chromatin immunoprecipitation (ChIP) (2009) Cold Spring Harb Protoc, , 2009; Pillai, S., Chellappan, S.P., ChIP on chip assays: genome-wide analysis of transcription factor binding and histone modifications (2009) Methods Mol Biol, 523, pp. 341-366; Johnson, D.S., Mortazavi, A., Myers, R.M., Wold, B., Genome-wide mapping of in vivo protein-DNA interactions (2007) Science, 316, pp. 1497-1502; Chaya, D., Hayamizu, T., Bustin, M., Zaret, K.S., Transcription factor FoxA (HNF3) on a nucleosome at an enhancer complex in liver chromatin (2001) J Biol Chem, 276, pp. 44385-44389; Mendoza-Parra, M.A., Walia, M., Sankar, M., Gronemeyer, H., Dissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics (2011) Mol Syst Biol, 7, p. 538; Metivier, R., Penot, G., Hubner, M.R., Reid, G., Brand, H., Kos, M., Gannon, F., Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter (2003) Cell, 115, pp. 751-763; Soutoglou, E., Talianidis, I., Coordination of PIC assembly and chromatin remodeling during differentiation-induced gene activation (2002) Science, 295, pp. 1901-1904; Jpenberg, I.A., Tan, N.S., Gelman, L., Kersten, S., Seydoux, J., Xu, J., Metzger, D., Wahli, W., In vivo activation of PPAR target genes by RXR homodimers (2004) EMBO J, 23, pp. 2083-2091; Ross-Innes, C.S., Stark, R., Holmes, K.A., Schmidt, D., Spyrou, C., Russell, R., Massie, C.E., Carroll, J.S., Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer (2010) Genes Dev, 24, pp. 171-182; Shankaranarayanan, P., Mendoza-Parra, M.A., Walia, M., Wang, L., Li, N., Trindade, L.M., Gronemeyer, H., Single-tube linear DNA amplification (LinDA) for robust ChIP-seq (2011) Nat Methods, 8, pp. 565-567; Nutiu, R., Friedman, R.C., Luo, S., Khrebtukova, I., Silva, D., Li, R., Zhang, L., Burge, C.B., Direct measurement of DNA affinity landscapes on a high-throughput sequencing instrument (2011) Nat Biotechnol, 29, pp. 659-664; Rhee, H.S., Pugh, B.F., Comprehensive genome-wide protein-DNA interactions detected at single-nucleotide resolution (2011) Cell, 147, pp. 1408-1419; Aldridge, S., Watt, S., Quail, M.A., Rayner, T., Lukk, M., Bimson, M.F., Gaffney, D., Odom, D.T., AHT-ChIP-seq: a completely automated robotic protocol for high-throughput chromatin immunoprecipitation (2013) Genome Biol, 14, p. R124; Schena, M., Shalon, D., Davis, R.W., Brown, P.O., Quantitative monitoring of gene expression patterns with a complementary DNA microarray (1995) Science, 270, pp. 467-470; Mortazavi, A., Williams, B.A., McCue, K., Schaeffer, L., Wold, B., Mapping and quantifying mammalian transcriptomes by RNA-Seq (2008) Nat Methods, 5, pp. 621-628; Takahashi, H., Lassmann, T., Murata, M., Carninci, P., 5′ end-centered expression profiling using cap-analysis gene expression and next-generation sequencing (2012) Nat Protoc, 7, pp. 542-561; Adelman, K., Marr, M.T., Werner, J., Saunders, A., Ni, Z., Andrulis, E.D., Lis, J.T., Efficient release from promoter-proximal stall sites requires transcript cleavage factor TFIIS (2005) Mol Cell, 17, pp. 103-112; Bengal, E., Flores, O., Krauskopf, A., Reinberg, D., Aloni, Y., Role of the mammalian transcription factors IIF, IIS, and IIX during elongation by RNA polymerase II (1991) Mol Cell Biol, 11, pp. 1195-1206; Cheung, A.C.M., Cramer, P., Structural basis of RNA polymerase II backtracking, arrest and reactivation (2011) Nature, 471, pp. 249-253; Fujinaga, K., Irwin, D., Huang, Y., Taube, R., Kurosu, T., Peterlin, B.M., Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element (2004) Mol Cell Biol, 24, pp. 787-795; Lee, C., Li, X., Hechmer, A., Eisen, M., Biggin, M.D., Venters, B.J., Jiang, C., Gilmour, D.S., NELF and GAGA factor are linked to promoter-proximal pausing at many genes in Drosophila (2008) Mol Cell Biol, 28, pp. 3290-3300; Yamaguchi, Y., Takagi, T., Wada, T., Yano, K., Furuya, A., Sugimoto, S., Hasegawa, J., Handa, H., NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation (1999) Cell, 97, pp. 41-51; Marshall, N.F., Price, D.H., Control of formation of two distinct classes of RNA polymerase II elongation complexes (1992) Mol Cell Biol, 12, pp. 2078-2090; Missra, A., Gilmour, D.S., Interactions between DSIF (DRB sensitivity inducing factor), NELF (negative elongation factor), and the Drosophila RNA polymerase II transcription elongation complex (2010) Proc Natl Acad Sci USA, 107, pp. 11301-11306; Wada, T., Takagi, T., Yamaguchi, Y., Ferdous, A., Imai, T., Hirose, S., Sugimoto, S., Winston, F., DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs (1998) Genes Dev, 12, pp. 343-356; Ardehali, M.B., Lis, J.T., Tracking rates of transcription and splicing in vivo (2009) Nat Struct Mol Biol, 16, pp. 1123-1124; Marshall, N.F., Price, D.H., Purification of P-TEFb, a transcription factor required for the transition into productive elongation (1995) J Biol Chem, 270, pp. 12335-12338; Ramanathan, Y., Rajpara, S.M., Reza, S.M., Lees, E., Shuman, S., Mathews, M.B., Pe'ery, T., Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences (2001) J Biol Chem, 276, pp. 10913-10920; Price, D.H., P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II (2000) Mol Cell Biol, 20, pp. 2629-2634; Lin, C., Smith, E.R., Takahashi, H., Lai, K.C., Martin-Brown, S., Florens, L., Washburn, M.P., Shilatifard, A., AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia (2010) Mol Cell, 37, pp. 429-437; Devaiah, B.N., Lewis, B.A., Cherman, N., Hewitt, M.C., Albrecht, B.K., Robey, P.G., Ozato, K., Singer, D.S., BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain (2012) Proc Natl Acad Sci USA, 109, pp. 6927-6932; Jang, M.K., Mochizuki, K., Zhou, M., Jeong, H.-S., Brady, J.N., Ozato, K., The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription (2005) Mol Cell, 19, pp. 523-534; Yang, Z., Yik, J.H.N., Chen, R., He, N., Jang, M.K., Ozato, K., Zhou, Q., Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4 (2005) Mol Cell, 19, pp. 535-545; Eberhardy, S.R., Farnham, P.J., Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter (2002) J Biol Chem, 277, pp. 40156-40162; Kanazawa, S., Soucek, L., Evan, G., Okamoto, T., Peterlin, B.M., c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis (2003) Oncogene, 22, pp. 5707-5711; Nguyen, V.T., Kiss, T., Michels, A.A., Bensaude, O., 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes (2001) Nature, 414, pp. 322-325; Yang, Z., Zhu, Q., Luo, K., Zhou, Q., The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription (2001) Nature, 414, pp. 317-322",Article,Scopus,2-s2.0-84928524398
"Raddatz B.B., Lehmbecker A., Kalkuhl A., Deschl U., Baumgartner W., Ulrich R.","Transcriptional analysis of glial cell differentiation in the postnatal murine spinal cord",2015,"International Journal of Developmental Neuroscience","42",,,"24","36",,,10.1016/j.ijdevneu.2015.02.005,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924691908&partnerID=40&md5=c47e5b39347ae8acf381b2524bc3d3fc","Department of Pathology, University of Veterinary Medicine HannoverHannover, Germany; Center for Systems Neuroscience, University of Veterinary Medicine HannoverHannover, Germany; Department of Non-Clinical Drug Safety, Boehringer Ingelheim Pharma GmbH and Co. KGBiberach (Riß), Germany","Raddatz, B.B., Department of Pathology, University of Veterinary Medicine HannoverHannover, Germany, Center for Systems Neuroscience, University of Veterinary Medicine HannoverHannover, Germany; Lehmbecker, A., Department of Pathology, University of Veterinary Medicine HannoverHannover, Germany, Center for Systems Neuroscience, University of Veterinary Medicine HannoverHannover, Germany; Kalkuhl, A., Department of Non-Clinical Drug Safety, Boehringer Ingelheim Pharma GmbH and Co. KGBiberach (Riß), Germany; Deschl, U., Department of Non-Clinical Drug Safety, Boehringer Ingelheim Pharma GmbH and Co. KGBiberach (Riß), Germany; Baumgärtner, W., Department of Pathology, University of Veterinary Medicine HannoverHannover, Germany, Center for Systems Neuroscience, University of Veterinary Medicine HannoverHannover, Germany; Ulrich, R., Department of Pathology, University of Veterinary Medicine HannoverHannover, Germany, Center for Systems Neuroscience, University of Veterinary Medicine HannoverHannover, Germany","Postnatal murine spinal cord represents a good model system to study mammalian central nervous system myelination in vivo as a basis for further studies in demyelinating diseases. Transcriptional changes were analyzed in SJL/J mice on postnatal day 0, 14, 49 and 231 (P0, P14, P49, P231) employing Affymetrix GeneChip Mouse Genome 430 2.0 Arrays. Additionally, marker gene signatures for astrocyte and oligodendrocyte lineage-stages were defined to study their gene expression in more detail. In addition, immunohistochemistry was used to quantify the abundance of commonly used glial cell markers.6092 differentially regulated genes (DEGs) were identified. The up-regulated DEGs at P14, P49 and P231 compared to P0 exhibited significantly enriched associations to gene ontology terms such as myelination and lipid metabolic transport and down-regulated DEGs to neurogenesis and axonogenesis. Expression values of marker gene signatures for neural stem cells, oligodendrocyte precursor cells, and developing astrocytes were constantly decreasing, whereas myelinating oligodendrocyte and mature astrocyte markers showed a steady increase. Molecular findings were substantiated by immunohistochemical observations. The transcriptional changes observed are an important reference for future analysis of degenerative and inflammatory conditions in the spinal cord. © 2015 Elsevier Ltd.","Development; Microarray; Myelination; Oligodendrocyte Precursor Cells; Oligodendrocytes; Spinal cord","Adam, S.A., Schnell, O., Poschl, J., Eigenbrod, S., Kretzschmar, H.A., Tonn, J.C., Schuller, U., ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients (2012) Brain Pathol., 22 (6), pp. 788-797; Aggarwal, S., Yurlova, L., Simons, M., Central nervous system myelin: structure, synthesis and assembly (2011) Trends Cell Biol., 21 (10), pp. 585-593; Ando, S., Tanaka, Y., Toyoda, Y., Kon, K., Turnover of myelin lipids in aging brain (2003) Neurochem. Res., 28 (1), pp. 5-13; Baek, R.C., Martin, D.R., Cox, N.R., Seyfried, T.N., Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease (2009) Lipids, 44 (3), pp. 197-205; Bajo-Graneras, R., Sanchez, D., Gutierrez, G., Gonzalez, C., Do Carmo, S., Rassart, E., Ganfornina, M.D., Apolipoprotein D alters the early transcriptional response to oxidative stress in the adult cerebellum (2011) J. Neurochem., 117 (6), pp. 949-960; Baumann, N., Pham-Dinh, D., Biology of oligodendrocyte and myelin in the mammalian central nervous system (2001) Physiol. Rev., 81 (2), pp. 871-927; Bordner, K.A., George, E.D., Carlyle, B.C., Duque, A., Kitchen, R.R., Lam, T.T., Colangelo, C.M., Simen, A.A., Functional genomic and proteomic analysis reveals disruption of myelin-related genes and translation in a mouse model of early life neglect (2011) Front Psychiatry, 2 (18); Brockschnieder, D., Sabanay, H., Riethmacher, D., Peles, E., Ermin, a myelinating oligodendrocyte-specific protein that regulates cell morphology (2006) J. Neurosci., 26 (3), pp. 757-762; Brumwell, C.L., Curran, T., Developmental mouse brain gene expression maps (2006) J. Physiol., 575, pp. 343-346; Bujalka, H., Koenning, M., Jackson, S., Perreau, V.M., Pope, B., Hay, C.M., Mitew, S., Emery, B., MYRF is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin genes (2013) PLoS Biol., 11 (8), p. e1001625; Bushong, E.A., Martone, M.E., Ellisman, M.H., Maturation of astrocyte morphology and the establishment of astrocyte domains during postnatal hippocampal development (2004) Int. J. Dev. Neurosci., 22 (2), pp. 73-86; Cahoy, J.D., Emery, B., Kaushal, A., Foo, L.C., Zamanian, J.L., Christopherson, K.S., Xing, Y., Barres, B.A., A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function (2008) J. Neurosci., 28 (1), pp. 264-278; Chang, Y.Z., Qian, Z.M., Wang, K., Zhu, L., Yang, X.D., Du, J.R., Jiang, L., Ke, Y., Effects of development and iron status on ceruloplasmin expression in rat brain (2005) J. Cell. Physiol., 204 (2), pp. 623-631; Chen, H., Boutros, P.C., VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R (2011) Bmc Bioinf., 12 (35); Chen, Y., Hor, H.H., Tang, B.L., AMIGO is expressed in multiple brain cell types and may regulate dendritic growth and neuronal survival (2012) J. Cell. Physiol., 227 (5), pp. 2217-2229; Chen, Y., Wu, H., Wang, S., Koito, H., Li, J., Ye, F., Hoang, J., Lu, Q.R., The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination (2009) Nat. Neurosci., 12 (11), pp. 1398-1406; Chung, A.Y., Kim, S., Kim, H., Bae, Y.K., Park, H.C., Microarray screening for genes involved in oligodendrocyte differentiation in the zebrafish CNS (2011) Exp. Neurobiol., 20 (2), pp. 85-91; Clinton, M., Manson, J., McBride, D., Miele, G., Gene expression changes during murine postnatal brain development (2000) Genome Biol., 1 (3). , research0005.1-0005.11; Cooper, E.C., Milroy, A., Jan, Y.N., Jan, L.Y., Lowenstein, D.H., Presynaptic localization of Kv1.4-containing A-type potassium channels near excitatory synapses in the hippocampus (1998) J. Neurosci., 18 (3), pp. 965-974; de Vente, J., Asan, E., Gambaryan, S., Markerink-van Ittersum, M., Axer, H., Gallatz, K., Lohmann, S.M., Palkovits, M., Localization of cGMP-dependent protein kinase type II in rat brain (2001) Neuroscience, 108 (1), pp. 27-49; Dombrowski, G.J., Swiatek, K.R., Chao, K.L., Lactate, 3-hydroxybutyrate, and glucose as substrates for the early postnatal rat brain (1989) Neurochem. Res., 14 (7), pp. 667-675; Dorrell, M.I., Global gene expression analysis of the developing postnatal mouse retina (2004) Invest. Ophthalmol. Vis. Sci., 45 (3), pp. 1009-1019; Dugas, J.C., Tai, Y.C., Speed, T.P., Ngai, J., Barres, B.A., Functional genomic analysis of oligodendrocyte differentiation (2006) J. Neurosci., 26 (43), pp. 10967-10983; Eda, A., Takahashi, M., Fukushima, T., Hohjoh, H., Alteration of microRNA expression in the process of mouse brain growth (2011) Gene, 485 (1), pp. 46-52; Fancy, S.P., Baranzini, S.E., Zhao, C., Yuk, D.I., Irvine, K.A., Kaing, S., Sanai, N., Rowitch, D.H., Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS (2009) Genes Dev., 23 (13), pp. 1571-1585; Folkerth, R.D., Alroy, J., Bhan, I., Kaye, E.M., Infantile G(M1) gangliosidosis: complete morphology and histochemistry of two autopsy cases, with particular reference to delayed central nervous system myelination (2000) Pediatr. Dev. Pathol., 3 (1), pp. 73-86; Freeman, M.R., Specification and morphogenesis of astrocytes (2010) Science, 330 (6005), pp. 774-778; Fu, H., Cai, J., Clevers, H., Fast, E., Gray, S., Greenberg, R., Jain, M.K., Stiles, C.D., A genome-wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development (2009) J. Neurosci., 29 (36), pp. 11399-11408; Gabory, A., Jammes, H., Dandolo, L., The H19 locus: role of an imprinted non-coding RNA in growth and development (2010) Bioessays, 32 (6), pp. 473-480; Gautier, L., Cope, L., Bolstad, B.M., Irizarry, R.A., Affy-analysis of Affymetrix GeneChip data at the probe level (2004) Bioinf., 20 (3), pp. 307-315; Ge, W.P., Miyawaki, A., Gage, F.H., Jan, Y.N., Jan, L.Y., Local generation of glia is a major astrocyte source in postnatal cortex (2012) Nature, 484 (7394), pp. 376-380; Ginsberg, S.D., Expression profile analysis of brain aging (2007) Brain Aging: Models, Methods, and Mechanisms, , CRC Press, Boca Raton (FL), ISBN-10: 0-8493-3818-2ISBN-13: 978-0-8493-3818-2, D.R. Riddle (Ed.); Golan, N., Adamsky, K., Kartvelishvily, E., Brockschnieder, D., Mobius, W., Spiegel, I., Roth, A.D., Peles, E., Identification of Tmem10/Opalin as an oligodendrocyte enriched gene using expression profiling combined with genetic cell ablation (2008) Glia, 56 (11), pp. 1176-1186; Gotz, M., Huttner, W.B., The cell biology of neurogenesis (2005) Nat. Rev. Mol. Cell. Biol., 6 (10), pp. 777-788; Hagemann, T.L., Boelens, W.C., Wawrousek, E.F., Messing, A., Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease (2009) Hum Mol Genet, 18 (7), pp. 1190-1199; Hansmann, F., Herder, V., Kalkuhl, A., Haist, V., Zhang, N., Schaudien, D., Deschl, U., Ulrich, R., Matrix metalloproteinase-12 deficiency ameliorates the clinical course and demyelination in Theiler's murine encephalomyelitis (2012) Acta Neuropathol., 124 (1), pp. 127-142; Herz, J., Farese, R.V., The LDL receptor gene family, apolipoprotein B and cholesterol in embryonic development (1999) J. Nutr., 129 (2 S SUPPL.), pp. 473S-475S; Huang, D.W., Sherman, B.T., Lempicki, R.A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources (2009) Nat. Protoc., 4 (1), pp. 44-57; Jakovcevski, I., Filipovic, R., Mo, Z., Rakic, S., Zecevic, N., Oligodendrocyte development and the onset of myelination in the human fetal brain (2009) Front Neuroanat., 3, p. 5; Johnson, M.B., Kawasawa, Y.I., Mason, C.E., Krsnik, Z., Coppola, G., Bogdanovic, D., Geschwind, D.H., Sestan, N., Functional and evolutionary insights into human brain development through global transcriptome analysis (2009) Neuron, 62 (4), pp. 494-509; Jukkola, P.I., Lovett-Racke, A.E., Zamvil, S.S., Gu, C., K+ channel alterations in the progression of experimental autoimmune encephalomyelitis (2012) Neurobiol. Dis., 47 (2), pp. 280-293; Jurado, S., Sanchez-Prieto, J., Torres, M., Expression of cGMP-dependent protein kinases (I and II) and neuronal nitric oxide synthase in the developing rat cerebellum (2005) Brain Res. Bull., 65 (2), pp. 111-115; Kagami, Y., Furuichi, T., Investigation of differentially expressed genes during the development of mouse cerebellum (2001) Brain Res. Gene Exp. Patterns, 1 (1), pp. 39-59; Kang, H.J., Kawasawa, Y.I., Cheng, F., Zhu, Y., Xu, X., Li, M., Sousa, A.M., Sestan, N., Spatio- temporal transcriptome of the human brain (2011) Nature, 478 (7370), pp. 483-489; Kegler, K., Imbschweiler, I., Ulrich, R., Kovermann, P., Fahlke, C., Deschl, U., Kalkuhl, A., Wewetzer, K., CNS Schwann cells display oligodendrocyte precursor-like potassium channel activation and antigenic expression in vitro (2014) J. Neural Transm., 121 (6), pp. 569-581; Kroll, R.A., Pagel, M.A., Roman-Goldstein, S., Barkovich, A.J., D'Agostino, A.N., Neuwelt, E.A., White matter changes associated with feline GM2 gangliosidosis (Sandhoff disease): correlation of MR findings with pathologic and ultrastructural abnormalities (1995) AJNR Am. J. Neuroradiol., 16 (6), pp. 1219-1226; Kuegler, P.B., Zimmer, B., Waldmann, T., Baudis, B., Ilmjärv, S., Hescheler, J., Gaughwin, P., Leist, M., Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing (2010) ALTEX, 27 (1), pp. 17-42; Lajtha, A., Toth, J., Fujimoto, K., Agrawal, H.C., Turnover of myelin proteins in mouse brain in vivo (1977) Biochem. J., 164 (2), pp. 323-329; LeDoux, M.S., Xu, L., Xiao, J., Ferrell, B., Menkes, D.L., Homayouni, R., Murine central and peripheral nervous system transcriptomes: comparative gene expression (2006) Brain Res., 1107 (1), pp. 24-41; Lee, C.K., Weindruch, R., Prolla, T.A., Gene- expression profile of the ageing brain in mice (2000) Nat. Genet., 25 (3), pp. 294-297; Li, H., Lorie, E.P., Fischer, J., Vahlquist, A., Torma, H., The expression of epidermal lipoxygenases and transglutaminase-1 is perturbed by NIPAL4 mutations: indications of a common metabolic pathway essential for skin barrier homeostasis (2012) J. Invest. Dermatol., 132 (10), pp. 2368-2375; Liu, G., Loraine, A.E., Shigeta, R., Cline, M., Cheng, J., Valmeekam, V., Sun, S., Siani-Rose, M.A., NetAffx: affymetrix probesets and annotations (2003) Nucleic Acids Res., 31 (1), pp. 82-86; Mager, G.M., Ward, R.M., Srinivasan, R., Jang, S.W., Wrabetz, L., Svaren, J., Active gene repression by the Egr2. NAB complex during peripheral nerve myelination (2008) J. Biol. Chem., 283 (26), pp. 18187-18197; Maglott, D., Ostell, J., Pruitt, K.D., Tatusova, T., Entrez Gene: gene-centered information at NCBI (2011) Nucleic Acids Res., 39 (D 52 D 57); Matsuoka, T., Sumiyoshi, T., Tsunoda, M., Takasaki, I., Tabuchi, Y., Uehara, T., Itoh, H., Kurachi, M., Change in the expression of myelination/oligodendrocyte- related genes during puberty in the rat brain (2010) J. Neural Transm., 117 (11), pp. 1265-1268; McConnell, J.A., Identification of early neurons in the brainstem and spinal cord. II. An autoradiographic study in the mouse (1981) J. Comp. Neurol., 200 (2), pp. 273-288; Mi, S., Miller, R.H., Lee, X., Scott, M.L., Shulag-Morskaya, S., Shao, Z., Chang, J., Pepinsky, R.B., LINGO-1 negatively regulates myelination by oligodendrocytes (2005) Nat. Neurosci., 8 (6), pp. 745-751; Middeldorp, J., Hol, E.M., GFAP in health and disease (2011) Prog. Neurobiol., 93 (3), pp. 421-443; Miller, C.J., (2013) Simpleaffy: very simple high level analysis of Affymetrix data R package version 2.38.0.; Miron, V.E., Kuhlmann, T., Antel, J.P., Cells of the oligodendroglial lineage, myelination, and remyelination (2011) Biochim. Biophys. Acta, 1812 (2), pp. 184-193; Monnier, P., Martinet, C., Pontis, J., Stancheva, I., Ait-Si-Ali, S., Dandolo, L., H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1 (2013) Proc. Natl. Acad. Sci. U. S. A., 110 (51), pp. 20693-20698; Muse, E.D., Jurevics, H., Toews, A.D., Matsushima, G.K., Morell, P., Parameters related to lipid metabolism as markers of myelination in mouse brain (2001) J. Neurochem., 76 (1), pp. 77-86; Nielsen, J.A., Maric, D., Lau, P., Barker, J.L., Hudson, L.D., Identification of a novel oligodendrocyte cell adhesion protein using gene expression profiling (2006) J. Neurosci., 26 (39), pp. 9881-9891; Norton, W.T., Recent advances in myelin biochemistry (1984) Ann. N. Y. Acad. Sci., 436, pp. 5-10; Oldham, M.C., Konopka, G., Iwamoto, K., Langfelder, P., Kato, T., Horvath, S., Geschwind, D.H., Functional organization of the transcriptome in human brain (2008) Nat. Neurosci., 11 (11), pp. 1271-1282; Oohashi, T., Hirakawa, S., Bekku, Y., Rauch, U., Zimmermann, D.R., Su, W.D., Ohtsuka, A., Ninomiya, Y., Bral1, a brain-specific link protein, colocalizing with the versican V2 isoform at the nodes of Ranvier in developing and adult mouse central nervous systems (2002) Mol. Cell. Neurosci., 19 (1), pp. 43-57; Orth, M., Bellosta, S., Cholesterol: its regulation and role in central nervous system disorders (2012) Cholesterol, 2012, p. 292598; Oudega, M., Marani, E., Expression of vimentin and glial fibrillary acidic protein in the developing rat spinal cord: an immunocytochemical study of the spinal cord glial system (1991) J. Anat., 179, pp. 97-114; Ousman, S.S., Tomooka, B.H., van Noort, J.M., Wawrousek, E.F., O'Connor, K.C., Hafler, D.A., Sobel, R.A., Steinman, L., Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination (2007) Nature, 448 (7152), pp. 474-479; Pandey, A.K., Lu, L., Wang, X., Homayouni, R., Williams, R.W., Functionally enigmatic genes: a case study of the brain ignorome (2014) PLoS One, 9 (2), p. e88889; Petrik, D., Yun, S., Latchney, S.E., Kamrudin, S., LeBlanc, J.A., Bibb, J.A., Eisch, A.J., Early postnatal in vivo gliogenesis from nestin-lineage progenitors requires cdk5 (2013) PLoS One, 8 (8), p. e72819; Potter, K.A., Kern, M.J., Fullbright, G., Bielawski, J., Scherer, S.S., Yum, S.W., Li, J.J., Hama, H., Central nervous system dysfunction in a mouse model of FA2H deficiency (2011) Glia, 59 (7), pp. 1009-1021; Primmer, C.R., Papakostas, S., Leder, E.H., Davis, M.J., Ragan, M.A., Annotated genes and nonannotated genomes: cross-species use of Gene Ontology in ecology and evolution research (2013) Mol. Ecol., 22 (12), pp. 3216-3241; Raddatz, B.B., Hansmann, F., Spitzbarth, I., Kalkuhl, A., Deschl, U., Baumgärtner, W., Ulrich, R., Transcriptomic meta-analysis of multiple sclerosis and its experimental models (2014) PLoS One, 9 (1), p. e86643; Rice, D., Barone, S., Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models (2000) Environ. Health Perspect., 108, pp. 511-533; Saeed, A.I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Quackenbush, J., TM4: a free, open-source system for microarray data management and analysis (2003) Biotechniques, 34 (2), pp. 374-378; Saher, G., Quintes, S., Nave, K.A., Cholesterol: a novel regulatory role in myelin formation (2011) Neuroscientist, 17 (1), pp. 79-93; Sanchez-Abarca, L.I., Tabernero, A., Medina, J.M., Oligodendrocytes use lactate as a source of energy and as a precursor of lipids (2001) Glia, 36 (3), pp. 321-329; Schiroli, D., Cirrincione, S., Donini, S., Peracchi, A., Strict reaction and substrate specificity of AGXT2L1, the human O-phosphoethanolamine phospho-lyase (2013) IUBMB Life, 65 (7), pp. 645-650; Semeralul, M.O., Boutros, P.C., Likhodi, O., Okey, A.B., Van Tol, H.H., Wong, A.H., Microarray analysis of the developing cortex (2006) J. Neurobiol., 66 (14), pp. 1646-1658; Semple, B.D., Blomgren, K., Gimlin, K., Ferriero, D.M., Noble-Haeusslein, L.J., Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species (2013) Prog. Neurobiol., 106-107, pp. 1-16; Sheen, V.L., Periventricular heterotopia: shuttling of proteins through vesicles and actin in cortical development and disease (2012) Scientifica (Cairo), 2012, p. 480129; Shi, M., Jones, W.D., Jensen, R.V., Harris, S.C., Perkins, R.G., Goodsaid, F.M., Guo, L., Tong, W.D., The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies (2008) Bmc Bioinformatics, 9 (ARTN S 10); Shimada, N., Handa, S., Uchida, Y., Fukuda, M., Maruyama, N., Asaga, H., Choi, E.K., Ishigami, A., Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain (2010) J. Neurosci. Res., 88 (4), pp. 798-806; Shimogori, T., Lee, D.A., Miranda-Angulo, A., Yang, Y., Wang, H., Jiang, L., Yoshida, A.C., Blackshaw, S., A genomic atlas of mouse hypothalamic development (2010) Nat. Neurosci., 13 (6), pp. 767-775; Sokoloff, L., Energy metabolism and effects of energy depletion or exposure to glutamate (1992) Can. J. Physiol. Pharmacol., 70 SUPPL., pp. S107-S112; Swiss, V.A., Nguyen, T., Dugas, J., Ibrahim, A., Barres, B., Androulakis, I.P., Casaccia, P., Identification of a gene regulatory network necessary for the initiation of oligodendrocyte differentiation (2011) PLoS One, 6 (4), p. e18088; Torrado, M., Senatorov, V.V., Trivedi, R., Fariss, R.N., Tomarev, S.I., Pdlim2, a novel PDZ-LIM domain protein, interacts with alpha-actinins and filamin A (2004) Invest. Ophthalmol. Vis. Sci., 45 (11), pp. 3955-3963; Tusher, V.G., Tibshirani, R., Chu, G., Significance analysis of microarrays applied to the ionizing radiation response (2001) Proc. Natl. Acad. Sci. U. S. A., 98 (9), pp. 5116-5121; Ulrich, R., Gerhauser, I., Seeliger, F., Baumgärtner, W., Alldinger, S., Matrix metalloproteinases and their inhibitors in the developing mouse brain and spinal cord: a reverse transcription quantitative polymerase chain reaction study (2005) Dev. Neurosci., 27 (6), pp. 408-418; Ulrich, R., Imbschweiler, I., Kalkuhl, A., Lehmbecker, A., Ziege, S., Kegler, K., Becker, K., Baumgärtner, W., Transcriptional profiling predicts overwhelming homology of Schwann cells, olfactory ensheathing cells, and Schwann cell-like glia (2014) Glia, 62 (10), pp. 1559-1581; Ulrich, R., Kalkuhl, A., Deschl, U., Baumgärtner, W., Machine learning approach identifies new pathways associated with demyelination in a viral model of multiple sclerosis (2010) J Cell Mol Med, 14 (1-2), pp. 434-448. , doi:JCMM646 [pii]; Ulrich, R., Puff, C., Wewetzer, K., Kalkuhl, A., Deschl, U., Baumgärtner, W., Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination (2014) PLoS One, 9 (4), p. e95917; Ulrich, R., Seeliger, F., Kreutzer, M., Germann, P.G., Baumgärtner, W., Limited remyelination in Theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells (2008) Neuropathol. Appl. Neurobiol., 34 (6), pp. 603-620; Verdier, V., Csardi, G., de Preux-Charles, A.S., Medard, J.J., Smit, A.B., Verheijen, M.H., Bergmann, S., Chrast, R., Aging of myelinating glial cells predominantly affects lipid metabolism and immune response pathways (2012) Glia, 60 (5), pp. 751-760; Wang, H., Kunkel, D.D., Martin, T.M., Schwartzkroin, P.A., Tempel, B.L., Heteromultimeric K+ channels in terminal and juxtaparanodal regions of neurons (1993) Nature, 365 (6441), pp. 75-79; Wu, Z., Irizarry, R.A., Gentry, J., MacDonald, J., (2013) gcrma: Background Adjustment Using Sequence Information R package version 2.34.0.; Yan, Z., Lathia, K.B., Clapshaw, P.A., Murine spinal cord transcriptome analysis following reduction of prevalent myelin cDNA sequences (2009) Cell. Mol. Neurobiol., 29 (8), pp. 1109-1119; Yang, Y., Vidensky, S., Jin, L.J.C., Lorenzini, I., Frankl, M., Rothstein, J.D., Molecular comparison of GLT1+ and ALDH1L1+ astrocytes in vivo in astroglial reporter mice (2011) Glia, 59 (2), pp. 107-200; Yoshikawa, F., Sato, Y., Tohyama, K., Akagi, T., Hashikawa, T., Nagakura-Takagi, Y., Sekine, Y., Furuichi, T., Opalin, a transmembrane sialylglycoprotein located in the central nervous system myelin paranodal loop membrane (2008) J. Biol. Chem., 283 (30), pp. 20830-20840; Zahn, J.M., Poosala, S., Owen, A.B., Ingram, D., Lustig, A., Carter, A., Weeraratna, A.T., Becker, K.G., AGEMAP: a gene expression database for aging in mice (2005) PLoS Genetics preprint, 2007, p. e201; Zapala, M.A., Hovatta, I., Ellison, J.A., Wodicka, L., Del Rio, J.A., Tennant, R., Tynan, W., Barlow, C., Adult mouse brain gene expression patterns bear an embryologic imprint (2005) Proc. Natl. Acad. Sci. U. S. A., 102 (29), pp. 10357-10362; Zöller, I., Meixner, M., Hartmann, D., Bussow, H., Meyer, R., Gieselmann, V., Eckhardt, M., Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration (2008) J. Neurosci., 28 (39), pp. 9741-9754",Article,Scopus,2-s2.0-84924691908
"Zanini S., Giovinazzo F., Alaimo D., Lawrence B., Pfragner R., Bassi C., Modlin I., Kidd M.","GNA15 expression in small intestinal neuroendocrine neoplasia: Functional and signalling pathway analyses",2015,"Cellular Signalling","27","5",,"899","907",,,10.1016/j.cellsig.2015.02.001,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84923356176&partnerID=40&md5=85fc11a07ead65f9ed76faecb7f7458b","Gastrointestinal Pathobiology Research Group, Yale University School of MedicineNew Haven, CT, United States; Department of Surgery, Laboratory of Translational Surgery, LURM, Hospital of G.B. Rossi, University of Verona, Piazzale L.A. ScuroVerona, Italy; Institute of Pathophysiology and Immunology, Centre for Molecular Medicine, Medical University of GrazGraz, Austria","Zanini, S., Gastrointestinal Pathobiology Research Group, Yale University School of MedicineNew Haven, CT, United States, Department of Surgery, Laboratory of Translational Surgery, LURM, Hospital of G.B. Rossi, University of Verona, Piazzale L.A. ScuroVerona, Italy; Giovinazzo, F., Gastrointestinal Pathobiology Research Group, Yale University School of MedicineNew Haven, CT, United States, Department of Surgery, Laboratory of Translational Surgery, LURM, Hospital of G.B. Rossi, University of Verona, Piazzale L.A. ScuroVerona, Italy; Alaimo, D., Gastrointestinal Pathobiology Research Group, Yale University School of MedicineNew Haven, CT, United States; Lawrence, B., Gastrointestinal Pathobiology Research Group, Yale University School of MedicineNew Haven, CT, United States; Pfragner, R., Institute of Pathophysiology and Immunology, Centre for Molecular Medicine, Medical University of GrazGraz, Austria; Bassi, C., Department of Surgery, Laboratory of Translational Surgery, LURM, Hospital of G.B. Rossi, University of Verona, Piazzale L.A. ScuroVerona, Italy; Modlin, I., Gastrointestinal Pathobiology Research Group, Yale University School of MedicineNew Haven, CT, United States; Kidd, M., Gastrointestinal Pathobiology Research Group, Yale University School of MedicineNew Haven, CT, United States","Gastroenteropancreatic neuroendocrine neoplasia (GEP-NEN) comprises a heterogeneous group of tumours that exhibit widely divergent biological behaviour. The identification of new targetable GPCR-pathways involved in regulating cell function could help to identify new therapeutic strategies. We assessed the function of a haematopoietic stem cell heterotrimeric G-protein, Gα15, in gut neuroendocrine cell models and examined the clinical implications of its over expression. Functional assays were undertaken to define the role of GNA15 in the small intestinal NEN cell line KRJ-I and in clinical samples from small intestinal NENs using quantitative polymerase chain reaction, western blot, proliferation and apoptosis assays, immunoprecipitation, immunohistochemistry (IHC) and automated quantitative analysis (AQUA). GNA15 was not expressed in normal neuroendocrine cells but was overexpressed in GEP-NEN cell lines. In KRJ-I cells, decreased expression of GNA15 was associated with inhibition of proliferation, activation of apoptosis and differential effects on pro-proliferative ERK, NFκB and Akt pathway signalling. Moreover, Gα15 was demonstrated to couple to the ß1 adrenergic receptor and modulated proliferative signals through this GPCR. Transcript and protein levels of GNA15 were significantly elevated in primary and metastatic tumours compared to normal mucosa and were particularly increased in low Ki-67 expressing tumours. IHC and AQUA revealed that a higher Gα15 expression was associated with a poorer survival. GNA15 may have a pathobiological role in SI-NENs. Targeting this signalling mediator could provide an opportunity for the development of new therapeutic strategies for this tumour type. © 2015 Elsevier Inc.","G protein; GNA15; Gα15; KRJ-I cell line; Small intestinal neuroendocrine neoplasia; ß1 adrenergic receptor","Modlin, I.M., (2008) Lancet Oncol., 9 (1), pp. 61-72; Frilling, A., (2012) Endocr. Relat. Cancer, 19 (5). , R163-R85; Modlin, I.M., Lye, K.D., Kidd, M., (2003) Cancer, 97 (4), pp. 934-959; Kloppel, G., Perren, A., Heitz, P.U., (2004) Ann. N. Y. Acad. Sci., 1014, pp. 13-27; Schimmack, S., (2011) Langenbecks Arch. Surg., 396 (3), pp. 273-298; Drozdov, I., (2011) PLoS One, 6 (8), p. e22457; Modlin, I.M., (2006) J. Clin. Endocrinol. Metab., 91 (6), pp. 2340-2348; Dorsam, R.T., Gutkind, J.S., (2007) Nat. Rev. Cancer, 7 (2), pp. 79-94; Wu, J., (2012) Cancer Genomics Proteomics, 9 (1), pp. 37-50; Amatruda, T.T., (1991) Proc. Natl. Acad. Sci. U. S. A., 88 (13), pp. 5587-5591; Wilkie, T.M., (1991) Proc. Natl. Acad. Sci. U. S. A., 88 (22), pp. 10049-10053; Giannone, F., (2010) J. Mol. Endocrinol., 44 (5), pp. 259-269; Su, Y., Ho, M.K., Wong, Y.H., (2009) Neurosignals, 17 (1), pp. 71-81; Kostenis, E., (2001) Trends Pharmacol. Sci., 22 (11), pp. 560-564; Giovinazzo, F., (2013) Cell. Signal., 25 (3), pp. 651-659; Innamorati, G., (2009) Cell. Signal., 21 (7), pp. 1135-1142; Offermanns, S., Simon, M.I., (1995) J. Biol. Chem., 270 (25), pp. 15175-15180; Zhu, X., Birnbaumer, L., (1996) Proc. Natl. Acad. Sci. U. S. A., 93 (7), pp. 2827-2831; Schuller, H.M., (1999) Cancer Res., 59 (18), pp. 4510-4515; Rivenson, A., (1988) Cancer Res., 48 (23), pp. 6912-6917; Kidd, M., (2007) J. Mol. Endocrinol., 38 (1-2), pp. 181-192; Pfragner, R., (2009) Anticancer Res., 29 (6), pp. 1951-1961; Siddique, Z.L., (2009) Neuroendocrinology, 89 (4), pp. 458-470; Cecconi, D., (2007) Proteomics, 7 (10), pp. 1644-1653; McLeod, A.A., Shand, D.G., (1982) Ann. Intern. Med., 96 (2), pp. 244-245; Svejda, B., (2011) Cancer, 117 (18), pp. 4141-4154; Kidd, M., (2005) Cancer, 103 (2), pp. 229-236; Kidd, M., (2007) Physiol. Genomics, 30 (3), pp. 363-370; Biankin, A.V., (2012) Nature, 491 (7424), pp. 399-405; Fiory, F., (2014) PLoS One, 9 (12), p. e113655; Kidd, M., (2006) Ann. Surg., 243 (2), pp. 273-280; Schimmack, S., (2014) Epigenetics Chromatin, 7, p. 15; Camp, R.L., Charette, L.A., Rimm, D.L., (2000) Lab. Invest., 80 (12), pp. 1943-1949; Gu, J.L., (2003) J. Cell. Biochem., 88 (6), pp. 1101-1111; Wong, S.C., (2001) J. Pathol., 194 (1), pp. 35-42; Maga, G., Hubscher, U., (2003) J. Cell Sci., 116, pp. 3051-3060; Lawrence, B., (2011) Endocrinol. Metab. Clin. North Am., 40 (1), pp. 111-134. , (viii); Tenailleau, S., Corre, I., Hermouet, S., (1997) Exp. Hematol., 25 (9), pp. 927-934; Pfeilstocker, M., (1996) Leukemia, 10 (7), pp. 1117-1121; Lappano, R., Maggiolini, M., (2011) Nat. Rev. Drug Discov., 10 (1), pp. 47-60; Sheppard, K., (2012) Crit. Rev. Oncog., 17 (1), pp. 69-95; Santarpia, L., Lippman, S.M., El-Naggar, A.K., (2012) Expert Opin. Ther. Targets, 16 (1), pp. 103-119; Aksamitiene, E., Kiyatkin, A., Kholodenko, B.N., (2012) Biochem. Soc. Trans., 40 (1), pp. 139-146; von Kriegsheim, A., (2009) Nat. Cell Biol., 11 (12), pp. 1458-1464; Kozma, S.C., Thomas, G., (1994) Semin. Cancer Biol., 5 (4), pp. 255-260; Zhao, M.Y., (2009) Clin. Cancer Res., 15 (5), pp. 1708-1720; Tannapfel, A., (2005) Am. J. Clin. Pathol., 123 (2), pp. 256-260; Karhoff, D., (2007) Neuroendocrinology, 85 (1), pp. 45-53; Liu, A.M., Wong, Y.H., (2004) J. Biol. Chem., 279 (51), pp. 53196-53204; Yang, M., (2001) J. Immunol., 166 (11), pp. 6885-6892; Hussain, A.R., (2012) PLoS One, 7 (6), p. e39945; Kwon, T., (2000) J. Biol. Chem., 275 (1), pp. 423-428; Gastonguay, A., (2012) Cancer Biol. Ther., 13 (8), pp. 647-656; Ahola, T.M., (2002) Endocrinology, 143 (12), pp. 4620-4626; Shin, V.Y., (2007) Toxicol. Sci., 96 (1), pp. 21-29; Park, P.G., (1995) Cancer Res., 55 (16), pp. 3504-3508; Cole, S.W., Sood, A.K., (2012) Clin. Cancer Res., 18 (5), pp. 1201-1206; Wu, W.K., (2005) Cancer Res., 65 (12), pp. 5272-5277; Weddle, D.L., (2001) Carcinogenesis, 22 (3), pp. 473-479; Vilar, E., (2007) Endocr. Relat. Cancer, 14 (2), pp. 221-232",Article,Scopus,2-s2.0-84923356176
"Bonaccorso C.M., Spatuzza M., Di Marco B., Gloria A., Barrancotto G., Cupo A., Musumeci S.A., D'Antoni S., Bardoni B., Catania M.V.","Fragile X mental retardation protein (FMRP) interacting proteins exhibit different expression patterns during development",2015,"International Journal of Developmental Neuroscience","42",,,"15","23",,,10.1016/j.ijdevneu.2015.02.004,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924243551&partnerID=40&md5=cc44710fabfed08e1c15dd9724576100","IRCCS Oasi Maria SSTroina, EN, Italy; Institute of Neurological Sciences, CNRCatania, Italy; International PhD Program in Neuropharmacology, Department of Clinical and Molecular Biomedicine, University of Catania, Italy; CNRS UMR 7275, Institute of Molecular and Cellular PharmacologyValbonne Sophia-Antipolis, France; University of Nice Sophia-AntipolisNice, France; CNRS LIA NEOGENEXValbonne Sophia-Antipolis, France","Bonaccorso, C.M., IRCCS Oasi Maria SSTroina, EN, Italy; Spatuzza, M., Institute of Neurological Sciences, CNRCatania, Italy; Di Marco, B., Institute of Neurological Sciences, CNRCatania, Italy, International PhD Program in Neuropharmacology, Department of Clinical and Molecular Biomedicine, University of Catania, Italy; Gloria, A., IRCCS Oasi Maria SSTroina, EN, Italy; Barrancotto, G., IRCCS Oasi Maria SSTroina, EN, Italy; Cupo, A., CNRS UMR 7275, Institute of Molecular and Cellular PharmacologyValbonne Sophia-Antipolis, France, University of Nice Sophia-AntipolisNice, France; Musumeci, S.A., IRCCS Oasi Maria SSTroina, EN, Italy; D'Antoni, S., Institute of Neurological Sciences, CNRCatania, Italy; Bardoni, B., CNRS UMR 7275, Institute of Molecular and Cellular PharmacologyValbonne Sophia-Antipolis, France, University of Nice Sophia-AntipolisNice, France, CNRS LIA NEOGENEXValbonne Sophia-Antipolis, France; Catania, M.V., IRCCS Oasi Maria SSTroina, EN, Italy, Institute of Neurological Sciences, CNRCatania, Italy","Fragile X syndrome is caused by the lack of expression of fragile X mental retardation protein (FMRP), an RNA-binding protein involved in mRNA transport and translation. FMRP is a component of mRNA ribonucleoprotein complexes and it can interact with a range of proteins either directly or indirectly, as demonstrated by two-hybrid selection and co-immunoprecipitation, respectively. Most of FMRP-interacting proteins are RNA-binding proteins such as FXR1P, FXR2P and 82-FIP. Interestingly, FMRP can also interact directly with the cytoplasmic proteins CYFIP1 and CYFIP2, which do not bind RNA and link FMRP to the RhoGTPase pathway. The interaction with these different proteins may modulate the functions of FMRP by influencing its affinity to RNA and by affecting the FMRP ability of cytoskeleton remodeling through Rho/Rac GTPases. To better define the relationship of FMRP with its interacting proteins during brain development, we have analyzed the expression pattern of FMRP and its interacting proteins in the cortex, striatum, hippocampus and cerebellum at different ages in wild type (WT) mice. FMRP and FXR2P were strongly expressed during the first week and gradually decreased thereafter, more rapidly in the cerebellum than in the cortex. FXR1P was also expressed early and showed a reduction at later stages of development with a similar developmental pattern in these two regions. CYFIP1 was expressed at all ages and peaked in the third post-natal week. In contrast, CYFIP2 and 82-FIP (only in forebrain regions) were moderately expressed at P3 and gradually increased after P7. In general, the expression pattern of each protein was similar in the regions examined, except for 82-FIP, which exhibited a strong expression at P3 and low levels at later developmental stages in the cerebellum. Our data indicate that FMRP and its interacting proteins have distinct developmental patterns of expression and suggest that FMRP may be preferentially associated to certain proteins in early and late developmental periods. In particular, the RNA-binding and cytoskeleton remodeling functions of FMRP may be differently modulated during development. © 2015 Elsevier Ltd.","82-FIP; CYFIP1; CYFIP2; FMRP; FXR1P; FXR2P","Abekhoukh, S., Bardoni, B., CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome (2014) Front. Cell Neurosci., 8, pp. 1-9; Adinolfi, S., Bagni, C., Musco, G., Gibson, T., Mazzarella, L., Pastore, A., Dissecting FMR1 the protein responsible for fragile X syndrome in its structural and functional domains (1999) RNA, 5, pp. 1248-1258; Akins, M.R., Leblanc, H.F., Stackpole, E.E., Chyung, E., Fallon, J.R., Systematic mapping of fragile X granules in the mouse brain reveals a potential role for presynaptic FMRP in sensorimotor functions (2012) J. Comp. Neurol., 520, pp. 3687-3706; Bardoni, B., Schenck, A., Mandel, J.L., A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein (1999) Hum. Mol. Genet., 8, pp. 2557-2566; Bardoni, B., Castets, M., Huot, M.E., Schenck, A., Adinolfi, S., Corbin, F., Pastore, A., Mandel, J.L., 82-FIP a novel FMRP (fragile X mental retardation protein) interacting protein shows a cell cycle-dependent intracellular localization (2003) Hum. Mol. Genet., 12, pp. 1689-1698; Bardoni, B., Davidovic, L., Bensaid, M., Khandjian, E.W., The fragile X syndrome:exploring its molecular basis and seeking a treatment (2006) Exp. Rev. Mol. Med., 8, pp. 1-16; Bechara, E., Davidovic, L., Melko, M., Bensaid, M., Tremblay, S., Grosgeorge, J., Khandjian, E.W., Bardoni, B., Fragile X related protein 1 isoforms differentially modulate the affinity of fragile X mental retardation protein for G-quartet RNA structure (2007) Nucleic Acids Res., 35, pp. 299-306; Bechara, E.G., Didiot, M.C., Melko, M., Davidovic, L., Bensaid, M., Martin, P., Castets, M., Bardoni, B., A novel function for fragile X mental retardation protein in translational activation (2009) PLoS Biol., 7, p. e16; Brown, V., Jin, P., Ceman, S., Darnell, J.C., O'Donnell, W.T., Tenenbaum, S.A., Jin, X., Warren, S.T., Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome (2001) Cell, 107, pp. 477-487; Castets, M., Schaeffer, C., Bechara, E., Schenck, A., Khandjian, E.W., Luche, S., Moine, H., Bardoni, B., FMRP interferes with the Rac1 pathway and controls actin cytoskeleton dynamics in murine fibroblasts (2005) Hum. Mol. Genet., 14, pp. 835-844; Christie, S.B., Akins, M.R., Schwob, J.E., Fallon, J.R., The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits (2009) J. Neurosci., 29, pp. 1514-1524; Coffee, R.L., Tessier, C.R., Woodruff, E.A., Broadie, K., Fragile X mental retardation protein has a unique: evolutionarily conserved neuronal function not shared with FXR1P or FXR2P (2010) Dis. Model Mech., 3, pp. 471-485; Cook, D., Sanchez-Carbente, M.R., Lachance, C., Radzioch, D., Tremblay, S., Khandjian, E.W., DesGroseillers, L., Murai, K.K., Fragile X related protein 1 clusters with ribosomes and messenger RNAs at a subset of dendritic spines in the mouse hippocampus (2011) PLos One, 6, p. e26120; Cook, D., Nuro, E., Jones, E.V., Altimimi, H.F., Farmer, W.T., Gandin, V., Hanna, E., Murai, K.K., FXR1P limits long-term memory, long-lasting synaptic potentiation, and de novo GluA2 translation (2014) Cell Rep., 9, pp. 1402-1416; Darnell, J.C., Jensen, K.B., Jin, P., Brown, V., Warren, S.T., Darnell, R.B., Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function (2001) Cell, 107, pp. 489-499; Darnell, J.C., Fraser, C.E., Mostovetsky, O., Darnell, R.B., Discrimination of common and unique RNA-binding activities among fragile X mental retardation protein paralogs (2009) Hum. Mol. Genet., 18, pp. 3164-3177; Darnell, J.C., Van Driesche, S.J., Zhang, C., Hung, K.Y., Mele, A., Fraser, C.E., Stone, E.F., Darnell, R.B., FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism (2011) Cell, 146, pp. 247-261; Davidovic, L., Navratil, V., Bonaccorso, C.M., Catania, M.V., Bardoni, B., Dumas, M.E., A metabolomic and systems biology perspective on the brain of the fragile X syndrome mouse model (2011) Genome Res., 21 (12), pp. 2190-2202; Darnell, J.C., Klann, E., The translation of translational control by FMRP: therapeutic targets for FXS (2013) Nat. Neurosci., 16, pp. 1530-1536; Davidovic, L., Durand, N., Khalfallah, O., Tabet, R., Barbry, P., Mari, B., Sacconi, S., Bardoni, B., A novel role for the RNA-binding protein FXR1P in myoblasts cell-cycle progression by modulating p21/Cdkn1a/Cip1/Waf1 mRNA stability (2013) PLoS Genet., 9, p. e1003367; De Diego Otero, Y., Bakker, C.E., Raghoe, P., Severijnen, L.W.F.M., Hoogeveen, A., Oostra, B.A., Willemsen, R., Immunocytochemical characterization of FMRP, FXR1P and FXR2P during embryonic development in the mouse (2000) Gene Funct. Dis., 1, pp. 28-37; Devys, D., Lutz, Y., Rouyer, N., Bellocq, J.P., Mandel, J.L., The FMR1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation (1993) Nat. Genet., 4, pp. 335-340; Dictenberg, J.B., Swanger, S.A., Antar, L.N., Singer, R.H., Bassell, G.J., A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome (2008) Dev. Cell, 14, pp. 926-939; Didiot, M.C., Subramanian, M., Flatter, E., Mandel, J.L., Moine, H., Cells lacking the fragile X mental retardation protein (FMRP) have normal RISC activity but exhibit altered stress granule assembly (2009) Mol. Biol. Cell, 19, pp. 428-437; Dubé, M., Huot, M.E., Khandjian, E.W., Muscle specific fragile X related protein 1 isoforms are sequestred in the nucleus of undifferentiated myoblast (2000) BMC Genet., 1, p. 4; FMR1 knockout mice: a model to study fragile X mental retardation (1994) Cell, 78, pp. 23-33; Gautier, J.J., Lomakina, M.E., Bouslama-Oueghlani, L., Derivery, E., Beilinson, H., Faigle, W., Loew, D., Gautreau, A., Clathrin is required for Scar/Wave-mediated lamellipodium formation (2011) J. Cell Sci., 124, pp. 3414-3427; Gholizadeh, S., Halder, S.K., Hampson, D.R., Expression of fragile X mental retardation protein in neurons and glia of the developing and adult mouse brain (2015) Brain Res., 1596, pp. 22-30; Gross, C., Yao, X., Pong, D.L., Jeromin, A., Bassell, G.J., Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4 (2011) J. Neurosci., 31, pp. 5693-5698; Khandjian, E.W., Corbin, F., Woerly, S., Rousseau, F., The fragile X mental retardation protein is associated with ribosomes (1996) Nat. Genet., 12, pp. 91-93; Khandjian, E.W., Bardoni, B., Corbin, F., Sittler, A., Giroux, S., Heitz, D., Tremblay, S., Mandel, J., Novel isoforms of the fragile X related protein FXR1P are expressed during myogenesis (1998) Hum. Mol. Genet., 7, pp. 2121-2128; Khandjian, E.W., Huot, M.E., Tremblay, S., Davidovic, L., Mazroui, R., Bardoni, B., Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 13357-13362; Laggerbauer, B., Ostareck, D., Keidel, E.M., Ostareck-Lederer, A., Fischer, U., Evidence that fragile X mental retardation protein is a negative regulator of translation (2001) Hum. Mol. Genet., 10, pp. 329-338; Lu, R., Wang, H., Liang, Z., Ku, L., O'donnell, W.T., Li, W., Warren, S.T., Feng, Y., The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development (2004) Proc. Natl. Acad. Sci. U. S. A., 42, pp. 15201-15206; Mientjes, E.J., Willemsen, R., Kirkpatrick, L.L., Nieuwenhuizen, I.M., Hoogeveen-Westerveld, M., Verweij, M., Reis, S., Nelson, D.L., Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo (2004) Hum. Mol. Genet., 13, pp. 1291-1302; Musumeci, S.A., Calabrese, G., Bonaccorso, C.M., D'Antoni, S., Brouwer, J.R., Bakker, C.E., Elia, M., Catania, M.V., Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes (2007) Exp. Neurol., 203, pp. 233-240; Napoli, I., Mercaldo, V., Boyl, P.P., Eleuteri, B., Zalfa, F., De Rubeis, S., Di Marino, D., Bagni, C., The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP (2008) Cell, 6, pp. 1042-1054; Oguro-Ando, A., Rosensweig, C., Herman, E., Nishimura, Y., Werling, D., Bill, B.R., Berg, J.M., Geschwind, D.H., Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR (2014) Mol. Psychiatry, p. 124; Pacey, L.K., Doering, L.C., Developmental expression of FMRP in the astrocyte lineage: implications for fragile X syndrome (2007) Glia, 55, pp. 1601-1609; Pacey, L.K., Xuan, I.C., Guan, S., Sussman, D., Henkelman, R.M., Chen, Y., Thomsen, C., Hampson, D.R., Delayed myelination in a mouse model of fragile X syndrome (2013) Hum. Mol. Genet., 22, pp. 3920-3930; Pathania, M., Davenport, E.C., Muir, J., Sheehan, D.F., López-Doménech, G., Kittler, J.T., The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines (2014) Transl. Psychiatry, 4, p. e374; Schenck, A., Bardoni, B., Moro, A., Bagni, C., Mandel, J.L., A highly conserved protein family interacting with the fragile X mental retardation protein and displaying selective interactions with the FMRP related proteins FXR1P and FXR2P (2001) Proc. Natl. Acad. Sci. U. S. A., 98, pp. 8844-8849; Schenck, A., Bardoni, B., Langmann, C., Harden, N., Mandel, J.L., Giangrande, A., CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein (2003) Neuron, 38, pp. 887-898; Spencer, C.M., Serysheva, E., Yuva-Paylor, L.A., Oostra, B.A., Nelson, D.L., Paylor, R., Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between fragile X-related proteins (2006) Hum. Mol. Genet., 15, pp. 1984-1994; Stefani, G., Fraser, C.E., Darnell, J.C., Darnell, R.B., Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells (2004) J. Neurosci., 24, pp. 9272-9276; Tamanini, F., Willemsen, R., Van Unen, L., Bontekoe, C., Galjaard, H., Oostra, B.A., Hoogeveen, A.T., Differential expression of FMR1: FXR1 and FXR2 proteins in human brain and testis (1997) Hum. Mol. Genet., 6, pp. 1315-1322; Wang, T., Bray, S.M., Warren, S.T., New perspectives on the biology of fragile X syndrome (2012) Curr. Opin. Genet. Dev., pp. 256-263; Zangenehpour, S., Cornish, K.M., Chaudhuri, A., Whole-brain expression analysis of FMRP in adult monkey and its relationship to cognitive deficits in fragile X syndrome (2009) Brain Res., 1264, pp. 76-84; Zhang, J., Fang, Z., Jud, C., Vansteensel, M.J., Kaasik, K., Lee, C.C., Albrecht, U., Nelson, D.L., Fragile X-related proteins regulate mammalian circadian behavioral rhythms (2008) Am. J. Hum. Genet., 83, pp. 43-52; Zhang, J., Hou, L., Klann, E., Nelson, D.L., Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models (2009) J. Neurophysiol., 101, pp. 2572-2580; Zhang, Y., O'Connor, J.P., Siomi, M.C., Srinivasan, S., Dutra, A., Nussbaum, R.L., Dreyfuss, G., The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2 (1995) EMBO J., 14, pp. 5358-5366",Article,Scopus,2-s2.0-84924243551
"Moldenhauer L.M., Cockshell M.P., Frost L., Parham K.A., Tvorogov D., Tan L.Y., Ebert L.M., Tooley K., Worthley S., Lopez A.F., Bonder C.S.","Interleukin-3 greatly expands non-adherent endothelial forming cells with pro-angiogenic properties",2015,"Stem Cell Research","14","3",,"380","395",,,10.1016/j.scr.2015.04.002,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927759566&partnerID=40&md5=c48dfc0744d92b6489c1475063ea5f33","Centre for Cancer Biology, SA Pathology and University of South AustraliaAdelaide, SA, Australia; Co-operative Research Centre for Biomarker Translation, La Trobe UniversityMelbourne, VIC, Australia; School of Medicine, University of AdelaideAdelaide, SA, Australia; Centre for Stem Cell Research, Robinson Institute, University of AdelaideAdelaide, SA, Australia","Moldenhauer, L.M., Centre for Cancer Biology, SA Pathology and University of South AustraliaAdelaide, SA, Australia, Co-operative Research Centre for Biomarker Translation, La Trobe UniversityMelbourne, VIC, Australia; Cockshell, M.P., Centre for Cancer Biology, SA Pathology and University of South AustraliaAdelaide, SA, Australia, Co-operative Research Centre for Biomarker Translation, La Trobe UniversityMelbourne, VIC, Australia; Frost, L., School of Medicine, University of AdelaideAdelaide, SA, Australia; Parham, K.A., Centre for Cancer Biology, SA Pathology and University of South AustraliaAdelaide, SA, Australia; Tvorogov, D., Centre for Cancer Biology, SA Pathology and University of South AustraliaAdelaide, SA, Australia; Tan, L.Y., Centre for Cancer Biology, SA Pathology and University of South AustraliaAdelaide, SA, Australia; Ebert, L.M., Centre for Cancer Biology, SA Pathology and University of South AustraliaAdelaide, SA, Australia; Tooley, K., Centre for Cancer Biology, SA Pathology and University of South AustraliaAdelaide, SA, Australia, Co-operative Research Centre for Biomarker Translation, La Trobe UniversityMelbourne, VIC, Australia; Worthley, S., School of Medicine, University of AdelaideAdelaide, SA, Australia, Centre for Stem Cell Research, Robinson Institute, University of AdelaideAdelaide, SA, Australia; Lopez, A.F., Centre for Cancer Biology, SA Pathology and University of South AustraliaAdelaide, SA, Australia, Co-operative Research Centre for Biomarker Translation, La Trobe UniversityMelbourne, VIC, Australia, School of Medicine, University of AdelaideAdelaide, SA, Australia; Bonder, C.S., Centre for Cancer Biology, SA Pathology and University of South AustraliaAdelaide, SA, Australia, Co-operative Research Centre for Biomarker Translation, La Trobe UniversityMelbourne, VIC, Australia, School of Medicine, University of AdelaideAdelaide, SA, Australia, Centre for Stem Cell Research, Robinson Institute, University of AdelaideAdelaide, SA, Australia","Circulating endothelial progenitor cells (EPCs) provide revascularisation for cardiovascular disease and the expansion of these cells opens up the possibility of their use as a cell therapy. Herein we show that interleukin-3 (IL3) strongly expands a population of human non-adherent endothelial forming cells (EXnaEFCs) with low immunogenicity as well as pro-angiogenic capabilities in vivo, making their therapeutic utilisation a realistic option. Non-adherent CD133+ EFCs isolated from human umbilical cord blood and cultured under different conditions were maximally expanded by day 12 in the presence of IL3 at which time a 350-fold increase in cell number was obtained. Cell surface marker phenotyping confirmed expression of the hematopoietic progenitor cell markers CD133, CD117 and CD34, vascular cell markers VEGFR2 and CD31, dim expression of CD45 and absence of myeloid markers CD14 and CD11b. Functional experiments revealed that EXnaEFCs exhibited classical properties of endothelial cells (ECs), namely binding of Ulex europaeus lectin, up-take of acetylated-low density lipoprotein and contribution to EC tube formation in vitro. These EXnaEFCs demonstrated a pro-angiogenic phenotype within two independent in vivo rodent models. Firstly, a Matrigel plug assay showed increased vascularisation in mice. Secondly, a rat model of acute myocardial infarction demonstrated reduced heart damage as determined by lower levels of serum creatinine and a modest increase in heart functionality. Taken together, these studies show IL3 as a potent growth factor for human CD133+ cell expansion with clear pro-angiogenic properties (in vitro and in vivo) and thus may provide clinical utility for humans in the future. © 2015 Published by Elsevier B.V.",,"Appleby, S.L., Cockshell, M.P., Pippal, J.B., Thompson, E.J., Barrett, J.M., Tooley, K., Sen, S., Nicholson, I., Characterization of a distinct population of circulating human non-adherent endothelial forming cells and their recruitment via intercellular adhesion molecule-3 (2012) PLoS One, 7, p. e46996; Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Isner, J.M., Isolation of putative progenitor endothelial cells for angiogenesis (1997) Science, 275, pp. 964-967; Assmus, B., Schachinger, V., Teupe, C., Britten, M., Lehmann, R., Dobert, N., Grunwald, F., Martin, H., Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI) (2002) Circulation, 106, pp. 3009-3017; Autiero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Kroll, J., Bono, F., Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 (2003) Nat. Med., 9, pp. 936-943; Bompais, H., Chagraoui, J., Canron, X., Crisan, M., Liu, X.H., Anjo, A., Tolla-Le Port, C., Bikfalvi, A., Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells (2004) Blood, 103, pp. 2577-2584; Cho, H.J., Kim, H.S., Lee, M.M., Kim, D.H., Yang, H.J., Hur, J., Hwang, K.K., Chae, I.H., Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation (2003) Circulation, 108, pp. 2918-2925; Collins, T., Lapierre, L.A., Fiers, W., Strominger, J.L., Pober, J.S., Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A (1986) B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc. Natl. Acad. Sci. U.S.A., 83, pp. 446-450; D'Atri, L.P., Etulain, J., Romaniuk, M.A., Torres, O., Negrotto, S., Schattner, M., The low viability of human CD34+ cells under acidic conditions is improved by exposure to thrombopoietin, stem cell factor, interleukin-3, or increased cyclic adenosine monophosphate levels (2011) Transfusion, 51, pp. 1784-1795; Dentelli, P., Del Sorbo, L., Rosso, A., Molinar, A., Garbarino, G., Camussi, G., Pegoraro, L., Brizzi, M.F., Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation (1999) J. Immunol., 163, pp. 2151-2159; Dick, J.E., Bhatia, M., Gan, O., Kapp, U., Wang, J.C., Assay of human stem cells by repopulation of NOD/SCID mice (1997) Stem Cells, 15, pp. 199-203. , (discussion 204-197); Dimmeler, S., Burchfield, J., Zeiher, A.M., Cell-based therapy of myocardial infarction (2008) Arterioscler. Thromb. Vasc. Biol., 28, pp. 208-216; Eizawa, T., Ikeda, U., Murakami, Y., Matsui, K., Yoshioka, T., Takahashi, M., Muroi, K., Shimada, K., Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease (2004) Heart, 90, pp. 685-686; Ertl, G., Frantz, S., Healing after myocardial infarction (2005) Cardiovasc. Res., 66, pp. 22-32; Estes, M.L., Mund, J.A., Mead, L.E., Prater, D.N., Cai, S., Wang, H., Pollok, K.E., Srour, E.F., Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential (2010) Cytometry A, 77, pp. 831-839; Gulati, R., Jevremovic, D., Peterson, T.E., Chatterjee, S., Shah, V., Vile, R.G., Simari, R.D., Diverse origin and function of cells with endothelial phenotype obtained from adult human blood (2003) Circ. Res., 93, pp. 1023-1025; Hayashida, K., Kitamura, T., Gorman, D.M., Arai, K., Yokota, T., Miyajima, A., Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor (1990) Proc. Natl. Acad. Sci. U. S. A., 87, pp. 9655-9659; Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N.R., Crystal, R.G., Moore, M.A., Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand (2002) Cell, 109, pp. 625-637; Hill, J.M., Zalos, G., Halcox, J.P., Schenke, W.H., Waclawiw, M.A., Quyyumi, A.A., Finkel, T., Circulating endothelial progenitor cells, vascular function, and cardiovascular risk (2003) N. Engl. J. Med., 348, pp. 593-600; Hirschi, K.K., Ingram, D.A., Yoder, M.C., Assessing identity, phenotype, and fate of endothelial progenitor cells (2008) Arterioscler. Thromb. Vasc. Biol., 28, pp. 1584-1595; Hong, S.J., Kihlken, J., Choi, S.C., March, K.L., Lim, D.S., Intramyocardial transplantation of human adipose-derived stromal cell and endothelial progenitor cell mixture was not superior to individual cell type transplantation in improving left ventricular function in rats with myocardial infarction (2013) Int. J. Cardiol., 164, pp. 205-211; Hu, C.H., Li, Z.M., Du, Z.M., Zhang, A.X., Yang, D.Y., Wu, G.F., Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction (2009) Chin Med J (Engl), 122, pp. 548-555; Hur, J., Yoon, C.H., Kim, H.S., Choi, J.H., Kang, H.J., Hwang, K.K., Oh, B.H., Park, Y.B., Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis (2004) Arterioscler. Thromb. Vasc. Biol., 24, pp. 288-293; Ingram, D.A., Mead, L.E., Tanaka, H., Meade, V., Fenoglio, A., Mortell, K., Pollok, K., Yoder, M.C., Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood (2004) Blood, 104, pp. 2752-2760; Ito, H., Rovira, I.I., Bloom, M.L., Takeda, K., Ferrans, V.J., Quyyumi, A.A., Finkel, T., Endothelial progenitor cells as putative targets for angiostatin (1999) Cancer Res., 59, pp. 5875-5877; Jacobs, M., Staufenberger, S., Gergs, U., Meuter, K., Brandstatter, K., Hafner, M., Ertl, G., Schorb, W., Tumor necrosis factor-alpha at acute myocardial infarction in rats and effects on cardiac fibroblasts (1999) J. Mol. Cell. Cardiol., 31, pp. 1949-1959; Janic, B., Guo, A.M., Iskander, A.S., Varma, N.R., Scicli, A.G., Arbab, A.S., Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion (2010) PLoS One, 5, p. e9173; Jeevanantham, V., Butler, M., Saad, A., Abdel-Latif, A., Zuba-Surma, E.K., Dawn, B., Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis (2012) Circulation, 126, pp. 551-568; Jiang, M., He, B., Zhang, Q., Ge, H., Zang, M.H., Han, Z.H., Liu, J.P., Jin, Y., Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis (2010) Expert. Opin. Biol. Ther., 10, pp. 667-680; Jin, D.K., Shido, K., Kopp, H.G., Petit, I., Shmelkov, S.V., Young, L.M., Hooper, A.T., Heissig, B., Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes (2006) Nat. Med., 12, pp. 557-567; Kalka, C., Masuda, H., Takahashi, T., Kalka-Moll, W.M., Silver, M., Kearney, M., Li, T., Asahara, T., Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization (2000) Proc. Natl. Acad. Sci. U. S. A., 97, pp. 3422-3427; Kloner, R.A., Fishbein, M.C., Lew, H., Maroko, P.R., Braunwald, E., Mummification of the infarcted myocardium by high dose corticosteroids (1978) Circulation, 57, pp. 56-63; Laing, A.J., Dillon, J.P., Condon, E.T., Street, J.T., Wang, J.H., McGuinness, A.J., Redmond, H.P., Mobilization of endothelial precursor cells: systemic vascular response to musculoskeletal trauma (2007) J. Orthop. Res., 25, pp. 44-50; Lee, J.S., Hong, J.M., Moon, G.J., Lee, P.H., Ahn, Y.H., Bang, O.Y., A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke (2010) Stem Cells, 28, pp. 1099-1106; Li, A., Dubey, S., Varney, M.L., Dave, B.J., Singh, R.K., IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis (2003) J. Immunol., 170, pp. 3369-3376; Li, B., Sharpe, E.E., Maupin, A.B., Teleron, A.A., Pyle, A.L., Carmeliet, P., Young, P.P., VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization (2006) FASEB J., 20, pp. 1495-1497; Lin, Y., Weisdorf, D.J., Solovey, A., Hebbel, R.P., Origins of circulating endothelial cells and endothelial outgrowth from blood (2000) J. Clin. Invest., 105, pp. 71-77; Lipinski, M.J., Biondi-Zoccai, G.G., Abbate, A., Khianey, R., Sheiban, I., Bartunek, J., Vanderheyden, M., Strauer, B.E., Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials (2007) J. Am. Coll. Cardiol., 50, pp. 1761-1767; Litwin, M., Clark, K., Noack, L., Furze, J., Berndt, M., Albelda, S., Vadas, M., Gamble, J., Novel cytokine-independent induction of endothelial adhesion molecules regulated by platelet/endothelial cell adhesion molecule (CD31) (1997) J. Cell Biol., 139, pp. 219-228; Liu, Z.J., Velazquez, O.C., Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing (2008) Antioxid. Redox Signal., 10, pp. 1869-1882; Loomans, C.J., de Koning, E.J., Staal, F.J., Rookmaaker, M.B., Verseyden, C., de Boer, H.C., Verhaar, M.C., van Zonneveld, A.J., Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes (2004) Diabetes, 53, pp. 195-199; Martin-Rendon, E., Brunskill, S.J., Hyde, C.J., Stanworth, S.J., Mathur, A., Watt, S.M., Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review (2008) Eur. Heart J., 29, pp. 1807-1818; Masuda, H., Alev, C., Akimaru, H., Ito, R., Shizuno, T., Kobori, M., Horii, M., Isozaki, M., Methodological development of a clonogenic assay to determine endothelial progenitor cell potential (2011) Circ. Res., 109, pp. 20-37; Masuda, H., Iwasaki, H., Kawamoto, A., Akimaru, H., Ishikawa, M., Ii, M., Shizuno, T., Horii, M., Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis (2012) Stem Cells Transl Med, 1, pp. 160-171; Melero-Martin, J.M., Khan, Z.A., Picard, A., Wu, X., Paruchuri, S., Bischoff, J., In vivo vasculogenic potential of human blood-derived endothelial progenitor cells (2007) Blood, 109, pp. 4761-4768; Lee, B.H.O.E., Ahn, H.Y., Shin, J.C., Kim, H.K., Kim, M., Park, I.Y., Park, Y.G., Joe, Y.A., Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization (2011) FASEB J., 25, pp. 159-169; Ono, K., Matsumori, A., Shioi, T., Furukawa, Y., Sasayama, S., Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling (1998) Circulation, 98, pp. 149-156; Palm, M., Lundblad, A., Creatinine concentration in plasma from dog, rat, and mouse: a comparison of 3 different methods (2005) Vet. Clin. Pathol., 34, pp. 232-236; Pober, J.S., Collins, T., Gimbrone, M.A., Cotran, R.S., Gitlin, J.D., Fiers, W., Clayberger, C., Reiss, C.S., Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon (1983) Nature, 305, pp. 726-729; Richardson, J.D., Bertaso, A.G., Psaltis, P.J., Frost, L., Carbone, A., Paton, S., Nelson, A.J., Gronthos, S., Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction (2013) J. Card. Fail., 19, pp. 342-353; Rojas-Canales, D., Krishnan, R., Jessup, C.F., Coates, P.T., Early exposure of interferon-gamma inhibits signal transducer and activator of transcription-6 signalling and nuclear factor kappaB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells (2012) Clin. Exp. Immunol., 167, pp. 447-458; Schachinger, V., Assmus, B., Britten, M.B., Honold, J., Lehmann, R., Teupe, C., Abolmaali, N.D., Martin, H., Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial (2004) J. Am. Coll. Cardiol., 44, pp. 1690-1699; Schmidt-Lucke, C., Rossig, L., Fichtlscherer, S., Vasa, M., Britten, M., Kamper, U., Dimmeler, S., Zeiher, A.M., Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair (2005) Circulation, 111, pp. 2981-2987; Schmidt-Lucke, C., Fichtlscherer, S., Aicher, A., Tschope, C., Schultheiss, H.P., Zeiher, A.M., Dimmeler, S., Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol (2010) PLoS One, 5, p. e13790; Schober, A., Chemokines in vascular dysfunction and remodeling (2008) Arterioscler. Thromb. Vasc. Biol., 28, pp. 1950-1959; Schuh, A., Liehn, E.A., Sasse, A., Hristov, M., Sobota, R., Kelm, M., Merx, M.W., Weber, C., Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model (2008) Basic Res. Cardiol., 103, pp. 69-77; Sen, S., McDonald, S.P., Coates, P.T., Bonder, C.S., Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease (2011) Clin. Sci. (Lond.), 120, pp. 263-283; Shultz, L.D., Schweitzer, P.A., Christianson, S.W., Gott, B., Schweitzer, I.B., Tennent, B., McKenna, S., Greiner, D.L., Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice (1995) J. Immunol., 154, pp. 180-191; Strauer, B.E., Brehm, M., Zeus, T., Kostering, M., Hernandez, A., Sorg, R.V., Kogler, G., Wernet, P., Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans (2002) Circulation, 106, pp. 1913-1918; Sun, Q., Woodcock, J.M., Rapoport, A., Stomski, F.C., Korpelainen, E.I., Bagley, C.J., Goodall, G.J., Vadas, M.A., Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist (1996) Blood, 87, pp. 83-92; Teo, K.S., Carbone, A., Piantadosi, C., Chew, D.P., Hammett, C.J., Brown, M.A., Worthley, S.G., Cardiac MRI assessment of left and right ventricular parameters in healthy Australian normal volunteers (2008) Heart Lung Circ, 17, pp. 313-317; Timmermans, F., Van Hauwermeiren, F., De Smedt, M., Raedt, R., Plasschaert, F., De Buyzere, M.L., Gillebert, T.C., Vandekerckhove, B., Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors (2007) Arterioscler. Thromb. Vasc. Biol., 27, pp. 1572-1579; Timmermans, F., Plum, J., Yoder, M.C., Ingram, D.A., Vandekerckhove, B., Case, J., Endothelial progenitor cells: identity defined? (2009) J. Cell. Mol. Med., 13, pp. 87-102; Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., Speleman, F., Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes (2002) Genome Biol., 3. , (RESEARCH0034); Wall, R.T., Harker, L.A., Quadracci, L.J., Striker, G.E., Factors influencing endothelial cell proliferation in vitro (1978) J. Cell. Physiol., 96, pp. 203-213; Werner, L., Deutsch, V., Barshack, I., Miller, H., Keren, G., George, J., Transfer of endothelial progenitor cells improves myocardial performance in rats with dilated cardiomyopathy induced following experimental myocarditis (2005) J. Mol. Cell. Cardiol., 39, pp. 691-697; Yoder, M.C., Human endothelial progenitor cells (2012) Cold Spring Harb Perspect Med, 2, p. a006692; Zeoli, A., Dentelli, P., Rosso, A., Togliatto, G., Trombetta, A., Damiano, L., di Celle, P.F., Brizzi, M.F., Interleukin-3 promotes expansion of hemopoietic-derived CD45+ angiogenic cells and their arterial commitment via STAT5 activation (2008) Blood, 112, pp. 350-361",Article,Scopus,2-s2.0-84927759566
"Mehdipour P., Santoro F., Minucci S.","Epigenetic alterations in acute myeloid leukemias",2015,"FEBS Journal","282","9",,"1786","1800",,1,10.1111/febs.13142,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928533993&partnerID=40&md5=d045062350552e28b28e849f326720ce","Department of Experimental Oncology, IFOM-IEO Campus, European Institute of OncologyMilan, Italy; Department of Biosciences, University of MilanMilan, Italy","Mehdipour, P., Department of Experimental Oncology, IFOM-IEO Campus, European Institute of OncologyMilan, Italy; Santoro, F., Department of Experimental Oncology, IFOM-IEO Campus, European Institute of OncologyMilan, Italy; Minucci, S., Department of Experimental Oncology, IFOM-IEO Campus, European Institute of OncologyMilan, Italy, Department of Biosciences, University of MilanMilan, Italy","Acute myeloid leukemia (AML) is a heterogeneous disease for which the standard treatment with cytotoxic chemotherapy has remained largely unchanged for over four decades, with unfavorable clinical results. Epigenetic alterations have been described in several AMLs, and in some cases their origin has been studied in detail mechanistically (such as in acute promyelocytic leukemia, caused by the promyelocytic leukemia-retinoic acid receptor-α fusion protein). Recently, the advent of massive parallel sequencing has revealed that > 70% of AML cases have mutations in DNA methylation-related genes or mutations in histone modifiers, showing that epigenetic alterations are key players in the development of most, if not all, AMLs, and pointing to the exploitation of new molecular targets for more efficacious therapies. This review provides a brief overview of the latest findings on the characterization of the epigenetic landscape of AML and discusses the rationale for the optimization of epigenetic therapy of AML. Acute myeloid Leukemia (AML) is the most common form of acute leukemia in adults. Mutations in epigenetic modifiers are emerging as a large class of mutations critical for AML development. This review gives a brief overview on the latest findings on the characterization of the epigenetic landscape in AML and the rational for the optimization of epigenetic therapy. © 2014 FEBS.","AML; APL; cancer stem cells; epi-drugs; epigenetic alterations","Dohner, K., Dohner, H., Molecular characterization of acute myeloid leukemia (2008) Haematologica, 93, pp. 976-982; Marcucci, G., Haferlach, T., Dohner, H., Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications (2011) J Clin Oncol, 29, pp. 475-486; O'Brien, C.P., Langabeer, S.E., O'Byrne, K.J., O'Leary, J.J., Finn, S.P., Predictive values for molecular diagnostics: converting unknown unknowns to known unknowns (2014) Mol Diagn Ther, 18, pp. 1-4; Sweet, K., Lancet, J.E., Novel therapeutics in acute myeloid leukemia (2014) Curr Hematol Malig Rep, 9, pp. 109-117; Dohner, H., Estey, E.H., Amadori, S., Appelbaum, F.R., Buchner, T., Burnett, A.K., Dombret, H., Larson, R.A., Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet (2010) Blood, 115, pp. 453-474; Verhaak, R.G., Wouters, B.J., Erpelinck, C.A., Abbas, S., Beverloo, H.B., Lugthart, S., Lowenberg, B., Valk, P.J., Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling (2009) Haematologica, 94, pp. 131-134; Bain, B.J., Classification of acute leukaemia: the need to incorporate cytogenetic and molecular genetic information (1998) J Clin Pathol, 51, pp. 420-423; Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R., Sultan, C., Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group (1976) Br J Haematol, 33, pp. 451-458; Vardiman, J.W., Harris, N.L., Brunning, R.D., The World Health Organization (WHO) classification of the myeloid neoplasms (2002) Blood, 100, pp. 2292-2302; Schlenk, R.F., Dohner, K., Krauter, J., Frohling, S., Corbacioglu, A., Bullinger, L., Habdank, M., Benner, A., Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia (2008) N Engl J Med, 358, pp. 1909-1918; Corces-Zimmerman, M.R., Hong, W.J., Weissman, I.L., Medeiros, B.C., Majeti, R., Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission (2014) Proc Natl Acad Sci USA, 111, pp. 2548-2553; Garraway, L.A., Lander, E.S., Lessons from the cancer genome (2013) Cell, 153, pp. 17-37; Sharma, S., Kelly, T.K., Jones, P.A., Epigenetics in cancer (2010) Carcinogenesis, 31, pp. 27-36; Goelz, S.E., Vogelstein, B., Hamilton, S.R., Feinberg, A.P., Hypomethylation of DNA from benign and malignant human colon neoplasms (1985) Science, 228, pp. 187-190; Esteller, M., Cancer epigenomics: DNA methylomes and histone-modification maps (2007) Nat Rev Genet, 8, pp. 286-298; Nguyen, C., Liang, G., Nguyen, T.T., Tsao-Wei, D., Groshen, S., Lubbert, M., Zhou, J.H., Jones, P.A., Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells (2001) J Natl Cancer Inst, 93, pp. 1465-1472; Sadikovic, B., Al-Romaih, K., Squire, J.A., Zielenska, M., Cause and consequences of genetic and epigenetic alterations in human cancer (2008) Curr Genomics, 9, pp. 394-408; Akalin, A., Garrett-Bakelman, F.E., Kormaksson, M., Busuttil, J., Zhang, L., Khrebtukova, I., Milne, T.A., Hess, J.L., Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia (2012) PLoS Genet, 8; Deneberg, S., Guardiola, P., Lennartsson, A., Qu, Y., Gaidzik, V., Blanchet, O., Karimi, M., Uggla, B., Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks (2011) Blood, 118, pp. 5573-5582; Figueroa, M.E., Lugthart, S., Li, Y., Erpelinck-Verschueren, C., Deng, X., Christos, P.J., Schifano, E., Skrabanek, L., DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia (2010) Cancer Cell, 17, pp. 13-27; Baylin, S.B., Jones, P.A., A decade of exploring the cancer epigenome - biological and translational implications (2011) Nat Rev Cancer, 11, pp. 726-734; Elsheikh, S.E., Green, A.R., Rakha, E.A., Powe, D.G., Ahmed, R.A., Collins, H.M., Soria, D., Ammar, A.A., Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome (2009) Cancer Res, 69, pp. 3802-3809; Fraga, M.F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Petrie, K., Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer (2005) Nat Genet, 37, pp. 391-400; Barlesi, F., Giaccone, G., Gallegos-Ruiz, M.I., Loundou, A., Span, S.W., Lefesvre, P., Kruyt, F.A., Rodriguez, J.A., Global histone modifications predict prognosis of resected non small-cell lung cancer (2007) J Clin Oncol, 25, pp. 4358-4364; Manuyakorn, A., Paulus, R., Farrell, J., Dawson, N.A., Tze, S., Cheung-Lau, G., Hines, O.J., Horvath, S., Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704 (2010) J Clin Oncol, 28, pp. 1358-1365; Seligson, D.B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M., Kurdistani, S.K., Global histone modification patterns predict risk of prostate cancer recurrence (2005) Nature, 435, pp. 1262-1266; You, J.S., Jones, P.A., Cancer genetics and epigenetics: two sides of the same coin? (2012) Cancer Cell, 22, pp. 9-20; Di Croce, L., Raker, V.A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Nervi, C., Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor (2002) Science, 295, pp. 1079-1082; Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Zamir, I., Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia (1998) Nature, 391, pp. 815-818; Lin, R.J., Nagy, L., Inoue, S., Shao, W., Miller, W.H., Jr., Evans, R.M., Role of the histone deacetylase complex in acute promyelocytic leukaemia (1998) Nature, 391, pp. 811-814; Zhou, J., Peres, L., Honore, N., Nasr, R., Zhu, J., De The, H., Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalization (2006) Proc Natl Acad Sci USA, 103, pp. 9238-9243; Minucci, S., Pelicci, P.G., Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer (2006) Nat Rev Cancer, 6, pp. 38-51; Villa, R., Pasini, D., Gutierrez, A., Morey, L., Occhionorelli, M., Vire, E., Nomdedeu, J.F., Minucci, S., Role of the polycomb repressive complex 2 in acute promyelocytic leukemia (2007) Cancer Cell, 11, pp. 513-525; Fenaux, P., Le Deley, M.C., Castaigne, S., Archimbaud, E., Chomienne, C., Link, H., Guerci, A., Bowen, D., Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group (1993) Blood, 82, pp. 3241-3249; Huang, M.E., Ye, Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhoa, L., Gu, L.J., Wang, Z.Y., Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia (1988) Blood, 72, pp. 567-572; Licht, J.D., Reconstructing a disease: what essential features of the retinoic acid receptor fusion oncoproteins generate acute promyelocytic leukemia? (2006) Cancer Cell, 9, pp. 73-74; Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Ogden, A., Shepherd, L., Rowe, J.M., All-trans-retinoic acid in acute promyelocytic leukemia (1997) N Engl J Med, 337, pp. 1021-1028; Zhou, G.B., Zhao, W.L., Wang, Z.Y., Chen, S.J., Chen, Z., Retinoic acid and arsenic for treating acute promyelocytic leukemia (2005) PLoS Med, 2, p. e12; Mathews, V., George, B., Chendamarai, E., Lakshmi, K.M., Desire, S., Balasubramanian, P., Viswabandya, A., Shaji, R.V., Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data (2010) J Clin Oncol, 28, pp. 3866-3871; Ablain, J., De The, H., Revisiting the differentiation paradigm in acute promyelocytic leukemia (2011) Blood, 117, pp. 5795-5802; Martens, J.H., Brinkman, A.B., Simmer, F., Francoijs, K.J., Nebbioso, A., Ferrara, F., Altucci, L., Stunnenberg, H.G., PML-RARalpha/RXR alters the epigenetic landscape in acute promyelocytic leukemia (2010) Cancer Cell, 17, pp. 173-185; Peterson, L.F., Zhang, D.E., The 8;21 translocation in leukemogenesis (2004) Oncogene, 23, pp. 4255-4262; Hatlen, M.A., Wang, L., Nimer, S.D., AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches (2012) Front Med, 6, pp. 248-262; Mulloy, J.C., Cammenga, J., MacKenzie, K.L., Berguido, F.J., Moore, M.A., Nimer, S.D., The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells (2002) Blood, 99, pp. 15-23; Oki, Y., Issa, J.P., Epigenetic mechanisms in AML - a target for therapy (2010) Cancer Treat Res, 145, pp. 19-40; Reikvam, H., Hatfield, K.J., Kittang, A.O., Hovland, R., Bruserud, O., Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications (2011) J Biomed Biotechnol, 2011, p. 104631; Maiques-Diaz, A., Chou, F.S., Wunderlich, M., Gomez-Lopez, G., Jacinto, F.V., Rodriguez-Perales, S., Larrayoz, M.J., Cigudosa, J.C., Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs (2012) Leukemia, 26, pp. 1329-1337; Wang, L., Gural, A., Sun, X.J., Zhao, X., Perna, F., Huang, G., Hatlen, M.A., Xu, H., The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation (2011) Science, 333, pp. 765-769; Becker, H., Pfeifer, D., Afonso, J.D., Nimer, S.D., Veelken, H., Schwabe, M., Lubbert, M., Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesis (2008) Leukemia, 22, pp. 1792-1794; Muller, A.M., Duque, J., Shizuru, J.A., Lubbert, M., Complementing mutations in core binding factor leukemias: from mouse models to clinical applications (2008) Oncogene, 27, pp. 5759-5773; Wiemels, J.L., Xiao, Z., Buffler, P.A., Maia, A.T., Ma, X., Dicks, B.M., Smith, M.T., Wiencke, J., In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia (2002) Blood, 99, pp. 3801-3805; Djabali, M., Selleri, L., Parry, P., Bower, M., Young, B.D., Evans, G.A., A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias (1992) Nat Genet, 2, pp. 113-118; Kourlas, P.J., Strout, M.P., Becknell, B., Veronese, M.L., Croce, C.M., Theil, K.S., Krahe, R., Bloomfield, C.D., Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia (2000) Proc Natl Acad Sci USA, 97, pp. 2145-2150; Krivtsov, A.V., Armstrong, S.A., MLL translocations, histone modifications and leukaemia stem-cell development (2007) Nat Rev Cancer, 7, pp. 823-833; Xiao, B., Wilson, J.R., Gamblin, S.J., SET domains and histone methylation (2003) Curr Opin Struct Biol, 13, pp. 699-705; Milne, T.A., Briggs, S.D., Brock, H.W., Martin, M.E., Gibbs, D., Allis, C.D., Hess, J.L., MLL targets SET domain methyltransferase activity to Hox gene promoters (2002) Mol Cell, 10, pp. 1107-1117; Daser, A., Rabbitts, T.H., Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis (2004) Genes Dev, 18, pp. 965-974; Argiropoulos, B., Humphries, R.K., Hox genes in hematopoiesis and leukemogenesis (2007) Oncogene, 26, pp. 6766-6776; Gutierrez, S.E., Romero-Oliva, F.A., Epigenetic changes: a common theme in acute myelogenous leukemogenesis (2013) J Hematol Oncol, 6, p. 57; Marschalek, R., Mixed lineage leukemia: roles in human malignancies and potential therapy (2010) FEBS J, 277, pp. 1822-1831; Cierpicki, T., Risner, L.E., Grembecka, J., Lukasik, S.M., Popovic, R., Omonkowska, M., Shultis, D.D., Bushweller, J.H., Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia (2010) Nat Struct Mol Biol, 17, pp. 62-68; Birke, M., Schreiner, S., Garcia-Cuellar, M.P., Mahr, K., Titgemeyer, F., Slany, R.K., The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation (2002) Nucleic Acids Res, 30, pp. 958-965; Erfurth, F.E., Popovic, R., Grembecka, J., Cierpicki, T., Theisler, C., Xia, Z.B., Stuart, T., Zeleznik-Le, N.J., MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression (2008) Proc Natl Acad Sci USA, 105, pp. 7517-7522; Xia, Z.B., Anderson, M., Diaz, M.O., Zeleznik-Le, N.J., MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein (2003) Proc Natl Acad Sci USA, 100, pp. 8342-8347; Lin, C., Smith, E.R., Takahashi, H., Lai, K.C., Martin-Brown, S., Florens, L., Washburn, M.P., Shilatifard, A., AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia (2010) Mol Cell, 37, pp. 429-437; Chang, M.J., Wu, H., Achille, N.J., Reisenauer, M.R., Chou, C.W., Zeleznik-Le, N.J., Hemenway, C.S., Zhang, W., Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes (2010) Cancer Res, 70, pp. 10234-10242; Nguyen, A.T., Zhang, Y., The diverse functions of Dot1 and H3K79 methylation (2011) Genes Dev, 25, pp. 1345-1358; Nie, Z., Xue, Y., Yang, D., Zhou, S., Deroo, B.J., Archer, T.K., Wang, W., A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex (2000) Mol Cell Biol, 20, pp. 8879-8888; Zeisig, B.B., Arteaga, M.F., Thirant, C., So, C.W., Collaboration between PcG proteins and MLL fusions in Leukemogenesis: an emerging paradigm (2011) Cancer Cell, 20, pp. 551-553; Ley, T.J., Ding, L., Walter, M.J., McLellan, M.D., Lamprecht, T., Larson, D.E., Kandoth, C., Welch, J., DNMT3A mutations in acute myeloid leukemia (2010) N Engl J Med, 363, pp. 2424-2433; Marcucci, G., Metzeler, K.H., Schwind, S., Becker, H., Maharry, K., Mrozek, K., Radmacher, M.D., Whitman, S.P., Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia (2012) J Clin Oncol, 30, pp. 742-750; Thol, F., Damm, F., Ludeking, A., Winschel, C., Wagner, K., Morgan, M., Yun, H., Hoelzer, D., Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia (2011) J Clin Oncol, 29, pp. 2889-2896; Yan, X.J., Xu, J., Gu, Z.H., Pan, C.M., Lu, G., Shen, Y., Shi, J.Y., Zhang, X.W., Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia (2011) Nat Genet, 43, pp. 309-315; Holz-Schietinger, C., Matje, D.M., Reich, N.O., Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation (2012) J Biol Chem, 287, pp. 30941-30951; Suzuki, M.M., Bird, A., DNA methylation landscapes: provocative insights from epigenomics (2008) Nat Rev Genet, 9, pp. 465-476; Issa, J.P., Baylin, S.B., Herman, J.G., DNA methylation changes in hematologic malignancies: biologic and clinical implications (1997) Leukemia, 11, pp. S7-S11; Santini, V., Kantarjian, H.M., Issa, J.P., Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications (2001) Ann Intern Med, 134, pp. 573-586; Conway O'Brien, E., Prideaux, S., Chevassut, T., The epigenetic landscape of acute myeloid leukemia (2014) Adv Hematol, 2014, p. 103175; Shlush, L.I., Zandi, S., Mitchell, A., Chen, W.C., Brandwein, J.M., Gupta, V., Kennedy, J.A., Yee, K.W., Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia (2014) Nature, 506, pp. 328-333; Wu, H., Zhang, Y., Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation (2011) Genes Dev, 25, pp. 2436-2452; Tan, L., Shi, Y.G., Tet family proteins and 5-hydroxymethylcytosine in development and disease (2012) Development, 139, pp. 1895-1902; Ko, M., Huang, Y., Jankowska, A.M., Pape, U.J., Tahiliani, M., Bandukwala, H.S., An, J., Ganetzky, R., Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 (2010) Nature, 468, pp. 839-843; Abdel-Wahab, O., Levine, R.L., Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia (2013) Blood, 121, pp. 3563-3572; Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Aravind, L., Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 (2009) Science, 324, pp. 930-935; Booth, M.J., Ost, T.W., Beraldi, D., Bell, N.M., Branco, M.R., Reik, W., Balasubramanian, S., Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine (2013) Nat Protoc, 8, pp. 1841-1851; Patel, K.P., Ravandi, F., Ma, D., Paladugu, A., Barkoh, B.A., Medeiros, L.J., Luthra, R., Acute myeloid leukemia with IDH1 or IDH2 mutation: frequency and clinicopathologic features (2011) Am J Clin Pathol, 135, pp. 35-45; Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Peng, Y., Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha (2009) Science, 324, pp. 261-265; Im, A.P., Sehgal, A.R., Carroll, M.P., Smith, B.D., Tefferi, A., Johnson, D.E., Boyiadzis, M., DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies (2014) Leukemia, 28, pp. 1774-1783; Koivunen, P., Lee, S., Duncan, C.G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J.A., Gross, S., Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation (2012) Nature, 483, pp. 484-488; Losman, J.A., Kaelin, W.G., Jr., What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer (2013) Genes Dev, 27, pp. 836-852; Katoh, M., Functional and cancer genomics of ASXL family members (2013) Br J Cancer, 109, pp. 299-306; Lee, S.W., Cho, Y.S., Na, J.M., Park, U.H., Kang, M., Kim, E.J., Um, S.J., ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1 (2010) J Biol Chem, 285, pp. 18-29; Nasmyth, K., Haering, C.H., Cohesin: its roles and mechanisms (2009) Annu Rev Genet, 43, pp. 525-558; Peters, J.M., Tedeschi, A., Schmitz, J., The cohesin complex and its roles in chromosome biology (2008) Genes Dev, 22, pp. 3089-3114; The Cancer Genome Atlas Research Network, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia (2013) N Engl J Med, 368, pp. 2059-2074; Leeke, B., Marsman, J., O'Sullivan, J.M., Horsfield, J.A., Cohesin mutations in myeloid malignancies: underlying mechanisms (2014) Exp Hematol Oncol, 3, p. 13; Kon, A., Shih, L.Y., Minamino, M., Sanada, M., Shiraishi, Y., Nagata, Y., Yoshida, K., Nakato, R., Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms (2013) Nat Genet, 45, pp. 1232-1237; Thota, S., Viny, A.D., Makishima, H., Spitzer, B., Radivoyevitch, T., Przychodzen, B., Sekeres, M.A., Maciejewski, J.P., Genetic alterations of the cohesin complex genes in myeloid malignancies (2014) Blood, 124, pp. 1790-1798; Fernandez, H.F., Sun, Z., Yao, X., Litzow, M.R., Luger, S.M., Paietta, E.M., Racevskis, J., Bennett, J.M., Anthracycline dose intensification in acute myeloid leukemia (2009) N Engl J Med, 361, pp. 1249-1259; Lowenberg, B., Ossenkoppele, G.J., Van Putten, W., Schouten, H.C., Graux, C., Ferrant, A., Sonneveld, P., Von Lilienfeld-Toal, M., High-dose daunorubicin in older patients with acute myeloid leukemia (2009) N Engl J Med, 361, pp. 1235-1248; Lowenberg, B., Pabst, T., Vellenga, E., Van Putten, W., Schouten, H.C., Graux, C., Ferrant, A., Gratwohl, A., Cytarabine dose for acute myeloid leukemia (2011) N Engl J Med, 364, pp. 1027-1036; Mercurio, C., Minucci, S., Pelicci, P.G., Histone deacetylases and epigenetic therapies of hematological malignancies (2010) Pharmacol Res, 62, pp. 18-34; Nebbioso, A., Carafa, V., Benedetti, R., Altucci, L., Trials with 'epigenetic' drugs: an update (2012) Mol Oncol, 6, pp. 657-682; Leone, G., D'alo, F., Zardo, G., Voso, M.T., Nervi, C., Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias (2008) Curr Med Chem, 15, pp. 1274-1287; Espada, J., Ballestar, E., Fraga, M.F., Villar-Garea, A., Juarranz, A., Stockert, J.C., Robertson, K.D., Esteller, M., Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification pattern (2004) J Biol Chem, 279, pp. 37175-37184; Soncini, M., Santoro, F., Gutierrez, A., Frige, G., Romanenghi, M., Botrugno, O.A., Pallavicini, I., Minucci, S., The DNA demethylating agent decitabine activates the TRAIL pathway and induces apoptosis in acute myeloid leukemia (2013) Biochim Biophys Acta, 1832, pp. 114-120; Stankov, M.V., El Khatib, M., Kumar Thakur, B., Heitmann, K., Panayotova-Dimitrova, D., Schoening, J., Bourquin, J.P., Welte, K., Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy (2014) Leukemia, 28, pp. 577-588; Quintas-Cardama, A., Santos, F.P., Garcia-Manero, G., Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia (2011) Leukemia, 25, pp. 226-235; Brogdon, J.L., Xu, Y., Szabo, S.J., An, S., Buxton, F., Cohen, D., Huang, Q., Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function (2007) Blood, 109, pp. 1123-1130; Kim, M.S., Kwon, H.J., Lee, Y.M., Baek, J.H., Jang, J.E., Lee, S.W., Moon, E.J., Chung, H.Y., Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes (2001) Nat Med, 7, pp. 437-443; Marks, P.A., Richon, V.M., Rifkind, R.A., Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells (2000) J Natl Cancer Inst, 92, pp. 1210-1216; Santoro, F., Botrugno, O.A., Dal Zuffo, R., Pallavicini, I., Matthews, G.M., Cluse, L., Barozzi, I., Moretti, S., A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance (2013) Blood, 121, pp. 3459-3468; Thurn, K.T., Thomas, S., Moore, A., Munster, P.N., Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer (2011) Future Oncol, 7, pp. 263-283; Welch, J.S., Ley, T.J., Link, D.C., Miller, C.A., Larson, D.E., Koboldt, D.C., Wartman, L.D., Xia, J., The origin and evolution of mutations in acute myeloid leukemia (2012) Cell, 150, pp. 264-278; Leiva, M., Moretti, S., Soilihi, H., Pallavicini, I., Peres, L., Mercurio, C., Dal Zuffo, R., De The, H., Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL (2012) Leukemia, 26, pp. 1630-1637; Mohn, F., Weber, M., Rebhan, M., Roloff, T.C., Richter, J., Stadler, M.B., Bibel, M., Schubeler, D., Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors (2008) Mol Cell, 30, pp. 755-766; Yamazaki, J., Estecio, M.R., Lu, Y., Long, H., Malouf, G.G., Graber, D., Huo, Y., Kornblau, S.M., The epigenome of AML stem and progenitor cells (2013) Epigenetics, 8, pp. 92-104; Raynal, N.J., Si, J., Taby, R.F., Gharibyan, V., Ahmed, S., Jelinek, J., Estecio, M.R., Issa, J.P., DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory (2012) Cancer Res, 72, pp. 1170-1181; Laribee, R.N., Klemsz, M.J., Loss of PU.1 expression following inhibition of histone deacetylases (2001) J Immunol, 167, pp. 5160-5166; Milhem, M., Mahmud, N., Lavelle, D., Araki, H., Desimone, J., Saunthararajah, Y., Hoffman, R., Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A (2004) Blood, 103, pp. 4102-4110; Zardo, G., Cimino, G., Nervi, C., Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming (2008) Leukemia, 22, pp. 1503-1518; Schenk, T., Chen, W.C., Gollner, S., Howell, L., Jin, L., Hebestreit, K., Klein, H.U., Mills, K., Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia (2012) Nat Med, 18, pp. 605-611; Mack, G.S., To selectivity and beyond (2010) Nat Biotechnol, 28, pp. 1259-1266; Valente, S., Mai, A., Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011-2013) (2014) Expert Opin Ther Pat, 24, pp. 401-415",Article,Scopus,2-s2.0-84928533993
"Bergkvist K., Winterling J., Johansson E., Johansson U.-B., Svahn B.-M., Remberger M., Mattsson J., Larsen J.","General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care",2015,"Supportive Care in Cancer","23","5",,"1273","1283",,,10.1007/s00520-014-2476-9,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84926199811&partnerID=40&md5=6f28f22870b49a0add0969268a046457","Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska InstitutetStockholm, Sweden; Sophiahemmet UniversityStockholm, Sweden; Division of Nursing, Department of Neurobiology, Care Sciences and Society, Karolinska InstitutetStockholm, Sweden; Department of Medicine Solna, Karolinska InstitutetStockholm, Sweden; Department of Clinical Sciences and Education, Södersjukhuset, Karolinska InstitutetStockholm, Sweden; Center for Allogeneic Stem Cells Transplantation, Karolinska University Hospital HuddingeStockholm, Sweden; The Swedish Red Cross University CollegeStockholm, Sweden","Bergkvist, K., Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska InstitutetStockholm, Sweden, Sophiahemmet UniversityStockholm, Sweden; Winterling, J., Division of Nursing, Department of Neurobiology, Care Sciences and Society, Karolinska InstitutetStockholm, Sweden; Johansson, E., Division of Nursing, Department of Neurobiology, Care Sciences and Society, Karolinska InstitutetStockholm, Sweden, Department of Medicine Solna, Karolinska InstitutetStockholm, Sweden; Johansson, U.-B., Sophiahemmet UniversityStockholm, Sweden, Department of Clinical Sciences and Education, Södersjukhuset, Karolinska InstitutetStockholm, Sweden; Svahn, B.-M., Center for Allogeneic Stem Cells Transplantation, Karolinska University Hospital HuddingeStockholm, Sweden; Remberger, M., Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska InstitutetStockholm, Sweden, Center for Allogeneic Stem Cells Transplantation, Karolinska University Hospital HuddingeStockholm, Sweden; Mattsson, J., Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska InstitutetStockholm, Sweden, Center for Allogeneic Stem Cells Transplantation, Karolinska University Hospital HuddingeStockholm, Sweden; Larsen, J., Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska InstitutetStockholm, Sweden, The Swedish Red Cross University CollegeStockholm, Sweden","Purpose: Earlier studies have shown that home care during the neutropenic phase after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is medically safe, with positive outcomes. However, there have been few results on long-term outcomes after home care. The aims of this study were to compare general health, symptom occurrence, and self-efficacy in adult survivors who received either home care or hospital care during the early neutropenic phase after allo-HSCT and to investigate whether demographic or medical variables were associated with general health or symptom occurrence in this patient population. Methods: In a cross-sectional survey, 117 patients (hospital care: n = 78; home care: n = 39) rated their general health (SF-36), symptom occurrence (SFID-SCT, HADS), and self-efficacy (GSE) at a median of 5 (1–11) years post-HSCT. Results: No differences were found regarding general health, symptom occurrence, or self-efficacy between groups. The majority of patients in both hospital care (77 %) and home care (78 %) rated their general health as “good” with a median of 14 (0–36) current symptoms. Symptoms of fatigue and sexual problems were among the most common. Poor general health was associated with acute graft-versus-host disease (GVHD), low self-efficacy, and cord blood stem cells. A high symptom occurrence was associated with female gender, acute GVHD, and low self-efficacy. Conclusions: No long-term differences in general health and symptom occurrence were observed between home care and hospital care. Thus, home care is an alternative treatment method for patients who for various reasons prefer this treatment option. We therefore encourage other centers to offer home care to patients. © 2014, Springer-Verlag Berlin Heidelberg.","Allogeneic hematopoietic stem cell transplantation; General health; Home care; Hospital care; Self-efficacy; Symptom occurrence","Gyurkocza, B., Rezvani, A., Storb, R.F., Allogeneic hematopoietic cell transplantation: the state of the art (2010) Expert Rev Hematol, 3 (3), pp. 285-299. , PID: 20871781; Remberger, M., Ackefors, M., Berglund, S., Blennow, O., Dahllof, G., Dlugosz, A., Garming-Legert, K., Ringden, O., Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study (2011) Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 17 (11), pp. 1688-1697; Russell, J.A., Poon, M.C., Jones, A.R., Woodman, R.C., Ruether, B.A., Allogeneic bone-marrow transplantation without protective isolation in adults with malignant disease (1992) Lancet, 339 (8784), pp. 38-40. , COI: 1:STN:280:DyaK387gs1yktg%3D%3D, PID: 1345961; Svahn, B.M., Bjurman, B., Myrback, K.E., Aschan, J., Ringden, O., Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial (2000) Bone Marrow Transplant, 26 (10), pp. 1057-1060. , COI: 1:STN:280:DC%2BD3Mzgtlyjuw%3D%3D, PID: 11108303; Solomon, S.R., Matthews, R.H., Barreras, A.M., Bashey, A., Manion, K.L., McNatt, K., Speckhart, D., Holland, H.K., Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM (2010) Bone Marrow Transplant, 45 (3), pp. 468-475. , COI: 1:STN:280:DC%2BC3c7msl2qsQ%3D%3D, PID: 19767781; McDiarmid, S., Hutton, B., Atkins, H., Bence-Bruckler, I., Bredeson, C., Sabri, E., Huebsch, L., Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes (2010) Bone Marrow Transplant, 45 (7), pp. 1220-1226. , COI: 1:STN:280:DC%2BC3cnkvFWjtQ%3D%3D, PID: 19946343; Svahn, B.M., Ringden, O., Remberger, M., Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation (2005) Bone Marrow Transplant, 36 (6), pp. 511-516. , COI: 1:STN:280:DC%2BD2MvmslChtg%3D%3D, PID: 16025151; Ringden, O., Remberger, M., Holmberg, K., Edeskog, C., Wikstrom, M., Eriksson, B., Finnbogadottir, S., Svahn, B.M., Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease (2013) Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 19 (2), pp. 314-320; Garnett, C., Apperley, J.F., Pavlu, J., Treatment and management of graft-versus-host disease: improving response and survival (2013) Therapeutic Adv Hematol, 4 (6), pp. 366-378. , COI: 1:CAS:528:DC%2BC2cXjvFOqur0%3D; Braamse, A.M., Gerrits, M.M., van Meijel, B., Visser, O., van Oppen, P., Boenink, A.D., Cuijpers, P., Dekker, J., Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies (2012) Bone Marrow Transplant, 47 (6), pp. 757-769. , COI: 1:STN:280:DC%2BC38zksleisQ%3D%3D, PID: 21725373; Pidala, J., Anasetti, C., Jim, H., Quality of life after allogeneic hematopoietic cell transplantation (2009) Blood, 114 (1), pp. 7-19. , COI: 1:CAS:528:DC%2BD1MXhtVOkur3K, PID: 19336756; Lee, S.J., Kim, H.T., Ho, V.T., Cutler, C., Alyea, E.P., Soiffer, R.J., Antin, J.H., Quality of life associated with acute and chronic graft-versus-host disease (2006) Bone Marrow Transplant, 38 (4), pp. 305-310. , COI: 1:STN:280:DC%2BD28vlvVKkug%3D%3D, PID: 16819438; Ringden, O., Hermans, J., Labopin, M., Apperley, J., Gorin, N.C., Gratwohl, A., The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT) (1996) Leuk Lymphoma, 24 (1-2), pp. 71-79. , COI: 1:STN:280:DyaK2s3gt1Cntg%3D%3D, PID: 9049963; Majhail, N.S., Rizzo, J.D., Surviving the cure: long term followup of hematopoietic cell transplant recipients (2013) Bone Marrow Transplant, 48 (9), pp. 1145-1151. , COI: 1:STN:280:DC%2BC3s3ntVGmtA%3D%3D, PID: 23292238; Syrjala, K.L., Martin, P.J., Lee, S.J., Delivering care to long-term adult survivors of hematopoietic cell transplantation (2012) J Clin Oncol Off J Am Soc Clin Oncol, 30 (30), pp. 3746-3751; Pallua, S., Giesinger, J., Oberguggenberger, A., Kemmler, G., Nachbaur, D., Clausen, J., Kopp, M., Holzner, B., Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation (2010) Bone Marrow Transplant, 45 (10), pp. 1534-1539. , COI: 1:STN:280:DC%2BC3cfosl2jsQ%3D%3D, PID: 20228854; Hows, J.M., Passweg, J.R., Tichelli, A., Locasciulli, A., Szydlo, R., Bacigalupo, A., Jacobson, N., Socie, G., Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors (2006) Bone Marrow Transplant, 38 (12), pp. 799-805. , COI: 1:STN:280:DC%2BD28npsVOntA%3D%3D, PID: 17075568; Syrjala, K.L., Langer, S.L., Abrams, J.R., Storer, B.E., Martin, P.J., Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls (2005) J Clin Oncol Off J Am Soc Clin Oncol, 23 (27), pp. 6596-6606; Lee, S.J., Fairclough, D., Parsons, S.K., Soiffer, R.J., Fisher, D.C., Schlossman, R.L., Antin, J.H., Weeks, J.C., Recovery after stem-cell transplantation for hematologic diseases (2001) J Clin Oncol Off J Am Soc Clin Oncol, 19 (1), pp. 242-252. , COI: 1:STN:280:DC%2BD38%2Fgs1Snsw%3D%3D; Bandura, A., Social cognitive theory: an agentic perspective (2001) Annu Rev Psychol, 52, pp. 1-26. , COI: 1:STN:280:DC%2BD3MzptlaksA%3D%3D, PID: 11148297; Bandura, A., (1997) Self-efficacy: the exercise of control, , W.H Freeman and Company, Ney York:; Mystakidou, K., Tsilika, E., Parpa, E., Gogou, P., Theodorakis, P., Vlahos, L., Self-efficacy beliefs and levels of anxiety in advanced cancer patients (2010) Eur J Cancer Care, 19 (2), pp. 205-211. , COI: 1:STN:280:DC%2BC3czkvVGksw%3D%3D; Kohno, Y., Maruyama, M., Matsuoka, Y., Matsushita, T., Koeda, M., Matsushima, E., Relationship of psychological characteristics and self-efficacy in gastrointestinal cancer survivors (2010) Psycho-Oncology, 19 (1), pp. 71-76. , PID: 19204934; Bergkvist, K., Larsen, J., Johansson, U.B., Mattsson, J., Svahn, B.M., Hospital care or home care after allogeneic hematopoietic stem cell transplantation—patients’ experiences of care and support (2013) Eur J Oncol Nurs, 17 (4), pp. 389-395. , PID: 23347992; Winterling, J., Johansson, E., Wennman-Larsen, A., Petersson, L.M., Ljungman, P., Alexanderson, K., Occupational status among adult survivors following allo-SCT (2014) Bone Marrow Transplant, , PID: 24614841; Svahn, B.M., Remberger, M., Myrback, K.E., Holmberg, K., Eriksson, B., Hentschke, P., Aschan, J., Ringden, O., Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care (2002) Blood, 100 (13), pp. 4317-4324. , COI: 1:CAS:528:DC%2BD38XpsFCqs70%3D, PID: 12393737; Olsson, R., Remberger, M., Hassan, Z., Omazic, B., Mattsson, J., Ringden, O., GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplants (2010) Eur J Haematol, 84 (4), pp. 323-331. , COI: 1:CAS:528:DC%2BC3cXks1Smtr8%3D, PID: 20002156; Forslow, U., Blennow, O., LeBlanc, K., Ringden, O., Gustafsson, B., Mattsson, J., Remberger, M., Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation (2012) Eur J Haematol, 89 (3), pp. 220-227. , PID: 22765507; Petersson, L.M., Wennman-Larsen, A., Nilsson, M., Olsson, M., Alexanderson, K., Work situation and sickness absence in the initial period after breast cancer surgery (2011) Acta Oncol (Stockholm, Sweden), 50 (2), pp. 282-288; Ware, J.E., Jr., Sherbourne, C.D., The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection (1992) Medical Care, 30 (6), pp. 473-483. , PID: 1593914; Larsen, J., Nordstrom, G., Ljungman, P., Gardulf, A., Symptom occurrence, symptom intensity, and symptom distress in patients undergoing high-dose chemotherapy with stem-cell transplantation (2004) Cancer Nurs, 27 (1), pp. 55-64. , PID: 15108952; Zigmond, A.S., Snaith, R.P., The hospital anxiety and depression scale (1983) Acta Psychiatr Scand, 67 (6), pp. 361-370. , COI: 1:STN:280:DyaL3s3nvFWjug%3D%3D, PID: 6880820; Bjelland, I., Dahl, A.A., Haug, T.T., Neckelmann, D., The validity of the hospital anxiety and depression scale. An updated literature review (2002) J Psychosom Res, 52 (2), pp. 69-77. , PID: 11832252; Bland, J.M., Altman, D.G., Cronbach’s alpha (1997) BMJ, 314 (7080), p. 572. , COI: 1:STN:280:DyaK2s3gvVOktA%3D%3D, PID: 9055718; Schwarzer, R., Jerusalem, M., Generalized self-efficacy scale (1995) Measures in health psychology: a user’s portfolio. Causal and control beliefs, pp. 35-37. , Weinman J, Wright S, Johnston M, (eds), NFER-NELSON, Windsor:; Labriola, M., Lund, T., Christensen, K.B., Albertsen, K., Bultmann, U., Jensen, J.N., Villadsen, E., Does self-efficacy predict return-to-work after sickness absence? A prospective study among 930 employees with sickness absence for 3 weeks or more (2007) Work, 29 (3), pp. 233-238. , PID: 17942994; Iacobelli, S., Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation (2013) Bone Marrow Transplant, 48, pp. 1-37. , PID: 23462821; Svahn, B.M., Remberger, M., Heijbel, M., Martell, E., Wikstrom, M., Eriksson, B., Milovsavljevic, R., Ringden, O., Case–control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition (2008) Transplantation, 85 (7), pp. 1000-1007. , PID: 18408581; Bostrom, L., Ringden, O., Gratama, J.W., Jacobsen, N., Prentice, H.G., Zwaan, F.E., Nilsson, B., A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation (1990) Bone Marrow Transplant, 5 (5), pp. 321-326. , COI: 1:STN:280:DyaK3c3nsFenuw%3D%3D, PID: 2190659; Reddy, P., Ferrara, J.L., Immunobiology of acute graft-versus-host disease (2003) Blood Rev, 17 (4), pp. 187-194. , PID: 14556773; Fondell, E., Axelsson, J., Franck, K., Ploner, A., Lekander, M., Balter, K., Gaines, H., Short natural sleep is associated with higher T cell and lower NK cell activities (2011) Brain Behav Immun, 25 (7), pp. 1367-1375. , COI: 1:CAS:528:DC%2BC3MXhtF2gsLnI, PID: 21496482; Mattsson, J., Westin, S., Edlund, S., Remberger, M., Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease (2006) Bone Marrow Transplant, 38 (9), pp. 629-633. , COI: 1:STN:280:DC%2BD28nksVKrtg%3D%3D, PID: 16964269; Berglund, S., Le Blanc, K., Remberger, M., Gertow, J., Uzunel, M., Svenberg, P., Winiarski, J., Mattsson, J., Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation (2012) Transplantation, 94 (10), pp. 1066-1074. , PID: 23076550; Morishita, S., Kaida, K., Yamauchi, S., Wakasugi, T., Yoshihara, S., Taniguchi, K., Ishii, S., Domen, K., Gender differences in health-related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation (2012) Psycho-Oncology, , PID: 22736382; Hochhausen, N., Altmaier, E.M., McQuellon, R., Davies, S.M., Papadopolous, E., Carter, S., Henslee-Downey, J., Social support, optimism, and self-efficacy predict physical and emotional well-being after bone marrow transplantation (2007) J Psychosoc Oncol, 25 (1), pp. 87-101. , PID: 17360317; Hirai, K., Suzuki, Y., Tsuneto, S., Ikenaga, M., Hosaka, T., Kashiwagi, T., A structural model of the relationships among self-efficacy, psychological adjustment, and physical condition in Japanese advanced cancer patients (2002) Psycho-Oncology, 11 (3), pp. 221-229. , PID: 12112482; Khera, N., Chow, E.J., Leisenring, W.M., Syrjala, K.L., Baker, K.S., Flowers, M.E., Martin, P.J., Lee, S.J., Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors (2011) Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 17 (7), pp. 995-1003; Wong, F.L., Francisco, L., Togawa, K., Bosworth, A., Gonzales, M., Hanby, C., Sabado, M., Bhatia, S., Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns (2010) Blood, 115 (12), pp. 2508-2519. , COI: 1:CAS:528:DC%2BC3cXktlOrsro%3D, PID: 20089962; Edman, L., Larsen, J., Hagglund, H., Gardulf, A., Health-related quality of life, symptom distress and sense of coherence in adult survivors of allogeneic stem-cell transplantation (2001) Eur J Cancer Care, 10 (2), pp. 124-130. , COI: 1:STN:280:DC%2BD38%2FpvFersQ%3D%3D; Tierney, D.K., Facione, N., Padilla, G., Dodd, M., Response shift: a theoretical exploration of quality of life following hematopoietic cell transplantation (2007) Cancer Nurs, 30 (2), pp. 125-138. , PID: 17413778; Sprangers, M.A., Schwartz, C.E., Integrating response shift into health-related quality of life research: a theoretical model (1999) Soc Sci Med, 48 (11), pp. 1507-1515. , COI: 1:STN:280:DyaK1MzisFynsg%3D%3D, PID: 10400253; Gielissen, M.F., Schattenberg, A.V., Verhagen, C.A., Rinkes, M.J., Bremmers, M.E., Bleijenberg, G., Experience of severe fatigue in long-term survivors of stem cell transplantation (2007) Bone Marrow Transplant, 39 (10), pp. 595-603. , COI: 1:STN:280:DC%2BD2s3mt1Gisw%3D%3D, PID: 17369868; Hjermstad, M.J., Knobel, H., Brinch, L., Fayers, P.M., Loge, J.H., Holte, H., Kaasa, S., A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation (2004) Bone Marrow Transplant, 34 (3), pp. 257-266. , COI: 1:STN:280:DC%2BD2czlsVOksQ%3D%3D, PID: 15170167; Thygesen, K.H., Schjodt, I., Jarden, M., The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature (2012) Bone Marrow Transplant, 47 (5), pp. 716-724. , COI: 1:STN:280:DC%2BC38zlsVOgtw%3D%3D, PID: 21874054; Mosher, C.E., DuHamel, K.N., Rini, C., Corner, G., Lam, J., Redd, W.H., Quality of life concerns and depression among hematopoietic stem cell transplant survivors (2011) Support Care Cancer, 19 (9), pp. 1357-1365. , PID: 20661753; Prieto, J.M., Atala, J., Blanch, J., Carreras, E., Rovira, M., Cirera, E., Espinal, A., Gasto, C., Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation (2005) J Clin Oncol Off J Am Soc Clin Oncol, 23 (25), pp. 6063-6071; Andrykowski, M.A., Bishop, M.M., Hahn, E.A., Cella, D.F., Beaumont, J.L., Brady, M.J., Horowitz, M.M., Wingard, J.R., Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation (2005) J Clin Oncol Off J Am Soc Clin Oncol, 23 (3), pp. 599-608",Article,Scopus,2-s2.0-84926199811
"Gebara E., Udry F., Sultan S., Toni N.","Taurine increases hippocampal neurogenesis in aging mice",2015,"Stem Cell Research","14","3",,"369","379",,,10.1016/j.scr.2015.04.001,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927622884&partnerID=40&md5=bb4804cad66007de7682eee9d45dbdba","Department of Fundamental Neurosciences, University of Lausanne, 9 rue du BugnonLausanne, Switzerland","Gebara, E., Department of Fundamental Neurosciences, University of Lausanne, 9 rue du BugnonLausanne, Switzerland; Udry, F., Department of Fundamental Neurosciences, University of Lausanne, 9 rue du BugnonLausanne, Switzerland; Sultan, S., Department of Fundamental Neurosciences, University of Lausanne, 9 rue du BugnonLausanne, Switzerland; Toni, N., Department of Fundamental Neurosciences, University of Lausanne, 9 rue du BugnonLausanne, Switzerland","Aging is associated with increased inflammation and reduced hippocampal neurogenesis, which may in turn contribute to cognitive impairment. Taurine is a free amino acid found in numerous diets, with anti-inflammatory properties. Although abundant in the young brain, the decrease in taurine concentration with age may underlie reduced neurogenesis. Here, we assessed the effect of taurine on hippocampal neurogenesis in middle-aged mice. We found that taurine increased cell proliferation in the dentate gyrus through the activation of quiescent stem cells, resulting in increased number of stem cells and intermediate neural progenitors. Taurine had a direct effect on stem/progenitor cells proliferation, as observed in vitro, and also reduced activated microglia. Furthermore, taurine increased the survival of newborn neurons, resulting in a net increase in adult neurogenesis. Together, these results show that taurine increases several steps of adult neurogenesis and support a beneficial role of taurine on hippocampal neurogenesis in the context of brain aging. © 2015.",,"Altman, J., Das, G.D., Post-natal origin of microneurones in the rat brain (1965) Nature, 207, pp. 953-956; Banay-Schwartz, M., Lajtha, A., Palkovits, M., Changes with aging in the levels of amino acids in rat CNS structural elements. II. Taurine and small neutral amino acids (1989) Neurochem. Res., 14, pp. 563-570; Bella, D.L., Hirschberger, L.L., Hosokawa, Y., Stipanuk, M.H., Mechanisms involved in the regulation of key enzymes of cysteine metabolism in rat liver in vivo (1999) Am. J. Physiol., 276, pp. E326-335; Benrabh, H., Bourre, J.M., Lefauconnier, J.M., Taurine transport at the blood-brain barrier: an in vivo brain perfusion study (1995) Brain Res., 692, pp. 57-65; Bernal, G.M., Peterson, D.A., Phenotypic and gene expression modification with normal brain aging in GFAP-positive astrocytes and neural stem cells (2011) Aging Cell, 10, pp. 466-482; Bolognin, S., Buffelli, M., Puolivali, J., Iqbal, K., Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound (2014) Neurobiol. Aging, 35, pp. 2134-2146; Bonaguidi, M.A., Wheeler, M.A., Shapiro, J.S., Stadel, R.P., Sun, G.J., Ming, G.L., Song, H., In vivo clonal analysis reveals self-renewing and multipotent adult neural stem cell characteristics (2011) Cell, 145, pp. 1142-1155; Calzolari, F., Michel, J., Baumgart, E.V., Theis, F., Gotz, M., Ninkovic, J., Fast clonal expansion and limited neural stem cell self-renewal in the adult subependymal zone (2015) Nat. Neurosci., 18, pp. 490-492; Chan, C.Y., Sun, H.S., Shah, S.M., Agovic, M.S., Friedman, E., Banerjee, S.P., Modes of direct modulation by taurine of the glutamate NMDA receptor in rat cortex (2014) Eur. J. Pharmacol., 728, pp. 167-175; Chen, S.W., Kong, W.X., Zhang, Y.J., Li, Y.L., Mi, X.J., Mu, X.S., Possible anxiolytic effects of taurine in the mouse elevated plus-maze (2004) Life Sci., 75, pp. 1503-1511; Choe, K.Y., Olson, J.E., Bourque, C.W., Taurine release by astrocytes modulates osmosensitive glycine receptor tone and excitability in the adult supraoptic nucleus (2012) J. Neurosci., 32, pp. 12518-12527; Drew, M.R., Hen, R., Adult hippocampal neurogenesis as target for the treatment of depression (2007) CNS Neurol. Disord. Drug Targets, 6, pp. 205-218; El Idrissi, A., Taurine improves learning and retention in aged mice (2008) Neurosci. Lett., 436, pp. 19-22; El Idrissi, A., Messing, J., Scalia, J., Trenkner, E., Prevention of epileptic seizures by taurine (2003) Adv. Exp. Med. Biol., 526, pp. 515-525; Encinas, J.M., Sierra, A., Neural stem cell deforestation as the main force driving the age-related decline in adult hippocampal neurogenesis (2012) Behav. Brain Res., 227, pp. 433-439; Encinas, J.M., Michurina, T.V., Peunova, N., Park, J.H., Tordo, J., Peterson, D.A., Fishell, G., Enikolopov, G., Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus (2011) Cell Stem Cell, 8, pp. 566-579; Foos, T.M., Wu, J.Y., The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis (2002) Neurochem. Res., 27, pp. 21-26; Frank, M.G., Barrientos, R.M., Biedenkapp, J.C., Rudy, J.W., Watkins, L.R., Maier, S.F., MRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging (2006) Neurobiol. Aging, 27, pp. 717-722; Gebara, E., Sultan, S., Kocher-Braissant, J., Toni, N., Adult hippocampal neurogenesis inversely correlates with microglia in conditions of voluntary running and aging (2013) Front. Neurosci., 7, p. 145; Gil-Mohapel, J., Brocardo, P.S., Choquette, W., Gothard, R., Simpson, J.M., Christie, B.R., Hippocampal neurogenesis levels predict WATERMAZE search strategies in the aging brain (2013) PLoS One, 8, p. e75125; Hernandez-Benitez, R., Ramos-Mandujano, G., Pasantes-Morales, H., Taurine stimulates proliferation and promotes neurogenesis of mouse adult cultured neural stem/progenitor cells (2012) Stem Cell Res., 9, pp. 24-34; Hodge, R.D., Kowalczyk, T.D., Wolf, S.A., Encinas, J.M., Rippey, C., Enikolopov, G., Kempermann, G., Hevner, R.F., Intermediate progenitors in adult hippocampal neurogenesis: Tbr2 expression and coordinate regulation of neuronal output (2008) J. Neurosci., 28, pp. 3707-3717; Huxtable, R.J., Physiological actions of taurine (1992) Physiol. Rev., 72, pp. 101-163; Katsimpardi, L., Litterman, N.K., Schein, P.A., Miller, C.M., Loffredo, F.S., Wojtkiewicz, G.R., Chen, J.W., Rubin, L.L., Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors (2014) Science, 344, pp. 630-634; Kheirbek, M.A., Klemenhagen, K.C., Sahay, A., Hen, R., Neurogenesis and generalization: a new approach to stratify and treat anxiety disorders (2012) Nat. Neurosci., 15, pp. 1613-1620; Kim, C., Cha, Y.N., Taurine chloramine produced from taurine under inflammation provides anti-inflammatory and cytoprotective effects (2014) Amino Acids, 46, pp. 89-100; Kim, J.W., Kim, C., Inhibition of LPS-induced NO production by taurine chloramine in macrophages is mediated though Ras-ERK-NF-kappaB (2005) Biochem. Pharmacol., 70, pp. 1352-1360; Kim, H.Y., Kim, H.V., Yoon, J.H., Kang, B.R., Cho, S.M., Lee, S., Kim, J.Y., Kim, Y., Taurine in drinking water recovers learning and memory in the adult APP/PS1 mouse model of Alzheimer's disease (2014) Sci. Rep., 4, p. 7467; Kohman, R.A., Aging microglia: relevance to cognition and neural plasticity (2012) Methods Mol. Biol., 934, pp. 193-218; Kronenberg, G., Reuter, K., Steiner, B., Brandt, M.D., Jessberger, S., Yamaguchi, M., Kempermann, G., Subpopulations of proliferating cells of the adult hippocampus respond differently to physiologic neurogenic stimuli (2003) J. Comp. Neurol., 467, pp. 455-463; Kuhn, H.G., Dickinson-Anson, H., Gage, F.H., Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation (1996) J. Neurosci., 16, pp. 2027-2033; Leon, R., Wu, H., Jin, Y., Wei, J., Buddhala, C., Prentice, H., Wu, J.Y., Protective function of taurine in glutamate-induced apoptosis in cultured neurons (2009) J. Neurosci. Res., 87, pp. 1185-1194; Mathieu, P., Battista, D., Depino, A., Roca, V., Graciarena, M., Pitossi, F., The more you have, the less you get: the functional role of inflammation on neuronal differentiation of endogenous and transplanted neural stem cells in the adult brain (2010) J. Neurochem., 112, pp. 1368-1385; Menzie, J., Prentice, H., Wu, J.Y., Neuroprotective mechanisms of taurine against ischemic stroke (2013) Brain Sci., 3, pp. 877-907; Miller, T.J., Hanson, R.D., Yancey, P.H., Developmental changes in organic osmolytes in prenatal and postnatal rat tissues (2000) Comp. Biochem. Physiol. A Mol. Integr. Physiol., 125, pp. 45-56; Muth-Kohne, E., Pachernegg, S., Karus, M., Faissner, A., Hollmann, M., Expression of NMDA receptors and Ca2+-impermeable AMPA receptors requires neuronal differentiation and allows discrimination between two different types of neural stem cells (2010) Cell. Physiol. Biochem., 26, pp. 935-946; Namba, T., Maekawa, M., Yuasa, S., Kohsaka, S., Uchino, S., The Alzheimer's disease drug memantine increases the number of radial glia-like progenitor cells in adult hippocampus (2009) Glia, 57, pp. 1082-1090; Neuwirth, L.S., Volpe, N.P., El Idrissi, A., Taurine effects on emotional learning and memory in aged mice: neurochemical alterations and differentiation in auditory cued fear and context conditioning (2013) Adv. Exp. Med. Biol., 775, pp. 195-214; Palmer, T.D., Takahashi, J., Gage, F.H., The adult rat hippocampus contains primordial neural stem cells (1997) Mol. Cell. Neurosci., 8, pp. 389-404; Preissler, J., Grosche, A., Lede, V., Le Duc, D., Krugel, K., Matyash, V., Szulzewsky, F., Schulz, A., Altered microglial phagocytosis in GPR34-deficient mice (2015) Glia, 63, pp. 206-215; Ramos-Mandujano, G., Hernandez-Benitez, R., Pasantes-Morales, H., Multiple mechanisms mediate the taurine-induced proliferation of neural stem/progenitor cells from the subventricular zone of the adult mouse (2014) Stem Cell Res., 12, pp. 690-702; Ripps, H., Shen, W., Review: taurine: a ""very essential"" amino acid (2012) Mol. Vis., 18, pp. 2673-2686; Schaffer, S.W., Azuma, J., Mozaffari, M., Role of antioxidant activity of taurine in diabetes (2009) Can. J. Physiol. Pharmacol., 87, pp. 91-99; Schmidt-Hieber, C., Jonas, P., Bischofberger, J., Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus (2004) Nature, 429, pp. 184-187; Seri, B., Garcia-Verdugo, J.M., Collado-Morente, L., McEwen, B.S., Alvarez-Buylla, A., Cell types, lineage, and architecture of the germinal zone in the adult dentate gyrus (2004) J. Comp. Neurol., 478, pp. 359-378; Streit, W.J., Walter, S.A., Pennell, N.A., Reactive microgliosis (1999) Prog. Neurobiol., 57, pp. 563-581; Sturman, J.A., Moretz, R.C., French, J.H., Wisniewski, H.M., Postnatal taurine deficiency in the kitten results in a persistence of the cerebellar external granule cell layer: correction by taurine feeding (1985) J. Neurosci. Res., 13, pp. 521-528; Sultan, S., Gebara, E.G., Moullec, K., Toni, N., D-serine increases adult hippocampal neurogenesis (2013) Front. Neurosci., 7, p. 155; Sultan, S., Gebara, E., Toni, N., Doxycycline increases neurogenesis and reduces microglia in the adult hippocampus (2013) Front. Neurosci., 7, p. 131; Tashiro, A., Sandler, V.M., Toni, N., Zhao, C., Gage, F.H., NMDA-receptor-mediated, cell-specific integration of new neurons in adult dentate gyrus (2006) Nature, 442, pp. 929-933; Taupin, P., BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation (2007) Brain Res. Rev., 53, pp. 198-214; Thuret, S., Toni, N., Aigner, S., Yeo, G.W., Gage, F.H., Hippocampus-dependent learning is associated with adult neurogenesis in MRL/MpJ mice (2009) Hippocampus, 19, pp. 658-669; van Praag, H., Shubert, T., Zhao, C., Gage, F.H., Exercise enhances learning and hippocampal neurogenesis in aged mice (2005) J. Neurosci., 25, pp. 8680-8685; van Praag, H., Lucero, M.J., Yeo, G.W., Stecker, K., Heivand, N., Zhao, C., Yip, E., Gage, F.H., Plant-derived flavanol (-)epicatechin enhances angiogenesis and retention of spatial memory in mice (2007) J. Neurosci., 27, pp. 5869-5878; Walter, J., Keiner, S., Witte, O.W., Redecker, C., Age-related effects on hippocampal precursor cell subpopulations and neurogenesis (2011) Neurobiol. Aging, 32, pp. 1906-1914; Wu, J.Y., Tang, X.W., Schloss, J.V., Faiman, M.D., Regulation of taurine biosynthesis and its physiological significance in the brain (1998) Adv. Exp. Med. Biol., 442, pp. 339-345; Wu, H., Jin, Y., Wei, J., Jin, H., Sha, D., Wu, J.Y., Mode of action of taurine as a neuroprotector (2005) Brain Res., 1038, pp. 123-131; Yamaguchi, M., Saito, H., Suzuki, M., Mori, K., Visualization of neurogenesis in the central nervous system using nestin promoter-GFP transgenic mice (2000) Neuroreport, 11, pp. 1991-1996",Article,Scopus,2-s2.0-84927622884
"Matsushita T., Lankford K.L., Arroyo E.J., Sasaki M., Neyazi M., Radtke C., Kocsis J.D.","Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells",2015,"Experimental Neurology","267",,,"152","164",,,10.1016/j.expneurol.2015.03.001,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925272832&partnerID=40&md5=fef949c2509dc6e7e3d6a3311d3ad850","Department of Neurology, Yale University School of Medicine, VA Connecticut Healthcare SystemWest Haven, CT, United States; Center for Neuroscience Regeneration Research, VA Connecticut Healthcare SystemWest Haven, CT, United States; Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical UniversitySapporo, Japan; Department of Plastic, Hand And Reconstructive Surgery, Hannover Medical SchoolHannover, Germany","Matsushita, T., Department of Neurology, Yale University School of Medicine, VA Connecticut Healthcare SystemWest Haven, CT, United States, Center for Neuroscience Regeneration Research, VA Connecticut Healthcare SystemWest Haven, CT, United States, Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical UniversitySapporo, Japan; Lankford, K.L., Department of Neurology, Yale University School of Medicine, VA Connecticut Healthcare SystemWest Haven, CT, United States, Center for Neuroscience Regeneration Research, VA Connecticut Healthcare SystemWest Haven, CT, United States; Arroyo, E.J., Department of Neurology, Yale University School of Medicine, VA Connecticut Healthcare SystemWest Haven, CT, United States, Center for Neuroscience Regeneration Research, VA Connecticut Healthcare SystemWest Haven, CT, United States; Sasaki, M., Department of Neurology, Yale University School of Medicine, VA Connecticut Healthcare SystemWest Haven, CT, United States, Center for Neuroscience Regeneration Research, VA Connecticut Healthcare SystemWest Haven, CT, United States, Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical UniversitySapporo, Japan; Neyazi, M., Department of Neurology, Yale University School of Medicine, VA Connecticut Healthcare SystemWest Haven, CT, United States, Center for Neuroscience Regeneration Research, VA Connecticut Healthcare SystemWest Haven, CT, United States, Department of Plastic, Hand And Reconstructive Surgery, Hannover Medical SchoolHannover, Germany; Radtke, C., Department of Neurology, Yale University School of Medicine, VA Connecticut Healthcare SystemWest Haven, CT, United States, Center for Neuroscience Regeneration Research, VA Connecticut Healthcare SystemWest Haven, CT, United States, Department of Plastic, Hand And Reconstructive Surgery, Hannover Medical SchoolHannover, Germany; Kocsis, J.D., Department of Neurology, Yale University School of Medicine, VA Connecticut Healthcare SystemWest Haven, CT, United States, Center for Neuroscience Regeneration Research, VA Connecticut Healthcare SystemWest Haven, CT, United States","Intravenous infusion of mesenchymal stem cells (MSCs) has been shown to reduce the severity of experimental spinal cord injury (SCI), but mechanisms are not fully understood. One important consequence of SCI is damage to the microvasculature and disruption of the blood spinal cord barrier (BSCB). In the present study we induced a contusive SCI at T9 in the rat and studied the effects of intravenous MSC infusion on BSCB permeability, microvascular architecture and locomotor recovery over a 10. week period. Intravenously delivered MSCs could not be identified in the spinal cord, but distributed primarily to the lungs where they survived for a couple of days. Spatial and temporal changes in BSCB integrity were assessed by intravenous infusions of Evans blue (EvB) with in vivo and ex vivo optical imaging and spectrophotometric quantitation of EvB leakage into the parenchyma. SCI resulted in prolonged BSCB leakage that was most severe at the impact site but disseminated extensively rostral and caudal to the lesion over 6. weeks. Contused spinal cords also showed an increase in vessel size, reduced vessel number, dissociation of pericytes from microvessels and decreases in von Willebrand factor (vWF) and endothelial barrier antigen (EBA) expression. In MSC-treated rats, BSCB leakage was reduced, vWF expression was increased and locomotor function improved beginning 1 week post-MSC infusion, i.e., 2. weeks post-SCI. These results suggest that intravenously delivered MSCs have important effects on reducing BSCB leakage which could contribute to their therapeutic efficacy. © 2015.","Blood spinal cord barrier; Mesenchymal stem cell; Pericytes; Spinal cord injury","Al Ahmad, A., Taboada, C.B., Gassmann, M., Ogunshola, O.O., Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult (2011) J. Cereb. Blood Flow Metab., 31 (2), pp. 693-705; Armulik, A., Genové, G., Mäe, M., Nisancioglu, M.H., Wallgard, E., Niaudet, C., He, L., Betsholtz, C., Pericytes regulate the blood-brain barrier (2010) Nature, 468 (7323), pp. 557-561; Bartanusz, V., Jezova, D., Alajajian, B., Digicaylioglu, M., The blood-spinal cord barrier: morphology and clinical implications (2011) Ann. Neurol., 70 (2), pp. 194-206; Basso, D.M., Beattie, M.S., Bresnahan, J.C., A sensitive and reliable locomotor rating scale for open field testing in rats (1995) J. Neurotrauma, 12 (1), pp. 1-21; Beck, K.D., Nguyen, H.X., Galvan, M.D., Salazar, D.L., Woodruff, T.M., Anderson, A.J., Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment (2010) Brain, 133, pp. 433-447; Byun, J.S., Kwak, B.K., Kim, J.K., Jung, J., Ha, B.C., Park, S., Engraftment of human mesenchymal stem cells in a rat photothrombotic cerebral infarction model: comparison of intra-arterial and intravenous infusion using MRI and histological analysis (2013) J. Korean Neurosurg. Soc., 54 (6), pp. 467-476; Carmeliet, P., Collen, D., Molecular basis of angiogenesis. Role of VEGF and VE-cadherin (2000) Ann. N. Y. Acad. Sci., 902, pp. 249-262. , (discussion 262-264); Cohen, D.M., Patel, C.B., Ahobila-Vajjula, P., Sundberg, L.M., Chacko, T., Liu, S.J., Narayana, P.A., Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI (2009) NMR Biomed., 22 (3), pp. 332-341; Danchuk, S., Ylostalo, J.H., Hossain, F., Sorge, R., Ramsey, A., Bonvillain, R.W., Lasky, J.A., Sullivan, D.E., Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6 (2011) Stem Cell Res. Ther., 2 (3), p. 27; Daneman, R., Zhou, L., Kebede, A.A., Barres, B.A., Pericytes are required for blood-brain barrier integrity during embryogenesis (2010) Nature, 468 (7323), pp. 562-566; Dore-Duffy, P., Owen, C., Balabanov, R., Murphy, S., Beaumont, T., Rafols, J.A., Pericyte migration from the vascular wall in response to traumatic brain injury (2000) Microvasc. Res., 60 (1), pp. 55-69; Figley, S.A., Khosravi, R., Legasto, J.M., Tseng, Y.F., Fehlings, M.G., Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury (2014) J. Neurotrauma, 31 (6), pp. 541-552; Gao, J., Dennis, J.E., Muzic, R.F., Lundberg, M., Caplan, A.I., The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion (2001) Cells Tissues Organs, 169 (1), pp. 12-20; Ghabriel, M.N., Zhu, C., Hermanis, G., Allt, G., Immunological targeting of the endothelial barrier antigen (EBA) in vivo leads to opening of the blood-brain barrier (2000) Brain Res., 878 (1-2), pp. 127-135; Göritz, C., Dias, D.O., Tomilin, N., Barbacid, M., Shupliakov, O., Frisén, J.A., Pericyte origin of spinal cord scar tissue (2011) Science, 333 (6039), pp. 238-242; Hamilton, N.B., Attwell, D., Hall, C.N., Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease (2010) Front. Neuroenerg., 2. , (pii: 5); Hatzi, V.I., Laskaratou, D.A., Mavragani, I.V., Nikitaki, Z., Mangelis, A., Panayiotidis, M.I., Pantelias, G.E., Georgakilas, A.G., Non-targeted radiation effects in vivo: a critical glance of the future in radiobiology (2015) Cancer Lett., 356 (1), pp. 34-42; Horner, P.J., Popovich, P.G., Mullin, B.B., Stokes, B.T., A quantitative spatial analysis of the blood-spinal cord barrier. II. Permeability after intraspinal fetal transplantation (1996) Exp. Neurol., 142 (2), pp. 226-243; Kaptanoglu, E., Okutan, O., Akbiyik, F., Solaroglu, I., Kilinc, A., Beskonakli, E., Correlation of injury severity and tissue Evans blue content, lipid peroxidation and clinical evaluation in acute spinal cord injury in rats (2004) J. Clin. Neurosci., 11 (8), pp. 879-885; Kassis, I., Grigoriadis, N., Gowda-Kurkalli, B., Mizrachi-Kol, R., Ben-Hur, T., Slavin, S., Abramsky, O., Karussis, D., Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis (2008) Arch. Neurol., 65 (6), pp. 753-761; Kilkenny, C., Browne, W., Cuthill, I.C., Emerson M, Altman DG; NC3Rs Reporting Guidelines Working Group. Animal research: reporting in vivo experiments: the ARRIVE guidelines (2010) J. Gene Med., 12 (7), pp. 561-563; Kilpinen, L., Impola, U., Sankkila, L., Ritamo, I., Aatonen, M., Kilpinen, S., Tuimala, J., Laitinen, S., Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning (2013) J. Extracell Vesicles, 10, p. 2; Lai, R.C., Arslan, F., Lee, M.M., Sze, N.S., Choo, A., Chen, T.S., Salto-Tellez, M., Lim, S.K., Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury (2010) Stem Cell Res., 4 (3), pp. 214-222; Lee, R.H., Pulin, A.A., Seo, M.J., Kota, D.J., Ylostalo, J., Larson, B.L., Semprun-Prieto, L., Prockop, D.J., Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 (2009) Cell Stem Cell, 5 (1), pp. 54-63; Lemmon, V.P., Ferguson, A.R., Popovich, P.G., Xu, X.M., Snow, D.M., Igarashi, M., Beattie, C.E., Bixby, J.L., Minimum information about a spinal cord injury experiment: a proposed reporting standard for spinal cord injury experiments (2014) J. Neurotrauma, 31 (15), pp. 1354-1361. , MIASCI Consortium; Lin, B., Ginsberg, M.D., Quantitative assessment of the normal cerebral microvasculature by endothelial barrier antigen (EBA) immunohistochemistry: application to focal cerebral ischemia (2000) Brain Res., 865 (2), pp. 237-244; Matthes, S.M., Reimers, K., Janssen, I., Liebsch, C., Kocsis, J.D., Vogt, P.M., Radtke, C., Intravenous transplantation of mesenchymal stromal cells to enhance peripheral nerve regeneration (2013) Biomed. Res. Int., p. 573169; Nakano, N., Nakai, Y., Seo, T.B., Homma, T., Yamada, Y., Ohta, M., Suzuki, Y., Ide, C., Effects of bone marrow stromal cell transplantation through CSF on the subacute and chronic spinal cord injury in rats (2013) PLoS One, 8 (9), p. e73494; Noble, L.J., Wrathall, J.R., Distribution and time course of protein extravasation in the rat spinal cord after contusive injury (1989) Brain Res., 482, pp. 57-66; Noubade, R., del Rio, R., McElvany, B., Zachary, J.F., Millward, J.M., Wagner, D.D., Offner, H., Teuscher, C., Von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis (2008) Am. J. Pathol., 173 (3), pp. 892-900; Ohshima, M., Taguchi, A., Tsuda, H., Sato, Y., Yamahara, K., Harada-Shiba, M., Miyazato, M., Tsuji, M., Intraperitoneal and intravenous deliveries are not comparable in terms of drug efficacy and cell distribution in neonatal mice with hypoxia-ischemia (2015) Brain Dev., 37 (4), pp. 376-386; Osaka, M., Honmou, O., Murakami, T., Nonaka, T., Houkin, K., Hamada, H., Kocsis, J.D., Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome (2010) Brain Res., 1343, pp. 226-235; Popovich, P.G., Horner, P.J., Mullin, B.B., Stokes, B.T., A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury (1996) Exp. Neurol., 142 (2), pp. 258-275; Quertainmont, R., Cantinieaux, D., Botman, O., Sid, S., Schoenen, J., Franzen, R., Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions (2012) PLoS One, 7 (6), p. e39500; Randi, A.M., Laffan, M.A., Starke, R.D., Von Willebrand factor, angiodysplasia and angiogenesis (2013) Mediterr. J. Hematol. Infect. Dis., 5 (1), p. e2013060; Rastogi, S., Boylan, M., Wright, E.G., Coates, P.J., Interactions of apoptotic cells with macrophages in radiation-induced bystander signaling (2013) Radiat. Res., 179 (2), pp. 135-145; Roddy, G.W., Oh, J.Y., Lee, R.H., Bartosh, T.J., Ylostalo, J., Coble, K., Rosa, R.H., Prockop, D.J., Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6 (2011) Stem Cells, 29 (10), pp. 1572-1579; Rosenstein, J.M., Krum, J.M., Sternberger, L.A., Pulley, M.T., Sternberger, N.H., Immunocytochemical expression of the endothelial barrier antigen (EBA) during brain angiogenesis (1992) Brain Res. Dev. Brain Res., 66 (1), pp. 47-54; Ryan, L.A., Smith, R.W., Seymour, C.B., Mothersill, C.E., Dilution of irradiated cell conditioned medium and the bystander effect (2008) Radiat. Res., 169 (2), pp. 188-196; Sasaki, M., Radtke, C., Tan, A.M., Zhao, P., Hamada, H., Houkin, K., Honmou, O., Kocsis, J.D., BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury (2009) J. Neurosci., 29 (47), pp. 14932-14941; Starke, R.D., Ferraro, F., Paschalaki, K.E., Dryden, N.H., McKinnon, T.A., Sutton, R.E., Payne, E.M., Randi, A.M., Endothelial von Willebrand factor regulates angiogenesis (2011) Blood, 117 (3), pp. 1071-1080; Suidan, G.L., Brill, A., De Meyer, S.F., Voorhees, J.R., Cifuni, S.M., Cabral, J.E., Wagner, D.D., Endothelial Von Willebrand factor promotes blood-brain barrier flexibility and provides protection from hypoxia and seizures in mice (2013) Arterioscler. Thromb. Vasc. Biol., 33 (9), pp. 2112-2120; Toyama, K., Honmou, O., Harada, K., Suzuki, J., Houkin, K., Hamada, H., Kocsis, J.D., Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia (2009) Exp. Neurol., 216 (1), pp. 47-55; Wang, N., Li, Q., Zhang, L., Lin, H., Hu, J., Li, D., Shi, S., Chen, X., Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6 (2012) PLoS One, 7 (8), p. e43768; Whetstone, W.D., Hsu, J.Y., Eisenberg, M., Werb, Z., Noble-Haeusslein, L.J., Blood-spinal cord barrier after spinal cord injury: relation to revascularization and wound healing (2003) J. Neurosci. Res., 74 (2), pp. 227-239; Winkler, E.A., Bell, R.D., Zlokovic, B.V., Central nervous system pericytes in health and disease (2011) Nat. Neurosci., 14 (11), pp. 1398-1405; Xin, H., Li, Y., Buller, B., Katakowski, M., Zhang, Y., Wang, X., Shang, X., Chopp, M., Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth (2012) Stem Cells, 30 (7), pp. 1556-1564; Xin, H., Li, Y., Liu, Z., Wang, X., Shang, X., Cui, Y., Zhang, Z.G., Chopp, M., MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles (2013) Stem Cells, 31 (12), pp. 2737-2746; Yilmaz, G., Vital, S., Yilmaz, C.E., Stokes, K.Y., Alexander, J.S., Granger, D.N., Selectin-mediated recruitment of bone marrow stromal cells in the postischemic cerebral microvasculature (2011) Stroke, 42 (3), pp. 806-811",Article,Scopus,2-s2.0-84925272832
"Nayal B., Vasudevan G., Rao A.C.K., Kudva R., Valliathan M., Mathew M., Rao L.","Primary small cell carcinoma of the esophagus – An eight year retrospective study",2015,"Journal of Clinical and Diagnostic Research","9","5",,"EC04","EC06",,,10.7860/JCDR/2015/12464.5927,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928984231&partnerID=40&md5=4a16ffc4347420d8c2c43d8d3be92980","Department of Pathology, Kasturba Medical College, Manipal UniversityManipal, Karnataka, India","Nayal, B., Department of Pathology, Kasturba Medical College, Manipal UniversityManipal, Karnataka, India; Vasudevan, G., Department of Pathology, Kasturba Medical College, Manipal UniversityManipal, Karnataka, India; Rao, A.C.K., Department of Pathology, Kasturba Medical College, Manipal UniversityManipal, Karnataka, India; Kudva, R., Department of Pathology, Kasturba Medical College, Manipal UniversityManipal, Karnataka, India; Valliathan, M., Department of Pathology, Kasturba Medical College, Manipal UniversityManipal, Karnataka, India; Mathew, M., Department of Pathology, Kasturba Medical College, Manipal UniversityManipal, Karnataka, India; Rao, L., Department of Pathology, Kasturba Medical College, Manipal UniversityManipal, Karnataka, India","Introduction: Primary small cell carcinoma of the esophagus is a rare and aggressive tumor. Patients present with metastatic disease and have a poor clinical outcome. The objective of the study was to correlate clinical and histopathological features of primary small cell carcinoma of the esophagus diagnosed and treated at our hospital. Materials and Methods: A retrospective study of 11 patients diagnosed with primary small cell carcinoma of the esophagus in Kasturba Hospital, Manipal between 2006 and 2014 was done. The histopathological and immunohistochemical features were correlated with clinical and endoscopic findings. Results: Eleven patients were diagnosed to have small cell carcinoma of esophagus with a male preponderance. Common presenting symptoms were dysphagia and weight loss. Majority of the patients showed mid esophageal ulceroproliferative growth. Biopsy findings were consistent with the characteristic morphology of small cell carcinoma and demonstrated immunoreactivity to neuroendocrine markers. In addition, few cases also showed adjacent squamous dysplasia/carcinoma. Most of the patients presented with metastatic disease, liver being the most common site. These patients were treated by chemotherapy and radiotherapy. Conclusion: Esophageal small cell carcinomas are aggressive tumors with high rates of distant metastasis. Presence of squamous dysplasia /squamous cell carcinoma in the adjacent mucosa supports the hypothesis that this neoplasm arise from pleuripotent stem cells. Presence of the latter is also useful to rule out spread from lung primary. © 2015, Journal of Clinical and Diagnostic Research. All rights reserved.","Neuroendocrine markers; Pleuripotent stem cell; Squamous dysplasia","Chen, W.W., Wang, F., Zhang, D.S., Luo, H.Y., Wang, Z.Q., Wang, F.H., Primary small cell carcinoma of the esophagus: Clinicopathological study of 44 cases (2014) BMC Cancer, 14, p. 222; Lv, J., Liang, J., Wang, J., Wang, L., He, J., Xiao, Z., Primary small cell carcinoma of the esophagus (2008) J Thorac Oncol, 3 (12), pp. 1460-1465; Wu, Z., Ma, J.Y., Yang, J.J., Zhao, Y.F., Zhang, S.F., Primary small cell carcinoma of esophagus: Report of 9 cases and review of literature (2004) World J Gastroenterol, 10 (24), pp. 3680-3682; Briggs, J.C., Ibrahim, N.B., Oat cell carcinomas of the oesophagus: A clinico-pathological study of 23 cases (1983) Histopathology, 7 (2), pp. 261-277; Nevárez, A., Saftoiu, A., Bhutani, M.S., Primary Small Cell Carcinoma of the Esophagus: Clinico- pathological Features and Therapeutic Options (2011) Curr Health Sci J, 37 (1), pp. 31-34. , Epub 2011 Mar 21; Pantvaidya, G.H., Pramesh, C.S., Deshpande, M.S., Jambhekar, N.A., Sharma, S., Deshpande, R.K., Small cell carcinoma of the esophagus: The Tata Memorial Hospital experience (2002) Ann Thorac Surg, 74 (6), pp. 1924-1927; Madroszyk, A., Egreteau, J., Martin, L., Queneau, P.E., Bosset, J.F., Merrouche, Y., Small-cell carcinoma of the esophagus: Report of three cases and review of the literature with emphasis on therapy (2001) Ann Oncol, 12 (9), pp. 1321-1325; Law, S.Y., Fok, M., Lam, K.Y., Loke, S.L., Ma, L.T., Wong, J., Small cell carcinoma of the esophagus (1994) Cancer, 73, pp. 2894-2899; Casas, F., Ferrer, F., Farrús, B., Casals, J., Biete, A., Primary small cell carcinoma of the esophagus: A review of the literature with emphasis on therapy and prognosis (1997) Cancer, 80 (8), pp. 1366-1372; Markogiannakis, H., Theodorou, D., Toutouzas, K.G., Larentzakis, A., Pattas, M., Bousiotou, A., Small cell carcinoma arising in Barrett's esophagus: A case report and review of the literature (2008) J Med Case Rep, 2, p. 15; Yun, J.P., Zhang, M.F., Hou, J.H., Tian, Q.H., Fu, J., Liang, X.M., Primary small cell carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 21 cases (2007) BMC Cancer, 7, p. 38; Shimoda, T., Koizumi, W., Tanabe, S., Higuchi, K., Sasaki, T., Nakayama, N., Small-cell carcinoma of the esophagus associated with a paraneoplastic neurological syndrome: A case report documenting a complete response (2006) Jpn J Clin Oncol, 36 (2), pp. 109-112; Eccles, D.M., Allan, S.G., Sang, C.T., Cornbleet, M.A., Small cell carcinoma of the oesophagus: Report of three cases and review of published cases (1989) Thorax, 44 (9), pp. 749-750; Medgyesy, C.D., Wolff, R.A., Putnam, J.B., Jr., Ajani, J.A., Small cell carcinoma of the esophagus: The University of Texas M. D. Anderson Cancer Center experience and literature review (2000) Cancer, 88, pp. 262-267",Article,Scopus,2-s2.0-84928984231
"Cominelli M., Grisanti S., Mazzoleni S., Branca C., Buttolo L., Furlan D., Liserre B., Bonetti M.F., Medicina D., Pellegrini V., Buglione M., Liserre R., Pellegatta S., Finocchiaro G., Dalerba P., Facchetti F., Pizzi M., Galli R., Poliani P.L.","EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide",2015,"Journal of the National Cancer Institute","107","5",,"","",,,10.1093/jnci/djv041,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928423267&partnerID=40&md5=94f678b5ac01334c0de63c6ffc25f7f9","Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP)","Cominelli, M., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Grisanti, S., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Mazzoleni, S., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Branca, C., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Buttolo, L., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Furlan, D., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Liserre, B., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Bonetti, M.F., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Medicina, D., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pellegrini, V., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Buglione, M., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Liserre, R., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pellegatta, S., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Finocchiaro, G., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Dalerba, P., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Facchetti, F., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Pizzi, M., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Galli, R., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP); Poliani, P.L., Pathology (MC, BL, MFB, DM, VP, FF, PLP) and Pharmacology Units (CB, MP), Department of Molecular and Translational Medicine, University of Brescia and National Institute of Neuroscience, Italy; Medical Oncology (SG), Neurosurgery (LB), Radiation Oncology (MB), and Neuroradiology Departments (RL), Spedali Civili of Brescia, University of Brescia, Italy; Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute, Milan (SM, RG); Pathology Unit, Department of Surgical and Morphological Sciences, University of Insubria, Italy (DF); Neurological Institute Besta, Milan, Italy (SP, GF); Herbert Irving Comprehensive Cancer Center, Department of Pathology & Cell Biology and Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY (PD); IRCCS San Camillo Hospital, Venice, Italy (MP)","BACKGROUND: Lack of robust predictive biomarkers, other than MGMT promoter methylation, makes temozolomide responsiveness in newly diagnosed glioblastoma (GBM) patients difficult to predict. However, we identified patients with long-term survival (≥35 months) within a group of newly diagnosed GBM patients treated with standard or metronomic adjuvant temozolomide schedules. We thus investigated possible molecular profiles associated with longer survival following temozolomide treatment.METHODS: We investigated the association of molecular features with progression-free (PFS) and overall survival (OS). Human-derived GBM cancer stem cells (CSCs) were used to investigate in vitro molecular mechanisms associated with temozolomide responsiveness. Surgically removed recurrences allowed investigation of molecular changes occurring during therapy in vivo. Statistical analyses included one- and two-way analysis of variance, Student's t test, Cox proportional hazards, and the Kaplan-Meier method. All statistical tests were two-sided.RESULTS: No association was found between survival and gene classifiers associated with different molecular GBM subtypes in the standard-treated group, while in metronomic-treated patients robust association was found between EGFR amplification/overexpression and PFS and OS (OS, EGFR-high vs low: hazard ratiodeath = 0.22, 95% confidence interval = 0.09 to 0.55, P = .001). The result for OS remained statistically significant after Bonferroni correction (P interaction < .0005). Long-term survival following metronomic temozolomide was independent from MGMT and EGFRvIII status and was more pronounced in EGFR-overexpressing GBM patients with PTEN loss. In vitro findings confirmed a selective dose- and time-dependent decrease in survival of temozolomide-treated EGFR+ human-derived glioblastoma CSCs, which occurred through inhibition of NF-κB transcriptional activity. In addition, reduction in EGFR-amplified cells, along with a statistically significant decrease in NF-κB/p65 expression, were observed in specimens from recurrent metronomic-treated EGFR-overexpressing GBM patients.CONCLUSIONS: EGFR-amplified/overexpressing glioblastomas strongly benefit from metronomic temozolomide-based therapies. © The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.",,,Article,Scopus,2-s2.0-84928423267
"Nishikawa M., Mori H., Hara M.","Reduced zinc cytotoxicity following differentiation of neural stem/progenitor cells into neurons and glial cells is associated with upregulation of metallothioneins",2015,"Environmental Toxicology and Pharmacology","39","3",,"1170","1176",,,10.1016/j.etap.2015.04.009,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928743877&partnerID=40&md5=40d412b0129a9c71ab4e65cd31b865c9","Department of Biological Science, Graduate School of Science, Osaka Prefecture University, 1-2 Gakuen-cho, Naka-kuSakai, Osaka, Japan","Nishikawa, M., Department of Biological Science, Graduate School of Science, Osaka Prefecture University, 1-2 Gakuen-cho, Naka-kuSakai, Osaka, Japan; Mori, H., Department of Biological Science, Graduate School of Science, Osaka Prefecture University, 1-2 Gakuen-cho, Naka-kuSakai, Osaka, Japan; Hara, M., Department of Biological Science, Graduate School of Science, Osaka Prefecture University, 1-2 Gakuen-cho, Naka-kuSakai, Osaka, Japan","We investigated zinc cytotoxicity in mouse neural stem/progenitor cells (NSPCs) and their differentiated progeny (neuronal/glial cells) in correlation with expression of metallothionein (MT) gene. Differentiated cells were less sensitive than NSPCs to ZnCl<inf>2</inf> (IC<inf>50</inf>: 128μM vs. 76μM). Differentiation of immature NSPCs to the differentiated cells led to an increase in expression of MT family genes (Mt1, Mt2, Mt3, and Mt4). Zinc exposure induced a dose-dependent increase in expression level of Mt1 and that of Mt2 in both NSPCs and the differentiated cells. Our results showed that the reduced cytotoxicity of zinc associated with differentiation from NSPCs into their progeny was related to the upregulation of MTs. © 2015 Elsevier B.V.","Astrocyte; Differentiation; Metallothionein; Neural stem cells; Zinc, Cytotoxicity","Acarin, L., González, B., Hidalgo, J., Castro, A.J., Castellano, B., Primary cortical glial reaction versus secondary thalamic glial response in the excitotoxically injured young brain: astroglial response and metallothionein expression (1999) Neuroscience, 92, pp. 827-839; Bitanihirwe, B.K., Cunningham, M.G., Zinc: the brain's dark horse (2009) Synapse, 63, pp. 1029-1049; Carpenè, E., Andreani, G., Isani, G., Metallothionein functions and structural characteristics (2007) J. Trace Elem. Med. Biol., 21, pp. 35-39; Choudhuri, S., Liu, W.L., Berman, N.E.J., Klaassen, C.D., Cadmium accumulation and metallothionein expression in brain of mice at different stages of development (1996) Toxicol. Lett., 84, pp. 127-133; Chung, R.S., Penkowa, M., Dittmann, J., King, C.E., Bartlett, C., Asmussen, J.W., Hidalgo, J., West, A.K., Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury (2008) J. Biol. Chem., 283, pp. 15349-15358; Colvin, R.A., Bush, A.I., Volitakis, I., Fontaine, C.P., Thomas, D., Kikuchi, K., Holmes, W.R., Insights into Zn2+ homeostasis in neurons from experimental and modeling studies (2008) Am. J. Physiol. Cell Physiol., 294, pp. C726-C742; Garrett, S.H., Phillips, V., Somji, S., Sens, M.A., Dutta, R., Park, S., Kim, D., Sens, D.A., Transient induction of metallothionein isoform 3 (MT-3), c-fos, c-jun and c-myc in human proximal tubule cells exposed to cadmium (2002) Toxicol. Lett., 126, pp. 69-80; Guérout, N., Li, X., Barnabé-Heider, F., Cell fate control in the developing central nervous system (2014) Exp. Cell. Res., 321, pp. 77-83; Haase, H., Beyersmann, D., Uptake and intracellular distribution of labile and total Zn(II) in C6 rat glioma cells investigated with fluorescent probes and atomic absorption (1999) Biometals, 12, pp. 247-254; Hoey, J.G., Garrett, S.H., Sens, M.A., Todd, J.H., Sens, D.A., Expression of MT-3 mRNA in human kidney, proximal tubule cell cultures, and renal cell carcinoma (1997) Toxicol. Lett., 92, pp. 149-160; Keen, C.L., Taubeneck, M.W., Zidenberg-Cherr, S., Daston, G.P., Rogers, J.M., Toxicant exposure and trace element metabolism in pregnancy (1997) Environ. Toxicol. Pharmacol., 4, pp. 301-308; Mori, H., Hara, M., Cultured stem cells as tools for toxicological assays (2013) J. Biosci. Bioeng., 116, pp. 647-652; Mori, H., Yoshida, Y., Hara, M., Neural stem/progenitor cells damaged by reactive oxygen species evolved in photosensitizing reaction (2011) Neurosci. Lett., 493, pp. 24-28; Palmiter, R.D., Findley, S.D., Whitmore, T.E., Durnam, D.M., MT-III, a brain-specific member of the metallothionein gene family (1992) Proc. Natl. Acad. Sci. U.S.A., 89, pp. 6333-6337; Pavlica, S., Gaunitz, F., Gebhardt, R., Comparative in vitro toxicity of seven zinc-salts towards neuronal PC12 cells (2009) Toxicol. In Vitro, 23, pp. 653-659; Quaife, C.J., Findley, S.D., Erickson, J.C., Froelick, G.J., Kelly, E.J., Zambrowicz, B.P., Palmiter, R.D., Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia (1994) Biochemistry, 33, pp. 7250-7259; Radtke, F., Heuchel, R., Georgiev, O., Hergersberg, M., Gariglio, M., Dembic, Z., Schaffner, W., Cloned transcription factor MTF-1 activates the mouse metallothionein I promoter (1993) EMBO J., 12, pp. 1355-1362; Reynolds, B.A., Tetzlaff, W., Weiss, S., A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes (1992) J. Neurosci., 12, pp. 4565-4574; Schmittgen, T.D., Livak, K.J., Analyzing real-time PCR data by the comparative Ct method (2008) Nat. Protoc., 3, pp. 1101-1108; Semple, B.D., Blomgren, K., Gimlin, K., Ferriero, D.M., Noble-Haeusslein, L.L., Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species (2013) Prog. Neurobiol., pp. 1-16; Shuttleworth, C.W., Weiss, J.H., Zinc: new clues to diverse roles in brain ischemia (2011) Trends Pharmacol. Sci., 32, pp. 480-486; Szewczyk, B., Zinc homeostasis and neurodegenerative disorders (2013) Front. Aging Neurosci., 5, p. 33; Yeiser, E.C., Fitch, C.A., Horning, M.S., Rutkoski, N., Levenson, C.W., Regulation of metallothionein-3 mRNA by thyroid hormone in developing rat brain and primary cultured of rat astrocytes and neurons (1999) Develop. Brain Res., 115, pp. 195-200; Vasák, M., Advances in metallothionein structure and functions (2005) J. Trace Elem. Med. Biol., 19, pp. 13-17",Article,Scopus,2-s2.0-84928743877
"Yaqubi M., Mohammadnia A., Fallahi H.","Predicting involvement of polycomb repressive complex 2 in direct conversion of mouse fibroblasts into induced neural stem cells",2015,"Stem Cell Research and Therapy","6","1", 42,"","",,,10.1186/s13287-015-0045-x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84927928793&partnerID=40&md5=e1ffb80d8c1ee08d6cf99dd2519b17d1","Department of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB)Tehran, Iran; Department of Molecular Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB)Tehran, Iran; Department of Biology, School of Science, Razi UniversityKermanshah, Iran; Medical Biology Research Center, Kermanshah University of Medical SciencesKermanshah, Iran","Yaqubi, M., Department of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB)Tehran, Iran; Mohammadnia, A., Department of Molecular Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB)Tehran, Iran; Fallahi, H., Department of Biology, School of Science, Razi UniversityKermanshah, Iran, Medical Biology Research Center, Kermanshah University of Medical SciencesKermanshah, Iran","Introduction: Mouse fibroblasts could be directly converted into induced neural stem cells (iNSCs), by introducing a set of known transcription factors (TFs). This process, known as direct reprogramming, is an alternative source of NSCs production for cell therapy applications, hence, more common sources for such cells including embryonic stem cell (ESCs) and induced pluripotent stem cell (iPSCs) are also in use. Despite their importance, the exact role of different TFs involved in the conversion of fibroblasts into iNSCs and the interactions between these factors has not been studied. Methods: Here, we have used available microarray data to construct a gene regulatory network to understand the dynamic of regulatory interactions during this conversion. We have implemented other types of data such as information regarding TFs binding sites and valid protein-protein interactions to improve the network reliability. The network contained 1857 differentially expressed (DE) genes, linked by11054 interactions. The most important TFs identified based on topology analysis of the network. Furthermore, in selecting such TFs, we have also considered their role in the regulation of nervous system development. Results: Based on these analyses, we found that Ezh2, Jarid2, Mtf2, Nanog, Pou5f1, Sall4, Smarca4, Sox2, Suz12, and Tcf3 are the main regulators of direct conversion of mouse fibroblasts into iNSCs. Because, members of the polycomb repressive complex 2 (PRC2) were present in the most effective TFs' list, we have concluded that this complex is one of the major factors in this conversion. Additionally, gene expression profiling of iNSCs, obtained from a different data sets, showed that Sox2 and Ezh2 are two main regulators of the direct reprogramming process. Conclusions: Our results provide an insight into molecular events that occur during direct reprogramming of fibroblasts into iNSCs. This information could be useful in simplifying the production of iNSCs, by reducing the number of required factors, for use in regenerative medicine. © 2015 Yaqubi et al.; licensee BioMed Central.",,"Pera, M.F., Stem cells: The dark side of induced pluripotency (2011) Nature, 471, pp. 46-47. , 1:CAS:528:DC%2BC3MXis1CrsLs%3D 21368819; Matsui, T., Takano, M., Yoshida, K., Ono, S., Fujisaki, C., Matsuzaki, Y., Neural stem cells directly differentiated from partially reprogrammed fibroblasts rapidly acquire gliogenic competency (2012) Stem Cells, 30, pp. 1109-1119. , 1:CAS:528:DC%2BC38XhtVWjsLvO 22467474; Thier, M., Wörsdörfer, P., Lakes, Y.B., Gorris, R., Herms, S., Opitz, T., Direct conversion of fibroblasts into stably expandable neural stem cells (2012) Cell Stem Cell, 10, pp. 473-479. , 1:CAS:528:DC%2BC38XksFenurc%3D 22445518; Han, D.W., Tapia, N., Hermann, A., Hemmer, K., Höing, S., Araúzo-Bravo, M.J., Direct reprogramming of fibroblasts into neural stem cells by defined factors (2012) Cell Stem Cell, 10, pp. 465-472. , 1:CAS:528:DC%2BC38XksFenu74%3D 22445517; Ring, K.L., Tong, L.M., Balestra, M.E., Javier, R., Andrews-Zwilling, Y., Li, G., Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor (2012) Cell Stem Cell, 11, pp. 100-109. , 3399516 1:CAS:528:DC%2BC38Xot12ms7c%3D 22683203; Lujan, E., Chanda, S., Ahlenius, H., Südhof, T.C., Wernig, M., Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells (2012) Proc Natl Acad Sci U S A, 109, pp. 2527-2532. , 3289376 1:CAS:528:DC%2BC38XivVKntb0%3D 22308465; Kim, J., Efe, J.A., Zhu, S., Talantova, M., Yuan, X., Wang, S., Direct reprogramming of mouse fibroblasts to neural progenitors (2011) Proc Natl Acad Sci U S A, 108, pp. 7838-7843. , 3093517 1:CAS:528:DC%2BC3MXmsVSktLs%3D 21521790; Kim, S.M., Flaßkamp, H., Hermann, A., Araúzo-Bravo, M.J., Lee, S.C., Lee, S.H., Direct conversion of mouse fibroblasts into induced neural stem cells (2014) Nat Protoc, 9, pp. 871-881. , 1:CAS:528:DC%2BC2cXmtVKkur4%3D 24651499; Zhu, S., Ambasudhan, R., Sun, W., Kim, H.J., Talantova, M., Wang, X., Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells (2014) Cell Res, 24, pp. 126-129. , 3879704 1:CAS:528:DC%2BC3sXhvFCqtbjM 24296783; Sheng, C., Zheng, Q., Wu, J., Xu, Z., Wang, L., Li, W., Direct reprogramming of sertoli cells into multipotent neural stem cells by defined factors (2012) Cell Res, 22, pp. 208-218. , 3351918 1:CAS:528:DC%2BC38Xks1Cisg%3D%3D 22064700; Corti, S., Nizzardo, M., Simone, C., Falcone, M., Donadoni, C., Salani, S., Direct reprogramming of human astrocytes into neural stem cells and neurons (2012) Exp Cell Res, 318, pp. 1528-1541. , 3405531 1:CAS:528:DC%2BC38XlsFGis70%3D 22426197; Qiang, L., Fujita, R., Yamashita, T., Angulo, S., Rhinn, H., Rhee, D., Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons (2011) Cell, 146, pp. 359-371. , 3151530 1:CAS:528:DC%2BC3MXpvFGhs7Y%3D 21816272; Kim, J., Su Susan, C., Wang, H., Cheng Albert, W., Cassady John, P., Lodato Michael, A., Functional integration of dopaminergic neurons directly converted from mouse fibroblasts (2011) Cell Stem Cell, 9, pp. 413-419. , 3210333 1:CAS:528:DC%2BC3MXhsVarsb3P 22019014; Son, E.Y., Ichida, J.K., Wainger, B.J., Toma, J.S., Rafuse, V.F., Woolf, C.J., Conversion of mouse and human fibroblasts into functional spinal motor neurons (2011) Cell Stem Cell, 9, pp. 205-218. , 3188987 1:CAS:528:DC%2BC3MXhtFeks7nF 21852222; Pfisterer, U., Kirkeby, A., Torper, O., Wood, J., Nelander, J., Dufour, A., Direct conversion of human fibroblasts to dopaminergic neurons (2011) Proc Natl Acad Sci U S A, 108, pp. 10343-10348. , 3121829 1:CAS:528:DC%2BC3MXotF2qtLw%3D 21646515; Pang, Z.P., Yang, N., Vierbuchen, T., Ostermeier, A., Fuentes, D.R., Yang, T.Q., Induction of human neuronal cells by defined transcription factors (2011) Nature, 476, pp. 220-223. , 3159048 1:CAS:528:DC%2BC3MXhtVOkurzN 21617644; Caiazzo, M., Dell'Anno, M.T., Dvoretskova, E., Lazarevic, D., Taverna, S., Leo, D., Direct generation of functional dopaminergic neurons from mouse and human fibroblasts (2011) Nature, 476, pp. 224-227. , 1:CAS:528:DC%2BC3MXotlCms7w%3D 21725324; Yoo, A.S., Sun, A.X., Li, L., Shcheglovitov, A., Portmann, T., Li, Y., MicroRNA-mediated conversion of human fibroblasts to neurons (2011) Nature, 476, pp. 228-231. , 3348862 1:CAS:528:DC%2BC3MXoslymtr4%3D 21753754; Ambasudhan, R., Talantova, M., Coleman, R., Yuan, X., Zhu, S., Lipton Stuart, A., Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions (2011) Cell Stem Cell, 9, pp. 113-118. , 1:CAS:528:DC%2BC3MXpvFGitrs%3D 21802386; Zhou, Q., Tripathi, P., How to remake a fibroblast into a neural stem cell (2012) Cell Stem Cell, 10, pp. 347-348. , 1:CAS:528:DC%2BC38XlsFGju70%3D 22482497; Crespo, I., Del Sol, A., A general strategy for cellular reprogramming: The importance of transcription factor cross-repression (2013) Stem Cells, 31, pp. 2127-2135. , 23873656; Crespo, I., Perumal, T., Jurkowski, W., Del Sol, A., Detecting cellular reprogramming determinants by differential stability analysis of gene regulatory networks (2013) BMC Syst Biol, 7, p. 140. , 3878265 24350678; Zhou, Q., Chipperfield, H., Melton, D.A., Wong, W.H., A gene regulatory network in mouse embryonic stem cells (2007) Proc Natl Acad Sci U S A, 104, pp. 16438-16443. , 2034259 1:CAS:528:DC%2BD2sXht1Wju7%2FJ 17940043; Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J., Scherf, U., Exploration, normalization, and summaries of high density oligonucleotide array probe level data (2003) Biostatistics, 4, pp. 249-264. , 12925520; Blazejczyk, M., Miron, M., Nadon, R., FlexArray (2007) A Statistical Data Analysis Software for Gene Expression Microarrays, , http://www.gqinnovationcenter.com/services/bioinformatics/flexarray/index.aspx?l=e, Genome Quebec, Montreal, Canada; Microarray Technical Documentation, Annotation Files, , http://www.affymetrix.com, Affymetrix; Deng, T., Zhu, Z.I., Zhang, S., Leng, F., Cherukuri, S., Hansen, L., HMGN1 modulates nucleosome occupancy and DNase i hypersensitivity at the CpG island promoters of embryonic stem cells (2013) Mol Cell Biol, 33, pp. 3377-3389. , 3753902 1:CAS:528:DC%2BC3sXht1arurjF 23775126; Kim, J.B., Sebastiano, V., Wu, G., Araúzo-Bravo, M.J., Sasse, P., Gentile, L., Oct4-induced pluripotency in adult neural stem cells (2009) Cell, 136, pp. 411-419. , 1:CAS:528:DC%2BD1MXltFSnsr4%3D 19203577; Cahoy, J.D., Emery, B., Kaushal, A., Foo, L.C., Zamanian, J.L., Christopherson, K.S., A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function (2008) J Neurosci, 28, pp. 264-278. , 1:CAS:528:DC%2BD1cXmtV2ltw%3D%3D 18171944; Huang, D.W., Sherman, B.T., Lempicki, R.A., Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists (2009) Nucleic Acids Res, 37, pp. 1-13. , 2615629; Huang, D.W., Sherman, B.T., Lempicki, R.A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources (2008) Nat Protoc, 4, pp. 44-57; Lachmann, A., Xu, H., Krishnan, J., Berger, S.I., Mazloom, A.R., Ma'Ayan, A., ChEA: Transcription factor regulation inferred from integrating genome-wide ChIP-X experiments (2010) Bioinformatics, 26, pp. 2438-2444. , 2944209 1:CAS:528:DC%2BC3cXht1WhtLnO 20709693; Stark, C., Breitkreutz, B.J., Reguly, T., Boucher, L., Breitkreutz, A., Tyers, M., BioGRID: A general repository for interaction datasets (2006) Nucleic Acids Res, 34, pp. 535-539. , 1347471 1:CAS:528:DC%2BD28XisFyhsA%3D%3D 16381927; Saito, R., Smoot, M.E., Ono, K., Ruscheinski, J., Wang, P.L., Lotia, S., A travel guide to Cytoscape plugins (2012) Nat Meth, 9, pp. 1069-1076. , 1:CAS:528:DC%2BC38Xhs1ajtLzI; Bindea, G., Mlecnik, B., Hackl, H., Charoentong, P., Tosolini, M., Kirilovsky, A., ClueGO: A cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks (2009) Bioinformatics, 25, pp. 1091-1093. , 2666812 1:CAS:528:DC%2BD1MXksVeiu74%3D 19237447; Bindea, G., Galon, J., Mlecnik, B., CluePedia cytoscape plugin: Pathway insights using integrated experimental and in silico data (2013) Bioinformatics, 29, pp. 661-663. , 3582273 1:CAS:528:DC%2BC3sXjtlGgsbY%3D 23325622; Wernicke, S., Rasche, F., FANMOD: A tool for fast network motif detection (2006) Bioinformatics, 22, pp. 1152-1153. , 1:CAS:528:DC%2BD28XjslKrsbs%3D 16455747; Wernicke, S., Efficient detection of network motifs (2006) IEEE/ACM Trans Comput Biol Bioinformatics, 3, pp. 347-359; Scardoni, G., Petterlini, M., Laudanna, C., Analyzing biological network parameters with CentiScaPe (2009) Bioinformatics, 25, pp. 2857-2859. , 2781755 1:CAS:528:DC%2BD1MXhtlWls7nL 19729372; Bader, G., Hogue, C., An automated method for finding molecular complexes in large protein interaction networks (2003) BMC Bioinformatics, 4, p. 2. , 149346 12525261; Ideker, T., Ozier, O., Schwikowski, B., Siegel, A.F., Discovering regulatory and signalling circuits in molecular interaction networks (2002) Bioinformatics, 18, pp. 233-240. , 12169552; Sher, F., Boddeke, E., Olah, M., Copray, S., Dynamic changes in Ezh2 gene occupancy underlie its involvement in neural stem cell self-renewal and differentiation towards oligodendrocytes (2012) PLoS One, 7, p. 40399. , 3395718 1:CAS:528:DC%2BC38XhtVOnsLfE 22808153; Sher, F., Rößler, R., Brouwer, N., Balasubramaniyan, V., Boddeke, E., Copray, S., Differentiation of neural stem cells into oligodendrocytes: Involvement of the polycomb group protein Ezh2 (2008) Stem Cells, 26, pp. 2875-2883. , 1:CAS:528:DC%2BD1MXmsF2q 18687996; Sher, F., Boddeke, E., Copray, S., Ezh2 expression in astrocytes induces their dedifferentiation toward neural stem cells (2010) Cell Reprogram, 13, pp. 1-6. , 20979531; Bracken, A.P., Dietrich, N., Pasini, D., Hansen, K.H., Helin, K., Genome-wide mapping of polycomb target genes unravels their roles in cell fate transitions (2006) Genes Dev, 20, pp. 1123-1136. , 1472472 1:CAS:528:DC%2BD28XkslCjsbs%3D 16618801; Pasini, D., Bracken, A.P., Hansen, J.B., Capillo, M., Helin, K., The polycomb group protein Suz12 is required for embryonic stem cell differentiation (2007) Mol Cell Biol, 27, pp. 3769-3779. , 1899991 1:CAS:528:DC%2BD2sXltlant7w%3D 17339329; Walker, E., Chang, W.Y., Hunkapiller, J., Cagney, G., Garcha, K., Torchia, J., Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation (2010) Cell Stem Cell, 6, pp. 153-166. , 2849004 1:CAS:528:DC%2BC3cXlt1Knu7s%3D 20144788; Walker, E., Manias, J.L., Chang, W.Y., Stanford, W.L., PCL2 modulates gene regulatory networks controlling self-renewal and commitment in embryonic stem cells (2011) Cell Cycle, 10, pp. 45-51. , 3048073 1:CAS:528:DC%2BC3MXit1KrtLw%3D 21193838; Shen, X., Kim, W., Fujiwara, Y., Simon, M.D., Liu, Y., Mysliwiec, M.R., Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells (2009) Cell, 139, pp. 1303-1314. , 2810107 20064376; Li, G., Margueron, R., Ku, M., Chambon, P., Bernstein, B.E., Reinberg, D., Jarid2 and PRC2, partners in regulating gene expression (2010) Genes Dev, 24, pp. 368-380. , 2816736 20123894; Graham, V., Khudyakov, J., Ellis, P., Pevny, L., SOX2 functions to maintain neural progenitor identity (2003) Neuron, 39, pp. 749-765. , 1:CAS:528:DC%2BD3sXnt1Wku78%3D 12948443; Pevny, L.H., Nicolis, S.K., Sox2 roles in neural stem cells (2010) Int J Biochem Cell Biol, 42, pp. 421-424. , 1:CAS:528:DC%2BC3cXit1Omtr4%3D 19733254; Young, R.A., Control of the embryonic stem cell state (2011) Cell, 144, pp. 940-954. , 3099475 1:CAS:528:DC%2BC3MXjsFCrtrw%3D 21414485; Yeo, J.C., Ng, H.H., Transcriptomic analysis of pluripotent stem cells: Insights into health and disease (2011) Genome Med, 3, pp. 1-12; Lim, C.Y., Tam, W.L., Zhang, J., Ang, H.S., Jia, H., Lipovich, L., Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages (2008) Cell Stem Cell, 3, pp. 543-554. , 1:CAS:528:DC%2BD1cXhsVaqs7%2FP 18804426; Böhm, J., Buck, A., Borozdin, W., Mannan, A.U., Matysiak-Scholze, U., Adham, I., Sall1, Sall2, and Sall4 are required for neural tube closure in mice (2008) Am J Pathol, 173, pp. 1455-1463. , 2570135 18818376; Mitchell, R.R., Szabo, E., Benoit, Y.D., Case, D.T., Mechael, R., Alamilla, J., Activation of neural cell fate programs toward direct conversion of adult human fibroblasts into tri-potent neural progenitors using OCT-4 (2014) Stem Cells Dev, 23, pp. 1937-1946. , 1:CAS:528:DC%2BC2cXht1KrtL%2FK 24694094; Matsumoto, S., Banine, F., Struve, J., Xing, R., Adams, C., Liu, Y., Brg1 is required for murine neural stem cell maintenance and gliogenesis (2006) Dev Biol, 289, pp. 372-383. , 1:CAS:528:DC%2BD28XksVGqtw%3D%3D 16330018; Cole, M.F., Johnstone, S.E., Newman, J.J., Kagey, M.H., Young, R.A., Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells (2008) Genes Dev, 22, pp. 746-755. , 2275428 1:CAS:528:DC%2BD1cXjvFeqsrc%3D 18347094; Pereira, L., Yi, F., Merrill, B.J., Repression of nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal (2006) Mol Cell Biol, 26, pp. 7479-7491. , 1636872 1:CAS:528:DC%2BD28XhtFCgur3O 16894029; Kim, H.S., Dorsky, R.I., Tcf7l1 is required for spinal cord progenitor maintenance (2011) Dev Dyn, 240, pp. 2256-2264. , 3177105 1:CAS:528:DC%2BC3MXhtF2jsbvO 21932308",Article,Scopus,2-s2.0-84927928793
"Nichols N.L., Vinit S., Bauernschmidt L., Mitchell G.S.","Respiratory function after selective respiratory motor neuron death from intrapleural CTB-saporin injections",2015,"Experimental Neurology","267",,,"18","29",,,10.1016/j.expneurol.2014.11.011,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84924266505&partnerID=40&md5=bff655601bca2fa28d5f56a968e3195e","Department of Comparative Biosciences, University of Wisconsin, 2015 Linden Dr.Madison, WI, United States","Nichols, N.L., Department of Comparative Biosciences, University of Wisconsin, 2015 Linden Dr.Madison, WI, United States; Vinit, S., Department of Comparative Biosciences, University of Wisconsin, 2015 Linden Dr.Madison, WI, United States; Bauernschmidt, L., Department of Comparative Biosciences, University of Wisconsin, 2015 Linden Dr.Madison, WI, United States; Mitchell, G.S., Department of Comparative Biosciences, University of Wisconsin, 2015 Linden Dr.Madison, WI, United States","Amyotrophic lateral sclerosis (ALS) causes progressive motor neuron degeneration, paralysis and death by ventilatory failure. In rodent ALS models: 1) breathing capacity is preserved until late in disease progression despite major respiratory motor neuron death, suggesting unknown forms of compensatory respiratory plasticity; and 2) spinal microglia become activated in association with motor neuron cell death. Here, we report a novel experimental model to study the impact of respiratory motor neuron death on compensatory responses without many complications attendant to spontaneous motor neuron disease. In specific, we used intrapleural injections of cholera toxin B fragment conjugated to saporin (CTB. -SAP) to selectively kill motor neurons with access to the pleural space. Motor neuron survival, CD11b labeling (microglia), ventilatory capacity and phrenic motor output were assessed in rats 3-28. days after intrapleural injections of: 1) CTB-SAP (25 and 50. μg), or 2) unconjugated CTB and SAP (i.e. control; (CTB. +. SAP). CTB-SAP elicited dose-dependent phrenic and intercostal motor neuron death; 7. days post-25. μg CTB-SAP, motor neuron survival approximated that in end-stage ALS rats (phrenic: 36 ± 7%; intercostal: 56 ± 10% of controls; n = 9; p. <. 0.05). CTB-SAP caused minimal cell death in other brainstem or spinal cord regions. CTB-SAP: 1) increased CD11b fractional area in the phrenic motor nucleus, indicating microglial activation; 2) decreased breathing during maximal chemoreceptor stimulation; and 3) diminished phrenic motor output in anesthetized rats (7. days post-25 μg, CTB-SAP: 0.3 ± 0.07. V; CTB + SAP: 1.5 ± 0.3; n = 9; p < 0.05). Intrapleural CTB-SAP represents a novel, inducible model of respiratory motor neuron death and provides an opportunity to study compensation for respiratory motor neuron loss. © 2014 Elsevier Inc.","Breathing; Intercostal; Motor neuron death; Neurodegenerative disease; Phrenic; Spinal cord","Aravamudan, B., Mantilla, C.B., Zhan, W.Z., Sieck, G.C., Denervation effects on myonuclear domain size of rat diaphragm fibers (2006) J. Appl. Physiol., 100 (5), pp. 1617-1622; Bach, K.B., Mitchell, G.S., Hypoxia-induced long-term facilitation of respiratory activity is serotonin dependent (1996) Respir. Physiol., 104, pp. 251-260; Bennett, J.A., Goodchild, C.S., Kidd, C., McWilliam, P.N., The location and characteristics of sympathetic preganglionic neurones in the lower thoracic spinal cord of dog and cat (1986) Q. J. Exp. Physiol., 71 (1), pp. 79-92; Boulenguez, P., Gestreau, C., Vinit, S., Stamegna, J.C., Kastner, A., Gauthier, P., Specific and artifactual labeling in the rat spinal cord and medulla after injection of monosynaptic retrograde tracers into the diaphragm (2007) Neurosci. Lett., 417 (2), pp. 206-211; Bryant, T.H., Yoshida, S., de Castro, D., Lipski, J., Expiratory neurons of the Bötzinger Complex in the rat: a morphological study following intracellular labeling with biocytin (1993) J. Comp. Neurol., 335 (2), pp. 267-282; Colton, C.A., Heterogeneity of microglial activation in the innate immune response in the brain (2009) J. NeuroImmune Pharmacol., 4 (4), pp. 399-418; Dale, E.A., Ben Mabrouk, F., Mitchell, G.S., Unexpected benefits of intermittent hypoxia: enhanced respiratory and nonrespiratory motor function (2014) Physiology, 29 (1), pp. 39-48; David, S., Kroner, A., Repertoire of microglial and macrophage responses after spinal cord injury (2011) Nat. Rev. Neurosci., 12 (7), pp. 388-399; de Carvalho, M., Matias, T., Coelho, F., Evangelista, T., Pinto, A., Luis, M.L., Motor neuron disease presenting with respiratory failure (1996) J. Neurol. Sci., 139, pp. 117-122; Dehkordi, O., Kc, P., Balan, K.V., Haxhiu, M.A., Airway-related vagal preganglionic neurons express multiple nicotinic acetylcholine receptor subunits (2006) Auton. Neurosci., 128 (1-2), pp. 53-63; Drorbaugh, J.E., Fenn, W.O., A barometric method for measuring ventilation in newborn infants (1955) Pediatrics, 16, pp. 81-87; Feldman, J.L., McCrimmon, D.R., Mitchell, G.S., Del Negro, C., Generation of respiratory rhythm in mammals (2009) Encyclopedia of Neuroscience, pp. 463-470. , Academic Press, Oxford, L.R. Squire (Ed.); Ferrazzano, P., Chanana, V., Uluc, K., Fidan, E., Akture, E., Kintner, D.B., Cengiz, P., Sun, D., Age-dependent microglial activation in immature brains after hypoxia-ischemia (2013) CNS Neurol. Disord. Drug Targets, 12 (3), pp. 338-349; Fontan, J.J., Diec, C.T., Velloff, C.R., Bilateral distribution of vagal motor and sensory nerve fibers in the rat's lungs and airways (2000) Am. J. Physiol. Regul. Integr. Comp. Physiol., 279 (2), pp. R713-R728; Grélot, L., Barillot, J.C., Bianchi, A.L., Central distributions of the efferent and afferent components of the pharyngeal branches of the vagus and glossopharyngeal nerves: an HRP study in the cat (1989) Exp. Brain Res., 78 (2), pp. 327-335; Hadziefendic, S., Haxhiu, M.A., CNS innervation of vagal preganglionic neurons controlling peripheral airways: a transneuronal labeling study using pseudorabies virus (1999) J. Auton. Nerv. Syst., 76 (2-3), pp. 135-145; Hanisch, U.K., Kettenmann, H., Microglia: active sensor and versatile effector cells in the normal and pathologic brain (2007) Nat. Neurosci., 10 (11), pp. 1387-1394; Haxhiu, M.A., Jansen, A.S., Cherniack, N.S., Loewy, A.D., CNS innervation of airway-related parasympathetic preganglionic neurons: a transneuronal labeling study using pseudorabies virus (1993) Brain Res., 618 (1), pp. 115-134; Hayes, H.B., Jayaraman, A., Herrmann, M., Mitchell, G.S., Rymer, W.Z., Trumbower, R.D., Daily intermittent hypoxia enhances walking after chronic spinal cord injury: a randomized trial (2014) Neurology, 82 (2), pp. 104-113; Hoffman, M.S., Nichols, N.L., MacFarlane, P.M., Mitchell, G.S., Phrenic long-term facilitation after acute intermittent hypoxia requires spinal ERK activation but not TrkB synthesis (2012) J. Appl. Physiol., 113 (8), pp. 1184-1193; Huxtable, A.G., Vinit, S., Windelborn, J.A., Crader, S.M., Guenther, C.H., Watters, J.J., Mitchell, G.S., Systemic inflammation impairs respiratory chemoreflexes and plasticity (2011) Respir. Physiol. Neurobiol., 178 (3), pp. 482-489; Huxtable, A.G., Smith, S.M., Vinit, S., Watters, J.J., Mitchell, G.S., Systemic LPS induces inflammatory gene expression and impairs phrenic long-term facilitation following acute intermittent hypoxia (2013) J. Appl. Physiol., 114 (7), pp. 879-887; Jacky, J.P., A plethysmograph for long-term measurements of ventilation in unrestrained animals (1978) J. Appl. Physiol., 45 (4), pp. 644-647; Kalia, M., Brain stem localization of vagal preganglionic neurons (1981) J. Auton. Nerv. Syst., 3 (2-4), pp. 451-481; Kalia, M., Sullivan, J.M., Brainstem projections of sensory and motor components of the vagus nerve in the rat (1982) J. Comp. Neurol., 211 (3), pp. 248-265; Levine, S., Nguyen, T., Taylor, N., Friscia, M.E., Budak, M.T., Rothenberg, P., Zhu, J., Shrager, J.B., Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans (2008) N. Engl. J. Med., 358 (13), pp. 1327-1335; Levine, S., Bashir, M.H., Clanton, T.L., Powers, S.K., Singhal, S., COPD elicits remodeling of the diaphragm and vastus lateralis muscles in humans (2013) J. Appl. Physiol., 114 (9), pp. 1235-1245; Lian, T., Ho, R.J., Cholera toxin B-mediated targeting of lipid vesicles containing ganglioside GM1 to mucosal epithelial cells (1997) Pharm. Res., 14 (10), pp. 1309-1315; Ling, E.A., Wong, W.C., The origin and nature of ramified and amoeboid microglia: a historical review and current concepts (1993) Glia, 7, pp. 9-18; Ling, E.A., Kaur, L.C., Yick, T.Y., Wong, W.C., Immunocytochemical localization of CR3 complement receptors with OX-42 in amoeboid microglia in postnatal rats (1990) Anat. Embryol., 182, pp. 481-486; Llado, J., Haenggeli, C., Pardo, A., Wong, V., Benson, L., Coccia, C., Rothstein, J.D., Maragakis, N.J., Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS (2006) Neurobiol. Dis., 21, pp. 110-118; Llewellyn-Smith, I.J., Martin, C.L., Arnolda, L.F., Minson, J.B., Retrogradely transported CTB saporin kills sympathetic preganglionic neurons (1999) Neuroreport, 10 (2), pp. 307-312; Llewellyn-Smith, I.J., Martin, C.L., Arnolda, L.F., Minson, J.B., Tracer-toxins: cholera toxin B saporin as a model (2000) J. Neurosci. Methods, 103 (1), pp. 83-90; Lovett-Barr, M.R., Satriotomo, I., Muir, G., Wilkerson, J.E.R., Hoffman, M.S., Vinit, S., Mitchell, G.S., Repetitive intermittent hypoxia induces respiratory and somatic motor recovery following chronic cervical spinal injury (2012) J. Neurosci., 32 (11), pp. 3591-3600; Lujan, H.L., Palani, G., Peduzzi, J.D., DiCarlo, S.E., Targeted ablation of mesenteric projecting sympathetic neurons reduces the hemodynamic response to pain in conscious, spinal cord-transected rats (2010) Am. J. Physiol. Regul. Integr. Comp. Physiol., 298 (5), pp. R1358-R1365; Mantilla, C.B., Sieck, G.C., Neuromuscular adaptations to respiratory muscle inactivity (2009) Respir. Physiol. Neurobiol., 169 (2), pp. 133-140; Mantilla, C.B., Sieck, G.C., Impact of diaphragm muscle fiber atrophy on neuromotor control (2013) Respir. Physiol. Neurobiol., 189 (2), pp. 411-418; Mantilla, C.B., Rowley, K.L., Zhan, W.Z., Fahim, M.A., Sieck, G.C., Synaptic vesicle pools at diaphragm neuromuscular junctions vary with motoneuron soma, not axon terminal, inactivity (2007) Neuroscience, 146 (1), pp. 178-189; Mantilla, C.B., Zhan, W.Z., Sieck, G.C., Retrograde labeling of phrenic motoneurons by intrapleural injection (2009) J. Neurosci. Methods, 182 (2), pp. 244-249; Mantilla, C.B., Greising, S.M., Zhan, W.Z., Seven, Y.B., Sieck, G.C., Prolonged C2 spinal hemisection-induced inactivity reduces diaphragm muscle specific force with modest, selective atrophy of type IIx and/or IIb fibers (2013) J. Appl. Physiol., 114, pp. 380-386; McCrimmon, D.R., Mitchell, G.S., Feldman, J.L., Alheid, G.F., Respiration: Network control (2009) Encyclopedia of Neuroscience, pp. 79-89. , Academic Press, Oxford, L.R. Squire (Ed.); Mitchell, G.S., McCrimmon, D.R., Feldman, J.L., Baker-Herman, T.L., Respiration (2009) Encyclopedia of Neuroscience, pp. 121-130. , Academic Press, Oxford, L.R. Squire (Ed.); Navarrete-Opazo, A.A., Mitchell, G.S., Recruitment and plasticity in diaphragm, intercostal and abdominal muscles in unanesthezised rats (2014) J. Appl. Physiol., 117 (2), pp. 180-188; Nichols, N.L., Dale, E.A., Mitchell, G.S., Severe acute intermittent hypoxia elicits phrenic long-term facilitation by a novel adenosine-dependent mechanism (2012) J. Appl. Physiol., 112 (10), pp. 1678-1688; Nichols, N.L., Gowing, G., Satriotomo, I., Nashold, L.J., Dale, E.A., Suzuki, M., Avalos, P., Mitchell, G.S., Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis (2013) Am. J. Respir. Crit. Care Med., 187 (5), pp. 535-542; Nichols, N.L., Van Dyke, J., Nashold, L., Satriotomo, I., Suzuki, M., Mitchell, G.S., Ventilatory control in ALS (2013) Respir. Physiol. Neurobiol., 189 (2), pp. 429-437; Nikodemova, M., Small, A.L., Smith, S.M., Mitchell, G.S., Watters, J.J., Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats (2013) Neurobiol. Dis., , (pii: S0969-9961(13)00321-5); Onimaru, H., Arata, A., Homma, I., Localization of respiratory rhythm-generating neurons in the medulla of brainstem-spinal cord preparations from newborn rats (1987) Neurosci. Lett., 78 (2), pp. 151-155; Perrin, J., Crousillat, J., Splanchnic afferent input to the lateral reticular nucleus of the cat (1983) J. Auton. Nerv. Syst., 8 (4), pp. 383-393; Powers, S.K., Kavazis, A.N., Levine, S., Prolonged mechanical ventilation alters diaphragmatic structure and function (2009) Crit. Care Med., 37 (10 Suppl), pp. S347-S353; Robinson, A.P., White, T.M., Mason, D.W., Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3 (1986) Immunology, 57, pp. 239-247; Roy, A., Fung, Y.K., Liu, X., Pahan, K., Up-regulation of microglial CD11b expression by nitric oxide (2006) J. Biol. Chem., 281, pp. 14971-14980; Sherrey, J.H., Megirian, D., After phrenicotomy the rat alters the output of the remaining respiratory muscles without changing its sleep-waking pattern (1990) Respir. Physiol., 81 (2), pp. 213-225; Shi, Y., Chanana, V., Watters, J.J., Ferrazzano, P., Sun, D., Role of sodium/hydrogen exchanger isoform 1 in microglial activation and proinflammatory responses in ischemic brains (2011) J. Neurochem., 119 (1), pp. 124-135; Sieck, G.C., Physiological effects of diaphragm muscle denervation and disuse (1994) Clin. Chest Med., 15, pp. 641-659; Smith, J.C., Ellenberger, H.H., Ballanyi, K., Richter, D.W., Feldman, J.L., Pre-Bötzinger complex: a brainstem region that may generate respiratory rhythm in mammals (1991) Science, 254, pp. 726-729; Smith, J.C., Abdala, A.P., Rybak, I.A., Paton, J.F., Structural and functional architecture of respiratory networks in the mammalian brainstem (2009) Philos. Trans. R. Soc. Lond. B Biol. Sci., 364 (1529), pp. 2577-2587; Trumbower, R.D., Jayaraman, A., Mitchell, G.S., Rymer, W.Z., Exposure to acute intermittent hypoxia augments somatic motor function in humans with incomplete spinal cord injury. Neurorehabil (2012) Neural Repair, 26, pp. 163-172; Vinit, S., Windelborn, J.A., Mitchell, G.S., Lipopolysaccharide attenuates phrenic long-term facilitation following acute intermittent hypoxia (2011) Respir. Physiol. Neurobiol., 176 (3), pp. 130-135; Watson, C., Paxinos, G., Kayalioglu, G., (2009) The Spinal Cord: A Christopher and Dana Reeve Foundation Text and Atlas, , Academic Press, London; Windelborn, J.A., Mitchell, G.S., Glial activation in the spinal ventral horn caudal to cervical injury (2012) Respir. Physiol. Neurobiol., 180 (1), pp. 61-68; Zaidi, S.I., Jafri, A., Doggett, T., Haxhiu, M.A., Airway-related vagal preganglionic neurons express brain-derived neurotrophic factor and TrkB receptors: implications for neuronal plasticity (2005) Brain Res., 1044 (2), pp. 133-143",Article,Scopus,2-s2.0-84924266505
"Fowler J.R., Lavasani M., Huard J., Goitz R.J.","Biologic strategies to improve nerve regeneration after peripheral nerve Repair",2015,"Journal of Reconstructive Microsurgery","31","4",,"243","248",,,10.1055/s-0034-1394091,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928537456&partnerID=40&md5=8eb0fbbdf88e34d768bec06a1e5b0e26","Department of Orthopaedics, University of PittsburghPittsburgha, PA, United States; Stem Cell Research Center, University of PittsburghPittsburgh, PA, United States","Fowler, J.R., Department of Orthopaedics, University of PittsburghPittsburgha, PA, United States; Lavasani, M., Stem Cell Research Center, University of PittsburghPittsburgh, PA, United States; Huard, J., Stem Cell Research Center, University of PittsburghPittsburgh, PA, United States; Goitz, R.J., Department of Orthopaedics, University of PittsburghPittsburgha, PA, United States","Background Peripheral nerve injuries remain a challenging problem for microsurgeons. Direct repair is the gold standard, but often the surgeon is left with a gap that prevents tension-free repair. The use of empty tubes/conduits/allograft has resulted in regeneration of some sensory and motor function, but the results remain suboptimal compared with autograft. However, the use of nerve autograft has associated donor site morbidity and limited availability. Methods A review of the literature was performed to determine current biologic strategies to improve nerve regeneration after nerve repair. Results Nerve conduits, various neurotrophic factors, and stem cells are currently being studied as alternatives to the use of nerve autograft. Conclusions Sensory and motor recovery after peripheral nerve regeneration remains suboptimal, especially in cases where primary nerve repair is not possible. Current strategies to augment nerve regeneration have focused on modulating the presence and activity of Schwann cells, either through direct implantation or by stimulating stem cells to differentiate toward Schwann cells, and through the use of neurotrophic factors to enhance the speed and quality of axon growth. Clinical studies will be necessary to determine the benefit of these strategies. © 2015 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY.","nerve repair; Schwann cells; stem cells","Berrocal, Y.A., Almeida, V.W., Gupta, R., Levi, A.D., Transplantation of Schwann cells in a collagen tube for the repair of large, segmental peripheral nerve defects in rats (2013) J Neurosurg, 119 (3), pp. 720-732; Griffin, J.W., Hogan, M.V., Chhabra, A.B., Deal, D.N., Peripheral nerve repair and reconstruction (2013) J Bone Joint Surg Am, 95 (23), pp. 2144-2151; Boeckstyns, M.E., Sorensen, A.I., Viñeta, J.F., Collagen conduit versus microsurgical neurorrhaphy: 2-year follow-up of a prospective, blinded clinical and electrophysiological multicenter randomized, controlled trial (2013) J Hand Surg Am, 38 (12), pp. 2405-2411; Brooks, D.N., Weber, R.V., Chao, J.D., Processed nerve allografts for peripheral nerve reconstruction: A multicenter study of utilization and outcomes in sensory, mixed, and motor nerve reconstructions (2012) Microsurgery, 32 (1), pp. 1-14; Bushnell, B.D., McWilliams, A.D., Whitener, G.B., Messer, T.M., Early clinical experience with collagen nerve tubes in digital nerve repair (2008) J Hand Surg Am, 33 (7), pp. 1081-1087; Dienstknecht, T., Klein, S., Vykoukal, J., Type i collagen nerve conduits for median nerve repairs in the forearm (2013) J Hand Surg Am, 38 (6), pp. 1119-1124; Karabekmez, F.E., Duymaz, A., Moran, S.L., Early clinical outcomes with the use of decellularized nerve allograft for repair of sensory defects within the hand (2009) Hand (NY), 4 (3), pp. 245-249; Taras, J.S., Amin, N., Patel, N., McCabe, L.A., Allograft reconstruction for digital nerve loss (2013) J Hand Surg Am, 38 (10), pp. 1965-1971; Weber, R.A., Breidenbach, W.C., Brown, R.E., Jabaley, M.E., Mass, D.P., A randomized prospective study of polyglycolic acid conduits for digital nerve reconstruction in humans (2000) Plast Reconstr Surg, 106 (5), pp. 1036-1045. , discussion 1046-1048; Di Summa, P.G., Kalbermatten, D.F., Pralong, E., Raffoul, W., Kingham, P.J., Terenghi, G., Long-term in vivo regeneration of peripheral nerves through bioengineered nerve grafts (2011) Neuroscience, 181, pp. 278-291; Best, T.J., Mackinnon, S.E., Midha, R., Hunter, D.A., Evans, P.J., Revascularization of peripheral nerve autografts and allografts (1999) Plast Reconstr Surg, 104 (1), pp. 152-160; Dellon, A.L., Mackinnon, S.E., An alternative to the classical nerve graft for the management of the short nerve gap (1988) Plast Reconstr Surg, 82 (5), pp. 849-856; Konofaos, P., Ver Halen, J.P., Nerve repair by means of tubulization: Past, present, future (2013) J Reconstr Microsurg, 29 (3), pp. 149-164; Lohmeyer, J.A., Kern, Y., Schmauss, D., Prospective clinical study on digital nerve repair with collagen nerve conduits and review of literature (2014) J Reconstr Microsurg, 30 (4), pp. 227-234; Mackinnon, S.E., Dellon, A.L., Clinical nerve reconstruction with a bioabsorbable polyglycolic acid tube (1990) Plast Reconstr Surg, 85 (3), pp. 419-424; Battiston, B., Geuna, S., Ferrero, M., Tos, P., Nerve repair by means of tubulization: Literature review and personal clinical experience comparing biological and synthetic conduits for sensory nerve repair (2005) Microsurgery, 25 (4), pp. 258-267; Haug, A., Bartels, A., Kotas, J., Kunesch, E., Sensory recovery 1 (2013) J Hand Surg Am, 38 (1), pp. 90-97. , year after bridging digital nerve defects with collagen tubes; Rinker, B., Liau, J.Y., A prospective randomized study comparing woven polyglycolic acid and autogenous vein conduits for reconstruction of digital nerve gaps (2011) J Hand Surg Am, 36 (5), pp. 775-781; Konofaos, P., Terzis, J.K., FK506 and nerve regeneration: Past, present, and future (2013) J Reconstr Microsurg, 29 (3), pp. 141-148; Gold, B.G., Katoh, K., Storm-Dickerson, T., The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve (1995) J Neurosci, 15 (11), pp. 7509-7516; Lee, M., Doolabh, V.B., Mackinnon, S.E., Jost, S., FK506 promotes functional recovery in crushed rat sciatic nerve (2000) Muscle Nerve, 23 (4), pp. 633-640; Büttemeyer, R., Rao, U., Jones, N.F., Peripheral nerve allograft transplantation with FK506: Functional, histological, and immunological results before and after discontinuation of immunosuppression (1995) Ann Plast Surg, 35 (4), pp. 396-401; Navarro, X., Udina, E., Ceballos, D., Gold, B.G., Effects of FK506 on nerve regeneration and reinnervation after graft or tube repair of long nerve gaps (2001) Muscle Nerve, 24 (7), pp. 905-915; Doolabh, V.B., Mackinnon, S.E., FK506 accelerates functional recovery following nerve grafting in a rat model (1999) Plast Reconstr Surg, 103 (7), pp. 1928-1936; Udina, E., Ceballos, D., Gold, B.G., Navarro, X., FK506 enhances reinnervation by regeneration and by collateral sprouting of peripheral nerve fibers (2003) Exp Neurol, 183 (1), pp. 220-231; Mohammadi, R., Masoumi-Verki, M., Ahsan, S., Khaleghjoo, A., Amini, K., Improvement of peripheral nerve defects using a silicone conduit filled with hepatocyte growth factor (2013) Oral Surg Oral Med Oral Pathol Oral Radiol, 116 (6), pp. 673-679; Li, Z., Peng, J., Wang, G., Effects of local release of hepatocyte growth factor on peripheral nerve regeneration in acellular nerve grafts (2008) Exp Neurol, 214 (1), pp. 47-54; Mohammadi, R., Yadegarazadi, M.J., Amini, K., Peripheral nerve regeneration following transection injury to rat sciatic nerve by local application of adrenocorticotropic hormone (2014) J Craniomaxillofac Surg, 42 (6), pp. 784-789; Mohammadi, R., Ahsan, S., Masoumi, M., Amini, K., Vascular endothelial growth factor promotes peripheral nerve regeneration after sciatic nerve transection in rat (2013) Chin J Traumatol, 16 (6), pp. 323-329; Mohammadi, R., Amini, K., Yousefi, A., Abdollahi-Pirbazari, M., Local effect of celecoxib on peripheral nerve repair combined with silicone tubulization in rat (2013) Chin J Traumatol, 16 (5), pp. 265-271; Mohammadi, R., Azad-Tirgan, M., Amini, K., Dexamethasone topically accelerates peripheral nerve repair and target organ reinnervation: A transected sciatic nerve model in rat (2013) Injury, 44 (4), pp. 565-569; Mohammadi, R., Esmaeil-Sani, Z., Amini, K., Effect of local administration of insulin-like growth factor i combined with inside-out artery graft on peripheral nerve regeneration (2013) Injury, 44 (10), pp. 1295-1301; Emel, E., Ergün, S.S., Kotan, D., Effects of insulin-like growth factor-I and platelet-rich plasma on sciatic nerve crush injury in a rat model (2011) J Neurosurg, 114 (2), pp. 522-528; Lichtenfels, M., Colomé, L., Sebben, A.D., Braga-Silva, J., Effect of Platelet Rich Plasma and Platelet Rich Fibrin on sciatic nerve regeneration in a rat model (2013) Microsurgery, 33 (5), pp. 383-390; Piskin, A., Kaplan, S., Aktas̈, A., Platelet gel does not improve peripheral nerve regeneration: An electrophysiological, stereological, and electron microscopic study (2009) Microsurgery, 29 (2), pp. 144-153; Sabongi, R.G., De Rizzo, L.A., Fernandes, M., Nerve Regeneration: Is There an Alternative to Nervous Graft (2014) J Reconstr Microsurg; Giannessi, E., Coli, A., Stornelli, M.R., An autologously generated platelet-rich plasma suturable membrane may enhance peripheral nerve regeneration after neurorraphy in an acute injury model of sciatic nerve neurotmesis (2014) J Reconstr Microsurg, 30 (9), pp. 417-425; Ladak, A., Olson, J., Tredget, E.E., Gordon, T., Differentiation of mesenchymal stem cells to support peripheral nerve regeneration in a rat model (2011) Exp Neurol, 228 (2), pp. 242-252; Terenghi, G., Peripheral nerve regeneration and neurotrophic factors (1999) J Anat, 194 (PART 1), pp. 1-14; Rodríguez, F.J., Verdú, E., Ceballos, D., Navarro, X., Nerve guides seeded with autologous schwann cells improve nerve regeneration (2000) Exp Neurol, 161 (2), pp. 571-584; Di Summa, P.G., Kingham, P.J., Raffoul, W., Wiberg, M., Terenghi, G., Kalbermatten, D.F., Adipose-derived stem cells enhance peripheral nerve regeneration (2010) J Plast Reconstr Aesthet Surg, 63 (9), pp. 1544-1552; Terenghi, G., Peripheral nerve injury and regeneration (1995) Histol Histopathol, 10 (3), pp. 709-718; Fawcett, J.W., Keynes, R.J., Peripheral nerve regeneration (1990) Annu Rev Neurosci, 13, pp. 43-60; Thompson, D.M., Buettner, H.M., Oriented Schwann cell monolayers for directed neurite outgrowth (2004) Ann Biomed Eng, 32 (8), pp. 1120-1130; Weber, R.V., Mackinnon, S.E., Bridging the neural gap (2005) Clin Plast Surg, 32 (4), pp. 605-616. , viii; Hudson, T.W., Evans, G.R., Schmidt, C.E., Engineering strategies for peripheral nerve repair (1999) Clin Plast Surg, 26 (4), pp. 617-628. , ix; Sun, X.H., Che, Y.Q., Tong, X.J., Improving nerve regeneration of acellular nerve allografts seeded with SCs bridging the sciatic nerve defects of rat (2009) Cell Mol Neurobiol, 29 (3), pp. 347-353; Aszmann, O.C., Korak, K.J., Luegmair, M., Frey, M., Bridging critical nerve defects through an acellular homograft seeded with autologous schwann cells obtained from a regeneration neuroma of the proximal stump (2008) J Reconstr Microsurg, 24 (3), pp. 151-158; Kingham, P.J., Kalbermatten, D.F., Mahay, D., Armstrong, S.J., Wiberg, M., Terenghi, G., Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro (2007) Exp Neurol, 207 (2), pp. 267-274; Walsh, S., Biernaskie, J., Kemp, S.W., Midha, R., Supplementation of acellular nerve grafts with skin derived precursor cells promotes peripheral nerve regeneration (2009) Neuroscience, 164 (3), pp. 1097-1107; Dedkov, E.I., Kostrominova, T.Y., Borisov, A.B., Carlson, B.M., Survival of Schwann cells in chronically denervated skeletal muscles (2002) Acta Neuropathol, 103 (6), pp. 565-574; Amoh, Y., Kanoh, M., Niiyama, S., Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: An advantageous alternative to ES and iPS cells (2009) J Cell Biochem, 107 (5), pp. 1016-1020; Schaakxs, D., Kalbermatten, D.F., Raffoul, W., Wiberg, M., Kingham, P.J., Regenerative cell injection in denervated muscle reduces atrophy and enhances recovery following nerve repair (2013) Muscle Nerve, 47 (5), pp. 691-701; Tohill, M., Mantovani, C., Wiberg, M., Terenghi, G., Rat bone marrow mesenchymal stem cells express glial markers and stimulate nerve regeneration (2004) Neurosci Lett, 362 (3), pp. 200-203; Tohill, M., Terenghi, G., Stem-cell plasticity and therapy for injuries of the peripheral nervous system (2004) Biotechnol Appl Biochem, 40 (PART 1), pp. 17-24; Dezawa, M., Takahashi, I., Esaki, M., Takano, M., Sawada, H., Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells (2001) Eur J Neurosci, 14 (11), pp. 1771-1776; Keilhoff, G., Goihl, A., Langnäse, K., Fansa, H., Wolf, G., Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells (2006) Eur J Cell Biol, 85 (1), pp. 11-24; Oliveira, J.T., Almeida, F.M., Biancalana, A., Mesenchymal stem cells in a polycaprolactone conduit enhance median-nerve regeneration, prevent decrease of creatine phosphokinase levels in muscle, and improve functional recovery in mice (2010) Neuroscience, 170 (4), pp. 1295-1303; Orbay, H., Uysal, A.C., Hyakusoku, H., Mizuno, H., Differentiated and undifferentiated adipose-derived stem cells improve function in rats with peripheral nerve gaps (2012) J Plast Reconstr Aesthet Surg, 65 (5), pp. 657-664; Kuroda, R., Usas, A., Kubo, S., Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells (2006) Arthritis Rheum, 54 (2), pp. 433-442; Lee, J.Y., Qu-Petersen, Z., Cao, B., Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing (2000) J Cell Biol, 150 (5), pp. 1085-1100; Oshima, H., Payne, T.R., Urish, K.L., Differential myocardial infarct repair with muscle stem cells compared to myoblasts (2005) Mol Ther, 12 (6), pp. 1130-1141; Peng, H., Wright, V., Usas, A., Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4 (2002) J Clin Invest, 110 (6), pp. 751-759; Lavasani, M., Thompson, S.D., Pollett, J.B., Human muscle-derived stem/progenitor cells promote functional murine peripheral nerve regeneration (2014) J Clin Invest, 124 (4), pp. 1745-1756; Lavasani, M., Gehrmann, S., Gharaibeh, B., Venous graft-derived cells participate in peripheral nerve regeneration (2011) PLoS ONE, 6 (9), p. e24801",Article,Scopus,2-s2.0-84928537456
"Khattak M., Pu F., Curran J.M., Hunt J.A., D'Sa R.A.","Human mesenchymal stem cell response to poly(ε-caprolactone/poly(methyl methacrylate) demixed thin films",2015,"Journal of Materials Science: Materials in Medicine","26","5",,"","",7,,10.1007/s10856-015-5507-2,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928400447&partnerID=40&md5=66454350ec9809836a46dca6a981bbeb","Centre for Materials and Structures, University of Liverpool, Brownlow HillLiverpool, United Kingdom; Department of Clinical Engineering, UK Centre for Tissue Engineering, Daulby StreetLiverpool, United Kingdom","Khattak, M., Centre for Materials and Structures, University of Liverpool, Brownlow HillLiverpool, United Kingdom; Pu, F., Department of Clinical Engineering, UK Centre for Tissue Engineering, Daulby StreetLiverpool, United Kingdom; Curran, J.M., Centre for Materials and Structures, University of Liverpool, Brownlow HillLiverpool, United Kingdom; Hunt, J.A., Department of Clinical Engineering, UK Centre for Tissue Engineering, Daulby StreetLiverpool, United Kingdom; D’Sa, R.A., Centre for Materials and Structures, University of Liverpool, Brownlow HillLiverpool, United Kingdom","Advances in material sciences have enabled the fabrication of biomaterials which are able to provide the requisite cues to stimulate cells to behave in a specific way. Nanoscale surface topographies are well known to be able to positively influence cell–substrate interactions. This study reports on a novel series of poly(ε-caprolactone) PCL and poly(methyl methacrylate) demixed nanotopographic films as non-biological cell-stimulating cues. The topographic features observed ranged from nanoislands to nanopits. PMMA was observed to segregate to the air interface, while PCL preferred the substrate interface. Preliminary response of human mesenchymal stem cells to these surfaces indicated that the substrate with nanoisland topography has the potential to differentiate to osteogenic, chondrogenic and adipogenic lineages. © 2015, Springer Science+Business Media New York.",,"Anselme, K., Ploux, L., Ponche, A., Cell/material interfaces: influence of surface chemistry and surface topography on cell adhesion (2010) J Adhes Sci Technol, 24 (5), pp. 831-852; Lord, M.S., Foss, M., Besenbacher, F., Influence of nanoscale surface topography on protein adsorption and cellular response (2010) Nano Today, 5 (1), pp. 66-78; Curran, J.M., Chen, R., Hunt, J.A., The guidance of human mesenchymal stem cell differentiation in vitro by controlled modifications to the cell substrate (2006) Biomaterials, 27 (27), pp. 4783-4793; D’Sa, R.A., Burke, G.A., Meenan, B.J., Protein adhesion and cell response on atmospheric pressure dielectric barrier discharge-modified polymer surfaces (2010) Acta Biomater, 6 (7), pp. 2609-2620; Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Multilineage potential of adult human mesenchymal stem cells (1999) Science, 284 (5411), pp. 143-147; Giancotti, F.G., Ruoslahti, E., Integrin signaling (1999) Science, 285 (5430), pp. 1028-1033; Boudreau, N., Myers, C., Bissell, M.J., From laminin to lamin: regulation of tissue-specific gene expression by the ECM (1995) Trends Cell Biol, 5 (1), pp. 1-4; Bruch, M., Landwehr, R., Engel, J., Dissection of laminin by cathepsin G into its long-arm and short-arm structures and localization of regions involved in calcium dependent stabilization and self-association (1989) Eur J Biochem, 185 (2), pp. 271-279; Engel, J., Odermatt, E., Engel, A., Madri, J.A., Furthmayr, H., Rohde, H., Shapes, domain organizations and flexibility of laminin and fibronectin, two multifunctional proteins of the extracellular matrix (1981) J Mol Biol, 150 (1), pp. 97-120; Li, S., Edgar, D., Fässler, R., Wadsworth, W., Yurchenco, P.D., The role of laminin in embryonic cell polarization and tissue organization (2003) Dev Cell, 4 (5), pp. 613-624; Weir, M.L., Oppizzi, M.L., Henry, M.D., Onishi, A., Campbell, K.P., Bissell, M.J., Dystroglycan loss disrupts polarity and β-casein induction in mammary epithelial cells by perturbing laminin anchoring (2006) J Cell Sci, 119 (19), pp. 4047-4058; Streuli, C.H., Schmidhauser, C., Bailey, N., Yurchenco, P., Skubitz, A., Roskelley, C., Laminin mediates tissue-specific gene expression in mammary epithelia (1995) J Cell Biol, 129 (3), pp. 591-603; Beck, K., Hunter, I., Engel, J., Structure and function of laminin: anatomy of a multidomain glycoprotein (1990) FASEB J, 4 (2), pp. 148-160; Buttiglieri, S., Pasqui, D., Migliori, M., Johnstone, H., Affrossman, S., Sereni, L., Endothelization and adherence of leucocytes to nanostructured surfaces (2003) Biomaterials, 24 (16), pp. 2731-2738; Dalby, M., Childs, S., Riehle, M., Johnstone, H., Affrossman, S., Curtis, A., Fibroblast reaction to island topography: changes in cytoskeleton and morphology with time (2003) Biomaterials, 24 (6), pp. 927-935; Dalby, M.J., Gadegaard, N., Tare, R., Andar, A., Riehle, M.O., Herzyk, P., The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder (2007) Nat Mater, 6 (12), pp. 997-1003; McMurray, R.J., Gadegaard, N., Tsimbouri, P.M., Burgess, K.V., McNamara, L.E., Tare, R., Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency (2011) Nat Mater, 10 (8), pp. 637-644; Dalby, M., Riehle, M., Johnstone, H., Affrossman, S., Curtis, A., In vitro reaction of endothelial cells to polymer demixed nanotopography (2002) Biomaterials, 23 (14), pp. 2945-2954; Affrossman, S., Henn, G., O’Neill, S.A., Pethrick, R.A., Stamm, M., Surface topography and composition of deuterated polystyrene-poly(bromostyrene) blends (1996) Macromolecules, 29 (14), pp. 5010-5016; Ton-That, C., Shard, A., Bradley, R., Surface feature size of spin cast PS/PMMA blends (2002) Polymer, 43 (18), pp. 4973-4977; Ton-That, C., Shard, A., Teare, D., Bradley, R., XPS and AFM surface studies of solvent-cast PS/PMMA blends (2001) Polymer, 42 (3), pp. 1121-1129; Broz, M.E., VanderHart, D.L., Washburn, N.R., Structure and mechanical properties of poly(d, l-lactic acid)/poly(ε-caprolactone) blends (2003) Biomaterials, 24 (23), pp. 4181-4190; Lim, J.Y., Hansen, J.C., Siedlecki, C.A., Runt, J., Donahue, H.J., Human foetal osteoblastic cell response to polymer-demixed nanotopographic interfaces (2005) J R Soc Interface, 2 (2), pp. 97-108; Berry, C.C., Dalby, M.J., McCloy, D., Affrossman, S., The fibroblast response to tubes exhibiting internal nanotopography (2005) Biomaterials, 26 (24), pp. 4985-4992; Dalby, M., Giannaras, D., Riehle, M., Gadegaard, N., Affrossman, S., Curtis, A., Rapid fibroblast adhesion to 27 nm high polymer demixed nano-topography (2004) Biomaterials, 25 (1), pp. 77-83; Dalby, M.J., Riehle, M.O., Johnstone, H., Affrossman, S., Curtis, A.S.G., In vitro reaction of endothelial cells to polymer demixed nanotopography (2002) Biomaterials, 23 (14), pp. 2945-2954; Affrossman, S., Stamm, M., The effect of molecular weight on the topography of thin films of blends of poly (4-bromostyrene) and polystyrene (2000) Colloid Polym Sci, 278 (9), pp. 888-893; Ton-That, C., Shard, A.G., Bradley, R.H., Surface feature size of spin cast PS/PMMA blends (2002) Polymer, 43 (18), pp. 4973-4977; Tanaka, K., Takahara, A., Kajiyama, T., Surface molecular aggregation structure and surface molecular motions of high-molecular-weight polystyrene/low-molecular-weight poly(methyl methacrylate) blend films (1998) Macromolecules, 31 (3), pp. 863-869; Raczkowska, J., Bernasik, A., Budkowski, A., Sajewicz, K., Penc, B., Lekki, J., Structures formed in spin-cast films of polystyrene blends with poly(butyl methacrylate) isomers (2004) Macromolecules, 37 (19), pp. 7308-7315; Tanaka, K., Yoon, J.-S., Takahara, A., Kajiyama, T., Ultrathinning-induced surface phase separation of polystyrene/poly(vinyl methyl ether) blend film (1995) Macromolecules, 28 (4), pp. 934-938; Biggs, M.J.P., Richards, R.G., Dalby, M.J., Nanotopographical modification: a regulator of cellular function through focal adhesions (2010) Nanomed Nanotechnol Biol Med, 6 (5), pp. 619-633; Dalby, M.J., Gadegaard, N., Tare, R., Andar, A., Riehle, M.O., Herzyk, P., The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder (2007) Nat Mater, 6 (12), pp. 997-1003; Biggs, M.J.P., Richards, R.G., Gadegaard, N., Wilkinson, C.D.W., Dalby, M.J., The effects of nanoscale pits on primary human osteoblast adhesion formation and cellular spreading (2007) J Mater Sci Mater Med, 18 (2), pp. 399-404",Article,Scopus,2-s2.0-84928400447
"You L., Yan K., Zou J., Zhao H., Bertos N.R., Park M., Wang E., Yang X.-J.","The chromatin regulator Brpf1 regulates embryo development and cell proliferation",2015,"Journal of Biological Chemistry","290","18",,"11349","11364",,,10.1074/jbc.M115.643189,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928777399&partnerID=40&md5=64a9458da30d89c8c860e0f8b3f12ab7","Rosalind and Morris Goodman Cancer Research Center, McGill UniversityMontreal, QC, Canada; Department of Medicine, McGill UniversityMontreal, QC, Canada; Department of Biochemistry, McGill UniversityMontreal, QC, Canada; National Research Council CanadaMontreal, QC, Canada; McGill University Health CenterMontreal, QC, Canada","You, L., Rosalind and Morris Goodman Cancer Research Center, McGill UniversityMontreal, QC, Canada, Department of Medicine, McGill UniversityMontreal, QC, Canada; Yan, K., Rosalind and Morris Goodman Cancer Research Center, McGill UniversityMontreal, QC, Canada, Department of Biochemistry, McGill UniversityMontreal, QC, Canada; Zou, J., National Research Council CanadaMontreal, QC, Canada; Zhao, H., Rosalind and Morris Goodman Cancer Research Center, McGill UniversityMontreal, QC, Canada; Bertos, N.R., Rosalind and Morris Goodman Cancer Research Center, McGill UniversityMontreal, QC, Canada; Park, M., Rosalind and Morris Goodman Cancer Research Center, McGill UniversityMontreal, QC, Canada, Department of Medicine, McGill UniversityMontreal, QC, Canada, Department of Biochemistry, McGill UniversityMontreal, QC, Canada, McGill University Health CenterMontreal, QC, Canada; Wang, E., National Research Council CanadaMontreal, QC, Canada; Yang, X.-J., Rosalind and Morris Goodman Cancer Research Center, McGill UniversityMontreal, QC, Canada, Department of Medicine, McGill UniversityMontreal, QC, Canada, Department of Biochemistry, McGill UniversityMontreal, QC, Canada, McGill University Health CenterMontreal, QC, Canada","With hundreds of chromatin regulators identified in mammals, an emerging issue is how they modulate biological and pathological processes. BRPF1 (bromodomain-and PHD finger-containing protein 1) is a unique chromatin regulator possessing two PHD fingers, one bromodomain and a PWWP domain for recognizing multiple histone modifications. In addition, it binds to the acetyltransferases MOZ, MORF, and HBO1 (also known as KAT6A, KAT6B, and KAT7, respectively) to promote complex formation, restrict substrate specificity, and enhance enzymatic activity.Wehave recently showed that ablation of the mouse Brpf1 gene causes embryonic lethality at E9.5. Here we present systematic analyses of the mutant animals and demonstrate that the ablation leads to vascular defects in the placenta, yolk sac, and embryo proper, as well as abnormal neural tube closure. At the cellular level, Brpf1 loss inhibits proliferation of embryonic fibroblasts and hematopoietic progenitors. Molecularly, the loss reduces transcription of a ribosomal protein L10 (Rpl10)-like gene and the cell cycle inhibitor p27, and increases expression of the cell-cycle inhibitor p16 and a novel protein homologous to Scp3, a synaptonemal complex protein critical for chromosome association and embryo survival. These results uncover a crucial role of Brpf1 in controlling mouse embryo development and regulating cellular and gene expression programs. © 2015 by The American Society for Biochemistry and Molecular Biology, Inc.",,"Strahl, B.D., Allis, C.D., The language of covalent histone modifications (2000) Nature, 403, pp. 41-45; Berger, S.L., The complex language of chromatin regulation during transcription (2007) Nature, 447, pp. 407-412; Bonasio, R., Tu, S., Reinberg, D., Molecular signals of epigenetic states (2010) Science, 330, pp. 612-616; Suganuma, T., Workman, J.L., Signals and combinatorial functions of histone modifications (2011) Annu. Rev. Biochem., 80, pp. 473-499; Taverna, S.D., Li, H., Ruthenburg, A.J., Allis, C.D., Patel, D.J., How chromatin-binding modules interpret histone modifications: Lessons from professional pocket pickers (2007) Nat. Struct. Mol. Biol., 14, pp. 1025-1040; Latham, J.A., Dent, S.Y., Cross-regulation of histone modifications (2007) Nat. Struct. Mol. Biol., 14, pp. 1017-1024; Musselman, C.A., Lalonde, M.E., Côté, J., Kutateladze, T.G., Perceiving the epigenetic landscape through histone readers (2012) Nat. Struct. Mol. Biol., 19, pp. 1218-1227; Yang, X.J., Ullah, M., MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells (2007) Oncogene, 26, pp. 5408-5419; Qin, S., Jin, L., Zhang, J., Liu, L., Ji, P., Wu, M., Wu, J., Shi, Y., Recognition of unmodified histone H3 by the first PHD finger of romodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF) (2011) J. Biol. Chem., 286, pp. 36944-36955; Lalonde, M.E., Avvakumov, N., Glass, K.C., Joncas, F.H., Saksouk, N., Holliday, M., Paquet, E., Côté, J., Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity (2013) Genes Dev., 27, pp. 2009-2024; Lubula, M.Y., Eckenroth, B.E., Carlson, S., Poplawski, A., Chruszcz, M., Glass, K.C., Structural insights into recognition of acetylated histone ligands by the BRPF1 bromodomain (2014) FEBS Lett., 588, pp. 3844-3854; Vezzoli, A., Bonadies, N., Allen, M.D., Freund, S.M., Santiveri, C.M., Kvinlaug, B.T., Huntly, B.J., Bycroft, M., Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1 (2010) Nat. Struct. Mol. Biol., 17, pp. 617-619; Wu, H., Zeng, H., Lam, R., Tempel, W., Amaya, M.F., Xu, C., Dombrovski, L., Min, J., Structural and histone binding ability characterizations of human PWWP domains (2011) PLoS ONE, 6, p. e18919; Doyon, Y., Cayrou, C., Ullah, M., Landry, A.J., Côté, V., Selleck, W., Lane, W.S., Côté, J., ING tumor suppressors are critical regulators of chromatin acetylation required for genome expression and perpetuation (2006) Mol. Cell, 21, pp. 51-64; Perry, J., The Epc-N domain: A predicted protein-protein interaction domain found in select chromatin associated proteins (2006) BMC Genomics, 7, p. 6; Ullah, M., Pelletier, N., Xiao, L., Zhao, S.P., Wang, K., Degerny, C., Tahmasebi, S., Yang, X.J., Molecular architecture of quartet MOZ/MORF histon acetyltransferase complexes (2008) Mol. Cell Biol., 28, pp. 6828-6843; Mishima, Y., Miyagi, S., Saraya, A., Negishi, M., Endoh, M., Endo, T.A., Toyoda, T., Iwama, A., The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis (2011) Blood, 118, pp. 2443-2453; Lalonde, M.E., Cheng, X., Côté, J., Histone target selection within chromatin: An exemplary case of teamwork (2014) Genes Dev., 28, pp. 1029-1041; Borrow, J., Stanton, V.P., Jr., Andresen, J.M., Becher, R., Behm, F.G., Chaganti, R.S., Civin, C.I., Housman, D.E., The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein (1996) Nat. Genet., 14, pp. 33-41; Chinen, Y., Taki, T., Tsutsumi, Y., Kobayashi, S., Matsumoto, Y., Sakamoto, N., Kuroda, J., Taniwaki, M., The leucine twenty homeobox (LEUTX) gene, which lacks a histone acetyltransferase domain, is fused to KAT6A in therapyrelated acute myeloid leukemia with t(8;19)(p11;q13) (2014) Genes Chromosomes Cancer, 53, pp. 299-308; Dulak, A.M., Stojanov, P., Peng, S., Lawrence, M.S., Fox, C., Stewart, C., Bandla, S., Bass, A.J., Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity (2013) Nat. Genet., 45, pp. 478-486; Moore, S.D., Herrick, S.R., Ince, T.A., Kleinman, M.S., Dal Cin, P., Morton, C.C., Quade, B.J., Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF (2004) Cancer Res., 64, pp. 5570-5577; Panagopoulos, I., Gorunova, L., Bjerkehagen, B., Heim, S., Novel KAT6B-KANSL1 fusion gene identified by RNA sequencing in retroperitoneal leiomyoma with t(10;17)(q22;q21) (2015) PLoS ONE, 10, p. e0117010; Lynch, H., Wen, H., Kim, Y.C., Snyder, C., Kinarsky, Y., Chen, P.X., Xiao, F., Wang, S.M., Can Unknown predisposition in familial breast cancer be family-specific? (2013) Breast. J., 19, pp. 520-528; Grasso, C.S., Wu, Y.M., Robinson, D.R., Cao, X., Dhanasekaran, S.M., Khan, A.P., Quist, M.J., Tomlins, S.A., The mutational landscape of lethal castration-resistant prostate cancer (2012) Nature, 487, pp. 239-243; Zack, T.I., Schumacher, S.E., Carter, S.L., Cherniack, A.D., Saksena, G., Tabak, B., Lawrence, M.S., Beroukhim, R., Pan-cancer patterns of somatic copy number alteration (2013) Nat. Genet., 45, pp. 1134-1140; Sheikh, B.N., Lee, S.C., El-Saafin, F., Vanyai, H.K., Hu, Y., Pang, S.H., Grabow, S., Thomas, T., MOZ regulates B cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development (2015) Blood, 125, pp. 1910-1921; Kraft, M., Cirstea, I.C., Voss, A.K., Thomas, T., Goehring, I., Sheikh, B.N., Gordon, L., Thiel, C.T., Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome-like phenotype and hyperactivated MAPK signaling in humans and mice (2011) J. Clin. Invest., 121, pp. 3479-3491; Clayton-Smith, J., O'sullivan, J., Daly, S., Bhaskar, S., Day, R., Anderson, B., Voss, A.K., Black, G., Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the say-barberbiesecker variant of Ohdo syndrome (2011) Am. J. Hum. Genet., 89, pp. 675-681; Campeau, P.M., Kim, J.C., Lu, J.T., Schwartzentruber, J.A., Abdul-Rahman, O.A., Schlaubitz, S., Murdock, D.M., Lee, B.H., Mutations in KAT6B, encoding a histone acetyltransferase, cause genitopatellar syndrome (2012) Am. J. Hum. Genet., 90, pp. 282-289; Simpson, M.A., Deshpande, C., Dafou, D., Vissers, L.E., Woollard, W.J., Holder, S.E., Gillessen-Kaesbach, G., Trembath, R.C., De novo mutations of the gene encoding the histone acetyltransferase KAT6B cause genitopatellar syndrome (2012) Am. J. Hum. Genet., 90, pp. 290-294; Szakszon, K., Salpietro, C., Kakar, N., Knegt, A.C., Olah, E., Dallapiccola, B., Borck, G., De novo mutations of the gene encoding the histone acetyltransferase KAT6B in two patients with Say-Barber/ Biesecker/Young-Simpson syndrome (2013) Am. J. Med. Genet. A, 161 A, pp. 884-888; Yu, H.C., Geiger, E.A., Medne, L., Zackai, E.H., Shaikh, T.H., An individual with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) and additional features expands the phenotype associated with mutations in KAT6B (2014) Am. J. Med. Genet. A, 164 A, pp. 950-957; Arboleda, V.A., Lee, H., Dorrani, N., Zadeh, N., Willis, M., Macmurdo, C.F., Manning, M.A., Nelson, S.F., De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay (2015) Am. J. Hum. Genet., 96, pp. 498-506; Tham, E., Lindstrand, A., Santani, A., Malmgren, H., Nesbitt, A., Dubbs, H.A., Zackai, E.H., Nordgren, A., Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features (2015) Am. J. Hum. Genet., 96, pp. 507-513; Huether, R., Dong, L., Chen, X., Wu, G., Parker, M., Wei, L., Ma, J., Downing, J.R., The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes (2014) Nat. Commun., 5, p. 3630; Kool, M., Jones, D.T., Jäger, N., Northcott, P.A., Pugh, T.J., Hovestadt, V., Piro, R.M., Hasselblatt, M., Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition (2014) Cancer Cell, 25, pp. 393-405; You, L., Chen, L., Penney, J., Miao, D., Yang, X.J., Expression atlas of the epigenetic regulator Brpf1 and its requirement for survival of mouse embryos (2014) Epigenetics, 9, pp. 860-872; You, L., Zou, J., Zhao, H., Bertos, N.R., Park, M., Wang, E., Yang, X.J., Deficiency of the chromatin regulator Brpf1 causes abnormal brain development (2015) J. Biol. Chem., 290, pp. 7114-7129; You, L., Yan, K., Zhou, J., Zhao, H., Bertos, N.R., Park, M., Wang, E., Yang, X.J., The lysine acetyltransferase activator Brpf1 governs dentate gyrus development through neural stem cells and progenitors (2015) PLoS Genet., 11, p. e1005034; Katsumoto, T., Aikawa, Y., Iwama, A., Ueda, S., Ichikawa, H., Ochiya, T., Kitabayashi, I., MOZ is essential for maintenance of hematopoietic stem cells (2006) Genes Dev., 20, pp. 1321-1330; Thomas, T., Corcoran, L.M., Gugasyan, R., Dixon, M.P., Brodnicki, T., Nutt, S.L., Metcalf, D., Voss, A.K., Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells (2006) Genes Dev., 20, pp. 1175-1186; Thomas, T., Voss, A.K., Chowdhury, K., Gruss, P., Querkopf, a MYST family histone acetyltransferase, is required for normal cerebral cortex development (2000) Development, 127, pp. 2537-2548; Kueh, A.J., Dixon, M.P., Voss, A.K., Thomas, T., HBO1 is required for H3K14 acetylation and normal transcriptional activity during embryonic development (2011) Mol. Cell Biol., 31, pp. 845-860; Orkin, S.H., Harosi, F.I., Leder, P., Differentiation in erythroleukemic cells and their somatic hybrids (1975) Proc. Natl. Acad. Sci. U.S.A., 72, pp. 98-102; Canault, M., Certel, K., Schatzberg, D., Wagner, D.D., Hynes, R.O., The lack of ADAM17 activity during embryonic development causes hemorrhage and impairs vessel formation (2010) PLoS ONE, 5, p. e13433; Kim, G.W., Li, L., Gorbani, M., You, L., Yang, X.J., Mice lacking α-tubulin acetyltransferase 1 are viable but display α-tubulin acetylation deficiency and dentate gyrus distortion (2013) J. Biol. Chem., 288, pp. 20334-20350; Vindelov, L.L., Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei (1977) Virchows Arch. B Cell Pathol., 24, pp. 227-242; Walkinshaw, D.R., Weist, R., Kim, G.W., You, L., Xiao, L., Nie, J., Li, C.S., Yang, X.J., The tumor suppressor kinase LKB1 activates the downstream kinases SIK2 and SIK3 to stimulate nuclear export of class IIa histone deacetylases (2013) J. Biol. Chem., 288, pp. 9345-9362; Horak, E.R., Leek, R., Klenk, N., Lejeune, S., Smith, K., Stuart, N., Greenall, M., Harris, A.L., Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer (1992) Lancet, 340, pp. 1120-1124; Kaufman, M.H., Bard, J.B.L., (1999) The Anatomical Basis of Mouse Development, , Academic Press, San Diego. CA; Rossant, J., Cross, J.C., Placental development: Lessons from mouse mutants (2001) Nat. Rev. Genet., 2, pp. 538-548; Simmons, D.G., Cross, J.C., Determinants of trophoblast lineage and cell subtype specification in the mouse placenta (2005) Dev. Biol., 284, pp. 12-24; Anson-Cartwright, L., Dawson, K., Holmyard, D., Fisher, S.J., Lazzarini, R.A., Cross, J.C., The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta (2000) Nat. Genet., 25, pp. 311-314; Li, Y., Behringer, R.R., Esx1 is an X-chromosome-imprinted regulator of placental development and fetal growth (1998) Nat. Genet., 20, pp. 309-311; Graham, V., Khudyakov, J., Ellis, P., Pevny, L., SOX2 functions to maintain neural progenitor identity (2003) Neuron, 39, pp. 749-765; Memberg, S.P., Hall, A.K., Dividing neuron precursors express neuron-specific tubulin (1995) J. Neurobiol., 27, pp. 26-43; Hans, F., Dimitrov, S., Histone H3 phosphorylation and cell division (2001) Oncogene, 20, pp. 3021-3027; Paull, T.T., Rogakou, E.P., Yamazaki, V., Kirchgessner, C.U., Gellert, M., Bonner, W.M., A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage (2000) Curr. Biol., 10, pp. 886-895; Baron, M.H., Vacaru, A., Nieves, J., Erythroid development in the mammalian embryo (2013) Blood Cells Mol. Dis., 51, pp. 213-219; Uechi, T., Maeda, N., Tanaka, T., Kenmochi, N., Functional second genes generated by retrotransposition of the X-linked ribosomal protein genes (2002) Nucleic Acids Res., 30, pp. 5369-5375; Sengupta, J., Bussiere, C., Pallesen, J., West, M., Johnson, A.W., Frank, J., Characterization of the nuclear export adaptor protein Nmd3 in association with the 60 S ribosomal subunit (2010) J. Cell Biol., 189, pp. 1079-1086; Sulima, S.O., Gülay, S.P., Anjos, M., Patchett, S., Meskauskas, A., Johnson, A.W., Dinman, J.D., Eukaryotic rpL10 drives ribosomal rotation (2014) Nucleic Acids Res., 42, pp. 2049-2063; De Keersmaecker, K., Atak, Z.K., Li, N., Vicente, C., Patchett, S., Girardi, T., Gianfelici, V., Cools, J., Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia (2013) Nat. Genet., 45, pp. 186-190; Sulima, S.O., Patchett, S., Advani, V.M., De Keersmaecker, K., Johnson, A.W., Dinman, J.D., Bypass of the pre-60 S ribosomal quality control as a pathway to oncogenesis (2014) Proc. Natl. Acad. Sci. U.S.A., 111, pp. 5640-5645; Chiocchetti, A., Pakalapati, G., Duketis, E., Wiemann, S., Poustka, A., Poustka, F., Klauck, S.M., Mutation and expression analyses of the ribosomal protein gene RPL10 in an extended German sample of patients with autism spectrum disorder (2011) Am. J. Med. Genet. A, 155 A, pp. 1472-1475; Vandewalle, J., Van Esch, H., Govaerts, K., Verbeeck, J., Zweier, C., Madrigal, I., Mila, M., Froyen, G., Dosage-dependent severity of the phenotype in patients with mental retardation due to a recurrent copy-number gain at Xq28 mediated by an unusual recombination (2009) Am. J. Hum. Genet., 85, pp. 809-822; Piton, A., Redin, C., Mandel, J.L., XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing (2013) Am. J. Hum. Genet., 93, pp. 368-383; Brooks, S.S., Wall, A.L., Golzio, C., Reid, D.W., Kondyles, A., Willer, J.R., Botti, C., Davis, E.E., A novel ribosomopathy caused by dysfunction of RPL10 disrupts neurodevelopment and causes X-linked microcephaly in humans (2014) Genetics, 198, pp. 723-733; Narla, A., Ebert, B.L., Translational medicine: Ribosomopathies (2011) Blood, 118, pp. 4300-4301; Kondrashov, N., Pusic, A., Stumpf, C.R., Shimizu, K., Hsieh, A.C., Xue, S., Ishijima, J., Barna, M., Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning (2011) Cell, 145, pp. 383-397; Zhang, Y., Duc, A.C., Rao, S., Sun, X.L., Bilbee, A.N., Rhodes, M., Li, Q., Wiest, D.L., Control of hematopoietic stem cell emergence by antagonistic functions of ribosomal protein paralogs (2013) Dev. Cell, 24, pp. 411-425; Signer, R.A., Magee, J.A., Salic, A., Morrison, S.J., Haematopoietic stem cells require a highly regulated protein synthesis rate (2014) Nature, 509, pp. 49-54; Yuan, L., Liu, J.G., Hoja, M.R., Wilbertz, J., Nordqvist, K., Höög, C., Female germ cell aneuploidy and embryo death in mice lacking the meiosis-specific protein SCP3 (2002) Science, 296, pp. 1115-1118; Tsutsumi, M., Kogo, H., Kowa-Sugiyama, H., Inagaki, H., Ohye, T., Kurahashi, H., Characterization of a novel mouse gene encoding an SYCP3-like protein that relocalizes from the XY body to the nucleolus during prophase of male meiosis i (2011) Biol. Reprod., 85, pp. 165-171; Shi, Y.Q., Zhuang, X.J., Xu, B., Hua, J., Liao, S.Y., Shi, Q., Cooke, H.J., Han, C., SYCP3-like X-linked 2 is expressed in meiotic germ cells and interacts with synaptonemal complex central element protein 2 and histone acetyltransferase TIP60 (2013) Gene, 527, pp. 352-359; Zhuang, X.J., Shi, Y.Q., Xu, B., Chen, L., Tang, W.H., Huang, J., Lian, Y., Qiao, J., SLX2 interacting with BLOS2 is differentially expressed during mouse oocyte meiotic maturation (2014) Cell Cycle, 13, pp. 2231-2237; Siegel, J.N., Turner, C.A., Klinman, D.M., Wilkinson, M., Steinberg, A.D., Macleod, C.L., Paul, W.E., Cohen, D.I., Sequence analysis and expression of an X-linked, lymphocyte-regulated gene family (XLR) (1987) J. Exp. Med., 166, pp. 1702-1715; Chamberlin, H.M., Thomas, J.H., The bromodomain protein LIN-49 and trithorax-related protein LIN-59 affect development and gene expression in Caenorhabditis elegans (2000) Development, 127, pp. 713-723; Chang, S., Johnston, R.J., Jr., Hobert, O., A transcriptional regulatory cascade that controls left/right asymmetry in chemosensory neurons of C. Elegans (2003) Genes Dev., 17, pp. 2123-2137; Laue, K., Daujat, S., Crump, J.G., Plaster, N., Roehl, H.H., Kimmel, C.B., Schneider, R., Hammerschmidt, M., The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity (2008) Development, 135, pp. 1935-1946; Hibiya, K., Katsumoto, T., Kondo, T., Kitabayashi, I., Kudo, A., Brpf1, a subunit of the MOZ histone acetyl transferase complex, maintains expression of anterior and posterior Hox genes for proper patterning of craniofacial and caudal skeletons (2009) Dev. Biol., 329, pp. 176-190; Champagne, N., Bertos, N.R., Pelletier, N., Wang, A.H., Vezmar, M., Yang, Y., Heng, H.H., Yang, X.J., Identification of a human histone acetyltransferase related to monocytic leukemia zinc finger protein (1999) J. Biol. Chem., 274, pp. 28528-28536; Grienenberger, A., Miotto, B., Sagnier, T., Cavalli, G., Schramke, V., Geli, V., Mariol, M.C., Pradel, J., The MYST domain acetyltransferase Chameau functions in epigenetic mechanisms of transcriptional repression (2002) Curr. Biol., 12, pp. 762-766; Perez-Campo, F.M., Borrow, J., Kouskoff, V., Lacaud, G., The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors (2009) Blood, 113, pp. 4866-4874; Bu, P., Evrard, Y.A., Lozano, G., Dent, S.Y., Loss of Gcn5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos (2007) Mol. Cell. Biol., 27, pp. 3405-3416; Yao, T.P., Oh, S.P., Fuchs, M., Zhou, N.D., Ch'ng, L.E., Newsome, D., Bronson, R.T., Eckner, R., Genedosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300 (1998) Cell, 93, pp. 361-372; Mishima, Y., Wang, C., Miyagi, S., Saraya, A., Hosokawa, H., Mochizuki-Kashio, M., Nakajima-Takagi, Y., Iwama, A., Histone acetylation mediated by Brd1 is crucial for Cd8 gene activation during early thymocyte development (2014) Nat. Commun., 5, p. 5872; Kaufmann, M.H., (1994) The Atlas of Mouse Development, , Revised 1994 Ed., Elsevier, Boston",Article,Scopus,2-s2.0-84928777399
"Walker L., Baumgartner L., Keller K.C., Ast J., Trettner S., zur Nieden N.I.","Non-human primate and rodent embryonic stem cells are differentially sensitive to embryotoxic compounds",2015,"Toxicology Reports","2",,,"165","174",,,10.1016/j.toxrep.2014.11.016,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925500204&partnerID=40&md5=2689959e31fabd3f4abac2cdd3ca48d8","Department of Cell Biology and Neuroscience and Stem Cell Center, College of Natural and Agricultural Sciences, University of California RiversideRiverside, CA, United States; Environmental Toxicology Graduate Program, College of Natural and Agricultural Sciences, University of California RiversideRiverside, CA, United States; Fraunhofer Institute for Cell Therapy and Immunology, Perlickstrasse 1Leipzig, Germany","Walker, L., Department of Cell Biology and Neuroscience and Stem Cell Center, College of Natural and Agricultural Sciences, University of California RiversideRiverside, CA, United States, Environmental Toxicology Graduate Program, College of Natural and Agricultural Sciences, University of California RiversideRiverside, CA, United States; Baumgartner, L., Fraunhofer Institute for Cell Therapy and Immunology, Perlickstrasse 1Leipzig, Germany; Keller, K.C., Department of Cell Biology and Neuroscience and Stem Cell Center, College of Natural and Agricultural Sciences, University of California RiversideRiverside, CA, United States; Ast, J., Fraunhofer Institute for Cell Therapy and Immunology, Perlickstrasse 1Leipzig, Germany; Trettner, S., Fraunhofer Institute for Cell Therapy and Immunology, Perlickstrasse 1Leipzig, Germany; zur Nieden, N.I., Department of Cell Biology and Neuroscience and Stem Cell Center, College of Natural and Agricultural Sciences, University of California RiversideRiverside, CA, United States, Environmental Toxicology Graduate Program, College of Natural and Agricultural Sciences, University of California RiversideRiverside, CA, United States, Fraunhofer Institute for Cell Therapy and Immunology, Perlickstrasse 1Leipzig, Germany","Many industrial chemicals and their respective by-products need to be comprehensively evaluated for toxicity using reliable and efficient assays. In terms of teratogenicity evaluations, the murine-based embryonic stem cell test (EST) offers a promising solution to screen for multiple tissue endpoints. However, use of a mouse model in the EST can yield only a limited understanding of human development, anatomy, and physiology. Non-human primate or human in vitro models have been suggested to be a pharmacologically and pathophysiologically desirable alternative to murine in vitro models. Here, we comparatively evaluated the sensitivity of embryonic stem cells (ESCs) of a non-human primate to skeletal teratogens with mouse ESCs hypothesizing that inclusion of non-human primate cells in in vitro tests would increase the reliability of safety predictions for humans.First, osteogenic capacity was compared between ESCs from the mouse and a New World monkey, the common marmoset. Then, cells were treated with compounds that have been previously reported to induce bone teratogenicity. Calcification and MTT assays evaluated effects on osteogenesis and cell viability, respectively. Our data indicated that marmoset ESCs responded differently than mouse ESCs in such embryotoxicity screens with no obvious dependency on chemical or compound classes and thus suggest that embryotoxicity screening results could be affected by species-driven response variation. In addition, ESCs derived from rhesus monkey, an Old World monkey, and phylogenetically closer to humans than the marmoset, were observed to respond differently to test compounds than marmoset ESCs. Together these results indicate that there are significant differences in the responses of non-human primate and mouse ESC to embryotoxic agents. © 2014 The Authors.","Embryonic stem cell test; Embryotoxicity; Marmoset; Osteogenesis; Rhesus; Sensitivity","http://www.marchofdimes.com/downloads/Birth_Defects_Report-PF.pdf, March of DimesWoodruff, T.J., Zota, A.R., Schwartz, J.M., Environmental chemicals in pregnant women in the United States: NHANES 2003-2004 (2011) Environ. Health Perspect., 119 (6), pp. 878-885; Scholz, G., Genschow, E., Pohl, I., Bremer, S., Paparella, M., Raabe, H., Southee, J., Spielmann, H., Prevalidation of the embryonic stem cell test (EST) - a new in vitro embryotoxicity test (1999) Toxicol. In Vitro, 13 (4-5), pp. 675-681; Spielmann, H., Pohl, I., Döring, B., Liebsch, M., Moldenhauer, F., The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells (1997) Toxicol. In Vitro, 10, p. 119; Festag, M., Viertel, B., Steinberg, P., Sehner, C., An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds (2007) Toxicol. In Vitro, 21 (8), pp. 1631-1640; zur Nieden, N.I., Kempka, G., Ahr, H.J., Multiple endpoint embryonic stem cell test - a possible approach to test for the teratogenic potential of compounds (2004) Toxicol. Appl. Pharmacol., 94, pp. 197-206; Hansen, J.M., In vivo models of developmental toxicology (2012) Methods Mol. Biol., 889, pp. 7-13; Meyer, O., Svendsen, O., Animal models in pharmacology and toxicology (2003) Handbook of Laboratory Animal Science, Vol II, Animal Models, pp. 11-40. , CRC Press, J. Hau, G.L. van Hoosier (Eds.); Toppari, J., Larsen, J.C., Christiansen, P., Giwercman, A., Grandjean, P., Guillette, L.J., Jégou, B., Skakkebaek, N.E., Male reproductive health and environmental xenoestrogens (1996) Environ. Health Perspect., 104, pp. 741-803; de Jong, E., van Beek, L., Piersma, A.H., Comparison of osteoblast and cardiomyocyte differentiation in the embryonic stem cell test for predicting embryotoxicity in vivo (2014) Reprod. Toxicol., 48, pp. 62-71; de Jong, E., van Beek, L., Piersma, A.H., Osteoblast differentiation of murine embryonic stem cells as a model to study the embryotoxic effect of compounds (2012) Toxicol. In Vitro, 26 (6), pp. 970-978; Pulyanina, P.Y., zur Nieden, N.I., Pluripotent stem cells as tools to assess developmental toxicity (2012) Advances in Medicine and Biology, 33. , Nova Science Publishers, Inc; zur Nieden, N.I., ESCs for the prediction of developmental toxicity in pharmacological screening (2008) Multiparameteranalytics - Methods, Applications, Perspectives, pp. 198-220. , Pabst Science Publishers, Lengerich, K. Conrad, W. Lehman, U. Sack, U. Schedler (Eds.); zur Nieden, N.I., Davis, L.A., Rancourt, D.E., Comparing three novel endpoints for developmental osteotoxicity in the EST (2010) Toxicol. Appl. Pharmacol., 247 (2), pp. 91-97; Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., Jones, J.M., Embryonic stem cell lines derived from human blastocysts (1998) Science, 282 (5391), pp. 1145-1147; Trettner, S., Findeisen, A., Taube, S., Horn, P.A., Sasaki, E., zur Nieden, N.I., Osteogenic induction from marmoset embryonic stem cells cultured in feeder-dependent and feeder-independent conditions (2014) Osteoporos. Int., 25 (4), pp. 1255-1266; Dienelt, A., zur Nieden, N.I., Hyperglycemia impairs skeletogenesis from embryonic stem cells by affecting osteoblast and osteoclast differentiation (2011) Stem Cells Dev., 20 (3), pp. 465-474; Sasaki, E., Hanazawa, K., Kurita, R., Akatsuka, A., Yoshizaki, T., Ishii, H., Tanioka, Y., Tani, K., Establishment of novel embryonic stem cell lines derived from the common marmoset (Callithrix jacchus) (2005) Stem Cells, 23 (9), pp. 1304-1313; zur Nieden, N.I., Kempka, G., Ahr, H.J., In vitro differentiation of ESCs into mineralized osteoblasts (2003) Differentiation, 71, pp. 18-27; zur Nieden, N.I., Davis, L.A., Rancourt, D.E., Monolayer cultivation of osteoprogenitors shortens duration of the EST while reliably predicting developmental osteotoxicity (2010) Toxicology, 277 (1-3), pp. 66-73; Brown, N.A., Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods (2002) Altern. Lab. Anim., 30 (2), pp. 177-198; zur Nieden, N.I., Baumgartner, L., Assessing developmental osteotoxicity of chlorides in the embryonic stem cell test (2010) Reprod. Toxicol., 30 (2), pp. 277-283; Davis, L.A., Dienelt, A., zur Nieden, N.I., Absorption-based assays for the analysis of osteogenic and chondrogenic yield (2011) Methods Mol. Biol., 690, pp. 255-272; Müller, T., Fleischmann, G., Eildermann, K., Mätz-Rensing, K., Horn, P.A., Sasaki, E., Behr, R., A novel embryonic stem cell line derived from the common marmoset monkey (Callithrix jacchus) exhibiting germ cell-like characteristics (2009) Hum. Reprod., 24 (6), pp. 1359-1372; Thomson, J.A., Kalishman, J., Golos, T., Durning, M., Harris, C., Hearn, J.P., Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts (1996) Biol. Reprod., 55 (2), pp. 254-259; zur Nieden, N.I., Price, F.D., Davis, L.A., Everitt, R.E., Rancourt, D.E., Gene profiling on mixed embryonic stem cell populations reveals a biphasic role for beta-catenin in osteogenic differentiation (2007) Mol. Endocrinol., 21 (3), pp. 674-685; Jacobson, S.J., Jones, K., Johnson, K., Ceolin, L., Kaur, P., Sahn, D., Donnenfeld, A.E., Smythe, J., Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester (1992) Lancet, 339, pp. 530-533; Schoonen, W.G., Westerink, W.M., Horbach, G.J., High-throughput screening for analysis of in vitro toxicity (2009) EXS, 99, pp. 401-452; Seiler, A.E., Spielmann, H., The validated embryonic stem cell test to predict embryotoxicity in vitro (2011) Nat. Protoc., 6 (7), pp. 961-978; Fanni, D., Ambu, R., Gerosa, C., Nemolato, S., Iacovidou, N., Van Eyken, P., Fanos, V., Faa, G., Aluminum exposure and toxicity in neonates: practical guide to haltaluminum overload in the prenatal and perinatal periods (2014) World J. Pediatr., 10 (2), pp. 101-107; Firling, C.E., Hill, T.A., Severson, A.R., Aluminum toxicity perturbs long bone calcification in the embryonic chick (1999) Arch. Toxicol., 73 (7), pp. 359-366; Severson, A.R., Haut, C.F., Firling, C.E., Huntley, T.E., Influence of short-term aluminum exposure on demineralized bone matrix induced bone formation (1992) Arch. Toxicol., 66 (10), pp. 706-712; Austad, S.N., Fischer, K.E., The development of small primate models for aging research (2011) ILAR J., 52 (1), pp. 78-88; Dagg, C.P., Sensitive stages for the production of developmental abnormalities in mice with 5-fluorouracil (1960) Am. J. Anat., 106, pp. 89-96; Eichele, G., Retinoids and vertebrate limb pattern formation (1989) Trends Genet., 5, pp. 246-251; Fernhoff, P.M., Lammer, E.J., Craniofacial features of isoretinoin embryopathy (1984) J. Pediatr., 105, pp. 595-597; Shuey, D.L., Lau, C., Logsdon, T.R., Zucker, R.M., Elstein, K.H., Narotsky, M.G., Setzer, R.W., Rogers, J.M., Biologically based dose-response modeling in developmental toxicology: biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat (1994) Toxicol. Appl. Pharmacol., 126, pp. 129-144; Stephens, J.D., Golbus, M.S., Miller, T.R., Wilber, R.R., Epstein, C.J., Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester (1980) Am. J. Obstet. Gynecol., 137, pp. 747-749; Genschow, E., Spielmann, H., Scholz, G., Pohl, I., Seiler, A., Clemann, N., Bremer, S., Becker, K., Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests (2004) Altern. Lab. Anim., 32 (3), pp. 209-244; Seiler, A., Visan, A., Buesen, R., Genschow, E., Spielmann, H., Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test (2004) Reprod. Toxicol., 18, pp. 231-240; Prigione, A., Adjaye, J., Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells (2010) Int. J. Dev. Biol., 54 (11-12), pp. 1729-1741; Mandal, S., Lindgren, A.G., Srivastava, A.S., Clark, A.T., Banerjee, U., Mitochondrial function controls proliferation and early differentiation potential of embryonic stem cells (2011) Stem Cells, 29 (3), pp. 486-495; Hayess, K., Riebeling, C., Pirow, R., Steinfath, M., Sittner, D., Slawik, B., Luch, A., Seiler, A.E., The DNT-EST: a predictive embryonic stem cell-based assay for developmental neurotoxicity testing in vitro (2013) Toxicology, 314 (1), pp. 135-147; Jiang, J., Ding, G., Lin, J., Zhang, M., Shi, L., Lv, W., Yang, H., Li, J., Different developmental potential of pluripotent stem cells generated by different reprogramming strategies (2011) J. Mol. Cell Biol., 3 (3), pp. 197-199; Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Daley, G.Q., Epigenetic memory in induced pluripotent stem cells (2010) Nature, 467 (7313), pp. 285-290; Polo, J.M., Liu, S., Figueroa, M.E., Kulalert, W., Eminli, S., Tan, K.Y., Apostolou, E., Hochedlinger, K., Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells (2010) Nat. Biotechnol., 28 (8), pp. 848-855; Buganim, Y., Markoulaki, S., van Wietmarschen, N., Hoke, H., Wu, T., Ganz, K., Akhtar-Zaidi, B., Jaenisch, R., The developmental potential of iPSCs is greatly influenced by reprogramming factor selection (2014) Cell Stem Cell, 15 (3), pp. 295-309; Seok, J., Warren, H.S., Cuenca, A.G., Mindrinos, M.N., Baker, H.V., Xu, W., Richards, D.R., Tompkins, R.G., Genomic responses in mouse models poorly mimic human inflammatory diseases (2013) Proc. Natl. Acad. Sci. U. S. A., 110 (9), pp. 3507-3512; Bailey, J., Non-human primates in medical research and drug development: a critical review (2005) Biog. Amines, 19 (4-6), pp. 235-255; Schardein, J.L., Schwertz, B.A., Kerrel, M., Species sensitivities and prediction of teratogenic potential (1985) Environ. Health Perspect., 61, pp. 55-67; Initial sequence of the chimpanzee genome and comparison with the human genome (2005) Nature, 437 (7055), pp. 69-87; Li, X., Han, Y., Guan, Y., Zhang, L., Bai, C., Li, Y., Aluminum induces osteoblast apoptosis through the oxidative stress-mediated JNK signaling pathway (2012) Biol. Trace Elem. Res., 150 (1-3), pp. 502-508; Lindsley, R.A., Gill, J.G., Kyba, M., Murphy, K.M., Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm (2006) Development, 133 (19), pp. 3787-3796; Rodda, S.J., McMahon, A.P., Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors (2006) Development, 133 (16), pp. 3231-3244; Genschow, E., Scholz, G., Brown, N., Piersma, A., Brady, M., Clemann, N., Huuskonen, H., Spielmann, H., Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study (2000) In Vitro Mol. Toxicol., 13 (1), pp. 51-66; Adler, S., Lindqvist, J., Uddenberg, K., Hyllner, J., Strehl, R., Testing potential developmental toxicants with a cytotoxicity assay based on human embryonic stem cells (2008) Altern. Lab. Anim., 36 (2), pp. 129-140; Jung, E.M., Choi, Y.U., Kang, H.S., Yang, H., Hong, E.J., An, B.S., Yang, J.Y., Jeung, E.B., Evaluation of developmental toxicity using undifferentiated human embryonic stem cells (2014) J. Appl. Toxicol., , (Epub ahead of print); West, P.R., Weir, A.M., Smith, A.M., Donley, E.L., Cezar, G.G., Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics (2010) Toxicol. Appl. Pharmacol., 247 (1), pp. 18-27; Kuske, B., Pulyanina, P.Y., zur Nieden NI, N.I., Embryonic stem cell test: stem cell use in predicting developmental cardiotoxicity and osteotoxicity (2012) Methods Mol. Biol., 889, pp. 147-179",Article,Scopus,2-s2.0-84925500204
"Vizan P., Beringer M., Ballare C., Di Croce L.","Role of PRC2-associated factors in stem cells and disease",2015,"FEBS Journal","282","9",,"1723","1735",,1,10.1111/febs.13083,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928491983&partnerID=40&md5=a24f7c48380f2d5837d864c7e529f7eb","Centre for Genomic RegulationBarcelona, Spain","Vizán, P., Centre for Genomic RegulationBarcelona, Spain; Beringer, M., Centre for Genomic RegulationBarcelona, Spain; Ballaré, C., Centre for Genomic RegulationBarcelona, Spain; Di Croce, L., Centre for Genomic RegulationBarcelona, Spain","The Polycomb group (PcG) of proteins form chromatin-binding complexes with histone-modifying activity. The two main PcG repressive complexes studied (PRC1 and PRC2) are generally associated with chromatin in its repressed state. PRC2 is responsible for methylation of histone H3 at lysine 27 (H3K27me3), an epigenetic mark that is linked with numerous biological processes, including development, adult homeostasis and cancer. The core canonical complex PRC2, which contains the EZH1/2, SUZ12 and EED proteins, may be extended and functionally manipulated through interactions with several other proteins. In this review, we focus on these PRC2-associated proteins. As PRC2 functions are diverse, the variability conferred by these sub-stoichiometrically associated members may help to understand specific changes in PRC2 activity, chromatin recruitment and distribution required for gene repression. It is well known that the Polycomb repressive complex 2 (PRC2) exerts gene repressive functions that are crucial during development and adult homeostasis. Therefore, it should be finely controlled and its deregulation could lead to disease states. Here, we review several factors that have been found associated with PRC2 and control its activity or its specific genomic targeting. © 2014 FEBS.","AEBP2; C17orf96; chromatin; epigenetics; gene expression; JARID2; polycomb; polycomb-like; RBAP46/48; stem cells","Margueron, R., Reinberg, D., Chromatin structure and the inheritance of epigenetic information (2010) Nat Rev Genet, 11, pp. 285-296; Bannister, A.J., Kouzarides, T., Regulation of chromatin by histone modifications (2011) Cell Res, 21, pp. 381-395; Di Croce, L., Helin, K., Transcriptional regulation by Polycomb group proteins (2013) Nat Struct Mol Biol, 20, pp. 1147-1155; Aloia, L., Di Stefano, B., Di Croce, L., Polycomb complexes in stem cells and embryonic development (2013) Development, 140, pp. 2525-2534; Bracken, A.P., Helin, K., Polycomb group proteins: navigators of lineage pathways led astray in cancer (2009) Nat Rev Cancer, 9, pp. 773-784; Sauvageau, M., Sauvageau, G., Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer (2010) Cell Stem Cell, 7, pp. 299-313; Luis, N.M., Morey, L., Di Croce, L., Benitah, S.A., Polycomb in stem cells: PRC1 branches out (2012) Cell Stem Cell, 11, pp. 16-21; Margueron, R., Li, G., Sarma, K., Blais, A., Zavadil, J., Woodcock, C.L., Dynlacht, B.D., Reinberg, D., Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms (2008) Mol Cell, 32, pp. 503-518; Ciferri, C., Lander, G.C., Maiolica, A., Herzog, F., Aebersold, R., Nogales, E., Molecular architecture of human Polycomb repressive complex 2 (2012) Elife, 1; Cao, R., Zhang, Y., SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex (2004) Mol Cell, 15, pp. 57-67; Smits, A.H., Jansen, P.W., Poser, I., Hyman, A.A., Vermeulen, M., Stoichiometry of chromatin-associated protein complexes revealed by label-free quantitative mass spectrometry-based proteomics (2013) Nucleic Acids Res, 41, p. e28; Song, J.J., Garlick, J.D., Kingston, R.E., Structural basis of histone H4 recognition by p55 (2008) Genes Dev, 22, pp. 1313-1318; Murzina, N.V., Pei, X.Y., Zhang, W., Sparkes, M., Vicente-Garcia, J., Pratap, J.V., Mclaughlin, S.H., Luisi, B.F., Structural basis for the recognition of histone H4 by the histone-chaperone RbAp46 (2008) Structure, 16, pp. 1077-1085; Migliori, V., Mapelli, M., Guccione, E., On WD40 proteins: propelling our knowledge of transcriptional control? (2012) Epigenetics, 7, pp. 815-822; Zhang, W., Tyl, M., Ward, R., Sobott, F., Maman, J., Murthy, A.S., Watson, A.A., Owen-Hughes, T., Structural plasticity of histones H3-H4 facilitates their allosteric exchange between RbAp48 and ASF1 (2013) Nat Struct Mol Biol, 20, pp. 29-35; Nekrasov, M., Wild, B., Muller, J., Nucleosome binding and histone methyltransferase activity of Drosophila PRC2 (2005) EMBO Rep, 6, pp. 348-353; Nowak, A.J., Alfieri, C., Stirnimann, C.U., Rybin, V., Baudin, F., Ly-Hartig, N., Lindner, D., Muller, C.W., Chromatin-modifying complex component Nurf55/p55 associates with histones H3 and H4 and Polycomb repressive complex 2 subunit Su(z)12 through partially overlapping binding sites (2011) J Biol Chem, 286, pp. 23388-23396; Schmitges, F.W., Prusty, A.B., Faty, M., Stutzer, A., Lingaraju, G.M., Aiwazian, J., Sack, R., Zhou, S., Histone methylation by PRC2 is inhibited by active chromatin marks (2011) Mol Cell, 42, pp. 330-341; Voigt, P., Leroy, G., Drury, W.J., 3rd, Zee, B.M., Son, J., Beck, D.B., Young, N.L., Reinberg, D., Asymmetrically modified nucleosomes (2012) Cell, 151, pp. 181-193; Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., Reinberg, D., Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein (2002) Genes Dev, 16, pp. 2893-2905; He, G.P., Kim, S., Ro, H.S., Cloning and characterization of a novel zinc finger transcriptional repressor. A direct role of the zinc finger motif in repression (1999) J Biol Chem, 274, pp. 14678-14684; Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R.S., Zhang, Y., Role of histone H3 lysine 27 methylation in Polycomb-group silencing (2002) Science, 298, pp. 1039-1043; Son, J., Shen, S.S., Margueron, R., Reinberg, D., Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin (2013) Genes Dev, 27, pp. 2663-2677; Kim, H., Kang, K., Kim, J., AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2 (2009) Nucleic Acids Res, 37, pp. 2940-2950; Kim, H., Kang, K., Ekram, M.B., Roh, T.Y., Kim, J., Aebp2 as an epigenetic regulator for neural crest cells (2011) PLoS One, 6, p. e25174; Takeuchi, T., Yamazaki, Y., Katoh-Fukui, Y., Tsuchiya, R., Kondo, S., Motoyama, J., Higashinakagawa, T., Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation (1995) Genes Dev, 9, pp. 1211-1222; Berge-Lefranc, J.L., Jay, P., Massacrier, A., Cau, P., Mattei, M.G., Bauer, S., Marsollier, C., Fontes, M., Characterization of the human jumonji gene (1996) Hum Mol Genet, 5, pp. 1637-1641; Klose, R.J., Kallin, E.M., Zhang, Y., JmjC-domain-containing proteins and histone demethylation (2006) Nat Rev Genet, 7, pp. 715-727; Shen, X., Kim, W., Fujiwara, Y., Simon, M.D., Liu, Y., Mysliwiec, M.R., Yuan, G.C., Orkin, S.H., Jumonji modulates Polycomb activity and self-renewal versus differentiation of stem cells (2009) Cell, 139, pp. 1303-1314; Li, G., Margueron, R., Ku, M., Chambon, P., Bernstein, B.E., Reinberg, D., Jarid2 and PRC2, partners in regulating gene expression (2010) Genes Dev, 24, pp. 368-380; Takeuchi, T., Watanabe, Y., Takano-Shimizu, T., Kondo, S., Roles of jumonji and jumonji family genes in chromatin regulation and development (2006) Dev Dyn, 235, pp. 2449-2459; Celestino-Soper, P.B., Skinner, C., Schroer, R., Eng, P., Shenai, J., Nowaczyk, M.M., Terespolsky, D., Immken, L., Deletions in chromosome 6p22.3-p24.3, including ATXN1, are associated with developmental delay and autism spectrum disorders (2013) Mol Cytogenet, 5, p. 17; Di Benedetto, D., Di Vita, G., Romano, C., Giudice, M.L., Vitello, G.A., Zingale, M., Grillo, L., Fichera, M., 6p22.3 deletion: report of a patient with autism, severe intellectual disability and electroencephalographic anomalies (2013) Mol Cytogenet, 6, p. 4; Baroy, T., Misceo, D., Stromme, P., Stray-Pedersen, A., Holmgren, A., Rodningen, O.K., Blomhoff, A., Tvedt, B., Haploinsufficiency of two histone modifier genes on 6p22.3, ATXN1 and JARID2, is associated with intellectual disability (2013) Orphanet J Rare Dis, 8, p. 3; Jung, J., Mysliwiec, M.R., Lee, Y., Roles of JUMONJI in mouse embryonic development (2005) Dev Dyn, 232, pp. 21-32; Toyoda, M., Shirato, H., Nakajima, K., Kojima, M., Takahashi, M., Kubota, M., Suzuki-Migishima, R., Takeuchi, T., jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression (2003) Dev Cell, 5, pp. 85-97; Nakajima, K., Inagawa, M., Uchida, C., Okada, K., Tane, S., Kojima, M., Kubota, M., Shirato, H., Coordinated regulation of differentiation and proliferation of embryonic cardiomyocytes by a jumonji (Jarid2)-cyclin D1 pathway (2011) Development, 138, pp. 1771-1782; Takahashi, M., Kojima, M., Nakajima, K., Suzuki-Migishima, R., Takeuchi, T., Functions of a jumonji-cyclin D1 pathway in the coordination of cell cycle exit and migration during neurogenesis in the mouse hindbrain (2007) Dev Biol, 303, pp. 549-560; Pasini, D., Cloos, P.A., Walfridsson, J., Olsson, L., Bukowski, J.P., Johansen, J.V., Bak, M., Helin, K., JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells (2010) Nature, 464, pp. 306-310; Peng, J.C., Valouev, A., Swigut, T., Zhang, J., Zhao, Y., Sidow, A., Wysocka, J., Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells (2009) Cell, 139, pp. 1290-1302; Landeira, D., Sauer, S., Poot, R., Dvorkina, M., Mazzarella, L., Jorgensen, H.F., Pereira, C.F., Spivakov, M., Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators (2010) Nat Cell Biol, 12, pp. 618-624; Landeira, D., Fisher, A.G., Inactive yet indispensable: the tale of Jarid2 (2011) Trends Cell Biol, 21, pp. 74-80; Kaneko, S., Bonasio, R., Saldana-Meyer, R., Yoshida, T., Son, J., Nishino, K., Umezawa, A., Reinberg, D., Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin (2014) Mol Cell, 53, pp. 290-300; Woo, C.J., Kharchenko, P.V., Daheron, L., Park, P.J., Kingston, R.E., Variable requirements for DNA-binding proteins at Polycomb-dependent repressive regions in human HOX clusters (2013) Mol Cell Biol, 33, pp. 3274-3285; Da Rocha, S.T., Boeva, V., Escamilla-Del-Arenal, M., Ancelin, K., Granier, C., Matias, N.R., Sanulli, S., Picard, C., Jarid2 Is Implicated in the Initial Xist-Induced Targeting of PRC2 to the Inactive X Chromosome (2014) Mol Cell, 53, pp. 301-316; Londhe, P., Davie, J.K., Interferon-gamma resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis (2013) Sci Signal, 6, p. ra107; Mejetta, S., Morey, L., Pascual, G., Kuebler, B., Mysliwiec, M.R., Lee, Y., Shiekhattar, R., Benitah, S.A., Jarid2 regulates mouse epidermal stem cell activation and differentiation (2011) EMBO J, 30, pp. 3635-3646; Kalb, R., Latwiel, S., Baymaz, H.I., Jansen, P.W., Muller, C.W., Vermeulen, M., Muller, J., Histone H2A monoubiquitination promotes histone H3 methylation in Polycomb repression (2014) Nat Struct Mol Biol, 21, pp. 569-571; Shirato, H., Ogawa, S., Nakajima, K., Inagawa, M., Kojima, M., Tachibana, M., Shinkai, Y., Takeuchi, T., A jumonji (Jarid2) protein complex represses cyclin D1 expression by methylation of histone H3-K9 (2009) J Biol Chem, 284, pp. 733-739; Mysliwiec, M.R., Carlson, C.D., Tietjen, J., Hung, H., Ansari, A.Z., Lee, Y., Jarid2 (Jumonji, AT rich interactive domain 2) regulates NOTCH1 expression via histone modification in the developing heart (2012) J Biol Chem, 287, pp. 1235-1241; Seok, H.Y., Chen, J., Kataoka, M., Huang, Z.P., Ding, J., Yan, J., Hu, X., Wang, D.Z., Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy (2014) Circ Res, 114, pp. 1585-1595; O'connell, R.M., Rao, D.S., Chaudhuri, A.A., Boldin, M.P., Taganov, K.D., Nicoll, J., Paquette, R.L., Baltimore, D., Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder (2008) J Exp Med, 205, pp. 585-594; Bolisetty, M.T., Dy, G., Tam, W., Beemon, K.L., Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival (2009) J Virol, 83, pp. 12009-12017; Walters, Z.S., Villarejo-Balcells, B., Olmos, D., Buist, T.W., Missiaglia, E., Allen, R., Al-Lazikani, B., Shipley, J., JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells (2014) Oncogene, 33, pp. 1148-1157; Duncan, I.M., Polycomblike: a gene that appears to be required for the normal expression of the bithorax and antennapedia gene complexes of Drosophila melanogaster (1982) Genetics, 102, pp. 49-70; Savla, U., Benes, J., Zhang, J., Jones, R.S., Recruitment of Drosophila Polycomb-group proteins by Polycomblike, a component of a novel protein complex in larvae (2008) Development, 135, pp. 813-817; Nekrasov, M., Klymenko, T., Fraterman, S., Papp, B., Oktaba, K., Kocher, T., Cohen, A., Muller, J., Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genes (2007) EMBO J, 26, pp. 4078-4088; Friberg, A., Oddone, A., Klymenko, T., Muller, J., Sattler, M., Structure of an atypical Tudor domain in the Drosophila Polycomblike protein (2010) Protein Sci, 19, pp. 1906-1916; Wang, S., Robertson, G.P., Zhu, J., A novel human homologue of Drosophila Polycomblike gene is up-regulated in multiple cancers (2004) Gene, 343, pp. 69-78; Boulay, G., Rosnoblet, C., Guerardel, C., Angrand, P.O., Leprince, D., Functional characterization of human Polycomb-like 3 isoforms identifies them as components of distinct EZH2 protein complexes (2011) Biochem J, 434, pp. 333-342; Hunkapiller, J., Shen, Y., Diaz, A., Cagney, G., Mccleary, D., Ramalho-Santos, M., Krogan, N., Reiter, J.F., Polycomb-like 3 promotes Polycomb repressive complex 2 binding to CpG islands and embryonic stem cell self-renewal (2012) PLoS Genet, 8; Ballaré, C., Lange, M., Lapinaite, A., Martin, G.M., Morey, L., Pascual, G., Liefke, R., Gozani, O., Phf19 links methylated Lys36 of histone H3 to regulation of Polycomb activity (2012) Nat Struct Mol Biol, 19, pp. 1257-1265; Brien, G.L., Gambero, G., O'connell, D.J., Jerman, E., Turner, S.A., Egan, C.M., Dunne, E.J., Piao, L., Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation (2012) Nat Struct Mol Biol, 19, pp. 1273-1281; Cai, L., Rothbart, S.B., Lu, R., Xu, B., Chen, W.Y., Tripathy, A., Rockowitz, S., Allis, C.D., An H3K36 methylation-engaging Tudor motif of Polycomb-like proteins mediates PRC2 complex targeting (2013) Mol Cell, 49, pp. 571-582; Qin, S., Guo, Y., Xu, C., Bian, C., Fu, M., Gong, S., Min, J., Tudor domains of the PRC2 components PHF1 and PHF19 selectively bind to histone H3K36me3 (2013) Biochem Biophys Res Commun, 430, pp. 547-553; Ferrari, K.J., Scelfo, A., Jammula, S., Cuomo, A., Barozzi, I., Stutzer, A., Fischle, W., Pasini, D., Polycomb-dependent H3K27me1 and H3K27me2 regulate active transcription and enhancer fidelity (2013) Mol Cell, 53, pp. 49-62; Ghislin, S., Deshayes, F., Middendorp, S., Boggetto, N., Alcaide-Loridan, C., PHF19 and Akt control the switch between proliferative and invasive states in melanoma (2012) Cell Cycle, 11, pp. 1634-1645; Coulson, M., Robert, S., Eyre, H.J., Saint, R., The identification and localization of a human gene with sequence similarity to Polycomblike of Drosophila melanogaster (1998) Genomics, 48, pp. 381-383; O'connell, S., Wang, L., Robert, S., Jones, C.A., Saint, R., Jones, R.S., Polycomblike PHD fingers mediate conserved interaction with enhancer of zeste protein (2001) J Biol Chem, 276, pp. 43065-43073; Cao, R., Wang, H., He, J., Erdjument-Bromage, H., Tempst, P., Zhang, Y., Role of hPHF1 in H3K27 methylation and Hox gene silencing (2008) Mol Cell Biol, 28, pp. 1862-1872; Sarma, K., Margueron, R., Ivanov, A., Pirrotta, V., Reinberg, D., Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo (2008) Mol Cell Biol, 28, pp. 2718-2731; Musselman, C.A., Avvakumov, N., Watanabe, R., Abraham, C.G., Lalonde, M.E., Hong, Z., Allen, C., Nickoloff, J., Molecular basis for H3K36me3 recognition by the Tudor domain of PHF1 (2012) Nat Struct Mol Biol, 19, pp. 1266-1272; Kycia, I., Kudithipudi, S., Tamas, R., Kungulovski, G., Dhayalan, A., Jeltsch, A., The Tudor domain of the PHD finger protein 1 is a dual reader of lysine trimethylation at lysine 36 of histone H3 and lysine 27 of histone variant H3t (2014) J Mol Biol, 426, pp. 1651-1660; Walker, E., Chang, W.Y., Hunkapiller, J., Cagney, G., Garcha, K., Torchia, J., Krogan, N.J., Stanford, W.L., Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation (2010) Cell Stem Cell, 6, pp. 153-166; Hong, Z., Jiang, J., Lan, L., Nakajima, S., Kanno, S., Koseki, H., Yasui, A., A Polycomb group protein, PHF1, is involved in the response to DNA double-strand breaks in human cell (2008) Nucleic Acids Res, 36, pp. 2939-2947; Chou, D.M., Adamson, B., Dephoure, N.E., Tan, X., Nottke, A.C., Hurov, K.E., Gygi, S.P., Elledge, S.J., A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive Polycomb and NuRD complexes to sites of DNA damage (2010) Proc Natl Acad Sci U S A, 107, pp. 18475-18480; Boulay, G., Dubuissez, M., Van Rechem, C., Forget, A., Helin, K., Ayrault, O., Leprince, D., Hypermethylated in cancer 1 (HIC1) recruits Polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human Polycomb-like (hPCL) proteins (2012) J Biol Chem, 287, pp. 10509-10524; Yang, Y., Wang, C., Zhang, P., Gao, K., Wang, D., Yu, H., Zhang, T., Hong, Z., Polycomb group protein PHF1 regulates p53-dependent cell growth arrest and apoptosis (2013) J Biol Chem, 288, pp. 529-539; Micci, F., Gorunova, L., Gatius, S., Matias-Guiu, X., Davidson, B., Heim, S., Panagopoulos, I., MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma (2014) Cancer Lett, 347, pp. 75-78; Micci, F., Panagopoulos, I., Bjerkehagen, B., Heim, S., Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma (2006) Cancer Res, 66, pp. 107-112; Panagopoulos, I., Mertens, F., Griffin, C.A., An endometrial stromal sarcoma cell line with the JAZF1/PHF1 chimera (2008) Cancer Genet Cytogenet, 185, pp. 74-77; D'angelo, E., Ali, R.H., Espinosa, I., Lee, C.H., Huntsman, D.G., Gilks, B., Prat, J., Endometrial stromal sarcomas with sex cord differentiation are associated with PHF1 rearrangement (2013) Am J Surg Pathol, 37, pp. 514-521; Gebre-Medhin, S., Nord, K.H., Moller, E., Mandahl, N., Magnusson, L., Nilsson, J., Jo, V.Y., Larsson, O., Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors (2012) Am J Pathol, 181, pp. 1069-1077; Antonescu, C.R., Sung, Y.S., Chen, C.L., Zhang, L., Chen, H.W., Singer, S., Agaram, N.P., Fletcher, C.D., Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors-molecular characterization shows genetic overlap with endometrial stromal sarcoma (2014) Genes Chromosom Cancer, 53, pp. 183-193; Kitaguchi, T., Nakata, K., Nagai, T., Aruga, J., Mikoshiba, K., Xenopus Polycomblike 2 (XPcl2) controls anterior to posterior patterning of the neural tissue (2001) Dev Genes Evol, 211, pp. 309-314; Wang, S., Yu, X., Zhang, T., Zhang, X., Zhang, Z., Chen, Y., Chick Pcl2 regulates the left-right asymmetry by repressing Shh expression in Hensen's node (2004) Development, 131, pp. 4381-4391; Wang, S., He, F., Xiong, W., Gu, S., Liu, H., Zhang, T., Yu, X., Chen, Y., Polycomblike-2-deficient mice exhibit normal left-right asymmetry (2007) Dev Dyn, 236, pp. 853-861; Casanova, M., Preissner, T., Cerase, A., Poot, R., Yamada, D., Li, X., Appanah, R., Koseki, H., Polycomblike 2 facilitates the recruitment of PRC2 Polycomb group complexes to the inactive X chromosome and to target loci in embryonic stem cells (2011) Development, 138, pp. 1471-1482; Li, X., Isono, K., Yamada, D., Endo, T.A., Endoh, M., Shinga, J., Mizutani-Koseki, Y., Kitamura, H., Mammalian Polycomb-Like Pcl2/Mtf2 Is a Novel Regulatory Component of PRC2 That Can Differentially Modulate Polycomb Activity both at the Hox Gene Cluster and at Cdkn2a Genes (2011) Mol Cell Biol, 34, p. 2773; De Cegli, R., Iacobacci, S., Flore, G., Gambardella, G., Mao, L., Cutillo, L., Lauria, M., Banfi, S., Reverse engineering a mouse embryonic stem cell-specific transcriptional network reveals a new modulator of neuronal differentiation (2013) Nucleic Acids Res, 41, pp. 711-726; Zhang, Z., Jones, A., Sun, C.W., Li, C., Chang, C.W., Joo, H.Y., Dai, Q., Guo, Y., PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming (2011) Stem Cells, 29, pp. 229-240; Bartke, T., Vermeulen, M., Xhemalce, B., Robson, S.C., Mann, M., Kouzarides, T., Nucleosome-interacting proteins regulated by DNA and histone methylation (2010) Cell, 143, pp. 470-484; Alekseyenko, A.A., Gorchakov, A.A., Kharchenko, P.V., Kuroda, M.I., Reciprocal interactions of human C10orf12 and C17orf96 with PRC2 revealed by BioTAP-XL cross-linking and affinity purification (2014) Proc Natl Acad Sci U S A, 111, pp. 2488-2493",Article,Scopus,2-s2.0-84928491983
"Tylkowski M.A., Yang K., Hoyer-Fender S., Stoykova A.","Pax6 controls centriole maturation in cortical progenitors through Odf2",2015,"Cellular and Molecular Life Sciences","72","9",,"1795","1809",,,10.1007/s00018-014-1766-1,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928563274&partnerID=40&md5=7a5dd06dac0845063462f8813d772b05","Research Group of Molecular Developmental Neurobiology, Department Molecular Cell Biology, Max-Planck Institute for Biophysical Chemistry, Am Faßberg 11Göttingen, Germany; Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)Göttingen, Germany; Johann-Friedrich-Blumenbach-Institute of Zoology and Anthropology, Developmental Biology, GZMB, Ernst-Caspari-Haus, Georg-August-Universität Göttingen, Justus-von-Liebig-Weg 11Göttingen, Germany","Tylkowski, M.A., Research Group of Molecular Developmental Neurobiology, Department Molecular Cell Biology, Max-Planck Institute for Biophysical Chemistry, Am Faßberg 11Göttingen, Germany, Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)Göttingen, Germany; Yang, K., Johann-Friedrich-Blumenbach-Institute of Zoology and Anthropology, Developmental Biology, GZMB, Ernst-Caspari-Haus, Georg-August-Universität Göttingen, Justus-von-Liebig-Weg 11Göttingen, Germany; Hoyer-Fender, S., Johann-Friedrich-Blumenbach-Institute of Zoology and Anthropology, Developmental Biology, GZMB, Ernst-Caspari-Haus, Georg-August-Universität Göttingen, Justus-von-Liebig-Weg 11Göttingen, Germany; Stoykova, A., Research Group of Molecular Developmental Neurobiology, Department Molecular Cell Biology, Max-Planck Institute for Biophysical Chemistry, Am Faßberg 11Göttingen, Germany, Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)Göttingen, Germany","Cortical glutamatergic neurons are generated by radial glial cells (RGCs), specified by the expression of transcription factor (TF) Pax6, in the germinative zones of the dorsal telencephalon. Here, we demonstrate that Pax6 regulates the structural assembly of the interphase centrosomes. In the cortex of the Pax6-deficient Small eye (Sey/Sey) mutant, we find a defect of the appendages of the mother centrioles, indicating incomplete centrosome maturation. Consequently, RGCs fail to generate primary cilia, and instead of staying in the germinative zone for renewal, RGCs detach from the ventricular surface thus affecting the interkinetic nuclear migration and they exit prematurely from mitosis. Mechanistically, we show that TF Pax6 directly regulates the activity of the Odf2 gene encoding for the appendage-specific protein Odf2 with a role for the assembly of mother centriole. Our findings demonstrate a molecular mechanism that explains important characteristics of the centrosome disassembly and malfunctioning in developing cortex lacking Pax6. © 2014 Springer Basel.","Centriole structure; Transcriptional control","Caviness, Jr.V.S., Takahashi, T., Proliferative events in the cerebral ventricular zone (1995) Brain Dev, 17 (3), pp. 159-163. , 7573753; Caviness, Jr.V.S., Takahashi, T., Nowakowski, R.S., Numbers, time and neocortical neuronogenesis: A general developmental and evolutionary model (1995) Trends Neurosci, 18 (9), pp. 379-383; Gotz, M., Huttner, W.B., The cell biology of neurogenesis (2005) Nat Rev Mol Cell Biol, 6 (10), pp. 777-788; Kriegstein, A., Noctor, S., Martinez-Cerdeno, V., Patterns of neural stem and progenitor cell division may underlie evolutionary cortical expansion (2006) Nat Rev Neurosci, 7 (11), pp. 883-890; Malatesta, P., Hartfuss, E., Gotz, M., Isolation of radial glial cells by fluorescent-activated cell sorting reveals a neuronal lineage (2000) Development, 127 (24), pp. 5253-5263. , 11076748; Miyata, T., Asymmetric cell division during brain morphogenesis (2007) Prog Mol Subcell Biol, 45, pp. 121-142; Noctor, S.C., Flint, A.C., Weissman, T.A., Dammerman, R.S., Kriegstein, A.R., Neurons derived from radial glial cells establish radial units in neocortex (2001) Nature, 409 (6821), pp. 714-720; Rakic, P., Evolution of the neocortex: A perspective from developmental biology (2009) Nat Rev Neurosci, 10 (10), pp. 724-735; McConnell, S.K., Kaznowski, C.E., Cell cycle dependence of laminar determination in developing neocortex (1991) Science, 254 (5029), pp. 282-285; Angevine, Jr.J.B., Sidman, R.L., Autoradiographic study of cell migration during histogenesis of cerebral cortex in the mouse (1961) Nature, 192, pp. 766-768; Rakic, P., Stensas, L.J., Sayre, E., Sidman, R.L., Computer-aided three-dimensional reconstruction and quantitative analysis of cells from serial electron microscopic montages of foetal monkey brain (1974) Nature, 250 (461), pp. 31-34; Haubensak, W., Attardo, A., Denk, W., Huttner, W.B., Neurons arise in the basal neuroepithelium of the early mammalian telencephalon: A major site of neurogenesis (2004) Proc Natl Acad Sci USA, 101 (9), pp. 3196-3201; Lukaszewicz, A., Savatier, P., Cortay, V., Giroud, P., Huissoud, C., Berland, M., Kennedy, H., Dehay, C., G1 phase regulation, area-specific cell cycle control, and cytoarchitectonics in the primate cortex (2005) Neuron, 47 (3), pp. 353-364; Noctor, S.C., Martinez-Cerdeno, V., Ivic, L., Kriegstein, A.R., Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases (2004) Nat Neurosci, 7 (2), pp. 136-144; Bishop, K.M., Goudreau, G., O'Leary, D.D., Regulation of area identity in the mammalian neocortex by Emx2 and Pax6 (2000) Science, 288 (5464), pp. 344-349; Georgala, P.A., Carr, C.B., Price, D.J., The role of Pax6 in forebrain development (2011) Dev Neurobiol, 71 (8), pp. 690-709; Hevner, R.F., Shi, L., Justice, N., Hsueh, Y., Sheng, M., Smiga, S., Bulfone, A., Rubenstein, J.L., Tbr1 regulates differentiation of the preplate and layer 6 (2001) Neuron, 29 (2), pp. 353-366; Tuoc, T.C., Radyushkin, K., Tonchev, A.B., Pinon, M.C., Ashery-Padan, R., Molnar, Z., Davidoff, M.S., Stoykova, A., Selective cortical layering abnormalities and behavioral deficits in cortex-specific Pax6 knock-out mice (2009) J Neurosci, 29 (26), pp. 8335-8349; Zembrzycki, A., Chou, S.J., Ashery-Padan, R., Stoykova, A., O'Leary, D.D., Sensory cortex limits cortical maps and drives top-down plasticity in thalamocortical circuits (2013) Nat Neurosci, 16 (8), pp. 1060-1067; Hill, R.E., Favor, J., Hogan, B.L., Ton, C.C., Saunders, G.F., Hanson, I.M., Prosser, J., Van Heyningen, V., Mouse small eye results from mutations in a paired-like homeobox-containing gene (1991) Nature, 354 (6354), pp. 522-525; Heins, N., Malatesta, P., Cecconi, F., Nakafuku, M., Tucker, K.L., Hack, M.A., Chapouton, P., Gotz, M., Glial cells generate neurons: The role of the transcription factor Pax6 (2002) Nat Neurosci, 5 (4), pp. 308-315; Caric, D., Gooday, D., Hill, R.E., McConnell, S.K., Price, D.J., Determination of the migratory capacity of embryonic cortical cells lacking the transcription factor Pax-6 (1997) Development, 124 (24), pp. 5087-5096. , 9362466; Georgala, P.A., Manuel, M., Price, D.J., The generation of superficial cortical layers is regulated by levels of the transcription factor Pax6 (2011) Cereb Cortex, 21 (1), pp. 81-94; Quinn, J.C., Molinek, M., Martynoga, B.S., Zaki, P.A., Faedo, A., Bulfone, A., Hevner, R.F., Price, D.J., Pax6 controls cerebral cortical cell number by regulating exit from the cell cycle and specifies cortical cell identity by a cell autonomous mechanism (2007) Dev Biol, 302 (1), pp. 50-65; Sansom, S.N., Livesey, F.J., Gradients in the brain: The control of the development of form and function in the cerebral cortex (2009) Cold Spring Harb Perspect Biol, 1 (2), p. 002519; Schmahl, W., Knoedlseder, M., Favor, J., Davidson, D., Defects of neuronal migration and the pathogenesis of cortical malformations are associated with Small eye (Sey) in the mouse, a point mutation at the Pax-6-locus (1993) Acta Neuropathol, 86 (2), pp. 126-135; Stoykova, A., Fritsch, R., Walther, C., Gruss, P., Forebrain patterning defects in Small eye mutant mice (1996) Development, 122 (11), pp. 3453-3465. , 8951061; Tarabykin, V., Stoykova, A., Usman, N., Gruss, P., Cortical upper layer neurons derive from the subventricular zone as indicated by Svet1 gene expression (2001) Development, 128 (11), pp. 1983-1993. , 11493521; Gotz, M., Stoykova, A., Gruss, P., Pax6 controls radial glia differentiation in the cerebral cortex (1998) Neuron, 21 (5), pp. 1031-1044; Asami, M., Pilz, G.A., Ninkovic, J., Godinho, L., Schroeder, T., Huttner, W.B., Gotz, M., The role of Pax6 in regulating the orientation and mode of cell division of progenitors in the mouse cerebral cortex (2011) Development, 138 (23), pp. 5067-5078; Tamai, H., Shinohara, H., Miyata, T., Saito, K., Nishizawa, Y., Nomura, T., Osumi, N., Pax6 transcription factor is required for the interkinetic nuclear movement of neuroepithelial cells (2007) Genes Cells, 12 (9), pp. 983-996; Tuoc, T.C., Stoykova, A., Er81 is a downstream target of Pax6 in cortical progenitors (2008) BMC Dev Biol, 8, p. 23; Kosodo, Y., Interkinetic nuclear migration: Beyond a hallmark of neurogenesis (2012) Cell Mol Life Sci, 69 (16), pp. 2727-2738; Bornens, M., Centrosome composition and microtubule anchoring mechanisms (2002) Curr Opin Cell Biol, 14 (1), pp. 25-34; Higginbotham, H.R., Gleeson, J.G., The centrosome in neuronal development (2007) Trends Neurosci, 30 (6), pp. 276-283; Tsou, M.F., Stearns, T., Mechanism limiting centrosome duplication to once per cell cycle (2006) Nature, 442 (7105), pp. 947-951; Bouckson-Castaing, V., Moudjou, M., Ferguson, D.J., Mucklow, S., Belkaid, Y., Milon, G., Crocker, P.R., Molecular characterisation of ninein, a new coiled-coil protein of the centrosome (1996) J Cell Sci, 109, pp. 179-190. , 8834802; Lange, B.M., Gull, K., A molecular marker for centriole maturation in the mammalian cell cycle (1995) J Cell Biol, 130 (4), pp. 919-927; Nakagawa, Y., Yamane, Y., Okanoue, T., Tsukita, S., Tsukita, S., Outer dense fiber 2 is a widespread centrosome scaffold component preferentially associated with mother centrioles: Its identification from isolated centrosomes (2001) Mol Biol Cell, 12 (6), pp. 1687-1697; Ou, Y.Y., Mack, G.J., Zhang, M., Rattner, J.B., CEP110 and ninein are located in a specific domain of the centrosome associated with centrosome maturation (2002) J Cell Sci, 115, pp. 1825-1835. , 11956314; Piel, M., Meyer, P., Khodjakov, A., Rieder, C.L., Bornens, M., The respective contributions of the mother and daughter centrioles to centrosome activity and behavior in vertebrate cells (2000) J Cell Biol, 149 (2), pp. 317-330; Wang, X., Tsai, J.W., Imai, J.H., Lian, W.N., Vallee, R.B., Shi, S.H., Asymmetric centrosome inheritance maintains neural progenitors in the neocortex (2009) Nature, 461 (7266), pp. 947-955; Hoyer-Fender, S., Centriole maturation and transformation to basal body (2010) Semin Cell Dev Biol, 21 (2), pp. 142-147; Kobayashi, T., Dynlacht, B.D., Regulating the transition from centriole to basal body (2011) J Cell Biol, 193 (3), pp. 435-444; Willaredt, M.A., Hasenpusch-Theil, K., Gardner, H.A., Kitanovic, I., Hirschfeld-Warneken, V.C., Gojak, C.P., Gorgas, K., Tucker, K.L., A crucial role for primary cilia in cortical morphogenesis (2008) J Neurosci, 28 (48), pp. 12887-12900; Willaredt, M.A., Tasouri, E., Tucker, K.L., Primary cilia and forebrain development (2012) Mech Dev; Ishikawa, H., Kubo, A., Tsukita, S., Odf2-deficient mother centrioles lack distal/subdistal appendages and the ability to generate primary cilia (2005) Nat Cell Biol, 7 (5), pp. 517-524; Tong, C.K., Han, Y.G., Shah, J.K., Obernier, K., Guinto, C.D., Alvarez-Buylla, A., Primary cilia are required in a unique subpopulation of neural progenitors (2014) Proc Natl Acad Sci USA; Imai, J.H., Wang, X., Shi, S.H., Kaede-centrin1 labeling of mother and daughter centrosomes in mammalian neocortical neural progenitors (2010) Curr Protoc Stem Cell Biol, 5, p. 5A; Ashery-Padan, R., Marquardt, T., Zhou, X., Gruss, P., Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye (2000) Genes Dev, 14 (21), pp. 2701-2711. , 317031 1:CAS:528:DC%2BD3cXotFOju70%3D 11069887; Gorski, J.A., Talley, T., Qiu, M., Puelles, L., Rubenstein, J.L., Jones, K.R., Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage (2002) J Neurosci, 22 (15), pp. 6309-6314. , doi: 10.1016/b0-12-227210-2/00147-3; Cai, L., Hayes, N.L., Nowakowski, R.S., Local homogeneity of cell cycle length in developing mouse cortex (1997) J Neurosci, 17 (6), pp. 2079-2087. , 9045735; Walther, C., Gruss, P., Pax-6, a murine paired box gene, is expressed in the developing CNS (1991) Development, 113 (4), pp. 1435-1449. , 1687460; Ibi, M., Zou, P., Inoko, A., Shiromizu, T., Matsuyama, M., Hayashi, Y., Enomoto, M., Inagaki, M., Trichoplein controls microtubule anchoring at the centrosome by binding to Odf2 and ninein (2011) J Cell Sci, 124, pp. 857-864; Pletz, N., Medack, A., Riess, E.M., Yang, K., Kazerouni, Z.B., Huber, D., Hoyer-Fender S (2013) Transcriptional activation of Odf2/Cenexin by cell cycle arrest and the stress activated signaling pathway (JNK pathway) (1833) Biochim Biophys Acta, 6, pp. 1338-1346; Baumer, N., Marquardt, T., Stoykova, A., Spieler, D., Treichel, D., Ashery-Padan, R., Gruss, P., Retinal pigmented epithelium determination requires the redundant activities of Pax2 and Pax6 (2003) Development, 130 (13), pp. 2903-2915; Stoykova, A., Treichel, D., Hallonet, M., Gruss, P., Pax6 modulates the dorsoventral patterning of the mammalian telencephalon (2000) J Neurosci, 20 (21), pp. 8042-8050. , 11050125; Yun, K., Potter, S., Rubenstein, J.L., Gsh2 and Pax6 play complementary roles in dorsoventral patterning of the mammalian telencephalon (2001) Development, 128 (2), pp. 193-205. , 11124115; Toresson, H., Potter, S.S., Campbell, K., Genetic control of dorsal-ventral identity in the telencephalon: Opposing roles for Pax6 and Gsh2 (2000) Development, 127 (20), pp. 4361-4371. , 11003836; Warren, N., Caric, D., Pratt, T., Clausen, J.A., Asavaritikrai, P., Mason, J.O., Hill, R.E., Price, D.J., The transcription factor, Pax6, is required for cell proliferation and differentiation in the developing cerebral cortex (1999) Cereb Cortex, 9 (6), pp. 627-635; Kroll, T.T., O'Leary, D.D., Ventralized dorsal telencephalic progenitors in Pax6 mutant mice generate GABA interneurons of a lateral ganglionic eminence fate (2005) Proc Natl Acad Sci USA, 102 (20), pp. 7374-7379; Estivill-Torrus, G., Pearson, H., Van Heyningen, V., Price, D.J., Rashbass, P., Pax6 is required to regulate the cell cycle and the rate of progression from symmetrical to asymmetrical division in mammalian cortical progenitors (2002) Development, 129 (2), pp. 455-466. , 11807037; Schuurmans, C., Armant, O., Nieto, M., Stenman, J.M., Britz, O., Klenin, N., Brown, C., Guillemot, F., Sequential phases of cortical specification involve Neurogenin-dependent and -independent pathways (2004) EMBO J, 23 (14), pp. 2892-2902; Messier, P.E., Auclair, C., Inhibition of nuclear migration in the absence of microtubules in the chick embryo (1973) J Embryol Exp Morphol, 30 (3), pp. 661-671. , 4772391; Osumi, N., Shinohara, H., Numayama-Tsuruta, K., Maekawa, M., Concise review: Pax6 transcription factor contributes to both embryonic and adult neurogenesis as a multifunctional regulator (2008) Stem Cells, 26 (7), pp. 1663-1672; Azimzadeh, J., Bornens, M., Structure and duplication of the centrosome (2007) J Cell Sci, 120, pp. 2139-2142; Bornens, M., The centrosome in cells and organisms (2012) Science, 335 (6067), pp. 422-426; Meraldi, P., Nigg, E.A., The centrosome cycle (2002) FEBS Lett, 521 (1-3), pp. 9-13; Shinohara, H., Sakayori, N., Takahashi, M., Osumi, N., Ninein is essential for the maintenance of the cortical progenitor character by anchoring the centrosome to microtubules (2013) Biol Open, 2 (7), pp. 739-749; Corbit, K.C., Shyer, A.E., Dowdle, W.E., Gaulden, J., Singla, V., Chen, M.H., Chuang, P.T., Reiter, J.F., Kif3a constrains beta-catenin-dependent Wnt signalling through dual ciliary and non-ciliary mechanisms (2008) Nat Cell Biol, 10 (1), pp. 70-76; Gerdes, J.M., Liu, Y., Zaghloul, N.A., Leitch, C.C., Lawson, S.S., Kato, M., Beachy, P.A., Katsanis, N., Disruption of the basal body compromises proteasomal function and perturbs intracellular Wnt response (2007) Nat Genet, 39 (11), pp. 1350-1360; Muzio, L., Dibenedetto, B., Stoykova, A., Boncinelli, E., Gruss, P., Mallamaci, A., Emx2 and Pax6 control regionalization of the pre-neuronogenic cortical primordium (2002) Cereb Cortex, 12 (2), pp. 129-139; Epstein, J.A., Glaser, T., Cai, J., Jepeal, L., Walton, D.S., Maas, R.L., Two independent and interactive DNA-binding subdomains of the Pax6 paired domain are regulated by alternative splicing (1994) Genes Dev, 8 (17), pp. 2022-2034; Muhlfriedel, S., Kirsch, F., Gruss, P., Chowdhury, K., Stoykova, A., Novel genes differentially expressed in cortical regions during late neurogenesis (2007) Eur J Neurosci, 26 (1), pp. 33-50",Article,Scopus,2-s2.0-84928563274
"Liu W., Zhou H., Liu L., Zhao C., Deng Y., Chen L., Wu L., Mandrycky N., McNabb C.T., Peng Y., Fuchs P.N., Lu J., Sheen V., Qiu M., Mao M., Richard Lu Q.","Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical region",2015,"Neurobiology of Disease","77",,,"106","116",,,10.1016/j.nbd.2015.02.021,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84925016766&partnerID=40&md5=4d54a742a970c61557834cd01d8ec956","Department of Pediatrics, West China Second Hospital, Sichuan UniversityChengdu, China; Department of Pediatrics, Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical CenterCincinnati, OH, United States; Key Lab of Obstetrics and Gyn. and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second Hospital, Sichuan UniversityChengdu, China; Department of Developmental Biology, University of Texas Southwestern Medical CenterTX, United States; Department of Psychology, University of TexasArlington, TX, United States; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical SchoolBoston, MA, United States; Institute of Developmental and Regenerative Biology, Key Laboratory of Organ Development and Regeneration of Zhejiang Province, College of Life Sciences, Hangzhou Normal UniversityHangzhou, China; Department of Anatomical Sciences and Neurobiology, University of LouisvilleLouisville, KY, United States; Key Laboratory of Birth Defects, Children's Hospital of Fudan UniversityShanghai, China","Liu, W., Department of Pediatrics, West China Second Hospital, Sichuan UniversityChengdu, China, Department of Pediatrics, Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical CenterCincinnati, OH, United States, Key Lab of Obstetrics and Gyn. and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second Hospital, Sichuan UniversityChengdu, China; Zhou, H., Department of Pediatrics, West China Second Hospital, Sichuan UniversityChengdu, China; Liu, L., Department of Pediatrics, West China Second Hospital, Sichuan UniversityChengdu, China; Zhao, C., Department of Pediatrics, Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical CenterCincinnati, OH, United States; Deng, Y., Department of Pediatrics, Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical CenterCincinnati, OH, United States; Chen, L., Department of Pediatrics, West China Second Hospital, Sichuan UniversityChengdu, China; Wu, L., Department of Pediatrics, Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical CenterCincinnati, OH, United States; Mandrycky, N., Department of Developmental Biology, University of Texas Southwestern Medical CenterTX, United States; McNabb, C.T., Department of Psychology, University of TexasArlington, TX, United States; Peng, Y., Department of Psychology, University of TexasArlington, TX, United States; Fuchs, P.N., Department of Psychology, University of TexasArlington, TX, United States; Lu, J., Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical SchoolBoston, MA, United States; Sheen, V., Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical SchoolBoston, MA, United States; Qiu, M., Institute of Developmental and Regenerative Biology, Key Laboratory of Organ Development and Regeneration of Zhejiang Province, College of Life Sciences, Hangzhou Normal UniversityHangzhou, China, Department of Anatomical Sciences and Neurobiology, University of LouisvilleLouisville, KY, United States; Mao, M., Department of Pediatrics, West China Second Hospital, Sichuan UniversityChengdu, China, Key Lab of Obstetrics and Gyn. and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second Hospital, Sichuan UniversityChengdu, China; Richard Lu, Q., Department of Pediatrics, Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical CenterCincinnati, OH, United States, Key Lab of Obstetrics and Gyn. and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second Hospital, Sichuan UniversityChengdu, China, Key Laboratory of Birth Defects, Children's Hospital of Fudan UniversityShanghai, China","The basic helix-loop-helix (bHLH) transcription factor Olig2 is crucial for mammalian central nervous system development. Human ortholog OLIG2 is located in the Down syndrome critical region in trisomy 21. To investigate the effect of Olig2 misexpression on brain development, we generated a developmentally regulated Olig2-overexpressing transgenic line with a Cre/loxP system. The transgenic mice with Olig2 misexpression in cortical neural stem/progenitor cells exhibited microcephaly, cortical dyslamination, hippocampus malformation, and profound motor deficits. Ectopic misexpression of Olig2 impaired cortical progenitor proliferation and caused precocious cell cycle exit. Massive neuronal cell death was detected in the developing cortex of Olig2-misexpressing mice. In addition, Olig2 misexpression led to a significant downregulation of neuronal specification factors including Ngn1, Ngn2 and Pax6, and a defect in cortical neurogenesis. Chromatin-immunoprecipitation and sequencing (ChIP-Seq) analysis indicates that Olig2 directly targets the promoter and/or enhancer regions of Nfatc4, Dscr1/Rcan1 and Dyrk1a, the critical neurogenic genes that contribute to Down syndrome phenotypes, and inhibits their expression. Together, our study suggests that Olig2 misexpression in neural stem cells elicits neurogenesis defects and neuronal cell death, which may contribute to developmental disorders including Down syndrome, where OLIG2 is triplicated on chromosomal 21. © 2015 Elsevier Inc.","Cortical development; Cortical progenitor proliferation; Down syndrome; Neural cell death; Neurogenesis; Olig2","Amano, K., Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome (2004) Hum. Mol. Genet., 13, pp. 1333-1340; Antonarakis, S.E., Chromosome 21 and down syndrome: from genomics to pathophysiology (2004) Nat. Rev. Genet., 5, pp. 725-738; Arron, J.R., NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21 (2006) Nature, 441, pp. 595-600; Aylward, E.H., Cerebellar volume in adults with Down syndrome (1997) Arch. Neurol., 54, pp. 209-212; Bambrick, L.L., Krueger, B.K., Neuronal apoptosis in mouse trisomy 16: mediation by caspases (1999) J. Neurochem., 72, pp. 1769-1772; Baxter, L.L., Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse (2000) Hum. Mol. Genet., 9, pp. 195-202; Belichenko, N.P., The ""Down syndrome critical region"" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome (2009) J. Neurosci., 29, pp. 5938-5948; Buffo, A., Expression pattern of the transcription factor Olig2 in response to brain injuries: implications for neuronal repair (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 18183-18188; Busciglio, J., Yankner, B.A., Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro (1995) Nature, 378, pp. 776-779; Cai, J., A crucial role for Olig2 in white matter astrocyte development (2007) Development, 134, pp. 1887-1899; Chakrabarti, L., Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome (2007) J. Neurosci., 27, pp. 11483-11495; Chakrabarti, L., Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome (2010) Nat. Neurosci., 13, pp. 927-934; Clark, S., Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome (2006) Exp. Neurol., 200, pp. 256-261; Contestabile, A., Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice (2007) Hippocampus, 17, pp. 665-678; Copray, S., Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes (2006) Stem Cells, 24, pp. 1001-1010; Dowjat, W.K., Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome (2007) Neurosci. Lett., 413, pp. 77-81; Dubois, N.C., Nestin-Cre transgenic mouse line Nes-Cre1 mediates highly efficient Cre/loxP mediated recombination in the nervous system, kidney, and somite-derived tissues (2006) Genesis, 44, pp. 355-360; Epstein, C.J., Down's syndrome: critical genes in a critical region (2006) Nature, 441, pp. 582-583; Esposito, G., Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury (2008) Hum Mol Genet., 17, pp. 440-457; Farley, F.W., Widespread recombinase expression using FLPeR (flipper) mice (2000) Genesis, 28, pp. 106-110; Fillat, C., Insights from mouse models to understand neurodegeneration in Down syndrome (2010) CNS Neurol. Disord. Drug Targets, 9, pp. 429-438; Fukuda, T., Generation of a mouse with conditionally activated signaling through the BMP receptor, ALK2 (2006) Genesis, 44, pp. 159-167; Gardiner, K., Down syndrome: from understanding the neurobiology to therapy (2010) J. Neurosci., 30, pp. 14943-14945; Golden, J.A., Hyman, B.T., Development of the superior temporal neocortex is anomalous in trisomy 21 (1994) J. Neuropathol. Exp. Neurol., 53, pp. 513-520; Guidi, S., Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome (2008) Brain Pathol., 18, pp. 180-197; Hallam, D.M., Maroun, L.E., Anti-gamma interferon can prevent the premature death of trisomy 16 mouse cortical neurons in culture (1998) Neurosci. Lett., 252, pp. 17-20; Haydar, T.F., Reeves, R.H., Trisomy 21 and early brain development (2012) Trends Neurosci., 35, pp. 81-91; Holtzman, D.M., Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome (1996) Proc. Natl. Acad. Sci. U. S. A., 93, pp. 13333-13338; Jensen, K.F., Altman, J., The contribution of late-generated neurons to the callosal projection in rat: a study with prenatal x-irradiation (1982) J. Comp. Neurol., 209, pp. 113-122; Komitova, M., NG2 cells are not a major source of reactive astrocytes after neocortical stab wound injury (2011) Glia, 59, pp. 800-809; Lu, Q.R., Ectopic expression of Olig1 promotes oligodendrocyte formation and reduces neuronal survival in developing mouse cortex (2001) Nat. Neurosci., 4, pp. 973-974; Lu, Q.R., Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection (2002) Cell, 109, pp. 75-86; Lu, J., OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors (2012) Hum. Mol. Genet., 21, pp. 2330-2340; Maire, C.L., Directing human neural stem/precursor cells into oligodendrocytes by overexpression of Olig2 transcription factor (2009) J. Neurosci. Res., 87, pp. 3438-3446; Mirsky, R., Schwann cell-derived desert hedgehog signals nerve sheath formation (1999) Ann. N. Y. Acad. Sci., 883, pp. 196-202; Miyoshi, G., Physiologically distinct temporal cohorts of cortical interneurons arise from telencephalic Olig2-expressing precursors (2007) J. Neurosci., 27, pp. 7786-7798; Ono, K., Olig2 transcription factor in the developing and injured forebrain; cell lineage and glial development (2009) Mol. Cells, 27, pp. 397-401; Park, J., Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome (2007) Mol. Cell. Neurosci., 36, pp. 270-279; Pinter, J.D., Amygdala and hippocampal volumes in children with Down syndrome: a high-resolution MRI study (2001) Neurology, 56, pp. 972-974; Reeves, R.H., Garner, C.C., A year of unprecedented progress in Down syndrome basic research (2007) Ment. Retard. Dev. Disabil. Res. Rev., 13, pp. 215-220; Reeves, R.H., A mouse model for Down syndrome exhibits learning and behaviour deficits (1995) Nat. Genet., 11, pp. 177-184; Roper, R.J., Reeves, R.H., Understanding the basis for Down syndrome phenotypes (2006) PLoS Genet., 2, p. e50; Ross, S.E., Basic helix-loop-helix factors in cortical development (2003) Neuron, 39, pp. 13-25; Scholzen, T., Gerdes, J., The Ki-67 protein: from the known and the unknown (2000) J. Cell. Physiol., 182, pp. 311-322; Shiotsuki, H., A Rotarod test for evaluation of motor skill learning (2010) J. Neurosci. Methods, 189, pp. 180-185; Stabel-Burow, J., Glutathione levels and nerve cell loss in hippocampal cultures from trisomy 16 mouse-a model of Down syndrome (1997) Brain Res., 765, pp. 313-318; Sun, T., Cross-repressive interaction of the Olig2 and Nkx2.2 transcription factors in developing neural tube associated with formation of a specific physical complex (2003) J. Neurosci., 23, pp. 9547-9556; Sylvester, P.E., The hippocampus in Down's syndrome (1983) J. Ment. Defic. Res., 27, pp. 227-236; Takebayashi, H., The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages (2002) Curr. Biol., 12, pp. 1157-1163; Wolvetang, E.J., ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway (2003) Hum. Mol. Genet., 12, pp. 247-255; Yao, R., Olig2 overexpression accelerates the differentiation of mouse embryonic stem cells into oligodendrocyte progenitor cells in vitro (2014) Dev. Growth Differ., 56, pp. 511-517; Yu, Y., Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation (2013) Cell, 152, pp. 248-261; Yue, T., A critical role for dorsal progenitors in cortical myelination (2006) J. Neurosci., 26, pp. 1275-1280; Xin, M., Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice (2005) J Neurosci., 25, pp. 1354-1365; Zhou, Q., Anderson, D.J., The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification (2002) Cell, 109, pp. 61-73",Article,Scopus,2-s2.0-84925016766
"Gaboriaud-Kolar N., Vougogiannopoulou K., Skaltsounis A.-L.","Indirubin derivatives: A patent review (2010-present)",2015,"Expert Opinion on Therapeutic Patents","25","5",,"583","593",,,10.1517/13543776.2015.1019865,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84928330767&partnerID=40&md5=24e6efbb7d8a5082c9556633d9729778","University of Athens, Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, Panepistimiopolis ZografouAthens, Greece","Gaboriaud-Kolar, N., University of Athens, Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, Panepistimiopolis ZografouAthens, Greece; Vougogiannopoulou, K., University of Athens, Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, Panepistimiopolis ZografouAthens, Greece; Skaltsounis, A.-L., University of Athens, Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, Panepistimiopolis ZografouAthens, Greece","Introduction: Indirubins are bisindole alkaloids naturally occurring in indigo-bearing plants or in mollusks from the Muricidae family. They belong to the rather small family of indigoids, which has nevertheless found an extreme importance in the fields of dyes and medicinal chemistry. Indirubin has been found to be the active ingredient of a traditional Chinese Medicine used to treat the symptoms of leukemia. Further biological explorations revealed the ability of indirubin to bind cyclin-dependent kinases and 6-bromoindirubin, extracted from mollusks, to bind glycogen synthase kinase-3. The high affinity displayed by the two natural products has opened a vast field of research and triggered the development of hundred of derivatives with biological activities.Areas covered: The traditional use of indirubin for the treatment of leukemia has prompted different research groups to study the cytotoxic effect of indirubin derivatives on both solid tumors and leukemia. Moreover, the affinity of indirubins for kinases also allowed the exploration of their activity towards stem cells.Expert opinion: The derivatives presented are in accordance with first discoveries and establish the close relation between activity and kinase inhibition. New derivatives have been patented and new interferences in signaling pathways are described. However, few in vivo studies have been performed and more efficient solutions are needed to unravel the major issue of solubility. © 2015 Informa UK, Ltd.","Cancer; Derivatives; Indirubin; Kinases; Leukemia; Patents; Stem cells","Clark, R.J.H., Cooksey, C.J., Daniels, M.A.M., Indigo, woad, and tyrian purple: Important vat dyes from antiquity to the present (1993) Endeavour, 17, pp. 191-199; Epstein, E., Nabors, M.W., Stowe, B.B., Origin of indigo of woad (1967) Nature, 216, pp. 547-549; Wu, E., Komolpis, K., Wang, H., Chemical extraction of indigo from indigofera tinctoria while attaining biological integrity (1999) Biotechnol Tech, 13, pp. 567-569; McGovern, P.E., Michel, R.H., Royal purple dye: The chemical reconstruction of the ancient mediterranean industry (1990) Acc Chem Res, 23, pp. 152-158; Koren, Z.C., Archaeo-chemical analysis of royal purple on a darius i stone jar (2008) Microchim Acta, 162, pp. 381-392; Oberthür, C., Schneider, B., Graf, H., The elusive indigo precursors in woad (isatis tinctoria l.)-identification of the major indigo precursor, isatan a, and a structure revision of isatan b (2004) Chem Biodiv, 1, pp. 174-182; Gilbert, K.G., Hill, D.J., Crespo, C., Qualitative analysis of indigo precursors from woad by hplc and hplc-ms (2000) Phytochem Anal, 11, pp. 18-20; Maier, W., Schumann, B., Gröger, D., Biosynthesis of indoxyl derivatives in isatis tinctoria and polygonum tinctorium (1990) Phytochem, 29, pp. 817-819; Oberthür, C., Graf, H., Hamburger, M., The content of indigo precursors in isatis tinctoria leaves ' a comparative study of selected accessions and post-harvest treatments (2004) Phytochem, 65, pp. 3261-3268; Cooksey, C.J., Tyrian purple 6,6'-dibromoindigo and related compounds (2001) Molecules, 6, pp. 736-769; Lopez Chavez, F.J., Chavez, P.R., Oyama, K., Brominated precursors of tyrian purple (c.i. Natural violet 1) from plicopurpura pansa plicopurpura columellaris and plicopurpura patula (2009) Dyes Pigments, 83, pp. 7-13; Westley, C., Benkendorff, K., Sex-specific tyrian purple genesis: Precursor and pigment distribution in the reproductive system of the marine mollusc dicathais orbita (2008) J Chem Ecol, 34, pp. 44-56; Baker, J.T., Duke, C.C., Isolation from marine mollusks hypobranchial glands of 6-bromo-2,2-bis(methylthio)indolin-3-one and 6-bromo-2-(methylthio) indoleninone as alternative precursors to tyrian purple (1973) Tetrahedron Lett, 27, pp. 2481-2482; Fouquet, H., Bielig, H.-J., Biological precursors and genesis of tyrian purple (1971) Angew Chem Int Ed, 10, pp. 816-817; Guengerich, F.P., Sorrells, J.L., Schmitt, S., Generation of new protein kinase inhibitors utilizing cytochrome p450 mutant enzymes for indigoid synthesis (2004) J Med Chem, 47, pp. 3236-3241; Hoessel, R., Leclerc, S., Endicott, J.A., Indirubin, the active constituent of a chinese antileukaemia medicine, inhibits cyclin-dependent kinases (1999) Nat Cell Biol, 1, pp. 60-67; Meijer, L., Skaltsounis, A.-L., Magiatis, P., Gsk-3 selective inhibitors derived from tyrian purple indirubins (2003) Chem Biol, 10, pp. 1255-1266; Jautelat, R., Brumby, T., Schäfer, M., From the insoluble dye indirubin towards highly active, soluble cdk2-inhibitors (2005) ChemBioChem, 6, pp. 531-540; Beauchard, A., Ferandin, Y., Frere, S., Synthesis of novel 5-substituted indirubins as protein kinases inhibitors (2006) Bioorg Med Chem, 14, pp. 6434-6443; Polychronopoulos, P., Magiatis, P., Skaltsounis, A.-L., Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases (2004) J Med Chem, 47, pp. 935-946; Myrianthopoulos, V., Kritsanida, M., Gaboriaud-Kolar, N., Novel inverse binding mode of indirubin derivatives yields improved selectivity for dyrk kinases (2013) ACS Med Chem Lett, 4, pp. 22-26; Choi, S.J., Moon, M.J., Lee, S.D., Indirubin derivatives as potent flt3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells (2010) Bioorg Med Chem Lett, 20, pp. 2033-2037; Myrianthopoulos, V., Magiatis, P., Ferandin, Y., An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases b and c by a series of 7-substituted indirubins (2007) J Med Chem, 50, pp. 4027-4037; Nam, S., Wen, W., Schroeder, A., Dual inhibition of janus and src family kinases by novel indirubin derivative blocks constitutively-Activated stat3 signaling associated with apoptosis of human pancreatic cancer cells (2013) Mol Oncol, 7, pp. 369-378; Cheng, X., Merz, K.-H., Vatter, S., 7,7-Diazaindirubin-A small molecule inhibitor of casein kinase 2 in vitro and in cells (2014) Bioorg Med Chem, 22, pp. 247-255; Ribas, J., Bettayeb, K., Ferandin, Y., 7-Bromoindirubin-3'-oxime induces caspase-independent cell death (2006) Oncogene, 25, pp. 6304-6318; Knockaert, M., Blondel, M., Bach, S., Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins (2004) Oncogene, 23, pp. 4400-4412; Xingi, E., Smirlis, D., Myrianthopoulos, V., 6-Br-5-Methylindirubin-3'-Oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: Exploitation of gsk-3 for treating leishmaniasis (2009) Int J Parasit, 39, pp. 1289-1303; Efstathiou, A., Gaboriaud-Kolar, N., Smirlis, D., An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial glycogen synthase kinase-3 over leishmanial cdc2-related protein kinase 3 (2014) Parasit Vectors, 7, p. 234; Krivogorsky, B., Grundt, P., Yolken, R., Inhibition of toxoplasma gondii by indirubin and tryptanthrin analogs (2008) Antimicrob Agents Chemother, 52, pp. 4466-4469; Jacquemin, D., Preat, J., Wathelet, V., Substitution and chemical environment effects on the absorption spectrum of indigo (2006) J Chem Phys, 124, pp. 074104-074112; Karapanagiotis, I., De Villemereuil, V., Magiatis, P., Identification of the coloring constituents of four natural indigoid dyes (2006) J Liq Chrom Rel Technol, 29, pp. 1491-1502; Method for preparing indirubin (2010) CN101648901, , Anhui Shenjian Bio Engineering; Method for countercurrent ultrasonic extraction of active ingredients from traditional chinese medicine radix isatidis and folium isatidis (2013) CN102973729, , Zhengzhou Ruilong Pharmaceutical Co. Ltd; Chen, H.J., Tsao, H.H., Lo, J.G., Supercritical fluid extraction coupled with solvent-less spray collection mode for rapid separation of indirubin and tryptanthrin from folium isatidis (2011) Sep Sci Technol, 46, pp. 972-977; Method for effectively extracting indirubin from chinese herbal medicine radix isatidis (2010) CN101638375, , Anhui Shenjian Bio Engineering; Baeyer, A., Ueber die verbindungen der indigogruppe (1883) Ber Dtsch Chem Ges, 16, pp. 2188-2204; Russell, G.A., Kaupp, G., Reactions of resonance stabilized carbanions. Xxxi. Oxidation of carbanions. 4. Oxidation of indoxyl to indigo in basic solution (1969) J Am Chem Soc, 91, pp. 3851-3859; Vougogiannopoulou, K., Skaltsounis, A.L., From tyrian purple to kinase modulators: Naturally halogenated indirubins and synthetic analogues (2012) Planta Med, 78, pp. 1515-1528; Gaboriaud-Kolar, N., Nam, S., Skaltsounis, A.L., A colorful history: The evolution of indigoids (2014) Prog Chem Org Nat Prod, 99, pp. 69-145; Indirubin derivatives and uses thereof in treating chronic myelogenous leukemia (2013) US0210834A1, , City of Hope; 7-substituted indirubin-3'oximes and their applications (2010) US331327(A1), , CNRS; 6-substituted indirubins and their biological applications (2011) US0136808A1, , CNRS. 3; Jove, R., Nam, S., Horne, D., 5-bromo-indirubins (2014) WO2014153023A1; Use of indirubin derivatives for producing pluripotent stem cells (2012) EP2518139A1, , Universitätsklinikum Jena; Kritsanida, M., Magiatis, P., Skaltsounis, A.-L., Synthesis and antiproliferative activity of 7-Azaindirubin-3'-oxime, a 7-Aza isostere of the natural indirubin pharmacophore (2009) J Nat Prod, 72, pp. 2199-2202; 1'-thio-Aza indirubin compound, application and preparation method thereof (2012) CN101747339, , Shanghai Jiao Tong University; Preparation method and use of 1'-oxo-indirubin (2013) CN103333161 A, , China Pharmaceutical University; Cytochrome p450 monooxygenases and their use for oxidizing organic compounds (2011) US7960155, , BASF AG; Biological methods for producing high concentrated indirubin by the recombinant e. Coli cells harboring a monooxygenase (2010) KR0089212, , Industry-Academic Cooperation Foundation, Chosun University; Han, G.H., Gim, G.H., Kim, W., Enhanced indirubin production in recombinant escherichia coli harboring a flavin-containing monooxygenase gene by cysteine supplementation (2013) J Biotechnol, 164, pp. 179-187; Lee, J., Kim, H., Lolita, A.S.P., Jeong, Y., Recombinant microorganism containing cornebacterium induced indole oxygenase gene and method for preparing indirubin using same WO060489, 2012. , Kyunsung University Industry Cooperation Foundation; Mining and improvement of isatin-generating enzyme, and their combined use with b-glucosidase for the production of natural indirubin (2011) KR0037687, , Industry foundation of Chonnam National University; The production method of natural indirubin from indican using wild type e. Coli cells (2011) KR101021789, , Industry foundation of Chonnam National University; Method for preparing indirubin with indigoplant as raw materials (2013) CN103468759, , Chongqing Academy of Chinese Medicine; Baptist University of Hong Kong; Institute of Medicina Plant Development, Chinese Academy of Medical Sciences; Shanghai University of Traditional Chinese Medicine; Method for preparing indirubin with fresh folium isatidis as raw material (2014) CN103509835, , Chongqing Academy of Chinese Medicine; Baptist University of Hong Kong; Institute of Medicina Plant Development, Chinese Academy of Medical Sciences; Shanghai University of Traditional Chinese Medicine; Indirubin-3'-oxime derivatives as potent cyclin dependent kinase inhibitors (2012) US0295948 A1, , Anygen Co Ltd; Deininger, M.W.N., Goldman, J.M., Melo, J.V., The molecular biology of chronic myeloid leukemia (2000) Blood, 96, pp. 3343-3356; Yuan, H., Wang, Z., Gao, C., Bcr-Abl gene expression is required for its mutations in a novel kcl-22 cell culture model for acquired resistance of chronic myelogenous leukemia (2010) J Biol Chem, 285, pp. 5085-5096; Li, S., Src kinase signaling in leukaemia (2007) Int J Biochem Cell Biol, 39, pp. 1483-1488; Yang, J., Ikezoe, T., Nishioka, C., Bcr-Abl activates aurka and aurkb in chronic myeloid leukemia cells via akt signaling (2014) Int J Cancer, 134 (5), pp. 1183-1194; Samanta, A.K., Lin, H., Sun, T., Janus kinase 2: A critical target in chronic myelogenous leukemia (2006) Cancer Res, 66, pp. 6468-6472; Indirubin derivatives, and uses thereof (2014) US0275168A1, , City of Hope; Levitzki, A., Klein, S., Signal transduction therapy of cancer (2010) Mol Aspects Med, 31, pp. 287-329; Indirubin derivative having highly selective cytotoxicity for malignant tumors (2014) US0200253A1, , Nihon University; Braig, S., Kressirer, C.A., Liebl, J., Indirubin derivative 6bio suppresses metastasis (2013) Cancer Res, 73, pp. 6004-6012; Braig, S., Bischoff, F., Abhari, B.A., The pleiotropic profile of the indirubin derivative 6bio overcomes trail resistance in cancer (2014) Biochem Pharm, 91, pp. 157-167; Liu, L., Nam, S., Tian, Y., 6-Bromoindirubin-3'-Oxime Inhibits JAK/STAT3 Signaling and induces apoptosis of human melanoma cells (2011) Cancer Res, 71, pp. 3972-3979; Choi, S.-J., Lee, J.-E., Jeong, S.-Y., 5,5'-Substituted Indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity (2010) J Med Chem, 53, pp. 3696-3706; Ross, S.A., Gulve, E.A., Wang, M., Chemistry and biochemistry of type 2 diabetes (2004) Chem Rev, 104, pp. 1255-1282; Freyberg, Z., Ferrando, S.J., Javitch, J.A., Roles of the akt/gsk-3 and wnt signaling pathways in schizophrenia and antipsychotic drug action (2010) Am J Psychiatry, 167, pp. 388-396; Takenaka, K., Kise, Y., Miki, H., Gsk-3beta positively regulates hedgehog signaling through sufu in mammalian cells (2007) Biochem Biophys Res Commun, 353, pp. 501-508; Manoukian, A.S., Woodgett, J.R., Role of glycogen synthase kinase-3 in cancer: Regulation by wnts and other signaling pathways (2002) Adv Cancer Res, 84, pp. 203-229; Ougolkov, A., Fernandez-Zapico, M., Bilim, V., Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: Association with kinase activity and tumor dedifferentiation (2006) Clin Cancer Res, 12, pp. 5074-5081; Garcea, G., Manson, M., Neal, C., Glycogen synthase kinase-3 beta a new target in pancreatic cancer (2007) Curr Cancer Drug Targets, 7, pp. 209-215; Irby, R.B., Yeatman, T.J., Role of src expression and activation in human cancer (2000) Oncogene, 19, pp. 5636-5642; Giamas, G., Man, Y.L., Hirner, H., Kinases as targets in the treatment of solid tumors (2010) Cell Signal, 22, pp. 984-1002; Übel, C., Mousset, S., Trufa, D., Establishing the role of tyrosine kinase 2 in cancer (2013) OncoImmunology, 2, p. e22840; Nam, S., Buettner, R., Turkson, J., Indirubin derivatives inhibit stat3 signaling and induce apoptosis in human cancer cells (2005) PNAS, 102, pp. 5998-6003; Liu, L., Gaboriaud, N., Vougogianopoulou, K., Mls-2384, a new 6-bromoindirubin derivative with dual jak/src kinase inhibitory activity, suppresses growth of diverse cancer cells (2014) Canc Biol Ther, 15, pp. 0-1; Liu, L., Kritsanida, M., Magiatis, P., A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of stat3 and akt signaling (2012) Canc Biol Ther, 13, pp. 1255-1261; Toledo, E.M., Colombres, M., Inestrosa, N.C., Wnt signaling in neuroprotection and stem cell differentiation (2008) Prog Neurobiol, 86, pp. 281-296; Coni, S., Infante, P., Gulino, A., Control of stem cells and cancer stem cells by hedgehog signaling: Pharmacologic clues from pathway dissection (2013) Biochem Pharm, 85, pp. 623-628; Rayasam, G.V., Tulasi, V.K., Sodhi, R., Glycogen synthase kinase-3: More than a namesake (2009) British J Pharm, 156, pp. 885-898; Sato, N., Meijer, L., Skaltsounis, L., Maintenance of pluripotency in human and mouse embryonic stem cells through activation of wnt signaling by a pharmacological gsk-3-specific inhibitor (2004) Nat Med, 10, pp. 55-63; Sato, H., Amagai, K., Shimizukawa, R., Stable generation of serum-And feeder-free embryonic stem cell-derived mice with full germline-competency by using a gsk-3 specific inhibitor (2009) Genesis, 47, pp. 414-422; Methods and pharmaceutical compositions for inhibiting influenza viruses replication (2014) WO2012136851A1, , INSERM; Vougogiannopoulou, K., Ferandin, Y., Bettayeb, K., Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase-3 alter circadian period (2008) J Med Chem, 51, pp. 6421-6431; Lai, X.-M., Indirubin particle and manufacturing method thereof (2014) TW201402113; Supersaturated selfmicroemulsion as well as preparation method and application thereof (2012) CN102228433, , Shanghai University of Traditional Chinese Medicine; Heshmati, N., Cheng, X., Eisenbrand, G., Enhancement of oral bioavailability of e804 by self-nanoemulsifying drug delivery system (snedds) in rats (2013) J Pharm Sci, 102, pp. 3792-3799; Nanoparticles of indirubin derivatives thereof and methods of making and using same (2013) WO192493, , Phosphorex Inc; Ji, X.J., Zhang, F.R., Lei, J.L., Studies on the antineoplastic action and toxicity of synthetic indirubin (1981) Pharmaceutica Sinica Acta, 16, pp. 146-148; University, H., Preparation method of indirubin derivative and product and application thereof (2014) CN103627748(A)",Review,Scopus,2-s2.0-84928330767
